Citrus Sinensis ID: 001143
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1141 | 2.2.26 [Sep-21-2011] | |||||||
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.196 | 0.237 | 0.277 | 3e-19 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.187 | 0.160 | 0.299 | 1e-17 | |
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.216 | 0.406 | 0.314 | 1e-17 | |
| P38692 | 1080 | Serine/threonine-protein | yes | no | 0.179 | 0.189 | 0.307 | 1e-17 | |
| Q54XJ4 | 1495 | Probable serine/threonine | no | no | 0.141 | 0.107 | 0.330 | 2e-17 | |
| Q9NQU5 | 681 | Serine/threonine-protein | yes | no | 0.179 | 0.301 | 0.269 | 2e-17 | |
| Q5R8Z4 | 681 | Serine/threonine-protein | yes | no | 0.179 | 0.301 | 0.269 | 2e-17 | |
| Q55EC7 | 960 | RasGEF domain-containing | no | no | 0.175 | 0.208 | 0.336 | 2e-17 | |
| Q8BTW9 | 593 | Serine/threonine-protein | yes | no | 0.150 | 0.290 | 0.305 | 3e-17 | |
| Q3ULB5 | 682 | Serine/threonine-protein | no | no | 0.152 | 0.255 | 0.293 | 3e-17 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 98.2 bits (243), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 68/292 (23%)
Query: 836 VRTLKVCGSSAD-EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ L++ ++D +++N S E+ ++ +LRH IV G + +L
Sbjct: 198 VKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL---------- 247
Query: 895 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
++F+EY+ GGS+ + + K E + V + + L LH+ I+HRDI
Sbjct: 248 ----SVFLEYIPGGSISSLLGKFGAFSENVIKV-----YTKQILQGLSFLHANSIIHRDI 298
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV-GTPRWMA 1013
K NILID K +VKL DF C + GI + + GTP WMA
Sbjct: 299 KGANILIDT-------KGIVKLSDFG-----------CSKSFSGIVSQFKSMQGTPYWMA 340
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
PEV+ K +G DIWS GC+++E+ T Q P+ ++EL
Sbjct: 341 PEVI----KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITEL------------------ 378
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ + +A S S P + + +F D C + +P ERP A L
Sbjct: 379 ----AAVMYHIASSNSIPNIP-SHMSQEAF--DFLNLCFKRDPKERPDANQL 423
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 121/264 (45%), Gaps = 50/264 (18%)
Query: 813 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 872
E GK S + + + D A K + + I+ F+ EV +LG+L+H +V
Sbjct: 1078 EIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFK----AEVELLGSLQHPNLV 1133
Query: 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL--- 929
YG+ + NP I ME++ G++ I S+ E+ S+KL
Sbjct: 1134 TCYGYSL----------NP------MCIVMEFLPSGNLFELIH--SKPSEQQQSIKLDST 1175
Query: 930 -ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 988
L IA D+A + LH+++I+HRD+KS N+L+D +K+ D A SF
Sbjct: 1176 LILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFN-------IKIADLGIARE-TSF 1227
Query: 989 LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048
T +GT W APE+LR H+ Y + D++SY +L ELLT + P
Sbjct: 1228 TQTMT-----------TIGTVAWTAPEILR--HES--YNQKADVYSYAIVLYELLTGEEP 1272
Query: 1049 YMGLSELEIHDLI-QMGKRPRLTD 1071
Y G+ + L+ G RP L D
Sbjct: 1273 YQGIPPMNAGILVASKGLRPELPD 1296
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 101/321 (31%), Positives = 139/321 (43%), Gaps = 74/321 (23%)
Query: 815 GKSVSSSLFRCKFGSADA-AAKVRTLKVCGSSADE-IRNFEYSCLGEVRMLGALRHSCIV 872
G+ S++ G D A K +L GS A E I+ E GE+++L L+H IV
Sbjct: 340 GRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLE----GEIKLLSQLQHQNIV 395
Query: 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 932
G + DG+ + IF+E V GS + KL + + SV ++L+
Sbjct: 396 RYRGT--------AKDGSNLY------IFLELVTQGS----LLKLYQRYQLRDSV-VSLY 436
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
Q + L LH K +HRDIK NIL+D A+G VKL DF A + F
Sbjct: 437 TRQ-ILDGLKYLHDKGFIHRDIKCANILVD-----ANG--AVKLADFGLA-KVSKFNDIK 487
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1052
C GTP WMAPEV+ + YG DIWS GC +LE+ T Q+PY L
Sbjct: 488 S-----------CKGTPFWMAPEVINRKDS-DGYGSPADIWSLGCTVLEMCTGQIPYSDL 535
Query: 1053 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112
++ I G P + D L L+ F++ +C
Sbjct: 536 EPVQALFRIGRGTLPEVPDTL-----------------------SLDARLFIL----KCL 568
Query: 1113 EENPTERPTAGDLYEM-FVAR 1132
+ NP ERPTA +L FV R
Sbjct: 569 KVNPEERPTAAELLNHPFVRR 589
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P38692|KIC1_YEAST Serine/threonine-protein kinase KIC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=KIC1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 83/270 (30%), Positives = 120/270 (44%), Gaps = 65/270 (24%)
Query: 820 SSLF-------RCKFGSADAAAKVRTLKVCG-------SSADEIRNFEYSCLGEVRMLGA 865
SSLF R KFG V+T +V S +DE+ + + E++ L +
Sbjct: 20 SSLFKRTEVIGRGKFGVVYKGYNVKTGRVYAIKVLNLDSDSDEVEDVQR----EIQFLAS 75
Query: 866 LRH-SCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 922
L+ S I YG K +S W I ME+ GGS+++ + + + E
Sbjct: 76 LKQISNITRYYGSYLKDTSLW----------------IIMEHCAGGSLRSLL-RPGKIDE 118
Query: 923 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 982
K++ V I +++ AL +H +++HRDIK+ N+LI E VKLCDF A
Sbjct: 119 KYIGV-----IMRELLVALKCIHKDNVIHRDIKAANVLITNEGN-------VKLCDFGVA 166
Query: 983 VPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041
+ ++ L +A GTP WMAPEV+ Y +VDIWS G E
Sbjct: 167 AQVNQTSLRRQTMA-----------GTPYWMAPEVIMEGV---YYDTKVDIWSLGITTYE 212
Query: 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1071
+ T PY + L LI K PRL D
Sbjct: 213 IATGNPPYCDVEALRAMQLIIKSKPPRLED 242
|
Protein kinase involved in morphogenesis and cell integrity. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 42/203 (20%)
Query: 853 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
+ S + E+ +L L H IV Y H +PS+ S I ME+++ GS++
Sbjct: 66 QISLMAEINLLKVLSHHNIVRYYEH------IPSSS--------HSYIVMEFIENGSLEK 111
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
I++ E V+V +IAQ V L LH + ++HRDIK+ N+LI DG
Sbjct: 112 IIKRHGLLPESLVTV----YIAQ-VLNGLEYLHRQGVIHRDIKAANLLIS-----TDGS- 160
Query: 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV-- 1030
+KL DF A + D GTP WMAPEV++ + G+
Sbjct: 161 -IKLADFGVATKVSDL--------SSDNPDDTFAGTPYWMAPEVIQ------MQGISTAC 205
Query: 1031 DIWSYGCLLLELLTLQVPYMGLS 1053
D+WS GC ++ELLT PY GL+
Sbjct: 206 DVWSLGCTIIELLTGTPPYFGLA 228
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NQU5|PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 1097 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8Z4|PAK6_PONAB Serine/threonine-protein kinase PAK 6 OS=Pongo abelii GN=PAK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 1097 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 84/250 (33%), Positives = 117/250 (46%), Gaps = 50/250 (20%)
Query: 805 FPSLSSCDEAGKSVSSSLFR-CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML 863
F SL ++ GK S+FR C G A K+ AD+ +Y EV ML
Sbjct: 18 FESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIE-------KADDPEYLKY-IDREVSML 69
Query: 864 GALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-E 922
+LRH IV G + S L I E+V GG V+ ++K G +
Sbjct: 70 QSLRHPFIVNFSGICVHSSGL--------------YIVTEFVSGGDVRQLLKKTPPIGWD 115
Query: 923 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 982
K VS IA D+A A+V LH+K I+HRD+KS+NIL+D ++ ++LCDF A
Sbjct: 116 KRVS------IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQR-------IRLCDFGFA 162
Query: 983 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042
R T H + GT W+APE+L M Y D++SYG +L EL
Sbjct: 163 ---RMSEQTKKSRHMTM------CGTEGWVAPEILLGMS----YDTSCDVFSYGVVLAEL 209
Query: 1043 LTLQVPYMGL 1052
+T + P + L
Sbjct: 210 ITGRKPGVDL 219
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus GN=Pak4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV ++ RH +VEMY + L + ME+++GG++ + +
Sbjct: 368 EVVIMRDYRHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 413
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 414 MNEEQIAAVCLA------VLQALAVLHAQGVIHRDIKSDSILLT-----HDGR--VKLSD 460
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 461 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGVM 506
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1071
++E++ + PY L+ +I+ PRL +
Sbjct: 507 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN 539
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3ULB5|PAK6_MOUSE Serine/threonine-protein kinase PAK 6 OS=Mus musculus GN=Pak6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 91.7 bits (226), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 41/215 (19%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EV ++ +H +VEMY + + L + ME+++GG++ + I +
Sbjct: 451 FNEVVIMRDYQHLNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIISQ 496
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 497 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 543
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 544 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 589
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1071
+++E++ + PY S ++ ++ P+L +
Sbjct: 590 IMVIEMVDGEPPYFSDSPVQAMKRLRDSAPPKLKN 624
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1141 | ||||||
| 225432806 | 1117 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.996 | 0.683 | 0.0 | |
| 255552033 | 1152 | ATP binding protein, putative [Ricinus c | 0.945 | 0.936 | 0.667 | 0.0 | |
| 449433293 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.973 | 0.982 | 0.601 | 0.0 | |
| 224099855 | 1214 | predicted protein [Populus trichocarpa] | 0.900 | 0.846 | 0.655 | 0.0 | |
| 356534187 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.964 | 0.992 | 0.610 | 0.0 | |
| 15219675 | 1112 | leucine-rich repeat protein kinase-like | 0.937 | 0.962 | 0.575 | 0.0 | |
| 297843232 | 1115 | leucine-rich repeat family protein [Arab | 0.945 | 0.967 | 0.566 | 0.0 | |
| 356574435 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.872 | 0.975 | 0.613 | 0.0 | |
| 449525764 | 970 | PREDICTED: uncharacterized protein LOC10 | 0.832 | 0.979 | 0.605 | 0.0 | |
| 218193736 | 1112 | hypothetical protein OsI_13471 [Oryza sa | 0.920 | 0.944 | 0.474 | 0.0 |
| >gi|225432806|ref|XP_002279386.1| PREDICTED: uncharacterized protein LOC100249467 [Vitis vinifera] gi|297737117|emb|CBI26318.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1535 bits (3973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 783/1145 (68%), Positives = 921/1145 (80%), Gaps = 32/1145 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E+ + E + + +K + + N+ DD S++DVSG+ ++F ++E+
Sbjct: 1 MQLPDSGEVVS------VTEPVKDDQSKPLDAASTGENNADDQSILDVSGRNLEFSVLEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
+++VEGLYLYKNV NLIP+ +G +L+ LKFF NEINLFP E NL+GLECLQ
Sbjct: 55 C-----ESTVEGLYLYKNVFNLIPQRLGELGRLKMLKFFANEINLFPPEFRNLVGLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG+NG L+KL+GLKELEL KVPPRPS LLSEIAGLKCLTKLSVCHFSIRYLP
Sbjct: 110 VKLSSPGLNGLPLHKLRGLKELELCKVPPRPSAFPLLSEIAGLKCLTKLSVCHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL+NLE LDLSFNKMK LPTEI YL ALISLKVANNKLVELPSGL LQRLENLDL
Sbjct: 170 PEIGCLNNLEDLDLSFNKMKSLPTEISYLSALISLKVANNKLVELPSGLSSLQRLENLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MHNLQNLNLQYNKLLS CQ+PSWICCNLEGNGKD+ ND+FISSS
Sbjct: 230 SNNRLTSLGSLELVSMHNLQNLNLQYNKLLSCCQIPSWICCNLEGNGKDACNDEFISSSV 289
Query: 301 EMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQ 359
EMDV E E D ++ + GS +TSSS T SSNSR AR S K WKR ++LQQ
Sbjct: 290 EMDVLETTNQEIDESICCN----GSPNTSSSTLTGPSSNSRCFVARMSQKGWKRRYYLQQ 345
Query: 360 RARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQL 418
RARQERLNNSRKW+ E HA+ ++K ++ + G L L E+ +E A DI+ LD+DDKQL
Sbjct: 346 RARQERLNNSRKWKSEDHAEVLTIKAAEKCEHGKLAVLHPESLAEHAPDIVVLDNDDKQL 405
Query: 419 LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG--KEGNDECSKHDSSSLSTAN 476
LS EAESENLL SVED + G SCA L+S + EC+ D+S S +
Sbjct: 406 LSEEAESENLLNSVEDAESGPRKG------SCAVLDSIAINQGSKSECNDDDASLSSLSK 459
Query: 477 GATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIED 536
GA+E++EGSSSE SK+ K+KRHSDRDLDNPKPCK+R+ + E+SN S KYS +S+C+IED
Sbjct: 460 GASEKNEGSSSEVSKSTPKSKRHSDRDLDNPKPCKARRPVNEHSNLSCKYSKISYCNIED 519
Query: 537 RLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQL 596
RLPDGFYDAGRDRPFM LT YEQ H DSREVIL+DR+ DEELDAI LSAQALV LKQL
Sbjct: 520 RLPDGFYDAGRDRPFMPLTVYEQNFHFDSREVILLDRERDEELDAITLSAQALVSQLKQL 579
Query: 597 NGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCST 656
NGLTK+ DNLQIA LLALFVSDHFGGSD+S ++ERTRK+VSGSNY+KPFVC+CST
Sbjct: 580 NGLTKERKQVTDDNLQIASLLALFVSDHFGGSDKSALIERTRKSVSGSNYQKPFVCSCST 639
Query: 657 GNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLK 716
GN ++ +TS KQ LD VEDIV+SDLCEKSLRSIK++RNS++VPIG++QFGVCRHRAVL+K
Sbjct: 640 GNRNNISTSNKQNLDTVEDIVVSDLCEKSLRSIKARRNSIIVPIGTLQFGVCRHRAVLMK 699
Query: 717 YLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFI 776
YLCDR+EPPVPCELVRGYLDF PHAWN + K+GDSW+RMIVDACRPHDIREE DPEYF
Sbjct: 700 YLCDRMEPPVPCELVRGYLDFLPHAWNVVHTKRGDSWVRMIVDACRPHDIREETDPEYFC 759
Query: 777 RYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKV 836
RYIPL R P ST+S +P +G GSFPSLS+CDE + SSSL +CKFGS +AAAKV
Sbjct: 760 RYIPLSRINVPLSTQS--TPVTG---GSFPSLSACDEIANAPSSSLIQCKFGSVEAAAKV 814
Query: 837 RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLL 896
R L+VCG S DE+RNFEY CLGEVR+LGAL+HSCIVE+YGH+ISSKW+P++DGN EH +L
Sbjct: 815 RILEVCGDSVDEVRNFEYCCLGEVRILGALKHSCIVEIYGHQISSKWIPASDGNLEHRVL 874
Query: 897 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956
QSAI ME+VKGGS+K+Y+EKLSE GEKHV V+LAL IA+DVA+AL ELHSKHI+HRDIKS
Sbjct: 875 QSAILMEHVKGGSLKSYLEKLSEAGEKHVPVELALCIARDVASALAELHSKHIIHRDIKS 934
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
ENILIDL++K+ADG PVVKLCDFDRAVPLRSFLH+CCIAH GIP PDVCVGTPRWMAPEV
Sbjct: 935 ENILIDLDKKRADGTPVVKLCDFDRAVPLRSFLHSCCIAHIGIPPPDVCVGTPRWMAPEV 994
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1076
LRAMHK +YGLEVDIWSYGCLLLELLTLQVPY LSE + HD +QMGKRP+L +ELEAL
Sbjct: 995 LRAMHKREIYGLEVDIWSYGCLLLELLTLQVPYFELSESQFHDQLQMGKRPQLPEELEAL 1054
Query: 1077 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1136
GS E E+AQSG E PE E+E L FLVD+ R CT+ NPT+RPTA +LY+M + +T +
Sbjct: 1055 GS-QEPEMAQSGKE-EGPETEVEKLGFLVDLVRWCTKGNPTDRPTAENLYKMLLTQTRTF 1112
Query: 1137 ISSRS 1141
SSRS
Sbjct: 1113 TSSRS 1117
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552033|ref|XP_002517061.1| ATP binding protein, putative [Ricinus communis] gi|223543696|gb|EEF45224.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1459 bits (3776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/1100 (66%), Positives = 866/1100 (78%), Gaps = 21/1100 (1%)
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
+GK++DF Y D+S++GLYLYKNV +L+PKSVG KLR KFFGNE+NLFP
Sbjct: 67 TGKSLDF----DYLLEKADDSLDGLYLYKNVFSLVPKSVGNLGKLRTFKFFGNEVNLFPI 122
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLE LQ+K+SS G+NG LNKLKGLKELELSK P RPSV T+LSEIAGLKCLTK
Sbjct: 123 EFGNLVGLERLQVKVSSLGLNGLGLNKLKGLKELELSKAPSRPSVFTILSEIAGLKCLTK 182
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL+ LE LD+SFNK+K LP EI +L ALISLKVANN+L+ELPS
Sbjct: 183 LSVCHFSIRYLPPEIGCLNKLEYLDISFNKIKSLPIEISHLNALISLKVANNRLMELPSA 242
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LLQRLENLDLSNNRLTSLGSL L LMHNLQNL+LQ+NKLLS C +P+WICCNLEGNG
Sbjct: 243 LSLLQRLENLDLSNNRLTSLGSLQLGLMHNLQNLDLQHNKLLSCCHIPAWICCNLEGNGL 302
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKS 348
D SNDD ISSS EMDVYE + + S + GS++ +SS+ T SNS+ AR+
Sbjct: 303 DLSNDDSISSSVEMDVYETTIQSDHTKFSCN----GSQNATSSLLTGPPSNSKCFAARRL 358
Query: 349 SKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSM-KEGQRYKSGNLDALASETPSEEAS 406
+K+WKR H+LQQRARQERLNNSRKW+GEG A S KE + KS NLD L SET + S
Sbjct: 359 NKRWKRRHYLQQRARQERLNNSRKWKGEGRADLSTPKESKNCKSDNLDLLTSETCEDGTS 418
Query: 407 DIIGL-----DDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGN 461
DIIGL D +DK + S E E+ENLL S +DD++ S G ++++CS ES
Sbjct: 419 DIIGLVDNNEDKEDKVVPSSEVEAENLLVSGKDDRMNSKKGFYIKSCS-HNPESVSNGEE 477
Query: 462 DECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSN 521
DEC H+ S T NG + +DEGSSSEN+K + K+KRH D LDNPKPCK R+ ++ +
Sbjct: 478 DECCVHEKSLALTQNGVSGEDEGSSSENTKFILKSKRHFDGALDNPKPCKCRRPTEDSLS 537
Query: 522 ASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDA 581
S KYS +SFCS ED LPDGFYDAGRDRPFM L YEQ HLDSREVIL+DR+ DE+LDA
Sbjct: 538 LSHKYSDLSFCSTEDHLPDGFYDAGRDRPFMPLRRYEQILHLDSREVILLDREKDEKLDA 597
Query: 582 IALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTV 641
LSAQALV LK+LNG ++G + VD LQIA LLALFVSDHFGGSDRS +ERTRK V
Sbjct: 598 TVLSAQALVCRLKRLNGFFEEGNKDAVDVLQIASLLALFVSDHFGGSDRSFTIERTRKAV 657
Query: 642 SGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIG 701
SGSNY+KPFVCTCSTGN +S NTS KQIL + EDIV SDLCEKSLRS+K+KRNS++VP+G
Sbjct: 658 SGSNYKKPFVCTCSTGNDESINTSTKQILGSAEDIVFSDLCEKSLRSVKAKRNSIIVPLG 717
Query: 702 SVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDAC 761
++QFGVCRHRA+L KYLCDR++PP+PCELVRGYLDF PHAWNTILVK+GDSW+RM+VDAC
Sbjct: 718 NLQFGVCRHRALLFKYLCDRMDPPIPCELVRGYLDFIPHAWNTILVKRGDSWVRMLVDAC 777
Query: 762 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSS 821
RPHDIREE DPEYF RY+PL T P STES HSP S S S+ DE K+V S+
Sbjct: 778 RPHDIREETDPEYFCRYVPLSHTRVPLSTESIHSPGC-----SITSFSTHDELEKTVLST 832
Query: 822 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881
+ +CKF S +AAAKVRTL++C + DEIRNFEYSC+GEVR+L ALRH CIVE+YGH+ISS
Sbjct: 833 VIQCKFESVEAAAKVRTLEICETPVDEIRNFEYSCIGEVRILRALRHPCIVELYGHQISS 892
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 941
KW+ + DG P H +L+S I ME+VKGGS+K+YIEK+S+T +KHV + AL IA+D++ A+
Sbjct: 893 KWIHAEDGKPPHQILRSTILMEHVKGGSLKSYIEKMSKTSKKHVPMDFALCIARDISCAM 952
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1001
+LHSKHI+HRD+KSENILIDL+ K+ADG PVVKLCDFDRAVPLRSFLHTCCIAH GIP
Sbjct: 953 ADLHSKHIIHRDVKSENILIDLDSKRADGMPVVKLCDFDRAVPLRSFLHTCCIAHNGIPP 1012
Query: 1002 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
PDVCVGTPRWMAPEVLRAMHK N YGLEVDIWS+GCLLLELLTLQ+PY GLSE I +L+
Sbjct: 1013 PDVCVGTPRWMAPEVLRAMHKRNPYGLEVDIWSFGCLLLELLTLQIPYSGLSEFHIKELL 1072
Query: 1062 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
QMG+RP LTDELE L S +E QSGS PEAE ETL FLVD+FRRCTE NP RPT
Sbjct: 1073 QMGERPPLTDELETLVSMNEPVATQSGSDVAAPEAESETLRFLVDLFRRCTEANPASRPT 1132
Query: 1122 AGDLYEMFVARTSSSISSRS 1141
A ++YE+ + +S+ SSRS
Sbjct: 1133 AAEIYELLLGCSSAFTSSRS 1152
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433293|ref|XP_004134432.1| PREDICTED: uncharacterized protein LOC101218031 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1332 bits (3448), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 687/1142 (60%), Positives = 877/1142 (76%), Gaps = 31/1142 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL NS E S E + E +++++ + ++ + ND DD SV+DVSG+ +D +E
Sbjct: 1 MQLINSEETVADSSETGLVESRNLKSSELVSFEDDNGNDADD-SVLDVSGRNLDSNFLE- 58
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G +SV+GLY+++N NLIPKSVG + +LR LKFFGNEINLFPSE+ N +GLECLQ
Sbjct: 59 ----GSSSSVKGLYVFRNAFNLIPKSVGDFRELRMLKFFGNEINLFPSELKNFVGLECLQ 114
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG G +L+KLKGLKELELSK+PP+PS +LSEIAGLKCLTKLSVCHFSIR+LP
Sbjct: 115 VKLSSPGFGGLSLHKLKGLKELELSKIPPKPSSFPILSEIAGLKCLTKLSVCHFSIRFLP 174
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP L LQ+LENLDL
Sbjct: 175 PEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPPALSSLQKLENLDL 234
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK-DSSNDDFISSS 299
S+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN + D++N+++ISS+
Sbjct: 235 SSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNLEYDTANEEWISST 294
Query: 300 AEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQW-KRHHLQ 358
EMDVYE +N+ + G R+ SS++ S+NSRS +++S K+W +RH+LQ
Sbjct: 295 VEMDVYEATDQDNENSFPLK----GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQ 350
Query: 359 QRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQ 417
Q+ARQERLN+SRKW+G H T +K + + LD A SET ++S I L D K+
Sbjct: 351 QKARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDEL-FDSKE 408
Query: 418 LLSPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTA 475
AE EN + S E+D VE+CS C T +EC + + T
Sbjct: 409 TCDVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLTG 468
Query: 476 NGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIE 535
NGA +Q EGSSS+ SK K KR S+++LDNPKPCKSRK + +S+ S KY+S SFC++E
Sbjct: 469 NGAHDQ-EGSSSQVSKDNAKLKRCSEKELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVE 527
Query: 536 DRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQ 595
D LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ
Sbjct: 528 DYLPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQ 587
Query: 596 LNGLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCT 653
+N LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCT
Sbjct: 588 INQLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRVVSGSKYQKPFVCT 644
Query: 654 CSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAV 713
CSTG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+
Sbjct: 645 CSTGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRAL 704
Query: 714 LLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPE 773
LLKYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADPE
Sbjct: 705 LLKYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPE 764
Query: 774 YFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAA 833
YF RYIPL R P S SP G+ SFPSLS+CDE K+ SSS+ +CK S +AA
Sbjct: 765 YFCRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAA 819
Query: 834 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 893
AK+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+
Sbjct: 820 AKLRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKR 879
Query: 894 HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 953
LL+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HRD
Sbjct: 880 RLLRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHRD 939
Query: 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
IKSENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMA
Sbjct: 940 IKSENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMA 998
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
PEVLRAMH P++YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMGKRP L +L
Sbjct: 999 PEVLRAMHTPHVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDL 1058
Query: 1074 -EALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131
E LG+ + ++QS E E + ET + L+D+FR+CT+ENP +RPTA +L+ + +
Sbjct: 1059 EEELGTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTAEELHRILLE 1118
Query: 1132 RT 1133
T
Sbjct: 1119 HT 1120
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099855|ref|XP_002311646.1| predicted protein [Populus trichocarpa] gi|222851466|gb|EEE89013.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1311 bits (3392), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 705/1076 (65%), Positives = 822/1076 (76%), Gaps = 48/1076 (4%)
Query: 1 MQLTNSVEITQKS---PEGPIKEKLPSEANKINNEKNGSVNDD---------DDDSVIDV 48
MQ +NS E KS PE P K PS + +D DD+ V+DV
Sbjct: 1 MQPSNSTESNSKSTDNPENPKSPKSPSTEFNATATTVTATSDSSFEKNSENVDDEVVLDV 60
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
GK+++F L+E D+SVEGLYLYKN +L+PKSVG +KLR LKFFGNE+NLFP+
Sbjct: 61 IGKSLEFDLLEK-----ADDSVEGLYLYKNAFSLVPKSVGGLKKLRTLKFFGNEVNLFPA 115
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLECLQ+K+SSPG+NG + NKLKGLKELELS+VPPRPSVLT+LSEI+G+KCLTK
Sbjct: 116 EFGNLVGLECLQVKVSSPGLNGLSFNKLKGLKELELSRVPPRPSVLTILSEISGIKCLTK 175
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFS+RYLPPEIGCLSNLE LDLSFNK+K LP EI YL ALISLKV+NNKLVELPS
Sbjct: 176 LSVCHFSVRYLPPEIGCLSNLEFLDLSFNKIKSLPNEITYLNALISLKVSNNKLVELPSS 235
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LQ LE+LDLSNNRLTSLGSL+L MHNLQ+LNLQYNKLLS CQ+PSWICCNLEGNGK
Sbjct: 236 LSSLQLLESLDLSNNRLTSLGSLELTSMHNLQHLNLQYNKLLSCCQIPSWICCNLEGNGK 295
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKS 348
D SND+FISSS EMDVYE E+D S + GS H+ SSI T SSN + R S
Sbjct: 296 DLSNDEFISSSVEMDVYETSFQEDDRKFSCN----GSNHSMSSIVTGPSSNRSFASRRSS 351
Query: 349 SKQWKRHHLQQRARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASD 407
+ +RH+LQQ+ARQERLNNSRKW+GEG A+ ++KE + +KS NLD L E SD
Sbjct: 352 KRWKRRHYLQQKARQERLNNSRKWKGEGCAEALALKESESFKSNNLDVLTPEVHEGGTSD 411
Query: 408 IIGLDDDDKQL-LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSK 466
++G+DDD++++ LS EAE ENL SVEDDKI S VE+CSC L S K + C
Sbjct: 412 VVGVDDDNEKVELSVEAEGENLHTSVEDDKISSKKVFSVESCSC-DLGSINKSEEEVCCV 470
Query: 467 HDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKY 526
D ST + A QDE SSSE SK K+KRH DRD+DNPKPCK R+ ++SN S KY
Sbjct: 471 QDEPLASTRDEAASQDESSSSEKSKITYKSKRHHDRDIDNPKPCKCRRPTEDSSNFSCKY 530
Query: 527 SSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSA 586
S +SFCSIEDRLPDGFYDAGRDRPFM L +EQ LDSREVIL+DR+ DE+LDA+ALSA
Sbjct: 531 SELSFCSIEDRLPDGFYDAGRDRPFMPLRRFEQILPLDSREVILLDREKDEQLDAVALSA 590
Query: 587 QALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNY 646
QALV K+ NG TK+ VDNLQIA LLALFVSDHFGGSDRSG VERTRK VSGSNY
Sbjct: 591 QALVFRFKRSNGSTKERNKVAVDNLQIASLLALFVSDHFGGSDRSGAVERTRKAVSGSNY 650
Query: 647 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 706
RKPFVCTC TGN++S + + KQ L+ VEDI+ SDLCE+SLRSIK++R S+V+P+GS+QFG
Sbjct: 651 RKPFVCTCPTGNNESISLAGKQALETVEDIIFSDLCERSLRSIKARRGSIVIPLGSLQFG 710
Query: 707 VCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDI 766
VCRHRA+L+KYLCDR++PPVPCELVRGYLDF PHAWN IL ++GDS +RM+VDAC PHDI
Sbjct: 711 VCRHRALLMKYLCDRMDPPVPCELVRGYLDFMPHAWNVILRRRGDSLVRMVVDACHPHDI 770
Query: 767 REEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCK 826
REE DPEYF RYIPL RT P STES P SFP++S+ D+ K+ SS+L RCK
Sbjct: 771 REETDPEYFCRYIPLSRTKVPLSTESVPGPGC-----SFPTMSTSDKIEKAGSSTLIRCK 825
Query: 827 FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886
FGS +AAAKVRTL+VC +SADEIRNFEY CLGE +SSKW+PS
Sbjct: 826 FGSVEAAAKVRTLEVCEASADEIRNFEYICLGE-------------------LSSKWVPS 866
Query: 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 946
DGNPE +LQS I MEYV GGS+KNY+E++S+TGEKHV V++AL IA+DVA AL E+HS
Sbjct: 867 EDGNPERRILQSVILMEYVDGGSLKNYLEEVSKTGEKHVPVEMALCIARDVACALAEIHS 926
Query: 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1006
K I+HRDIKSENILIDL+ +ADG PVVKLCDFDRAVP +SFLHTCCIAHRGI PDVCV
Sbjct: 927 KDIIHRDIKSENILIDLDDTRADGMPVVKLCDFDRAVPRKSFLHTCCIAHRGIAPPDVCV 986
Query: 1007 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1062
GTPRWMAPEVLR M K N Y LEVDIWSYGCLLLELLTLQVPY GL E IH+L+Q
Sbjct: 987 GTPRWMAPEVLRTMDKRNTYALEVDIWSYGCLLLELLTLQVPYAGLPESRIHELLQ 1042
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534187|ref|XP_003535639.1| PREDICTED: uncharacterized protein LOC100819959 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1295 bits (3350), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 693/1136 (61%), Positives = 839/1136 (73%), Gaps = 35/1136 (3%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K P N + + DD + +DV+GK+V+FP E+
Sbjct: 1 MQLLHSDEPAPERGDSPEKPDDP------NADTDSLDPGTDDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G+ S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 AGD-----SAESLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTALECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLQLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEISYLKGLISMKVANNKLVELPAAMSSLSRLERLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSWICCN++GN K DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLGIFQIPSWICCNMDGNDKARCKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQ 359
EMD+YE END +S G +TSSS+ T SSS+SR +RKS K+WKR HHLQQ
Sbjct: 289 EMDLYESNFQENDETLS-----DGPHNTSSSMLTSSSSSSRCFASRKSGKRWKRRHHLQQ 343
Query: 360 RARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQ 417
+ARQERLNNSRKW+ H S K + + N D+LASE+ +E S+ LDD++K+
Sbjct: 344 KARQERLNNSRKWKAVDHDDQLLSKKIHRISEPENHDSLASESCAEIVSENGSLDDNNKR 403
Query: 418 LLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANG 477
+ S A ++N + + +D++ + E+C E DE + S S
Sbjct: 404 ISSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KEESLCSLDKR 453
Query: 478 ATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDR 537
+EQDE S E + V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC IED
Sbjct: 454 PSEQDEASCLELLECVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGIEDH 513
Query: 538 LPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLN 597
L DGFYDAGRDR FM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LN
Sbjct: 514 LSDGFYDAGRDRLFMPLECYEQNHCLASREVILLDRKIDEELDAVMLAAQALVYNLKKLN 573
Query: 598 GLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTG 657
GL++ G + VDNLQ+A LLALFVSDHFGGSDRSGIVERTRK+VSGSNY KPFVCTCS G
Sbjct: 574 GLSRYGNQDGVDNLQMASLLALFVSDHFGGSDRSGIVERTRKSVSGSNYNKPFVCTCSAG 633
Query: 658 NSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKY 717
+S S ++ + + + +EDI LS + EKSL SIK +RNS+++PIGSVQ+GVCRHRA+L KY
Sbjct: 634 SSTSISSPTEPVANTIEDITLSKMSEKSLDSIKKRRNSIIIPIGSVQYGVCRHRALLFKY 693
Query: 718 LCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIR 777
LCD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DACRP DIREE DPEYF R
Sbjct: 694 LCDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACRPLDIREEKDPEYFCR 753
Query: 778 YIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVR 837
YIPL RT P S+ P SFPSL++CDE S++L +CKFGS +AAAKVR
Sbjct: 754 YIPLNRTTIPISSIGSPGP-----DYSFPSLTTCDELETKASTTLVKCKFGSVEAAAKVR 808
Query: 838 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
TL+ GSSAD+I+NFEY+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+
Sbjct: 809 TLEEQGSSADKIKNFEYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLR 868
Query: 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
SAIFMEYV+GGS+KNY+EKLSE GEKHV V+LAL IA+DV+ AL ELHSKHI+HRDIKSE
Sbjct: 869 SAIFMEYVEGGSLKNYLEKLSEAGEKHVPVELALHIAKDVSCALSELHSKHIIHRDIKSE 928
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
NIL +L+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P +CVGTPRWMAPEV+
Sbjct: 929 NILFNLDRKRDDGTPTVKLCDFDSAVPLRSTLHVCCIAHAGTPPPCICVGTPRWMAPEVM 988
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1077
R M+K N YGLE DIWS+GCLLLE+LTLQ+PY GLS+ D +QMGKRP+LTDEL L
Sbjct: 989 RTMYKKNSYGLEADIWSFGCLLLEMLTLQIPYSGLSDSHFLDSLQMGKRPQLTDELRVLS 1048
Query: 1078 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133
S + + SG EK +A ++ L FLVD+F +C EENP++RPTA ++++M +A T
Sbjct: 1049 SMNGPTMIPSGEELEKSDAGVDMLKFLVDLFHKCVEENPSKRPTAEEIHKMVLAHT 1104
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219675|ref|NP_171917.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|3142291|gb|AAC16742.1| Contains similarity to adenylate cyclase gb|AF012921 from Magnaporthe grisae. EST gb|Z24512 comes from this gene [Arabidopsis thaliana] gi|20466532|gb|AAM20583.1| unknown protein [Arabidopsis thaliana] gi|34365545|gb|AAQ65084.1| At1g04210 [Arabidopsis thaliana] gi|332189549|gb|AEE27670.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1225 bits (3170), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/1097 (57%), Positives = 795/1097 (72%), Gaps = 27/1097 (2%)
Query: 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFG 100
+DDSV+DVSG+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF
Sbjct: 34 EDDSVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFS 88
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE 159
NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S LTLLSE
Sbjct: 89 NEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSE 148
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
I+GLKCLT+LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+
Sbjct: 149 ISGLKCLTRLSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAH 208
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC +P+WI
Sbjct: 209 NRLMELSPVLALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWI 268
Query: 280 CCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSN 339
CN EGN ++ D SS EMDV+E P N V GS ++ST SS
Sbjct: 269 QCNFEGNYEEMGVDTCSSSMVEMDVFETPYENNVITVPHK----GSHRNPLNMSTGISSI 324
Query: 340 SRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALA 397
SR +ARKSSK+WKR ++ QQRARQERLNNSRKW+GE + + + ++G
Sbjct: 325 SRCFSARKSSKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKV 384
Query: 398 SETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG 457
+ + D D++DK E + + E+++ + +N C + T
Sbjct: 385 PQNTDRGSVDNSCSDENDKLF------EEASVITSEEEESSLKADVVSDNSQCVETQLTS 438
Query: 458 KEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMG 517
+ N E + +SS S+ + D SSSE K K+KR S++ LDNPK K K
Sbjct: 439 ERDNYESCEIKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLST 498
Query: 518 ENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDE 577
+ +N S+KYSS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE
Sbjct: 499 DITNLSRKYSSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDE 558
Query: 578 ELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERT 637
LDAI LSA+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERT
Sbjct: 559 VLDAITLSARALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERT 618
Query: 638 RKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVV 697
RK VSG+NY+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+V
Sbjct: 619 RKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIV 678
Query: 698 VPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMI 757
VP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+
Sbjct: 679 VPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMV 738
Query: 758 VDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKS 817
VDACRPHDIRE+ D EYF RYIPL R + L+PG S S + +
Sbjct: 739 VDACRPHDIREDTDQEYFCRYIPLNRLNESIRIKEK------LEPGCSVSSLSTGKGVER 792
Query: 818 VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877
+SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH
Sbjct: 793 ANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGH 852
Query: 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 937
+ISSKW+ S +GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D+
Sbjct: 853 EISSKWITSENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDI 911
Query: 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 997
+ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH
Sbjct: 912 SGALMELHSKDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHV 971
Query: 998 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 1057
GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+I
Sbjct: 972 GIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQI 1031
Query: 1058 HDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEEN 1115
H+ +Q GKRP+L +LE L S E E + + F+ E++L+T+ FL+DVF +CTEE+
Sbjct: 1032 HESLQNGKRPKLPKKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEES 1091
Query: 1116 PTERPTAGDLYEMFVAR 1132
P++R AGDL+EM ++R
Sbjct: 1092 PSDRLNAGDLHEMILSR 1108
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843232|ref|XP_002889497.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297335339|gb|EFH65756.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1218 bits (3152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 625/1103 (56%), Positives = 793/1103 (71%), Gaps = 24/1103 (2%)
Query: 36 SVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95
SV +D+SV+DVSG+ ++F L+++ D+SV+GLY ++NV NL+PKS+G +LR
Sbjct: 29 SVISLEDESVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLLPKSIGGLGRLRK 83
Query: 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVL 154
LKFF NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S L
Sbjct: 84 LKFFSNEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSAL 143
Query: 155 TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214
TLLSEI+GLKCLT+LSVCHFSIRYLP EIGCL +LE LDLSFNK+K LP EI YL +L
Sbjct: 144 TLLSEISGLKCLTRLSVCHFSIRYLPAEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTF 203
Query: 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
LKVA+N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC
Sbjct: 204 LKVAHNRLMELSPALALLQNLESLDVSNNRLTNLHPLDLSLMPRLQILNLRYNKLPSYCW 263
Query: 275 VPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSIST 334
+P+WI CNLEGN ++ D SS EMDV+E P N + + GS ++ST
Sbjct: 264 IPTWIHCNLEGNYEEMGVDTCSSSMVEMDVFETPYENN----TITVPHKGSHRNPLNMST 319
Query: 335 VSSSNSRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGN 392
SS SR +ARKSSK+WKR H+ QQRARQERLNNSRKW+GE + + ++G
Sbjct: 320 GISSISRCFSARKSSKRWKRRQHYFQQRARQERLNNSRKWKGEVPPGGLSLKMEVEETGK 379
Query: 393 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 452
E + D D+DK L E+ + E+++ +N
Sbjct: 380 QGMKVPENTDRGSVDSTYSGDNDKLL----EEASVITSEEEEEESSLKAKFASDNSRFVE 435
Query: 453 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 512
+ T + N+E + +SS S+ + D SSSE K K+KR S++ LDNPK K
Sbjct: 436 TQLTSERDNNESCEIKASSPSSGDAPGTADYNSSSERKKPNNKSKRCSEKYLDNPKGSKC 495
Query: 513 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVD 572
+ + +N S KYS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+D
Sbjct: 496 HRPSTDFANLSHKYSRNSFCSTEDSLPDGFFDAGRDRPFMSLSKYEEILPLDSREVILLD 555
Query: 573 RKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSG 632
R DE LDAI LSA+ LV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+
Sbjct: 556 RAKDEVLDAITLSARTLVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTA 615
Query: 633 IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSK 692
I+ERTRK VSG+NY+KPF+CTC TGN D KQ+ ED++LSD+CEKSLRSIKSK
Sbjct: 616 IIERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDVILSDVCEKSLRSIKSK 675
Query: 693 RNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDS 752
RNS+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G S
Sbjct: 676 RNSIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSS 735
Query: 753 WIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCD 812
W+RM+VDACRPHDIRE+ D EYF RYIPL R T+ + L+PG S
Sbjct: 736 WVRMVVDACRPHDIREDTDQEYFCRYIPLNRLNESIRTKEN------LEPGCSVSSLLTG 789
Query: 813 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 872
+ + +SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIV
Sbjct: 790 KGVERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIV 849
Query: 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 932
E+YGH+ISSKW+ S +G+ +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL
Sbjct: 850 ELYGHEISSKWITSENGDEHRRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALS 909
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
IA+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+ +VKLCDFDRAVPLRS LH C
Sbjct: 910 IARDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEAIVKLCDFDRAVPLRSHLHGC 969
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1052
CIAH GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY L
Sbjct: 970 CIAHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDL 1029
Query: 1053 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFRR 1110
SEL+IH+ +Q GKRP+L +LE L S E + + + F+ E++L+T+ FL+DVF +
Sbjct: 1030 SELQIHESLQKGKRPKLPKKLETLSSETEEDESTNKLCEEFDLTESDLDTMRFLIDVFHQ 1089
Query: 1111 CTEENPTERPTAGDLYEMFVART 1133
CTEE+P++R AGDL+EM ++RT
Sbjct: 1090 CTEESPSDRLNAGDLHEMILSRT 1112
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574435|ref|XP_003555353.1| PREDICTED: uncharacterized protein LOC100811118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1178 bits (3047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/1031 (61%), Positives = 768/1031 (74%), Gaps = 35/1031 (3%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K + P N ++ +G+ DD + +DV+GK+V+FP E+
Sbjct: 1 MQLVHSDEPAPERRDWPEKPEDPKADN--DSLDSGT----DDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
++S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 -----AEDSAECLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTTLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLPLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE+LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEITYLKGLISMKVANNKLVELPAAMSSLSRLESLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSW+CCN+EGN + DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLRIFQIPSWMCCNMEGNDEARYKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQ 359
EMD+YE END +S G +TSSS+ T SS+SR +RKS K+WKR ++LQQ
Sbjct: 289 EMDLYESNFQENDETLS-----DGPHNTSSSMLTSPSSSSRCFASRKSGKRWKRRYYLQQ 343
Query: 360 RARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQ 417
+ARQERLNNSRKW+ H S K + +SGN D+LASE+ +E S+ LDD++K+
Sbjct: 344 KARQERLNNSRKWKAVDHDDLLLSKKIHRISESGNHDSLASESCAEIESENGSLDDNNKR 403
Query: 418 LLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANG 477
+ S A ++N + + +D++ + E+C E DE D+S S
Sbjct: 404 IFSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KDASLCSLEKR 453
Query: 478 ATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDR 537
+EQ+E S E ++V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC ED
Sbjct: 454 QSEQEEASCLELLESVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGTEDH 513
Query: 538 LPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLN 597
L DGFYDAGRDRPFM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LN
Sbjct: 514 LSDGFYDAGRDRPFMPLESYEQNQCLASREVILLDRKRDEELDAVMLAAQALVYNLKKLN 573
Query: 598 GLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTG 657
GL + G VDNLQ A LLALFVSDHFGGSDRS IVERTRK+VSGSNY KPFVCTCS G
Sbjct: 574 GLNRHGNQVGVDNLQTASLLALFVSDHFGGSDRSAIVERTRKSVSGSNYNKPFVCTCSAG 633
Query: 658 NSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKY 717
+S S ++ + + + +EDI LS + EKSL S+K ++NS+++PIGSVQ+GVCRHRA+L KY
Sbjct: 634 SSTSISSPTEPVANTIEDITLSKMSEKSLDSMKKRQNSIIIPIGSVQYGVCRHRALLFKY 693
Query: 718 LCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIR 777
LCD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DAC+P DIREE DPEYF R
Sbjct: 694 LCDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACQPLDIREEKDPEYFCR 753
Query: 778 YIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVR 837
YIPL RT P ST C G D SFPSL++CDE S+SL +CKFGS +AAAKVR
Sbjct: 754 YIPLNRTTIPLSTIG----CPGPD-YSFPSLTTCDELETKASTSLVKCKFGSVEAAAKVR 808
Query: 838 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
TL+ GSSAD+I+NF+Y+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+
Sbjct: 809 TLEEQGSSADKIKNFKYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLR 868
Query: 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
SAIFMEYV+GGS+K+Y+EKLSE GEKHV V+LAL IA+DV+ AL ELHS+HI+HRDIKSE
Sbjct: 869 SAIFMEYVEGGSLKSYLEKLSEAGEKHVPVELALLIAKDVSCALSELHSRHIIHRDIKSE 928
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
NIL DL+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P VCVGTPRWMAPEV+
Sbjct: 929 NILFDLDRKRDDGTPTVKLCDFDSAVPLRSTLHACCIAHAGTPPPCVCVGTPRWMAPEVM 988
Query: 1018 RAMHKPNLYGL 1028
R M+K N YGL
Sbjct: 989 RTMYKKNSYGL 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525764|ref|XP_004169886.1| PREDICTED: uncharacterized protein LOC101227936, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1150 bits (2974), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/975 (60%), Positives = 751/975 (77%), Gaps = 25/975 (2%)
Query: 168 KLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
K+ FS R+LPPEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP
Sbjct: 1 KICCVSFSFRFLPPEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPP 60
Query: 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
L LQ+LENLDLS+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN
Sbjct: 61 ALSSLQKLENLDLSSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNL 120
Query: 288 K-DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTAR 346
+ D++N+++ISS+ EMDVYE + +N+ + G R+ SS++ S+NSRS ++
Sbjct: 121 EYDTANEEWISSTVEMDVYEATVQDNENSFPLK----GMRNISSNLLMGPSTNSRSFASK 176
Query: 347 KSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEE 404
+S K+W+R H+LQQ+ARQERLN+SRKW+G H T +K + + LD A SET +
Sbjct: 177 RSGKRWRRRHYLQQKARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGD 235
Query: 405 ASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGND 462
+S I L D K+ + AE EN + S E+D VE+CS C T +
Sbjct: 236 SSAIDELFDS-KETCAVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDEN 294
Query: 463 ECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNA 522
EC + + T NGA +Q EGSSS+ SK K KR S+R+LDNPKPCKSRK + +S+
Sbjct: 295 ECCETSKTLPLTGNGAHDQ-EGSSSQVSKDNAKLKRCSERELDNPKPCKSRKPVEYSSSL 353
Query: 523 SQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAI 582
S KY+S SFC++ED LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I
Sbjct: 354 SCKYNSTSFCNVEDYLPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSI 413
Query: 583 ALSAQALVLHLKQLNGLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKT 640
++A++LVL LKQ+N LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+
Sbjct: 414 TIAAKSLVLRLKQINQLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRA 470
Query: 641 VSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPI 700
VSGS Y+KPFVCTCSTG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+
Sbjct: 471 VSGSKYQKPFVCTCSTGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPL 530
Query: 701 GSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 760
G++QFGVCRHRA+LLKYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDA
Sbjct: 531 GALQFGVCRHRALLLKYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDA 590
Query: 761 CRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSS 820
CRP+DIREEADPEYF RYIPL R P S SP G+ SFPSLS+CDE K+ SS
Sbjct: 591 CRPNDIREEADPEYFCRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSS 645
Query: 821 SLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880
S+ +CK S +AAAK+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+IS
Sbjct: 646 SVIKCKLASVEAAAKLRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQIS 705
Query: 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 940
S+W+PS +G P+ LL+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+A
Sbjct: 706 SEWIPSENGKPKRRLLRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASA 765
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1000
LVELHSKHI+HRDIKSENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP
Sbjct: 766 LVELHSKHIIHRDIKSENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIP 824
Query: 1001 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1060
PDVCVGTPRWMAPEVLRAMH PN+YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D
Sbjct: 825 PPDVCVGTPRWMAPEVLRAMHTPNVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFDH 884
Query: 1061 IQMGKRPRLTDEL-EALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTE 1118
+QMGKRP L +L E LG+ + ++QS E E + ET + L+D+FR+CT+ENP +
Sbjct: 885 LQMGKRPELAGDLEEELGTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPND 944
Query: 1119 RPTAGDLYEMFVART 1133
RPTA +L+ + + T
Sbjct: 945 RPTAEELHRILLEHT 959
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218193736|gb|EEC76163.1| hypothetical protein OsI_13471 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/1118 (47%), Positives = 709/1118 (63%), Gaps = 68/1118 (6%)
Query: 47 DVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINL 105
DV+G T D + E +Y+Y+N NL+P+S+G +R+LKFFGN++ +
Sbjct: 22 DVAGNTWDLAALPPPPPAARGGGGE-VYIYRNTYNLVPRSIGGCRGSVRSLKFFGNDVEV 80
Query: 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC 165
P E G L LE LQ+K+S+P V+G L +++ LKELELS VPPRPS ++L E+A LKC
Sbjct: 81 LPPEAGELDQLESLQVKVSAPRVSGAPLRRMRALKELELSIVPPRPSACSILVEVAALKC 140
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
LTKL++CHFSIRYLPPEIG L L++LDLSFNK+K LP I L AL LKV NNKLV+L
Sbjct: 141 LTKLTICHFSIRYLPPEIGSLRKLQELDLSFNKLKNLPNCITELGALKFLKVTNNKLVDL 200
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEG 285
PSG+ L+ LE+LDLSNNRLTSLGS+ L M LQ LNLQ+N++ + C +P+W+CC++ G
Sbjct: 201 PSGISSLRCLESLDLSNNRLTSLGSVKLISMLTLQYLNLQFNRISNSCVIPAWVCCDMRG 260
Query: 286 NGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSR---HTSSSISTVS----SS 338
NG+++ + S A + S + A SR HT ++ S S+
Sbjct: 261 NGENNMKPGKLKSIAVV----------------SNTSAESRSMNHTCNASRLCSHPEASA 304
Query: 339 NSRSLTARKSSKQWKRHH-LQQRARQERLNNSRKWRGEGHAQT-------------SMKE 384
N + +K+ K WKR LQQ+ARQERL +SR + + M+
Sbjct: 305 NLKVHPTQKTKKGWKRRDCLQQQARQERLESSRSKLNDDYVDEMAVNMTEDESPLHDMEN 364
Query: 385 GQRYKSGNLDALASETPSEEAS---DIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGT 441
K + +A + P E +S D+ + DDD + ++ +++ + G
Sbjct: 365 KSEMKGIDEEASLQDLPKETSSISEDLSCIVDDDSY---GHIKDSGMMLQDHNEEEKPGL 421
Query: 442 GLHVE-NCSC----AGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKT 496
+ NCSC + S + + E DS+ S+ + A E + SE SK K+
Sbjct: 422 SMKSHGNCSCISGNTDILSRRRIRSVENELEDSA--SSVHDAAVVVEENPSETSKHSWKS 479
Query: 497 KRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG 556
KRH D D NPKP K + E S S KYS SFCSI+D LPDGFYDAGRD PFM L
Sbjct: 480 KRHPDMDC-NPKPSKCPRPFDECSKLSYKYSVQSFCSIDDHLPDGFYDAGRDMPFMPLEE 538
Query: 557 YEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALL 616
YE++ L +REVIL+DR+ DEELDAIA SAQ L+ +LK + D + +L A +
Sbjct: 539 YERSIGLYAREVILLDREQDEELDAIASSAQILLSNLKMPSCFVADE--DAGQDLLRASV 596
Query: 617 LALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDI 676
LALFVSD FGG DRS + RTR+ + +PFVCTCS G+ + + K+I +
Sbjct: 597 LALFVSDCFGGCDRSASLSRTRRAIVSLRKEQPFVCTCSAGSICDSIEASKRINNLYGHF 656
Query: 677 VLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLD 736
+ LC+KS+ IK +RNS +VPIG++QFGVCRHRAVL+KYLCDR +PP+PCELVRG+LD
Sbjct: 657 DFTGLCDKSIHIIKERRNSGIVPIGALQFGVCRHRAVLMKYLCDRADPPIPCELVRGHLD 716
Query: 737 FQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSP 796
+ PHAWN + V+KG++W+RMIVDAC P +I+EE DPEYF RY+PL R +
Sbjct: 717 YTPHAWNVVPVRKGNTWVRMIVDACYPTNIKEETDPEYFCRYVPLSRLQIILDDQ----- 771
Query: 797 CSGLDPGS-FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS 855
G P S FPS+S C E + SSS++ CK G+ DAAAKVR L +S+DE++NFEY
Sbjct: 772 --GYTPRSPFPSVSLCKEIETTASSSVYYCKIGAVDAAAKVRYLDTRCASSDEVKNFEYK 829
Query: 856 CLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
L EVRMLGALR H IVE+YGH++ SKW+ AD + E+ +LQS I MEYVKGGS+K Y+
Sbjct: 830 LLAEVRMLGALRKHQSIVEIYGHQLYSKWV-QADDDKEYKILQSTIMMEYVKGGSLKGYL 888
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
KL + G+KH + LA +I ++VA AL+ELH K ++HRDIKSEN+L+DL+ +++DG PVV
Sbjct: 889 TKLLKEGKKHAPIDLAFYIVREVACALLELHKKLVIHRDIKSENVLVDLDLERSDGTPVV 948
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
KL DFD A+PL S HTCCIAH G P+VCVGTP WMAPEVLRAM N YGLEVDIWS
Sbjct: 949 KLSDFDNAIPLHSLSHTCCIAHLGTYPPNVCVGTPCWMAPEVLRAMRDKNQYGLEVDIWS 1008
Query: 1035 YGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEK 1093
+GC LLE+LTL++PY GL + EI+DLI K RPRLT ELEA + + + + G
Sbjct: 1009 FGCFLLEMLTLRIPYQGLPDSEIYDLIMRKKQRPRLTQELEAFWTL-DKPITRLELGITS 1067
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131
+A E L L+D+F +CT+ +ERP A +Y + +
Sbjct: 1068 -DAHAEKLRLLIDLFYQCTKGIASERPKAEAVYNLLCS 1104
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1141 | ||||||
| TAIR|locus:2020220 | 1112 | AT1G04210 [Arabidopsis thalian | 0.929 | 0.954 | 0.546 | 7.3e-304 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.056 | 0.065 | 0.420 | 7.4e-19 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.056 | 0.063 | 0.420 | 5.4e-18 | |
| DICTYBASE|DDB_G0278509 | 1248 | DDB_G0278509 "MLK family prote | 0.078 | 0.071 | 0.426 | 7.6e-15 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.077 | 0.1 | 0.320 | 1.1e-14 | |
| DICTYBASE|DDB_G0269250 | 3184 | pats1 "LRRK family protein kin | 0.155 | 0.055 | 0.298 | 2.3e-14 | |
| DICTYBASE|DDB_G0279417 | 2147 | roco6 "LRRK family protein kin | 0.143 | 0.076 | 0.299 | 2.9e-14 | |
| DICTYBASE|DDB_G0286127 | 1867 | roco8 "LRRK family protein kin | 0.140 | 0.085 | 0.294 | 3.3e-14 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.175 | 0.247 | 0.243 | 7e-14 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.062 | 0.076 | 0.448 | 1.1e-13 |
| TAIR|locus:2020220 AT1G04210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2916 (1031.5 bits), Expect = 7.3e-304, P = 7.3e-304
Identities = 595/1088 (54%), Positives = 751/1088 (69%)
Query: 50 GKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE 109
G+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF NEI+LFP E
Sbjct: 43 GQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFSNEIDLFPPE 97
Query: 110 VGNLLGLECLQIKISSPGV-NGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTK 168
+GNL+ LE LQ+KISSPG +G + VP R S LTLLSEI+GLKCLT+
Sbjct: 98 LGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSEISGLKCLTR 157
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+N+L+EL
Sbjct: 158 LSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAHNRLMELSPV 217
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDXXXXXXXXXXXXXXXXXXSYCQVPSWICCNLEGNGK 288
L LLQ LE+LD+SNNRLT+L LD SYC +P+WI CN EGN +
Sbjct: 218 LALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWIQCNFEGNYE 277
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGXXXXXXXXXXXXXXXXXXXXXXXX 348
+ D SS EMDV+E P EN NV + G
Sbjct: 278 EMGVDTCSSSMVEMDVFETPY-EN--NV-ITVPHKGSHRNPLNMSTGISSISRCFSARKS 333
Query: 349 XKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEEAS 406
K+WKR ++ QQRARQERLNNSRKW+GE + + + ++G + +
Sbjct: 334 SKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNTDRGSV 393
Query: 407 DIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSK 466
D D++DK L EA + + E+++ + +N C + T + N E +
Sbjct: 394 DNSCSDENDK--LFEEAS----VITSEEEESSLKADVVSDNSQCVETQLTSERDNYESCE 447
Query: 467 HDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKY 526
+SS S+ + D SSSE K K+KR S++ LDNPK K K + +N S+KY
Sbjct: 448 IKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITNLSRKY 507
Query: 527 SSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSA 586
SS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LSA
Sbjct: 508 SSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDAITLSA 567
Query: 587 QALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNY 646
+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+NY
Sbjct: 568 RALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTNY 627
Query: 647 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 706
+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G +QFG
Sbjct: 628 QKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLGKLQFG 687
Query: 707 VCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDI 766
+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHDI
Sbjct: 688 ICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDI 747
Query: 767 REEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCK 826
RE+ D EYF RYIPL R ES L+PG S S + + +SSL RCK
Sbjct: 748 REDTDQEYFCRYIPLNRL-----NESIRIK-EKLEPGCSVSSLSTGKGVERANSSLIRCK 801
Query: 827 FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886
GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S
Sbjct: 802 LGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWITS 861
Query: 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 946
+GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELHS
Sbjct: 862 ENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELHS 920
Query: 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1006
K I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP P++CV
Sbjct: 921 KDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICV 980
Query: 1007 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR 1066
GTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +Q GKR
Sbjct: 981 GTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESLQNGKR 1040
Query: 1067 PRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124
P+L +LE L S E E + + F+ E++L+T+ FL+DVF +CTEE+P++R AGD
Sbjct: 1041 PKLPKKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEESPSDRLNAGD 1100
Query: 1125 LYEMFVAR 1132
L+EM ++R
Sbjct: 1101 LHEMILSR 1108
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 127 (49.8 bits), Expect = 7.4e-19, Sum P(5) = 7.4e-19
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 688 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 745
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y A N+I
Sbjct: 282 SLKATLRSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSDDVAMNSI 339
Query: 746 LVKKGDSWI 754
G +I
Sbjct: 340 KTDDGREYI 348
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 5.4e-18, Sum P(4) = 5.4e-18
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 688 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 745
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y + A N I
Sbjct: 306 SLKATLGSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSEDVAMNFI 363
Query: 746 LVKKGDSWI 754
G +I
Sbjct: 364 KADDGREYI 372
|
|
| DICTYBASE|DDB_G0278509 DDB_G0278509 "MLK family protein kinase DDB_G0278509" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 163 (62.4 bits), Expect = 7.6e-15, Sum P(5) = 7.6e-15
Identities = 38/89 (42%), Positives = 55/89 (61%)
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
+A L L KL++ + I+ LP I LS+L +L+ S N ++ LP ICYL L L + N
Sbjct: 614 VASLSRLAKLTISNNKIKQLPFAINNLSSLIELNASNNVIELLPDSICYLSNLKKLNLNN 673
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSL 248
N L ELPS + L +L +L L NN+++SL
Sbjct: 674 NNLKELPSNIGFLTKLVDLQLYNNQISSL 702
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 123 (48.4 bits), Expect = 1.1e-14, Sum P(4) = 1.1e-14
Identities = 33/103 (32%), Positives = 56/103 (54%)
Query: 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
VVK+CDF L H ++ + GTP WMAPEVLR ++P + D+
Sbjct: 745 VVKVCDFG----LSRMKHHTYLSSKST------AGTPEWMAPEVLR--NEPA--NEKCDV 790
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELE 1074
+S+G +L EL T +VP+ GL+ +++ + +R + D+++
Sbjct: 791 YSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDID 833
|
|
| DICTYBASE|DDB_G0269250 pats1 "LRRK family protein kinase Pats1" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 168 (64.2 bits), Expect = 2.3e-14, Sum P(2) = 2.3e-14
Identities = 55/184 (29%), Positives = 85/184 (46%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEK-LRNLKFFGNEINLFPSEVG---NLLGLECLQIKIS 124
S+ L L N L +P + K L+ L N + P +G NL+ L+ ++ +S
Sbjct: 1467 SLTELNLSSNQLIDLPIEFSMFSKSLKKLHLKNNRFSAIPEVLGMLENLIELDLSELDLS 1526
Query: 125 SPGVNGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S +G + ++ L E LK L KL + S+ LP
Sbjct: 1527 SSTNSGVGIPTKLSKLCILNLN---QTRIVELPKEFGDLKSLEKLYLDFNSLVTLPHSFR 1583
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NLE+L LSFN M LP E+C+L L L + N++ LP+ + L +L L++ N+
Sbjct: 1584 QLTNLEELSLSFNSMTELPREVCFLINLKKLMIEGNQIQFLPNEISQLSKLMILNVCKNK 1643
Query: 245 LTSL 248
L SL
Sbjct: 1644 LDSL 1647
|
|
| DICTYBASE|DDB_G0279417 roco6 "LRRK family protein kinase Roco6" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 172 (65.6 bits), Expect = 2.9e-14, Sum P(3) = 2.9e-14
Identities = 56/187 (29%), Positives = 94/187 (50%)
Query: 902 MEYVKGGSVKNYIEKLSETGEK-HVSVKLALFIAQDVAAALVELHS--KHIMHRDIKSEN 958
MEY+ G + ++ S G++ + + L L +A D+A + LHS ++HRD+KS N
Sbjct: 1429 MEYIDCGDLHKFLH--SPIGDQLNGNWALILKLALDIAKGMEFLHSVTPPLLHRDLKSPN 1486
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+L+ ++ DG K+ DF + R F+ R P VG W+APE+LR
Sbjct: 1487 VLLSMK----DGVYTAKVGDF--GLSSRMFIQALKHKLRNFP-----VGNITWVAPEILR 1535
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSELEIH-DLIQMGKRPRLTDELEA 1075
Y ++ D++++G +L ELLT + PY S + + D I+ G RP ++
Sbjct: 1536 EEE----YTVKSDVYAFGLILHELLTRKHPYREFNYSMVSLQEDAIKNGLRPTISPSYTQ 1591
Query: 1076 LGSCHEH 1082
+ HE+
Sbjct: 1592 TVTGHEY 1598
|
|
| DICTYBASE|DDB_G0286127 roco8 "LRRK family protein kinase Roco8" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 154 (59.3 bits), Expect = 3.3e-14, Sum P(3) = 3.3e-14
Identities = 55/187 (29%), Positives = 89/187 (47%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KHIMHRDIKS 956
AI MEY+ GS+ ++++K E G+ + ++ L I D+A+ + LH+ ++HRD+KS
Sbjct: 1666 AIVMEYMDIGSLSSFLKKKKEDGQV-LDWQMLLKIVTDIASGMAFLHNITPPLVHRDLKS 1724
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
NIL+ + K+ DF + RS + V P W +PEV
Sbjct: 1725 PNILL-ASHPTNPNEISAKVSDFGLS---RSIVQNFS---------SKVVDNPTWQSPEV 1771
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTD 1071
L+ M Y + DI+S+G +L E L++P+ +S LE D I G RP +
Sbjct: 1772 LKGME----YNEKSDIYSFGMILWECYHLELPFDEFDFKFMSTLE--DNILSGLRPSINQ 1825
Query: 1072 ELEALGS 1078
+ S
Sbjct: 1826 NCNRMYS 1832
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 111 (44.1 bits), Expect = 7.0e-14, Sum P(4) = 7.0e-14
Identities = 54/222 (24%), Positives = 94/222 (42%)
Query: 647 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 706
+K + +G + T K+I V D+ + +S +S N + +G ++ G
Sbjct: 126 QKQLITKLVSGLNSKPATIIKKIAGLVADVYKQSTLQSPAKSTQSFENCGIQLLGQIKHG 185
Query: 707 VCRHRAVLLKYLCD------RVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 760
CR RA+L K L D R+ +P + +D H T+L+ + M+VD
Sbjct: 186 SCRPRAILFKVLADTVGLQSRLVVGLPSDGAAESVDSYSHISVTVLLNS----VEMLVDL 241
Query: 761 CR-PHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC-SGLDPGS----FPSLSSCDEA 814
R P + + F+ +I + A S +++ C S L+P S +P + A
Sbjct: 242 MRFPGQLIPLSTKAIFMSHI----SAAGESDSAENDSCDSPLEPNSPMFGYPEKFDHENA 297
Query: 815 GKSVSSSLFRCKFGSADAAAKV-RTLKVCGSSADEIRNFEYS 855
K + SL R GS + + R + + +SA E R +S
Sbjct: 298 EKDENLSLHRKLDGSPNTSGPPSRNMLLRSASALE-RKLSFS 338
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 1.1e-13, Sum P(3) = 1.1e-13
Identities = 35/78 (44%), Positives = 45/78 (57%)
Query: 672 AVED--IVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCE 729
+ ED IVL+ EKS K+ N+ V PIG V+ G+ RHRA+L K L D V +PC
Sbjct: 233 SAEDSSIVLARWTEKS-SEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVR--LPCR 289
Query: 730 LVRG--YLDFQPHAWNTI 745
LV+G Y + A NTI
Sbjct: 290 LVKGSHYTGNEDDAVNTI 307
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1141 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 83/282 (29%), Positives = 117/282 (41%), Gaps = 71/282 (25%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
+I+ L E+++L L+H IV +Y E L + MEY +
Sbjct: 35 KKIKKDRERILREIKILKKLKHPNIVRLYDV-----------FEDEDKLY---LVMEYCE 80
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG + + ++K +S A F + + +AL LHSK I+HRD+K ENIL+
Sbjct: 81 GGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL----- 130
Query: 967 KADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
D VKL DF R + L T GTP +MAPEVL
Sbjct: 131 --DEDGHVKLADFGLARQLDPGEKLTTFV-------------GTPEYMAPEVLLGKG--- 172
Query: 1025 LYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHE 1083
YG VDIWS G +L ELLT + P+ G +L E+ I K P E +
Sbjct: 173 -YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI-------- 223
Query: 1084 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
PEA D+ R+ ++P +R TA +
Sbjct: 224 ---------SPEA--------KDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 60/281 (21%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
E + + E+R+L L H IV + A + +H + MEY +
Sbjct: 36 SEKSKKDQTARREIRILRRLSHPNIVRLID----------AFEDKDH----LYLVMEYCE 81
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG + +Y+ + +S A IA + L LHS I+HRD+K ENIL+
Sbjct: 82 GGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL----- 131
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
D VVK+ DF A + + VGTP +MAPEVL N Y
Sbjct: 132 --DENGVVKIADFGLA----------KKLLKSSSSLTTFVGTPWYMAPEVLL---GGNGY 176
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1086
G +VD+WS G +L ELLT + P+ G + L+ LI+ P L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------------- 219
Query: 1087 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
+ E + ++C ++P++RPTA ++ +
Sbjct: 220 EFDEPKWSSGSEEAKDLI----KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 815 GKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 872
G+ +++ + A K+ + S +E+ E+ +L L H IV
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR-------EIEILKKLNHPNIV 54
Query: 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 932
++YG L + MEY +GGS+K+ +++ E +S L
Sbjct: 55 KLYGVFEDENHL--------------YLVMEYCEGGSLKDLLKEN----EGKLSEDEILR 96
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
I + L LHS I+HRD+K ENIL+D VKL DF + L S
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLD------SDNGKVKLADFGLSKLLTSDKSLL 150
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042
VGTP +MAPEVL Y + DIWS G +L EL
Sbjct: 151 K----------TIVGTPAYMAPEVLLGKGY---YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 92/297 (30%), Positives = 131/297 (44%), Gaps = 79/297 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+++++ G S +E+ + E+R+L +L+H IV YG + ++ L
Sbjct: 30 VKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYYGSERD---------EEKNTL 76
Query: 896 LQSAIFMEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
IF+EYV GGS+ + ++K L E + + + L LHS I+HR
Sbjct: 77 N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--------TRQILEGLAYLHSNGIVHR 125
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DIK NIL+D +DG VVKL DF A L GTP WM
Sbjct: 126 DIKGANILVD-----SDG--VVKLADFGCAKRLGDIETGEGTGSV--------RGTPYWM 170
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLT 1070
APEV+R YG DIWS GC ++E+ T GK P L
Sbjct: 171 APEVIRGE----EYGRAADIWSLGCTVIEMAT-------------------GKPPWSELG 207
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ + AL +++ SG E PE L E FL R+C +P +RPTA +L
Sbjct: 208 NPMAAL-----YKIGSSGEPPEIPE-HLSEEAKDFL----RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 85/306 (27%), Positives = 126/306 (41%), Gaps = 81/306 (26%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 881
R K + A KV L+ I E+++L +H IV+ YG K
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIIN--------EIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAA 940
W I ME+ GGS+K+ ++ ++T E ++ ++ +++
Sbjct: 72 LW----------------IVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1000
L LHS I+HRDIK+ NIL+ +DG+ VKL DF + L
Sbjct: 111 LEYLHSNGIIHRDIKAANILL-----TSDGE--VKLIDFGLSAQLSD-----------TK 152
Query: 1001 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1060
A + VGTP WMAPEV+ Y + DIWS G +EL + PY SEL
Sbjct: 153 ARNTMVGTPYWMAPEVINGKP----YDYKADIWSLGITAIELAEGKPPY---SELPPMKA 205
Query: 1061 IQMGKRPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTER 1119
+ +A +G G P E + F D ++C ++NP +R
Sbjct: 206 LFK--------------------IATNGPPGLRNP--EKWSDEF-KDFLKKCLQKNPEKR 242
Query: 1120 PTAGDL 1125
PTA L
Sbjct: 243 PTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S +I F L E R++ L H IV++ G + ++ E +
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNIVKLLG--VCTE--------EEPLM 77
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ MEY+ GG + +Y L + K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMPGGDLLDY---LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 131 ARNCLVGENL-------VVKISDFGLSRDLYDDDYYKV---KGGKLPI--------RWMA 172
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 173 PESLKE----GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR------ 222
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L +C L + +C E+P +RPT +L E+
Sbjct: 223 LPKPPNCPPE---------------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 8e-32
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 75/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S +I F L E R++ L H +V++ G + ++ E
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNVVKLLG--VCTE--------EEPLY 77
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ MEY++GG + +Y+ K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 130 ARNCLV-------GENLVVKISDFGLSRDLYDDDYYRK---RGGKLPI--------RWMA 171
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 172 PESLKEGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------ 221
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L +C L D+ +C E+P +RPT +L E+
Sbjct: 222 LPQPPNCPPE---------------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK G+S +E F L E ++ L H IV + G + ++ L
Sbjct: 33 VKTLK-EGASEEEREEF----LEEASIMKKLSHPNIVRLLG--VCTQ---------GEPL 76
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GG + +++ K E +++K L +A +A + L SK+ +HRD+
Sbjct: 77 Y---IVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N L+ VVK+ DF R + + G P +WMA
Sbjct: 130 ARNCLV-------TENLVVKISDFGLSRDIYEDDYYR----KRGGGKLP------IKWMA 172
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ +L++ G R
Sbjct: 173 PESLKDGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR------ 222
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L +C + L ++ +C +P +RPT +L E
Sbjct: 223 LPRPENCPDE---------------------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 67/286 (23%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
S E + L EV++L L H I++ Y L I M
Sbjct: 37 NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-----------KLC---IVM 78
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
EY GG + I+K + G K + L + AL LHS+ I+HRDIK +NI +
Sbjct: 79 EYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
++G +VKL DF + + T +A VGTP +++PE+ + +K
Sbjct: 138 -----SNG--LVKLGDFGIS---KVLSSTVDLAK-------TVVGTPYYLSPELCQ--NK 178
Query: 1023 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1082
P Y + DIWS GC+L EL TL+ P+ G + LE+ I G+ P +
Sbjct: 179 P--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI------------- 223
Query: 1083 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
P L LV +++P ERP+ + +
Sbjct: 224 -----------PSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 78/274 (28%), Positives = 115/274 (41%), Gaps = 74/274 (27%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+ +L L+H IV+ G + L IF+E V GGS+ ++K
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNL--------------YIFLELVPGGSLAKLLKKY 96
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
E + L+ Q + L LH ++ +HRDIK NIL+D +G VVKL
Sbjct: 97 GSFPEPVIR----LYTRQ-ILLGLEYLHDRNTVHRDIKGANILVD-----TNG--VVKLA 144
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
DF A + F G+P WMAPEV+ + YGL DIWS GC
Sbjct: 145 DFGMAKQVVEFSFA-----------KSFKGSPYWMAPEVIA---QQGGYGLAADIWSLGC 190
Query: 1038 LLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093
+LE+ T + P+ S+LE + + + + P + D L
Sbjct: 191 TVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLS------------------- 228
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
EA+ D +C + +P+ RPTA +L E
Sbjct: 229 DEAK--------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 70/299 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S +E ++F L E R++ L H +V + G + ++ E L
Sbjct: 28 VKTLK-EDASEEERKDF----LKEARVMKKLGHPNVVRLLG--VCTE---------EEPL 71
Query: 896 LQSAIFMEYVKGGSVKNYIEK----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+ +EY++GG + +Y+ K + +S+K L A +A + L SK +H
Sbjct: 72 Y---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RD+ + N L+ VVK+ DF + + + +P RW
Sbjct: 129 RDLAARNCLV-------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--------RW 173
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1070
MAPE L K ++ + D+WS+G LL E+ TL PY GLS E+ + ++ G R
Sbjct: 174 MAPESL----KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--- 226
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
KPE + L ++ C + +P +RPT +L E
Sbjct: 227 ---------------------PKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 88/281 (31%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGS----V 910
+ E+ ++ +H IV+ Y + +L+ ++ MEY+ GGS +
Sbjct: 63 INEILIMKDCKHPNIVDYY----------------DSYLVGDELWVVMEYMDGGSLTDII 106
Query: 911 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
+++E ++ ++ ++V L LHS++++HRDIKS+NIL+ DG
Sbjct: 107 TQNFVRMNEP---QIA-----YVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-----DG 153
Query: 971 KPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
VKL DF + R+ + VGTP WMAPEV++
Sbjct: 154 --SVKLADFGFAAQLTKEKSKRNSV----------------VGTPYWMAPEVIKR----K 191
Query: 1025 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 1084
YG +VDIWS G + +E+ + PY+ L LI P L +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP------------ 239
Query: 1085 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
EK E FL +C ++P +RP+A +L
Sbjct: 240 -------EKWSPEF--KDFL----NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 69/211 (32%), Positives = 92/211 (43%), Gaps = 52/211 (24%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
S + E+ +L L+H IV+ G +S L I +EY + GS++ I
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSL--------------YIILEYAENGSLRQII 90
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+K E V+V ++ Q V L LH + ++HRDIK+ NIL DG VV
Sbjct: 91 KKFGPFPESLVAV----YVYQ-VLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VV 138
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 1032
KL DF A L VGTP WMAPEV+ + G DI
Sbjct: 139 KLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVI------EMSGASTASDI 182
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
WS GC ++ELLT PY +DL M
Sbjct: 183 WSLGCTVIELLTGNPPY--------YDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 26/164 (15%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY GG + +++ K E S + A F A ++ AL LHS I++RD+K ENIL+
Sbjct: 72 LEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D ADG +KL DF A L S + GTP ++APEVL +
Sbjct: 127 D-----ADGH--IKLTDFGLAKELSSEGSRT----------NTFCGTPEYLAPEVL--LG 167
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
K YG VD WS G LL E+LT + P+ EI++ I
Sbjct: 168 KG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 59/269 (21%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+++L L+H +V+ YG E H + IFMEY GG+ +E+L
Sbjct: 48 DEMKVLELLKHPNLVKYYG--------------VEVHREKVYIFMEYCSGGT----LEEL 89
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
E G + ++ Q + L LHS I+HRDIK NI +D +G V+KL
Sbjct: 90 LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHGIVHRDIKPANIFLD-----HNG--VIKLG 141
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
DF AV L++ +T + GTP +MAPEV+ K +G DIWS GC
Sbjct: 142 DFGCAVKLKN--NTTTMGEEV----QSLAGTPAYMAPEVITG-GKGKGHGRAADIWSLGC 194
Query: 1038 LLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
++LE+ T + P+ L +E +I + G +P + D L+
Sbjct: 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK---------------- 238
Query: 1097 ELETLSFLVDVFRRCTEENPTERPTAGDL 1125
D RC E +P +RPTA +L
Sbjct: 239 ---------DFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 69/271 (25%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 916
E+++L L+H IV+ YG + E +IFMEY+ GGSVK+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG----------CLRDDET----LSIFMEYMPGGSVKDQLKAY 98
Query: 917 --LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L+ET V+ K I + V LHS I+HRDIK NIL D V
Sbjct: 99 GALTET----VTRKYTRQILEGVEY----LHSNMIVHRDIKGANILRDSAGN-------V 143
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
KL DF + L T C + G+ + GTP WM+PEV+ YG + D+WS
Sbjct: 144 KLGDFGAS----KRLQTICSSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADVWS 192
Query: 1035 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1094
GC ++E+LT + P+ + + ++ +P P
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP------------------------TNP 226
Query: 1095 EAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ + RR EN +RP+A +L
Sbjct: 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 78/269 (28%), Positives = 110/269 (40%), Gaps = 71/269 (26%)
Query: 859 EVRMLGALRHSCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E++ L R I + YG K S W I MEY GGS + + K
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLW----------------IIMEYCGGGSCLDLL-K 91
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E +++ FI ++V L LH + +HRDIK+ NIL+ +G VKL
Sbjct: 92 PGKLDETYIA-----FILREVLLGLEYLHEEGKIHRDIKAANILLS-----EEGD--VKL 139
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF + L S ++ R + VGTP WMAPEV+ K + Y + DIWS G
Sbjct: 140 ADFGVSGQLTS-----TMSKR-----NTFVGTPFWMAPEVI----KQSGYDEKADIWSLG 185
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+EL + P L + + LI P L G+ F KP
Sbjct: 186 ITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE-----------------GNKFSKP-- 226
Query: 1097 ELETLSFLVDVFRRCTEENPTERPTAGDL 1125
D C ++P ERP+A +L
Sbjct: 227 -------FKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H IV Y I + + L I MEY +GG + I+K
Sbjct: 49 EVNILRELKHPNIVRYYDRII----------DRSNQTLY--IVMEYCEGGDLAQLIQKCK 96
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILIDLERKKADGKPV 973
+ + + + I + AL E H ++HRD+K NI +D
Sbjct: 97 KERKY-IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-------ANNN 148
Query: 974 VKLCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030
VKL DF A L SF T VGTP +M+PE L M Y +
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTY-------------VGTPYYMSPEQLNHMS----YDEKS 191
Query: 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1069
DIWS GCL+ EL L P+ ++L++ I+ GK R+
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 76/293 (25%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 850 RNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 908
L E+++L +L H IV++Y + MEYV GG
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--------------SLYLVMEYVDGG 83
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
S+++ ++K+ G +S ALFI + +AL LHSK I+HRDIK ENIL+D + +
Sbjct: 84 SLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV- 140
Query: 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028
VKL DF L L P VGTP +MAPEVL +
Sbjct: 141 -----VKLIDF----GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY-ASS 190
Query: 1029 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1088
DIWS G L ELLT P+ G T L
Sbjct: 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL--------------- 235
Query: 1089 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 1141
+ P D+ ++ ++P R ++ + S
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 71/229 (31%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY +GGSV+ + K EK++SV I ++V AL +H ++HRDIK+ NI
Sbjct: 79 IIMEYAEGGSVRT-LMKAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANI 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ VKLCDF A L VGTP WMAPEV+
Sbjct: 133 LVTNTGN-------VKLCDFGVAALLNQ----------NSSKRSTFVGTPYWMAPEVIT- 174
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1079
+ Y + DIWS G + E+ T PY + LI K PRL D
Sbjct: 175 --EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN------- 225
Query: 1080 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
G+ K L + C +E P ER +A +L +
Sbjct: 226 ----------GYSK---------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 43/210 (20%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
L E R+L ++RH +V +YG L +L+ MEYV GG + +++
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNL---------YLV-----MEYVPGGELFSHLR 93
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
K E A F A V AL LHS I++RD+K EN+L+D +DG +K
Sbjct: 94 KSGRFPEPV-----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----SDGY--IK 141
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
+ DF A ++ +T C GTP ++APE++ K YG VD W+
Sbjct: 142 ITDFGFAKRVKGRTYTLC-------------GTPEYLAPEIIL--SKG--YGKAVDWWAL 184
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
G L+ E+L P+ + ++I++ I GK
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/272 (27%), Positives = 107/272 (39%), Gaps = 67/272 (24%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+ ML RH IV +G + L I MEY GGS+++ +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKL--------------WIVMEYCGGGSLQDIYQVT 94
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
+S ++ ++ L LH +HRDIK NIL+ DG VKL
Sbjct: 95 RG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-----TEDGD--VKLA 143
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
DF + L T IA R +GTP WMAPEV A+ + Y + DIW+ G
Sbjct: 144 DFGVSAQL-----TATIAKR-----KSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGI 192
Query: 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEHEVAQSGSGFEK 1093
+EL LQ P L + L + K P+L D+
Sbjct: 193 TAIELAELQPPMFDLHPMRA--LFLISKSNFPPPKLKDK--------------------- 229
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
E + F D ++C ++P +RPTA L
Sbjct: 230 ---EKWSPVF-HDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 76/269 (28%), Positives = 118/269 (43%), Gaps = 70/269 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
EV ++ +H IVEMY +L+ ++ ME+++GG++ + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSS----------------YLVGDELWVVMEFLEGGALTDIVTH 109
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
E+ +V LA V AL LH++ ++HRDIKS++IL+ +DG VKL
Sbjct: 110 TRMNEEQIATVCLA------VLKALSFLHAQGVIHRDIKSDSILL-----TSDG--RVKL 156
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF F C + +P VGTP WMAPEV+ P YG EVDIWS G
Sbjct: 157 SDF-------GF---CAQVSKEVPRRKSLVGTPYWMAPEVIS--RLP--YGTEVDIWSLG 202
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+++E++ + PY L+ I+ P+L + H+V+ F
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK---------NLHKVSPRLRSF----- 248
Query: 1097 ELETLSFLVDVFRRCTEENPTERPTAGDL 1125
R +P +R TA +L
Sbjct: 249 -----------LDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 75/302 (24%), Positives = 113/302 (37%), Gaps = 70/302 (23%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 890
A K+ + + +EI+ E +L H I YG I N
Sbjct: 34 VAIKI--MDIIEDEEEEIKE-------EYNILRKYSNHPNIATFYGAFIKK--------N 76
Query: 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHS 946
P + Q + ME GGSV + ++ L + G E+ ++ +I ++ L LH
Sbjct: 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-----YILRETLRGLAYLHE 131
Query: 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1006
++HRDIK +NIL+ K A+ VKL DF + L S L + +
Sbjct: 132 NKVIHRDIKGQNILLT---KNAE----VKLVDFGVSAQLDSTLG----------RRNTFI 174
Query: 1007 GTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
GTP WMAPEV+ +P+ Y D+WS G +EL + P + + I
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 1066 RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
P L E + F D C +N +RP +L
Sbjct: 235 PPTLK------------------------SPENWSKKF-NDFISECLIKNYEQRPFMEEL 269
Query: 1126 YE 1127
E
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 69/255 (27%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 520 SNASQKYSSVSFCSIEDRLPDGFYD---------AGRDRPFMQLTGYEQTPHLD-SREVI 569
S +Y S +D++PDGFYD L + P D S EV+
Sbjct: 5 EALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSSFEVV 64
Query: 570 LVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSD 629
LVDR++D +L + A+ LV + + LA VSDH GG
Sbjct: 65 LVDRRTDPKLKELEQLARCLVSGC-------------GTNTAALVQKLAGLVSDHMGGP- 110
Query: 630 RSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSI 689
V + S L S
Sbjct: 111 -----------VKDAE---------------------------------SMLARWKECSN 126
Query: 690 KSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTILV 747
+ K NS VVP+GS++ G+CRHRA+L K L D + +PC LV+G Y A N LV
Sbjct: 127 ELKENSGVVPLGSLKIGLCRHRALLFKVLADSIG--LPCRLVKGCKYCGSDDDASN--LV 182
Query: 748 KKGDSWIRMIVDACR 762
K D +VD
Sbjct: 183 KFDDG-REYLVDLMG 196
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 82/308 (26%), Positives = 136/308 (44%), Gaps = 74/308 (24%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSK-WLPSADG 889
AAAK+ ++ S +E+ +F + E+ +L +H IV +Y + +K W
Sbjct: 33 AAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYENKLW------ 78
Query: 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 949
I +E+ GG++ + + +L E+ ++ ++ + + AL LHS +
Sbjct: 79 ----------ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKV 124
Query: 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
+HRD+K+ NIL+ L+ VKL DF + +S L D +GTP
Sbjct: 125 IHRDLKAGNILLTLDGD-------VKLADFGVSAKNKSTLQK----------RDTFIGTP 167
Query: 1010 RWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1068
WMAPEV+ K N Y + DIWS G L+EL ++ P+ L+ + + I + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 1069 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L Q S + SF D + C ++P +RPTA +L +
Sbjct: 228 L---------------DQP-SKWSS--------SF-NDFLKSCLVKDPDDRPTAAELLKH 262
Query: 1129 -FVARTSS 1135
FV+ S
Sbjct: 263 PFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 57/217 (26%)
Query: 855 SCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSV 910
+ L E+ +L L+H IV++ H +L +F + +
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYL---------------VFEYCDM----DL 84
Query: 911 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
K Y++K +S L I + L HS I+HRD+K +NILI +
Sbjct: 85 KKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-------NR 133
Query: 971 KPVVKLCDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
V+KL DF RA +PLR++ H V T + APE+L Y
Sbjct: 134 DGVLKLADFGLARAFGIPLRTYTHE--------------VVTLWYRAPEILLGSKH---Y 176
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
VDIWS GC+ E++T + + G S EI L ++
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKI 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY G + YI K + K F A ++ AL LHSK I+HRD+K ENIL+
Sbjct: 81 LEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 962 DLERKKADGKPVVKLCDFDRA-------VPLRSFLHTCCIAHRGIPAPDVC---VGTPRW 1011
D D +K+ DF A P + I + VGT +
Sbjct: 136 D-----KDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1062
++PE+L KP G D+W+ GC++ ++LT + P+ G +E I
Sbjct: 189 VSPELLN--EKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 77/285 (27%), Positives = 117/285 (41%), Gaps = 90/285 (31%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L L H IV+ G E +IF+EYV GGS+ + +
Sbjct: 58 EIETLKDLDHLNIVQYLGF--------------ETTEEYLSIFLEYVPGGSIGSCLRTYG 103
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E+ V F + V L LHSK I+HRD+K++N+L+D ADG + K+ D
Sbjct: 104 RFEEQLVR-----FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----ADG--ICKISD 151
Query: 979 F------------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
F D+ + ++ G+ WMAPEV+ + + Y
Sbjct: 152 FGISKKSDDIYDNDQNMSMQ--------------------GSVFWMAPEVIHSYSQG--Y 189
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMG---KRPRLTDELEALGSCHEH 1082
+VDIWS GC++LE+ + P+ S+ E I + ++G P + ++ S
Sbjct: 190 SAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLS---- 242
Query: 1083 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
P A L FL C NP RPTA +L +
Sbjct: 243 -----------PVA----LDFL----NACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 76/321 (23%), Positives = 125/321 (38%), Gaps = 69/321 (21%)
Query: 812 DEAGKSVSSSLFR--CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 869
+ G ++ ++ C + A K L+ C +S DE+R EV+ + H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAMSQCNHP 59
Query: 870 CIVEMYGHKI--SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-KLSETGEKHVS 926
+V+ Y + W + M Y+ GGS+ + ++ G
Sbjct: 60 NVVKYYTSFVVGDELW----------------LVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 927 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986
+ + ++V L LHS +HRDIK+ NIL+ DG VK+ DF +
Sbjct: 104 IA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-----EDGS--VKIADFGVSA--- 150
Query: 987 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046
S + VGTP WMAPEV M + + Y + DIWS+G +EL T
Sbjct: 151 SLADGGDRTRK---VRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGITAIELATGA 204
Query: 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1106
PY +++ L P L + + F K ++
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLE---------TGADYKKYSKSFRK----------MIS 245
Query: 1107 VFRRCTEENPTERPTAGDLYE 1127
C +++P++RPTA +L +
Sbjct: 246 ---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 67/278 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQTR 113
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E+ +V + V AL LHS+ ++HRDIKS++IL+ L DG+ VKL D
Sbjct: 114 LNEEQIATV------CESVLQALCYLHSQGVIHRDIKSDSILLTL-----DGR--VKLSD 160
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F C + +P VGTP WMAPEV+ YG EVDIWS G +
Sbjct: 161 FG----------FCAQISKDVPKRKSLVGTPYWMAPEVI----SRTPYGTEVDIWSLGIM 206
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
++E++ + PY S ++ ++ P+L + H+++
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------AHKIS------------- 244
Query: 1099 ETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 1135
L D R P ER TA +L + F+ +T
Sbjct: 245 ---PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 68/268 (25%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L IV+ YG + L I MEY GSV + ++ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-----------DLW---IVMEYCGAGSVSDIMKITN 93
Query: 919 ET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
+T E+ ++ I L LHS +HRDIK+ NIL++ +G KL
Sbjct: 94 KTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIKAGNILLN-----EEG--QAKLA 141
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
DF + L + A R +GTP WMAPEV+ + Y + DIWS G
Sbjct: 142 DFGVSGQLTDTM-----AKRN-----TVIGTPFWMAPEVI----QEIGYNNKADIWSLGI 187
Query: 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097
+E+ + PY +IH + + P + PE
Sbjct: 188 TAIEMAEGKPPYS-----DIHPMRAIFMIPN-----------------KPPPTLSDPE-- 223
Query: 1098 LETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ D ++C ++P ERP+A L
Sbjct: 224 -KWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 46/234 (19%)
Query: 842 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 901
++ E+ E C E+++L LRH IV+ YG +PE L +IF
Sbjct: 41 SQETSKEVNALE--C--EIQLLKNLRHDRIVQYYG----------CLRDPEEKKL--SIF 84
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY+ GGS+K+ ++ E V+ + I Q V+ LHS I+HRDIK NIL
Sbjct: 85 VEYMPGGSIKDQLKAYGALTEN-VTRRYTRQILQGVSY----LHSNMIVHRDIKGANIL- 138
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D VKL DF + + T C++ GI + GTP WM+PEV+
Sbjct: 139 ------RDSAGNVKLGDFGAS----KRIQTICMSGTGIKS---VTGTPYWMSPEVISG-- 183
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTD 1071
YG + D+WS C ++E+LT + P+ +E E I + +P L D
Sbjct: 184 --EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 58/290 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ + +++ E + E+R++ L H I+ M G A H
Sbjct: 30 VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG----------ATCEDSHF- 78
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+F+E++ GGSV + + K E V + + + L LH I+HRD+K
Sbjct: 79 ---NLFVEWMAGGSVSHLLSKYGAFKEA-VIINYTEQLLR----GLSYLHENQIIHRDVK 130
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
N+LID + G+ +++ DF A L + T +G +GT +MAPE
Sbjct: 131 GANLLID-----STGQ-RLRIADFGAAARLAAKG-TGAGEFQG-----QLLGTIAFMAPE 178
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1075
VLR YG D+WS GC+++E+ T K P ++
Sbjct: 179 VLRGEQ----YGRSCDVWSVGCVIIEMAT-------------------AKPPWNAEKH-- 213
Query: 1076 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
S H + + S P L DV RC E P +RP + +L
Sbjct: 214 --SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
CL E+ +L L H +++ I + L I +E G + I+
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNEL--------------NIVLELADAGDLSRMIK 94
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + + Q + +AL +HSK IMHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPERTIWKYFVQ-LCSALEHMHSKRIMHRDIKPANVFIT-----ATG--VVK 146
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
L D R F AH VGTP +M+PE + N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPERIHE----NGYNFKSDIWSL 192
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQ 1062
GCLL E+ LQ P+ G ++ ++ L +
Sbjct: 193 GCLLYEMAALQSPFYG-DKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A +V V SS D R+ + E+ +L L+H IV+ G + + L
Sbjct: 29 AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL------- 81
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
IF+EYV GGSV + E V F+ Q + L LH++ I+H
Sbjct: 82 -------NIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQ-ILKGLNYLHNRGIIH 129
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
RDIK NIL+D K +K+ DF + + S L T R P + G+
Sbjct: 130 RDIKGANILVD-------NKGGIKISDFGISKKLEANS-LSTKTNGAR----PSL-QGSV 176
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
WMAPEV+ K Y + DIWS GCL++E+LT + P+ ++L+
Sbjct: 177 FWMAPEVV----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 35/191 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+++L L H IV+ YG E L +IFME++ GGS+K+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG---------CLRDPMERTL---SIFMEHMPGGSIKDQLKSYG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E V+ K I + V+ LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTEN-VTRKYTRQILEGVSY----LHSNMIVHRDIKGANIL-------RDSVGNVKLGD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F + L T C++ G+ + GTP WM+PEV+ YG + DIWS GC
Sbjct: 150 FGAS----KRLQTICLSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADIWSVGCT 198
Query: 1039 LLELLTLQVPY 1049
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 65/191 (34%), Positives = 92/191 (48%), Gaps = 35/191 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+++L L+H IV+ YG E L IFMEY+ GGSVK+ ++
Sbjct: 54 EIQLLKNLQHERIVQYYG---------CLRDRAEKTL---TIFMEYMPGGSVKDQLKAYG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E V+ K + + + LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTES-VTRKYT----RQILEGMSYLHSNMIVHRDIKGANIL-------RDSAGNVKLGD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F + L T C++ GI + GTP WM+PEV+ YG + D+WS GC
Sbjct: 150 FGAS----KRLQTICMSGTGIRS---VTGTPYWMSPEVISG----EGYGRKADVWSLGCT 198
Query: 1039 LLELLTLQVPY 1049
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 66/267 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 112
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 113 MNEEQIAAVCLA------VLKALSVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 159
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 160 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGIM 205
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
++E++ + PY L+ +I+ P+L + H+V+ S GF
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN---------LHKVSPSLKGF------- 249
Query: 1099 ETLSFLVDVFRRCTEENPTERPTAGDL 1125
R +P +R TA +L
Sbjct: 250 ---------LDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY+ GG + + +E + E ++IA+ + AL LHS I+HRD+K +NI
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA----RIYIAE-IVLALEYLHSNGIIHRDLKPDNI 124
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDV-CVGTPRWMAPEVL 1017
LID ++G +KL DF L L I D VGTP ++APEV+
Sbjct: 125 LID-----SNGH--LKLTDFG----LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+ VD WS GC+L E L P+ G + EI I GK
Sbjct: 174 LGQG----HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 27/172 (15%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ME+++GG++ + + E+ +V L+ V AL LH++ ++HRDIKS++I
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLS------VLRALSYLHNQGVIHRDIKSDSI 149
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ +DG+ +KL DF C + +P VGTP WMAPEV+
Sbjct: 150 LL-----TSDGR--IKLSDFG----------FCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1071
+ YG EVDIWS G +++E++ + PY L+ I+ PR+ D
Sbjct: 193 LP----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 55/293 (18%)
Query: 845 SADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSKWLPSADGNPEHHLLQSAIFME 903
++++ + L EV++L LRH IV + + + +L+ E
Sbjct: 39 DDEDVKK---TALREVKVLRQLRHENIVNLKEAFRRKGRL----------YLV-----FE 80
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
YV ++ +E S G +V+ ++ + A+ HS +I+HRDIK ENIL+
Sbjct: 81 YV-ERTLLELLEA-SPGGLPPDAVRSYIW---QLLQAIAYCHSHNIIHRDIKPENILVSE 135
Query: 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHK 1022
V+KLCDF A LR+ R V T RW APE+L
Sbjct: 136 SG-------VLKLCDFGFARALRA---------RPASPLTDYVAT-RWYRAPELLV---G 175
Query: 1023 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1082
YG VD+W+ GC++ ELL + + G S+++ LIQ P L + L S +
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP-LPPSHQELFSSNPR 234
Query: 1083 -------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
E +Q S + ++ S +D + C +P ER T +L +
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVS--SPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 67/276 (24%)
Query: 854 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
L E+ +L L+H I+ Y H + L I MEY GG
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTL--------------LIEMEYANGG---TL 86
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+K+ + ++ L+ + +A+ +H I+HRDIK+ NI + KA +
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAG---L 139
Query: 974 VKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
+KL DF + L S + + VGTP +M+PE+ + + Y + DI
Sbjct: 140 IKLGDFGISKILGSEYSMA-----------ETVVGTPYYMSPELCQGVK----YNFKSDI 184
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092
W+ GC+L ELLTL+ + + L + I G + V+ S
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--------------YTPVVSVYSSE-- 228
Query: 1093 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L+ + +++P +RPTA ++ +
Sbjct: 229 -----------LISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 59/184 (32%), Positives = 80/184 (43%), Gaps = 38/184 (20%)
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
E HL + MEY+ GG + N + + E+ A F ++ AL +H +H
Sbjct: 73 EEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKLGFIH 124
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPA 1001
RDIK +NILID ADG +KL DF DR L + + +
Sbjct: 125 RDIKPDNILID-----ADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 1002 PD---------VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1052
D VGTP ++APEVLR YGLE D WS G +L E+L P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 1053 SELE 1056
+ E
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
+RN L E R+L L H +V ++ + + E+ L ++ +
Sbjct: 42 GSVRNV----LNERRILQELNHPFLVNLW----------YSFQDEENMYL----VVDLLL 83
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG ++ ++ + + E+ V F ++ AL LHSK I+HRDIK +NIL+D
Sbjct: 84 GGDLRYHLSQKVKFSEEQVK-----FWICEIVLALEYLHSKGIIHRDIKPDNILLD---- 134
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
G V + DF+ A GTP +MAPEVL Y
Sbjct: 135 -EQGH--VHITDFNIA----------TKVTPDTLTTSTS-GTPGYMAPEVLCR----QGY 176
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
+ VD WS G E L + PY G S +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E R+L + H I+ ++ + + L + MEYV GG + +Y+
Sbjct: 51 EKRVLKEVSHPFIIRLF-----------WTEHDQRFLY---MLMEYVPGGELFSYLR--- 93
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
S LF A ++ AL LHSK I++RD+K ENIL+D +G +KL D
Sbjct: 94 --NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----KEGH--IKLTD 144
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A LR T C GTP ++APEV+++ + VD W+ G L
Sbjct: 145 FGFAKKLRDRTWTLC-------------GTPEYLAPEVIQSKG----HNKAVDWWALGIL 187
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGK 1065
+ E+L P+ + I++ I GK
Sbjct: 188 IYEMLVGYPPFFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I++ E A F A ++ L LH + I++RD+K +N+L+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPR-----ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D ++G +K+ DF + T C GTP ++APE+L
Sbjct: 130 D-----SEGH--IKIADFGMCKEGILGGVTTSTFC-------------GTPDYIAPEILS 169
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
YG VD W+ G LL E+L Q P+ G E E+ I
Sbjct: 170 YQ----PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 77/283 (27%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 914
L E ++ +L H ++ +YG +L + M E GS+ +
Sbjct: 44 LKEAAIMHSLDHENLIRLYGV-----------------VLTHPLMMVTELAPLGSL---L 83
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
++L + H + A +A + L SK +HRD+ + NIL+ + K V
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-------V 136
Query: 975 KLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---HKPNLYGLE 1029
K+ DF RA+P H H +P W APE LR H
Sbjct: 137 KIGDFGLMRALPQNE-DHYVMEEHLKVPFA--------WCAPESLRTRTFSHAS------ 181
Query: 1030 VDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1088
D+W +G L E+ T + P+ GLS +I I E E L
Sbjct: 182 -DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--------KEGERL------------ 220
Query: 1089 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131
E+PEA + + +V +C NP +RPT L E
Sbjct: 221 ---ERPEACPQD---IYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 29/162 (17%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + + E A F V A LH++ I++RD+K EN+L+
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D ++G VKL DF A L+S T GTP ++APE++
Sbjct: 127 D-----SNG--YVKLVDFGFAKKLKSGQKTWTF-----------CGTPEYVAPEIILNKG 168
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE--LEIHDLI 1061
Y VD WS G LL ELLT + P+ E +EI++ I
Sbjct: 169 ----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 30/158 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ + E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1019
D A+G +K+ DF C + G C GTP ++APE++
Sbjct: 135 D-----AEGH--IKIADFGM-----------CKENIFGGKTTRTFC-GTPDYIAPEII-- 173
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 1057
++P YG VD W++G LL E+L Q P+ G E E+
Sbjct: 174 AYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-17
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 42/204 (20%)
Query: 900 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 959 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1073
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 186 VVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 1074 EA-----LGSCHEHEVAQSGSGFE 1092
A L C E +V + GS E
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 70/238 (29%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSE 957
+I +EY+ GGS+ + ++K+ + E ++ +IA+ + L LH+K HI+HRDIK
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 958 NILIDLERKKADGKPVVKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
N+LI+ K VK+ DF + +F VGT
Sbjct: 130 NLLINS-------KGEVKIADFGISKVLENTLDQCNTF-----------------VGTVT 165
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL---IQMGKRP 1067
+M+PE ++ Y DIWS G LLE + P++ + +L I G P
Sbjct: 166 YMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
L E E E F+ C +++P +RP+A +L
Sbjct: 222 SLPAE----------------------EFSPEFRDFI----SACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 84/320 (26%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS--CLGEVRMLGALRHS 869
DE G+ V L + +G AA + T R+ Y E+ + L+H
Sbjct: 8 DENGERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 870 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL 929
IV+ G + + IFME V GGS+ + S+ G + +
Sbjct: 66 NIVQYLGSDSENGFF--------------KIFMEQVPGGSLSALLR--SKWGPLKDNEQT 109
Query: 930 ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 989
+F + + L LH I+HRDIK +N+L++ VVK+ DF
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG------VVKISDFG--------- 154
Query: 990 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
T P + GT ++MAPEV+ P YG DIWS GC ++E+ T + P+
Sbjct: 155 -TSKRLAGINPCTETFTGTLQYMAPEVID--KGPRGYGAPADIWSLGCTIVEMATGKPPF 211
Query: 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVF 1108
I++G E + A G K E+ E+LS F
Sbjct: 212 -----------IELG----------------EPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 1109 -RRCTEENPTERPTAGDLYE 1127
RC E +P +R +A DL +
Sbjct: 245 ILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ E+R+L ++ H I+ + DGN + I MEY G + I
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFL--------DGN------KLCIVMEYAPFGDLSKAI 90
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
K + K + + I + L LH + I+HRD+KS NIL+ +V
Sbjct: 91 SKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL------VAND-LV 142
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
K+ D + L+ + I GTP +MAPEV + +P Y + DIWS
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------------GTPHYMAPEVWKG--RP--YSYKSDIWS 186
Query: 1035 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1069
GCLL E+ T P+ S ++ +Q GK P +
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 72/235 (30%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I MEY +GGS+ + +K+ + G + + K+ IA+ V L LHS+ I+HRDIK N
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
IL+ K VKLCDF + L S T GT +MAPE
Sbjct: 136 ILLTR-------KGQVKLCDFGVSGELVNSLAGT-------------FTGTSFYMAPE-- 173
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTDE 1072
R KP Y + D+WS G LLE+ + P+ L +E+ I P L DE
Sbjct: 174 RIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
P ++ D ++C E++PT RPT D+ E
Sbjct: 232 ---------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + + L E H A F ++ A+ LH +HRD+K EN LI
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D A G +KL DF + + ++ ++ VG+P +MAPEVLR
Sbjct: 135 D-----ASGH--IKLTDFGLSKGIVTYANS-------------VVGSPDYMAPEVLRGKG 174
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI----QMGKRPRLTD 1071
Y VD WS GC+L E L P+ G + E + + + +RP D
Sbjct: 175 ----YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 52/227 (22%)
Query: 825 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884
C+ + ++ + V + DE + E ++L L H I+E Y + + K L
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74
Query: 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----LSETGEKHVSVKLALFIAQDVAA 939
I MEY GG++ YI+K L E H V++ L
Sbjct: 75 --------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-------- 112
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 999
AL +H+K I+HRD+K++NIL+D + K VVK+ DF + L S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLD--KHKM----VVKIGDFGISKILSS-----------K 155
Query: 1000 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046
VGTP +++PE+ KP Y + DIW+ GC+L EL +L+
Sbjct: 156 SKAYTVVGTPCYISPELCEG--KP--YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + I+++ E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1019
D E +K+ DF C + G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKENMWDGVTTKTFC-GTPDYIAPEIIA- 174
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
++P YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 175 -YQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 958
I MEY+ GGS ++K+ + + + ++ IA V L LH KH I+HRD+K N
Sbjct: 76 ICMEYMDGGS----LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL++ + G+ +KLCDF + L +A VGT +MAPE ++
Sbjct: 132 ILVN-----SRGQ--IKLCDFGVSGQL-----VNSLA-------KTFVGTSSYMAPERIQ 172
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-----LSELEIHDLIQMGKRPRLTDEL 1073
N Y ++ DIWS G L+EL T + PY E+ I PRL
Sbjct: 173 ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--- 225
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
F D C ++P ERP+ +L E
Sbjct: 226 --------------SGKFSPD---------FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ + E A+F A +++ L LH + I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1019
D E +K+ DF C H G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKEHMVDGVTTRTFC-GTPDYIAPEII-- 173
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
++P YG VD W+YG LL E+L Q P+ G E E+ I
Sbjct: 174 AYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 63/297 (21%)
Query: 828 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
GS V+TL+ G++ E + F L E ++ H IV++ G
Sbjct: 23 GSGPIRVAVKTLRK-GATDQEKKEF----LKEAHLMSNFNHPNIVKLLG--------VCL 69
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIE--KLSETGEKHVSVKLALFIAQDVAAALVELH 945
P++ I ME ++GG + +Y+ ++ G +++K L I DVA V L
Sbjct: 70 LNEPQY------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1005
H +HRD+ + N L+ K D VVK+ DF A + + +P
Sbjct: 124 QMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177
Query: 1006 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMG 1064
RWMAPE L + + D+WS+G L+ E+LTL Q PY L+ E+ + G
Sbjct: 178 ----RWMAPESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 1065 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
R L+ +C + + + C ++P+ERPT
Sbjct: 230 GR------LQKPENCPDK---------------------IYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E +L H IV++ G P + I ME V GGS+ ++ K
Sbjct: 40 LQEAEILKQYDHPNIVKLIG--------VCVQKQPIY------IVMELVPGGSLLTFLRK 85
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ ++VK L ++ D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 ----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF + ++T + IP +W APE L Y E D+WSYG
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPI--------KWTAPEALNY----GRYTSESDVWSYG 182
Query: 1037 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDE 1072
LL E +L PY G+S + + I+ G R P+L E
Sbjct: 183 ILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 51/245 (20%)
Query: 830 ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK------- 882
AA K+ L++ D I+ GEV+++ RH ++Y K+ SK
Sbjct: 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLV---RHKSSKQVYAMKLLSKFEMIKRS 85
Query: 883 -----WLPS---ADGNPE-----HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHV 925
W A N E H+ Q + MEY+ GG + N +
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL------MSNYDI 139
Query: 926 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 985
K A F +V AL +HS +HRD+K +N+L+D G +KL DF
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH--LKLADFG----- 187
Query: 986 RSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
TC G+ D VGTP +++PEVL++ YG E D WS G L E+L
Sbjct: 188 -----TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 1045 LQVPY 1049
P+
Sbjct: 243 GDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 72/272 (26%), Positives = 104/272 (38%), Gaps = 69/272 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L +L+H IV+ G + + +IFME+V GGS+ + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTI--------------SIFMEFVPGGSISSILNRFG 97
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E V K I VA LH+ ++HRDIK N+++ +G ++KL D
Sbjct: 98 PLPEP-VFCKYTKQILDGVAY----LHNNCVVHRDIKGNNVML-----MPNG--IIKLID 145
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
F A L ++ GTP WMAPEV+ YG + DIWS
Sbjct: 146 FGCARRL-------AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG----YGRKSDIWSI 194
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093
GC + E+ T + P + L I G PRL D A
Sbjct: 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA---------------- 238
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+D C + ERP+A L
Sbjct: 239 -----------IDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + +I+ E A F A ++ L LH K I++RD+K +N+L+
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEAR-----ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D DG +K+ DF C G GTP ++APE+L
Sbjct: 130 D-----KDGH--IKIADFG----------MCKENMNGEGKASTFCGTPDYIAPEIL---- 168
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
K Y VD WS+G LL E+L Q P+ G E E+ D I
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 73/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ M+ +H IV +G +S + L I MEY GGS+++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKL--------------WICMEYCGGGSLQDIYHVTG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E ++ ++ ++ L LHSK MHRDIK NIL+ D VKL D
Sbjct: 102 PLSELQIA-----YVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGD----VKLAD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A + T IA R +GTP WMAPEV A+ K Y DIW+ G
Sbjct: 150 FGVAAKI-----TATIAKR-----KSFIGTPYWMAPEV-AAVEKNGGYNQLCDIWAVGIT 198
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 1093
+EL LQ P L + L M K P+L D+ + + H +++ + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
Query: 1094 PEAE 1097
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 30/162 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME+V GG + +I+K E A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRA 1019
D E KL DF C G C GTP ++APE+L+
Sbjct: 130 DHEGH-------CKLADFGM-----------CKEGIFNGKTTSTFC-GTPDYIAPEILQE 170
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
M LYG VD W+ G LL E+L P+ +E ++ + I
Sbjct: 171 M----LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 58/277 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L L H IV+ G + G L+ MEY+ GS+++Y+++
Sbjct: 56 EIEILRTLDHENIVKYKG-------VCEKPGGRSLRLI-----MEYLPSGSLRDYLQRHR 103
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ +++K L + + + L S+ +HRD+ + NIL++ E VK+ D
Sbjct: 104 D----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-------VKISD 152
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
F + +P + P W APE LR + + D+WS+G
Sbjct: 153 FGLAKVLPEDKDYYY-VKEPGESPI--------FWYAPECLRT----SKFSSASDVWSFG 199
Query: 1037 CLLLELLTL----QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092
L EL T Q P + QM +T LE L + G
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQM----IVTRLLELL---------KEGERLP 246
Query: 1093 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+P + + D+ + C E P +RP+ DL +
Sbjct: 247 RPPS---CPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-15
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 900 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 959 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
IL+ + DG VKL DF + P +S VGTP WMAPE
Sbjct: 147 ILLGM-----DGS--VKLTDFGFCAQITPEQS-------------KRSTMVGTPYWMAPE 186
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1073
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 187 VVTR----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 1074 EA-----LGSCHEHEVAQSGSG-------FEKPEAELETLSFLVDVFRRCTEEN 1115
A L C + +V + GS F K L +L+ L+ + T+ N
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 40/203 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY+ GGS+ + + +ET + + ++ AL LH+ ++HRDIKS+N+
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 960 LIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
L+ ++ VKL DF + P +S T VGTP WMAPEV
Sbjct: 147 LLGMDGS-------VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPEV 186
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE---- 1072
+ YG +VDIWS G + +E++ + PY+ + L LI P L +
Sbjct: 187 VTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 1073 ---LEALGSCHEHEVAQSGSGFE 1092
+ L C E +V + GS E
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 42/204 (20%)
Query: 900 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALDFLHSNQVIHRDIKSDN 145
Query: 959 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1073
V+ YG +VDIWS G + +E++ + PY+ + L LI P L + L
Sbjct: 186 VVTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 1074 EA-----LGSCHEHEVAQSGSGFE 1092
A L C E +V + GS E
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 59/270 (21%)
Query: 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG 864
FP+L K++ + L R K D K+R L++ + ++ GEV+++
Sbjct: 12 FPAL----RKNKNIDNFLNRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV- 62
Query: 865 ALRHSCIVEMYGHKISSKW--LPSADGN---PEHHLLQSA-------------------I 900
RH ++Y K+ SK+ + +D E ++ A +
Sbjct: 63 --RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 901 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960
MEY+ GG + N + V K A F +V AL +HS +HRD+K +N+L
Sbjct: 121 VMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRA 1019
+D +KL DF TC ++ G+ D VGTP +++PEVL++
Sbjct: 175 LDKSGH-------LKLADFG----------TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
YG E D WS G L E+L P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 63/311 (20%), Positives = 115/311 (36%), Gaps = 71/311 (22%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883
G + ++T+ S E F L E ++ +V + G + S
Sbjct: 29 GVVKGEPETRVAIKTVNENASM-RERIEF----LNEASVMKEFNCHHVVRLLG--VVST- 80
Query: 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-----VSVKLALFIAQDVA 938
G P + + ME + G +K+Y+ E + +++ + +A ++A
Sbjct: 81 -----GQP------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 998
+ L +K +HRD+ + N ++ + VK+ DF + +
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDL-------TVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 999 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEI 1057
+P RWMAPE L K ++ + D+WS+G +L E+ TL + PY GLS E+
Sbjct: 183 LPV--------RWMAPESL----KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 1058 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117
+ G L + L+++ R C + NP
Sbjct: 231 LKFVIDGGHLDLPENCP---------------------------DKLLELMRMCWQYNPK 263
Query: 1118 ERPTAGDLYEM 1128
RPT ++
Sbjct: 264 MRPTFLEIVSS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-14
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 835 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW--LPSADGN-- 890
K+R L++ D ++ GEV+++ RH ++Y K+ SK+ + +D
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLV---RHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 891 -PEHHLLQSA-------------------IFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 930
E ++ A + MEY+ GG + N + V K A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWA 144
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
F +V AL +HS ++HRD+K +N+L+D +KL DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------LKLADFG---------- 187
Query: 991 TCC-IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
TC + G+ D VGTP +++PEVL++ YG E D WS G L E+L P+
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + +I+ + + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 75 MEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D + +K+ DF C G GTP ++APE+L
Sbjct: 130 DTDGH-------IKIADFG----------MCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 173 ----YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
I + L +H HRD+K EN+L+ G VVK+ DF A +RS
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV-------SGPEVVKIADFGLAREIRS----- 151
Query: 993 CIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
P V T RW APE+L + + Y VDIW+ GC++ EL TL+ + G
Sbjct: 152 ------RPPYTDYVST-RWYRAPEIL--LRSTS-YSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 1052 LSELEIHDLIQ--MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE---LETL----- 1101
SE++ I +G P D E +++A GF P+ L L
Sbjct: 202 SSEIDQLYKICSVLGT-PTKQDWPEG------YKLASK-LGFRFPQFAPTSLHQLIPNAS 253
Query: 1102 SFLVDVFRRCTEENPTERPTAGDLYEM 1128
+D+ + +P +RPTA +
Sbjct: 254 PEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGN 112
L + ++ L L N + IP +G L+ L N+I PS + N
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRN 161
Query: 113 LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172
L LK L+LS + L ++ L L L +
Sbjct: 162 L-----------------------PNLKNLDLSF----NDLSDLPKLLSNLSNLNNLDLS 194
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
I LPPEI LS LE+LDLS N + L + + LK L L+++NNKL +LP + L
Sbjct: 195 GNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNL 254
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LE LDLSNN+++S+ S L + NL+ L+L N L +
Sbjct: 255 SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291
|
Length = 394 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 68/285 (23%)
Query: 859 EVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
E+RML LRH +V E++ K + +L+ E+V +V + +E
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK--KRL----------YLV-----FEFVDH-TVLDDLE 91
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
K G V+ LF + + HS +I+HRDIK ENIL+ VVK
Sbjct: 92 KY-PNGLDESRVRKYLF---QILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVK 140
Query: 976 LCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
LCDF A L + ++T +A R AP++ VG + YG VDIW
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK---------------YGRAVDIW 185
Query: 1034 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGF 1091
+ GCL+ E+LT + + G S++ D + + L L H+ ++ +G
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDI---DQLY-----HIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 1092 EKPEA-ELETL--------SFLVDVFRRCTEENPTERPTAGDLYE 1127
PE E+E L ++D+ ++C +P +RP++ L
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 66/206 (32%), Positives = 92/206 (44%), Gaps = 54/206 (26%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 999
L LHS I+HRD+K N+LI +DG V+KL DF A RSF
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-----SDG--VLKLADFGLA---RSF----------- 152
Query: 1000 PAPDVCVGTP----RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 1053
+P+ T RW APE+L YG+ VD+WS GC+ ELL L+VP++ G S
Sbjct: 153 GSPNR-KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELL-LRVPFLPGDS 207
Query: 1054 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-----SGSGFEK-PEAELETL-----S 1102
+++ Q+GK EALG+ E F+ P L+ +
Sbjct: 208 DID-----QLGKI------FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 1103 FLVDVFRRCTEENPTERPTAGDLYEM 1128
+D+ +R NP +R TA E
Sbjct: 257 DALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 60/212 (28%), Positives = 86/212 (40%), Gaps = 54/212 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 915
E+++L LRH IV + S + +I+M V Y++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYM-------VFEYMDHDL 86
Query: 916 -KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L ++ E + + + L LHS I+HRDIK NILI+ DG V+
Sbjct: 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-----NDG--VL 139
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR----WM-APEVLRAMHKPNLYGLE 1029
KL DF A R + T R W PE+L + YG E
Sbjct: 140 KLADFGLA--------------RPYTKRNSADYTNRVITLWYRPPELL--LGATR-YGPE 182
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
VD+WS GC+L EL + + G +ELE + I
Sbjct: 183 VDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 57/236 (24%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I ME V+GG ++ T + VK + + ++ AA + L SKH +HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ K V+K+ DF + ++ + IP +W APE L
Sbjct: 126 LV-------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV--------KWTAPEALNY 170
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
Y E D+WS+G LL E +L VPY LS + + I+ G R L
Sbjct: 171 ----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------LPCPEL 220
Query: 1079 CHEHEVAQSGSGFEKPEAELETLSFLVDVFR---RCTEENPTERPTAGDLYEMFVA 1131
C + V+R RC E +P +RP+ +++ +
Sbjct: 221 CPD------------------------AVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 73/278 (26%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E +++ LRH +V++Y + S + P + I EY+ GS+ ++++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYA--VCS------EEEPIY------IVTEYMSKGSLLDFLK- 93
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
S G+K +L AQ +A + L S++ +HRD+ + NIL+ V K+
Sbjct: 94 -SGEGKKLRLPQLVDMAAQ-IAEGMAYLESRNYIHRDLAARNILV-------GENLVCKI 144
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1033
DF A R A G P +W APE YG ++ D+W
Sbjct: 145 ADFGLA---RLIEDDEYTAREGAKFP------IKWTAPEAA-------NYGRFTIKSDVW 188
Query: 1034 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGF 1091
S+G LL E++T +VPY G++ E+ + ++ G R PR + C
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN-------C------------ 229
Query: 1092 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
PE L D+ +C +++P ERPT L
Sbjct: 230 --PEE-------LYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 82/311 (26%), Positives = 138/311 (44%), Gaps = 70/311 (22%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AAAKV K S +E+ ++ + E+ +L H IV++ G + W DG
Sbjct: 40 AAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLG---AFYW----DG-- 82
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+ I +E+ GG+V + +L + G +++ I + + AL LHS I+H
Sbjct: 83 -----KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQV---ICRQMLEALQYLHSMKIIH 133
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RD+K+ N+L+ L DG +KL DF V ++ + + D +GTP W
Sbjct: 134 RDLKAGNVLLTL-----DGD--IKLADF--GVSAKNV--------KTLQRRDSFIGTPYW 176
Query: 1012 MAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 1070
MAPEV+ K Y + DIWS G L+E+ ++ P+ L+ + + I + P L+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-F 1129
+ + +E FL + +++P RP+A L E F
Sbjct: 237 ---------------------QPSKWSMEFRDFL----KTALDKHPETRPSAAQLLEHPF 271
Query: 1130 VARTSSSISSR 1140
V+ +S+ R
Sbjct: 272 VSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 35/256 (13%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G +++ + A ++ + V G +EI+ E+ ML H +
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EINMLKKYSHHRNIAT 67
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
Y K P D Q + ME+ GSV + I+ T + + +I
Sbjct: 68 YYGAFIKKNPPGMDD-------QLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYIC 117
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+++ L LH ++HRDIK +N+L+ + VKL DF + L
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------VKLVDFGVSAQL--------- 161
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLS 1053
R + + +GTP WMAPEV+ P+ Y + D+WS G +E+ P +
Sbjct: 162 -DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
Query: 1054 ELEIHDLIQMGKRPRL 1069
+ LI PRL
Sbjct: 221 PMRALFLIPRNPAPRL 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 23/152 (15%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY GG + I + + G ++ + Q ++ L +H + I+HRDIKS+NI
Sbjct: 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQ-ISLGLKHIHDRKILHRDIKSQNI 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
+ +G V KL DF A R + +A+ CVGTP +++PE+ +
Sbjct: 133 FL-----SKNGM-VAKLGDFGIA---RQLNDSMELAY-------TCVGTPYYLSPEICQ- 175
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
++P Y + DIWS GC+L EL TL+ P+ G
Sbjct: 176 -NRP--YNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 893 HHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+ Q M+Y GG + + K E + +A F ++ A+ +H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
+HRDIK +N+L+D ++L DF + L + G +V VGT
Sbjct: 123 YVHRDIKPDNVLLDKNGH-------IRLADFGSCLRLLA---------DGTVQSNVAVGT 166
Query: 1009 PRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
P +++PE+L+AM YG E D WS G + E+L + P+ S +E + I
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 834 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPE 892
A ++ + V +EI+ E+ ML H I YG I +P
Sbjct: 44 AAIKVMDVTEDEEEEIKL-------EINMLKKYSHHRNIATYYGAFIKK--------SPP 88
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
H Q + ME+ GSV + ++ K + +I +++ L LH+ ++HR
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA---YICREILRGLAHLHAHKVIHR 145
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DIK +N+L+ + A+ VKL DF + L R + + +GTP WM
Sbjct: 146 DIKGQNVLLT---ENAE----VKLVDFGVSAQL----------DRTVGRRNTFIGTPYWM 188
Query: 1013 APEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1069
APEV+ P+ Y DIWS G +E+ P + + LI P+L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ M+ +HS IV +G + L I ME+ GGS+++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKL--------------WICMEFCGGGSLQDIYHVTG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E ++ +++++ L LHSK MHRDIK NIL+ VKL D
Sbjct: 102 PLSESQIA-----YVSRETLQGLYYLHSKGKMHRDIKGANILL-------TDNGHVKLAD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F + + T IA R +GTP WMAPEV A+ + Y DIW+ G
Sbjct: 150 FGVSAQI-----TATIAKR-----KSFIGTPYWMAPEV-AAVERKGGYNQLCDIWAVGIT 198
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 1093
+EL LQ P L + L M K P+L D+++ S H ++A + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256
Query: 1094 PEAE 1097
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 50/231 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 960
ME++ GS+ +K + V++ IA V L L++ H IMHRDIK NIL
Sbjct: 82 MEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
+ + + +KLCDF + L + IA D VGT +M+PE ++
Sbjct: 137 V-------NSRGQIKLCDFGVSGELIN-----SIA-------DTFVGTSTYMSPERIQG- 176
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1080
K Y ++ D+WS G ++EL + P+ + + MG L+ L
Sbjct: 177 GK---YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-------LDLL---- 222
Query: 1081 EHEVAQSGSGFEKPEAELETLSF---LVDVFRRCTEENPTERPTAGDLYEM 1128
++ Q +P L + F L D C ++PTERPT L M
Sbjct: 223 -QQIVQ------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +NI
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D+ ++L DF + L G V VGTP +++PE+L+A
Sbjct: 134 LMDMNGH-------IRLADFGSCLKL---------MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 1020 MHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL--------- 1069
M YG E D WS G + E+L + P+ S +E + I M + R
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHKERFQFPAQVTDV 236
Query: 1070 ----TDELEALGSCHEHEVAQSG 1088
D + L EH + Q+G
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNG 259
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 51/231 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I E++ G N ++ L E + V+ + L++A +++A+ L K+ +HRD+ + N
Sbjct: 79 IITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ E +VK+ DF + + +T AH G P +W APE L
Sbjct: 136 LVG-ENH------LVKVADFGLSRLMTGDTYT---AHAGAKFP------IKWTAPESLAY 179
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
N + ++ D+W++G LL E+ T + PY G+ ++++L++ G R
Sbjct: 180 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------ 223
Query: 1079 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
E+PE + ++ R C + NP++RP+ ++++ F
Sbjct: 224 ------------MERPEGCPPK---VYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 34/100 (34%), Positives = 45/100 (45%), Gaps = 19/100 (19%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+H+ IMHRD+K N+LI ADG V+K+ DF A
Sbjct: 115 MHANGIMHRDLKPANLLIS-----ADG--VLKIADFGLARLFSE---------EEPRLYS 158
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043
V T + APE+L K Y VD+W+ GC+ ELL
Sbjct: 159 HQVATRWYRAPELLYGARK---YDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
C+ E+ +L L H +++ Y I L I +E G + I+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMIK 94
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + + Q + +AL +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 1036 GCLLLELLTLQVPYMG 1051
GCLL E+ LQ P+ G
Sbjct: 193 GCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 958
I ME++ GGS+ ++K E + I+ V L L KH IMHRD+K N
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHKIMHRDVKPSN 130
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
IL++ + G+ +KLCDF + L SF VGT +M+
Sbjct: 131 ILVN-----SRGE--IKLCDFGVSGQLIDSMANSF-----------------VGTRSYMS 166
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
PE L+ H Y ++ DIWS G L+E+ + P E+ + E
Sbjct: 167 PERLQGTH----YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222
Query: 1074 EALGSCHEHEVAQSGSGFE-------KPEAELETLSF---LVDVFRRCTEENPTERPTAG 1123
S H + + + FE +P +L + +F D +C ++NP ER
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA--- 279
Query: 1124 DLYEMFVA 1131
DL E+
Sbjct: 280 DLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 61/251 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S D ++FE E +L +H IV+ YG +G+P
Sbjct: 40 VKTLKE-TASNDARKDFER----EAELLTNFQHENIVKFYG--------VCTEGDPPI-- 84
Query: 896 LQSAIFMEYVKGGSVKNYIEK-------LSETGEKHVSVKLA--LFIAQDVAAALVELHS 946
+F EY++ G + ++ L + L+ L IA +A+ +V L S
Sbjct: 85 ---MVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 947 KHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
+H +HRD+ + N L+ DL VVK+ DF + + + + H +P
Sbjct: 141 QHFVHRDLATRNCLVGYDL---------VVKIGDFGMSRDVYTTDYYRVGGHTMLPI--- 188
Query: 1005 CVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1060
RWM PE + +Y E D+WS+G +L E+ T + P+ GLS E+ +
Sbjct: 189 -----RWMPPESI-------MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 1061 IQMGK---RPR 1068
I G+ RPR
Sbjct: 237 ITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 50/163 (30%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + +I S A+F A V L LH I++RD+K +N+L+
Sbjct: 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D E VK+ DF + T C GTP ++APEVL
Sbjct: 135 DTE-------GFVKIADFGLCKEGMGFGDRTSTFC-------------GTPEFLAPEVLT 174
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
Y VD W G L+ E+L + P+ G E E+ D I
Sbjct: 175 ETS----YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 55/208 (26%)
Query: 857 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
L E+++L L H I+ +++ HK L + E++
Sbjct: 46 LREIKLLKELNHPNIIKLLDVFRHK--------------GDL---YLVFEFMDTD----- 83
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+ KL + ++ + L + L HS I+HRD+K EN+LI +G V
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-----NTEG--V 136
Query: 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKPNLYGL 1028
+KL DF A RSF V T RW APE+L Y
Sbjct: 137 LKLADFGLA---RSF------------GSPVRPYTHYVVTRWYRAPELLLGD---KGYST 178
Query: 1029 EVDIWSYGCLLLELLTLQVPYMGLSELE 1056
VDIWS GC+ ELL+ + + G SE++
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 80/287 (27%)
Query: 857 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EVR L LRH +E G + + WL MEY G S + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWL----------------VMEYCLG-SASDIL 105
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E + ++ V++A I L LHS +HRDIK+ NIL+ G V
Sbjct: 106 EVHKKPLQE---VEIAA-ICHGALQGLAYLHSHERIHRDIKAGNILL-----TEPG--TV 154
Query: 975 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 155 KLADFGSASLVSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 196
Query: 1032 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G 1090
+WS G +EL + P + + + AL + +AQ+ S
Sbjct: 197 VWSLGITCIELAERKPPLFNM------------------NAMSAL-----YHIAQNDSPT 233
Query: 1091 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSS 1136
+ +F+ C ++ P +RP++ +L + FV R
Sbjct: 234 LSSNDWSDYFRNFV----DSCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 61/275 (22%), Positives = 97/275 (35%), Gaps = 75/275 (27%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
+ E R+L L S I+ Y + L I MEY + G + ++
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKL--------------NIVMEYAENGDLHKLLK 91
Query: 916 K-----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
L E +++ L L LHSK I+HRDIKS N+ +D D
Sbjct: 92 MQRGRPLPEDQVWRFFIQILL--------GLAHLHSKKILHRDIKSLNLFLD----AYDN 139
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030
VK+ D A L I VGTP +++PE+ KP Y +
Sbjct: 140 ---VKIGDLGVA----KLLSDNTNFANTI------VGTPYYLSPELCE--DKP--YNEKS 182
Query: 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1090
D+W+ G +L E T + P+ ++ + I G P +
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV------------------SQM 224
Query: 1091 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ + L + +C ++ +RP L
Sbjct: 225 YSQQ---------LAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 7e-13
Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 999
AL +HS +++HRD+K NIL++ + + VKL DF A RS + +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-------VKLADFGLA---RSL--SELEENPEN 166
Query: 1000 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH 1058
P V T RW APE+L + Y VD+WS GC+L E+L + + G S L
Sbjct: 167 PVLTDYVAT-RWYRAPEILLGSTR---YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222
Query: 1059 DLIQMGKRPRLTDE-LEALGSCHEHEV-AQSGSGFEKPEAEL------ETLSFLVDVFRR 1110
+ I + + E +E++ S + S KP EL + L L ++
Sbjct: 223 EKI-IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL----KK 277
Query: 1111 CTEENPTERPTA 1122
NP +R TA
Sbjct: 278 LLVFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 68/240 (28%), Positives = 101/240 (42%), Gaps = 55/240 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY+ GGS + + K E +++ I +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-KPGPLEETYIAT-----ILREILKGLDYLHSERKIHRDIKAANV 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ ++ D VKL DF A L T R + VGTP WMAPEV+
Sbjct: 133 LLS---EQGD----VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI-- 173
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1079
K + Y + DIWS G +EL + P L + + LI P L +
Sbjct: 174 --KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ------- 224
Query: 1080 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 1138
+ KP + C ++P RPTA +L + F+ R + S
Sbjct: 225 -----------YSKP---------FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D+ ++L DF + + G V VGTP +++PE+L+A
Sbjct: 134 LLDMNGH-------IRLADFGSCLKMNQ---------DGTVQSSVAVGTPDYISPEILQA 177
Query: 1020 MHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
M YG E D WS G + E+L + P+ S +E + I
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +++ L H +V++YG + +K P I EY+ G + NY+ +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIF------------IVTEYMANGCLLNYLRERK 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ L + DV A+ L S +HRD+ + N L+ + VVK+ D
Sbjct: 95 GKLGT----EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSD 143
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A R L + +G P +W PEV + + + + D+WS+G L
Sbjct: 144 FGLA---RYVLDDQYTSSQGTKFP------VKWAPPEVF--DY--SRFSSKSDVWSFGVL 190
Query: 1039 LLELLTL-QVPYMGLSELEIHDLIQMG---KRPRL--TDELEALGSCHEH 1082
+ E+ + ++PY S E+ + + G RP+L T+ + SC
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 32/153 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ +EYV GG + ++++ + E+H A F A ++ AL LH + I++RD+K +N+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1016
L+D ADG +KL D+ + G+ D GTP ++APE+
Sbjct: 128 LLD-----ADGH--IKLTDYG-------------MCKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
LR YG VD W+ G L+ E++ + P+
Sbjct: 168 LRGEE----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME++ GG + +I+ + + A F A ++ L LHSK I++RD+K +N+++
Sbjct: 75 MEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D DG +K+ DF C G GTP ++APE+L+ +
Sbjct: 130 D-----RDGH--IKIADFG----------MCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
Y VD WS+G LL E+L Q P+ G E E+ + I++
Sbjct: 173 ----YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 81/353 (22%), Positives = 145/353 (41%), Gaps = 107/353 (30%)
Query: 813 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 872
E GK V ++ FR K + V+ LK +S+ E+R+ L E +L + H ++
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDL----LSEFNLLKQVNHPHVI 66
Query: 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI------------------ 914
++YG S DG + +EY K GS+++++
Sbjct: 67 KLYG-------ACSQDGPL-------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
L E+ +++ + A ++ + L ++HRD+ + N+L+ A+G+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------AEGR-K 165
Query: 974 VKLCDF--------DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAPEVLRAMHKPN 1024
+K+ DF + + RS +G IP +WMA E L H
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRS---------KGRIPV--------KWMAIESL-FDH--- 204
Query: 1025 LYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1083
+Y + D+WS+G LL E++TL PY G++ + +L++ G R
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------- 247
Query: 1084 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVAR 1132
E+PE E + L+ C ++ P +RPT + +L +M V
Sbjct: 248 -------MERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-12
Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 28/174 (16%)
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
D ++L A+ ++Y G ++ I+ ++T + L Q V A+ +HSK
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-VLLAVHHVHSK 162
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--- 1004
H++HRDIKS NIL+ ++G +VKL DF + + + T + DV
Sbjct: 163 HMIHRDIKSANILL-----CSNG--LVKLGDFGFS---KMYAATV--------SDDVGRT 204
Query: 1005 -CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 1057
C GTP ++APE+ R KP Y + D++S G LL ELLTL+ P+ G + E+
Sbjct: 205 FC-GTPYYVAPEIWR--RKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+E+V GG + ++ K +A F ++ A LHSK I++RD+K EN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 960 LIDLERKKADGKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
L+ D K VK+ DF A VP R+F T C GTP ++APEV+
Sbjct: 150 LL-------DNKGHVKVTDFGFAKKVPDRTF--TLC-------------GTPEYLAPEVI 187
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
++ +G VD W+ G LL E + P+ + I++ I G+
Sbjct: 188 QSKG----HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + I++ + E + F A +V AL+ LH +++RD+K +NIL+
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVL 1017
D A+G KL DF + GI V GTP ++APE+L
Sbjct: 130 D-----AEGH--CKLADFG-------------MCKEGI-LNGVTTTTFCGTPDYIAPEIL 168
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
+ + YG VD W+ G L+ E++ Q P+ +E ++ + I
Sbjct: 169 QELE----YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 880 SSKWLPSADG--NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 937
+S W+P + +L + MEY GG + + + + + ++ +A F ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNRYEDQFDE----DMAQFYLAEL 111
Query: 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 997
A+ +H +HRDIK EN+LID +KL DF A L +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGH-------IKLADFGSAARLTANKMV------ 158
Query: 998 GIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+ VGTP ++APEVL M+ YG+E D WS G + E++ + P+
Sbjct: 159 ---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 37/184 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ +EY+ GG + ++E+ E A F +++ AL LH + I++RD+K ENI
Sbjct: 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 960 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
L+D A G VKL DF ++ + HT C GT +MAPE+
Sbjct: 132 LLD-----AQGH--VKLTDFGLCKESIHEGTVTHTFC-------------GTIEYMAPEI 171
Query: 1017 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDE 1072
L R+ H G VD WS G L+ ++LT P+ + + D I GK P LT E
Sbjct: 172 LMRSGH-----GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 1073 LEAL 1076
L
Sbjct: 227 ARDL 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 72/287 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK + L E +++ LRH ++++Y P +
Sbjct: 35 VKTLKPGTMDPKDF-------LAEAQIMKKLRHPKLIQLYA--------VCTLEEPIY-- 77
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I E +K GS+ Y++ + + + + +A VA+ + L +++ +HRD+
Sbjct: 78 ----IVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N+L+ + + K+ DF A R A G P +W APE
Sbjct: 131 ARNVLV------GENN-ICKVADFGLA---RVIKEDIYEAREGAKFP------IKWTAPE 174
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
N + ++ D+WS+G LL E++T ++PY G++ E+ + G R +
Sbjct: 175 AALY----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MP 224
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
C P+ L D+ C +E+P +RPT
Sbjct: 225 CPPGC--------------PKE-------LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I +E+ GG+V + +L E+ ++ + + AL LH I+HRD+K+ NI
Sbjct: 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L L DG +KL DF + R I D +GTP WMAPEV+
Sbjct: 135 LFTL-----DGD--IKLADFGVSAK----------NTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 1020 -MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1069
K Y + D+WS G L+E+ ++ P+ L+ + + I + P L
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ EY G + N++ + E+ ++++ L + VA + L SK+ +HRD+ + N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG---IPAPDVCVGTPRWMAPEV 1016
L+ GK +VK+CDF A R ++ +G +P +WMAPE
Sbjct: 173 LL------THGK-IVKICDFGLA---RDIMNDSNYVVKGNARLPV--------KWMAPES 214
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEA 1075
+ +Y E D+WSYG LL E+ +L PY G+ D
Sbjct: 215 IFN----CVYTFESDVWSYGILLWEIFSLGSNPYPGM----------------PVDSK-- 252
Query: 1076 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
+++ + G +PE + D+ + C + +P +RPT
Sbjct: 253 -----FYKLIKEGYRMAQPEHAPAE---IYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 62/274 (22%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
C+ E+ +L L H ++ K+L S + E + I +E G + I+
Sbjct: 49 CVKEIDLLKQLNHPNVI---------KYLDSFIEDNELN-----IVLELADAGDLSQMIK 94
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + + Q + +A+ +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 YFKKQKRLIPERTVWKYFVQ-LCSAVEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1095
GCLL E+ LQ P+ G D++ C + E + P
Sbjct: 193 GCLLYEMAALQSPFYG-------------------DKMNLFSLCQKIEQC------DYPP 227
Query: 1096 AELETLS-FLVDVFRRCTEENPTERPTAGDLYEM 1128
E S L ++ C +P +RP G ++++
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 32/151 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+E+V GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLR 1018
D A+G +KL D+ + GI D GTP ++APE+LR
Sbjct: 130 D-----AEGH--IKLTDYG-------------MCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
YG VD W+ G L+ E++ + P+
Sbjct: 170 GED----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 71/319 (22%), Positives = 113/319 (35%), Gaps = 82/319 (25%)
Query: 817 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876
SV ++ K G A V+TLK + I + L E ++ L H CIV + G
Sbjct: 10 SVVKGVYLMKSGKEVEVA-VKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 936
+ + ME G + Y++K + + V +A
Sbjct: 64 VCKGEPLM---------------LVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQ 103
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCI 994
VA + L SKH +HRD+ + N+L L + K+ DF RA+ S +
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVL--LVNRHQ-----AKISDFGMSRALGAGSDYYR--- 153
Query: 995 AHRGIPAPDVCVGTPRWMAPEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 1050
A P +W APE + + K D+WSYG L E + PY
Sbjct: 154 ATTAGRWP------LKWYAPECINYGKFSSKS-------DVWSYGVTLWEAFSYGAKPYG 200
Query: 1051 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110
+ E+ +++ G+R L C + + +
Sbjct: 201 EMKGAEVIAMLESGER------LPRPEECPQE---------------------IYSIMLS 233
Query: 1111 CTEENPTERPTAGDLYEMF 1129
C + P +RPT +L F
Sbjct: 234 CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 914
E +L L+H IV+ YG DG+P + EY+K G + ++
Sbjct: 57 EAELLTNLQHEHIVKFYG--------VCGDGDP------LIMVFEYMKHGDLNKFLRAHG 102
Query: 915 ---------EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965
+ GE + + L IA +A+ +V L S+H +HRD+ + N L+
Sbjct: 103 PDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---- 156
Query: 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025
+VK+ DF + + S + H +P RWM PE + M++
Sbjct: 157 ---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI--------RWMPPESI--MYRK-- 201
Query: 1026 YGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK---RPRL 1069
+ E D+WS+G +L E+ T + P+ LS E+ + I G+ RPR+
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 23/150 (15%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ++YV GG + ++ + E V V +A ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-----EIVLALDHLHQLGIIYRDIKLENI 136
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D ++G V L DF + + FL A A C GT +MAPEV+R
Sbjct: 137 LLD-----SEGH--VVLTDFGLS---KEFL-----AEEEERAYSFC-GTIEYMAPEVIRG 180
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+ VD WS G L ELLT P+
Sbjct: 181 --GSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 67/267 (25%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E ++ L+H +V +Y + +K P I EY+ GS+ ++++
Sbjct: 49 LEEANLMKTLQHDKLVRLYA--VVTKEEPIY------------IITEYMAKGSLLDFLK- 93
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
S+ G K + KL F AQ +A + + K+ +HRD+++ N+L+ + K+
Sbjct: 94 -SDEGGKVLLPKLIDFSAQ-IAEGMAYIERKNYIHRDLRAANVLVS-------ESLMCKI 144
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF A + +T A G P +W APE + + ++ D+WS+G
Sbjct: 145 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAINF----GSFTIKSDVWSFG 191
Query: 1037 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 1094
LL E++T ++PY G+S ++ +Q G R PR+ + C +
Sbjct: 192 ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN-------CPDE------------ 232
Query: 1095 EAELETLSFLVDVFRRCTEENPTERPT 1121
L D+ + C +E ERPT
Sbjct: 233 ---------LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 72/269 (26%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E ++ L+H +V++ H + +K P + I E++ GS+ ++++
Sbjct: 49 LAEANVMKTLQHDKLVKL--HAVVTK-------EPIY------IITEFMAKGSLLDFLK- 92
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
S+ G K KL F AQ +A + + ++ +HRD+++ NIL+ V K+
Sbjct: 93 -SDEGSKQPLPKLIDFSAQ-IAEGMAFIEQRNYIHRDLRAANILVS-------ASLVCKI 143
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1033
DF A + +T A G P +W APE + +G ++ D+W
Sbjct: 144 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAIN-------FGSFTIKSDVW 187
Query: 1034 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092
S+G LL+E++T ++PY G+S E+ ++ G R + +C E
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE------NCPEE---------- 231
Query: 1093 KPEAELETLSFLVDVFRRCTEENPTERPT 1121
L ++ RC + P ERPT
Sbjct: 232 -----------LYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 64/214 (29%), Positives = 91/214 (42%), Gaps = 51/214 (23%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVK---GGS 909
S L E+ +L LRH IVE+ + K L S IF MEY +
Sbjct: 52 SSLREITLLLNLRHPNIVELK-EVVVGKHLDS-------------IFLVMEYCEQDLASL 97
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
+ N SE+ VK + + L LH I+HRD+K N+L+
Sbjct: 98 LDNMPTPFSES-----QVKC---LMLQLLRGLQYLHENFIIHRDLKVSNLLL-------T 142
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAMHKPNLYG 1027
K +K+ DF A R++ G+PA + V T + APE+L Y
Sbjct: 143 DKGCLKIADFGLA---RTY---------GLPAKPMTPKVVTLWYRAPELLLGCTT---YT 187
Query: 1028 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
+D+W+ GC+L ELL + G SE+E DLI
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I ME + G++ N+ L G VSV L + DVA + L SK ++HRD+ + NI
Sbjct: 75 IVMELMSKGNLVNF---LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ DG V K+ DF +A G D +W APE L
Sbjct: 132 LV-----SEDG--VAKVSDFG-------------LARVGSMGVDNSKLPVKWTAPEAL-- 169
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA--- 1075
K + + D+WSYG LL E+ + + PY +S E+ + ++ G R + A
Sbjct: 170 --KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 1076 --LGSCHEHEVAQSGSGFEKPEAELE 1099
+ SC E E + S F K +LE
Sbjct: 228 VLMTSCWETEPKKRPS-FHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY GG + ++K+ K L + + +H K ++HRDIKS+NI
Sbjct: 75 IVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
+ +GK VKL DF A L S C VGTP ++ PE+
Sbjct: 132 FL-----TQNGK--VKLGDFGSARLLTSPGAYAC----------TYVGTPYYVPPEIWEN 174
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1053
M Y + DIWS GC+L EL TL+ P+ S
Sbjct: 175 MP----YNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 999
+L +H I HRDIK ENILI + ++KL DF +C +
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD--------ILKLADFG----------SCRGIYSKP 153
Query: 1000 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-- 1056
P + + T RW APE L YG ++DIW+ GC+ E+L+L + G +EL+
Sbjct: 154 PYTEY-IST-RWYRAPECLLTD---GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208
Query: 1057 --IHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRC 1111
IHD+ +G + + + + ++ G+G K P A E L D+ ++
Sbjct: 209 AKIHDV--LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL----DLLKKL 262
Query: 1112 TEENPTERPTA 1122
+P ER TA
Sbjct: 263 LAYDPDERITA 273
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M + GG +K +I GE A+F A + L LH + I++RD+K EN+L+
Sbjct: 72 MTLMNGGDLKYHI---YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D G V++ D AV L +G GTP +MAPEVL
Sbjct: 129 D-----DHGN--VRISDLGLAVEL-----------KGGKKIKGRAGTPGYMAPEVL---- 166
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQM 1063
+ +Y VD ++ GC L E++ + P+ E +E +L +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-12
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 35/181 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISDGATMKTFC-------------GTPEYLAPEVL- 167
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEA 1075
+ N YG VD W G ++ E++ ++P+ + +LI M + PR L+ E ++
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 224
Query: 1076 L 1076
L
Sbjct: 225 L 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + I+ L E +A +V + +LH + I+HRDIK EN+LI
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIA-----EVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D G +KL DF ++ G+ VGTP ++APE + +
Sbjct: 131 D-----QTGH--LKLTDFG-------------LSRNGLENKKF-VGTPDYLAPETI--LG 167
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+ D WS GC++ E L P+
Sbjct: 168 VGDDK--MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 33/152 (21%)
Query: 910 VKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
+K +++ +G +K LF + Q +A HS ++HRD+K +N+LI+
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC----HSHRVLHRDLKPQNLLIN-----T 135
Query: 969 DGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
+G +KL DF A VP+R++ H V T + APE+L
Sbjct: 136 EGA--IKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGC---K 176
Query: 1025 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
Y VDIWS GC+ E++T + + G SE++
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++YV GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1017
D + G V L DF + GI C GTP ++APEVL
Sbjct: 130 D-----SQGH--VVLTDFG-------------LCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
R +P Y VD W G +L E+L P+ E++D I
Sbjct: 169 R--KQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 74/311 (23%), Positives = 111/311 (35%), Gaps = 94/311 (30%)
Query: 852 FEYSCLGEVRMLGALRHSCIV---EMY--GHKISSKWLPS---------AD-----GNPE 892
F + L E+++L L+H +V +M S + S D NP
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
L +S I K Y+ +L E G + LH HI+HR
Sbjct: 110 VKLTESQI----------KCYMLQLLE-GINY-------------------LHENHILHR 139
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----CVG 1007
DIK+ NILI D + ++K+ DF A R + +G V
Sbjct: 140 DIKAANILI-------DNQGILKIADFGLA---RPY-DGPPPNPKGGGGGGTRKYTNLVV 188
Query: 1008 TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR 1066
T RW PE+L + + Y VDIW GC+ E+ T + G S+++ LI
Sbjct: 189 T-RWYRPPELL--LGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI----- 239
Query: 1067 PRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEE---------- 1114
+ G+ E +S G E + L + F + E
Sbjct: 240 ------FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 1115 -NPTERPTAGD 1124
+P +R TA D
Sbjct: 294 LDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 26/148 (17%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D E +KL D+ C R GTP ++APE+LR
Sbjct: 130 DSEGH-------IKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
YG VD W+ G L+ E++ + P+
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
+ H+L M+Y+K G + + ++K E +S I + + AL +LH +
Sbjct: 79 TTLKGHVL----IMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
I+H DIK EN+L D + + + LCD+ C I P GT
Sbjct: 130 IIHNDIKLENVLYDRAKDR------IYLCDYG----------LCKIIG----TPSCYDGT 169
Query: 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+ +PE ++ Y + D W+ G L ELLT + P+
Sbjct: 170 LDYFSPEKIK--GHN--YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 75/274 (27%), Positives = 103/274 (37%), Gaps = 77/274 (28%)
Query: 857 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EV+ L L+H +E G K + WL MEY G +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWL----------------VMEYCLGSA----- 107
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L E +K + I L LHS +++HRDIK+ NIL+ + V
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------V 160
Query: 975 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 161 KLADFGSASKSSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 202
Query: 1032 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1091
+WS G +EL + P ++ + I P L +E S GF
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----------QSNEWTDSFRGF 252
Query: 1092 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
VD C ++ P ERP + +L
Sbjct: 253 -------------VDY---CLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 71/242 (29%), Positives = 103/242 (42%), Gaps = 59/242 (24%)
Query: 900 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
I MEY+ GGS + +E L ET ++A I +++ L LHS+ +HRDIK+
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDET-------QIAT-ILREILKGLDYLHSEKKIHRDIKAA 130
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
N+L+ + VKL DF A L T R + VGTP WMAPEV+
Sbjct: 131 NVLLSEHGE-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI 173
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1077
K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 174 ----KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------- 222
Query: 1078 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSS 1136
+ KP L + C + P+ RPTA +L + F+ R +
Sbjct: 223 -----------GNYSKP---------LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
Query: 1137 IS 1138
S
Sbjct: 263 TS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + ++ + E+ S A F ++ +AL LHS +++RD+K EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D DG +K+ DF S G C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISD---------GATMKTFC-GTPEYLAPEVL---- 167
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEAL 1076
+ N YG VD W G ++ E++ ++P+ ++ +LI M + PR L+ E ++L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 68/298 (22%)
Query: 836 VRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 893
V+T+K+ + EI F E +C+ + H ++++ G + S+
Sbjct: 32 VKTMKLDIHTYSEIEEFLSEAACMKD------FDHPNVMKLIGVCFEA----SSLQKIPK 81
Query: 894 HLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
+ + + ++K G + +++ + + ++ L D+A + L +++ +HR
Sbjct: 82 PM----VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137
Query: 953 DIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
D+ + N ++ + V + DF + + + IA +P +
Sbjct: 138 DLAARNCMLREDMT-------VCVADFGLSKKIYSGDYYRQGRIAK--MPV--------K 180
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1069
W+A E L +Y + D+W++G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 181 WIAIESL----ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--- 233
Query: 1070 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
++PE + L L D+ C +P +RPT L E
Sbjct: 234 ---------------------LKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 39/209 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV+ L LRH ++ + + S G P + I E ++ GS+ + L
Sbjct: 52 EVQALKRLRHKHLISL--FAVCSV------GEPVY------IITELMEKGSLLAF---LR 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + V + +A VA + L ++ +HRD+ + NIL+ + V K+ D
Sbjct: 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-------VCKVAD 147
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A ++ ++ + + IP +W APE + + D+WS+G L
Sbjct: 148 FGLARLIKEDVYLS--SDKKIPY--------KWTAPEAASHGT----FSTKSDVWSFGIL 193
Query: 1039 LLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
L E+ T QVPY G++ E++D I G R
Sbjct: 194 LYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +++ L H +V++YG + +K P I EY+ G + NY L
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIY------------IVTEYMSNGCLLNY---LR 91
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E G++ +L L + +DV + L SK +HRD+ + N L+D G VK+ D
Sbjct: 92 EHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-----DQG--CVKVSD 143
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F + R L + G P RW PEVL + + D+W++G L
Sbjct: 144 FGLS---RYVLDDEYTSSVGSKFP------VRWSPPEVLLYSK----FSSKSDVWAFGVL 190
Query: 1039 LLELLTL-QVPYMGLSELEIHDLIQMGK---RPRLTDE--LEALGSCHEHEVAQSGSGFE 1092
+ E+ +L ++PY + E + + G RP L E + SC HE A+ F+
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW-HEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 62/229 (27%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ +++++GG + + K E+ V LA ++A AL LHS I++RD+K ENI
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLHSLGIIYRDLKPENI 129
Query: 960 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
L+D +G +KL DF ++ ++ C GT +MAPEV
Sbjct: 130 LLD-----EEGH--IKLTDFGLSKESIDHEKKAYSFC-------------GTVEYMAPEV 169
Query: 1017 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1075
+ R H D WS+G L+ E+LT +P+ G E +I K
Sbjct: 170 VNRRGHT-----QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------- 214
Query: 1076 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124
LG F PEA+ S L +F+R NP R AG
Sbjct: 215 LGMPQ----------FLSPEAQ----SLLRALFKR----NPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L A H IV+ + D + LL + MEY GG + I++
Sbjct: 115 ELHCLAACDHFGIVKHFD-----------DFKSDDKLL---LIMEYGSGGDLNKQIKQRL 160
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP--VVKL 976
+ ++ L Q + AL E+HS+ +MHRD+KS NI + P ++KL
Sbjct: 161 KEHLPFQEYEVGLLFYQ-IVLALDEVHSRKMMHRDLKSANIFL---------MPTGIIKL 210
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF + + + + + A C GTP ++APE+ Y + D+WS G
Sbjct: 211 GDFGFS---KQYSDSVSLD----VASSFC-GTPYYLAPELWERKR----YSKKADMWSLG 258
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+L ELLTL P+ G S+ EI + GK
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 92/301 (30%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK ++A + L E ++ LRH +V++ G GNP +
Sbjct: 34 VKCLKDDSTAAQ-------AFLAEASVMTTLRHPNLVQLLG--------VVLQGNPLY-- 76
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ +Y L G +++ L A DV + L K+ +HRD+
Sbjct: 77 ----IVTEYMAKGSLVDY---LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ + V K+ DF G+ A + G
Sbjct: 130 ARNVLVSEDL-------VAKVSDF------------------GL-AKEASQGQDSGKLPV 163
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY--MGLSELEIHDLIQMGKR 1066
+W APE LR + + D+WS+G LL E+ + +VPY + L ++ H ++ G R
Sbjct: 164 KWTAPEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH--VEKGYR 217
Query: 1067 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126
+EA C + V + C E +P +RPT L
Sbjct: 218 ------MEAPEGCPPE---------------------VYKVMKDCWELDPAKRPTFKQLR 250
Query: 1127 E 1127
E
Sbjct: 251 E 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 28/149 (18%)
Query: 900 IFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
I M+Y +GG + I ++ E + L F+ + AL +H + I+HRDIKS+
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFV--QICLALKHVHDRKILHRDIKSQ 130
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
NI + DG +KL DF A L S T +A C+GTP +++PE+
Sbjct: 131 NIFL-----TKDG--TIKLGDFGIARVLNS---TVELAR-------TCIGTPYYLSPEIC 173
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046
++P Y + DIW+ GC+L E+ TL+
Sbjct: 174 E--NRP--YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 836 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+TLK CG E+ +L L H IV+ G ++ +
Sbjct: 38 VKTLKRECGQQNTS------GWKKEINILKTLYHENIVKYKG--------CCSEQGGKGL 83
Query: 895 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
L MEYV GS+++Y+ K +++ L AQ + + LHS+H +HRD+
Sbjct: 84 QL----IMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133
Query: 955 KSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
+ N+L+D +R +VK+ DF +AVP +R D V W
Sbjct: 134 AARNVLLDNDR-------LVKIGDFGLAKAVP------EGHEYYRVREDGDSPV---FWY 177
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
A E L K N + D+WS+G L ELLT
Sbjct: 178 AVECL----KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 87/298 (29%), Positives = 123/298 (41%), Gaps = 88/298 (29%)
Query: 857 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
L E+RML L+H +V E++ K + L HL+ EY +V N
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRK---RKL---------HLV-----FEYCDH-TVLNE 89
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+EK +H+ K+ Q V H + +HRD+K ENILI K
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFC----HKHNCIHRDVKPENILI----TKQG---Q 138
Query: 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWM-APEVLRAMHKPNLYGL 1028
+KLCDF A R + P V T RW APE+L + YG
Sbjct: 139 IKLCDFGFA--------------RILTGPGDDYTDYVAT-RWYRAPELLVGDTQ---YGP 180
Query: 1029 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKR-PRLTDELEALGSCHEHEVA 1085
VD+W+ GC+ ELLT Q + G S+++ LI+ +G PR H+ +
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-----------HQQIFS 229
Query: 1086 QSG--SGFEKPEAE----LE---------TLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
+ G PE E LE LSFL + C + +PTER + +L E
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFL----KGCLQMDPTERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV+GG ++ + + V +A + AL LH+ I+HRD+K +N+LI
Sbjct: 80 MEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 962 DLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPE 1015
+ G +KL DF + + L + L+ I R VC GTP ++APE
Sbjct: 135 -----TSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPE 186
Query: 1016 V-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
V LR YG VD W+ G +L E L VP+ G + E+ + ++D++E
Sbjct: 187 VILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-------ISDDIE 234
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
G E A+ + D+ R +NP ER G +E+
Sbjct: 235 WPE------------GDEALPADAQ------DLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 64/247 (25%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 900 IFMEYVKGGSVKNYI-------EKLS-----ETGEKHVSVKLALFIAQDVAAALVELHSK 947
+ +EY G++++++ E S E L F Q VA + L SK
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ-VARGMEFLASK 151
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007
+HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 152 KCIHRDLAARNVLVTEDH-------VMKIADFGLA--------------RDIHHIDYYRK 190
Query: 1008 TPR------WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDL 1060
T WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L
Sbjct: 191 TTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 1061 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120
++ G R EKP L + R C E P++RP
Sbjct: 247 LKEGYR------------------------MEKP---QNCTQELYHLMRDCWHEVPSQRP 279
Query: 1121 TAGDLYE 1127
T L E
Sbjct: 280 TFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S + ++F E +L L+H IV+ YG +G+P
Sbjct: 40 VKTLK--DASDNARKDFHR----EAELLTNLQHEHIVKFYG--------VCVEGDP---- 81
Query: 896 LQSAIFMEYVKGGSVKNYIEK------LSETGE--KHVSVKLALFIAQDVAAALVELHSK 947
+ EY+K G + ++ L G ++ L IAQ +AA +V L S+
Sbjct: 82 --LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007
H +HRD+ + N L+ +VK+ DF + + S + H +P
Sbjct: 140 HFVHRDLATRNCLV-------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI------ 186
Query: 1008 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK- 1065
RWM PE + M++ + E D+WS G +L E+ T + P+ LS E+ + I G+
Sbjct: 187 --RWMPPESI--MYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240
Query: 1066 --RPR 1068
RPR
Sbjct: 241 LQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 61/232 (26%), Positives = 87/232 (37%), Gaps = 47/232 (20%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV RN L E +L L H + +Y + +L L+
Sbjct: 31 LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL---------CLV-- 79
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
M+Y GG L K +S ++A F A +V AL LH I++RD+K EN
Sbjct: 80 ---MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLH-TCCIAHRGIPAPDV------------- 1004
IL+ G + L DFD + +G V
Sbjct: 134 ILL-----HESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 1005 -----CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
VGT ++APEV+ + +G VD W+ G LL E+L P+ G
Sbjct: 187 FRSNSFVGTEEYIAPEVISG----DGHGSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 57/249 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK SA + +F+ E +L L+H IV YG +G P
Sbjct: 40 VKALKEASESARQ--DFQR----EAELLTVLQHQHIVRFYG--------VCTEGRP---- 81
Query: 896 LQSAIFMEYVKGGSVKNYIE------KLSETGEKHVSVKLAL----FIAQDVAAALVELH 945
+ EY++ G + ++ K+ GE +L L IA +A+ +V L
Sbjct: 82 --LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139
Query: 946 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
S H +HRD+ + N L+ L VVK+ DF + + S + +P
Sbjct: 140 SLHFVHRDLATRNCLVGQGL---------VVKIGDFGMSRDIYSTDYYRVGGRTMLPI-- 188
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 1062
RWM PE + +++ + E DIWS+G +L E+ T + P+ LS E + I
Sbjct: 189 ------RWMPPESI--LYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 1063 MGK---RPR 1068
G+ RPR
Sbjct: 239 QGRELERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 74/309 (23%), Positives = 114/309 (36%), Gaps = 83/309 (26%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
V+TL S DE +F L E ++ H IV + G S + P
Sbjct: 38 QVAVKTLPESCSEQDES-DF----LMEALIMSKFNHQNIVRLIG--------VSFERLPR 84
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIM 950
I +E + GG +K+++ + E+ S+ + LF A+DVA L H +
Sbjct: 85 F------ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----C 1005
HRDI + N L+ K G+ V K+ DF A R I
Sbjct: 139 HRDIAARNCLLT---CKGPGR-VAKIADFGMA--------------RDIYRASYYRKGGR 180
Query: 1006 VGTP-RWMAPEVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1060
P +WM PE L G+ + D+WS+G LL E+ +L +PY G + E+ +
Sbjct: 181 AMLPIKWMPPEAF-------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 1061 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120
+ G R L+ C P + + C + P +RP
Sbjct: 234 VTGGGR------LDPPKGC--------------PGP-------VYRIMTDCWQHTPEDRP 266
Query: 1121 TAGDLYEMF 1129
+ E
Sbjct: 267 NFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + ++ + E+ S F ++ +AL LHS I++RD+K EN+++
Sbjct: 74 MEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGITDAATMKTFC-------------GTPEYLAPEVL- 167
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR 1068
+ N YG VD W G ++ E++ ++P+ ++ +LI M K PR
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 72/271 (26%), Positives = 108/271 (39%), Gaps = 45/271 (16%)
Query: 804 SFPSLSSCDEA----GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 859
SFP S E GK +F+ + A V+ L D I + + E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAE 64
Query: 860 VRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+L AL H +V+ YG K + + D Q + +E GGSV + ++
Sbjct: 65 YNILKALSDHPNVVKFYG-MYYKKDVKNGD--------QLWLVLELCNGGSVTDLVKGFL 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ GE+ + + +I + L LH +HRD+K NIL+ E VKL D
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-------VKLVD 167
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 1037
F + L S + VGTP WMAPEV+ + + Y D+WS G
Sbjct: 168 FGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217
Query: 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1068
+EL P ++H + + K PR
Sbjct: 218 TAIELGDGDPPLA-----DLHPMRALFKIPR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 58/226 (25%)
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
Y+ K + G + + + + + + LHS I+HRD+K +NIL+ + +
Sbjct: 95 YLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ------ 145
Query: 973 VVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
VK+ DF + L S V T + APEVL + Y
Sbjct: 146 -VKIADFGLARIYSFEMALTS-----------------VVVTLWYRAPEVL--LQSS--Y 183
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--- 1083
VD+WS GC+ EL + + G SE + D I + +G E E
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI-----------FDVIGLPSEEEWPR 232
Query: 1084 -VAQSGSGFE----KPEAEL--ETLSFLVDVFRRCTEENPTERPTA 1122
V+ S F + E +D+ ++ NP +R +A
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 41/115 (35%), Positives = 52/115 (45%), Gaps = 23/115 (20%)
Query: 940 ALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 998
AL L KH ++HRD+K NIL+D A G VKLCDF I+ R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-----ASG--NVKLCDFG-------------ISGRL 165
Query: 999 IP--APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
+ A G +MAPE + Y + D+WS G L+EL T Q PY
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 46/198 (23%)
Query: 933 IAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
IA + AL LHSK ++HRD+K N+LI+ + VKLCDF + L +
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-------VKLCDFGISGYLVDSV-- 158
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
A + G +MAPE + Y ++ D+WS G ++EL T + PY
Sbjct: 159 ---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 1052 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRR 1110
+ L +V + S P+ E S D +
Sbjct: 208 ---------------DSWKTPFQQL-----KQVVEEPS----PQLPAEKFSPEFQDFVNK 243
Query: 1111 CTEENPTERPTAGDLYEM 1128
C ++N ERP +L +
Sbjct: 244 CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ + + GG +K +I + G + + ALF A ++ L +LH ++ ++RD+K ENI
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1016
L+D G +++ D AV IP + VGT +MAPEV
Sbjct: 134 LLD-----DYGH--IRISDLGLAVK--------------IPEGESIRGRVGTVGYMAPEV 172
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1054
L Y L D W GCL+ E++ Q P+ G E
Sbjct: 173 L----NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG +K +I + G + A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 84 GGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---- 136
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
+++ D AV + I R VGT +MAPEV+ K Y
Sbjct: 137 ---DYGHIRISDLGLAVEIPE---GETIRGR--------VGTVGYMAPEVV----KNERY 178
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSE 1054
D W GCL+ E++ + P+ E
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 29/118 (24%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIAHRGI 999
H +MHRD+K +N+L+D K ++K+ D RA +P++S+ H
Sbjct: 126 CHKHGVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKSYTHE-------- 171
Query: 1000 PAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
+ T + APEVL + H Y VDIWS GC+ E+ Q + G SEL+
Sbjct: 172 ------IVTLWYRAPEVLLGSTH----YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/240 (24%), Positives = 90/240 (37%), Gaps = 56/240 (23%)
Query: 896 LQSAIF--MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHR 952
++ A++ MEY+ GS+ T V L I V L L +H I+HR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LR-RITYAVVKGLKFLKEEHNIIHR 127
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
D+K N+L+ +G VKLCDF + L + L I G +M
Sbjct: 128 DVKPTNVLV-------NGNGQVKLCDFGVSGNLVASLAKTNI------------GCQSYM 168
Query: 1013 APEVLRA--MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM---GKRP 1067
APE +++ ++ Y ++ D+WS G +LE+ + PY + I + G P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
L +A+ D +C + P RPT L E
Sbjct: 229 TLPSGYS-------------------DDAQ--------DFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 88/324 (27%), Positives = 127/324 (39%), Gaps = 97/324 (29%)
Query: 827 FGSADAAAKVRTLKVCGSSADEIRNFEYS----------CLGEVRMLGALRHSCIVEMYG 876
FG+ A VRT +V I+ YS + EV+ L ++H +E G
Sbjct: 38 FGAVYFARDVRTNEVVA-----IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 936
+ EH + + MEY G + L E +K + I
Sbjct: 93 CYLR-----------EH---TAWLVMEYCLGSA-----SDLLEVHKKPLQEVEIAAITHG 133
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV---PLRSFLHTCC 993
L LHS +++HRDIK+ NIL+ + VKL DF A P SF
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------VKLADFGSASIASPANSF----- 181
Query: 994 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1053
VGTP WMAPEV+ AM + Y +VD+WS G +EL + P +
Sbjct: 182 ------------VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNM- 227
Query: 1054 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR--- 1110
+ + AL + +AQ+ E P + S D FR
Sbjct: 228 -----------------NAMSAL-----YHIAQN----ESPTLQSNEWS---DYFRNFVD 258
Query: 1111 -CTEENPTERPTAGDLYE-MFVAR 1132
C ++ P +RPT+ +L + MFV R
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 59/203 (29%)
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
L IA+ VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLV-------GENMVVKIADFGLS-------- 177
Query: 991 TCCIAHRGIPAPDVCVGTP------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
R I + D + RWM PE + N Y E D+W+YG +L E+ +
Sbjct: 178 ------RNIYSADYYKASENDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFS 227
Query: 1045 LQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103
+ PY G++ E+ ++ G + SC ++
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGN----------VLSCPDN-----------------CPLE 260
Query: 1104 LVDVFRRCTEENPTERPTAGDLY 1126
L ++ R C + P++RP+ +
Sbjct: 261 LYNLMRLCWSKLPSDRPSFASIN 283
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 31/150 (20%)
Query: 911 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
K Y++ TG +K ++ Q + + HS ++HRD+K +N+LID E
Sbjct: 85 KKYMDSSPLTGLDPPLIKS--YLYQ-LLQGIAYCHSHRVLHRDLKPQNLLIDREG----- 136
Query: 971 KPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
+KL DF A VP+R++ H V T + APE+L Y
Sbjct: 137 --ALKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGSR---QY 177
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
VDIWS GC+ E++ + + G SE++
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 64/267 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++L L H IV+ + + I EY +G + +E+L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAF--------------CIITEYCEGRDLDCKLEELK 97
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
TG+ ++ + Q + + +H + I+HRD+K++NI + ++K+ D
Sbjct: 98 HTGKTLSENQVCEWFIQ-LLLGVHYMHQRRILHRDLKAKNIFLK--------NNLLKIGD 148
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F + R + +C +A GTP +M+PE L+ H+ Y + DIWS GC+
Sbjct: 149 FGVS---RLLMGSCDLA-------TTFTGTPYYMSPEALK--HQG--YDSKSDIWSLGCI 194
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
L E+ L + G + L + I G P L PE
Sbjct: 195 LYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL------------------------PETYS 230
Query: 1099 ETLSFLVDVFRRCTEENPTERPTAGDL 1125
L+ ++ ++P+ RP+A ++
Sbjct: 231 RQLNSIMQ---SMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 41/256 (16%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 873
GK +++ + A V+ L D I + + E +L +L H +V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 933
YG + L Q + +E GGSV ++ L G++ ++ +I
Sbjct: 84 FYGMFYKADKLVGG---------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS-YI 133
Query: 934 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 993
L LH+ I+HRD+K NIL+ E VKL DF + L T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFGVSAQL-----TST 181
Query: 994 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL 1052
R + VGTP WMAPEV+ + + Y D+WS G +EL P
Sbjct: 182 RLRR-----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL--- 233
Query: 1053 SELEIHDLIQMGKRPR 1068
++H + + K PR
Sbjct: 234 --FDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-- 914
L E ++ L H IV +Y I S DG+P ++ M Y++G ++K+ +
Sbjct: 50 LREAKIAADLIHPGIVPVY--SICS------DGDPVYYT------MPYIEGYTLKSLLKS 95
Query: 915 ----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
E LS+ + SV L I + A + +HSK ++HRD+K +NIL+ L G
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-----G 150
Query: 971 KPVV------KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
+ V+ + L + I + + P VGTP +MAPE L
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----V 206
Query: 1025 LYGLEVDIWSYGCLLLELLTLQVPY 1049
DI++ G +L ++LTL PY
Sbjct: 207 PASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 30/117 (25%)
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 999
HS+ ++HRD+K +N+LI D K V+KL DF A +P+R + H + +R
Sbjct: 118 HSRRVLHRDLKPQNLLI-------DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR-- 168
Query: 1000 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
AP+V +G+PR+ P VDIWS G + E+ T + + G SE++
Sbjct: 169 -APEVLLGSPRYSTP---------------VDIWSIGTIFAEMATKKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 3e-10
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 60/204 (29%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LHS +++HRD+K NIL++ +K+CDF A RG+ +
Sbjct: 119 LHSANVIHRDLKPSNILVNSN-------CDLKICDFGLA--------------RGVDPDE 157
Query: 1004 VCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
G RW APE+L + + Y +DIWS GC+ ELLT + + G ++
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSR---YTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-----LVDVFRRC 1111
+LI +E LG+ E ++ S EK L++L L +F
Sbjct: 215 QLNLI-----------VEVLGTPSEEDLKFITS--EKARNYLKSLPKKPKKPLSKLFPGA 261
Query: 1112 TEE-----------NPTERPTAGD 1124
+ E +P +R TA +
Sbjct: 262 SPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 85/304 (27%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEM----YGHKISSKWLPSADGNPEHHLLQSAIF- 901
E F + L E+ +L L+H IV + G + I+
Sbjct: 42 KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK------------------IYM 83
Query: 902 -MEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
MEYV+ +K+ +E + + E VK + + + + LH I+HRD+K+
Sbjct: 84 VMEYVEH-DLKSLMETMKQPFLQSE----VK---CLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 958 NILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
N+L++ + ++K+CDF A PL+ + V T + A
Sbjct: 136 NLLLN-------NRGILKICDFGLAREYGSPLKPYTQL--------------VVTLWYRA 174
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL---- 1069
PE+L + Y +D+WS GC+ ELLT + + G SE++ Q+ K +L
Sbjct: 175 PELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFKLLGTP 226
Query: 1070 TDE-------LEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120
T++ L ++ Q F P L F D+ R +P +R
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKF--PALSLSDNGF--DLLNRLLTYDPAKRI 282
Query: 1121 TAGD 1124
+A D
Sbjct: 283 SAED 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 904 YVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960
Y+ G++K ++++ + +S + + +A +A + LH + ++H+DI + N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT----P-RWMAPE 1015
ID E + VK+ D A+ F P C+G P +WMA E
Sbjct: 150 IDEELQ-------VKITD--NALSRDLF-----------PMDYHCLGDNENRPVKWMALE 189
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR----PRLT 1070
L Y D+WS+G LL EL+TL Q PY+ + E+ ++ G R
Sbjct: 190 SLVN----KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCP 245
Query: 1071 DELEALGSC 1079
DEL A+ +C
Sbjct: 246 DELFAVMAC 254
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKP--VVKLCDFDRA----VPLRSFLHTCCIAHR 997
LHS ++HRD+K NIL+ +G VVK+ D A PL+
Sbjct: 124 LHSNWVLHRDLKPANILV-----MGEGPERGVVKIGDLGLARLFNAPLKPLADL------ 172
Query: 998 GIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
D V T + APE+L A H Y +DIW+ GC+ ELLTL+ + G
Sbjct: 173 -----DPVVVTIWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EVR L LRH ++ G + + WL MEY G +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSA-----SD 103
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP-VVK 975
L E +K + + L LHS +++HRD+K+ NIL+ +P +VK
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------EPGLVK 155
Query: 976 LCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
L DF A P F VGTP WMAPEV+ AM + Y +VD+
Sbjct: 156 LGDFGSASIMAPANXF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVDV 197
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1069
WS G +EL + P ++ + I + P L
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKI--SSKWLPSADGNPEHHLLQSA-IFMEYVKGGSVK 911
L E++++ L H IV++Y + S L G+ L S I EY++ +
Sbjct: 48 HALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLTE--LNSVYIVQEYMET-DLA 103
Query: 912 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971
N +E+ E+H LF+ Q + L +HS +++HRD+K N+ I+ E
Sbjct: 104 NVLEQ-GPLSEEHAR----LFMYQ-LLRGLKYIHSANVLHRDLKPANVFINTE------D 151
Query: 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEV 1030
V+K+ DF A + +H+G + + +W +P +L + PN Y +
Sbjct: 152 LVLKIGDFGLARIVDPHY-----SHKGYLSEGL---VTKWYRSPRLLLS---PNNYTKAI 200
Query: 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLTDELEALGSCHEHEVAQSG 1088
D+W+ GC+ E+LT + + G ELE LI + P R D E L + V G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVVREEDRNELL-NVIPSFVRNDG 258
Query: 1089 SGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTA 1122
+P +L +D + NP +R TA
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
+Y+ GG + +++K E S A F ++ AL LH I++RD+K ENIL+D
Sbjct: 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 963 LERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
A G + LCDF + + +T C GT ++APEVL
Sbjct: 131 -----ATGH--IALCDFGLSKANLTDNKTTNTFC-------------GTTEYLAPEVLL- 169
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
Y VD WS G L+ E+ P+ +++ I GK
Sbjct: 170 --DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 42/178 (23%)
Query: 893 HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+ Q+A ++YV GG + ++++ E+ A F A +VA+A+ LHS +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVC 1005
I++RD+K ENIL+D + V L DF V T C
Sbjct: 117 IIYRDLKPENILLDSQGH-------VVLTDFGLCKEGVEPEETTSTFC------------ 157
Query: 1006 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
GTP ++APEVLR +P Y VD W G +L E+L GL D+ QM
Sbjct: 158 -GTPEYLAPEVLR--KEP--YDRTVDWWCLGAVLYEML------YGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 57/226 (25%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I EY++ GS+ ++++ + G K KL AQ +A + + K+ +HRD+++ NI
Sbjct: 77 IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQ-IAEGMAFIERKNYIHRDLRAANI 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ K+ DF A R A G P +W APE +
Sbjct: 134 LVSETL-------CCKIADFGLA---RLIEDNEYTAREGAKFP------IKWTAPEAIN- 176
Query: 1020 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 1075
YG ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 177 ------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---- 226
Query: 1076 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
+C PE L ++ R C +E P ERPT
Sbjct: 227 --NC--------------PEE-------LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 54/195 (27%), Positives = 75/195 (38%), Gaps = 63/195 (32%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y+ GG + + + +L E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 962 DLERKKADGKPVVKLCDF-----------------------------------DRAVP-- 984
D DG +KL DF DR
Sbjct: 135 DR-----DGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 985 ---LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041
R H C+AH VGTP ++APEVL Y D WS G +L E
Sbjct: 188 LERRRKRQHQRCLAHS-------LVGTPNYIAPEVLLRTG----YTQLCDWWSVGVILYE 236
Query: 1042 LLTLQVPYMGLSELE 1056
+L Q P++ + E
Sbjct: 237 MLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-10
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
VKN LS+ G + ++ L VA + L SK+ +HRD+ + N+L+
Sbjct: 220 SEVKNL---LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL------ 270
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
A GK +VK+CDF A R +H +G V +WMAPE + NLY
Sbjct: 271 AQGK-IVKICDFGLA---RDIMHDSNYVSKGSTFLPV-----KWMAPESIF----DNLYT 317
Query: 1028 LEVDIWSYGCLLLELLTL-QVPYMGL 1052
D+WSYG LL E+ +L PY G+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 33/166 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 960
MEY GG + ++ + E+ S A F ++ +AL LHS K++++RD+K EN++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 961 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 168
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
+ N YG VD W G ++ E++ ++P+ ++ +LI M
Sbjct: 169 ----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK GSS + +F L E ++G H I+ + G S+ +
Sbjct: 37 IKTLKA-GSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPV----------- 80
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ + L E K +L + + + +A+ + L + +HRD+
Sbjct: 81 ---MIITEYMENGSLDKF---LRENDGKFTVGQL-VGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL++ V K+ DF + L T IP RW APE
Sbjct: 134 ARNILVNSNL-------VCKVSDFGLSRRLEDSEATYTTKGGKIPI--------RWTAPE 178
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
+ + D+WS+G ++ E+++ + PY +S ++ ++ G R
Sbjct: 179 AIAYRK----FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 28/128 (21%)
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIP 1000
HS ++HRD+K +N+LID +KL DF A +P+R+F H
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLARAFGIPVRTFTHE--------- 163
Query: 1001 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHD 1059
V T + APE+L Y VDIWS GC+ E++ + + G SE+ E+
Sbjct: 164 -----VVTLWYRAPEILLGSRH---YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 1060 LIQMGKRP 1067
+ ++ P
Sbjct: 216 IFRILGTP 223
|
Length = 294 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 70/276 (25%), Positives = 106/276 (38%), Gaps = 78/276 (28%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E R+L H IV++ G + ++ P I ME V GG +++ K
Sbjct: 40 LSEARILKQYDHPNIVKLIG--VCTQRQPIY------------IVMELVPGGDFLSFLRK 85
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ + VK AL D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 KKDELKTKQLVKFAL----DAAAGMAYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 977 CDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030
DF D + S L + IP +W APE L Y E
Sbjct: 135 SDFGMSRQEDDGIYSSSGL-------KQIPI--------KWTAPEALNY----GRYSSES 175
Query: 1031 DIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1089
D+WSYG LL E +L V PY G++ + + ++ G R + C +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------MSCPQKCPDD------- 222
Query: 1090 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ V +RC + P RP +L
Sbjct: 223 --------------VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 32/163 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+++V GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 1018
D + G V L DF + GI D GTP ++APEV+R
Sbjct: 130 D-----SQGHVV--LTDFG-------------LCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
+P Y VD W G +L E+L P+ E++D I
Sbjct: 170 --KQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 52/235 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK G+ + E S L E +++ LRH +V++Y + S+ P +
Sbjct: 35 VKTLKP-GTMSPE------SFLEEAQIMKKLRHDKLVQLYA--VVSE-------EPIY-- 76
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ ++ L + + + + + +A VAA + + + +HRD++
Sbjct: 77 ----IVTEYMSKGSLLDF---LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
S NIL+ DG V K+ DF A + +T A +G P +W APE
Sbjct: 130 SANILV------GDGL-VCKIADFGLARLIEDNEYT---ARQGAKFP------IKWTAPE 173
Query: 1016 VLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
LYG ++ D+WS+G LL EL+T +VPY G++ E+ + ++ G R
Sbjct: 174 AA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 72/269 (26%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E +++ LRH +V +Y P + I E++ GS+ ++
Sbjct: 49 LQEAQIMKKLRHDKLVPLYA---------VVSEEPIY------IVTEFMGKGSLLDF--- 90
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
L E K++ + + +A +A + + + +HRD+++ NIL+ D V K+
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV------GDNL-VCKI 143
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1033
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 1034 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092
S+G LL EL+T +VPY G+ E+ + ++ G R + C
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------MPCPQGC------------- 228
Query: 1093 KPEAELETLSFLVDVFRRCTEENPTERPT 1121
PE+ L ++ + C +++P ERPT
Sbjct: 229 -PES-------LHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY+ GGS + + + E ++ L +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-RAGPFDEFQIATML-----KEILKGLDYLHSEKKIHRDIKAANV 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ + VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLSEQGD-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIQQ 175
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1079
+ Y + DIWS G +EL + P + + + LI P LT E
Sbjct: 176 ----SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE------- 224
Query: 1080 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 1138
F KP E C ++P+ RPTA +L + F+ + + S
Sbjct: 225 -----------FSKPFKEF---------IDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 69/292 (23%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
S+A+ +R+FE E+ +L +L+H IV+ G S+ G L+ ME
Sbjct: 44 STAEHLRDFER----EIEILKSLQHDNIVKYKGVCYSA-------GRRNLRLV-----ME 87
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
Y+ GS+++Y++K E+ KL L+ +Q + + L SK +HRD+ + NIL++
Sbjct: 88 YLPYGSLRDYLQK---HRERLDHRKLLLYASQ-ICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 964 ERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR-----WMAPEV 1016
E + VK+ DF + +P + V P W APE
Sbjct: 144 ENR-------VKIGDFGLTKVLPQDKEYYK--------------VREPGESPIFWYAPES 182
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1076
L + + + D+WS+G +L EL T + MG D+ +
Sbjct: 183 L----TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR---MMGN-----DKQGQM 230
Query: 1077 GSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERPTAGDL 1125
H E+ ++ P AE+ + + C +P++RP+ +L
Sbjct: 231 IVYHLIELLKNNGRLPAPPGCPAEIYAI------MKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 59/234 (25%), Positives = 88/234 (37%), Gaps = 65/234 (27%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+I E++ GGS+ Y K+ E HV + IA V L L S I+HRD+K N
Sbjct: 75 SICTEFMDGGSLDVY-RKIPE----HVLGR----IAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+L++ + VKLCDF + L + + VGT +MAPE +
Sbjct: 126 MLVNTRGQ-------VKLCDFGVSTQLVNSIAK------------TYVGTNAYMAPERIS 166
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-------GLSELEIHDLIQMGKRPRLTD 1071
YG+ D+WS G +EL + PY L L++ I P L
Sbjct: 167 GEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222
Query: 1072 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ ++ V +C + P ERP +L
Sbjct: 223 ----------GQFSEK----------------FVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 66/271 (24%), Positives = 99/271 (36%), Gaps = 78/271 (28%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEV-----LARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 962 DLERKKADGKPVVKLCDF-----------------------------------------D 980
DL DG +KL DF D
Sbjct: 135 DL-----DGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 981 RAVPLRSFL---HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
R L H C+AH VGTP ++APEVL + K Y D WS G
Sbjct: 188 RLKTLEQRATKQHQRCLAHS-------LVGTPNYIAPEVL--LRKG--YTQLCDWWSVGV 236
Query: 1038 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1086
+L E+L Q P++ + E +H Q+ P D + L E + +
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 1087 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117
+G+ K + F D+ + P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LHS I+HRDIK N+L+ + V+K+CDF A + + +
Sbjct: 119 LHSAGILHRDIKPGNLLV-------NSNCVLKICDFGLA-RVEEPDESKHMTQE------ 164
Query: 1004 VCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1062
V T + APE+L + H Y VDIWS GC+ ELL ++ + S ++ DLI
Sbjct: 165 --VVTQYYRAPEILMGSRH----YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 1063 --MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+G T LEA+ S E A G KP +
Sbjct: 219 DLLG-----TPSLEAMRSACEGARAHILRGPHKPPS 249
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ + +C+ ++ K ++E + + L E++ML L+ IVE+
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEKLSETGEKHVSVKLALF 932
E + +++ EYV+ KN +E L E K+ +
Sbjct: 66 ----------------KEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSY 105
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL--- 989
I Q + A+ H I+HRDIK EN+LI V+KLCDF A L
Sbjct: 106 IYQ-LIKAIHWCHKNDIVHRDIKPENLLIS-------HNDVLKLCDFGFARNLSEGSNAN 157
Query: 990 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+T +A R +P++ +G P YG VD+WS GC+L EL Q +
Sbjct: 158 YTEYVATRWYRSPELLLGAP----------------YGKAVDMWSVGCILGELSDGQPLF 201
Query: 1050 MGLSELE 1056
G SE++
Sbjct: 202 PGESEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-09
Identities = 67/271 (24%), Positives = 102/271 (37%), Gaps = 78/271 (28%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPED-----LARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
Query: 962 DLERKKADGKPVVKLCDF-----------------------------------------D 980
D DG +KL DF D
Sbjct: 135 D-----RDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 981 RAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
R PL + H C+AH VGTP ++APEVL L D WS G
Sbjct: 188 RLKPLERRAARQHQRCLAHS-------LVGTPNYIAPEVLLRTGYTQL----CDWWSVGV 236
Query: 1038 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1086
+L E+L Q P++ + LE +H Q P +D + L E + +
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGK 296
Query: 1087 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117
+G+ K +T+ F D+ ++ P
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 956
+I ME++ GGS+ ++K E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA------VIKGLTYLREKHKIMHRDVKP 132
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1076
L+ H Y ++ DIWS G L+E+ + P + + +L M P D E+
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVEMAIGRYP---IPPPDAKELELMFGCPVEGDPAESE 226
Query: 1077 GSCHEHEVAQSGSGF----EKPEAELETLSFLV-----------------DVFRRCTEEN 1115
S + S + P A E L ++V D +C +N
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286
Query: 1116 PTERPTAGDLYEMFV 1130
P ER DL ++ V
Sbjct: 287 PAER---ADLKQLMV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 37/188 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++L L+H IV Y W DG I M + +GG + + +++
Sbjct: 49 EAQLLSQLKHPNIV-AY----RESW-EGEDG-------LLYIVMGFCEGGDLYHKLKE-- 93
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ G+ ++ + Q +A AL LH KHI+HRD+K++N+ L R ++K+ D
Sbjct: 94 QKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNVF--LTRTN-----IIKVGD 145
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
A R + C +A +GTP +M+PE+ +KP Y + D+W+ GC
Sbjct: 146 LGIA---RVLENQCDMA-------STLIGTPYYMSPELFS--NKP--YNYKSDVWALGCC 191
Query: 1039 LLELLTLQ 1046
+ E+ TL+
Sbjct: 192 VYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D + + L DF L I H G + GTP ++APEVL H
Sbjct: 130 DSQGH-------IVLTDFG--------LCKENIEHNGTTS--TFCGTPEYLAPEVL---H 169
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
K Y VD W G +L E+L P+ + E++D I
Sbjct: 170 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E +++ LRH +V++Y P + I EY+ GS+ ++++
Sbjct: 49 LQEAQVMKKLRHEKLVQLYA---------VVSEEPIY------IVTEYMSKGSLLDFLK- 92
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
E G+ +L AQ +A+ + + + +HRD+++ NIL+ V K+
Sbjct: 93 -GEMGKYLRLPQLVDMAAQ-IASGMAYVERMNYVHRDLRAANILVG-------ENLVCKV 143
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1033
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 1034 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
S+G LL EL T +VPY G+ E+ D ++ G R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 31/153 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ + + GG +K +I + E G + A+F A ++ L +LH + I++RD+K ENI
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1016
L+D G +++ D AV +P VGT +MAPEV
Sbjct: 134 LLD-----DHGH--IRISDLGLAV--------------HVPEGQTIKGRVGTVGYMAPEV 172
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+ K Y D W+ GCLL E++ Q P+
Sbjct: 173 V----KNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 35/154 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSEN 958
+ +E++ GGS++ H++ + L +A+ + + + LH +HI+HRDIK N
Sbjct: 149 VLLEFMDGGSLEG----------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+LI+ + VK+ DF + L + C + VGT +M+PE +
Sbjct: 199 LLINSAKN-------VKIADFGVSRILAQTMDPC----------NSSVGTIAYMSPERIN 241
Query: 1019 AMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMG 1051
Y G DIWS G +LE Y+G
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEF------YLG 269
|
Length = 353 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 50/195 (25%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VA + L SK+ +HRD+ + NIL+ R + K+CDF A +R+ + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLARDIRNDSNYVVKGN 275
Query: 997 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-E 1054
+P +WMAPE + +Y E D+WSYG LL E+ +L PY G+ +
Sbjct: 276 ARLPV--------KWMAPESIFNC----VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTE 1113
+ + +I+ G R PE A E + D+ + C +
Sbjct: 324 SKFYKMIKEGYR------------------------MLSPECAPSE----MYDIMKSCWD 355
Query: 1114 ENPTERPTAGDLYEM 1128
+P +RPT + ++
Sbjct: 356 ADPLKRPTFKQIVQL 370
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 900 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 948
+ +EY G+++ Y+ G E+ ++ K + A VA + L S+
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
+HRD+ + N+L+ + V+K+ DF A + + + + +P
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLARDVHNIDYYKKTTNGRLPV------- 200
Query: 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1067
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 201 -KWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
++ +C HE L + R C P++RPT L E
Sbjct: 255 -----MDKPANC-THE--------------------LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 70/246 (28%)
Query: 900 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
+ +EY G+++ ++ +++ E+ +S K + A VA + L S+
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
+HRD+ + N+L+ + V+K+ DF A RG+ D T
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RGVHDIDYYKKT 193
Query: 1009 P------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI 1061
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L+
Sbjct: 194 SNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 1062 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
+ G R ++ +C HE L + R C PT+RPT
Sbjct: 250 REGHR------MDKPSNC-THE--------------------LYMLMRECWHAVPTQRPT 282
Query: 1122 AGDLYE 1127
L E
Sbjct: 283 FKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 900 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 948
+ +EY G+++ Y+ G E+ +S K + A VA + L SK
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
+HRD+ + N+L+ + V+K+ DF A + + + +P
Sbjct: 161 CIHRDLAARNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPV------- 206
Query: 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1067
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 207 -KWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR- 260
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
+KP L ++ R C P++RPT L E
Sbjct: 261 -----------------------MDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 65/272 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 914
E+ M L H +V + G + P + +L EY G +K ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGL--------CREAEPHYMIL------EYTDLGDLKQFLRATK 103
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
K + +S K + + +A + L + +HRD+ + N L+ +R+
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL-- 161
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
L + V + R P RW+APE ++ + + + D+WS
Sbjct: 162 SLS---KDVYNSEYYK-----LRNALIP------LRWLAPEAVQE----DDFSTKSDVWS 203
Query: 1035 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093
+G L+ E+ T ++P+ GLS+ E+ + +Q GK E
Sbjct: 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-------------------------LEL 238
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
P E S L + RC NP +RP+ +L
Sbjct: 239 PVPE-GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 78/296 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T K C +S F L E ++ H IV++ G + ++ NP
Sbjct: 39 VKTCKNC-TSPSVREKF----LQEAYIMRQFDHPHIVKLIG--VITE-------NP---- 80
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME G +++Y++ + + L L+ Q ++ AL L SK +HRDI
Sbjct: 81 --VWIVMELAPLGELRSYLQVNKYSLD---LASLILYSYQ-LSTALAYLESKRFVHRDIA 134
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWM 1012
+ N+L+ VKL DF R + S+ A +G +P +WM
Sbjct: 135 ARNVLV-------SSPDCVKLGDFGLSRYLEDESYYK----ASKGKLPI--------KWM 175
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTD 1071
APE + + D+W +G + E+L L V P+ G+ ++ I+ G+R
Sbjct: 176 APESINFRR----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---- 227
Query: 1072 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
P TL L+ +C +P++RP +L
Sbjct: 228 --------------------PMPPNCPPTLYSLM---TKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+ ++ GG + +++++ E + A F ++ AL LH ++++RD+K ENIL+
Sbjct: 72 LAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D + A LCDF C + + + GTP ++APE+L
Sbjct: 127 DYQGHIA-------LCDFG----------LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
Y VD W+ G LL E+LT P+
Sbjct: 170 ----YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 72/273 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +++ L H +V++YG K L I E+++ G + NY+ +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPL--------------YIVTEFMENGCLLNYLRQ-- 92
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ +S + L + QDV + L +HRD+ + N L+ VVK+ D
Sbjct: 93 --RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------VVKVSD 143
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F R L + G P +W PEV + Y + D+WS+G L
Sbjct: 144 FGMT---RYVLDDEYTSSSGAKFP------VKWSPPEVFNF----SKYSSKSDVWSFGVL 190
Query: 1039 LLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHEHEVAQSGSGFEKP 1094
+ E+ T ++P+ S E+ ++I G R P+L +
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--------ASM-------------- 228
Query: 1095 EAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
+ +V C E P RPT +L
Sbjct: 229 --------TVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M + GG +K +I + GE+ + ++ + + + ++ LHS I++RD+K EN+
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D + +L D AV L+ A GT +MAPE+L
Sbjct: 127 LLDDQGN-------CRLSDLGLAVELKDGKTITQRA-----------GTNGYMAPEIL-- 166
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
K Y VD ++ GC + E++ + P+ E + + KR L DE++
Sbjct: 167 --KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 26/180 (14%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ++Y+ GG + ++ + E+ V + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKLGIIYRDIKLENI 136
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D ++G V L DF + + F A C GT +MAP+++R
Sbjct: 137 LLD-----SNGHVV--LTDFGLS---KEFH-----EDEVERAYSFC-GTIEYMAPDIVRG 180
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEAL 1076
+ VD WS G L+ ELLT P+ E I + P E+ AL
Sbjct: 181 GDGG--HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 28/137 (20%)
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
L IA +AA + L S H +HRD+ + N L+ +G VK+ DF + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLV------GEGL-TVKISDFGLSRDIYSADY 179
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 1045
+ +P RWM PE + LYG E DIWS+G +L E+ + L
Sbjct: 180 YRVQSKSLLPV--------RWMPPEAI-------LYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 1046 QVPYMGLSELEIHDLIQ 1062
Q PY G S E+ ++I+
Sbjct: 225 Q-PYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 31/152 (20%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 956
+I ME++ GGS+ +++ E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA------VLRGLAYLREKHQIMHRDVKP 132
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048
L+ H Y ++ DIWS G L+EL + P
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 38/157 (24%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ++YV GG + ++ + E V F + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVR-----FYSGEIILALEHLHKLGIVYRDIKLENI 136
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFL-------HTCCIAHRGIPAPDVCVGTPRWM 1012
L+D ++G V L DF + + FL ++ C GT +M
Sbjct: 137 LLD-----SEGHVV--LTDFGLS---KEFLSEEKERTYSFC-------------GTIEYM 173
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
APE++R +G VD WS G L+ ELLT P+
Sbjct: 174 APEIIRGKGG---HGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 60/230 (26%)
Query: 906 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965
K S E+ E ++ ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS--- 207
Query: 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAPD-VCVGTPR----WMAPEVLRA 1019
VVK+CDF A R I PD V G R WMAPE +
Sbjct: 208 ----ENNVVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPESIF- 248
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
+Y + D+WS+G LL E+ +L PY G+ E + + K
Sbjct: 249 ---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKE------------ 291
Query: 1079 CHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
G+ PE A E S ++D C NP +RPT +L E
Sbjct: 292 ---------GTRMRAPEYATPEIYSIMLD----CWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 61/232 (26%)
Query: 902 MEYVKGGSVKNYIEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950
+EY G++ +++ K ++ + +S + L A DVA + L K +
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
HRD+ + NIL+ V K+ DF + ++ +P R
Sbjct: 147 HRDLAARNILVGENY-------VAKIADFGLSRGQEVYVKK---TMGRLPV--------R 188
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1069
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++ + G R
Sbjct: 189 WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 241
Query: 1070 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
EKP L + D+ R+C E P ERP+
Sbjct: 242 ---------------------LEKP---LNCDDEVYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 23/100 (23%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS ++HRD+K NILI+ + D +K+CDF A P
Sbjct: 124 VHSAGVVHRDLKPSNILIN---ENCD----LKICDFGLARIQD-------------PQMT 163
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043
V T + APE++ K Y +EVDIWS GC+ E+L
Sbjct: 164 GYVSTRYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 50/173 (28%)
Query: 902 MEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
MEY+ GG + + K +E + F + A+ +H +HRDIK +N
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTE--------EETRFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDV----------- 1004
+L+D A G +KL DF L+ ++H
Sbjct: 132 LLLD-----AKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 1005 --------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043
VGTP ++APEV Y E D WS G ++ E+L
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVF----LQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 36/158 (22%)
Query: 901 FMEYVKGGSVKN-----YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
M Y GS ++ + E L E FI +DV AL +HSK +HR +K
Sbjct: 80 LMAY---GSCEDLLKTHFPEGLPEL--------AIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ +IL+ DGK V L +V + P V W++
Sbjct: 129 ASHILLS-----GDGK--VVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLS 176
Query: 1014 PEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPY 1049
PEVL+ NL Y + DI+S G EL VP+
Sbjct: 177 PEVLQQ----NLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (137), Expect = 5e-08
Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 41/172 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHS-------KHI 949
I ME+ G + I+K + E+H V I + + AL H+ + +
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----ITRQLLHALAYCHNLKDGPNGERV 146
Query: 950 MHRDIKSENIL----------IDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHR 997
+HRD+K +NI I + +G+P+ K+ DF + + + S H+C
Sbjct: 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC----- 201
Query: 998 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
VGTP + +PE+L +H+ Y + D+W+ GC++ EL + + P+
Sbjct: 202 --------VGTPYYWSPELL--LHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 38/158 (24%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VA + L SK+ +HRD+ + N+LI +GK +VK+CDF A R +
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGK-LVKICDFGLA---RDIMRDSNYIS 297
Query: 997 RG---IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 1052
+G +P +WMAPE + NLY D+WS+G LL E+ TL PY
Sbjct: 298 KGSTFLPL--------KWMAPESIFN----NLYTTLSDVWSFGILLWEIFTLGGTPY--- 342
Query: 1053 SELEIHDLI--------QMGKRPRLTDEL-EALGSCHE 1081
EL +++ +M K +DE+ E + C E
Sbjct: 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE 380
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M + GG ++ +I + E A F + + L LH + I++RD+K EN+L+
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D DG V++ D AV L+ G GTP +MAPE+L+
Sbjct: 131 D-----NDGN--VRISDLGLAVELKD----------GQSKTKGYAGTPGFMAPELLQGEE 173
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
Y VD ++ G L E++ + P+
Sbjct: 174 ----YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 72/274 (26%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 914
L E ++ LRHS +V++ G + K +++ EY+ GS+ +Y
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEK---------------GGLYIVTEYMAKGSLVDY- 90
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L G + L + DV A+ L + + +HRD+ + N+L+ + V
Sbjct: 91 --LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-------VA 141
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
K+ DF S T +P +W APE LR + + D+WS
Sbjct: 142 KVSDFGLTKEASSTQDTG-----KLPV--------KWTAPEALRE----KKFSTKSDVWS 184
Query: 1035 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093
+G LL E+ + +VPY + ++ ++ G + ++A C
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------MDAPDGC-------------- 224
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
P + DV ++C + RP+ L E
Sbjct: 225 PPV-------VYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 52/236 (22%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+E+ G +KNY+ + + +A +VA+ L+ LH +H D+ N +
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP----APDVCVGTP-RWMAPEV 1016
AD VK+ D+ +A P C P RW+APE+
Sbjct: 134 -----TADLS--VKIGDYG-------------LALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 1017 LRAMH---KPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDE 1072
+ P + +IWS G + EL T PY LS+ ++ + + +L
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--- 230
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
KP+ +L+ +V + C + P RPTA +++E+
Sbjct: 231 -------------------PKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHEL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++ + GG + ++ + EK + F A ++ L +H++ +++RD+K NIL+
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMR-----FYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D E + CDF + P S VGT +MAPEVL+
Sbjct: 131 D-EHGHVRISDLGLACDFSKKKPHAS------------------VGTHGYMAPEVLQ--- 168
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
K Y D +S GC+L +LL P+ + H++ +M
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 77/207 (37%)
Query: 855 SCLGEVRMLGALRHSCIVEMYG-----HKIS----------SKWLPSADGNPEHHLLQSA 899
S L E+ +L L+H IV +Y K++ K+ S +G+ + +++S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+F + +KG L HS +++HRD+K +N+
Sbjct: 105 MF-QLLKG---------------------------------LAFCHSHNVLHRDLKPQNL 130
Query: 960 LIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
LI+ +G+ +KL DF A +P+R + V T + P+
Sbjct: 131 LIN-----KNGE--LKLADFGLARAFGIPVRCYSAE--------------VVTLWYRPPD 169
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLEL 1042
VL LY +D+WS GC+ EL
Sbjct: 170 VLFG---AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 932 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
F A ++ L +H++ +++RD+K NIL+D E + CDF + P S
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
VGT +MAPEVL+ K Y D +S GC+L +LL P+
Sbjct: 156 --------------VGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
Query: 1052 LSELEIHDLIQM 1063
+ H++ +M
Sbjct: 199 HKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 64/314 (20%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 817 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876
SV + + + GS A V+ LK S+ +I F L E + H ++++ G
Sbjct: 14 SVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIG 68
Query: 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI--A 934
+ S+ + L + + ++K G + ++ +S GE+ ++ L +
Sbjct: 69 VSLRSR--------AKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFTLPLQTLVRFM 119
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTC 992
D+A+ + L SK+ +HRD+ + N +++ V + DF + + S +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMT-------VCVADFGLSKKIYSGDYYRQG 172
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG 1051
C + +P +W+A E L N+Y D+W++G + E++T Q PY G
Sbjct: 173 CASK--LPV--------KWLALESL----ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
Query: 1052 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111
+ EI++ + G R ++P + L + ++ +C
Sbjct: 219 VENSEIYNYLIKGNR------------------------LKQP---PDCLEDVYELMCQC 251
Query: 1112 TEENPTERPTAGDL 1125
P RP+ L
Sbjct: 252 WSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 30/154 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKL-ALFIAQDVAAALVELH-SKHIMHRDIKSE 957
I M+ ++G + + L E ++ ++ +F+ + AL LH K I+HRD+
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV--QMVLALRYLHKEKRIVHRDLTPN 143
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPE 1015
NI++ E K V + DF +A + P + VGT + PE
Sbjct: 144 NIMLG-EDDK------VTITDFG-------------LAKQKQPESKLTSVVGTILYSCPE 183
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+++ P YG + D+W++GC+L ++ TLQ P+
Sbjct: 184 IVKNE--P--YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 905 VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964
+ GG +K +I + G + A+F A ++ L +L + I++RD+K ENIL+
Sbjct: 82 MNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--- 135
Query: 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMH 1021
D + +++ D AV IP + VGT +MAPEV+
Sbjct: 136 ----DDRGHIRISDLGLAVQ--------------IPEGETVRGRVGTVGYMAPEVI---- 173
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
Y D W GCL+ E++ Q P+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 33/128 (25%)
Query: 932 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
FI Q + L +HS +++HRD+K N+L++ AD + +K+CDF A
Sbjct: 110 FIYQ-ILCGLKYIHSANVLHRDLKPGNLLVN-----ADCE--LKICDFGLA--------- 152
Query: 992 CCIAHRGI-PAPDVCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043
RG P G RW APE++ + Y +D+WS GC+L ELL
Sbjct: 153 -----RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAELL 204
Query: 1044 TLQVPYMG 1051
+ + G
Sbjct: 205 GRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 78/275 (28%)
Query: 853 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
E++C VR+LG + + G P + + ME + G +K+
Sbjct: 65 EFNCHHVVRLLGVV--------------------SQGQP------TLVIMELMTRGDLKS 98
Query: 913 YIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
Y+ L + + S+K + +A ++A + L++ +HRD+ + N ++ +
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-- 156
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
VK+ DF R T G V RWM+PE L K ++
Sbjct: 157 -----TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMSPESL----KDGVFT 199
Query: 1028 LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1086
D+WS+G +L E+ TL + PY G+S ++ +
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------------------------M 235
Query: 1087 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
G +KP+ L ++ R C + NP RP+
Sbjct: 236 EGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 43/208 (20%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E ++L + H V +YG +L + +E+V GG ++ +
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYL--------------YLVLEFVIGGEFFTFLRR 124
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K + F A + L S +I++RD+K EN+L+D DG +K+
Sbjct: 125 -----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-----KDG--FIKM 172
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF A + + +T C GTP ++APE+L + +G D W+ G
Sbjct: 173 TDFGFAKVVDTRTYTLC-------------GTPEYIAPEILLNVG----HGKAADWWTLG 215
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMG 1064
+ E+L P+ L I+ I G
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 900 IFMEYVKGGSVKNYIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
+ ME + G +K+Y+ L + G +++ + +A ++A + L++K +HRD+
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
+ N ++ + VK+ DF R T G V RWMAP
Sbjct: 146 AARNCMVAHDF-------TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMAP 190
Query: 1015 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
E L K ++ D+WS+G +L E+ +L + PY GLS ++ +
Sbjct: 191 ESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 234
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
G ++P+ E ++ D+ R C + NP RPT ++ +
Sbjct: 235 ------------MDGGYLDQPDNCPERVT---DLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)
Query: 838 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
LKV GS + F + ++ L H +V++YG + D N
Sbjct: 34 VLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYG-------VCVRDEN------- 75
Query: 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
+ EYVK G + ++ + +VS+ L +A+ +A+AL L K ++H ++ +
Sbjct: 76 -IMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
NIL+ P +KL D + + S R P W+APE +
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIP--------WIAPECI 176
Query: 1018 RAMH-KPNLYGLEVDIWSYGCLLLEL 1042
R + D WS+G LLE+
Sbjct: 177 RNGQASLTIAA---DKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 828 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
G + A ++TLK G + + ++F L E ++G H I+ + G + +K+ P+
Sbjct: 30 GRKEVAVAIKTLKP-GYTEKQRQDF----LSEASIMGQFSHHNIIRLEG--VVTKFKPAM 82
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
I EY++ G++ Y L + + S +L + + +AA + L
Sbjct: 83 ------------IITEYMENGALDKY---LRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 1006
+ +HRD+ + NIL+ + K+ DF + L G IP
Sbjct: 127 NYVHRDLAARNILV-------NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI----- 174
Query: 1007 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 1065
RW APE + A K + D+WS+G ++ E+++ + PY +S E+ I G
Sbjct: 175 ---RWTAPEAI-AYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 1066 R 1066
R
Sbjct: 228 R 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 900 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
+ +EY G+++ Y+ ++ ++ ++ K + VA + L S+
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
+HRD+ + N+L+ V+K+ DF A + + + + +P
Sbjct: 158 CIHRDLAARNVLVTENN-------VMKIADFGLARDVNNIDYYKKTTNGRLPV------- 203
Query: 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L++ G R
Sbjct: 204 -KWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--------DRAVPLRSFLHTC 992
L LH + MHRD+ NI I+ K + K+ DF S T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFIN-------SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1052
V T + APE+L K Y VD+WS GC+ ELLT + + G
Sbjct: 185 QRREEMTSK----VVTLWYRAPELLMGAEK---YHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 1053 SELEIHDLIQMGK 1065
+E++ Q+G+
Sbjct: 238 NEID-----QLGR 245
|
Length = 335 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 20/117 (17%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VA + L SK+ +HRD+ + N+L+ DG+ V K+CDF A R ++
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLL------TDGR-VAKICDFGLA---RDIMNDSNYVV 270
Query: 997 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 1052
+G V +WMAPE + +Y ++ D+WSYG LL E+ +L + PY G+
Sbjct: 271 KGNARLPV-----KWMAPESIFDC----VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 30/148 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ME++ +V Y++ + + L+ Q + AL +HSK I HRD+K +N+
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNL 201
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPL----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
LID +KLCDF A L RS + C +R AP++ +G
Sbjct: 202 LIDPNTH------TLKLCDFGSAKNLLAGQRSVSYICSRFYR---APELMLGATN----- 247
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELL 1043
Y +D+WS GC++ E++
Sbjct: 248 ----------YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
++ Y++K+ G ++K + + L LH+ I+HRD+K ENIL+ +
Sbjct: 93 LRTYLDKVPPPGLPAETIK---DLMRQFLRGLDFLHANCIVHRDLKPENILV-----TSG 144
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1029
G+ VKL DF A +++C +A V T + APEVL + Y
Sbjct: 145 GQ--VKLADFGLAR-----IYSCQMAL------TPVVVTLWYRAPEVLLQ----STYATP 187
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
VD+WS GC+ E+ + + G SE + Q+GK
Sbjct: 188 VDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 828 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
G + ++TLK G + + R+F L E ++G H I+ + G SK +
Sbjct: 29 GKREIPVAIKTLKA-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKPV--- 80
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
I EY++ GS+ ++ K + +V + + + +A+ + L
Sbjct: 81 -----------MIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 1006
+HRD+ + NIL++ V K+ DF + L G IP
Sbjct: 126 GYVHRDLAARNILVN-------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI----- 173
Query: 1007 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 1065
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ I+ G
Sbjct: 174 ---RWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 1066 R 1066
R
Sbjct: 227 R 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 40/126 (31%), Positives = 54/126 (42%), Gaps = 36/126 (28%)
Query: 925 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984
+ + AL I + + L LH++ I+HRD+K+ENI I+ D D
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---------------DVD---- 194
Query: 985 LRSFLHTCCIAHRG-----IPAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
CI G + AP GT APEVL A K Y + DIWS G
Sbjct: 195 ------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL-ARDK---YNSKADIWSAGI 244
Query: 1038 LLLELL 1043
+L E+L
Sbjct: 245 VLFEML 250
|
Length = 357 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
+A + L K ++HRD+ + N+L+ + VK+ DF A L A
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQH-------VKITDFGLA-KLLDVDEKEYHAE 169
Query: 997 RGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 1054
G P +WMA E + +Y + D+WSYG + EL+T PY G+
Sbjct: 170 GGK--------VPIKWMALESILH----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
Query: 1055 LEIHDLIQMGKR 1066
+EI DL++ G+R
Sbjct: 218 VEIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 45/191 (23%), Positives = 67/191 (35%), Gaps = 61/191 (31%)
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP------- 1000
I+HRD+K NIL+ D +KLCDF GI
Sbjct: 128 KIIHRDVKPSNILL-------DRNGNIKLCDF------------------GISGQLVDSI 162
Query: 1001 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1060
A G +MAPE + + Y + D+WS G L E+ T + PY + + D
Sbjct: 163 AKTRDAGCRPYMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQ 219
Query: 1061 IQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117
+ G P L + E E + S V+ C ++ +
Sbjct: 220 LTQVVKGDPPI-------LSNSEEREFSPS----------------FVNFINLCLIKDES 256
Query: 1118 ERPTAGDLYEM 1128
+RP +L E
Sbjct: 257 KRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 51/204 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM-EYVKGGSVKNYIEKL 917
E +L L+H+ IV + H I H ++ + EY+ +K Y++
Sbjct: 53 EASLLKDLKHANIVTL--HDII-------------HTKKTLTLVFEYLDT-DLKQYMDDC 96
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
G +V+L LF + L H + ++HRD+K +N+LI ER + +KL
Sbjct: 97 G-GGLSMHNVRLFLF---QLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGE------LKLA 145
Query: 978 DFDRA----VPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
DF A VP +++ + + +R PDV +G+ Y +D+
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYR---PPDVLLGSTE---------------YSTSLDM 187
Query: 1033 WSYGCLLLELLTLQVPYMGLSELE 1056
W GC+ E+ T + + G +++E
Sbjct: 188 WGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 212 LISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L SL ++NN+L +P G L L+ LDLS N LTS+ + +L++L+L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 188 NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRL 245
NL+ LDLS N++ +P L L L ++ N L + L L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 69/254 (27%), Positives = 111/254 (43%), Gaps = 49/254 (19%)
Query: 64 RGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNE-INLFPSEVGNLLGLECLQI 121
RG ++E L L N+L+ IP +G + L+ L GN + P+ + NL LE L +
Sbjct: 136 RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 122 KISSPGVNGFA--LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
S+ V L ++K LK + L ++P EI GL L L + +
Sbjct: 196 A-SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP---------YEIGGLTSLNHLDLVY 245
Query: 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-------- 223
++ +P +G L NL+ L L NK+ +P I L+ LISL +++N L
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 224 -----------------ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
++P L L RL+ L L +N+ + +L +NL L+L
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 267 NKLLSYCQVPSWIC 280
N L ++P +C
Sbjct: 366 NNLTG--EIPEGLC 377
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 6 SVEITQKSPEG----PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESY 61
S T K P P + L +NK + E ++ ++ +V+D+S + + E
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 62 GNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL 119
+ G ++ L L+ N L IPKS+G LR ++ N + PSE L + L
Sbjct: 377 CSSG---NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
Query: 120 QIKISSPGVNGFALNKLK----GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
I S+ + G +N K L+ L L+ R L + G K L L +
Sbjct: 434 DI--SNNNLQG-RINSRKWDMPSLQMLSLA----RNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 176 IR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLL 232
+P ++G LS L QL LS NK+ +P E+ K L+SL +++N+L ++P+ +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L LDLS N+L+ +L + +L +N+ +N L
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ + Y+K G ++N+I E H +VK + VA + L SK +HRD+ + N
Sbjct: 74 VVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
++D VK+ DF A + + H G P +WMA E L+
Sbjct: 129 CMLD-------ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP------VKWMALESLQ 175
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKR 1066
K + + D+WS+G LL EL+T PY + +I + G+R
Sbjct: 176 T-QK---FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 60/300 (20%), Positives = 118/300 (39%), Gaps = 72/300 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG---HKISSKWLPSADGNPE 892
V+T+K+ + E+ +F L E + H ++ + G + S+ PS
Sbjct: 31 VKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----- 81
Query: 893 HHLLQSAIFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950
+ + ++K G + +++ +L + + + L F+ D+A+ + L SK +
Sbjct: 82 ------VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-DIASGMEYLSSKSFI 134
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGT 1008
HRD+ + N +++ V + DF + + + + IA +
Sbjct: 135 HRDLAARNCMLNENMN-------VCVADFGLSKKIYNGDYYRQGRIAKMPV--------- 178
Query: 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1067
+W+A E L +Y + D+WS+G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 179 -KWIAIESL----ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR- 232
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
++P + L L + C NP +RP+ L
Sbjct: 233 -----------------------LKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 852 FEYSCLGEVRMLGALRHSCIVEMYGHKI-SSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 910
F + L E+++L L+H +V + +I +K P +L+ F E+ G +
Sbjct: 54 FPITALREIKILQLLKHENVVNLI--EICRTKATPYNRYKGSFYLVFE--FCEHDLAGLL 109
Query: 911 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
N K + E +K+ L L +H I+HRD+K+ NILI DG
Sbjct: 110 SNKNVKFTL-SEIKKVMKMLL-------NGLYYIHRNKILHRDMKAANILIT-----KDG 156
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMHKPNLYG 1027
++KL DF A R+F + P+ V T + PE+L YG
Sbjct: 157 --ILKLADFGLA---RAF------SLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YG 202
Query: 1028 LEVDIWSYGCLLLELLTLQVPYM-GLSE 1054
+D+W GC++ E+ T P M G +E
Sbjct: 203 PPIDMWGAGCIMAEMWTRS-PIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 39/117 (33%), Positives = 51/117 (43%), Gaps = 31/117 (26%)
Query: 932 FIAQDVAAALVELHSKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFL 989
F+ + L +HS I+HRD+K NI + D E +K+ DF A +
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---------LKILDFGLARHTDDEM 172
Query: 990 HTCCIAHRGIPAPDVCVGTPRW-MAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
V T RW APE+ L MH Y VDIWS GC++ ELLT
Sbjct: 173 TG-------------YVAT-RWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV S RN+ S M+ L H +V YG + E ++Q
Sbjct: 32 LKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD---------ESIMVQ- 78
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
EYVK GS+ Y++K +++ L +A+ +A AL L K + H ++ ++N
Sbjct: 79 ----EYVKFGSLDTYLKKNKNL----INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130
Query: 959 ILIDLERKKADGK-PVVKLCD--FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+L+ E + G P +KL D V + L IP W+ PE
Sbjct: 131 VLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL------LERIP----------WVPPE 174
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLEL 1042
+ P L D WS+G L E+
Sbjct: 175 CIE---NPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 6e-06
Identities = 36/110 (32%), Positives = 49/110 (44%), Gaps = 27/110 (24%)
Query: 940 ALVELHSKHIMHRDIKSENILI----DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 995
L +HS +++HRD+K N+L+ DL K+CDF A R
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDL-----------KICDFGLA---RI--ADPEHD 161
Query: 996 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
H G V RW APE+ M Y +DIWS GC+L E+L+
Sbjct: 162 HTGFLTEYVAT---RWYRAPEI---MLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 52/223 (23%)
Query: 913 YIEKLSETGEKHVSVK---LALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
Y++K+ E G ++K L D LHS ++HRD+K +NIL+ +
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQLLRGLDF------LHSHRVVHRDLKPQNILV-----TSS 146
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1029
G+ +KL DF A + SF A V T + APEVL + Y
Sbjct: 147 GQ--IKLADFGLA-RIYSFQ----------MALTSVVVTLWYRAPEVLLQ----SSYATP 189
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVA 1085
VD+WS GC+ E+ + + G S+++ Q+GK L+ +G E +VA
Sbjct: 190 VDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKI------LDVIGLPGEEDWPRDVA 238
Query: 1086 QSGSGFE-KPEAELETLSFLVD-----VFRRCTEENPTERPTA 1122
F K +E +D + +C NP +R +A
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 24/102 (23%)
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
H ++HRD+K +N+LI+ + +KL DF A R+F GIP
Sbjct: 117 HENRVLHRDLKPQNLLIN-------KRGELKLADFGLA---RAF---------GIPVNTF 157
Query: 1005 C--VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
V T + AP+VL Y +DIWS GC++ E++T
Sbjct: 158 SNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 57/200 (28%), Positives = 80/200 (40%), Gaps = 58/200 (29%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VA + L S+ +HRD+ + NIL+ VVK+CDF A
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLA-------------- 221
Query: 997 RGI-PAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 1049
R I PD V G+ R WMAPE + +Y + D+WS+G LL E+ +L PY
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1109
G+ E + Q RL D G+ PE + +
Sbjct: 278 PGVQINE--EFCQ-----RLKD----------------GTRMRAPE---NATPEIYRIML 311
Query: 1110 RCTEENPTERPTAGDLYEMF 1129
C + +P ERPT L E+
Sbjct: 312 ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 30/122 (24%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VA + L S+ +HRD+ + NIL+ VVK+CDF +A
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLS-------ENNVVKICDFG-------------LAR 227
Query: 997 RGIPAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYM 1050
PD V G R WMAPE + +Y ++ D+WS+G LL E+ +L PY
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 1051 GL 1052
G+
Sbjct: 284 GV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 61/233 (26%)
Query: 900 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 948
I +EY G++ +++ K + ET ++H ++ + L A DVA + L K
Sbjct: 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
+HRD+ + N+L+ K+ DF + ++ +P
Sbjct: 140 FIHRDLAARNVLVG-------ENLASKIADFGLSRGEEVYVKK---TMGRLPV------- 182
Query: 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1067
RWMA E L ++Y + D+WS+G LL E+++L PY G++ E+++ + G R
Sbjct: 183 -RWMAIESLNY----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120
+E +C + + ++ R+C + P ERP
Sbjct: 237 -----MEKPRNCDDE---------------------VYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS +++HRD+K N+L++ D +K+CDF A T +
Sbjct: 124 IHSANVLHRDLKPSNLLLN---ANCD----LKICDFGLA-------RTTSEKGDFMTE-- 167
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
V T + APE+L + Y +D+WS GC+ ELL
Sbjct: 168 -YVVTRWYRAPELLLNCSE---YTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 26/140 (18%)
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
Y+++ + ++ A+ I + + AL LH + I+HRD+K+ENI +D +P
Sbjct: 175 YVDRSGP-----LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD--------EP 221
Query: 973 V-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031
L DF A L AH P GT +PE+L A+ + Y + D
Sbjct: 222 ENAVLGDFGAACKLD--------AHPDTPQCYGWSGTLETNSPELL-AL---DPYCAKTD 269
Query: 1032 IWSYGCLLLELLTLQVPYMG 1051
IWS G +L E+ V G
Sbjct: 270 IWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 61/254 (24%), Positives = 92/254 (36%), Gaps = 57/254 (22%)
Query: 901 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960
FM Y GS + ++ G + LF A L LH +HR+IK+ +IL
Sbjct: 80 FMAY---GSANSLLKTYFPEGMSEALIGNILFGA---LRGLNYLHQNGYIHRNIKASHIL 133
Query: 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA------PDVCVGTPRWMAP 1014
I DG V L H + G A P W++P
Sbjct: 134 I-----SGDG-----------LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 1015 EVLRAMHKPNLYGLEV--DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1072
E+LR +LYG V DI+S G EL T +VP+ + ++ L+Q K P +
Sbjct: 178 ELLRQ----DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPL 231
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSF---------------------LVDVFRRC 1111
C E + S SG + E + ++ C
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 1112 TEENPTERPTAGDL 1125
+++P +RP+A L
Sbjct: 292 LQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
H K+ +HRDIK NIL+ + K +KL DF A R + + P +
Sbjct: 133 HKKNFLHRDIKCSNILL-------NNKGQIKLADFGLA---RLY-----NSEESRPYTNK 177
Query: 1005 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
V T + PE+L + YG +D+WS GC+L EL T + + EL +LI
Sbjct: 178 -VITLWYRPPELLLGEER---YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-05
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
+A+ + +A+ +H + I+HRDIK+EN+L+ +G + L DF A R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLV-------NGPEDICLGDFGAACFAR------ 311
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041
P GT APEVL + Y VDIWS G ++ E
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 75/240 (31%)
Query: 900 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 948
+ +EY G++ +++ K + ET + +S + L A DVA + L K
Sbjct: 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132
Query: 949 IMHRDIKSENILI--DLERKKAD-----GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1001
+HRD+ + NIL+ + K AD G+ V R +P+R
Sbjct: 133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVR--------------- 176
Query: 1002 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1060
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++
Sbjct: 177 ---------WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 1061 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120
+ G R LE +C + + D+ R+C E P ERP
Sbjct: 224 LPQGYR------LEKPLNCDDE---------------------VYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 24/109 (22%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 1002
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 134 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 176
Query: 1003 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
V T + APEV+ M Y VDIWS GC++ E++ V + G
Sbjct: 177 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ME++ GS+K Y+ + + +++K L A + + L S+ +HRD+ + N+
Sbjct: 85 LIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 960 LIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
L++ E + VK+ DF +A+ +T D W APE L
Sbjct: 141 LVESEHQ-------VKIGDFGLTKAIETDKEYYT---------VKDDLDSPVFWYAPECL 184
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1077
+ + + D+WS+G L ELLT Y + ++M +G
Sbjct: 185 --IQSK--FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKM------------IG 224
Query: 1078 SCHEH-------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1130
H V + G +P E + L+ R+C E P++R T +L E F
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLM---RKCWEFQPSKRTTFQNLIEGFE 281
Query: 1131 A 1131
A
Sbjct: 282 A 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV +E ++ + E +L L+H+ IV + H I H ++
Sbjct: 35 LKVISMKTEE--GVPFTAIREASLLKGLKHANIVLL--HDII-------------HTKET 77
Query: 899 AIF-MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
F EY+ + I+ G H + LF+ Q + L +H +HI+HRD+K +
Sbjct: 78 LTFVFEYMHTDLAQYMIQ---HPGGLH-PYNVRLFMFQ-LLRGLAYIHGQHILHRDLKPQ 132
Query: 958 NILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
N+LI + +KL DF RA + S ++ + PDV +G
Sbjct: 133 NLLISYLGE-------LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD----- 180
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1055
Y +DIW GC+ +E+L Q + G+S++
Sbjct: 181 ----------YSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 22/113 (19%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LHS I+HRD+K NI++ K+D +K+ DF A T C P
Sbjct: 139 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLA-------RTACTNFMMTPY-- 182
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
V T + APEV+ M Y VDIWS GC++ EL+ V + G ++
Sbjct: 183 --VVTRYYRAPEVILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-05
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
V AL H++ I+HRD+K +NI++ + +P K+ DF L
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMV----SQTGVRPHAKVLDFGIGTLLPGVRD---ADV 140
Query: 997 RGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1055
+ +GTP + APE LR PN D++++G + LE LT Q G S
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPN-----SDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 1056 EI 1057
EI
Sbjct: 196 EI 197
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 36/158 (22%)
Query: 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
G+ N I K + + HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 105 GADLNNIVKCQKLTDDHVQ-----FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE- 158
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWM-APEV-LRAMHKP 1023
+K+ DF A HT D G RW APE+ L MH
Sbjct: 159 ------LKILDFGLA------RHT----------DDEMTGYVATRWYRAPEIMLNWMH-- 194
Query: 1024 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 195 --YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E ++ L + IV M G + W+ + ME + G + +++K
Sbjct: 44 LREANVMQQLDNPYIVRMIGICEAESWM---------------LVMELAELGPLNKFLQK 88
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
KHV+ K + V+ + L + +HRD+ + N+L+ + K+
Sbjct: 89 -----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-------YAKI 136
Query: 977 CDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
DF + L + + H P +W APE + +K + + D+WS+
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPV--------KWYAPECMN-YYK---FSSKSDVWSF 184
Query: 1036 GCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
G L+ E + Q PY G+ E+ +I+ G+R
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL-QRLENLDLSNN 243
L L LDL+ N+++ +E+ L L SL + NN + ++P + LL L+ LDLS+N
Sbjct: 91 NLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ SL L + NL+NL+L +N L
Sbjct: 151 KIESL-PSPLRNLPNLKNLDLSFNDLSD 177
|
Length = 394 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 75/309 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L+ +S + +F EV++L L I + G L
Sbjct: 51 VKVLR-PDASDNAREDFL----KEVKILSRLSDPNIARLLGVCTVDPPL----------- 94
Query: 896 LQSAIFMEYVKGGSVKNYIEK------LSETGEKHVSVKLALFIAQDVAAALVELHSKHI 949
+ MEY++ G + +++K K +S L++A +A+ + L S +
Sbjct: 95 ---CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151
Query: 950 MHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007
+HRD+ + N L+ +K+ DF R + + + R P P
Sbjct: 152 VHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSSDY---YRVQGRA-PLP----- 195
Query: 1008 TPRWMAPE-VLRAMHKPNLYGLEVDIWSYGCLLLELLTL--QVPYMGLSELEIHDLIQ-M 1063
RWMA E VL + K + + D+W++G L E+LTL + PY L +I+
Sbjct: 196 -IRWMAWESVL--LGK---FTTKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVIENA 246
Query: 1064 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123
G R L +P + + ++ C + +RPT
Sbjct: 247 GHFFRDDGRQIYLP---------------RPPNCPKD---IYELMLECWRRDEEDRPTFR 288
Query: 1124 DLYEMFVAR 1132
+++ +F+ R
Sbjct: 289 EIH-LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 28/137 (20%)
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
+ I +AA + L S H++H+D+ + N+L+ K VK+ D + + +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-------DKLNVKISDLGLFREVYAADY 179
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 1045
+ + +P RWM+PE + +YG ++ DIWSYG +L E+ + L
Sbjct: 180 YKLMGNSLLPI--------RWMSPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 1046 QVPYMGLSELEIHDLIQ 1062
Q PY G S ++ ++I+
Sbjct: 225 Q-PYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 916
E +++ L H +V++YG +S I + E+++ G + +Y+
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTE----------------RSPICLVFEFMEHGCLSDYLR- 91
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
++ G+ S + L + DV + L S +++HRD+ + N L+ + VVK+
Sbjct: 92 -AQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------VVKV 141
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF R L + G P +W +PEV + Y + D+WS+G
Sbjct: 142 SDFGMT---RFVLDDQYTSSTGTKFP------VKWSSPEVF----SFSKYSSKSDVWSFG 188
Query: 1037 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRL 1069
L+ E+ + + PY S E+ + I G R PRL
Sbjct: 189 VLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 26/110 (23%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 999
AL +H+ ++ HRD+K +NIL + AD K +K+CDF A +F T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-----ADCK--LKICDFGLARV--AFNDT-------- 157
Query: 1000 PAPDVCVGT----PRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
P T RW APE+ + Y +DIWS GC+ E+LT
Sbjct: 158 --PTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-05
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS +++HRD+K N+L++ +++ DF A L S H+
Sbjct: 123 IHSANVIHRDLKPSNLLVN-------EDCELRIGDFGMARGLSSS----PTEHKYFMTEY 171
Query: 1004 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043
V RW APE+L ++ + Y +D+WS GC+ E+L
Sbjct: 172 V---ATRWYRAPELLLSLPE---YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 53 EVSLLKNLKHANIVTL--HDII------------HTERCLTLVFEYLDS-DLKQYLDNCG 97
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
H +VK+ +F + L H + I+HRD+K +N+LI + K +KL D
Sbjct: 98 NLMSMH-NVKIFMF---QLLRGLSYCHKRKILHRDLKPQNLLI-------NEKGELKLAD 146
Query: 979 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
F ++VP +++ + + +R PDV +G+ + P +D+W
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSTEYSTP---------------IDMW 188
Query: 1034 SYGCLLLELLT 1044
GC+L E+ T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 20/131 (15%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
+A + L + ++HRD+ + N+L+ VK+ DF A L +
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVK-------TPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 997 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 1055
+P +WMA E + +H+ +Y + D+WSYG + EL+T PY G+
Sbjct: 171 GKVPI--------KWMALESI--LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
Query: 1056 EIHDLIQMGKR 1066
EI +++ G+R
Sbjct: 219 EISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSL--------------TLVFEYLDK-DLKQYMDDCG 98
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
H +VK+ L+ + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NIMSMH-NVKIFLY---QILRGLAYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 979 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
F ++VP +++ + + +R PDV +G+ Y ++D+W
Sbjct: 148 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSSE---------------YSTQIDMW 189
Query: 1034 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 1067
GC+ E+ + + + G + E E+H + ++ P
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 20/146 (13%)
Query: 922 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 981
+ ++ +L L +A ++ L + ++HRD+ + N+L+ VK+ DF
Sbjct: 103 KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-------VKITDFGL 155
Query: 982 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041
A L +P +WMA E + + + D+WSYG + E
Sbjct: 156 ARLLEGDEKEYNADGGKMPI--------KWMALECIHYRK----FTHQSDVWSYGVTIWE 203
Query: 1042 LLTL-QVPYMGLSELEIHDLIQMGKR 1066
L+T PY G+ EI DL++ G+R
Sbjct: 204 LMTFGGKPYDGIPTREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 40/133 (30%), Positives = 58/133 (43%), Gaps = 32/133 (24%)
Query: 929 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV-----------VKL 976
LA I Q AL H++ H+MH D+K ENIL++ D PV V++
Sbjct: 233 LAQIIFQ-TGVALDYFHTELHLMHTDLKPENILMETSDTVVD--PVTNRALPPDPCRVRI 289
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
CD L CC A V T + +PEV+ + + D+WS G
Sbjct: 290 CD----------LGGCCDERHSRTA---IVSTRHYRSPEVVLGLG----WMYSTDMWSMG 332
Query: 1037 CLLLELLTLQVPY 1049
C++ EL T ++ Y
Sbjct: 333 CIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 20/133 (15%)
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
L IA +AA + L S +H+D+ + NILI + VK+ D + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-------VKISDLGLSREIYSADY 179
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 1049
+P RWM PE + + + DIWS+G +L E+ + + PY
Sbjct: 180 YRVQPKSLLPI--------RWMPPEAIMY----GKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 1050 MGLSELEIHDLIQ 1062
G S E+ ++++
Sbjct: 228 YGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 828 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
G + ++TLK G + + R+F L E ++G H I+ + G + +K P
Sbjct: 29 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEG--VVTKSRPVM 81
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
I E+++ G++ +++ + + +V + + + +AA + L
Sbjct: 82 ------------IITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007
+ +HRD+ + NIL+ + V K+ DF L FL P +G
Sbjct: 126 NYVHRDLAARNILV-------NSNLVCKVSDFG----LSRFLED----DTSDPTYTSSLG 170
Query: 1008 TP---RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 1063
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ + I+
Sbjct: 171 GKIPIRWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 1064 GKR 1066
R
Sbjct: 227 DYR 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
I + + A+ +H K ++HRDIK ENI ++ DGK V L DF A+P
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLN-----CDGKIV--LGDFGTAMPFEK----- 319
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
VGT +PE+L + Y DIWS G +LL++L+
Sbjct: 320 ----EREAFDYGWVGTVATNSPEILAG----DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)
Query: 896 LQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
LQSA + MEY+ GG VK+ + E+ +A+ +VA AL LH I+H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLHRHGIIH 127
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDF 979
RD+K +N+LI E +KL DF
Sbjct: 128 RDLKPDNMLISNEGH-------IKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 1002
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 142 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 184
Query: 1003 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1061
V T + APEV+ M Y VDIWS GC++ E++ V + G ++ + +
Sbjct: 185 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 1062 -QMGKR-PRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDV-FRRCTEENPT 1117
Q+G P +L+ + E+ +G FEK DV F +E N
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK---------LFPDVLFPADSEHNKL 289
Query: 1118 ERPTAGDLY-EMFVARTSSSIS 1138
+ A DL +M V S IS
Sbjct: 290 KASQARDLLSKMLVIDASKRIS 311
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 50/215 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSL--------------TLVFEYLDK-DLKQYLDDCG 98
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ H +VKL LF + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NSINMH-NVKLFLF---QLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 979 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
F +++P +++ + + +R PD+ +G+ Y ++D+W
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYR---PPDILLGSTD---------------YSTQIDMW 189
Query: 1034 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 1067
GC+ E+ T + + G + E ++H + ++ P
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 38/204 (18%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV S R+ + M+ + H IV +YG + +++
Sbjct: 37 LKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRD--------------VEN 79
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ E+V+ G + ++ + S+ ++ +A+ +A+AL L K ++H ++ ++N
Sbjct: 80 IMVEEFVEFGPLDLFMHRKSDV----LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN 135
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+ E + P +KL D +P+ C+ IP W+APE +
Sbjct: 136 ILLAREGIDGECGPFIKLS--DPGIPITVLSRQECVER--IP----------WIAPECVE 181
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLEL 1042
NL + D WS+G L E+
Sbjct: 182 --DSKNL-SIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 1002
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T + R AP
Sbjct: 135 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 1003 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
+V +G Y VDIWS GC++ E++ ++ + G
Sbjct: 188 EVILGMG----------------YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
E+V+ G + + K E G V V + +AQ +A+AL L K+++H ++ ++NIL
Sbjct: 96 EFVEHGPLDVCLRK--EKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL-- 149
Query: 963 LERKK-ADG-KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
L R A+G P +KL D P SF + + V W+APE +
Sbjct: 150 LARLGLAEGTSPFIKLSD-----PGVSF---------TALSREERVERIPWIAPECV--- 192
Query: 1021 HKPNLYGLE--VDIWSYGCLLLEL-LTLQVPYMGLSELEIHDLIQMGKRPRLTD----EL 1073
P L D WS+G LLE+ +VP + E + K+ RL + EL
Sbjct: 193 --PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--KKHRLPEPSCKEL 248
Query: 1074 EAL-GSCHEHEVAQSGS 1089
L C +E Q S
Sbjct: 249 ATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 48/256 (18%)
Query: 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM 862
G S ++ G+ +++++ G + K+ LKV +E ++ + E +
Sbjct: 2 GKADSYEKLEKLGEGSYATVYK---GKSKVNGKLVALKVIRLQEEE--GTPFTAIREASL 56
Query: 863 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 922
L L+H+ IV + H I H + EYV + Y++K G
Sbjct: 57 LKGLKHANIVLL--HDII------------HTKETLTLVFEYVHT-DLCQYMDK-HPGGL 100
Query: 923 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD-- 980
+VKL LF + L +H ++I+HRD+K +N+LI + +KL DF
Sbjct: 101 HPENVKLFLF---QLLRGLSYIHQRYILHRDLKPQNLLISDTGE-------LKLADFGLA 150
Query: 981 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040
RA + S ++ + PDV +G+ Y +D+W GC+ +
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTE---------------YSTCLDMWGVGCIFV 195
Query: 1041 ELLTLQVPYMGLSELE 1056
E++ + G+ +++
Sbjct: 196 EMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-04
Identities = 34/113 (30%), Positives = 45/113 (39%), Gaps = 15/113 (13%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL----- 222
IR L + NLE LDL+ N L + LK+L L + +N L
Sbjct: 179 DAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238
Query: 223 VELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCL----MHNLQNLNLQYNKLL 270
L S L L L LS N +T G+ DL +L L+L+ NK
Sbjct: 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 65/265 (24%), Positives = 95/265 (35%), Gaps = 74/265 (27%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ME++ GG + + K E+ +IA+ V A + +H +HRDIK +N+
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQ----FYIAETVLA-IDSIHQLGFIHRDIKPDNL 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR---------GIPAPDV------ 1004
L+ D K VKL DF L+ AHR +P+
Sbjct: 133 LL-------DSKGHVKLSDFGLCTGLKK-------AHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 1005 -----------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047
VGTP ++APEV Y D WS G ++ E+L
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ----TGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 1048 PYMGLSELEIHDLIQMGKRPRLTDELEA----------LGSCHEHEVAQSGSGFEKPEAE 1097
P+ + E + + M + L E L C E E G E E
Sbjct: 235 PFCSETPQETYKKV-MNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE----E 289
Query: 1098 LETLSFLVDVFRRCTEENPTERPTA 1122
++T F F E+ ERP A
Sbjct: 290 IKTNPF----FEGVDWEHIRERPAA 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 22/132 (16%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
+A + L ++HRD+ + N+L+ VK+ DF A L T A
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNH-------VKITDFGLA-RLLDIDETEYHAD 169
Query: 997 RG-IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSE 1054
G +P +WMA E + +H+ + + D+WSYG + EL+T PY G+
Sbjct: 170 GGKVPI--------KWMALESI--LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
Query: 1055 LEIHDLIQMGKR 1066
EI DL++ G+R
Sbjct: 218 REIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 41/116 (35%), Positives = 49/116 (42%), Gaps = 20/116 (17%)
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
L I + V A+ LH I+HRDIK+ENI I+ D V L DF A
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGD----VCLGDFGAA-------- 229
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046
C GT APE+L P YG VDIWS G +L E+ T
Sbjct: 230 -CFPVDINANKYYGWAGTIATNAPELL--ARDP--YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 7e-04
Identities = 17/37 (45%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLSNN++T L L + NL+ L+L NK+
Sbjct: 1 TNLETLDLSNNQITDLPPL--SNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-04
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 175 SIRYL---------PPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV- 223
S+RYL G + NLE LDLS N + +P +I +L L + N LV
Sbjct: 119 SLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178
Query: 224 ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++P+ L L LE L L++N+L +L M +L+ + L YN L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
|
Length = 968 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 27/127 (21%)
Query: 932 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
F+ + L +H+ I+HRD+K N+ ++ + + +K+ DF A S +
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-------LKILDFGLARQTDSEMTG 174
Query: 992 CCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
+ RW APEV L MH Y VDIWS GC++ E+LT + +
Sbjct: 175 YVVT--------------RWYRAPEVILNWMH----YTQTVDIWSVGCIMAEMLTGKPLF 216
Query: 1050 MGLSELE 1056
G L+
Sbjct: 217 KGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 0.001
Identities = 64/255 (25%), Positives = 95/255 (37%), Gaps = 66/255 (25%)
Query: 838 TLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVE--MYGH-KISSKWLPSADGNPEH 893
+LKV G A E+R + G + + LR + ++E H + L ADG
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 894 HLLQS-------AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 946
+ S + ME++ GG + + K E+ +IA+ V A + +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQ----FYIAETVLA-IDAIHQ 119
Query: 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI------- 999
+HRDIK +N+L+ D K VKL DF L+ AHR
Sbjct: 120 LGFIHRDIKPDNLLL-------DAKGHVKLSDFGLCTGLKK-------AHRTEFYRNLTH 165
Query: 1000 -PAPDV------------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
P D VGTP ++APEV Y D WS
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG----YNKLCDWWS 221
Query: 1035 YGCLLLELLTLQVPY 1049
G ++ E+L P+
Sbjct: 222 LGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS I+HRD+K N+ ++ + + +K+ DF A R A
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-------LKILDFGLA--------------RHADAEM 171
Query: 1004 VCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
RW APEV L MH Y VDIWS GC++ E+LT + + G
Sbjct: 172 TGYVVTRWYRAPEVILNWMH----YNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 28/144 (19%)
Query: 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
G+ N I K + ++HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 103 GADLNNIVKCQKLSDEHVQ-----FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE- 156
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
+++ DF A + T +A R AP++ +L MH Y
Sbjct: 157 ------LRILDFGLARQADDEM-TGYVATRWYRAPEI-----------MLNWMH----YN 194
Query: 1028 LEVDIWSYGCLLLELLTLQVPYMG 1051
VDIWS GC++ ELL + + G
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 67/263 (25%), Positives = 102/263 (38%), Gaps = 80/263 (30%)
Query: 837 RTLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVEMY-----GH---------KISS 881
T+KV G A E+R + G++ + L S EM+ H + S
Sbjct: 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS---EMFKKDQLAHVKAERDVLAESDS 60
Query: 882 KWLPSADGNPEHHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 937
W+ S ++ Q A + ME++ GG + + K +T + V+ ++A+ V
Sbjct: 61 PWVVSL-----YYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVT---RFYMAECV 111
Query: 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF----------DRAV---P 984
A + +H +HRDIK +NILID G +KL DF D A
Sbjct: 112 LA-IEAVHKLGFIHRDIKPDNILID-----RGGH--IKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 985 LRSFLHTCCIAHRGIPAPDV------------------------CVGTPRWMAPEVLRAM 1020
L+ + I +R A D VGTP ++APE+
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 1021 HKPNLYGLEVDIWSYGCLLLELL 1043
YG E D WS G ++ E L
Sbjct: 224 G----YGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 49/210 (23%)
Query: 863 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 922
+G+L H+ IV + G P A LQ + + GS+ +++ + ++
Sbjct: 63 MGSLDHAYIVRLLG------ICPGAS-------LQ--LVTQLSPLGSLLDHVRQHRDS-- 105
Query: 923 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 982
+ + L +A + L ++HR++ + NIL+ K+D +V++ DF A
Sbjct: 106 --LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL-----KSDS--IVQIADFGVA 156
Query: 983 VPL----RSFLHTCCIAHRGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
L + + ++ TP +WMA L ++ Y + D+WSYG
Sbjct: 157 DLLYPDDKKYFYSE-------------HKTPIKWMA---LESILFGR-YTHQSDVWSYGV 199
Query: 1038 LLLELLTLQV-PYMGLSELEIHDLIQMGKR 1066
+ E+++ PY G+ E+ DL++ G+R
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1141 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.92 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.82 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.72 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.72 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.47 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.46 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.41 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.19 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.18 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.11 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.09 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.98 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.95 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.78 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.76 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.61 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.49 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.33 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-59 Score=612.13 Aligned_cols=293 Identities=21% Similarity=0.206 Sum_probs=202.3
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~~L 96 (1141)
+++.|.+..|+++...+..|.++++|+.|+|++|.+++.+|..++.+ ++|+.|+|++|.++ .+|..+..+++|+.|
T Consensus 285 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l---~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L 361 (968)
T PLN00113 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL---PRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361 (968)
T ss_pred CcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC---CCCCEEECcCCCCcCcCChHHhCCCCCcEE
Confidence 45555555555555555555555555555555555555555444333 55555555555554 445555555555555
Q ss_pred EccCCCCC-cCch------------------------hhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCC
Q 001143 97 KFFGNEIN-LFPS------------------------EVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPR 150 (1141)
Q Consensus 97 ~Ls~N~L~-~lP~------------------------~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~N~ln 150 (1141)
+|++|+++ .+|. .++++++|+.|+|++|++. .+|..+..+++|+.|++++|.+
T Consensus 362 ~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l- 440 (968)
T PLN00113 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL- 440 (968)
T ss_pred ECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcc-
Confidence 55555554 3444 4445555555555555532 3444455555555555555333
Q ss_pred CCcccchhhhcCCCCCcEEEccCCCCC-ccCccccCCCCCCEEEccCCccc-cccccccCCCCCCEEEccCCCCC-cCCc
Q 001143 151 PSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPS 227 (1141)
Q Consensus 151 ~~~~~lp~~l~~L~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~IP~ 227 (1141)
.+.+|..+..+++|+.|+|++|++. .+|..+ .+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.
T Consensus 441 --~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 517 (968)
T PLN00113 441 --QGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517 (968)
T ss_pred --cCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCCh
Confidence 2334445556666666777776666 344433 4577888888888887 67888999999999999999998 7899
Q ss_pred CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcccccccCC
Q 001143 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEG 307 (1141)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~~~~~~~~ 307 (1141)
.+.++++|+.|+|++|++++.+|..|..+++|+.|+|++|++++ .+|..+.....+..+++++|.+.+..|. .
T Consensus 518 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~l~ls~N~l~~~~p~-----~ 590 (968)
T PLN00113 518 ELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG--EIPKNLGNVESLVQVNISHNHLHGSLPS-----T 590 (968)
T ss_pred HHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc--cCChhHhcCcccCEEeccCCcceeeCCC-----c
Confidence 99999999999999999999999999999999999999999998 6899999888899999999999998885 3
Q ss_pred CCCCCCCCCCcCCCC-CC
Q 001143 308 PMLENDGNVSFSESD-AG 324 (1141)
Q Consensus 308 ~~l~~~~~~sf~~n~-~~ 324 (1141)
..+.++...+|.||+ +|
T Consensus 591 ~~~~~~~~~~~~~n~~lc 608 (968)
T PLN00113 591 GAFLAINASAVAGNIDLC 608 (968)
T ss_pred chhcccChhhhcCCcccc
Confidence 445567778888884 45
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=408.60 Aligned_cols=275 Identities=23% Similarity=0.301 Sum_probs=221.6
Q ss_pred CCCCCCC-ceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 801 DPGSFPS-LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 801 ~~~~~~~-y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
.+.++.+ |.+.+.||+|+||.|-+|.. .+..||+||+...+.......... ...+++|+++|++|+|||||+++++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~-~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAK-TRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccc-hhhhHHHHHHHHhcCCCCEEEEeee
Confidence 4555555 68999999999999999987 577899998654433222111111 1224799999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
|+..+.. ||||||++||+|.+.+-. .+.+.+...+.+++|++.|+.|||++||+||||||+
T Consensus 245 f~~~ds~--------------YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPe 305 (475)
T KOG0615|consen 245 FEVPDSS--------------YMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPE 305 (475)
T ss_pred eecCCce--------------EEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcc
Confidence 9987644 999999999999999876 456888999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||+..+ .....+||+|||+|+...... ...+.+|||.|.|||++.... ...+..++|+||+||
T Consensus 306 NILl~~~----~e~~llKItDFGlAK~~g~~s-----------fm~TlCGTpsYvAPEVl~~kg-~~~~~~kVDiWSlGc 369 (475)
T KOG0615|consen 306 NILLSND----AEDCLLKITDFGLAKVSGEGS-----------FMKTLCGTPSYVAPEVLASKG-VEYYPSKVDIWSLGC 369 (475)
T ss_pred eEEeccC----CcceEEEecccchhhccccce-----------ehhhhcCCccccChhheecCC-eecccchheeeeccc
Confidence 9999765 234789999999998765321 123567999999999997632 233456999999999
Q ss_pred HHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+||-+++|.+||.+..... +.++|..+.....+..+. .++++..+||.+||..||
T Consensus 370 vLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~------------------------~Iseea~dlI~~mL~VdP 425 (475)
T KOG0615|consen 370 VLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD------------------------RISEEALDLINWMLVVDP 425 (475)
T ss_pred eEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh------------------------hhhHHHHHHHHHhhEeCc
Confidence 9999999999998754444 778888887655433221 678889999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001143 1117 TERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~s 1135 (1141)
++|||++|+|+|+|++..+
T Consensus 426 ~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 426 ENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ccCcCHHHHhcChhhhccc
Confidence 9999999999999998654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=396.59 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=217.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~--vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.+..+++..+.||+|..|+||+++++.+. +|+|+..+. .... ++.++.+|+++++..+|||||.+||.|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~----~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPA----LQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHH----HHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34557889999999999999999997554 555554222 1222 23345899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NI 959 (1141)
+.. ..+|+||||++|||++++.. .+++++...-+|+.+|++||.|||. ++||||||||+||
T Consensus 149 ~~~-------------~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 149 NGE-------------EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred CCc-------------eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 552 35999999999999999986 2579999999999999999999995 9999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.. |.|||||||.++.+... ...+++||..|||||.+.+ ..|+.++||||||+++
T Consensus 211 LvNsk-------GeVKicDFGVS~~lvnS------------~a~tfvGT~~YMsPERi~g----~~Ys~~sDIWSLGLsl 267 (364)
T KOG0581|consen 211 LVNSK-------GEVKICDFGVSGILVNS------------IANTFVGTSAYMSPERISG----ESYSVKSDIWSLGLSL 267 (364)
T ss_pred eeccC-------CCEEeccccccHHhhhh------------hcccccccccccChhhhcC----CcCCcccceecccHHH
Confidence 99987 89999999999876542 2246789999999999998 6899999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 001143 1040 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1114 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~-----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~ 1114 (1141)
+|+++|+.||... +..+++..|..+..|.++.. .+++++++|+..||++
T Consensus 268 lE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--------------------------~fS~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 268 LELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--------------------------EFSPEFRSFVSCCLRK 321 (364)
T ss_pred HHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHhcC
Confidence 9999999999763 56677788877777665531 3677899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcC
Q 001143 1115 NPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1115 DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
||.+|||+.|+++|+|.+..
T Consensus 322 dp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 322 DPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CcccCCCHHHHhcCHHHhhc
Confidence 99999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=408.58 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=220.1
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
++.. ..|...+.||+|+|+.+|.+++ .+..+|+|+...+.... ....+ ++.+||+|.++|+|||||+++++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-~~~re----Kv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-PKQRE----KVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-cchHH----HHHHHHHHHHhcCCCcEEeeeeEe
Confidence 3444 6799999999999999999997 57788999865332222 22222 347999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
++.+++ |||.|+|+.++|..++++ .+++++.+++.+++||+.||.|||+++|+|||||..|
T Consensus 88 EDs~nV--------------YivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 88 EDSNNV--------------YIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred ecCCce--------------EEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 988755 999999999999999986 5689999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
+|++++ .+|||+|||+|..+..... ...+.+|||.|.|||++.. ...+..+||||+||+
T Consensus 149 lfL~~~-------~~VKIgDFGLAt~le~~~E----------rk~TlCGTPNYIAPEVl~k----~gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 149 LFLNEN-------MNVKIGDFGLATQLEYDGE----------RKKTLCGTPNYIAPEVLNK----SGHSFEVDIWSLGCV 207 (592)
T ss_pred eeecCc-------CcEEecccceeeeecCccc----------ccceecCCCcccChhHhcc----CCCCCchhhhhhhhH
Confidence 999998 8999999999988764322 2236689999999999985 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|.|+.|++||...+..+.+..|......... ..+.++++||.++|+.||.+
T Consensus 208 mYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----------------------------~ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 208 MYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----------------------------HLSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HHhhhhCCCCcccchHHHHHHHHHhcCccccc----------------------------ccCHHHHHHHHHHhcCCccc
Confidence 99999999999988888888888665432111 45667999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
|||+++|+.|.||.
T Consensus 260 Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 260 RPSLDEVLDHPFFK 273 (592)
T ss_pred CCCHHHHhcCHhhh
Confidence 99999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=380.33 Aligned_cols=266 Identities=26% Similarity=0.420 Sum_probs=219.3
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee-Ee
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH-KI 879 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~-~~ 879 (1141)
+..+..+|++.++||+|+||+||++....+...++.+++.-...+....+.. ..|+.+|++|+|||||+++++ |.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~----v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDC----VKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHH----HHHHHHHHhcCCchHHHHHHHhhh
Confidence 4567788999999999999999999875444344433344222333333444 899999999999999999994 44
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KH--IMHRDIK 955 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs--~g--IvHrDLK 955 (1141)
++.. .++||||||.+|+|..+|+.+... .+.+++..+++++.|+++||.++|+ .. |+|||||
T Consensus 90 ~~~e-------------vlnivmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 90 EDNE-------------VLNIVMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred ccch-------------hhHHHHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 3332 258999999999999999976554 4689999999999999999999999 45 9999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
|.||+++.+ |.|||+|||+++.+..... .....+|||+||+||.+.+ ..|+.|+||||+
T Consensus 156 PaNIFl~~~-------gvvKLGDfGL~r~l~s~~t----------fA~S~VGTPyYMSPE~i~~----~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 156 PANIFLTAN-------GVVKLGDFGLGRFLSSKTT----------FAHSLVGTPYYMSPERIHE----SGYNFKSDIWSL 214 (375)
T ss_pred chheEEcCC-------CceeeccchhHhHhcchhH----------HHHhhcCCCcccCHHHHhc----CCCCcchhHHHH
Confidence 999999988 8999999999998765332 2236789999999999987 789999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
||++|||+.-++||.+.+..++...|..+..++++.. ..+.++..||..|+..|
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~--------------------------~YS~~l~~li~~ci~vd 268 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE--------------------------HYSTDLRELINMCIAVD 268 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH--------------------------HhhhHHHHHHHHHccCC
Confidence 9999999999999999999999999999988777643 56778999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 001143 1116 PTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~ 1131 (1141)
|+.||+.-.++..+..
T Consensus 269 ~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 269 PEQRPDTVPYVQDIQS 284 (375)
T ss_pred cccCCCcchHHHHHHH
Confidence 9999996555555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=381.96 Aligned_cols=270 Identities=24% Similarity=0.390 Sum_probs=213.6
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
....+.+|.+.++||+|+||+||+|+++.+...|+||.+.+..-.....+. +..|+.+|+.++|||||++++++..
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~----L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVEL----LLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHH----HHHHHHHHHhcCCcceeeEEEEEec
Confidence 345678899999999999999999998655445555444443223333333 3899999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
++++ |||||||.||+|.++|++ .+.+++..++.++.||+.||++||+++||||||||+|||
T Consensus 81 ~~~i--------------~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 81 DDFI--------------YLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred CCeE--------------EEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 7754 999999999999999997 347999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++..... .....+||+|||+|+.+.... ...+.+|++.|||||++.. ..|+.|+|+||+|+++|
T Consensus 142 Ls~~~~~-~~~~~LKIADFGfAR~L~~~~-----------~a~tlcGSplYMAPEV~~~----~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 142 LSTTARN-DTSPVLKIADFGFARFLQPGS-----------MAETLCGSPLYMAPEVIMS----QQYDAKADLWSIGTILY 205 (429)
T ss_pred eccCCCC-CCCceEEecccchhhhCCchh-----------HHHHhhCCccccCHHHHHh----ccccchhhHHHHHHHHH
Confidence 9875211 111679999999999876422 1235679999999999976 68999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|+.||...+..++...+..+..... ..+...+..+.+++...++.+|.+|.
T Consensus 206 q~l~g~~Pf~a~t~~eL~~~~~k~~~~~~-------------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~ 260 (429)
T KOG0595|consen 206 QCLTGKPPFDAETPKELLLYIKKGNEIVP-------------------------VLPAELSNPLRELLISLLQRNPKDRI 260 (429)
T ss_pred HHHhCCCCccccCHHHHHHHHhccccccC-------------------------chhhhccCchhhhhhHHHhcCccccC
Confidence 99999999999999998887765543211 01113334466778888888888888
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
++.+-..|.+....
T Consensus 261 ~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 261 SFEDFFDHPFLAAN 274 (429)
T ss_pred chHHhhhhhhcccC
Confidence 88877777665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=394.63 Aligned_cols=263 Identities=30% Similarity=0.456 Sum_probs=217.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCcc-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~-vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..++.++.+.+.||+|+||+||+|.|.+.. ||+|++.-. ....... ..|.+|+.+|.+++|||||+++|++.+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~--~~~~~~~----~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDP--DFDDESR----KAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecch--hcChHHH----HHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 344566778888999999999999999988 899886432 2222223 345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g-IvHrDLKP~NI 959 (1141)
... ..+|||||+++|+|..+++.. ....+++..+.+|+.||++||+|||+++ ||||||||+||
T Consensus 111 ~~~-------------~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~Ni 174 (362)
T KOG0192|consen 111 PPG-------------SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNI 174 (362)
T ss_pred CCC-------------ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhE
Confidence 541 359999999999999999863 3457999999999999999999999999 99999999999
Q ss_pred eeecccccCCCCC-eEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 960 LIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|++.+ + ++||+|||+++....... ......||+.|||||++.+. ...|+.|+||||||++
T Consensus 175 Lv~~~-------~~~~KI~DFGlsr~~~~~~~----------~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIv 235 (362)
T KOG0192|consen 175 LVDLK-------GKTLKIADFGLSREKVISKT----------SMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIV 235 (362)
T ss_pred EEcCC-------CCEEEECCCccceeeccccc----------cccCCCCCccccChhhhcCC--CCcCCccchhhhHHHH
Confidence 99987 6 999999999976543210 11235699999999999853 3679999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|||+||+.||.+....++...+ ..+.+|.++. .+++.+..++.+||..||.
T Consensus 236 lWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~---------------------------~~~~~l~~l~~~CW~~dp~ 288 (362)
T KOG0192|consen 236 LWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK---------------------------ECPPHLSSLMERCWLVDPS 288 (362)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHhCCCCCC
Confidence 99999999999998886666555 4666555443 3566799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+||++.+++..+...
T Consensus 289 ~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 289 RRPSFLEIVSRLESI 303 (362)
T ss_pred cCCCHHHHHHHHHHH
Confidence 999999999988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=378.88 Aligned_cols=261 Identities=27% Similarity=0.322 Sum_probs=219.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+++|++.++||+|+||.||+++.. ++-+|+|+.+.+..... .+.+ ....|..+|.+++||.||+++-.|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~----~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVR----HTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHH----HHHHHHHHHHhCCCCcEeeeEEecc
Confidence 456789999999999999999999874 55677777443322222 2223 3379999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+... +|+|+||+.||.|..+|++ .+.+++..++.++.+|+.||.|||++|||||||||+||
T Consensus 96 t~~k--------------LylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI 156 (357)
T KOG0598|consen 96 TEEK--------------LYLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI 156 (357)
T ss_pred cCCe--------------EEEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence 7664 4999999999999999987 45799999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|+|.+ |+++|+|||+|+..-... ....+++||+.|||||++.+ ..|+..+|+||+|+++
T Consensus 157 LLd~~-------GHi~LtDFgL~k~~~~~~----------~~t~tfcGT~eYmAPEil~~----~gy~~~vDWWsLGill 215 (357)
T KOG0598|consen 157 LLDEQ-------GHIKLTDFGLCKEDLKDG----------DATRTFCGTPEYMAPEILLG----KGYDKAVDWWSLGILL 215 (357)
T ss_pred eecCC-------CcEEEeccccchhcccCC----------CccccccCCccccChHHHhc----CCCCcccchHhHHHHH
Confidence 99998 999999999997533221 12335789999999999997 6899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|||++|.+||.+.+...+.+.|..+..+..+. ..+.+.++++.++|..||++|
T Consensus 216 YeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---------------------------~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 216 YEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---------------------------YLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred HHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---------------------------cCCHHHHHHHHHHhccCHHHh
Confidence 99999999999999888999988776433321 245568999999999999999
Q ss_pred C----CHHHHHHHHHhhcC
Q 001143 1120 P----TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 P----Sa~ElL~~L~~~~~ 1134 (1141)
. ++.+|-+|++|..-
T Consensus 269 Lg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 269 LGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred cCCCCChHHhhcCcccccC
Confidence 4 79999999999754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=389.29 Aligned_cols=287 Identities=23% Similarity=0.271 Sum_probs=223.1
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~ 883 (1141)
.++|.+.++||.|+||.||+|+.......|+||+.+......++.-+ +||+..|++|. |||||++.+.+.+.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-----LREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-----HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 46799999999999999999998554444555556655555444444 59999999998 9999999999987541
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
++|+|||||+ .+|++++++ . ...|++..++.|++||++||+|+|.+|+.|||+||+|||+..
T Consensus 84 -------------~L~fVfE~Md-~NLYqLmK~---R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~ 145 (538)
T KOG0661|consen 84 -------------ILYFVFEFMD-CNLYQLMKD---R-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG 145 (538)
T ss_pred -------------eEeeeHHhhh-hhHHHHHhh---c-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc
Confidence 4699999997 899999987 2 568999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
. ..+||+|||+|+.+.... .....+.|.+|+|||++.. ...|+.++||||+|||++|+.
T Consensus 146 ~-------~~iKiaDFGLARev~Skp-----------PYTeYVSTRWYRAPEvLLr---s~~Ys~pvD~wA~GcI~aEl~ 204 (538)
T KOG0661|consen 146 N-------DVIKIADFGLAREVRSKP-----------PYTEYVSTRWYRAPEVLLR---SGYYSSPVDMWAVGCIMAELY 204 (538)
T ss_pred c-------ceeEecccccccccccCC-----------CcchhhhcccccchHHhhh---ccccCCchHHHHHHHHHHHHH
Confidence 5 689999999998765422 2345678999999999986 468999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHH-HhCCCCCchhHHh---hhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLI-QMGKRPRLTDELE---ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+-++.|.|.++.+.+.+| ...+.|....... ........ +.+ ..+......-..++.++.++|.+|+.+||.+|
T Consensus 205 sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~-~P~-~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kR 282 (538)
T KOG0661|consen 205 SLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR-FPQ-VKPSPLKDLLPNASSEAASLIERLLAWDPDKR 282 (538)
T ss_pred HhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC-CCc-CCCCChHHhCcccCHHHHHHHHHHhcCCCccC
Confidence 999999999888766666 3333333221111 01000111 111 11111122223578889999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCC
Q 001143 1120 PTAGDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s~~ 1137 (1141)
|||.|+++|++|+.....
T Consensus 283 pTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 283 PTASQALQHPFFQVGRAS 300 (538)
T ss_pred ccHHHHhcCccccccccc
Confidence 999999999999866444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=365.11 Aligned_cols=284 Identities=24% Similarity=0.343 Sum_probs=216.5
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
+.|+...++|+|+||+||+++++.+...|+|++.....++ +..+.+ .++|+++|++++|||+|.++++|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKI---AlREIrmLKqLkH~NLVnLiEVFrrkrk-- 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKI---ALREIRMLKQLKHENLVNLIEVFRRKRK-- 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHH---HHHHHHHHHhcccchHHHHHHHHHhcce--
Confidence 4688899999999999999998665555555444433322 333333 4899999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
.++|+|||+ .++.+-+.+ .+ ..++...++++++|++.|+.|+|++++|||||||+||||+.+
T Consensus 76 ------------lhLVFE~~d-hTvL~eLe~---~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~- 137 (396)
T KOG0593|consen 76 ------------LHLVFEYCD-HTVLHELER---YP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN- 137 (396)
T ss_pred ------------eEEEeeecc-hHHHHHHHh---cc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-
Confidence 499999998 444444443 22 358999999999999999999999999999999999999988
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.+||||||+|+.+..+... ....+.|.+|+|||.+.+ ...|+..+||||+||++.||++|
T Consensus 138 ------gvvKLCDFGFAR~L~~pgd~----------YTDYVATRWYRaPELLvG---DtqYG~pVDiWAiGCv~aEl~~G 198 (396)
T KOG0593|consen 138 ------GVVKLCDFGFARTLSAPGDN----------YTDYVATRWYRAPELLVG---DTQYGKPVDIWAIGCVFAELLTG 198 (396)
T ss_pred ------CcEEeccchhhHhhcCCcch----------hhhhhhhhhccChhhhcc---cCcCCCcccchhhhHHHHHHhcC
Confidence 89999999999987643322 234578999999999998 46899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC-ccccc--cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEV--AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
.+.|.+.++.+....|.....+-++......... .+..+ .+....-..+...+..+..+.+|+..||+.||++|++.
T Consensus 199 ~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc 278 (396)
T KOG0593|consen 199 EPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC 278 (396)
T ss_pred CcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH
Confidence 9999999888877777554444444433322211 11111 11111111111223566788999999999999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
+|++.|.+|.
T Consensus 279 ~qll~H~yFd 288 (396)
T KOG0593|consen 279 EQLLHHPYFD 288 (396)
T ss_pred HHHhcChHHH
Confidence 9999999883
|
|
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=361.47 Aligned_cols=182 Identities=36% Similarity=0.517 Sum_probs=145.2
Q ss_pred CcccccccccccccccCCCCCccccCCCCC----------CcccccccccC-CCCCcceEEEecccCCHHHHHHHHHHHH
Q 001143 520 SNASQKYSSVSFCSIEDRLPDGFYDAGRDR----------PFMQLTGYEQT-PHLDSREVILVDRKSDEELDAIALSAQA 588 (1141)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (1141)
..+|||||++|+|+|+|||||||||++++. .+-+|++++.. +.++++|||||||..|+.|++|+++|+.
T Consensus 4 e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~a~~ 83 (204)
T PF14381_consen 4 ESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQRAHE 83 (204)
T ss_pred HHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHHHHH
Confidence 468999999999999999999999886652 11225555543 6899999999999999999999999999
Q ss_pred HHHHhhccCCccccCcccccchHHHHHHHHHHHhhhcCCCcCCcccccccccccCCCCCCCcccccCCCCCCCcchhhHH
Q 001143 589 LVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 668 (1141)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (1141)
+...+. .+..+++.+||.+||++|||++..++ .
T Consensus 84 ~~~~~~-------------~~~~~~v~~LA~lVa~~MGG~~~~~~----------------------------------~ 116 (204)
T PF14381_consen 84 LSKGLS-------------TNTKELVQKLAKLVADRMGGPVSDAE----------------------------------D 116 (204)
T ss_pred HHhccc-------------cCHHHHHHHHHHHHHHHhCCCCCcch----------------------------------h
Confidence 997631 13578899999999999999984331 1
Q ss_pred HHHHHHHHHhhhHHHHHHHHHhhccCceeEeccccccchhhhhHHHHHHhhhccCCCCcccccccccccCC-CCcceeEE
Q 001143 669 ILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP-HAWNTILV 747 (1141)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~g~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~~~~-~~~~~~~~ 747 (1141)
...+ |+...+.+|. ++.+||||+|++|+|||||||||+|||+|+ ||||||||++||+. ..-..++|
T Consensus 117 ~~~~---------w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ig--lpCrLvrG~~y~g~~~~~a~~~V 183 (204)
T PF14381_consen 117 MLFR---------WELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIG--LPCRLVRGCYYCGWDDDDASNLV 183 (204)
T ss_pred hhHH---------HHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcC--CCceEEeeccCCccCCCCceEEE
Confidence 1123 4555555666 999999999999999999999999999999 99999999999976 22233556
Q ss_pred eeCChhhhhhhhhcC
Q 001143 748 KKGDSWIRMIVDACR 762 (1141)
Q Consensus 748 ~~~~~~~~~~~~~~~ 762 (1141)
+.++ ..++++|.+.
T Consensus 184 ~~~~-~~eyiVDLm~ 197 (204)
T PF14381_consen 184 KFDD-GREYIVDLMG 197 (204)
T ss_pred EcCC-CcEEEEEcCC
Confidence 6554 4678888874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=383.62 Aligned_cols=269 Identities=24% Similarity=0.277 Sum_probs=220.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
..+..+|.+++.||+|+|++|++|+.. +..+|+|| +.+...- .+.-...+.+|-.+|.+| .||.|+++|-.|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKV--l~K~~Ii---ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKV--LDKRYII---KEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhh--hhHHHHH---hhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 567889999999999999999999974 56677777 3322111 111122347899999999 799999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.++..+ |+|+||+++|+|.++|++ .+.|++..++.++.||+.||+|||++|||||||||+|
T Consensus 144 QD~~sL--------------YFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 144 QDEESL--------------YFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred ecccce--------------EEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 987654 999999999999999998 3579999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccc---cccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~---~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
||+|.+ +++||.|||.|+.+........ ...........++||..|.+||++.+ ...++.+|+|||
T Consensus 205 ILLd~d-------mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~----~~~~~~sDiWAl 273 (604)
T KOG0592|consen 205 ILLDKD-------GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND----SPAGPSSDLWAL 273 (604)
T ss_pred eeEcCC-------CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC----CCCCcccchHHH
Confidence 999999 8999999999998765433211 00111111256899999999999987 677899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
||+||+|+.|++||.+.++.-+++.|......-. ...++.+++|+.++|..|
T Consensus 274 GCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp----------------------------~~fp~~a~dLv~KLLv~d 325 (604)
T KOG0592|consen 274 GCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP----------------------------EGFPEDARDLIKKLLVRD 325 (604)
T ss_pred HHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC----------------------------CCCCHHHHHHHHHHHccC
Confidence 9999999999999999988888888765433211 144567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001143 1116 PTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~ 1133 (1141)
|.+|+|+.||-+|+||..
T Consensus 326 p~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 326 PSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ccccccHHHHhhCccccc
Confidence 999999999999999964
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=369.59 Aligned_cols=276 Identities=25% Similarity=0.367 Sum_probs=224.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+....+|++.++||.|..++||+|+. .+..||+|+..++.+... ...+ .+|+..|+.++||||++++..|.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~---ld~l----~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND---LDAL----RKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh---HHHH----HHHHHHhhhcCCCCcceEEEEEE
Confidence 34467899999999999999999998 467788888877765322 3444 79999999999999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.+..+ |+||+||.+||+.++++..+..+ +++..+..|++++++||.|||.+|.||||||+.||
T Consensus 95 v~~~L--------------WvVmpfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnI 157 (516)
T KOG0582|consen 95 VDSEL--------------WVVMPFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNI 157 (516)
T ss_pred eccee--------------EEeehhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccE
Confidence 87755 99999999999999999876654 99999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
||+.+ |.|||+|||.+..+....... .... ..++||++|||||++... ...|+.|+||||||++.
T Consensus 158 Li~~d-------G~VkLadFgvsa~l~~~G~R~-----~~rf-~tfvgtp~wmAPEvl~q~--~~GYdfKaDIwSfGITA 222 (516)
T KOG0582|consen 158 LIDSD-------GTVKLADFGVSASLFDSGDRQ-----VTRF-NTFVGTPCWMAPEVLMQQ--LHGYDFKADIWSFGITA 222 (516)
T ss_pred EEcCC-------CcEEEcCceeeeeecccCcee-----eEee-ccccCcccccChHHhhhc--ccCccchhhhhhhhHHH
Confidence 99998 899999999887655432111 0111 567899999999996553 35799999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
.||++|..||....++++.-.-.++..|.+.. . ....+.....+..+++++..||+.||.+|
T Consensus 223 ~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t--~----------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kR 284 (516)
T KOG0582|consen 223 CELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT--S----------------GLDKDEDKKFSKSFREMIALCLVKDPSKR 284 (516)
T ss_pred HHHhcCCCCcccCChHHHHHHHhcCCCCCccc--c----------------cCChHHhhhhcHHHHHHHHHHhhcCcccC
Confidence 99999999999988888765555555543220 0 00111112445679999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
|||+++++|.||+..
T Consensus 285 ptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 285 PTASKLLKHAFFKKA 299 (516)
T ss_pred CCHHHHhccHHHhhc
Confidence 999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=388.44 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=219.5
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
...|...++||+|+.|.||.|+...+...|||+++....... ++ .+..|+.+|+..+|+|||.+++.|...+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---ke---LilnEi~Vm~~~~H~NiVnfl~Sylv~d-- 343 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KE---LLLNEILVMRDLHHPNIVNFLDSYLVGD-- 343 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hh---hhHHHHHHHHhccchHHHHHHHHhcccc--
Confidence 345788899999999999999986555455555444332222 11 2479999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.+|+||||++||+|.+.+.. ..+++.++..|.++++.||+|||.+||+|||||.+|||++.+
T Consensus 344 ------------eLWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~ 405 (550)
T KOG0578|consen 344 ------------ELWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD 405 (550)
T ss_pred ------------eeEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC
Confidence 35999999999999999976 359999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||+|..+.... ......+|||+|||||+... ..|++|+||||||++++||+-
T Consensus 406 -------g~vKltDFGFcaqi~~~~----------~KR~TmVGTPYWMAPEVvtr----k~YG~KVDIWSLGIMaIEMve 464 (550)
T KOG0578|consen 406 -------GSVKLTDFGFCAQISEEQ----------SKRSTMVGTPYWMAPEVVTR----KPYGPKVDIWSLGIMAIEMVE 464 (550)
T ss_pred -------CcEEEeeeeeeecccccc----------CccccccCCCCccchhhhhh----cccCccccchhhhhHHHHHhc
Confidence 889999999998765422 24457899999999999986 789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|++||...++......|.....|.+... ...+..+++|+.+||+.||.+|++|.|
T Consensus 465 GEPPYlnE~PlrAlyLIa~ng~P~lk~~-------------------------~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 465 GEPPYLNENPLRALYLIATNGTPKLKNP-------------------------EKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred CCCCccCCChHHHHHHHhhcCCCCcCCc-------------------------cccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 9999998888888888877776665421 156778999999999999999999999
Q ss_pred HHHHHHhhcCCCC
Q 001143 1125 LYEMFVARTSSSI 1137 (1141)
Q Consensus 1125 lL~~L~~~~~s~~ 1137 (1141)
+|+|+|+......
T Consensus 520 LL~HpFl~~a~p~ 532 (550)
T KOG0578|consen 520 LLEHPFLKMAKPE 532 (550)
T ss_pred HhcChhhhhcCCH
Confidence 9999999765443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.47 Aligned_cols=289 Identities=20% Similarity=0.234 Sum_probs=220.5
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
.+|...++||+|+||.||+|++..+...|+||+++.... .+.+.....+|+..|+.++||||+.++++|...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~----kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l- 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA----KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL- 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc----ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce-
Confidence 468889999999999999999965554455544544321 122333458999999999999999999999876644
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
.||+||++ .+|+..|++ ....++..+++.|+.++++||+|||++.|+||||||.|+|++.+
T Consensus 77 -------------~lVfEfm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~- 137 (318)
T KOG0659|consen 77 -------------SLVFEFMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD- 137 (318)
T ss_pred -------------EEEEEecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-
Confidence 89999998 899999986 35689999999999999999999999999999999999999998
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.+||+|||+|+.+...... ....+-|.+|+|||.+.|. ..|+..+||||.||++.||+-|
T Consensus 138 ------g~lKiADFGLAr~f~~p~~~----------~~~~V~TRWYRAPELLfGs---r~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 138 ------GQLKIADFGLARFFGSPNRI----------QTHQVVTRWYRAPELLFGS---RQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred ------CcEEeecccchhccCCCCcc----------cccceeeeeccChHHhccc---hhcCCcchhhhHHHHHHHHHcc
Confidence 89999999999987654322 1123679999999999984 5789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
.+-|.+.++.+....|...-..+.++.++...........+.............++.++.+|+.+||.+||.+|+|+.|+
T Consensus 199 ~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa 278 (318)
T KOG0659|consen 199 VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA 278 (318)
T ss_pred CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH
Confidence 99899988888777774333222232333222211111111000001111222556778999999999999999999999
Q ss_pred HHHHHhhcCCCC
Q 001143 1126 YEMFVARTSSSI 1137 (1141)
Q Consensus 1126 L~~L~~~~~s~~ 1137 (1141)
++|.||.+.+..
T Consensus 279 L~~~yf~~~P~p 290 (318)
T KOG0659|consen 279 LKHPYFKSLPLP 290 (318)
T ss_pred hcchhhhcCCCC
Confidence 999999875443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=377.67 Aligned_cols=294 Identities=21% Similarity=0.251 Sum_probs=225.3
Q ss_pred CCCCCCCCCCceEeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCcccee
Q 001143 798 SGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 875 (1141)
Q Consensus 798 ~~~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~--vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkll 875 (1141)
.+|.+...+.|+..++||+|+||.||+|++..+. ||+|-.+++.. ...|.....+||.||++|.||||+++.
T Consensus 109 ~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~------~~~~~~t~~REI~ILr~l~HpNIikL~ 182 (560)
T KOG0600|consen 109 HGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE------KEGFPITAIREIKILRRLDHPNIIKLE 182 (560)
T ss_pred ccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC------CCcchHHHHHHHHHHHhcCCCccccee
Confidence 3667777888999999999999999999986555 66665444321 123334457999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLK 955 (1141)
+.+.+.. ...+|||+|||+ .+|..++.. +...|++.+++.|++||+.||+|+|++||+|||||
T Consensus 183 eivt~~~------------~~siYlVFeYMd-hDL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK 245 (560)
T KOG0600|consen 183 EIVTSKL------------SGSIYLVFEYMD-HDLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIK 245 (560)
T ss_pred eEEEecC------------CceEEEEEeccc-chhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeecccc
Confidence 9998752 124699999998 799888864 45689999999999999999999999999999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
.+|||||.+ |.+||+|||+|+.+...... .....+-|.+|+|||.+.| ...|+.++|+||.
T Consensus 246 ~SNiLidn~-------G~LKiaDFGLAr~y~~~~~~---------~~T~rVvTLWYRpPELLLG---~t~Yg~aVDlWS~ 306 (560)
T KOG0600|consen 246 GSNILIDNN-------GVLKIADFGLARFYTPSGSA---------PYTSRVVTLWYRPPELLLG---ATSYGTAVDLWSV 306 (560)
T ss_pred ccceEEcCC-------CCEEeccccceeeccCCCCc---------ccccceEEeeccChHHhcC---Ccccccceeehhh
Confidence 999999988 89999999999876543221 1335678999999999998 4679999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCC--chhhhhhHHHHHHHHHHhcc
Q 001143 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
||||.||++|++.|++.++.+.++.|......+-...+... ........+....+.. .+.....+....+|+..||.
T Consensus 307 GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~-kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ 385 (560)
T KOG0600|consen 307 GCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS-KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLS 385 (560)
T ss_pred hHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc-cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhc
Confidence 99999999999999999988888888433322222222211 1111111111111111 11122456778999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001143 1114 ENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.||.+|.||.++|++.||.+.
T Consensus 386 ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 386 LDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cCccccccHHHHhcCcccccC
Confidence 999999999999999999544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=351.69 Aligned_cols=259 Identities=26% Similarity=0.344 Sum_probs=219.5
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+..+++|++.+.||.|+||.|.+++. .+..+|+|+...... ....+.+ ...+|..+|+.+.||+++++++.+.
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQve----H~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQVE----HTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHHH----HHhhHHHHHhhccCceeEEEEEeec
Confidence 37789999999999999999999987 466778887432211 1112222 3379999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.+. +|+||||++||.|.+++++ .+++++..++.++.||+.||+|||+.+|++|||||+||
T Consensus 115 d~~~--------------lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi 175 (355)
T KOG0616|consen 115 DNSN--------------LYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL 175 (355)
T ss_pred cCCe--------------EEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence 7664 4999999999999999987 35799999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|+|.+ |.+||+|||+|+...... -+.+|||.|+|||+++. ..|+.++|+|||||++
T Consensus 176 LlD~~-------G~iKitDFGFAK~v~~rT-------------~TlCGTPeYLAPEii~s----k~ynkavDWWalGVLI 231 (355)
T KOG0616|consen 176 LLDQN-------GHIKITDFGFAKRVSGRT-------------WTLCGTPEYLAPEIIQS----KGYNKAVDWWALGVLI 231 (355)
T ss_pred eeccC-------CcEEEEeccceEEecCcE-------------EEecCCccccChHHhhc----CCCCcchhHHHHHHHH
Confidence 99998 999999999998765431 14579999999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|||+.|.+||.+.++.+++++|..+...- +. ..+.++++|+..+|+.|-.+|
T Consensus 232 YEMlaG~pPF~~~~~~~iY~KI~~~~v~f-P~---------------------------~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 232 YEMLAGYPPFYDDNPIQIYEKILEGKVKF-PS---------------------------YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHcCCCCCcCCChHHHHHHHHhCcccC-Cc---------------------------ccCHHHHHHHHHHHhhhhHhh
Confidence 99999999999999999999997765421 11 345569999999999999999
Q ss_pred -----CCHHHHHHHHHhhcCCC
Q 001143 1120 -----PTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1120 -----PSa~ElL~~L~~~~~s~ 1136 (1141)
....+|.+|+||+...+
T Consensus 284 ~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 284 FGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred hcCcCCCccccccCcccccccH
Confidence 46789999999986543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=356.02 Aligned_cols=293 Identities=24% Similarity=0.306 Sum_probs=226.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..+++.|+...+|++|+||.||+|+++.+...|++++++... +...|....++||.+|.+++|||||.+-.++...
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek----ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK----EKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc----ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 567888999999999999999999998777777766665432 3344555668999999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ....|||||||+ .+|.+++... ..+|...+++.++.|+++|++|||.+.|+|||||++|+|+
T Consensus 148 ~------------~d~iy~VMe~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm 210 (419)
T KOG0663|consen 148 N------------MDKIYIVMEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL 210 (419)
T ss_pred c------------cceeeeeHHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee
Confidence 3 225699999998 8999999873 2479999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.. |.+||+|||+|+.+..+... ....+-|.+|+|||.+.+ ...|++++|+||+|||+.|
T Consensus 211 ~~~-------G~lKiaDFGLAR~ygsp~k~----------~T~lVVTLWYRaPELLLG---~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 211 SHK-------GILKIADFGLAREYGSPLKP----------YTPLVVTLWYRAPELLLG---AKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred ccC-------CcEEecccchhhhhcCCccc----------CcceEEEeeecCHHHhcC---CcccCcchhhhhHHHHHHH
Confidence 988 89999999999988764322 234567999999999998 4679999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCcccc---cc-ccCCCCCCchhh-hhhHHHHHHHHHHhcccC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHE---VA-QSGSGFEKPEAE-LETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~---~~-~~~~~~~~~~~~-~~~~~~L~dLI~~cL~~D 1115 (1141)
|+++++.|.+.+..+..+.|.. ...|. ...++......... +. .....+. ..+. ...++.-.+|++.+|.+|
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPt-e~iwpg~~~lp~~k~~~f~~~pyn~lr-~kF~~~~lse~g~~Lln~llt~d 348 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPS-EAIWPGYSELPAVKKMTFSEHPYNNLR-KKFGALSLSEQGFDLLNKLLTYD 348 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCc-cccCCCccccchhhccccCCCCchhhh-hhccccccchhHHHHHHHHhccC
Confidence 9999999999988887777733 22222 11122111111000 00 0000000 0000 124577899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCCC
Q 001143 1116 PTERPTAGDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~~s~~ 1137 (1141)
|.+|.||.|.|+|-||...+..
T Consensus 349 P~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 349 PGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred ccccccHHHhhcccccccCCCC
Confidence 9999999999999999875433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=373.22 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=219.7
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
++|.+.+.||+|+||.||+|+.+.+...|+++.+.+......+.+++ .+|++|++.++|||||.++++|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l----~~ev~i~r~lkHpniv~m~esfEt~~~-- 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNL----RQEVRILRSLKHPNIVEMLESFETSAH-- 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHH----HHHHHHHHhcCCcchhhHHHhhcccce--
Confidence 67999999999999999999987666666666677777777777777 899999999999999999999998764
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
+++|+||+.| +|..++.. ++.++++.++.|+.|++.||.|||+++|+|||+||.|||++..
T Consensus 76 ------------~~vVte~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~- 136 (808)
T KOG0597|consen 76 ------------LWVVTEYAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG- 136 (808)
T ss_pred ------------EEEEehhhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-
Confidence 4999999985 99999987 5679999999999999999999999999999999999999987
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+++|+||||+|+.+.... .......|||.|||||...+ ..|+..+|+||+||++|||++|
T Consensus 137 ------~~~KlcdFg~Ar~m~~~t----------~vltsikGtPlYmAPElv~e----~pyd~~sDlWslGcilYE~~~G 196 (808)
T KOG0597|consen 137 ------GTLKLCDFGLARAMSTNT----------SVLTSIKGTPLYMAPELVEE----QPYDHTSDLWSLGCILYELYVG 196 (808)
T ss_pred ------CceeechhhhhhhcccCc----------eeeeeccCcccccCHHHHcC----CCccchhhHHHHHHHHHHHhcC
Confidence 899999999998765422 12335679999999999987 7899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
++||...+..++.+.|......... ..+..+..|++.+|..||.+|.|..++
T Consensus 197 ~PPF~a~si~~Lv~~I~~d~v~~p~----------------------------~~S~~f~nfl~gLL~kdP~~RltW~~L 248 (808)
T KOG0597|consen 197 QPPFYARSITQLVKSILKDPVKPPS----------------------------TASSSFVNFLQGLLIKDPAQRLTWTDL 248 (808)
T ss_pred CCCchHHHHHHHHHHHhcCCCCCcc----------------------------cccHHHHHHHHHHhhcChhhcccHHHH
Confidence 9999987777777777554332111 456679999999999999999999999
Q ss_pred HHHHHhhc
Q 001143 1126 YEMFVART 1133 (1141)
Q Consensus 1126 L~~L~~~~ 1133 (1141)
+.|+|-+.
T Consensus 249 l~HpF~k~ 256 (808)
T KOG0597|consen 249 LGHPFWKG 256 (808)
T ss_pred hcChHHhh
Confidence 99987654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=366.82 Aligned_cols=263 Identities=32% Similarity=0.449 Sum_probs=205.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|...+.||+|+||+||++.+. +...|||...+. .....+.+ .+|+.+|.+++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~----~~~~~~~l----~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE----DSPTSESL----EREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc----cchhHHHH----HHHHHHHHhCCCCCEEeeCCcccccc
Confidence 556899999999999999999986 477888875544 11113333 79999999999999999999744322
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ..++++|||+++|+|.+++.+ .+. .+++..++++++||+.||.|||++|||||||||+|||++
T Consensus 88 ~------------~~~~i~mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 88 N------------DEYNIFMEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred C------------eeeEeeeeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 1 245999999999999999987 333 699999999999999999999999999999999999999
Q ss_pred c-ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 963 L-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 963 ~-~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
. + +.+||+|||+++........ ........||+.|||||++.. +.....++|||||||++.|
T Consensus 152 ~~~-------~~~KlaDFG~a~~~~~~~~~-------~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 152 PSN-------GDVKLADFGLAKKLESKGTK-------SDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVE 214 (313)
T ss_pred CCC-------CeEEeccCcccccccccccc-------ccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEe
Confidence 8 5 78999999999766531100 112234679999999999984 1223369999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1042 LLTLQVPYMGL-SELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1042 LLTGk~Pf~~~-~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+||+.||... ...+....+ .....|.++ ...+.++++|+.+|+..||++|
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip---------------------------~~ls~~a~~Fl~~C~~~~p~~R 267 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIP---------------------------DSLSDEAKDFLRKCFKRDPEKR 267 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHhhcCcccC
Confidence 99999999862 222222222 222222222 2566789999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001143 1120 PTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s 1135 (1141)
|||+++|+|+|.....
T Consensus 268 pta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 268 PTAEELLEHPFLKQNS 283 (313)
T ss_pred cCHHHHhhChhhhccc
Confidence 9999999999997654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=371.36 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=214.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~ 879 (1141)
.....|.+.+.||+|+||.|++|.+ .+..||+|+...+...... ......+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 4466899999999999999999987 4678888875433111111 122233468999999998 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... .++||||+.||+|.++|.+ .+++.+.+++++++||++|++|+|++||+||||||+||
T Consensus 91 t~~~--------------~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi 151 (370)
T KOG0583|consen 91 TPTK--------------IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI 151 (370)
T ss_pred cCCe--------------EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 7653 4999999999999999986 45799999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+. +++||+|||++..... ........+||+.|+|||++.+.. ...+.++||||+||+|
T Consensus 152 lld~~~------~~~Kl~DFG~s~~~~~----------~~~~l~t~cGsp~Y~aPEvl~~~~--~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 152 LLDGNE------GNLKLSDFGLSAISPG----------EDGLLKTFCGSPAYAAPEVLSGKG--TYSGKAADVWSLGVIL 213 (370)
T ss_pred EecCCC------CCEEEeccccccccCC----------CCCcccCCCCCcccCCHHHhCCCC--CcCCchhhhhhhHHHH
Confidence 998762 6899999999976531 111334668999999999998722 1336899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh-HHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET-LSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~dLI~~cL~~DP~~ 1118 (1141)
|.|++|..||...+...++..|..+...-.. .. +.++++|+.+||..||.+
T Consensus 214 y~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----------------------------~~~S~~~~~Li~~mL~~~P~~ 265 (370)
T KOG0583|consen 214 YVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----------------------------YLLSPEARSLIEKMLVPDPST 265 (370)
T ss_pred HHHHhCCCCCCCccHHHHHHHHhcCCccCCC----------------------------CcCCHHHHHHHHHHcCCCccc
Confidence 9999999999987777777776655432111 22 667999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
|+|+.+|++|+|++.
T Consensus 266 R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 266 RITLLEILEHPWFQK 280 (370)
T ss_pred CCCHHHHhhChhhcc
Confidence 999999999999997
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=373.27 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=214.2
Q ss_pred CceEeeeecccCceEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~-~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
.+++.+.||+|-||.||.|.|++. .||+|..+.. . ...+.| .+|+++|++|+|+|||++++++..+..+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~---m~~~~f----~~Ea~iMk~L~H~~lV~l~gV~~~~~pi- 276 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--S---MSPEAF----LREAQIMKKLRHEKLVKLYGVCTKQEPI- 276 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--c---cChhHH----HHHHHHHHhCcccCeEEEEEEEecCCce-
Confidence 368999999999999999999776 8999986533 1 122334 7999999999999999999999875533
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
||||||++.|+|.++++. .....+...+.+.++.||+.|++||+++++|||||-+.||||+++
T Consensus 277 -------------yIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~- 339 (468)
T KOG0197|consen 277 -------------YIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED- 339 (468)
T ss_pred -------------EEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-
Confidence 999999999999999986 445679999999999999999999999999999999999999998
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT- 1044 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT- 1044 (1141)
..+||+|||+|+...+..... . ...--...|.|||.+.. ..++.|+|||||||+||||+|
T Consensus 340 ------~~vKIsDFGLAr~~~d~~Y~~---~------~~~kfPIkWtAPEa~~~----~~FS~kSDVWSFGVlL~E~fT~ 400 (468)
T KOG0197|consen 340 ------LVVKISDFGLARLIGDDEYTA---S------EGGKFPIKWTAPEALNY----GKFSSKSDVWSFGVLLWELFTY 400 (468)
T ss_pred ------ceEEEcccccccccCCCceee---c------CCCCCCceecCHHHHhh----CCcccccceeehhhhHHHHhcc
Confidence 799999999999554432221 1 11123567999999987 679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||.+.+..++...+..|.+.+-+. .+++.+.+++..||+.+|++|||++.
T Consensus 401 G~~py~~msn~ev~~~le~GyRlp~P~---------------------------~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 401 GRVPYPGMSNEEVLELLERGYRLPRPE---------------------------GCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred CCCCCCCCCHHHHHHHHhccCcCCCCC---------------------------CCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 999999999999999998888754332 68889999999999999999999998
Q ss_pred HHHHHHhh
Q 001143 1125 LYEMFVAR 1132 (1141)
Q Consensus 1125 lL~~L~~~ 1132 (1141)
+...+...
T Consensus 454 L~~~l~~~ 461 (468)
T KOG0197|consen 454 LREVLEDF 461 (468)
T ss_pred HHHHHHHh
Confidence 77665443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=376.00 Aligned_cols=260 Identities=21% Similarity=0.291 Sum_probs=220.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.++..|++++.||.|+.|.|-+|++ +|+.+||||....... ... ..+.+.+|+.+|+-+.||||+++|++++.
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s----~~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSS----QPAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccc----cccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 4567789999999999999999998 6788999986544211 111 12344799999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
..+ +|+|.||++||.|++++.. .+++++.++.++++||+.|+.|+|..+|+||||||+|+|
T Consensus 84 ~~~--------------lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 84 KQH--------------LYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred Cce--------------EEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 664 5999999999999999986 467999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
+|.. +++||+|||+|..-... ....+.+|+|.|.|||++.|. .+.+.++||||.|||||
T Consensus 145 Ld~~-------~nIKIADFGMAsLe~~g-----------klLeTSCGSPHYA~PEIV~G~---pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 145 LDVK-------NNIKIADFGMASLEVPG-----------KLLETSCGSPHYAAPEIVSGR---PYDGRPSDVWSCGVILF 203 (786)
T ss_pred hhcc-------cCEeeeccceeecccCC-----------ccccccCCCcccCCchhhcCC---CCCCCccccchhHHHHH
Confidence 9988 67999999999653221 123356799999999999983 44579999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
.|+||+.||.+++...++.+++.|...-. ..++.++++||.+||..||++|.
T Consensus 204 ALLtG~LPFdDdNir~LLlKV~~G~f~MP----------------------------s~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRVLLLKVQRGVFEMP----------------------------SNISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCcccCC----------------------------CcCCHHHHHHHHHHhccCccccc
Confidence 99999999999888888888888765211 16777899999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001143 1121 TAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~s 1135 (1141)
|++||++|+|...-.
T Consensus 256 T~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 256 TTEEILKHPFLSGYT 270 (786)
T ss_pred cHHHHhhCchhhcCC
Confidence 999999999987543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=367.65 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=214.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.+++|++.++||+|+||.||+|+.+ +..+|+|+. ++... ...+.+. ++.|-.+|....+|+||++|..|.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~L--kKS~M~~~~Qv~h----V~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKIL--KKSEMLKKNQVEH----VRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecc--cHHHHHhhhhHHH----HHHHHHHhhhcCCCcEEEEEEEecC
Confidence 5789999999999999999999864 556677764 33221 1223333 3789999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
..++ ||||||++||++..+|.+ ...|++..++.++.+++.|++.||+.|+|||||||+|+|
T Consensus 213 ~~~L--------------YLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 213 KEYL--------------YLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL 273 (550)
T ss_pred CCee--------------EEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence 7755 999999999999999987 457999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccc------------c-ccCCCC------------------------CCC
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC------------I-AHRGIP------------------------APD 1003 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~------------~-~~~~~~------------------------~~~ 1003 (1141)
||.. |++||+|||+|..+........ . .....+ ..-
T Consensus 274 iD~~-------GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 274 IDAK-------GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred ecCC-------CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 9998 9999999999965432111000 0 000000 011
Q ss_pred CccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccc
Q 001143 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEH 1082 (1141)
Q Consensus 1004 ~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~ 1082 (1141)
..+|||.|||||++.+ ..|+..+|+||||||+||||.|.+||.+.++.+.+..|..... ...+.
T Consensus 347 StVGTPDYiAPEVll~----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----------- 411 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLG----KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----------- 411 (550)
T ss_pred cccCCccccchHHHhc----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-----------
Confidence 3589999999999998 6689999999999999999999999999999999888743221 11110
Q ss_pred cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhcCC
Q 001143 1083 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP---Sa~ElL~~L~~~~~s 1135 (1141)
+...++++++||.+||. ||++|. .++||-+|+||+.-.
T Consensus 412 --------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 412 --------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred --------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 01455789999999999 999996 599999999998653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=361.66 Aligned_cols=278 Identities=24% Similarity=0.252 Sum_probs=215.2
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCC-----hHHHH-HhHHhHHHHHHHHhhCCCCCcc
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-----ADEIR-NFEYSCLGEVRMLGALRHSCIV 872 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~-----~~~~~-~~~~~~~~Ei~iL~~L~HpNIV 872 (1141)
+-..+++|++.+.||+|.||.|-+|++ .+..+|+||+..+..... ..... .-.+++.+||.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 456789999999999999999999998 467788888432211110 01111 0012458999999999999999
Q ss_pred ceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCccc
Q 001143 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMH 951 (1141)
Q Consensus 873 kllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~-Ls~~~i~~Ia~QIa~gL~yLHs~gIvH 951 (1141)
+++++..+.. ...+|||+|||..|.+..+= ...+ +++.++++|+++++.||+|||.+||||
T Consensus 172 ~LiEvLDDP~------------s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiH 233 (576)
T KOG0585|consen 172 KLIEVLDDPE------------SDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIH 233 (576)
T ss_pred EEEEeecCcc------------cCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 9999987643 23679999999988865432 2334 999999999999999999999999999
Q ss_pred cCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001143 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031 (1141)
Q Consensus 952 rDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1031 (1141)
|||||+|+|++.+ ++|||+|||.+........... .......+|||.|+|||.+.+.......+.+.|
T Consensus 234 RDIKPsNLLl~~~-------g~VKIsDFGVs~~~~~~~~~~~-----d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~D 301 (576)
T KOG0585|consen 234 RDIKPSNLLLSSD-------GTVKISDFGVSNEFPQGSDEGS-----DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALD 301 (576)
T ss_pred cccchhheEEcCC-------CcEEeeccceeeecccCCcccc-----HHHHhhcCCCccccchHhhcCCCCccccchhhh
Confidence 9999999999988 8999999999875422211000 001123579999999999987544455689999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001143 1032 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111 (1141)
Q Consensus 1032 VWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~c 1111 (1141)
|||+||+||.|+.|+.||.+....+++++|....... + +. .+...++++||.+|
T Consensus 302 iWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~f-P------------------------~~-pe~~e~~kDli~~l 355 (576)
T KOG0585|consen 302 IWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEF-P------------------------EN-PEINEDLKDLIKRL 355 (576)
T ss_pred hhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccC-C------------------------Cc-ccccHHHHHHHHHH
Confidence 9999999999999999999988888998886543211 1 00 14566799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001143 1112 TEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1112 L~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
|++||.+|.+..+|..|+|....
T Consensus 356 L~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 356 LEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hhcChhheeehhhheecceeccC
Confidence 99999999999999999998654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=355.13 Aligned_cols=283 Identities=21% Similarity=0.266 Sum_probs=213.3
Q ss_pred CceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|+-.+++|.|+||.||+|..... .+|+|- .-.. ...+ .+|+.+|+.+.|||||++.-+|......
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKK--v~~d----~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKK--VLQD----KRYK------NRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEE--ecCC----CCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 478899999999999999998544 455553 2211 1112 4799999999999999999988764310
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
......+||||+| .+|.+.++..... ...++.-.++-+++||.+||.|||+.||+||||||.|+|+|.+
T Consensus 93 ---------d~~~lnlVleymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 93 ---------DEVYLNLVLEYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD 161 (364)
T ss_pred ---------chhHHHHHHHhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC
Confidence 1235679999998 8999999864333 4578999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
. +.+||||||.|+.+...... .....|..|+|||.+.+ ...|+.++||||.||++.||+-
T Consensus 162 t------g~LKicDFGSAK~L~~~epn-----------iSYicSRyYRaPELifg---a~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 162 T------GVLKICDFGSAKVLVKGEPN-----------ISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred C------CeEEeccCCcceeeccCCCc-----------eeEEEeccccCHHHHcC---ccccCceeEEhhhhHHHHHHhc
Confidence 5 89999999999887543211 24567999999999998 4679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhc-cCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1045 LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALG-SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
|++.|.+.+..+....| ...+.|...+ +.... ......+.+.....-..-.....++++.+|+.++|+++|.+|.++
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~-I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~ 300 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTRED-IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA 300 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHH-HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH
Confidence 99999998877666555 4444444332 22221 111111111111110001222567789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.|++.|++|..
T Consensus 301 ~~~l~h~fFde 311 (364)
T KOG0658|consen 301 LEALAHPFFDE 311 (364)
T ss_pred HHHhcchhhHH
Confidence 99999999964
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.38 Aligned_cols=262 Identities=26% Similarity=0.331 Sum_probs=216.7
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.|++.++||+|+|+.||++.+ .+..+++|+...++.... ..+.+ .+|++|++.|+|||||++.+.+.+..+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l----~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL----EREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHH----HHHHHHHHhcCCCcEeehhhhhcccce
Confidence 4689999999999999999877 467788888665544332 33444 799999999999999999998876654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. |+|+|++.|++|..-|-.. ..+++..+-.+++||+.||.|+|.+||||||+||+|+++-.
T Consensus 85 ~--------------ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLAS 145 (355)
T KOG0033|consen 85 H--------------YLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLAS 145 (355)
T ss_pred e--------------EEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeee
Confidence 3 9999999999997666541 36899999999999999999999999999999999999965
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
.. ...-+||+|||+|..+.... .....+|||.|||||++.. .+|+..+|||+.||+||-|+
T Consensus 146 K~----~~A~vKL~~FGvAi~l~~g~-----------~~~G~~GtP~fmaPEvvrk----dpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 146 KA----KGAAVKLADFGLAIEVNDGE-----------AWHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYILL 206 (355)
T ss_pred cc----CCCceeecccceEEEeCCcc-----------ccccccCCCcccCHHHhhc----CCCCCcchhhhhhHHHHHHH
Confidence 42 22569999999998776321 2235689999999999986 67999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
.|.+||.+.+...+++.|..+...-....+ ..++++.++|+++||..||.+|.|+.
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w------------------------~~is~~Ak~LvrrML~~dP~kRIta~ 262 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEW------------------------DTVTPEAKSLIRRMLTVNPKKRITAD 262 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCccc------------------------CcCCHHHHHHHHHHhccChhhhccHH
Confidence 999999998888899998776643222111 15667899999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001143 1124 DLYEMFVARTSS 1135 (1141)
Q Consensus 1124 ElL~~L~~~~~s 1135 (1141)
|+|+|+|.....
T Consensus 263 EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 263 EALKHPWICNRE 274 (355)
T ss_pred HHhCCchhcchH
Confidence 999999987543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=355.51 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=205.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+. +..+|+|+....... ..... ..+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQE----QHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHH----HHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 46899999999999999999985 667888876432110 11112 23478999999999999999998877654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 -------------FLYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred -------------eEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 45999999999999999976 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 137 E-------GHIKLTDFGFAKKLRDR-------------TWTLCGTPEYLAPEVIQS----KGHNKAVDWWALGILIYEML 192 (291)
T ss_pred C-------CCEEEEecCcchhccCC-------------cccccCChhhcCHHHHcC----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999998754321 112458999999999876 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS-- 1121 (1141)
+|+.||.+....+....+..+... ++ ...+..+.+++.+||+.||.+||+
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~dp~~R~~~~ 244 (291)
T cd05612 193 VGYPPFFDDNPFGIYEKILAGKLE-FP---------------------------RHLDLYAKDLIKKLLVVDRTRRLGNM 244 (291)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCcC-CC---------------------------ccCCHHHHHHHHHHcCCCHHHccCCc
Confidence 999999987777766666443321 11 023456899999999999999995
Q ss_pred ---HHHHHHHHHhhc
Q 001143 1122 ---AGDLYEMFVART 1133 (1141)
Q Consensus 1122 ---a~ElL~~L~~~~ 1133 (1141)
++++++|+|+..
T Consensus 245 ~~~~~~~l~h~~~~~ 259 (291)
T cd05612 245 KNGADDVKNHRWFKS 259 (291)
T ss_pred cCCHHHHhcCccccC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=348.90 Aligned_cols=289 Identities=19% Similarity=0.271 Sum_probs=218.1
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
|...+.||+|+||.|+.|.+..+...|+||++..........++ ..+|+.+|+.++|+||+.+++.+..+.
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akR----tlRElklLr~~~HeNIi~l~di~~p~~----- 94 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKR----TLRELKLLRHLRHENIIGLLDIFRPPS----- 94 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHH----HHHHHHHHHHhcCCCcceEEeeccccc-----
Confidence 45579999999999999999666556666555533333333333 379999999999999999999987521
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.......|+|+|+|+ .+|...|+. +..++...+..+++||++||.|+|+.+|+||||||+|+|++.+
T Consensus 95 ----~~~f~DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~--- 161 (359)
T KOG0660|consen 95 ----RDKFNDVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD--- 161 (359)
T ss_pred ----ccccceeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC---
Confidence 123446799999995 899999986 3359999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~ 1047 (1141)
+.+||+|||+|+........ ..-+..+.|.+|+|||++.. ...|+.++||||.|||+.||++|++
T Consensus 162 ----c~lKI~DFGLAR~~~~~~~~--------~~mTeYVaTRWYRAPElll~---~~~Yt~aiDiWSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 162 ----CDLKICDFGLARYLDKFFED--------GFMTEYVATRWYRAPELLLN---SSEYTKAIDIWSVGCILAEMLTGKP 226 (359)
T ss_pred ----CCEEeccccceeeccccCcc--------cchhcceeeeeecCHHHHhc---cccccchhhhhhhhHHHHHHHcCCC
Confidence 88999999999887542111 11124578999999999876 4679999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1048 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1048 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
.|.+.+..+.+..|......+-+..+............+.... ...........+.+.+|+.+||..||.+|+|++|
T Consensus 227 lFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 227 LFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 9999887777766644333333333333321111111111111 1111122367788999999999999999999999
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+++..
T Consensus 307 AL~hPYl~~ 315 (359)
T KOG0660|consen 307 ALAHPYLAP 315 (359)
T ss_pred HhcChhhhh
Confidence 999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=367.73 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=216.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...++...+.+.||+|+||+||+|+|.+ +||||+...+ ....+..+.| +.|+..+++-+|.||+-|+|++..+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~--~pt~~qlqaF----KnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVD--DPTPEQLQAF----KNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc-ceEEEEEecC--CCCHHHHHHH----HHHHHHHhhcchhhheeeehhhcCC
Confidence 3455667899999999999999999976 5788886544 4455566666 8999999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..||+.+|+|.+|+.+++.. ...|+....+.|++||++|+.|||.++|||||||..|||+
T Consensus 461 ~---------------~AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 461 P---------------LAIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL 521 (678)
T ss_pred c---------------eeeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE
Confidence 3 28999999999999999862 3469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
.++ +.|||+|||++....... +.......-|...|||||++. +....+|++.+||||||+++||
T Consensus 522 ~~~-------~kVkIgDFGLatvk~~w~--------g~~q~~qp~gsilwmAPEvIR-mqd~nPfS~qSDVYaFGiV~YE 585 (678)
T KOG0193|consen 522 HED-------LKVKIGDFGLATVKTRWS--------GEQQLEQPHGSLLWMAPEVIR-MQDDNPFSFQSDVYAFGIVWYE 585 (678)
T ss_pred ccC-------CcEEEecccceeeeeeec--------cccccCCCccchhhhcHHHHh-hcccCCCCcccchhhhhHHHHH
Confidence 987 789999999996533221 111122334788999999997 4456789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++|..||.....++++.++-+|.. +.... ....+++++.+|+..||.+++++||
T Consensus 586 Lltg~lPysi~~~dqIifmVGrG~l~pd~s~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 586 LLTGELPYSIQNRDQIIFMVGRGYLMPDLSK------------------------IRSNCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred HHhCcCCcCCCChhheEEEecccccCccchh------------------------hhccCHHHHHHHHHHHHhcCcccCc
Confidence 9999999996666666555544422 11110 1127788999999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
.+.+|+..+.....
T Consensus 642 ~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 642 LFPQLLSKLEELLP 655 (678)
T ss_pred cHHHHHHHHHHhhh
Confidence 99999997776654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=351.00 Aligned_cols=282 Identities=20% Similarity=0.229 Sum_probs=206.4
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+++|++.++||+|+||+||+|++. +..+|+|+.+.... . ... ..+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~-~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--E-GAP----CTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--C-Ccc----hhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45778999999999999999999874 56677777543321 1 111 123689999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 75 ~~--------------~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (288)
T cd07871 75 ER--------------CLTLVFEYLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLL 135 (288)
T ss_pred CC--------------eEEEEEeCCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 54 3499999998 5999988651 235889999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++....... ......+++.|+|||++.+ ...++.++||||+||++|
T Consensus 136 ~~~~-------~~~kl~DfG~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 195 (288)
T cd07871 136 INEK-------GELKLADFGLARAKSVPTK----------TYSNEVVTLWYRPPDVLLG---STEYSTPIDMWGVGCILY 195 (288)
T ss_pred ECCC-------CCEEECcCcceeeccCCCc----------cccCceecccccChHHhcC---CcccCcHHHHHHHHHHHH
Confidence 9887 7899999999865432111 1123457999999999865 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|++|+.||.+.+..+....+...........++...... .....+.. ...........+.++.+|+.+||++||.
T Consensus 196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dp~ 274 (288)
T cd07871 196 EMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR-AQPLINHAPRLDTDGIDLLSSLLLYETK 274 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccC-CCchHHhCCCCCHHHHHHHHHhcCcCcc
Confidence 9999999998877766665553322222222221110000 00000000 0000011124567789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001143 1118 ERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~ 1131 (1141)
+|||++|+++|+||
T Consensus 275 ~R~t~~~~l~hp~f 288 (288)
T cd07871 275 SRISAEAALRHSYF 288 (288)
T ss_pred cCCCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=372.10 Aligned_cols=258 Identities=27% Similarity=0.342 Sum_probs=215.1
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~ 878 (1141)
...+++|.+.++||+|+||.|++|..+ +..+|+|+.+..... ..++.+.. +.|.+|+..+. ||.++.++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il-~~d~Ve~~----~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL-QRDEVESL----MCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee-ccccHHHH----HHHHHHHHHhccCCeEeeccccc
Confidence 556889999999999999999999985 456777775433322 23344444 78999998875 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.++ +|+||||+.||++..+++ ...+++..++.|+..|+.||+|||++||||||||.+|
T Consensus 439 QT~~~--------------l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdN 498 (694)
T KOG0694|consen 439 QTKEH--------------LFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDN 498 (694)
T ss_pred ccCCe--------------EEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhh
Confidence 98775 499999999999544443 2579999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||+|.+ |++||+|||+|+..-... ....+++|||.|||||++.+ ..|+.++|+|||||+
T Consensus 499 iLLD~e-------Gh~kiADFGlcKe~m~~g----------~~TsTfCGTpey~aPEil~e----~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 499 LLLDTE-------GHVKIADFGLCKEGMGQG----------DRTSTFCGTPEFLAPEVLTE----QSYTRAVDWWGLGVL 557 (694)
T ss_pred eEEccc-------CcEEecccccccccCCCC----------CccccccCChhhcChhhhcc----CcccchhhHHHHHHH
Confidence 999998 999999999997533211 12347789999999999997 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
||||+.|+.||.+.++.++++.|........ ...+.+..++++++|..+|++
T Consensus 558 lyeML~Gq~PF~gddEee~FdsI~~d~~~yP----------------------------~~ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 558 LYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----------------------------RFLSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----------------------------CcccHHHHHHHHHHhccCccc
Confidence 9999999999999999999999876543211 155678999999999999999
Q ss_pred CCC-----HHHHHHHHHhhc
Q 001143 1119 RPT-----AGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPS-----a~ElL~~L~~~~ 1133 (1141)
|.. +.+|.+|++|+.
T Consensus 610 RLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 610 RLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred ccCCCCCCchhhhhCCcccc
Confidence 974 688999999975
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=359.47 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=208.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+.+|++.+.||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQV----QHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhH----HHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345788999999999999999999984 566888876432110 11112 23479999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 89 ~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI 149 (329)
T PTZ00263 89 DEN--------------RVYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149 (329)
T ss_pred cCC--------------EEEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence 655 34999999999999999976 34689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ll~~~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 205 (329)
T PTZ00263 150 LLDNK-------GHVKVTDFGFAKKVPDRT-------------FTLCGTPEYLAPEVIQS----KGHGKAVDWWTMGVLL 205 (329)
T ss_pred EECCC-------CCEEEeeccCceEcCCCc-------------ceecCChhhcCHHHHcC----CCCCCcceeechHHHH
Confidence 99887 789999999987543211 12458999999999976 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|..||.+....+....+..+..+ ++. ..+..+.+|+.+||+.||.+|
T Consensus 206 ~elltg~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~R 257 (329)
T PTZ00263 206 YEFIAGYPPFFDDTPFRIYEKILAGRLK-FPN---------------------------WFDGRARDLVKGLLQTDHTKR 257 (329)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHhcCCcC-CCC---------------------------CCCHHHHHHHHHHhhcCHHHc
Confidence 9999999999887776666666543211 110 234568999999999999999
Q ss_pred CC-----HHHHHHHHHhhc
Q 001143 1120 PT-----AGDLYEMFVART 1133 (1141)
Q Consensus 1120 PS-----a~ElL~~L~~~~ 1133 (1141)
|+ ++++++|+|+..
T Consensus 258 ~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 258 LGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCCCCCHHHHhcCCccCC
Confidence 97 799999999865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=361.80 Aligned_cols=258 Identities=29% Similarity=0.418 Sum_probs=214.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..|+..+.||+|+||.||+|.+. +..||+|+..++. ..++++++ ++|+.++.+++++||.++|+.|.....
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIedi----qqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDI----QQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHH----HHHHHHHHhcCcchHHhhhhheeeccc
Confidence 34777799999999999999985 5567777765543 23445555 799999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+ +++||||.||++.+.++. ...+++..+..|+++++.||.|||.++.+|||||+.|||+..
T Consensus 86 L--------------wiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~ 146 (467)
T KOG0201|consen 86 L--------------WIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE 146 (467)
T ss_pred H--------------HHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEec
Confidence 4 999999999999999975 345588999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+..+..... ....++||+.|||||++.+ ..|+.|+||||||++.+||+
T Consensus 147 ~-------g~vkl~DfgVa~ql~~~~~----------rr~tfvGTPfwMAPEVI~~----~~Y~~KADIWSLGITaiEla 205 (467)
T KOG0201|consen 147 S-------GDVKLADFGVAGQLTNTVK----------RRKTFVGTPFWMAPEVIKQ----SGYDTKADIWSLGITAIELA 205 (467)
T ss_pred c-------CcEEEEecceeeeeechhh----------ccccccccccccchhhhcc----ccccchhhhhhhhHHHHHHh
Confidence 8 8999999999987655322 2257789999999999986 67999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|.+||....++.+...|.+..+|.+. ...++.+++|+..||..||+.||+|.
T Consensus 206 ~GePP~s~~hPmrvlflIpk~~PP~L~---------------------------~~~S~~~kEFV~~CL~k~P~~RpsA~ 258 (467)
T KOG0201|consen 206 KGEPPHSKLHPMRVLFLIPKSAPPRLD---------------------------GDFSPPFKEFVEACLDKNPEFRPSAK 258 (467)
T ss_pred cCCCCCcccCcceEEEeccCCCCCccc---------------------------cccCHHHHHHHHHHhhcCcccCcCHH
Confidence 999999987775555554444443332 25566799999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 001143 1124 DLYEMFVARTSSSI 1137 (1141)
Q Consensus 1124 ElL~~L~~~~~s~~ 1137 (1141)
++++|.|.+...+.
T Consensus 259 ~LLKh~FIk~a~k~ 272 (467)
T KOG0201|consen 259 ELLKHKFIKRAKKT 272 (467)
T ss_pred HHhhhHHHHhcCCc
Confidence 99999998875443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=346.12 Aligned_cols=281 Identities=24% Similarity=0.260 Sum_probs=201.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|++. +..+|+|+..... ...... ..+.+|+.++++++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVK----ETTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc--ccccch----hhHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 36999999999999999999985 4567777654321 111112 23478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||++++.+..+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 74 -------------KLYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 34999999997766554432 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslGvil~el~ 195 (287)
T cd07848 136 N-------DVLKLCDFGFARNLSEGSNA---------NYTEYVATRWYRSPELLLG----APYGKAVDMWSVGCILGELS 195 (287)
T ss_pred C-------CcEEEeeccCcccccccccc---------cccccccccccCCcHHHcC----CCCCCchhHHhHHHHHHHHH
Confidence 7 78999999999765332111 1123468999999999876 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc---cccccccCCCCC-CchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFE-KPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|+.||.+.+..+....+.....+............. ............ ........+.++.+|+.+||++||++|
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R 275 (287)
T cd07848 196 DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275 (287)
T ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccC
Confidence 9999998776655444443322221111111000000 000000000000 000011356789999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
||++|+++|+||
T Consensus 276 ~s~~~~l~hp~f 287 (287)
T cd07848 276 YLTEQCLNHPAF 287 (287)
T ss_pred CCHHHHhcCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=351.17 Aligned_cols=292 Identities=20% Similarity=0.231 Sum_probs=205.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.++||+|+||.||+|.+. +..+|+|..... ........ ++.+|+.++++++||||+++++++......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV--FEHVSDAT----RILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechh--hccchhHH----HHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 5899999999999999999974 566777764321 11112222 347999999999999999999988643211
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 75 ---------EFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred ---------CCceEEEEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 1235699999995 799998875 3468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||+++........ ........||+.|+|||++.+. ...++.++|||||||++|+|++
T Consensus 140 -------~~~kL~Dfg~~~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 140 -------CKLKICDFGLARVAFNDTPT-------AIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred -------CcEEEccCccccccccccCc-------cccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHc
Confidence 78999999999754321111 0111234689999999998642 1457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccc-ccc--ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVA--QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|+.||.+.+.......+..................... ... ...............+..+.+++.+||+.||++|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 99999876655444433221111111111111000000 000 000000000011134567899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001143 1122 AGDLYEMFVARTSS 1135 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s 1135 (1141)
++|+++|+|+....
T Consensus 284 ~~e~l~hp~f~~~~ 297 (338)
T cd07859 284 AEEALADPYFKGLA 297 (338)
T ss_pred HHHHhcCchhhhcC
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.61 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=220.5
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~ 881 (1141)
+..|.-.+.||.|..++|-++.+ ++...|+|+.....+....+...++.+...+|+.||+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 56688889999999999998876 466778887554433333333555555668999999999 599999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.++ ++|+|.|+.|.|.+++.. ...++++..++|++|+..|+.|||.++||||||||+|||+
T Consensus 96 sF~--------------FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl 156 (411)
T KOG0599|consen 96 AFV--------------FLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL 156 (411)
T ss_pred chh--------------hhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee
Confidence 765 999999999999999976 4579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLGviL 1039 (1141)
+++ .++||+|||+|..+..... ....+|||+|.|||.+.... ....|+..+|+||+||++
T Consensus 157 ddn-------~~i~isDFGFa~~l~~Gek-----------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 157 DDN-------MNIKISDFGFACQLEPGEK-----------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred ccc-------cceEEeccceeeccCCchh-----------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 988 8899999999987765322 22457999999999987643 235688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|.|+.|.+||......-+...|..|...--. |++. +.+....+||.+||+.||.+|
T Consensus 219 yTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s-----------------------peWa-dis~~~KdLIsrlLqVdp~~R 274 (411)
T KOG0599|consen 219 YTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS-----------------------PEWA-DISATVKDLISRLLQVDPTKR 274 (411)
T ss_pred HHHHcCCCchhHHHHHHHHHHHHhcccccCC-----------------------cchh-hccccHHHHHHHHHeeCchhc
Confidence 9999999999866566667777776653221 1111 667789999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001143 1120 PTAGDLYEMFVAR 1132 (1141)
Q Consensus 1120 PSa~ElL~~L~~~ 1132 (1141)
.|++|+|+|+||.
T Consensus 275 itake~LaHpff~ 287 (411)
T KOG0599|consen 275 ITAKEALAHPFFI 287 (411)
T ss_pred ccHHHHhcChHHH
Confidence 9999999999994
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=355.95 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=199.4
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g 889 (1141)
+.||+|+||.||+|++ .+..+|+|+.+..... ..... ..+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEV----AHTLTESRVLQNTRHPFLTALKYSFQTHD------- 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhCCCCCCCCEEEEEEcCC-------
Confidence 4799999999999987 4567888876532211 11122 23478999999999999999999988655
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCC
Q 001143 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~ 969 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~----- 131 (323)
T cd05571 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-----
Confidence 34999999999999999875 3468999999999999999999999999999999999999887
Q ss_pred CCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001143 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049 (1141)
Q Consensus 970 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf 1049 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 132 --~~~kl~DfG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 132 --GHIKITDFGLCKEGISDG----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEEeeCCCCcccccCC----------CcccceecCccccChhhhcC----CCCCccccCcccchhhhhhhcCCCCC
Confidence 789999999986432111 11223469999999999876 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001143 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1124 (1141)
Q Consensus 1050 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----Sa~E 1124 (1141)
.+.+.......+..... .++ ...+.++.+++.+||+.||++|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 196 YNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 87766665555533221 111 13456789999999999999999 8999
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+|+..
T Consensus 248 ll~h~~f~~ 256 (323)
T cd05571 248 IMEHRFFAS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=358.25 Aligned_cols=257 Identities=20% Similarity=0.275 Sum_probs=207.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
...+.+|++.+.||+|+||.||+|.+.. ..+|+|+....... .....+ .+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVD----HVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHH----HHHHHHHHHHhCCCCCCcceEEEE
Confidence 4567889999999999999999998643 35777775432111 111222 347899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.. ..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 101 ~~~~--------------~~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 161 (340)
T PTZ00426 101 KDES--------------YLYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161 (340)
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHH
Confidence 8655 34999999999999999976 3468999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 162 ILl~~~-------~~ikL~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvi 217 (340)
T PTZ00426 162 LLLDKD-------GFIKMTDFGFAKVVDTR-------------TYTLCGTPEYIAPEILLN----VGHGKAADWWTLGIF 217 (340)
T ss_pred EEECCC-------CCEEEecCCCCeecCCC-------------cceecCChhhcCHHHHhC----CCCCccccccchhhH
Confidence 999877 78999999998754321 113468999999999976 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||++|..||.+.+.......+..+... ++ ...+..+.+++.+||+.||.+
T Consensus 218 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~l~~dp~~ 269 (340)
T PTZ00426 218 IYEILVGCPPFYANEPLLIYQKILEGIIY-FP---------------------------KFLDNNCKHLMKKLLSHDLTK 269 (340)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CC---------------------------CCCCHHHHHHHHHHcccCHHH
Confidence 99999999999987766666665433211 00 033456899999999999999
Q ss_pred CC-----CHHHHHHHHHhhcC
Q 001143 1119 RP-----TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RP-----Sa~ElL~~L~~~~~ 1134 (1141)
|+ +++++++|+|+...
T Consensus 270 R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 270 RYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred cCCCCCCCHHHHHcCCCcCCC
Confidence 95 89999999999753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.33 Aligned_cols=296 Identities=21% Similarity=0.252 Sum_probs=220.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCC-ccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkllg~~~~~ 881 (1141)
...|...++||+|+||+||+|+. .+..||+|..+++... +.......+|+.+++.++|+| ||.+++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 55688889999999999999997 4566787776665332 112333479999999999999 99999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
... .....+++||||++ .+|..++....... ..++...++.+++||+.||+|||+++|+||||||+||||
T Consensus 84 ~~~--------~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 84 NNH--------RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI 153 (323)
T ss_pred ccc--------cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE
Confidence 521 22346799999997 89999998743221 357779999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
++. +.+||+|||+|+....+... ....++|..|+|||++.+. ..|+...||||+|||++|
T Consensus 154 ~~~-------G~lKlaDFGlAra~~ip~~~----------yt~evvTlWYRaPEvLlGs---~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 154 SSS-------GVLKLADFGLARAFSIPMRT----------YTPEVVTLWYRAPEVLLGS---TSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCC-------CcEeeeccchHHHhcCCccc----------ccccEEEeeccCHHHhcCC---CcCCCCcchHhHHHHHHH
Confidence 987 89999999999865543322 2345789999999999983 468999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccc--cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEH--EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+++++.|.+.++.+....|.. ...|.. ..++........ .+.+...................+++.+||+++|.+
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e-~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~ 292 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNE-KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAK 292 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCc-cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCccc
Confidence 9999999999888777766633 333321 222211111111 111111010011111123357899999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCC
Q 001143 1119 RPTAGDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~s~~ 1137 (1141)
|.|++.++.|++|......
T Consensus 293 R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 293 RISAKGALTHPYFSELPEK 311 (323)
T ss_pred CcCHHHHhcChhhcccccc
Confidence 9999999999999866443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=343.07 Aligned_cols=284 Identities=21% Similarity=0.236 Sum_probs=202.9
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEe
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 879 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkllg~~~ 879 (1141)
.+|++.+.||+|+||.||+|++. +..+|+|+.+....... .... +.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~----~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLS----TIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHH----HHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 46999999999999999999873 45678887654322111 1112 24677776665 6999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... ......++||||++ ++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+||
T Consensus 75 ~~~~---------~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 75 VSRT---------DRETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred cccC---------CCCCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 4221 01234699999997 799999875 2234589999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il 199 (290)
T cd07862 142 LVTSS-------GQIKLADFGLARIYSFQM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 199 (290)
T ss_pred EEcCC-------CCEEEccccceEeccCCc-----------ccccccccccccChHHHhC----CCCCCccchHHHHHHH
Confidence 99887 789999999987543211 1123468999999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|||++|++||.+....+....+........+..++........ .................+..+.+++.+||+.||++|
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 278 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccch-hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhc
Confidence 9999999999987776666555332222211111110000000 000000000111112456778999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
||+.|+++|+||
T Consensus 279 ~s~~~~l~hp~f 290 (290)
T cd07862 279 ISAYSALSHPYF 290 (290)
T ss_pred CCHHHHhcCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=345.69 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=199.6
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|++.+.||+|+||.||+|.+ .+..+|+|+........ .. ....+.+|+.++.+++|+||+++++++.+.+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~----~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~- 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RK----GEAMALNEKRILEKVNSRFVVSLAYAYETKDA- 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hh----hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe-
Confidence 378899999999999999987 46677877654221111 11 11234789999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.++||||+++|+|.+++.. .....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 -------------~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 75 -------------LCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred -------------EEEEEEecCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4999999999999988865 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~~ 196 (285)
T cd05631 139 -------GHIRISDLGLAVQIPEGET-----------VRGRVGTVGYMAPEVINN----EKYTFSPDWWGLGCLIYEMIQ 196 (285)
T ss_pred -------CCEEEeeCCCcEEcCCCCe-----------ecCCCCCCCccCHhhhcC----CCCCcccCchhHHHHHHHHHh
Confidence 7899999999876432111 113468999999999976 568899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS--- 1121 (1141)
|+.||...........+........ . ......+..+.+|+.+||+.||.+||+
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~-----~~~~~~s~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05631 197 GQSPFRKRKERVKREEVDRRVKEDQ-------------------E-----EYSEKFSEDAKSICRMLLTKNPKERLGCRG 252 (285)
T ss_pred CCCCCCCCCcchhHHHHHHHhhccc-------------------c-----cCCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 9999986543222222211000000 0 000134567899999999999999997
Q ss_pred --HHHHHHHHHhhcC
Q 001143 1122 --AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 --a~ElL~~L~~~~~ 1134 (1141)
++++++|+|+...
T Consensus 253 ~~~~~~~~h~~~~~~ 267 (285)
T cd05631 253 NGAAGVKQHPIFKNI 267 (285)
T ss_pred CCHHHHhcCHhhcCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=363.53 Aligned_cols=289 Identities=19% Similarity=0.243 Sum_probs=204.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.-.+|++.++||+|+||.||+|.+. +..+|+|..... . .. ..+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~----~~----~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----P----QY----KNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----c----ch----HHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4467999999999999999999984 556777754211 0 11 14799999999999999999987643
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
... ........++||||++ ++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 132 ~~~------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl 203 (440)
T PTZ00036 132 CFK------KNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI 203 (440)
T ss_pred ccc------cCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE
Confidence 211 1112235689999997 688888765322 23579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.++ +.+||+|||+|+.+.... ......||+.|+|||++.+ ...++.++|||||||++||
T Consensus 204 ~~~~------~~vkL~DFGla~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~e 263 (440)
T PTZ00036 204 DPNT------HTLKLCDFGSAKNLLAGQ-----------RSVSYICSRFYRAPELMLG---ATNYTTHIDLWSLGCIIAE 263 (440)
T ss_pred cCCC------CceeeeccccchhccCCC-----------CcccCCCCcCccCHHHhcC---CCCCCcHHHHHHHHHHHHH
Confidence 8652 479999999997653211 1113468999999999875 2357899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhc-cCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALG-SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|++|.+||.+....+....+ .....+... .+.... ......+................+.++.+||.+||++||.+|
T Consensus 264 lltG~~pf~~~~~~~~~~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTED-QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHH-HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 99999999887665554444 322222221 111100 000000000000000000111346789999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.|+++|+||..
T Consensus 343 ~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 343 LNPIEALADPFFDD 356 (440)
T ss_pred cCHHHHhCChhHHh
Confidence 99999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.50 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=220.1
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
...++++|++++.||+|-||.||+|+.+.+...|+++.+.+. .-.....+.++.+|++|...|+||||.++|++|.+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs---qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS---QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH---HHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 345688999999999999999999998766655554444332 23333455677999999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
+... |+++||.++|+|+..++. ....++++..+..+++|++.||.|+|.++||||||||+|+|
T Consensus 94 ~~ri--------------yLilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL 156 (281)
T KOG0580|consen 94 SKRI--------------YLILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL 156 (281)
T ss_pred ccee--------------EEEEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence 7644 999999999999999985 34567999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+|++|||-+..-.. ....+.+||..|.+||+..+ ..++..+|+|++|++.|
T Consensus 157 lg~~-------~~lkiAdfGwsV~~p~------------~kR~tlcgt~dyl~pEmv~~----~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 157 LGSA-------GELKIADFGWSVHAPS------------NKRKTLCGTLDYLPPEMVEG----RGHDKFVDLWSLGVLCY 213 (281)
T ss_pred cCCC-------CCeeccCCCceeecCC------------CCceeeecccccCCHhhcCC----CCccchhhHHHHHHHHH
Confidence 9988 7899999998865321 12346789999999999887 66789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++.|.+||......+.+..|........ ..++..++++|.+|+..+|.+|.
T Consensus 214 eflvg~ppFes~~~~etYkrI~k~~~~~p----------------------------~~is~~a~dlI~~ll~~~p~~r~ 265 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRKVDLKFP----------------------------STISGGAADLISRLLVKNPIERL 265 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHHccccCC----------------------------cccChhHHHHHHHHhccCccccc
Confidence 99999999998887788888765432110 15667899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
+..|+++|+|....
T Consensus 266 ~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 266 ALTEVMDHPWIVAN 279 (281)
T ss_pred cHHHHhhhHHHHhc
Confidence 99999999997643
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.14 Aligned_cols=275 Identities=24% Similarity=0.302 Sum_probs=218.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+..|++.+.||+|.-|+||+|+..+ ...|+||. ++.. -..+.-..+++.|-+||+.+.||.++.+|+.|+.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVm--dK~~---l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVM--DKES---LASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEe--cHHH---HhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 346678999999999999999999876 56677764 3221 1112222456889999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
+.+. |+|||||+||+|..+.++ +..+.+++..++.++.+|+.||+|||-.|||+|||||+|||
T Consensus 149 ~~~~--------------cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL 211 (459)
T KOG0610|consen 149 DKYS--------------CLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL 211 (459)
T ss_pred ccee--------------EEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE
Confidence 7755 999999999999999887 56678999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeecccccccccccc---------------------cc-------ccc-----------------
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLH---------------------TC-------CIA----------------- 995 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~---------------------~~-------~~~----------------- 995 (1141)
|.++ |++.|+||.++......-. .+ ...
T Consensus 212 vred-------GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 212 VRED-------GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred EecC-------CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 9988 9999999998864311000 00 000
Q ss_pred -cCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHh
Q 001143 996 -HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1074 (1141)
Q Consensus 996 -~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~ 1074 (1141)
.........++||-.|.|||++.+ ...+.++|+|+|||++|||+.|..||.+.+..+.+..|..... .++.
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G----~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-~Fp~--- 356 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRG----EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-KFPE--- 356 (459)
T ss_pred cCCCCccccccccccccccceeeec----CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-cCCC---
Confidence 011122346799999999999998 5567999999999999999999999999988887777643221 1111
Q ss_pred hhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC----HHHHHHHHHhhcCCC
Q 001143 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1075 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS----a~ElL~~L~~~~~s~ 1136 (1141)
. ...+..+++||+++|.+||.+|.. |.||-+|+||+.-.|
T Consensus 357 ---------------------~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 357 ---------------------E-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred ---------------------C-CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 0 155677999999999999999998 999999999986544
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=357.10 Aligned_cols=258 Identities=26% Similarity=0.319 Sum_probs=218.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|..++++|+|+||.+++++++ +..+++|.+.+.... ....+. ..+|+.++++++|||||.+.+.|.+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~----A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRS----AIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHH----HHHHHHHHHhccCCCeeeeccchhcCC
Confidence 568999999999999999998874 456777776655433 232223 379999999999999999999998876
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++|||+||+||++.+.|... ....++++.+..|+.||+.|++|||+++|+|||||+.|||++
T Consensus 77 ~-------------~l~Ivm~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 77 Q-------------LLCIVMEYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT 140 (426)
T ss_pred c-------------eEEEEEeecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence 4 259999999999999999873 246799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ ..|+|+|||+|+.+..... .....+||+.||.||++.+ .+|+.|+|||||||++|||
T Consensus 141 k~-------~~VkLgDfGlaK~l~~~~~----------~a~tvvGTp~YmcPEil~d----~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 141 KD-------KKVKLGDFGLAKILNPEDS----------LASTVVGTPYYMCPEILSD----IPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred cc-------CceeecchhhhhhcCCchh----------hhheecCCCcccCHHHhCC----CCCCccCcchhhcchHHHH
Confidence 88 6789999999998765321 2346789999999999998 7899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++-+++|.+.+...+...|..+...+++. ..+.+++.+|..||..+|..||++
T Consensus 200 ~~lk~aF~a~~m~~Li~ki~~~~~~Plp~---------------------------~ys~el~~lv~~~l~~~P~~RPsa 252 (426)
T KOG0589|consen 200 CTLKPAFKASNMSELILKINRGLYSPLPS---------------------------MYSSELRSLVKSMLRKNPEHRPSA 252 (426)
T ss_pred HhcccccCccchHHHHHHHhhccCCCCCc---------------------------cccHHHHHHHHHHhhcCCccCCCH
Confidence 99999999988888888886665443332 566789999999999999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
.++|.++...
T Consensus 253 ~~LL~~P~l~ 262 (426)
T KOG0589|consen 253 LELLRRPHLL 262 (426)
T ss_pred HHHhhChhhh
Confidence 9999986554
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.31 Aligned_cols=284 Identities=20% Similarity=0.277 Sum_probs=201.4
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
+..++|++.++||+|+||.||+|++. +..+|+|+...... . ... ..+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~-~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--E-GTP----FTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--c-ccc----hhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 34578999999999999999999984 56788887543221 1 111 123689999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 75 ~~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil 135 (303)
T cd07869 75 KE--------------TLTLVFEYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLL 135 (303)
T ss_pred CC--------------eEEEEEECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 54 3499999996 788888765 1246899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||++........ ......+|+.|+|||++.+ ...++.++|||||||++|
T Consensus 136 l~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 195 (303)
T cd07869 136 ISDT-------GELKLADFGLARAKSVPSH----------TYSNEVVTLWYRPPDVLLG---STEYSTCLDMWGVGCIFV 195 (303)
T ss_pred ECCC-------CCEEECCCCcceeccCCCc----------cCCCCcccCCCCChHHHcC---CCCCCcHHHHHHHHHHHH
Confidence 9877 7899999999865432111 1123458999999999865 235788999999999999
Q ss_pred HHHhCCCCCCCCCHH-HHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCch-----hhhhhHHHHHHHHHHhcc
Q 001143 1041 ELLTLQVPYMGLSEL-EIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-----AELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~-el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~L~dLI~~cL~ 1113 (1141)
+|++|+.||.+.... +....+ .....+.. ..+....... .............. .....++.+.+|+.+||+
T Consensus 196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 273 (303)
T cd07869 196 EMIQGVAAFPGMKDIQDQLERIFLVLGTPNE-DTWPGVHSLP-HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQ 273 (303)
T ss_pred HHHhCCCCCCCCccHHHHHHHHHHHhCCCCh-hhccchhhcc-ccccccccccCCccHHHHhhccCCChHHHHHHHHHhc
Confidence 999999999864332 223322 11111111 0000000000 00000000000000 001234678899999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001143 1114 ENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.||++|||+.|+++|+||...
T Consensus 274 ~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 274 CFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cCchhccCHHHHhcCcccccC
Confidence 999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=353.80 Aligned_cols=267 Identities=20% Similarity=0.204 Sum_probs=202.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||+||+|.+. +..+|+|+...... ........+.+|+.++.+++||||+++++.+.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 47899999999999999999874 56788887542211 011112334789999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 76 --------------LYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred --------------EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 4999999999999999976 346999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecccccccccccccccccc-------------------------CCCCCCCCccCCCcccchhhhc
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH-------------------------RGIPAPDVCVGTPRWMAPEVLR 1018 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~-------------------------~~~~~~~~~~GT~~Y~APE~l~ 1018 (1141)
+ +.+||+|||+++.+........... .........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred C-------CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 7 7899999999975432111000000 0000012347999999999997
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1019 ~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
+ ..++.++|||||||++|||++|+.||.+....+....+..... ..++. .
T Consensus 210 ~----~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (363)
T cd05628 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP-------------------------E 260 (363)
T ss_pred C----CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCC-------------------------c
Confidence 6 5678999999999999999999999998777776666643221 11110 0
Q ss_pred hhhHHHHHHHHHHhcccCCC---CCCCHHHHHHHHHhhc
Q 001143 1098 LETLSFLVDVFRRCTEENPT---ERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~---~RPSa~ElL~~L~~~~ 1133 (1141)
...++++.+++.+|+. +|. .||+++||++|+|+..
T Consensus 261 ~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 261 VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 0345568888888664 444 4689999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=351.23 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=206.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEV----RHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHH----HHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 36999999999999999999984 567888876533211 11112 23478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 75 -------------YLYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred -------------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 35999999999999999975 346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~Dfg~a~~~~~-------------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell 192 (333)
T cd05600 137 S-------GHIKLTDFGLSKGIVT-------------YANSVVGSPDYMAPEVLRG----KGYDFTVDYWSLGCMLYEFL 192 (333)
T ss_pred C-------CCEEEEeCcCCccccc-------------ccCCcccCccccChhHhcC----CCCCCccceecchHHHhhhh
Confidence 7 7899999999875432 1123468999999999976 46889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|..||...+..+....+...... ..+. ........+.++.+++.+||..+|.+||++
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 193 CGFPPFSGSTPNETWENLKYWKETLQRPV---------------------YDDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred hCCCCCCCCCHHHHHHHHHhccccccCCC---------------------CCccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 999999987776666555332110 0000 000001446679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.++++|+|+..
T Consensus 252 ~~ll~h~~~~~ 262 (333)
T cd05600 252 EDIKNHPFFKE 262 (333)
T ss_pred HHHHhCcccCC
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=348.24 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=197.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
-++|++.++||+|+||.||+|.+. +..||+|+.+.. ......+. +.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKA----LMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHH----HHHHHHHHHHhccCcceeeEEe
Confidence 457999999999999999999752 245777764321 12222233 47999999999 8999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------------------------
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 920 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~------------------------------------ 920 (1141)
++..... ..++||||+++|+|.+++......
T Consensus 79 ~~~~~~~-------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (338)
T cd05102 79 ACTKPNG-------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL 145 (338)
T ss_pred EecCCCC-------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence 8765321 358999999999999999752110
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeec
Q 001143 921 ---------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 979 (1141)
Q Consensus 921 ---------------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DF 979 (1141)
...++++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-------~~~kl~Df 218 (338)
T cd05102 146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICDF 218 (338)
T ss_pred ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-------CcEEEeec
Confidence 01358889999999999999999999999999999999999877 78999999
Q ss_pred cccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-H
Q 001143 980 DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-I 1057 (1141)
Q Consensus 980 GlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~e-l 1057 (1141)
|+++.+...... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ .
T Consensus 219 G~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~ 286 (338)
T cd05102 219 GLARDIYKDPDY--------VRKGSARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286 (338)
T ss_pred ccccccccCcch--------hcccCCCCCccccCcHHhhc----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 999764321110 01122346788999999876 567899999999999999997 999998644322 2
Q ss_pred HHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1058 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1058 ~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
...+..+..+..+ ...++.+.+++.+||+.||.+|||+.|+++.+...
T Consensus 287 ~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 287 CQRLKDGTRMRAP---------------------------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3333322221111 13456799999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=345.29 Aligned_cols=281 Identities=23% Similarity=0.300 Sum_probs=204.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|++. +..+|+|+..... .... ..++.+|++++++++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAI----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHH----HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 467999999999999999999985 4556677654321 1222 233489999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NILl 961 (1141)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 77 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~ 137 (331)
T cd06649 77 --------------EISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137 (331)
T ss_pred --------------EEEEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE
Confidence 34999999999999999976 24689999999999999999999986 69999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~e 194 (331)
T cd06649 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (331)
T ss_pred cCC-------CcEEEccCcccccccccc------------cccCCCCcCcCCHhHhcC----CCCCchHhHHHHHHHHHH
Confidence 887 789999999986543211 123468999999999876 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCc---hhHHhhhccCcccccc----------------c-cCCCCCCchhhhhhH
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRL---TDELEALGSCHEHEVA----------------Q-SGSGFEKPEAELETL 1101 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l---~~~l~~~~~~~~~~~~----------------~-~~~~~~~~~~~~~~~ 1101 (1141)
|++|+.||......++...+........ ................ . ..............+
T Consensus 195 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
T cd06649 195 LAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFT 274 (331)
T ss_pred HHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCcccc
Confidence 9999999987665554433321100000 0000000000000000 0 000000000011356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1102 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.++++|+.+||+.||++|||+.++++|+|+...
T Consensus 275 ~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 275 PDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 789999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=354.73 Aligned_cols=267 Identities=21% Similarity=0.263 Sum_probs=204.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||+||+|++. +..+|+|+....... ..... ..+.+|+.++..++||||+++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQV----AHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 47999999999999999999984 567888876532111 11112 234789999999999999999999987653
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 76 --------------LYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred --------------EEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 4999999999999999875 346999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccC----------------------------CCCCCCCccCCCcccchh
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----------------------------GIPAPDVCVGTPRWMAPE 1015 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~----------------------------~~~~~~~~~GT~~Y~APE 1015 (1141)
+ +.+||+|||++..+............ ........+||+.|+|||
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 137 K-------GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred C-------CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 7 78999999998754321110000000 000011246999999999
Q ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CchhHHhhhccCccccccccCCCCCCc
Q 001143 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKP 1094 (1141)
Q Consensus 1016 ~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~ 1094 (1141)
++.. ..++.++|||||||++|||++|..||.+.+..+....+...... ..+.
T Consensus 210 ~~~~----~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------- 262 (364)
T cd05599 210 VFLQ----TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD----------------------- 262 (364)
T ss_pred HHcC----CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----------------------
Confidence 9875 56789999999999999999999999887776665555332110 0000
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhc
Q 001143 1095 EAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFVART 1133 (1141)
Q Consensus 1095 ~~~~~~~~~L~dLI~~cL~~DP~~RPS---a~ElL~~L~~~~ 1133 (1141)
....++.+.++|.+|+. +|.+|++ +.|+++|+|+..
T Consensus 263 --~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 263 --EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred --CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 00345678999999996 9999997 999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=347.54 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=196.5
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||+|+||.||+|++. +..+|+|+...... ....... .+.+|+.++++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------- 66 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVT----HTLAERTVLAQVNCPFIVPLKFSFQSPE--------- 66 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCcEeceeeEEecCC---------
Confidence 799999999999985 45677776542211 1112222 3378999999999999999999987654
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~------- 129 (312)
T cd05585 67 -----KLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ------- 129 (312)
T ss_pred -----eEEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-------
Confidence 34999999999999999875 3468999999999999999999999999999999999999887
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 130 ~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 130 GHIALCDFGLCKLNMKDD----------DKTNTFCGTPEYLAPELLLG----HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcEEEEECcccccCccCC----------CccccccCCcccCCHHHHcC----CCCCCccceechhHHHHHHHhCCCCcCC
Confidence 789999999986532211 01123468999999999976 5678999999999999999999999988
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 001143 1052 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 1128 (1141)
Q Consensus 1052 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP---Sa~ElL~~ 1128 (1141)
.+..+....+..... .++ ...+..+.+++.+||..||.+|| ++.|++.|
T Consensus 196 ~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 196 ENVNEMYRKILQEPL-RFP---------------------------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 776666555543221 110 13456789999999999999997 58999999
Q ss_pred HHhhc
Q 001143 1129 FVART 1133 (1141)
Q Consensus 1129 L~~~~ 1133 (1141)
+|+..
T Consensus 248 p~~~~ 252 (312)
T cd05585 248 PFFSQ 252 (312)
T ss_pred CCcCC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=340.17 Aligned_cols=287 Identities=18% Similarity=0.234 Sum_probs=207.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+..+++|.+.++||+|+||.||+|++. +..+|+|..+.... . .... .+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~-~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~ 74 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--E-GAPC----TAIREVSLLKDLKHANIVTLHDIVH 74 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--C-Ccch----hHHHHHHHHHhCCCCCcceEEEEEe
Confidence 456788999999999999999999874 45677776543321 1 1111 2368999999999999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.++. .++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 ~~~~--------------~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni 135 (309)
T cd07872 75 TDKS--------------LTLVFEYLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135 (309)
T ss_pred eCCe--------------EEEEEeCCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 6553 499999997 5888887652 23589999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||++........ ......+|+.|+|||++.+ ...++.++|||||||++
T Consensus 136 ll~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il 195 (309)
T cd07872 136 LINER-------GELKLADFGLARAKSVPTK----------TYSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIF 195 (309)
T ss_pred EECCC-------CCEEECccccceecCCCcc----------ccccccccccccCCHHHhC---CCCCCcHHHHHHHHHHH
Confidence 99887 7899999999865432111 1112357899999999865 24578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCC--chhhhhhHHHHHHHHHHhcccCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
|+|++|+.||.+.+..+....+...........+.................... .......+.++.+++.+||+.||.
T Consensus 196 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 275 (309)
T cd07872 196 FEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESK 275 (309)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChh
Confidence 999999999988776665555433222222111111100000000000000000 001124567789999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+|||+.|+++|+|++..
T Consensus 276 ~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 276 KRISAEEAMKHAYFRSL 292 (309)
T ss_pred hCCCHHHHhcChhhhhc
Confidence 99999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=348.15 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
++||+|+||.||+|++ .+..+|+|+............ ...+..|+.+++.++||||+++++++..++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~---- 73 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKD----TAHTKAERNILEAVKHPFIVDLIYAFQTGG---- 73 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhh----HHHHHHHHHHHHhCCCCchhceeeEEecCC----
Confidence 6899999999999986 356788887643211111111 123478999999999999999999988655
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..|+||||+++++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 ----------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-- 136 (323)
T cd05584 74 ----------KLYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-- 136 (323)
T ss_pred ----------eEEEEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC--
Confidence 34999999999999999876 3468899999999999999999999999999999999999887
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 137 -----~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~G~ 197 (323)
T cd05584 137 -----GHVKLTDFGLCKESIHEG----------TVTHTFCGTIEYMAPEILMR----SGHGKAVDWWSLGALMYDMLTGA 197 (323)
T ss_pred -----CCEEEeeCcCCeecccCC----------CcccccCCCccccChhhccC----CCCCCcceecccHHHHHHHhcCC
Confidence 789999999986432111 01123468999999999876 45778999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----C
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----T 1121 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----S 1121 (1141)
.||...+..+....+..+... ++ ...++.+.+++.+||+.||++|| +
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 249 (323)
T cd05584 198 PPFTAENRKKTIDKILKGKLN-LP---------------------------PYLTPEARDLLKKLLKRNPSSRLGAGPGD 249 (323)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHcccCHhHcCCCCCCC
Confidence 999887766655555433211 10 13456789999999999999999 8
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.++++|+|+..
T Consensus 250 ~~~l~~h~~~~~ 261 (323)
T cd05584 250 AAEVQSHPFFRH 261 (323)
T ss_pred HHHHhcCCCcCC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=348.93 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=197.8
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g 889 (1141)
+.||+|+||.||+|.+. +..+|+|+...... ....... .+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 68 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVA----HTLTESRVLKNTRHPFLTSLKYSFQTKD------- 68 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCCCcceEEEEEcCC-------
Confidence 47999999999999874 56788887643221 1112222 3478999999999999999999988655
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCC
Q 001143 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~ 969 (1141)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~Ey~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----- 131 (328)
T cd05593 69 -------RLCFVMEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD----- 131 (328)
T ss_pred -------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-----
Confidence 34999999999999988865 3469999999999999999999999999999999999999887
Q ss_pred CCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001143 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049 (1141)
Q Consensus 970 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf 1049 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 132 --~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 132 --GHIKITDFGLCKEGITDA----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred --CcEEEecCcCCccCCCcc----------cccccccCCcCccChhhhcC----CCCCccCCccccchHHHHHhhCCCCC
Confidence 789999999986432111 01123468999999999876 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001143 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1124 (1141)
Q Consensus 1050 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----Sa~E 1124 (1141)
.+.+..+....+..... .++ ...+.++.+++.+||+.||.+|| ++.|
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 196 YNQDHEKLFELILMEDI-KFP---------------------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCCHHHHHHHhccCCc-cCC---------------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 87666655554432211 111 13456789999999999999997 8999
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+|+..
T Consensus 248 il~h~~~~~ 256 (328)
T cd05593 248 IMRHSFFTG 256 (328)
T ss_pred HhcCCCcCC
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=347.87 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=198.2
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g 889 (1141)
+.||+|+||.||+|++ .+..+|+|+....... ...... .+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVA----HTVTESRVLQNTRHPFLTALKYAFQTHD------- 68 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHH----HHHHHHHHHHhCCCCCCcceeeEEecCC-------
Confidence 4799999999999987 4567888876533211 111222 3368999999999999999999988654
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCC
Q 001143 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~ 969 (1141)
..|+||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----- 131 (323)
T cd05595 69 -------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-----
Confidence 34999999999999988875 3468999999999999999999999999999999999999887
Q ss_pred CCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001143 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049 (1141)
Q Consensus 970 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf 1049 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 132 --~~~kL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 132 --GHIKITDFGLCKEGISDG----------ATMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEecccHHhccccCCC----------CccccccCCcCcCCcccccC----CCCCchhchhhhHHHHHHHHhCCCCC
Confidence 789999999986432111 01123468999999999876 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001143 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1124 (1141)
Q Consensus 1050 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----Sa~E 1124 (1141)
...+.......+..... .++ ...++.+.+++.+||+.||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 196 YNQDHERLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 87766665555432211 000 13456789999999999999998 9999
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+|+..
T Consensus 248 ~l~h~~~~~ 256 (323)
T cd05595 248 VMEHRFFLS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=347.78 Aligned_cols=257 Identities=25% Similarity=0.270 Sum_probs=197.9
Q ss_pred CceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
+|++.++||+|+||.||+|+. .+..+|+|+............ ...+..|+.++.++ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKT----VEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhH----HHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 589999999999999999986 356788888643211111111 22347899999999 59999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~--------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 77 EA--------------KLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 54 34999999999999999875 346899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++........ ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 138 i~~~-------~~~kl~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 198 (332)
T cd05614 138 LDSE-------GHVVLTDFGLSKEFLSEEKE---------RTYSFCGTIEYMAPEIIRG---KGGHGKAVDWWSLGILIF 198 (332)
T ss_pred ECCC-------CCEEEeeCcCCccccccCCC---------ccccccCCccccCHHHhcC---CCCCCCccccccchhhhh
Confidence 9887 78999999998754321111 1123468999999999875 234678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
||++|+.||..... ..+...+.... +.++ ...+..+.+++.+||+.||
T Consensus 199 elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 199 ELLTGASPFTLEGERNTQSEVSRRILKCD-PPFP---------------------------SFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHcCCCH
Confidence 99999999964321 22222222111 1110 1345678999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhc
Q 001143 1117 TERP-----TAGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RP-----Sa~ElL~~L~~~~ 1133 (1141)
++|| +++++++|+|+..
T Consensus 251 ~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 251 KKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHcCCCCCCCHHHHHcCCCcCC
Confidence 9999 8899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=354.47 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=201.0
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||+|.+ .+..+|+|+...... ..... ...+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQ----LAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHH----HHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 4789999999999999999987 456677776532211 01112 2334789999999999999999999987553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 76 --------------LYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred --------------eEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 4999999999999999875 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccc--------cccCC-----------------------------CCCCCCcc
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCC--------IAHRG-----------------------------IPAPDVCV 1006 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~--------~~~~~-----------------------------~~~~~~~~ 1006 (1141)
+ +.+||+|||+++.+........ ..... .......+
T Consensus 137 ~-------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 137 G-------GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred C-------CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 7 7899999999864321100000 00000 00001246
Q ss_pred CCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCcccccc
Q 001143 1007 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVA 1085 (1141)
Q Consensus 1007 GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~ 1085 (1141)
||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+.... ...++.
T Consensus 210 gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------- 271 (377)
T cd05629 210 GTPDYIAPEIFLQ----QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-------------- 271 (377)
T ss_pred CCccccCHHHHcc----CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--------------
Confidence 9999999999876 567899999999999999999999998777666555553211 111100
Q ss_pred ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHhhc
Q 001143 1086 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMFVART 1133 (1141)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R---PSa~ElL~~L~~~~ 1133 (1141)
....+.++.+++.+||. +|.+| +++.|++.|+|+..
T Consensus 272 -----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 272 -----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred -----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 00345678999999997 67665 69999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.55 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=212.1
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.|-+|+. .++.||+|..+.+...+. .+. -.+.+|++||..|+||||+++|.+|+..+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde-qDl----vhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE-QDL----VHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH-HHH----HHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 5799999999999999999986 466777776543332222 112 234799999999999999999999997664
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+ .|||||..+|.|+++|.. ...+++.+++.+++||.+|+.|+|.++++|||||.+|||+|.
T Consensus 128 I--------------vivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~ 188 (668)
T KOG0611|consen 128 I--------------VIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ 188 (668)
T ss_pred E--------------EEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC
Confidence 4 999999999999999987 357999999999999999999999999999999999999999
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +++||+|||++..+.... ...+++|+|.|.+||++.+. ..-++.+|.|||||+||.|.
T Consensus 189 N-------~NiKIADFGLSNly~~~k-----------fLqTFCGSPLYASPEIvNG~---PY~GPEVDsWsLGvLLYtLV 247 (668)
T KOG0611|consen 189 N-------NNIKIADFGLSNLYADKK-----------FLQTFCGSPLYASPEIVNGT---PYKGPEVDSWSLGVLLYTLV 247 (668)
T ss_pred C-------CCeeeeccchhhhhcccc-----------HHHHhcCCcccCCccccCCC---CCCCCccchhhHHHHHHHHh
Confidence 8 889999999997654322 22467899999999999872 23368999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
.|..||++.+...+..+|..+.+... ..+.+..-||+.||..+|++|.|+.
T Consensus 248 yGtMPFDG~Dhk~lvrQIs~GaYrEP-----------------------------~~PSdA~gLIRwmLmVNP~RRATie 298 (668)
T KOG0611|consen 248 YGTMPFDGRDHKRLVRQISRGAYREP-----------------------------ETPSDASGLIRWMLMVNPERRATIE 298 (668)
T ss_pred hcccccCCchHHHHHHHhhcccccCC-----------------------------CCCchHHHHHHHHHhcCcccchhHH
Confidence 99999999888888888877654322 2334577899999999999999999
Q ss_pred HHHHHHHhh
Q 001143 1124 DLYEMFVAR 1132 (1141)
Q Consensus 1124 ElL~~L~~~ 1132 (1141)
+|..|+|..
T Consensus 299 DiAsHWWvN 307 (668)
T KOG0611|consen 299 DIASHWWVN 307 (668)
T ss_pred HHhhhheee
Confidence 999999974
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=355.06 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=208.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
....+|++.++||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34678999999999999999999984 556777775321110 11111 223689999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. +.++||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 115 ~~--------------~~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 174 (370)
T cd05596 115 DK--------------YLYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (370)
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 55 35999999999999999875 25889999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||++........ .......||+.|+|||++.+......++.++|||||||++|
T Consensus 175 l~~~-------~~~kL~DfG~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvily 238 (370)
T cd05596 175 LDKS-------GHLKLADFGTCMKMDANGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (370)
T ss_pred EcCC-------CCEEEEeccceeeccCCCc---------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHH
Confidence 9887 7899999999876432111 11124469999999999876443345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 1118 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~- 1118 (1141)
||++|+.||.+.+.......+..... ..++. ....+.++.++|.+||..+|.+
T Consensus 239 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~p~r~ 293 (370)
T cd05596 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD-------------------------DIEISKQAKDLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC-------------------------cCCCCHHHHHHHHHHccChhhcc
Confidence 99999999998776666665543221 11110 0135677999999999999988
Q ss_pred -CCCHHHHHHHHHhhcC
Q 001143 1119 -RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 -RPSa~ElL~~L~~~~~ 1134 (1141)
||++.++++|+|++..
T Consensus 294 ~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 294 GRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCCHHHHhcCcccCCC
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=353.27 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=201.6
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+|+...-.+-||.|+.|.||+|+..+..||||..+ +.+ ..+|.-|++|+||||+.|.|++.+...
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~---------elk------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR---------ELK------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeeccCceehhHHHh---------hhh------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 34444556789999999999999999999988422 111 357888999999999999999987553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+|||||||..|-|..+++. ..+++......|..+||.|++|||.+.|||||||.-||||..
T Consensus 187 --------------yCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~ 247 (904)
T KOG4721|consen 187 --------------YCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY 247 (904)
T ss_pred --------------eEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec
Confidence 4999999999999999986 457889999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ ..|||+|||.++....... .-.+.||..|||||++.. .+.+.|+|||||||+||||+
T Consensus 248 ~-------d~VKIsDFGTS~e~~~~ST-----------kMSFaGTVaWMAPEvIrn----ePcsEKVDIwSfGVVLWEmL 305 (904)
T KOG4721|consen 248 D-------DVVKISDFGTSKELSDKST-----------KMSFAGTVAWMAPEVIRN----EPCSEKVDIWSFGVVLWEML 305 (904)
T ss_pred c-------ceEEeccccchHhhhhhhh-----------hhhhhhhHhhhCHHHhhc----CCcccccceehhHHHHHHHH
Confidence 8 7899999999987655322 225679999999999987 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
||..||.+.+...++ ++...... ..+ .+..+++.+.=|++.||+-.|..||+|.
T Consensus 306 T~EiPYkdVdssAII----wGVGsNsL---------------------~Lp-vPstcP~GfklL~Kqcw~sKpRNRPSFr 359 (904)
T KOG4721|consen 306 TGEIPYKDVDSSAII----WGVGSNSL---------------------HLP-VPSTCPDGFKLLLKQCWNSKPRNRPSFR 359 (904)
T ss_pred hcCCCccccchheeE----EeccCCcc---------------------ccc-CcccCchHHHHHHHHHHhcCCCCCccHH
Confidence 999999865443322 22211110 001 1126788899999999999999999999
Q ss_pred HHHHHHHhh
Q 001143 1124 DLYEMFVAR 1132 (1141)
Q Consensus 1124 ElL~~L~~~ 1132 (1141)
+|+.|+...
T Consensus 360 qil~HldIa 368 (904)
T KOG4721|consen 360 QILLHLDIA 368 (904)
T ss_pred HHHHHHhhc
Confidence 999998654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.80 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=206.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||+||+|++. +..+|+|+........ .... ..+..|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQI----AHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHH----HHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 46999999999999999999986 6778888865332111 1112 23478999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+.++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 75 -------------HLYLVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred -------------eEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 34999999999999999976 246999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecccccccccccccccc-------------------ccCCCCCCCCccCCCcccchhhhccccCCC
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~-------------------~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1024 (1141)
+ +.+||+|||++............ ............||+.|+|||++.+ .
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 205 (350)
T cd05573 137 D-------GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG----T 205 (350)
T ss_pred C-------CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC----C
Confidence 7 78999999999765432200000 0000011234569999999999986 4
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 001143 1025 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1025 ~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1141)
.++.++|||||||++|+|++|+.||......+....+.... ....+ . ....++.
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~-~~~~~~~ 260 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFP------------------------P-DPPVSPE 260 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCC------------------------C-CCCCCHH
Confidence 68899999999999999999999998877665555543311 00000 0 0024667
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHHHHHhhc
Q 001143 1104 LVDVFRRCTEENPTERPT-AGDLYEMFVART 1133 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPS-a~ElL~~L~~~~ 1133 (1141)
+.++|.+||. ||.+||+ +.++++|+|+..
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9999999997 9999999 999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=360.80 Aligned_cols=269 Identities=25% Similarity=0.331 Sum_probs=211.4
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-.+|++.++||+|+||+||+|++ .+..+|+|+.... ......... +.+|+.++..++|+||+++++.+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~--~~~~~~~~~----~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME--GMSEADKNR----AQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecc--cCCHHHHHH----HHHHHHHHhcCCCCcEEEeecceeccc
Confidence 45899999999999999999987 4677888876543 222333333 378999999999999999988776432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ........++||||+++|+|.++++.... ....+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 105 ~~------~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 105 PR------NPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC 177 (496)
T ss_pred cc------CcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe
Confidence 11 11122346899999999999999975332 234799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 178 ~~-------~~vkL~DFGls~~~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~----~~~s~k~DVwSlGvilyeL 238 (496)
T PTZ00283 178 SN-------GLVKLGDFGFSKMYAATVSD--------DVGRTFCGTPYYVAPEIWRR----KPYSKKADMFSLGVLLYEL 238 (496)
T ss_pred CC-------CCEEEEecccCeeccccccc--------cccccccCCcceeCHHHhCC----CCCCcHHHHHHHHHHHHHH
Confidence 87 78999999999765432111 11224569999999999976 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..++...+..+....++ ...++++.+++.+||+.||.+||++
T Consensus 239 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~L~~dP~~RPs~ 291 (496)
T PTZ00283 239 LTLKRPFDGENMEEVMHKTLAGRYDPLP---------------------------PSISPEMQEIVTALLSSDPKRRPSS 291 (496)
T ss_pred HHCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcccChhhCcCH
Confidence 9999999887776666665444332211 1445679999999999999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
.++++|+|++
T Consensus 292 ~ell~~p~~~ 301 (496)
T PTZ00283 292 SKLLNMPICK 301 (496)
T ss_pred HHHHhCHHHH
Confidence 9999998865
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=355.87 Aligned_cols=278 Identities=23% Similarity=0.268 Sum_probs=212.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C-----CCccceeeeE
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-----SCIVEMYGHK 878 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pNIVkllg~~ 878 (1141)
+|++.+.||+|+||.|-+|.+. +..||+||.+-+. .|-++...|+.+|..|+ | -|+|+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 7899999999999999999984 5678888755332 22233368999999996 4 3899999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
...++ .|||+|++. .+|+++++. +....++...++.|+.||+.||.+||+.||||+||||+|
T Consensus 258 ~fr~H--------------lciVfELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPEN 319 (586)
T KOG0667|consen 258 YFRNH--------------LCIVFELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPEN 319 (586)
T ss_pred ccccc--------------eeeeehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhh
Confidence 87665 499999996 899999987 556679999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||+....+ ..|||+|||.|........ ..+.+..|+|||++.| .+|+.++||||||||
T Consensus 320 ILL~~~~r-----~~vKVIDFGSSc~~~q~vy-------------tYiQSRfYRAPEVILG----lpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 320 ILLKDPKR-----SRIKVIDFGSSCFESQRVY-------------TYIQSRFYRAPEVILG----LPYDTAIDMWSLGCI 377 (586)
T ss_pred eeeccCCc-----CceeEEecccccccCCcce-------------eeeeccccccchhhcc----CCCCCccceeehhhh
Confidence 99976533 6899999999976544221 3457889999999998 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC---ccc--cccc-----c-----------------CCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEH--EVAQ-----S-----------------GSGF 1091 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~--~~~~-----~-----------------~~~~ 1091 (1141)
++||++|.+.|.+.++.+.+..|......+....++..... ... ...+ . ....
T Consensus 378 lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~ 457 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLER 457 (586)
T ss_pred HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccc
Confidence 99999999999999988877766333222222222221110 000 0000 0 0000
Q ss_pred CCc--------hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1092 EKP--------EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1092 ~~~--------~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
..| .........+.+++.+||.+||.+|+|+.|+++|+|+..
T Consensus 458 ~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 458 RGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred cCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 011 011244567899999999999999999999999999984
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=344.84 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=198.9
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH---hhCCCCCccceeeeEecCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL---~~L~HpNIVkllg~~~~~~ 882 (1141)
|++.+.||+|+||.||+|.+. +..+|+|+.+..... .....+ .+.+|+.++ ..++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVE----SLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 788999999999999999984 567888876432111 111122 235666555 5667999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.|+||||+++++|..+++. ..+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 76 --------------~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 76 --------------HVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred --------------EEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 45999999999999988754 3699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 136 ~~-------~~~kL~Dfg~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el 194 (324)
T cd05589 136 TE-------GFVKIADFGLCKEGMGFG----------DRTSTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred CC-------CcEEeCcccCCccCCCCC----------CcccccccCccccCHhHhcC----CCCCcccchhhHHHHHHHH
Confidence 87 789999999986432211 11124568999999999876 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC--
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-- 1120 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-- 1120 (1141)
++|+.||.+.+..+....+...... .+ ...+..+.+++.+||+.||.+||
T Consensus 195 ~~G~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 195 LVGESPFPGDDEEEVFDSIVNDEVR-YP---------------------------RFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 9999999987777666665443221 10 13456689999999999999999
Q ss_pred ---CHHHHHHHHHhhc
Q 001143 1121 ---TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 ---Sa~ElL~~L~~~~ 1133 (1141)
++.++++|+|+..
T Consensus 247 ~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 247 GEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCHHHHhhCCCcCC
Confidence 7999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=345.34 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=198.0
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||.||+|++. +..+|+|+....... .....+ .+..|..++..+ +||||+++++++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~h~~iv~~~~~~~~~~------ 69 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVE----CTMTEKRILSLARNHPFLTQLYCCFQTPD------ 69 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHH----HHHHHHHHHHhccCCCchhceeeEEEcCC------
Confidence 47999999999999984 556888875432111 111122 236788888877 6999999999987654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~iv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---- 132 (320)
T cd05590 70 --------RLFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---- 132 (320)
T ss_pred --------EEEEEEcCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 34999999999999999876 3469999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 133 ---GHCKLADFGMCKEGIFNG----------KTTSTFCGTPDYIAPEILQE----MLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred ---CcEEEeeCCCCeecCcCC----------CcccccccCccccCHHHHcC----CCCCCccchhhhHHHHHHHhhCCCC
Confidence 789999999986432111 11223468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH------
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA------ 1122 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa------ 1122 (1141)
|.+.+..++...+....... + ...+.++.+++.+||+.||.+||++
T Consensus 196 f~~~~~~~~~~~i~~~~~~~-~---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (320)
T cd05590 196 FEAENEDDLFEAILNDEVVY-P---------------------------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247 (320)
T ss_pred CCCCCHHHHHHHHhcCCCCC-C---------------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence 99877777766664432110 0 0345578999999999999999998
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
+++++|+|+..
T Consensus 248 ~~~~~h~~f~~ 258 (320)
T cd05590 248 EAILRHPFFKE 258 (320)
T ss_pred HHHHcCCCcCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.05 Aligned_cols=252 Identities=20% Similarity=0.257 Sum_probs=199.8
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
..||+|++|.||+|.+++..||+|...... ... +.+...+.+|+.+|++++||||+++++++.+..
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~--~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~--------- 91 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFH--KGH---KVLIDITENEIKNLRRIDSNNILKIYGFIIDIV--------- 91 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccc--ccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc---------
Confidence 679999999999999999999999854321 111 112233479999999999999999999987511
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeeecccccCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADG 970 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NILld~~~~~~~~ 970 (1141)
......++||||+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.+
T Consensus 92 -~~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~------ 159 (283)
T PHA02988 92 -DDLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN------ 159 (283)
T ss_pred -cCCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC------
Confidence 011246999999999999999975 24689999999999999999999984 99999999999999987
Q ss_pred CCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001143 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1050 (1141)
Q Consensus 971 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~ 1050 (1141)
+.+||+|||+++...... ....|+..|+|||++.+. ...++.++|||||||++|||++|+.||.
T Consensus 160 -~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~--~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 160 -YKLKIICHGLEKILSSPP-------------FKNVNFMVYFSYKMLNDI--FSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred -CcEEEcccchHhhhcccc-------------ccccCcccccCHHHhhhc--cccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 789999999987543211 123588999999998652 1467899999999999999999999999
Q ss_pred CCCHHHHHHHHHhC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001143 1051 GLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129 (1141)
Q Consensus 1051 ~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L 1129 (1141)
+.+..++...+... ..+..+ ..++..+.+++.+||+.||.+|||+.|+++.+
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLP---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCC---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 87777766665322 221111 14566799999999999999999999999987
Q ss_pred Hhh
Q 001143 1130 VAR 1132 (1141)
Q Consensus 1130 ~~~ 1132 (1141)
..-
T Consensus 277 ~~~ 279 (283)
T PHA02988 277 SLY 279 (283)
T ss_pred HHH
Confidence 543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=343.78 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=200.8
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC-CCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkllg~~~~~~~ 883 (1141)
+|++.+.||+|+||.||+|++.+ ..+|+|+....... .....+ .+..|+.++..+.| ++|+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVE----CTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 58999999999999999999854 46888876533211 112222 23689999999975 56888888887654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 35999999999999999875 346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 137 E-------GHIKIADFGMCKENIFGGK----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred C-------CCEEEeecCcceecCCCCC----------ceeeecCCccccChhhhcC----CCCCcccchhhhHHHHHHHH
Confidence 7 7899999999864321110 1123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa- 1122 (1141)
+|+.||.+.+..+....+..... .++ ...+..+.+++.+||..||.+|+++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 196 AGQPPFDGEDEDELFQSIMEHNV-SYP---------------------------KSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 99999998777766666543221 111 0345568999999999999999976
Q ss_pred ----HHHHHHHHhhc
Q 001143 1123 ----GDLYEMFVART 1133 (1141)
Q Consensus 1123 ----~ElL~~L~~~~ 1133 (1141)
.++++|+|+..
T Consensus 248 ~~~~~~~~~hp~~~~ 262 (324)
T cd05587 248 PTGERDIREHAFFRR 262 (324)
T ss_pred CCCHHHHhcCCCcCC
Confidence 89999998864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=345.46 Aligned_cols=285 Identities=17% Similarity=0.210 Sum_probs=205.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.+.||+|+||.||+|.+. +..+|+|+.... ......... +.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc--ccCchhHHH----HHHHHHHHHhcCCCCccccceeeccc
Confidence 3578999999999999999999974 556777764322 222222233 36899999999999999999988654
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
... ......|+||||++ ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 96 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll 159 (364)
T cd07875 96 KSL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159 (364)
T ss_pred ccc--------cccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE
Confidence 321 12235699999997 678887754 48889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 160 ~~~-------~~~kL~DfG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 217 (364)
T cd07875 160 KSD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 217 (364)
T ss_pred CCC-------CcEEEEeCCCccccCCCC-----------cccCCcccCCcCCHHHHhC----CCCCchhhHHhHHHHHHH
Confidence 887 789999999997543211 1123468999999999976 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC-----------ccccccccCCCCC---CchhhhhhHHHHHHH
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-----------HEHEVAQSGSGFE---KPEAELETLSFLVDV 1107 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-----------~~~~~~~~~~~~~---~~~~~~~~~~~L~dL 1107 (1141)
|++|+.||.+.+..+....+........+......... ......+...... ...........++++
T Consensus 218 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 297 (364)
T cd07875 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297 (364)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHH
Confidence 99999999987776665555332222222111111000 0000000000000 000111234578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
|.+||+.||.+|||+.|+++|+|+.
T Consensus 298 l~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 298 LSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHhcCcCcccCCCHHHHhcCcccc
Confidence 9999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=345.23 Aligned_cols=284 Identities=18% Similarity=0.224 Sum_probs=202.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.+.||+|+||.||+|.+. +..+|+|+.... ......... +.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP--FQNQTHAKR----AYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc--ccchhHHHH----HHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 4678999999999999999999874 566777765322 222222223 37899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
... ......|+||||++ ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~ 156 (359)
T cd07876 93 KSL--------EEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 156 (359)
T ss_pred CCc--------cccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 322 12235699999997 567776643 48889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 157 ~~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 214 (359)
T cd07876 157 KSD-------CTLKILDFGLARTACTNF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 214 (359)
T ss_pred CCC-------CCEEEecCCCccccccCc-----------cCCCCcccCCCCCchhccC----CCCCcchhhHHHHHHHHH
Confidence 887 789999999986532211 1123468999999999876 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhc-----------cCccccccccCCCCCC---chhhhhhHHHHHH
Q 001143 1042 LLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALG-----------SCHEHEVAQSGSGFEK---PEAELETLSFLVD 1106 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~-----------~~~~~~~~~~~~~~~~---~~~~~~~~~~L~d 1106 (1141)
|++|+.||.+.+..+....+ .....+... ...... ........+....+.. .......+..+++
T Consensus 215 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAE-FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCcHH-HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 99999999876655443333 222222111 000000 0000000000000000 0011123567899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1107 VFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1107 LI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
|+.+||+.||++|||+.|+++|+|+.
T Consensus 294 li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 294 LLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHhccCcccCCCHHHHhcCchhh
Confidence 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=352.11 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=199.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|++.++||+|+||+||+|++. +..+|+|+...... ...... ..+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~----~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQV----AHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHH----HHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 5899999999999999999984 45677777543211 111122 23489999999999999999999998655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
+.++||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 75 ------------NLYFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 35999999999999999876 3468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccc-------------------------------------cCCCCCCCCccC
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------------------HRGIPAPDVCVG 1007 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-------------------------------------~~~~~~~~~~~G 1007 (1141)
+.+||+|||++..+.......... ..........+|
T Consensus 138 -------~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 138 -------GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred -------CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 789999999986432110000000 000001123579
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccc
Q 001143 1008 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQ 1086 (1141)
Q Consensus 1008 T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~ 1086 (1141)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.. ......+.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------- 271 (381)
T cd05626 211 TPNYIAPEVLLR----KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--------------- 271 (381)
T ss_pred CccccCHHHHcC----CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC---------------
Confidence 999999999876 5678999999999999999999999987665554444322 11111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhc--ccCCCCCCCHHHHHHHHHhhc
Q 001143 1087 SGSGFEKPEAELETLSFLVDVFRRCT--EENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~L~dLI~~cL--~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
....++++.+++.+|+ ..+|..||++.++++|+|+..
T Consensus 272 ----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 272 ----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred ----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 0134567889998855 556666999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=345.19 Aligned_cols=284 Identities=17% Similarity=0.218 Sum_probs=202.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.+.||+|+||.||+|.+. +..+|+|+.. ........... +.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeC--CcccChHHHHH----HHHHHHHHHHhCCCchhceeeeeecc
Confidence 4678999999999999999999874 5566776543 22222222233 36899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
... ......++||||++ ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill 152 (355)
T cd07874 89 KSL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152 (355)
T ss_pred ccc--------cccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 321 12235699999997 577777654 48899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~e 210 (355)
T cd07874 153 KSD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 210 (355)
T ss_pred CCC-------CCEEEeeCcccccCCCcc-----------ccCCccccCCccCHHHHcC----CCCCchhhHHHHHHHHHH
Confidence 887 789999999997543211 1123468999999999876 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC----cc-----------ccccccCCCCCCchhhhhhHHHHHH
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC----HE-----------HEVAQSGSGFEKPEAELETLSFLVD 1106 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~----~~-----------~~~~~~~~~~~~~~~~~~~~~~L~d 1106 (1141)
|++|+.||.+.+..+....+........+......... .. ....+...+. ........+..+++
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 289 (355)
T cd07874 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA-DSEHNKLKASQARD 289 (355)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccc-ccccccccchHHHH
Confidence 99999999887665544333221111111111000000 00 0000000000 00011123567899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1107 VFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1107 LI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
||.+||+.||++|||+.|+++|+|+.
T Consensus 290 li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 290 LLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHHHhcCCchhcCCHHHHhcCcchh
Confidence 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=344.00 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
++||+|+||.||+|++. +..+|+|+....... .....+ .+..|.+++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~hp~i~~~~~~~~~~~~----- 70 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVD----CTMTEKRILALAAKHPFLTALHCCFQTKDR----- 70 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCCe-----
Confidence 46999999999999985 456888876533211 112222 236788888876 79999999999986553
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
.|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---- 132 (321)
T cd05591 71 ---------LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---- 132 (321)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC----
Confidence 4999999999999999875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 133 ---GHCKLADFGMCKEGILNG----------VTTTTFCGTPDYIAPEILQE----LEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ---CCEEEeecccceecccCC----------ccccccccCccccCHHHHcC----CCCCCccceechhHHHHHHhcCCCC
Confidence 789999999986532211 01123468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-------C
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-------T 1121 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-------S 1121 (1141)
|...+..+....+....... + ...+.++.+++.+||+.||++|| +
T Consensus 196 f~~~~~~~~~~~i~~~~~~~-p---------------------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~ 247 (321)
T cd05591 196 FEADNEDDLFESILHDDVLY-P---------------------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGG 247 (321)
T ss_pred CCCCCHHHHHHHHHcCCCCC-C---------------------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence 99888777776664432110 0 02345689999999999999999 9
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.++++|+|+..
T Consensus 248 ~~~~~~hp~~~~ 259 (321)
T cd05591 248 EDAIKQHPFFKE 259 (321)
T ss_pred HHHHhcCCccCC
Confidence 999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=357.95 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=205.3
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..|.+.+.||+|++|.||+|... +..+++|..... ....... +.+|+.+++.++|||||++++++...+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~----~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAY----ARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHH----HHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 34999999999999999999874 344555543211 2222222 378999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.|+||||++||+|.+++++... ...++++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 139 --------------~~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 203 (478)
T PTZ00267 139 --------------KLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203 (478)
T ss_pred --------------EEEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC
Confidence 35999999999999999875322 234689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 204 ~~-------~~~kL~DFgla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el 264 (478)
T PTZ00267 204 PT-------GIIKLGDFGFSKQYSDSVSL--------DVASSFCGTPYYLAPELWER----KRYSKKADMWSLGVILYEL 264 (478)
T ss_pred CC-------CcEEEEeCcCceecCCcccc--------ccccccCCCccccCHhHhCC----CCCCcHHhHHHHHHHHHHH
Confidence 87 78999999999765432110 11224569999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..++...+..+..+..+. ..+..+.++|.+||..||++||++
T Consensus 265 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~Rps~ 317 (478)
T PTZ00267 265 LTLHRPFKGPSQREIMQQVLYGKYDPFPC---------------------------PVSSGMKALLDPLLSKNPALRPTT 317 (478)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------cCCHHHHHHHHHHhccChhhCcCH
Confidence 99999998877777666665443322111 345679999999999999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
.+++.+.|..
T Consensus 318 ~~~l~~~~~~ 327 (478)
T PTZ00267 318 QQLLHTEFLK 327 (478)
T ss_pred HHHHhCHHHH
Confidence 9999987764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=351.41 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=217.1
Q ss_pred ceEeeeecccCceEEEEEEECCccE--EEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADA--AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~v--AvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|.|+..||.|+||.||+|..+.+.+ |.|+ ++. ....+.++| +-||.||..+.||+||++++.|+.++.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKv--Iet--kseEELEDy----lVEIeILa~CdHP~ivkLl~ayy~enk-- 103 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKV--IET--KSEEELEDY----LVEIEILAECDHPVIVKLLSAYYFENK-- 103 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhh--hcc--cchhHHhhh----hhhhhhhhcCCChHHHHHHHHHhccCc--
Confidence 6899999999999999999865543 4444 332 234556666 789999999999999999998876554
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
++|+.|||.||-....+-.. ...+++.++..+.+|++.||.|||+++|||||||+.|||++-+
T Consensus 104 ------------LwiliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld- 166 (1187)
T KOG0579|consen 104 ------------LWILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD- 166 (1187)
T ss_pred ------------eEEEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-
Confidence 49999999999999888653 4579999999999999999999999999999999999999988
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHHHh
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
|.++|+|||.+...... ....+.+.|||+|||||+..... ...+|+.++||||||++|.||..
T Consensus 167 ------GdirLADFGVSAKn~~t----------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq 230 (1187)
T KOG0579|consen 167 ------GDIRLADFGVSAKNKST----------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ 230 (1187)
T ss_pred ------CcEeeecccccccchhH----------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc
Confidence 89999999987543321 12345788999999999986542 45789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
+.+|....+++.++-.|....+|.+... ...+..+.+|+.+||..||..||++++
T Consensus 231 iEPPHhelnpMRVllKiaKSePPTLlqP-------------------------S~Ws~~F~DfLk~cL~Knp~~Rp~aaq 285 (1187)
T KOG0579|consen 231 IEPPHHELNPMRVLLKIAKSEPPTLLQP-------------------------SHWSRSFSDFLKRCLVKNPRNRPPAAQ 285 (1187)
T ss_pred cCCCccccchHHHHHHHhhcCCCcccCc-------------------------chhhhHHHHHHHHHHhcCCccCCCHHH
Confidence 9999999999888888877776655431 145567999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001143 1125 LYEMFVARTSS 1135 (1141)
Q Consensus 1125 lL~~L~~~~~s 1135 (1141)
+++|+|+....
T Consensus 286 ll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 286 LLKHPFVQNAP 296 (1187)
T ss_pred HhhCcccccCC
Confidence 99999998543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.10 Aligned_cols=260 Identities=22% Similarity=0.359 Sum_probs=204.2
Q ss_pred CCCCceEeeeecccCceEEEEEEECCc-------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~-------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
++++|++.+.||+|+||.||+|.+... .+++|..+ .. ....... .+.+|+.++.+++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~--~~-~~~~~~~----~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK--EN-AEPKVQQ----EFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecc--cC-CCHHHHH----HHHHHHHHHHhcCCcccceEEE
Confidence 456899999999999999999987433 35566532 21 1122222 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE-----------KHVSVKLALFIAQDVAAALVELH 945 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~-----------~~Ls~~~i~~Ia~QIa~gL~yLH 945 (1141)
++..... .+++|||+++++|.+++........ ..+++..+..++.||+.||.|||
T Consensus 76 ~~~~~~~--------------~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 76 VCTKEQP--------------TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EEcCCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9876543 4999999999999999976322111 46889999999999999999999
Q ss_pred HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 946 s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
++||+||||||+||+++.+ +.++|+|||++......... .......+++.|+|||.+.+ ..
T Consensus 142 ~~~i~H~dlkp~Nil~~~~-------~~~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEG-------LTVKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILY----GK 202 (283)
T ss_pred hCCeeccccccceEEEcCC-------CcEEECCCcceeeccccccc--------cccCCCcccccccCHHHhcc----Cc
Confidence 9999999999999999887 78999999998754321110 01123346788999999875 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
++.++|||||||++|||++ |..||.+....++...+.....+..+ ..++.++
T Consensus 203 ~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~ 255 (283)
T cd05048 203 FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP---------------------------EDCPARV 255 (283)
T ss_pred CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHH
Confidence 7899999999999999998 99999887777777666544332211 1556789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
.+|+.+||+.||.+||++.||++++.
T Consensus 256 ~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 256 YALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHh
Confidence 99999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=347.15 Aligned_cols=262 Identities=28% Similarity=0.360 Sum_probs=215.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~ 882 (1141)
..|++.+.||+|.||.||+++.. +..+|+|+......... ..... +.+|+.+|+++. |||||.+++.|++..
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~----v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDRED----VRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHH----HHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 45899999999999999999984 66788887644332221 12233 379999999998 999999999999866
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++|||++.||.|.+.|... .+++..+..++.||+.|+.|||+.||+||||||+|+|+.
T Consensus 110 ~--------------~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~ 169 (382)
T KOG0032|consen 110 S--------------VYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLA 169 (382)
T ss_pred e--------------EEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeec
Confidence 4 49999999999999999872 399999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
... .+.+.+|++|||++....... .....+||+.|+|||++.+ ..|+..+||||+||++|.|
T Consensus 170 ~~~---~~~~~ik~~DFGla~~~~~~~-----------~~~~~~Gtp~y~APEvl~~----~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 170 SKD---EGSGRIKLIDFGLAKFIKPGE-----------RLHTIVGTPEYVAPEVLGG----RPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred ccc---CCCCcEEEeeCCCceEccCCc-----------eEeeecCCccccCchhhcC----CCCCcccchhHHHHHHHHH
Confidence 652 122579999999998765411 1235679999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+.|.+||.+.+.......|..+...-... .+ ..++..+.+++..|+..||.+|+|+
T Consensus 232 L~G~~PF~~~~~~~~~~~i~~~~~~f~~~-----------------------~w-~~is~~akd~i~~ll~~dp~~R~ta 287 (382)
T KOG0032|consen 232 LSGVPPFWGETEFEIFLAILRGDFDFTSE-----------------------PW-DDISESAKDFIRKLLEFDPRKRLTA 287 (382)
T ss_pred hhCCCCCcCCChhHHHHHHHcCCCCCCCC-----------------------Cc-cccCHHHHHHHHHhcccCcccCCCH
Confidence 99999999988877777776665421111 11 1567789999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
.++++|+|....
T Consensus 288 ~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 288 AQALQHPWIKSI 299 (382)
T ss_pred HHHhcCccccCC
Confidence 999999998764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=352.19 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=205.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.++||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3567999999999999999999985 456777775321111 11112 2247899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~--------------~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl 175 (370)
T cd05621 116 K--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 175 (370)
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence 5 34999999999999999875 258899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|........ .......||+.|+|||++.+......++.++||||+||++|+
T Consensus 176 ~~~-------~~~kL~DFG~a~~~~~~~~---------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilye 239 (370)
T cd05621 176 DKH-------GHLKLADFGTCMKMDETGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239 (370)
T ss_pred CCC-------CCEEEEecccceecccCCc---------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHH
Confidence 887 7899999999976532211 011245699999999999764333457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~-- 1118 (1141)
|++|+.||.+.+.......+..... ..++. ....+..+.+++..||..+|.+
T Consensus 240 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~~L~~~~~r~~ 294 (370)
T cd05621 240 MLVGDTPFYADSLVGTYSKIMDHKNSLNFPE-------------------------DVEISKHAKNLICAFLTDREVRLG 294 (370)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCcccCCCC-------------------------cccCCHHHHHHHHHHccCchhccC
Confidence 9999999988776666655543221 11110 0144667899999999865544
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
|+++.|+++|+|+...
T Consensus 295 R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 295 RNGVEEIKQHPFFKND 310 (370)
T ss_pred CCCHHHHhcCcccCCC
Confidence 8999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=353.06 Aligned_cols=267 Identities=22% Similarity=0.253 Sum_probs=201.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++. +..+|+|+..... .........+.+|+.++++++||||+++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD-----VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH-----HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 36999999999999999999974 5667887753211 001111233478999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 75 -------------NLYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 34999999999999999976 346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccc---------------------------------cCCCCCCCCccCCCc
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA---------------------------------HRGIPAPDVCVGTPR 1010 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~---------------------------------~~~~~~~~~~~GT~~ 1010 (1141)
+ +.+||+|||+|..+.......... ...........||+.
T Consensus 137 ~-------~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 137 D-------GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred C-------CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 7 789999999985332100000000 000001123479999
Q ss_pred ccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCC
Q 001143 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGS 1089 (1141)
Q Consensus 1011 Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~ 1089 (1141)
|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..... ...+.
T Consensus 210 y~aPE~~~~----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------ 267 (376)
T cd05598 210 YIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS------------------ 267 (376)
T ss_pred ccCHHHHcC----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCC------------------
Confidence 999999976 5678999999999999999999999988776655444432111 00000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhc
Q 001143 1090 GFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVART 1133 (1141)
Q Consensus 1090 ~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP---Sa~ElL~~L~~~~ 1133 (1141)
....+..+.++|.+|+ .+|.+|+ ++.++++|+|+..
T Consensus 268 -------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 268 -------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred -------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 0134566888999876 5999999 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=342.65 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
++||+|+||.||+|++. +..+|+|+.+...... ....+. +..|..++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~----~~~e~~~l~~~~~hp~i~~~~~~~~~~~------ 69 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVEC----TMVERRVLALAWEHPFLTHLFCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHH----HHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 47999999999999985 4557888765332111 111222 24677777654 7999999999987654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||++|++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---- 132 (316)
T cd05592 70 --------HLFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---- 132 (316)
T ss_pred --------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC----
Confidence 35999999999999999875 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 133 ---GHIKIADFGMCKENMNGE----------GKASTFCGTPDYIAPEILKG----QKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCcCCeECCCCC----------CccccccCCccccCHHHHcC----CCCCCcccchhHHHHHHHHHhCCCC
Confidence 789999999986532211 11224468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 1127 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa-~ElL~ 1127 (1141)
|.+.+..++...+.... +.++ ...+.++.+++.+||+.||.+||++ .++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~---------------------------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 196 FHGEDEDELFDSILNDR-PHFP---------------------------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHcCC-CCCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99877776666654322 1111 1345568999999999999999986 47889
Q ss_pred HHHhhc
Q 001143 1128 MFVART 1133 (1141)
Q Consensus 1128 ~L~~~~ 1133 (1141)
|+|+..
T Consensus 248 h~~~~~ 253 (316)
T cd05592 248 HPFFRG 253 (316)
T ss_pred CcccCC
Confidence 988764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.99 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=203.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|.+. +..+++|..... ......... +.+|+.++++++||||+++++++.+.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREE----AIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehh--hCCHHHHHH----HHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 5889999999999999999984 566777765433 222233333 378999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.++++.. ....+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 73 ------------KLNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred ------------EEEEEEEeCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 349999999999999999762 23468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+..+..... ......|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~~ 196 (256)
T cd08529 138 -------DNVKIGDLGVAKLLSDNTN----------FANTIVGTPYYLSPELCED----KPYNEKSDVWALGVVLYECCT 196 (256)
T ss_pred -------CCEEEcccccceeccCccc----------hhhccccCccccCHHHhcC----CCCCCccchHHHHHHHHHHHh
Confidence 7899999999876543211 1123357889999999876 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...+..+....+..+..+.+.. ..+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 197 GKHPFDANNQGALILKIIRGVFPPVSQ---------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 999998777666555554443332221 34456899999999999999999999
Q ss_pred HHHHHH
Q 001143 1125 LYEMFV 1130 (1141)
Q Consensus 1125 lL~~L~ 1130 (1141)
+++++|
T Consensus 250 ll~~~~ 255 (256)
T cd08529 250 LLRNPS 255 (256)
T ss_pred HhhCCC
Confidence 999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=347.91 Aligned_cols=286 Identities=20% Similarity=0.235 Sum_probs=205.5
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.++||+|+||.||+|.+ .+..+|+|.. ..........+. +.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~--~~~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKR----VFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEec--cccccchHHHHH----HHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478899999999999999997 4566777754 222222222233 37999999999999999999998754311
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 75 ---------PFEEIYVVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred ---------ccceEEEEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 1225699999997 688888754 3469999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||+++........ ......+|+.|+|||++.+ ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~ 200 (372)
T cd07853 140 -------CVLKICDFGLARVEEPDESK---------HMTQEVVTQYYRAPEILMG---SRHYTSAVDIWSVGCIFAELLG 200 (372)
T ss_pred -------CCEEeccccceeecccCccc---------cCCCCCcCCCcCCHHHHcC---CCCCCcHHHHHhHHHHHHHHHc
Confidence 78999999998754321110 1123357899999999876 2347899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCC-CCc---hhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1045 LQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGF-EKP---EAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+.||.+.+..+....+.. ...+... .+.................. ... ......++++.+||.+||+.||.+|
T Consensus 201 g~~pf~~~~~~~~~~~i~~~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 279 (372)
T cd07853 201 RRILFQAQSPIQQLDLITDLLGTPSLE-AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR 279 (372)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHH-HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhC
Confidence 9999998777766665533 2222221 11110000000000000000 000 0011346778999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.|+++|+|+..
T Consensus 280 ~t~~e~l~hp~~~~ 293 (372)
T cd07853 280 ISAADALAHPYLDE 293 (372)
T ss_pred cCHHHHhcCHhhCC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=346.37 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g 889 (1141)
+.||+|+||.||+|.+ .+..+|+|+....... ...... .+..|+.++..++||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~----~~~~e~~~l~~~~hp~i~~~~~~~~~~~------- 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVA----HTLTENRVLQNSRHPFLTALKYSFQTHD------- 68 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhCCCCCCCceEEEEEcCC-------
Confidence 4799999999999987 4567888876533211 111222 3368999999999999999999987655
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeecccccC
Q 001143 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---- 132 (325)
T cd05594 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---- 132 (325)
T ss_pred -------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC----
Confidence 34999999999999988865 3468999999999999999999997 799999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 133 ---GHIKITDFGLCKEGIKDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred ---CCEEEecCCCCeecCCCCc----------ccccccCCcccCCHHHHcc----CCCCCccccccccceeeeeccCCCC
Confidence 7899999999864321110 1123468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAG 1123 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----Sa~ 1123 (1141)
|.+....+....+..... .++ ...++++.+++.+||+.||++|+ ++.
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 196 FYNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 987766655555432221 110 13456789999999999999996 999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
++++|+|+..
T Consensus 248 ~il~h~~~~~ 257 (325)
T cd05594 248 EIMQHKFFAG 257 (325)
T ss_pred HHhcCCCcCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=342.18 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
++||+|+||.||+|++. +..+|+|+.+....... ...+ ....|..++... +||||+++++++.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 69 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVE----CTMVEKRVLALAWENPFLTHLYCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHH----HHHHHHHHHHhccCCCCccCeeEEEEeCC------
Confidence 47999999999999984 55678887653321111 1112 225788888755 8999999999998655
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
+.|+||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---- 132 (316)
T cd05620 70 --------HLFFVMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---- 132 (316)
T ss_pred --------EEEEEECCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 34999999999999999875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 133 ---GHIKIADFGMCKENVFGD----------NRASTFCGTPDYIAPEILQG----LKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEeCccCCCeecccCC----------CceeccCCCcCccCHHHHcC----CCCCcccchhhhHHHHHHHHhCCCC
Confidence 789999999986422111 11224568999999999976 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 1127 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa-~ElL~ 1127 (1141)
|.+.+..++...+..... ..+ ...+.++.+++.+||+.||.+||++ +++++
T Consensus 196 f~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 196 FHGDDEDELFESIRVDTP-HYP---------------------------RWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHhCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 988777666665543221 111 0245568999999999999999997 58888
Q ss_pred HHHhhc
Q 001143 1128 MFVART 1133 (1141)
Q Consensus 1128 ~L~~~~ 1133 (1141)
|+|+..
T Consensus 248 h~~f~~ 253 (316)
T cd05620 248 HPFFKT 253 (316)
T ss_pred CCCcCC
Confidence 999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=342.20 Aligned_cols=254 Identities=25% Similarity=0.326 Sum_probs=201.0
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~ 883 (1141)
+|++.+.||+|+||.||+|++. +..+|+|+....... .....+ .+..|..++..+ +||+|+++++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVE----CTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 5889999999999999999985 456788876532211 111112 236788888777 5899999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 75 -------------RLYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 34999999999999999875 246899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 137 E-------GHIKIADFGMCKENMWDG----------VTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred C-------CcEEEccCCCceecCCCC----------CccccCCCChhhcCHHHhcC----CCCCCccchhchhHHHHHHH
Confidence 7 789999999986432111 01123468999999999976 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS-- 1121 (1141)
+|+.||.+.+..++...+...... ++ ...+.++.+++.+||+.||.+|++
T Consensus 196 tg~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 196 AGQAPFEGEDEDELFQSIMEHNVA-YP---------------------------KSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 999999987777776665433211 11 034567899999999999999997
Q ss_pred ---HHHHHHHHHhhc
Q 001143 1122 ---AGDLYEMFVART 1133 (1141)
Q Consensus 1122 ---a~ElL~~L~~~~ 1133 (1141)
..++++|+|++.
T Consensus 248 ~~~~~~i~~h~~~~~ 262 (323)
T cd05616 248 PEGERDIKEHAFFRY 262 (323)
T ss_pred CCCHHHHhcCCCcCC
Confidence 489999988863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=339.73 Aligned_cols=281 Identities=23% Similarity=0.298 Sum_probs=202.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-++|++.++||+|+||.||+|.+. +..+++|+..... ....... +.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHH----HHHHHHHHHHCCCCcccceeEEEEECC
Confidence 357999999999999999999985 4456666644321 2222233 479999999999999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NILl 961 (1141)
+.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 77 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili 137 (333)
T cd06650 77 --------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137 (333)
T ss_pred --------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE
Confidence 34999999999999999975 34689999999999999999999975 79999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++..+.... .....||..|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~ 194 (333)
T cd06650 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (333)
T ss_pred cCC-------CCEEEeeCCcchhhhhhc------------cccCCCCccccCHHHhcC----CCCCcHHHHHHHHHHHHH
Confidence 877 789999999986543211 123458999999999876 467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhc-cCccccc----------------cc-cCCCCCCchhhhhhHHH
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG-SCHEHEV----------------AQ-SGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~-~~~~~~~----------------~~-~~~~~~~~~~~~~~~~~ 1103 (1141)
|++|+.||......+....+................ ....... .. ..............+.+
T Consensus 195 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (333)
T cd06650 195 MAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAE 274 (333)
T ss_pred HHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHH
Confidence 999999998655444333221100000000000000 0000000 00 00000000000124567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
+.+|+.+||+.||++|||+.|+++|+|++..
T Consensus 275 ~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 275 FQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 9999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=362.37 Aligned_cols=267 Identities=25% Similarity=0.381 Sum_probs=218.9
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
.+-.+..+.+.||+|+||.||+|+.. +....|+||.++.. ......++| ++|++++..++|||||+++|.
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF----~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDF----RREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHH----HHHHHHHHhccCCCeEEEEEE
Confidence 34556789999999999999999862 34445555556542 223344555 899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG---------EKHVSVKLALFIAQDVAAALVELHSKH 948 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~---------~~~Ls~~~i~~Ia~QIa~gL~yLHs~g 948 (1141)
+.+.+.+ ++|+|||..|||.++++...... ..+++..+.+.|+.|||.|++||-++.
T Consensus 558 C~~~~P~--------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~ 623 (774)
T KOG1026|consen 558 CREGDPL--------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH 623 (774)
T ss_pred EccCCee--------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc
Confidence 9987754 99999999999999998654322 223899999999999999999999999
Q ss_pred ccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001143 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1141)
Q Consensus 949 IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1028 (1141)
+|||||-..|+||.++ ..|||+|||+++.+-...... .+ ....-...|||||.+.. ..|+.
T Consensus 624 FVHRDLATRNCLVge~-------l~VKIsDfGLsRdiYssDYYk---~~-----~~t~lPIRWMppEsIly----~kFTt 684 (774)
T KOG1026|consen 624 FVHRDLATRNCLVGEN-------LVVKISDFGLSRDIYSSDYYK---VR-----GNTLLPIRWMPPESILY----GKFTT 684 (774)
T ss_pred ccccchhhhhceeccc-------eEEEecccccchhhhhhhhhc---cc-----CCceeeeecCCHHHhhc----Ccccc
Confidence 9999999999999988 899999999998654433221 11 12234678999999987 78999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|||||||+|||+++ |+.||.+.+..++++.|+.+....-+ ..++.++++|
T Consensus 685 eSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~P---------------------------e~CP~~vY~L 737 (774)
T KOG1026|consen 685 ESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCP---------------------------ENCPTEVYSL 737 (774)
T ss_pred hhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCC---------------------------CCCCHHHHHH
Confidence 9999999999999999 99999999999999999887653222 2788899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
|..||+.+|.+||+++||-..|.....
T Consensus 738 M~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 738 MLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 999999999999999999988876543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=343.64 Aligned_cols=249 Identities=26% Similarity=0.315 Sum_probs=194.6
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||+||+|++. +..+|+|+........ ..... .+..|.. +++.++||||+++++.+....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~~~~~l~hp~iv~~~~~~~~~~------ 69 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQK----HIMAERNVLLKNVKHPFLVGLHYSFQTAD------ 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHH----HHHHHHHHHHhhCCCCCCCCeeEEEEeCC------
Confidence 47999999999999984 5678888764321111 11111 2245554 457789999999999987654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---- 132 (323)
T cd05575 70 --------KLYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---- 132 (323)
T ss_pred --------EEEEEEcCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 34999999999999999875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 133 ---GHVVLTDFGLCKEGIEHS----------KTTSTFCGTPEYLAPEVLRK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred ---CcEEEeccCCCcccccCC----------CccccccCChhhcChhhhcC----CCCCccccccccchhhhhhhcCCCC
Confidence 789999999986432111 11123468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1124 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa----~E 1124 (1141)
|...+..+....+...... +. ...+..+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLR-LK---------------------------PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 9887776666665432211 00 1345678999999999999999987 69
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+|+..
T Consensus 248 il~~~~~~~ 256 (323)
T cd05575 248 IKNHVFFSS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.29 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=197.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..+|++.+.||+|+||.||+|.+. ...+|+|+. +... ....... +.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~--~~~~-~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL--RAGC-SDKQRRG----FLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEec--CCCC-CHHHHHH----HHHHHHHHhcCCCCCcCeEEEEEe
Confidence 457899999999999999999863 234555553 3221 1222223 479999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... .++||||+++++|.+++... ...+++..++.++.||+.||+|||++|++||||||+||
T Consensus 77 ~~~~--------------~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni 138 (266)
T cd05064 77 RGNT--------------MMIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV 138 (266)
T ss_pred cCCC--------------cEEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence 6543 49999999999999998751 23689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.++++|||.+........ .......++..|+|||.+.+ ..++.++|||||||++
T Consensus 139 li~~~-------~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 198 (266)
T cd05064 139 LVNSD-------LVCKISGFRRLQEDKSEAI---------YTTMSGKSPVLWAAPEAIQY----HHFSSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CcEEECCCcccccccccch---------hcccCCCCceeecCHHHHhh----CCccchhHHHHHHHHH
Confidence 99887 7899999998754321110 01112235678999999876 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
||+++ |..||......+....+..+..+..+ ..++..+.+++.+||+.+|.+
T Consensus 199 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 199 WEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP---------------------------RNCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCchh
Confidence 99775 99999887776666665444322111 145567999999999999999
Q ss_pred CCCHHHHHHHHH
Q 001143 1119 RPTAGDLYEMFV 1130 (1141)
Q Consensus 1119 RPSa~ElL~~L~ 1130 (1141)
||++.+|++.+.
T Consensus 252 RP~~~~i~~~l~ 263 (266)
T cd05064 252 RPRFSQIHSILS 263 (266)
T ss_pred CCCHHHHHHHHH
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.82 Aligned_cols=282 Identities=22% Similarity=0.221 Sum_probs=198.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEecC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISS 881 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkllg~~~~~ 881 (1141)
+|++.+.||+|+||+||+|.+. +..+|+|+.+........ ... +.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~----~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL--PLS----TVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC--chH----HHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 5899999999999999999984 556777765433211111 111 24566666655 699999999988653
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. ......++||||++ ++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 75 ~~---------~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 75 RT---------DRETKVTLVFEHVD-QDLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred cC---------CCCceEEEEEcccc-cCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 21 12235699999997 689998875 223458999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++....... ......||..|+|||++.+ ..++.++|||||||++|+
T Consensus 142 ~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 142 TSG-------GQVKLADFGLARIYSCQM-----------ALTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAE 199 (288)
T ss_pred CCC-------CCEEECccCccccccCcc-----------cCCCccccccccCchHhhC----CCCCCcchhhhHHHHHHH
Confidence 887 789999999987543211 1123458999999999876 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++|++||.+....+....+.. ...+.. ..+........... ...............+..+.+++.+||+.||++||
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 277 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPE-DDWPRDVTLPRGAF-SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI 277 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCCh-hhCccccccccccc-CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC
Confidence 9999999987666554444422 111111 01000000000000 00000001111124567789999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
|+.|++.|+||
T Consensus 278 t~~~~l~hp~f 288 (288)
T cd07863 278 SAFRALQHPFF 288 (288)
T ss_pred CHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=350.27 Aligned_cols=266 Identities=23% Similarity=0.279 Sum_probs=200.3
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|++.++||+|+||.||+|++. +..+|+|+..... .........+.+|+.++++++|||||++++.+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-----VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 5899999999999999999984 4557777643221 111122234478999999999999999999998655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
+.|+||||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 75 ------------NLYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred ------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 34999999999999999876 2468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecccccccccccccccc-------------------------------------ccCCCCCCCCccC
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------------------AHRGIPAPDVCVG 1007 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~-------------------------------------~~~~~~~~~~~~G 1007 (1141)
+.+||+|||+|..+......... ...........+|
T Consensus 138 -------g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 138 -------GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred -------CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 78999999998543211000000 0000001123469
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccc
Q 001143 1008 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQ 1086 (1141)
Q Consensus 1008 T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~ 1086 (1141)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.... ....+.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--------------- 271 (382)
T cd05625 211 TPNYIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--------------- 271 (382)
T ss_pred CcccCCHHHhcC----CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC---------------
Confidence 999999999876 567899999999999999999999998877665554443211 111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhc
Q 001143 1087 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFVART 1133 (1141)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS---a~ElL~~L~~~~ 1133 (1141)
....++++.++|.+|+ .+|.+|++ +.++++|+|+..
T Consensus 272 ----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 272 ----------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred ----------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 0134567888898876 59999987 999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=340.22 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||.||+|++. +..+|+|+.+....... .... ....|..++..+ +||||+++++++.+.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~----~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~----- 70 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-DDVE----CTMVEKRVLSLAWEHPFLTHLYCTFQTKEN----- 70 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-chHH----HHHHHHHHHHhccCCCcCcceEEEEEeCCE-----
Confidence 47999999999999985 45678887653321111 1112 225688888765 89999999999886553
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
.++||||+++|+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---- 132 (316)
T cd05619 71 ---------LFFVMEYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---- 132 (316)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC----
Confidence 4999999999999999875 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 133 ---GHIKIADFGMCKENMLGD----------AKTCTFCGTPDYIAPEILLG----QKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCCcceECCCCC----------CceeeecCCccccCHHHHcC----CCCCchhhhhhHHHHHHHHHhCCCC
Confidence 789999999986432111 01123468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 1127 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~-ElL~ 1127 (1141)
|.+.+..++...+..... ..+ ...+..+.+++.+||+.||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 196 FHGHDEEELFQSIRMDNP-CYP---------------------------RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHhCCC-CCC---------------------------ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 988777666666543221 111 02345689999999999999999996 8999
Q ss_pred HHHhhc
Q 001143 1128 MFVART 1133 (1141)
Q Consensus 1128 ~L~~~~ 1133 (1141)
|+|+..
T Consensus 248 h~~~~~ 253 (316)
T cd05619 248 HPFFRE 253 (316)
T ss_pred CcccCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=345.33 Aligned_cols=277 Identities=23% Similarity=0.260 Sum_probs=197.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.++||+|+||.||+|.+. +..+|+|. .. ... +.+|+.++++++|||||++++++...
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~--~~--------~~~----~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKA--GQ--------RGG----TATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEec--hh--------hhh----hHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 3457999999999999999999985 44556653 21 112 26899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. .++|||++. ++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 156 ~~--------------~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll 215 (391)
T PHA03212 156 KF--------------TCLILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215 (391)
T ss_pred Ce--------------eEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE
Confidence 43 499999996 789888865 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|........ .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 216 ~~~-------~~vkL~DFG~a~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~e 275 (391)
T PHA03212 216 NHP-------GDVCLGDFGAACFPVDINA---------NKYYGWAGTIATNAPELLAR----DPYGPAVDIWSAGIVLFE 275 (391)
T ss_pred cCC-------CCEEEEeCCcccccccccc---------cccccccCccCCCChhhhcC----CCCCcHHHHHHHHHHHHH
Confidence 877 7899999999864322110 01123469999999999876 568899999999999999
Q ss_pred HHhCCCCCCCCC--------HHHHHHHHHhCCC-CC-chhHH-hhhccCcccccc-ccCCCCCCch--hhhhhHHHHHHH
Q 001143 1042 LLTLQVPYMGLS--------ELEIHDLIQMGKR-PR-LTDEL-EALGSCHEHEVA-QSGSGFEKPE--AELETLSFLVDV 1107 (1141)
Q Consensus 1042 LLTGk~Pf~~~~--------~~el~~~I~~~~~-p~-l~~~l-~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~L~dL 1107 (1141)
|++|+.||.... ...+...+..... +. .+... ............ ........+. .....+.++.+|
T Consensus 276 lltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L 355 (391)
T PHA03212 276 MATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYL 355 (391)
T ss_pred HHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHH
Confidence 999998875321 1122222222111 11 00000 000000000000 0000000111 112456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
|.+||++||.+|||+.|+++|+||..-
T Consensus 356 i~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 356 ICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHhcCChhhCCCHHHHhcChhhccC
Confidence 999999999999999999999999763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=333.31 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=196.6
Q ss_pred CCCceEeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 866 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~------------------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L 866 (1141)
..+|++.++||+|+||.||+|.+.. ..+|+|+.... ........ +.+|+.++.++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~E~~~l~~l 76 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARND----FLKEVKILSRL 76 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHHH----HHHHHHHHhhc
Confidence 3578999999999999999998632 24677765322 12222333 47999999999
Q ss_pred CCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh--------------cCCCCCCHHHHHH
Q 001143 867 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------------TGEKHVSVKLALF 932 (1141)
Q Consensus 867 ~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~--------------~~~~~Ls~~~i~~ 932 (1141)
+||||+++++++.+... .++||||+++++|.+++..... .....+++..+.+
T Consensus 77 ~h~niv~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05096 77 KDPNIIRLLGVCVDEDP--------------LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLH 142 (304)
T ss_pred CCCCeeEEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHH
Confidence 99999999999886543 4999999999999999865321 1113478889999
Q ss_pred HHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCccc
Q 001143 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012 (1141)
Q Consensus 933 Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 1012 (1141)
++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+...... .......++..|+
T Consensus 143 i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~-------~~~kl~DfG~~~~~~~~~~~--------~~~~~~~~~~~y~ 207 (304)
T cd05096 143 VALQIASGMKYLSSLNFVHRDLATRNCLVGEN-------LTIKIADFGMSRNLYAGDYY--------RIQGRAVLPIRWM 207 (304)
T ss_pred HHHHHHHHHHHHHHCCccccCcchhheEEcCC-------ccEEECCCccceecccCcee--------EecCcCCCCcccc
Confidence 99999999999999999999999999999987 78999999998754332111 0112334678899
Q ss_pred chhhhccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCC
Q 001143 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1090 (1141)
Q Consensus 1013 APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT--Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~ 1090 (1141)
|||++.+ ..++.++|||||||++|||++ +..||...+..+....+...........
T Consensus 208 aPE~~~~----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------ 265 (304)
T cd05096 208 AWECILM----GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV------------------ 265 (304)
T ss_pred CHHHHhc----CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc------------------
Confidence 9999875 568899999999999999987 5678877665554443321110000000
Q ss_pred CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1091 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1091 ~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
.......++..+.+++.+||..||.+|||+.+|.+.+.
T Consensus 266 --~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 266 --YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred --cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 00001145667999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.21 Aligned_cols=284 Identities=18% Similarity=0.232 Sum_probs=206.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+..+++|++.++||+|+||.||+|++. +..+|+|....... .. ... .+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~-~~~----~~~~E~~~l~~l~h~nI~~~~~~~~ 74 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EG-APC----TAIREVSLLKDLKHANIVTLHDIIH 74 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cC-chh----HHHHHHHHHHhcCCCCcceEEEEEe
Confidence 456789999999999999999999885 45677776543321 11 111 2368999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
... ..++||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 75 ~~~--------------~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni 135 (301)
T cd07873 75 TEK--------------SLTLVFEYLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135 (301)
T ss_pred cCC--------------eEEEEEeccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence 654 3499999997 6999888652 33589999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.++|+|||++........ ......+++.|+|||++.+ ...++.++|||||||++
T Consensus 136 l~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l 195 (301)
T cd07873 136 LINER-------GELKLADFGLARAKSIPTK----------TYSNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIF 195 (301)
T ss_pred EECCC-------CcEEECcCcchhccCCCCC----------cccccceeecccCcHHHhC---CCCCccHHHHHHHHHHH
Confidence 99887 7899999999865432111 1112347889999999865 23567899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccC-CCCC---CchhhhhhHHHHHHHHHHhcccC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGFE---KPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|+|++|+.||...+..+....+...........+...... ....... .... ........++.+.+||.+||+.|
T Consensus 196 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d 273 (301)
T cd07873 196 YEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN--EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFE 273 (301)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc--ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCC
Confidence 9999999999877665554444322211111111110000 0000000 0000 00111245677899999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001143 1116 PTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~ 1133 (1141)
|.+|||++|+++|+|++.
T Consensus 274 p~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 274 GRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccCcCHHHHhcCccccc
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=341.76 Aligned_cols=285 Identities=18% Similarity=0.221 Sum_probs=202.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|.+. +..+|+|+.. .........+ .+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS--RPFQSLIHAR----RTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeC--chhhhhHHHH----HHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 357999999999999999999874 4456777643 2111111222 3368999999999999999999886433
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ......|++||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 88 ~~--------~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~ 152 (343)
T cd07878 88 SI--------ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152 (343)
T ss_pred cc--------cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence 11 1233569999998 6899888753 3699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 153 ED-------CELRILDFGLARQADDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEcCCccceecCCC-------------cCCccccccccCchHhcC---CccCCchhhhHhHHHHHHHH
Confidence 87 78999999998754321 113468999999999875 23578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCch---hhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
++|+.||.+....+....+.................................. .....++.+.+|+.+||+.||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 99999998766655544442221111111111110000000000000000000 001234568899999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.|+++|+|+..
T Consensus 290 ~s~~ell~hp~~~~ 303 (343)
T cd07878 290 ISASEALAHPYFSQ 303 (343)
T ss_pred CCHHHHhcCcchhc
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=345.48 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=205.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||+||+|++. +..+|+|+.+..... .... ...+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQET----VSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhH----HHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 46899999999999999999974 566788876532110 1112 223478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 75 -------------NLYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred -------------eEEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 349999999999999999762 246999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC--CCCCCchhhHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVWSLGviL~E 1041 (1141)
+ +.+||+|||++..+...... ......||+.|+|||++..... ...++.++|||||||++|+
T Consensus 138 ~-------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 138 T-------GHIKLADFGSAARLTANKMV---------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred C-------CCEEeccCCCCeECCCCCce---------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 7 78999999999765432111 1123468999999999864221 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++|+.||...........+..... ...+. ....+..+.+|+..||+ +|.+||
T Consensus 202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-------------------------DPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCccCCCC-------------------------CCCCCHHHHHHHHHHcc-ChhhCC
Confidence 9999999987766665555533211 10000 01345678999999998 999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
++.++++|+|+..
T Consensus 256 t~~~l~~h~~~~~ 268 (330)
T cd05601 256 GYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=347.32 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=204.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.+.||+|+||.||+|++. +..+|+|+...... ...... ..+.+|+.+++.++||||+++++.+.+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~----~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDS----AFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHH----HHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3578999999999999999999985 45567776432111 011111 2347899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~--------------~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll 175 (371)
T cd05622 116 R--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (371)
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 4 35999999999999999875 258899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++..+..... .......||+.|+|||++.+......++.++|||||||++||
T Consensus 176 ~~~-------~~ikL~DfG~a~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilye 239 (371)
T cd05622 176 DKS-------GHLKLADFGTCMKMNKEGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (371)
T ss_pred CCC-------CCEEEEeCCceeEcCcCCc---------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHH
Confidence 887 7899999999976532111 111245699999999999764333457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~-- 1118 (1141)
|++|+.||.+.+.......+..... ..++. ....+..+.++|..||..++.+
T Consensus 240 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~~~r~~ 294 (371)
T cd05622 240 MLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRLG 294 (371)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCcccCCC-------------------------cCCCCHHHHHHHHHHcCChhhhcC
Confidence 9999999998777666666543221 11110 0145667899999999844443
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
|+++.++++|+|+...
T Consensus 295 r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 295 RNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCHHHHhcCcccCCC
Confidence 7899999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=342.94 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=197.9
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+.+|++.++||+|+||.||+|++. +..+|+|+..... ... ....+.+|++++++++|+||+++++++.
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 142 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDT----VRRQICREIEILRDVNHPNVVKCHDMFD 142 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHH----HHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence 345678999999999999999999984 5678888753221 112 2233489999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.+ ..++||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~--------------~~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 199 (353)
T PLN00034 143 HNG--------------EIQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199 (353)
T ss_pred cCC--------------eEEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 654 34999999999998643 2356788889999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC-CCCCCchhhHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVWSLGvi 1038 (1141)
|++.+ +.+||+|||+++.+..... ......||..|+|||++..... ....+.++|||||||+
T Consensus 200 ll~~~-------~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvi 262 (353)
T PLN00034 200 LINSA-------KNVKIADFGVSRILAQTMD----------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262 (353)
T ss_pred EEcCC-------CCEEEcccccceecccccc----------cccccccCccccCccccccccccCcCCCcchhHHHHHHH
Confidence 99887 7899999999876543211 1123468999999998754221 2334579999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHH---HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1039 LLELLTLQVPYMGLSELEIH---DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~---~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
+|||++|+.||......+.. ..+.....+. .....+.++.+||.+||+.|
T Consensus 263 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~ 315 (353)
T PLN00034 263 ILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE---------------------------APATASREFRHFISCCLQRE 315 (353)
T ss_pred HHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC---------------------------CCCccCHHHHHHHHHHccCC
Confidence 99999999999743222211 1111111111 01145667999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 001143 1116 PTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~~s 1135 (1141)
|++|||+.|+++|+|+....
T Consensus 316 P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 316 PAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred hhhCcCHHHHhcCcccccCC
Confidence 99999999999999998764
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=346.37 Aligned_cols=267 Identities=20% Similarity=0.233 Sum_probs=203.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+. +..+|+|+...... ........+..|+.++..++||||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-----LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 46899999999999999999984 56678887542211 11112234478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+.++||||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 75 -------------NLYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred -------------EEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 34999999999999999975 346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccc-------------------------cCCCCCCCCccCCCcccchhhhc
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 1018 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-------------------------~~~~~~~~~~~GT~~Y~APE~l~ 1018 (1141)
+ +.+||+|||++..+.......... ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred C-------CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 7 789999999987543211100000 00000111346999999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1019 ~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
+ ..++.++|||||||++|||++|+.||.+....+....+..... ..++. .
T Consensus 210 ~----~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (360)
T cd05627 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP-------------------------E 260 (360)
T ss_pred C----CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC-------------------------C
Confidence 6 5678999999999999999999999988777666655543211 10000 0
Q ss_pred hhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhc
Q 001143 1098 LETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVART 1133 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RP---Sa~ElL~~L~~~~ 1133 (1141)
...+.++.++|.+|+ .||.+|+ ++.++++|+|+..
T Consensus 261 ~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 261 VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 034567889999877 4999998 5899999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=338.64 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=197.3
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||+||+|++. +..+|+|+.+..... ...... .+..|..++..+ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~h~~i~~~~~~~~~~~------ 69 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVE----CTMTEKRVLALAGKHPFLTQLHSCFQTKD------ 69 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 47999999999999984 456888876532211 111222 236888899888 6999999999987654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
+.++||||+++++|..++.+ ...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---- 132 (318)
T cd05570 70 --------RLFFVMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---- 132 (318)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC----
Confidence 35999999999999998876 2469999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 133 ---GHIKIADFGMCKEGILGG----------VTTSTFCGTPDYIAPEILSY----QPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred ---CcEEecccCCCeecCcCC----------CcccceecCccccCHHHhcC----CCCCcchhhhhHHHHHHHHhhCCCC
Confidence 789999999986422111 01123458999999999976 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----H
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----G 1123 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa-----~ 1123 (1141)
|.+.+..+....+..... ..+ ...+..+.+++.+||+.||.+||++ .
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 196 FEGDDEDELFQSILEDEV-RYP---------------------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred CCCCCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 988776666655533221 110 1345678999999999999999999 9
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
++++|+|+..
T Consensus 248 ~ll~~~~~~~ 257 (318)
T cd05570 248 DIKGHPFFRE 257 (318)
T ss_pred HHhcCCCcCC
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=343.16 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
+.||+|+||.||++++ .+..+|+|+...... ..... .++..|+.++++++||||+++++++.+..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDR----VRTKMERDILAEVNHPFIVKLHYAFQTEG---- 71 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhH----HHHHHHHHHHHhCCCCCcccEEEEEEcCC----
Confidence 6799999999999875 356788888653211 11111 23368999999999999999999988654
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..|+||||+++++|.+++.+ ...+++..++.|+.||+.||.|||++||+||||||+|||++.+
T Consensus 72 ----------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-- 134 (318)
T cd05582 72 ----------KLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-- 134 (318)
T ss_pred ----------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC--
Confidence 34999999999999999865 3468999999999999999999999999999999999999887
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 135 -----~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 135 -----GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -----CcEEEeeccCCcccCCCCC----------ceecccCChhhcCHHHHcC----CCCCCccceeccceEeeeeccCC
Confidence 7899999999865432110 1123468999999999876 45688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 1121 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS----- 1121 (1141)
.||......+....+...... ++ ...++.+.+++.+||+.||.+||+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKLG-MP---------------------------QFLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 999887766666555432211 00 134567899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.+++.|+|+..
T Consensus 248 ~~~~~~~~~~~~ 259 (318)
T cd05582 248 VEEIKRHPFFST 259 (318)
T ss_pred HHHHhCCCCcCC
Confidence 778999988753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=321.52 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=198.4
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..+|++.+.||+|+||.||+|.+.. ..+++|... ..... ...+ .+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~--~~~~~---~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN--EGAMS---EEDF----IEEAKVMMKLSHPKLVQLYGVCTQQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecc--cCCcc---HHHH----HHHHHHHHHCCCCCceeEEEEEccCCC
Confidence 4568999999999999999999854 366777533 21111 2233 789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.++++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 74 --------------~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 74 --------------LYIVTEFMENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred --------------EEEEEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 49999999999999998751 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.++........ ......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 136 T-------GVVKVSDFGMTRYVLDDEYT---------SSSGAKFPVKWSPPEVFNF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCCCccccCCCcee---------ccCCCCCchhhCChhhccc----CccchhhhhHHHHHHHHHHH
Confidence 7 78999999998754321111 1112235678999999875 45788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||...+..+....+..+..+..+. ..+..+.+++.+||+.||.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~~Rps~ 248 (256)
T cd05114 196 TEGKMPFEKKSNYEVVEMISRGFRLYRPK---------------------------LASMTVYEVMYSCWHEKPEGRPTF 248 (256)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHccCCcccCcCH
Confidence 9 899998877777766665543322111 234568999999999999999999
Q ss_pred HHHHHHH
Q 001143 1123 GDLYEMF 1129 (1141)
Q Consensus 1123 ~ElL~~L 1129 (1141)
.++++.+
T Consensus 249 ~~l~~~l 255 (256)
T cd05114 249 AELLRAI 255 (256)
T ss_pred HHHHHhh
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=340.83 Aligned_cols=248 Identities=24% Similarity=0.304 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||+||+|++. +..+|+|+........ ..... .+..|.. +++.++||||+++++++...+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~------ 69 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEEK----HIMSERNVLLKNVKHPFLVGLHFSFQTAD------ 69 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHHH----HHHHHHHHHHHhCCCCCCCceeEEEEcCC------
Confidence 47999999999999984 4567888764321111 11111 2234444 567789999999999987655
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---- 132 (325)
T cd05602 70 --------KLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------eEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 34999999999999999875 3468899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~DfG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 133 ---GHIVLTDFGLCKENIEHN----------GTTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEccCCCCcccccCC----------CCcccccCCccccCHHHHcC----CCCCCccccccccHHHHHHhcCCCC
Confidence 789999999986432211 01224469999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 1124 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~----E 1124 (1141)
|.+.+..+....+....... ....+..+.+++.+||+.||.+||++. +
T Consensus 196 f~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQL----------------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHhCCcCC----------------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 98877766665553321110 014456789999999999999999875 8
Q ss_pred HHHHHHhh
Q 001143 1125 LYEMFVAR 1132 (1141)
Q Consensus 1125 lL~~L~~~ 1132 (1141)
+++|+|+.
T Consensus 248 i~~~~~~~ 255 (325)
T cd05602 248 IKNHIFFS 255 (325)
T ss_pred HhcCcccC
Confidence 88888874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.18 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=199.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|++.++||+|+||.||++.+. +..+|+|+...... ... .....+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKR---KGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhh---hhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 4889999999999999999974 56677776532211 111 11223468999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
+.++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 74 ------------ALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred ------------eEEEEEeccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 35999999999999998865 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++....... ......|++.|+|||++.+ ..++.++||||+||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diws~G~~l~el~~ 196 (285)
T cd05605 139 -------GHIRISDLGLAVEIPEGE-----------TIRGRVGTVGYMAPEVVKN----ERYTFSPDWWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEeeCCCceecCCCC-----------ccccccCCCCccCcHHhcC----CCCCccccchhHHHHHHHHHH
Confidence 789999999987543211 0113358999999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---- 1120 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP---- 1120 (1141)
|+.||.+.........+........ .......+..+.+|+.+||..||.+||
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 197 GKSPFRQRKEKVKREEVERRVKEDQ------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred CCCCCCCCchhhHHHHHHHHhhhcc------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 9999987554332222211100000 000013456789999999999999999
Q ss_pred -CHHHHHHHHHhhc
Q 001143 1121 -TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 -Sa~ElL~~L~~~~ 1133 (1141)
++.++++|+|+..
T Consensus 253 ~~~~~l~~~~~~~~ 266 (285)
T cd05605 253 EGAEEVKAHPFFRT 266 (285)
T ss_pred CCHHHHhcCcCccC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.99 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=200.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|.+. +..+++|....+ .......+. +.+|+.++++++|||++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR--NASRRERKA----AEQEAQLLSQLKHPNIVAYRESWEGED-- 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehh--hcCHHHHHH----HHHHHHHHHhCCCCCeeeeeeeecCCC--
Confidence 4899999999999999999974 455777765432 112222223 378999999999999999998775322
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
...++||||+++++|.+++.. .....+++.+++.++.|++.|+.|||++||+||||||+||+++.+
T Consensus 73 -----------~~~~lv~e~~~~~~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 73 -----------GLLYIVMGFCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred -----------CEEEEEecccCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 135899999999999999975 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+........ ......+++.|+|||++.+ ..++.++||||||+++++|++
T Consensus 139 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 139 -------NIIKVGDLGIARVLENQCD----------MASTLIGTPYYMSPELFSN----KPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred -------CcEEEecccceEEecccCC----------ccccccCCcCccChhHhcC----CCCCchhhhHHHHHHHHHHHc
Confidence 7899999999876532110 1123458899999999876 567789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...+.......+..+..+..+ ...++.+.+++.+||+.||.+|||+.+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 198 LKHAFNAKDMNSLVYRIIEGKLPPMP---------------------------KDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCc---------------------------cccCHHHHHHHHHHhccCcccCCCHHH
Confidence 99999876655554444433322211 145567999999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
+++|+|+
T Consensus 251 ~l~~~~~ 257 (257)
T cd08223 251 ILRQPYI 257 (257)
T ss_pred HhcCCCC
Confidence 9999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=341.17 Aligned_cols=249 Identities=25% Similarity=0.293 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||.||+|++. +..+|+|+...+.... ..... .+..|.. +++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~~~l~~~~hp~iv~~~~~~~~~~------ 69 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQK----HIMAERNVLLKNVKHPFLVGLHYSFQTTE------ 69 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHH----HHHHHHHHHHHhCCCCCCccEEEEEecCC------
Confidence 46999999999999974 5678888865332111 11112 2245554 467789999999999988655
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---- 132 (325)
T cd05604 70 --------KLYFVLDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC----
Confidence 34999999999999988865 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 133 ---GHVVLTDFGLCKEGIAQS----------DTTTTFCGTPEYLAPEVIRK----QPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEeecCCcccCCCCC----------CCcccccCChhhCCHHHHcC----CCCCCcCccccccceehhhhcCCCC
Confidence 789999999986432111 11124468999999999876 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1124 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa----~E 1124 (1141)
|...+..++...+........ ...+..+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVLR----------------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHHHHHHHHHcCCccCC----------------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 988776666665543221100 0344568899999999999999976 58
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+|+..
T Consensus 248 i~~h~~f~~ 256 (325)
T cd05604 248 IQEHPFFES 256 (325)
T ss_pred HhcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.94 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||+|+||+||++.+. +..+|+|........ ..... ..+..|+.++++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~----~~~~~E~~il~~l~~~~i~~~~~~~~~~~--------- 66 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGY----EGAMVEKRILAKVHSRFIVSLAYAFQTKT--------- 66 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHH----HHHHHHHHHHHhCCCCcEeeeeEEEcCCC---------
Confidence 799999999999874 556777764322110 11111 23478999999999999999999887654
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
+.++||||+++|+|..++..... ....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~------- 133 (280)
T cd05608 67 -----DLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND------- 133 (280)
T ss_pred -----eEEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-------
Confidence 34999999999999988865322 23469999999999999999999999999999999999999877
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
+.++|+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 134 ~~~~l~dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 134 GNVRISDLGLAVELKDGQS----------KTKGYAGTPGFMAPELLQG----EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCEEEeeCccceecCCCCc----------cccccCCCcCccCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 7899999999875433111 1123468999999999986 5678999999999999999999999975
Q ss_pred CCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHH
Q 001143 1052 LSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDL 1125 (1141)
Q Consensus 1052 ~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----Sa~El 1125 (1141)
.........+.. ...... ......+..+.+++.+||+.||++|| +++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 200 RGEKVENKELKQRILNDSV-------------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred CCcchhHHHHHHhhcccCC-------------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 432211111110 000000 00014566799999999999999999 88999
Q ss_pred HHHHHhhcC
Q 001143 1126 YEMFVARTS 1134 (1141)
Q Consensus 1126 L~~L~~~~~ 1134 (1141)
++|+|+...
T Consensus 255 l~h~~~~~~ 263 (280)
T cd05608 255 RTHPLFRDL 263 (280)
T ss_pred hcChhhhcC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=336.24 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=200.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~ 883 (1141)
+|++.+.||+|+||.||+|.+. +..+|+|+....... .....+. +..|..++..+. |++|+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~----~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVEC----TMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHH----HHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4788999999999999999984 567888876532211 1112222 367888888885 678888998887654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..|+||||+++|+|.+++.. ...+++.++..|+.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 34999999999999999875 346999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~ikL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 137 E-------GHIKIADFGMCKEHMVDGV----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred C-------CCEEEeccccccccCCCCc----------cccCccCCccccCHHHHcC----CCCCCccchhhhHHHHHHHH
Confidence 7 7899999999864322110 1123458999999999876 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS-- 1121 (1141)
+|+.||.+....+....+...... .+ ...+.++.+++.+||+.||.+|++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 196 AGQPPFDGEDEDELFQSIMEHNVS-YP---------------------------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 999999987776666665432211 10 034456899999999999999997
Q ss_pred ---HHHHHHHHHhhc
Q 001143 1122 ---AGDLYEMFVART 1133 (1141)
Q Consensus 1122 ---a~ElL~~L~~~~ 1133 (1141)
..++.+|+|+..
T Consensus 248 ~~~~~~i~~h~~f~~ 262 (323)
T cd05615 248 PEGERDIREHAFFRR 262 (323)
T ss_pred CCCHHHHhcCcccCC
Confidence 578999998875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=339.80 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=191.5
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
++||+|+||.||+|++. +..+|+|+.+..... ...... .+..|..++.++ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~----~~~~e~~il~~~~~hp~Iv~~~~~~~~~~------ 69 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDID----WVQTEKHVFETASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCCCCceEEEEEcCC------
Confidence 47999999999999984 556788875432211 111222 347899999988 6999999999988655
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---- 132 (329)
T cd05588 70 --------RLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 34999999999999998865 3469999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 133 ---GHIKLTDYGMCKEGIRPG----------DTTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEECcCccccccccCC----------CccccccCCccccCHHHHcC----CCCCCccceechHHHHHHHHHCCCC
Confidence 789999999986422111 11123468999999999976 5678999999999999999999999
Q ss_pred CCCCCH--------HH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1049 YMGLSE--------LE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1049 f~~~~~--------~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|..... .+ ....+.... ..++ ...+..+.+++.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEKQ-IRIP---------------------------RSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred cccccccccccccchHHHHHHHHcCC-CCCC---------------------------CCCCHHHHHHHHHHhccCHHHc
Confidence 963211 11 112111111 1100 1345678999999999999999
Q ss_pred CC------HHHHHHHHHhhc
Q 001143 1120 PT------AGDLYEMFVART 1133 (1141)
Q Consensus 1120 PS------a~ElL~~L~~~~ 1133 (1141)
|+ ++++++|+|+..
T Consensus 248 ~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 248 LGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCC
Confidence 87 799999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=341.77 Aligned_cols=265 Identities=27% Similarity=0.378 Sum_probs=196.2
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
++|.-..+||+|+||.||+|...+ ..+|||. +....... .++| .+|+.++.+++|||+|+++|||.+.+.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~--~~~~~~~~--~~eF----~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKR--LSSNSGQG--EREF----LNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEE--ecCCCCcc--hhHH----HHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 457777899999999999999866 6777774 33322221 2335 899999999999999999999987541
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCeee
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILI 961 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---gIvHrDLKP~NILl 961 (1141)
+.+||+||+++|+|.++++.. ... +++|..+.+|+.++|+||+|||.. .||||||||+|||+
T Consensus 146 ------------~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 146 ------------HRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ------------eEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 359999999999999999862 111 789999999999999999999975 49999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccc-cccccccccCCCCCCCCc-cCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVC-VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~-~~~~~~~~~~~~~~~~~~-~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|.+ +++||+|||+|+.... ... .... .||.+|+|||++.. ...+.|+|||||||++
T Consensus 211 D~~-------~~aKlsDFGLa~~~~~~~~~-----------~~~~~~gt~gY~~PEy~~~----g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 211 DED-------FNAKLSDFGLAKLGPEGDTS-----------VSTTVMGTFGYLAPEYAST----GKLTEKSDVYSFGVVL 268 (361)
T ss_pred CCC-------CCEEccCccCcccCCccccc-----------eeeecCCCCccCChhhhcc----CCcCcccccccchHHH
Confidence 988 8999999999965432 110 0111 69999999999975 5678999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHH----HHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1040 LELLTLQVPYMGLS---ELEIHD----LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~---~~el~~----~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
+||+||+.|..... ...+.. .+..+. +.. +.+..... ...........+..+..+|+
T Consensus 269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~---~~e------------iiD~~l~~-~~~~~~~~~~~~~~~a~~C~ 332 (361)
T KOG1187|consen 269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEGK---LRE------------IVDPRLKE-GEYPDEKEVKKLAELALRCL 332 (361)
T ss_pred HHHHhCCcccCCCCCcccccHHHHHHHHHHCcc---hhh------------eeCCCccC-CCCChHHHHHHHHHHHHHHc
Confidence 99999998876422 111111 111111 111 11111000 00000134556888899999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 001143 1113 EENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+|.+||+|.||++.+...
T Consensus 333 ~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 333 RPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcCCCcCcCHHHHHHHHHhh
Confidence 99999999999999988443
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=334.06 Aligned_cols=290 Identities=19% Similarity=0.223 Sum_probs=199.6
Q ss_pred Eeeeeccc--CceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 810 SCDEAGKS--VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 810 i~~~LG~G--sfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
+.++||+| +||+||++++. +..+|+|....+ .......+ .+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~e~~~l~~l~hpniv~~~~~~~~~~~-- 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLE--ACTNEMVT----FLQGELHVSKLFNHPNIVPYRATFIADNE-- 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechh--hccHHHHH----HHHHHHHHHHhcCCCCeeeEEEEEEECCE--
Confidence 56789999 77899999985 455666654322 22222222 34789999999999999999999987653
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
.++||||+++++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 74 ------------~~lv~e~~~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~- 137 (327)
T cd08227 74 ------------LWVVTSFMAYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD- 137 (327)
T ss_pred ------------EEEEEeccCCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-
Confidence 49999999999999999652 22358999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++++||+.+............ .........++..|+|||++.+. ...++.++|||||||++|+|++|
T Consensus 138 ------~~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 138 ------GKVYLSGLRSNLSMINHGQRLRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ------CcEEEcccchhhccccccccccc---cccccccccceecccChHHhhcc--cCCCCchhhHHHHHHHHHHHHHC
Confidence 78999999876543221110000 00112234577889999998752 13578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc--------C-ccccccc------cCC---CCCCchhhhhhHHHHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS--------C-HEHEVAQ------SGS---GFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~--------~-~~~~~~~------~~~---~~~~~~~~~~~~~~L~dL 1107 (1141)
+.||......+.......+..+...+....... . ....... ... ...........++.+.+|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 999986555443333333322211110000000 0 0000000 000 000000112446789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
+.+||+.||++|||++|+++|+|++.-
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=329.12 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=200.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
-..+.+|++.+.||+|+||.||+|.+. +..++++++..+.. ........ +.+|+.++.++ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~----~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRD----FAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHH----HHHHHHHHHHhcCCCCcceEEEEE
Confidence 345788999999999999999999974 34455555544321 12222333 37899999999 899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSK 947 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~ 947 (1141)
..... .++||||+++++|.++++.... .....+++..++.++.||+.||+|||++
T Consensus 78 ~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 143 (303)
T cd05088 78 EHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143 (303)
T ss_pred CCCCC--------------ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 76553 3999999999999999975321 1123589999999999999999999999
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCC
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1027 (1141)
||+||||||+|||++.+ +.+||+|||++....... ......++..|+|||++.+ ..++
T Consensus 144 gi~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~ 201 (303)
T cd05088 144 QFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNY----SVYT 201 (303)
T ss_pred CccccccchheEEecCC-------CcEEeCccccCcccchhh-----------hcccCCCcccccCHHHHhc----cCCc
Confidence 99999999999999887 789999999985321100 0111234667999999865 4578
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 001143 1028 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1106 (1141)
Q Consensus 1028 ~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1106 (1141)
.++|||||||++|+|+| |..||......+....+.....+..+ ...+..+.+
T Consensus 202 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 254 (303)
T cd05088 202 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYD 254 (303)
T ss_pred ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC---------------------------CCCCHHHHH
Confidence 99999999999999998 99999876665555544322111100 134456899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1107 VFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1107 LI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
++.+||+.+|.+||++.+++.++...
T Consensus 255 li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 255 LMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=338.57 Aligned_cols=248 Identities=26% Similarity=0.295 Sum_probs=192.1
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
++||+|+||.||+|++. +..+|+|+....... ..... ..+..|.. +++.++||||+++++++.+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~------ 69 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQ----NHIMAERNVLLKNLKHPFLVGLHYSFQTAE------ 69 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHH----HHHHHHHHHHHHhCCCCCccceeeEEEcCC------
Confidence 47999999999999984 566888875432111 11111 22345554 577889999999999987654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---- 132 (321)
T cd05603 70 --------KLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---- 132 (321)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 34999999999999988865 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 133 ---GHVVLTDFGLCKEGVEPE----------ETTSTFCGTPEYLAPEVLRK----EPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred ---CCEEEccCCCCccCCCCC----------CccccccCCcccCCHHHhcC----CCCCCcCcccccchhhhhhhcCCCC
Confidence 789999999986432111 11123468999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1124 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa----~E 1124 (1141)
|.+.+..++...+..... .++ ...+..+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 196 FYSRDVSQMYDNILHKPL-QLP---------------------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 988776666655543221 110 1344568999999999999999875 58
Q ss_pred HHHHHHhh
Q 001143 1125 LYEMFVAR 1132 (1141)
Q Consensus 1125 lL~~L~~~ 1132 (1141)
+++|+|+.
T Consensus 248 ~~~~~~~~ 255 (321)
T cd05603 248 IKNHVFFS 255 (321)
T ss_pred HhCCCCcC
Confidence 99988875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=342.00 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=197.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
.++|++.++||+|+||.||+|++. +..+|+|+.+.. . .....+ .+.+|+.++..+ +||||+++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~--~-~~~~~~----~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS--A-HLTERE----ALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC--c-CcHHHH----HHHHHHHHHHHhcCCcceeeeee
Confidence 457999999999999999999752 335777764321 1 122223 347899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------------------------------
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------- 919 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~------------------------------------- 919 (1141)
++.+... .++||||+++|+|.++++....
T Consensus 107 ~~~~~~~--------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (375)
T cd05104 107 ACTVGGP--------------TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK 172 (375)
T ss_pred eeccCCc--------------ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence 9876553 3999999999999999975211
Q ss_pred ---------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 920 ---------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 920 ---------------------------------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
.....+++..+..|+.||+.||.|||++||+||||||+|||++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-- 250 (375)
T cd05104 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-- 250 (375)
T ss_pred CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC--
Confidence 012357889999999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1045 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1045 (1141)
+.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 251 -----~~~kl~DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDi~slG~~l~ellt~g 313 (375)
T cd05104 251 -----RITKICDFGLARDIRNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVWSYGILLWEIFSLG 313 (375)
T ss_pred -----CcEEEecCccceeccCcccc--------cccCCCCCCcceeChhHhcC----CCCCCCCCHHHHHHHHHHHHhcC
Confidence 78999999999765332111 01112235678999999876 568899999999999999998 8
Q ss_pred CCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1046 QVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1046 k~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
..||....... ....+..+..+..+ ...+.++.+|+.+||+.||++||++.|
T Consensus 314 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs~~e 366 (375)
T cd05104 314 SSPYPGMPVDSKFYKMIKEGYRMLSP---------------------------ECAPSEMYDIMKSCWDADPLKRPTFKQ 366 (375)
T ss_pred CCCCCCCCchHHHHHHHHhCccCCCC---------------------------CCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99997654332 33333322211100 023457999999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
|++.+..
T Consensus 367 il~~l~~ 373 (375)
T cd05104 367 IVQLIEQ 373 (375)
T ss_pred HHHHHHh
Confidence 9998874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.74 Aligned_cols=264 Identities=28% Similarity=0.381 Sum_probs=203.4
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+|.+...||+|++|.||+|.+ .+..+++|.......... ......+...+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999987 456788887544332222 12222333456899999999999999999999886554
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.
T Consensus 81 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 81 --------------LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN 141 (267)
T ss_pred --------------cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC
Confidence 3999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.++.......... .........|+..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 142 K-------GGIKISDFGISKKLEANSLSTK----TNGARPSLQGSVFWMAPEVVKQ----TSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred C-------CCEEecccCCCcccccccccCC----ccccccccCCCcCccChhHhcc----CCCCchhhhHHHHHHHHHHh
Confidence 7 7899999999976643211100 0011123458889999999876 45778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||...........+.....+..+ ...+..+.+++.+||+.||.+||++.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENASPEIP---------------------------SNISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccCCCcCC---------------------------cccCHHHHHHHHHHccCCchhCcCHH
Confidence 999999875544433333222222111 13456789999999999999999999
Q ss_pred HHHHHHHh
Q 001143 1124 DLYEMFVA 1131 (1141)
Q Consensus 1124 ElL~~L~~ 1131 (1141)
|+++|+|+
T Consensus 260 ~il~~~~~ 267 (267)
T cd06628 260 ELLKHPFL 267 (267)
T ss_pred HHhhCCCC
Confidence 99999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.85 Aligned_cols=264 Identities=20% Similarity=0.331 Sum_probs=199.2
Q ss_pred ceEeeeecccCceEEEEEEECCc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~----~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
|.+.++||+|+||.||+|.+... .+|+|..+.. .......+.+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC--cCCHHHHHHH----HHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 45789999999999999997543 3566654332 2223333444 789999999999999999998754321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ......++||||+++++|.+++..... .....+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 75 ~--------~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 146 (272)
T cd05075 75 S--------EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN 146 (272)
T ss_pred c--------cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc
Confidence 1 112245899999999999998853221 1234589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 147 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slG~il~el 207 (272)
T cd05075 147 EN-------MNVCVADFGLSKKIYNGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC-------CCEEECCCCcccccCcccce--------ecCCcccCCcccCCHHHccC----CCcChHHHHHHHHHHHHHH
Confidence 77 78999999999765432110 01112346778999999876 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |+.||.+....+....+..+..+..+ ...+..+.+++.+||+.||++|||
T Consensus 208 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 208 ATRGQTPYPGVENSEIYDYLRQGNRLKQP---------------------------PDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCcccCcC
Confidence 99 89999877666666665543322111 134556899999999999999999
Q ss_pred HHHHHHHHHh
Q 001143 1122 AGDLYEMFVA 1131 (1141)
Q Consensus 1122 a~ElL~~L~~ 1131 (1141)
+.++++++..
T Consensus 261 ~~~l~~~l~~ 270 (272)
T cd05075 261 FETLRCELEK 270 (272)
T ss_pred HHHHHHHHHh
Confidence 9999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.70 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=200.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.++|++.++||+|+||.||+|.+. +..+++|..... ....+. +.+|+.++++++||||+++++.+....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQA----FLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHH----HHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4678999999999999999999874 445677653321 112233 378999999999999999999887654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+++++|.++++.. ....+++..+..++.|++.||+|||+.+++||||||+||+++
T Consensus 75 ~--------------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~ 137 (261)
T cd05072 75 P--------------IYIITEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137 (261)
T ss_pred C--------------cEEEEecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec
Confidence 3 39999999999999999752 234688999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+......... ......++..|+|||++.. ..++.++|||||||++|+|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 197 (261)
T cd05072 138 ES-------LMCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLYEI 197 (261)
T ss_pred CC-------CcEEECCCccceecCCCcee---------ccCCCccceecCCHHHhcc----CCCChhhhhhhhHHHHHHH
Confidence 87 78999999999765432111 1112235678999999875 4578899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |..||......+....+......... ...+.++.+++.+||..+|++||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 250 (261)
T cd05072 198 VTYGKIPYPGMSNSDVMSALQRGYRMPRM---------------------------ENCPDELYDIMKTCWKEKAEERPT 250 (261)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCcC
Confidence 98 99999877666666555433221100 134567899999999999999999
Q ss_pred HHHHHHHHH
Q 001143 1122 AGDLYEMFV 1130 (1141)
Q Consensus 1122 a~ElL~~L~ 1130 (1141)
++++.+.+.
T Consensus 251 ~~~i~~~l~ 259 (261)
T cd05072 251 FDYLQSVLD 259 (261)
T ss_pred HHHHHHHHh
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.77 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=200.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.++||+|+||.||+|.+. +..+++|+.. .. ......+ .+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~--~~---~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--ED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEec--CC---chHHHHH----HHHHHHHHhCCCCChhheEEEEcCCC
Confidence 456899999999999999999985 5566776643 21 1222333 78999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+++++|.+++.. .....+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~ 138 (263)
T cd05052 76 P--------------FYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138 (263)
T ss_pred C--------------cEEEEEeCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 3 3999999999999999875 2234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.+......... ......++..|+|||.+.+ ..++.++|||||||++|||
T Consensus 139 ~~-------~~~kl~df~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 139 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred CC-------CcEEeCCCccccccccceee---------ccCCCCCccccCCHHHhcc----CCCCchhHHHHHHHHHHHH
Confidence 77 78999999998765432111 1112234668999999876 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |..||.+....+....+.....+..+ ...+..+.+++.+||..||++||+
T Consensus 199 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~ 251 (263)
T cd05052 199 ATYGMSPYPGIDLSQVYELLEKGYRMERP---------------------------EGCPPKVYELMRACWQWNPSDRPS 251 (263)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCCC
Confidence 98 99999877666665555433222111 145567999999999999999999
Q ss_pred HHHHHHHHH
Q 001143 1122 AGDLYEMFV 1130 (1141)
Q Consensus 1122 a~ElL~~L~ 1130 (1141)
+.++++.+.
T Consensus 252 ~~~l~~~l~ 260 (263)
T cd05052 252 FAEIHQAFE 260 (263)
T ss_pred HHHHHHHHH
Confidence 999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.53 Aligned_cols=258 Identities=32% Similarity=0.443 Sum_probs=198.1
Q ss_pred ceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.+.||+|+||+||+|++... .+|+|+..... ....... ...+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~--- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IEEEERE----ENIREIKILRRLRHPNIVQILDVFQDDN--- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HHHHHHH----HHHHHHHHHHHHTBTTBCHEEEEEEESS---
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--ccccccc----hhhhhhhccccccccccccccccccccc---
Confidence 78999999999999999999655 48888765331 1111111 2246999999999999999999998755
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 72 -----------~~~~v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~- 134 (260)
T PF00069_consen 72 -----------YLYIVMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN- 134 (260)
T ss_dssp -----------EEEEEEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-
T ss_pred -----------cccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccc-
Confidence 34899999998899999983 2468999999999999999999999999999999999999977
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||.+....... .......++..|+|||++.. ...++.++||||+|+++|+|++|
T Consensus 135 ------~~~~l~Dfg~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 135 ------GEVKLIDFGSSVKLSENN----------ENFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ------SEEEESSGTTTEESTSTT----------SEBSSSSSSGGGSCHHHHTT---TSSBSTHHHHHHHHHHHHHHHHS
T ss_pred ------cccccccccccccccccc----------cccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 789999999987531111 11123468999999999871 25678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
..||......+....+.............. .......+.+++.+||+.||++||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 196 KLPFEESNSDDQLEIIEKILKRPLPSSSQQ---------------------SREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp SSSSTTSSHHHHHHHHHHHHHTHHHHHTTS---------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred ccccccccchhhhhhhhhcccccccccccc---------------------cchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 999987633333333221111111100000 00224789999999999999999999999
Q ss_pred HHHHHh
Q 001143 1126 YEMFVA 1131 (1141)
Q Consensus 1126 L~~L~~ 1131 (1141)
++|+|+
T Consensus 255 ~~~~~~ 260 (260)
T PF00069_consen 255 LKHPWF 260 (260)
T ss_dssp HTSGGG
T ss_pred hcCCCC
Confidence 999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=341.56 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=215.0
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
|.-.+.||.|+||.||-|++..+..+|+|++....... .+.-.++ ++|+.+|.+++|||+|.+-|+|..+.
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDI----lKEVrFL~~l~HPntieYkgCyLre~---- 99 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI----LKEVRFLRQLRHPNTIEYKGCYLREH---- 99 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHH----HHHHHHHHhccCCCcccccceeeccc----
Confidence 56678999999999999999766666777665543322 2223333 89999999999999999999987654
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..|||||||- ||-.+++.-. .+++.+.++..|..+.+.||.|||+.+.||||||+.|||+++.
T Consensus 100 ----------TaWLVMEYCl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-- 162 (948)
T KOG0577|consen 100 ----------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-- 162 (948)
T ss_pred ----------hHHHHHHHHh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC--
Confidence 3499999996 7878887642 3579999999999999999999999999999999999999987
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
|.|||+|||.|..... ...++|||+|||||++..+- .+.|+-++||||||++..||...+
T Consensus 163 -----g~VKLaDFGSAsi~~P--------------AnsFvGTPywMAPEVILAMD-EGqYdgkvDvWSLGITCIELAERk 222 (948)
T KOG0577|consen 163 -----GLVKLADFGSASIMAP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERK 222 (948)
T ss_pred -----CeeeeccccchhhcCc--------------hhcccCCccccchhHheecc-ccccCCccceeeccchhhhhhhcC
Confidence 8999999999865432 34678999999999998754 568999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL 1126 (1141)
+|+..++.+.....|.....|.+... +.+..++.|+..||+.-|.+|||.++++
T Consensus 223 PPlFnMNAMSALYHIAQNesPtLqs~--------------------------eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 223 PPLFNMNAMSALYHIAQNESPTLQSN--------------------------EWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CCccCchHHHHHHHHHhcCCCCCCCc--------------------------hhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 99999998888888877776665421 5677899999999999999999999999
Q ss_pred HHHHhhcC
Q 001143 1127 EMFVARTS 1134 (1141)
Q Consensus 1127 ~~L~~~~~ 1134 (1141)
+|.|....
T Consensus 277 ~H~fv~R~ 284 (948)
T KOG0577|consen 277 KHRFVLRE 284 (948)
T ss_pred hcchhccC
Confidence 99988654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.00 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=200.7
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|++|.||+|.. .+..+++|+...... ....... ...+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~--~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPD--SPETKKE-VNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeeccc--chhhHHH-HHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4689999999999999999986 456788887543321 1111111 123478999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.
T Consensus 78 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 78 -------------TLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred -------------eEEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 45999999999999999876 246889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.++........ ........++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 140 A-------GNVKLGDFGASKRLQTICSS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred C-------CCEEEeecccceeccccccc-------cccccCCCcCccccCcceecc----CCCCchhhhHHHHHHHHHHH
Confidence 7 78999999998754332111 001123357889999999876 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|+.||...........+... ..+.+ ....+..+.+++.+||..+|.+|||+
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 202 TEKPPWAEFEAMAAIFKIATQPTNPQL---------------------------PSHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred hCCCCccccchHHHHHHHhccCCCCCC---------------------------CccCCHHHHHHHHHHhhcCcccCCCH
Confidence 999999765544433332211 11111 11455678999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.++++|+|+
T Consensus 255 ~~ll~~~~~ 263 (263)
T cd06625 255 EELLRHFFV 263 (263)
T ss_pred HHHhhCCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.98 Aligned_cols=265 Identities=23% Similarity=0.386 Sum_probs=201.0
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
..++|.+.+.||+|++|.||+|.+.. ..+.++++....... ......+ .+|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDF----LMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHH----HHHHHHHHhCCCCCEeeEEEEE
Confidence 34678999999999999999999865 445555554433221 2222233 7899999999999999999988
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
.+... .++||||+++++|.+++...... ....+++..+..++.||+.||+|||+++++||||||
T Consensus 79 ~~~~~--------------~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 144 (277)
T cd05036 79 FERLP--------------RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144 (277)
T ss_pred ccCCC--------------cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccch
Confidence 76543 38999999999999999764211 123589999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+||+++.++ ....+||+|||+++.+...... ........+..|+|||++.+ ..++.++||||||
T Consensus 145 ~nil~~~~~----~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG 208 (277)
T cd05036 145 RNCLLTCKG----PGRVAKIADFGMARDIYRASYY--------RKGGRAMLPIKWMPPEAFLD----GIFTSKTDVWSFG 208 (277)
T ss_pred heEEEeccC----CCcceEeccCccccccCCccce--------ecCCCCCccHhhCCHHHHhc----CCcCchhHHHHHH
Confidence 999998652 1146999999999765321110 00111224567999999876 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1037 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1037 viL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|++|+|++ |..||.+....+....+.....+..+ ...+..+.+++.+||+.+
T Consensus 209 ~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~cl~~~ 261 (277)
T cd05036 209 VLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP---------------------------KGCPGPVYRIMTDCWQHT 261 (277)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCC
Confidence 99999997 99999877766665555433222111 134567899999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 001143 1116 PTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~ 1130 (1141)
|++||++.+|++++.
T Consensus 262 p~~Rps~~~vl~~l~ 276 (277)
T cd05036 262 PEDRPNFATILERIQ 276 (277)
T ss_pred cccCcCHHHHHHHhh
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=337.96 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=190.6
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||.||+|++. +..+|+|+.+..... ...... .+..|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~------ 69 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDID----WVQTEKHVFEQASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHH----HHHHHHHHHHhcCCCCcCCceeeEEEeCC------
Confidence 47999999999999984 456788875433211 112222 236888888777 7999999999988655
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||+++.+
T Consensus 70 --------~~~lv~E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---- 132 (329)
T cd05618 70 --------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC----
Confidence 34999999999999988865 3469999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 133 ---GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEEeeCCccccccCCCC----------ccccccCCccccCHHHHcC----CCCCCccceecccHHHHHHhhCCCC
Confidence 7899999999864321110 1123468999999999976 5678999999999999999999999
Q ss_pred CCCCCH--------H-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1049 YMGLSE--------L-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1049 f~~~~~--------~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|..... . .+...+... ...++ ...+..+.+++.+||+.||++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p---------------------------~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEK-QIRIP---------------------------RSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcC-CCCCC---------------------------CCCCHHHHHHHHHHhcCCHHHc
Confidence 952110 1 111111111 11110 1345678999999999999999
Q ss_pred CC------HHHHHHHHHhhc
Q 001143 1120 PT------AGDLYEMFVART 1133 (1141)
Q Consensus 1120 PS------a~ElL~~L~~~~ 1133 (1141)
|+ +.++++|+|+..
T Consensus 248 ~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 248 LGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCC
Confidence 98 589999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.94 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=213.1
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
|.++++||+|+||.||+|.++....+++|+++.+. .+.+++ .+|+.+|.++..|++|++||.|....
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEI----IKEISIMQQC~S~yVVKYYGSYFK~s----- 101 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEI----IKEISIMQQCKSKYVVKYYGSYFKHS----- 101 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHH----HHHHHHHHHcCCchhhhhhhhhccCC-----
Confidence 78999999999999999998776666777666542 334444 79999999999999999999877544
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.+|||||||-.||..+.++. ..+++++.++..+++..++||+|||...-||||||+.|||++.+
T Consensus 102 ---------DLWIVMEYCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~--- 165 (502)
T KOG0574|consen 102 ---------DLWIVMEYCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD--- 165 (502)
T ss_pred ---------ceEeehhhcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc---
Confidence 34999999999999999986 35689999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~ 1047 (1141)
|..||+|||.|..+.... ....+..|||.|||||++.. -.|+.++||||||++..||..|++
T Consensus 166 ----G~AKLADFGVAGQLTDTM----------AKRNTVIGTPFWMAPEVI~E----IGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 166 ----GIAKLADFGVAGQLTDTM----------AKRNTVIGTPFWMAPEVIEE----IGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred ----chhhhhhccccchhhhhH----------HhhCccccCcccccHHHHHH----hccchhhhHhhhcchhhhhhcCCC
Confidence 899999999997765422 13346789999999999987 568899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001143 1048 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127 (1141)
Q Consensus 1048 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~ 1127 (1141)
||....++..+-.|-...+|.+ ..| ...+.++.+++++||...|++|-||.++++
T Consensus 228 PYsDIHPMRAIFMIPT~PPPTF----------------------~KP---E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMIPTKPPPTF----------------------KKP---EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CcccccccceeEeccCCCCCCC----------------------CCh---HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 9987766544444332222221 122 256778999999999999999999999999
Q ss_pred HHHhhcCCC
Q 001143 1128 MFVARTSSS 1136 (1141)
Q Consensus 1128 ~L~~~~~s~ 1136 (1141)
|+|.+....
T Consensus 283 H~FiknA~g 291 (502)
T KOG0574|consen 283 HTFIKNAPG 291 (502)
T ss_pred hhhhcCCCc
Confidence 999876543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=349.44 Aligned_cols=283 Identities=19% Similarity=0.213 Sum_probs=196.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC------CCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------HpNIVkllg 876 (1141)
-.+|++.++||+|+||+||+|.+. +..||+|+.+... ..... +..|+.++..++ |++|+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~----~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRD----AKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHH----HHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 467999999999999999999874 5567888753211 11111 245666666664 456888888
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIK 955 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLK 955 (1141)
++.... .+.++|||++ |++|.+++.+ ...+++..+..|+.||+.||+|||+ .||||||||
T Consensus 199 ~~~~~~-------------~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 199 YFQNET-------------GHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred EEEcCC-------------ceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 876432 2469999998 6899998875 2469999999999999999999998 599999999
Q ss_pred CCCeeeeccccc---------CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001143 956 SENILIDLERKK---------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1141)
Q Consensus 956 P~NILld~~~~~---------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1026 (1141)
|+|||++.++.. ....+.+||+|||.+..... .....+||+.|+|||++.+ ..+
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------------~~~~~~gt~~Y~APE~~~~----~~~ 322 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-------------SRTAIVSTRHYRSPEVVLG----LGW 322 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-------------ccccccCCccccCcHHhhc----CCC
Confidence 999999765210 00123699999998753211 1124579999999999986 568
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc-cccccccCC---CC-----------
Q 001143 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGS---GF----------- 1091 (1141)
Q Consensus 1027 s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~---~~----------- 1091 (1141)
+.++|||||||++|||++|+.||.+.+..+....+....... +..+....... ...+..... ..
T Consensus 323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL-PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 899999999999999999999998877666555553321111 11111000000 000000000 00
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1092 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1092 ~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
..+.........+.+||.+||++||++|||++|+++|+|+..
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 000011123466889999999999999999999999999975
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=361.74 Aligned_cols=272 Identities=20% Similarity=0.329 Sum_probs=204.9
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+.+|++.++||+|+||+||+|.+.. ..+++|+.... ......... +..|+.++++++|||||+++++|.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~--~l~e~~~~~----~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR--GLKEREKSQ----LVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecc--ccCHHHHHH----HHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4456789999999999999999999854 45666664432 222333333 478999999999999999999986
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-------Ccccc
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------HIMHR 952 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-------gIvHr 952 (1141)
+... ..+||||||+++++|.++|...... ...+++..++.|+.||+.||.|||+. +||||
T Consensus 83 de~~------------~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR 149 (1021)
T PTZ00266 83 NKAN------------QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR 149 (1021)
T ss_pred ecCC------------CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec
Confidence 5321 2469999999999999999764332 24699999999999999999999984 59999
Q ss_pred CCCCCCeeeecccc----------cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 953 DIKSENILIDLERK----------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 953 DLKP~NILld~~~~----------~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
||||+||||+.... ...+...+||+|||++..+.... ......||+.|+|||++.+.
T Consensus 150 DLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----------~~~s~vGTp~YmAPEvL~ge-- 216 (1021)
T PTZ00266 150 DLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-----------MAHSCVGTPYYWSPELLLHE-- 216 (1021)
T ss_pred cCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-----------cccccCCCccccCHHHHhcc--
Confidence 99999999975311 01223569999999997543211 11245699999999998652
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1141)
...++.++|||||||+||+|++|+.||....... +...+.......+ ...+
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi----------------------------~~~S 268 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI----------------------------KGKS 268 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc----------------------------CCCC
Confidence 2457899999999999999999999997644332 3333222211000 0345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1102 SFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.++.+||..||..+|.+||++.|++.|+|+..
T Consensus 269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 269 KELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 67999999999999999999999999999863
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.78 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=200.2
Q ss_pred CCCCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
++.+|++.++||+|+||.||+|.+ .+..+++|. +.... ....... +.+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~--~~~~~-~~~~~~~----~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKT--LKDIN-NPQQWGE----FQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEe--ccCCC-CHHHHHH----HHHHHHHHhhCCCCCeeeEEEE
Confidence 467899999999999999999985 223455554 33221 2222233 3789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh------------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------TGEKHVSVKLALFIAQDVAAALVELH 945 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~------------~~~~~Ls~~~i~~Ia~QIa~gL~yLH 945 (1141)
+..... .|+||||+++++|.+++..... .....+++..+..++.||+.||.|||
T Consensus 76 ~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 141 (283)
T cd05090 76 VTQEQP--------------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EecCCc--------------eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 876543 3999999999999999864211 01235789999999999999999999
Q ss_pred HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 946 s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
++||+||||||+|||++.+ +.+||+|||+++........ .......++..|+|||++.+ ..
T Consensus 142 ~~~i~H~dlkp~nili~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05090 142 SHFFVHKDLAARNILIGEQ-------LHVKISDLGLSREIYSADYY--------RVQPKSLLPIRWMPPEAIMY----GK 202 (283)
T ss_pred hcCeehhccccceEEEcCC-------CcEEeccccccccccCCcce--------ecccCCCccceecChHHhcc----CC
Confidence 9999999999999999887 78999999999765332111 01122345778999999875 45
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
++.++|||||||++|||++ |..||.+.....+...+.....+..+ ...+..+
T Consensus 203 ~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~ 255 (283)
T cd05090 203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS---------------------------EDCPPRM 255 (283)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHH
Confidence 7899999999999999999 99999877666666655443322111 1345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
.+++.+||+.||.+||++.+|++++..
T Consensus 256 ~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 256 YSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=343.44 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=206.7
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
-+||+|+||+||.|++..+.|.++|+.+..... ...+ -+..|+.+.++|+|.|||+++|.+.+++++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~Q----PLhEEIaLH~~LrHkNIVrYLGs~senGf~------- 647 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQ----PLHEEIALHSTLRHKNIVRYLGSVSENGFF------- 647 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc--hhhc----cHHHHHHHHHHHhhHhHHHHhhccCCCCeE-------
Confidence 479999999999999999999999887764322 2222 237899999999999999999998776644
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
-|.||-++||||.++++. ..+...-.+..+-.+.+||+.||.|||.+.|||||||-+|+||+.-.
T Consensus 648 -------kIFMEqVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS------ 712 (1226)
T KOG4279|consen 648 -------KIFMEQVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS------ 712 (1226)
T ss_pred -------EEEeecCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc------
Confidence 899999999999999986 23333338899999999999999999999999999999999997542
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
|.+||+|||.++.+.... +-..++.||..|||||++.... ..|+.++|||||||++.||.||++||..
T Consensus 713 GvlKISDFGTsKRLAgin----------P~TETFTGTLQYMAPEvIDqG~--RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAGIN----------PCTETFTGTLQYMAPEVIDQGP--RGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ceEEecccccchhhccCC----------ccccccccchhhhChHhhccCC--cCCCchhhhhhccceeEeeccCCCCeee
Confidence 899999999998764321 2234678999999999998643 5789999999999999999999999975
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1052 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1052 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
....+. .+.+.|... ..|..+.+.+.+.+.+|.+|+.+||.+||+|.+++..+|.
T Consensus 781 lgspqA-AMFkVGmyK------------------------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFl 835 (1226)
T KOG4279|consen 781 LGSPQA-AMFKVGMYK------------------------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFL 835 (1226)
T ss_pred cCChhH-hhhhhccee------------------------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccc
Confidence 433321 111222110 0122233677889999999999999999999999999998
Q ss_pred hcC
Q 001143 1132 RTS 1134 (1141)
Q Consensus 1132 ~~~ 1134 (1141)
...
T Consensus 836 q~~ 838 (1226)
T KOG4279|consen 836 QHN 838 (1226)
T ss_pred ccC
Confidence 755
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=341.25 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=196.8
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
..++|++.++||+|+||.||+|++.. ..||+|+.+.. . .....+ .+.+|+.+++++ +|||||+++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~--~-~~~~~~----~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--A-HTDERE----ALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC--C-CHHHHH----HHHHHHHHHHhhccCCceeeEe
Confidence 35579999999999999999998622 24777764322 1 222223 347899999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh------------------------------------
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 919 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~------------------------------------ 919 (1141)
+++..... .++||||+++|+|.++++....
T Consensus 109 ~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 109 GACTHGGP--------------VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred eEecCCCC--------------eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 99876553 4999999999999999865321
Q ss_pred -----------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCC
Q 001143 920 -----------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1141)
Q Consensus 920 -----------------------------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~ 970 (1141)
....++++..+.+|+.||+.||.|||++||+||||||+|||++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~------ 248 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG------ 248 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC------
Confidence 012357889999999999999999999999999999999999877
Q ss_pred CCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001143 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1049 (1141)
Q Consensus 971 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf 1049 (1141)
+.+||+|||+++.+...... .......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||
T Consensus 249 -~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~ellt~G~~Pf 315 (374)
T cd05106 249 -RVAKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGKSPY 315 (374)
T ss_pred -CeEEEeeceeeeeccCCcce--------eeccCCCCccceeCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 78999999998764332110 01112235678999999875 568899999999999999997 99999
Q ss_pred CCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001143 1050 MGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128 (1141)
Q Consensus 1050 ~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~ 1128 (1141)
......... ..+..+..+..+ ...+.++.+++.+||+.||.+|||+.++++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 316 PGILVNSKFYKMVKRGYQMSRP---------------------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred ccccccHHHHHHHHcccCccCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 765433222 222221111100 0235679999999999999999999999998
Q ss_pred HHh
Q 001143 1129 FVA 1131 (1141)
Q Consensus 1129 L~~ 1131 (1141)
+..
T Consensus 369 l~~ 371 (374)
T cd05106 369 IQR 371 (374)
T ss_pred HHH
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.30 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=193.9
Q ss_pred eecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 813 EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 813 ~LG~GsfG~Vy~a~~----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
.||+|+||.||+|.+ .+..+++|+.+.. .......+. +.+|+.+++.++||||+++++++..+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~------- 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDE----LLREANVMQQLDNPYIVRMIGICEAE------- 68 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHHHHH----HHHHHHHHHhCCCCCcceEEEEEcCC-------
Confidence 689999999999976 3456777764322 222222333 47899999999999999999987532
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 69 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---- 131 (257)
T cd05116 69 --------SWMLVMELAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---- 131 (257)
T ss_pred --------CcEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC----
Confidence 23899999999999999875 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 1047 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~ 1047 (1141)
+.+||+|||.+..+....... .......++..|+|||.+.. ..++.++|||||||++|||++ |+.
T Consensus 132 ---~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 132 ---HYAKISDFGLSKALGADENYY-------KAKTHGKWPVKWYAPECMNY----YKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ---CeEEECCCccccccCCCCCee-------eecCCCCCCccccCHhHhcc----CCcCchhHHHHHHHHHHHHHhCCCC
Confidence 789999999997654322110 00112234678999999865 457789999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001143 1048 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127 (1141)
Q Consensus 1048 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~ 1127 (1141)
||......++.+.+..+..+..+. ..+.++.++|.+||+.||++||++++|.+
T Consensus 198 p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 198 PYKGMKGNEVTQMIESGERMECPQ---------------------------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 998877777777766544332211 34567999999999999999999999998
Q ss_pred HHH
Q 001143 1128 MFV 1130 (1141)
Q Consensus 1128 ~L~ 1130 (1141)
.|.
T Consensus 251 ~l~ 253 (257)
T cd05116 251 RLR 253 (257)
T ss_pred HHh
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=323.36 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=194.2
Q ss_pred eEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
++.+.||.|+||.||+|.+. +..|+||+.+ . .......+.+ .+|+..+++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~--~-~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILK--P-SSSEEEEEEF----LNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEES--T-TSSHHHHHHH----HHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEec--c-ccccccceee----eecccccccccccccccccccccccc
Confidence 57789999999999999997 4566777652 2 2223334444 89999999999999999999998544
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+++|+|.+++... ....+++..+..|+.||+.||.|||+++|+||||+++||+++
T Consensus 75 ~--------------~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 75 P--------------LFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp S--------------EEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred c--------------cccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccc
Confidence 2 49999999999999999872 235799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++.......... ......+...|+|||.+.+ ..++.++||||||+++|||
T Consensus 138 ~~-------~~~Kl~~f~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 138 SN-------GQVKLSDFGLSRPISEKSKYK--------NDSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TT-------TEEEEESTTTGEETTTSSSEE--------ESTTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHH
T ss_pred cc-------ccccccccccccccccccccc--------ccccccccccccccccccc----ccccccccccccccccccc
Confidence 87 899999999997652211110 1112346778999999987 4478999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |+.||......++...+..+..+..+. .++..+.+++..||..||.+|||
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPD---------------------------NCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBT---------------------------TSBHHHHHHHHHHT-SSGGGS--
T ss_pred cccccccccccccccccccccccccceecc---------------------------chhHHHHHHHHHHcCCChhhCcC
Confidence 99 789998888877777775554432221 45567999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1122 AGDLYEMF 1129 (1141)
Q Consensus 1122 a~ElL~~L 1129 (1141)
+.++++.|
T Consensus 252 ~~~i~~~L 259 (259)
T PF07714_consen 252 FQEILQEL 259 (259)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.55 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=202.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
..+|.+.+.||+|+||.||+|.+. ...+++|+.... . ..+..+. +.+|++++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~-~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--A-SNDARKD----FEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--C-CHHHHHH----HHHHHHHHHhcCCCCchheeeE
Confidence 456899999999999999999863 245777764321 1 1222233 4899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhh---------hcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGEKHVSVKLALFIAQDVAAALVELHSKH 948 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~---------~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g 948 (1141)
+.... ..++||||+++++|.++++... ......+++..+..++.||+.||.|||++|
T Consensus 77 ~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 142 (280)
T cd05049 77 CTEGD--------------PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142 (280)
T ss_pred EecCC--------------CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 87654 3499999999999999997632 112345889999999999999999999999
Q ss_pred ccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001143 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1141)
Q Consensus 949 IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1028 (1141)
++||||||+||+++.+ +.++|+|||.+......... .......+++.|+|||++.+ ..++.
T Consensus 143 i~h~dlkp~nili~~~-------~~~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~ 203 (280)
T cd05049 143 FVHRDLATRNCLVGYD-------LVVKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTT 203 (280)
T ss_pred eeccccccceEEEcCC-------CeEEECCcccceecccCcce--------ecCCCCcccceecChhhhcc----CCcch
Confidence 9999999999999887 88999999998754321110 01123346788999999876 56889
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|||||||++|+|++ |..||......+....+..+..+..+ ...+..+.++
T Consensus 204 ~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 256 (280)
T cd05049 204 ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRP---------------------------RTCPSEVYDI 256 (280)
T ss_pred hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999998 99999877776666665543322211 1345679999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
+.+||+.||++||++.|+++.+.
T Consensus 257 i~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 257 MLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCCcccCCCHHHHHHHhh
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.26 Aligned_cols=280 Identities=21% Similarity=0.264 Sum_probs=199.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|++. +..+++|+..... ......+ .+.+|+.++++++||||+++++++.++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPS----TAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc--ccCCchH----HHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 5899999999999999999984 5667777654332 1111112 2368999999999999999999988654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||++ ++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 137 (285)
T cd07861 73 ------------RLYLIFEFLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137 (285)
T ss_pred ------------eEEEEEecCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC
Confidence 3499999997 68998886522 22468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++........ ......+++.|+|||++.+ ...++.++|||||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 138 -------GVIKLADFGLARAFGIPVR----------VYTHEVVTLWYRAPEVLLG---SPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred -------CcEEECcccceeecCCCcc----------cccCCcccccccChHHhcC---CCCcCcHHHHHHHHHHHHHHHH
Confidence 7899999999865432111 1112357889999999865 2346789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccC--ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1045 LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSC--HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|+.||.+....+....+ .....+. ...+...... ....... .............++++.++|.+||+.||.+|||
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 275 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPT-EDVWPGVTSLPDYKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCC-hhhhhcchhhHHHHhhccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC
Confidence 99999876654433222 2111111 1110000000 0000000 0000000011145678899999999999999999
Q ss_pred HHHHHHHHHh
Q 001143 1122 AGDLYEMFVA 1131 (1141)
Q Consensus 1122 a~ElL~~L~~ 1131 (1141)
+.+|++|+|+
T Consensus 276 ~~~ll~~~~~ 285 (285)
T cd07861 276 AKKALNHPYF 285 (285)
T ss_pred HHHHhcCCCC
Confidence 9999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=340.00 Aligned_cols=249 Identities=25% Similarity=0.292 Sum_probs=193.2
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEecCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
||+|+||+||+|++. +..+|+|+........ ..... ....|..++... +||||+++++.+.....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----- 70 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVA----HTIGERNILVRTLLDESPFIVGLKFSFQTDSD----- 70 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHH----HHHHHHHHHHHhccCCCCcCcceEEEEecCCe-----
Confidence 799999999999984 5678888754221111 11111 224677777655 69999999999886553
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
.|+||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---- 132 (330)
T cd05586 71 ---------LYLVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---- 132 (330)
T ss_pred ---------EEEEEcCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 4999999999999998875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||++....... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 133 ---GHIALCDFGLSKANLTDN----------KTTNTFCGTTEYLAPEVLLD---EKGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred ---CCEEEecCCcCcCCCCCC----------CCccCccCCccccCHHHHcC---CCCCCCccceeccccEEEEeccCCCC
Confidence 789999999986432211 11123469999999999875 23478999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----CHHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----TAGD 1124 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP----Sa~E 1124 (1141)
|.+....+....+..+... ++. ...++.+.+++.+||+.||.+|| ++.+
T Consensus 197 f~~~~~~~~~~~i~~~~~~-~~~--------------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 197 FYAEDTQQMYRNIAFGKVR-FPK--------------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCHHHHHHHHHcCCCC-CCC--------------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 9887776666665433221 100 02455689999999999999998 7999
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+|+..
T Consensus 250 ll~h~~~~~ 258 (330)
T cd05586 250 LKEHPFFAD 258 (330)
T ss_pred HhcCccccC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.65 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=212.6
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
-|.+.+.||+|.|.+|-+|++ .+..||||| ++++.........+ .+|++.|+-++|||||++|++.....
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKv--iDKTKlD~~st~hl----fqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKV--IDKTKLDTLSTGHL----FQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEE--ecccccchhhhhHH----HHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 388999999999999999986 788899998 44444433333333 68999999999999999999887544
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.+|||+|+-++|+|++||-+. ...+.+..+++++.||+.|+.|+|+..+|||||||+||.+-+.
T Consensus 91 ------------KlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK 154 (864)
T KOG4717|consen 91 ------------KLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK 154 (864)
T ss_pred ------------eEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee
Confidence 459999999999999999762 3469999999999999999999999999999999999977655
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
- |-|||.|||++..+.... .....+|+..|-|||++.+. .+..+++||||||||||.|..
T Consensus 155 l------GlVKLTDFGFSNkf~PG~-----------kL~TsCGSLAYSAPEILLGD---sYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 155 L------GLVKLTDFGFSNKFQPGK-----------KLTTSCGSLAYSAPEILLGD---SYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred c------CceEeeeccccccCCCcc-----------hhhcccchhhccCchhhhcC---ccCCcchhhhHHHHHHHHHHh
Confidence 2 889999999986554322 22356799999999999983 344689999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|++||+..+..+...+|....+.- + ...+.+.++||..||..||.+|.+.+|
T Consensus 215 Gq~PFqeANDSETLTmImDCKYtv-P---------------------------shvS~eCrdLI~sMLvRdPkkRAslEe 266 (864)
T KOG4717|consen 215 GQPPFQEANDSETLTMIMDCKYTV-P---------------------------SHVSKECRDLIQSMLVRDPKKRASLEE 266 (864)
T ss_pred CCCccccccchhhhhhhhcccccC-c---------------------------hhhhHHHHHHHHHHHhcCchhhccHHH
Confidence 999999888888877776554321 1 166788999999999999999999999
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
|..+.|.+.
T Consensus 267 I~s~~Wlq~ 275 (864)
T KOG4717|consen 267 IVSTSWLQA 275 (864)
T ss_pred HhccccccC
Confidence 999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=329.12 Aligned_cols=284 Identities=20% Similarity=0.260 Sum_probs=189.7
Q ss_pred eeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 811 CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
.++||+|+||+||+|++. +..+|+|.. +..... .. +.+|+.++++++||||+++++++.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~--~~~~~~----~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGIS----MS----ACREIALLRELKHPNVISLQKVFLSHAD--- 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEE--CCCCCc----HH----HHHHHHHHHhcCCCCCcceeeeEecCCC---
Confidence 468999999999999863 244666654 322111 11 2689999999999999999998864321
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~----~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
...++||||+. ++|.+++..... .....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~ 142 (317)
T cd07868 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------cEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEe
Confidence 24699999996 689888764221 1123589999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+. ...+.+||+|||+|......... ........||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 143 ~~~---~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 143 GEG---PERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCC---CCcCcEEEeecCceeccCCCCcc-------ccccCCccccccccCCHHHcC---CCCcCchhhHHHHHHHHHHH
Confidence 431 12268999999999765432111 011224568999999999876 23578999999999999999
Q ss_pred HhCCCCCCCCCH---------HHHHHHH-HhCCCCCchhHHhhhccCccc-----ccccc-CCCCC----CchhhhhhHH
Q 001143 1043 LTLQVPYMGLSE---------LEIHDLI-QMGKRPRLTDELEALGSCHEH-----EVAQS-GSGFE----KPEAELETLS 1102 (1141)
Q Consensus 1043 LTGk~Pf~~~~~---------~el~~~I-~~~~~p~l~~~l~~~~~~~~~-----~~~~~-~~~~~----~~~~~~~~~~ 1102 (1141)
++|++||..... .+....+ .....+.. ..+......... ..... ..... ........+.
T Consensus 210 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07868 210 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD-KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 288 (317)
T ss_pred HhCCCCccCCcccccccccccHHHHHHHHHhcCCCCh-HHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCCh
Confidence 999999964321 1122222 21111111 111110000000 00000 00000 0000012235
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
.+.+|+.+||++||.+|||++|+++|+||
T Consensus 289 ~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 68899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.10 Aligned_cols=258 Identities=21% Similarity=0.349 Sum_probs=198.0
Q ss_pred CCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
++|++.+.||+|+||.||+|.+.+ ..+|+|+.. ... ....... +.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~--~~~-~~~~~~~----~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAA-SMRERIE----FLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecc--ccC-CHHHHHH----HHHHHHHHHhCCCCCeeeEEEEE
Confidence 468999999999999999998642 346666532 211 1222223 37899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 953 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrD 953 (1141)
.+.. +.++||||+++++|.+++++.... ....+++..+..++.|++.||.|||+.|++|||
T Consensus 79 ~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~d 144 (277)
T cd05062 79 SQGQ--------------PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRD 144 (277)
T ss_pred cCCC--------------CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 7544 349999999999999999763221 023467889999999999999999999999999
Q ss_pred CCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHH
Q 001143 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033 (1141)
Q Consensus 954 LKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVW 1033 (1141)
|||+||+++.+ +.++|+|||++.......... ......+++.|+|||++.+ ..++.++|||
T Consensus 145 lkp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~ 205 (277)
T cd05062 145 LAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDVW 205 (277)
T ss_pred cchheEEEcCC-------CCEEECCCCCccccCCcceee--------cCCCCccCHhhcChhHhhc----CCcCchhHHH
Confidence 99999999987 789999999987543211110 0112245778999999875 5678999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1034 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1034 SLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
||||++|||++ |..||.+....+....+.....+..+ ...+..+.+++.+||
T Consensus 206 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l 258 (277)
T cd05062 206 SFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP---------------------------DNCPDMLFELMRMCW 258 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 99999999999 78999887766666555443322111 134557899999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 001143 1113 EENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~ 1130 (1141)
+.||++|||+.|+++++.
T Consensus 259 ~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 259 QYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCChhhCcCHHHHHHHhh
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=322.20 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=202.0
Q ss_pred CCCceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..+|.+.+.||+|+||.||++.. ....+.++++.+... .....+. +.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKD----FHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHH----HHHHHHHHHhCCCCCcceEEEEEe
Confidence 45789999999999999999985 223333333333321 2222333 378999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~--------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvH 951 (1141)
.... .++||||+++++|.+++..... .....+++..+..++.||+.||+|||++|++|
T Consensus 78 ~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H 143 (288)
T cd05093 78 EGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143 (288)
T ss_pred cCCc--------------cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 6543 3999999999999999975321 11235899999999999999999999999999
Q ss_pred cCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001143 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031 (1141)
Q Consensus 952 rDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1031 (1141)
|||||+||+++.+ +.+||+|||.+......... .......+++.|+|||++.+ ..++.++|
T Consensus 144 ~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sD 204 (288)
T cd05093 144 RDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTTESD 204 (288)
T ss_pred cccCcceEEEccC-------CcEEeccCCccccccCCcee--------ecCCCCCccccccCHHHhcc----CCCCchhh
Confidence 9999999999887 78999999998754322111 01112346788999999876 56789999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1032 IWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1032 VWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
||||||++|+|++ |..||......+....+..+..+..+. ..+.++.+++.+
T Consensus 205 iwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~ 257 (288)
T cd05093 205 VWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPKEVYDLMLG 257 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHH
Confidence 9999999999998 999998777766666665543322110 334569999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhc
Q 001143 1111 CTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1111 cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
||+.||.+|||+.++++.+....
T Consensus 258 ~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 258 CWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HccCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999988876654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.76 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=203.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||.|+||.||+|.+. +..+++|+... ........+. +..|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY--GNMTEKEKQQ----LVSEVNILRELKHPNIVRYYDRIIDRSN- 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEec--ccCCHHHHHH----HHHHHHHHHhcCCCccceeeeeeecCCC-
Confidence 5889999999999999999874 45566665432 2222333333 4789999999999999999998764321
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCCe
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENI 959 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH-----s~gIvHrDLKP~NI 959 (1141)
...++||||+++++|.+++..... ...++++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 74 -----------~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 74 -----------QTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred -----------CEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 246999999999999999976432 2357999999999999999999999 89999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||.+......... .....+++.|+|||++.+ ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pE~~~~----~~~~~~~Dv~slG~il 200 (265)
T cd08217 142 FLDAN-------NNVKLGDFGLAKILGHDSSF----------AKTYVGTPYYMSPEQLNH----MSYDEKSDIWSLGCLI 200 (265)
T ss_pred EEecC-------CCEEEecccccccccCCccc----------ccccccCCCccChhhhcC----CCCCchhHHHHHHHHH
Confidence 99987 78999999998765432110 113358899999999876 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||......++.+.+..+..+.++ ...+..+.+++.+||..+|++|
T Consensus 201 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 201 YELCALSPPFTARNQLQLASKIKEGKFRRIP---------------------------YRYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred HHHHHCCCcccCcCHHHHHHHHhcCCCCCCc---------------------------cccCHHHHHHHHHHccCCcccC
Confidence 9999999999877665555555444332221 1345678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
|++.+|++|+|.
T Consensus 254 p~~~~il~~~~~ 265 (265)
T cd08217 254 PSTEELLQLPLI 265 (265)
T ss_pred CCHHHHhhCCCC
Confidence 999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.46 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=203.1
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
|++.+.||+|+||.||+|.+......++++.+... .....+.+ .+|+.+++.++||||+++++++....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~----~~e~~~l~~l~h~~ii~~~~~~~~~~----- 75 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYEN----- 75 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHH----HHHHHHHHHCCCCCeeeEEEEEeeCC-----
Confidence 68889999999999999998665554444444322 22333334 78999999999999999999987644
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
..++||||+++++|..++.+ ...++++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 76 ---------~~~~v~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~--- 139 (282)
T cd06643 76 ---------NLWILIEFCAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD--- 139 (282)
T ss_pred ---------EEEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---
Confidence 34999999999999988764 13468999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
+.+||+|||++........ ......+++.|+|||++.... ....++.++|||||||++|+|++|+
T Consensus 140 ----~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 140 ----GDIKLADFGVSAKNTRTIQ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred ----CCEEEcccccccccccccc----------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence 7899999999865432111 112345899999999985321 2345778999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL 1126 (1141)
.||...+..+....+.....+.... ....+..+.+++.+||+.||.+||++.+++
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 206 PPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CCccccCHHHHHHHHhhcCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 9998766655444443332221110 013456799999999999999999999999
Q ss_pred HHHHhhcCCC
Q 001143 1127 EMFVARTSSS 1136 (1141)
Q Consensus 1127 ~~L~~~~~s~ 1136 (1141)
+|+|+...+.
T Consensus 261 ~~~~~~~~~~ 270 (282)
T cd06643 261 QHPFVTVNSN 270 (282)
T ss_pred cCCCEeccCC
Confidence 9999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.78 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=198.1
Q ss_pred CCCceEeeeecccCceEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~-~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..+|++.+.||+|+||.||+|.+.+. .+|+|..+ ..... ...+ .+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~--~~~~~---~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMS---EDEF----IEEAKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcC--CCccc---HHHH----HHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence 45789999999999999999988554 47777643 21111 2233 789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 74 --------------IYIVTEYMSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred --------------cEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 39999999999999998751 226899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.++........ ......++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 136 Q-------GCVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLLY----SKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred C-------CCEEECCCccceecCCCcee---------ecCCCccChhhCCHHHHhc----CcccchhHHHHHHHHHHHHh
Confidence 7 78999999998754321110 0112235678999999875 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||......+....+..+..+..+. ..+..+.+++.+||+.||.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 196 SLGKMPYERFNNSETVEKVSQGLRLYRPH---------------------------LASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred cCCCCCcCcCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCCCH
Confidence 9 999998776666666654443321110 234578999999999999999999
Q ss_pred HHHHHHH
Q 001143 1123 GDLYEMF 1129 (1141)
Q Consensus 1123 ~ElL~~L 1129 (1141)
.++++++
T Consensus 249 ~~ll~~~ 255 (256)
T cd05113 249 QQLLSSI 255 (256)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.55 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=202.5
Q ss_pred ceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
|++.+.||+|+||.||+|.+.. ..+|+|+.+.+ .........+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD--IHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC--cCCHHHHHHH----HHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5788999999999999998742 45777765432 2222333334 79999999999999999999876543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. ......++||||+++++|..++..... .....+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 75 ~~--------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~ 146 (273)
T cd05035 75 SL--------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146 (273)
T ss_pred cc--------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE
Confidence 21 112345999999999999999865321 123468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.++........ .......++..|+|||++.+ ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 147 RED-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred CCC-------CeEEECCccceeeccccccc--------cccccccCCccccCHhhccc----CCCCcccchHHHHHHHHH
Confidence 887 78999999999765432111 01112235678999999865 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |..||.+....+..+.+..+..+..+ ...+..+.+++.+||+.||.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGNRLKQP---------------------------EDCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------cCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999887776666665544332211 14456799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
|+.|+++++..
T Consensus 261 ~~~e~~~~l~~ 271 (273)
T cd05035 261 TFTKLREVLEN 271 (273)
T ss_pred CHHHHHHHHHh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=344.52 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=211.2
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEE--EecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSADAAAKV--RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~~vAvKI--~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
++..+||+|+|-+||+|.+..+.+.|+. +++..........+. +..|+.+|+.|+|||||++|+++.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR----~~~Ev~lLKsL~H~NIirfy~SW~d~~n--- 115 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELER----LYSEVHLLKSLKHPNIIRFYDSWVDTDN--- 115 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHH----HHHHHHHHccCCCCceeeeeeheecCCC---
Confidence 7778999999999999999766666553 222222223333344 4899999999999999999999987543
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCeeeecc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLE 964 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--gIvHrDLKP~NILld~~ 964 (1141)
....+|+|++..|+|..|+++ .+..+.+.++.|++||++||.|||++ .|||||||-+||||+.+
T Consensus 116 ---------~~in~iTEL~TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 116 ---------KTINFITELFTSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred ---------ceeeeeeecccCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 245899999999999999988 35689999999999999999999987 69999999999999876
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
. |.|||+|+|+|+.+.... ...++|||.|||||++.. .|+..+||||||++++||+|
T Consensus 182 ~------G~VKIGDLGLAtl~r~s~------------aksvIGTPEFMAPEmYEE-----~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 182 L------GEVKIGDLGLATLLRKSH------------AKSVIGTPEFMAPEMYEE-----NYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred c------CceeecchhHHHHhhccc------------cceeccCccccChHHHhh-----hcchhhhhhhhhHHHHHHHh
Confidence 4 899999999998765422 234789999999999874 68999999999999999999
Q ss_pred CCCCCCC-CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 LQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 Gk~Pf~~-~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+.+||.. .++.++++++..|..|.-... -..+++++||.+||.. ..+|||+.
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--------------------------V~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPAALSK--------------------------VKDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHHHhhc--------------------------cCCHHHHHHHHHHhcC-chhccCHH
Confidence 9999975 567889999988876643221 2245699999999999 99999999
Q ss_pred HHHHHHHhhcC
Q 001143 1124 DLYEMFVARTS 1134 (1141)
Q Consensus 1124 ElL~~L~~~~~ 1134 (1141)
|+|+++||...
T Consensus 292 eLL~d~Ff~~d 302 (632)
T KOG0584|consen 292 ELLKDPFFDED 302 (632)
T ss_pred HHhhChhhccc
Confidence 99999999864
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.53 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=200.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|+||.||+|.+. +..+++|..... .......+. +.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLA----AQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecc--ccccHHHHH----HHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 5899999999999999999874 556677765432 222333333 478999999999999999999887544
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 73 ------------ALMIVMEYAPGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred ------------EEEEEEecCCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 349999999999999999762 23458999999999999999999999999999999999999755
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
. +.++|+|||.+....... ......++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 138 K------MVVKIGDFGISKILSSKS-----------KAYTVVGTPCYISPELCEG----KPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred C------CEEEEccCCCceecCCCc-----------cccccccCCcccCchhccC----CCCCcccchHHHHHHHHHHHh
Confidence 2 568999999997654321 1113457889999999875 456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|..||...+.......+.......++. ..+..+.+++.+||..||.+|||+.|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPISD---------------------------RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCCC---------------------------CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998766555554443332221111 34566899999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
+++|+|+
T Consensus 250 ll~~p~~ 256 (256)
T cd08220 250 IMAQPIC 256 (256)
T ss_pred HhhCCCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=327.34 Aligned_cols=257 Identities=19% Similarity=0.312 Sum_probs=198.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~----~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
..+|++.+.||+|+||.||+|++. +. .+|+|+.. .. ......+. +.+|+.+++.++||||+++++++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~~~----~~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EA-TSPKANKE----ILDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecc--cc-CCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEE
Confidence 457999999999999999999873 22 25666543 21 11222233 47899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.... .++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 79 ~~~~---------------~~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~N 139 (316)
T cd05108 79 LTST---------------VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN 139 (316)
T ss_pred cCCC---------------ceeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 6532 27999999999999998752 2358899999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+++.+....... ......++..|+|||++.+ ..++.++|||||||+
T Consensus 140 ill~~~-------~~~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slGv~ 200 (316)
T cd05108 140 VLVKTP-------QHVKITDFGLAKLLGADEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVT 200 (316)
T ss_pred eEecCC-------CcEEEccccccccccCCCcce--------eccCCccceeecChHHhcc----CCCCchhhhHHHHHH
Confidence 999887 789999999998654322110 0111234678999999876 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|||++ |..||.+....+....+.....+..+ ..++..+.+++.+||..||.
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~ 253 (316)
T cd05108 201 VWELMTFGSKPYDGIPASEISSILEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDAD 253 (316)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CCCCHHHHHHHHHHccCChh
Confidence 999998 99999876665554444333221111 03445689999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001143 1118 ERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~ 1133 (1141)
+||++.+++.++....
T Consensus 254 ~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 254 SRPKFRELIIEFSKMA 269 (316)
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.07 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=188.7
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||+|+||.||+++.. +..+|+|....+..... ... ..+..|++++++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~----~~~~~E~~il~~l~hp~i~~~~~~~~~~~--------- 66 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGE----KMALLEKEILEKVNSPFIVNLAYAFESKT--------- 66 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhh----HHHHHHHHHHHhcCCCcEEEEEEEEecCC---------
Confidence 799999999999875 55667766432211111 111 12257999999999999999999987654
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
+.++||||++|++|.+++.. .....+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 67 -----~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~------- 131 (277)
T cd05607 67 -----HLCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ------- 131 (277)
T ss_pred -----eEEEEEecCCCCCHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-------
Confidence 34999999999999998865 233468999999999999999999999999999999999999887
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
+.++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 132 ~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 132 GNCRLSDLGLAVELKDGKT-----------ITQRAGTNGYMAPEILKE----EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCEEEeeceeeeecCCCce-----------eeccCCCCCccCHHHHcc----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 7899999999875533111 112358999999999876 4588999999999999999999999975
Q ss_pred CCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HHHH
Q 001143 1052 LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GDLY 1126 (1141)
Q Consensus 1052 ~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa----~ElL 1126 (1141)
.........+ ......... . .....+.++.+++.+||+.||.+||++ ++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~----------------------~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 197 HKEKVAKEELKRRTLEDEVK----------------------F--EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CcchhhHHHHHHHhhccccc----------------------c--ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 4321111111 100000000 0 001345678999999999999999999 6778
Q ss_pred HHHHhhc
Q 001143 1127 EMFVART 1133 (1141)
Q Consensus 1127 ~~L~~~~ 1133 (1141)
.|.|+..
T Consensus 253 ~h~~f~~ 259 (277)
T cd05607 253 KHEFFKT 259 (277)
T ss_pred cChhhcC
Confidence 9999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.64 Aligned_cols=280 Identities=21% Similarity=0.263 Sum_probs=197.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.++||+|+||.||+|++. +..+++|....+. .... ....+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~--~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc--cccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 4889999999999999999984 5667777654332 1111 1122368999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 73 ------------KLTLVFEYCD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred ------------ceEEEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 3499999997 6888887641 3468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||++........ ......+++.|+|||++.+ ...++.++|||||||++|+|++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 136 -------GELKLADFGLARAFGIPVR----------CYSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred -------CcEEECccchhhccCCCCC----------CcCCCccccCCcChHHHhC---CcccCcHHHHHHHHHHHHHHHh
Confidence 7899999999875433211 1112357889999999865 2356889999999999999999
Q ss_pred CCCCC-CCCCHHHHHHHHHhCCCCCchhHHhhhccCccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1045 LQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1045 Gk~Pf-~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
|..|| .+.+..+....+...........+......... ..................++++.+++.+||+.||.+|||+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence 98885 444444444443222111111111111000000 0000000000001112456788999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
+++++|+|+
T Consensus 276 ~~il~h~~f 284 (284)
T cd07839 276 EEALQHPYF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=324.86 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=201.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|.+. +..+++|...... . ...+. +.+|+.+++.+.||||+++++.+....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~--~~~~~----~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--Q--PKKEL----IINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--c--chHHH----HHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 457999999999999999999874 4566666544321 1 12223 378999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.++||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++
T Consensus 91 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~ 150 (296)
T cd06654 91 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (296)
T ss_pred --------------EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 45999999999999999865 3588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~~l 209 (296)
T cd06654 151 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (296)
T ss_pred CC-------CCEEECccccchhcccccc----------ccCcccCCccccCHHHHcC----CCCCccchHHHHHHHHHHH
Confidence 77 7899999999865432110 1123458899999999876 4567999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||...........+.....+.... ....+..+.+++.+||..||++||++
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~ 264 (296)
T cd06654 210 IEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLDMDVEKRGSA 264 (296)
T ss_pred HhCCCCCCCCCHHHhHHHHhcCCCCCCCC-------------------------ccccCHHHHHHHHHHCcCCcccCcCH
Confidence 99999998665533322222111111100 01345668999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001143 1123 GDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s~~ 1137 (1141)
.++++|+|+....+.
T Consensus 265 ~eil~~~~~~~~~~~ 279 (296)
T cd06654 265 KELLQHQFLKIAKPL 279 (296)
T ss_pred HHHhhChhhhccCCc
Confidence 999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.42 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=203.1
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|+||.||++.. .+..+++|...... ......+.+ .+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK--MSPKEREES----RKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh--CChHHHHHH----HHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 589999999999999999987 45567777654322 122223333 78999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
+.++||||+++++|.+++.. .....+++..+..|+.|++.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 73 ------------NLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 45999999999999999875 223358899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+........ ......|++.|+|||++.+ ..++.++|||||||++++|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 138 -------GTIKLGDFGIARVLNSTVE----------LARTCIGTPYYLSPEICEN----RPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred -------CCEEEeeccceeecCcchh----------hhhhccCCccccCHHHhCC----CCCCCccchhHHHHHHHHHHc
Confidence 7899999999876533211 1123457889999999876 457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||......+....+..+..+..+. ..+..+.+++.+||+.+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVSS---------------------------HYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 999998776666665554444332211 34556999999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
+++|+|+
T Consensus 250 vl~~~~~ 256 (256)
T cd08218 250 ILEKNFI 256 (256)
T ss_pred HhhCcCC
Confidence 9999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.64 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=200.2
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
..+|++.+.||+|+||.||++...+..+++|..+.. ...+.+ .+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~------~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG- 73 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC------chHHHH----HHHHHHHHhCCCCCeeeEEEEEEcCCC-
Confidence 567999999999999999999999988988875321 112233 789999999999999999998654321
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.++++. .....+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~ 138 (256)
T cd05082 74 ------------GLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED 138 (256)
T ss_pred ------------ceEEEEECCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC
Confidence 34999999999999999875 223358899999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 139 -------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred -------CcEEecCCccceeccccC-------------CCCccceeecCHHHHcc----CCCCchhhhHHHHHHHHHHHh
Confidence 789999999986543211 12234567999999875 567889999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||......+....+..+..+... ..++..+.+++.+||+.+|++|||+.
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~ 247 (256)
T cd05082 195 FGRVPYPRIPLKDVVPRVEKGYKMDAP---------------------------DGCPPVVYDVMKQCWHLDAATRPSFL 247 (256)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 99999876666665555443222111 14456799999999999999999999
Q ss_pred HHHHHHH
Q 001143 1124 DLYEMFV 1130 (1141)
Q Consensus 1124 ElL~~L~ 1130 (1141)
++++.+.
T Consensus 248 ~l~~~l~ 254 (256)
T cd05082 248 QLREQLE 254 (256)
T ss_pred HHHHHHh
Confidence 9998775
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=322.10 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=203.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..+|.+.+.||+|+||.||+|.+.. ..+.+.++..+.. .....+. +.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKD----FQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHH----HHHHHHHHhcCCCCCcceEEEEEc
Confidence 4578999999999999999998532 2233333333321 1222233 378999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKH 948 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g 948 (1141)
.... .++||||+++++|.+++..... .....+++..++.++.||+.||+|||++|
T Consensus 78 ~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 143 (291)
T cd05094 78 DGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143 (291)
T ss_pred cCCc--------------eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6543 4999999999999999975321 11235899999999999999999999999
Q ss_pred ccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001143 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1141)
Q Consensus 949 IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1028 (1141)
|+||||||+||+++.+ +.++|+|||++......... .......++..|+|||++.+ ..++.
T Consensus 144 i~H~dlkp~Nil~~~~-------~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~ 204 (291)
T cd05094 144 FVHRDLATRNCLVGAN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTT 204 (291)
T ss_pred eeecccCcceEEEccC-------CcEEECCCCcccccCCCcee--------ecCCCCCcceeecChHHhcc----CCCCc
Confidence 9999999999999987 78999999998754332111 01123346788999999876 56788
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|||||||++|+|++ |+.||...+..+....+..+..+... ...+..+.++
T Consensus 205 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 257 (291)
T cd05094 205 ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP---------------------------RVCPKEVYDI 257 (291)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------ccCCHHHHHH
Confidence 9999999999999999 99999877766665555443322111 1345668999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~~s 1135 (1141)
+.+||+.||.+|||+.++++.+.....+
T Consensus 258 i~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 258 MLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999998776443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.50 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=201.3
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.+|++.++||+|+||.||+|++ .+..+++|....... ........ +.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQD----CVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHH----HHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 36799999999999999999997 466777776432211 12222223 378999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++..... ....+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 76 --------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 76 --------------ELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred --------------eEEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc
Confidence 34999999999999999875332 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ ......+++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 141 AT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECccccceeccchhH----------HHhcCCCCccccChhhhcc----CCCCchhhHHHHHHHHHHH
Confidence 87 7899999999876543211 0112358889999999876 4577899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1043 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1043 LTGk~Pf~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
++|+.||.... ..+....+.....+... ....+..+.+++.+||+.+|.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 200 AALQSPFYGDKMNLFSLCQKIEQCDYPPLP--------------------------TEHYSEKLRELVSMCIYPDPDQRP 253 (267)
T ss_pred hcCCCCCccccccHHHHHHHHhcCCCCCCC--------------------------hhhcCHHHHHHHHHHCCCCcccCc
Confidence 99999996542 23344444333322211 013456799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
++.++++.+..
T Consensus 254 ~~~~vl~~~~~ 264 (267)
T cd08228 254 DIGYVHQIAKQ 264 (267)
T ss_pred CHHHHHHHHHH
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=334.03 Aligned_cols=265 Identities=23% Similarity=0.283 Sum_probs=201.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|++. +..+|+|+...... ...... ..+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAET----ACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhH----HHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 47999999999999999999984 56678887542110 011112 23478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+.|+||||++|++|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 75 -------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred -------------eEEEEEecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 349999999999999999752 236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC-CCCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVWSLGviL~EL 1042 (1141)
+ +.+||+|||++..+..... .......||+.|+|||++..... ...++.++|||||||++|+|
T Consensus 138 ~-------~~~kl~Dfg~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (331)
T cd05597 138 N-------GHIRLADFGSCLRLLADGT---------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEECCceeecCCCCC---------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence 7 7899999999865432111 01123468999999999874221 23567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~--R 1119 (1141)
++|+.||.+.+..+....+..... ..++ ......+..+++++.+||..++.+ |
T Consensus 202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~~li~~ll~~~~~r~~r 257 (331)
T cd05597 202 LYGETPFYAESLVETYGKIMNHKEHFQFP------------------------PDVTDVSEEAKDLIRRLICSPETRLGR 257 (331)
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCcccCC------------------------CccCCCCHHHHHHHHHHccCcccccCC
Confidence 999999987766665555432211 1100 000135667899999988664444 7
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
|++.++++|+|+..
T Consensus 258 ~~~~~~l~hp~~~~ 271 (331)
T cd05597 258 NGLQDFKDHPFFEG 271 (331)
T ss_pred CCHHHHhcCCCCCC
Confidence 89999999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.05 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=198.0
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~ 883 (1141)
.|++.+.||+|+||.||+|.+. +..+++|+.... ... ...+ .+|+.++.++ +||||+++++++.....
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~---~~~~----~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDE---EEEI----KQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--Ccc---HHHH----HHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 4788899999999999999884 455666665422 111 1223 6899999998 69999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.......++||||+++++|.+++.. .....+++..+..++.||+.||+|||+++|+||||||+||+++.
T Consensus 78 --------~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~ 146 (272)
T cd06637 78 --------PGMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 146 (272)
T ss_pred --------CCCCcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC
Confidence 1112357999999999999999875 22346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1042 (1141)
+ +.++|+|||++........ ......|++.|+|||++.+.. ....++.++|||||||++|+|
T Consensus 147 ~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el 209 (272)
T cd06637 147 N-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209 (272)
T ss_pred C-------CCEEEccCCCceecccccc----------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHH
Confidence 7 7899999999875432111 112346899999999986421 124578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||...........+.....+.. .....+..+.+|+.+||..||.+|||+
T Consensus 210 ~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~ 263 (272)
T cd06637 210 AEGAPPLCDMHPMRALFLIPRNPAPRL--------------------------KSKKWSKKFQSFIESCLVKNHSQRPTT 263 (272)
T ss_pred HhCCCCccccCHHHHHHHHhcCCCCCC--------------------------CCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence 999999976544333222211111000 001345678999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.++++|+|+
T Consensus 264 ~~il~~~~~ 272 (272)
T cd06637 264 EQLMKHPFI 272 (272)
T ss_pred HHHhhCCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=314.43 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=202.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|+||.||.++.. +..+++|..... .......+.+ .+|++++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~----~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT--RLSEKERRDA----LNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeec--ccchhHHHHH----HHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 5899999999999999988874 555666664433 2223333334 78999999999999999999998654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.+
T Consensus 73 ------------~~~~~~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 73 ------------TLLIEMEYANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred ------------eEEEEEEecCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 349999999999999999762 23468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||.+........ ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 -------~~~kl~d~~~~~~~~~~~~----------~~~~~~~~~~y~ape~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08221 138 -------GLIKLGDFGISKILGSEYS----------MAETVVGTPYYMSPELCQG----VKYNFKSDIWALGCVLYELLT 196 (256)
T ss_pred -------CCEEECcCcceEEcccccc----------cccccCCCccccCHhhcCC----CCCCCcchhHHHHHHHHHHHH
Confidence 7899999999876533211 1123458999999999876 456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|..||......+....+..+..+... ...+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 197 LKRTFDATNPLNLVVKIVQGNYTPVV---------------------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCc---------------------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999876666666555443322111 144567899999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
+++++|.
T Consensus 250 ll~~~~l 256 (256)
T cd08221 250 VLDQPLL 256 (256)
T ss_pred HhhCcCC
Confidence 9999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=316.11 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=200.4
Q ss_pred CCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
.++|++.+.||+|+||.||+|.+.. ..+++|+. +... .......+ .+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~--~~~~-~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGS-SDKQRLDF----LTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEc--CCCC-ChHHHHHH----HHHHHHHHhCCCCCcceEeEEEe
Confidence 4579999999999999999999842 24566653 3221 22223333 78999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+... .++||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 76 ~~~~--------------~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 76 KSRP--------------VMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred cCCc--------------eEEEEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 6543 49999999999999998751 23689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.++|+|||.+......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~Pe~~~~----~~~~~~~Dv~slG~~l 198 (266)
T cd05033 138 LVNSN-------LVCKVSDFGLSRRLEDSEAT--------YTTKGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CCEEECccchhhcccccccc--------eeccCCCCCccccChhhhcc----CCCccccchHHHHHHH
Confidence 99887 78999999999876421111 00112235678999999876 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++ |..||......+....+........+ ...+..+.+++.+||+.+|++
T Consensus 199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---------------------------MDCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99998 99999876666666665443222111 134567899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
||++.++++++..
T Consensus 252 Rp~~~ei~~~l~~ 264 (266)
T cd05033 252 RPTFSQIVSTLDK 264 (266)
T ss_pred CcCHHHHHHHHHh
Confidence 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.27 Aligned_cols=262 Identities=29% Similarity=0.487 Sum_probs=206.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|.+. +..+++|+.... .....+.+ .+|+.++++++||||+++++++....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHH----HHHHHHHHhCCCCceeEEEEEEecCC
Confidence 457999999999999999999984 556777765432 22333344 78999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~ 137 (280)
T cd06611 76 --------------KLWILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137 (280)
T ss_pred --------------eEEEEeeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC
Confidence 349999999999999998752 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~E 1041 (1141)
.+ +.++|+|||.+........ ......+++.|+|||.+.... ....++.++||||||+++|+
T Consensus 138 ~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~ 200 (280)
T cd06611 138 LD-------GDVKLADFGVSAKNKSTLQ----------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200 (280)
T ss_pred CC-------CCEEEccCccchhhccccc----------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHH
Confidence 87 7899999998765432111 112345889999999986321 22456789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|+.||......+....+..+..+.+.. ....+.++.+++.+||+.||.+||+
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rps 255 (280)
T cd06611 201 LAQMEPPHHELNPMRVLLKILKSEPPTLDQ-------------------------PSKWSSSFNDFLKSCLVKDPDDRPT 255 (280)
T ss_pred HHhCCCCcccCCHHHHHHHHhcCCCCCcCC-------------------------cccCCHHHHHHHHHHhccChhhCcC
Confidence 999999998766655554444333222110 0134567899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.++++|+|+...
T Consensus 256 ~~~il~~~~~~~~ 268 (280)
T cd06611 256 AAELLKHPFVSDQ 268 (280)
T ss_pred HHHHhcChhhccc
Confidence 9999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=322.10 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=196.8
Q ss_pred CCCceEeeeecccCceEEEEEEECCc--c--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSA--D--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~--~--vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~ 879 (1141)
|++|++.++||+|+||.||+|.+... . +++|. ++.. ......+. +.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~--~~~~-~~~~~~~~----~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKM--LKEF-ASENDHRD----FAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEE--cccc-CCHHHHHH----HHHHHHHHHhhcCCCchhheEEEEc
Confidence 56899999999999999999987432 2 34444 3321 12222233 37899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKH 948 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g 948 (1141)
.... .++||||+++++|.++++..... ....+++..+..|+.||+.||+|||++|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 74 NRGY--------------LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cCCc--------------ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6543 39999999999999999752210 1135889999999999999999999999
Q ss_pred ccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001143 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1141)
Q Consensus 949 IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1028 (1141)
|+||||||+|||++.+ +.+||+|||++....... .......+..|+|||++.+ ..++.
T Consensus 140 ivH~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~ 197 (297)
T cd05089 140 FIHRDLAARNVLVGEN-------LASKIADFGLSRGEEVYV-----------KKTMGRLPVRWMAIESLNY----SVYTT 197 (297)
T ss_pred cccCcCCcceEEECCC-------CeEEECCcCCCcccccee-----------ccCCCCcCccccCchhhcc----CCCCc
Confidence 9999999999999877 789999999985322110 0011123557999999875 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|||||||++|||++ |..||......+....+..+..+..+ ...+..+.+|
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 250 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP---------------------------RNCDDEVYEL 250 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999998 99999887776666555433222111 1345678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+||+.+|.+||+++++++.+...
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=322.05 Aligned_cols=286 Identities=21% Similarity=0.229 Sum_probs=205.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|.+. +..+++|.......... .......+..|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA---KDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc---cchhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 4888999999999999999974 56788887654322111 1112233468999999999999999999988644
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+ +++|.+++.. . ...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 76 ------------~~~lv~e~~-~~~L~~~i~~---~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 76 ------------NINLVFEFM-ETDLEKVIKD---K-SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred ------------EEEEEEccc-CCCHHHHHhc---c-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 349999999 8999999975 1 1369999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++........ ......+++.|+|||.+.+ ...++.++|||||||++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 139 -------GVLKLADFGLARSFGSPNR----------KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred -------CCEEEccceeeeeccCCCc----------cccccccceeeeCHHHHhC---CCCCCcHHHHHHHHHHHHHHHc
Confidence 7899999999876543211 1112346788999999864 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|.+||.+....+....+...........+...........................+..+.+++.+||++||++|||+.|
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 98888776655544444222111111111110000000000000011111111245678999999999999999999999
Q ss_pred HHHHHHhhcC
Q 001143 1125 LYEMFVARTS 1134 (1141)
Q Consensus 1125 lL~~L~~~~~ 1134 (1141)
+++|.|+...
T Consensus 279 ~l~~~~~~~~ 288 (298)
T cd07841 279 ALEHPYFSND 288 (298)
T ss_pred HhhCccccCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=314.55 Aligned_cols=250 Identities=26% Similarity=0.332 Sum_probs=199.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.++||+|+||.||++.+. +..+++|.++... .....+.+ .+|+.+++.++||||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDS----RKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHH----HHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 5889999999999999999974 5667777654332 12222333 68999999999999999999988655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 72 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 72 ------------HLYIVMEYCDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred ------------EEEEEEeeCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 34999999999999998865 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++++|||.+........ ......|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 137 -------GKVKLGDFGSARLLTSPGA----------YACTYVGTPYYVPPEIWEN----MPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred -------CcEEEcccCcceeeccccc----------ccccccCCccccCHHHHcc----CCcCchhhhhhhchhheehhh
Confidence 7899999999865533211 1123458889999999876 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|..||...+.......+..+.....+. ..+..+.+++.+||+.||.+||++.+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLPS---------------------------HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCCc---------------------------ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 999998776665555554443322211 33456899999999999999999999
Q ss_pred HHHH
Q 001143 1125 LYEM 1128 (1141)
Q Consensus 1125 lL~~ 1128 (1141)
++..
T Consensus 249 il~~ 252 (255)
T cd08219 249 ILSR 252 (255)
T ss_pred Hhhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=316.51 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=200.6
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.+|++.++||.|+||.||+|.+. +..+++|+.... .......+ ..|+.+++.++||||+++++++.+...
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~----~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~~- 76 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD----DLLKQQDF----QKEVQALKRLRHKHLISLFAVCSVGEP- 76 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc----chhhHHHH----HHHHHHHhcCCCcchhheeeeEecCCC-
Confidence 46899999999999999999985 456677764322 11122233 789999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.++||||+++++|.++++. .....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 77 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~ 140 (261)
T cd05148 77 -------------VYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED 140 (261)
T ss_pred -------------eEEEEeecccCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC
Confidence 4999999999999999976 223468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||.+......... .....++..|+|||++.. ..++.++||||||+++|+|++
T Consensus 141 -------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~~l~~l~~ 199 (261)
T cd05148 141 -------LVCKVADFGLARLIKEDVYL----------SSDKKIPYKWTAPEAASH----GTFSTKSDVWSFGILLYEMFT 199 (261)
T ss_pred -------ceEEEccccchhhcCCcccc----------ccCCCCceEecCHHHHcc----CCCCchhhHHHHHHHHHHHHc
Confidence 78999999999765332111 112235678999999875 467889999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||...+..+....+..+..+..+ ...++.+.+++.+||+.||.+|||+.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~ 252 (261)
T cd05148 200 YGQVPYPGMNNHEVYDQITAGYRMPCP---------------------------AKCPQEIYKIMLECWAAEPEDRPSFK 252 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHhCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 89999877766666665433222111 14456789999999999999999999
Q ss_pred HHHHHHH
Q 001143 1124 DLYEMFV 1130 (1141)
Q Consensus 1124 ElL~~L~ 1130 (1141)
++++.|.
T Consensus 253 ~l~~~L~ 259 (261)
T cd05148 253 ALREELD 259 (261)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=358.04 Aligned_cols=268 Identities=26% Similarity=0.403 Sum_probs=216.4
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001143 800 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874 (1141)
Q Consensus 800 ~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~---~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 874 (1141)
++.......++.+.||+|+||.||.|... +. .+.|++|.++... ...+..+| ++|..+|++++|||||++
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~F----l~Ea~~m~~f~HpNiv~l 760 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDF----LKEALLMSKFDHPNIVSL 760 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHH----HHHHHHHhcCCCcceeeE
Confidence 34455666799999999999999999873 22 5667777776533 33444555 899999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHr 952 (1141)
+|++.+... .+|++|||+||+|..+|++.+.. ....++..+.+.++.|||+|++||+++++|||
T Consensus 761 iGv~l~~~~--------------~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHR 826 (1025)
T KOG1095|consen 761 IGVCLDSGP--------------PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHR 826 (1025)
T ss_pred EEeecCCCC--------------cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCc
Confidence 999887443 39999999999999999975332 14469999999999999999999999999999
Q ss_pred CCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001143 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032 (1141)
Q Consensus 953 DLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1032 (1141)
||-+.|+|++.. ..|||+|||+|+.+....... .+ ....-...|||||.+.. ..++.|+||
T Consensus 827 DLAaRNCLL~~~-------r~VKIaDFGlArDiy~~~yyr--~~------~~a~lPvkWm~PEsl~d----~iFtskSDv 887 (1025)
T KOG1095|consen 827 DLAARNCLLDER-------RVVKIADFGLARDIYDKDYYR--KH------GEAMLPVKWMPPESLKD----GIFTSKSDV 887 (1025)
T ss_pred chhhhheeeccc-------CcEEEcccchhHhhhhchhee--cc------CccccceecCCHHHHhh----cccccccch
Confidence 999999999987 789999999998543322111 00 01124568999999997 689999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001143 1033 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111 (1141)
Q Consensus 1033 WSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~c 1111 (1141)
|||||++||++| |..||.+.+..++...+..+.+...+ ..+++.+.++|..|
T Consensus 888 WsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P---------------------------~~CP~~ly~lM~~C 940 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP---------------------------SYCPEKLYQLMLQC 940 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC---------------------------CCCChHHHHHHHHH
Confidence 999999999999 89999999999888866555543222 16778899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhh
Q 001143 1112 TEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1112 L~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
|+.+|++||++..|++.+...
T Consensus 941 W~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 941 WKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ccCChhhCccHHHHHhhhhhh
Confidence 999999999999999976554
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=316.94 Aligned_cols=262 Identities=26% Similarity=0.356 Sum_probs=201.5
Q ss_pred CceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
+|++.+.||+|+||.||+|.. .+..+++|+...+.. ...........+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS--NVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCcc--chhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC---
Confidence 478899999999999999987 456688887554322 11222222345689999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+|+||+|+||+++.+
T Consensus 76 -----------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~- 138 (265)
T cd06631 76 -----------TISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN- 138 (265)
T ss_pred -----------eEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-
Confidence 34999999999999999975 2358899999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||.+........... .........|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 ------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 139 ------GIIKLIDFGCARRLAWVGLHGT----HSNMLKSMHGTPYWMAPEVINE----SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred ------CeEEeccchhhHhhhhcccccc----ccccccccCCCccccChhhhcC----CCCcchhhHHHHHHHHHHHHhC
Confidence 7899999999875432111100 0011123458999999999876 4577999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhC--CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1046 QVPYMGLSELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~--~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+.||...+.......+... ..+.+ ....+.++.+++.+||+.+|.+||++.
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRL---------------------------PDSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCC---------------------------CCCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 9999765544333222211 11111 114556789999999999999999999
Q ss_pred HHHHHHHh
Q 001143 1124 DLYEMFVA 1131 (1141)
Q Consensus 1124 ElL~~L~~ 1131 (1141)
++++|+|+
T Consensus 258 ~~l~~~~~ 265 (265)
T cd06631 258 QLLRHDFL 265 (265)
T ss_pred HHhcCCCC
Confidence 99999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=318.95 Aligned_cols=281 Identities=23% Similarity=0.297 Sum_probs=201.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|++|.||+|++. +..+++|+..... ......+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKK----IALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc--cCccccH----HHHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 46899999999999999999985 5667777654221 1111112 2378999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||++++.|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 74 -------------KLHLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred -------------EEEEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 34999999998888777654 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.+........ ......++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~i~~~l~ 195 (286)
T cd07847 136 Q-------GQIKLCDFGFARILTGPGD----------DYTDYVATRWYRAPELLVG---DTQYGPPVDVWAIGCVFAELL 195 (286)
T ss_pred C-------CcEEECccccceecCCCcc----------cccCcccccccCCHHHHhC---CCCcCchhhhHHHHHHHHHHH
Confidence 7 7899999999976543211 1112347889999999865 235678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc-Cccc--cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-CHEH--EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+....+....+................. .... ..................+..+.+|+.+||+.||++||
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 196 TGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 99999987665554433322211111110000000 0000 00000000000001124467799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
++.|++.|+||
T Consensus 276 ~~~eil~~~~f 286 (286)
T cd07847 276 SCEELLEHPYF 286 (286)
T ss_pred CHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.58 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=196.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|++.++||+|+||.||+|.+. +..+|+|...... .... .....+.+|+.++++++|+||+.+++.+.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~--~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh--ccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3788899999999999999985 4567777543221 1111 11123368999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. .+...+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~g~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 74 ------------ALCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred ------------EEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 34999999999999999865 223468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 196 (285)
T cd05630 139 -------GHIRISDLGLAVHVPEGQ-----------TIKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLYEMIA 196 (285)
T ss_pred -------CCEEEeeccceeecCCCc-----------cccCCCCCccccChHHHcC----CCCCCccccHHHHHHHHHHHh
Confidence 789999999986543211 0112368999999999876 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS--- 1121 (1141)
|+.||...........+..... .... . .....+..+.+|+.+||+.||.+|||
T Consensus 197 g~~Pf~~~~~~~~~~~~~~~~~-~~~~------------------~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 252 (285)
T cd05630 197 GQSPFQQRKKKIKREEVERLVK-EVQE------------------E-----YSEKFSPDARSLCKMLLCKDPKERLGCQG 252 (285)
T ss_pred CCCCCCCCCccchHHHHHhhhh-hhhh------------------h-----cCccCCHHHHHHHHHHhhcCHHHccCCCC
Confidence 9999976432111111110000 0000 0 00134566899999999999999999
Q ss_pred --HHHHHHHHHhhc
Q 001143 1122 --AGDLYEMFVART 1133 (1141)
Q Consensus 1122 --a~ElL~~L~~~~ 1133 (1141)
+.|+++|+|+..
T Consensus 253 ~~~~~~~~h~~~~~ 266 (285)
T cd05630 253 GGAREVKEHPLFKQ 266 (285)
T ss_pred CchHHHHcChhhhc
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=334.87 Aligned_cols=265 Identities=23% Similarity=0.289 Sum_probs=201.8
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||++++.. ..+|+|+...... ...... ..+..|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAET----ACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHH----HHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 479999999999999999999854 4567776432110 011111 22478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++|+|.+++.+. ...+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 75 -------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 349999999999999999752 236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1042 (1141)
+ +.+||+|||++..+..... .......||+.|+|||++.... ....++.++|||||||++|||
T Consensus 138 ~-------~~~kL~DfG~a~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el 201 (332)
T cd05623 138 N-------GHIRLADFGSCLKLMEDGT---------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201 (332)
T ss_pred C-------CCEEEeecchheecccCCc---------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence 7 7899999999865432111 1112346999999999986422 124578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~--R 1119 (1141)
++|+.||...+..+....+..... ..++ ......+.++.+++.+|+..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 202 LYGETPFYAESLVETYGKIMNHKERFQFP------------------------AQVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCccccCC------------------------CccccCCHHHHHHHHHHccChhhhcCC
Confidence 999999998777666666543221 1110 001145677999999999765554 7
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
+++.++++|+|+..
T Consensus 258 ~~~~~~~~h~~f~~ 271 (332)
T cd05623 258 NGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHhCCCCcCC
Confidence 89999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=322.18 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=199.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|+..+.||+|+||+||+|.+. +..+|+|+...... ... .....+.+|++++++++|+||+.+++.+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKR---KGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhh---hHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 3778899999999999999985 55677776533211 111 11122368999999999999999999887654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. .+...+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 74 ------------ALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred ------------EEEEEEEeccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 34999999999999998865 223469999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++....... ......|+..|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~-----------~~~~~~g~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~ 196 (285)
T cd05632 139 -------GHIRISDLGLAVKIPEGE-----------SIRGRVGTVGYMAPEVLNN----QRYTLSPDYWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEecCCcceecCCCC-----------cccCCCCCcCccChHHhcC----CCCCcccchHHHHHHHHHHHh
Confidence 789999999986543211 1123468999999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS--- 1121 (1141)
|+.||.+.........+......... ......+..+.+|+..||+.||++||+
T Consensus 197 g~~P~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 197 GQSPFRGRKEKVKREEVDRRVLETEE------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHhhhcccc------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 99999876554333332111100000 000134556899999999999999999
Q ss_pred --HHHHHHHHHhhcC
Q 001143 1122 --AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 --a~ElL~~L~~~~~ 1134 (1141)
+.++++|.|+...
T Consensus 253 ~~~~~l~~~~~~~~~ 267 (285)
T cd05632 253 EGAGEVKRHPFFRNM 267 (285)
T ss_pred cChHHHHcChhhhcC
Confidence 8999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=319.85 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=198.4
Q ss_pred CceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+|++.+.||+|+||.||+|.+.. ..+++|+. .... .....+. +.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~--~~~~-~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENA-SSSELRD----LLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEec--CCCC-CHHHHHH----HHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47889999999999999998632 23555543 2211 1222333 478999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------------cCCCCCCHHHHHHHHHHHHHH
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVAAA 940 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-------------------~~~~~Ls~~~i~~Ia~QIa~g 940 (1141)
.... .++||||+++++|.+++..... .....+++..++.++.|++.|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 74 QDGP--------------LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred cCCC--------------cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 6543 3999999999999999875321 112358899999999999999
Q ss_pred HHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccc
Q 001143 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020 (1141)
Q Consensus 941 L~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1020 (1141)
|.|||+++|+||||||+|||++.+ +.+||+|||++......... .......++..|+|||++.+
T Consensus 140 l~~LH~~~ivH~dikp~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~- 203 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLVAEG-------RKMKISDFGLSRDVYEEDSY--------VKRSKGRIPVKWMAIESLFD- 203 (290)
T ss_pred HHHHHHCCeehhhhhhheEEEcCC-------CcEEeccccccccccCccch--------hcccCCCCCccccCHHHHcc-
Confidence 999999999999999999999877 78999999998754321110 00112235678999999865
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 001143 1021 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1099 (1141)
Q Consensus 1021 ~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1141)
..++.++||||||+++|+|++ |..||.+....++...+........+ ..
T Consensus 204 ---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 253 (290)
T cd05045 204 ---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---------------------------EN 253 (290)
T ss_pred ---CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CC
Confidence 567899999999999999998 99999877766665554433221111 13
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1100 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1100 ~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+..+.+++.+||+.||.+||++.++++.+...
T Consensus 254 ~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 254 CSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 456799999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.12 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=204.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||.|+||+||+|.+. +..+++|+...... . ...+.+ .+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--Q-TSVDEL----RKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--c-hHHHHH----HHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 47899999999999999999974 45667776543221 1 133333 78999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.++++.... ...+++..+..++.|++.||.|||++||+||||+|+||++++
T Consensus 73 -------------~~~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 73 -------------ELWLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 34999999999999999976321 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++..+....... ........|+..|+|||++... ..++.++|+|||||++|+|+
T Consensus 138 ~-------~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 138 D-------GSVKIADFGVSASLADGGDRT------RKVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELA 201 (267)
T ss_pred C-------CCEEEcccchHHHhccCcccc------ccccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHH
Confidence 7 789999999987654432110 0112344689999999998762 35788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||...+..+....+.....+.+... ......+..+.+++.+||..||++||++.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPPSLETG----------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCCCcCCc----------------------cccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 99999987665554444333222211110 00114567789999999999999999999
Q ss_pred HHHHHHHh
Q 001143 1124 DLYEMFVA 1131 (1141)
Q Consensus 1124 ElL~~L~~ 1131 (1141)
++++|+|+
T Consensus 260 ~ll~~p~~ 267 (267)
T cd06610 260 ELLKHKFF 267 (267)
T ss_pred HHhhCCCC
Confidence 99999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=321.57 Aligned_cols=259 Identities=20% Similarity=0.300 Sum_probs=200.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
+.+|++.+.||+|+||.||+|.+.+ ..+|+|+...+ . .... ...+.+|+.++.+++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~-~~~~----~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--A-EGPL----REEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--C-CHHH----HHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 4568899999999999999998742 44666664322 1 1122 2234789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHS 946 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs 946 (1141)
+.+... .++++||+++++|.+++..... .....+++..+..++.|++.||+|||+
T Consensus 77 ~~~~~~--------------~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 77 VTKEQP--------------LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred EcCCCc--------------eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 876543 4999999999999999853110 112358889999999999999999999
Q ss_pred CCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001143 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1141)
Q Consensus 947 ~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1026 (1141)
+||+||||||+||+++.+ +.+||+|||+++........ .......+++.|+|||++.+ ..+
T Consensus 143 ~gi~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 203 (283)
T cd05091 143 HHVVHKDLATRNVLVFDK-------LNVKISDLGLFREVYAADYY--------KLMGNSLLPIRWMSPEAIMY----GKF 203 (283)
T ss_pred cCccccccchhheEecCC-------CceEecccccccccccchhe--------eeccCccCCccccCHHHHhc----CCC
Confidence 999999999999999877 78999999998765332111 01122346788999999875 457
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 001143 1027 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1105 (1141)
Q Consensus 1027 s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1105 (1141)
+.++|||||||++|||++ |..||.+....+....+........+ ..++..+.
T Consensus 204 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~ 256 (283)
T cd05091 204 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP---------------------------DDCPAWVY 256 (283)
T ss_pred CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHH
Confidence 899999999999999998 88999887777777666554432211 14566799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1106 DVFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1106 dLI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
+++..||+.+|.+||++.+|+..+.
T Consensus 257 ~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 257 TLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHhCCCcccCCCHHHHHHHhh
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=332.84 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=191.0
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||.||+|.+. +..+|+|+....... .....+ .+.+|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 69 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDID----WVQTEKHVFEQASSNPFLVGLHSCFQTTS------ 69 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhhcCCCCEeeEEEEEEeCC------
Confidence 47999999999999974 456777775432111 112222 347899999888 5999999999987654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
+.++||||+++++|..++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---- 132 (327)
T cd05617 70 --------RLFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---- 132 (327)
T ss_pred --------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC----
Confidence 35999999999999998865 3469999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 133 ---GHIKLTDYGMCKEGLGPGD----------TTSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred ---CCEEEeccccceeccCCCC----------ceecccCCcccCCHHHHCC----CCCCchheeehhHHHHHHHHhCCCC
Confidence 7899999999864221110 1123468999999999876 5678999999999999999999999
Q ss_pred CCCCC------HHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1049 YMGLS------ELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1049 f~~~~------~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|.... ..+ ....+.. ....++ ...+..+.+++.+||+.||.+|++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~-~~~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILE-KPIRIP---------------------------RFLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCccCCCcccccHHHHHHHHHh-CCCCCC---------------------------CCCCHHHHHHHHHHhccCHHHcCC
Confidence 95321 111 2222211 111111 134566899999999999999997
Q ss_pred ------HHHHHHHHHhhc
Q 001143 1122 ------AGDLYEMFVART 1133 (1141)
Q Consensus 1122 ------a~ElL~~L~~~~ 1133 (1141)
+.++++|+|+..
T Consensus 248 ~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 248 CQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCCCCCHHHHHcCCCCCC
Confidence 579999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=316.22 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=198.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~----~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
...+|++.++||+|+||+||+|++. +. .||+|+.+.. ......+. +.+|+.++..++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKE----ILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHH----HHHHHHHHHhcCCCCCceEEEE
Confidence 3567899999999999999999873 22 2566664322 12222233 4789999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+.... .+++|||+++|+|.++++. ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus 78 ~~~~~---------------~~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~ 138 (279)
T cd05109 78 CLTST---------------VQLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAAR 138 (279)
T ss_pred EcCCC---------------cEEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 86422 3799999999999999875 1246899999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.+||+|||+++......... ......+++.|+|||.+.+ ..++.++|||||||
T Consensus 139 Nil~~~~-------~~~kL~dfG~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~ 199 (279)
T cd05109 139 NVLVKSP-------NHVKITDFGLARLLDIDETEY--------HADGGKVPIKWMALESILH----RRFTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEECCCCceeeccccccee--------ecCCCccchhhCCHHHhcc----CCCCchhHHHHHHH
Confidence 9999876 679999999997654321110 0111235678999999875 46789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|||++ |..||...........+..+..+..+ ...+..+.+++.+||..||
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 200 TVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---------------------------ccCCHHHHHHHHHHcCCCh
Confidence 9999998 99999876666555555443322211 1345678999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001143 1117 TERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~ 1133 (1141)
++||++.++++.+....
T Consensus 253 ~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 253 ECRPRFRELVDEFSRMA 269 (279)
T ss_pred hhCcCHHHHHHHHHHhh
Confidence 99999999998775543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.35 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=197.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..+|++.+.||+|+||.||+|.+.. ..+++|+.. ..... ...+ .+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~--~~~~~---~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR--EGAMS---EDDF----IEEAKVMMKLSHPNLVQLYGVCTKQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEec--cCCCC---HHHH----HHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4568999999999999999998854 467787643 21111 1223 689999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 74 --------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 74 --------------IFIVTEYMANGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred --------------eEEEEecCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 49999999999999998751 236899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.++........ ......++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~il~~l~ 195 (256)
T cd05059 136 D-------NVVKVSDFGLARYVLDDQYT---------SSQGTKFPVKWAPPEVFDY----SRFSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CcEEECCcccceeccccccc---------ccCCCCCCccccCHHHhcc----CCCCchhhHHHHHHHHHHHh
Confidence 7 78999999998754321110 0111124567999999876 46788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||......+....+.....+..+ ...+..+.+++.+||..+|++|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rpt~ 248 (256)
T cd05059 196 SEGKMPYERFSNSEVVESVSAGYRLYRP---------------------------KLAPTEVYTIMYSCWHEKPEDRPAF 248 (256)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9 89999876666665555433221111 1345679999999999999999999
Q ss_pred HHHHHHH
Q 001143 1123 GDLYEMF 1129 (1141)
Q Consensus 1123 ~ElL~~L 1129 (1141)
.|+++.+
T Consensus 249 ~~~l~~l 255 (256)
T cd05059 249 KKLLSQL 255 (256)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=312.21 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=201.7
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
..+|++.+.||.|+||.||+|...+..+++|...... ...+. +.+|+.++++++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~-----~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 73 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS-----TAAQA----FLAEASVMTTLRHPNLVQLLGVVLQGN-- 73 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccch-----hHHHH----HHHHHHHHHhcCCcceeeeEEEEcCCC--
Confidence 5678999999999999999999999999999864331 12233 378999999999999999999987544
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.++++. .....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~ 138 (256)
T cd05039 74 ------------PLYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED 138 (256)
T ss_pred ------------CeEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC
Confidence 34999999999999999976 222368999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+....... .....+..|+|||++.. ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~d~g~~~~~~~~~-------------~~~~~~~~~~ape~~~~----~~~~~~~Di~slG~il~~l~~ 194 (256)
T cd05039 139 -------LVAKVSDFGLAKEASQGQ-------------DSGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred -------CCEEEccccccccccccc-------------ccCCCcccccCchhhcC----CcCCcHHHHHHHHHHHHHHHh
Confidence 789999999987653211 01224567999999865 457789999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|..||......++...+.....+..+ ...++.+.+++.+||..+|.+|||+.
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 247 (256)
T cd05039 195 FGRVPYPRIPLKDVVPHVEKGYRMEAP---------------------------EGCPPEVYKVMKDCWELDPAKRPTFK 247 (256)
T ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------cCCCHHHHHHHHHHhccChhhCcCHH
Confidence 99999877666665555433221111 13456799999999999999999999
Q ss_pred HHHHHHH
Q 001143 1124 DLYEMFV 1130 (1141)
Q Consensus 1124 ElL~~L~ 1130 (1141)
++++.+.
T Consensus 248 ~l~~~l~ 254 (256)
T cd05039 248 QLREQLA 254 (256)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.42 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=196.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.+.||+|+||.||+|++. +..+++|+..... ...... +.+|+.++++++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~----~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSL----IQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHH----HHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3457999999999999999999974 5567777754321 112222 36899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.++++. ...+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 79 ~--------------~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill 139 (267)
T cd06646 79 E--------------KLWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL 139 (267)
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 4 35999999999999999875 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||++........ ......|++.|+|||.+.... ...++.++|||||||++|+
T Consensus 140 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~-~~~~~~~~Dvws~G~il~e 201 (267)
T cd06646 140 TDN-------GDVKLADFGVAAKITATIA----------KRKSFIGTPYWMAPEVAAVEK-NGGYNQLCDIWAVGITAIE 201 (267)
T ss_pred CCC-------CCEEECcCccceeeccccc----------ccCccccCccccCHhHccccc-CCCCcchhhHHHHHHHHHH
Confidence 877 7899999999976532110 112345889999999975321 2446789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|+.||......+....+....... + ........+..+.+++.+||..||++|||
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~-~----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 258 (267)
T cd06646 202 LAELQPPMFDLHPMRALFLMSKSNFQP-P----------------------KLKDKTKWSSTFHNFVKISLTKNPKKRPT 258 (267)
T ss_pred HHhCCCCccccchhhhheeeecCCCCC-C----------------------CCccccccCHHHHHHHHHHhhCChhhCcC
Confidence 999999996544322221111110000 0 00000134567999999999999999999
Q ss_pred HHHHHHHHH
Q 001143 1122 AGDLYEMFV 1130 (1141)
Q Consensus 1122 a~ElL~~L~ 1130 (1141)
++++++|+|
T Consensus 259 ~~~il~~l~ 267 (267)
T cd06646 259 AERLLTHLF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=324.15 Aligned_cols=280 Identities=23% Similarity=0.300 Sum_probs=199.3
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
++|++.++||+|+||.||+|.+..+...++++.+.... .... ..++.+|++++.+++||||+++++++..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAI----RNQIIRELKVLHECNSPYIVGFYGAFYSDG--- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---
Confidence 36899999999999999999986444333333333211 1222 223478999999999999999999998655
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeecc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.++++. ...+++..+..++.||+.||.|||+ .+++||||||+|||++.+
T Consensus 73 -----------~~~lv~ey~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~ 136 (308)
T cd06615 73 -----------EISICMEHMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR 136 (308)
T ss_pred -----------EEEEEeeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC
Confidence 34999999999999999976 2468999999999999999999997 599999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||++...... ......++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 137 -------~~~~l~dfg~~~~~~~~------------~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 193 (308)
T cd06615 137 -------GEIKLCDFGVSGQLIDS------------MANSFVGTRSYMSPERLQG----THYTVQSDIWSLGLSLVEMAI 193 (308)
T ss_pred -------CcEEEccCCCccccccc------------ccccCCCCcCccChhHhcC----CCCCccchHHHHHHHHHHHHh
Confidence 78999999998654221 1123468899999999865 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHh-hhccCccc---------cccccCCCCCCch-hhhhhHHHHHHHHHHhcc
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELE-ALGSCHEH---------EVAQSGSGFEKPE-AELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~-~~~~~~~~---------~~~~~~~~~~~~~-~~~~~~~~L~dLI~~cL~ 1113 (1141)
|+.||...........+..... ....... ........ ...+....-..+. .....+.++.+++.+||.
T Consensus 194 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 272 (308)
T cd06615 194 GRYPIPPPDAKELEAMFGRPVS-EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLK 272 (308)
T ss_pred CCCCCCCcchhhHHHhhcCccc-cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHcc
Confidence 9999976554433333221110 0000000 00000000 0000000000000 001256679999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhc
Q 001143 1114 ENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.||++|||+.++++|+|+..
T Consensus 273 ~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 273 KNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CChhhCcCHHHHhcChhhhh
Confidence 99999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=333.81 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=201.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||++++. +..+|+|+...... ...... ..+..|+.++..++|+||+++++++.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAET----ACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 47999999999999999999985 45577776532110 011111 23478899999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..|+||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 75 -------------YLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 349999999999999999752 236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-CCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDVWSLGviL~EL 1042 (1141)
+ +.+||+|||++......... ......||+.|+|||++.+.... ..++.++|||||||++|+|
T Consensus 138 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 138 N-------GHIRLADFGSCLKMNQDGTV---------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEeccceeeccCCCce---------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 7 78999999998755332110 11234699999999998753211 3467899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~--R 1119 (1141)
++|+.||...+..+....+.... ...++. .....+.++.+++.+||..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~~~~~~~li~~ll~~~~~~~~~ 257 (331)
T cd05624 202 LYGETPFYAESLVETYGKIMNHEERFQFPS------------------------HITDVSEEAKDLIQRLICSRERRLGQ 257 (331)
T ss_pred hhCCCCccCCCHHHHHHHHHcCCCcccCCC------------------------ccccCCHHHHHHHHHHccCchhhcCC
Confidence 99999998877666655553321 111110 00134567999999999876655 5
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
++++++++|+|+..
T Consensus 258 ~~~~~~~~h~~f~~ 271 (331)
T cd05624 258 NGIEDFKKHAFFEG 271 (331)
T ss_pred CCHHHHhcCCCcCC
Confidence 79999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=321.56 Aligned_cols=263 Identities=29% Similarity=0.449 Sum_probs=202.3
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.|++.++||+|+||.||+|.+.. ..+++|+.... .....+.+ .+|+.++++++||||+++++.+..+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~- 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLGAFYWDG- 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCcEeeeEEEEEeCC-
Confidence 569999999999999999999854 55666654321 22333334 78999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|..++.+. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 83 -------------~~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~ 145 (292)
T cd06644 83 -------------KLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145 (292)
T ss_pred -------------eEEEEEecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC
Confidence 349999999999998887641 236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1042 (1141)
+ +.++|+|||.+........ ......+++.|+|||++.+.. ....++.++|||||||++|+|
T Consensus 146 ~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el 208 (292)
T cd06644 146 D-------GDIKLADFGVSAKNVKTLQ----------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208 (292)
T ss_pred C-------CCEEEccCccceecccccc----------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHH
Confidence 6 7899999998865322110 112345788999999985322 234578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|..||...+.......+.....+.... ....+.++.+++.+||..||++||++
T Consensus 209 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 263 (292)
T cd06644 209 AQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRPSA 263 (292)
T ss_pred hcCCCCCccccHHHHHHHHhcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCcCH
Confidence 99999998766554444433222211110 01345568999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 001143 1123 GDLYEMFVARTSSS 1136 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s~ 1136 (1141)
.++++|+|+..-.+
T Consensus 264 ~~il~~~~~~~~~~ 277 (292)
T cd06644 264 AQLLEHPFVSSVTS 277 (292)
T ss_pred HHHhcCcccccccc
Confidence 99999999975433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=320.66 Aligned_cols=290 Identities=18% Similarity=0.217 Sum_probs=202.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~ 882 (1141)
++|++.+.||+|+||.||+|.+. +..+++|+...... ...... .+.+|+.+++++. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPP----TALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCch----HHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 46899999999999999999984 56677776544321 111112 2368999999995 799999999987643
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. .....|+||||++ ++|.+++..........+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 75 ~~---------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~ 144 (295)
T cd07837 75 KN---------GKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD 144 (295)
T ss_pred CC---------CCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe
Confidence 21 1224699999998 5899988764332234689999999999999999999999999999999999998
Q ss_pred c-ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 963 L-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 963 ~-~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
. + +.+||+|||.+..+..... ......+++.|+|||++.+ ...++.++||||||+++|+
T Consensus 145 ~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~ 204 (295)
T cd07837 145 KQK-------GLLKIADLGLGRAFSIPVK----------SYTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAE 204 (295)
T ss_pred cCC-------CeEEEeecccceecCCCcc----------ccCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHH
Confidence 7 4 7899999999875432111 1112246888999999865 2356899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++|..||.+.+..+....+.. ...+... .+...........................+..+.++|.+||..||.+||
T Consensus 205 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~ 283 (295)
T cd07837 205 MSRKQPLFPGDSELQQLLHIFKLLGTPTEQ-VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283 (295)
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHhCCCChh-hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC
Confidence 9999999987665554433321 1111100 0000000000000000000000011124567799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
++.|++.|+|+.
T Consensus 284 ~~~eil~~~~~~ 295 (295)
T cd07837 284 SAKAALTHPYFD 295 (295)
T ss_pred CHHHHhcCCCcC
Confidence 999999999973
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=316.81 Aligned_cols=280 Identities=20% Similarity=0.263 Sum_probs=203.3
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|.+. +..+++|+...... .....+. +.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQ----ALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHH----HHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 5899999999999999999974 56777777554321 1122223 478999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~~v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 73 ------------GFVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred ------------eeEEEeccc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 349999999 99999998752 2469999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+........ .......++..|+|||++.+ ...++.++||||+||++|+|++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 136 -------GVLKIADFGLARLFSEEEP---------RLYSHQVATRWYRAPELLYG---ARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred -------CcEEEeeeeecccccCCCC---------CccccccCcccccCceeeec---cccCCchhHHHHHHHHHHHHHc
Confidence 7899999999876543211 01123458899999999865 2356789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccc-cc-cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1045 LQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEH-EV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++||.+.........+.. ...+.. ..++........ .. ................+..+.+++.+||..||.+|||
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNE-ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCCh-HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence 9888877665554444322 222211 111110000000 00 0000000000111244578999999999999999999
Q ss_pred HHHHHHHHHh
Q 001143 1122 AGDLYEMFVA 1131 (1141)
Q Consensus 1122 a~ElL~~L~~ 1131 (1141)
++++++|+|+
T Consensus 276 ~~~~l~h~~~ 285 (286)
T cd07832 276 AAEALRHPYF 285 (286)
T ss_pred HHHHhhCcCc
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=317.39 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=196.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--Ccc----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~----vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
..+|++.+.||+|+||+||+|.+. +.. +++|.. ... ....... .+..|+.+++++.||||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~--~~~-~~~~~~~----~~~~~~~~l~~l~h~~iv~~~~~~ 78 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDR-SGRQTFQ----EITDHMLAMGSLDHAYIVRLLGIC 78 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeec--ccc-cchHHHH----HHHHHHHHHhcCCCCCcceEEEEE
Confidence 457899999999999999999983 333 333332 211 1111222 336888899999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
... ..++||||+++|+|.+++... ...+++..+..|+.||+.||.|||++|++||||||+|
T Consensus 79 ~~~---------------~~~~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~n 139 (279)
T cd05111 79 PGA---------------SLQLVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARN 139 (279)
T ss_pred CCC---------------ccEEEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcce
Confidence 432 237999999999999999751 2468999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|+++.+ +.+||+|||.++........ .......++..|+|||++.+ ..++.++|||||||+
T Consensus 140 ili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~i 200 (279)
T cd05111 140 ILLKSD-------SIVQIADFGVADLLYPDDKK--------YFYSEHKTPIKWMALESILF----GRYTHQSDVWSYGVT 200 (279)
T ss_pred EEEcCC-------CcEEEcCCccceeccCCCcc--------cccCCCCCcccccCHHHhcc----CCcCchhhHHHHHHH
Confidence 999877 78999999999764322111 01122346778999999875 467899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|||++ |+.||.+.......+.+..+..+..+. .++..+.+++.+||..||.
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~ 253 (279)
T cd05111 201 VWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMIDEN 253 (279)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC---------------------------CCCHHHHHHHHHHcCCCcc
Confidence 999998 999998776665555554443322111 2334578899999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+|||+.|+++.+...
T Consensus 254 ~Rps~~el~~~l~~~ 268 (279)
T cd05111 254 VRPTFKELANEFTRM 268 (279)
T ss_pred cCcCHHHHHHHHHHH
Confidence 999999999987664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=319.68 Aligned_cols=261 Identities=24% Similarity=0.373 Sum_probs=201.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
..+|++.+.||+|+||.||+|.+.+ ..+++|+.... ........ +.+|+.+++++ +||||+++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHH----HHHHHHHHHhhcCCCCeeeEEE
Confidence 4568999999999999999998743 34566654321 11222233 37899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 945 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~yLH 945 (1141)
++..... .++||||+++++|.++++.... .....+++..++.++.||+.||+|||
T Consensus 84 ~~~~~~~--------------~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 84 VCTQEGP--------------LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred EEcCCCC--------------eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9876543 4999999999999999975321 22346899999999999999999999
Q ss_pred HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 946 s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
+++|+||||||+||+++.+ +.+||+|||.++.+....... ......++..|+|||++.+ ..
T Consensus 150 ~~~ivH~dlkp~Nil~~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~ 210 (293)
T cd05053 150 SKKCIHRDLAARNVLVTED-------HVMKIADFGLARDIHHIDYYR--------KTTNGRLPVKWMAPEALFD----RV 210 (293)
T ss_pred HCCccccccceeeEEEcCC-------CeEEeCcccccccccccccee--------ccCCCCCCccccCHHHhcc----CC
Confidence 9999999999999999887 789999999997654321110 0111234677999999865 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
++.++|||||||++|||++ |..||.+....+....+..+..+..+ ...+..+
T Consensus 211 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~ 263 (293)
T cd05053 211 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP---------------------------QNCTQEL 263 (293)
T ss_pred cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHH
Confidence 7899999999999999998 99999887766666655443322111 1345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+|+.+||..||.+|||+.++++++...
T Consensus 264 ~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 264 YHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=318.49 Aligned_cols=268 Identities=26% Similarity=0.380 Sum_probs=200.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~ 879 (1141)
...++|++.+.||+|+||.||+|.+. +..+++|+.... ...... +.+|+.+++++ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~----~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEE----IEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHH----HHHHHHHHHHHhcCCCeeeeeeeee
Confidence 45678999999999999999999874 566777764311 111122 36899999999 6999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... ......++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 86 ~~~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 86 KKDV---------KNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred eccc---------CCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 4221 0123569999999999999998753222 34689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGvi 1038 (1141)
+++.+ +.++|+|||++..+..... ......|++.|+|||++.... ....++.++|||||||+
T Consensus 156 li~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 156 LLTTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred EECCC-------CCEEEccCCceeecccCCC----------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 99887 7799999999876532110 112345899999999985321 12457889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|+.||...........+.....+... .+ ...+..+.+++.+||+.||++
T Consensus 219 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~---~~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd06638 219 AIELGDGDPPLADLHPMRALFKIPRNPPPTLH----------------------QP---ELWSNEFNDFIRKCLTKDYEK 273 (286)
T ss_pred HHHHhcCCCCCCCCchhHHHhhccccCCCccc----------------------CC---CCcCHHHHHHHHHHccCCccc
Confidence 99999999999765543332222111111100 00 023456899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
|||+.|+++|+|+
T Consensus 274 Rps~~ell~~~~~ 286 (286)
T cd06638 274 RPTVSDLLQHVFI 286 (286)
T ss_pred CCCHHHHhhcccC
Confidence 9999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=315.59 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=200.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
.++|++.+.||+|+||.||+|.+.. ..+++|+.. ... ....... +.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~--~~~-~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENA-SMRERIE----FLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecC--Ccc-CHHHHHH----HHHHHHHHHhCCCCceeEEEEE
Confidence 4578999999999999999998743 446777632 211 1222223 3789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHr 952 (1141)
+..... .++||||+++++|.+++...... ....+++..+..++.||+.||.|||+++|+||
T Consensus 78 ~~~~~~--------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 143 (277)
T cd05032 78 VSTGQP--------------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143 (277)
T ss_pred EcCCCC--------------cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 876543 39999999999999999753221 12347889999999999999999999999999
Q ss_pred CCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001143 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032 (1141)
Q Consensus 953 DLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1032 (1141)
||||+||+++.+ +.+||+|||.++.+...... .......++..|+|||.+.+ ..++.++||
T Consensus 144 di~p~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 204 (277)
T cd05032 144 DLAARNCMVAED-------LTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTKSDV 204 (277)
T ss_pred ccChheEEEcCC-------CCEEECCcccchhhccCccc--------ccCCCCCccccccCHHHHhc----CCCCcccch
Confidence 999999999987 78999999998754332110 01122346788999999865 457899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001143 1033 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111 (1141)
Q Consensus 1033 WSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~c 1111 (1141)
|||||++|||++ |..||.+.+..+....+.....+..+. ..+..+.+++.+|
T Consensus 205 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~ 257 (277)
T cd05032 205 WSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE---------------------------NCPDKLLELMRMC 257 (277)
T ss_pred HHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999998 999998777666666554333222111 3456799999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 001143 1112 TEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1112 L~~DP~~RPSa~ElL~~L~ 1130 (1141)
|+.+|++|||+.++++.+.
T Consensus 258 l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 258 WQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCChhhCCCHHHHHHHhc
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=313.32 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=198.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..+|++.+.||+|++|.||+|.+. +..+++|..+ .... ..+.+ .+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~--~~~~---~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK--PGTM---DPKDF----LAEAQIMKKLRHPKLIQLYAVCTLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeC--CCcc---cHHHH----HHHHHHHHHCCCCCccceeEEEecCCC
Confidence 356899999999999999999874 3456666543 2111 12233 789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 76 --------------~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 138 (261)
T cd05068 76 --------------IYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE 138 (261)
T ss_pred --------------eeeeeecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC
Confidence 49999999999999999762 2346899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++......... .......+..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 139 ~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~ 198 (261)
T cd05068 139 N-------NICKVADFGLARVIKEDIYE---------AREGAKFPIKWTAPEAALY----NRFSIKSDVWSFGILLTEIV 198 (261)
T ss_pred C-------CCEEECCcceEEEccCCccc---------ccCCCcCceeccCcccccc----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999999765421110 0011123457999999875 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||.+....+....+........+ ...+..+.+++.+||+.+|.+||++
T Consensus 199 t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 199 TYGRMPYPGMTNAEVLQQVDQGYRMPCP---------------------------PGCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHhhcCcccCCCH
Confidence 9 99999887766666555433221110 1345679999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
.++++.+.
T Consensus 252 ~~l~~~l~ 259 (261)
T cd05068 252 ETLQWKLE 259 (261)
T ss_pred HHHHHHHh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=312.16 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=201.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||.|+||.||+|.+. +..+++|+..... ....+. +.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEI----IQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHH----HHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 357999999999999999999974 4568888765432 112333 378999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||+|+||+++
T Consensus 74 --------------~~~l~~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 74 --------------KLWIVMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred --------------EEEEEEeCCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 359999999999999998751 24689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.+........ ......++..|+|||.+..... ..++.++|||||||++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~Pe~~~~~~~-~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 136 ED-------GDVKLADFGVSAQLTATIA----------KRKSFIGTPYWMAPEVAAVERK-GGYDGKCDIWALGITAIEL 197 (262)
T ss_pred CC-------CCEEECccccchhhhhhhh----------ccccccCCccccCchhhccccc-CCcCchhhhHHHHHHHHHH
Confidence 87 7899999999876543211 1123457889999999875211 3677899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||...........+......... .......+.++.+++.+||..||.+|||+
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPK-----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCcc-----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCH
Confidence 9999999876655444433322111000 00011456679999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
.+++.|.|
T Consensus 255 ~~il~~~~ 262 (262)
T cd06613 255 TKLLQHPF 262 (262)
T ss_pred HHHhcCCC
Confidence 99999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.76 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=190.5
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g 889 (1141)
+.||+|+||.||+|++ .++.+++|+.. .. ...+... .+.+|++++++++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~--~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 67 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR--ET-LPPDLKA----KFLQEARILKQYSHPNIVRLIGVCTQKQP------ 67 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecC--cc-CCHHHHH----HHHHHHHHHHhCCCCCcceEEEEEcCCCC------
Confidence 4799999999999987 45667777642 11 1222222 34799999999999999999999876543
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCC
Q 001143 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~ 969 (1141)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 68 --------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~----- 130 (252)
T cd05084 68 --------IYIVMELVQGGDFLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK----- 130 (252)
T ss_pred --------eEEEEeeccCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-----
Confidence 4999999999999999875 12358999999999999999999999999999999999999877
Q ss_pred CCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 001143 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 1048 (1141)
Q Consensus 970 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~P 1048 (1141)
+.+||+|||.+......... . ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..|
T Consensus 131 --~~~kl~dfg~~~~~~~~~~~---~-----~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 131 --NVLKISDFGMSREEEDGVYA---S-----TGGMKQIPVKWTAPEALNY----GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred --CcEEECccccCccccccccc---c-----cCCCCCCceeecCchhhcC----CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 78999999998654321100 0 0011123467999999876 457889999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~ 1128 (1141)
|...........+........+ ...+..+.+++.+||+.||++|||+.++++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 197 YANLSNQQTREAIEQGVRLPCP---------------------------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred ccccCHHHHHHHHHcCCCCCCc---------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9766655554444332221111 1345678999999999999999999999987
Q ss_pred HH
Q 001143 1129 FV 1130 (1141)
Q Consensus 1129 L~ 1130 (1141)
+.
T Consensus 250 l~ 251 (252)
T cd05084 250 LQ 251 (252)
T ss_pred Hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=320.82 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=203.8
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||.|++|.||+|.+ .+..+++|...... ....+. +.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKEL----IINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHH----HHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 46799999999999999999986 45667777654321 112223 378999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++
T Consensus 90 --------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 90 --------------ELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred --------------eEEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 45999999999999999865 3589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 150 ~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~~l 208 (296)
T cd06655 150 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 208 (296)
T ss_pred CC-------CCEEEccCccchhcccccc----------cCCCcCCCccccCcchhcC----CCCCchhhHHHHHHHHHHH
Confidence 77 7899999999875432111 1123458889999999875 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||...+.......+.....+.+.. ....+..+.++|.+||..||.+||++
T Consensus 209 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rpt~ 263 (296)
T cd06655 209 VEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSPIFRDFLNRCLEMDVEKRGSA 263 (296)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCcccCC-------------------------cccCCHHHHHHHHHHhhcChhhCCCH
Confidence 99999998766544433332222111100 01345678999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 001143 1123 GDLYEMFVARTSSS 1136 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s~ 1136 (1141)
.++++|+|+.....
T Consensus 264 ~~il~~~~~~~~~~ 277 (296)
T cd06655 264 KELLQHPFLKLAKP 277 (296)
T ss_pred HHHhhChHhhhccc
Confidence 99999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.07 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=197.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.++|++.++||+|+||.||+|.+. +..+++|...... .. .+. +.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~---~~~----~~~E~~~l~~l~~~~i~~~~~~~~~~-- 73 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MS---PES----FLEEAQIMKKLRHDKLVQLYAVVSEE-- 73 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CC---HHH----HHHHHHHHHhcCCCceEEEEeEECCC--
Confidence 457899999999999999999874 4457777643221 11 122 37899999999999999999887432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.++++. .....+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~ 137 (260)
T cd05070 74 -------------PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD 137 (260)
T ss_pred -------------CcEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC
Confidence 23899999999999999975 22346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.+..+...... ......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 138 ~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05070 138 G-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred C-------ceEEeCCceeeeeccCcccc---------cccCCCCCccccChHHHhc----CCCcchhhhHHHHHHHHHHH
Confidence 7 78999999999765332111 1112235667999999865 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |..||.+....+....+.....+..+ ...+..+.+++.+||..||.+|||+
T Consensus 198 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~ 250 (260)
T cd05070 198 TKGRVPYPGMNNREVLEQVERGYRMPCP---------------------------QDCPISLHELMLQCWKKDPEERPTF 250 (260)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcccCcccCcCH
Confidence 9 89999877666666655433222111 1345679999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
.++.+.+.
T Consensus 251 ~~l~~~l~ 258 (260)
T cd05070 251 EYLQSFLE 258 (260)
T ss_pred HHHHHHHh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.32 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=200.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.++||+|+||.||+|.+. +..+++|..... ...+. +.+|+.++++++||||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~----~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQE----IIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHH----HHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 467999999999999999999985 456777765322 11333 379999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.|++|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||+|+||+++
T Consensus 72 --------------~~~l~~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~ 133 (256)
T cd06612 72 --------------DLWIVMEYCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133 (256)
T ss_pred --------------cEEEEEecCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence 34999999999999999865 134689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ ......++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 134 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s~G~il~~l 192 (256)
T cd06612 134 EE-------GQAKLADFGVSGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNNKADIWSLGITAIEM 192 (256)
T ss_pred CC-------CcEEEcccccchhcccCcc----------ccccccCCccccCHHHHhc----CCCCchhhHHHHHHHHHHH
Confidence 87 7899999999876543211 1123457889999999876 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||......+....+.....+... .....+..+.+++.+||+.||.+|||+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~ 247 (256)
T cd06612 193 AEGKPPYSDIHPMRAIFMIPNKPPPTLS-------------------------DPEKWSPEFNDFVKKCLVKDPEERPSA 247 (256)
T ss_pred HhCCCCCCCcchhhhhhhhccCCCCCCC-------------------------chhhcCHHHHHHHHHHHhcChhhCcCH
Confidence 9999999865544333222111111000 011345678999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.|+++|+|+
T Consensus 248 ~~il~~~~~ 256 (256)
T cd06612 248 IQLLQHPFI 256 (256)
T ss_pred HHHhcCCCC
Confidence 999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=316.75 Aligned_cols=256 Identities=30% Similarity=0.447 Sum_probs=205.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||.|++|.||+|.+. +..+++|+..... .......+ .+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDI----QQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHH----HHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 36889999999999999999984 5667787764332 12222333 78999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. .++++..+..++.|++.||.|||+++++||||+|+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 73 -------------KLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred -------------eEEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 45999999999999999875 26899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.++.+..... ......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 134 ~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~sDv~slG~il~~l~ 192 (274)
T cd06609 134 E-------GDVKLADFGVSGQLTSTMS----------KRNTFVGTPFWMAPEVIKQ----SGYDEKADIWSLGITAIELA 192 (274)
T ss_pred C-------CCEEEcccccceeeccccc----------ccccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 7899999999977653211 1123458889999999876 44889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||...+.......+.....+.+.. ...+..+.+++.+||..||++|||++
T Consensus 193 tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~ 246 (274)
T cd06609 193 KGEPPLSDLHPMRVLFLIPKNNPPSLEG--------------------------NKFSKPFKDFVSLCLNKDPKERPSAK 246 (274)
T ss_pred hCCCCcccCchHHHHHHhhhcCCCCCcc--------------------------cccCHHHHHHHHHHhhCChhhCcCHH
Confidence 9999998766555444443332222111 01455689999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001143 1124 DLYEMFVARTSS 1135 (1141)
Q Consensus 1124 ElL~~L~~~~~s 1135 (1141)
++++|+|+....
T Consensus 247 ~il~~~~~~~~~ 258 (274)
T cd06609 247 ELLKHKFIKKAK 258 (274)
T ss_pred HHhhChhhcCCC
Confidence 999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=329.11 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=198.1
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
.++|++.++||+|+||.||+|.+.+ ..+|+|+++.. ......+.+ .+|+.++.++ +||||+++++
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~----~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKAL----MTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHHH----HHHHHHHHhhccCcchhheee
Confidence 3479999999999999999997532 45788865422 122222333 7899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------------------------
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 920 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~------------------------------------ 920 (1141)
++...+. ..++||||+++++|.+++......
T Consensus 79 ~~~~~~~-------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (337)
T cd05054 79 ACTKPGG-------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASS 145 (337)
T ss_pred eEecCCC-------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccc
Confidence 8765331 458999999999999998642110
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeecc
Q 001143 921 --------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD 980 (1141)
Q Consensus 921 --------------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFG 980 (1141)
...++++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-------~~vkL~DfG 218 (337)
T cd05054 146 GFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICDFG 218 (337)
T ss_pred ccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-------CcEEEeccc
Confidence 01368999999999999999999999999999999999999977 789999999
Q ss_pred ccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HH
Q 001143 981 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IH 1058 (1141)
Q Consensus 981 lA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~e-l~ 1058 (1141)
++..+...... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ ..
T Consensus 219 ~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~ 286 (337)
T cd05054 219 LARDIYKDPDY--------VRKGDARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286 (337)
T ss_pred cchhcccCcch--------hhccCCCCCccccCcHHhcC----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH
Confidence 99765332111 01123346778999999876 568899999999999999998 999997644332 22
Q ss_pred HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1059 DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1059 ~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
..+..+..+..+ ...+.++.+++.+||+.+|++||++.|+++++...
T Consensus 287 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 287 RRLKEGTRMRAP---------------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHhccCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 333222211110 13445789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=337.53 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=206.8
Q ss_pred CceEeeeecccCceEEEEEEECC-----cc-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGS-----AD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~-----~~-vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
+-.+.++||+|+||.||+|+... .. ||+|..+.+ .....+...++ .+|+++|++++|||||++||+...
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~----m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEF----MKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEcC
Confidence 44677999999999999998732 12 566654431 12344556666 899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
...+ ++|||+|+||+|.+++++. + ..++..+...++.|.+.||+|||++++|||||-+.|+|
T Consensus 233 ~~Pl--------------~ivmEl~~gGsL~~~L~k~---~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL 294 (474)
T KOG0194|consen 233 EEPL--------------MLVMELCNGGSLDDYLKKN---K-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCL 294 (474)
T ss_pred CCcc--------------EEEEEecCCCcHHHHHHhC---C-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhe
Confidence 6654 9999999999999999872 2 25999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ ..+||+|||+++.-...... .....-...|+|||.+.. ..|++++|||||||++|
T Consensus 295 ~~~~-------~~vKISDFGLs~~~~~~~~~----------~~~~klPirWLAPEtl~~----~~~s~kTDV~sfGV~~~ 353 (474)
T KOG0194|consen 295 YSKK-------GVVKISDFGLSRAGSQYVMK----------KFLKKLPIRWLAPETLNT----GIFSFKTDVWSFGVLLW 353 (474)
T ss_pred ecCC-------CeEEeCccccccCCcceeec----------cccccCcceecChhhhcc----CccccccchhheeeeEE
Confidence 9987 67899999998654311100 001124578999999986 58999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+++ |..||.+....++...| ..+.+...+. ..+..+..++.+||..||++
T Consensus 354 Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---------------------------~~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 354 EIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---------------------------KTPKELAKVMKQCWKKDPED 406 (474)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---------------------------CCHHHHHHHHHHhccCChhh
Confidence 9999 88999999999888888 4454433322 45667889999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
||+|.++.+.+.....
T Consensus 407 R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 407 RPTMSTIKKKLEALEK 422 (474)
T ss_pred ccCHHHHHHHHHHHHh
Confidence 9999999988766543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=314.23 Aligned_cols=261 Identities=27% Similarity=0.396 Sum_probs=196.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|+..+.||+|+||.||+|.+. +..+++|......... ... .....+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP--ETS-KEVSALECEIQLLKNLQHERIVQYYGCLRDRA- 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc--hhH-HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC-
Confidence 36899999999999999999874 5667777654332111 111 11123478999999999999999999886532
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
....++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||+++.
T Consensus 78 -----------~~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~ 141 (266)
T cd06651 78 -----------EKTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS 141 (266)
T ss_pred -----------CCEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 1245899999999999999975 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++..+...... ........++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 142 A-------GNVKLGDFGASKRLQTICMS-------GTGIRSVTGTPYWMSPEVISG----EGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred C-------CCEEEccCCCcccccccccc-------CCccccCCccccccCHHHhCC----CCCCchhhhHHHHHHHHHHH
Confidence 7 78999999998765321111 001123457889999999875 45788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHH-hCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|+.||......+....+. ....+.++ ...++.+.+++ +||..+|++||++
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li-~~~~~~p~~Rp~~ 255 (266)
T cd06651 204 TEKPPWAEYEAMAAIFKIATQPTNPQLP---------------------------SHISEHARDFL-GCIFVEARHRPSA 255 (266)
T ss_pred HCCCCccccchHHHHHHHhcCCCCCCCc---------------------------hhcCHHHHHHH-HHhcCChhhCcCH
Confidence 9999998654433332221 11111111 13445677888 6888999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
+||++|+|+.
T Consensus 256 ~eil~hp~~~ 265 (266)
T cd06651 256 EELLRHPFAQ 265 (266)
T ss_pred HHHhcCcccc
Confidence 9999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.57 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=196.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|.+. +..+++|+.+... ...... +.+|+.+++.++||||+++++.+....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~----~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAV----VQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHH----HHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 357899999999999999999974 5667777754331 122222 368999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ...+++.++..++.|++.||.|||++||+|+||||+||+++
T Consensus 80 --------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 140 (267)
T cd06645 80 --------------KLWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred --------------EEEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 34999999999999999875 34689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+....... .......|+..|+|||++... ....++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~DvwSlG~il~~l 202 (267)
T cd06645 141 DN-------GHVKLADFGVSAQITATI----------AKRKSFIGTPYWMAPEVAAVE-RKGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred CC-------CCEEECcceeeeEccCcc----------cccccccCcccccChhhhccc-cCCCCCchhhhHHHHHHHHHH
Confidence 77 789999999986543211 111234689999999997521 124577899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|..||...........+......... . ......+..+.+++.+||..||++||++
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 259 (267)
T cd06645 203 AELQPPMFDLHPMRALFLMTKSNFQPPK--L---------------------KDKMKWSNSFHHFVKMALTKNPKKRPTA 259 (267)
T ss_pred hcCCCCcccccchhhHHhhhccCCCCCc--c---------------------cccCCCCHHHHHHHHHHccCCchhCcCH
Confidence 9999998754433322222111110000 0 0001334568999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
+++++|+|
T Consensus 260 ~~ll~~~~ 267 (267)
T cd06645 260 EKLLQHPF 267 (267)
T ss_pred HHHhcCCC
Confidence 99999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=322.96 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=201.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|.+ .+..+++|...... ....+. +.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKEL----IINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHH----HHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36799999999999999999987 46677777654321 112222 378999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++
T Consensus 90 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~ 149 (297)
T cd06656 90 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149 (297)
T ss_pred --------------EEEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 34999999999999999865 3588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 150 ~~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slGvil~~l 208 (297)
T cd06656 150 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 208 (297)
T ss_pred CC-------CCEEECcCccceEccCCcc----------CcCcccCCccccCHHHHcC----CCCCcHHHHHHHHHHHHHH
Confidence 77 7899999999865432111 1123458889999999876 5578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||...+.......+.....+... .....+..+.+++.+||..||.+||++
T Consensus 209 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~ 263 (297)
T cd06656 209 VEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPERLSAVFRDFLNRCLEMDVDRRGSA 263 (297)
T ss_pred HhCCCCCCCCCcchheeeeccCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcCH
Confidence 9999999765433222111111111100 011345668999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 001143 1123 GDLYEMFVARTSSS 1136 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s~ 1136 (1141)
.++++|+|+.....
T Consensus 264 ~~il~~~~~~~~~~ 277 (297)
T cd06656 264 KELLQHPFLKLAKP 277 (297)
T ss_pred HHHhcCchhccccc
Confidence 99999999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.76 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=186.8
Q ss_pred eeecccCceEEEEEEEC-C---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG-S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~-~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
+.||+|+||.||+|... . ..+++|. +... ....... .+.+|+.+++.++||||+++++.+.+...
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~--~~~~-~~~~~~~----~~~~e~~~~~~l~h~nii~~~~~~~~~~~---- 69 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKE--LRAS-ATPDEQL----LFLQEVQPYRELNHPNVLQCLGQCIESIP---- 69 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEee--cCcc-CChHHHH----HHHHHHHHHHhCCCCCcceEEEEECCCCc----
Confidence 46999999999999752 2 2334443 2221 1222222 34789999999999999999999876543
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.++||||+++|+|.+++...........++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--- 136 (269)
T cd05042 70 ----------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD--- 136 (269)
T ss_pred ----------eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---
Confidence 4999999999999999976432223345788889999999999999999999999999999999887
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc---CCCCCCchhhHHHHHHHHHHHHh
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||++......... .......+++.|+|||++.... ....++.++|||||||++|||++
T Consensus 137 ----~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 137 ----LSVKIGDYGLALEQYPEDYY--------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ----CcEEEeccccccccccchhe--------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 78999999998643221100 0112234677899999975421 12456789999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|..||......+....+.......++. +......+..+.+++..|| .||++|||++
T Consensus 205 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 205 AADQPYPDLSDEQVLKQVVREQDIKLPK----------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred CCCCCCCcCCHHHHHHHHhhccCccCCC----------------------CcccccCCHHHHHHHHHHh-cCcccccCHH
Confidence 788998766555544443322222111 0111145566788899998 5999999999
Q ss_pred HHHHHH
Q 001143 1124 DLYEMF 1129 (1141)
Q Consensus 1124 ElL~~L 1129 (1141)
+|++.+
T Consensus 262 ~v~~~l 267 (269)
T cd05042 262 EVHELL 267 (269)
T ss_pred HHHHHh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=318.75 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=199.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~ 881 (1141)
...|++.+.||+|+||.||+|.+. +..+++|+.... ......+ ..|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~----~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEI----KLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHH----HHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 357899999999999999999984 456777765332 1222233 6899999998 699999999998643
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. .......++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 86 ~~--------~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili 154 (282)
T cd06636 86 SP--------PGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL 154 (282)
T ss_pred cc--------cCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 21 11233679999999999999998752 23458889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ 1040 (1141)
+.+ +.++|+|||.+........ ......|++.|+|||.+.... ....++.++|||||||++|
T Consensus 155 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~ 217 (282)
T cd06636 155 TEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAI 217 (282)
T ss_pred CCC-------CCEEEeeCcchhhhhcccc----------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHH
Confidence 877 7899999999865432110 122346899999999976321 1245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|..||...........+.....+... ....+..+.++|.+||..||.+||
T Consensus 218 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp 271 (282)
T cd06636 218 EMAEGAPPLCDMHPMRALFLIPRNPPPKLK--------------------------SKKWSKKFIDFIEGCLVKNYLSRP 271 (282)
T ss_pred HHHhCCCCccccCHHhhhhhHhhCCCCCCc--------------------------ccccCHHHHHHHHHHhCCChhhCc
Confidence 999999999765543333222221111100 013556799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
|+.|+++|+|+
T Consensus 272 ~~~ell~~~~~ 282 (282)
T cd06636 272 STEQLLKHPFI 282 (282)
T ss_pred CHHHHhcCCCC
Confidence 99999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=314.61 Aligned_cols=269 Identities=25% Similarity=0.360 Sum_probs=205.7
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~ 879 (1141)
...++|++.+.||+|++|.||+|.+. +..+++|+..... ...+. +.+|+.+++++ .||||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEE----IKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHH----HHHHHHHHHHhcCCCChheEEEEEE
Confidence 44678999999999999999999984 4567777754321 12233 37899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
..... ......++||||+++++|.+++...... ...+++..+..++.|++.||.|||++|++||||+|+||
T Consensus 74 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 74 KKNPP--------GNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred ecCCC--------CcceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 64420 1234579999999999999998764322 34689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGvi 1038 (1141)
+++.+ +.++|+|||.+........ ......|+..|+|||++.... ....++.++|||||||+
T Consensus 145 ~~~~~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 145 LLTKN-------AEVKLVDFGVSAQLDSTLG----------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred EEccC-------CeEEECCCccceecccchh----------hhcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 99887 7899999999865432111 112345899999999986422 23456789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|+.||...........+.....+.... ....+..+.+++.+||..||.+
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~ 262 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPTLKS-------------------------PENWSKKFNDFISECLIKNYEQ 262 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCCCCc-------------------------hhhcCHHHHHHHHHHhhcChhh
Confidence 999999999997655444433333222211110 0134567999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
|||+.++++|+|.
T Consensus 263 Rpt~~~ll~~~~~ 275 (275)
T cd06608 263 RPFMEELLEHPFI 275 (275)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999884
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.50 Aligned_cols=270 Identities=26% Similarity=0.303 Sum_probs=205.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|++|+||+|... +..+++|...... ... ......+..|+++++.++||||+++++.+.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE--MIK---RNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc--cch---HHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 36899999999999999999984 4667777654321 111 111223478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+.+++|.+++.. .....+++..+..++.||+.||+|||+.|++||||||+||+++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 75 -------------YLCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred -------------EEEEEEEecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 35999999999999999875 22346999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccc-------------------cCCCCCCCCccCCCcccchhhhccccCCC
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-------------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1024 (1141)
+ +.++|+|||++............. ...........||..|+|||++.+ .
T Consensus 139 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~ 207 (316)
T cd05574 139 S-------GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG----D 207 (316)
T ss_pred C-------CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC----C
Confidence 7 789999999987543221100000 000011223468999999999876 4
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1025 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1025 ~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
.++.++||||||+++|+|++|+.||.+.+.......+..... ..+. ....+..+
T Consensus 208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~ 261 (316)
T cd05574 208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-TFPG-------------------------SPPVSSSA 261 (316)
T ss_pred CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-cCCC-------------------------ccccCHHH
Confidence 578999999999999999999999987665554443322111 0000 00246679
Q ss_pred HHHHHHhcccCCCCCCC----HHHHHHHHHhhcC
Q 001143 1105 VDVFRRCTEENPTERPT----AGDLYEMFVARTS 1134 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPS----a~ElL~~L~~~~~ 1134 (1141)
.+++.+||..||++||| ++|+++|+|+...
T Consensus 262 ~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 99999999999999999 9999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=336.62 Aligned_cols=278 Identities=20% Similarity=0.255 Sum_probs=196.7
Q ss_pred CCceEeeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+|++.+.||+|+||.||+|...+ ..+++|.. ... .. ..+|+.++++++|||||++++++...
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~--~~~-------~~----~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--TGG-------KT----PGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEec--ccc-------cc----HHHHHHHHHhcCCCCccceeeeEeeC
Confidence 469999999999999999997633 34555543 211 11 15799999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 159 ~--------------~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill 218 (392)
T PHA03207 159 S--------------TVCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL 218 (392)
T ss_pred C--------------EEEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 4 3499999996 789888854 3469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 219 ~~~-------~~~~l~DfG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~e 279 (392)
T PHA03207 219 DEP-------ENAVLGDFGAACKLDAHPDT--------PQCYGWSGTLETNSPELLAL----DPYCAKTDIWSAGLVLFE 279 (392)
T ss_pred cCC-------CCEEEccCccccccCccccc--------ccccccccccCccCHhHhcC----CCCCchhhHHHHHHHHHH
Confidence 887 78999999998765432111 11123569999999999876 567899999999999999
Q ss_pred HHhCCCCCCCCCH----HHHHHHHHhCCCCCc--hhHHh-hhccCccccccccCCCCCCch--hhhhhHHHHHHHHHHhc
Q 001143 1042 LLTLQVPYMGLSE----LEIHDLIQMGKRPRL--TDELE-ALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~----~el~~~I~~~~~p~l--~~~l~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~L~dLI~~cL 1112 (1141)
|++|+.||.+... ..+...+........ +.... ................+..+. .....+.++.++|.+||
T Consensus 280 l~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml 359 (392)
T PHA03207 280 MSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKML 359 (392)
T ss_pred HHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHh
Confidence 9999999976432 122222221111111 00000 000000000000000011110 01134567889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCC
Q 001143 1113 EENPTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~~~~~s 1135 (1141)
..||.+|||+.|++.|+||....
T Consensus 360 ~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 360 TFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred ccChhhCCCHHHHhhCchhhccc
Confidence 99999999999999999997543
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.87 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=201.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~---------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 874 (1141)
.++|.+.+.||+|+||.||+|.+.+ ..+|+|+.... ........ +..|+.+++++ +||||+++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~----~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSD----LISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHH----HHHHHHHHHHhcCCCCEeeE
Confidence 3679999999999999999998632 24677764322 11222233 37899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~y 943 (1141)
++++..... .++||||+++++|.+++...... ....+++.+++.++.||+.||+|
T Consensus 90 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 155 (307)
T cd05098 90 LGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155 (307)
T ss_pred EEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 999876543 49999999999999999763211 12358999999999999999999
Q ss_pred HHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 944 LHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
||++|++||||||+||+++.+ +.+||+|||.+.......... ......+++.|+|||++.+
T Consensus 156 lH~~gi~H~dlkp~Nill~~~-------~~~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 216 (307)
T cd05098 156 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD---- 216 (307)
T ss_pred HHHCCcccccccHHheEEcCC-------CcEEECCCcccccccccchhh--------ccccCCCccceeChHHhcc----
Confidence 999999999999999999877 789999999987543211100 0011224568999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 001143 1024 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1102 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1141)
..++.++|||||||++|+|++ |..||.+....++...+........+ ...+.
T Consensus 217 ~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 269 (307)
T cd05098 217 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP---------------------------SNCTN 269 (307)
T ss_pred CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCH
Confidence 567899999999999999998 89999877666666655443322111 13456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
++.+++.+||..+|.+|||+.++++++.....
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 78999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=314.87 Aligned_cols=265 Identities=22% Similarity=0.348 Sum_probs=200.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
.++|++.++||+|+||.||+|.+. +..+|+|.. .... ....... +.+|+.+++.++||||++++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~--~~~~-~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESA-SLRERIE----FLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEEC--CCcC-CHHHHHH----HHHHHHHHHhCCCCCeeeEEEE
Confidence 467999999999999999999753 224566653 2211 1222222 3789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHr 952 (1141)
+.+... .++||||+++|+|.++++..... +...++...+..++.||+.||.|||+++|+||
T Consensus 78 ~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~ 143 (288)
T cd05061 78 VSKGQP--------------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHR 143 (288)
T ss_pred EcCCCC--------------cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 876543 39999999999999999763221 12346778899999999999999999999999
Q ss_pred CCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001143 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032 (1141)
Q Consensus 953 DLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1032 (1141)
||||+||+++.+ +.++|+|||+++........ .......++..|+|||.+.+ ..++.++||
T Consensus 144 dikp~nili~~~-------~~~~L~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv 204 (288)
T cd05061 144 DLAARNCMVAHD-------FTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTSSDM 204 (288)
T ss_pred CCChheEEEcCC-------CcEEECcCCccccccccccc--------cccCCCcccccccCHHHhcc----CCCChHhHH
Confidence 999999999887 78999999998754321110 01112235678999999876 467899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001143 1033 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111 (1141)
Q Consensus 1033 WSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~c 1111 (1141)
|||||++|||++ |..||.+....+....+..+..+..+ ...+..+.+++.+|
T Consensus 205 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~ 257 (288)
T cd05061 205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP---------------------------DNCPERVTDLMRMC 257 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHH
Confidence 999999999998 78999877766665555433322111 13346799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCCC
Q 001143 1112 TEENPTERPTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1112 L~~DP~~RPSa~ElL~~L~~~~~s~ 1136 (1141)
|+.||++|||+.++++.+......+
T Consensus 258 l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 258 WQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred cCCChhHCcCHHHHHHHHHhhcCCC
Confidence 9999999999999999776654433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=316.85 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=197.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIVkllg~~~~~~ 882 (1141)
++|++.+.||+|+||.||+|.+. +..+|+|..... ...... .. +..|+.+ ++.++||||+++++++..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~-~~----~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQ-KR----LLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecC--CCcHHH-HH----HHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 47899999999999999999985 566777764332 222222 22 2456665 45668999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NILl 961 (1141)
. .++||||++ ++|.++++..... ...+++..++.++.||+.||+|||++ +++||||||+||++
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 74 D--------------VWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred c--------------EEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 3 499999997 7999888764322 35799999999999999999999997 99999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.+..+.... ......++..|+|||.+.+......++.++|+|||||++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 138 NRN-------GQVKLCDFGISGYLVDSV-----------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCC-------CCEEEeeccccccccccc-----------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 887 789999999987543211 11123578899999998753333456889999999999999
Q ss_pred HHhCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++|+.||.... ..+....+.....+..+. ...+.++.+++.+||..+|.+||
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVEEPSPQLPA--------------------------EKFSPEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCc
Confidence 999999996422 222222222222111110 13456799999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001143 1121 TAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~s~ 1136 (1141)
++.++++|+|+.....
T Consensus 254 ~~~~il~~~~~~~~~~ 269 (283)
T cd06617 254 NYPELLQHPFFELHLS 269 (283)
T ss_pred CHHHHhcCchhhhccc
Confidence 9999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.47 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
++||+|+||.||+|.+.. ..+++|+.. ..... ...+ .+.+|+.+++++.||||+++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~--~~~~~-~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIA-AGKK----EFLREASVMAQLDHPCIVRLIGVCKGE----- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecc--cccch-HHHH----HHHHHHHHHHhcCCCCeeeEEEEEcCC-----
Confidence 479999999999998743 345666543 22111 2222 347899999999999999999986532
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||.++++||||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-- 131 (257)
T cd05060 69 ----------PLMLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-- 131 (257)
T ss_pred ----------ceEEEEEeCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC--
Confidence 24899999999999999976 2368999999999999999999999999999999999999887
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1045 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1045 (1141)
+.+||+|||.++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |
T Consensus 132 -----~~~kl~df~~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~~g 195 (257)
T cd05060 132 -----HQAKISDFGMSRALGAGSDYY-------RATTAGRWPLKWYAPECINY----GKFSSKSDVWSYGVTLWEAFSYG 195 (257)
T ss_pred -----CcEEeccccccceeecCCccc-------ccccCccccccccCHHHhcC----CCCCccchHHHHHHHHHHHHcCC
Confidence 789999999987654322110 01111224567999999875 567899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
..||...+..+....+........+ ..++..+.+++.+||..||.+||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 196 AKPYGEMKGAEVIAMLESGERLPRP---------------------------EECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred CCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9999877766666665443321111 1345678999999999999999999999
Q ss_pred HHHHHhh
Q 001143 1126 YEMFVAR 1132 (1141)
Q Consensus 1126 L~~L~~~ 1132 (1141)
++.+...
T Consensus 249 ~~~l~~~ 255 (257)
T cd05060 249 ESTFRRD 255 (257)
T ss_pred HHHHHhc
Confidence 9987653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.42 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=199.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++.+|++.+.||+|+||.||++...+..+++|+..... ..+. +.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~------~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV------TAQA----FLEETAVMTKLHHKNLVRLLGVILHNG- 72 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc------hHHH----HHHHHHHHHhCCCCCcCeEEEEEcCCC-
Confidence 35679999999999999999999888889988754321 1223 378999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++.. .....+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 73 --------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 73 --------------LYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred --------------cEEEEECCCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 3899999999999999976 23346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+....... .....+..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 136 D-------GVAKVSDFGLARVGSMGV-------------DNSKLPVKWTAPEALKH----KKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred C-------CcEEECCCccceeccccC-------------CCCCCCceecCHHHhcc----CCcCchhhHHHHHHHHHHHH
Confidence 7 789999999986532210 11224567999999875 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||......+....+..+..+... ...+..+.+++.+||+.+|.+||++
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 244 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKGYRMEPP---------------------------EGCPADVYVLMTSCWETEPKKRPSF 244 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCcCH
Confidence 8 99999877766665555443222111 1445678999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
+++++.+.
T Consensus 245 ~~l~~~l~ 252 (254)
T cd05083 245 HKLREKLE 252 (254)
T ss_pred HHHHHHHc
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=333.25 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=197.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg 876 (1141)
-.+|.+.++||+|+||.||+|++.+ ..||+|+.+.. ......+. +.+|+.+++++. |||||++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~----~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQA----LMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHHH----HHHHHHHHHhcCCCCCeeeEEE
Confidence 4568999999999999999998632 24777764322 12222233 489999999996 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------------------------
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 920 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~------------------------------------ 920 (1141)
++.+... .++||||+++|+|.+++......
T Consensus 109 ~~~~~~~--------------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 109 ACTKSGP--------------IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred EEccCCc--------------eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 9976543 49999999999999998753210
Q ss_pred -------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001143 921 -------------------------------------------------------GEKHVSVKLALFIAQDVAAALVELH 945 (1141)
Q Consensus 921 -------------------------------------------------------~~~~Ls~~~i~~Ia~QIa~gL~yLH 945 (1141)
....+++..+..++.||+.||+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1135788899999999999999999
Q ss_pred HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 946 s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
+++|+||||||+|||++.+ +.+||+|||+++........ .......+++.|+|||.+.+ ..
T Consensus 255 ~~~ivH~dikp~Nill~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 315 (400)
T cd05105 255 SKNCVHRDLAARNVLLAQG-------KIVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFD----NL 315 (400)
T ss_pred hCCeeCCCCChHhEEEeCC-------CEEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcC----CC
Confidence 9999999999999999887 78999999998764322110 11123346788999999876 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1141)
++.++|||||||++|+|++ |..||....... ....+..+..+..+ ...+..
T Consensus 316 ~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 368 (400)
T cd05105 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP---------------------------DHATQE 368 (400)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------ccCCHH
Confidence 7899999999999999997 999997644332 22333322211110 145567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+++.+||+.||++||++.+|.+.+...
T Consensus 369 l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 369 VYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.75 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=198.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|+||.||+|.+. +..+++|...... ......+. +.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK--MPVKEKEA----SKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh--ccchhhHH----HHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 5889999999999999999984 4566777654321 11122223 378999999999999999999887654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.+ .....+++..+..++.||+.||.|||+.+++|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 73 ------------RLFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 34999999999999999875 223358999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
. ..++|+|||.+........ ......|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 138 G------MVAKLGDFGIARQLNDSME----------LAYTCVGTPYYLSPEICQN----RPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred C------CeEEecccccchhccCCcc----------cccccCCCccccCHHHHcC----CCCCchhhHHHHHHHHHHHHh
Confidence 2 3579999999876533111 1123458899999999875 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...+..+....+.....+... ...+..+.+++.+||..+|++|||+.+
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYFAPIS---------------------------PNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCC---------------------------CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999876555444433322211110 134456999999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
+++|+|+
T Consensus 251 ll~~~~~ 257 (257)
T cd08225 251 ILKRPFL 257 (257)
T ss_pred HhhCCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.76 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=199.3
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.+|++.+.||+|++|.||+|.+ .+..+++|...... ........ .+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-LMDAKARA----DCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-hhhHHHHH----HHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 46789999999999999999997 45667777543221 11112222 3478999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+++++|.+++..... ....+++..++.++.||+.||.|||++|++|+||||+||+++
T Consensus 76 ~--------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 140 (267)
T cd08229 76 E--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 3 4999999999999999875322 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 141 AT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECcchhhhccccCCc----------ccccccCCcCccCHHHhcC----CCccchhhHHHHHHHHHHH
Confidence 77 7899999999865432111 1123458899999999875 4577899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1043 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1043 LTGk~Pf~~~~~--~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
++|..||.+... .+....+.....+..+ ....+..+.+++.+||+.||.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLP--------------------------SDHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCC--------------------------cccccHHHHHHHHHhcCCCcccCC
Confidence 999999975432 2222332222211111 014566799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
|+.+|++.+..
T Consensus 254 t~~~i~~~~~~ 264 (267)
T cd08229 254 DITYVYDVAKR 264 (267)
T ss_pred CHHHHHHHHhh
Confidence 99999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.44 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=196.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
-.+|++.++||+|+||.||+|.+.+ ..+++|+.. ..... .+. +.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~--~~~~~---~~~----~~~E~~~l~~l~~~~i~~~~~~~~~~-- 73 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-- 73 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecc--cCccC---HHH----HHHHHHHHHhCCCCCcceEEEEECCC--
Confidence 3569999999999999999998854 356666543 21111 123 37899999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.++++. .....+++..+..++.|++.||.|||+.+|+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~ 137 (262)
T cd05071 74 -------------PIYIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 137 (262)
T ss_pred -------------CcEEEEEcCCCCcHHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC
Confidence 23899999999999999975 22345899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.+..+...... ......++..|+|||+..+ ..++.++|||||||++|+|+
T Consensus 138 ~-------~~~~L~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l~ell 197 (262)
T cd05071 138 N-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELT 197 (262)
T ss_pred C-------CcEEeccCCceeeccccccc---------cccCCcccceecCHhHhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999999765432111 1112346778999998865 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |..||.+....+....+......... ...+..+.+++.+||+.||++||++
T Consensus 198 t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rp~~ 250 (262)
T cd05071 198 TKGRVPYPGMVNREVLDQVERGYRMPCP---------------------------PECPESLHDLMCQCWRKEPEERPTF 250 (262)
T ss_pred cCCCCCCCCCChHHHHHHHhcCCCCCCc---------------------------cccCHHHHHHHHHHccCCcccCCCH
Confidence 9 88899876666655554333211110 1445678999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
.++++.+.
T Consensus 251 ~~~~~~l~ 258 (262)
T cd05071 251 EYLQAFLE 258 (262)
T ss_pred HHHHHHHH
Confidence 99998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=319.04 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=193.2
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||+|.+ .+..+++|+..... .....+. +.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQ----IMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHH----HHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 3688999999999999999987 45567777654321 1222233 4789999999999999999999987553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+||+++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 74 --------------ISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred --------------EEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 48999999999986542 4788899999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++....... .....||..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 131 ~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~ 187 (279)
T cd06619 131 R-------GQVKLCDFGVSTQLVNSI------------AKTYVGTNAYMAPERISG----EQYGIHSDVWSLGISFMELA 187 (279)
T ss_pred C-------CCEEEeeCCcceeccccc------------ccCCCCChhhcCceeecC----CCCCCcchHHHHHHHHHHHH
Confidence 7 789999999986543211 123468999999999876 45789999999999999999
Q ss_pred hCCCCCCCCCHH-------HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1044 TLQVPYMGLSEL-------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1044 TGk~Pf~~~~~~-------el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|+.||...... .....+.....+.. .....+.++.+++.+||+.||
T Consensus 188 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 188 LGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--------------------------PVGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred hCCCCchhhcccccccchHHHHHHHhccCCCCC--------------------------CCCcCCHHHHHHHHHHhhCCh
Confidence 999999642211 11111111110000 001345678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
++||++.++++|+|+...
T Consensus 242 ~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 242 KERPAPENLMDHPFIVQY 259 (279)
T ss_pred hhCCCHHHHhcCcccccc
Confidence 999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=332.60 Aligned_cols=270 Identities=19% Similarity=0.223 Sum_probs=190.0
Q ss_pred CCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++.+. .+|+|+. ... . ...|+.++++++||||+++++++.....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~--~~~--------~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIG--QKG--------T----TLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeC--Ccc--------c----cHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 4699999999999999999998654 5666642 110 1 1469999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+. ++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 132 --------------~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 192 (357)
T PHA03209 132 --------------TCMVLPHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND 192 (357)
T ss_pred --------------eEEEEEccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 499999996 788888864 2346999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 193 ~-------~~~kl~DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 193 V-------DQVCIGDLGAAQFPVVAP-----------AFLGLAGTVETNAPEVLAR----DKYNSKADIWSAGIVLFEML 250 (357)
T ss_pred C-------CCEEEecCccccccccCc-----------ccccccccccccCCeecCC----CCCCchhhHHHHHHHHHHHH
Confidence 7 789999999986432111 1113458999999999876 56889999999999999999
Q ss_pred hCCCCC-CCCCH----------HHHHHHHHhCC-CC-CchhHHhhhccCccccccc----cCCCCCC--chhhhhhHHHH
Q 001143 1044 TLQVPY-MGLSE----------LEIHDLIQMGK-RP-RLTDELEALGSCHEHEVAQ----SGSGFEK--PEAELETLSFL 1104 (1141)
Q Consensus 1044 TGk~Pf-~~~~~----------~el~~~I~~~~-~p-~l~~~l~~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~L 1104 (1141)
++..|+ ..... ..+...+.... .+ .++... . ......+.. ....... .......+.++
T Consensus 251 ~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (357)
T PHA03209 251 AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP--G-SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDG 327 (357)
T ss_pred HcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC--c-cHHHHHHHhhcccCCCcccccHHHhccCCCchH
Confidence 865544 32111 11122221111 11 000000 0 000000000 0000000 00011345667
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.++|.+||+.||.+||||.|+++|+||+.
T Consensus 328 ~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 328 EFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 88999999999999999999999999974
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.26 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=201.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|.+. +..+++|..+..... .....+. +.+|+.++++++|+||+++++++....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~----~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQD----CLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHH----HHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 57999999999999999999984 667788765432211 1122233 479999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++..... ....+++..+..++.||+.||.|||+.||+||||+|+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~ 141 (267)
T cd08224 76 -------------ELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA 141 (267)
T ss_pred -------------eEEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC
Confidence 34999999999999999976432 2346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 142 T-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred C-------CcEEEeccceeeeccCCCc----------ccceecCCccccCHHHhcc----CCCCchhcHHHHHHHHHHHH
Confidence 7 7899999999875433111 1112357889999999875 55788999999999999999
Q ss_pred hCCCCCCCCC--HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1044 TLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+|+.||.... ..+..+.+..+..+..+. ...+..+.+++.+||..+|.+|||
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~cl~~~p~~Rp~ 254 (267)
T cd08224 201 ALQSPFYGDKMNLYSLCKKIEKCDYPPLPA--------------------------DHYSEELRDLVSRCINPDPEKRPD 254 (267)
T ss_pred HCCCCcccCCccHHHHHhhhhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCcccCCC
Confidence 9999996532 222333333222221110 134557899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
+.+|++.+...
T Consensus 255 ~~~il~~~~~~ 265 (267)
T cd08224 255 ISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHHHHh
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=338.93 Aligned_cols=274 Identities=19% Similarity=0.267 Sum_probs=195.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-..|.+.+.||+|+||.||+|.+.. ..|++|.. .. .. +.+|++++++++|||||++++++...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~--~~--------~~----~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAG--WY--------AS----SVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecc--cc--------cC----HHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 3469999999999999999999864 44555531 10 11 258999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++|||++. ++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 234 --------------~~~lv~e~~~-~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 234 --------------LTCLVLPKYR-SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred --------------EEEEEEEccC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 3499999995 799888864 123699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 295 ~~-------~~vkL~DFGla~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~sDvwSlGviL~El 355 (461)
T PHA03211 295 GP-------EDICLGDFGAACFARGSWST--------PFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFEA 355 (461)
T ss_pred CC-------CCEEEcccCCceeccccccc--------ccccccCCCcCCcCHHHHcC----CCCCchHHHHHHHHHHHHH
Confidence 77 78999999999765321111 11123469999999999976 5688999999999999999
Q ss_pred HhCCCCCCCC--------CHHHHHHHHHhCCCC--Cchh----HH-hhhccCccccccccCCCCCCchh--hhhhHHHHH
Q 001143 1043 LTLQVPYMGL--------SELEIHDLIQMGKRP--RLTD----EL-EALGSCHEHEVAQSGSGFEKPEA--ELETLSFLV 1105 (1141)
Q Consensus 1043 LTGk~Pf~~~--------~~~el~~~I~~~~~p--~l~~----~l-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~L~ 1105 (1141)
++|..|+... ...++...+...... .++. .+ ..... ............+.+ ....+..+.
T Consensus 356 ~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (461)
T PHA03211 356 AVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH---RAARNRRPAYTRPAWTRYYKLDLDVE 432 (461)
T ss_pred HHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHh---hhhcccCCccCCcchhhhccccchHH
Confidence 9987655321 123344444332221 1100 00 00000 000000000001111 113345789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1106 DVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1106 dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+||.+||+.||.+|||+.|+|+|+||..
T Consensus 433 dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 433 YLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 9999999999999999999999999964
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.40 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=203.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|++|.||+|.+. +..+++|+...... ..... ...+.+|++++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQ----VEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhH----HHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 46899999999999999999984 56677776542211 01111 233479999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.
T Consensus 75 -------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 75 -------------NLYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred -------------eEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 34999999999999999976 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 137 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 192 (290)
T cd05580 137 D-------GYIKITDFGFAKRVKGR-------------TYTLCGTPEYLAPEIILS----KGYGKAVDWWALGILIYEML 192 (290)
T ss_pred C-------CCEEEeeCCCccccCCC-------------CCCCCCCccccChhhhcC----CCCCccccHHHHHHHHHHHH
Confidence 7 78999999998764321 113358899999999875 45678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP--- 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP--- 1120 (1141)
+|+.||......+....+..+.. .++. ..+..+.+++.+||..||.+|+
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 193 AGYPPFFDDNPIQIYEKILEGKV-RFPS---------------------------FFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCc-cCCc---------------------------cCCHHHHHHHHHHccCCHHHccCcc
Confidence 99999987665555555443221 1110 2345689999999999999999
Q ss_pred --CHHHHHHHHHhhcCC
Q 001143 1121 --TAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1121 --Sa~ElL~~L~~~~~s 1135 (1141)
+++|+++|+|+....
T Consensus 245 ~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 245 KNGVNDIKNHPWFAGID 261 (290)
T ss_pred cCCHHHHHcCcccccCC
Confidence 999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=319.58 Aligned_cols=288 Identities=21% Similarity=0.226 Sum_probs=207.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
++++|++.+.||+|+||.||+|.+. +..+|+|+.+.+.... ... ..+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIP----ISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCc----chhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 5778999999999999999999984 6678888765442211 111 1225799999999999999999998753
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. ...++||||+. ++|.+++... ...+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 79 ~~------------~~~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 141 (309)
T cd07845 79 HL------------DSIFLVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141 (309)
T ss_pred CC------------CeEEEEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 21 24599999997 6898888752 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.+........ ......+++.|+|||.+.+ ...++.++|||||||++|+
T Consensus 142 ~~~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 142 TDK-------GCLKIADFGLARTYGLPAK----------PMTPKVVTLWYRAPELLLG---CTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CCC-------CCEEECccceeeecCCccC----------CCCcccccccccChhhhcC---CCCcCchHHHHHHHHHHHH
Confidence 887 7899999999876543211 1112245788999999865 2356789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcc-ccccccCCCCCC-chhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEK-PEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|++|+.||.+.+..+....+...........+........ ..+......... .......++.+.++|.+||++||++|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 9999999988777776665543222211111111000000 000000000000 00011246778999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||+.+++.|+|+...
T Consensus 282 ~t~~~il~h~~f~~~ 296 (309)
T cd07845 282 ATAEEALESSYFKEK 296 (309)
T ss_pred cCHHHHhcChhhccC
Confidence 999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=325.37 Aligned_cols=285 Identities=17% Similarity=0.209 Sum_probs=203.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|.+. +..+|+|+.. ...........+ .+|+.++++++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS--RPFQNVTHAKRA----YRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecC--ccccChhHHHHH----HHHHHHHHhcCCCCCcceeeeeccCC
Confidence 567999999999999999999974 5566777542 222222222233 68999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.+ ......|+||||+. ++|.+.+.. .++...+..++.||+.||+|||++||+||||||+||+++
T Consensus 89 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~ 152 (353)
T cd07850 89 SL--------EEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152 (353)
T ss_pred Cc--------cccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 22 12235699999996 688888764 388999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.+....... ......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 153 ~~-------~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 153 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred CC-------CCEEEccCccceeCCCCC-----------CCCCCcccccccCHHHHhC----CCCCCchhhHhHHHHHHHH
Confidence 87 789999999997643311 1112357889999999876 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc-----------cccccccCCCC----CCchhhhhhHHHHHHH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-----------EHEVAQSGSGF----EKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-----------~~~~~~~~~~~----~~~~~~~~~~~~L~dL 1107 (1141)
++|+.||...+.......+................... ...+.+..... .........+..++++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 99999998776655444442211111111111100000 00000000000 0000011346678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+.+||+.||++|||+.|+++|+|+..
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHhh
Confidence 99999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=312.15 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=187.4
Q ss_pred eeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
+.||+|+||.||+|.+.+ ..+++|. ++.... ...... +.+|+.++++++||||+++++++.+...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~--~~~~~~-~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 69 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE--LRVSAS-VQEQMK----FLEEAQPYRSLQHSNLLQCLGQCTEVTP---- 69 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEe--cCCCCC-hHHHHH----HHHHHHHHHhCCCCCEeeEEEEEcCCCC----
Confidence 468999999999998643 2345554 332221 122223 4789999999999999999999876543
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.++||||+++++|.++++.........+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~--- 136 (269)
T cd05087 70 ----------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD--- 136 (269)
T ss_pred ----------cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---
Confidence 3999999999999999976433333457788889999999999999999999999999999999887
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC---CCCCCchhhHHHHHHHHHHHHh
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||.+......... .......++..|+|||++.+... ...++.++||||||+++|||++
T Consensus 137 ----~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 137 ----LTVKIGDYGLSHNKYKEDYY--------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ----CcEEECCccccccccCccee--------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 78999999998643221110 01123357788999999864211 1235789999999999999996
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|..||......+.............. .+......++.+.+++..|| .+|++|||++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 205 LGSQPYRHLSDEQVLTYTVREQQLKLP----------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred CCCCCCCCCChHHHHHHHhhcccCCCC----------------------CCccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 99999876555443332221111111 01111134556889999999 6899999999
Q ss_pred HHHHHHH
Q 001143 1124 DLYEMFV 1130 (1141)
Q Consensus 1124 ElL~~L~ 1130 (1141)
||+..|.
T Consensus 262 ~l~~~l~ 268 (269)
T cd05087 262 EVHLLLS 268 (269)
T ss_pred HHHHHhc
Confidence 9998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.08 Aligned_cols=266 Identities=21% Similarity=0.306 Sum_probs=198.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 866 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~------------------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L 866 (1141)
..+|++.++||+|+||.||+|.+.. ..+++|+..... .....+. +.+|+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~----~~~e~~~l~~l 76 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNARED----FLKEVKILSRL 76 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHH----HHHHHHHHHhc
Confidence 4579999999999999999998643 235666543221 1222333 47899999999
Q ss_pred CCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------CCCCCCHHHHHHHHHHHHHH
Q 001143 867 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAA 940 (1141)
Q Consensus 867 ~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~------~~~~Ls~~~i~~Ia~QIa~g 940 (1141)
+||||+++++++..+.. .++||||+++++|.+++...... ....+++..++.++.|++.|
T Consensus 77 ~~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05051 77 SDPNIARLLGVCTVDPP--------------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG 142 (296)
T ss_pred CCCCEeEEEEEEecCCC--------------cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 99999999999876543 39999999999999999764311 12368999999999999999
Q ss_pred HHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccc
Q 001143 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020 (1141)
Q Consensus 941 L~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1020 (1141)
|.|||++||+||||||+||+++.+ +.++|+|||.+......... .......+++.|+|||++.+
T Consensus 143 l~~LH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 206 (296)
T cd05051 143 MRYLESLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLL- 206 (296)
T ss_pred HHHHHHcCccccccchhceeecCC-------CceEEccccceeecccCcce--------eecCcCCCCceecCHHHhhc-
Confidence 999999999999999999999887 78999999998754322110 01123346788999999876
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhh
Q 001143 1021 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098 (1141)
Q Consensus 1021 ~~~~~~s~ksDVWSLGviL~ELLT--Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1141)
..++.++|||||||++|||++ +..||......+....+......... .... ....
T Consensus 207 ---~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~-~~~~ 263 (296)
T cd05051 207 ---GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGR-------------------QIYL-PRPP 263 (296)
T ss_pred ---CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccc-------------------cccC-CCcc
Confidence 467899999999999999998 77888766655554443221100000 0000 0011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1099 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1099 ~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
..+.++.+++.+||+.||.+|||+.||++.|.
T Consensus 264 ~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 264 NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 34567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=317.38 Aligned_cols=252 Identities=28% Similarity=0.423 Sum_probs=197.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|+..+.||+|+||.||+|.+. +..+++|+..... .....+ .+.+|+.++++++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIE----DIQQEITVLSQCDSPYITRYYGSYLKGT-- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHH----HHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence 4778899999999999999874 4567777643221 112223 3479999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. ..+++..+..++.||+.|+.|||++|++|+||+|+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~ 137 (277)
T cd06642 76 ------------KLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137 (277)
T ss_pred ------------ceEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC
Confidence 34999999999999998864 368999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 138 -------GDVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIKQ----SAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEccccccccccCcch----------hhhcccCcccccCHHHhCc----CCCchhhhHHHHHHHHHHHHh
Confidence 7899999999876543111 1112357889999999876 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...........+.....+.+ ....+..+.+++.+||+.+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 197 GEPPNSDLHPMRVLFLIPKNSPPTL---------------------------EGQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred CCCCCcccchhhHHhhhhcCCCCCC---------------------------CcccCHHHHHHHHHHccCCcccCcCHHH
Confidence 9999976544443333222211111 1134567899999999999999999999
Q ss_pred HHHHHHhhc
Q 001143 1125 LYEMFVART 1133 (1141)
Q Consensus 1125 lL~~L~~~~ 1133 (1141)
+++|+|+..
T Consensus 250 il~~~~~~~ 258 (277)
T cd06642 250 LLKHKFITR 258 (277)
T ss_pred HHHhHHHHH
Confidence 999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=314.20 Aligned_cols=266 Identities=27% Similarity=0.383 Sum_probs=200.1
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|+..+.||+|++|.||+|.. .+..+++|+...... ...........+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN--TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccC--CchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 478889999999999999987 566788887543321 11122222344589999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
+.++||||+++++|.+++.+ ..++++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 77 ------------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 77 ------------HFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred ------------eEEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 34999999999999999976 2468999999999999999999999999999999999999765
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+ ..+||+|||.+..+...... .........++..|+|||.+.+ ..++.++||||+|+++|+|++
T Consensus 140 ~------~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 140 G------QRLRIADFGAAARLAAKGTG------AGEFQGQLLGTIAFMAPEVLRG----EQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred C------CEEEEccccccccccccccc------CCccccccccccceeCHhHhcc----CCCCcccchHHHHHHHHHHHh
Confidence 2 36999999998765432111 0011223458899999999875 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|..||...........+...... ...+......++++.+++.+||..+|.+||++.+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASA-----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhcc-----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999653322211111100000 0001111145567999999999999999999999
Q ss_pred HHHHHHhh
Q 001143 1125 LYEMFVAR 1132 (1141)
Q Consensus 1125 lL~~L~~~ 1132 (1141)
+++|+|++
T Consensus 261 ll~~~~~~ 268 (268)
T cd06630 261 LLKHPVFR 268 (268)
T ss_pred HhcCcccC
Confidence 99999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=317.18 Aligned_cols=279 Identities=20% Similarity=0.264 Sum_probs=198.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||.|++|.||+|++. +..+++|....+. ....... .+.+|++++++++||||+++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPS----TAIREISLLKELNHPNIVKLLDVIHTENK- 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc--cccccch----HHHHHHHHHHhcCCCCCcchhhhcccCCc-
Confidence 4889999999999999999984 5567777644322 1111112 33789999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.++||||+. ++|.+++.. .....+++..+..++.||+.||+|||+++++||||+|+||+++.+
T Consensus 74 -------------~~~v~e~~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 74 -------------LYLVFEFLH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred -------------EEEEeeccc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 499999996 689998865 233468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||.+......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 196 (284)
T cd07860 137 -------GAIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVT 196 (284)
T ss_pred -------CCEEEeeccchhhcccCccc----------cccccccccccCCeEEec---CCCCCcHHHHHHHHHHHHHHHH
Confidence 78999999998654321111 112346888999998765 2345789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccC--ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1045 LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSC--HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|+.||.+.+..+....+ .....+. ...++..... ....+... ............+..+.++|.+||+.||.+|||
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 274 (284)
T cd07860 197 RRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSLPDYKPSFPKW-ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS 274 (284)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCC-hhhhhhhhHHHHHHhhcccc-cccCHHHHcccCCHHHHHHHHHhcCCCcccCCC
Confidence 99999876654433333 3222221 1100000000 00000000 000000011134567899999999999999999
Q ss_pred HHHHHHHHHh
Q 001143 1122 AGDLYEMFVA 1131 (1141)
Q Consensus 1122 a~ElL~~L~~ 1131 (1141)
+.++++|+||
T Consensus 275 ~~~~l~~~~f 284 (284)
T cd07860 275 AKAALAHPFF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.58 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=198.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..+|++.+.||+|+||.||+|.+. +..+.++++.++... .....+.+ .+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHH----HHHHHHHHhCCCCCcceEEEEEecC
Confidence 457899999999999999999873 232333343343322 22223333 7899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. .++||||+++++|.+++.. . ...+++.++..++.||+.||.|||+++++||||||+||++
T Consensus 78 ~~--------------~~lv~e~~~~~~L~~~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili 139 (267)
T cd05066 78 KP--------------VMIVTEYMENGSLDAFLRK---H-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV 139 (267)
T ss_pred Cc--------------cEEEEEcCCCCCHHHHHHh---c-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE
Confidence 53 3999999999999999975 1 2368999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||.+..+....... .......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l~e 201 (267)
T cd05066 140 NSN-------LVCKVSDFGLSRVLEDDPEAA-------YTTRGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVMWE 201 (267)
T ss_pred CCC-------CeEEeCCCCccccccccccee-------eecCCCccceeecCHhHhcc----CccCchhhhHHHHHHHHH
Confidence 877 789999999997654321110 00111223568999999876 467899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+++ |..||......+....+..+..+... ...+..+.+++.+||+.+|.+||
T Consensus 202 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 254 (267)
T cd05066 202 VMSYGERPYWEMSNQDVIKAIEEGYRLPAP---------------------------MDCPAALHQLMLDCWQKDRNERP 254 (267)
T ss_pred HhcCCCCCcccCCHHHHHHHHhCCCcCCCC---------------------------CCCCHHHHHHHHHHcccCchhCC
Confidence 887 99999876666655555433221110 13456789999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
++.++++.+..
T Consensus 255 ~~~~i~~~l~~ 265 (267)
T cd05066 255 KFEQIVSILDK 265 (267)
T ss_pred CHHHHHHHHHh
Confidence 99999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.25 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
+.||+|+||.||+|.+. +..+++|+.... ... ...+. +.+|+.++..++|+||+++++++.....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--~~~-~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~~--- 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASE-EERKD----FLKEARVMKKLGHPNVVRLLGVCTEEEP--- 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccc--cch-hHHHH----HHHHHHHHhhcCCCChheeeeeecCCCc---
Confidence 47999999999999985 556777765422 111 12333 3799999999999999999999876443
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.++||||+++++|.+++...... ....+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 71 -----------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~ 139 (262)
T cd00192 71 -----------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG 139 (262)
T ss_pred -----------eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC
Confidence 49999999999999999862111 025799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.+......... .......+++.|+|||.+.. ..++.++||||+|+++|+|
T Consensus 140 ~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (262)
T cd00192 140 ED-------LVVKISDFGLSRDVYDDDYY--------RKKTGGKLPIRWMAPESLKD----GIFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred CC-------CcEEEccccccccccccccc--------ccccCCCcCccccCHHHhcc----CCcchhhccHHHHHHHHHH
Confidence 87 78999999999765432210 11123457889999999876 4678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |..||......+....+..+.....+ ...+.++.+++.+||+.||.+|||
T Consensus 201 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 201 FTLGATPYPGLSNEEVLEYLRKGYRLPKP---------------------------EYCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------ccCChHHHHHHHHHccCCcccCcC
Confidence 99 69999887776666666543222111 134567999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1122 AGDLYEMF 1129 (1141)
Q Consensus 1122 a~ElL~~L 1129 (1141)
+.|+++++
T Consensus 254 ~~~l~~~l 261 (262)
T cd00192 254 FSELVERL 261 (262)
T ss_pred HHHHHHhh
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=320.83 Aligned_cols=284 Identities=19% Similarity=0.258 Sum_probs=188.4
Q ss_pred eeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 811 CDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~~----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
..+||+|+||.||+|++.. ..+|+|.. ..... ... +.+|+.++++++||||+++++++.....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~--~~~~~----~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGI----SMS----ACREIALLRELKHPNVIALQKVFLSHSD--- 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEe--cCCCC----cHH----HHHHHHHHHhCCCCCeeeEEEEEeccCC---
Confidence 3689999999999999642 44666653 32111 112 3689999999999999999999864321
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~----~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
...++||||++ ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~ 142 (317)
T cd07867 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------CeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEc
Confidence 24699999997 688888753211 1123588999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+. ...+.+||+|||+++........ ........||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~~---~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 143 GEG---PERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCC---CCCCcEEEeeccceeccCCCccc-------ccccCcceecccccCcHHhcC---CCccCcHHHHHhHHHHHHHH
Confidence 331 12268999999999765432111 011223468999999999875 23578999999999999999
Q ss_pred HhCCCCCCCCCH----------HHHHHHHHhCCCCCchhHHhhhccCccc-cccc--cCCCCCC-------chhhhhhHH
Q 001143 1043 LTLQVPYMGLSE----------LEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQ--SGSGFEK-------PEAELETLS 1102 (1141)
Q Consensus 1043 LTGk~Pf~~~~~----------~el~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~--~~~~~~~-------~~~~~~~~~ 1102 (1141)
+||++||..... .+....+.....+.. ..+......... .... ....... +........
T Consensus 210 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07867 210 LTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPAD-KDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS 288 (317)
T ss_pred HhCCCCcccccccccccccccHHHHHHHHHhcCCCCh-hhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCCh
Confidence 999999964321 111111111111111 011100000000 0000 0000000 000112345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
.+.+|+.+||+.||.+|||+.|+++|+||
T Consensus 289 ~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 289 KVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 68899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=313.83 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=201.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|+..++||.|+||.||+|.+. +..+++|+..... ....... +.+|+.+++++.||||+++++++.+..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIED----IQQEITVLSQCDSPYVTKYYGSYLKGT-- 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 4788899999999999999874 5667777754321 1222333 378999999999999999999988654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. .++++..+..++.|++.||+|||+.+++|+||+|+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~ 137 (277)
T cd06640 76 ------------KLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ 137 (277)
T ss_pred ------------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC
Confidence 34999999999999999864 358899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~apE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06640 138 -------GDVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIQQ----SAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEcccccceeccCCcc----------ccccccCcccccCHhHhcc----CCCccHHHHHHHHHHHHHHHH
Confidence 7899999999865433110 1112357889999999875 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...........+.....+... ...+..+.+++.+||+.+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06640 197 GEPPNSDMHPMRVLFLIPKNNPPTLT---------------------------GEFSKPFKEFIDACLNKDPSFRPTAKE 249 (277)
T ss_pred CCCCCCCcChHhHhhhhhcCCCCCCc---------------------------hhhhHHHHHHHHHHcccCcccCcCHHH
Confidence 99999876655444433222222111 145667899999999999999999999
Q ss_pred HHHHHHhhcC
Q 001143 1125 LYEMFVARTS 1134 (1141)
Q Consensus 1125 lL~~L~~~~~ 1134 (1141)
+++|+|+...
T Consensus 250 il~~~~~~~~ 259 (277)
T cd06640 250 LLKHKFIVKN 259 (277)
T ss_pred HHhChHhhhc
Confidence 9999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=316.84 Aligned_cols=281 Identities=23% Similarity=0.288 Sum_probs=199.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||+|.+. +..+++|+.... .......+. +.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES--EDDKMVKKI----AMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhc--cCcchhhHH----HHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 46899999999999999999984 566777764322 111112222 378999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|..+... ...+++..++.++.||+.||.|||+.||+||||+|+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 74 -------------RLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred -------------eEEEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 34999999999888887654 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++..+..... ......++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 136 S-------GVVKLCDFGFARTLAAPGE----------VYTDYVATRWYRAPELLVG---DTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred C-------CcEEEEeeeeeeeccCCcc----------ccCcccceeeccCcHHhcc---ccccCchHhHHHHHHHHHHHH
Confidence 7 7899999999876433211 1123457889999999865 234678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC---ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||......+....+.................. .....................+..+.+++.+||+.+|++||
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred cCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 999999866554433333211111000000000000 00000000000000000124567799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
++.++++|+||
T Consensus 276 ~~~~il~~~~~ 286 (286)
T cd07846 276 SSSQLLHHEFF 286 (286)
T ss_pred hHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.45 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=200.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+. +..+++|..+... ....... +.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQ----IIMELDILHKAVSPYIVDFYGAFFIEG- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHH----HHHHHHHHHhcCCCcHHhhhhheecCC-
Confidence 46899999999999999999985 5667777644321 2222233 378999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 962 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|..+++.. .....+++..+..++.||+.||.|||+ .+|+||||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 73 -------------AVYMCMEYMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred -------------eEEEEEeecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 349999999999999998752 112368999999999999999999997 5999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLGviL~ 1040 (1141)
.+ +.+||+|||.+..+.... .....+++.|+|||.+.+.. ....++.++|||||||++|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 138 GN-------GQVKLCDFGVSGNLVASL------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred CC-------CCEEEeecCCcccccCCc------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 86 789999999986543211 11235788999999986522 1234578999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHH---HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLI---QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I---~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|++|+.||...........+ ..+..+.++ ...+.++.+++.+||+.+|.
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDGDPPTLP---------------------------SGYSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC---------------------------cccCHHHHHHHHHHcccCcc
Confidence 999999999765443333322 222211111 13566789999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+||++.++++|+|+...
T Consensus 252 ~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 252 RRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cCCCHHHHhcChhhhhc
Confidence 99999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.44 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=198.1
Q ss_pred CCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
-++|++.++||+|+||.||+|.. .+..+++|..... ... ...+ .+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~---~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~-- 73 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMS---PEAF----LAEANLMKQLQHPRLVRLYAVVTQE-- 73 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCc---HHHH----HHHHHHHHhcCCcCeeeEEEEEccC--
Confidence 35689999999999999999987 4466777765322 111 2233 7899999999999999999886432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~ 137 (260)
T cd05067 74 -------------PIYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE 137 (260)
T ss_pred -------------CcEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC
Confidence 24999999999999999875 23346899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.+......... ......++..|+|||++.. ..++.++||||||+++|+|+
T Consensus 138 ~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~el~ 197 (260)
T cd05067 138 T-------LCCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIV 197 (260)
T ss_pred C-------CCEEEccCcceeecCCCCcc---------cccCCcccccccCHHHhcc----CCcCcccchHHHHHHHHHHH
Confidence 7 78999999998765421110 1112235678999999875 45788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||.+.+..+....+..+..+..+ ...+.++.+++.+||..+|++||++
T Consensus 198 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05067 198 TYGRIPYPGMTNPEVIQNLERGYRMPRP---------------------------DNCPEELYELMRLCWKEKPEERPTF 250 (260)
T ss_pred hCCCCCCCCCChHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCCCH
Confidence 9 99999877766665555433222111 1344579999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
++++..+.
T Consensus 251 ~~l~~~l~ 258 (260)
T cd05067 251 EYLRSVLE 258 (260)
T ss_pred HHHHHHhh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.55 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=197.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
+.+|.+.++||+|+||.||+|... +..+++|. +... .....+. +.+|+++++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~--~~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEA--SESARQD----FQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEe--cCcC--CHHHHHH----HHHHHHHHhcCCCCCCceEEEE
Confidence 467899999999999999999742 23444554 3321 2222333 4799999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHSK 947 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~----------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~ 947 (1141)
+..... .++||||+++++|.+++...... ....+++..+..++.||+.||+|||++
T Consensus 76 ~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 141 (280)
T cd05092 76 CTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL 141 (280)
T ss_pred EecCCc--------------eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 876543 49999999999999999763211 113588999999999999999999999
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCC
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1027 (1141)
||+||||||+|||++.+ +.+||+|||++......... .......+++.|+|||.+.+ ..++
T Consensus 142 ~i~H~dlkp~nil~~~~-------~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 202 (280)
T cd05092 142 HFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RKFT 202 (280)
T ss_pred CeecccccHhhEEEcCC-------CCEEECCCCceeEcCCCcee--------ecCCCccccccccCHHHhcc----CCcC
Confidence 99999999999999877 78999999998654321110 01112335788999999876 4578
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 001143 1028 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1106 (1141)
Q Consensus 1028 ~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1106 (1141)
.++|||||||++|+|++ |..||......+....+..+..+..+ ..++..+.+
T Consensus 203 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 255 (280)
T cd05092 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP---------------------------RTCPPEVYA 255 (280)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCC---------------------------CCCCHHHHH
Confidence 99999999999999998 99999876666655555443322111 134567899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1107 VFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1107 LI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
++.+||+.||.+||++.+|++.+.
T Consensus 256 li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 256 IMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHccCChhhCCCHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.08 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=191.1
Q ss_pred eecccCceEEEEEEEC--C--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 813 EAGKSVSSSLFRCKFG--S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 813 ~LG~GsfG~Vy~a~~~--~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
.||+|+||.||+|.+. + ..+|+|+.. ... .....+ .+.+|+.++++++||||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~--~~~-~~~~~~----~~~~E~~~l~~l~h~~ii~~~~~~~~~------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK--NEN-EKSVRD----EMMREAEIMHQLDNPYIVRMIGVCEAE------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcc--ccc-ChHHHH----HHHHHHHHHHhcCCCCeEEEEEEEcCC-------
Confidence 4899999999999874 2 236666543 211 122222 347999999999999999999987532
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|.+++.. ....+++..+.+++.||+.||.|||++|++||||||+||+++.+
T Consensus 68 --------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---- 131 (257)
T cd05115 68 --------ALMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---- 131 (257)
T ss_pred --------CeEEEEEeCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC----
Confidence 24899999999999999864 13468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 1047 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~ 1047 (1141)
+.+||+|||.+.......... .......++..|+|||++.. ..++.++|||||||++|+|++ |+.
T Consensus 132 ---~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 132 ---HYAKISDFGLSKALGADDSYY-------KARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred ---CcEEeccCCccccccCCccce-------eccCCCCCCcccCCHHHHcc----CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 789999999987543321110 00111224578999999875 457889999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001143 1048 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127 (1141)
Q Consensus 1048 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~ 1127 (1141)
||......+....+..+..+..+ ..++.++.+++.+||..||++||++.+|.+
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 198 PYKKMKGPEVMSFIEQGKRLDCP---------------------------AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99887776666666554432211 144567999999999999999999999998
Q ss_pred HHHh
Q 001143 1128 MFVA 1131 (1141)
Q Consensus 1128 ~L~~ 1131 (1141)
.+..
T Consensus 251 ~l~~ 254 (257)
T cd05115 251 RMRT 254 (257)
T ss_pred HHhh
Confidence 7753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=318.42 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=201.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 874 (1141)
..+|++.+.||+|+||.||+|++. ...+++|+.. .. ......+. +.+|+.+++.+ +||||+++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~--~~-~~~~~~~~----~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DD-ATEKDLSD----LVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecc--cc-cchHHHHH----HHHHHHHHHhhccCCCchhe
Confidence 557899999999999999999752 1235666532 11 11222233 37899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~y 943 (1141)
++++..... .++||||+++++|.+++...... ....+++..+..++.||+.||.|
T Consensus 87 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 152 (304)
T cd05101 87 LGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEY 152 (304)
T ss_pred eEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHH
Confidence 999876543 49999999999999999763211 12357889999999999999999
Q ss_pred HHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 944 LHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
||++||+||||||+||+++.+ +.+||+|||.++......... ......+++.|+|||++.+
T Consensus 153 LH~~givH~dlkp~Nili~~~-------~~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 213 (304)
T cd05101 153 LASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFD---- 213 (304)
T ss_pred HHHCCeeecccccceEEEcCC-------CcEEECCCccceecccccccc--------cccCCCCCceeeCchhhcc----
Confidence 999999999999999999877 789999999997654321110 0112235678999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 001143 1024 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1102 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1141)
..++.++||||||+++|+|++ |..||.+.+..++...+........+ ..++.
T Consensus 214 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 266 (304)
T cd05101 214 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANCTN 266 (304)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCCH
Confidence 567899999999999999998 78899877777766665443322111 14556
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.+.+++.+||+.+|.+|||+.|+++.+....
T Consensus 267 ~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 267 ELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 7999999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=308.69 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=195.8
Q ss_pred CCceEeeeecccCceEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~-~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
++|.+.++||+|++|.||+|.+.+. .+++|+.. .... ..+ .+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~--~~~~---~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLK--PGTM---MPE----AFLQEAQIMKKLRHDKLVPLYAVVSEE--- 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcc--cCCc---cHH----HHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence 5689999999999999999998543 56666532 2111 112 237899999999999999999887432
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.++++. .....+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~ 138 (260)
T cd05069 74 ------------PIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN 138 (260)
T ss_pred ------------CcEEEEEcCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC
Confidence 23899999999999999975 223458999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+......... ......++..|+|||...+ ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 139 -------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred -------CeEEECCCccceEccCCccc---------ccCCCccchhhCCHHHhcc----CCcChHHHHHHHHHHHHHHHh
Confidence 78999999999765322111 1112235678999998875 557899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|..||.+....+....+.....+..+ ...+..+.+++.+||..||.+||+++
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 199 KGRVPYPGMVNREVLEQVERGYRMPCP---------------------------QGCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcCHH
Confidence 89999877666655555433221111 13456799999999999999999999
Q ss_pred HHHHHHH
Q 001143 1124 DLYEMFV 1130 (1141)
Q Consensus 1124 ElL~~L~ 1130 (1141)
++++.+.
T Consensus 252 ~i~~~l~ 258 (260)
T cd05069 252 YIQSFLE 258 (260)
T ss_pred HHHHHHh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=345.82 Aligned_cols=267 Identities=23% Similarity=0.338 Sum_probs=201.5
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeee-EecCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH-KISSK 882 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~-~~~~~ 882 (1141)
++++.++|.+|||+.||+|.+.+ ..+|+|..... +....+.+ .+||.+|++|+ |+|||.+++. .....
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v----~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAV----KREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHH----HHHHHHHHHhcCCCceeeEecccccccc
Confidence 46999999999999999999843 67777764322 33444444 89999999996 9999999994 33211
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 960 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NIL 960 (1141)
.......+.|.||||.||+|-+++.... ...|++.++++|++|+++|+.+||..+ |||||||-+|||
T Consensus 110 --------~~~~~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvL 178 (738)
T KOG1989|consen 110 --------SNNGVWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVL 178 (738)
T ss_pred --------CCCceeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheE
Confidence 0112357799999999999999998632 234999999999999999999999886 999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccc-ccc--ccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFL-HTC--CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~-~~~--~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|+.+ ++.||||||.|....... ... ...+.. -....|+.|+|||++.- ..+..+++|+|||||||
T Consensus 179 ls~~-------g~~KLCDFGSatt~~~~~~~~~e~~~ve~e----I~k~TTp~YRsPEMIDl-ysg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 179 LSAD-------GNYKLCDFGSATTKILSPTSAQEVNYVEEE----IEKYTTPQYRSPEMIDL-YSGLPIGEKSDIWALGC 246 (738)
T ss_pred EcCC-------CCEEeCcccccccccCCCccHHHHHHHHHH----HHhhCCccccChHHHhh-hcCCCCcchhHHHHHHH
Confidence 9988 889999999986432111 000 000000 01246999999999864 33467899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+||-|+..+.||....... |..+.+. .|.. ..++..+.+||+.||+.||.
T Consensus 247 lLYkLCy~t~PFe~sg~la----Ilng~Y~-------------------------~P~~-p~ys~~l~~LI~~mL~~nP~ 296 (738)
T KOG1989|consen 247 LLYKLCYFTTPFEESGKLA----ILNGNYS-------------------------FPPF-PNYSDRLKDLIRTMLQPNPD 296 (738)
T ss_pred HHHHHHHhCCCcCcCccee----EEecccc-------------------------CCCC-ccHHHHHHHHHHHHhccCcc
Confidence 9999999999998643322 2222211 1111 16778899999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+||++.|++.+++....
T Consensus 297 ~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 297 ERPNIYQVLEEIFELAN 313 (738)
T ss_pred cCCCHHHHHHHHHHHhc
Confidence 99999999999887654
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=319.37 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=201.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccc
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 873 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~---------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVk 873 (1141)
+..+|.+.++||+|+||.||+|.+. ...+++|+.. ... .......+ .+|+.+++++ +||||++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~--~~~-~~~~~~~~----~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DNA-TDKDLADL----ISEMELMKLIGKHKNIIN 82 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecC--CCC-ChHHHHHH----HHHHHHHHhccCCCCeee
Confidence 3467899999999999999999752 2346666643 211 22223333 7899999999 5999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHH
Q 001143 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 874 llg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+++++..... .++||||+++++|.+++..... .....+++..+..++.||+.||.
T Consensus 83 ~~~~~~~~~~--------------~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 148 (314)
T cd05099 83 LLGVCTQEGP--------------LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGME 148 (314)
T ss_pred EEEEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHH
Confidence 9999876543 4999999999999999976321 11235899999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||++||+||||||+|||++.+ +.+||+|||.++......... ......++..|+|||++.+
T Consensus 149 ~lH~~gi~H~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~--- 210 (314)
T cd05099 149 YLESRRCIHRDLAARNVLVTED-------NVMKIADFGLARGVHDIDYYK--------KTSNGRLPVKWMAPEALFD--- 210 (314)
T ss_pred HHHHCCeeeccccceeEEEcCC-------CcEEEcccccccccccccccc--------ccccCCCCccccCHHHHcc---
Confidence 9999999999999999999877 789999999997654211100 0111124567999999875
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1141)
..++.++|||||||++|+|++ |..||.+....+....+..+.....+ ..++
T Consensus 211 -~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 262 (314)
T cd05099 211 -RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP---------------------------SNCT 262 (314)
T ss_pred -CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCC
Confidence 567899999999999999999 89999887776666665443322111 1345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1102 SFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.++.+++.+||..||++|||+.++++.+....
T Consensus 263 ~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 263 HELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 57899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=309.92 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=196.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.+|++.++||+|+||.||+|.+. +..+++|....+..... ....+ .+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN----ALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHH----HHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 47899999999999999999974 45677776543322111 12223 3478999999999999999999876532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ...++||||+++++|.+++.+ ...+++..+..++.|++.||.|||+++|+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 78 E------------RTLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred C------------ceEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 1 245899999999999999875 23588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+......... ........++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 141 SV-------GNVKLGDFGASKRLQTICLS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CC-------CCEEECcCcccccccccccc-------ccccccCCCCccccChhhhcC----CCCCcchhHHHHHHHHHHH
Confidence 77 78999999998754321110 001123358899999999875 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|+.||...........+.... .+.. ....+..+.+++.+|+. +|++||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPTNPVL---------------------------PPHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCCCCCC---------------------------chhhCHHHHHHHHHHhc-ChhhCCC
Confidence 99999997654443333222111 1111 11345568899999995 9999999
Q ss_pred HHHHHHHHHh
Q 001143 1122 AGDLYEMFVA 1131 (1141)
Q Consensus 1122 a~ElL~~L~~ 1131 (1141)
++++++|+|.
T Consensus 255 ~~~il~~~~~ 264 (265)
T cd06652 255 ADELLRHTFV 264 (265)
T ss_pred HHHHhcCccc
Confidence 9999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=313.78 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=199.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
...+|++.+.||+|+||.||+|.+. +..+++|+.. .. ........ +.+|+.+++++.||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~--~~-~~~~~~~~----~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EE-ASADMQAD----FQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecC--CC-cCHHHHHH----HHHHHHHHHhcCCCchheEEE
Confidence 3467999999999999999999863 3456666543 21 12222233 378999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------------cCCCCCCHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------TGEKHVSVKLALFIAQDVAA 939 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------------~~~~~Ls~~~i~~Ia~QIa~ 939 (1141)
++.+... .++||||+++++|.+++..... .....+++..++.++.||+.
T Consensus 76 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 76 VCAVGKP--------------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred EEcCCCc--------------cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 9876543 3999999999999999975311 11235788999999999999
Q ss_pred HHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcc
Q 001143 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019 (1141)
Q Consensus 940 gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1019 (1141)
||.|||+++++||||||+||+++.+ +.++|+|||.+..+...... ........++.|+|||.+.+
T Consensus 142 aL~~lH~~~i~H~dl~p~nil~~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 142 GMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KASENDAIPIRWMPPESIFY 206 (288)
T ss_pred HHHHHHhCCeecccccHhheEecCC-------CceEECccccceecccCccc--------cccCCCccChhhcCHHHHhc
Confidence 9999999999999999999999877 78999999998654321110 01112234677999999876
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhh
Q 001143 1020 MHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098 (1141)
Q Consensus 1020 ~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1141)
..++.++|||||||++|+|++ |..||.+....+....+..+.....+ .
T Consensus 207 ----~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~ 255 (288)
T cd05050 207 ----NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCP---------------------------D 255 (288)
T ss_pred ----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------C
Confidence 567899999999999999998 88899877766666555443322111 1
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1099 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1099 ~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
..+..+.+++.+||+.||.+|||+.|+++.|.
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 256 NCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 34567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.71 Aligned_cols=267 Identities=25% Similarity=0.349 Sum_probs=202.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~ 881 (1141)
..+|++.+.||+|+||.||+|... +..+++|+.. ... ..... +.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~--~~~---~~~~~----~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD--PIS---DVDEE----IEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEec--ccc---cHHHH----HHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 567999999999999999999984 5567777643 211 11122 36899999999 799999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+.. .....++||||+++++|.++++..... ...+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 92 ~~~---------~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili 161 (291)
T cd06639 92 DKL---------VGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL 161 (291)
T ss_pred ccc---------CCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 321 123569999999999999998753322 3468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ 1040 (1141)
+.+ +.+||+|||.+........ ......|+..|+|||.+.... ....++.++|||||||++|
T Consensus 162 ~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~ 224 (291)
T cd06639 162 TTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI 224 (291)
T ss_pred cCC-------CCEEEeecccchhcccccc----------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHH
Confidence 887 7899999999876443111 111335888999999986421 1123678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|+.||......+....+.....+.+.. + ......+.+++.+||+.||++||
T Consensus 225 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~---~~~~~~l~~li~~~l~~~p~~Rp 279 (291)
T cd06639 225 ELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH----------------------P---EKWCRSFNHFISQCLIKDFEARP 279 (291)
T ss_pred HHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc----------------------c---cccCHHHHHHHHHHhhcChhhCc
Confidence 9999999998765544443333322211110 0 12345689999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
++.|+++|+|++
T Consensus 280 s~~~il~~~~~~ 291 (291)
T cd06639 280 SVTHLLEHPFIK 291 (291)
T ss_pred CHHHHhcCcccC
Confidence 999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=310.06 Aligned_cols=259 Identities=20% Similarity=0.333 Sum_probs=197.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..+|++.+.||+|+||.||+|.+.. ..+++|+.. .. ......+.+ ..|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~~~~----~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK--SG-YTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcC--CC-CCHHHHHHH----HHHHHHHHhCCCcCcceEEEEEC
Confidence 4568999999999999999998742 236776643 21 122333344 89999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+... .++||||+++++|.+++... ...+++.+++.++.|++.||.|||++|++||||||+||
T Consensus 76 ~~~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 76 KSRP--------------VMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred CCCc--------------eEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 6543 49999999999999998751 34689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||.+.......... ..........+..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l 201 (269)
T cd05065 138 LVNSN-------LVCKVSDFGLSRFLEDDTSDP-----TYTSSLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 201 (269)
T ss_pred EEcCC-------CcEEECCCccccccccCcccc-----ccccccCCCcceeecCHhHhcc----CcccchhhhhhhHHHH
Confidence 99877 789999999986543321110 0000011112457999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|||++ |..||......+....+........+ ..++..+.+++.+||..+|.+
T Consensus 202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 254 (269)
T cd05065 202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---------------------------MDCPTALHQLMLDCWQKDRNA 254 (269)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHHHHHHHHHcCCChhh
Confidence 99887 99999877766666555432211110 134566899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
||++.+++..+..
T Consensus 255 Rp~~~~i~~~l~~ 267 (269)
T cd05065 255 RPKFGQIVSTLDK 267 (269)
T ss_pred CcCHHHHHHHHHh
Confidence 9999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=318.46 Aligned_cols=285 Identities=22% Similarity=0.284 Sum_probs=203.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+++|++.+.||+|+||.||+|.+. +..+++|..+... .. +.+...+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EK----EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecc--cc----ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 3568999999999999999999985 4456666544322 11 11222346899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ....++||||++ ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 77 ~------------~~~~~lv~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 77 N------------LDKIYMVMEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred C------------CCcEEEEehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 2 124599999997 5999988752 2368999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||.+........ ......+++.|+|||.+.+. ..++.++||||||+++|+
T Consensus 140 ~~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 140 NNR-------GILKICDFGLAREYGSPLK----------PYTQLVVTLWYRAPELLLGA---KEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CCC-------CcEEEeecCceeeccCCcc----------ccccccccccccCchhhcCC---ccccchhhHHHHHHHHHH
Confidence 887 7899999999876543211 11123478899999998752 346789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcc---ccccccCCCCCCchhhhh-hHHHHHHHHHHhcccCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HEVAQSGSGFEKPEAELE-TLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~L~dLI~~cL~~DP~ 1117 (1141)
|++|..||......+....+...........+........ .................. .++.+.++|.+||+.||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 9999999988776665555432221111111111000000 000000000000000001 467789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001143 1118 ERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~ 1131 (1141)
+|||+.|+++|.||
T Consensus 280 ~R~t~~ell~~~~f 293 (293)
T cd07843 280 KRISAEDALKHPYF 293 (293)
T ss_pred ccCCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.39 Aligned_cols=266 Identities=25% Similarity=0.417 Sum_probs=199.9
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.|.+.+.||+|+||.||+|.. .+..+++|..+........ .........+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578899999999999999986 4566777765433221111 112222334578999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++++ ...+++..+..++.||+.||.|||+++++||||+|+||+++
T Consensus 82 --------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~ 142 (272)
T cd06629 82 --------------YLSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142 (272)
T ss_pred --------------ceEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence 34999999999999999976 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+......... .......++..|+|||.+.... ..++.++||||||+++|+|
T Consensus 143 ~~-------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 143 AD-------GICKISDFGISKKSDDIYDN--------DQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred CC-------CeEEEeeccccccccccccc--------cccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHH
Confidence 77 78999999998654321100 0112335788999999987522 2468899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHH-hCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|..||......+....+. ....+.++. ......+..+.+++.+||..||.+||+
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPP-----------------------DVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCc-----------------------cccccCCHHHHHHHHHHhcCChhhCCC
Confidence 99999997554433222221 111111110 011145678999999999999999999
Q ss_pred HHHHHHHHHh
Q 001143 1122 AGDLYEMFVA 1131 (1141)
Q Consensus 1122 a~ElL~~L~~ 1131 (1141)
+.++++|+|+
T Consensus 263 ~~~il~~~~~ 272 (272)
T cd06629 263 ARELLQHPFI 272 (272)
T ss_pred HHHHhhCCCC
Confidence 9999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.30 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=200.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|.....||+|+||.||++... +..+++|..... .....+. +.+|+.++++++||||+++++.+...+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~ii~~~~~~~~~~-- 92 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRREL----LFNEVVIMRDYHHENVVDMYNSYLVGD-- 92 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHH----HHHHHHHHHhCCCCcHHHHHHheecCC--
Confidence 3566788999999999999874 556777764321 1222223 478999999999999999999987644
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 93 ------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 154 (292)
T cd06658 93 ------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154 (292)
T ss_pred ------------eEEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 34999999999999998854 358999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++........ ......|+..|+|||.+.+ ..++.++||||||+++|||++
T Consensus 155 -------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~el~~ 213 (292)
T cd06658 155 -------GRIKLSDFGFCAQVSKEVP----------KRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMID 213 (292)
T ss_pred -------CCEEEccCcchhhcccccc----------cCceeecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHHh
Confidence 7899999999865432110 1123458899999999865 467889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||......+....+.....+.... ....+..+.+++.+||..||.+|||+.+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 214 GEPPYFNEPPLQAMRRIRDNLPPRVKD-------------------------SHKVSSVLRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCcccc-------------------------ccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 999998766555444433222111110 0134556889999999999999999999
Q ss_pred HHHHHHhhcCCCCC
Q 001143 1125 LYEMFVARTSSSIS 1138 (1141)
Q Consensus 1125 lL~~L~~~~~s~~s 1138 (1141)
+++|+|+.....-+
T Consensus 269 il~~~~~~~~~~~~ 282 (292)
T cd06658 269 LLQHPFLKLAGPPS 282 (292)
T ss_pred HhhChhhhccCCcc
Confidence 99999998654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=309.18 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=197.3
Q ss_pred CCceEeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~-----~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.+|.+.++||+|+||.||+|.+... .+++|..... . .....+. +.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~-~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--T-SPSVREK----FLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--C-CHHHHHH----HHHHHHHHHhCCCCchhceeEEEcC
Confidence 4689999999999999999987432 3555553321 1 1222233 4789999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
. ..++||||+++++|.+++... ...+++..+..++.||+.||+|||++|++||||||+||+
T Consensus 79 ~---------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil 139 (270)
T cd05056 79 N---------------PVWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139 (270)
T ss_pred C---------------CcEEEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence 2 238999999999999999751 235899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.++|+|||++......... ......++..|+|||.+.. ..++.++||||||+++|
T Consensus 140 i~~~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 199 (270)
T cd05056 140 VSSP-------DCVKLGDFGLSRYLEDESYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMW 199 (270)
T ss_pred EecC-------CCeEEccCceeeecccccce---------ecCCCCccccccChhhhcc----CCCCchhhhHHHHHHHH
Confidence 9887 78999999998765432110 0111234568999999865 45789999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|++ |..||......+....+..+..+..+ ...+..+.+++.+||..+|.+|
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~R 252 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENGERLPMP---------------------------PNCPPTLYSLMTKCWAYDPSKR 252 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhC
Confidence 9996 99999877766655555444332211 1445679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001143 1120 PTAGDLYEMFVAR 1132 (1141)
Q Consensus 1120 PSa~ElL~~L~~~ 1132 (1141)
||+.++++.+...
T Consensus 253 pt~~~~~~~l~~~ 265 (270)
T cd05056 253 PRFTELKAQLSDI 265 (270)
T ss_pred cCHHHHHHHHHHH
Confidence 9999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.92 Aligned_cols=255 Identities=28% Similarity=0.404 Sum_probs=198.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||+||+|.+. +..+++|+..... .... ...+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSV----RKQILRELQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchH----HHHHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence 457899999999999999999985 6667777654321 1122 233479999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILl 961 (1141)
..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+ .+++||||||+||++
T Consensus 77 --------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 137 (284)
T cd06620 77 --------------NICMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV 137 (284)
T ss_pred --------------EEEEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence 45999999999999999875 2468999999999999999999997 699999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||++....... .....|+..|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~~l~d~gl~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~ 194 (284)
T cd06620 138 NSR-------GQIKLCDFGVSGELINSI------------ADTFVGTSTYMSPERIQG----GKYTVKSDVWSLGISIIE 194 (284)
T ss_pred CCC-------CcEEEccCCcccchhhhc------------cCccccCcccCCHHHHcc----CCCCccchHHHHHHHHHH
Confidence 877 789999999886432211 113468999999999875 467889999999999999
Q ss_pred HHhCCCCCCCCCHH-----------HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1042 LLTLQVPYMGLSEL-----------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~-----------el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
|++|..||...... +....+.....+.++ ....+..+.+++.+
T Consensus 195 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~ 248 (284)
T cd06620 195 LALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--------------------------SSDFPEDLRDFVDA 248 (284)
T ss_pred HHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--------------------------chhcCHHHHHHHHH
Confidence 99999999754432 111111111111100 01245678999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1111 CTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1111 cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
||+.||.+|||+.|+++|+|+...
T Consensus 249 ~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 249 CLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HhcCCcccCcCHHHHhcCcccccc
Confidence 999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=362.26 Aligned_cols=267 Identities=27% Similarity=0.437 Sum_probs=214.5
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
++.-..+||.|.||.||-|....+.+.++++.+..........+. +.+|+.++..++|||+|++||+-.+.+.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~----i~eEm~vlE~lnHpNlV~YyGVEvHRek--- 1308 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKL----IAEEMKVLEGLNHPNLVRYYGVEVHREK--- 1308 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcc----hHHHHHHHHhccCccccccCceeecHHH---
Confidence 356778999999999999998555444444434433322222333 3789999999999999999998776553
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
.+|.||||++|+|.++++. .+..++.....+..|++.|+.|||++|||||||||.||+++.+
T Consensus 1309 -----------v~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-- 1370 (1509)
T KOG4645|consen 1309 -----------VYIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-- 1370 (1509)
T ss_pred -----------HHHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC--
Confidence 4899999999999999986 3457888888899999999999999999999999999999988
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
|.+|++|||.|+.+.....+.. .......||+.|||||++.+... ....-++||||+||++.||+||+
T Consensus 1371 -----g~iK~~DFGsa~ki~~~~~~~~------~el~~~~GT~~YMAPEvit~t~~-kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1371 -----GLIKYGDFGSAVKIKNNAQTMP------GELQSMMGTPMYMAPEVITGTKG-KGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred -----CcEEeecccceeEecCchhcCC------HHHHhhcCCchhcCchhhccccc-CCCCcchhhhcccceEEEeecCC
Confidence 8999999999988766432221 12345689999999999988543 23457899999999999999999
Q ss_pred CCCCCC-CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1047 VPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1047 ~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
.||... +..++...+..+..|.++.. .+.+-++||..||..||++|.++.|+
T Consensus 1439 rPW~~~dne~aIMy~V~~gh~Pq~P~~---------------------------ls~~g~dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1439 RPWAELDNEWAIMYHVAAGHKPQIPER---------------------------LSSEGRDFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred CchhhccchhHHHhHHhccCCCCCchh---------------------------hhHhHHHHHHHHHhcCchhhhHHHHH
Confidence 999764 45677788888888877753 45568999999999999999999999
Q ss_pred HHHHHhhcCCCC
Q 001143 1126 YEMFVARTSSSI 1137 (1141)
Q Consensus 1126 L~~L~~~~~s~~ 1137 (1141)
++|-+.+.....
T Consensus 1492 le~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1492 LEHAFGKSCTDE 1503 (1509)
T ss_pred HHhhcccccccc
Confidence 999888765443
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.90 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=198.4
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~ 883 (1141)
..|++.++||.||.+.||++...+ +.+|+|..... ..+......| ..|+..|.+|+ |.+||++++|-..+++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy----~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGY----RNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHH----HHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 459999999999999999998743 33444432222 2334445555 89999999996 9999999999887664
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+ ||||||-+ .+|..+++.. ...++...++.+.+||+.|+.++|.+||||.||||.|+|+-.
T Consensus 435 l--------------YmvmE~Gd-~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 435 L--------------YMVMECGD-IDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred E--------------EEEeeccc-ccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 4 99999875 8999999872 223443488999999999999999999999999999998854
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-------CCCCchhhHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-------NLYGLEVDIWSYG 1036 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-------~~~s~ksDVWSLG 1036 (1141)
|.+||+|||.|..+...... ......+||+.||+||.+..+... -..+.++||||+|
T Consensus 496 --------G~LKLIDFGIA~aI~~DTTs--------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 496 --------GRLKLIDFGIANAIQPDTTS--------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred --------eeEEeeeechhcccCccccc--------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 78999999999877653322 233466899999999999765432 1257899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
||||+|+.|+.||.... ..+.++.....|.- ..+.|+. ....++.++++.||..||
T Consensus 560 CILYqMvYgktPf~~~~--n~~aKl~aI~~P~~--------------------~Iefp~~--~~~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQII--NQIAKLHAITDPNH--------------------EIEFPDI--PENDELIDVMKCCLARDP 615 (677)
T ss_pred hHHHHHHhcCCchHHHH--HHHHHHHhhcCCCc--------------------cccccCC--CCchHHHHHHHHHHhcCc
Confidence 99999999999997432 23333333222211 1111111 222338999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001143 1117 TERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~ 1133 (1141)
.+|||+.++|+|+|...
T Consensus 616 kkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 616 KKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCcHHHhcCccccc
Confidence 99999999999999865
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=314.05 Aligned_cols=282 Identities=19% Similarity=0.242 Sum_probs=198.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
+.+++|++.+.||+|++|.||+|.+. +..+++|........ ..... +.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFT----AIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchh----HHHHHHHHhhCCCcceeeEEEEEec
Confidence 45688999999999999999999974 566777775433211 11111 2689999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||++ ++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 75 ~~--------------~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil 135 (291)
T cd07844 75 KK--------------TLTLVFEYLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL 135 (291)
T ss_pred CC--------------eEEEEEecCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEE
Confidence 54 3499999998 5999988752 236899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||.++........ .....++..|+|||++.+ ...++.++||||+|+++|
T Consensus 136 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~ 195 (291)
T cd07844 136 ISER-------GELKLADFGLARAKSVPSKT----------YSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFY 195 (291)
T ss_pred EcCC-------CCEEECccccccccCCCCcc----------ccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHH
Confidence 9887 78999999998653221110 112246788999999865 234678999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchh-----hhhhHHHHHHHHHHhccc
Q 001143 1041 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA-----ELETLSFLVDVFRRCTEE 1114 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~L~dLI~~cL~~ 1114 (1141)
+|++|+.||.... ..+....+...........+............. ......... .......+.+++.+||+.
T Consensus 196 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (291)
T cd07844 196 EMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS-FPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274 (291)
T ss_pred HHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc-ccccCChhHHHhCcCCCCchhHHHHHHHHhcc
Confidence 9999999997654 223232221111111111111110000000000 000000000 011226788999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 001143 1115 NPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1115 DP~~RPSa~ElL~~L~~ 1131 (1141)
||++|||+.+++.|+||
T Consensus 275 ~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 275 EPKKRISAAEAMKHPYF 291 (291)
T ss_pred CcccccCHHHHhcCCCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=315.69 Aligned_cols=296 Identities=17% Similarity=0.197 Sum_probs=203.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+++|++.++||+|+||.||+|.+. +..+|+|....... ... +...+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEG----FPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCC----chhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 34678999999999999999999984 56677776543221 111 11223689999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.... ........++||||+. ++|.+++.. ....+++.+++.++.||+.||+|||++||+|+||||+||+
T Consensus 83 ~~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil 151 (310)
T cd07865 83 KATP------YNRYKGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151 (310)
T ss_pred cccc------ccCCCceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 4321 1112335699999996 688888765 2236899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||.+.......... ........++..|+|||.+.+. ..++.++||||||+++|
T Consensus 152 ~~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~~l~ 215 (310)
T cd07865 152 ITKD-------GILKLADFGLARAFSLSKNSK------PNRYTNRVVTLWYRPPELLLGE---RDYGPPIDMWGAGCIMA 215 (310)
T ss_pred ECCC-------CcEEECcCCCcccccCCcccC------CCCccCcccCccccCcHHhcCC---cccCchhhhHHHHHHHH
Confidence 9887 789999999997654322110 0111233578899999998652 34678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcc-ccccccCCCCCC-c--hhhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEK-P--EAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~-~--~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|++|..||.+.........+........+..++....... ............ . ......+..+.++|.+||..||
T Consensus 216 el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P 295 (310)
T cd07865 216 EMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295 (310)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCCh
Confidence 99999999987766554444432111111100000000000 000000000000 0 0000124567899999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001143 1117 TERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~ 1131 (1141)
.+|||++|+++|+||
T Consensus 296 ~~R~t~~e~l~h~~f 310 (310)
T cd07865 296 AKRIDADTALNHDFF 310 (310)
T ss_pred hhccCHHHHhcCCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=307.45 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=199.0
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.-++|++.++||+|+||.||+|.+.+ ..+++|... .... ..+.+ .+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~--~~~~---~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK--PGTM---SPEAF----LQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEec--CCcc---CHHHH----HHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 35679999999999999999998743 456666543 2111 12233 78999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 75 ~--------------~~~v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~ 137 (261)
T cd05034 75 P--------------IYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137 (261)
T ss_pred c--------------eEEEEeccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc
Confidence 3 4999999999999999975 2234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 138 ~~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l 197 (261)
T cd05034 138 EN-------LVCKIADFGLARLIEDDEYT---------AREGAKFPIKWTAPEAANY----GRFTIKSDVWSFGILLTEI 197 (261)
T ss_pred CC-------CCEEECccccceeccchhhh---------hhhccCCCccccCHHHhcc----CCcCchhHHHHHHHHHHHH
Confidence 87 78999999998765431110 0112234578999999876 4578999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |+.||.+.........+..+.....+ ...+..+.+++.+||..+|.+||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~ 250 (261)
T cd05034 198 VTYGRVPYPGMTNREVLEQVERGYRMPRP---------------------------PNCPEELYDLMLQCWDKDPEERPT 250 (261)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcccCcccCCC
Confidence 99 99999877666666655433221111 033557899999999999999999
Q ss_pred HHHHHHHHH
Q 001143 1122 AGDLYEMFV 1130 (1141)
Q Consensus 1122 a~ElL~~L~ 1130 (1141)
++++.+.+.
T Consensus 251 ~~~l~~~l~ 259 (261)
T cd05034 251 FEYLQSFLE 259 (261)
T ss_pred HHHHHHHHh
Confidence 999998664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.88 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=197.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..+|++.+.||+|+||.||+|.+. +..+++|+.. ..... ...+ .+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~--~~~~~---~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR--EGAMS---EEDF----IEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECC--CCCCC---HHHH----HHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 457899999999999999999885 5667777643 21111 1233 68999999999999999999987544
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++++||||||+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 73 -------------PICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred -------------ceEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 34999999999999999875 1235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~aPe~~~~----~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 136 N-------QVVKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWSSPEVFSF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCcceeecccCccc---------ccCCCccchhhcCHhHhcc----CCcChHHHHHHHHHHHHHHH
Confidence 6 78999999998754321100 0112235678999999875 46788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |..||......+..+.+..+..+..+ ...+..+.+|+.+||+.+|++|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp~~ 248 (256)
T cd05112 196 SEGKTPYENRSNSEVVETINAGFRLYKP---------------------------RLASQSVYELMQHCWKERPEDRPSF 248 (256)
T ss_pred cCCCCCCCcCCHHHHHHHHhCCCCCCCC---------------------------CCCCHHHHHHHHHHcccChhhCCCH
Confidence 8 99999877666666655433221111 0234569999999999999999999
Q ss_pred HHHHHHH
Q 001143 1123 GDLYEMF 1129 (1141)
Q Consensus 1123 ~ElL~~L 1129 (1141)
.++++++
T Consensus 249 ~~~l~~l 255 (256)
T cd05112 249 SLLLHQL 255 (256)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=309.32 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||.||+|.+... .+.++++..+... .....+.+ .+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~----~~E~~~l~~l~~h~~iv~~~~~~~~~~~----- 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHRGY----- 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHH----HHHHHHHHhhccCCCeeeEEEEEecCCC-----
Confidence 4689999999999997543 3334444333211 12222333 7899999999 79999999999886553
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
.++||||+++++|.+++..... .....+++..+..++.|++.||+|||++|++||||||+
T Consensus 71 ---------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 141 (270)
T cd05047 71 ---------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 141 (270)
T ss_pred ---------ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccc
Confidence 3999999999999999975321 11235889999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
||+++.+ +.+||+|||++....... .......+..|+|||++.. ..++.++|||||||
T Consensus 142 nili~~~-------~~~kl~dfgl~~~~~~~~-----------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~ 199 (270)
T cd05047 142 NILVGEN-------YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNY----SVYTTNSDVWSYGV 199 (270)
T ss_pred eEEEcCC-------CeEEECCCCCccccchhh-----------hccCCCCccccCChHHHcc----CCCCchhhHHHHHH
Confidence 9999887 789999999985321100 0111224567999999865 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|||++ |..||.+.+..+....+........+ ...+.++.+++.+||+.||
T Consensus 200 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p 252 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDLMRQCWREKP 252 (270)
T ss_pred HHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcccCh
Confidence 9999997 99999876665555554332211110 1344568999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001143 1117 TERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~ 1131 (1141)
.+|||+.++++.+..
T Consensus 253 ~~Rps~~~il~~l~~ 267 (270)
T cd05047 253 YERPSFAQILVSLNR 267 (270)
T ss_pred hhCCCHHHHHHHHHH
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=311.20 Aligned_cols=271 Identities=22% Similarity=0.289 Sum_probs=193.8
Q ss_pred Cc-eEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 807 SL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 807 ~y-~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+| ++.+.||+|+||+||++.+ .+..+++|+..... ....... +.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~ 76 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSG----WKKEINILKTLYHENIVKYKGCCS 76 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHH----HHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45 8999999999999998764 24567887754321 1122233 378999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... ...++||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 77 ~~~~------------~~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni 138 (283)
T cd05080 77 EQGG------------KGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138 (283)
T ss_pred cCCC------------ceEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence 5321 145899999999999999875 2599999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.++|+|||++.......... .......++..|+|||++.+ ..++.++||||||+++
T Consensus 139 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l 200 (283)
T cd05080 139 LLDND-------RLVKIGDFGLAKAVPEGHEYY-------RVREDGDSPVFWYAVECLKE----NKFSYASDVWSFGVTL 200 (283)
T ss_pred EEcCC-------CcEEEeecccccccCCcchhh-------ccCCCCCCCceeeCHhHhcc----cCCCcccccHHHHHHH
Confidence 99887 789999999987654321110 01112235677999999875 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|..||...... ....+.............. ....... +......+..+.+++.+||+.||++|
T Consensus 201 ~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~R 268 (283)
T cd05080 201 YELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIE--------LLERGMR---LPCPKNCPQEVYILMKNCWETEAKFR 268 (283)
T ss_pred HHHHhCCCCCCCCcch-hhhhhcccccccchhhhhh--------hhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhC
Confidence 9999999998653221 1111111000000000000 0000000 00112456789999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001143 1120 PTAGDLYEMFVAR 1132 (1141)
Q Consensus 1120 PSa~ElL~~L~~~ 1132 (1141)
||++++++.+...
T Consensus 269 ps~~~i~~~l~~~ 281 (283)
T cd05080 269 PTFRSLIPILKEM 281 (283)
T ss_pred CCHHHHHHHHHHh
Confidence 9999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=303.21 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=191.1
Q ss_pred eeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~ 890 (1141)
++||+|+||.||+|... +..+++|+.. ... ...... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~--~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 66 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCK--EDL-PQELKI----KFLSEARILKQYDHPNIVKLIGVCTQRQP------- 66 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecC--CcC-CHHHHH----HHHHHHHHHHhCCCCCcCeEEEEEecCCc-------
Confidence 47999999999999864 4557777643 211 122222 34789999999999999999999876543
Q ss_pred CccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCC
Q 001143 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1141)
Q Consensus 891 ~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~ 970 (1141)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 67 -------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~------ 129 (250)
T cd05085 67 -------IYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN------ 129 (250)
T ss_pred -------cEEEEECCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC------
Confidence 39999999999999998651 2358899999999999999999999999999999999999877
Q ss_pred CCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001143 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1049 (1141)
Q Consensus 971 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf 1049 (1141)
+.+||+|||++........ .......+++.|+|||++.. ..++.++||||||+++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 130 -NVLKISDFGMSRQEDDGIY---------SSSGLKQIPIKWTAPEALNY----GRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred -CeEEECCCccceecccccc---------ccCCCCCCcccccCHHHhcc----CCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 7899999999865332110 01112234677999999875 457889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001143 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129 (1141)
Q Consensus 1050 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L 1129 (1141)
...........+..+.....+ ...+..+.+++.+||..+|.+||++.++++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 196 PGMTNQQAREQVEKGYRMSCP---------------------------QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 877666555554433221111 13456799999999999999999999999876
Q ss_pred H
Q 001143 1130 V 1130 (1141)
Q Consensus 1130 ~ 1130 (1141)
.
T Consensus 249 ~ 249 (250)
T cd05085 249 A 249 (250)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=316.02 Aligned_cols=301 Identities=19% Similarity=0.207 Sum_probs=206.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+++|++.++||+|+||.||+|.+. +..+++|+........ ..... +.+|++++++++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPIT----ALREIKILKKLKHPNVVPLIDMAVE 78 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--Ccchh----HHHHHHHHHhcCCCCccchhhheec
Confidence 34789999999999999999999984 5567777654332211 11112 2689999999999999999998765
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.... ........++||||+. ++|...+.. ....+++..+..++.||++||.|||++||+||||||+||+
T Consensus 79 ~~~~------~~~~~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil 147 (311)
T cd07866 79 RPDK------SKRKRGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANIL 147 (311)
T ss_pred cccc------ccccCceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 4321 0112336799999997 577777654 2346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeecccccccccccccccccc-CCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH-RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
++.+ +.++|+|||++.............. ..........+++.|+|||.+.+ ...++.++|||||||++
T Consensus 148 ~~~~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il 217 (311)
T cd07866 148 IDNQ-------GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVF 217 (311)
T ss_pred ECCC-------CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHH
Confidence 9887 7899999999976543221110000 00111223457889999999865 23578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhh---ccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|+|++|+.||.+.+.......+........+..+... ........ ..................+.+++.+||..||
T Consensus 218 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 296 (311)
T cd07866 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS-FTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296 (311)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhccccccccc-CCCCCccHHHHcccCChhHHHHHHHHcccCc
Confidence 9999999999877766555544222111111111100 00000000 0000000000111334678999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001143 1117 TERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~ 1131 (1141)
.+|||+.|++.|+||
T Consensus 297 ~~R~t~~ell~~~~f 311 (311)
T cd07866 297 YKRLTASDALEHPYF 311 (311)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=310.57 Aligned_cols=266 Identities=29% Similarity=0.438 Sum_probs=201.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|+..++||.|++|.||+|.+. +..+++|+.... .. .... ..+.+|++++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~-~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD--PN-PDLQ----KQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC--Cc-hHHH----HHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 36889999999999999999984 566777765432 11 1222 234789999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
...++||||+++++|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus 74 ------------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~ 140 (287)
T cd06621 74 ------------SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140 (287)
T ss_pred ------------CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 246999999999999998875433 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++....... .....++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 141 ~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 141 K-------GQVKLCDFGVSGELVNSL------------AGTFTGTSFYMAPERIQG----KPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred C-------CeEEEeeccccccccccc------------cccccCCccccCHHHhcC----CCCCchhhHHHHHHHHHHHH
Confidence 7 789999999986543211 112347888999999875 46788999999999999999
Q ss_pred hCCCCCCCCC-----HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1044 TLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1044 TGk~Pf~~~~-----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+.||.... ..+....+.....+.+... +......++.+.+++.+||..||.+
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---------------------PGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred hCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---------------------CCCCCchHHHHHHHHHHHcCCCccc
Confidence 9999997542 2223333222111111100 0000134567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001143 1119 RPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~s 1135 (1141)
|||+.|+++|+|++...
T Consensus 257 Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 257 RPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCHHHHHhCccccccc
Confidence 99999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=309.86 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=201.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
-++|++.+.||+|+||.||+|.+.. ..+++|+. .. .......+.+ .+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~--~~-~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV--KD-HASEIQVTLL----LQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEc--cC-CCCHHHHHHH----HHHHHHHHhCCCCCCCeEEEEE
Confidence 4679999999999999999999754 45555553 22 1223333333 7899999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~---~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLK 955 (1141)
..... ..++++||+++++|.+++...... ....+++..+..++.||+.||+|||+++++|||||
T Consensus 78 ~~~~~-------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~ 144 (280)
T cd05043 78 IEDGE-------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA 144 (280)
T ss_pred ecCCC-------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 65321 248999999999999999763221 11468999999999999999999999999999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
|+||+++.+ +.+||+|||+++.+....... ......++..|+|||++.+ ..++.++|||||
T Consensus 145 p~nil~~~~-------~~~kl~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~sl 205 (280)
T cd05043 145 ARNCVIDEE-------LQVKITDNALSRDLFPMDYHC--------LGDNENRPVKWMALESLVN----KEYSSASDVWSF 205 (280)
T ss_pred HhhEEEcCC-------CcEEECCCCCcccccCCceEE--------eCCCCCcchhccCHHHHhc----CCCCchhhHHHh
Confidence 999999877 789999999997653321110 0112235778999999876 467899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 001143 1036 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1114 (1141)
Q Consensus 1036 GviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~ 1114 (1141)
||++||+++ |+.||......+....+..+..+... ..+++++.+++.+||..
T Consensus 206 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~ 258 (280)
T cd05043 206 GVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP---------------------------INCPDELFAVMACCWAL 258 (280)
T ss_pred HHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcCC
Confidence 999999999 99999877766655554433221110 13456789999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 001143 1115 NPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1115 DP~~RPSa~ElL~~L~~~ 1132 (1141)
||++|||+.++++.+...
T Consensus 259 ~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 259 DPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ChhhCCCHHHHHHHHHHH
Confidence 999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=311.46 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=181.3
Q ss_pred eecccCceEEEEEEEC------------------------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC
Q 001143 813 EAGKSVSSSLFRCKFG------------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 868 (1141)
Q Consensus 813 ~LG~GsfG~Vy~a~~~------------------------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 868 (1141)
.||+|+||.||+|.+. ...+.|+++.++.. ... ....+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~----~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRD----IALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHH----HHHHHHHHHHHHhcCCC
Confidence 6999999999999742 11122333333211 111 12234788999999999
Q ss_pred CCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 001143 869 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948 (1141)
Q Consensus 869 pNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g 948 (1141)
|||+++++++..... .++||||+++++|..++.. ....+++..+..++.||+.||+|||++|
T Consensus 76 ~niv~~~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (274)
T cd05076 76 IHLAFVHGVCVRGSE--------------NIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDKN 137 (274)
T ss_pred CCeeeEEEEEEeCCc--------------eEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 999999999886553 3999999999999999864 2346899999999999999999999999
Q ss_pred ccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001143 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1141)
Q Consensus 949 IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1028 (1141)
|+||||||+|||++..+........+|++|||.+...... ....++..|+|||.+.+ ...++.
T Consensus 138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~---~~~~~~ 200 (274)
T cd05076 138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPG---GNSLST 200 (274)
T ss_pred ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--------------cccccCCcccCchhhcC---CCCCCc
Confidence 9999999999999865321222245899999987543211 12247788999998865 245789
Q ss_pred hhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1029 ksDVWSLGviL~ELL-TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|||||||++|||+ +|+.||......+....+..... .+ . .....+.++
T Consensus 201 ~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~----------------------~-----~~~~~~~~l 251 (274)
T cd05076 201 AADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR--LP----------------------E-----PSCKELATL 251 (274)
T ss_pred HHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccC--CC----------------------C-----CCChHHHHH
Confidence 999999999999985 69999976554443222211100 00 0 123458999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 001143 1108 FRRCTEENPTERPTAGDLYEMF 1129 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L 1129 (1141)
+.+||+.+|++|||+.++++++
T Consensus 252 i~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 252 ISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHcccChhhCcCHHHHHHhh
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=315.82 Aligned_cols=268 Identities=23% Similarity=0.275 Sum_probs=201.7
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+.. ..+++|..... .. ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~--~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ--NL---ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehh--hh---hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 368999999999999999999854 55777764322 11 11111123478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+.++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 75 -------------HLCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 34999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecccccccccccccccc-----ccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~-----~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
+ +.+||+|||.++........... ............++..|+|||.+.+ ..++.++|||||||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~v 205 (305)
T cd05609 137 M-------GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGII 205 (305)
T ss_pred C-------CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----CCCCchhhHHHHHHH
Confidence 7 78999999998642111000000 0000001112357889999999875 467899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|..||.+....++...+.....+... .....+..+.+++.+||+.||++
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~ 260 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-------------------------GDEALPADAQDLISRLLRQNPLE 260 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------ccccCCHHHHHHHHHHhccChhh
Confidence 99999999999877666665554433211100 00134567899999999999999
Q ss_pred CCC---HHHHHHHHHhhc
Q 001143 1119 RPT---AGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPS---a~ElL~~L~~~~ 1133 (1141)
||+ +.++++|+|+..
T Consensus 261 R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 261 RLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCccCHHHHHhCccccC
Confidence 998 799999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=305.84 Aligned_cols=252 Identities=22% Similarity=0.390 Sum_probs=197.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
-++|++.++||+|+||.||+|.+. +..+++|.... .....+.+ .+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~-----~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~-~- 73 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAF----LAEANVMKTLQHDKLVKLHAVVTK-E- 73 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCC-----ChhHHHHH----HHHHHHHHhcCCCCcceEEEEEcC-C-
Confidence 467899999999999999999874 44567765331 11222333 789999999999999999998765 2
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~ 137 (260)
T cd05073 74 -------------PIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 137 (260)
T ss_pred -------------CeEEEEEeCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC
Confidence 24899999999999999976 22346888999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+......... ......++..|+|||++.. ..++.++|||||||++|+|+
T Consensus 138 ~-------~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05073 138 S-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEIV 197 (260)
T ss_pred C-------CcEEECCCcceeeccCCCcc---------cccCCcccccccCHhHhcc----CCcCccccchHHHHHHHHHH
Confidence 7 78999999998755321111 1112235677999999875 45788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |..||.+.+..+....+..+...... ...+.++.+++.+||+.+|++||++
T Consensus 198 t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~ 250 (260)
T cd05073 198 TYGRIPYPGMSNPEVIRALERGYRMPRP---------------------------ENCPEELYNIMMRCWKNRPEERPTF 250 (260)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCCCCCc---------------------------ccCCHHHHHHHHHHcccCcccCcCH
Confidence 9 99999877666555555433221111 1345679999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
.++++.|.
T Consensus 251 ~~l~~~L~ 258 (260)
T cd05073 251 EYIQSVLD 258 (260)
T ss_pred HHHHHHHh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=325.48 Aligned_cols=344 Identities=22% Similarity=0.268 Sum_probs=249.7
Q ss_pred hhhhhHHHHHHhhhccCCCCcccccccccc-cCCCCcceeEEeeC--ChhhhhhhhhcCCCCCCCCCCchhhhhcccccc
Q 001143 707 VCRHRAVLLKYLCDRVEPPVPCELVRGYLD-FQPHAWNTILVKKG--DSWIRMIVDACRPHDIREEADPEYFIRYIPLYR 783 (1141)
Q Consensus 707 ~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (1141)
.++-|.++-.+|....-..+||=-.++..- |+.|-... +.++ ....+.+.+.++..++....+..||.++..|.+
T Consensus 99 ~~~~~~i~~~~l~~~~~~~~~~~s~~~~v~~~~~~l~~~--~~~~lf~~~~~~~~~~L~~~pF~~f~~S~yf~rFlQWK~ 176 (591)
T KOG0986|consen 99 KDKARQILDAYLMKELLACLPQFSSKDLVTHVQEHLLEK--PPKDLFQPLARAICAYLRGDPFQEFLESDYFTRFLQWKW 176 (591)
T ss_pred hhhHHHHHHHHhhccccccCCCcchhhhhHHHhhhcccc--CchhhhHHHHHHHHHHhccchHhHhHHHHHHHHHHHHHH
Confidence 356677777777766544444322111111 11111111 0111 122455666778888999999999999988888
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHH
Q 001143 784 TIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR 861 (1141)
Q Consensus 784 ~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~ 861 (1141)
. +..+.+-+.|+..++||+|+||.||-+.. ++..+|.|. +++...... .-+...+.|-.
T Consensus 177 l--------------E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKk--L~KKRiKkr---~ge~maLnEk~ 237 (591)
T KOG0986|consen 177 L--------------ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKK--LDKKRIKKR---KGETMALNEKQ 237 (591)
T ss_pred H--------------HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHH--HHHHHHHHh---hhhHHhhHHHH
Confidence 6 33567778889999999999999998875 455555553 322111111 11223478999
Q ss_pred HHhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 001143 862 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 941 (1141)
Q Consensus 862 iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL 941 (1141)
+|.+++.+.||.+--.|++.+.+ |+||..|.||+|.-+|.+ .+...+++..++.++.+|+.||
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~L--------------ClVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGL 300 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDAL--------------CLVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGL 300 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCce--------------EEEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhH
Confidence 99999999999988888877654 999999999999999876 4456799999999999999999
Q ss_pred HHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001143 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1141)
Q Consensus 942 ~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1021 (1141)
+|||+.+||+|||||+|||+|+. |+|.|+|+|+|..+..... ....+||.+|||||++..
T Consensus 301 ehlH~~~iVYRDLKPeNILLDd~-------GhvRISDLGLAvei~~g~~-----------~~~rvGT~GYMAPEvl~n-- 360 (591)
T KOG0986|consen 301 EHLHRRRIVYRDLKPENILLDDH-------GHVRISDLGLAVEIPEGKP-----------IRGRVGTVGYMAPEVLQN-- 360 (591)
T ss_pred HHHHhcceeeccCChhheeeccC-------CCeEeeccceEEecCCCCc-----------cccccCcccccCHHHHcC--
Confidence 99999999999999999999988 9999999999987765321 123489999999999987
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 001143 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101 (1141)
Q Consensus 1022 ~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1141)
..|+...|+||+||+||||+.|+.||.......-.+.+.+.... .... .+...+
T Consensus 361 --e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-------------------~~~e-----y~~kFS 414 (591)
T KOG0986|consen 361 --EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-------------------DPEE-----YSDKFS 414 (591)
T ss_pred --CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-------------------chhh-----cccccC
Confidence 56999999999999999999999999754332222222111000 0000 012567
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhcC
Q 001143 1102 SFLVDVFRRCTEENPTERP-----TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RP-----Sa~ElL~~L~~~~~ 1134 (1141)
+++++|.+.+|..||.+|. .++++-+|++|+.-
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 7899999999999999995 56799999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=343.75 Aligned_cols=294 Identities=18% Similarity=0.192 Sum_probs=192.0
Q ss_pred CCCceEeeeecccCceEEEEEEECCcc---EEEEEEecc---------cCCCChHHHHHhHHhHHHHHHHHhhCCCCCcc
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSAD---AAAKVRTLK---------VCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 872 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~---vAvKI~~l~---------~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 872 (1141)
..+|++.++||+|+||+||+|.+.... .+.|..... ...............+.+|+.++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 568999999999999999998763211 111100000 00000001111233458999999999999999
Q ss_pred ceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 001143 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1141)
Q Consensus 873 kllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHr 952 (1141)
++++++...+. .|+|||++. ++|.+++...............++.|+.||+.||+|||++|||||
T Consensus 227 ~l~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHr 291 (501)
T PHA03210 227 KIEEILRSEAN--------------TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291 (501)
T ss_pred cEeEEEEECCe--------------eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999987553 499999996 788887754221112234567788999999999999999999999
Q ss_pred CCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001143 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032 (1141)
Q Consensus 953 DLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1032 (1141)
||||+|||++.+ +.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++||
T Consensus 292 DLKP~NILl~~~-------~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di 351 (501)
T PHA03210 292 DIKLENIFLNCD-------GKIVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILAG----DGYCEITDI 351 (501)
T ss_pred CCCHHHEEECCC-------CCEEEEeCCCceecCccccc---------ccccccCCcCCCCchhhcC----CCCCcHHHH
Confidence 999999999887 78999999999765432111 1123469999999999876 568899999
Q ss_pred HHHHHHHHHHHhCCCC-CCCC--CH-HHHHHHHHhCCCC--CchhHHhhhccCc-cccccccCCCCCCchhhhhhHHHHH
Q 001143 1033 WSYGCLLLELLTLQVP-YMGL--SE-LEIHDLIQMGKRP--RLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLV 1105 (1141)
Q Consensus 1033 WSLGviL~ELLTGk~P-f~~~--~~-~el~~~I~~~~~p--~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~ 1105 (1141)
|||||++|||++|..+ |... .. .++.+.+...... .+++......... ....................+..+.
T Consensus 352 wSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (501)
T PHA03210 352 WSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFE 431 (501)
T ss_pred HHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHH
Confidence 9999999999998754 4321 22 2233333221111 0110000000000 0000000000000001113456688
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1106 DVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1106 dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+++.+||++||.+|||+.|++.|+||..
T Consensus 432 ~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 432 YPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 8999999999999999999999999964
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=311.76 Aligned_cols=286 Identities=21% Similarity=0.257 Sum_probs=200.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.+.||+|++|.||+|.+. +..+++|...... ........ +.+|+.++++++||||+++++++....
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ--EDEGVPST----AIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc--ccccchHH----HHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 367999999999999999999975 4567777643321 11111122 368999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+++|+||||+|+||+++
T Consensus 75 --------------~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 75 --------------RLYLVFEYLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred --------------eEEEEEeccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 3499999996 688888754 2233468889999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.++ +.+||+|||++........ ......+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~~------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 137 RRT------NALKLADFGLARAFGIPVR----------TFTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred CCC------CEEEEcccccccccCCCcc----------ccccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 542 5799999999865432111 1112357889999999865 23577899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccC-CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+||+.||......+....+.. ...+ ....+............... ............++.+.+++.+||+.+|++||
T Consensus 198 ~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (294)
T PLN00009 198 VNQKPLFPGDSEIDELFKIFRILGTP-NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI 276 (294)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCC-ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc
Confidence 999999987665544433321 1111 11111000000000000000 00000001124567789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
++.++++|+|+...
T Consensus 277 s~~~~l~~~~~~~~ 290 (294)
T PLN00009 277 TARAALEHEYFKDL 290 (294)
T ss_pred CHHHHhcCchHhHH
Confidence 99999999999753
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=305.81 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=197.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC--c---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS--A---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~--~---~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..+|+..+.||+|+||.||+|+... . .+++|. ++... .....+. +.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~--~~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKT--LKPGY-TEKQRQD----FLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEe--ccccC-CHHHHHH----HHHHHHHHhcCCCCCeeEEEEEEc
Confidence 3468899999999999999998742 2 345554 33221 1222333 378999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
..+. .++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 77 ~~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 77 KFKP--------------AMIITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred cCCC--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 6543 4999999999999999875 224689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||++.......... ........+..|+|||++.. ..++.++|||||||++
T Consensus 139 li~~~-------~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~il 200 (268)
T cd05063 139 LVNSN-------LECKVSDFGLSRVLEDDPEGT-------YTTSGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 200 (268)
T ss_pred EEcCC-------CcEEECCCccceecccccccc-------eeccCCCcCceecCHHHhhc----CCcChHhHHHHHHHHH
Confidence 99877 789999999987553321110 00011123457999999875 4678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|||++ |..||......+....+..+...... ...+..+.+++.+||+.||.+
T Consensus 201 ~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~ 253 (268)
T cd05063 201 WEVMSFGERPYWDMSNHEVMKAINDGFRLPAP---------------------------MDCPSAVYQLMLQCWQQDRAR 253 (268)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99998 99999876666666665433221110 134567899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
||++.+|++.+..
T Consensus 254 Rp~~~~i~~~l~~ 266 (268)
T cd05063 254 RPRFVDIVNLLDK 266 (268)
T ss_pred CcCHHHHHHHHHh
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=319.37 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=200.5
Q ss_pred CCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~---------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
.+|++.+.||+|+||.||+|.+.+ ..+++|+.... ......+.+ .+|+.+++++ +||||++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDL----VSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHH----HHHHHHHHhhcCCCCeeeee
Confidence 368999999999999999998621 24566654321 122223333 7899999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHH
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVEL 944 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~yL 944 (1141)
+++..... .++||||+++++|.+++..... .....+++..+..++.||+.||.||
T Consensus 85 ~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 85 GACTQDGP--------------LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred EEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 99876543 4999999999999999975321 1123588899999999999999999
Q ss_pred HHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC
Q 001143 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024 (1141)
Q Consensus 945 Hs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1024 (1141)
|++||+||||||+|||++.+ +.+||+|||.++......... ......++..|+|||++.+ .
T Consensus 151 H~~givH~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~ 211 (334)
T cd05100 151 ASQKCIHRDLAARNVLVTED-------NVMKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFD----R 211 (334)
T ss_pred HHCCeeccccccceEEEcCC-------CcEEECCcccceecccccccc--------cccCCCcCceEcCHHHhcc----C
Confidence 99999999999999999877 789999999987654321110 0111234567999999876 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 001143 1025 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1025 ~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1141)
.++.++|||||||++|||++ |..||.+.+..+....+.....+..+ ...+..
T Consensus 212 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 264 (334)
T cd05100 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANCTHE 264 (334)
T ss_pred CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHH
Confidence 67889999999999999998 88999887776666665443222111 134557
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+.+++.+||+.+|.+||++.|+++++....
T Consensus 265 l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 265 LYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=315.77 Aligned_cols=293 Identities=21% Similarity=0.258 Sum_probs=200.3
Q ss_pred CceEeeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.|++.++||+|+||.||+|.+. +..+|+|+....... ...+...+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 4889999999999999999984 467888876543210 1111122368999999999999999999987642
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ...++||||++ ++|.+++..........+++..++.++.||+.||.|||+++|+||||||+||+++
T Consensus 76 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 76 D------------KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred C------------ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 1 24699999997 5788887654433334789999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.++ ...+.+||+|||++......... ........+++.|+|||++.+ ...++.++|||||||++++|
T Consensus 143 ~~~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l 209 (316)
T cd07842 143 GEG---PERGVVKIGDLGLARLFNAPLKP-------LADLDPVVVTIWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (316)
T ss_pred CCC---CccceEEECCCccccccCCCccc-------ccccCCccccccccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 721 11288999999998765432210 111223467899999998865 23567899999999999999
Q ss_pred HhCCCCCCCCCHHH---------HHHHH-HhCCCCCchhHHhhhccCcc-ccc--cccCCCCCCch----hhh--hhHHH
Q 001143 1043 LTLQVPYMGLSELE---------IHDLI-QMGKRPRLTDELEALGSCHE-HEV--AQSGSGFEKPE----AEL--ETLSF 1103 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~e---------l~~~I-~~~~~p~l~~~l~~~~~~~~-~~~--~~~~~~~~~~~----~~~--~~~~~ 1103 (1141)
++|+.||.+..... ....+ .....+. ............ ... ........... ... ..+..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd07842 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPT-EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288 (316)
T ss_pred HhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCc-hhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHH
Confidence 99999997543221 11111 1111111 110000000000 000 00000000000 011 34567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
+.+++.+||++||++|||+.|+++|+||
T Consensus 289 ~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 8999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.04 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=198.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+|+..+.||+|++|.||+|.+. +..+++|+......... ....+ .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK----QLEQEIALLSKLQHPNIVQYLGTEREED- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHH----HHHHHHHHHHhcCCCCchheeeeEecCC-
Confidence 4778899999999999999984 66788887543321111 12223 3479999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.+ ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 76 -------------NLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137 (258)
T ss_pred -------------eEEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 34999999999999999976 235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+....... ......++..|+|||.+... ..++.++|+|||||++|+|+
T Consensus 138 ~-------~~~kl~d~~~~~~~~~~~-----------~~~~~~~~~~y~~pe~~~~~---~~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 138 N-------GVVKLADFGMAKQVVEFS-----------FAKSFKGSPYWMAPEVIAQQ---GGYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred C-------CCEEEccCccceeccccc-----------cccccCCCcceeCHHHhcCC---CCCCchhhhHHHHHHHHHHH
Confidence 7 789999999987643321 11234588999999998651 23789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|+.||......+....+.. ...+.+ ....+..+.+++.+||..+|.+||++
T Consensus 197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 197 TGKPPWSQLEGVAAVFKIGRSKELPPI---------------------------PDHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred hCCCCcccCcHHHHHHHHHhcccCCCc---------------------------CCCcCHHHHHHHHHHhhcCcccCcCH
Confidence 99999976554333333221 111111 11345678999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.+++.|+|+
T Consensus 250 ~~~l~~~~~ 258 (258)
T cd06632 250 AELLEHPFV 258 (258)
T ss_pred HHHhcCCCC
Confidence 999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.17 Aligned_cols=254 Identities=30% Similarity=0.424 Sum_probs=199.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|++|.||+|.+. +..+++|..... .. ....+ .+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~-~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--IN-EAIQK----QILRELDILHKCNSPYIVGFYGAFYNNG- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecc--cC-hHHHH----HHHHHHHHHHHCCCCchhhhheeeecCC-
Confidence 36888999999999999999986 556677764332 11 12223 3478999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 962 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .|++||||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 73 -------------DISICMEYMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred -------------EEEEEEEecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 459999999999999999762 1478999999999999999999999 9999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ ....++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~------------~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l 192 (265)
T cd06605 136 SR-------GQIKLCDFGVSGQLVNSLA------------KTFVGTSSYMAPERIQG----NDYSVKSDIWSLGLSLIEL 192 (265)
T ss_pred CC-------CCEEEeecccchhhHHHHh------------hcccCChhccCHHHHcC----CCCCchhhHHHHHHHHHHH
Confidence 87 7899999999865432110 11457889999999876 4678999999999999999
Q ss_pred HhCCCCCCCCC-----HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1043 LTLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1043 LTGk~Pf~~~~-----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++|+.||.... ..+..+.+.....+..+. ...+..+.++|.+||..||+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~ 246 (265)
T cd06605 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS--------------------------GKFSPDFQDFVNLCLIKDPR 246 (265)
T ss_pred HhCCCCCCccccccccHHHHHHHHhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCch
Confidence 99999996532 222222322222221111 02556799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001143 1118 ERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~ 1133 (1141)
+|||+.+++.|+|+..
T Consensus 247 ~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 247 ERPSYKELLEHPFIKK 262 (265)
T ss_pred hCcCHHHHhhCchhhc
Confidence 9999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=314.22 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=196.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 874 (1141)
...++|.+.+.||+|+||.||+|.+. ...+|+|+.+ ... .....+. +.+|+.+++++ +||||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~----~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTA-HSSEREA----LMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecC--ccC-ChHHHHH----HHHHHHHHHhccCCCCcceE
Confidence 44567999999999999999999852 2245666533 211 1222233 37899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL 954 (1141)
++++...+. .++||||+++++|.++++. .....+++.++..++.||+.||+|||+++|+|+||
T Consensus 105 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 105 LGACTIGGP--------------ILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred EEEEecCCc--------------eEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999876543 4999999999999999975 22234899999999999999999999999999999
Q ss_pred CCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001143 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034 (1141)
Q Consensus 955 KP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1034 (1141)
||+||+++.+ +.++|+|||.+..+...... .......++..|+|||.+.+ ..++.++||||
T Consensus 168 kp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Diws 228 (302)
T cd05055 168 AARNVLLTHG-------KIVKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVWS 228 (302)
T ss_pred ccceEEEcCC-------CeEEECCCcccccccCCCce--------eecCCCCcccccCCHhhhcc----CCCCcHhHHHH
Confidence 9999999876 78999999998755332111 01112346788999999876 45789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHH-HHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1035 YGCLLLELLT-LQVPYMGLSELEIHDL-IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1035 LGviL~ELLT-Gk~Pf~~~~~~el~~~-I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
|||++|+|++ |..||......+.... +..+..+..+ ...+..+.+++.+||
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl 281 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP---------------------------EHAPAEIYDIMKTCW 281 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 9999999998 9999987554433322 2222111100 133457999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 001143 1113 EENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~~ 1131 (1141)
..+|++|||+.|+++.+..
T Consensus 282 ~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 282 DADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCCchhCcCHHHHHHHHHh
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=319.80 Aligned_cols=289 Identities=19% Similarity=0.234 Sum_probs=202.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||+|.+. +..|++|+.. .... .... ..+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~--~~~~-~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS--PFEH-QTFC----QRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEec--cccc-chhH----HHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 57999999999999999999874 5567777643 2111 1112 233789999999999999999998765432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. .....++||||++ ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 78 ~---------~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~ 141 (336)
T cd07849 78 E---------SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141 (336)
T ss_pred c---------ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 1 1235699999997 688887754 36999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++......... ........||+.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 142 ~-------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 142 N-------CDLKICDFGLARIADPEHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred C-------CCEEECcccceeeccccccc-------cCCcCCcCcCCCccChHHhhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 78999999998764332111 011123468999999998754 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+.+.......+......................... ..............+.++.+++.+||+.||.+||
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 9999998765544333332211111111111100000000000 0000000011123467799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|+.|+++|+|+..-
T Consensus 285 t~~e~l~hp~~~~~ 298 (336)
T cd07849 285 TVEEALAHPYLEQY 298 (336)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=310.95 Aligned_cols=256 Identities=32% Similarity=0.494 Sum_probs=199.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccceeeeEecC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISS 881 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkllg~~~~~ 881 (1141)
.|++.+.||+|+||.||+|.+. +..+++|+..... .....+.+ .+|+.++++++ |||++++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~----~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDI----QREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHH----HHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 4788899999999999999984 5667777654321 12223333 68999999986 99999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.++++. ..+++..+..++.|++.||.|||+.||+||||+|+||++
T Consensus 75 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 75 P--------------RLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred C--------------EEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 4 35999999999999999864 268999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||.+........ ......|+..|+|||.+.+ ...++.++|||||||++|+
T Consensus 135 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 135 TNT-------GNVKLCDFGVAALLNQNSS----------KRSTFVGTPYWMAPEVITE---GKYYDTKADIWSLGITIYE 194 (277)
T ss_pred cCC-------CCEEEccCCceeecCCCcc----------ccccccCCcceeCHHHhcc---CCccccchhHHHHHHHHHH
Confidence 987 7899999999876543211 1123358899999999864 2456789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|..||...........+.....+.+.. ...+.++.+++.+||+.||++||+
T Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 195 MATGNPPYSDVDAFRAMMLIPKSKPPRLED--------------------------NGYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred HHhCCCCCCCCChhhhhhccccCCCCCCCc--------------------------ccCCHHHHHHHHHHcCCCcccCcC
Confidence 999999998755443332222211111110 024567999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001143 1122 AGDLYEMFVARTSS 1135 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s 1135 (1141)
+.++++|.|++...
T Consensus 249 ~~~il~~~~~~~~~ 262 (277)
T cd06917 249 AEELLKSKWIKAHS 262 (277)
T ss_pred HHHHhhChHhhccc
Confidence 99999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=311.62 Aligned_cols=282 Identities=25% Similarity=0.308 Sum_probs=199.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|++|.||+|.+. +..+++|+.+... .... ....+.+|++++++++||||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDED----VKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--cccc----chhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 36899999999999999999985 4567777643321 1111 2233479999999999999999999987644
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||++++.+..++.. ...+++..+..++.||+.||.|||+++++||||+|+||+++.
T Consensus 74 -------------~~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 74 -------------RLYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 35999999997666655543 245899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+......... ......++..|+|||++.+. ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~---~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 136 S-------GVLKLCDFGFARALRARPAS---------PLTDYVATRWYRAPELLVGD---TNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred C-------CCEEEEeeecccccCCCccc---------cccCcccccCCcCCchhcCC---CCcCchhhHHHHHHHHHHHH
Confidence 7 78999999998765432210 11234578899999998762 26789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC---ccccccccCCCCCCch-hhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|+.||.+....+....+........+......... ................ .....+.++.+++.+||..||++|
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (288)
T cd07833 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKER 276 (288)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhc
Confidence 999999876655443333221111111100000000 0000000000000000 011236789999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
|+++++++|+||
T Consensus 277 ps~~~il~~~~f 288 (288)
T cd07833 277 LTCDELLQHPYF 288 (288)
T ss_pred ccHHHHhcCCCC
Confidence 999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=328.25 Aligned_cols=261 Identities=24% Similarity=0.330 Sum_probs=198.7
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkll 875 (1141)
+.++|.+.++||+|+||.||+|++.+ ..||+|+.+.. . .....+. +.+|+.++.++. |||||+++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~-~~~~~~~----~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST--A-RSSEKQA----LMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC--C-ChhHHHH----HHHHHHHHHhcCCCCCeEEEE
Confidence 34568899999999999999999743 35777775422 1 1222223 479999999997 99999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh------------------------------------
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 919 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~------------------------------------ 919 (1141)
+++..... .++||||+++|+|.++++....
T Consensus 108 ~~~~~~~~--------------~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 108 GACTKGGP--------------IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred EEEccCCC--------------cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 99876553 3999999999999999975321
Q ss_pred ---------------------------------------------------------cCCCCCCHHHHHHHHHHHHHHHH
Q 001143 920 ---------------------------------------------------------TGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 920 ---------------------------------------------------------~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
.....+++..+..|+.||+.||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 01134778889999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||+.+|+||||||+|||++.+ +.+||+|||+++.+...... .......++..|+|||.+.+
T Consensus 254 ~LH~~~ivHrdlkp~NiLl~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--- 315 (401)
T cd05107 254 FLASKNCVHRDLAARNVLICEG-------KLVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFN--- 315 (401)
T ss_pred HHhcCCcCcccCCcceEEEeCC-------CEEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcC---
Confidence 9999999999999999999876 78999999999754321110 01112346788999999875
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1100 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1141)
..++.++|||||||++|||++ |..||......+.. ..+..+.++..+ ..+
T Consensus 316 -~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~ 367 (401)
T cd05107 316 -NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP---------------------------AHA 367 (401)
T ss_pred -CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC---------------------------CCC
Confidence 567899999999999999998 89999765444432 333333221111 134
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1101 LSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1101 ~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
+.++.+++.+||..+|.+||++++|++.+..
T Consensus 368 ~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 368 SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 5679999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=307.40 Aligned_cols=246 Identities=21% Similarity=0.368 Sum_probs=181.7
Q ss_pred eeecccCceEEEEEEECCc--------------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 812 DEAGKSVSSSLFRCKFGSA--------------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~--------------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
+.||+|+||.||+|++... .+++|+ +... ... ....+..|+.++..++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~--~~~~--~~~----~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKV--LDPS--HRD----ISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEee--cChh--hhh----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4689999999999985321 244444 2211 111 12234788999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+...... ++||||+++++|..++.. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 73 ~~~~~~~--------------~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 73 CVRDVEN--------------IMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EecCCCC--------------EEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 8765433 899999999999988764 2246899999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.++........++++|||.+..... .....++..|+|||.+.. ...++.++|||||||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~--------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ 197 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLS--------------RQECVERIPWIAPECVED---SKNLSIAADKWSFGT 197 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccC--------------cccccccccccChhhhcC---CCCCCchhHHHHHHH
Confidence 999986532222224589999998864322 113457889999998863 245788999999999
Q ss_pred HHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELL-TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|||+ +|..||......+..... ...... .. ....++.+|+.+||+.||
T Consensus 198 ~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~~-----------------------~~-----~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 198 TLWEICYNGEIPLKDKTLAEKERFY-EGQCML-----------------------VT-----PSCKELADLMTHCMNYDP 248 (262)
T ss_pred HHHHHHhCCCCCCCCcchhHHHHHH-hcCccC-----------------------CC-----CChHHHHHHHHHHcCCCh
Confidence 999998 588888764433322111 111000 00 234568999999999999
Q ss_pred CCCCCHHHHHHHH
Q 001143 1117 TERPTAGDLYEMF 1129 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L 1129 (1141)
.+||++.+|++++
T Consensus 249 ~~Rp~~~~il~~~ 261 (262)
T cd05077 249 NQRPFFRAIMRDI 261 (262)
T ss_pred hhCcCHHHHHHhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.28 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=215.3
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
+....++||-|.||.||.|.|+.-...|+|+.++.. ..+.++| ++|+.+|+.++|||+|+++|+|..+..+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEF----LkEAAvMKeikHpNLVqLLGVCT~EpPF-- 338 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTHEPPF-- 338 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHH----HHHHHHHHhhcCccHHHHhhhhccCCCe--
Confidence 357889999999999999999887777777666642 3445566 8999999999999999999999876544
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
|||+|||..|+|.++++.+ ....++.-..+.++.||..|++||..+++|||||-+.|.|+.++
T Consensus 339 ------------YIiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-- 401 (1157)
T KOG4278|consen 339 ------------YIITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-- 401 (1157)
T ss_pred ------------EEEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc--
Confidence 9999999999999999884 33457888889999999999999999999999999999999988
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1045 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1045 (1141)
..||++|||+++.+.....+ ++.+ .--.+.|.|||-+.. ..++.|+|||+|||+|||+.| |
T Consensus 402 -----hiVKvADFGLsRlMtgDTYT---AHAG------AKFPIKWTAPEsLAy----NtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 402 -----HIVKVADFGLSRLMTGDTYT---AHAG------AKFPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred -----ceEEeeccchhhhhcCCcee---cccC------ccCcccccCcccccc----cccccchhhHHHHHHHHHHHhcC
Confidence 78999999999988765433 2222 224567999999876 678899999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
..||.+.+..+++..+..+.+..-+ ..|++.+.+|++.||++.|.+||+++|+
T Consensus 464 MsPYPGidlSqVY~LLEkgyRM~~P---------------------------eGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYGLLEKGYRMDGP---------------------------EGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCCCccHHHHHHHHhccccccCC---------------------------CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 9999999998999888777654322 1788889999999999999999999999
Q ss_pred HHHHHhh
Q 001143 1126 YEMFVAR 1132 (1141)
Q Consensus 1126 L~~L~~~ 1132 (1141)
-+.++-.
T Consensus 517 HqafEtm 523 (1157)
T KOG4278|consen 517 HQAFETM 523 (1157)
T ss_pred HHHHHHH
Confidence 8776654
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=304.78 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=202.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|++|.||+|.+. +..+++|+..... .. ..... +.+|+..+.+++||||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~--~~-~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DE-EFRKQ----LLRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc--ch-HHHHH----HHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 36899999999999999999985 5667777654321 11 22233 479999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 962 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+++||||+|+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 73 -------------EISIVLEYMDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred -------------eEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 45999999999999999976 2468999999999999999999999 9999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ ......++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l 193 (264)
T cd06623 135 SK-------GEVKIADFGISKVLENTLD----------QCNTFVGTVTYMSPERIQG----ESYSYAADIWSLGLTLLEC 193 (264)
T ss_pred CC-------CCEEEccCccceecccCCC----------cccceeecccccCHhhhCC----CCCCchhhHHHHHHHHHHH
Confidence 87 7899999999876543211 1113457889999999876 4678999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhh-hHHHHHHHHHHhcccCCCC
Q 001143 1043 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE-TLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1043 LTGk~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~dLI~~cL~~DP~~ 1118 (1141)
++|+.||.... ..+....+.....+... .. .+..+.+++.+||..+|++
T Consensus 194 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~ 246 (264)
T cd06623 194 ALGKFPFLPPGQPSFFELMQAICDGPPPSLP---------------------------AEEFSPEFRDFISACLQKDPKK 246 (264)
T ss_pred HhCCCCCccccccCHHHHHHHHhcCCCCCCC---------------------------cccCCHHHHHHHHHHccCChhh
Confidence 99999997653 33333333322211111 12 5567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
||++.++++|+|++.
T Consensus 247 R~~~~~ll~~~~~~~ 261 (264)
T cd06623 247 RPSAAELLQHPFIKK 261 (264)
T ss_pred CCCHHHHHhCHHHHh
Confidence 999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=305.94 Aligned_cols=261 Identities=30% Similarity=0.474 Sum_probs=200.0
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|+||.||+|.+ .+..+++|+..... ...... ..+..|+.++++++|+||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTI----KEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc--cchHHH----HHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 588999999999999999987 45677888765432 122223 34489999999999999999999876544
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. ...+++..+..|+.|++.||.|||+.||+|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 73 ------------KVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred ------------EEEEEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 35999999999999999875 2358899999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||.+........... .......+++.|+|||++.+.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~kl~d~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 136 -------GVIKLGDFGCAVKLKNNTTTMG------EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred -------CCEEEcccccccccCCCCCccc------ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHh
Confidence 7899999999876543221110 0011245788999999987622 1237889999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 Gk~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||.... .......+.....+.++.. ...+..+.+++.+||+.+|.+||++.
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPPIPDS-------------------------LQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCCCCcc-------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 999997543 2222223332222222110 13356688999999999999999999
Q ss_pred HHHHHHHh
Q 001143 1124 DLYEMFVA 1131 (1141)
Q Consensus 1124 ElL~~L~~ 1131 (1141)
+++.|+|.
T Consensus 257 ~i~~~~~~ 264 (264)
T cd06626 257 ELLQHPFV 264 (264)
T ss_pred HHhcCCCC
Confidence 99999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.23 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=187.8
Q ss_pred eeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
+.||+|+||.||+|.+.. ..+++|. .... ......+.+ .+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~--~~~~-~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKS--LNRI-TDLEEVEQF----LKEGIIMKDFSHPNVLSLLGICLPSEG--- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEe--cCcc-CCHHHHHHH----HHHHHHHccCCCCCcceEEEEeecCCC---
Confidence 468999999999998632 2355554 3221 122223333 789999999999999999997654221
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 71 ----------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-- 134 (262)
T cd05058 71 ----------SPLVVLPYMKHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-- 134 (262)
T ss_pred ----------CcEEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--
Confidence 238999999999999999752 2346788889999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1045 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1045 (1141)
+.+||+|||+++......... ........++..|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 135 -----~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 135 -----FTVKVADFGLARDIYDKEYYS------VHNHTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred -----CcEEECCccccccccCCccee------ecccccCcCCccccChhHhcc----CccchHHHHHHHHHHHHHHHcCC
Confidence 789999999987543311100 001112345778999999875 467899999999999999999 5
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
.+||......+....+..+..+..+ ...+..+.+++.+||..+|++||++.++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQP---------------------------EYCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 6677766655555544433222111 0335578999999999999999999999
Q ss_pred HHHHHhh
Q 001143 1126 YEMFVAR 1132 (1141)
Q Consensus 1126 L~~L~~~ 1132 (1141)
++.+...
T Consensus 253 l~~l~~~ 259 (262)
T cd05058 253 VSRIEQI 259 (262)
T ss_pred HHHHHHH
Confidence 9987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=321.27 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=196.1
Q ss_pred CCCceEeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~-------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
.++|++.++||+|+||.||+|.+ .+..+|+|+.+... ....... +.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRA----LMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHH----HHHHHHHHHhccCCccHhhhcc
Confidence 45799999999999999999985 24567887754221 2222333 37899999999 6899999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------------------------
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 920 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~------------------------------------ 920 (1141)
++...+. ..++||||+++|+|.++++.....
T Consensus 79 ~~~~~~~-------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (343)
T cd05103 79 ACTKPGG-------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQ 145 (343)
T ss_pred eeecCCC-------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccc
Confidence 8765331 348999999999999999752100
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeE
Q 001143 921 --------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974 (1141)
Q Consensus 921 --------------------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~v 974 (1141)
....+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-------~~~ 218 (343)
T cd05103 146 SSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-------NVV 218 (343)
T ss_pred ccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-------CcE
Confidence 01247888999999999999999999999999999999999877 789
Q ss_pred EEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001143 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS 1053 (1141)
Q Consensus 975 KL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~ 1053 (1141)
||+|||++......... .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||....
T Consensus 219 kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 219 KICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred EEEecccccccccCcch--------hhcCCCCCCcceECcHHhcC----CCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 99999998764321111 01112235678999999875 567899999999999999997 999997643
Q ss_pred HH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1054 EL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1054 ~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.. +....+..+..+..+. ..+..+.+++..||+.||.+|||+.+|++++...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 287 IDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ccHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 32 2233333222211110 2345689999999999999999999999998764
Q ss_pred c
Q 001143 1133 T 1133 (1141)
Q Consensus 1133 ~ 1133 (1141)
.
T Consensus 340 ~ 340 (343)
T cd05103 340 L 340 (343)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=303.05 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=204.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||.|++|.||+|.+. +..+++|+.... .......+. +.+|++++++++|||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~----~~~e~~~l~~l~~~~~~~~~~~~~~~~-- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS--NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecc--cCChHHHHH----HHHHHHHHHhcCCCChhheEEEEecCC--
Confidence 5889999999999999999986 566777765432 222233333 378999999999999999999987643
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++..... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 73 ------------KLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 45999999999999999986322 23579999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||+|+++++|++
T Consensus 140 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 140 -------GLVKLGDFGISKVLSSTVD----------LAKTVVGTPYYLSPELCQN----KPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred -------CcEEECCccceeecccCcc----------eecceeeeecccChhHhcc----CCCCccccHHHHHHHHHHHHc
Confidence 7899999999876543210 1123458889999999875 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||......+....+.....+.++. ..+..+.+++.+||..+|++|||+.+
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 199 LKHPFEGENLLELALKILKGQYPPIPS---------------------------QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999998766665555544333222211 34567899999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
+++|+|+
T Consensus 252 ll~~~~~ 258 (258)
T cd08215 252 ILQSPFI 258 (258)
T ss_pred HhcCCCC
Confidence 9999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=307.92 Aligned_cols=278 Identities=23% Similarity=0.270 Sum_probs=196.5
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~~ 884 (1141)
|++.++||+|+||.||+|.+. +..+++|..+.. ......... .+|+.++.++. ||||+++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~--~~~~~~~~~-----~~e~~~l~~l~~h~~i~~~~~~~~~~~~- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNN-----LREIQALRRLSPHPNILRLIEVLFDRKT- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhc--cCCchhhhH-----HHHHHHHhhcCCCCCccceEEEEecCCC-
Confidence 688999999999999999874 566777764322 122222222 47899999885 9999999999876411
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
...++||||++ ++|.+.+... ...+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 73 -----------~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 -----------GRLALVFELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred -----------CcEEEEEecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 14599999997 6888887651 246899999999999999999999999999999999999975
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||.+..+.... ......++..|+|||++.. ...++.++|||||||++|||++
T Consensus 136 -------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 136 -------DILKLADFGSCRGIYSKP-----------PYTEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred -------CCeEEEecccccccccCC-----------CcCCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHc
Confidence 479999999987653211 1112357889999998654 2356789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||.+.+..+....+.................. .....................+..+.+++.+||..||++||++.
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 99999887766655444322111111100000000 00000000000000011124578899999999999999999999
Q ss_pred HHHHHHHh
Q 001143 1124 DLYEMFVA 1131 (1141)
Q Consensus 1124 ElL~~L~~ 1131 (1141)
++++|+|+
T Consensus 275 ~~l~~~~~ 282 (282)
T cd07831 275 QALRHPYF 282 (282)
T ss_pred HHhhCCCC
Confidence 99999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=309.33 Aligned_cols=281 Identities=18% Similarity=0.235 Sum_probs=201.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.++||.|++|.||+|++. +..+++|+...... ....+. +.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPST----AIREISLMKELKHENIVRLHDVIHTENK- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHH----HHHHHHHHHhhcCCCEeeeeeeEeeCCc-
Confidence 5899999999999999999984 55677776543321 111122 3689999999999999999999987553
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.++||||++ ++|.+++.... ....+++..+..++.||+.||.|||+.|++||||||+||+++.+
T Consensus 73 -------------~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 73 -------------LMLVFEYMD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred -------------EEEEEecCC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 499999998 58999887522 12468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+........ ......++..|++||++.+ ...++.++|||||||++|+|++
T Consensus 137 -------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 137 -------GELKLADFGLARAFGIPVN----------TFSNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred -------CcEEEeecchhhhhcCCcc----------ccccccccccccChHHhcC---CCCCCcHHHHHHHHHHHHHHHh
Confidence 7899999999865432111 1112347889999999865 2356789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcccccc-ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA-QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||.+.+..+....+...........+............ ...............+..+.+++.+||+.||.+||++.
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 276 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAH 276 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHH
Confidence 99999877665555444322211111111111100000000 00000000011123467789999999999999999999
Q ss_pred HHHHHHHh
Q 001143 1124 DLYEMFVA 1131 (1141)
Q Consensus 1124 ElL~~L~~ 1131 (1141)
++++|+||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07836 277 DALQHPWF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=309.35 Aligned_cols=251 Identities=29% Similarity=0.417 Sum_probs=199.2
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.++||+|+||.||+|.+. +..+|+|+..... .....+. +.+|+.++.+++||||+++++++.....
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 76 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIED----IQQEITVLSQCDSPYVTKYYGSYLKDTK-- 76 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHH----HHHHHHHHHhcCCCCEeEEEEEEEeCCe--
Confidence 678899999999999999874 4567777643221 1122233 4789999999999999999999986553
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
.++||||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.+
T Consensus 77 ------------~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~- 137 (277)
T cd06641 77 ------------LWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH- 137 (277)
T ss_pred ------------EEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-
Confidence 4999999999999999864 358999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||++..+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|
T Consensus 138 ------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~g 197 (277)
T cd06641 138 ------GEVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred ------CCEEEeecccceecccchh----------hhccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHHcC
Confidence 7899999999865433110 1112357889999999875 4567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
..||...........+.....+.+. ...+.++.+++.+||+.+|.+||++.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 198 EPPHSELHPMKVLFLIPKNNPPTLE---------------------------GNYSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred CCCCCccchHHHHHHHhcCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999876555444444333222111 1345678999999999999999999999
Q ss_pred HHHHHhhc
Q 001143 1126 YEMFVART 1133 (1141)
Q Consensus 1126 L~~L~~~~ 1133 (1141)
++|+|+..
T Consensus 251 l~~~~~~~ 258 (277)
T cd06641 251 LKHKFIVR 258 (277)
T ss_pred HhCHHHhh
Confidence 99999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=311.97 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=194.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC--------------c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS--------------A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 868 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~--------------~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 868 (1141)
..+|++.++||+|+||.||+|.+.+ . .+++|+.. .. ........ +.+|++++++++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~ei~~l~~l~h 76 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR--AD-VTKTARND----FLKEIKIMSRLKN 76 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecC--CC-CCHHHHHH----HHHHHHHHHhCCC
Confidence 4589999999999999999987632 2 25555533 21 12222233 4799999999999
Q ss_pred CCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------cCCCCCCHHHHHHHHHHHHHHH
Q 001143 869 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------TGEKHVSVKLALFIAQDVAAAL 941 (1141)
Q Consensus 869 pNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-------~~~~~Ls~~~i~~Ia~QIa~gL 941 (1141)
|||+++++++..... .++||||+++++|.+++..... .....+++..+..++.|++.||
T Consensus 77 ~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 142 (295)
T cd05097 77 PNIIRLLGVCVSDDP--------------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM 142 (295)
T ss_pred CCcCeEEEEEcCCCc--------------cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHH
Confidence 999999999876543 4999999999999999965211 0112478899999999999999
Q ss_pred HHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001143 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1141)
Q Consensus 942 ~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1021 (1141)
+|||++|++||||||+||+++.+ +.+||+|||++......... .......++..|+|||++.+
T Consensus 143 ~~lH~~~i~H~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-- 205 (295)
T cd05097 143 KYLASLNFVHRDLATRNCLVGNH-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILL-- 205 (295)
T ss_pred HHHHhcCeeccccChhhEEEcCC-------CcEEecccccccccccCcce--------eccCcCcCceeecChhhhcc--
Confidence 99999999999999999999877 78999999998754321110 01122345778999999875
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 001143 1022 KPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1099 (1141)
Q Consensus 1022 ~~~~~s~ksDVWSLGviL~ELLT--Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1141)
..++.++|||||||++|+|++ +..||......+....+......... .. .......
T Consensus 206 --~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~-----~~~~~~~ 263 (295)
T cd05097 206 --GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR---------------QI-----YLSQTPL 263 (295)
T ss_pred --CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccc---------------cc-----cCCCCCC
Confidence 457899999999999999998 67788766655544433211000000 00 0000013
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1100 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1100 ~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
.+..+.+|+.+||..||++||++++|++.+.
T Consensus 264 ~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 264 CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 4567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.78 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~---~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
++||+|++|.||+|.+.. . .+++|... ..... ... ..+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~--~~~~~-~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~-~---- 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK--SDKLS-DIM----DDFLKEAAIMHSLDHENLIRLYGVVLT-H---- 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecC--CcccH-HHH----HHHHHHHHHHhhcCCCCccceeEEEcC-C----
Confidence 478999999999998733 2 35666533 22111 223 334899999999999999999999875 3
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..++||||+++++|.+++.+. ....+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-- 133 (257)
T cd05040 69 ----------PLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-- 133 (257)
T ss_pred ----------eEEEEEEecCCCcHHHHHHhc---ccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC--
Confidence 349999999999999999762 11468999999999999999999999999999999999999987
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1045 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1045 (1141)
+.+||+|||.+..+....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |
T Consensus 134 -----~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Di~slG~~l~el~t~g 197 (257)
T cd05040 134 -----DKVKIGDFGLMRALPQNEDHY-------VMEEHLKVPFAWCAPESLRT----RTFSHASDVWMFGVTLWEMFTYG 197 (257)
T ss_pred -----CEEEeccccccccccccccce-------ecccCCCCCceecCHHHhcc----cCcCchhhhHHHHHHHHHHHhCC
Confidence 789999999997654322110 01112347788999999876 567889999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
..||...+..+....+..... ... .+ ...+..+.+++.+||+.+|++||++.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~-~~~----------------------~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 198 EEPWAGLSGSQILKKIDKEGE-RLE----------------------RP---EACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCC-cCC----------------------CC---ccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 999987776666555432111 000 00 1345679999999999999999999999
Q ss_pred HHHHH
Q 001143 1126 YEMFV 1130 (1141)
Q Consensus 1126 L~~L~ 1130 (1141)
++.+.
T Consensus 252 ~~~l~ 256 (257)
T cd05040 252 REFLP 256 (257)
T ss_pred HHHhc
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=345.02 Aligned_cols=270 Identities=24% Similarity=0.291 Sum_probs=195.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.+|++.++||+|+||.||+|.+. +..+|+|+..... ... .....++.+|++++++++||||+++++++.+.+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--SEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--ccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 468999999999999999999985 5667777654221 111 122334589999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG------EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
..++||||++|++|.+++....... ...+++..+..++.||+.||+|||++||+||||||
T Consensus 76 --------------~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP 141 (932)
T PRK13184 76 --------------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141 (932)
T ss_pred --------------EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 3499999999999999997532211 23466778899999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeecccccccccccccccc--------ccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI--------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~--------~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1028 (1141)
+||+++.+ +.+||+|||+++........... .......+...+||+.|+|||++.+ ..++.
T Consensus 142 eNILLd~d-------g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g----~~~S~ 210 (932)
T PRK13184 142 DNILLGLF-------GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----VPASE 210 (932)
T ss_pred heEEEcCC-------CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC----CCCCc
Confidence 99999887 78999999999765211100000 0001112234579999999999876 56789
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1108 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1108 (1141)
++|||||||++|||+||..||.............. ..+ .... .....++.+.+++
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i-~~P---~~~~---------------------p~~~iP~~L~~LI 265 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI-LSP---IEVA---------------------PYREIPPFLSQIA 265 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhc-cCh---hhcc---------------------ccccCCHHHHHHH
Confidence 99999999999999999999976443322211100 000 0000 0014556789999
Q ss_pred HHhcccCCCCCCCH-HHHHHHH
Q 001143 1109 RRCTEENPTERPTA-GDLYEMF 1129 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa-~ElL~~L 1129 (1141)
.+||..||++||+. +++++.+
T Consensus 266 ~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 266 MKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred HHHccCChhhCcCHHHHHHHHH
Confidence 99999999999764 4454443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.14 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=199.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC--c----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~--~----~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
....+|++.+.||+|+||.||+|.+.. . .+++|+. .... ....... +.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~--~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REET-SPKANKE----ILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEec--cCCC-CHHHHHH----HHHHHHHHHhCCCCCcceEEE
Confidence 345678999999999999999998732 2 2455543 2221 1222233 378999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++.. . ..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||
T Consensus 77 ~~~~-~--------------~~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p 137 (279)
T cd05057 77 ICLS-S--------------QVQLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA 137 (279)
T ss_pred EEec-C--------------ceEEEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence 9875 2 34999999999999999875 223589999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+||+++.+ +.+||+|||.++......... ......++..|+|||.+.. ..++.++||||||
T Consensus 138 ~nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG 198 (279)
T cd05057 138 RNVLVKTP-------QHVKITDFGLAKLLDVDEKEY--------HAEGGKVPIKWMALESILH----RIYTHKSDVWSYG 198 (279)
T ss_pred ceEEEcCC-------CeEEECCCcccccccCcccce--------ecCCCcccccccCHHHhhc----CCcCchhhHHHHH
Confidence 99999877 789999999997654321110 0111224568999999865 5678999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1037 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1037 viL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
+++||+++ |+.||.+....++...+..+.....+. ..+..+.+++.+||..|
T Consensus 199 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~ 251 (279)
T cd05057 199 VTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP---------------------------ICTIDVYMVLVKCWMID 251 (279)
T ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCC
Confidence 99999999 999998877776666655433221110 23456889999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 001143 1116 PTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~ 1132 (1141)
|.+||++.++++.+...
T Consensus 252 p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 252 AESRPTFKELINEFSKM 268 (279)
T ss_pred hhhCCCHHHHHHHHHHH
Confidence 99999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.76 Aligned_cols=261 Identities=22% Similarity=0.339 Sum_probs=185.7
Q ss_pred eeecccCceEEEEEEE-CCccEEEEE-EecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF-GSADAAAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~-~~~~vAvKI-~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g 889 (1141)
+.||+|+||.||+|.+ ....++.++ +.+.. .......+ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~----~~~~e~~~~~~l~h~~iv~~~~~~~~~~~------ 69 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKA-NASSKEQN----EFLQQGDPYRILQHPNILQCLGQCVEAIP------ 69 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecC-CCChHHHH----HHHHHHHHHhccCCcchhheEEEecCCCc------
Confidence 4699999999999975 333333222 22222 11122223 34899999999999999999999876543
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCC
Q 001143 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~ 969 (1141)
.++||||+++++|.+++++.... ...+++..++.++.||+.||+|||+.+|+||||||+|||++.+
T Consensus 70 --------~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~----- 135 (268)
T cd05086 70 --------YLLVFEYCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD----- 135 (268)
T ss_pred --------cEEEEecCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-----
Confidence 49999999999999999763221 2356778889999999999999999999999999999999877
Q ss_pred CCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC---CCCCCchhhHHHHHHHHHHHHh-C
Q 001143 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLEVDIWSYGCLLLELLT-L 1045 (1141)
Q Consensus 970 ~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~s~ksDVWSLGviL~ELLT-G 1045 (1141)
+.++|+|||.+........ ........++..|+|||++..... ...++.++|||||||++|||++ |
T Consensus 136 --~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 136 --LTVKVGDYGIGPSRYKEDY--------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred --ccEEecccccccccCcchh--------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 7899999998754221110 001123457889999999753211 1245789999999999999997 5
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
..||......+....+.......+.. +......++.+.+++..|| .+|++||++.+|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 206 AQPYSHLSDREVLNHVIKDQQVKLFK----------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred CCCCCCCCHHHHHHHHHhhcccccCC----------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence 77887766655555443222211110 1111134567888999999 689999999999
Q ss_pred HHHHH
Q 001143 1126 YEMFV 1130 (1141)
Q Consensus 1126 L~~L~ 1130 (1141)
++.+.
T Consensus 263 ~~~l~ 267 (268)
T cd05086 263 HRLLT 267 (268)
T ss_pred HHHhc
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=314.58 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=201.4
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||++.. .+..+++|...... ....+. +.+|+.++++++||||+++++.+....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~----~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKEL----IINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHH----HHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 56899999999999999999986 45667777653221 122222 378999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 90 --------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~ 149 (293)
T cd06647 90 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149 (293)
T ss_pred --------------cEEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence 34999999999999999875 2578999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ ......+++.|+|||.+.. ..++.++|||||||++|+|
T Consensus 150 ~~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~ll~~l 208 (293)
T cd06647 150 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 208 (293)
T ss_pred CC-------CCEEEccCcceeccccccc----------ccccccCChhhcCchhhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 7899999998865432111 1123458889999999875 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||...+..+....+.....+... .....+..+.+++.+||..+|.+||++
T Consensus 209 l~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~ 263 (293)
T cd06647 209 VEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLEMDVEKRGSA 263 (293)
T ss_pred HhCCCCCCCCChhhheeehhcCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcCH
Confidence 9999999865543322222111111110 001345578999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001143 1123 GDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s~~ 1137 (1141)
.+++.|.|+......
T Consensus 264 ~~il~h~~~~~~~~~ 278 (293)
T cd06647 264 KELLQHPFLKIAKPL 278 (293)
T ss_pred HHHhcCHHHhcCccc
Confidence 999999999865433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.52 Aligned_cols=272 Identities=24% Similarity=0.372 Sum_probs=193.8
Q ss_pred CCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
.+|++.+.||+|+||.||+|.+ .+..+++|..... .....+.+ .+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDF----EREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCCeeEEEEEEc
Confidence 4689999999999999999975 2456777764321 22333334 78999999999999999999875
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
..+. ...++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 76 ~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ni 139 (284)
T cd05081 76 SAGR------------RNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139 (284)
T ss_pred cCCC------------CceEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhE
Confidence 4221 1359999999999999999751 23589999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++|||||||++
T Consensus 140 li~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 201 (284)
T cd05081 140 LVESE-------NRVKIGDFGLTKVLPQDKEYYK-------VREPGESPIFWYAPESLTE----SKFSVASDVWSFGVVL 201 (284)
T ss_pred EECCC-------CeEEECCCcccccccCCCccee-------ecCCCCCceEeeCHHHhcc----CCcChHHHHHHHHHHH
Confidence 99887 7899999999976543211100 0011124456999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|||++|..|+.... ......+..... +.....+... ........ .....+..+.+++.+||..+|++
T Consensus 202 ~el~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05081 202 YELFTYSDKSCSPP-AEFMRMMGNDKQGQMIVYHLIEL--------LKNNGRLP---APPGCPAEIYAIMKECWNNDPSQ 269 (284)
T ss_pred HHHhhcCCcCCCcc-hhhhhhcccccccccchHHHHHH--------HhcCCcCC---CCCCCCHHHHHHHHHHccCChhh
Confidence 99999987765432 122222211111 1111110000 00000000 11245677999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
|||+.+|++.+..
T Consensus 270 Rpt~~ei~~~l~~ 282 (284)
T cd05081 270 RPSFSELALQVEA 282 (284)
T ss_pred CCCHHHHHHHHHh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=302.55 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=201.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.++||+|+||.||++.+. +..+++|..... .........+ .+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLG--SMSQKEREDA----VNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehh--hccHHHHHHH----HHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 5889999999999999999874 445666664432 2222223333 68999999999999999999887543
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.+... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 73 ------------KLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred ------------EEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 45999999999999999876332 23568999999999999999999999999999999999999886
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||.+....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 140 -------~~~kl~d~g~~~~~~~~~------------~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 140 -------DLVKIGDLGISKVLKKNM------------AKTQIGTPHYMAPEVWKG----RPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -------CcEEEeeccchhhhccCC------------cccccCCccccCHHHHCC----CCCCchhhHHHHHHHHHHHHh
Confidence 789999999987654321 112347889999999876 567789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...+..+....+.....+..+. ..+.++.+++.+||..+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRGKYPPIPP---------------------------IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCch---------------------------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999998877665555554433332221 34566999999999999999999999
Q ss_pred HHHHHH
Q 001143 1125 LYEMFV 1130 (1141)
Q Consensus 1125 lL~~L~ 1130 (1141)
+++|++
T Consensus 250 ~l~~p~ 255 (256)
T cd08530 250 ILASPA 255 (256)
T ss_pred HhcCCC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=306.34 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=188.4
Q ss_pred eEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
.....||+|+||.||+|++... .+++|.. ... .....+.+ .+|+.++++++||||+++++++....
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~--~~~--~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~---- 78 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PER--DSRYVQPL----HEEIALHSYLKHRNIVQYLGSDSENG---- 78 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEe--cCC--CHHHHHHH----HHHHHHHHhcCCCCeeeeeeeeccCC----
Confidence 4446899999999999997544 4555543 321 12223333 79999999999999999999987654
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV--SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~L--s~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.++++.. ...+ ++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 79 ----------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 79 ----------FFKIFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY 144 (268)
T ss_pred ----------EEEEEEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 349999999999999999752 1234 888899999999999999999999999999999999763
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
. +.++|+|||.+........ ......+++.|+|||++.... ..++.++||||||+++|+|++
T Consensus 145 ~------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Dv~slGvvl~~l~~ 206 (268)
T cd06624 145 S------GVVKISDFGTSKRLAGINP----------CTETFTGTLQYMAPEVIDKGP--RGYGAPADIWSLGCTIVEMAT 206 (268)
T ss_pred C------CeEEEecchhheecccCCC----------ccccCCCCccccChhhhcccc--ccCCchhhhHHHHHHHHHHHh
Confidence 2 6799999999865432110 111234788999999986521 346789999999999999999
Q ss_pred CCCCCCCCCHHH-HHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1045 LQVPYMGLSELE-IHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1045 Gk~Pf~~~~~~e-l~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
|..||....... ....+ .....+. .+...++++.+++.+||+.+|.+|||+
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~ 259 (268)
T cd06624 207 GKPPFIELGEPQAAMFKVGMFKIHPE---------------------------IPESLSAEAKNFILRCFEPDPDKRASA 259 (268)
T ss_pred CCCCCccccChhhhHhhhhhhccCCC---------------------------CCcccCHHHHHHHHHHcCCCchhCCCH
Confidence 999997533211 11111 0011111 111445678999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.|++.|+|+
T Consensus 260 ~~ll~~~~~ 268 (268)
T cd06624 260 HDLLQDPFL 268 (268)
T ss_pred HHHHhCCCC
Confidence 999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=314.76 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=198.7
Q ss_pred ceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|.....||+|+||.||+|.+ .+..+++|+..... ....+. +.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~----~~~e~~~l~~l~hp~i~~~~~~~~~~~--- 91 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRREL----LFNEVVIMRDYQHQNVVEMYKSYLVGE--- 91 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHH----HHHHHHHHHhCCCCchhhhhhheeeCC---
Confidence 45556899999999999987 46778888754321 111222 378999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 92 -----------~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~- 153 (297)
T cd06659 92 -----------ELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD- 153 (297)
T ss_pred -----------eEEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-
Confidence 34999999999999998754 358999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.+||+|||++..+..... ......|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 154 ------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~g 213 (297)
T cd06659 154 ------GRVKLSDFGFCAQISKDVP----------KRKSLVGTPYWMAPEVISR----TPYGTEVDIWSLGIMVIEMVDG 213 (297)
T ss_pred ------CcEEEeechhHhhcccccc----------cccceecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999999865432111 1123458899999999876 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
+.||......+....+.....+... .....+..+.+++.+||+.+|.+||++.++
T Consensus 214 ~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 214 EPPYFSDSPVQAMKRLRDSPPPKLK-------------------------NAHKISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred CCCCCCCCHHHHHHHHhccCCCCcc-------------------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 9999876655544444322111100 001345568999999999999999999999
Q ss_pred HHHHHhhcC
Q 001143 1126 YEMFVARTS 1134 (1141)
Q Consensus 1126 L~~L~~~~~ 1134 (1141)
++|+|+...
T Consensus 269 l~~~~~~~~ 277 (297)
T cd06659 269 LDHPFLLQT 277 (297)
T ss_pred hhChhhccC
Confidence 999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=306.14 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=196.7
Q ss_pred CceEeeeecccCceEEEEEEECCc--cEEEEEEec-ccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTL-KVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l-~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+|.+.++||+|+||.||++++... .+++|+.+. ............ +..|+.++++++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ----ANQEAQLLSKLDHPAIVKFHASFLERD- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHH----HHHHHHHHHhCCCCcHHHHHHHHhcCC-
Confidence 588999999999999999988543 345554321 111111111122 357999999999999999999987544
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++...... ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 76 -------------AFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred -------------ceEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 349999999999999999764333 347999999999999999999999999999999999999974
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 142 --------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 142 --------NLLKIGDFGVSRLLMGSCD----------LATTFTGTPYYMSPEALKH----QGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred --------CCEeecccCceeecCCCcc----------cccCCCCCcCccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 4599999999866432111 1123457889999999865 45678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||...........+..+..+..+ ...+.++.+++.+||..||++||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (260)
T cd08222 200 CLAHAFEGQNFLSVVLRIVEGPTPSLP---------------------------ETYSRQLNSIMQSMLNKDPSLRPSAA 252 (260)
T ss_pred hCCCCCCCccHHHHHHHHHcCCCCCCc---------------------------chhcHHHHHHHHHHhcCChhhCcCHH
Confidence 999999765555444444333222211 14556789999999999999999999
Q ss_pred HHHHHHHh
Q 001143 1124 DLYEMFVA 1131 (1141)
Q Consensus 1124 ElL~~L~~ 1131 (1141)
++++|+|+
T Consensus 253 ~il~~~~~ 260 (260)
T cd08222 253 EILRNPFI 260 (260)
T ss_pred HHhhCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.45 Aligned_cols=298 Identities=20% Similarity=0.266 Sum_probs=213.7
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
..+..|++.+.||+|+||.||+|... ...+|+|.++..+...+ +.....+|+.+++.++||||+.+..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG------iS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG------ISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC------cCHHHHHHHHHHHHhcCCcchhHHH
Confidence 34667999999999999999999642 12456665443322111 1223369999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
+|...+ ..+++++||.+ .+|...|+-.+....+.++...++.|++||+.|+.|||++=|+||||||
T Consensus 95 Vfl~~d-------------~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 95 VFLSHD-------------KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred HHhccC-------------ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 887522 24699999998 8999999876666667899999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
.||||..+++ .+|.|||+|||+|+.+....... ...+..+-|.+|+|||.+.+. ..|++++||||.|
T Consensus 161 aNIlvmgdgp---erG~VKIaDlGlaR~~~~plkpl-------~s~d~VVVTiWYRAPELLLGa---~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 161 ANILVMGDGP---ERGRVKIADLGLARLFNNPLKPL-------ASLDPVVVTIWYRAPELLLGA---RHYTKAIDVWAIG 227 (438)
T ss_pred ceEEEeccCC---ccCeeEeecccHHHHhhcccccc-------ccCCceEEEEEecChHHhccc---ccccchhhhHHHH
Confidence 9999987743 35899999999999877654332 123456789999999999984 5789999999999
Q ss_pred HHHHHHHhCCCCCCCCCH---------HHHHHHH-HhCCCCCchhHHhhhccCcccc--ccc----cCCCCCCchh---h
Q 001143 1037 CLLLELLTLQVPYMGLSE---------LEIHDLI-QMGKRPRLTDELEALGSCHEHE--VAQ----SGSGFEKPEA---E 1097 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~---------~el~~~I-~~~~~p~l~~~l~~~~~~~~~~--~~~----~~~~~~~~~~---~ 1097 (1141)
||+.||+|-++.|.+... .+..+.| .....|. ...++......+.. +.+ .....+.... .
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt-~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~ 306 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPT-DKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKH 306 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCc-cccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHh
Confidence 999999999888865211 1223333 2222222 11122221111110 000 0000000000 0
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
...++...+|+.+||.+||.+|.|++++++|++|...
T Consensus 307 k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 307 KVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred cCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 1123457899999999999999999999999999865
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=319.09 Aligned_cols=290 Identities=18% Similarity=0.220 Sum_probs=204.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|++|.||+|.+. +..+++|+.... .......+ .+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~--~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA--FDVPTLAK----RTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccc--cccccchH----HHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 57899999999999999999874 566777764322 21112222 23689999999999999999998764321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.....++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 79 ----------~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 79 ----------DFKDVYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred ----------CCceEEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 1235699999996 689888864 345999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++......... .........++..|+|||++.+ ...++.++|||||||++|+|+
T Consensus 143 ~-------~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 143 D-------CELRIGDFGMARGLSSSPTE------HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred C-------CcEEecccccceeecccCcC------CCcccccccccccccChHHhcC---CcccccccchHHHHHHHHHHH
Confidence 7 78999999998765332111 0011123468899999999865 234789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|+.||.+.+.......+.. ...+.. ..+............+ ..............+..+.++|.+||+.||.+|
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPSE-EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCChh-HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 99999987665554443322 121111 1111000000000000 000000011112456789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
|++.+++.|+|+...
T Consensus 286 pt~~~~l~~~~~~~~ 300 (334)
T cd07855 286 ITVEQALQHPFLAQY 300 (334)
T ss_pred cCHHHHHhChhhhhc
Confidence 999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=312.68 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=200.0
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..|.+.+.||+|+||.||+|.+ .+..+++|+..... .......+. +.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~----~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQD----IIKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHH----HHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 4588999999999999999987 45667777653221 112222233 3789999999999999999999886543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.
T Consensus 90 --------------~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~ 150 (307)
T cd06607 90 --------------AWLVMEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150 (307)
T ss_pred --------------EEEEHHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC
Confidence 499999997 6887777541 236899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++...... ....+++.|+|||++.+.. ...++.++||||||+++|+|+
T Consensus 151 ~-------~~~kL~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~s~G~il~el~ 208 (307)
T cd06607 151 P-------GTVKLADFGSASLVSPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 208 (307)
T ss_pred C-------CCEEEeecCcceecCCC--------------CCccCCccccCceeeeccC-CCCCCcccchHHHHHHHHHHH
Confidence 7 78999999988643221 1335788999999875321 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||.+.........+.....+.... ...+..+.+++.+||..||.+||++.
T Consensus 209 tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 262 (307)
T cd06607 209 ERKPPLFNMNAMSALYHIAQNDSPTLSS--------------------------NDWSDYFRNFVDSCLQKIPQDRPSSE 262 (307)
T ss_pred cCCCCCCCccHHHHHHHHhcCCCCCCCc--------------------------hhhCHHHHHHHHHHhcCChhhCcCHH
Confidence 9999998766555444433322221110 13456799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001143 1124 DLYEMFVARTS 1134 (1141)
Q Consensus 1124 ElL~~L~~~~~ 1134 (1141)
+++.|+|+...
T Consensus 263 ~il~~~~~~~~ 273 (307)
T cd06607 263 ELLKHRFVLRE 273 (307)
T ss_pred HHhcChhhccc
Confidence 99999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=312.34 Aligned_cols=265 Identities=24% Similarity=0.321 Sum_probs=195.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~ 881 (1141)
.++|+..++||+|+||.||++.+. +..+++|..... ... .... .+.+|+.++.++. ||||+++++++..+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~--~~~-~~~~----~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDE-KEQK----RLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhc--cCh-HHHH----HHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 456778899999999999999985 456666654322 212 2222 3478999999996 99999999988764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 960 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NIL 960 (1141)
. ..++||||+. ++|.++...........+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 76 ~--------------~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 140 (288)
T cd06616 76 G--------------DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140 (288)
T ss_pred C--------------cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEE
Confidence 4 3489999986 6776655432223335799999999999999999999975 9999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.++|+|||++..+.... ......|++.|+|||++.+.. ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 141 LDRN-------GNIKLCDFGISGQLVDSI-----------AKTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLY 201 (288)
T ss_pred EccC-------CcEEEeecchhHHhccCC-----------ccccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHH
Confidence 9877 789999999986543211 111235788999999987521 135789999999999999
Q ss_pred HHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|++|+.||..... .+....+.....+.+.. ......+.++.+|+.+||+.||++|
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 202 EVATGKFPYPKWNSVFDQLTQVVKGDPPILSN-----------------------SEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred HHHhCCCCchhcchHHHHHhhhcCCCCCcCCC-----------------------cCCCccCHHHHHHHHHHccCChhhC
Confidence 99999999975431 11111111111111110 0001456679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.+|++|+|+..
T Consensus 259 pt~~~i~~~~~~~~ 272 (288)
T cd06616 259 PKYKELLEHPFIKD 272 (288)
T ss_pred cCHHHHhcChhhhc
Confidence 99999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.66 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEECC--------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 812 DEAGKSVSSSLFRCKFGS--------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~--------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.||+|+||.||+|++.. ..+++|... .. ........ +.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~--~~-~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KG-ATDQEKKE----FLKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhh--cc-cchhhHHH----HHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 468999999999998743 345666532 11 11122233 3789999999999999999999876443
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.++||||+++++|.+++++.... ....+++..+..++.||+.||.|||+.+++|+||||+||++
T Consensus 74 --------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 74 --------------QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred --------------eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 49999999999999999763221 22358899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+.. .....++|+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~~~--~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e 205 (269)
T cd05044 140 SEKGY--DADRVVKIGDFGLARDIYKSDYY--------RKEGEGLLPVRWMAPESLLD----GKFTTQSDVWSFGVLMWE 205 (269)
T ss_pred ecCCC--CCCcceEECCccccccccccccc--------ccCcccCCCccccCHHHHcc----CCcccchhHHHHHHHHHH
Confidence 87620 11237999999998754322111 01112245778999999876 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |+.||......+....+........+ ...+..+.+++.+||..+|.+||
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAGGRLQKP---------------------------ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcCCccCCc---------------------------ccchHHHHHHHHHHcCCCcccCC
Confidence 998 99999876666655554333221111 14456789999999999999999
Q ss_pred CHHHHHHHHH
Q 001143 1121 TAGDLYEMFV 1130 (1141)
Q Consensus 1121 Sa~ElL~~L~ 1130 (1141)
++.++++.+.
T Consensus 259 ~~~~i~~~l~ 268 (269)
T cd05044 259 TFDRIQEILQ 268 (269)
T ss_pred CHHHHHHHHh
Confidence 9999998764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=308.92 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=193.5
Q ss_pred CCceEeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 867 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~------------------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 867 (1141)
.+|++.++||+|+||.||+|.+.+ ..+|+|+.... ........ +.+|+.++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~----~~~E~~~l~~l~ 77 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARND----FLKEIKIMSRLK 77 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHH----HHHHHHHHHhCC
Confidence 469999999999999999986532 23555554321 11222233 479999999999
Q ss_pred CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------CCCCCCHHHHHHHHHHHHHHH
Q 001143 868 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAAL 941 (1141)
Q Consensus 868 HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~------~~~~Ls~~~i~~Ia~QIa~gL 941 (1141)
||||+++++++...+. .++||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 78 ~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05095 78 DPNIIRLLAVCITSDP--------------LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGM 143 (296)
T ss_pred CCCcceEEEEEecCCc--------------cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHH
Confidence 9999999999876553 39999999999999999763211 112478889999999999999
Q ss_pred HHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001143 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1141)
Q Consensus 942 ~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1021 (1141)
+|||++||+||||||+|||++.+ +.++|+|||++..+...... .......+++.|+|||...+
T Consensus 144 ~~lH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~-- 206 (296)
T cd05095 144 KYLSSLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILL-- 206 (296)
T ss_pred HHHHHCCeecccCChheEEEcCC-------CCEEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhc--
Confidence 99999999999999999999876 78999999998754321110 01112234678999998765
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 001143 1022 KPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1099 (1141)
Q Consensus 1022 ~~~~~s~ksDVWSLGviL~ELLT--Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1141)
..++.++|||||||++|||++ |..||...+..+............. . ...... ...
T Consensus 207 --~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------~-~~~~~~---~~~ 264 (296)
T cd05095 207 --GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG----------------R-QVYLPK---PAL 264 (296)
T ss_pred --CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcc----------------c-cccCCC---CCC
Confidence 467899999999999999998 7789976665554432211000000 0 000000 013
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001143 1100 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1100 ~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~ 1130 (1141)
++..+.+++.+||+.||.+||++.+|++.+.
T Consensus 265 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 265 CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.98 Aligned_cols=247 Identities=27% Similarity=0.322 Sum_probs=195.6
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||.|++|.||+|++. +..+++|+....... .... ...+.+|+.+++.++||||+++++.+.+...
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQ----QEHIFSEKEILEECNHPFIVKLYRTFKDKKY-------- 67 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhH----HHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--------
Confidence 799999999999986 677888875432211 1112 2334899999999999999999999876553
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
.++||||+++++|.+++.+ ...+++..+..++.||+.||.|||+++++|+||+|+||+++.+
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~------- 129 (262)
T cd05572 68 ------IYMLMEYCLGGELWTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN------- 129 (262)
T ss_pred ------cEEEEecCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-------
Confidence 3999999999999999976 2358999999999999999999999999999999999999887
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
+.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 130 ~~~~l~df~~~~~~~~~~-----------~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQ-----------KTWTFCGTPEYVAPEIILN----KGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCEEEeeCCcccccCccc-----------ccccccCCcCccChhHhcC----CCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 789999999987654321 1112357889999999865 4578999999999999999999999976
Q ss_pred CC--HHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----HH
Q 001143 1052 LS--ELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-----AG 1123 (1141)
Q Consensus 1052 ~~--~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS-----a~ 1123 (1141)
.. ..+....+..+. .+..+ ...+..+.+++.+||..||++||+ +.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKLEFP---------------------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CCCCHHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 55 444444433211 11110 123567999999999999999999 99
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|+..
T Consensus 248 ~l~~~~~~~~ 257 (262)
T cd05572 248 DIKKHKWFNG 257 (262)
T ss_pred HHhcChhhhC
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.30 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=199.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|...++||+|++|.||+|.+. +..+++|..... .....+. +.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~----~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRREL----LFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHH----HHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 3556689999999999999874 455777754322 1122222 378999999999999999999987644
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
+.++||||+++++|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||+++.+
T Consensus 90 ------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 90 ------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred ------------eEEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 34999999999999999875 358999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+....... .......|++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 152 -------~~~~l~d~g~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~ell~ 210 (285)
T cd06648 152 -------GRVKLSDFGFCAQVSKEV----------PRRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMVD 210 (285)
T ss_pred -------CcEEEcccccchhhccCC----------cccccccCCccccCHHHhcC----CCCCCcccHHHHHHHHHHHHh
Confidence 789999999876443211 11123458899999999875 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...+..+....+.....+.... ....+..+.+++.+||..+|.+||++.+
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 211 GEPPYFNEPPLQAMKRIRDNLPPKLKN-------------------------LHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CCCCCcCCCHHHHHHHHHhcCCCCCcc-------------------------cccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999998766655555544332211110 0024567999999999999999999999
Q ss_pred HHHHHHhhcC
Q 001143 1125 LYEMFVARTS 1134 (1141)
Q Consensus 1125 lL~~L~~~~~ 1134 (1141)
+++|.|+...
T Consensus 266 il~~~~~~~~ 275 (285)
T cd06648 266 LLNHPFLAKA 275 (285)
T ss_pred HccCcccccC
Confidence 9999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.19 Aligned_cols=276 Identities=22% Similarity=0.246 Sum_probs=203.4
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-.+|++.++||+|+|+.||+++. .+..+|+|..... ..++.+.. ++|++..++++||||++++++...+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~----~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEA----LREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHH----HHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 35799999999999999999985 4566677654322 23444444 79999999999999999999876432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 960 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NIL 960 (1141)
. | .....||+++|+..|||.+.|+.....+ ..+++.+++.|+.+|++||++||+.. +.||||||.|||
T Consensus 92 ~----D-----~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NIL 161 (302)
T KOG2345|consen 92 K----D-----GKHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANIL 161 (302)
T ss_pred c----c-----CceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeE
Confidence 1 1 2235799999999999999999765444 47999999999999999999999998 999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
+... +.++|+|||.+............+.+-.. ......|..|+|||.+.- ......++++|||||||+||
T Consensus 162 ls~~-------~~~vl~D~GS~~~a~i~i~~~~~a~~lQe-~a~e~Ct~pyRAPELf~v-k~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 162 LSDS-------GLPVLMDLGSATQAPIQIEGSRQALRLQE-WAEERCTIPYRAPELFNV-KSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred ecCC-------CceEEEeccCccccceEeechHHHHHHHH-HHHHhCCCcccCchheec-ccCcccccccchhhhhHHHH
Confidence 9886 78999999999765433222111111000 112247999999999864 33467789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.|..||... + ..|....+.- .....+.|... ..+..+.++++.||+.||.+||
T Consensus 233 a~mf~~sPfe~~-----~---~~GgSlaLAv---------------~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP 288 (302)
T KOG2345|consen 233 AMMFGESPFERI-----Y---QQGGSLALAV---------------QNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRP 288 (302)
T ss_pred HHHHcCCcchHH-----h---hcCCeEEEee---------------eccccccCCCC-CccHHHHHHHHHHhcCCcccCC
Confidence 999999999631 1 1222111100 00001111111 3677899999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
++.+++.++..
T Consensus 289 ~i~~ll~~~d~ 299 (302)
T KOG2345|consen 289 TIPELLSKLDD 299 (302)
T ss_pred CHHHHHHHHHh
Confidence 99999988754
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=308.60 Aligned_cols=278 Identities=21% Similarity=0.263 Sum_probs=198.5
Q ss_pred ceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.+.||.|++|.||+|.+ .+..+++|+...+.. ....... +.+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~----~~~E~~~l~~l~~~~iv~~~~~~~~~~--- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPST----AIREISLLKELNHPNIVRLLDVVHSEN--- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhH----HHHHHHHHHhcCCCCccCHhheeccCC---
Confidence 67889999999999999987 466777777554321 1111122 368999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++++||||+|+||+++.+
T Consensus 72 -----------~~~iv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~- 135 (283)
T cd07835 72 -----------KLYLVFEFLD-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE- 135 (283)
T ss_pred -----------eEEEEEeccC-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-
Confidence 3499999995 7999998752 22368999999999999999999999999999999999999886
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||.+......... .....++..|+|||++.+ ...++.++||||||+++|+|++|
T Consensus 136 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 136 ------GALKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred ------CcEEEeecccccccCCCccc----------cCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhC
Confidence 78999999998654321110 112246889999998765 23467899999999999999999
Q ss_pred CCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1046 QVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+.||...+.......+ .....+. ...+....... ...+... ............+..+.+++.+||+.||.+|||+
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPD-EDVWPGVTSLPDYKPTFPKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCC-hHHhhhhhhchhhhhhcccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999876654433333 2222111 11110000000 0000000 0000011112455779999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.|+++|+||
T Consensus 275 ~~il~~~~~ 283 (283)
T cd07835 275 KAALQHPYF 283 (283)
T ss_pred HHHhcCCCC
Confidence 999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.98 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~ 890 (1141)
++||+|+||.||+|.+. +..+++|+..... . ....+. +.+|+.+++++.||||+++++++.+...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~--~-~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 66 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL--P-PDLKRK----FLQEAEILKQYDHPNIVKLIGVCVQKQP------- 66 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccC--C-HHHHHH----HHHHHHHHHhCCCCCeEEEEEEEecCCC-------
Confidence 47999999999999975 6777777644321 1 122233 4789999999999999999999876553
Q ss_pred CccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCC
Q 001143 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1141)
Q Consensus 891 ~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~ 970 (1141)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 67 -------~~~v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~------ 129 (251)
T cd05041 67 -------IYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN------ 129 (251)
T ss_pred -------eEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC------
Confidence 49999999999999998751 2358899999999999999999999999999999999999887
Q ss_pred CCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001143 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1049 (1141)
Q Consensus 971 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf 1049 (1141)
+.++|+|||.+......... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 130 -NVLKISDFGMSREEEGGIYT--------VSDGLKQIPIKWTAPEALNY----GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred -CcEEEeeccccccccCCcce--------eccccCcceeccCChHhhcc----CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 78999999998754321110 00111224567999999876 467899999999999999999 88999
Q ss_pred CCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001143 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129 (1141)
Q Consensus 1050 ~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L 1129 (1141)
...........+........+ ...+..+.+++.+||..+|.+|||+.|+++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 197 PGMSNQQTRERIESGYRMPAP---------------------------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred ccCCHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 876655555544332211111 13456799999999999999999999999876
Q ss_pred H
Q 001143 1130 V 1130 (1141)
Q Consensus 1130 ~ 1130 (1141)
.
T Consensus 250 ~ 250 (251)
T cd05041 250 Q 250 (251)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=307.49 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=195.8
Q ss_pred CCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
.+|++.+.||+|+||.||+|++. ...+++|+.. .. ......+. +.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~-~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KT-KDENLQSE----FRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccC--Cc-cchHHHHH----HHHHHHHHHhcCCcceeeeEEEE
Confidence 56899999999999999999963 2345666532 11 11112333 47899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~----~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL 954 (1141)
.+... .++||||+++++|.+++....... ...+++..+..++.||+.||+|||+++|+||||
T Consensus 78 ~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl 143 (275)
T cd05046 78 REAEP--------------HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143 (275)
T ss_pred CCCCc--------------ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcC
Confidence 76543 399999999999999997632110 125899999999999999999999999999999
Q ss_pred CCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001143 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034 (1141)
Q Consensus 955 KP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1034 (1141)
||+||+++.+ +.++++|||++........ .......+++.|+|||.+.+ ..++.++||||
T Consensus 144 kp~Nili~~~-------~~~~l~~~~~~~~~~~~~~---------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s 203 (275)
T cd05046 144 AARNCLVSSQ-------REVKVSLLSLSKDVYNSEY---------YKLRNALIPLRWLAPEAVQE----DDFSTKSDVWS 203 (275)
T ss_pred ccceEEEeCC-------CcEEEcccccccccCcccc---------cccCCceeEEeecChhhhcc----CCCCchhhHHH
Confidence 9999999887 7899999999864322110 01122346778999999875 45678999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1035 YGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1035 LGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
||+++|+|++ |..||......+....+..+.... . . ....+..+.+++.+||+
T Consensus 204 lG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~-~----------------------~---~~~~~~~l~~~i~~~l~ 257 (275)
T cd05046 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL-P----------------------V---PEGCPSRLYKLMTRCWA 257 (275)
T ss_pred HHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC-C----------------------C---CCCCCHHHHHHHHHHcC
Confidence 9999999999 888997665555544443222110 0 0 01445679999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 001143 1114 ENPTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~ 1130 (1141)
.||.+|||+.|+++++.
T Consensus 258 ~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 258 VNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcccCCCHHHHHHHhc
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.10 Aligned_cols=282 Identities=21% Similarity=0.243 Sum_probs=195.8
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|.+.+.||+|+||.||+|.+ .+..+++|+...+.. . .... .+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~-~~~~----~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--E-GVPF----TAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--C-CCcH----HHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 356899999999999999999987 466788887643321 1 1111 236899999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+. ++|.+++.. . ...+++..+..++.||+.||.|||++||+|+||||+||++
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~---~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~ 136 (291)
T cd07870 76 E--------------TLTFVFEYMH-TDLAQYMIQ---H-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI 136 (291)
T ss_pred C--------------eEEEEEeccc-CCHHHHHHh---C-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 4 3499999996 788777654 1 2357888999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||+++........ .....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 137 SYL-------GELKLADFGLARAKSIPSQT----------YSSEVVTLWYRPPDVLLG---ATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred cCC-------CcEEEeccccccccCCCCCC----------CCCccccccccCCceeec---CCCCCcHHHHHHHHHHHHH
Confidence 877 78999999998654321111 122347889999999865 2346789999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHH-HhCCCCCch--hHHhhhccCccccccc-cCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1042 LLTLQVPYMGLSEL-EIHDLI-QMGKRPRLT--DELEALGSCHEHEVAQ-SGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~-el~~~I-~~~~~p~l~--~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|++|+.||.+.... +....+ .....+... ................ ..............+..+.+++.+|+..||
T Consensus 197 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp 276 (291)
T cd07870 197 MLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276 (291)
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCc
Confidence 99999999764432 222222 111111100 0000000000000000 000000000011235678999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001143 1117 TERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~ 1131 (1141)
.+|||+.|++.|+|+
T Consensus 277 ~~R~t~~~~l~h~~~ 291 (291)
T cd07870 277 KDRISAQDALLHPYF 291 (291)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=333.98 Aligned_cols=263 Identities=21% Similarity=0.362 Sum_probs=218.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
+.....+.++||.|-||.|++|+.+ +..+.|+||.++... ...+..+| +.|+.||.++.||||+++.|++..
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdF----L~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDF----LSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhh----hhhhhhcccCCCCcEEEEEEEEec
Confidence 3445689999999999999999873 456667776676532 33444555 999999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.... +||+|||++|+|+.+++. .++.|+..+..-++++|+.|++||-+.++|||||-+.|||
T Consensus 702 s~Pv--------------MIiTEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 702 SKPV--------------MIITEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNIL 763 (996)
T ss_pred Ccee--------------EEEhhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhee
Confidence 6543 999999999999999987 2356999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ -.+|++|||+++.+.+.....+.+.. ---...|.|||.+.. ..++.++||||||+++|
T Consensus 764 VNsn-------LvCKVsDFGLSRvledd~~~~ytt~G-------GKIPiRWTAPEAIa~----RKFTsASDVWSyGIVmW 825 (996)
T KOG0196|consen 764 VNSN-------LVCKVSDFGLSRVLEDDPEAAYTTLG-------GKIPIRWTAPEAIAY----RKFTSASDVWSYGIVMW 825 (996)
T ss_pred eccc-------eEEEeccccceeecccCCCccccccC-------CccceeecChhHhhh----cccCchhhccccceEEE
Confidence 9988 89999999999977554322111111 112467999999986 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|.++ |..||...+..+++..|..+.+.+.+ .+++..+.+|+..||++|-.+|
T Consensus 826 EVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---------------------------mDCP~aL~qLMldCWqkdR~~R 878 (996)
T KOG0196|consen 826 EVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---------------------------MDCPAALYQLMLDCWQKDRNRR 878 (996)
T ss_pred EecccCCCcccccchHHHHHHHHhccCCCCC---------------------------CCCcHHHHHHHHHHHHHHhhcC
Confidence 9888 99999999999999999877664322 2788889999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
|.+.||+.++-....
T Consensus 879 P~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 879 PKFAQIVSTLDKLIR 893 (996)
T ss_pred CCHHHHHHHHHHHhc
Confidence 999999999876543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=316.18 Aligned_cols=287 Identities=18% Similarity=0.217 Sum_probs=202.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|.+.+.||+|+||+||+|++. +..+++|..... ......... +.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA--FDNRIDAKR----TLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccc--ccccchhHH----HHHHHHHHHhcCCCCccchHHheecccc
Confidence 46999999999999999999974 556777764321 111112222 3689999999999999999998765321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. .....++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+||+++.
T Consensus 79 ~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~ 143 (337)
T cd07858 79 E---------AFNDVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143 (337)
T ss_pred c---------ccCcEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 1 1234699999996 789888865 346999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++........ ......++..|+|||.+... ..++.++|||||||++|+|+
T Consensus 144 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 144 N-------CDLKICDFGLARTTSEKGD----------FMTEYVVTRWYRAPELLLNC---SEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred C-------CCEEECcCccccccCCCcc----------cccccccccCccChHHHhcC---CCCCCcccHHHHHHHHHHHH
Confidence 7 7899999999876532110 11233578899999998642 34778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+.+.......+........................+.... ..........++.+.+++.+||+.||++||
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence 99999987655444433322111111111100000000000000000 000111124677899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
|+.++++|+|+..
T Consensus 284 s~~ell~h~~~~~ 296 (337)
T cd07858 284 TVEEALAHPYLAS 296 (337)
T ss_pred CHHHHHcCcchhh
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=309.58 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=196.4
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~----~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
...+|+..+.||+|+||.||+|.+. +. .+++|+. .... ...... .+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~--~~~~-~~~~~~----~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETT-GPKANV----EFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEec--cccC-CHHHHH----HHHHHHHHHHhCCCCCcccEEEE
Confidence 3457889999999999999999873 32 2455543 2211 112122 24789999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+.... .++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 78 ~~~~~---------------~~~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 78 CLSPT---------------IQLVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred EcCCC---------------ceeeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 86422 2799999999999999875 1235899999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
||+++.+ +.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||
T Consensus 139 Nill~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~DiwslG~ 199 (303)
T cd05110 139 NVLVKSP-------NHVKITDFGLARLLEGDEKE--------YNADGGKMPIKWMALECIHY----RKFTHQSDVWSYGV 199 (303)
T ss_pred eeeecCC-------CceEEccccccccccCcccc--------cccCCCccccccCCHHHhcc----CCCChHHHHHHHHH
Confidence 9999876 67999999999765432111 01112335778999999875 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|||++ |+.||.+....+....+..+..+..+ ...+..+.+++.+||..+|
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p 252 (303)
T cd05110 200 TIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP---------------------------PICTIDVYMVMVKCWMIDA 252 (303)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCh
Confidence 9999998 89999876655555554433222111 0234568999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001143 1117 TERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~ 1133 (1141)
++||++.++++.+....
T Consensus 253 ~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 253 DSRPKFKELAAEFSRMA 269 (303)
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.35 Aligned_cols=249 Identities=21% Similarity=0.263 Sum_probs=185.0
Q ss_pred eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHH---HhhCCCCCccceeeeEecCCCCCCC
Q 001143 813 EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM---LGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 813 ~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~i---L~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
.||+|+||.||+|.+. +..+|+|+........... ...+ .+|..+ +....||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA----LNERIMLSLVSTGDCPFIVCMTYAFHTPDK---- 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-HHHH----HHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence 4899999999999984 5678888754322111111 1111 334433 334479999999999876543
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.++||||+++++|.+++.. ...+++..+..|+.|++.||+|||+++|+||||||+||+++.+
T Consensus 72 ----------~~lv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~--- 133 (279)
T cd05633 72 ----------LCFILDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH--- 133 (279)
T ss_pred ----------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---
Confidence 4999999999999999875 3469999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~ 1047 (1141)
+.++|+|||++....... .....|++.|+|||.+.. ...++.++|||||||++|+|++|..
T Consensus 134 ----~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~ 194 (279)
T cd05633 134 ----GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRGHS 194 (279)
T ss_pred ----CCEEEccCCcceeccccC------------ccCcCCCcCccCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCC
Confidence 789999999986443211 112358999999999863 2457889999999999999999999
Q ss_pred CCCCCCHHH--HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 001143 1048 PYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 1120 (1141)
Q Consensus 1048 Pf~~~~~~e--l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP----- 1120 (1141)
||....... ............ .....+..+.+++.+||+.||.+||
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 247 (279)
T cd05633 195 PFRQHKTKDKHEIDRMTLTVNVE---------------------------LPDSFSPELKSLLEGLLQRDVSKRLGCLGR 247 (279)
T ss_pred CcCCCCCcCHHHHHHHhhcCCcC---------------------------CccccCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 997532211 111111000000 0114566799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
++.++++|+|++.-
T Consensus 248 ~~~~~~~h~~~~~~ 261 (279)
T cd05633 248 GAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHHHhCccccCC
Confidence 69999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=298.48 Aligned_cols=252 Identities=30% Similarity=0.433 Sum_probs=199.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|.+. +..+++|..... ......... +.+|++++.+++|||++++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE--KIKEEALKS----IMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccc--ccCHHHHHH----HHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 5889999999999999999874 456777775433 222223333 489999999999999999999987644
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 73 ------------SLYIILEYAENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 34999999999999999876 2468999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+......... .....++..|+|||...+ ..++.++||||+|+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~~lG~~l~~l~~ 194 (254)
T cd06627 136 -------GVVKLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVIEM----SGASTASDIWSLGCTVIELLT 194 (254)
T ss_pred -------CCEEEeccccceecCCCccc----------ccccccchhhcCHhhhcC----CCCCcchhHHHHHHHHHHHHh
Confidence 78999999999765432110 123457889999999875 347789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|..||...........+.....+.++ ...+..+.+++.+||..+|++|||+.+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 195 GNPPYYDLNPMAALFRIVQDDHPPLP---------------------------EGISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCCCCccHHHHHHHHhccCCCCCC---------------------------CCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 99999765544333333222211111 134567899999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
++.+.|+
T Consensus 248 ~l~~~~~ 254 (254)
T cd06627 248 LLKHPWI 254 (254)
T ss_pred HhcCCCC
Confidence 9998875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=306.72 Aligned_cols=270 Identities=23% Similarity=0.337 Sum_probs=191.4
Q ss_pred ceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 808 LSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
|++.+.||+|+||.||+|.+ .+..+++|... ... ....... +.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~--~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PES-GGNHIAD----LKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcC--ccc-cHHHHHH----HHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 68899999999999999985 24556776643 211 1222233 48999999999999999999988754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. ...++||||++|++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 79 ~~------------~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~ 142 (284)
T cd05079 79 GG------------NGIKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142 (284)
T ss_pred CC------------CceEEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE
Confidence 21 1348999999999999998651 2358999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||++..+....... .......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 143 ~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~e 204 (284)
T cd05079 143 ESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDLDSPVFWYAPECLIQ----SKFYIASDVWSFGVTLYE 204 (284)
T ss_pred cCC-------CCEEECCCccccccccCccce-------eecCCCCCCccccCHHHhcc----CCCCccccchhhhhhhhh
Confidence 877 789999999987654321110 01123456778999999875 467889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++++.|+..... .......... ........... ....... ....++..+.+|+.+||+.||.+||
T Consensus 205 llt~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 271 (284)
T cd05079 205 LLTYCDSESSPMT-LFLKMIGPTHGQMTVTRLVRVL---------EEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRT 271 (284)
T ss_pred hhcCCCCCccccc-hhhhhcccccccccHHHHHHHH---------HcCccCC---CCCCCCHHHHHHHHHHccCCcccCc
Confidence 9998776542111 0111000000 00000000000 0000000 0114567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
|+.++++.+..
T Consensus 272 t~~~il~~l~~ 282 (284)
T cd05079 272 TFQNLIEGFEA 282 (284)
T ss_pred CHHHHHHHHHh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=306.12 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=198.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||.|+||.||+|.+. +..+++|+...+.. ......+ .+.+|++++++++||||+++++.+.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVR----NVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHH----HHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 5899999999999999999985 67788887643221 1112223 3479999999999999999999887544
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. ..++++..+..|+.||+.||.|||++|++|+||+|+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 74 ------------NMYLVVDLLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred ------------eEEEEEeCCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 45999999999999999976 2468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+....... ......|+..|+|||++.. ..++.++|+||||+++|+|++
T Consensus 137 -------~~~~l~d~~~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 137 -------GHVHITDFNIATKVTPDT-----------LTTSTSGTPGYMAPEVLCR----QGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred -------CCEEEeecccccccCCCc-----------cccccCCChhhcCHHHHcc----cCCCCcccchhhHHHHHHHHh
Confidence 789999999986543321 1113457889999999876 447899999999999999999
Q ss_pred CCCCCCCCCH---HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1045 LQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|..||..... .+....... ..+.. ....+..+.++|.+||..||.+||+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~~~~i~~~l~~~p~~R~~ 246 (258)
T cd05578 195 GKRPYRGHSRTIRDQIRAKQET-ADVLY---------------------------PATWSTEAIDAINKLLERDPQKRLG 246 (258)
T ss_pred CCCCCCCCCccHHHHHHHHhcc-ccccC---------------------------cccCcHHHHHHHHHHccCChhHcCC
Confidence 9999986553 222222111 11110 0134567999999999999999999
Q ss_pred H--HHHHHHHHh
Q 001143 1122 A--GDLYEMFVA 1131 (1141)
Q Consensus 1122 a--~ElL~~L~~ 1131 (1141)
+ .|+++|+||
T Consensus 247 ~~~~~l~~~~~~ 258 (258)
T cd05578 247 DNLKDLKNHPYF 258 (258)
T ss_pred ccHHHHhcCCCC
Confidence 9 999999885
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=298.99 Aligned_cols=250 Identities=28% Similarity=0.466 Sum_probs=196.4
Q ss_pred ceEeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
+++.+.||.|+||.||+|.+.. ..+++|+.... . .....+.+ ..|+.++..++||||+++++++.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~-~~~~~~~~----~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--A-DEQQIEEF----LREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--C-ChHHHHHH----HHHHHHHHhcCCCchheEEEEEcCC
Confidence 3678899999999999999865 55677764322 1 11133344 7899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+ ..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 74 ~--------------~~~~i~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 74 E--------------PLMIVMEYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred C--------------eeEEEEeccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 4 349999999999999999762 11128999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||.+......... ......+++.|+|||.+.+ ..++.++||||+|+++++
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~i~~~ 196 (258)
T smart00219 137 GEN-------LVVKISDFGLSRDLYDDDYY---------KKKGGKLPIRWMAPESLKD----GKFTSKSDVWSFGVLLWE 196 (258)
T ss_pred ccC-------CeEEEcccCCceeccccccc---------ccccCCCcccccChHHhcc----CCCCcchhHHHHHHHHHH
Confidence 887 78999999999765432111 0001226788999999854 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |..||......+....+.....+..+. ..+.++.+++.+||..||.+||
T Consensus 197 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 197 IFTLGESPYPGMSNEEVLEYLKKGYRLPKPE---------------------------NCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHCcCChhhCc
Confidence 998 889998776666666655443322111 3456799999999999999999
Q ss_pred CHHHHHHH
Q 001143 1121 TAGDLYEM 1128 (1141)
Q Consensus 1121 Sa~ElL~~ 1128 (1141)
|+.|+++.
T Consensus 250 t~~~ll~~ 257 (258)
T smart00219 250 TFSELVEI 257 (258)
T ss_pred CHHHHHhh
Confidence 99999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=324.54 Aligned_cols=262 Identities=23% Similarity=0.356 Sum_probs=211.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~---~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
+..++..+.++||+|+||.|++|.|+ ++ .||||+ +...... ....+| ++|+.+|.+|+|||++++||.
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKc--lr~d~l~-~~mddf----lrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKC--LRDDSLN-AIMDDF----LREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEe--ccCCccc-hhHHHH----HHHHHHHHhccCcceeEEeee
Confidence 33456788999999999999999994 34 455555 4332222 245555 899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+.+.. ..+|||+++.|||.+++++ .....|.......++.||+.||.||.++++|||||-..
T Consensus 180 Vl~qp---------------~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR 241 (1039)
T KOG0199|consen 180 VLDQP---------------AMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR 241 (1039)
T ss_pred eccch---------------hhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 98632 3799999999999999987 34457889999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|+|+-.. ..|||+|||+.+.+......+... ....-.+.|+|||.+.. ..++.++|||+|||
T Consensus 242 Nlllasp-------rtVKI~DFGLmRaLg~ned~Yvm~-------p~rkvPfAWCaPEsLrh----~kFShaSDvWmyGV 303 (1039)
T KOG0199|consen 242 NLLLASP-------RTVKICDFGLMRALGENEDMYVMA-------PQRKVPFAWCAPESLRH----RKFSHASDVWMYGV 303 (1039)
T ss_pred hheeccc-------ceeeeecccceeccCCCCcceEec-------CCCcCcccccCHhHhcc----ccccccchhhhhhh
Confidence 9999765 689999999999887654332111 11123567999999986 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+||||+| |..||.+....++++.|..+.+..-+ ..+++++++++..||..+|
T Consensus 304 TiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---------------------------k~csedIY~imk~cWah~p 356 (1039)
T KOG0199|consen 304 TIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---------------------------KYCSEDIYQIMKNCWAHNP 356 (1039)
T ss_pred hHHhhhccCCCCCCCCCHHHHHHhccccccCCCC---------------------------CCChHHHHHHHHHhccCCc
Confidence 9999999 89999999999988888644432211 1788899999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+||||..|.+.+.....
T Consensus 357 aDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 357 ADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred cccccHHHHHHhHHHHhc
Confidence 999999999876655443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=315.88 Aligned_cols=284 Identities=20% Similarity=0.216 Sum_probs=201.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|.+.+.||+|+||.||+|.+. +..+|+|+..... .... +...+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEI----FAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--cccc----chhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 47899999999999999999874 5667777643221 1111 11234789999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. ......++||||+. .+|..++. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 89 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~ 152 (342)
T cd07879 89 G--------DEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152 (342)
T ss_pred C--------CCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 1 12235699999996 57766542 25899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++..... .....++..|+|||++.+ ...++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 153 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred C-------CCEEEeeCCCCcCCCCC-------------CCCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHH
Confidence 7 78999999998653221 112357889999999865 234778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCch---hhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+.+.......+........+......................... .....+..+.+++.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 9999998876655554443322222221111110000000000000000000 0113456789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
++.+++.|+|+..-
T Consensus 290 ~~~e~l~h~~f~~~ 303 (342)
T cd07879 290 TATEALEHPYFDSF 303 (342)
T ss_pred CHHHHhcCcchhhc
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=320.99 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=209.3
Q ss_pred eEeeeecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
++.+.||.|-||.||.|.+ ++...||+|+..+... ..+..+.| +.|..+|++++|||||+++|.+.+..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekf----lqEa~iMrnfdHphIikLIGv~~e~P-- 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKF----LQEASIMRNFDHPHIIKLIGVCVEQP-- 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHH----HHHHHHHHhCCCcchhheeeeeeccc--
Confidence 5678999999999999997 3556777776665432 23334555 89999999999999999999998643
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.|||||+++-|.|..+++. ....++......+++||..||.|||+.++|||||-..|||+...
T Consensus 465 -------------~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp 527 (974)
T KOG4257|consen 465 -------------MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP 527 (974)
T ss_pred -------------eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc
Confidence 3999999999999999986 23469999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
..|||+|||+++.+....... + ....-...|||||.+.- ..++.++|||-|||.+||++.
T Consensus 528 -------~CVKLaDFGLSR~~ed~~yYk--a-------S~~kLPIKWmaPESINf----RrFTtASDVWMFgVCmWEIl~ 587 (974)
T KOG4257|consen 528 -------QCVKLADFGLSRYLEDDAYYK--A-------SRGKLPIKWMAPESINF----RRFTTASDVWMFGVCMWEILS 587 (974)
T ss_pred -------ceeeecccchhhhccccchhh--c-------cccccceeecCccccch----hcccchhhHHHHHHHHHHHHH
Confidence 789999999999876644221 1 12224567999999875 678999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|..||++....+++..+..|.+++.+. .+++.+..|+.+||.+||.+||.+.
T Consensus 588 lGvkPfqgvkNsDVI~~iEnGeRlP~P~---------------------------nCPp~LYslmskcWayeP~kRPrft 640 (974)
T KOG4257|consen 588 LGVKPFQGVKNSDVIGHIENGERLPCPP---------------------------NCPPALYSLMSKCWAYEPSKRPRFT 640 (974)
T ss_pred hcCCccccccccceEEEecCCCCCCCCC---------------------------CCChHHHHHHHHHhccCcccCCcHH
Confidence 999999988778877777777765543 7788899999999999999999999
Q ss_pred HHHHHHH
Q 001143 1124 DLYEMFV 1130 (1141)
Q Consensus 1124 ElL~~L~ 1130 (1141)
|+...+.
T Consensus 641 ei~~~ls 647 (974)
T KOG4257|consen 641 EIKAILS 647 (974)
T ss_pred HHHHHHH
Confidence 9877653
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=315.64 Aligned_cols=291 Identities=23% Similarity=0.253 Sum_probs=205.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
-.++|++.+.||+|+||.||+|.+. +..+++|... ...........+ .+|+.+++++ +||||+++++++..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~--~~~~~~~~~~~~----~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF--DAFRNATDAQRT----FREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeec--cccCcchhhhhh----hHHHHHHHHhcCCCCccceeeeecc
Confidence 3567999999999999999999984 4556666532 211122222233 6899999999 99999999998865
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.+. ...++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+||+
T Consensus 79 ~~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nil 139 (337)
T cd07852 79 END------------KDIYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNIL 139 (337)
T ss_pred CCC------------ceEEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 321 24699999997 699988865 26889999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||.+.......... .........|+..|+|||++.+ ...++.++||||||+++|
T Consensus 140 l~~~-------~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l~ 204 (337)
T cd07852 140 LNSD-------CRVKLADFGLARSLSELEENP-----ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCILG 204 (337)
T ss_pred EcCC-------CcEEEeeccchhccccccccc-----cCcchhcccccccccCceeeec---cccccccchHHHHHHHHH
Confidence 9987 889999999997654322110 0112223468999999998765 245678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|++|+.||.+....+....+......................... ..............+.++.+++.+||+.||.
T Consensus 205 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 284 (337)
T cd07852 205 EMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284 (337)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcc
Confidence 9999999998766655544442222111111111110000000000 0000000111123567899999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+|||+.++++|+|+...
T Consensus 285 ~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 285 KRLTAEEALEHPYVAQF 301 (337)
T ss_pred cccCHHHHhhChhhhhh
Confidence 99999999999988643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=301.39 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=197.7
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.+|++.+.||+|+||.||+|.+ .+..+++|+........ ..... ..+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~----~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV----NALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHH----HHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 4689999999999999999987 45678888654332111 11222 24489999999999999999999986532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 78 E------------KKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred C------------CEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 1 245899999999999999875 23588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+......... ........++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 141 SA-------GNVKLGDFGASKRIQTICMS-------GTGIKSVTGTPYWMSPEVISG----EGYGRKADVWSVACTVVEM 202 (264)
T ss_pred CC-------CCEEECcccccccccccccc-------CccccccCCcccccCHhhhcC----CCCCccccHHHHHHHHHHH
Confidence 77 78999999999765321100 001123458899999999876 4567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|+.||......+....+... ..+.++ ...++.+.+++.+||. +|.+||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 203 LTEKPPWAEYEAMAAIFKIATQPTKPMLP---------------------------DGVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred HhCCCCCCccCHHHHHHHHHcCCCCCCCC---------------------------cccCHHHHHHHHHHhc-CcccCcc
Confidence 9999999876544433333211 111111 1455679999999999 5799999
Q ss_pred HHHHHHHHH
Q 001143 1122 AGDLYEMFV 1130 (1141)
Q Consensus 1122 a~ElL~~L~ 1130 (1141)
+.+++.|+|
T Consensus 255 ~~~~~~~~~ 263 (264)
T cd06653 255 AEFLLRHPF 263 (264)
T ss_pred HHHHhcCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.34 Aligned_cols=250 Identities=23% Similarity=0.266 Sum_probs=191.0
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH-hhCCCCCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
+.||+|+||.||+|.+ .+..+|+|+...... ....... .+..|..++ ...+||||+++++++...+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~-~~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 70 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-IAKNQVT----NVKAERAIMMIQGESPYVAKLYYSFQSKD------ 70 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh-hHHHHHH----HHHHHHHHHhhcCCCCCeeeeeeeEEcCC------
Confidence 5799999999999998 456788887532110 0011111 124555544 4458999999999998654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
..++||||+++++|.++++. ...+++..+..++.||+.||.|||+.+++||||+|+||+++.+
T Consensus 71 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---- 133 (260)
T cd05611 71 --------YLYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---- 133 (260)
T ss_pred --------eEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC----
Confidence 34999999999999999976 2368999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
+.++|+|||.+..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 134 ---~~~~l~dfg~~~~~~~--------------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 134 ---GHLKLTDFGLSRNGLE--------------NKKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ---CcEEEeecccceeccc--------------cccCCCCcCccChhhhcC----CCCcchhhhHHHHHHHHHHHHCCCC
Confidence 7899999998864322 113357889999999876 3478999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDL 1125 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP---Sa~El 1125 (1141)
|......+....+....... + .......+..+.+++.+||+.||++|| +++|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 193 FHAETPDAVFDNILSRRINW-P-----------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCCCHHHHHHHHHhcccCC-C-----------------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 98776666555543322110 0 000013566799999999999999999 45799
Q ss_pred HHHHHhhcC
Q 001143 1126 YEMFVARTS 1134 (1141)
Q Consensus 1126 L~~L~~~~~ 1134 (1141)
+.|+|+...
T Consensus 249 l~~~~~~~~ 257 (260)
T cd05611 249 KSHPFFKSI 257 (260)
T ss_pred HcChHhhcC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=300.68 Aligned_cols=264 Identities=20% Similarity=0.335 Sum_probs=198.4
Q ss_pred ceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
|++.+.||+|+||.||+|.+. +..+++|+...+. ......+.+ .+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEF----LREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHH----HHHHHHHhcCCCCCcceEEEEEccCC
Confidence 678899999999999999863 3567887754332 222333333 78999999999999999999886532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. ......++++||+++++|.+++...... ....+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 75 ~~--------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili 146 (273)
T cd05074 75 AK--------GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146 (273)
T ss_pred CC--------CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE
Confidence 11 1122458899999999999887542211 12357899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.++........ .......+++.|++||.+.. ..++.++|||||||++|+
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~sDi~slG~il~e 207 (273)
T cd05074 147 NEN-------MTVCVADFGLSKKIYSGDYY--------RQGCASKLPVKWLALESLAD----NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred cCC-------CCEEECcccccccccCCcce--------ecCCCccCchhhcCHhHHhc----CccchhhhhHHHHHHHHH
Confidence 876 78999999998765321110 01112235678999999875 457789999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |+.||.+....+....+......... ...+..+.+++.+||..+|++||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGNRLKQP---------------------------PDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999877666555554433221110 13456799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
++.++++.+..
T Consensus 261 s~~~~~~~l~~ 271 (273)
T cd05074 261 SFQHLRDQLEL 271 (273)
T ss_pred CHHHHHHHHHh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=306.45 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=205.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
....|++.+.||+|++|.||+|.+. +..+++|+...... ..+. +.+|++++++++|+||+++++++...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKEL----IINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHH----HHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 3456889999999999999999985 66778887643321 2223 37899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.+++... . ..+++..+..++.|++.||.|||+.||+|+||+|+||++
T Consensus 88 ~--------------~~~lv~e~~~~~~L~~~l~~~---~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i 149 (286)
T cd06614 88 D--------------ELWVVMEYMDGGSLTDIITQN---F-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149 (286)
T ss_pred C--------------EEEEEEeccCCCcHHHHHHHh---c-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence 4 359999999999999999862 1 369999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.++|+|||.+........ ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slGvil~~ 208 (286)
T cd06614 150 SKD-------GSVKLADFGFAAQLTKEKS----------KRNSVVGTPYWMAPEVIKR----KDYGPKVDIWSLGIMCIE 208 (286)
T ss_pred cCC-------CCEEECccchhhhhccchh----------hhccccCCcccCCHhHhcC----CCCCCccccHHHHHHHHH
Confidence 877 7899999998865432111 1123347889999999875 457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|+.||...........+.....+.... ....+..+.+++.+||+.+|.+||+
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt 263 (286)
T cd06614 209 MAEGEPPYLREPPLRALFLITTKGIPPLKN-------------------------PEKWSPEFKDFLNKCLVKDPEKRPS 263 (286)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCcc-------------------------hhhCCHHHHHHHHHHhccChhhCcC
Confidence 999999998766554444433222211110 0134567999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.++++|+|+...
T Consensus 264 ~~~il~~~~~~~~ 276 (286)
T cd06614 264 AEELLQHPFLKKA 276 (286)
T ss_pred HHHHhhChHhhcc
Confidence 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=313.28 Aligned_cols=285 Identities=20% Similarity=0.223 Sum_probs=202.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+. +..+|+|+.... ..... ....+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP--FQSEL----FAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc--ccchH----HHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 46999999999999999999874 556777764322 11111 12234789999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. ......++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 89 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~ 153 (343)
T cd07880 89 L--------DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153 (343)
T ss_pred c--------cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 1 1223568999999 6899888764 36899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++|+|||++...... .....+++.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 154 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~ll~~l~ 210 (343)
T cd07880 154 D-------CELKILDFGLARQTDSE-------------MTGYVVTRWYRAPEVILN---WMHYTQTVDIWSVGCIMAEML 210 (343)
T ss_pred C-------CCEEEeecccccccccC-------------ccccccCCcccCHHHHhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 78999999998654321 112357889999999865 134678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|..||.+.........+................................ .......+..+.+++.+||+.||.+||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 290 (343)
T cd07880 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290 (343)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence 99999987665444433322221111111110000000000000000000 011124566799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|+.++++|+|+...
T Consensus 291 t~~~~l~~~~~~~~ 304 (343)
T cd07880 291 TAAEALAHPYFEEF 304 (343)
T ss_pred CHHHHhcCccHhhh
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.82 Aligned_cols=282 Identities=22% Similarity=0.261 Sum_probs=200.6
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.+.||+|++|.||+|++. +..+++|+..... ........ +.+|+.++++++||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPIT----AIREIKLLQKLRHPNIVRLKEIVTSKG--- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHH----HHHHHHHHHhccCCCeeeheeeEecCC---
Confidence 688999999999999999985 4667777765332 11122222 378999999999999999999987641
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
....++||||++ ++|.+++.. ....+++..++.++.||+.||+|||++|++|+||||+||+++.+
T Consensus 72 ---------~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~- 136 (287)
T cd07840 72 ---------KGSIYMVFEYMD-HDLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND- 136 (287)
T ss_pred ---------CCcEEEEecccc-ccHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-
Confidence 124599999997 589888865 12469999999999999999999999999999999999999987
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||.+......... ......++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 137 ------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 137 ------GVLKLADFGLARPYTKRNSA---------DYTNRVITLWYRPPELLLG---ATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred ------CCEEEccccceeeccCCCcc---------cccccccccccCCceeeEc---cccCChHHHHHHHHHHHHHHHhC
Confidence 78999999998765432210 1112346788999998765 23567999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCC--CCchhhhh-hHHHHHHHHHHhcccCCCCCCCH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--EKPEAELE-TLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+.||...........+...........+.................. ...+.... .+..+.+++.+||..||.+||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999877765555544322111111111100000000000000000 00000112 26789999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.++++++|+
T Consensus 279 ~~~l~~~~~ 287 (287)
T cd07840 279 DQALQHEYF 287 (287)
T ss_pred HHHhhCcCC
Confidence 999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=346.38 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=214.9
Q ss_pred CCCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
-++|.+.++||+|+||.|..++++.+ -+|+|+ +.+...- ..+..- |..|-.+|..-..+-||.++-.|.++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~--lnK~eMlKr~~tA~----F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKI--LNKWEMLKRAETAC----FREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHH--hhHHHHhhchhHHH----HHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 35789999999999999999998654 455555 3321110 111222 36788888888899999999999887
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.++ |+|||||+||+|-.++.++ .++++..++.++..|+.||.-||+.|+|||||||+|||+
T Consensus 148 ~~L--------------YlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 148 RYL--------------YLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL 208 (1317)
T ss_pred cce--------------EEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe
Confidence 755 9999999999999999873 369999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-CCCCchhhHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDVWSLGviL~ 1040 (1141)
|.. |++||+|||.|..+..... -.....+|||.|.+||++..+..+ +.|++.+|+||+||++|
T Consensus 209 d~~-------GHikLADFGsClkm~~dG~---------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~Y 272 (1317)
T KOG0612|consen 209 DKS-------GHIKLADFGSCLKMDADGT---------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMY 272 (1317)
T ss_pred ccc-------CcEeeccchhHHhcCCCCc---------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHH
Confidence 998 9999999999987764332 223466899999999999887766 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
||+.|..||...+..+.+..|..... .+..| ....++.++++||.+.+. +|+.|.
T Consensus 273 EMlyG~TPFYadslveTY~KIm~hk~-----------------------~l~FP-~~~~VSeeakdLI~~ll~-~~e~RL 327 (1317)
T KOG0612|consen 273 EMLYGETPFYADSLVETYGKIMNHKE-----------------------SLSFP-DETDVSEEAKDLIEALLC-DREVRL 327 (1317)
T ss_pred HHHcCCCcchHHHHHHHHHHHhchhh-----------------------hcCCC-cccccCHHHHHHHHHHhc-Chhhhc
Confidence 99999999998888888877743311 11122 122578889999999884 788888
Q ss_pred C---HHHHHHHHHhhcCCC
Q 001143 1121 T---AGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1121 S---a~ElL~~L~~~~~s~ 1136 (1141)
. ++++-.|+||..-.|
T Consensus 328 grngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 328 GRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ccccHHHHHhCccccCCCh
Confidence 7 999999999976543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=302.50 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=198.4
Q ss_pred CceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhh-CCCCCccceeeeEec
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 880 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~-L~HpNIVkllg~~~~ 880 (1141)
.|++.+.||+|+||.||+|.+.. ..+++|........... .........+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999854 66788865433211110 0111111233688888875 689999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NI 959 (1141)
.+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ .+++||||+|+||
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 81 ND--------------RLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 54 349999999999999998654333 3469999999999999999999996 7899999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.++|+|||.+....... ......|+..|+|||.+.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~ll 203 (269)
T cd08528 146 MLGED-------DKVTITDFGLAKQKQPES-----------KLTSVVGTILYSCPEIVKN----EPYGEKADVWAFGCIL 203 (269)
T ss_pred EECCC-------CcEEEecccceeeccccc-----------ccccccCcccCcChhhhcC----CCCchHHHHHHHHHHH
Confidence 99887 789999999987643321 1123458889999999876 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||...........+.......... ...+..+.+++.+||+.||++|
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 204 YQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE--------------------------GMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHHHhCCCcccccCHHHHHHHHhhccCCcCCc--------------------------ccCCHHHHHHHHHHCCCCCccC
Confidence 99999999998766555544443322211110 1345679999999999999999
Q ss_pred CCHHHHHHHHH
Q 001143 1120 PTAGDLYEMFV 1130 (1141)
Q Consensus 1120 PSa~ElL~~L~ 1130 (1141)
|++.|+.+++.
T Consensus 258 p~~~e~~~~~~ 268 (269)
T cd08528 258 PDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHhc
Confidence 99999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=314.93 Aligned_cols=299 Identities=17% Similarity=0.212 Sum_probs=203.8
Q ss_pred CCCce-EeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChH------HHHHhHHhHHHHHHHHhhCCCCCcccee
Q 001143 805 FPSLS-SCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSAD------EIRNFEYSCLGEVRMLGALRHSCIVEMY 875 (1141)
Q Consensus 805 ~~~y~-i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~------~~~~~~~~~~~Ei~iL~~L~HpNIVkll 875 (1141)
.++|. +.+.||+|+||+||+|.+. +..+|+|+.+......... ....+...+.+|+.++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34564 5678999999999999874 5678888754332211000 0001112347899999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLK 955 (1141)
+++..... .++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+
T Consensus 87 ~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~ 146 (335)
T PTZ00024 87 DVYVEGDF--------------INLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS 146 (335)
T ss_pred EEEecCCc--------------EEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 99876553 499999997 699998865 3468999999999999999999999999999999
Q ss_pred CCCeeeecccccCCCCCeEEEeecccccccccccccccccc----CCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~----~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1031 (1141)
|+||+++.+ +.++|+|||.+.............. ..........+++.|+|||.+.+ ...++.++|
T Consensus 147 ~~nill~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~D 216 (335)
T PTZ00024 147 PANIFINSK-------GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFAVD 216 (335)
T ss_pred HHHeEECCC-------CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcHHH
Confidence 999999877 7899999999976542110000000 00011122346889999999865 234678999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1032 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1032 VWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
||||||++|+|++|+.||.+.+..+....+.. ...+.. ..+...........................+..+.+++.+
T Consensus 217 v~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 295 (335)
T PTZ00024 217 MWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE-DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295 (335)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCch-hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHH
Confidence 99999999999999999987776655544422 111111 0000000000000000000000001111346778999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1111 CTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1111 cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
||+.||++|||++|++.|+|++..
T Consensus 296 ~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 296 LLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HcCCCchhccCHHHHhcCcccCCC
Confidence 999999999999999999999854
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=309.23 Aligned_cols=292 Identities=18% Similarity=0.182 Sum_probs=201.6
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
|.+.+.+|.|+++.||++...+..+|+|+..... ......+. +.+|+.++++++||||+++++++.....
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~~---- 73 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKL----LQQEIITSRQLQHPNILPYVTSFIVDSE---- 73 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHH----HHHHHHHHHhcCCcchhhhhheeecCCe----
Confidence 3556667777777777777778888998865431 12233333 4899999999999999999999876553
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.+++|||+++++|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+||+++.+
T Consensus 74 ----------~~~~~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~--- 137 (314)
T cd08216 74 ----------LYVVSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD--- 137 (314)
T ss_pred ----------EEEEEeccCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---
Confidence 499999999999999998632 2358899999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~ 1047 (1141)
+.+||+|||.+........... ..........++..|+|||++.... ..++.++|||||||++|+|++|+.
T Consensus 138 ----~~~kl~d~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 138 ----GKVVLSGLRYSVSMIKHGKRQR---VVHDFPKSSVKNLPWLSPEVLQQNL--QGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred ----CceEEecCccceeecccccccc---ccccccccccccccccCHHHhcCCC--CCCCcchhHHHHHHHHHHHHhCCC
Confidence 7899999999876533221100 0011123345788899999986521 347789999999999999999999
Q ss_pred CCCCCCHHHHH-HHHHhCCCCCchhH-HhhhccCcccc---ccccCCCC-CCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1048 PYMGLSELEIH-DLIQMGKRPRLTDE-LEALGSCHEHE---VAQSGSGF-EKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1048 Pf~~~~~~el~-~~I~~~~~p~l~~~-l~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
||......... +.+.......+... ........... ........ .........+.++.+++.+||..||++|||
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 288 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence 99865544322 22221111110000 00000000000 00000000 000111244677899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.++++|+|+...
T Consensus 289 ~~~ll~~p~~~~~ 301 (314)
T cd08216 289 ASQLLNHSFFKQC 301 (314)
T ss_pred HHHHhcCchHhhh
Confidence 9999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.48 Aligned_cols=246 Identities=23% Similarity=0.401 Sum_probs=181.2
Q ss_pred eeecccCceEEEEEEECCc---------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 812 DEAGKSVSSSLFRCKFGSA---------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~---------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.||+|+||.||+|.+... .+++|+. ... . ......+..|+.+++.+.||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~--~~~--~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL--DKS--H----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhh--cch--h----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 4799999999999987422 2444432 111 1 112223478999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 73 ~--------------~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 73 E--------------SIMVQEYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred C--------------cEEEEecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 3 38999999999999999751 23589999999999999999999999999999999999998
Q ss_pred ccccc-CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 963 LERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 963 ~~~~~-~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
.++.. ....+.++++|||.+..... .....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~--------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLP--------------KEILLERIPWVPPECIEN---PQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred cccccccCCCceEEecccccccccCC--------------chhccccCCccCchhccC---CCCCCchhhHHHHHHHHHH
Confidence 76321 11224589999998854322 113457889999999875 2346789999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++| ..||.............. ...++ .....++.+++.+||+.||++||
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~--~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYED--RHQLP---------------------------APKWTELANLINQCMDYEPDFRP 248 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHc--cccCC---------------------------CCCcHHHHHHHHHHhccChhhCC
Confidence 9998 466655443332221111 11110 02335689999999999999999
Q ss_pred CHHHHHHHH
Q 001143 1121 TAGDLYEMF 1129 (1141)
Q Consensus 1121 Sa~ElL~~L 1129 (1141)
|++++++.+
T Consensus 249 s~~~il~~l 257 (258)
T cd05078 249 SFRAIIRDL 257 (258)
T ss_pred CHHHHHHhc
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=295.13 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=199.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||++.+. +..+++|+...... ..... +.+|+.++++++||||+++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEK----IINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHH----HHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 4889999999999999999985 55677776543211 22233 378999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..+++|||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++.+
T Consensus 71 ------------~~~l~~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 71 ------------ELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred ------------eEEEEEecCCCCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 349999999999999998761 1468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++++|++
T Consensus 135 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~il~~l~~ 192 (253)
T cd05122 135 -------GEVKLIDFGLSAQLSDTKA-----------RNTMVGTPYWMAPEVING----KPYDYKADIWSLGITAIELAE 192 (253)
T ss_pred -------CeEEEeecccccccccccc-----------ccceecCCcccCHHHHcC----CCCCccccHHHHHHHHHHHHh
Confidence 7899999999876543210 123458889999999876 447889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...+..+....+.....+..... ...+..+.+++.+||+.||.+|||+.+
T Consensus 193 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 193 GKPPYSELPPMKALFKIATNGPPGLRNP-------------------------EKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCCCCCCchHHHHHHHHhcCCCCcCcc-------------------------cccCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999987655444433332222211110 023567999999999999999999999
Q ss_pred HHHHHH
Q 001143 1125 LYEMFV 1130 (1141)
Q Consensus 1125 lL~~L~ 1130 (1141)
+++|+|
T Consensus 248 ~l~~~~ 253 (253)
T cd05122 248 LLKHPF 253 (253)
T ss_pred HhcCCC
Confidence 999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=313.91 Aligned_cols=296 Identities=22% Similarity=0.263 Sum_probs=202.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||.|+||.||+|.+. +..+++|...... . ...+. +.+|++++++++||||+++++.+.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~--~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--P--QSVKH----ALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--C--chHHH----HHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 57999999999999999999985 4566666644332 1 22223 3789999999999999999988765321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
....+-.........++||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 10000001112335799999997 688888753 35899999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++ ..+||+|||.+..+...... ........++..|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 150 ~~------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 150 ED------LVLKIGDFGLARIVDPHYSH-------KGYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CC------ceEEECCcccceecCCcccc-------ccccccccccccccCHHHHhC---ccccCchhhHHHHHHHHHHHH
Confidence 42 57899999998765322111 001122357889999998754 245778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCC--chhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+|+.||.+....+....+................................ .......+.++.+++.+||+.||.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 99999987766555444432221111111100000000000000000000 0111245677899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
+.+++.|+|+.
T Consensus 294 ~~ell~h~~~~ 304 (342)
T cd07854 294 AEEALMHPYMS 304 (342)
T ss_pred HHHHhCCCccc
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=313.29 Aligned_cols=284 Identities=19% Similarity=0.232 Sum_probs=200.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+. +..+|+|... .........+ .+.+|+.++++++||||+++++++.....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~----~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAK----RTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEec--CcchhhHHHH----HHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 67999999999999999999874 4556666543 2111111122 34789999999999999999998865432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. ......+++++++ +++|.++++. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 91 ~--------~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 91 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155 (345)
T ss_pred c--------cccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC
Confidence 1 1122458899987 6899888764 35899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 156 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 156 D-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred C-------CCEEEeccccccccccc-------------ccccccCCCccCHHHHhC---ccCCCchhhHHHHHHHHHHHH
Confidence 7 78999999998653221 112357889999999865 235678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||...+.......+........+................. .......+.....+..+.++|.+||+.||.+||
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 99999987665554444432222211111111100000000000 000000011113466789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
++.+++.|+|+..
T Consensus 293 t~~e~l~h~~f~~ 305 (345)
T cd07877 293 TAAQALAHAYFAQ 305 (345)
T ss_pred CHHHHhcChhhhh
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.88 Aligned_cols=257 Identities=26% Similarity=0.325 Sum_probs=197.6
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||.|+||.||+|.+. +..+++|+..... ...+.....+.+|+.++++++||||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------- 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-----MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--------- 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh-----hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc---------
Confidence 689999999999985 6677777753221 111222334588999999999999999999887544
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
..|+||||+++++|.+++.+ ...+++..+..++.||+.||.|||++|++||||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~------- 129 (265)
T cd05579 67 -----NLYLVMEYLPGGDLASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN------- 129 (265)
T ss_pred -----EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-------
Confidence 35999999999999999976 2368999999999999999999999999999999999999987
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
+.++|+|||++.......... ............++..|+|||.... ..++.++||||||+++|+|++|+.||..
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQIN--LNDDEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred CCEEEEecccchhcccCcccc--cccccccccCcccCccccCHHHhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 789999999986533211100 0000111223457889999999876 4477899999999999999999999987
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 001143 1052 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 1128 (1141)
Q Consensus 1052 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa---~ElL~~ 1128 (1141)
....+....+..+.... +.. ...+..+.+++.+||+.+|.+|||+ .++++|
T Consensus 204 ~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 204 ETPEEIFQNILNGKIEW-PED-------------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHhcCCcCC-Ccc-------------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 77666665554322211 100 0235678999999999999999999 999999
Q ss_pred HHhhc
Q 001143 1129 FVART 1133 (1141)
Q Consensus 1129 L~~~~ 1133 (1141)
+|+..
T Consensus 258 ~~~~~ 262 (265)
T cd05579 258 PFFKG 262 (265)
T ss_pred ccccC
Confidence 99964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.19 Aligned_cols=278 Identities=23% Similarity=0.280 Sum_probs=199.8
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.+.||+|++|.||+|.+. +..+++|...... ...... ..+.+|+.++++++||||+++++++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIP----KTALREIKLLKELNHPNIIKLLDVFRHKG--- 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc--ccchhH----HHHHHHHHHHHHhcCCCcchHHHhhccCC---
Confidence 678899999999999999984 5556666543221 111112 23478999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..++||||++ ++|.+++... ...+++..+..++.||+.||.|||+++|+|+||||+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~- 134 (283)
T cd05118 72 -----------DLYLVFEFMD-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE- 134 (283)
T ss_pred -----------CEEEEEeccC-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-
Confidence 3499999997 5888887651 2468999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||.+........ ......++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 135 ------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 135 ------GVLKLADFGLARSFGSPVR----------PYTHYVVTRWYRAPELLLG---DKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred ------CcEEEeeeeeeEecCCCcc----------cccCccCcccccCcHHHhc---CCCCCchhHHHHHHHHHHHHHhC
Confidence 7899999999876543210 0112357889999999875 23578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc---CccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS---CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+.||...+..+....+........+..+..... ........ .............+..+.++|.+||+.||.+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK-KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc-ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 999987766555444422111111111111000 00000000 00001111223567889999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.+++.|+|+
T Consensus 275 ~~ll~~~~~ 283 (283)
T cd05118 275 EQALAHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=310.21 Aligned_cols=288 Identities=19% Similarity=0.234 Sum_probs=201.0
Q ss_pred CceEeeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~ 881 (1141)
+|++.+.||+|+||.||+|++.. ..+|+|..... .......+ .+.+|+.+++++ +||||+++++.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV--FSKKILAK----RALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc--cccchhHH----HHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 48899999999999999999854 46777764321 11112222 237899999999 599999999875432
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ......+++|||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~----------~~~~~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 75 P----------GNFNELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred c----------ccCCcEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 1 01224589999986 799988864 3468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.++.+...... .........||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~~ 202 (332)
T cd07857 139 NAD-------CELKICDFGLARGFSENPGE------NAGFMTEYVATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAE 202 (332)
T ss_pred cCC-------CCEEeCcCCCceeccccccc------ccccccCcccCccccCcHHHhC---CCCCCcHHHHHHHHHHHHH
Confidence 887 78999999999765432111 0011123468999999998764 2357899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|++|+.||...+.......+...........+.............. ......+......+..+.+++.+||+.||.+
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 282 (332)
T cd07857 203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282 (332)
T ss_pred HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence 9999999987666555544432221111111111100000000000 0000001111134667999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
|||+.+++.|+|+.
T Consensus 283 R~t~~~ll~~~~~~ 296 (332)
T cd07857 283 RISVEEALEHPYLA 296 (332)
T ss_pred CCCHHHHhcChhhh
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=308.31 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=198.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|+..+.||+|+||.||+|++. +..+++|+..... ........ .+.+|++++++++|||++++++++.+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 99 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQ----DIIKEVKFLQRIKHPNSIEYKGCYLREHT- 99 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC-CCchHHHH----HHHHHHHHHHhCCCCCEEEEEEEEeeCCe-
Confidence 4788999999999999999974 4556666643221 11122222 34789999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.++||||++ |+|.+++... ..++++..+..++.||+.||.|||++||+||||+|+||+++.+
T Consensus 100 -------------~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~ 161 (317)
T cd06635 100 -------------AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161 (317)
T ss_pred -------------EEEEEeCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC
Confidence 499999997 5888877541 3468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||++..... .....+++.|+|||++.... ...++.++|||||||++|+|++
T Consensus 162 -------~~~kl~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Dv~slGvil~el~~ 219 (317)
T cd06635 162 -------GQVKLADFGSASIASP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 219 (317)
T ss_pred -------CCEEEecCCCccccCC--------------cccccCCccccChhhhhcCC-CCCCCccccHHHHHHHHHHHHh
Confidence 7899999998854322 11235788999999975321 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||...........+.....+... ....++.+.+++.+||+.+|.+||++.+
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 220 RKPPLFNMNAMSALYHIAQNESPTLQ--------------------------SNEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred CCCCCCCccHHHHHHHHHhccCCCCC--------------------------CccccHHHHHHHHHHccCCcccCcCHHH
Confidence 99999876655554444333222111 0134566899999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001143 1125 LYEMFVARTSSS 1136 (1141)
Q Consensus 1125 lL~~L~~~~~s~ 1136 (1141)
+++|+|+.....
T Consensus 274 il~~~~~~~~~~ 285 (317)
T cd06635 274 LLKHMFVLRERP 285 (317)
T ss_pred HHhChhhhccCc
Confidence 999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=301.48 Aligned_cols=282 Identities=22% Similarity=0.213 Sum_probs=200.6
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEecCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSK 882 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkllg~~~~~~ 882 (1141)
|++.+.||+|+||.||+|++. +..+++|+.+.... ....... +.+|+.+++++ .||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~----~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLS----TLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhh----HHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 688999999999999999985 57788887654432 1111122 25677777666 5999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. .....+++|||++ ++|.+++... ....+++..++.++.||+.||.|||+.+++|+||+|+||+++
T Consensus 75 ~~---------~~~~~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 75 TD---------RELKLTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CC---------CCceeEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 21 2234699999997 5899988752 223589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+........ .....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 142 ~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 142 SD-------GQVKIADFGLARIYSFEMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred cC-------CCEEEeccCcceeccCCcc-----------cccccccccccChHHhcc----CCCCCcchhhhHHHHHHHH
Confidence 87 7899999999876533211 112347889999999876 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|++||......+....+...........+... .......................+..+.+++.+||+.||.+||++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN-VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC-cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 9999999887766655544221111000000000 000000000000001111122456778999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.+++.|+|+
T Consensus 279 ~~il~~~~~ 287 (287)
T cd07838 279 FEALQHPYF 287 (287)
T ss_pred HHHhcCcCC
Confidence 999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.67 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=191.3
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||+|+||+||+|.+. +..+++|+...... ... .....+..|+.++++++||||+++++.+...+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------- 66 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKR---KGEQMALNEKKILEKVSSRFIVSLAYAFETKD--------- 66 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhh---hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC---------
Confidence 699999999999874 56677776542211 111 11223368999999999999999999987654
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
..|+||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~------- 131 (277)
T cd05577 67 -----DLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH------- 131 (277)
T ss_pred -----eEEEEEecCCCCcHHHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-------
Confidence 349999999999999998762 22368999999999999999999999999999999999999887
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
+.++|+|||.+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 132 ~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 132 GNVRISDLGLAVELKGGK-----------KIKGRAGTPGYMAPEVLQG----EVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CCEEEccCcchhhhccCC-----------ccccccCCCCcCCHHHhcC----CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 789999999986543211 1123357889999999876 4478899999999999999999999976
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 001143 1052 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDLY 1126 (1141)
Q Consensus 1052 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----Sa~ElL 1126 (1141)
.........+........ .......++.+.+++.+||+.||.+|| ++.+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 197 RKEKVEKEELKRRTLEMA------------------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred CcccccHHHHHhcccccc------------------------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 433111111111110000 000013466789999999999999999 899999
Q ss_pred HHHHhhcC
Q 001143 1127 EMFVARTS 1134 (1141)
Q Consensus 1127 ~~L~~~~~ 1134 (1141)
.|+|+..-
T Consensus 253 ~h~~~~~~ 260 (277)
T cd05577 253 EHPLFKDL 260 (277)
T ss_pred hChhhhcC
Confidence 99999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=298.28 Aligned_cols=245 Identities=23% Similarity=0.362 Sum_probs=182.4
Q ss_pred eeecccCceEEEEEEECCcc------------EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 812 DEAGKSVSSSLFRCKFGSAD------------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~~------------vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+.||+|+||.||+|.+.... +++|+.... ...... +.+|+.++++++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-----HRDSLA----FFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc-----hhhHHH----HHHHHHHHHcCCCcchhheeeEEe
Confidence 47999999999999985433 444443211 111233 378999999999999999999887
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
. .. .++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 72 ~-~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 72 R-DE--------------NIMVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred c-CC--------------cEEEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 5 32 38999999999999999762 12689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+.........+||+|||++...... ....++..|+|||++.+.. ..++.++|||||||++
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~~~ 196 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLSR--------------EERVERIPWIAPECIRNGQ--ASLTIAADKWSFGTTL 196 (259)
T ss_pred EEecCccccCCceeEEeCCCCcccccccc--------------cccccCCCccChhhhcCCC--CCcchhhHHHHHHHHH
Confidence 99876321122237999999998754321 1234677899999987621 3678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++ |..||......+........... .. .....+.+++.+||..+|.+
T Consensus 197 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~------------------------~~-----~~~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL------------------------PM-----PDCAELANLINQCWTYDPTK 247 (259)
T ss_pred HHHHhCCCCCcccCCchhHHHHHhcCCCC------------------------CC-----CCchHHHHHHHHHhccChhh
Confidence 99999 57788665433222221111000 00 11256899999999999999
Q ss_pred CCCHHHHHHHH
Q 001143 1119 RPTAGDLYEMF 1129 (1141)
Q Consensus 1119 RPSa~ElL~~L 1129 (1141)
|||+.++++.+
T Consensus 248 Rpt~~~il~~l 258 (259)
T cd05037 248 RPSFRAILRDL 258 (259)
T ss_pred CCCHHHHHHhc
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.63 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=202.6
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~ 882 (1141)
++|.+.+.||+|++|.||+|.+ .+..+++|++...... ..... ..+.+|+.++++++ ||||+++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKV----KYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHH----HHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 4799999999999999999998 4677888876432111 11112 23478999999998 999999999887654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.+ ...+++..+..|+.|++.||.|||+.|++|+||+|+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 76 --------------NLYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred --------------eEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 34999999999999999976 23699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccc----------cccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCC----------IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~----------~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1032 (1141)
.+ +.++|+|||++........... .............++..|+|||+..+ ..++.++||
T Consensus 137 ~~-------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di 205 (280)
T cd05581 137 KD-------MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----KPAGKSSDL 205 (280)
T ss_pred CC-------CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC----CCCChhhhH
Confidence 77 7899999999876543221100 00000112234567899999999875 457889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1033 WSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
||||++++++++|..||...........+...... ++ ...++.+.+++.+||
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l 257 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS-FP---------------------------PNFPPDAKDLIEKLL 257 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC-CC---------------------------CccCHHHHHHHHHHh
Confidence 99999999999999999876654444443321110 00 133566899999999
Q ss_pred ccCCCCCCCH----HHHHHHHHh
Q 001143 1113 EENPTERPTA----GDLYEMFVA 1131 (1141)
Q Consensus 1113 ~~DP~~RPSa----~ElL~~L~~ 1131 (1141)
+.||.+||++ .++++|+|+
T Consensus 258 ~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 258 VLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCCHhhCCCcccCHHHHhcCCCC
Confidence 9999999999 999999986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=310.02 Aligned_cols=287 Identities=19% Similarity=0.257 Sum_probs=197.3
Q ss_pred eeeccc--CceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 812 DEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 812 ~~LG~G--sfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
..||+| +||+||+|.+ .+..||+|+..... ......+. +.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~e~~~~~~l~h~niv~~~~~~~~~~~---- 73 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLKA----LQNEVVLSHFFRHPNIMTSWTVFTTGSW---- 73 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHHH----HHHHHHHHHhCCCCCcceEeeeEecCCc----
Confidence 456776 9999999998 57788888865432 22222333 4789999999999999999999987554
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.++||||+.+++|.+++.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 74 ----------~~~v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~--- 137 (328)
T cd08226 74 ----------LWVISPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD--- 137 (328)
T ss_pred ----------eEEEEecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---
Confidence 399999999999999988632 2358999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~ 1047 (1141)
+.++++||+.+............ ....+....++..|+|||++.+. ...++.++|||||||++|+|++|+.
T Consensus 138 ----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 138 ----GLVSLSGLSHLYSLVRNGQKAKV---VYDFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred ----CcEEEechHHHhhhhccCccccc---cccccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCCC
Confidence 78999999865432221100000 00111223456779999998752 1346799999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhH------Hhhhcc---Ccc----ccc-c-----ccCCCCCCchhhhhhHHHHHHHH
Q 001143 1048 PYMGLSELEIHDLIQMGKRPRLTDE------LEALGS---CHE----HEV-A-----QSGSGFEKPEAELETLSFLVDVF 1108 (1141)
Q Consensus 1048 Pf~~~~~~el~~~I~~~~~p~l~~~------l~~~~~---~~~----~~~-~-----~~~~~~~~~~~~~~~~~~L~dLI 1108 (1141)
||......+................ ...... ... ... . ...............+..+.+|+
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 288 (328)
T cd08226 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288 (328)
T ss_pred CCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence 9987654443322222111100000 000000 000 000 0 00000001111224677899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1109 RRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.+||+.||++|||+.|+++|+|+..
T Consensus 289 ~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 289 ELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred HHHccCCcccCCCHHHHhhCHHHHH
Confidence 9999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=307.33 Aligned_cols=294 Identities=20% Similarity=0.204 Sum_probs=202.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..++|++.+.||+|+||.||+|.+. +..+++|+.+...... .. ...+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~----~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE--GF----PITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc--Cc----hHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 3567999999999999999999984 5667777755432111 11 12236899999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
..... ........++||||+++ ++...+.. ....+++..+..++.||+.||.|||+.||+||||||+||++
T Consensus 79 ~~~~~----~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 149 (302)
T cd07864 79 QDALD----FKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149 (302)
T ss_pred chhhh----ccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 31000 00112257999999984 77777654 13468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.+......... ......++..|+|||.+.+ ...++.++|||||||++|+
T Consensus 150 ~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~~~e 210 (302)
T cd07864 150 NNK-------GQIKLADFGLARLYNSEESR---------PYTNKVITLWYRPPELLLG---EERYGPAIDVWSCGCILGE 210 (302)
T ss_pred CCC-------CcEEeCcccccccccCCccc---------ccccceeccCccChHHhcC---CCCCCchhHHHHHHHHHHH
Confidence 887 78999999998765432110 1112246788999998864 2346789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCC--CCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--EKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|++|++||......+....+........+..+............+..... .........+..+.+++.+||+.||.+|
T Consensus 211 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 290 (302)
T cd07864 211 LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290 (302)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhC
Confidence 99999999876665554444332111111111100000000000000000 0000011346779999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
|++.+++.|+|+
T Consensus 291 p~~~~il~~~~~ 302 (302)
T cd07864 291 CTAEEALNSPWL 302 (302)
T ss_pred CCHHHHhcCCCC
Confidence 999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=295.17 Aligned_cols=256 Identities=32% Similarity=0.483 Sum_probs=199.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|.+. +..+++|+..... ......+. +.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEA----LEREIRILSSLQHPNIVRYYGSERDEE-- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHH----HHHHHHHHHHcCCCCEeeEEEEEecCC--
Confidence 4788999999999999999986 6667777754332 22223333 489999999999999999999987641
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 73 ----------~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 73 ----------KNTLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred ----------CCeEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 1145999999999999999976 2279999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+......... .......++..|+|||.+.+ ..++.++||||||+++++|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 138 -------GVVKLADFGCAKRLGDIETG--------EGTGSVRGTPYWMAPEVIRG----EEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred -------CCEEEcccccEEeccccccc--------ccccCCCCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 78999999998765442210 00123458889999999876 347899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1045 LQVPYMGLS-ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1045 Gk~Pf~~~~-~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
|..||.... .......+.. ...+. .....+..+.+++.+||..||.+||++
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~ 251 (260)
T cd06606 199 GKPPWSELGNPMAALYKIGSSGEPPE---------------------------IPEHLSEEAKDFLRKCLRRDPKKRPTA 251 (260)
T ss_pred CCCCCCCCCchHHHHHhccccCCCcC---------------------------CCcccCHHHHHHHHHhCcCChhhCCCH
Confidence 999997654 2222222111 01111 011346679999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.++++|+|+
T Consensus 252 ~~ll~~~~~ 260 (260)
T cd06606 252 DELLQHPFL 260 (260)
T ss_pred HHHhhCCCC
Confidence 999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=304.61 Aligned_cols=251 Identities=21% Similarity=0.258 Sum_probs=186.2
Q ss_pred eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCC
Q 001143 813 EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1141)
Q Consensus 813 ~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~ 890 (1141)
.||+|+||.||+|.+. +..+|+|+...+........ ..+ .....++..+....||||+++++++...+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-------- 70 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA-LNERIMLSLVSTGDCPFIVCMSYAFHTPD-------- 70 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH-HHH-HHHHHHHHHHHhCCCCcEeeeeeeeecCC--------
Confidence 4899999999999874 56788887543221111111 111 00012234445567999999999988654
Q ss_pred CccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCC
Q 001143 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1141)
Q Consensus 891 ~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~ 970 (1141)
..++||||++|++|..++.. ...+++..++.|+.|++.||.|||+++|+||||||+||+++.+
T Consensus 71 ------~~~~v~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~------ 133 (278)
T cd05606 71 ------KLSFILDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH------ 133 (278)
T ss_pred ------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC------
Confidence 34999999999999998865 3469999999999999999999999999999999999999877
Q ss_pred CCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001143 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1050 (1141)
Q Consensus 971 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~ 1050 (1141)
+.++|+|||++....... .....|+..|+|||++.+ ...++.++||||+||++|+|++|+.||.
T Consensus 134 -~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 134 -GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred -CCEEEccCcCccccCccC------------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 789999999986543211 113468999999999874 2357889999999999999999999997
Q ss_pred CCCH---HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CH
Q 001143 1051 GLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TA 1122 (1141)
Q Consensus 1051 ~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-----Sa 1122 (1141)
.... ......+. ...+.++ ...+..+.+++.+||..+|.+|| ++
T Consensus 198 ~~~~~~~~~~~~~~~-~~~~~~~---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~ 249 (278)
T cd05606 198 QHKTKDKHEIDRMTL-TMAVELP---------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 249 (278)
T ss_pred CCCccchHHHHHHhh-ccCCCCC---------------------------CcCCHHHHHHHHHHhhcCHHhccCCCCCCH
Confidence 6422 11111111 1111110 13456799999999999999999 99
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
.++++|+|++..
T Consensus 250 ~~ll~~~~~~~~ 261 (278)
T cd05606 250 QEVKEHPFFRSL 261 (278)
T ss_pred HHHHhCccccCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=306.75 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=199.0
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|....+||+|+||.||++... +..+++|..... ...... .+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 90 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRE----LLFNEVVIMRDYQHENVVEMYNSYLVGD--- 90 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHH----HHHHHHHHHHhcCCcchhheeeEEEeCC---
Confidence 344578999999999999884 456666654221 112222 3478999999999999999999988654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
+.++||||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.+
T Consensus 91 -----------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~- 152 (292)
T cd06657 91 -----------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD- 152 (292)
T ss_pred -----------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-
Confidence 34999999999999998754 358999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 153 ------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slGvil~el~tg 212 (292)
T cd06657 153 ------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMVDG 212 (292)
T ss_pred ------CCEEEcccccceecccccc----------cccccccCccccCHHHhcC----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999998865432110 1123458899999999865 4567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
+.||.+....+....+.....+.+.. ....+..+.+++.+||+.||.+||++.++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~l 267 (292)
T cd06657 213 EPPYFNEPPLKAMKMIRDNLPPKLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAEL 267 (292)
T ss_pred CCCCCCCCHHHHHHHHHhhCCcccCC-------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence 99998766655544443322211110 01345568899999999999999999999
Q ss_pred HHHHHhhcCCCCC
Q 001143 1126 YEMFVARTSSSIS 1138 (1141)
Q Consensus 1126 L~~L~~~~~s~~s 1138 (1141)
++|+|+......+
T Consensus 268 l~~~~~~~~~~~~ 280 (292)
T cd06657 268 LKHPFLAKAGPPS 280 (292)
T ss_pred hcChHHhccCCCc
Confidence 9999997654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=298.31 Aligned_cols=271 Identities=24% Similarity=0.349 Sum_probs=210.2
Q ss_pred CCC-ceE-eeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001143 805 FPS-LSS-CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~-y~i-~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~ 879 (1141)
+.+ |++ .+.||+|+|+.|--+.. .+..+|||| +++. .+.. . .++.+|++++.+.+ |+||++++++|+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKi--idKq-~gHs-R----~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKI--IDKQ-PGHS-R----SRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhh--hhcC-CchH-H----HHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 444 443 46799999999998875 677889998 4443 2222 2 23469999999996 999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
++..+ |||||-+.||+|..+|++ .+.+++.++.+++++|+.||.|||.+||.||||||+||
T Consensus 147 dd~~F--------------YLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENi 207 (463)
T KOG0607|consen 147 DDTRF--------------YLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENI 207 (463)
T ss_pred ccceE--------------EEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccce
Confidence 87755 999999999999999987 45799999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGvi 1038 (1141)
|-...+ ...-||||||.+..-+.....- +....+..-+.+|+..|||||+..--. ....|+.+.|.||||||
T Consensus 208 LC~~pn----~vsPvKiCDfDLgSg~k~~~~~---spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvI 280 (463)
T KOG0607|consen 208 LCESPN----KVSPVKICDFDLGSGIKLNNDC---SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVI 280 (463)
T ss_pred eecCCC----CcCceeeeccccccccccCCCC---CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHH
Confidence 986542 2356999999887544332211 111223334567999999999864321 23568999999999999
Q ss_pred HHHHHhCCCCCCCCC---------------HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 001143 1039 LLELLTLQVPYMGLS---------------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~---------------~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1141)
+|-|++|.+||.+.- ...+++.|+.+...-...++ ..++.+
T Consensus 281 lYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW------------------------ahIS~e 336 (463)
T KOG0607|consen 281 LYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW------------------------AHISSE 336 (463)
T ss_pred HHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh------------------------HHhhHH
Confidence 999999999997632 23456777766653322221 267888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
..+++..+|..|+.+|.++.++++|||+..
T Consensus 337 akdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 337 AKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred HHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 999999999999999999999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=312.10 Aligned_cols=289 Identities=19% Similarity=0.219 Sum_probs=207.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|++.+.||+|++|.||+|++. +..+++|... .........+ .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~--~~~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS--NVFDDLIDAK----RILREIKLLRHLRHENIIGLLDILRPPSP- 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeec--cccccchhhh----hHHHHHHHHHhcCCcchhhhhhhhcccCc-
Confidence 5899999999999999999985 4566776543 2221122222 34789999999999999999999876431
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
......|+||||++ ++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 --------~~~~~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 74 --------EDFNDVYIVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred --------ccccceEEEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 11235699999997 688888865 2379999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+......... ........++..|+|||++.+. ..++.++||||||+++|+|++
T Consensus 140 -------~~~~L~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~il~~l~~ 202 (330)
T cd07834 140 -------CDLKICDFGLARGVDPDEDE-------KGFLTEYVVTRWYRAPELLLSS---SRYTKAIDIWSVGCIFAELLT 202 (330)
T ss_pred -------CCEEEcccCceEeecccccc-------cccccccccccCcCCceeeecc---cCCCcchhHHHHHHHHHHHHc
Confidence 78999999999765442210 0011234578899999998762 267899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC-ccccccc--cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQ--SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|+.||.+.+..+....+...........+...... ....... ..............+..+.+++.+||+.||.+||+
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence 99999987776665555332221111111100000 0000000 00000001111235678999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.+++.|+|+..
T Consensus 283 ~~~ll~~~~~~~ 294 (330)
T cd07834 283 ADEALAHPYLAQ 294 (330)
T ss_pred HHHHHhCccHHh
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=302.63 Aligned_cols=277 Identities=24% Similarity=0.268 Sum_probs=197.3
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~~ 884 (1141)
|++.+.||+|++|+||+|.+. +..+++|..... ........ ..+|+..+++++ ||||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~-----~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK--FYSWEECM-----NLREVKSLRKLNEHPNIVKLKEVFREND-- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhh--ccchhHHH-----HHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence 678999999999999999985 455666654322 11112111 247999999998 999999999987644
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+ +++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 72 ------------~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 72 ------------ELYFVFEYM-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred ------------cEEEEEecC-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 349999999 68999988762 22468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+....... ......++..|+|||++.. ...++.++|+||||+++++|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~-----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 136 -------EVVKIADFGLAREIRSRP-----------PYTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred -------CCEEEeecccceeccCCC-----------CcCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHh
Confidence 789999999987543311 1113457889999998864 2456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhh---ccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|+.||......+....+...........+... ........... ............+..+.+++.+||+.||.+|||
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF-APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccc-ccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 99999876655544443222111111111000 00000000000 000000011123567999999999999999999
Q ss_pred HHHHHHHHHh
Q 001143 1122 AGDLYEMFVA 1131 (1141)
Q Consensus 1122 a~ElL~~L~~ 1131 (1141)
+.|++.|+|+
T Consensus 274 ~~ei~~~~~~ 283 (283)
T cd07830 274 ASQALQHPYF 283 (283)
T ss_pred HHHHhhCCCC
Confidence 9999999885
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=321.16 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=213.0
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
....+..|.+.+.||+|.|+.|.+|++ .+..||+|+ ++++.......+.+ .+|+++|+.++|||||+++.+.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~--idkt~ln~~~~~k~----~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKI--IDKTQLNPSKRQKL----GREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEE--ehhcccChHHHHHH----HHHHHHHHhcCCcceeeeeeee
Confidence 345567799999999999999999998 567777776 55555444433333 6999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
..... +|+||||+.+|.+++++.+ ..++.+..+..++.|+.+|++|||+++|||||||++|
T Consensus 125 ~t~~~--------------lylV~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 125 ETEAT--------------LYLVMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred eecce--------------eEEEEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 87664 4999999999999999987 3457779999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ .++||+|||++..+.... ..+..+|++.|.|||++.+. ...++.+|+||+|++
T Consensus 186 ilL~~~-------mnikIaDfgfS~~~~~~~-----------~lqt~cgsppyAaPEl~~g~---~y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 186 ILLDEN-------MNIKIADFGFSTFFDYGL-----------MLQTFCGSPPYAAPELFNGK---KYDGPEVDIWSLGVV 244 (596)
T ss_pred cccccc-------cceeeeccccceeecccc-----------cccccCCCCCccChHhhcCc---ccCCcceehhhhhhh
Confidence 999988 789999999998765321 23466799999999999883 355799999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|-|+.|..||.+....++...+..+... ++ ...+.+..++|+++|..+|.+
T Consensus 245 ly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-Ip---------------------------~~ms~dce~lLrk~lvl~Psk 296 (596)
T KOG0586|consen 245 LYALVEGSLPFDGQNLKELRPRVLRGKYR-IP---------------------------FYMSCDCEDLLRKFLVLNPSK 296 (596)
T ss_pred heeeeecccccCCcccccccchheeeeec-cc---------------------------ceeechhHHHHHHhhccCccc
Confidence 99999999999987666655544333221 00 134556889999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
|++.+++.+|.|.-
T Consensus 297 r~~~dqim~~~W~n 310 (596)
T KOG0586|consen 297 RGPCDQIMKDRWRN 310 (596)
T ss_pred cCCHHHhhhhcccc
Confidence 99999999998864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=294.31 Aligned_cols=264 Identities=22% Similarity=0.381 Sum_probs=209.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~ 880 (1141)
..++++.++...||.|+.|.||++++..+...++|+....+.. .++.+. ++..+.++.+-+ .|+||+.+|||..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kR----ILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKR----ILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHH----HHHhhhHHhhccCCCeeeeeeeEEee
Confidence 4567788899999999999999999988666666665555433 333444 378888887765 9999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NI 959 (1141)
+... ++.||.|. .-++.++++. .+++++..+-++...++.||.||.. +||+|||+||+||
T Consensus 163 n~dV--------------~IcMelMs-~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNI 223 (391)
T KOG0983|consen 163 NTDV--------------FICMELMS-TCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 223 (391)
T ss_pred CchH--------------HHHHHHHH-HHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccce
Confidence 6544 89999984 5556666552 3579999999999999999999985 6999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|+|+. |++||||||.+-.+.+... .....|-+.|||||.+.- .....|+-++||||||+.+
T Consensus 224 LlDe~-------GniKlCDFGIsGrlvdSkA-----------htrsAGC~~YMaPERidp-~~~~kYDiRaDVWSlGITl 284 (391)
T KOG0983|consen 224 LLDER-------GNIKLCDFGISGRLVDSKA-----------HTRSAGCAAYMAPERIDP-PDKPKYDIRADVWSLGITL 284 (391)
T ss_pred EEccC-------CCEEeecccccceeecccc-----------cccccCCccccCccccCC-CCCCccchhhhhhhhccch
Confidence 99988 8999999999977654321 123468899999999864 2346789999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+||.||+.||.+. .+.++...|....+|.++... ..++.+++|+..||..|+.+
T Consensus 285 veLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-------------------------gFSp~F~~fv~~CL~kd~r~ 339 (391)
T KOG0983|consen 285 VELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-------------------------GFSPDFQSFVKDCLTKDHRK 339 (391)
T ss_pred hhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-------------------------CcCHHHHHHHHHHhhcCccc
Confidence 9999999999873 445677777665555443211 35677999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
||...++++|+|...
T Consensus 340 RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 340 RPKYNKLLEHPFIKR 354 (391)
T ss_pred CcchHHHhcCcceee
Confidence 999999999988653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.92 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=215.2
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
.-.+.++|.+.++||+|.||.|-+++- .+..+|+||.+.++.... ++...- +.|-++|+..+||.+..+--.|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-dEVAHT----lTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-DEVAHT----LTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-HHhhhh----hhHHHHHHhccCcHHHHhhhhh
Confidence 456789999999999999999999986 467789998765554333 333332 6899999999999999887777
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
...+ ++|+||||..||.|.-++.+ ...+++..++.+...|+.||.|||+++||+||||.+|
T Consensus 238 Qt~d--------------rlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN 298 (516)
T KOG0690|consen 238 QTQD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN 298 (516)
T ss_pred ccCc--------------eEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence 7655 45999999999999998876 4579999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
.|+|.+ |++||.|||+|+.--.... ....++|||.|.|||++.. ..|+.++|+|.+||+
T Consensus 299 LlLDkD-------GHIKitDFGLCKE~I~~g~----------t~kTFCGTPEYLAPEVleD----nDYgraVDWWG~GVV 357 (516)
T KOG0690|consen 299 LLLDKD-------GHIKITDFGLCKEEIKYGD----------TTKTFCGTPEYLAPEVLED----NDYGRAVDWWGVGVV 357 (516)
T ss_pred heeccC-------CceEeeecccchhcccccc----------eeccccCChhhcCchhhcc----ccccceeehhhhhHH
Confidence 999999 9999999999975322211 2246789999999999987 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||+.|+.||...+...+++.|..... .++ ...+++.+.|+..+|..||.+
T Consensus 358 MYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFP---------------------------r~ls~eAktLLsGLL~kdP~k 409 (516)
T KOG0690|consen 358 MYEMMCGRLPFYNKDHEKLFELILMEDL-KFP---------------------------RTLSPEAKTLLSGLLKKDPKK 409 (516)
T ss_pred HHHHHhccCcccccchhHHHHHHHhhhc-cCC---------------------------ccCCHHHHHHHHHHhhcChHh
Confidence 9999999999998777777777643221 111 145567899999999999999
Q ss_pred CC-----CHHHHHHHHHhhcC
Q 001143 1119 RP-----TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RP-----Sa~ElL~~L~~~~~ 1134 (1141)
|. .+.||.+|.+|..-
T Consensus 410 RLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 410 RLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hcCCCchhHHHHHhhhhhccC
Confidence 94 58999999998754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=313.05 Aligned_cols=286 Identities=20% Similarity=0.219 Sum_probs=204.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|++|.||+|++. +..+++|+.... .......+ .+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHAK----RTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc--cchhhHHH----HHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 457999999999999999999985 456777764321 11112222 2368999999999999999999876543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ......++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 88 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07851 88 SL--------EDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152 (343)
T ss_pred cc--------cccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 21 1223469999999 5799998864 3699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+...... .....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 153 ED-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEcccccccccccc-------------ccCCcccccccCHHHHhC---CCCCCchHhHHHHHHHHHHH
Confidence 87 78999999998754321 113357889999999864 13567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
++|+.||.+....+....+........+.............+........ ........+..+.+++.+||..||.+|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 99999998766665555543322222111111110000000000000000 001111346789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||+.+|++|+|+...
T Consensus 290 pt~~ell~h~~~~~~ 304 (343)
T cd07851 290 ITAAEALAHPYLAEY 304 (343)
T ss_pred CCHHHHhcCCCcccc
Confidence 999999999999643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=303.79 Aligned_cols=260 Identities=22% Similarity=0.257 Sum_probs=196.6
Q ss_pred CceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
+|++.+.||+|+||.||+|.+ .+..+|+|+.+....... ......+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc----chHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 488999999999999999986 456788887643211111 11122347899999999 59999999998876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
+. ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+|||
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 77 DT--------------KLHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 54 34899999999999999875 246889999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||++......... ......|+..|+|||.+... ...++.++||||||+++|
T Consensus 138 ~~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 138 LDSN-------GHVVLTDFGLSKEFHEDEVE---------RAYSFCGTIEYMAPDIVRGG--DGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred ECCC-------CCEEEeeCccceeccccccc---------ccccccCCcccCChhhccCC--CCCCCccccHHHHHHHHH
Confidence 9887 78999999998754321110 11134588999999998642 134578999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|++|..||..... .++...+..... ..+ ...+..+.+++.+||..||
T Consensus 200 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~ll~~~l~~~p 251 (290)
T cd05613 200 ELLTGASPFTVDGEKNSQAEISRRILKSEP-PYP---------------------------QEMSALAKDIIQRLLMKDP 251 (290)
T ss_pred HHhcCCCCCCcCCccccHHHHHHHhhccCC-CCC---------------------------ccCCHHHHHHHHHHhcCCH
Confidence 99999999964222 122222211111 000 1345568999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhcCC
Q 001143 1117 TERP-----TAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1117 ~~RP-----Sa~ElL~~L~~~~~s 1135 (1141)
++|| ++.+++.|+|+....
T Consensus 252 ~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 252 KKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHhcCCCCCCHHHHHcCcccccCC
Confidence 9997 899999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=304.44 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=198.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~ 878 (1141)
...+++|++.+.||+|+||.||+|.+. +..+++|+.... .. ......+ ..|+.++.+.. ||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~--~~-~~~~~~~----~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT--GN-KEENKRI----LMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEecc--CC-hHHHHHH----HHHHHHHHhccCCCchHhhheee
Confidence 456788999999999999999999986 667788775422 11 1222222 56777777775 99999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSE 957 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~ 957 (1141)
.+... .++||||+. ++|.+++... ...+++..+..++.||+.||.|||+ .||+||||+|+
T Consensus 84 ~~~~~--------------~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ 144 (296)
T cd06618 84 ITDSD--------------VFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPS 144 (296)
T ss_pred ecCCe--------------EEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHH
Confidence 86543 499999985 6888877652 2368999999999999999999997 59999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
||+++.+ +.+||+|||++..+..... .....++..|+|||.+.+......++.++||||||+
T Consensus 145 nill~~~-------~~~kL~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 206 (296)
T cd06618 145 NILLDAS-------GNVKLCDFGISGRLVDSKA-----------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI 206 (296)
T ss_pred HEEEcCC-------CCEEECccccchhccCCCc-----------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHH
Confidence 9999877 7899999999865432111 112247888999999875322244788999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|+|++|+.||..... .+....+.....+..+. ....+.++.+++.+||..||
T Consensus 207 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p 261 (296)
T cd06618 207 SLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP-------------------------NEGFSPDFCSFVDLCLTKDH 261 (296)
T ss_pred HHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC-------------------------CCCCCHHHHHHHHHHccCCh
Confidence 99999999999975322 22333332222111110 00345679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+||++.++++|+|+..-
T Consensus 262 ~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 262 RKRPKYRELLQHPFIRRY 279 (296)
T ss_pred hhCCCHHHHhcChhhhcc
Confidence 999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=300.50 Aligned_cols=272 Identities=24% Similarity=0.381 Sum_probs=194.3
Q ss_pred CCceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..|++.+.||+|+||.||+|.+. +..+|+|+.... ... ...+. +.+|+.+++++.||||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~--~~~-~~~~~----~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEE-QHRSD----FEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccc--cch-HHHHH----HHHHHHHHHhCCCCChheEEeeee
Confidence 45788899999999999999864 456777775422 111 12333 489999999999999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... ...++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 77 ~~~~------------~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 140 (284)
T cd05038 77 KPGG------------RSLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140 (284)
T ss_pred cCCC------------CceEEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 5321 2459999999999999999762 22599999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.++|+|||.+.......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 141 l~~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di~slG~~l 202 (284)
T cd05038 141 LVESE-------DLVKISDFGLAKVLPEDKDYY-------YVKEPGESPIFWYAPECLRT----SKFSSASDVWSFGVTL 202 (284)
T ss_pred EEcCC-------CCEEEcccccccccccCCcce-------eccCCCCCcccccCcHHHcc----CCCCcccchHHHhhhh
Confidence 99887 789999999997654221110 00111235567999999876 4678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++|..|+........ ........ .......... ........ ...++.++.+++.+||+.+|.+
T Consensus 203 ~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05038 203 YELFTYGDPSQSPPAEFL-RMIGIAQGQMIVTRLLELL---------KEGERLPR---PPSCPDEVYDLMKLCWEAEPQD 269 (284)
T ss_pred heeeccCCCcccccchhc-cccccccccccHHHHHHHH---------HcCCcCCC---CccCCHHHHHHHHHHhccChhh
Confidence 999999999865322110 00000000 0000000000 00000000 1134567999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
|||+.||++.+..
T Consensus 270 Rpt~~ei~~~l~~ 282 (284)
T cd05038 270 RPSFADLILIVDR 282 (284)
T ss_pred CCCHHHHHHHHhh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=302.04 Aligned_cols=273 Identities=18% Similarity=0.211 Sum_probs=185.9
Q ss_pred CCceEeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHH--HHH-hHHhHHHHHHHHhhCCCCCccceeee
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADE--IRN-FEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~-----~vAvKI~~l~~~~~~~~~--~~~-~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
.+|++.++||+|+||.||+|.+.+. .+++|+..........+. ... .......+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998544 455665433221110000 000 00111234445566789999999987
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+..... .....+++||++. .++.+.+.. ....++..+..|+.||+.||+|||+++|+||||||+
T Consensus 92 ~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRC----------RMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred eeEecC----------CceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 654321 1234578999885 577777654 123678889999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.++|+|||+|+.+......... .........||+.|+|||++.+ ..++.++|||||||
T Consensus 156 Nill~~~-------~~~~l~DFGla~~~~~~~~~~~~---~~~~~~~~~gt~~y~ape~~~~----~~~~~~~DiwSlG~ 221 (294)
T PHA02882 156 NIMVDGN-------NRGYIIDYGIASHFIIHGKHIEY---SKEQKDLHRGTLYYAGLDAHNG----ACVTRRGDLESLGY 221 (294)
T ss_pred HEEEcCC-------CcEEEEEcCCceeeccCCccccc---ccccccccCCCccccCHHHhCC----CCCCcHHHHHHHHH
Confidence 9999876 78999999999765432211100 0111223469999999999876 56889999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|||++|+.||.+... ..............+.. .. .. ....++.+.+++..|+..+|
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~---------------~~--~~----~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE---------------GK--IK----IKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh---------------hh--hc----cCCCCHHHHHHHHHHHhCCC
Confidence 99999999999986532 22221111000000000 00 00 01345779999999999999
Q ss_pred CCCCCHHHHHHHH
Q 001143 1117 TERPTAGDLYEMF 1129 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L 1129 (1141)
++||++.++++.+
T Consensus 281 ~~rp~~~~l~~~~ 293 (294)
T PHA02882 281 EEKPDYDALIKIF 293 (294)
T ss_pred CCCCCHHHHHHhh
Confidence 9999999998754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=299.05 Aligned_cols=279 Identities=23% Similarity=0.265 Sum_probs=201.0
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.+.||+|++|.||+|++. +..+++|+..... ......+ .+..|+.++++++||||+++++++....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPS----TALREISLLKELKHPNIVKLLDVIHTER--- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccH----HHHHHHHHHHhcCCCCHHHHHhhhhcCC---
Confidence 677899999999999999985 5678888765332 1111122 2368999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..++||||++ ++|.+++... ...+++..+..++.|++.||.|||++||+||||+|+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~- 134 (282)
T cd07829 72 -----------KLYLVFEYCD-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD- 134 (282)
T ss_pred -----------ceEEEecCcC-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-
Confidence 3499999997 6999999862 1369999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.++|+|||.+........ ......++..|+|||.+.+ ...++.++|||||||++|+|++|
T Consensus 135 ------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 135 ------GVLKLADFGLARAFGIPLR----------TYTHEVVTLWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred ------CCEEEecCCcccccCCCcc----------ccCccccCcCcCChHHhcC---CcCCCccccHHHHHHHHHHHHhC
Confidence 7899999999876533211 1112345778999999875 23678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
..||......+....+...........+....... ....................+..+.+++.+||..||++||++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 99998766655544442222111111111111000 00000000000000111133677999999999999999999999
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
++.|+|+
T Consensus 276 ~l~~p~~ 282 (282)
T cd07829 276 ALKHPYF 282 (282)
T ss_pred HhhCcCC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=304.56 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=196.1
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|...++||+|+||+||+|++. +..+++|+..... .......+. +.+|+.+++.++|||++++++++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG-KQTNEKWQD----IIKEVKFLQQLKHPNTIEYKGCYLKEH--- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc-cCchHHHHH----HHHHHHHHHhCCCCCCccEEEEEEeCC---
Confidence 677788999999999999974 5556666543221 112222233 378999999999999999999988654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..|+||||+. ++|.+++.. ...++++..+..++.||+.||.|||++||+||||+|+||+++.+
T Consensus 95 -----------~~~lv~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~- 157 (313)
T cd06633 95 -----------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP- 157 (313)
T ss_pred -----------EEEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-
Confidence 3499999996 688887764 13468999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.+||+|||.+..... .....|+..|+|||++.... ...++.++|||||||++|+|++|
T Consensus 158 ------~~~kL~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 158 ------GQVKLADFGSASKSSP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ------CCEEEeecCCCcccCC--------------CCCccccccccChhhccccC-CCCCCchhhHHHHHHHHHHHHhC
Confidence 7899999998753211 11345888999999985321 24577899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
..||...........+.....+.... ...+..+.+++.+||+.+|.+||++.++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDSPTLQS--------------------------NEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99998766555444443322221110 1334568999999999999999999999
Q ss_pred HHHHHhhcC
Q 001143 1126 YEMFVARTS 1134 (1141)
Q Consensus 1126 L~~L~~~~~ 1134 (1141)
+.|+|+...
T Consensus 271 l~~~~~~~~ 279 (313)
T cd06633 271 LRHDFVRRD 279 (313)
T ss_pred hcCcccCCC
Confidence 999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=273.99 Aligned_cols=284 Identities=20% Similarity=0.256 Sum_probs=209.0
Q ss_pred CCceEeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~--vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..|.-.++||+|+||+||+|+...+. ||+|-.+++.... ......++|+-+++.++|.|||++++....+..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde------gvpssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC------CCcHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 35777899999999999999976554 5555554443222 223344799999999999999999999876654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+-+|+|||. .+|..+... -.+.++.+.++.++.|+++||.|+|++++.||||||.|.||+.
T Consensus 76 --------------ltlvfe~cd-qdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ 136 (292)
T KOG0662|consen 76 --------------LTLVFEFCD-QDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR 136 (292)
T ss_pred --------------eEEeHHHhh-HHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc
Confidence 489999996 677776654 3457999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ |.+|++|||+|+.+..+..-. ...+-|.+|++|.++.+ ...|+...|+||.||++.|+.
T Consensus 137 n-------gelkladfglarafgipvrcy----------saevvtlwyrppdvlfg---akly~tsidmwsagcifaela 196 (292)
T KOG0662|consen 137 N-------GELKLADFGLARAFGIPVRCY----------SAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_pred C-------CcEEecccchhhhcCCceEee----------eceeeeeeccCcceeee---eehhccchHhhhcchHHHHHh
Confidence 8 899999999998776543211 12357999999999998 457899999999999999998
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc---CccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS---CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
. |.+.|.+.+..+....|.+....+..+.++.... ............++ ...+.....-+++++++|.-+|.+|
T Consensus 197 nagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattsws--qivp~lns~grdllqkll~cnp~qr 274 (292)
T KOG0662|consen 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWS--QIVPKLNSTGRDLLQKLLKCNPAQR 274 (292)
T ss_pred hcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHH--HHhhhhcchhHHHHHHHhccCcccc
Confidence 7 7777888777776666643322222222221110 00000000011110 1112333446899999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001143 1120 PTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s~ 1136 (1141)
.++++.++|++|...++
T Consensus 275 isaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 275 ISAEAALQHPYFSDFSP 291 (292)
T ss_pred cCHHHHhcCccccccCC
Confidence 99999999999976543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=299.83 Aligned_cols=245 Identities=21% Similarity=0.263 Sum_probs=184.1
Q ss_pred CCceEeeee--cccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 806 PSLSSCDEA--GKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 806 ~~y~i~~~L--G~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
+.|++.+.+ |+|+||.||++... +..+++|+..... ... .|+.....+ +||||+++++.+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN--FNA-----------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhh--cch-----------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 345666665 99999999999874 4566777653221 111 122222222 69999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+
T Consensus 81 ~~--------------~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 141 (267)
T PHA03390 81 LK--------------GHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141 (267)
T ss_pred CC--------------eeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 55 34999999999999999976 237999999999999999999999999999999999999
Q ss_pred eecccccCCCCC-eEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 961 IDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 961 ld~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
++.+ + .++|+|||.+...... ....++..|+|||++.+ ..++.++||||||+++
T Consensus 142 ~~~~-------~~~~~l~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il 196 (267)
T PHA03390 142 YDRA-------KDRIYLCDYGLCKIIGTP--------------SCYDGTLDYFSPEKIKG----HNYDVSFDWWAVGVLT 196 (267)
T ss_pred EeCC-------CCeEEEecCccceecCCC--------------ccCCCCCcccChhhhcC----CCCCchhhHHHHHHHH
Confidence 9887 4 8999999998654321 12357899999999876 4578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHH-HHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++|+.||........ ...+........ ......+..+.++|.+||+.||.+
T Consensus 197 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~ 251 (267)
T PHA03390 197 YELLTGKHPFKEDEDEELDLESLLKRQQKKL-------------------------PFIKNVSKNANDFVQSMLKYNINY 251 (267)
T ss_pred HHHHHCCCCCCCCCcchhhHHHHHHhhcccC-------------------------CcccccCHHHHHHHHHHhccChhh
Confidence 999999999975433221 111111000000 000145667999999999999999
Q ss_pred CCC-HHHHHHHHHhh
Q 001143 1119 RPT-AGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPS-a~ElL~~L~~~ 1132 (1141)
||+ ++|+++|+|+.
T Consensus 252 R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 252 RLTNYNEIIKHPFLK 266 (267)
T ss_pred CCchHHHHhcCCccc
Confidence 996 69999999985
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=302.70 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=196.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|+..+.||+|+||.||+|++. +..+++|....... ........ +.+|+.+++.++|||++++++++....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 88 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQD----IIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHH----HHHHHHHHHhCCCCCcccEEEEEEcCC--
Confidence 4788899999999999999984 45567776432211 11222223 378999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 89 ------------~~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~ 151 (308)
T cd06634 89 ------------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (308)
T ss_pred ------------eeEEEEEccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC
Confidence 3499999997 688887754 12458999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+...... ....+++.|+|||.+.+.. ...++.++|||||||++|+|++
T Consensus 152 -------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 152 -------GLVKLGDFGSASIMAPA--------------NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred -------CcEEECCcccceeecCc--------------ccccCCccccCHHHHhhcc-cCCCCcccchHHHHHHHHHHHc
Confidence 78999999988654321 1235788999999985421 2346789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||......+....+.....+... ....+..+.++|.+||..+|.+||++.+
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 210 RKPPLFNMNAMSALYHIAQNESPALQ--------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred CCCCCccccHHHHHHHHhhcCCCCcC--------------------------cccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 99999765554444433332222111 0134566899999999999999999999
Q ss_pred HHHHHHhhcC
Q 001143 1125 LYEMFVARTS 1134 (1141)
Q Consensus 1125 lL~~L~~~~~ 1134 (1141)
+++|+|+...
T Consensus 264 ll~~~~~~~~ 273 (308)
T cd06634 264 LLKHRFVLRE 273 (308)
T ss_pred HhhCcccccc
Confidence 9999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=294.20 Aligned_cols=298 Identities=18% Similarity=0.256 Sum_probs=212.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
...|+-..+||+|.||.||+|+.+ +..||+|++-.+ .+.+.|.....+|+.+|..++|+|++.+++.+....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme------neKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME------NEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 445888899999999999999874 445566543322 112233334479999999999999999998876533
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.- .-+.....|+||.+|+ .+|..++.+ ...+++..++.+++.+++.||.|+|+..|+|||+||.|+||+
T Consensus 90 Tp------~~r~r~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 90 TP------TNRDRATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT 158 (376)
T ss_pred CC------cccccceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc
Confidence 21 1112335799999998 799998865 235799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++.+....... .+.....+-|.+|++||.+.+ ...|+++.|||+.||++.||
T Consensus 159 ~d-------gilklADFGlar~fs~~~n~~------kprytnrvvTLwYrppEllLG---~r~yg~~iDiWgAgCimaeM 222 (376)
T KOG0669|consen 159 KD-------GILKLADFGLARAFSTSKNVV------KPRYTNRVVTLWYRPPELLLG---DREYGPPIDIWGAGCIMAEM 222 (376)
T ss_pred CC-------ceEEeeccccccceecccccC------CCCcccceeeeecCCHHHhhc---ccccCCcchhHhHHHHHHHH
Confidence 98 899999999997765433221 112334567999999999998 45789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCC---CCCchhHHhhhc---cCccccccccCCCCCC-chhhhhhHHHHHHHHHHhcccC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGK---RPRLTDELEALG---SCHEHEVAQSGSGFEK-PEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~---~p~l~~~l~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
+|+.+-+++....+....|.... .+..+...+..+ ......+.+....... ...+....++..+|+..+|..|
T Consensus 223 wtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~D 302 (376)
T KOG0669|consen 223 WTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLD 302 (376)
T ss_pred HccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccC
Confidence 99999999887777666663321 111111111000 0000000000000000 0000123457889999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 001143 1116 PTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~~s 1135 (1141)
|.+|++++++++|.||....
T Consensus 303 P~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 303 PTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cccCcchHhhhchhhhhcCC
Confidence 99999999999999998654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=299.64 Aligned_cols=259 Identities=24% Similarity=0.254 Sum_probs=193.8
Q ss_pred CceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
+|++.+.||+|++|.||+|++ .+..+++|+.+.... .........+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 488999999999999999985 345688887542211 11111122347899999999 59999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 77 DT--------------KLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CC--------------EEEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 44 34899999999999999865 246899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.++|+|||++......... ......|+..|+|||.+.+.. ...+.++||||||+++|
T Consensus 138 ~~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 138 LDSE-------GHVVLTDFGLSKEFLAEEEE---------RAYSFCGTIEYMAPEVIRGGS--GGHDKAVDWWSLGVLTF 199 (288)
T ss_pred ECCC-------CCEEEEECcccccccccccc---------ccccccCCccccCHHHhcCCC--CCCcchhhhHHHHHHHH
Confidence 9877 78999999998654322110 111335789999999986521 23578999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|++|..||..... .+....+..... .. ....+..+.+++.+||+.||
T Consensus 200 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQSEISRRILKSKP-PF---------------------------PKTMSAEARDFIQKLLEKDP 251 (288)
T ss_pred HHHhCCCCcccCcccchHHHHHHHHHccCC-CC---------------------------CcccCHHHHHHHHHHhcCCH
Confidence 99999999964321 112222111110 00 01344568999999999999
Q ss_pred CCCCC---HHHHHHHHHhhcC
Q 001143 1117 TERPT---AGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPS---a~ElL~~L~~~~~ 1134 (1141)
++||| +.++++|+|++.-
T Consensus 252 ~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 252 KKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred hhccCcchHHHHhcCcccccC
Confidence 99998 5677999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=331.88 Aligned_cols=149 Identities=26% Similarity=0.290 Sum_probs=126.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
++++|.+.++||+|+||.||+|.+. +..||+|+.+.... .... ....+..|+.++..++||||+++++.+...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~----~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKN----MVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHH----HHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 3678999999999999999999986 67888888653221 1112 223347899999999999999999888765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. +.|+||||++|++|.+++.. ...+++..++.|+.||+.||+|||+++|+||||||+|||+
T Consensus 77 ~--------------~~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl 137 (669)
T cd05610 77 N--------------NVYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137 (669)
T ss_pred C--------------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE
Confidence 4 35999999999999999975 2358899999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccc
Q 001143 962 DLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
+.+ +.+||+|||+++
T Consensus 138 ~~~-------g~vkL~DFGls~ 152 (669)
T cd05610 138 SNE-------GHIKLTDFGLSK 152 (669)
T ss_pred cCC-------CCEEEEeCCCCc
Confidence 877 789999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=292.88 Aligned_cols=261 Identities=25% Similarity=0.286 Sum_probs=202.5
Q ss_pred CCCceE-eeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 805 FPSLSS-CDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i-~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
.++|++ .++||-|-.|.|-.+.++ +..+|+|+. .. ... ..+|+++.-.. .|||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL--~D---s~K--------ARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVL--LD---SPK--------ARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHH--hc---CHH--------HHhHhhhhhhhcCCCceEEeehhhhh
Confidence 345643 478999999999999874 556777763 21 111 15788877555 59999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.-. ....+.+|||.++||.|++.|++ .+...+++.++-.|++||..|+.|||+.+|.||||||+|+|
T Consensus 127 s~~----------~rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 127 SYQ----------GRKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL 193 (400)
T ss_pred hcc----------CceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence 321 12356899999999999999987 56668999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
..... ....+||+|||+|+.-.... ...+.+.||+|.|||++.. ..|+...|+||+||++|
T Consensus 194 yt~t~----~na~lKLtDfGFAK~t~~~~-----------~L~TPc~TPyYvaPevlg~----eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 194 YTTTS----PNAPLKLTDFGFAKETQEPG-----------DLMTPCFTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_pred eecCC----CCcceEecccccccccCCCc-----------cccCCcccccccCHHHhCc----hhcCCCCCccchhHHHH
Confidence 97652 33789999999997643211 1224468999999999865 56899999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
-|+.|.+||..... ..+...|..+... +..+++. ..+++.+++|+.+|..+|
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~~gqy~-----------------------FP~pEWs-~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIRTGQYE-----------------------FPEPEWS-CVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhhccCcc-----------------------CCChhHh-HHHHHHHHHHHHHhcCCc
Confidence 99999999975332 2234455444432 1122222 778899999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+|.|+.++++|+|..+.
T Consensus 311 teRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 311 TERLTIEEVMDHPWINQY 328 (400)
T ss_pred hhheeHHHhhcCchhccc
Confidence 999999999999998754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=303.65 Aligned_cols=280 Identities=20% Similarity=0.232 Sum_probs=197.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-++|++.+.||.|+||.||+|.+. +..+++|..... .......+.+ .+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP--FSTPVLAKRT----YRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccc--ccccchhHHH----HHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 356999999999999999999875 455677754322 1111222233 68999999999999999999886532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ..++||||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||+|+||+++
T Consensus 83 ~-------------~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~ 142 (328)
T cd07856 83 E-------------DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142 (328)
T ss_pred C-------------cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC
Confidence 1 358999999 4789888764 3588899999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.++|+|||.+...... .....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 143 ~~-------~~~~l~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el 199 (328)
T cd07856 143 EN-------CDLKICDFGLARIQDPQ-------------MTGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEM 199 (328)
T ss_pred CC-------CCEEeCccccccccCCC-------------cCCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHH
Confidence 76 78999999998643221 112357888999998754 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcc-ccccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
++|+.||...........+.........+.......... ....... ............+..+.++|.+||+.+|++|
T Consensus 200 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 200 LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhC
Confidence 999999987665443333322111111111000000000 0000000 0000001111356789999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
|++.+++.|+|+..
T Consensus 280 ~t~~ell~~~~~~~ 293 (328)
T cd07856 280 ISAAEALAHPYLAP 293 (328)
T ss_pred CCHHHHhcCCcccc
Confidence 99999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=320.52 Aligned_cols=265 Identities=24% Similarity=0.369 Sum_probs=217.9
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~ 881 (1141)
-+-|++.++||.|.+|.||+++. .++.+|+||+.... +..++. ..|.++++.. .|||++.+|++|.-.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEi----E~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEI----ELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHH----HHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34589999999999999999875 67889999975443 222222 5688999888 599999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+.. ...++|||||||.|||..++++.+. ..++.|..+..|++.++.|+.|||.+.++|||||-.|||+
T Consensus 89 ~~~---------~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL 156 (953)
T KOG0587|consen 89 DPG---------NGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL 156 (953)
T ss_pred cCC---------CCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE
Confidence 432 3458899999999999999999854 5579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ 1040 (1141)
+.+ +.|||+|||.+..++... ....+++|||.|||||++..+. ....|+.++|+||||++..
T Consensus 157 T~e-------~~VKLvDFGvSaQldsT~----------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaI 219 (953)
T KOG0587|consen 157 TEN-------AEVKLVDFGVSAQLDSTV----------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAI 219 (953)
T ss_pred ecc-------CcEEEeeeeeeeeeeccc----------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceee
Confidence 998 889999999998766522 2345778999999999997643 2456789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
||..|.+|+..+.++..+-.|....+|.+... ...++++.++|..||..|-.+||
T Consensus 220 EladG~PPl~DmHPmraLF~IpRNPPPkLkrp-------------------------~kWs~~FndFIs~cL~Kd~e~RP 274 (953)
T KOG0587|consen 220 EMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP-------------------------KKWSKKFNDFISTCLVKDYEQRP 274 (953)
T ss_pred hhcCCCCCccCcchhhhhccCCCCCCccccch-------------------------hhHHHHHHHHHHHHHhhccccCc
Confidence 99999999988777655555544444433211 15677899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
++.++++|+|..
T Consensus 275 ~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 275 STEELLKHPFIT 286 (953)
T ss_pred chhhhccCCccc
Confidence 999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=299.52 Aligned_cols=266 Identities=26% Similarity=0.384 Sum_probs=204.5
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC--CCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkllg~~~~~~~~ 884 (1141)
+..+.+.||+|.||.||+|+|.+..||||||.-. ++ ..+.+|.+|.... +|+||..|++.-..+.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr------dE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-- 278 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR------DE-----RSWFRETEIYQTVMLRHENILGFIAADNKDN-- 278 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEeccc------ch-----hhhhhHHHHHHHHHhccchhhhhhhccccCC--
Confidence 4689999999999999999999999999998522 21 2335777777654 8999999998754432
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCC
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKS 956 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--------gIvHrDLKP 956 (1141)
....++|||++|-+.|||+|++.+ ..++....++++..+|.||+|||.. .|.|||||+
T Consensus 279 --------gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 279 --------GSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred --------CceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 246789999999999999999986 4699999999999999999999952 599999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC--CchhhHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY--GLEVDIWS 1034 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~--s~ksDVWS 1034 (1141)
.||||..+ +.+-|+|+|+|.........- ...++..+||..|||||++........+ -..+||||
T Consensus 345 KNILVKkn-------~~C~IADLGLAv~h~~~t~~i------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 345 KNILVKKN-------GTCCIADLGLAVRHDSDTDTI------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred ccEEEccC-------CcEEEeeceeeEEecccCCcc------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 99999988 899999999998765543221 1234566899999999999764332222 25799999
Q ss_pred HHHHHHHHHhC----------CCCCCC-----CCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhh
Q 001143 1035 YGCLLLELLTL----------QVPYMG-----LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098 (1141)
Q Consensus 1035 LGviL~ELLTG----------k~Pf~~-----~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1141)
||.++||++-. +.||.+ .+..++.+.+ ....+|.++..+.. .
T Consensus 412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s----------------------~ 469 (513)
T KOG2052|consen 412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKS----------------------D 469 (513)
T ss_pred HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccccc----------------------C
Confidence 99999999853 577754 2334444444 33444444433221 1
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1099 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1099 ~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
+....+.++++.||..+|.-|.||--+-+.+-...+
T Consensus 470 ~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 470 PALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 566778999999999999999999888877766543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=289.19 Aligned_cols=245 Identities=30% Similarity=0.354 Sum_probs=193.8
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||+|+||.||++.+. +..+++|+....... ....... +..|+.++++++||||+++++.+.....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEH----TLTERNILSRINHPFIVKLHYAFQTEEK-------- 67 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHH----HHHHHHHHHHcCCCcHHHHHHHeecCCe--------
Confidence 699999999999985 567777775433211 1122223 3789999999999999999999876543
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.+
T Consensus 68 ------~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~------- 129 (250)
T cd05123 68 ------LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD------- 129 (250)
T ss_pred ------eEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-------
Confidence 4999999999999999976 2368999999999999999999999999999999999999887
Q ss_pred CeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001143 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 972 ~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~ 1051 (1141)
+.++|+|||.+....... .......++..|+|||...+ ..++.++|+||||+++|+|++|+.||..
T Consensus 130 ~~~~l~d~~~~~~~~~~~----------~~~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 130 GHIKLTDFGLAKELSSEG----------SRTNTFCGTPEYLAPEVLLG----KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcEEEeecCcceecccCC----------CcccCCcCCccccChHHhCC----CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 789999999987653321 01123457889999999876 4467899999999999999999999987
Q ss_pred CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 001143 1052 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 1128 (1141)
Q Consensus 1052 ~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa---~ElL~~ 1128 (1141)
....+....+.... ..++ ...+..+.+++.+||..||++||++ .++++|
T Consensus 196 ~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 196 EDRKEIYEKILKDP-LRFP---------------------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 66555554443311 1111 0235668999999999999999999 899999
Q ss_pred HHh
Q 001143 1129 FVA 1131 (1141)
Q Consensus 1129 L~~ 1131 (1141)
+||
T Consensus 248 ~~f 250 (250)
T cd05123 248 PFF 250 (250)
T ss_pred CCC
Confidence 986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=308.72 Aligned_cols=265 Identities=21% Similarity=0.319 Sum_probs=205.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
-..+.+.++||+|-||.|.++...+ ..||||+.+-.. ......+| .+|+++|.+|+|||||+++|++..++.
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~r~~F----~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNARNDF----LKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhHHHHH----HHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3446899999999999999998765 788888754321 12223444 899999999999999999999998775
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+ ++||||+++|+|.+++.+.. ...+......+|+.||+.|++||.+.++|||||.+.|+|++.
T Consensus 610 i--------------cmI~EYmEnGDLnqFl~ahe---apt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~ 672 (807)
T KOG1094|consen 610 L--------------CMITEYMENGDLNQFLSAHE---LPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDG 672 (807)
T ss_pred h--------------HHHHHHHhcCcHHHHHHhcc---CcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecC
Confidence 5 99999999999999998732 122455667789999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +++||+|||+++.+-..... ......+-...|||||.+.- ..++.++|||+||+++||++
T Consensus 673 e-------~~iKiadfgmsR~lysg~yy--------~vqgr~vlpiRwmawEsill----gkFttaSDvWafgvTlwE~~ 733 (807)
T KOG1094|consen 673 E-------FTIKIADFGMSRNLYSGDYY--------RVQGRAVLPIRWMAWESILL----GKFTTASDVWAFGVTLWEVF 733 (807)
T ss_pred c-------ccEEecCcccccccccCCce--------eeecceeeeeeehhHHHHHh----ccccchhhhhhhHHHHHHHH
Confidence 8 89999999999865432211 11223456789999999886 68899999999999999998
Q ss_pred h--CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1044 T--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1044 T--Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+ ...||......++.+.....-...-.. . .+..+.-++..+.+++.+||..|-.+||+
T Consensus 734 ~~C~e~Py~~lt~e~vven~~~~~~~~~~~-----------~---------~l~~P~~cp~~lyelml~Cw~~es~~RPs 793 (807)
T KOG1094|consen 734 MLCREQPYSQLTDEQVVENAGEFFRDQGRQ-----------V---------VLSRPPACPQGLYELMLRCWRRESEQRPS 793 (807)
T ss_pred HHHhhCchhhhhHHHHHHhhhhhcCCCCcc-----------e---------eccCCCcCcHHHHHHHHHHhchhhhcCCC
Confidence 7 678998877777665432211100000 0 00111257788999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
++++..++...
T Consensus 794 Fe~lh~~lq~~ 804 (807)
T KOG1094|consen 794 FEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHh
Confidence 99998877643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=331.23 Aligned_cols=282 Identities=25% Similarity=0.355 Sum_probs=197.9
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|+..+.||+||||.||+++. .+..+|+|-..++ . ..... .++.+|+..+++|+|||||++|..+.+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~--~-s~~~~----skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK--A-SDKLY----SKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc--h-HHHHH----HHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 45678999999999999999997 5777888765443 2 11222 23479999999999999999997765321
Q ss_pred ------------------------------------------------------CCC------C----------CCC---
Q 001143 883 ------------------------------------------------------WLP------S----------ADG--- 889 (1141)
Q Consensus 883 ------------------------------------------------------~~~------~----------~~g--- 889 (1141)
..+ . .++
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 000 0 000
Q ss_pred --------------------------C-Cc-----cccceEEEEEeeccCCCHHHHHHHhhhcCCCCC-CHHHHHHHHHH
Q 001143 890 --------------------------N-PE-----HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQD 936 (1141)
Q Consensus 890 --------------------------~-~~-----~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~L-s~~~i~~Ia~Q 936 (1141)
+ .+ .....+||-||||+...|.++|++ .... .....+++++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-----N~~~~~~d~~wrLFre 705 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-----NHFNSQRDEAWRLFRE 705 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-----cccchhhHHHHHHHHH
Confidence 0 00 012468999999998777788776 1122 47789999999
Q ss_pred HHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccc-------ccc-ccccccCCCCCCCCccCC
Q 001143 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS-------FLH-TCCIAHRGIPAPDVCVGT 1008 (1141)
Q Consensus 937 Ia~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~-------~~~-~~~~~~~~~~~~~~~~GT 1008 (1141)
|+.||.|+|++|||||||||.|||++.+ ..|||+|||+|+.... ... ...............+||
T Consensus 706 IlEGLaYIH~~giIHRDLKP~NIFLd~~-------~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT 778 (1351)
T KOG1035|consen 706 ILEGLAYIHDQGIIHRDLKPRNIFLDSR-------NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT 778 (1351)
T ss_pred HHHHHHHHHhCceeeccCCcceeEEcCC-------CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence 9999999999999999999999999987 7899999999987220 000 001111111234567899
Q ss_pred CcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccC
Q 001143 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1088 (1141)
Q Consensus 1009 ~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~ 1088 (1141)
..|+|||++.+... ..|+.|+|+||+||+++||+ +||. ..++-...+..-+.+.++..
T Consensus 779 alYvAPEll~~~~~-~~Yn~KiDmYSLGIVlFEM~---yPF~--TsMERa~iL~~LR~g~iP~~---------------- 836 (1351)
T KOG1035|consen 779 ALYVAPELLSDTSS-NKYNSKIDMYSLGIVLFEML---YPFG--TSMERASILTNLRKGSIPEP---------------- 836 (1351)
T ss_pred eeeecHHHhccccc-ccccchhhhHHHHHHHHHHh---ccCC--chHHHHHHHHhcccCCCCCC----------------
Confidence 99999999987443 47999999999999999998 3564 34444444433333333321
Q ss_pred CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1089 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1089 ~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+++..+..+.-..+|+.|++.||.+||||.|+|++=++-
T Consensus 837 -----~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 -----ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred -----cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 011113334467899999999999999999999876654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=298.24 Aligned_cols=261 Identities=25% Similarity=0.320 Sum_probs=210.7
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 800 LDPGSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 800 ~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
.+.....+|.+..+||+|+||.|.+|..+++ .+|+||.+.++.... ++.+-- +.|-++|.-. +-|.+++++.
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvect----m~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECT----MVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-Ccccce----ehhhhheecCCCCchHHHHHH
Confidence 3455677899999999999999999988654 578887654443222 222222 4677777666 5889999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
.|..-+.+ |+||||+.||+|.-.|++. +.+.+..+..++..|+-||-|||++|||+||||.
T Consensus 418 cFQTmDRL--------------yFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKL 478 (683)
T KOG0696|consen 418 CFQTMDRL--------------YFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKL 478 (683)
T ss_pred Hhhhhhhe--------------eeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccc
Confidence 99876644 9999999999999999873 4688899999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|||++.+ |++||.|||+++.--... ....+++|||.|+|||++.. .+|+..+|+||||
T Consensus 479 DNvmLd~e-------GHiKi~DFGmcKEni~~~----------~TTkTFCGTPdYiAPEIi~Y----qPYgksvDWWa~G 537 (683)
T KOG0696|consen 479 DNVMLDSE-------GHIKIADFGMCKENIFDG----------VTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFG 537 (683)
T ss_pred cceEeccC-------CceEeeecccccccccCC----------cceeeecCCCcccccceEEe----cccccchhHHHHH
Confidence 99999998 999999999997532211 12346789999999999987 6899999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|+||||+.|++||.+.++.+++..|...... .+ ...+.++.+++...|...|
T Consensus 538 VLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-yP---------------------------KslSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 538 VLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-YP---------------------------KSLSKEAVAICKGLLTKHP 589 (683)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-Cc---------------------------ccccHHHHHHHHHHhhcCC
Confidence 9999999999999999999999888543221 01 0456678899999999999
Q ss_pred CCCCCH-----HHHHHHHHhhc
Q 001143 1117 TERPTA-----GDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RPSa-----~ElL~~L~~~~ 1133 (1141)
.+|... .+|-.|++|+.
T Consensus 590 ~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 590 GKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ccccCCCCccccchhhCcchhh
Confidence 999543 67888888864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=309.69 Aligned_cols=264 Identities=26% Similarity=0.309 Sum_probs=221.2
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 799 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 799 ~~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~--vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
.+....+.+++.+..||-|+||.|-++..+... .|+|+.+.....+ ..+.+. +..|-.+|..++.|.||++|.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeH----v~sEr~Im~~~~s~fIvrLYr 487 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEH----VFSERNIMMECRSDFIVRLYR 487 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHH----HHhHHHHHHhcCchHHHHHHH
Confidence 455667888999999999999999999886665 5677643322222 222222 268999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
.|.++.++ |+.||-|-||.|+..+++ .+.|+...++.++..++.|++|||++|||+|||||
T Consensus 488 Tfrd~kyv--------------YmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP 548 (732)
T KOG0614|consen 488 TFRDSKYV--------------YMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP 548 (732)
T ss_pred Hhccchhh--------------hhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence 99887755 999999999999999987 45799999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|.+++.+ |.+||.|||+|+.+.....++ +++|||.|.|||++.. ...+.++|.||||
T Consensus 549 ENllLd~~-------Gy~KLVDFGFAKki~~g~KTw-----------TFcGTpEYVAPEIILn----KGHD~avDyWaLG 606 (732)
T KOG0614|consen 549 ENLLLDNR-------GYLKLVDFGFAKKIGSGRKTW-----------TFCGTPEYVAPEIILN----KGHDRAVDYWALG 606 (732)
T ss_pred hheeeccC-------CceEEeehhhHHHhccCCcee-----------eecCCcccccchhhhc----cCcchhhHHHHHH
Confidence 99999988 899999999999887755443 5789999999999987 5567999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+++|||++|.+||.+.+++..+..|..+...- +++..+.....++|+++...+|
T Consensus 607 Ili~ELL~G~pPFs~~dpmktYn~ILkGid~i--------------------------~~Pr~I~k~a~~Lik~LCr~~P 660 (732)
T KOG0614|consen 607 ILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------------------------EFPRRITKTATDLIKKLCRDNP 660 (732)
T ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------------------hcccccchhHHHHHHHHHhcCc
Confidence 99999999999999999999998887664310 0111556678999999999999
Q ss_pred CCCCC-----HHHHHHHHHhhcC
Q 001143 1117 TERPT-----AGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPS-----a~ElL~~L~~~~~ 1134 (1141)
.+|.. +.+|-+|.||..-
T Consensus 661 ~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 661 TERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HhhhccccCChHHHHhhhhhhcC
Confidence 99975 8999999999754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=304.74 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=204.0
Q ss_pred eeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 811 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
.++||.|.||+||-|++ .++.||||+. ++..........+ ..|++||.+++||.||.+...|+..+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvI--dKlrFp~kqesql----R~EVaILq~l~HPGiV~le~M~ET~er----- 637 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVI--DKLRFPTKQESQL----RNEVAILQNLHHPGIVNLECMFETPER----- 637 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeee--ecccCCCchHHHH----HHHHHHHHhcCCCCeeEEEEeecCCce-----
Confidence 48899999999999987 5778888874 4433333333333 799999999999999999999987664
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
.++|||-+. |+..++|-. ...+++++...+.++.||+.||.|||-++|+|+||||+|||+....
T Consensus 638 ---------vFVVMEKl~-GDMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~--- 701 (888)
T KOG4236|consen 638 ---------VFVVMEKLH-GDMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS--- 701 (888)
T ss_pred ---------EEEEehhhc-chHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC---
Confidence 499999997 555555543 2345799999999999999999999999999999999999997652
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
.-..+||||||+|+.+.+.. .....+|||.|.|||++.. ..|+..-|+||.|||+|--++|..|
T Consensus 702 -~FPQvKlCDFGfARiIgEks-----------FRrsVVGTPAYLaPEVLrn----kGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 702 -PFPQVKLCDFGFARIIGEKS-----------FRRSVVGTPAYLAPEVLRN----KGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred -CCCceeeccccceeecchhh-----------hhhhhcCCccccCHHHHhh----ccccccccceeeeEEEEEEeccccc
Confidence 23679999999999887643 2346789999999999987 6789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001143 1049 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128 (1141)
Q Consensus 1049 f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~ 1128 (1141)
|.. ..++-++|+.......+..+. +++....+||..+|+..-.+|.|.++.+.|
T Consensus 766 FNE--dEdIndQIQNAaFMyPp~PW~------------------------eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 766 FNE--DEDINDQIQNAAFMYPPNPWS------------------------EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCC--ccchhHHhhccccccCCCchh------------------------hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 974 344566665443322211111 566779999999999999999999999999
Q ss_pred HHhhc
Q 001143 1129 FVART 1133 (1141)
Q Consensus 1129 L~~~~ 1133 (1141)
+|.+.
T Consensus 820 ~Wlq~ 824 (888)
T KOG4236|consen 820 PWLQD 824 (888)
T ss_pred hhhhc
Confidence 99864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=292.70 Aligned_cols=268 Identities=22% Similarity=0.317 Sum_probs=201.0
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC--CCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkllg~~~~~~ 882 (1141)
.....+.++||+|.||.||+|...++.||||++.. .+.+.| +.|-+|.+-. +|+||++|+++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-------~~kqs~----~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-------QEKQSF----QNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-------HHHHHH----HhHHHHHhccCccchhHHHhhchhccCC
Confidence 55678899999999999999999999999999753 333444 6777776544 7999999998754322
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccC
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMHRD 953 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---------gIvHrD 953 (1141)
.. ...++||+||.+.|+|.++++. ..++|....+|+..|++||+|||+. .|+|||
T Consensus 278 ---------~~-~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD 341 (534)
T KOG3653|consen 278 ---------AD-RMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD 341 (534)
T ss_pred ---------cc-ccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence 11 3467999999999999999987 4799999999999999999999962 699999
Q ss_pred CCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC--CCCchhh
Q 001143 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVD 1031 (1141)
Q Consensus 954 LKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksD 1031 (1141)
||+.||||..+ +++.|+|||+|..+...... ...-..+||..|||||++.+...-. ..=.+.|
T Consensus 342 lkSkNVLvK~D-------lTccIaDFGLAl~~~p~~~~--------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~D 406 (534)
T KOG3653|consen 342 LKSKNVLVKND-------LTCCIADFGLALRLEPGKPQ--------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRID 406 (534)
T ss_pred ccccceEEccC-------CcEEeeccceeEEecCCCCC--------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHH
Confidence 99999999988 89999999999887642211 1112368999999999998754221 1115799
Q ss_pred HHHHHHHHHHHHhCCCCCC--C---------------CCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCC
Q 001143 1032 IWSYGCLLLELLTLQVPYM--G---------------LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093 (1141)
Q Consensus 1032 VWSLGviL~ELLTGk~Pf~--~---------------~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~ 1093 (1141)
|||+|.++|||+++..-++ . ....++.+.+ ..-.+|.+++.+..
T Consensus 407 vYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~------------------ 468 (534)
T KOG3653|consen 407 VYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK------------------ 468 (534)
T ss_pred HHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc------------------
Confidence 9999999999998754332 1 1122233222 33444444433221
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001143 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1094 ~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~s~ 1136 (1141)
......+.+.+..||..||+.|.|+.=+.+..+.....+
T Consensus 469 ----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 469 ----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred ----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 144667999999999999999999988877777654433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=311.28 Aligned_cols=212 Identities=25% Similarity=0.362 Sum_probs=169.1
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..+..-+.||+|+||.||++++ .|..+|||.++.. ....+. +++.+|+++|++++|||||++++.-++...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~--~~~r~~-----e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKE--SSLRPR-----ERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhh--cccchH-----HHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 3457778999999999999997 4667788775432 222221 233799999999999999999987554331
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. .-.....+|||||.||||...+++ +.....+++.+.+.++.++..||.|||++|||||||||.||++..
T Consensus 86 ~--------~~~~~~vlvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~ 155 (732)
T KOG4250|consen 86 G--------LVTRLPVLVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQI 155 (732)
T ss_pred C--------cccccceEEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Confidence 1 012245899999999999999986 344557999999999999999999999999999999999998855
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
.. ++.-..||+|||+|+.+..... -...+||+.|.+||.+.. ...|+..+|.|||||++|+.+
T Consensus 156 Ge---dgq~IyKLtDfG~Arel~d~s~-----------~~S~vGT~~YLhPel~E~---q~~y~~tVDLWS~GvtlY~ca 218 (732)
T KOG4250|consen 156 GE---DGQSIYKLTDFGAARELDDNSL-----------FTSLVGTEEYLHPELYER---QKKYTATVDLWSFGVTLYECA 218 (732)
T ss_pred cC---CCceEEeeecccccccCCCCCe-----------eeeecCchhhcChHHHhh---ccCcCceeehhhhhhHHHHHh
Confidence 41 2346789999999998766432 236789999999999984 367899999999999999999
Q ss_pred hCCCCCCC
Q 001143 1044 TLQVPYMG 1051 (1141)
Q Consensus 1044 TGk~Pf~~ 1051 (1141)
||..||..
T Consensus 219 TG~lPF~p 226 (732)
T KOG4250|consen 219 TGELPFIP 226 (732)
T ss_pred ccCCCCCc
Confidence 99999953
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=292.00 Aligned_cols=286 Identities=19% Similarity=0.222 Sum_probs=205.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCC----ccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSC----IVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpN----IVkllg 876 (1141)
-++|.+...+|+|+||.|-.+.+. +..+|+||.+. +..+.+..+-|++++.++. -|+ +|++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 367999999999999999999875 45677776431 1222233468999999994 233 677777
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
+|...+ +.|||+|.+ |-|+++++.. ++..+++...++.|++|++.+++|||+.+++|.||||
T Consensus 159 wFdyrg--------------hiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 159 WFDYRG--------------HICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred hhhccC--------------ceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 776554 459999998 5799999986 5677899999999999999999999999999999999
Q ss_pred CCeeeeccc-------------ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 957 ENILIDLER-------------KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 957 ~NILld~~~-------------~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
+|||+-... ........|+++|||.|+..... ....+.|..|+|||++.+
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-------------hs~iVsTRHYRAPEViLg---- 283 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-------------HSTIVSTRHYRAPEVILG---- 283 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-------------cceeeeccccCCchheec----
Confidence 999885431 01223467999999999754331 135678999999999998
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhh-ccCc------c----------ccccc
Q 001143 1024 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL-GSCH------E----------HEVAQ 1086 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~-~~~~------~----------~~~~~ 1086 (1141)
-.++.++||||+||||+|+.||...|+..+..+.+.+++....|......... ...+ . ..+.+
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~ 363 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFE 363 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhc
Confidence 67899999999999999999999999876665644444333332222221111 0000 0 00000
Q ss_pred cCCCCCCch-hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1087 SGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1087 ~~~~~~~~~-~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
...+...-. .......++.+|+++||.+||.+|+|+.|++.|+||...
T Consensus 364 ~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 364 PCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred CCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 000000000 011334568999999999999999999999999999754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=306.20 Aligned_cols=243 Identities=25% Similarity=0.253 Sum_probs=194.0
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
..+.|.+...+|.|+|+.|-.+.+ +....++|+.. ..... . .+|+.++... +||||+++.+.+.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~--~~~~~------~----~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIIS--KRADD------N----QDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecc--ccccc------c----ccccchhhhhcCCCcceeecceecC
Confidence 466799999999999999999987 45667888743 22111 1 4677777666 69999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. +.|+|||++.|+-|.+.|.. . +.....+..|+.||+.|+.|||++|||||||||+|||
T Consensus 388 ~~--------------~~~~v~e~l~g~ell~ri~~-----~-~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL 447 (612)
T KOG0603|consen 388 GK--------------EIYLVMELLDGGELLRRIRS-----K-PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL 447 (612)
T ss_pred Cc--------------eeeeeehhccccHHHHHHHh-----c-chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence 55 45999999999988887765 1 2333778889999999999999999999999999999
Q ss_pred ee-cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 961 ID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 961 ld-~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
++ .. ++++|+|||.++.....- ...+-|..|.|||++.. ..|++++||||||++|
T Consensus 448 ~~~~~-------g~lrltyFG~a~~~~~~~-------------~tp~~t~~y~APEvl~~----~~yt~acD~WSLGvlL 503 (612)
T KOG0603|consen 448 LDGSA-------GHLRLTYFGFWSELERSC-------------DTPALTLQYVAPEVLAI----QEYTEACDWWSLGVLL 503 (612)
T ss_pred ecCCC-------CcEEEEEechhhhCchhh-------------cccchhhcccChhhhcc----CCCCcchhhHHHHHHH
Confidence 95 44 889999999997655421 12246888999999985 6899999999999999
Q ss_pred HHHHhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++|+.||...... ++...+..+.. . ..+++.+++|++.||+.||.+
T Consensus 504 y~ML~G~tp~~~~P~~~ei~~~i~~~~~---s---------------------------~~vS~~AKdLl~~LL~~dP~~ 553 (612)
T KOG0603|consen 504 YEMLTGRTLFAAHPAGIEIHTRIQMPKF---S---------------------------ECVSDEAKDLLQQLLQVDPAL 553 (612)
T ss_pred HHHHhCCCccccCCchHHHHHhhcCCcc---c---------------------------cccCHHHHHHHHHhccCChhh
Confidence 9999999999764443 44444433221 1 267788999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
||++.++..|+|+.
T Consensus 554 Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 554 RLGADEIGAHPWFL 567 (612)
T ss_pred CcChhhhccCcchh
Confidence 99999999999993
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=285.45 Aligned_cols=265 Identities=24% Similarity=0.313 Sum_probs=204.5
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~ 884 (1141)
++++-...||.|+||+|++..++...+.++++++..... ..+. .+++.|.....+- +.||||++||....++.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq----~rll~e~d~~mks~~cp~IVkfyGa~F~EGd- 137 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQ----KRLLMEHDTVMKSSNCPNIVKFYGALFSEGD- 137 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHH----HHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-
Confidence 445667889999999999999987776666666665433 2222 3447888776555 69999999999765442
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeec
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDL 963 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILld~ 963 (1141)
.||.||+|+ .||..+-+....-....+++...-.|+.-.+.||+||-. ..|||||+||+|||++.
T Consensus 138 -------------cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 138 -------------CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR 203 (361)
T ss_pred -------------eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec
Confidence 499999997 788777665554555679999999999999999999986 58999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
. |.|||||||.+..+..... ...-+|-.+|||||.+.... ..|+-++||||||++|||++
T Consensus 204 ~-------G~vKLCDFGIcGqLv~SiA-----------kT~daGCrpYmAPERi~p~~--~gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 204 H-------GDVKLCDFGICGQLVDSIA-----------KTVDAGCRPYMAPERIDPSD--KGYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred C-------CCEeeecccchHhHHHHHH-----------hhhccCCccccChhccCCcc--CCcchhhhhhhhcceEeeee
Confidence 8 8999999999976544221 12345888999999987633 36889999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
||..||.+-+ ..+....+..+.+|.+...... ...+..+..+|..||.+|-..||..
T Consensus 264 tG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~----------------------~~~s~~~~~fintCl~Kd~~~Rpky 321 (361)
T KOG1006|consen 264 TGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC----------------------VHYSFSMVRFINTCLIKDRSDRPKY 321 (361)
T ss_pred cCCCCcchHHHHHHHHHHHHcCCCCeecCcccc----------------------cccCHHHHHHHHHHhhcccccCcch
Confidence 9999997633 3344455556665554322111 1566779999999999999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
.+++++++-+
T Consensus 322 ~~Lk~~~fyr 331 (361)
T KOG1006|consen 322 DDLKKFPFYR 331 (361)
T ss_pred hhhhcCchhh
Confidence 9999998765
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=291.28 Aligned_cols=278 Identities=21% Similarity=0.216 Sum_probs=215.9
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|-+.++||+|+|+.||+|.+ ..+.|||||..+.+.- ..+..+++..-..+|.+|.+.|.||.||++|++|.-+..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~W-rdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNW-RDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccch-hhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4699999999999999999987 5778999997766432 223344555566899999999999999999999975432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCeee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILI 961 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--gIvHrDLKP~NILl 961 (1141)
.+|-|+|||+|.+|.-+++. .+.+++++++.|+.||+.||.||... .|||-||||.|||+
T Consensus 542 -------------sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 542 -------------SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred -------------cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 34999999999999999987 45799999999999999999999965 69999999999988
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
-... ..|.+||.|||+++.+...... ...+........||.+|++||.+.-.......+.|+||||.|||+|.
T Consensus 604 v~Gt----acGeIKITDFGLSKIMdddSy~---~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 604 VNGT----ACGEIKITDFGLSKIMDDDSYN---SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred ecCc----ccceeEeeecchhhhccCCccC---cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 5431 2378999999999988764422 23345556667899999999998765556778999999999999999
Q ss_pred HHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
.+.|+.||..... .+++. ........ +...|. .+..+.+..+||++||++.-++|.
T Consensus 677 ClYGrKPFGhnqsQQdILq---eNTIlkAt-------------------EVqFP~-KPvVsseAkaFIRRCLaYRKeDR~ 733 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQDILQ---ENTILKAT-------------------EVQFPP-KPVVSSEAKAFIRRCLAYRKEDRI 733 (775)
T ss_pred hhccCCCCCCchhHHHHHh---hhchhcce-------------------eccCCC-CCccCHHHHHHHHHHHHhhhhhhh
Confidence 9999999964322 12221 11100000 000000 015566789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
...++..++++.
T Consensus 734 DV~qLA~dpyll 745 (775)
T KOG1151|consen 734 DVQQLACDPYLL 745 (775)
T ss_pred hHHHHccCcccc
Confidence 999999999885
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=309.79 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=202.7
Q ss_pred CceEeeeecccCceEEEEEEEC----C---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG----S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~----~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
+..+.+.||+|+||.|++|... . ..+.|+++.++..... .+.+.+ ..|+.+|+.+ +||||+.++|++
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~----~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDL----MSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHH----HHHHHHHHHhcCCcchhhheeee
Confidence 3467779999999999999742 1 1334444444443333 444555 8999999999 599999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhh---------hcCC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGE--KHVSVKLALFIAQDVAAALVELHSK 947 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~---------~~~~--~~Ls~~~i~~Ia~QIa~gL~yLHs~ 947 (1141)
..... .++|+||+..|+|.++++..+ .... ..++..+.+.+++||+.|++||++.
T Consensus 372 t~~~~--------------~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 372 TQDGP--------------LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred ccCCc--------------eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 87553 399999999999999998754 1111 1389999999999999999999999
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccC--CCcccchhhhccccCCCC
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~~~~~ 1025 (1141)
++|||||-+.|||++.+ ..+||+|||+|+.......... ....+ ...|||||.+.. ..
T Consensus 438 ~~vHRDLAaRNVLi~~~-------~~~kIaDFGlar~~~~~~~y~~---------~~~~~~LP~kWmApEsl~~----~~ 497 (609)
T KOG0200|consen 438 PCVHRDLAARNVLITKN-------KVIKIADFGLARDHYNKDYYRT---------KSSAGTLPVKWMAPESLFD----RV 497 (609)
T ss_pred CccchhhhhhhEEecCC-------CEEEEccccceeccCCCCceEe---------cCCCCccceeecCHHHhcc----Cc
Confidence 99999999999999988 7899999999985443221110 01112 345999999986 67
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1141)
|+.++|||||||+|||++| |..||.+.. ..++.+.+..|.+...+. .+.++
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~---------------------------~c~~e 550 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPE---------------------------HCSDE 550 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHH
Confidence 9999999999999999999 899998755 556666777776644332 56778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
+.+++..||+.+|++||++.++.+.+..
T Consensus 551 iY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 551 IYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 9999999999999999999999887655
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=308.03 Aligned_cols=291 Identities=14% Similarity=0.097 Sum_probs=177.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
...++|++.++||+|+||.||+|++.. ..+|+|.. ... ... +.. ..| .+....+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~--~~~--~~~--e~~----~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA--TEY--GAV--EIW----MNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEe--ccc--chh--HHH----HHH--HHHhhchhhHHHHHH
Confidence 457789999999999999999999853 45666643 221 111 111 111 122223334443333
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---------------CCCCCCHHHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------GEKHVSVKLALFIAQDVAAAL 941 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~---------------~~~~Ls~~~i~~Ia~QIa~gL 941 (1141)
.+..... .......++||||+++++|.++++..... .........+..|+.||+.||
T Consensus 197 ~~~~~~~--------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL 268 (566)
T PLN03225 197 GFLEPVS--------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFAL 268 (566)
T ss_pred hhhcccc--------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHH
Confidence 3222110 01223569999999999999998752100 001122345678999999999
Q ss_pred HHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001143 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1141)
Q Consensus 942 ~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1021 (1141)
.|||+++|+||||||+|||++.+. +.+||+|||+|+.+..... ..+....+|+.|+|||.+....
T Consensus 269 ~yLH~~gIiHRDLKP~NILl~~~~------~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 269 DGLHSTGIVHRDVKPQNIIFSEGS------GSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHHHHCCEEeCcCCHHHEEEeCCC------CcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhccC
Confidence 999999999999999999998642 6899999999975533211 1223456899999999764321
Q ss_pred CC------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcccc
Q 001143 1022 KP------------------NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1083 (1141)
Q Consensus 1022 ~~------------------~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~ 1083 (1141)
.. ..++.++|||||||++|||+++..|+.. ........+.........+ ..... ...
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~-~~~~~~~~l~~~~~~~~~~-~~~~~---~~~ 408 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS-NLIQFNRQLKRNDYDLVAW-RKLVE---PRA 408 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch-HHHHHHHHHHhcCCcHHHH-HHhhc---ccc
Confidence 11 1234567999999999999997766542 1222223332222111111 00000 000
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001143 1084 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~s~ 1136 (1141)
.......+.. ........++||.+||+.||.+|||+.|+++|+|+.....
T Consensus 409 ~~~~~~~~~~---~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 409 SPDLRRGFEV---LDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred chhhhhhhhh---ccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 0000000000 0012334679999999999999999999999999986544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=300.82 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=204.6
Q ss_pred ceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+..++||+|+||+||+|.|- +.+||+|++.-. .......++ +.|+.+|.++.|||++++++++..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~----LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIEL----LDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHH----HHHHHHHhcCCCchHHHHhhhcccc
Confidence 467789999999999999982 345677765322 122223344 7999999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. +.||++|+++|+|.++++.. +..+-.+..+.|..||++||.|||.+++|||||-+.||||
T Consensus 771 ~---------------~qlvtq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV 831 (1177)
T KOG1025|consen 771 T---------------LQLVTQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV 831 (1177)
T ss_pred h---------------HHHHHHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence 3 37999999999999999862 3468889999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
..- ..+|+.|||+|+.+........ .....-.+.|||-|.+.. ..|+.++|||||||++||
T Consensus 832 ksP-------~hvkitdfgla~ll~~d~~ey~--------~~~gK~pikwmale~i~~----~~~thqSDVWsfGVtiWE 892 (1177)
T KOG1025|consen 832 KSP-------NHVKITDFGLAKLLAPDEKEYS--------APGGKVPIKWMALESIRI----RKYTHQSDVWSFGVTIWE 892 (1177)
T ss_pred cCC-------CeEEEEecchhhccCccccccc--------ccccccCcHHHHHHHhhc----cCCCchhhhhhhhhhHHH
Confidence 876 7899999999998765443211 112223567999998876 789999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
++| |..||++....++.+.+..+.+..-+ +.++.++..++.+||..|+..||
T Consensus 893 lmTFGa~Py~gi~~~eI~dlle~geRLsqP---------------------------piCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 893 LMTFGAKPYDGIPAEEIPDLLEKGERLSQP---------------------------PICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred HHhcCCCccCCCCHHHhhHHHhccccCCCC---------------------------CCccHHHHHHHHHHhccCcccCc
Confidence 999 99999999998888887766652211 15677899999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
+|+++...+-.
T Consensus 946 ~fkel~~~fs~ 956 (1177)
T KOG1025|consen 946 TFKELAEEFSR 956 (1177)
T ss_pred cHHHHHHHHHH
Confidence 99999886544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=278.37 Aligned_cols=227 Identities=20% Similarity=0.140 Sum_probs=172.5
Q ss_pred cCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCccc
Q 001143 817 SVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 894 (1141)
Q Consensus 817 GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~ 894 (1141)
|.+|.||+|.+. +..+++|..... . .+ .+|...+....||||+++++++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~--~-------~~----~~~~~~~~~~~~~~i~~~~~~~~~~~------------ 58 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS--S-------EY----SRERLTIIPHCVPNMVCLHKYIVSED------------ 58 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch--h-------hh----hhHHHHHHhcCCCceeehhhheecCC------------
Confidence 899999999984 455666664321 1 11 24445555667999999999987654
Q ss_pred cceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeE
Q 001143 895 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974 (1141)
Q Consensus 895 ~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~v 974 (1141)
..++||||++|++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+
T Consensus 59 --~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-------~~~ 124 (237)
T cd05576 59 --SVFLVLQHAEGGKLWSHISK-----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-------GHI 124 (237)
T ss_pred --eEEEEEecCCCCCHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-------CCE
Confidence 34999999999999999875 2358999999999999999999999999999999999999887 789
Q ss_pred EEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 001143 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1054 (1141)
Q Consensus 975 KL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~ 1054 (1141)
+++|||.+....... ....++..|+|||.+.. ..++.++||||+|+++|+|++|..|+.....
T Consensus 125 ~l~df~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 125 QLTYFSRWSEVEDSC-------------DGEAVENMYCAPEVGGI----SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred EEecccchhcccccc-------------ccCCcCccccCCcccCC----CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 999999875543211 11235677999998765 4567899999999999999999988753211
Q ss_pred HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHHH
Q 001143 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----GDLYEMF 1129 (1141)
Q Consensus 1055 ~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa-----~ElL~~L 1129 (1141)
. +...... ..+...+..+.+++.+||+.||.+||++ +++++|+
T Consensus 188 ~-----~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~ 235 (237)
T cd05576 188 G-----INTHTTL---------------------------NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHP 235 (237)
T ss_pred h-----ccccccc---------------------------CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence 0 0000000 0001345678999999999999999996 9999998
Q ss_pred Hh
Q 001143 1130 VA 1131 (1141)
Q Consensus 1130 ~~ 1131 (1141)
|+
T Consensus 236 ~~ 237 (237)
T cd05576 236 FF 237 (237)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=265.86 Aligned_cols=283 Identities=20% Similarity=0.261 Sum_probs=204.7
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceee
Q 001143 800 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 876 (1141)
Q Consensus 800 ~~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg 876 (1141)
++-+..++|++.+++|+|.|+.||.|.. +...+++|+.+- -..+.+ .+|+.||..|. ||||+++++
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKI----kREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKI----KREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHH----HHHHHHHHhccCCCCeeehhh
Confidence 3445678999999999999999999985 566777777431 122233 79999999996 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
.+.+...- ...+|+||+.+.++..+.. .++..+++.++.|++.||.|+|++||+|||+||
T Consensus 101 iV~Dp~Sk------------tpaLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GImHRDVKP 160 (338)
T KOG0668|consen 101 IVKDPESK------------TPSLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKP 160 (338)
T ss_pred hhcCcccc------------CchhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCc
Confidence 98874321 3489999999988877654 388899999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|++||... -.++|+|+|+|..+...... ...+.+.+|.-||.+.. -..|+..-|+||||
T Consensus 161 hNvmIdh~~------rkLrlIDWGLAEFYHp~~eY-----------nVRVASRyfKGPELLVd---y~~YDYSLD~WS~G 220 (338)
T KOG0668|consen 161 HNVMIDHEL------RKLRLIDWGLAEFYHPGKEY-----------NVRVASRYFKGPELLVD---YQMYDYSLDMWSLG 220 (338)
T ss_pred ceeeechhh------ceeeeeecchHhhcCCCcee-----------eeeeehhhcCCchheee---chhccccHHHHHHH
Confidence 999999874 47999999999776543221 24567888999999876 35678999999999
Q ss_pred HHHHHHHhCCCCCC-CCCHHHHHHHH-HhCCCCCchhHHhhhccCcc--------ccccccCCCCCCchhhhhhHHHHHH
Q 001143 1037 CLLLELLTLQVPYM-GLSELEIHDLI-QMGKRPRLTDELEALGSCHE--------HEVAQSGSGFEKPEAELETLSFLVD 1106 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~-~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~L~d 1106 (1141)
|++..|+..+.||. +.+..+..-.| .......+...+........ ....+....+...+-..-.++++.+
T Consensus 221 cmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiD 300 (338)
T KOG0668|consen 221 CMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAID 300 (338)
T ss_pred HHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHH
Confidence 99999999999975 33333322222 22221111111111100000 0001111111112212234578999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1107 VFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1107 LI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
|+.++|.+|..+|+||.|++.|++|..
T Consensus 301 lldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 301 LLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHhhccccccchHHHhcCchHHH
Confidence 999999999999999999999999964
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=279.98 Aligned_cols=285 Identities=22% Similarity=0.281 Sum_probs=199.8
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----C---CCcccee
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----H---SCIVEMY 875 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pNIVkll 875 (1141)
.+|.+.++||.|.|++||+|.+ ..+.||+||.+.. +.+.+..+.||.+|++++ | .+||+++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 5799999999999999999998 4667888886522 223334479999999984 2 3699999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDI 954 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDL 954 (1141)
++|...+ .+..|+|+|+|++ |.+|..+|... ..+.++...++.|++||+.||.|||.. ||||-||
T Consensus 149 D~FkhsG----------pNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 149 DHFKHSG----------PNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred ccceecC----------CCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 9998744 3566899999999 78999999874 344699999999999999999999965 9999999
Q ss_pred CCCCeeeeccc---------------------------------------------------------------------
Q 001143 955 KSENILIDLER--------------------------------------------------------------------- 965 (1141)
Q Consensus 955 KP~NILld~~~--------------------------------------------------------------------- 965 (1141)
||+|||+....
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 99999985430
Q ss_pred ------------------------------------------cc------------------------------------
Q 001143 966 ------------------------------------------KK------------------------------------ 967 (1141)
Q Consensus 966 ------------------------------------------~~------------------------------------ 967 (1141)
+.
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence 00
Q ss_pred ------------CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 968 ------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 968 ------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
......|||+|||-|....... ..-..|..|+|||++.+ ..|++.+||||+
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-------------T~DIQTRQYRapEVllG----sgY~~~ADiWS~ 437 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF-------------TEDIQTRQYRAPEVLLG----SGYSTSADIWST 437 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhhhh-------------chhhhhhhccCcceeec----CCCCCchhHHHH
Confidence 0001135566666554322100 11257889999999998 789999999999
Q ss_pred HHHHHHHHhCCCCCCC-------CCHHHHHHHH-HhCCCCCchhHHhhhccCccccccc--------cCCCCCC------
Q 001143 1036 GCLLLELLTLQVPYMG-------LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQ--------SGSGFEK------ 1093 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~-------~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~--------~~~~~~~------ 1093 (1141)
+|++|||+||...|.. .++..+...+ ..+..|+ .+...+......+.. ..+.+..
T Consensus 438 AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr---~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~e 514 (590)
T KOG1290|consen 438 ACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPR---KIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIE 514 (590)
T ss_pred HHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccH---HHHhcCcchHhhhccccceecccccCCCcHHHHHHH
Confidence 9999999999988852 1222222333 2222221 111111111111111 1111111
Q ss_pred -chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1094 -PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1094 -~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
-++..+...++.+|+.-||+.+|++||||.++++|+|...
T Consensus 515 KY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 515 KYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred HhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccC
Confidence 1223466788999999999999999999999999999973
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=287.23 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=196.0
Q ss_pred ceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|..++.||-|+||.|.+++...+ .+|.|. +.+.. --.++-..-++.|-.||.....+-||++|-.|.+++.+
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKT--LrKaD---Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL- 704 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKT--LRKAD---VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL- 704 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhh--hHHHH---HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce-
Confidence 57889999999999999986444 445554 33211 11111122347899999999999999999999987755
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
|+||+|++||++.+++-+ .+.|.+..++.++.++..|+++.|..|+|||||||+|||||.+
T Consensus 705 -------------YFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd- 765 (1034)
T KOG0608|consen 705 -------------YFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD- 765 (1034)
T ss_pred -------------EEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-
Confidence 999999999999998876 3579999999999999999999999999999999999999998
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCC--------------------------------CCCCCCccCCCcccc
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--------------------------------IPAPDVCVGTPRWMA 1013 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~--------------------------------~~~~~~~~GT~~Y~A 1013 (1141)
|++||.|||+|+-+.......+..... .......+||+.|+|
T Consensus 766 ------GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 766 ------GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred ------CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 999999999997543322211111000 001123589999999
Q ss_pred hhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCC
Q 001143 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092 (1141)
Q Consensus 1014 PE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~ 1092 (1141)
||++.. ..|+.-+|+||.|||||||+.|+.||....+.+....| .+.....++.
T Consensus 840 pevl~r----~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~--------------------- 894 (1034)
T KOG0608|consen 840 PEVLAR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPY--------------------- 894 (1034)
T ss_pred hHHhcc----cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccccc---------------------
Confidence 999986 67899999999999999999999999876665543333 2211111110
Q ss_pred CchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhc
Q 001143 1093 KPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVART 1133 (1141)
Q Consensus 1093 ~~~~~~~~~~~L~dLI~~cL~~DP~~RP---Sa~ElL~~L~~~~ 1133 (1141)
....+++..++|.+++ -+++.|. .++||-.|+||+.
T Consensus 895 ----~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 895 ----QGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred ----ccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 0145566777776654 3556664 5778999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=270.52 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=199.7
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~ 879 (1141)
..+.+|.+.++||+|+|..|.+++...+ -+|+||.+.+..... +++ .+++.|-.+..+. +||.+|-++.+|.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edi----dwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDI----DWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccc----hhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 3477899999999999999999988554 466666443322211 112 2347888888777 5999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.+..+ ++|.||++||+|.-++++ +..++++.++.+...|..||.|||++|||+||||.+|+
T Consensus 322 tesrl--------------ffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnv 382 (593)
T KOG0695|consen 322 TESRL--------------FFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNV 382 (593)
T ss_pred ccceE--------------EEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccce
Confidence 77644 999999999999888876 45799999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|+|.+ +++||.|+|+++.--.+. ....+++|||.|.|||++.+ ..|+..+|+||+||++
T Consensus 383 lldae-------ghikltdygmcke~l~~g----------d~tstfcgtpnyiapeilrg----eeygfsvdwwalgvlm 441 (593)
T KOG0695|consen 383 LLDAE-------GHIKLTDYGMCKEGLGPG----------DTTSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLM 441 (593)
T ss_pred EEccC-------CceeecccchhhcCCCCC----------cccccccCCCcccchhhhcc----cccCceehHHHHHHHH
Confidence 99998 899999999997532211 12346789999999999998 6799999999999999
Q ss_pred HHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1040 LELLTLQVPYMG-------LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~-------~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
+||+.|+.||.- .+..+..-++.......++. ..+.....+++.-|
T Consensus 442 femmagrspfdivgm~n~d~ntedylfqvilekqiripr---------------------------slsvkas~vlkgfl 494 (593)
T KOG0695|consen 442 FEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR---------------------------SLSVKASHVLKGFL 494 (593)
T ss_pred HHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc---------------------------eeehhhHHHHHHhh
Confidence 999999999962 12222222222112222221 22334667788999
Q ss_pred ccCCCCCC------CHHHHHHHHHhhc
Q 001143 1113 EENPTERP------TAGDLYEMFVART 1133 (1141)
Q Consensus 1113 ~~DP~~RP------Sa~ElL~~L~~~~ 1133 (1141)
.+||.+|. .++++-.|.+|+.
T Consensus 495 nkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 495 NKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred cCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999984 4688888888863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=303.10 Aligned_cols=261 Identities=26% Similarity=0.335 Sum_probs=193.0
Q ss_pred ceEeeeecccCceE-EEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~-Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~ 885 (1141)
|.-.+.+|.|+.|+ ||+|.+.++.||||-.. .++...+++|+..|+.- .|||||++|+.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll-----------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q--- 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLL-----------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ--- 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHh-----------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCc---
Confidence 45568899999998 89999999988888532 12223347999999888 4999999998766555
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..||..|+|. .+|.+++.... ...........+.++.|+++||+|||+.+||||||||.||||+...
T Consensus 577 -----------F~YIalELC~-~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 577 -----------FLYIALELCA-CSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred -----------eEEEEehHhh-hhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 3599999997 89999998621 1111111144577899999999999999999999999999998741
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
..+...++|+|||+++.+....... .......||-+|+|||++.... -+.++||||+||++|..++|
T Consensus 644 --~~~~~ra~iSDfglsKkl~~~~sS~-------~r~s~~sGt~GW~APE~L~~~~----~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 644 --ADGTLRAKISDFGLSKKLAGGKSSF-------SRLSGGSGTSGWQAPEQLREDR----KTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred --CCcceeEEecccccccccCCCcchh-------hcccCCCCcccccCHHHHhccc----cCcccchhhcCceEEEEecC
Confidence 2334789999999999876543221 1134567999999999998733 35699999999999999995
Q ss_pred -CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1046 -QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1046 -k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
.+||... .+....|..+...... . ....++ ++.+||.+|+++||..||+|.+
T Consensus 711 G~HpFGd~--~~R~~NIl~~~~~L~~-----L------------------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 711 GSHPFGDS--LERQANILTGNYTLVH-----L------------------EPLPDC--EAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred CccCCCch--HHhhhhhhcCccceee-----e------------------ccCchH--HHHHHHHHhcCCCcccCCCHHH
Confidence 9999642 2222333333221100 0 000012 7899999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001143 1125 LYEMFVARTSS 1135 (1141)
Q Consensus 1125 lL~~L~~~~~s 1135 (1141)
|+.||+|....
T Consensus 764 VL~HPlFW~~e 774 (903)
T KOG1027|consen 764 VLNHPLFWDSE 774 (903)
T ss_pred HhCCCccCChH
Confidence 99999997653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=261.02 Aligned_cols=241 Identities=33% Similarity=0.424 Sum_probs=187.9
Q ss_pred CceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCcccc
Q 001143 818 VSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895 (1141)
Q Consensus 818 sfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~ 895 (1141)
+||.||+|.+.+ ..+++|+...... ... .+. +.+|+..+++++|+||+++++++....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~-~~~----~~~e~~~~~~l~~~~i~~~~~~~~~~~------------- 60 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKI--KKK-RER----ILREISILKKLKHPNIVRLYDVFEDED------------- 60 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccc--ccH-HHH----HHHHHHHHHhCCCCcHHHHHhheeeCC-------------
Confidence 589999999854 6778887543321 111 233 379999999999999999999987643
Q ss_pred ceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEE
Q 001143 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975 (1141)
Q Consensus 896 ~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vK 975 (1141)
..++||||+++++|.+++.. ...+++..+..++.+++.++.|||+.+++|+||+|+||+++.+ +.++
T Consensus 61 -~~~l~~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-------~~~~ 127 (244)
T smart00220 61 -KLYLVMEYCDGGDLFDLLKK-----RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-------GHVK 127 (244)
T ss_pred -EEEEEEeCCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-------CcEE
Confidence 45999999998899999876 1238999999999999999999999999999999999999887 7899
Q ss_pred EeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCH
Q 001143 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSE 1054 (1141)
Q Consensus 976 L~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~-~~~ 1054 (1141)
|+|||.+....... ......++..|++||.+.+ ..++.++||||||+++++|++|..||.. ...
T Consensus 128 l~d~~~~~~~~~~~-----------~~~~~~~~~~~~~pE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 192 (244)
T smart00220 128 LADFGLARQLDPGG-----------LLTTFVGTPEYMAPEVLLG----KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL 192 (244)
T ss_pred Eccccceeeecccc-----------ccccccCCcCCCCHHHHcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999997654321 1123457889999999875 5677899999999999999999999976 444
Q ss_pred HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1055 ~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
......+.......... ....+..+.+++.+||..+|++||++.++++|+|+
T Consensus 193 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 193 LELFKKIGKPKPPFPPP-------------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHhccCCCCccc-------------------------cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 44444433322211100 00145679999999999999999999999999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=287.70 Aligned_cols=293 Identities=17% Similarity=0.168 Sum_probs=185.3
Q ss_pred CCCCceEeeeecccCceEEEEEEE------------------CCccEEEEEEecccCCCChHHH------HHhHHhHHHH
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF------------------GSADAAAKVRTLKVCGSSADEI------RNFEYSCLGE 859 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~------------------~~~~vAvKI~~l~~~~~~~~~~------~~~~~~~~~E 859 (1141)
+.++|++.++||+|+||+||+|.+ .+..||+|...........+.. ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 1235677764332111000000 0011223467
Q ss_pred HHHHhhCCCCCc-----cceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh---------------
Q 001143 860 VRMLGALRHSCI-----VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------------- 919 (1141)
Q Consensus 860 i~iL~~L~HpNI-----Vkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~--------------- 919 (1141)
+.++.+++|.++ +++++++..... ++ .......++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~----~g--~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~ 296 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTA----DG--AFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK 296 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccc----cc--cccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence 888888876554 677777754211 01 0112246999999999999999874210
Q ss_pred ----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccc
Q 001143 920 ----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 995 (1141)
Q Consensus 920 ----~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~ 995 (1141)
.....+++..++.++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||++.........
T Consensus 297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-------~~~kL~DFGla~~~~~~~~~---- 365 (507)
T PLN03224 297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-------GQVKIIDFGAAVDMCTGINF---- 365 (507)
T ss_pred hhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-------CcEEEEeCcCccccccCCcc----
Confidence 011235678899999999999999999999999999999999887 78999999998654321110
Q ss_pred cCCCCCCCCccCCCcccchhhhccccCCC----------------CC--CchhhHHHHHHHHHHHHhCCC-CCCCCCHHH
Q 001143 996 HRGIPAPDVCVGTPRWMAPEVLRAMHKPN----------------LY--GLEVDIWSYGCLLLELLTLQV-PYMGLSELE 1056 (1141)
Q Consensus 996 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~----------------~~--s~ksDVWSLGviL~ELLTGk~-Pf~~~~~~e 1056 (1141)
......+|+.|+|||.+....... .+ ..+.||||+||++++|+++.. ||.......
T Consensus 366 -----~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~ 440 (507)
T PLN03224 366 -----NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN 440 (507)
T ss_pred -----CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh
Confidence 111223588999999976421100 01 135799999999999999875 665321111
Q ss_pred HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC---CCCCCHHHHHHHHHhhc
Q 001143 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP---TERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1057 l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP---~~RPSa~ElL~~L~~~~ 1133 (1141)
..+.........+... ......+. .....++..++|+.+||..+| .+|+|++|+++|+||..
T Consensus 441 --~~~~~~~~~~~~~r~~----------~~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 441 --TELRQYDNDLNRWRMY----------KGQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred --hHHhhccchHHHHHhh----------cccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0110000000000000 00000011 011456779999999999766 68999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=281.57 Aligned_cols=280 Identities=21% Similarity=0.266 Sum_probs=209.5
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC------CCCccceeee
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYGH 877 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------HpNIVkllg~ 877 (1141)
.+|.+....|+|-|++|-+|.+ .+..|||||.+-.. .-.+.- ++|++||++|+ --|+++++.+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtG----l~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTG----LKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhh----hHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3589999999999999999998 46688999865321 112222 68999999995 3479999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
|...+ |+|||+|-+. .+|.++++.+... ..|....+..++.|+..||.+|-..||+|.||||+
T Consensus 503 F~hkn--------------HLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 503 FKHKN--------------HLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred hhhcc--------------eeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 88665 4599999996 8999999986443 45899999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||+++.. ..+||||||.|........+ ...-+..|.|||++.| -+|+...|+||.||
T Consensus 566 NiLVNE~k------~iLKLCDfGSA~~~~eneit------------PYLVSRFYRaPEIiLG----~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 566 NILVNESK------NILKLCDFGSASFASENEIT------------PYLVSRFYRAPEIILG----LPYDYPIDTWSVGC 623 (752)
T ss_pred ceEeccCc------ceeeeccCcccccccccccc------------HHHHHHhccCcceeec----CcccCCccceeece
Confidence 99998764 68999999999765543322 1234667999999998 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCchhH----Hhhhcc----Ccc---cccc-----------ccC-----
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDE----LEALGS----CHE---HEVA-----------QSG----- 1088 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I--~~~~~p~l~~~----l~~~~~----~~~---~~~~-----------~~~----- 1088 (1141)
+||||.||+..|.+....+++... ..|..|.-.-. .+.... +.. +.+. ++.
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 999999999999998777765444 34444331100 000000 000 0000 000
Q ss_pred ---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1089 ---SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1089 ---~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
..-..++.......++++|+..||..||++|.|..|+|+|+|+..
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 000123334466788999999999999999999999999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=267.41 Aligned_cols=290 Identities=17% Similarity=0.250 Sum_probs=203.2
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
-.+.+--+.||.|+||.||.+++......|..+++.........-+ ++.+|+.+|..++|.|+...++...-...
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~k----rvFre~kmLcfFkHdNVLSaLDILQPph~- 126 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCK----RVFREIKMLSSFRHDNVLSLLDILQPANP- 126 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHH----HHHHHHHHHHhhccccHHHHHHhcCCCCc-
Confidence 3445667899999999999999854333333333332222222223 34799999999999999999887653211
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
......|+|+|++. .+|...|-. ...++...++-+++||++||+|||+.+|.||||||.|.|++.+
T Consensus 127 --------dfFqEiYV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN 192 (449)
T KOG0664|consen 127 --------SFFQELYVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN 192 (449)
T ss_pred --------hHHHHHHHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC
Confidence 11224688999996 788888865 3479999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
..+||||||+|+........ .-...+-|.+|+|||++.+. ..|+.++||||.|||+.|++.
T Consensus 193 -------CvLKICDFGLARvee~d~~~---------hMTqEVVTQYYRAPEiLMGa---RhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 193 -------CILKICDFGLARTWDQRDRL---------NMTHEVVTQYYRAPELLMGA---RRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred -------ceEEecccccccccchhhhh---------hhHHHHHHHHhccHHHhhcc---hhhcCccceehhhHHHHHHHh
Confidence 89999999999864432211 01123568899999999984 578999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchh-----hhhhHHHHHHHHHHhcccCCCC
Q 001143 1045 LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA-----ELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
.+..|+..++.+..+.| .....|..+.....-.....+......+..+.+.. ......+...++..++.+||++
T Consensus 254 RrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dk 333 (449)
T KOG0664|consen 254 RKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDK 333 (449)
T ss_pred hhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcc
Confidence 99999988888877777 33344444322111100000000000000000000 0123345677889999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
|.+.++.+.|++..
T Consensus 334 ris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 334 RISVEEALQHRYLE 347 (449)
T ss_pred cccHhhhccccccc
Confidence 99999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=249.11 Aligned_cols=227 Identities=24% Similarity=0.374 Sum_probs=179.9
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~ 883 (1141)
-+++.-...||+|+||.|-+.++......++++++..+..... +.+.++|+.+..+. .+|.+|.|||.+....
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-----q~r~L~dldi~~r~~~CPf~V~FyGa~~reg- 118 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-----QKRLLMDLDIIMRTVDCPFTVHFYGALFREG- 118 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-----HHHHHHhhhhhccCCCCCeEEEeehhhhccc-
Confidence 3456778899999999998888755555555555555443332 22347899887665 6999999999876544
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCeeee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILID 962 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NILld 962 (1141)
..+|.||.|+ .||..+-+.....+ ..+++..+-+|+..|+.||.|||++ .|||||+||+|||++
T Consensus 119 -------------dvwIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn 183 (282)
T KOG0984|consen 119 -------------DVWICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN 183 (282)
T ss_pred -------------cEEEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc
Confidence 3499999997 89988877765554 4799999999999999999999986 899999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ |+||+||||.+-.+.+.... ....|-..|||||.+........|+-|+||||||+.+.||
T Consensus 184 ~~-------GqVKiCDFGIsG~L~dSiAk-----------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiEl 245 (282)
T KOG0984|consen 184 YD-------GQVKICDFGISGYLVDSIAK-----------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEM 245 (282)
T ss_pred cC-------CcEEEcccccceeehhhhHH-----------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhh
Confidence 98 89999999999776543211 1235788999999998777677899999999999999999
Q ss_pred HhCCCCCCC-CCHHHHHHHHHhCCCCCch
Q 001143 1043 LTLQVPYMG-LSELEIHDLIQMGKRPRLT 1070 (1141)
Q Consensus 1043 LTGk~Pf~~-~~~~el~~~I~~~~~p~l~ 1070 (1141)
.+++.||.. ..+.+...++.....|.++
T Consensus 246 A~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 246 AILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred hhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 999999964 4667777777766666554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=266.67 Aligned_cols=283 Identities=19% Similarity=0.224 Sum_probs=201.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|.-.+.+|.|+- .|-.|.+. +..|++| +...........+ +..+|...+..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ik--k~~~pf~n~~~ak----ra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIK--KLSRPFQNQTHAK----RAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehh--hhcCccccCccch----hhhhhhhhhhhhcccceeeeeeccCccc
Confidence 346777888999998 67777764 4445544 3332222222222 2379999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ......|+||||+. .+|...+.- .++-..+..|++|++.|++|||+.||+||||||+||++.
T Consensus 89 ~l--------~~~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 89 TL--------EEFQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN 152 (369)
T ss_pred cH--------HHHHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec
Confidence 32 22335699999997 899999874 478899999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||.|||+|+.-.... .-...+.|..|+|||++.+ ..|.+.+||||.||++.||
T Consensus 153 ~~-------~~lKi~dfg~ar~e~~~~-----------~mtpyVvtRyyrapevil~----~~~ke~vdiwSvGci~gEl 210 (369)
T KOG0665|consen 153 SD-------CTLKILDFGLARTEDTDF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEL 210 (369)
T ss_pred ch-------hheeeccchhhcccCccc-----------ccCchhheeeccCchheec----cCCcccchhhhhhhHHHHH
Confidence 88 899999999997543321 1124568999999999998 3488999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHH-HhCCCCCch--hHHhhhccCcc--------ccccccCCCCCCch---hhhhhHHHHHHHH
Q 001143 1043 LTLQVPYMGLSELEIHDLI-QMGKRPRLT--DELEALGSCHE--------HEVAQSGSGFEKPE---AELETLSFLVDVF 1108 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I-~~~~~p~l~--~~l~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~~~~L~dLI 1108 (1141)
++|+..|.+.+..+...++ .....|... ..+......+. ..+.........+. .+......+++++
T Consensus 211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll 290 (369)
T KOG0665|consen 211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLL 290 (369)
T ss_pred hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHH
Confidence 9999999887665544433 333333321 11111100000 00000000000000 0113456789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1109 RRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+||..||++|.+++++|.|++++
T Consensus 291 ~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 291 SKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhccChhhcccHHHHhcCCeee
Confidence 999999999999999999999986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-29 Score=288.06 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=211.9
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
+-++|++.+++|.|+||.||+|++ .+..+|+|+.+++.. +..... ++|+-+++..+|||||.+++.+...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~i----qqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGI----QQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----cccccc----ccceeeeecCCCcChHHHHhhhhhh
Confidence 346799999999999999999998 567889999877643 333333 7899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+.+ +++||||.||+|.+.-+- .+++++.++-...+..++||+|||++|-+|||||-.||++
T Consensus 85 dkl--------------wicMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 85 DKL--------------WICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred cCc--------------EEEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 543 999999999999987654 5689999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
++. +.+|+.|||.+..+.... .....+.||++|||||+-.- .+...|++.+||||+|+...|
T Consensus 146 td~-------gDvklaDfgvsaqitati----------~KrksfiGtpywmapEvaav-erkggynqlcdiwa~gitAie 207 (829)
T KOG0576|consen 146 TDE-------GDVKLADFGVSAQITATI----------AKRKSFIGTPYWMAPEVAAV-ERKGGYNQLCDIWALGITAIE 207 (829)
T ss_pred ccc-------CceeecccCchhhhhhhh----------hhhhcccCCccccchhHHHH-Hhcccccccccccccccchhh
Confidence 988 899999999987665422 12346789999999999643 334678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+..-++|.....+++....+....+.+... +. .....+.+.+|++.+|..+|++||+
T Consensus 208 l~eLqpplfdlhpmr~l~LmTkS~~qpp~l--------------kD---------k~kws~~fh~fvK~altknpKkRpt 264 (829)
T KOG0576|consen 208 LGELQPPLFDLHPMRALFLMTKSGFQPPTL--------------KD---------KTKWSEFFHNFVKGALTKNPKKRPT 264 (829)
T ss_pred hhhcCCcccccchHHHHHHhhccCCCCCcc--------------cC---------CccchHHHHHHHHHHhcCCCccCCC
Confidence 999999987777766655553322211110 00 0144567899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
++.++.|++....
T Consensus 265 aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 265 AEKLLQHPFVSQT 277 (829)
T ss_pred hhhheeceeeccc
Confidence 9999999877544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=303.57 Aligned_cols=274 Identities=23% Similarity=0.261 Sum_probs=210.6
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~~ 95 (1141)
..+..|.+..|++++..+. ..+++|++|||++|.+++.+|..++.+ ++|++|+|++|.++ .+|..|.++++|++
T Consensus 118 ~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 192 (968)
T PLN00113 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF---SSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192 (968)
T ss_pred CCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC---CCCCEEECccCcccccCChhhhhCcCCCe
Confidence 3677888888887754443 457788888888888888777766554 78888888888876 67777888888888
Q ss_pred EEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001143 96 LKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1141)
Q Consensus 96 L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1141)
|+|++|.++ .+|..++++++|+.|+|++|.+. .+|..+.++++|++|++++|.+ .+.+|..|+++++|+.|++++
T Consensus 193 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l---~~~~p~~l~~l~~L~~L~L~~ 269 (968)
T PLN00113 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL---TGPIPSSLGNLKNLQYLFLYQ 269 (968)
T ss_pred eeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCcee---ccccChhHhCCCCCCEEECcC
Confidence 888888887 66888888888888888888754 5677788888888888887543 445677788888888888888
Q ss_pred CCCC-ccCccccCCCCCCEEEccCCccc-cccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 174 N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
|.++ .+|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++.+|
T Consensus 270 n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 349 (968)
T PLN00113 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349 (968)
T ss_pred CeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCC
Confidence 8877 56777788888888888888887 67777888888888888888886 567777788888888888888887777
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 251 LDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
..+..+++|+.|+|++|++++ .+|.+++.......+.+..|.+.+..|
T Consensus 350 ~~l~~~~~L~~L~Ls~n~l~~--~~p~~~~~~~~L~~L~l~~n~l~~~~p 397 (968)
T PLN00113 350 KNLGKHNNLTVLDLSTNNLTG--EIPEGLCSSGNLFKLILFSNSLEGEIP 397 (968)
T ss_pred hHHhCCCCCcEEECCCCeeEe--eCChhHhCcCCCCEEECcCCEecccCC
Confidence 778888888888888888876 477777766666666677776665544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=253.93 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=204.5
Q ss_pred CceEeeeecccCceEEEEEEECCc-------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~-------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
++++..++-+|.||.||+|.|... .+.+|. ++. ....-+.. +++.|.-.+..+.|||+..+.+...
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKT--vk~-~AS~iQv~----~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKT--VKQ-HASQIQVN----LLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHH--HHh-cccHHHHH----HHHHHHHHHhcCcCCCccceeEEEe
Confidence 367778889999999999987432 233332 221 12222222 3488998999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhh---hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~---~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++.. ..++++.+..-|+|..+++.++ ......++..+...++.|++.|++|||++||||.||-+
T Consensus 358 e~~~-------------~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAa 424 (563)
T KOG1024|consen 358 EDYA-------------TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAA 424 (563)
T ss_pred eccC-------------cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhh
Confidence 6432 3488999998899999998543 22334577788899999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
.|.+|++. -.|||+|=.+++.+......+.. +.......||+||.+.. ..|+.++||||||
T Consensus 425 RNCvIdd~-------LqVkltDsaLSRDLFP~DYhcLG--------DnEnRPvkWMslEal~n----~~yssasDvWsfG 485 (563)
T KOG1024|consen 425 RNCVIDDQ-------LQVKLTDSALSRDLFPGDYHCLG--------DNENRPVKWMSLEALQN----SHYSSASDVWSFG 485 (563)
T ss_pred hcceehhh-------eeEEeccchhccccCcccccccC--------CCCCCcccccCHHHHhh----hhhcchhhhHHHH
Confidence 99999987 78999999999877655443321 11224567999999987 6799999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1037 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1037 viL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|++|||+| |+.||...++.++...+..|.+..-+ .++++++..++.-||..+
T Consensus 486 VllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP---------------------------~NCPDeLf~vMacCWall 538 (563)
T KOG1024|consen 486 VLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP---------------------------FNCPDELFTVMACCWALL 538 (563)
T ss_pred HHHHHHHhcCCCCccccCHHHHHHHHhccceecCC---------------------------CCCcHHHHHHHHHHHhcC
Confidence 99999999 99999999999999888877653211 188999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 001143 1116 PTERPTAGDLYEMFV 1130 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~ 1130 (1141)
|++||+++|+..-+-
T Consensus 539 peeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 539 PEERPSFSQLVICLS 553 (563)
T ss_pred cccCCCHHHHHHHHH
Confidence 999999999987663
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-28 Score=280.59 Aligned_cols=267 Identities=25% Similarity=0.274 Sum_probs=170.3
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCC--CCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTV--DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~L--s~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
.++.|.++.|++..++ +-++.|+.|+.+++.+|+| +|++++. ..|..|+.||||+|+|+++|..+..-+++-+
T Consensus 56 kLEHLs~~HN~L~~vh-GELs~Lp~LRsv~~R~N~LKnsGiP~di----F~l~dLt~lDLShNqL~EvP~~LE~AKn~iV 130 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLISVH-GELSDLPRLRSVIVRDNNLKNSGIPTDI----FRLKDLTILDLSHNQLREVPTNLEYAKNSIV 130 (1255)
T ss_pred hhhhhhhhhhhhHhhh-hhhccchhhHHHhhhccccccCCCCchh----cccccceeeecchhhhhhcchhhhhhcCcEE
Confidence 5677777788877775 5567777777777777766 3444432 2346777777777777777777777777777
Q ss_pred EEccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCC----------------------
Q 001143 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPS---------------------- 152 (1141)
Q Consensus 96 L~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~---------------------- 152 (1141)
|+||+|+|.+||.. |-+|+.|-.|+||+|++..+|+.+..|..|++|.|++|+++..
T Consensus 131 LNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT 210 (1255)
T KOG0444|consen 131 LNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT 210 (1255)
T ss_pred EEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch
Confidence 77777777777766 4567777777777777777777777777777777777664221
Q ss_pred cccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccc-----------------------cccccCC
Q 001143 153 VLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-----------------------PTEICYL 209 (1141)
Q Consensus 153 ~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~i-----------------------P~~l~~l 209 (1141)
...+|.++..|.+|..+||+.|.|..+|..+-++.+|+.|+||+|+|+.+ |++++.|
T Consensus 211 l~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL 290 (1255)
T KOG0444|consen 211 LDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKL 290 (1255)
T ss_pred hhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhh
Confidence 12245555566666666777777666666666666666665555555544 4444444
Q ss_pred CCCCEEEccCCCCC--cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCC
Q 001143 210 KALISLKVANNKLV--ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287 (1141)
Q Consensus 210 ~~L~~L~Ls~N~L~--~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~ 287 (1141)
+.|+.|.+.+|+|+ .||+.++.|.+|+.+.+++|+|.-+ |+.++.+..|+.|.|+.|+|.. +|..+..+.....
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElV-PEglcRC~kL~kL~L~~NrLiT---LPeaIHlL~~l~v 366 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELV-PEGLCRCVKLQKLKLDHNRLIT---LPEAIHLLPDLKV 366 (1255)
T ss_pred HHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccC-chhhhhhHHHHHhcccccceee---chhhhhhcCCcce
Confidence 45555555555444 4455555555555555555555433 3466666677777777777665 7777777777777
Q ss_pred CCCCCC
Q 001143 288 KDSSND 293 (1141)
Q Consensus 288 l~~~~n 293 (1141)
+++-.|
T Consensus 367 LDlreN 372 (1255)
T KOG0444|consen 367 LDLREN 372 (1255)
T ss_pred eeccCC
Confidence 776444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=268.94 Aligned_cols=208 Identities=26% Similarity=0.368 Sum_probs=166.9
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChH---HHHHhHHhHHHHHHHHhhCC---CCCcccee
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSAD---EIRNFEYSCLGEVRMLGALR---HSCIVEMY 875 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~---~~~~~~~~~~~Ei~iL~~L~---HpNIVkll 875 (1141)
+..+.+|+..+.+|.|+||.|++|.++...+.|.+|.+.+...-.+ ..+.+ -.+-.|++||..++ |+||++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkL-GtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKL-GTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccccc-CccchhHHHHHHhhhcCccchhhhh
Confidence 5667889999999999999999999976554444443332211110 00110 12246999999996 99999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeec-cCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYV-KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~-~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL 954 (1141)
++|++++++ ||+||-- +|.+|+++|.. ...+++.+++.|++||+.|++|||++|||||||
T Consensus 636 dfFEddd~y--------------yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdi 696 (772)
T KOG1152|consen 636 DFFEDDDYY--------------YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDI 696 (772)
T ss_pred heeecCCee--------------EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccCceeccc
Confidence 999988865 9999964 45699999986 457999999999999999999999999999999
Q ss_pred CCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001143 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034 (1141)
Q Consensus 955 KP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1034 (1141)
|-+|+.++.+ |-+||+|||.|...... +-+.++||..|.|||++.+. ...+..-||||
T Consensus 697 kdenvivd~~-------g~~klidfgsaa~~ksg------------pfd~f~gtv~~aapevl~g~---~y~gk~qdiwa 754 (772)
T KOG1152|consen 697 KDENVIVDSN-------GFVKLIDFGSAAYTKSG------------PFDVFVGTVDYAAPEVLGGE---KYLGKPQDIWA 754 (772)
T ss_pred ccccEEEecC-------CeEEEeeccchhhhcCC------------CcceeeeeccccchhhhCCC---ccCCCcchhhh
Confidence 9999999988 89999999998654331 12467899999999999873 45578899999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 001143 1035 YGCLLLELLTLQVPYMG 1051 (1141)
Q Consensus 1035 LGviL~ELLTGk~Pf~~ 1051 (1141)
+|++||.++....||..
T Consensus 755 lgillytivykenpyyn 771 (772)
T KOG1152|consen 755 LGILLYTIVYKENPYYN 771 (772)
T ss_pred hhheeeEEEeccCCCcC
Confidence 99999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=257.62 Aligned_cols=288 Identities=23% Similarity=0.319 Sum_probs=195.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~ 878 (1141)
...|..+++||.|+|++||+|.+. ...+|+|- +..+.... ++..|+++|..+. +.||+++.+++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~--i~~ts~p~--------ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKA--IYRTSSPS--------RILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeee--cccccCch--------HHHHHHHHHHHhccchhhhcchhhh
Confidence 456899999999999999999863 34455554 44433322 2478999999995 99999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
...+ +..+||||++.....++... ++..+++.+++.++.||.|+|.+|||||||||+|
T Consensus 105 rnnd--------------~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsN 162 (418)
T KOG1167|consen 105 RNND--------------QVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSN 162 (418)
T ss_pred ccCC--------------eeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccc
Confidence 7655 45999999998888888765 7889999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccc--ccc-c----------------------------cc---cCCCCCCCC
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFL--HTC-C----------------------------IA---HRGIPAPDV 1004 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~--~~~-~----------------------------~~---~~~~~~~~~ 1004 (1141)
+|.+... +.-.|+|||+|....... ..+ . .. .........
T Consensus 163 FL~n~~t------~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~an 236 (418)
T KOG1167|consen 163 FLYNRRT------QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERAN 236 (418)
T ss_pred ccccccc------CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecc
Confidence 9998764 567899999997211100 000 0 00 000111224
Q ss_pred ccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHH-HHHHH-------------HhCC----
Q 001143 1005 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS-ELE-IHDLI-------------QMGK---- 1065 (1141)
Q Consensus 1005 ~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~-~~e-l~~~I-------------~~~~---- 1065 (1141)
..||++|+|||++... ..-++++||||.|||++-++++.+||.... ..+ +.+.+ ..+.
T Consensus 237 rAGT~GfRaPEvL~k~---~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~ 313 (418)
T KOG1167|consen 237 RAGTPGFRAPEVLFRC---PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW 313 (418)
T ss_pred cCCCCCCCchHHHhhc---cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence 5799999999999874 345789999999999999999999986321 111 11111 1111
Q ss_pred ----CCCchhHHhhhccCccccccccCCC-CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1066 ----RPRLTDELEALGSCHEHEVAQSGSG-FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1066 ----~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.+.++..........-..+.+.... ..........+..+.+++.+|+..||.+|.||+++|+|+||..
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0011110000000000000000000 1111122244558999999999999999999999999999963
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=226.31 Aligned_cols=212 Identities=33% Similarity=0.500 Sum_probs=173.1
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 814 LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
||+|++|.||++... +..+++|++..... .. ..+ .+.+|+..++.++|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~-~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SS-LLE----ELLREIEILKKLNHPNIVKLYGVFEDEN--------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc--hh-HHH----HHHHHHHHHHhcCCCCeeeEeeeeecCC---------
Confidence 689999999999986 67788887653321 10 122 3479999999999999999999987643
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec-ccccCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL-ERKKADG 970 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~-~~~~~~~ 970 (1141)
..++||||+++++|.+++.... ..+++..+..++.+++.+++|||+.|++|+||+|.||+++. +
T Consensus 65 -----~~~~~~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~------ 129 (215)
T cd00180 65 -----HLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN------ 129 (215)
T ss_pred -----eEEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC------
Confidence 4599999999999999987621 36899999999999999999999999999999999999988 5
Q ss_pred CCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001143 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1050 (1141)
Q Consensus 971 ~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~ 1050 (1141)
+.++|+|||.+........ ......+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 130 -~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 130 -GKVKLADFGLSKLLTSDKS----------LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred -CcEEEecCCceEEccCCcc----------hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH--------
Confidence 6899999999876543210 01123478889999998752 2667899999999999998
Q ss_pred CCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001143 1051 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129 (1141)
Q Consensus 1051 ~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L 1129 (1141)
..+.+++..|+..||.+||++.++++++
T Consensus 188 ---------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 0277889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-27 Score=266.37 Aligned_cols=275 Identities=21% Similarity=0.217 Sum_probs=219.3
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~ 95 (1141)
+.++.+++..|.|+.|+...|..-.++++|+|++|.|+.+-...|..| .+|..|.|++|+|+++|. .|.+|++|+.
T Consensus 149 ~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~l---nsL~tlkLsrNrittLp~r~Fk~L~~L~~ 225 (873)
T KOG4194|consen 149 PALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSL---NSLLTLKLSRNRITTLPQRSFKRLPKLES 225 (873)
T ss_pred hhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccccccc---chheeeecccCcccccCHHHhhhcchhhh
Confidence 367888899999999999999998999999999999988877666555 788999999999999986 4677999999
Q ss_pred EEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001143 96 LKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1141)
Q Consensus 96 L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1141)
|+|..|+|..+ --.|.+|.+|+.|.|..|.+..+. ..|..|.++++|+|..|++.... -+++.+|+.|+.|+|++
T Consensus 226 LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn---~g~lfgLt~L~~L~lS~ 302 (873)
T KOG4194|consen 226 LDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN---EGWLFGLTSLEQLDLSY 302 (873)
T ss_pred hhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh---cccccccchhhhhccch
Confidence 99999998866 345888999999999888866555 57888999999999986664333 24678888999999999
Q ss_pred CCCCcc-CccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCc
Q 001143 174 FSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 174 N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
|.|..| +..+...++|.+|+|+.|+|+.+| .+|..|.+|+.|+|++|.++.|-. .|..+++|+.|||++|.|++.+.
T Consensus 303 NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 303 NAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred hhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 999877 677788888999999999999885 567778889999999999988754 44458889999999998887775
Q ss_pred c---cccCCCCCCEEEccCCcCCCCCCCchh-hhhcccCCCCCCCCCCcccCcc
Q 001143 251 L---DLCLMHNLQNLNLQYNKLLSYCQVPSW-ICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 251 ~---~l~~L~~L~~L~Ls~N~L~~~~~iP~~-~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
+ .|..|++|+.|+|.||+|.. ||.- +..+-.+..+++.+|.+-..-+
T Consensus 383 Daa~~f~gl~~LrkL~l~gNqlk~---I~krAfsgl~~LE~LdL~~NaiaSIq~ 433 (873)
T KOG4194|consen 383 DAAVAFNGLPSLRKLRLTGNQLKS---IPKRAFSGLEALEHLDLGDNAIASIQP 433 (873)
T ss_pred cchhhhccchhhhheeecCceeee---cchhhhccCcccceecCCCCcceeecc
Confidence 4 37788889999999998886 5533 3345556677777777655433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-27 Score=266.10 Aligned_cols=275 Identities=20% Similarity=0.238 Sum_probs=232.0
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L 96 (1141)
.+++|.+..|.|+.+....++-++.|+.||||.|.|+.+...+|..- .+|++|+|++|+||++-. .|.+|.+|..|
T Consensus 126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~---~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAK---VNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred ceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCC---CCceEEeeccccccccccccccccchheee
Confidence 58889999999999999999999999999999999998877766543 689999999999998854 69999999999
Q ss_pred EccCCCCCcCchh-hcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001143 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1141)
.|++|.|+++|.- |.+|++|+.|+|..|++... +..|.+|.+|+.|.|..|.+..+.- +.|..|..+++|+|..|
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D---G~Fy~l~kme~l~L~~N 279 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD---GAFYGLEKMEHLNLETN 279 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC---cceeeecccceeecccc
Confidence 9999999999765 77799999999999998887 6789999999999999977765543 36888999999999999
Q ss_pred CCCccCc-cccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCCCcc
Q 001143 175 SIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSL 251 (1141)
Q Consensus 175 ~L~~iP~-~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p~ 251 (1141)
+++.+-. ++.+|+.|+.|+||.|.|..| ++++...++|++|+|++|+|+++| .+|..|..|+.|+|++|+++.+-..
T Consensus 280 ~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~ 359 (873)
T KOG4194|consen 280 RLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEG 359 (873)
T ss_pred hhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhh
Confidence 9998844 678999999999999999977 577888899999999999999985 5666799999999999999999988
Q ss_pred cccCCCCCCEEEccCCcCCCCC-CCchhhhhcccCCCCCCCCCCcccC
Q 001143 252 DLCLMHNLQNLNLQYNKLLSYC-QVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 252 ~l~~L~~L~~L~Ls~N~L~~~~-~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
.|..+++|+.|||++|.|+.-. +-...+..+.+++.+.+.+|++...
T Consensus 360 af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I 407 (873)
T KOG4194|consen 360 AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSI 407 (873)
T ss_pred HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeec
Confidence 9999999999999999987621 1222333455666677777766543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=227.08 Aligned_cols=216 Identities=32% Similarity=0.438 Sum_probs=170.5
Q ss_pred ceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.+.||.|++|.||++...+ ..+++|+...... . ...+ .+.+|++.+.+++|+|++++++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~-~~~~----~~~~e~~~~~~~~~~~i~~~~~~~~~~~--- 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKT--E-KQRE----EFLREIRILKKLKHPNIVKLYGVFEDPE--- 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccc--h-HHHH----HHHHHHHHHHhCCCCChhhheeeeecCC---
Confidence 6788999999999999999854 6677777543321 1 1223 3478999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~-Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..+++|||+++++|.+++... .. +++..+..++.|++.++.|||+++++|+||+|+||+++.+
T Consensus 71 -----------~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~ 134 (225)
T smart00221 71 -----------PLYLVMEYCEGGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD 134 (225)
T ss_pred -----------ceEEEEeccCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 349999999988999999762 23 8899999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.++|+|||.+........ .......++..|++||.+. ....++.++|||+||+++++|++
T Consensus 135 -------~~~~l~d~g~~~~~~~~~~---------~~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 135 -------GLVKLADFGLARFIHRDLA---------ALLKTVKGTPFYLAPEVLL---GGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -------CCEEEeeCceeeEecCccc---------ccccceeccCCcCCHhHhc---CCCCCCchhhHHHHHHHHHHHHH
Confidence 7899999999876543210 0112345788899999984 12567789999999999999999
Q ss_pred CCCCCCC-CCH-HHHHHHHHhCCCCC
Q 001143 1045 LQVPYMG-LSE-LEIHDLIQMGKRPR 1068 (1141)
Q Consensus 1045 Gk~Pf~~-~~~-~el~~~I~~~~~p~ 1068 (1141)
|+.||.. ... .++.+.+..+..+.
T Consensus 196 g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 196 GPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred CCCCccccchhHHHHHHHHhcCCccc
Confidence 9999976 333 35667776665443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=236.81 Aligned_cols=258 Identities=19% Similarity=0.258 Sum_probs=187.0
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeee-EecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH-KISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~-~~~~~~ 883 (1141)
+.|.+.+.||+|.||.+-+|.++++...+.++.+.. .....++| .+|...--.|. |.||+..|+. |+..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~---p~tt~~dF----~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR---PQTTQADF----VREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc---chhhHHHH----HHHhccceeeccchhhhHHHHHHhhcCce
Confidence 359999999999999999999987665555554443 34445566 78887766774 9999998877 443443
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++|||++.|+|.+-+.. ..+.+...++++.|+++|+.|+|++++||||||.+||||-.
T Consensus 97 --------------YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 97 --------------YVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred --------------EEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 3899999999999988764 35888999999999999999999999999999999999854
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC-CCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ -..|||||||..+..+..... .-.+..|.|||........ -...+.+|||.||+++|..
T Consensus 157 ~d-----f~rvKlcDFG~t~k~g~tV~~-------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~c 218 (378)
T KOG1345|consen 157 AD-----FYRVKLCDFGLTRKVGTTVKY-------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYC 218 (378)
T ss_pred CC-----ccEEEeeecccccccCceehh-------------hhhhcccCCcHHHhhccccceEecccccchheeeeeeee
Confidence 31 158999999998765432211 1245679999987643211 2346889999999999999
Q ss_pred HhCCCCCCCCCHHH----HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1043 LTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~e----l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+||+.||+....++ -..+...+..+..+..+. ..++.+..+.++-|..+|++
T Consensus 219 ltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~------------------------~fs~~a~r~Fkk~lt~~~~d 274 (378)
T KOG1345|consen 219 LTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN------------------------PFSEKALRLFKKSLTPRFKD 274 (378)
T ss_pred ecCCCcchhhhccCchHHHHHHHhcccCccCchhhc------------------------ccCHHHHHHHHHhcCCcccc
Confidence 99999998432221 112223333333332221 33455777888999999999
Q ss_pred C---CCHHHHHHHHHhh
Q 001143 1119 R---PTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 R---PSa~ElL~~L~~~ 1132 (1141)
| .++......+|..
T Consensus 275 rcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 275 RCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cchhHHHHHHHHHHHHH
Confidence 9 5666666666664
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=280.62 Aligned_cols=225 Identities=12% Similarity=0.130 Sum_probs=149.2
Q ss_pred hhCCC-CCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 001143 864 GALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 864 ~~L~H-pNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+.++| +||++++++|..... ++ ......+++|||+. ++|.+++.. ....+++.+++.|++||+.||.
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~ 94 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNL----DG---LDDDSIVRALECED-VSLRQWLDN----PDRSVDAFECFHVFRQIVEIVN 94 (793)
T ss_pred chhhHHHHHHHhhcccCCccc----cc---cccchhhhhhccCC-ccHHHHHhc----ccccccHHHHHHHHHHHHHHHH
Confidence 34556 688888888743221 11 11123578899884 799999974 2346999999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeeccccc------------CCCCCeEEEeeccccccccccccc---cccccCCC---CCCCC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHT---CCIAHRGI---PAPDV 1004 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~------------~~~~~~vKL~DFGlA~~l~~~~~~---~~~~~~~~---~~~~~ 1004 (1141)
|||++||+||||||+||||+..+.. ....+.+|++|||+++........ ......+. .....
T Consensus 95 ~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 95 AAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred HHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 9999999999999999999653100 011245677777777542210000 00000000 01112
Q ss_pred ccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccc
Q 001143 1005 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 1084 (1141)
Q Consensus 1005 ~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~ 1084 (1141)
..||+.|||||++.+ ..++.++|||||||+||||++|..|+... ......+.....+..
T Consensus 175 ~~gt~~Y~APE~~~~----~~~~~~sDVwSlGviL~ELl~~~~~~~~~--~~~~~~~~~~~~~~~--------------- 233 (793)
T PLN00181 175 AMEMSWYTSPEEDNG----SSSNCASDVYRLGVLLFELFCPVSSREEK--SRTMSSLRHRVLPPQ--------------- 233 (793)
T ss_pred cCCCcceEChhhhcc----CCCCchhhhhhHHHHHHHHhhCCCchhhH--HHHHHHHHHhhcChh---------------
Confidence 468999999999876 56789999999999999999998886532 112222211111100
Q ss_pred cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1085 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.........+++.+||++||.+||++.|+++|+|+..
T Consensus 234 ------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 234 ------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred ------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 0011233567889999999999999999999999864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-25 Score=257.11 Aligned_cols=160 Identities=28% Similarity=0.341 Sum_probs=127.6
Q ss_pred CchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccC
Q 001143 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC 185 (1141)
Q Consensus 106 lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~ 185 (1141)
||.++..|.+|..++||.|.+..+|..+.++.+|+.|+||+|.+..+ .-..+.+.+|+.|+|+.|+|+.+|..+..
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL----~~~~~~W~~lEtLNlSrNQLt~LP~avcK 289 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITEL----NMTEGEWENLETLNLSRNQLTVLPDAVCK 289 (1255)
T ss_pred CCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeee----eccHHHHhhhhhhccccchhccchHHHhh
Confidence 44444555555555555555555666666666666666666544322 22344456778888888888889999999
Q ss_pred CCCCCEEEccCCccc--cccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEE
Q 001143 186 LSNLEQLDLSFNKMK--YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263 (1141)
Q Consensus 186 l~~L~~L~Ls~N~L~--~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~ 263 (1141)
|+.|+.|++.+|+|+ .||+.||.|.+|+.+..++|+|.-+|.++..|..|+.|.|++|+|-.+| +.+.-|+.|+.||
T Consensus 290 L~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLP-eaIHlL~~l~vLD 368 (1255)
T KOG0444|consen 290 LTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLP-EAIHLLPDLKVLD 368 (1255)
T ss_pred hHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeech-hhhhhcCCcceee
Confidence 999999999999988 8999999999999999999999999999999999999999999998886 4899999999999
Q ss_pred ccCCcCC
Q 001143 264 LQYNKLL 270 (1141)
Q Consensus 264 Ls~N~L~ 270 (1141)
|..|+=-
T Consensus 369 lreNpnL 375 (1255)
T KOG0444|consen 369 LRENPNL 375 (1255)
T ss_pred ccCCcCc
Confidence 9999743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=214.16 Aligned_cols=168 Identities=24% Similarity=0.307 Sum_probs=126.4
Q ss_pred CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccc
Q 001143 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 987 (1141)
Q Consensus 908 gSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~ 987 (1141)
|+|.++++.. ...+++.+++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||.+.....
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-------~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-------GLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-------cceee--ccceEeecc
Confidence 6899999751 346999999999999999999999998 9999999887 77888 999865432
Q ss_pred cccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC
Q 001143 988 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKR 1066 (1141)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~-el~~~I~~~~~ 1066 (1141)
. ...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 62 ~---------------~~~g~~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 62 E---------------QSRVDPYFMAPEVIQG----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred c---------------cCCCcccccChHHhcC----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 1 1248899999999976 56789999999999999999999999754322 22222222111
Q ss_pred CCchhHHhhhccCccccccccCCCCCCchhhhhhHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1067 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS--FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1067 p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
+..+.. .+ ....... .+.+++.+||..||.+||++.|+++|++....
T Consensus 123 ~~~~~~--------------------~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 123 ADDPRD--------------------RS-NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cCCccc--------------------cc-cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 110000 00 0012222 68999999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-26 Score=251.46 Aligned_cols=242 Identities=27% Similarity=0.366 Sum_probs=116.9
Q ss_pred cccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001143 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1141)
++++.+..|.+..+. .++.++..|++|++++|+++..+|+ ++ .+..++.|+.++|++.++|+++.++.+|..|++
T Consensus 47 l~~lils~N~l~~l~-~dl~nL~~l~vl~~~~n~l~~lp~a-ig---~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 47 LQKLILSHNDLEVLR-EDLKNLACLTVLNVHDNKLSQLPAA-IG---ELEALKSLNVSHNKLSELPEQIGSLISLVKLDC 121 (565)
T ss_pred hhhhhhccCchhhcc-HhhhcccceeEEEeccchhhhCCHH-HH---HHHHHHHhhcccchHhhccHHHhhhhhhhhhhc
Confidence 344444455555443 2344555555555555555544332 22 224555555555555555555555555555555
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001143 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1141)
Q Consensus 99 s~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1141)
++|.+.++|++++.+..|..|+..+|++...|..+.++.+|..|++.+|.+ ..+|+..-+++.|++|++.+|-++.
T Consensus 122 s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l----~~l~~~~i~m~~L~~ld~~~N~L~t 197 (565)
T KOG0472|consen 122 SSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKL----KALPENHIAMKRLKHLDCNSNLLET 197 (565)
T ss_pred cccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccch----hhCCHHHHHHHHHHhcccchhhhhc
Confidence 555555555555555555555555555555555555555555555554322 1222222224444444555555444
Q ss_pred cCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCcc-CCCCCCEEeCCCCCCCCCCcccccCCC
Q 001143 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1141)
Q Consensus 179 iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~-~L~~L~~L~Ls~N~Lt~~~p~~l~~L~ 257 (1141)
+|++++.|.+|.-|||.+|+|..+| +|..+..|.+|+++.|+|..+|.+.. +|.+|..|||..|+|+..|. .++-|.
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pd-e~clLr 275 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPD-EICLLR 275 (565)
T ss_pred CChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCch-HHHHhh
Confidence 4444444445555555555554444 44444444444444444444444444 34444444444444444432 444444
Q ss_pred CCCEEEccCCcCCC
Q 001143 258 NLQNLNLQYNKLLS 271 (1141)
Q Consensus 258 ~L~~L~Ls~N~L~~ 271 (1141)
+|..||+|+|.+++
T Consensus 276 sL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 276 SLERLDLSNNDISS 289 (565)
T ss_pred hhhhhcccCCcccc
Confidence 44444444444444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-24 Score=236.76 Aligned_cols=272 Identities=22% Similarity=0.270 Sum_probs=222.0
Q ss_pred cCCCCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeec-CCCCccCc-cccC
Q 001143 12 KSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK-NVLNLIPK-SVGR 89 (1141)
Q Consensus 12 ~~~~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~-N~Lt~iP~-~l~~ 89 (1141)
+.+-|+.+..|.++.|+|+.|++++|+.+++|+.||||+|+|+.+-|..|.. |.+|..|-|.+ |+|+.||+ .|.+
T Consensus 62 P~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~G---L~~l~~Lvlyg~NkI~~l~k~~F~g 138 (498)
T KOG4237|consen 62 PANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKG---LASLLSLVLYGNNKITDLPKGAFGG 138 (498)
T ss_pred cccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhh---hHhhhHHHhhcCCchhhhhhhHhhh
Confidence 4445566999999999999999999999999999999999999999987754 47777776655 99999997 5999
Q ss_pred CcCCcEEEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCC---C------Ccccchh
Q 001143 90 YEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPR---P------SVLTLLS 158 (1141)
Q Consensus 90 L~~L~~L~Ls~N~L~~lP-~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln---~------~~~~lp~ 158 (1141)
|..|+.|.|.-|+|..++ +.|..|++|..|.|..|.+..++. +|..+..++.+.+..|++- + .....|.
T Consensus 139 L~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 139 LSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred HHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchh
Confidence 999999999999999775 558899999999999999888886 8999999999999988721 0 1111222
Q ss_pred hhcCCCCCcEEEcc--------------------------CCCCCccCc-cccCCCCCCEEEccCCccccc-cccccCCC
Q 001143 159 EIAGLKCLTKLSVC--------------------------HFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLK 210 (1141)
Q Consensus 159 ~l~~L~~L~~L~Ls--------------------------~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~ 210 (1141)
.+++.....-..+. .+....-|. .|..|++|+.|+|++|+|+.| +.+|..+.
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 33332222222222 222222344 578999999999999999988 67888999
Q ss_pred CCCEEEccCCCCCcCCcCcc-CCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCC
Q 001143 211 ALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286 (1141)
Q Consensus 211 ~L~~L~Ls~N~L~~IP~~l~-~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~ 286 (1141)
.|+.|.|..|+|..+-..++ ++..|+.|+|.+|+|+.+.|..|..+.+|..|+|-.|+|.|.|.+-+.-.|+....
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~ 375 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS 375 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC
Confidence 99999999999998865544 59999999999999999999999999999999999999999999987777776665
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-25 Score=242.53 Aligned_cols=249 Identities=24% Similarity=0.284 Sum_probs=232.5
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEE
Q 001143 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120 (1141)
Q Consensus 41 ~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~ 120 (1141)
..|+.|+|++|.++...++ +.+|..|++|++.+|+++++|++++.+..++.|+.++|+++.+|+.++.+.+|..|+
T Consensus 45 v~l~~lils~N~l~~l~~d----l~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 45 VDLQKLILSHNDLEVLRED----LKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLD 120 (565)
T ss_pred cchhhhhhccCchhhccHh----hhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhh
Confidence 3788999999999877665 345589999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccc
Q 001143 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK 200 (1141)
Q Consensus 121 Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~ 200 (1141)
+++|.+..+++.++.+..|..|+..+|++ .++|+.+..+..|..|++.+|.+..+|+..-+|+.|+.|++.+|.++
T Consensus 121 ~s~n~~~el~~~i~~~~~l~dl~~~~N~i----~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 121 CSSNELKELPDSIGRLLDLEDLDATNNQI----SSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE 196 (565)
T ss_pred ccccceeecCchHHHHhhhhhhhcccccc----ccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh
Confidence 99999999999999999999999998544 57888899999999999999999999998877999999999999999
Q ss_pred cccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhh
Q 001143 201 YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1141)
Q Consensus 201 ~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1141)
++|+.++.+.+|.-|+|.+|+|..+| +|..+..|..|+++.|+|+-++.+....|++|..|||.+|+++. +|+.+|
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke---~Pde~c 272 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE---VPDEIC 272 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccccc---CchHHH
Confidence 99999999999999999999999999 89999999999999999999988777799999999999999997 999999
Q ss_pred hcccCCCCCCCCCCcccCccc
Q 001143 281 CNLEGNGKDSSNDDFISSSAE 301 (1141)
Q Consensus 281 ~~l~~~~l~~~~n~l~~~~~~ 301 (1141)
...+.+.+++++|.+.+-.+.
T Consensus 273 lLrsL~rLDlSNN~is~Lp~s 293 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISSLPYS 293 (565)
T ss_pred HhhhhhhhcccCCccccCCcc
Confidence 999999999999999887664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=215.78 Aligned_cols=269 Identities=22% Similarity=0.222 Sum_probs=188.7
Q ss_pred CceEeeeecccCceEEEEEEECCc---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC----CCccceeeeEe
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----SCIVEMYGHKI 879 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~---~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H----pNIVkllg~~~ 879 (1141)
.|.+.++||+|+||.||+|.+... .+|+|+.......... . +..|+.++..+.. +++..+++.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~----~----l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS----V----LKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc----c----chhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999998554 5788875533221111 1 2568888888762 68888888874
Q ss_pred -cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 880 -SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 880 -~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
... ..++||+.+ |.+|.++.... +...++..++.+|+.|++.+|++||+.|++||||||.|
T Consensus 91 ~~~~--------------~~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 91 STED--------------FNFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred CCCc--------------eeEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 333 239999998 79999987652 24679999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCC-CCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
+++..... .....+.|.|||+|+........... .+.. .....+.||..|+++.+..+ ...+.+.|+||++.
T Consensus 153 ~~~g~~~~--~~~~~~~llDfGlar~~~~~~~~~~~-~~~~r~~~~~~rGT~ry~S~~~H~~----~e~~r~DDles~~Y 225 (322)
T KOG1164|consen 153 FVVGQSSR--SEVRTLYLLDFGLARRFKYVGDSGGN-LRPPRPQKGLFRGTLRYASINVHLG----IEQGRRDDLESLFY 225 (322)
T ss_pred eeecCCCC--cccceEEEEecCCCccccccCCCCcc-cccCCCCccCCCCccccccHHHhCC----CccCCchhhhhHHH
Confidence 99976520 11146999999999843321111100 1111 11345669999999999887 56789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++.++..|..||.+.........+........... .....+.++.++...+-..+..
T Consensus 226 ~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~ 282 (322)
T KOG1164|consen 226 MLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDYE 282 (322)
T ss_pred HHHHHhcCCCCCccccccchHHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCCc
Confidence 99999999999976543222222211110000000 0013345567777777778999
Q ss_pred CCCCHHHHHHHHHh
Q 001143 1118 ERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~ 1131 (1141)
.+|....+...+..
T Consensus 283 ~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 283 DKPDYEKLAELLKD 296 (322)
T ss_pred CCCCHHHHHHHHHH
Confidence 99999988877544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=238.31 Aligned_cols=200 Identities=25% Similarity=0.221 Sum_probs=98.3
Q ss_pred CccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001143 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1141)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ 148 (1141)
+|+.|+|++|.|+.+|..+ ++|+.|+|++|+|+.+|.. +++|+.|+|++|++..+|..+ .+|+.|++++|.
T Consensus 263 sL~~L~Ls~N~L~~Lp~lp---~~L~~L~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~Lp~lp---~~L~~L~Ls~N~ 333 (788)
T PRK15387 263 GLLELSIFSNPLTHLPALP---SGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLASLPALP---SELCKLWAYNNQ 333 (788)
T ss_pred ccceeeccCCchhhhhhch---hhcCEEECcCCcccccccc---ccccceeECCCCccccCCCCc---ccccccccccCc
Confidence 3444444444444444311 2344444555554444432 234555555555544444322 234444444433
Q ss_pred CCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcC
Q 001143 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228 (1141)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~ 228 (1141)
+.. +|.. ..+|+.|+|++|+|+.+|.. ..+|+.|++++|+|+.||... .+|+.|+|++|+|+.+|..
T Consensus 334 L~~----LP~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~LP~l 400 (788)
T PRK15387 334 LTS----LPTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTSLPVL 400 (788)
T ss_pred ccc----cccc---ccccceEecCCCccCCCCCC---CcccceehhhccccccCcccc---cccceEEecCCcccCCCCc
Confidence 321 2210 12455566666666655542 234555556666665555422 3456666666666655543
Q ss_pred ccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 229 l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
. ++|+.|+|++|+|+++|. . ..+|+.|+|++|+|+. ||..++.+.....+++++|.|.+..+
T Consensus 401 ~---s~L~~LdLS~N~LssIP~-l---~~~L~~L~Ls~NqLt~---LP~sl~~L~~L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 401 P---SELKELMVSGNRLTSLPM-L---PSGLLSLSVYRNQLTR---LPESLIHLSSETTVNLEGNPLSERTL 462 (788)
T ss_pred c---cCCCEEEccCCcCCCCCc-c---hhhhhhhhhccCcccc---cChHHhhccCCCeEECCCCCCCchHH
Confidence 2 345666666666665432 1 2345556666666653 56655555555566666666655443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-19 Score=200.71 Aligned_cols=272 Identities=31% Similarity=0.402 Sum_probs=196.3
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC-CccceeeeEecCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIVkllg~~~~~~~~~~ 886 (1141)
|.+.+.||.|+||.||++.+. ..+++|+...... ... .....+.+|+.++..+.|+ +|+++++.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~--~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLE--SKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEG---- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhc--cch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCC----
Confidence 788999999999999999988 5667776543322 111 1233448999999999977 7999999995433
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..+++++|+.++++.+++...... ..++...+..++.|++.++.|+|+.+++|||+||+||+++..
T Consensus 72 ----------~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~-- 137 (384)
T COG0515 72 ----------SLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-- 137 (384)
T ss_pred ----------EEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCC--
Confidence 259999999999999777652111 268999999999999999999999999999999999999876
Q ss_pred cCCCCC-eEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 967 KADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 967 ~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
. .++++|||.+............ ........||..|+|||.+.+.. ...+....|+||+|++++++++|
T Consensus 138 -----~~~~~l~dfg~~~~~~~~~~~~~~----~~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 138 -----GRVVKLIDFGLAKLLPDPGSTSSI----PALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred -----CCeEEEeccCcceecCCCCccccc----cccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhC
Confidence 4 6999999999754432211000 01224567999999999987521 03567899999999999999999
Q ss_pred CCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1046 QVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1046 k~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
..||..... .+....+.....+........ . .. ......+.+++..|+..+|..|.+
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~--~~---~~~~~~~~~~~~~~~~~~~~~r~~ 268 (384)
T COG0515 208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLSP--------------S--NP---ELISKAASDLLKKLLAKDPKNRLS 268 (384)
T ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccccCc--------------c--cc---chhhHHHHHHHHHHHhcCchhcCC
Confidence 999876542 344444433332200000000 0 00 123456889999999999999999
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
..+...+.+..
T Consensus 269 ~~~~~~~~~~~ 279 (384)
T COG0515 269 SSSDLSHDLLA 279 (384)
T ss_pred HHHHhhchHhh
Confidence 99888775544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-22 Score=243.50 Aligned_cols=270 Identities=19% Similarity=0.201 Sum_probs=191.1
Q ss_pred CCCc-eEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 805 FPSL-SSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y-~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+.| ....++|.|++|.|+.+... ....+.|.++.+ .. .......+...+..|+-+-..+.|||++..+..+.+.
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence 3445 67889999999988877652 222333333322 10 2222333333357888888899999999888877653
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
... .-+||||++ +|+.++.. ...++..++..++.|++.|++|+|+.||.|||||++|+++
T Consensus 394 ~~~--------------~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~ 453 (601)
T KOG0590|consen 394 DGI--------------LQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV 453 (601)
T ss_pred ccc--------------hhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE
Confidence 322 334999998 99999976 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC-CchhhHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~-s~ksDVWSLGviL~ 1040 (1141)
+.. +.+||+|||.+......... ........+|+.+|+|||++.+ ..| ....||||.|+++.
T Consensus 454 ~~~-------g~lki~Dfg~~~vf~~~~e~------~~~~~~g~~gS~pY~apE~~~~----~~ydpr~vDiwS~~ii~~ 516 (601)
T KOG0590|consen 454 TEN-------GILKIIDFGAASVFRYPWEK------NIHESSGIVGSDPYLAPEVLTG----KEYDPRAVDVWSCGIIYI 516 (601)
T ss_pred ecC-------CceEEeecCcceeeccCcch------hhhhhcCcccCCcCcCcccccc----cccCcchhhhhhccceEE
Confidence 988 89999999998665432221 1122345679999999999987 333 46799999999999
Q ss_pred HHHhCCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
.|++|+.||......+.. ............ ..........+...+.+|.+||++||.+|
T Consensus 517 ~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R 576 (601)
T KOG0590|consen 517 CMILGRFPWKVAKKSDNSFKTNNYSDQRNIF--------------------EGPNRLLSLLPRETRIIIYRMLQLDPTKR 576 (601)
T ss_pred EEecCCCccccccccccchhhhccccccccc--------------------cChHHHHHhchhhHHHHHHHHccCChhhe
Confidence 999999999643222111 000000000000 00011122556678899999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
.|+++|++..|++.
T Consensus 577 ~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 577 ITIEQILNDEWIRS 590 (601)
T ss_pred ecHHHHhhChHhhh
Confidence 99999999999974
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-20 Score=201.16 Aligned_cols=218 Identities=23% Similarity=0.286 Sum_probs=171.4
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~ 882 (1141)
..|+++++||+|+||.++.|+. ++..||+|....+ ...++ +..|.+..+.|. .+.|..+|-+..+..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQ-------LrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQ-------LRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcch-------HHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 3699999999999999999986 7888999864332 22222 257888888884 899998887665433
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+-.||||++ |.||++++.-+ ...|+.+++..+|.|++.-++|+|++.+|+|||||+|+||.
T Consensus 98 --------------~NiLVidLL-GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 98 --------------YNILVIDLL-GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred --------------hhhhhhhhh-CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 238999999 79999998753 45799999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
..+ ......+.++|||+|+.+.++.... +.+........||..||+-....+ ..-+.+-|+=|+|.++..+
T Consensus 159 rp~--~k~~n~IhiiDFGmAK~YrDp~Tkq---HIPYrE~KSLsGTARYMSINTHlG----rEQSRRDDLEaLGHvFmYF 229 (449)
T KOG1165|consen 159 RPG--TKDANVIHIIDFGMAKEYRDPKTKQ---HIPYREHKSLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 229 (449)
T ss_pred CCC--CCCCceEEEEeccchhhhcCccccc---cCccccccccccceeeeEeecccc----chhhhhhhHHHhhhhhhhh
Confidence 652 2233578999999999877654332 223334456679999999888776 4567899999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHH
Q 001143 1043 LTLQVPYMGLS---ELEIHDLI 1061 (1141)
Q Consensus 1043 LTGk~Pf~~~~---~~el~~~I 1061 (1141)
+-|..||++.. ..+-+++|
T Consensus 230 LRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 230 LRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccCCCccccccCcchHHHHHHh
Confidence 99999998743 34445555
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=239.52 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=175.8
Q ss_pred cccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001143 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1141)
...|.+..++++.++... .++|+.|+|++|+|+..+.. + + ++|+.|+|++|+|+.||..+. .+|+.|+|
T Consensus 180 ~~~L~L~~~~LtsLP~~I---p~~L~~L~Ls~N~LtsLP~~-l--~---~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~L 248 (754)
T PRK15370 180 KTELRLKILGLTTIPACI---PEQITTLILDNNELKSLPEN-L--Q---GNIKTLYANSNQLTSIPATLP--DTIQEMEL 248 (754)
T ss_pred ceEEEeCCCCcCcCCccc---ccCCcEEEecCCCCCcCChh-h--c---cCCCEEECCCCccccCChhhh--ccccEEEC
Confidence 456777777787776432 24788888888888865432 2 1 578888888888888887654 36888888
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001143 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1141)
Q Consensus 99 s~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1141)
++|+|+.||..+. ++|+.|+|++|++..+|..+. .+|+.|+|++|.+.. +|..+. ++|+.|++++|+|+.
T Consensus 249 s~N~L~~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~----LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 249 SINRITELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRT----LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccCcCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCcccc----Ccccch--hhHHHHHhcCCcccc
Confidence 8888888887764 578888888888887776553 478888888876654 333332 357788888888888
Q ss_pred cCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCC
Q 001143 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHN 258 (1141)
Q Consensus 179 iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~ 258 (1141)
+|..+. ++|+.|++++|.|+.+|..+. ++|+.|+|++|+|+.||..+. ++|+.|+|++|+|+.+|+. +. ..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~~-l~--~s 389 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPEN-LP--AA 389 (754)
T ss_pred CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCHh-HH--HH
Confidence 876543 688888888888888887664 688888888888888887664 5788888888888877663 32 36
Q ss_pred CCEEEccCCcCCCCCCCchhhhhc----ccCCCCCCCCCCcc
Q 001143 259 LQNLNLQYNKLLSYCQVPSWICCN----LEGNGKDSSNDDFI 296 (1141)
Q Consensus 259 L~~L~Ls~N~L~~~~~iP~~~~~~----l~~~~l~~~~n~l~ 296 (1141)
|+.|++++|+|+. +|..+... .....+.+.+|.+.
T Consensus 390 L~~LdLs~N~L~~---LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 390 LQIMQASRNNLVR---LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHhhccCCccc---CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 8888888888876 55544322 22334455555544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-21 Score=235.47 Aligned_cols=230 Identities=22% Similarity=0.163 Sum_probs=181.5
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCC--------------CCCccEEEeecCCCCc
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGG--------------DNSVEGLYLYKNVLNL 82 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~--------------L~~L~~L~Ls~N~Lt~ 82 (1141)
+.+..|.+..|+|+.++. .+++|++|+|++|+|+.++ ..+..+.. ..+|+.|+|++|+|+.
T Consensus 222 ~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~LtsLP-~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt~ 296 (788)
T PRK15387 222 AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLP-VLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS 296 (788)
T ss_pred cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCccc-CcccccceeeccCCchhhhhhchhhcCEEECcCCcccc
Confidence 357777888888887764 2577888888888887553 22222211 1468899999999999
Q ss_pred cCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcC
Q 001143 83 IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG 162 (1141)
Q Consensus 83 iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~ 162 (1141)
+|.. +++|+.|+|++|+|+.+|... .+|+.|++++|+++.+|..+ .+|+.|+|++|.+.. +|..
T Consensus 297 LP~~---p~~L~~LdLS~N~L~~Lp~lp---~~L~~L~Ls~N~L~~LP~lp---~~Lq~LdLS~N~Ls~----LP~l--- 360 (788)
T PRK15387 297 LPVL---PPGLQELSVSDNQLASLPALP---SELCKLWAYNNQLTSLPTLP---SGLQELSVSDNQLAS----LPTL--- 360 (788)
T ss_pred cccc---ccccceeECCCCccccCCCCc---ccccccccccCccccccccc---cccceEecCCCccCC----CCCC---
Confidence 9863 468999999999999998643 46788899999998887532 579999999987753 3432
Q ss_pred CCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCC
Q 001143 163 LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242 (1141)
Q Consensus 163 L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~ 242 (1141)
..+|+.|++++|+|+.+|.. +.+|+.|+|++|+|+.+|... ++|+.|+|++|+|+.||... .+|+.|+|++
T Consensus 361 p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt~LP~l~---s~L~~LdLS~N~LssIP~l~---~~L~~L~Ls~ 431 (788)
T PRK15387 361 PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTSLPVLP---SELKELMVSGNRLTSLPMLP---SGLLSLSVYR 431 (788)
T ss_pred CcccceehhhccccccCccc---ccccceEEecCCcccCCCCcc---cCCCEEEccCCcCCCCCcch---hhhhhhhhcc
Confidence 24688899999999999864 368999999999999998643 57999999999999999643 4688999999
Q ss_pred CCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhh
Q 001143 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279 (1141)
Q Consensus 243 N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~ 279 (1141)
|+|+.+| ..++++++|+.|+|++|+|++ .+|..+
T Consensus 432 NqLt~LP-~sl~~L~~L~~LdLs~N~Ls~--~~~~~L 465 (788)
T PRK15387 432 NQLTRLP-ESLIHLSSETTVNLEGNPLSE--RTLQAL 465 (788)
T ss_pred CcccccC-hHHhhccCCCeEECCCCCCCc--hHHHHH
Confidence 9999765 579999999999999999998 455544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=240.16 Aligned_cols=229 Identities=19% Similarity=0.237 Sum_probs=192.3
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
++.+..|.+..|+|+.++...+ .+|+.|+|++|+|+.+ |..+. .+|+.|+|++|.|+.||..+. .+|+.
T Consensus 198 p~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~LtsL-P~~l~-----~~L~~L~Ls~N~L~~LP~~l~--s~L~~ 266 (754)
T PRK15370 198 PEQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTSI-PATLP-----DTIQEMELSINRITELPERLP--SALQS 266 (754)
T ss_pred ccCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccccC-Chhhh-----ccccEEECcCCccCcCChhHh--CCCCE
Confidence 4568999999999999987655 4899999999999965 44332 479999999999999998775 47999
Q ss_pred EEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 96 L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
|+|++|+|+.||..+. ++|+.|+|++|+++.+|..+. .+|+.|++++|.+.. +|..+ .++|+.|++++|.
T Consensus 267 L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~----LP~~l--~~sL~~L~Ls~N~ 336 (754)
T PRK15370 267 LDLFHNKISCLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTA----LPETL--PPGLKTLEAGENA 336 (754)
T ss_pred EECcCCccCccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCcccc----CCccc--cccceeccccCCc
Confidence 9999999999998775 589999999999988886543 479999999977754 34333 2579999999999
Q ss_pred CCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCc---cc
Q 001143 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS---LD 252 (1141)
Q Consensus 176 L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p---~~ 252 (1141)
|+.+|..+. ++|+.|+|++|+|+.+|..+. ++|+.|+|++|+|+.||..+. ..|+.|++++|+|++++. ..
T Consensus 337 Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~ 410 (754)
T PRK15370 337 LTSLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLVRLPESLPHF 410 (754)
T ss_pred cccCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcccCchhHHHH
Confidence 999998764 799999999999999998764 689999999999999998775 469999999999997753 23
Q ss_pred ccCCCCCCEEEccCCcCCC
Q 001143 253 LCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+..++.+..|+|.+|+|+.
T Consensus 411 ~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 411 RGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred hhcCCCccEEEeeCCCccH
Confidence 4456889999999999974
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-21 Score=204.41 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=199.2
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 799 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 799 ~~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
.+.-.++.++.+..+|.+..+|..|+|+|.+..+++||..+.. ......++| ..|.-.|+-+.||||..+++.+
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~--~t~risrdf----neefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVRE--VTARISRDF----NEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhh--cchhhcchh----hhhCcceeeecCCchhhhhhhc
Confidence 3445567778889999999999999999999999999865443 233333444 7788888888999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 956 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP 956 (1141)
.... ++.++..|++.|||+..++. ......+..++.+++.+|++|+.|||+.. |.---|.+
T Consensus 257 nspp--------------nlv~isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns 319 (448)
T KOG0195|consen 257 NSPP--------------NLVIISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNS 319 (448)
T ss_pred cCCC--------------CceEeeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhccc
Confidence 7643 45999999999999999986 34456788999999999999999999863 44556889
Q ss_pred CCeeeecccccCCCCCeEEE--eeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001143 957 ENILIDLERKKADGKPVVKL--CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL--~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1034 (1141)
..++||++ .+.+| +|--++.. .....-.|.||+||.++.... ...-.++|+||
T Consensus 320 ~hvmided-------ltarismad~kfsfq-----------------e~gr~y~pawmspealqrkpe-d~n~raadmws 374 (448)
T KOG0195|consen 320 KHVMIDED-------LTARISMADTKFSFQ-----------------EVGRAYSPAWMSPEALQRKPE-DLNIRAADMWS 374 (448)
T ss_pred ceEEecch-------hhhheecccceeeee-----------------ccccccCcccCCHHHHhcCch-hcchhhhhHHH
Confidence 99999987 34443 34332211 012235788999999986332 12336899999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1035 YGCLLLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1035 LGviL~ELLTGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
|++++||+.|...||...++++.--+| ..+.++.++ +.++..+..|+.-|+.
T Consensus 375 faillwel~trevpfadlspmecgmkialeglrv~ip---------------------------pgis~hm~klm~icmn 427 (448)
T KOG0195|consen 375 FAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP---------------------------PGISRHMNKLMNICMN 427 (448)
T ss_pred HHHHHHHhhccccccccCCchhhhhhhhhccccccCC---------------------------CCccHHHHHHHHHHhc
Confidence 999999999999999998888876555 445444433 2566778999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 001143 1114 ENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.||.+||.++.|+-.++..
T Consensus 428 edpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 428 EDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCcCCCcceehhhHHHh
Confidence 9999999999988776643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-19 Score=187.12 Aligned_cols=212 Identities=19% Similarity=0.228 Sum_probs=163.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~ 879 (1141)
.-...|.++++||.|+||.+|.|.. .+..||+|+...+. ..+ . +..|..+...|+ -..|..+..++.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hp---q----L~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHP---Q----LLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCc---c----hhHHHHHHHHhccCCCCchhhhhcc
Confidence 3456799999999999999999987 57788888754332 222 1 257888888886 456666666666
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+..+- .+||+++ |.||++++.-+ ...++..+++-++-|++.-++|+|.+++|||||||+|+
T Consensus 82 e~~yn--------------vlVMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 82 EKDYN--------------VLVMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred ccccc--------------eeeeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 54432 8999999 79999998753 34699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|..-.. ....+.++|||+|+.+.+..... +-+........||..|.+-....+ ...+.+.|+=|+|.+|
T Consensus 143 LMGlgr----h~~kl~LIDFGLaKky~d~~t~~---HIpyre~r~ltGTaRYASinAh~g----~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 143 LMGLGR----HCNKLYLIDFGLAKKYRDIRTRQ---HIPYREDRNLTGTARYASINAHLG----IEQSRRDDMESVGYVL 211 (341)
T ss_pred eecccc----ccceEEEEeccchhhhccccccc---cCccccCCccceeeeehhhhhhhh----hhhhhhhhhhhhccee
Confidence 986541 12568999999998876543221 222223345679999999877765 3446789999999999
Q ss_pred HHHHhCCCCCCCCCH
Q 001143 1040 LELLTLQVPYMGLSE 1054 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~ 1054 (1141)
..+.-|..||++...
T Consensus 212 mYfnrG~LPWQglka 226 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKA 226 (341)
T ss_pred eeeecCCCcccccch
Confidence 999999999998543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-22 Score=203.29 Aligned_cols=186 Identities=23% Similarity=0.350 Sum_probs=132.8
Q ss_pred CCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEEC
Q 001143 65 GGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELEL 144 (1141)
Q Consensus 65 ~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~L 144 (1141)
..+..++.|.||+|+|+.+|+.+..|.+|+.|+++||+|+.+|.+++.|++|+.|+++.|++..+|..
T Consensus 30 f~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprg------------ 97 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRG------------ 97 (264)
T ss_pred cchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccc------------
Confidence 34578899999999999999999999999999999999999999999999999999887776665544
Q ss_pred CCCCCCCCcccchhhhcCCCCCcEEEccCCCCC--ccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCC
Q 001143 145 SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR--YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222 (1141)
Q Consensus 145 s~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~--~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L 222 (1141)
|+.++.|+.|||.+|++. .+|..|..|+.|+.|+|++|.++-+|..++++++|+.|.|..|.|
T Consensus 98 ---------------fgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 98 ---------------FGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred ---------------cCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCch
Confidence 445555555555555555 456666666666666666666666666666666666666666666
Q ss_pred CcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCC---CCCEEEccCCcCCCCCCCchhhh
Q 001143 223 VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH---NLQNLNLQYNKLLSYCQVPSWIC 280 (1141)
Q Consensus 223 ~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~---~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1141)
-++|.+++.|++|+.|.+.+|+|+-+|| .++++. +=+.+.+.+|+|.. +|..++.
T Consensus 163 l~lpkeig~lt~lrelhiqgnrl~vlpp-el~~l~l~~~k~v~r~E~NPwv~--pIaeQf~ 220 (264)
T KOG0617|consen 163 LSLPKEIGDLTRLRELHIQGNRLTVLPP-ELANLDLVGNKQVMRMEENPWVN--PIAEQFL 220 (264)
T ss_pred hhCcHHHHHHHHHHHHhcccceeeecCh-hhhhhhhhhhHHHHhhhhCCCCC--hHHHHHH
Confidence 6666666666666666666666666666 344433 23456677888866 4554444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=212.60 Aligned_cols=172 Identities=20% Similarity=0.180 Sum_probs=121.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHhhCCCCCccc-eeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVE-MYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~-~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVk-llg~~~ 879 (1141)
..+|.+.++||+|+||+||+|.+. +..+|+|........ ..... ...+.+|+++|++++|+||+. ++++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~----~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLA----RHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHH----HHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 456999999999999999999873 444577654311100 01111 233589999999999999985 4332
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSEN 958 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL-KP~N 958 (1141)
. ..|+||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|
T Consensus 91 --~--------------~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~N 142 (365)
T PRK09188 91 --G--------------KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQN 142 (365)
T ss_pred --C--------------CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcce
Confidence 1 2399999999999962 211 11 1467899999999999999999999 9999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcc
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1019 (1141)
||++.+ +.+||+|||+|+.+.......... .........+++.|+|||++..
T Consensus 143 ILv~~~-------~~ikLiDFGlA~~~~~~~~~~~~~--~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 143 WLMGPD-------GEAAVIDFQLASVFRRRGALYRIA--AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEcCC-------CCEEEEECccceecccCcchhhhh--hhhhhhhhhccCccCCcccCCh
Confidence 999876 689999999998765432111100 0011125568899999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.7e-22 Score=237.73 Aligned_cols=220 Identities=26% Similarity=0.298 Sum_probs=157.4
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEc
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI 121 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~L 121 (1141)
+|+++|+|+|++++.+ +|++.+ .+|+.|...+|+|+.+|..+..+.+|+.|.+.+|.++.+|.....++.|++|+|
T Consensus 242 nl~~~dis~n~l~~lp-~wi~~~---~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNLP-EWIGAC---ANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred cceeeecchhhhhcch-HHHHhc---ccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeee
Confidence 6677777777777654 666554 677777777777777777777777777777777777777776666777777777
Q ss_pred cCCCCCCCcccccC--------------------------CCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 122 KISSPGVNGFALNK--------------------------LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 122 s~N~l~~~~~~~~~--------------------------L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
..|++..+|+.+.. ++.|+.|++.+|.++... -..+-+..+|+.|+|++|+
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c---~p~l~~~~hLKVLhLsyNr 394 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC---FPVLVNFKHLKVLHLSYNR 394 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc---hhhhccccceeeeeecccc
Confidence 77776666653211 122344455554443322 2245667788888888888
Q ss_pred CCccCc-cccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCccccc
Q 001143 176 IRYLPP-EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1141)
Q Consensus 176 L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~ 254 (1141)
|..+|+ .+.+++.|+.|+||+|+|+.||..+.+++.|++|...+|+|...| ++.+++.|+.+|||.|+|+...-..-.
T Consensus 395 L~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 395 LNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 888887 457888888888888888888888888888888888888888888 788888888888888888755432333
Q ss_pred CCCCCCEEEccCCcC
Q 001143 255 LMHNLQNLNLQYNKL 269 (1141)
Q Consensus 255 ~L~~L~~L~Ls~N~L 269 (1141)
..++|++|||+||..
T Consensus 474 p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 474 PSPNLKYLDLSGNTR 488 (1081)
T ss_pred CCcccceeeccCCcc
Confidence 337888888888874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=200.63 Aligned_cols=216 Identities=23% Similarity=0.337 Sum_probs=148.7
Q ss_pred CCCCccceeeeEecCCC-CCCC-----CC-------CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHH
Q 001143 867 RHSCIVEMYGHKISSKW-LPSA-----DG-------NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 933 (1141)
Q Consensus 867 ~HpNIVkllg~~~~~~~-~~~~-----~g-------~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~I 933 (1141)
+|||||+++++|.+.-. +|.. +- ....+...+|+||.-++ .+|..++.. ...+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 59999999999876421 1110 00 12223456899999997 899999875 24677888889
Q ss_pred HHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccc
Q 001143 934 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013 (1141)
Q Consensus 934 a~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 1013 (1141)
+.|+++|+.|||.+||.|||+|++|||+.-+ +++...+.++|||+|-.-+...-...... ..-...|.-.-||
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~Eld---dD~~P~LVvaDFGCcLAd~~hGlqlpy~S----~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELD---DDEIPQLVVADFGCCLADDNHGLQLPYES----DEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEec---CCCCcEEEEcccceeeecccccccccccc----ccccCCCcceecc
Confidence 9999999999999999999999999999655 23446789999999854222110000000 0112246777899
Q ss_pred hhhhccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCC
Q 001143 1014 PEVLRAMHKPN--LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1090 (1141)
Q Consensus 1014 PE~l~~~~~~~--~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~ 1090 (1141)
||+........ ..-.|+|.|+.|.+.||+++...||.+...+.+- ...+....|.++
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp-------------------- 479 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP-------------------- 479 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc--------------------
Confidence 99987643211 1236999999999999999999999874332211 112222222222
Q ss_pred CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1091 FEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1091 ~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
..+++.+++++...|+.||.+|++..
T Consensus 480 -------~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 480 -------SRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred -------ccCChHHHHHHHHHhcCCccccCCcc
Confidence 25667799999999999999998854
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-22 Score=198.35 Aligned_cols=184 Identities=24% Similarity=0.358 Sum_probs=154.7
Q ss_pred cccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCC
Q 001143 86 SVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC 165 (1141)
Q Consensus 86 ~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~ 165 (1141)
.+.++..++.|-||+|+|+.+|+.+..|.+|++|++++|++..+| ..++.|+.
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp---------------------------~~issl~k 80 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELP---------------------------TSISSLPK 80 (264)
T ss_pred cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcC---------------------------hhhhhchh
Confidence 466777888899999999999888888888888888876655544 45666777
Q ss_pred CcEEEccCCCCCccCccccCCCCCCEEEccCCccc--cccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCC
Q 001143 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK--YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243 (1141)
Q Consensus 166 L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~--~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N 243 (1141)
|+.|.++-|++..+|..|+.++.|+.|||+.|++. .+|..|..++.|+.|+|+.|.+.-+|..+++|++|+.|.|..|
T Consensus 81 lr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 81 LRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccC
Confidence 78888888888889999999999999999999998 7999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhh---cccCCCCCCCCCCcccCcc
Q 001143 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC---NLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 244 ~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~---~l~~~~l~~~~n~l~~~~~ 300 (1141)
.|-.+|. .++.|..|+.|.+.+|+|+- +|+.+.. ........+..|.+..++.
T Consensus 161 dll~lpk-eig~lt~lrelhiqgnrl~v---lppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 161 DLLSLPK-EIGDLTRLRELHIQGNRLTV---LPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred chhhCcH-HHHHHHHHHHHhcccceeee---cChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 9988865 89999999999999999997 8887763 2223344455565555543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.8e-20 Score=222.68 Aligned_cols=260 Identities=20% Similarity=0.199 Sum_probs=182.7
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
+|...+.||.+.|=.|.+|++....++||||..+.........++ + +.|++ .+.++|||.+.+.-....+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~q---r-L~~ik-~~l~~~pn~lPfqk~~~t~kA--- 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQ---R-LEEIK-FALMKAPNCLPFQKVLVTDKA--- 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHH---H-HHHHH-HHhhcCCcccchHHHHHhhHH---
Confidence 788999999999999999999888899999875543333333332 2 45566 556689999998776554432
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
.|||-+|+. .+|++.+.. +.-+...+.+.|+.|++.||.-+|..||+|||||.+||||+.-
T Consensus 96 -----------AylvRqyvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-- 156 (1431)
T KOG1240|consen 96 -----------AYLVRQYVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-- 156 (1431)
T ss_pred -----------HHHHHHHHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee--
Confidence 388889986 799999865 3457888899999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-------CCCCCCchhhHHHHHHHH
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVWSLGviL 1039 (1141)
..+.|+||..-++.--+..... .-.... ++...-..|.|||.+-... .....+++.||||+||++
T Consensus 157 -----NW~~LtDFAsFKPtYLPeDNPa--df~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 157 -----NWLYLTDFASFKPTYLPEDNPA--DFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred -----chhhhhcccccCCccCCCCCcc--cceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 6799999987654211110000 000000 0111234699999886411 111257899999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+||++ |++||. ..+++.. +.+........+.. -....++.++..|++.||.+
T Consensus 229 aELf~Eg~PlF~---LSQL~aY-r~~~~~~~e~~Le~-----------------------Ied~~~Rnlil~Mi~rdPs~ 281 (1431)
T KOG1240|consen 229 AELFLEGRPLFT---LSQLLAY-RSGNADDPEQLLEK-----------------------IEDVSLRNLILSMIQRDPSK 281 (1431)
T ss_pred HHHHhcCCCccc---HHHHHhH-hccCccCHHHHHHh-----------------------CcCccHHHHHHHHHccCchh
Confidence 99998 788885 2233222 22222221211111 11235899999999999999
Q ss_pred CCCHHHHHHH
Q 001143 1119 RPTAGDLYEM 1128 (1141)
Q Consensus 1119 RPSa~ElL~~ 1128 (1141)
|.+|++.|+.
T Consensus 282 RlSAedyL~~ 291 (1431)
T KOG1240|consen 282 RLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHh
Confidence 9999999986
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-21 Score=228.60 Aligned_cols=263 Identities=21% Similarity=0.232 Sum_probs=209.1
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
+++.|..+.|++..+.. ..++|+.|+.++|-|+...+... -.+|+++++++|+++.+|.++..+.+|+.|+
T Consensus 200 ~l~~l~c~rn~ls~l~~----~g~~l~~L~a~~n~l~~~~~~p~-----p~nl~~~dis~n~l~~lp~wi~~~~nle~l~ 270 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELEI----SGPSLTALYADHNPLTTLDVHPV-----PLNLQYLDISHNNLSNLPEWIGACANLEALN 270 (1081)
T ss_pred chhhhhhhhcccceEEe----cCcchheeeeccCcceeeccccc-----cccceeeecchhhhhcchHHHHhcccceEec
Confidence 55666666666665543 34678888888888885544322 1589999999999999999999999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccc----hh---------------
Q 001143 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTL----LS--------------- 158 (1141)
Q Consensus 98 Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~l----p~--------------- 158 (1141)
+++|+|+.+|..+...++|+.|.+.+|.+..+|+....++.|++|+|..|.+..+.... +.
T Consensus 271 ~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~l 350 (1081)
T KOG0618|consen 271 ANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTL 350 (1081)
T ss_pred ccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccc
Confidence 99999999999999999999999999999999999999999999999997653221110 00
Q ss_pred -hh--cCCCCCcEEEccCCCCC-ccCccccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcCCcCccCCC
Q 001143 159 -EI--AGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQ 233 (1141)
Q Consensus 159 -~l--~~L~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~~l~~L~ 233 (1141)
.+ .....|+.|++.+|.|+ ..-+-+-++.+|+.|+|++|+|.++|.+ +.+|..|+.|+||+|+|+.||.++.++.
T Consensus 351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~ 430 (1081)
T KOG0618|consen 351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLG 430 (1081)
T ss_pred ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhh
Confidence 00 11245677888999998 3333468889999999999999999954 7889999999999999999999999999
Q ss_pred CCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCC
Q 001143 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSND 293 (1141)
Q Consensus 234 ~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n 293 (1141)
.|+.|...+|+|...| .+..++.|+.+|++.|.|+.. -+|...-| -.+..+++++|
T Consensus 431 ~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~-~l~~~~p~-p~LkyLdlSGN 486 (1081)
T KOG0618|consen 431 RLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEV-TLPEALPS-PNLKYLDLSGN 486 (1081)
T ss_pred hhHHHhhcCCceeech--hhhhcCcceEEecccchhhhh-hhhhhCCC-cccceeeccCC
Confidence 9999999999999887 689999999999999999873 22322221 34445555555
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=182.68 Aligned_cols=145 Identities=14% Similarity=0.090 Sum_probs=107.4
Q ss_pred eeeecccCceEEEEEEE-CCccEEEEEEecccCCCChH-H-----------------HHHhHHhHHHHHHHHhhCCCCCc
Q 001143 811 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD-E-----------------IRNFEYSCLGEVRMLGALRHSCI 871 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~-~-----------------~~~~~~~~~~Ei~iL~~L~HpNI 871 (1141)
.+.||+|++|.||+|.. .+..||+|+.+......... . .+........|+.++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999997 47789999876543211110 0 00112233569999999988877
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcc
Q 001143 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIM 950 (1141)
Q Consensus 872 Vkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yL-Hs~gIv 950 (1141)
.....+... ..+|||||++|+++...+.. ...++...+..++.|++.+|.|+ |+.||+
T Consensus 82 ~~p~~~~~~----------------~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 82 PCPEPILLK----------------SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCcEEEec----------------CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 544332211 12899999998777654322 24689999999999999999999 799999
Q ss_pred ccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 951 HrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
||||||+|||++. +.++|+|||+|..
T Consensus 141 HrDlkP~NIli~~--------~~v~LiDFG~a~~ 166 (190)
T cd05147 141 HADLSEYNLLYHD--------GKLYIIDVSQSVE 166 (190)
T ss_pred cCCCCHHHEEEEC--------CcEEEEEcccccc
Confidence 9999999999973 5699999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=191.94 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=154.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC----------CCCccce
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR----------HSCIVEM 874 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~----------HpNIVkl 874 (1141)
.+...+.||.|+++.||.+++. +...++|++.... .......+++ ++|.-....+. |-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~----~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQL----KEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHH----HHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHH----HHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3578899999999999999995 4889999987665 2222334444 44543333332 2234444
Q ss_pred eeeEecCCCCCCCCCCCc---cccceEEEEEeeccCCCHHHHHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 001143 875 YGHKISSKWLPSADGNPE---HHLLQSAIFMEYVKGGSVKNYIEKLSETGEK--HVSVKLALFIAQDVAAALVELHSKHI 949 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~---~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~--~Ls~~~i~~Ia~QIa~gL~yLHs~gI 949 (1141)
++...-.+.-+....... ......+++|+-+. ++|.+++.-.+..... .+.......+..|+++.+++||+.|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 444332211101111111 11224578999885 8999887654433322 23344456677999999999999999
Q ss_pred cccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc----CCCC
Q 001143 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNL 1025 (1141)
Q Consensus 950 vHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~ 1025 (1141)
+|+||+|+|++++.+ |.++|+||+........... ...+..|.+||...... ....
T Consensus 167 VHgdi~~~nfll~~~-------G~v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 167 VHGDIKPENFLLDQD-------GGVFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp EEST-SGGGEEE-TT-------S-EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred EecccceeeEEEcCC-------CCEEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCcccce
Confidence 999999999999998 89999999988655432110 12457799999875421 1235
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1105 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1105 (1141)
++.+.|.|++|+++|.|+.+..||........... . ...+. +.++.++
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----------~--------------------f~~C~-~~Pe~v~ 274 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----------D--------------------FSRCR-DMPEPVQ 274 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----------G--------------------GTTSS----HHHH
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----------c--------------------chhcC-CcCHHHH
Confidence 78999999999999999999999975322110000 0 01112 5567799
Q ss_pred HHHHHhcccCCCCC
Q 001143 1106 DVFRRCTEENPTER 1119 (1141)
Q Consensus 1106 dLI~~cL~~DP~~R 1119 (1141)
.||..+|+.||.+|
T Consensus 275 ~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 275 FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHT-SSGGGS
T ss_pred HHHHHHccCCcccC
Confidence 99999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-18 Score=184.52 Aligned_cols=183 Identities=13% Similarity=0.131 Sum_probs=130.8
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHh--HHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~--~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.++||.|+||.||++...+..+++|++.-+... .......+ ...+.+|+..+.++.||+|..+.+++.....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 46899999999999999998887888999997543221 11111111 1114789999999999999999998765321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. ........++||||++|.+|.++.. +++ ....+|+.++..+|+.|++|||+||+||++++
T Consensus 110 ~------~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 110 K------TLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred c------cccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 1 0011234699999999999987732 232 24568999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
+ + ++|+|||.......... ...+... ..++.++|+|+||+++.-+
T Consensus 171 ~-------g-i~liDfg~~~~~~e~~a----------------------~d~~vle----r~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 171 N-------G-LRIIDLSGKRCTAQRKA----------------------KDRIDLE----RHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred C-------C-EEEEECCCcccccchhh----------------------HHHHHHH----hHhcccccccceeEeehHH
Confidence 6 6 99999998754321100 0112222 3456799999999988754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-19 Score=209.39 Aligned_cols=237 Identities=23% Similarity=0.274 Sum_probs=181.3
Q ss_pred eecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCCCC
Q 001143 813 EAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 813 ~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~~~~ 886 (1141)
++|+|+||.|++++. .+..++.|+.+.......... . ...|..++..++ ||.+|++.-.+..+...
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~----t~~er~il~~~~~~~f~v~lhyafqt~~kl-- 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--H----TKQERIILAFVHNTPFLVKLHYAFQTDGKL-- 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--c----cccHHHHHhhccCCCceeeeeeeeccccch--
Confidence 479999999998753 455566666332211111111 1 146778888886 99999999888876644
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
+++++|..||.|...+.. ...+++.....+...++-|++++|+.+|+|||+|++||+++.+
T Consensus 73 ------------~l~ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-- 133 (612)
T KOG0603|consen 73 ------------YLILDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-- 133 (612)
T ss_pred ------------hHhhhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc--
Confidence 999999999999887765 3468888888899999999999999999999999999999998
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
|++++.|||.++..-... ..+||..|||||++.+ ....+|.||||++.+||+||.
T Consensus 134 -----Ghi~~tdfglske~v~~~--------------~~cgt~eymApEI~~g------h~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 134 -----GHIKLTDFGLSKEAVKEK--------------IACGTYEYRAPEIING------HLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -----CccccCCchhhhHhHhhh--------------hcccchhhhhhHhhhc------cCCcccchhhhhhHHHHhhCC
Confidence 899999999987643311 1168999999999974 358999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 1121 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS----- 1121 (1141)
.||.. ++...|.....+. + ......+++++..++..+|..|.-
T Consensus 189 ~pf~~----~~~~~Il~~~~~~-p---------------------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 189 LPFGG----DTMKRILKAELEM-P---------------------------RELSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred CCCch----HHHHHHhhhccCC-c---------------------------hhhhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 99986 4455553322211 1 145566889999999999999954
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.|+.+|.++..
T Consensus 237 ~~eik~h~f~~~ 248 (612)
T KOG0603|consen 237 VDEIKQHEFFQS 248 (612)
T ss_pred hHHHhccchhee
Confidence 477888877753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=177.18 Aligned_cols=146 Identities=14% Similarity=0.133 Sum_probs=109.3
Q ss_pred eeeecccCceEEEEEEEC-CccEEEEEEecccCCCChH------------------HHHHhHHhHHHHHHHHhhCCCCCc
Q 001143 811 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRMLGALRHSCI 871 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~------------------~~~~~~~~~~~Ei~iL~~L~HpNI 871 (1141)
.+.||+|++|.||+|.+. +..||+|+.+......... ........+..|+..+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 578999999999999974 8899999876542211000 001112234689999999999988
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHH-HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q 001143 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY-IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 949 (1141)
Q Consensus 872 Vkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~-I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gI 949 (1141)
.....+.... .++||||++|+++... +.. ..++...+..++.|++.++.++|+ +||
T Consensus 82 ~~p~~~~~~~----------------~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~gi 139 (190)
T cd05145 82 PVPEPILLKK----------------NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGL 139 (190)
T ss_pred CCceEEEecC----------------CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5544443221 2899999998755433 332 357889999999999999999999 999
Q ss_pred cccCCCCCCeeeecccccCCCCCeEEEeecccccccc
Q 001143 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1141)
Q Consensus 950 vHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~ 986 (1141)
+||||||+||+++ + +.++|+|||+|....
T Consensus 140 vHrDlkP~NIll~-~-------~~~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-D-------GKPYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-C-------CCEEEEEcccceecC
Confidence 9999999999998 4 689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.4e-17 Score=214.08 Aligned_cols=254 Identities=22% Similarity=0.219 Sum_probs=172.0
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-CCCccCccccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N-~Lt~iP~~l~~L~~L~~L 96 (1141)
.+..|.+..+.++.++.. | ...+|+.|+|++|+|... +..+ ..+++|+.|+|++| .++.+|. +..+++|+.|
T Consensus 590 ~Lr~L~~~~~~l~~lP~~-f-~~~~L~~L~L~~s~l~~L-~~~~---~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L 662 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSN-F-RPENLVKLQMQGSKLEKL-WDGV---HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETL 662 (1153)
T ss_pred ccEEEEecCCCCCCCCCc-C-CccCCcEEECcCcccccc-cccc---ccCCCCCEEECCCCCCcCcCCc-cccCCcccEE
Confidence 466666667777766543 3 456778888888777643 3323 34477788888765 3566763 6677778888
Q ss_pred EccCCC-CCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001143 97 KFFGNE-INLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1141)
Q Consensus 97 ~Ls~N~-L~~lP~~~~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1141)
+|++|. +..+|..+++|++|+.|+|++|. ++.+|..+ ++++|+.|+++++. ....+|.. ..+|+.|++++|
T Consensus 663 ~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~---~L~~~p~~---~~nL~~L~L~~n 735 (1153)
T PLN03210 663 KLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCS---RLKSFPDI---STNISWLDLDET 735 (1153)
T ss_pred EecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCC---Cccccccc---cCCcCeeecCCC
Confidence 887754 45777777778888888887754 66666544 67777777777743 23333322 345667777777
Q ss_pred CCCccCccc------------------------------cCCCCCCEEEccCCc-cccccccccCCCCCCEEEccCC-CC
Q 001143 175 SIRYLPPEI------------------------------GCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANN-KL 222 (1141)
Q Consensus 175 ~L~~iP~~l------------------------------~~l~~L~~L~Ls~N~-L~~iP~~l~~l~~L~~L~Ls~N-~L 222 (1141)
.+..+|..+ ..+++|+.|+|++|. +..+|.+++++++|+.|+|++| .|
T Consensus 736 ~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L 815 (1153)
T PLN03210 736 AIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL 815 (1153)
T ss_pred ccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc
Confidence 766666432 113467778888875 4478888888999999999886 57
Q ss_pred CcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCC
Q 001143 223 VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSN 292 (1141)
Q Consensus 223 ~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~ 292 (1141)
+.||..+ ++++|+.|+|++|..-...|. ...+|+.|+|++|.+.. +|.++..+..+..+.+.+
T Consensus 816 ~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~---~~~nL~~L~Ls~n~i~~---iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 816 ETLPTGI-NLESLESLDLSGCSRLRTFPD---ISTNISDLNLSRTGIEE---VPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CeeCCCC-CccccCEEECCCCCccccccc---cccccCEeECCCCCCcc---ChHHHhcCCCCCEEECCC
Confidence 7888766 688888888888644333332 23578888888888875 788777666666666655
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=172.62 Aligned_cols=201 Identities=13% Similarity=0.049 Sum_probs=136.6
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~~~~~ 887 (1141)
.+...|++|+||+||.+...+..++.+-+... ......-+..++.+|+++|++|. |++|++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~----~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------- 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAA----PWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------- 71 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccc----hhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------
Confidence 56789999999999988876666554443221 11111111224589999999995 68899998862
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCeeeecccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENILIDLERK 966 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL-KP~NILld~~~~ 966 (1141)
..+++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+
T Consensus 72 ---------~~~lvmeyI~G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-- 128 (218)
T PRK12274 72 ---------GRHLDRSYLAGAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-- 128 (218)
T ss_pred ---------CEEEEEeeecCccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC--
Confidence 13899999999998754321 1 1347789999999999999999999 7999999876
Q ss_pred cCCCCCeEEEeeccccccccccccccc-cccCCC--CCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCC-IAHRGI--PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~-~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+.++|+|||+|........... ...+.. -.......++.|++|+...-.. ..--...+.++-|+-+|.++
T Consensus 129 -----g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 129 -----GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred -----CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cchhHHHHHHHhcchHHHHH
Confidence 7899999999975432211000 000000 0000123578888888654311 11126778999999999999
Q ss_pred hCCCCCCCC
Q 001143 1044 TLQVPYMGL 1052 (1141)
Q Consensus 1044 TGk~Pf~~~ 1052 (1141)
|+..|+.++
T Consensus 202 ~~~~~~~~~ 210 (218)
T PRK12274 202 TRRVLHWED 210 (218)
T ss_pred hccCCcccc
Confidence 999887653
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-16 Score=211.58 Aligned_cols=258 Identities=20% Similarity=0.233 Sum_probs=189.8
Q ss_pred CcccccCCCCC------ccccCCCCCCCCC-CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCC
Q 001143 18 IKEKLPSEANK------INNEKNGSVNDDD-DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY 90 (1141)
Q Consensus 18 ~l~~L~~~~N~------i~~i~~~~f~~l~-~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L 90 (1141)
++..|.+..+. ++...+..|..++ +|+.|++.+|.++..+ ..| .+.+|+.|+|++|+|..+|..+..+
T Consensus 559 ~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP-~~f----~~~~L~~L~L~~s~l~~L~~~~~~l 633 (1153)
T PLN03210 559 NLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMP-SNF----RPENLVKLQMQGSKLEKLWDGVHSL 633 (1153)
T ss_pred cccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCC-CcC----CccCCcEEECcCccccccccccccC
Confidence 56666664432 3333345566654 6999999999887554 434 2378999999999999999888899
Q ss_pred cCCcEEEccCCC-CCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcE
Q 001143 91 EKLRNLKFFGNE-INLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168 (1141)
Q Consensus 91 ~~L~~L~Ls~N~-L~~lP~~~~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~ 168 (1141)
++|+.|+|++|. ++.+|. ++.+++|+.|+|++|. +..+|..+.++++|+.|+++++ +....+|..+ ++++|+.
T Consensus 634 ~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c---~~L~~Lp~~i-~l~sL~~ 708 (1153)
T PLN03210 634 TGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC---ENLEILPTGI-NLKSLYR 708 (1153)
T ss_pred CCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC---CCcCccCCcC-CCCCCCE
Confidence 999999998764 677874 8889999999999876 7888888999999999999983 4455667655 7889999
Q ss_pred EEccCCC-CCccCccccCCCCCCEEEccCCcccccccccc------------------------------CCCCCCEEEc
Q 001143 169 LSVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEIC------------------------------YLKALISLKV 217 (1141)
Q Consensus 169 L~Ls~N~-L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~------------------------------~l~~L~~L~L 217 (1141)
|+|++|. +..+|.. +++|++|+|++|.|+.+|..+. ..++|+.|+|
T Consensus 709 L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~L 785 (1153)
T PLN03210 709 LNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFL 785 (1153)
T ss_pred EeCCCCCCccccccc---cCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeC
Confidence 9999875 4466643 4688999999999888875431 1247888888
Q ss_pred cCCCC-CcCCcCccCCCCCCEEeCCCC-CCCCCCcccccCCCCCCEEEccCCc-CCCCCCCchhhhhcccCCCCCCCCCC
Q 001143 218 ANNKL-VELPSGLYLLQRLENLDLSNN-RLTSLGSLDLCLMHNLQNLNLQYNK-LLSYCQVPSWICCNLEGNGKDSSNDD 294 (1141)
Q Consensus 218 s~N~L-~~IP~~l~~L~~L~~L~Ls~N-~Lt~~~p~~l~~L~~L~~L~Ls~N~-L~~~~~iP~~~~~~l~~~~l~~~~n~ 294 (1141)
++|.. ..+|.++++|++|+.|+|++| .|+.+ |..+ ++++|+.|+|++|. +.. +|... .....+.++++.
T Consensus 786 s~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~L-P~~~-~L~sL~~L~Ls~c~~L~~---~p~~~---~nL~~L~Ls~n~ 857 (1153)
T PLN03210 786 SDIPSLVELPSSIQNLHKLEHLEIENCINLETL-PTGI-NLESLESLDLSGCSRLRT---FPDIS---TNISDLNLSRTG 857 (1153)
T ss_pred CCCCCccccChhhhCCCCCCEEECCCCCCcCee-CCCC-CccccCEEECCCCCcccc---ccccc---cccCEeECCCCC
Confidence 88854 589999999999999999986 45554 4333 78999999999864 333 44322 233445555555
Q ss_pred cc
Q 001143 295 FI 296 (1141)
Q Consensus 295 l~ 296 (1141)
+.
T Consensus 858 i~ 859 (1153)
T PLN03210 858 IE 859 (1153)
T ss_pred Cc
Confidence 54
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-19 Score=200.42 Aligned_cols=247 Identities=19% Similarity=0.213 Sum_probs=174.5
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEccC-CCCCcCchh-hcCCCCCCE
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFG-NEINLFPSE-VGNLLGLEC 118 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~Ls~-N~L~~lP~~-~~~L~~L~~ 118 (1141)
.-+.|+|..|+|+.+++..|+.+ ++|++||||+|.|+.| |++|..|++|..|-|.+ |+|+.||.. |++|..|+.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l---~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTL---HRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQR 144 (498)
T ss_pred cceEEEeccCCcccCChhhccch---hhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHH
Confidence 45677888888887777666544 8888888888888877 66788888766555544 888888765 777888888
Q ss_pred EEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEEccCCCCC-------------ccCccc
Q 001143 119 LQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHFSIR-------------YLPPEI 183 (1141)
Q Consensus 119 L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~-~l~~L~~L~~L~Ls~N~L~-------------~iP~~l 183 (1141)
|.+.-|++.-+. ..|..|++|..|.+.+|.++ .++. .|..+..++.+.+..|.+- ..|..+
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q----~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iet 220 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ----SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIET 220 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhhh----hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhc
Confidence 888777766554 56888888888888875543 3333 5677777777777777621 112222
Q ss_pred cCCCCCCEEEc--------------------------cCCcccccc-ccccCCCCCCEEEccCCCCCcC-CcCccCCCCC
Q 001143 184 GCLSNLEQLDL--------------------------SFNKMKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRL 235 (1141)
Q Consensus 184 ~~l~~L~~L~L--------------------------s~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L 235 (1141)
+...-..-..| ..+.....| ..|..|++|++|+|++|+|+.| +.+|..+..|
T Consensus 221 sgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l 300 (498)
T KOG4237|consen 221 SGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAEL 300 (498)
T ss_pred ccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhh
Confidence 22211111111 122222334 3467799999999999999988 6677789999
Q ss_pred CEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCccc
Q 001143 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297 (1141)
Q Consensus 236 ~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~ 297 (1141)
+.|+|..|+|..+....|.++..|+.|+|.+|+|+++ -|..+....+...+.+..|.|+|
T Consensus 301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~--~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTV--APGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEE--ecccccccceeeeeehccCcccC
Confidence 9999999999999888999999999999999999984 45555555555556655555554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-18 Score=200.30 Aligned_cols=201 Identities=30% Similarity=0.392 Sum_probs=125.5
Q ss_pred EEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCC
Q 001143 46 IDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS 125 (1141)
Q Consensus 46 LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~ 125 (1141)
|.|++-++...+-..+. -.|+-....||+.|++.++|..+..+..|+.|.|+.|.|..||..+++|..|+.|+|+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~--~~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAAS--YDLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCcccc--ccccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccch
Confidence 44455444433322221 2334445556666666666655555555555666666666666655555555555555555
Q ss_pred CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccccc
Q 001143 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE 205 (1141)
Q Consensus 126 l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~ 205 (1141)
+..+| ..++.|+ |+.|-+++|+++.+|..++.+..|..|+.+.|+|.++|..
T Consensus 133 lS~lp---------------------------~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slpsq 184 (722)
T KOG0532|consen 133 LSHLP---------------------------DGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPSQ 184 (722)
T ss_pred hhcCC---------------------------hhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhhhchHH
Confidence 44444 3444554 6677777777777777777666777777777777777777
Q ss_pred ccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhh
Q 001143 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1141)
Q Consensus 206 l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1141)
++.+.+|+.|.+..|++..+|.++..|+ |..||+|+|+++.+| ..|..|..|++|-|.+|+|+. -|..+|.
T Consensus 185 l~~l~slr~l~vrRn~l~~lp~El~~Lp-Li~lDfScNkis~iP-v~fr~m~~Lq~l~LenNPLqS---PPAqIC~ 255 (722)
T KOG0532|consen 185 LGYLTSLRDLNVRRNHLEDLPEELCSLP-LIRLDFSCNKISYLP-VDFRKMRHLQVLQLENNPLQS---PPAQICE 255 (722)
T ss_pred hhhHHHHHHHHHhhhhhhhCCHHHhCCc-eeeeecccCceeecc-hhhhhhhhheeeeeccCCCCC---ChHHHHh
Confidence 7777777777777777777777777554 777777777777654 367777777777777777766 5666663
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-17 Score=201.67 Aligned_cols=161 Identities=28% Similarity=0.327 Sum_probs=122.9
Q ss_pred HHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccc-----cCCCCCCCCccCCCccc
Q 001143 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----HRGIPAPDVCVGTPRWM 1012 (1141)
Q Consensus 938 a~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-----~~~~~~~~~~~GT~~Y~ 1012 (1141)
+.+++|||+.||+|||+||+|.+|+.- |++|+.|||+.+.......++..+ ..........+||+.|+
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~m-------GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyi 225 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSM-------GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYI 225 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeec-------ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCcccc
Confidence 789999999999999999999999987 899999999987532111111000 01112334567999999
Q ss_pred chhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCC
Q 001143 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092 (1141)
Q Consensus 1013 APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~ 1092 (1141)
|||++.. ..|+..+|+|++|+|+||.+.|+.||.++.+.+++..+.......
T Consensus 226 aPeVilr----qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w------------------------ 277 (1205)
T KOG0606|consen 226 APEVILR----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW------------------------ 277 (1205)
T ss_pred Chhhhhh----hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc------------------------
Confidence 9999986 568999999999999999999999999999999887764432211
Q ss_pred CchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHhhcC
Q 001143 1093 KPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1093 ~~~~~~~~~~~L~dLI~~cL~~DP~~R---PSa~ElL~~L~~~~~ 1134 (1141)
++.....+.++++++.++|+.+|..| +.+-+|.+|-+|+.-
T Consensus 278 -pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 278 -PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred -cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 11112456779999999999999999 567778888777643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4e-16 Score=167.55 Aligned_cols=142 Identities=20% Similarity=0.234 Sum_probs=111.9
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
+.||+|++|.||+|.+.+..+++|+..................++.+|+.++..+.|++|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-------- 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-------- 73 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC--------
Confidence 679999999999999988899999865332222111112122345789999999999998877766654332
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
.++||||++|++|.+++.. ... ....++.+++.+|.++|+.|++|||++|.|||++ +
T Consensus 74 ------~~lv~e~~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~------- 130 (211)
T PRK14879 74 ------FIIVMEYIEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G------- 130 (211)
T ss_pred ------CEEEEEEeCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-------
Confidence 3899999999999999865 112 7889999999999999999999999999999998 4
Q ss_pred CeEEEeecccccc
Q 001143 972 PVVKLCDFDRAVP 984 (1141)
Q Consensus 972 ~~vKL~DFGlA~~ 984 (1141)
+.++|+|||.+..
T Consensus 131 ~~~~liDf~~a~~ 143 (211)
T PRK14879 131 GKIYLIDFGLAEF 143 (211)
T ss_pred CCEEEEECCcccC
Confidence 6799999998854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-16 Score=168.80 Aligned_cols=144 Identities=14% Similarity=0.135 Sum_probs=102.6
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-----CCCCccceeeeEecCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-----RHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-----~HpNIVkllg~~~~~~~ 883 (1141)
.-.+.||+|+||.||. .-.....++|+..... ....+. +.+|+.+++++ .||||++++|++.++..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~----~~~~~~----~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRG----DGGDKE----IRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCeEEEEEeccc----cchHHH----HHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 3457899999999996 2122334566654321 112223 48999999999 57999999999987531
Q ss_pred CCCCCCCCccccceEEEEEee--ccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCCee
Q 001143 884 LPSADGNPEHHLLQSAIFMEY--VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL-VELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy--~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL-~yLHs~gIvHrDLKP~NIL 960 (1141)
. .....+|||| +++++|.+++.+ ..+++. ..++.|++.++ +|||+++|+||||||+|||
T Consensus 76 ~----------g~v~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NIL 137 (210)
T PRK10345 76 T----------GYVYDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNIL 137 (210)
T ss_pred C----------eEEEEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 0 1123489999 557999999965 135555 35678888887 9999999999999999999
Q ss_pred eecccccCCCCCeEEEeecccc
Q 001143 961 IDLERKKADGKPVVKLCDFDRA 982 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA 982 (1141)
++..+ .+...++|+||+.+
T Consensus 138 l~~~~---~~~~~~~LiDg~G~ 156 (210)
T PRK10345 138 CQRIS---ESEVIPVVCDNIGE 156 (210)
T ss_pred EeccC---CCCCcEEEEECCCC
Confidence 97542 12258999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=185.75 Aligned_cols=214 Identities=26% Similarity=0.353 Sum_probs=159.0
Q ss_pred HhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 001143 863 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 863 L~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
|+.+.|.|+.+++|.+.+.. ..++|.+||..|+|.+.+.. ....+++.-...++++|+.||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------EMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLA 62 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------ceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHH
Confidence 35788999999999988654 45999999999999999976 3456899999999999999999
Q ss_pred HHHHCCc-cccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc
Q 001143 943 ELHSKHI-MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1141)
Q Consensus 943 yLHs~gI-vHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1021 (1141)
|||...| .|+.+++.|.+++.. +.+||.|||+.......... .......-..-|.|||.+.+..
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~--------~~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEP--------EAHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHhcCcceeeeeeccccceeeee-------EEEEechhhhcccccccccc--------cccchhHHHHhccCHHHhcccc
Confidence 9998765 999999999999988 99999999998665321000 0001112345699999998743
Q ss_pred CCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCC
Q 001143 1022 KPNL---YGLEVDIWSYGCLLLELLTLQVPYMGL----SELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEK 1093 (1141)
Q Consensus 1022 ~~~~---~s~ksDVWSLGviL~ELLTGk~Pf~~~----~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~ 1093 (1141)
.... .+++.||||||++++|+++.+.||... ...++...+..+.. +..+.. ..
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i-~~------------------ 188 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSI-EL------------------ 188 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcch-hh------------------
Confidence 2222 578899999999999999999999752 23345555544222 111111 00
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1094 ~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
. ....+++..++..||..+|.+||+++++-..+.-
T Consensus 189 --~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 189 --L-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred --h-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 0 0333468899999999999999999998766543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=162.41 Aligned_cols=138 Identities=21% Similarity=0.268 Sum_probs=105.3
Q ss_pred eecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCc
Q 001143 813 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892 (1141)
Q Consensus 813 ~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~ 892 (1141)
.||+|++|.||+|.+.+..+++|++..+.......+...-..++.+|++++..++|+++.....++.....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--------- 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN--------- 71 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC---------
Confidence 48999999999999999999999865332211111111112455789999999998876555444443322
Q ss_pred cccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCC
Q 001143 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972 (1141)
Q Consensus 893 ~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~ 972 (1141)
.++||||++|++|.+++.. .. . .++.|++.+|.+||+.|++|||++|.||+++ + +
T Consensus 72 -----~~lv~e~~~g~~l~~~~~~-----~~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-------~ 126 (199)
T TIGR03724 72 -----KTIVMEYIEGKPLKDVIEE-----GN-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-------D 126 (199)
T ss_pred -----CEEEEEEECCccHHHHHhh-----cH-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-------C
Confidence 3899999999999988754 11 1 7899999999999999999999999999998 4 6
Q ss_pred eEEEeecccccc
Q 001143 973 VVKLCDFDRAVP 984 (1141)
Q Consensus 973 ~vKL~DFGlA~~ 984 (1141)
.++++|||.+..
T Consensus 127 ~~~liDfg~a~~ 138 (199)
T TIGR03724 127 KLYLIDFGLGKY 138 (199)
T ss_pred cEEEEECCCCcC
Confidence 799999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.1e-16 Score=192.93 Aligned_cols=201 Identities=18% Similarity=0.238 Sum_probs=148.4
Q ss_pred CCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccceeeeEec
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkllg~~~~ 880 (1141)
-..|.|.+.||+|+||.||+|.. ++..+|+|+-+-.. .-+ | .--.+++.+|+ -+.|..+...+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WE----f----YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWE----F----YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---cee----e----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 45689999999999999999986 56778888743221 100 0 01112333343 2345555544432
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.+ ..++|+||.+-|+|.+++.. .+.+++..+..++.|++.-+++||..+||||||||+|+|
T Consensus 766 ~~--------------~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfl 826 (974)
T KOG1166|consen 766 QN--------------ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFL 826 (974)
T ss_pred CC--------------cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeE
Confidence 22 23899999999999999973 567999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
|......+.+...++|+|||.+..+.-..... .-....+|-.+-.+|+..| ..|+..+|.|.++.+++
T Consensus 827 l~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~--------~F~~~~~td~f~C~EM~~g----rpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 827 LRREICADSDSKGLYLIDFGRSIDMKLFPDGT--------KFKAVWHTDLFDCIEMREG----RPWTYQIDYFGLAATVH 894 (974)
T ss_pred eecccCCCCcccceEEEecccceeeeEcCCCc--------EEeeeeccccchhHHHhcC----CCCchhhhhHHHHHHHH
Confidence 97654333445679999999997654322110 0123457888999999887 78999999999999999
Q ss_pred HHHhCCC
Q 001143 1041 ELLTLQV 1047 (1141)
Q Consensus 1041 ELLTGk~ 1047 (1141)
-|+.|++
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999864
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.1e-17 Score=186.94 Aligned_cols=248 Identities=22% Similarity=0.194 Sum_probs=178.7
Q ss_pred cccCCCCCcc-ccCCCCCCCCCCCCEEEccCCCCCCC----CcccccCCCCCCCccEEEeecCCCCc-------cCcccc
Q 001143 21 KLPSEANKIN-NEKNGSVNDDDDDSVIDVSGKTVDFP----LIESYGNRGGDNSVEGLYLYKNVLNL-------IPKSVG 88 (1141)
Q Consensus 21 ~L~~~~N~i~-~i~~~~f~~l~~L~~LdLs~N~Ls~~----~p~~~~~l~~L~~L~~L~Ls~N~Lt~-------iP~~l~ 88 (1141)
.|.+..++++ .-....|..+.+|+.|+|+++.++.. ++..+ ...++|++|+++.|.+.. ++..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l---~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~ 78 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASAL---RPQPSLKELCLSLNETGRIPRGLQSLLQGLT 78 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHH---hhCCCceEEeccccccCCcchHHHHHHHHHH
Confidence 3566666766 33345566777899999999998653 23333 344779999999987763 234567
Q ss_pred CCcCCcEEEccCCCCC-cCchhhcCCCC---CCEEEccCCCCCC-----CcccccCC-CCCCEEECCCCCCCCCc-ccch
Q 001143 89 RYEKLRNLKFFGNEIN-LFPSEVGNLLG---LECLQIKISSPGV-----NGFALNKL-KGLKELELSKVPPRPSV-LTLL 157 (1141)
Q Consensus 89 ~L~~L~~L~Ls~N~L~-~lP~~~~~L~~---L~~L~Ls~N~l~~-----~~~~~~~L-~~L~~L~Ls~N~ln~~~-~~lp 157 (1141)
.+++|+.|+|++|.+. ..+..+..+.+ |+.|++++|.+.. +...+..+ ++|+.|++++|.+.... ..++
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 7889999999999997 44555655555 9999999998663 22345666 88999999997765321 2345
Q ss_pred hhhcCCCCCcEEEccCCCCC-----ccCccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCCcC-C
Q 001143 158 SEIAGLKCLTKLSVCHFSIR-----YLPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVEL-P 226 (1141)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~~I-P 226 (1141)
..+..+++|+.|++++|.++ .++..+..+++|++|+|++|.|+ .++..+..+++|+.|++++|.++.. +
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 56777888999999999988 23445666789999999999987 3345667788999999999998731 2
Q ss_pred cCcc-----CCCCCCEEeCCCCCCCCC----CcccccCCCCCCEEEccCCcCCC
Q 001143 227 SGLY-----LLQRLENLDLSNNRLTSL----GSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 227 ~~l~-----~L~~L~~L~Ls~N~Lt~~----~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
..+. ..++|+.|++++|.++.. ....+..+++|+.|++++|+++.
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 2222 247899999999998722 12345667899999999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=186.17 Aligned_cols=145 Identities=20% Similarity=0.224 Sum_probs=112.8
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
...|...+.||+|+||+||++.+.+..+++|++..+..............++.+|++++.+++|++++....+..+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~- 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE- 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-
Confidence 3445778999999999999999988777777654332211111111223456899999999999999887766654332
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
.++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||++ +
T Consensus 411 -------------~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~ 463 (535)
T PRK09605 411 -------------KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D 463 (535)
T ss_pred -------------CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C
Confidence 389999999999998875 2457899999999999999999999999999994 3
Q ss_pred cccCCCCCeEEEeecccccc
Q 001143 965 RKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~ 984 (1141)
+.++|+|||+++.
T Consensus 464 -------~~~~liDFGla~~ 476 (535)
T PRK09605 464 -------DRLYLIDFGLGKY 476 (535)
T ss_pred -------CcEEEEeCccccc
Confidence 5799999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=167.50 Aligned_cols=146 Identities=14% Similarity=0.187 Sum_probs=108.0
Q ss_pred ceEeeeecccCceEEEEEE-E--CCccEEEEEEecccCCCCh----------------HHHHHhHHhHHHHHHHHhhCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCK-F--GSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALRH 868 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~-~--~~~~vAvKI~~l~~~~~~~----------------~~~~~~~~~~~~Ei~iL~~L~H 868 (1141)
|++.+.||+|++|.||+|. + .+..||+|+.+........ ...+.....+.+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6888999999999999998 3 6788999987643211000 0111122345789999999975
Q ss_pred C--CccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 001143 869 S--CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 946 (1141)
Q Consensus 869 p--NIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs 946 (1141)
. .+.+++++ . ..++||||++|.+|...... ...+....+..++.||+.++.+||+
T Consensus 110 ~~i~~p~~~~~---~---------------~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 110 AGVPVPKPIAW---R---------------RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred cCCCCCeeeEe---c---------------CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh
Confidence 3 33444432 1 12899999998888765422 2346667788999999999999999
Q ss_pred CC-ccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 947 KH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 947 ~g-IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
+| |+||||||+||+++ + +.++|+|||.|..
T Consensus 167 ~g~iiH~Dikp~NIli~-~-------~~i~LiDFg~a~~ 197 (237)
T smart00090 167 EGELVHGDLSEYNILVH-D-------GKVVIIDVSQSVE 197 (237)
T ss_pred cCCEEeCCCChhhEEEE-C-------CCEEEEEChhhhc
Confidence 99 99999999999998 4 6799999998854
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.2e-16 Score=181.99 Aligned_cols=250 Identities=22% Similarity=0.197 Sum_probs=185.6
Q ss_pred EEEccCCCCC-CCCcccccCCCCCCCccEEEeecCCCC-----ccCccccCCcCCcEEEccCCCCCc-------Cchhhc
Q 001143 45 VIDVSGKTVD-FPLIESYGNRGGDNSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEINL-------FPSEVG 111 (1141)
Q Consensus 45 ~LdLs~N~Ls-~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-----~iP~~l~~L~~L~~L~Ls~N~L~~-------lP~~~~ 111 (1141)
.|+|..+.++ ......+..+ ..|+.|+|+++.++ .++..+...++|+.|++++|.+.. ++..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l---~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~ 78 (319)
T cd00116 2 QLSLKGELLKTERATELLPKL---LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLT 78 (319)
T ss_pred ccccccCcccccchHHHHHHH---hhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHH
Confidence 5789999997 3344444434 78999999999995 466677888899999999998873 345678
Q ss_pred CCCCCCEEEccCCCCCC-CcccccCCCC---CCEEECCCCCCCC-CcccchhhhcCC-CCCcEEEccCCCCC-----ccC
Q 001143 112 NLLGLECLQIKISSPGV-NGFALNKLKG---LKELELSKVPPRP-SVLTLLSEIAGL-KCLTKLSVCHFSIR-----YLP 180 (1141)
Q Consensus 112 ~L~~L~~L~Ls~N~l~~-~~~~~~~L~~---L~~L~Ls~N~ln~-~~~~lp~~l~~L-~~L~~L~Ls~N~L~-----~iP 180 (1141)
.+++|+.|+|++|.+.. .+..+..+.+ |++|++++|.+.. ....+...+..+ ++|+.|++++|.++ .++
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 89999999999999763 4445555555 9999999977653 122334456677 89999999999998 344
Q ss_pred ccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCC-----cCCcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 181 PEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~-----~IP~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
..+..+.+|+.|+|++|.|+ .++..+..+++|+.|+|++|.++ .++..+..+++|+.|+|++|.++....
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 55677789999999999998 34556777789999999999997 345567778999999999999996433
Q ss_pred ccccC-----CCCCCEEEccCCcCCC--CCCCchhhhhcccCCCCCCCCCCccc
Q 001143 251 LDLCL-----MHNLQNLNLQYNKLLS--YCQVPSWICCNLEGNGKDSSNDDFIS 297 (1141)
Q Consensus 251 ~~l~~-----L~~L~~L~Ls~N~L~~--~~~iP~~~~~~l~~~~l~~~~n~l~~ 297 (1141)
..+.. .+.|+.|++++|.++. ...+...+........++.+.|.+..
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 33332 3799999999999873 11233333334455666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-16 Score=180.63 Aligned_cols=186 Identities=23% Similarity=0.292 Sum_probs=136.5
Q ss_pred ceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEE
Q 001143 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975 (1141)
Q Consensus 896 ~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vK 975 (1141)
.++||.|++|.-.+|.+||.+. ......++...+.++.|++.|++| ++.+|+|+||.||++..+ ..+|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-------~q~k 396 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-------DQLK 396 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-------hhhh
Confidence 3579999999999999999752 223457888999999999999999 999999999999999877 6799
Q ss_pred EeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH
Q 001143 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 1054 (1141)
Q Consensus 976 L~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG-k~Pf~~~~~ 1054 (1141)
|+|||+............ ........+||..||+||.+.+ ..|+.|+||||||++|+|++.- ..+|. .
T Consensus 397 IgDFgl~ts~~~~~~~~~----~~a~~t~~~gt~~YmsPEQi~g----~~y~~kvdIyaLGlil~EL~~~f~T~~e---r 465 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAP----AAASHTQQVGTLLYMSPEQIRG----QQYSEKVDIYALGLILAELLIQFSTQFE---R 465 (516)
T ss_pred hhhhhheeecccCCcccc----hhhhhhhcccccccCCHHHHhh----hhhhhhcchhhHHHHHHHHHHHhccHHH---H
Confidence 999999876554331100 0112234579999999999997 6799999999999999999972 22221 1
Q ss_pred HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1055 ~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
......+..+..|+... ...+.-..|+.+|+.+.|.+||++.+..-|.|.
T Consensus 466 ~~t~~d~r~g~ip~~~~---------------------------~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFL---------------------------QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHhhhhhhcCCCChHHh---------------------------hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11233344444332111 111234688999999999999988777666654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.6e-17 Score=186.53 Aligned_cols=204 Identities=28% Similarity=0.404 Sum_probs=168.1
Q ss_pred cccccCCCCCccccCCCCCC-CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 19 KEKLPSEANKINNEKNGSVN-DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~-~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
.+.+.+..-+++.-+-+.+. ++..-...||+.|++..+ |..+..| ..|+.|.|+.|.|..||..+.+|..|++||
T Consensus 52 sg~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~el-p~~~~~f---~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ 127 (722)
T KOG0532|consen 52 SGRLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSEL-PEEACAF---VSLESLILYHNCIRTIPEAICNLEALTFLD 127 (722)
T ss_pred hcccccccchhhcCCCccccccccchhhhhccccccccC-chHHHHH---HHHHHHHHHhccceecchhhhhhhHHHHhh
Confidence 34455656666666655544 566777899999999865 4445555 789999999999999999999999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001143 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1141)
Q Consensus 98 Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1141)
|+.|+|+.+|..++.|+ |+.|-+++|+++.+| ..++.+..|.+|+.+.|.|.
T Consensus 128 ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~~lp---------------------------~~ig~~~tl~~ld~s~nei~ 179 (722)
T KOG0532|consen 128 LSSNQLSHLPDGLCDLP-LKVLIVSNNKLTSLP---------------------------EEIGLLPTLAHLDVSKNEIQ 179 (722)
T ss_pred hccchhhcCChhhhcCc-ceeEEEecCccccCC---------------------------cccccchhHHHhhhhhhhhh
Confidence 99999999999998764 777777766655544 45556677888999999999
Q ss_pred ccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCC
Q 001143 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1141)
Q Consensus 178 ~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L 256 (1141)
.+|..++.+.+|+.|.+..|++..+|.+++.|+ |..||+|.|+++.||-.|.+|+.|++|-|.+|.|+..+. .++..
T Consensus 180 slpsql~~l~slr~l~vrRn~l~~lp~El~~Lp-Li~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSPPA-qIC~k 256 (722)
T KOG0532|consen 180 SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLP-LIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSPPA-QICEK 256 (722)
T ss_pred hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCc-eeeeecccCceeecchhhhhhhhheeeeeccCCCCCChH-HHHhc
Confidence 999999999999999999999999999998665 899999999999999999999999999999999997765 55443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.5e-15 Score=156.35 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=105.5
Q ss_pred ceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChH--------------HHHHhHHhHHHHHHHHhhCCCCC--
Q 001143 808 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHSC-- 870 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~--------------~~~~~~~~~~~Ei~iL~~L~HpN-- 870 (1141)
|.+.+.||+|+||.||+|.+ .+..+++|+........... ........+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67789999999999999988 57889999866432111000 00011123478999999998774
Q ss_pred ccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 001143 871 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950 (1141)
Q Consensus 871 IVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIv 950 (1141)
++..++. . ..++||||++|++|...... .....++.+++.++.++|+.||+
T Consensus 97 v~~~~~~----~--------------~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 97 VPKPIDW----N--------------RHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCceeec----C--------------CceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 3443321 1 12899999999998765321 23567889999999999999999
Q ss_pred ccCCCCCCeeeecccccCCCCCeEEEeecccccccc
Q 001143 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1141)
Q Consensus 951 HrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~ 986 (1141)
||||||+||+++.+ +.++|+|||.+....
T Consensus 148 H~Dl~p~Nill~~~-------~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDD-------EKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCC-------CcEEEEECCccccCC
Confidence 99999999999876 789999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-13 Score=151.60 Aligned_cols=146 Identities=15% Similarity=0.185 Sum_probs=105.4
Q ss_pred eeeec-ccCceEEEEEEECCccEEEEEEecccC-----CCChHHHHHhHHhHHHHHHHHhhCCCCCc--cceeeeEecCC
Q 001143 811 CDEAG-KSVSSSLFRCKFGSADAAAKVRTLKVC-----GSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSK 882 (1141)
Q Consensus 811 ~~~LG-~GsfG~Vy~a~~~~~~vAvKI~~l~~~-----~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI--Vkllg~~~~~~ 882 (1141)
...|| .|+.|+||.+...+..+++|.+..... ............++.+|++++.++.|++| ++.+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45677 888899999988888899988742110 00000001112345899999999998775 67777644322
Q ss_pred CCCCCCCCCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~g-gSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. .....++||||++| .+|.+++.. ..++... +.||+.+|.+||++||+||||||.|||+
T Consensus 116 ~----------~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 116 G----------LFYRADILIERIEGARDLVALLQE------APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred C----------cceeeeEEEEecCCCCCHHHHHhc------CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 1 12234799999997 699988764 2355443 5789999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccc
Q 001143 962 DLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
+.+ +.++|+|||.+.
T Consensus 176 ~~~-------~~v~LIDfg~~~ 190 (239)
T PRK01723 176 DPD-------GKFWLIDFDRGE 190 (239)
T ss_pred cCC-------CCEEEEECCCcc
Confidence 876 679999999874
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-14 Score=170.49 Aligned_cols=193 Identities=35% Similarity=0.400 Sum_probs=99.9
Q ss_pred EEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCC-CCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCC
Q 001143 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLL-GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP 151 (1141)
Q Consensus 73 L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~ 151 (1141)
|+++.|.+..-+..+..++.++.|++.+|.++.||.....++ +|+.|+++.|.+..++..+..+++|+.|++++|++.
T Consensus 98 l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~- 176 (394)
T COG4886 98 LDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS- 176 (394)
T ss_pred eeccccccccCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-
Confidence 444444443222333344444555555555554444444442 455555555554444444444555555555543332
Q ss_pred CcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccC
Q 001143 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231 (1141)
Q Consensus 152 ~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~ 231 (1141)
.+|...+.++.|+.|++++|+++.+|..+..+..|..|.+++|.+..++..+..+.++..|.+++|++..+|..++.
T Consensus 177 ---~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~ 253 (394)
T COG4886 177 ---DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGN 253 (394)
T ss_pred ---hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccchhcc
Confidence 22323334555555666666666555544444456666666665545555555555566666666666555555555
Q ss_pred CCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 232 L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+++|+.|++++|+++.+.+ +..+.+|+.|++++|.+..
T Consensus 254 l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 254 LSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred ccccceecccccccccccc--ccccCccCEEeccCccccc
Confidence 5556666666666665544 5555566666666665554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.7e-15 Score=186.08 Aligned_cols=267 Identities=22% Similarity=0.227 Sum_probs=192.3
Q ss_pred CCCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~ 881 (1141)
+...|.+.+.||+|+|+.|-.+.. .....+++.+.+........... +...|..+-..+. |+|++.+++...+.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~----~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSE----HIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhh----hcCccccccccccccccccccCCccCCC
Confidence 356688889999999999988775 34444555544444332222222 2356888888886 99999999987765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENIL 960 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH-s~gIvHrDLKP~NIL 960 (1141)
... +++++|..|+++.+-+.. ......+...+..++.|+..++.|+| ..++.|+||||+|.+
T Consensus 94 ~~~--------------~~~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 94 RSY--------------LLSLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred ccc--------------ccccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 543 899999999999988831 12225677788899999999999999 999999999999999
Q ss_pred eecccccCCCCC-eEEEeeccccccccccccccccccCCCCCCCCccC-CCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 961 IDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 961 ld~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~G-T~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
++.. + ..++.|||+|..+...... ........| ++.|+|||...+. ....+..|+||.|++
T Consensus 157 l~~s-------~~~l~~~df~~At~~~~~~g~-------~~~~~~~~g~s~~y~a~E~~~~~---~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 157 LDES-------GSALKIADFGLATAYRNKNGA-------ERSLKDRCGSSPPYGAPEHLSGK---AYRGPSVDVWSLGIV 219 (601)
T ss_pred hccC-------CCcccCCCchhhccccccCCc-------ceeeecccCCCCCCCCcccccch---hhcCCCccccccccc
Confidence 9887 5 8999999999876552111 111223457 9999999998762 344689999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHH--HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1039 LLELLTLQVPYMGLSELEIH--DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~--~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+.-+++|..||......+.. ..+..... .....-........+++.+++..+|
T Consensus 220 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~l~k~l~~~~ 274 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSRKDGRYSSWKSNKGR-------------------------FTQLPWNSISDQAHDLLHKILKENP 274 (601)
T ss_pred ccccccCCCCccccccccccceeecccccc-------------------------cccCccccCChhhhhcccccccCCc
Confidence 99999999999754332210 00000000 0000001445567888999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001143 1117 TERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~ 1133 (1141)
..|.+.+++..+.|...
T Consensus 275 ~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 275 SNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhccccccccccccccc
Confidence 99999999999998876
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.2e-13 Score=142.19 Aligned_cols=142 Identities=15% Similarity=0.191 Sum_probs=94.9
Q ss_pred eeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHH----------------HHhHHhHHHHHHHHhhCCCCC--c
Q 001143 811 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEI----------------RNFEYSCLGEVRMLGALRHSC--I 871 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~----------------~~~~~~~~~Ei~iL~~L~HpN--I 871 (1141)
.+.||+|+||+||+|.+. +..+++|+.+........... .........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999986 788999986543221111000 000011135666666664332 3
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHH-HHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q 001143 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 949 (1141)
Q Consensus 872 Vkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~-~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gI 949 (1141)
.+.++.. ..++||||++++++.. .+... ... ..+..++.+++.++.++|. .||
T Consensus 82 ~~~~~~~------------------~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~~i 136 (187)
T cd05119 82 PKPIDLN------------------RHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREAGL 136 (187)
T ss_pred CceEecC------------------CCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhccCc
Confidence 3333321 2389999999854321 12210 011 6678899999999999999 999
Q ss_pred cccCCCCCCeeeecccccCCCCCeEEEeeccccccc
Q 001143 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 985 (1141)
Q Consensus 950 vHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l 985 (1141)
+||||||+||+++ + +.++|+|||.+...
T Consensus 137 vH~Dl~p~Nili~-~-------~~~~liDfg~a~~~ 164 (187)
T cd05119 137 VHGDLSEYNILVD-D-------GKVYIIDVPQAVEI 164 (187)
T ss_pred CcCCCChhhEEEE-C-------CcEEEEECcccccc
Confidence 9999999999998 5 78999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.6e-14 Score=164.31 Aligned_cols=200 Identities=30% Similarity=0.339 Sum_probs=176.6
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCc-CCcEEEccCCCCCcCchhhcCCCCCCEEEccC
Q 001143 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1141)
Q Consensus 45 ~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~-~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~ 123 (1141)
.|+++.|.+...+.. +..++.++.|++.+|.++.||.....+. +|+.|++++|+|..+|..++++++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~~----~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNISE----LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCchh----hhcccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCC
Confidence 688888888555443 2334789999999999999999888885 99999999999999998999999999999999
Q ss_pred CCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccc
Q 001143 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP 203 (1141)
Q Consensus 124 N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP 203 (1141)
|++..++.....+++|+.|++++|.+ ..+|.....+..|+.|.+++|.+..++..+.++.++..|.+.+|++..+|
T Consensus 173 N~l~~l~~~~~~~~~L~~L~ls~N~i----~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~ 248 (394)
T COG4886 173 NDLSDLPKLLSNLSNLNNLDLSGNKI----SDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP 248 (394)
T ss_pred chhhhhhhhhhhhhhhhheeccCCcc----ccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeecc
Confidence 99999998777999999999999655 45565555666799999999987777888899999999999999999989
Q ss_pred ccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccc
Q 001143 204 TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253 (1141)
Q Consensus 204 ~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l 253 (1141)
..++.+++|+.|++++|.++.++. ++.+.+|+.|++++|.++..++...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhccccccceecccccccccccc-ccccCccCEEeccCccccccchhhh
Confidence 999999999999999999999987 9999999999999999999988543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.8e-13 Score=131.26 Aligned_cols=132 Identities=20% Similarity=0.230 Sum_probs=104.2
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC--CCccceeeeEecCCCCCCC
Q 001143 810 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkllg~~~~~~~~~~~ 887 (1141)
+.+.||+|.++.||++...+..+++|+..... . ... +.+|+.++..++| +++++++++....+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~--~----~~~----~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSRE--K----GAD----REREVAILQLLARKGLPVPKVLASGESDG----- 66 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCC--c----hhH----HHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----
Confidence 45789999999999999988888888753221 1 122 3789999999975 58888887765432
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCeeeecc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILIDLE 964 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---gIvHrDLKP~NILld~~ 964 (1141)
..+++|||++|+.+..+ +......++.+++.++.++|.. +++|||++|.||+++..
T Consensus 67 ---------~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 67 ---------WSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ---------ccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 34999999998766533 4456677889999999999984 79999999999999875
Q ss_pred cccCCCCCeEEEeecccccc
Q 001143 965 RKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~ 984 (1141)
+.++++|||.+..
T Consensus 126 -------~~~~l~Df~~~~~ 138 (155)
T cd05120 126 -------KILGIIDWEYAGY 138 (155)
T ss_pred -------cEEEEEecccccC
Confidence 7899999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.2e-12 Score=156.03 Aligned_cols=91 Identities=29% Similarity=0.430 Sum_probs=68.1
Q ss_pred CCEEEccCCccc-cccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccC
Q 001143 189 LEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1141)
Q Consensus 189 L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~ 266 (1141)
++.|+|++|.|+ .+|..++.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+|.+|..+..|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 567777777777 67777777777777777777776 6777777777777777777777777777777777777777777
Q ss_pred CcCCCCCCCchhhhh
Q 001143 267 NKLLSYCQVPSWICC 281 (1141)
Q Consensus 267 N~L~~~~~iP~~~~~ 281 (1141)
|+|++ .+|..+..
T Consensus 500 N~l~g--~iP~~l~~ 512 (623)
T PLN03150 500 NSLSG--RVPAALGG 512 (623)
T ss_pred Ccccc--cCChHHhh
Confidence 77776 57766553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=123.97 Aligned_cols=143 Identities=14% Similarity=0.105 Sum_probs=102.9
Q ss_pred eeeecccCceEEEEEEEC--------CccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHHHh
Q 001143 811 CDEAGKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLG 864 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~--------~~~vAvKI~~l~~~~~~~------------------~~~~~~~~~~~~Ei~iL~ 864 (1141)
...||.|--+.||.|... +..+|+|+++........ ...+.+..+..+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999754 368999997754321111 112223334569999999
Q ss_pred hCC--CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHH-HHHHhhhcCCCCCCHHHHHHHHHHHHHHH
Q 001143 865 ALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAAL 941 (1141)
Q Consensus 865 ~L~--HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~-~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL 941 (1141)
++. .-++.+++++.. -+|||||+.+..+.. .+++ ..++..+...+..|++.+|
T Consensus 82 rl~~~Gv~vP~pi~~~~------------------~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 82 RMQKAGIPCPEVVVLKK------------------HVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred HHHHcCCCCCeEEEecC------------------CEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHH
Confidence 995 456777776521 289999997654422 2222 2355667778889999999
Q ss_pred HHH-HHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccc
Q 001143 942 VEL-HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 985 (1141)
Q Consensus 942 ~yL-Hs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l 985 (1141)
..| |..|||||||++.||+++. +.++|+|||.+...
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~~--------~~v~iIDF~qav~~ 174 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWHD--------GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEEC--------CcEEEEECCCceeC
Confidence 999 8999999999999999974 56999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-12 Score=155.06 Aligned_cols=220 Identities=27% Similarity=0.245 Sum_probs=125.2
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCC
Q 001143 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117 (1141)
Q Consensus 38 ~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~ 117 (1141)
..+..+..++|..|.|.... ..++.+++|..|+|.+|+|..+...+..+++|++|+|++|+|+.+. .+..|+.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~----~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~-~l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKIL----NHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE-GLSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhhhhh----cccccccceeeeeccccchhhcccchhhhhcchheecccccccccc-chhhccchh
Confidence 34455556666666665411 1133446777777777777766544666777777777777777663 255566677
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCC
Q 001143 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN 197 (1141)
Q Consensus 118 ~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N 197 (1141)
.|++++|.+..+.. +..+.+|+.|++++|.+...... . ...+..|+.+++.+|.+..+ ..+..+..+..+++..|
T Consensus 144 ~L~l~~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~--~-~~~~~~l~~l~l~~n~i~~i-~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 144 ELNLSGNLISDISG-LESLKSLKLLDLSYNRIVDIEND--E-LSELISLEELDLGGNSIREI-EGLDLLKKLVLLSLLDN 218 (414)
T ss_pred hheeccCcchhccC-CccchhhhcccCCcchhhhhhhh--h-hhhccchHHHhccCCchhcc-cchHHHHHHHHhhcccc
Confidence 77777777665543 33366666666666554322221 0 34455666666666666644 22333444444566666
Q ss_pred ccccccccccCCCC--CCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCC
Q 001143 198 KMKYLPTEICYLKA--LISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270 (1141)
Q Consensus 198 ~L~~iP~~l~~l~~--L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~ 270 (1141)
.++.+ ..+..+.. |+.+++++|.+..+|..+..+.++..|++++|+++..- .+...+.+..+.+..|++.
T Consensus 219 ~i~~~-~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 219 KISKL-EGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cceec-cCcccchhHHHHHHhcccCccccccccccccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence 66644 22222333 66666666666666555556666666666666666553 2444555555666666554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.4e-11 Score=133.34 Aligned_cols=214 Identities=21% Similarity=0.236 Sum_probs=144.3
Q ss_pred HHHhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 001143 861 RMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 940 (1141)
Q Consensus 861 ~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~g 940 (1141)
.-+.++-|.|||+++.|+.+.++ ...+...+++||+..|++..++++..... ..+......+|.-||+.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~---------~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKY---------EEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHHhhccccc---------ccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhh
Confidence 34556679999999999987543 13456789999999999999999876554 578899999999999999
Q ss_pred HHHHHHC--CccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001143 941 LVELHSK--HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018 (1141)
Q Consensus 941 L~yLHs~--gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1018 (1141)
|.|||+. .|+|+++..+-|++..+ +-+|++--... ........... .......+-++|.|||.=.
T Consensus 189 l~yLhs~~PpiihgnlTc~tifiq~n-------gLIkig~~ap~-s~h~s~~~~~~-----~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 189 LSYLHSCDPPIIHGNLTCDTIFIQHN-------GLIKIGSVAPD-STHPSVNSTRE-----AEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred hhhhhccCCccccCCcchhheeecCC-------ceEEecccCcc-ccchhhhhhhH-----hhhhccccCCccccCCcCc
Confidence 9999976 69999999999999876 55665421111 11110011000 0111224677899999743
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1019 ~~~~~~~~s~ksDVWSLGviL~ELLTGk~P-f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
. ...+.++|||+||....||..+..- -.+.+..+....+......
T Consensus 256 ~----tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~------------------------------ 301 (458)
T KOG1266|consen 256 T----TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG------------------------------ 301 (458)
T ss_pred c----cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee------------------------------
Confidence 2 3456789999999999999887532 2222222222222111100
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
-....-++++.+|++..|..||+|.+++-|+...
T Consensus 302 -len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 302 -LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred -ccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 0001134568999999999999999999987543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.3e-12 Score=152.02 Aligned_cols=238 Identities=23% Similarity=0.205 Sum_probs=185.7
Q ss_pred ccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEcc
Q 001143 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF 99 (1141)
Q Consensus 20 ~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls 99 (1141)
..+.+..|.|..+ .+.+..+.+|..|+|.+|+|..+... +..+.+|++|+|++|+|+.| ..+..++.|+.|+++
T Consensus 75 ~~l~l~~n~i~~~-~~~l~~~~~l~~l~l~~n~i~~i~~~----l~~~~~L~~L~ls~N~I~~i-~~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 75 KELNLRQNLIAKI-LNHLSKLKSLEALDLYDNKIEKIENL----LSSLVNLQVLDLSFNKITKL-EGLSTLTLLKELNLS 148 (414)
T ss_pred Hhhccchhhhhhh-hcccccccceeeeeccccchhhcccc----hhhhhcchheeccccccccc-cchhhccchhhheec
Confidence 3344555666652 45578889999999999999876531 34559999999999999998 457788889999999
Q ss_pred CCCCCcCchhhcCCCCCCEEEccCCCCCCCccc-ccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001143 100 GNEINLFPSEVGNLLGLECLQIKISSPGVNGFA-LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1141)
Q Consensus 100 ~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~-~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1141)
+|.|+.++. +..++.|+.+++++|.+..+... ...+.+|+.|++.+|.+.... .+..+..+..+++..|.++.
T Consensus 149 ~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~-----~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 149 GNLISDISG-LESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE-----GLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred cCcchhccC-CccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc-----chHHHHHHHHhhccccccee
Confidence 999998854 66699999999999998877765 588999999999997764332 33445556666999999997
Q ss_pred cCccccCCCC--CCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCC---Cccc-
Q 001143 179 LPPEIGCLSN--LEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL---GSLD- 252 (1141)
Q Consensus 179 iP~~l~~l~~--L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~---~p~~- 252 (1141)
+ ..+..+.. |+.|++++|.+..++..+..+..+..|++++|++..+. .+.....+..+.++.|.+... ....
T Consensus 223 ~-~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (414)
T KOG0531|consen 223 L-EGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE-GLERLPKLSELWLNDNKLALSEAISQEYI 300 (414)
T ss_pred c-cCcccchhHHHHHHhcccCccccccccccccccccccchhhccccccc-cccccchHHHhccCcchhcchhhhhcccc
Confidence 6 22334444 89999999999998888899999999999999998663 344566778888888887732 2222
Q ss_pred ccCCCCCCEEEccCCcCCC
Q 001143 253 LCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~ 271 (1141)
....+.+..+.+.+|++..
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 301 TSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred ccccccccccccccCcccc
Confidence 5677899999999999877
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-11 Score=128.60 Aligned_cols=130 Identities=20% Similarity=0.167 Sum_probs=43.6
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhc-CCCC
Q 001143 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVG-NLLG 115 (1141)
Q Consensus 37 f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~-~L~~ 115 (1141)
+.+...++.|+|++|+|+.+- .++. .+.+|+.|+|++|.|+.|+ .+..++.|+.|+|++|.|+.+++.+. .+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~--~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGA--TLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--T--T-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-TT
T ss_pred ccccccccccccccccccccc--chhh--hhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCCc
Confidence 445556777888888777531 2221 3467788888888887774 46777778888888888887765553 5777
Q ss_pred CCEEEccCCCCCCCcc--cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001143 116 LECLQIKISSPGVNGF--ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1141)
Q Consensus 116 L~~L~Ls~N~l~~~~~--~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~L 171 (1141)
|+.|+|++|++..+.. .+..+++|+.|+|.+|++.....--...+..+|+|+.||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 8888887777665543 3555666666666666554333222334455666666654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.7e-11 Score=139.67 Aligned_cols=257 Identities=22% Similarity=0.193 Sum_probs=176.4
Q ss_pred ceEeeeecc--cCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001143 808 LSSCDEAGK--SVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1141)
Q Consensus 808 y~i~~~LG~--GsfG~Vy~a~~----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~ 880 (1141)
+.+.+.+|. |.+|.||.+.. ....+|+|.-+.... ........ .+|+....+++ |+|.++.+..+..
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k-----~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRK-----LREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCC-Cccccccc-----cchhhcccccCccccccccCccccc
Confidence 467788999 99999999876 344455554222211 11111222 47777777885 9999998888777
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCC
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA----ALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~----gL~yLHs~gIvHrDLKP 956 (1141)
.+.. ++-+|++. .+|.++.+. ....++...++.++.+... ||.++|+.+++|-|+||
T Consensus 190 ~~~l--------------fiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp 250 (524)
T KOG0601|consen 190 SGIL--------------FIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKP 250 (524)
T ss_pred CCcc--------------eeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCcccccccch
Confidence 6644 88899985 788877764 2334788888888999888 99999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
.||+...+. ..++++|||....+....-..... ......|...|++||...+ .++...|+|++|
T Consensus 251 ~~i~~~~~~------~s~~~~df~~v~~i~~~~~~~~~~-----~~~r~~~~~~Y~~ke~~~~-----l~~~~~di~sl~ 314 (524)
T KOG0601|consen 251 ANIFTTSDW------TSCKLTDFGLVSKISDGNFSSVFK-----VSKRPEGDCIYAAKELLNG-----LATFASDIFSLG 314 (524)
T ss_pred hheeccccc------ceeecCCcceeEEccCCcccccee-----eeecCCCCceEeChhhhcc-----ccchHhhhcchh
Confidence 999997762 578999999988776543211100 0011146778999999875 678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
.++.+..++..++...-. .....+..+. + ..+.-...+.++...+..|++.+|
T Consensus 315 ev~l~~~l~~~~~~~g~~-~~W~~~r~~~---i-----------------------p~e~~~~~s~~l~~~~~~~~d~~~ 367 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKN-SSWSQLRQGY---I-----------------------PLEFCEGGSSSLRSVTSQMLDEDP 367 (524)
T ss_pred hhhHhhHhhcccccCCCC-CCcccccccc---C-----------------------chhhhcCcchhhhhHHHHhcCcch
Confidence 999999988766542100 0011111110 0 111111333446668999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
..|++++.+.++.+..
T Consensus 368 ~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIH 383 (524)
T ss_pred hhhhHHHHHhcccccc
Confidence 9999999998876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.5e-11 Score=151.71 Aligned_cols=272 Identities=22% Similarity=0.248 Sum_probs=181.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.+++.+.+.+-+-.|+++.++.++-.+. ..+.++......... .+.+.. ..+-.++...+||-++...--+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~----r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESI----RSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-cccccc----CCccCccccCCCCceecccCCCCC
Confidence 4677889999999999999998765322 223333211110000 111111 233333333445666654433222
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..+|||+|+.+++|...++.. ...+..-++.....+..+++|||+..+.|+|++|.|++
T Consensus 876 rs--------------P~~L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 876 RS--------------PLPLVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL 936 (1205)
T ss_pred CC--------------CcchhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccchhhcccccccchh
Confidence 11 348999999999999999862 24666667777888899999999999999999999999
Q ss_pred eecccccCCCCCeEEEeecccccccccccccc--------------c-------cccCCCCCCCCccCCCcccchhhhcc
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTC--------------C-------IAHRGIPAPDVCVGTPRWMAPEVLRA 1019 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~--------------~-------~~~~~~~~~~~~~GT~~Y~APE~l~~ 1019 (1141)
+..+ +..++.|||............ . .............||+.|.+||...+
T Consensus 937 ~~~~-------gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 937 IAYD-------GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred hccc-------CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 9887 789999998443221110000 0 00000011234579999999999987
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 001143 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1099 (1141)
Q Consensus 1020 ~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1141)
......+|+|++|++++|.++|.+||......++++.|..+..+.. +-...
T Consensus 1010 ----~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p-------------------------~g~~~ 1060 (1205)
T KOG0606|consen 1010 ----RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWP-------------------------EGPEE 1060 (1205)
T ss_pred ----ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCC-------------------------CCccc
Confidence 4456889999999999999999999998888877776654443221 11124
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHH---HHHHHHHhhcC
Q 001143 1100 TLSFLVDVFRRCTEENPTERPTAG---DLYEMFVARTS 1134 (1141)
Q Consensus 1100 ~~~~L~dLI~~cL~~DP~~RPSa~---ElL~~L~~~~~ 1134 (1141)
.+....+++...+..+|.+|..+. ++-.|.+|...
T Consensus 1061 ~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred cChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 556688999999999999998776 77777776543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-11 Score=133.09 Aligned_cols=201 Identities=24% Similarity=0.202 Sum_probs=137.0
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCC-CCCCc---ccccCCCCCCEEE
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNG---FALNKLKGLKELE 143 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~-l~~~~---~~~~~L~~L~~L~ 143 (1141)
.+|..+.+|...-..|-.-...-|-|+.|.+.+..++..|.-+ -.+.+. |...-. -+..+ ..+..+..|++|+
T Consensus 214 ~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~-pe~~~~--D~~~~E~~t~~G~~~~~~dTWq~LtelD 290 (490)
T KOG1259|consen 214 RNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLL-PETILA--DPSGSEPSTSNGSALVSADTWQELTELD 290 (490)
T ss_pred hhhheeeeeccchhheeceeecCchhheeeeeccccccccccc-chhhhc--CccCCCCCccCCceEEecchHhhhhhcc
Confidence 5566666665544444222223345777777666655332211 111111 222222 11111 2345566789999
Q ss_pred CCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCC
Q 001143 144 LSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV 223 (1141)
Q Consensus 144 Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~ 223 (1141)
|++|.+. .+-.++.-++.++.|++++|.|..+-. +..|++|+.||||+|.|+.+..+=..+.+++.|.|++|.|.
T Consensus 291 LS~N~I~----~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE 365 (490)
T KOG1259|consen 291 LSGNLIT----QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIE 365 (490)
T ss_pred ccccchh----hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHh
Confidence 9996654 334455667889999999999998744 88899999999999999988766667788999999999998
Q ss_pred cCCcCccCCCCCCEEeCCCCCCCCCCcc-cccCCCCCCEEEccCCcCCCCCCCchhhh
Q 001143 224 ELPSGLYLLQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1141)
Q Consensus 224 ~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~-~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1141)
.+. ++..|-+|..||+++|+|...... .+++||.|+.|.|.+|||.+ +|+.-.
T Consensus 366 ~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~---~vdYRT 419 (490)
T KOG1259|consen 366 TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG---SVDYRT 419 (490)
T ss_pred hhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc---cchHHH
Confidence 874 688888999999999999866432 48899999999999999988 554433
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.6e-11 Score=139.20 Aligned_cols=203 Identities=19% Similarity=0.143 Sum_probs=111.6
Q ss_pred CCCccEEEeecCCCCccCc--cccCCcCCcEEEccCCCCCcCc---hhhcCCCCCCEEEccCCCCCCCc--ccccCCCCC
Q 001143 67 DNSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLFP---SEVGNLLGLECLQIKISSPGVNG--FALNKLKGL 139 (1141)
Q Consensus 67 L~~L~~L~Ls~N~Lt~iP~--~l~~L~~L~~L~Ls~N~L~~lP---~~~~~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L 139 (1141)
+.+|+...|.+....-.+. ....+++++.||||.|-|..+- .-...|++|+.|+|+.|++...- ..-..+..|
T Consensus 120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~l 199 (505)
T KOG3207|consen 120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHL 199 (505)
T ss_pred HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhh
Confidence 3455555555554443331 3445555555555555554331 11334555555555555533221 112245556
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC-CCccCccccCCCCCCEEEccCCcccccc--ccccCCCCCCEEE
Q 001143 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLK 216 (1141)
Q Consensus 140 ~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~-L~~iP~~l~~l~~L~~L~Ls~N~L~~iP--~~l~~l~~L~~L~ 216 (1141)
+.|.|+...++. ..+-..+..+|+|++|+|..|. +..--.....+..|+.|+|++|++-..+ ..++.++.|..|+
T Consensus 200 K~L~l~~CGls~--k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 200 KQLVLNSCGLSW--KDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred heEEeccCCCCH--HHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 666666654432 1222334456777777777774 2211112244567777777777777665 4567777777777
Q ss_pred ccCCCCCcC--CcC-----ccCCCCCCEEeCCCCCCCCCCc-ccccCCCCCCEEEccCCcCCC
Q 001143 217 VANNKLVEL--PSG-----LYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 217 Ls~N~L~~I--P~~-----l~~L~~L~~L~Ls~N~Lt~~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
++.+.+.+| |+. ...+++|++|+++.|++..... ..+..+++|+.|.+..|+|+.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 777777644 543 3346777777777777754332 134455666777777777765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.6e-10 Score=138.05 Aligned_cols=149 Identities=15% Similarity=0.155 Sum_probs=96.1
Q ss_pred eeecccCceEEEEEEE-CCccEEEEEEecccCCCC--------------------------hHHHHHhHH------hHHH
Q 001143 812 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS--------------------------ADEIRNFEY------SCLG 858 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~--------------------------~~~~~~~~~------~~~~ 858 (1141)
+.||.|++|.||+|+. .+..||||+.+-.....- ....+++.. .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999997 578899999643211000 011112222 2345
Q ss_pred HHHHHhhCC----CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHH
Q 001143 859 EVRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934 (1141)
Q Consensus 859 Ei~iL~~L~----HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia 934 (1141)
|+..+.+++ |.+-+.+-..+.+. ....+|||||++|++|.++.... .. .. ....++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-------------~~~~vLvmE~i~G~~L~~~~~~~-~~---~~---~~~~ia 262 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-------------TSERVLTMEWIDGIPLSDIAALD-EA---GL---DRKALA 262 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-------------cCCceEEEEeECCcccccHHHHH-hc---CC---CHHHHH
Confidence 565555552 22222222222211 11238999999999998876531 11 12 234566
Q ss_pred HHHHH-HHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccc
Q 001143 935 QDVAA-ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 987 (1141)
Q Consensus 935 ~QIa~-gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~ 987 (1141)
.+++. .+..+|..|++|+|+||.||+++.+ +.++++|||++..+..
T Consensus 263 ~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-------g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 263 ENLARSFLNQVLRDGFFHADLHPGNIFVLKD-------GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHhCCceeCCCCcccEEECCC-------CcEEEEeCCCeeECCH
Confidence 66666 4788999999999999999999877 7899999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-10 Score=140.61 Aligned_cols=166 Identities=14% Similarity=0.184 Sum_probs=98.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCC--------------------------CChHHHHHhHHhH
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG--------------------------SSADEIRNFEYSC 856 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~--------------------------~~~~~~~~~~~~~ 856 (1141)
+..|+. +.||.|++|.||+|+.. ++.||||+.+-.... ......+++...+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445666 78999999999999974 788999997532100 0111233444455
Q ss_pred HHHHHHHhhCCCCCccceeeeEecCCCC--CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC--CCCCCHHHHHH
Q 001143 857 LGEVRMLGALRHSCIVEMYGHKISSKWL--PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALF 932 (1141)
Q Consensus 857 ~~Ei~iL~~L~HpNIVkllg~~~~~~~~--~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~--~~~Ls~~~i~~ 932 (1141)
.+|+.+.... +|+.++...|.+...+ |.. ........+|||||++|+.+.++-.- ...+ ...+....+..
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v---~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEV---YWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeeccee---ecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHH
Confidence 5555554444 3444444433322211 000 00011234799999999999875321 1111 11233333444
Q ss_pred HHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccc
Q 001143 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 987 (1141)
Q Consensus 933 Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~ 987 (1141)
++.|| +..|++|+|+||.||+++.++. ..+.++++|||++..+..
T Consensus 272 ~~~Qi-------f~~GffHaDpHPGNIlv~~~g~---~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQV-------FRDGFFHADMHPGNIFVSYDPP---ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHH-------HhCCeeeCCCChHHeEEecCCC---CCCeEEEEecceEEECCH
Confidence 44444 4689999999999999987621 123899999999977654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.5e-10 Score=116.05 Aligned_cols=127 Identities=16% Similarity=0.199 Sum_probs=91.9
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCc-cceeeeEecCCCCCCCCC
Q 001143 811 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkllg~~~~~~~~~~~~g 889 (1141)
.+.|+.|.++.||+++..+..+++|+..... ..... +.+|+.++..+.+.++ .+++.+...
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~-----~~~~~----~~~E~~~l~~l~~~~~~P~~~~~~~~--------- 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGT-----ELLIN----RENEAENSKLAAEAGIGPKLYYFDPE--------- 64 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCc-----ccccC----HHHHHHHHHHHHHhCCCCceEEEeCC---------
Confidence 4678999999999999988889998753221 01112 2578999988865444 445544321
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCCeeeecc
Q 001143 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI-----MHRDIKSENILIDLE 964 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gI-----vHrDLKP~NILld~~ 964 (1141)
..++||||++|.++... . .....++.+++.+|..||+.++ +|||++|.||+++ +
T Consensus 65 -------~~~lv~e~i~G~~l~~~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 65 -------TGVLITEFIEGSELLTE--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred -------CCeEEEEecCCCccccc--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 12799999998877542 0 0113456789999999999885 9999999999998 3
Q ss_pred cccCCCCCeEEEeeccccc
Q 001143 965 RKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~ 983 (1141)
+.++++|||.+.
T Consensus 124 -------~~~~liDf~~a~ 135 (170)
T cd05151 124 -------GRLWLIDWEYAG 135 (170)
T ss_pred -------CeEEEEeccccc
Confidence 569999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-09 Score=111.39 Aligned_cols=153 Identities=22% Similarity=0.241 Sum_probs=109.9
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCC
Q 001143 810 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g 889 (1141)
....+-+|+-+.|+++.+.++...+|-...+.-..+.-+.+--..+..+|++++.++.--.|.-..=++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~------- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY------- 83 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-------
Confidence 5678889999999999999999888875544433333333444567789999999986444433333333321
Q ss_pred CCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 890 NPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~~g-gSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
.-.|+|||++| .++.+++...... .........++.+|-..+.-||.++||||||..+||++..++
T Consensus 84 -------~~~i~ME~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~--- 150 (229)
T KOG3087|consen 84 -------GGQIYMEFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG--- 150 (229)
T ss_pred -------CCeEEEEeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC---
Confidence 12899999986 4888888763222 222233367888888999999999999999999999997763
Q ss_pred CCCCeEEEeeccccc
Q 001143 969 DGKPVVKLCDFDRAV 983 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~ 983 (1141)
....+.++|||++.
T Consensus 151 -~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 151 -NQITPILIDFGLSS 164 (229)
T ss_pred -CcCceEEEeecchh
Confidence 23667999999874
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.6e-11 Score=123.14 Aligned_cols=108 Identities=22% Similarity=0.200 Sum_probs=29.3
Q ss_pred CCCCccEEEeecCCCCccCcccc-CCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccc-cCCCCCCEEE
Q 001143 66 GDNSVEGLYLYKNVLNLIPKSVG-RYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFAL-NKLKGLKELE 143 (1141)
Q Consensus 66 ~L~~L~~L~Ls~N~Lt~iP~~l~-~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~-~~L~~L~~L~ 143 (1141)
+..++++|+|++|.|+.|. .++ .+.+|+.|+|++|.|+.|+ .+..|++|++|++++|.++.++..+ ..+++|++|+
T Consensus 17 n~~~~~~L~L~~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTIE-NLGATLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccccccc-chhhhhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 3356788888888887773 455 5677888888888888775 4667777777777777766665333 2455555555
Q ss_pred CCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001143 144 LSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1141)
Q Consensus 144 Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1141)
|++|.+.....- ..+..+++|+.|+|.+|.++
T Consensus 95 L~~N~I~~l~~l--~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNEL--EPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCC--GGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHh--HHHHcCCCcceeeccCCccc
Confidence 555544332211 22334444444444444444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-09 Score=112.04 Aligned_cols=138 Identities=20% Similarity=0.240 Sum_probs=98.3
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 891 (1141)
..+++|+-+.||.+.|.+..+.+|...-+.-..+.-+.+--..+..+|+.++.+++--.|...+=+..+..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--------- 72 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC---------
Confidence 46789999999999998878888875433222222222222346689999999986444333322333222
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCC
Q 001143 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1141)
Q Consensus 892 ~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~ 971 (1141)
...|+|||++|..|.+.+... . ..++..|-.-+.-||..|||||||.++||++...
T Consensus 73 -----~~~I~me~I~G~~lkd~l~~~--------~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~------- 128 (204)
T COG3642 73 -----NGLIVMEYIEGELLKDALEEA--------R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG------- 128 (204)
T ss_pred -----CCEEEEEEeCChhHHHHHHhc--------c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-------
Confidence 237999999998888888761 1 3455666667788999999999999999999764
Q ss_pred CeEEEeeccccc
Q 001143 972 PVVKLCDFDRAV 983 (1141)
Q Consensus 972 ~~vKL~DFGlA~ 983 (1141)
.+.++|||++.
T Consensus 129 -~i~~IDfGLg~ 139 (204)
T COG3642 129 -RIYFIDFGLGE 139 (204)
T ss_pred -cEEEEECCccc
Confidence 59999999985
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.8e-10 Score=136.64 Aligned_cols=255 Identities=22% Similarity=0.156 Sum_probs=175.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~ 879 (1141)
....+|..+..||.|.|+.|+....+ .....++++.+...... ..++.. ..|+.+...+. |.+++.++..+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-----l~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-----LGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-----hhhhhHhhHhhcccccCCCCCCcc
Confidence 34567889999999999999998754 34444444433332222 222223 47888887774 999998877766
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... .|+--|||+++++...+.- ...+++...+++..|++.++.++|+..++|+|+||+||
T Consensus 337 ~~r~--------------~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni 397 (524)
T KOG0601|consen 337 QLRQ--------------GYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNI 397 (524)
T ss_pred cccc--------------ccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhcccccccce
Confidence 5432 3788899999987766532 23578888999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCccc-chhhhccccCCCCCCchhhHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~-APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
++..++ +..+++|||.++.+..... ...+.-.+. ..|++.. ...+..+.|++|||..
T Consensus 398 ~i~~~~------~~~~~~~~~~~t~~~~~~~-------------~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~~~ 455 (524)
T KOG0601|consen 398 LISNDG------FFSKLGDFGCWTRLAFSSG-------------VFHHIDRLYPIAEILLE---DYPHLSKADIFSLGLS 455 (524)
T ss_pred eeccch------hhhhccccccccccceecc-------------cccccccccccchhhcc---cccccccccccccccc
Confidence 997752 5688999999865332111 111233344 3455443 2566789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+.+.+++...-... .....|..+..+..+ ....++..+...+...++..
T Consensus 456 ~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~----------------------------~~~~~~q~~~kv~~~~~~~~ 504 (524)
T KOG0601|consen 456 VDEAITGSPLSESG---VQSLTIRSGDTPNLP----------------------------GLKLQLQVLLKVMINPDRKR 504 (524)
T ss_pred ccccccCcccCccc---ccceeeecccccCCC----------------------------chHHhhhhhhhhhcCCcccc
Confidence 99999885422111 112223333333222 22255778889999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
||.+.++..|..+...
T Consensus 505 ~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 505 RPSAVELSLHSEFYRD 520 (524)
T ss_pred chhhhhhcccchhhhh
Confidence 9999999888776543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.6e-11 Score=129.25 Aligned_cols=132 Identities=23% Similarity=0.179 Sum_probs=105.3
Q ss_pred CCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEE
Q 001143 113 LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192 (1141)
Q Consensus 113 L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L 192 (1141)
+..|+.||||+|.++.+..+..-++.++.|++++|++... ..++.|++|+.|||++|.++.+-.+-..|-+++.|
T Consensus 283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v-----~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV-----QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTL 357 (490)
T ss_pred HhhhhhccccccchhhhhhhhhhccceeEEeccccceeee-----hhhhhcccceEeecccchhHhhhhhHhhhcCEeee
Confidence 3556666777777666666666667777777777554211 23677889999999999999886655778899999
Q ss_pred EccCCccccccccccCCCCCCEEEccCCCCCcC--CcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 193 ~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~I--P~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
.|+.|.|.++ ..++.+-+|..||+++|+|..+ -..+++|+-|+.|.|-+|.|.+++.
T Consensus 358 ~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 9999999988 5788899999999999999865 4689999999999999999998875
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.2e-11 Score=136.80 Aligned_cols=207 Identities=20% Similarity=0.172 Sum_probs=150.9
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC---ccccCCcCCcEEEccCCCCCcCchh--hcC
Q 001143 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP---KSVGRYEKLRNLKFFGNEINLFPSE--VGN 112 (1141)
Q Consensus 38 ~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP---~~l~~L~~L~~L~Ls~N~L~~lP~~--~~~ 112 (1141)
+++.+|+.+.|.+..+.-...+ +....|++++.||||.|.|...- .-...|++|+.|+|+.|.+...-++ -..
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~--~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIE--EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhHHhhhheeecCccccccchh--hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 4667888888888877644332 33455688999999999887542 2356888999999999998743222 235
Q ss_pred CCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccC--ccccCCCC
Q 001143 113 LLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP--PEIGCLSN 188 (1141)
Q Consensus 113 L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP--~~l~~l~~ 188 (1141)
+++|+.|.|+.+.++. +.-....+++|+.|+|..|.. -..... ....+..|+.|+|++|++-..+ ...+.++.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~-~~~~~~--~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~ 272 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEI-ILIKAT--STKILQTLQELDLSNNNLIDFDQGYKVGTLPG 272 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccc-cceecc--hhhhhhHHhhccccCCcccccccccccccccc
Confidence 7888899998888663 223567788999999998751 122222 2334667999999999988776 45689999
Q ss_pred CCEEEccCCccccc--ccc-----ccCCCCCCEEEccCCCCCcCC--cCccCCCCCCEEeCCCCCCCCCC
Q 001143 189 LEQLDLSFNKMKYL--PTE-----ICYLKALISLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLG 249 (1141)
Q Consensus 189 L~~L~Ls~N~L~~i--P~~-----l~~l~~L~~L~Ls~N~L~~IP--~~l~~L~~L~~L~Ls~N~Lt~~~ 249 (1141)
|+.|+++.+.|++| |+. ...+++|++|+++.|++...+ ..+..+++|+.|....|.|+..-
T Consensus 273 L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e~ 342 (505)
T KOG3207|consen 273 LNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKET 342 (505)
T ss_pred hhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccccc
Confidence 99999999999954 554 455789999999999997665 34555788888898899988543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.7e-11 Score=134.43 Aligned_cols=233 Identities=19% Similarity=0.171 Sum_probs=153.5
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccC-CCCCCCccEEEeecCCCC----ccCcc-------ccCCcCCcEEEccCCCCC-
Q 001143 38 NDDDDDSVIDVSGKTVDFPLIESYGN-RGGDNSVEGLYLYKNVLN----LIPKS-------VGRYEKLRNLKFFGNEIN- 104 (1141)
Q Consensus 38 ~~l~~L~~LdLs~N~Ls~~~p~~~~~-l~~L~~L~~L~Ls~N~Lt----~iP~~-------l~~L~~L~~L~Ls~N~L~- 104 (1141)
.....++.|+||+|.+...-..+++. +...++|+.-++++=... ++|+. +...+.|++||||.|.|.
T Consensus 27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~ 106 (382)
T KOG1909|consen 27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP 106 (382)
T ss_pred cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence 34557788888888875433322221 233367777777654222 45543 345567888888888886
Q ss_pred cCch----hhcCCCCCCEEEccCCCCCCCccc--------------ccCCCCCCEEECCCCCCCCCccc-chhhhcCCCC
Q 001143 105 LFPS----EVGNLLGLECLQIKISSPGVNGFA--------------LNKLKGLKELELSKVPPRPSVLT-LLSEIAGLKC 165 (1141)
Q Consensus 105 ~lP~----~~~~L~~L~~L~Ls~N~l~~~~~~--------------~~~L~~L~~L~Ls~N~ln~~~~~-lp~~l~~L~~ 165 (1141)
.-+. -+..++.|+.|+|.+|.++..... ...-+.|+.+....|++-+-... +-..|...+.
T Consensus 107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~ 186 (382)
T KOG1909|consen 107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPT 186 (382)
T ss_pred cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccc
Confidence 2222 256678888888887776654421 23345688888888776544332 3345666788
Q ss_pred CcEEEccCCCCCc--c---CccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCC-----cCCcCcc
Q 001143 166 LTKLSVCHFSIRY--L---PPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----ELPSGLY 230 (1141)
Q Consensus 166 L~~L~Ls~N~L~~--i---P~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~-----~IP~~l~ 230 (1141)
|+.+.+..|.|.. + -..+..+++|+.|||.+|-|+ .+-..+..|++|+.|+++.+.|+ .+-..+.
T Consensus 187 leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~ 266 (382)
T KOG1909|consen 187 LEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALK 266 (382)
T ss_pred cceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHh
Confidence 8888888888762 2 234677888888888888887 34566778888888888888886 2223333
Q ss_pred C-CCCCCEEeCCCCCCCCCC----cccccCCCCCCEEEccCCcCC
Q 001143 231 L-LQRLENLDLSNNRLTSLG----SLDLCLMHNLQNLNLQYNKLL 270 (1141)
Q Consensus 231 ~-L~~L~~L~Ls~N~Lt~~~----p~~l~~L~~L~~L~Ls~N~L~ 270 (1141)
. .++|+.|.|.+|.++.-- ...+...+.|..|+|++|.|.
T Consensus 267 ~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 267 ESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 2 678889999998887332 223556788888999999883
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5e-11 Score=132.27 Aligned_cols=229 Identities=18% Similarity=0.175 Sum_probs=175.6
Q ss_pred CcccccCCCCCccccC----CCCCCCCCCCCEEEccCC---CCCCCCccccc----CCCCCCCccEEEeecCCCC-c-cC
Q 001143 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGK---TVDFPLIESYG----NRGGDNSVEGLYLYKNVLN-L-IP 84 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~----~~~f~~l~~L~~LdLs~N---~Ls~~~p~~~~----~l~~L~~L~~L~Ls~N~Lt-~-iP 84 (1141)
.+.+|.+.+|.+..-. ...+.+.++|+..++|+= ++...+|+.+. .+.+.++|++|+||.|-|. . ++
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 6788889988875433 345677789999999974 33444454332 2345569999999999997 3 33
Q ss_pred c---cccCCcCCcEEEccCCCCCcCch--------------hhcCCCCCCEEEccCCCCCCCcc-----cccCCCCCCEE
Q 001143 85 K---SVGRYEKLRNLKFFGNEINLFPS--------------EVGNLLGLECLQIKISSPGVNGF-----ALNKLKGLKEL 142 (1141)
Q Consensus 85 ~---~l~~L~~L~~L~Ls~N~L~~lP~--------------~~~~L~~L~~L~Ls~N~l~~~~~-----~~~~L~~L~~L 142 (1141)
. -|.+..+|+.|+|.||-|...-. -.+.-++|+++..+.|++..-|. .|...+.|+.+
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leev 190 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEV 190 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceE
Confidence 2 36778899999999999873321 23567899999999999887773 57788999999
Q ss_pred ECCCCCCCCCcc-cchhhhcCCCCCcEEEccCCCCCc-----cCccccCCCCCCEEEccCCccc-----ccccccc-CCC
Q 001143 143 ELSKVPPRPSVL-TLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEIC-YLK 210 (1141)
Q Consensus 143 ~Ls~N~ln~~~~-~lp~~l~~L~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~-~l~ 210 (1141)
.++.|.+...-. .+-..|..+++|+.|+|..|-++. +...+..+++|+.|++++..++ .+-..+. ..+
T Consensus 191 r~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p 270 (382)
T KOG1909|consen 191 RLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAP 270 (382)
T ss_pred EEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCC
Confidence 999998865444 345678999999999999999983 3456788899999999999998 2333333 368
Q ss_pred CCCEEEccCCCCC-----cCCcCccCCCCCCEEeCCCCCCC
Q 001143 211 ALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLT 246 (1141)
Q Consensus 211 ~L~~L~Ls~N~L~-----~IP~~l~~L~~L~~L~Ls~N~Lt 246 (1141)
+|+.|.|++|.++ .+-..+...+.|..|+|++|+|.
T Consensus 271 ~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 271 SLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9999999999997 33456677899999999999993
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.8e-08 Score=117.99 Aligned_cols=142 Identities=18% Similarity=0.255 Sum_probs=109.0
Q ss_pred HHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 001143 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 936 (1141)
Q Consensus 857 ~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~Q 936 (1141)
.+-+.-|+.++||||+++++.++.++. .|||+|-+. .|..++.. +....+...+.|
T Consensus 57 ~~A~k~lKtlRHP~Il~yL~t~e~~~~--------------~ylvTErV~--Pl~~~lk~--------l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 57 KRAVKRLKTLRHPNILSYLDTTEEEGT--------------LYLVTERVR--PLETVLKE--------LGKEEVCLGLFQ 112 (690)
T ss_pred HHHHHHhhhccCchhhhhhhhhcccCc--------------eEEEeeccc--cHHHHHHH--------hHHHHHHHHHHH
Confidence 567888999999999999999887664 499999984 78888876 446777788999
Q ss_pred HHHHHHHHH-HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchh
Q 001143 937 VAAALVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015 (1141)
Q Consensus 937 Ia~gL~yLH-s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 1015 (1141)
|+.||.||| ..+++|++|.-+-|+|+.. |..||++|..+........ ......--..|..|+
T Consensus 113 Il~AL~FL~~d~~lvHgNv~~~SVfVn~~-------GeWkLggle~v~~~~~~~~----------~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 113 ILAALSFLNDDCNLVHGNVCKDSVFVNES-------GEWKLGGLELVSKASGFNA----------PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHhccCCeeeccEeeeeEEEcCC-------CcEEEeeeEEEeccccCCc----------ccccchhhhcccChh
Confidence 999999998 5689999999999999998 8899999998754332110 001111223356666
Q ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 1016 ~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
.+.. -+...|.|-|||+++|++.|
T Consensus 176 ~~~~------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCc------cccchhhhhHHHHHHHHhCc
Confidence 5432 11457999999999999998
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.6e-08 Score=105.64 Aligned_cols=131 Identities=21% Similarity=0.243 Sum_probs=83.7
Q ss_pred EEEEEEE-CCccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHHHhhCCCC--CccceeeeEe
Q 001143 821 SLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKI 879 (1141)
Q Consensus 821 ~Vy~a~~-~~~~vAvKI~~l~~~~~~~------------------~~~~~~~~~~~~Ei~iL~~L~Hp--NIVkllg~~~ 879 (1141)
.||.|.. .+..+|+|+++........ ........+..+|++.|.++..- ++.+++++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 3899987 5778999998764332221 11222234668999999999754 5677775532
Q ss_pred cCCCCCCCCCCCccccceEEEEEeecc--CCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVK--GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE-LHSKHIMHRDIKS 956 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~--ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~y-LHs~gIvHrDLKP 956 (1141)
-+|||||++ |..+..+... .++......++.+++..+.. +|..||+||||.+
T Consensus 81 ------------------~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~ 135 (188)
T PF01163_consen 81 ------------------NVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE 135 (188)
T ss_dssp ------------------TEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST
T ss_pred ------------------CEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh
Confidence 189999998 6555544332 12244566778888886555 5799999999999
Q ss_pred CCeeeecccccCCCCCeEEEeecccccc
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
.||+++.+ .+.++|||.+..
T Consensus 136 ~NIlv~~~--------~~~iIDf~qav~ 155 (188)
T PF01163_consen 136 YNILVDDG--------KVYIIDFGQAVD 155 (188)
T ss_dssp TSEEEETT--------CEEE--GTTEEE
T ss_pred hhEEeecc--------eEEEEecCccee
Confidence 99999864 699999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.3e-09 Score=128.85 Aligned_cols=106 Identities=24% Similarity=0.346 Sum_probs=97.7
Q ss_pred CcEEEccCCCCC-ccCccccCCCCCCEEEccCCccc-cccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCC
Q 001143 166 LTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSN 242 (1141)
Q Consensus 166 L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~ 242 (1141)
++.|+|++|.|+ .+|..++.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+|..+++|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 778999999999 78999999999999999999998 89999999999999999999998 8899999999999999999
Q ss_pred CCCCCCCcccccCC-CCCCEEEccCCcCCC
Q 001143 243 NRLTSLGSLDLCLM-HNLQNLNLQYNKLLS 271 (1141)
Q Consensus 243 N~Lt~~~p~~l~~L-~~L~~L~Ls~N~L~~ 271 (1141)
|+|+|.+|..+..+ .++..+++.+|+..|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCcccc
Confidence 99999999888764 467889999998655
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5e-09 Score=133.87 Aligned_cols=200 Identities=22% Similarity=0.244 Sum_probs=135.7
Q ss_pred cccccCCCCCccccCCCCCCCCCCCCEEEccCCC--CCCCCcccccCCCCCCCccEEEeecC-CCCccCccccCCcCCcE
Q 001143 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT--VDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~--Ls~~~p~~~~~l~~L~~L~~L~Ls~N-~Lt~iP~~l~~L~~L~~ 95 (1141)
...+.+..|++..+.... ..++|++|-+..|. +.....++|..+ +.|.+|||++| .++++|..+++|-+|++
T Consensus 525 ~rr~s~~~~~~~~~~~~~--~~~~L~tLll~~n~~~l~~is~~ff~~m---~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 525 VRRMSLMNNKIEHIAGSS--ENPKLRTLLLQRNSDWLLEISGEFFRSL---PLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred eeEEEEeccchhhccCCC--CCCccceEEEeecchhhhhcCHHHHhhC---cceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 445556666666554322 33379999999986 555555555444 89999999977 56789999999999999
Q ss_pred EEccCCCCCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001143 96 LKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1141)
Q Consensus 96 L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1141)
|+|+...|+.+|..+++|+.|.+|++..+. +..++.....|.+|++|.+..-.. ......-..+.+|.+|+.|.....
T Consensus 600 L~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~-~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSAL-SNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecccc-ccchhhHHhhhcccchhhheeecc
Confidence 999999999999999999999999998877 555667777799999999876431 222333445566777776666544
Q ss_pred CCCccCccccCCCCCC----EEEccCCccccccccccCCCCCCEEEccCCCCCcC
Q 001143 175 SIRYLPPEIGCLSNLE----QLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1141)
Q Consensus 175 ~L~~iP~~l~~l~~L~----~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~I 225 (1141)
.. .+-..+..+++|. .+.+......+.+..+..+.+|+.|.+.+..+.++
T Consensus 679 s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 679 SV-LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred hh-HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchh
Confidence 43 2212222333332 33333444445666777777888888877777643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.5e-08 Score=104.06 Aligned_cols=143 Identities=19% Similarity=0.189 Sum_probs=97.3
Q ss_pred eeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC--CCccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkllg~~~~~~~~~~~~ 888 (1141)
+.|+.|.++.||++...+ ..+++|+....... .... .+.+|+++++.+.+ .++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~----~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~------ 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAH----DVAREYRVLRALAGTGVPVPKVLALCEDPS------ 70 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccc----cHHHHHHHHHHhhCCCCCCCCEEEECCCCC------
Confidence 678999999999998865 77888874322110 0112 23789999999965 44667776654321
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 946 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs---------------------- 946 (1141)
.....++||||++|.++.+.+.. ..++......++.+++++|.+||+
T Consensus 71 -----~~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 71 -----VLGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred -----ccCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 00123899999998877665421 135666666677777777777763
Q ss_pred ----------------------------------CCccccCCCCCCeeeecccccCCCCCeEEEeeccccc
Q 001143 947 ----------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 947 ----------------------------------~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
..++|+|++|.||+++.+. ...+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~~~iID~e~~~ 205 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-----PRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-----CcEEEEEeccccc
Confidence 2469999999999998720 0568999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.5e-07 Score=102.47 Aligned_cols=150 Identities=16% Similarity=0.141 Sum_probs=97.5
Q ss_pred ceEEEEEEECCccEEEEEEecccCCCChHHHHHh------HHhHHHHHHHHhhCCCCC--ccceeeeEecCCCCCCCCCC
Q 001143 819 SSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF------EYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGN 890 (1141)
Q Consensus 819 fG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~------~~~~~~Ei~iL~~L~HpN--IVkllg~~~~~~~~~~~~g~ 890 (1141)
...|++..+.+..+.+|....... ....+.+ ...+.+|...+.++..-+ .+++++++.....
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~---~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~------- 104 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGW---GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN------- 104 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcH---HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC-------
Confidence 334667778888888886532110 0001110 002468988888885333 3444555543210
Q ss_pred CccccceEEEEEeeccCC-CHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCC
Q 001143 891 PEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1141)
Q Consensus 891 ~~~~~~~~~LVmEy~~gg-SL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~ 969 (1141)
......+||||++++. +|.+++.... ....+......++.+++..+.-||..||+|||++++|||++.+.....
T Consensus 105 --~~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 105 --PATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred --CccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCC
Confidence 0122458999999975 8999986421 234566778899999999999999999999999999999975200011
Q ss_pred CCCeEEEeeccccc
Q 001143 970 GKPVVKLCDFDRAV 983 (1141)
Q Consensus 970 ~~~~vKL~DFGlA~ 983 (1141)
+...+.|+||+.+.
T Consensus 180 ~~~~~~LIDl~r~~ 193 (268)
T PRK15123 180 EDLKLSVIDLHRAQ 193 (268)
T ss_pred CCceEEEEECCccc
Confidence 23689999999874
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-08 Score=129.28 Aligned_cols=249 Identities=22% Similarity=0.202 Sum_probs=152.4
Q ss_pred CcccccCCCCC--ccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 18 IKEKLPSEANK--INNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 18 ~l~~L~~~~N~--i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
.+.+|-+..|. +..+....|..++.|++||||+|.=-+.+|+.++.+ -+|++|+|+...++.+|..|.+|.+|.+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L---i~LryL~L~~t~I~~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL---VHLRYLDLSDTGISHLPSGLGNLKKLIY 622 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh---hhhhcccccCCCccccchHHHHHHhhhe
Confidence 57777777776 888888889999999999999987777888877666 8999999999999999999999999999
Q ss_pred EEccCCCCC-cCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc----EEE
Q 001143 96 LKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT----KLS 170 (1141)
Q Consensus 96 L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~----~L~ 170 (1141)
||+..+.-. .+|..+..|++|++|.|...........+..+.+|+.|..-....... .+...+..+..|. .+.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence 999988754 556667779999999997655333333344444444444433222221 1111222222222 333
Q ss_pred ccCCCCCccCccccCCCCCCEEEccCCccccccc-cccC------CCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCC
Q 001143 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT-EICY------LKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243 (1141)
Q Consensus 171 Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~-~l~~------l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N 243 (1141)
+..+.....+..++.+.+|+.|.+.+..+.++.. .... +++|..+...+...-..+...--.++|+.|.+...
T Consensus 701 ~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 701 IEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred hcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEecc
Confidence 3344444556667778888888888777764321 1111 11122221111111122222223466777777655
Q ss_pred CCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 244 ~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
.....+......+..+..+-+..+.+.+
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred cccccCCCHHHHhhhcccEEeccccccc
Confidence 4433333244444555544444444444
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3e-09 Score=104.19 Aligned_cols=117 Identities=21% Similarity=0.192 Sum_probs=88.8
Q ss_pred chhhhcCCCCCcEEEccCCCCCccCccc-cCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCC
Q 001143 156 LLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234 (1141)
Q Consensus 156 lp~~l~~L~~L~~L~Ls~N~L~~iP~~l-~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~ 234 (1141)
.+..+.....|+.++|++|.+..+|+.| ..++.++.|+|++|+|+.+|.++..++.|+.|+++.|.|...|.-+..|.+
T Consensus 45 avy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~ 124 (177)
T KOG4579|consen 45 AVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIK 124 (177)
T ss_pred HHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccccchHHHHHHHh
Confidence 3444555667777888888888888877 455678888888888888888888888888888888888888888888888
Q ss_pred CCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCC
Q 001143 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273 (1141)
Q Consensus 235 L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~ 273 (1141)
|..|+..+|.+..++-. +..-..+...++.+|+|.+.|
T Consensus 125 l~~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~~~ 162 (177)
T KOG4579|consen 125 LDMLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGDET 162 (177)
T ss_pred HHHhcCCCCccccCcHH-HhccccHHHHHhcCCcccccC
Confidence 88888888888877664 333334444566777777643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.8e-10 Score=132.39 Aligned_cols=179 Identities=27% Similarity=0.283 Sum_probs=123.2
Q ss_pred CccccCCcCCcEEEccCCCCCcCchhhcCC-CCCCEEEccCCCCCCCccccc----------CCCCCCEEECCCCCCCCC
Q 001143 84 PKSVGRYEKLRNLKFFGNEINLFPSEVGNL-LGLECLQIKISSPGVNGFALN----------KLKGLKELELSKVPPRPS 152 (1141)
Q Consensus 84 P~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L-~~L~~L~Ls~N~l~~~~~~~~----------~L~~L~~L~Ls~N~ln~~ 152 (1141)
|-.|..+.+|++|.|.+..|+.+-. +..| ..|+.|-. .|.+..+...|. ....|...+.+.|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~G-L~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAKG-LQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhhhhh-hHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH--
Confidence 4456677778888888887765321 1111 12333322 222222111111 1234666677775553
Q ss_pred cccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcCCcCccC
Q 001143 153 VLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYL 231 (1141)
Q Consensus 153 ~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~~l~~ 231 (1141)
.+-.++.-++.|+.|+|++|+++.+- .+..++.|++|||+.|.|..+|.- ...++ |+.|.|++|.|+++ ..+.+
T Consensus 178 --~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL-~gie~ 252 (1096)
T KOG1859|consen 178 --LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL-RGIEN 252 (1096)
T ss_pred --hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh-hhHHh
Confidence 33345666788999999999999874 788899999999999999988742 33344 99999999999987 36888
Q ss_pred CCCCCEEeCCCCCCCCCCcc-cccCCCCCCEEEccCCcCCC
Q 001143 232 LQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 232 L~~L~~L~Ls~N~Lt~~~p~-~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
|++|+.|||+.|-|++...- .+..|..|..|+|.|||+.|
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99999999999998866432 25667889999999999988
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.8e-08 Score=85.63 Aligned_cols=59 Identities=46% Similarity=0.591 Sum_probs=34.8
Q ss_pred CCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcC
Q 001143 211 ALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1141)
Q Consensus 211 ~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L 269 (1141)
+|++|+|++|+|+.||. .|..+++|+.|+|++|+|+.+++..|..+++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 45566666666665553 334466666666666666666665666666666666666653
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.9e-06 Score=99.17 Aligned_cols=224 Identities=16% Similarity=0.108 Sum_probs=144.3
Q ss_pred CceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCCCCCccccce
Q 001143 818 VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897 (1141)
Q Consensus 818 sfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~ 897 (1141)
-..+.|+|...-...++-.+++........ .+. ..-+++++++.|+|||++.++|....+ ....
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~-----t~lve~wkkl~h~NvV~frevf~t~tF----------~D~S 351 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKD-----TSLVEAWKKLCHTNVVPFREVFLTYTF----------GDLS 351 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc-ccc-----hHHHHHHHHhccCceeehhhhhhhhcc----------Ccce
Confidence 345689988754444444444421111111 011 245778899999999999999885432 1235
Q ss_pred EEEEEeeccC-CCHHHHHHHhh----------hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 898 SAIFMEYVKG-GSVKNYIEKLS----------ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 898 ~~LVmEy~~g-gSL~~~I~~~~----------~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
+++|++|+++ ++|.++--... .......++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+
T Consensus 352 lvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-- 429 (655)
T KOG3741|consen 352 LVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-- 429 (655)
T ss_pred EEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc--
Confidence 7999999985 47776542111 1223468889999999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
..++|..-|....+.... . |.+.+ -++-|.-.||.+++.|.||.
T Consensus 430 -----~RIriS~C~i~Dvl~~d~----------------------~--~~le~-------~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 430 -----MRIRISGCGIMDVLQEDP----------------------T--EPLES-------QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred -----ceEEEecccceeeecCCC----------------------C--cchhH-------HhhhhHHHHHHHHHHHhhcc
Confidence 567766555443222100 0 11222 15779999999999999995
Q ss_pred CC-CCCCCHHHH-HHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1047 VP-YMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1047 ~P-f~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
.- +......+. .+.|. ...+.++++++.-....++++ -++.+
T Consensus 474 ~ns~~~d~~~~s~~~~I~-----------------------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 474 ENSNRTDSTQSSHLTRIT-----------------------------------TTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred cccccccchHHHHHHHhh-----------------------------------hhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 32 222222221 12211 145566777888777777776 67777
Q ss_pred HHHHHHh
Q 001143 1125 LYEMFVA 1131 (1141)
Q Consensus 1125 lL~~L~~ 1131 (1141)
++.+...
T Consensus 518 llp~~~~ 524 (655)
T KOG3741|consen 518 LLPMIGS 524 (655)
T ss_pred HHHHHHH
Confidence 7776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.8e-07 Score=99.07 Aligned_cols=141 Identities=18% Similarity=0.187 Sum_probs=103.0
Q ss_pred eEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChH--------------HHHHhHHhHHHHHHHHhhCCCC--Cc
Q 001143 809 SSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHS--CI 871 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~--------------~~~~~~~~~~~Ei~iL~~L~Hp--NI 871 (1141)
.++..||-|--+.||.|... +.++++|.-++-.++...- ....-....++|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 67899999999999999984 8899999866543322110 0011122457899999999644 67
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 001143 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951 (1141)
Q Consensus 872 Vkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvH 951 (1141)
.+.+++- ..++||||++|--|... +++.+....++..|+.-+..+-..||||
T Consensus 174 P~P~~~n------------------RHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 174 PKPIAWN------------------RHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCccccc------------------cceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 7766542 23899999998665433 2234555666777777777777899999
Q ss_pred cCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 952 rDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
||+.+-||+++++ |.++++||-.+..
T Consensus 226 GDlSefNIlV~~d-------g~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTED-------GDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecC-------CCEEEEeCccccc
Confidence 9999999999998 7899999987754
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.49 E-value=8.5e-08 Score=82.65 Aligned_cols=57 Identities=28% Similarity=0.410 Sum_probs=28.7
Q ss_pred CccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCc-hhhcCCCCCCEEEccCCC
Q 001143 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISS 125 (1141)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP-~~~~~L~~L~~L~Ls~N~ 125 (1141)
+|++|+|++|+|+.||. .|..+++|++|+|++|+|+.+| ..|.++++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34555555555555543 3445555555555555555443 234555555555555543
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.8e-09 Score=124.13 Aligned_cols=131 Identities=23% Similarity=0.227 Sum_probs=107.9
Q ss_pred CCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCC
Q 001143 164 KCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSN 242 (1141)
Q Consensus 164 ~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~ 242 (1141)
..|...++++|.|..+-..+.-++.|+.|+|++|+++... .+..|+.|++|||+.|.|+.+|. +...+. |+.|.|+|
T Consensus 164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 4577889999999988888888999999999999999875 88899999999999999999984 233355 99999999
Q ss_pred CCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCc
Q 001143 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299 (1141)
Q Consensus 243 N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~ 299 (1141)
|-++.+- .+.+|.+|..|||++|-|.+..++- .+..+.++..+-+.+|.+||..
T Consensus 242 N~l~tL~--gie~LksL~~LDlsyNll~~hseL~-pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 242 NALTTLR--GIENLKSLYGLDLSYNLLSEHSELE-PLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cHHHhhh--hHHhhhhhhccchhHhhhhcchhhh-HHHHHHHHHHHhhcCCccccCH
Confidence 9999885 4789999999999999998865542 2334455666777778777754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=95.02 Aligned_cols=111 Identities=23% Similarity=0.237 Sum_probs=85.0
Q ss_pred hHHHHHHHHhhCC--CCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCC-CHHHHHHHhhhcCCCCCCHHHHH
Q 001143 855 SCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLAL 931 (1141)
Q Consensus 855 ~~~~Ei~iL~~L~--HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~gg-SL~~~I~~~~~~~~~~Ls~~~i~ 931 (1141)
+..+|...+..+. .=.+++.+++.+..... ....++|||++++. +|.+++... ...+.....
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~----------~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~ 121 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG----------GYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRR 121 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC----------ceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHH
Confidence 3468888887775 34456777776653211 13568999999974 899998762 126667788
Q ss_pred HHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 932 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 932 ~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
.++.+++..+.-||..||+|+|+++.|||++.+. +...+.++||+.++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhcee
Confidence 9999999999999999999999999999998872 235799999997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.7e-08 Score=118.53 Aligned_cols=162 Identities=19% Similarity=0.197 Sum_probs=112.3
Q ss_pred HHHHHHHHHHHC-CccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccch
Q 001143 936 DVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014 (1141)
Q Consensus 936 QIa~gL~yLHs~-gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 1014 (1141)
+++.|+.|+|.. ++||++|.|++|.++.. +.+||+.|+++......... .........+....-...|.||
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~-------~~wkl~Gf~f~v~~~~~~~~-p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN-------GDWKLAGFSFCVNANGPTEY-PFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC-------cceeeccchhhhccCCCCcc-ccccCCCCCChhhccCcccccc
Confidence 344999999965 89999999999999988 88999999998765443221 1222233344455677889999
Q ss_pred hhhccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCC
Q 001143 1015 EVLRAMHKPNLYGLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093 (1141)
Q Consensus 1015 E~l~~~~~~~~~s~ksDVWSLGviL~ELL-TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~ 1093 (1141)
|++.. ...+.++|+||+||++|.+. .|+.-+......... ....... ... ....+
T Consensus 179 E~~~~----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~-~~~-----------------~~~~s- 234 (700)
T KOG2137|consen 179 EYLLG----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLL-NAG-----------------AFGYS- 234 (700)
T ss_pred hhhcc----ccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhccc-ccc-----------------ccccc-
Confidence 99987 45679999999999999988 466555433221111 1111100 000 00000
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1094 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1094 ~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
...+.++++=+.+++..++..||++.++...++|..
T Consensus 235 ----~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 235 ----NNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred ----ccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 156778999999999999999999999888877754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.3e-06 Score=93.21 Aligned_cols=274 Identities=17% Similarity=0.141 Sum_probs=157.9
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~~~ 887 (1141)
.....||+|+.+.+|-.-.-. +.+.||+... ....+ .+-++.|.+. .||-+-.-+.+=.. .-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~P-----ppa~~------aqk~a~la~~p~~p~~~~rvaWPqa-~L~--- 77 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAP-----PPAAQ------AQKVAELAATPDAPLLNYRVAWPQA-TLH--- 77 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCC-----CchHH------HHHHHHhccCCCCcchhhhhcccHH-Hhh---
Confidence 456789999999999643322 2345665322 11111 1234445455 57755432222111 000
Q ss_pred CCCCccccceEEEEEeeccCCC-HHHHHH-HhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGS-VKNYIE-KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggS-L~~~I~-~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..+......+.|+.++|.- ...+.. +.+........|.-.++.++.++.+...||..|.+-||+.++|+|+.++
T Consensus 78 ---G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~- 153 (637)
T COG4248 78 ---GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD- 153 (637)
T ss_pred ---CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-
Confidence 1112223689999988652 222221 1112234468899999999999999999999999999999999999988
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhc-cccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.|.|.|=..-....... ...-.+|...|.+||... ..-.+..-+...|.|.|||++++++.
T Consensus 154 ------~~V~LVdsDsfqi~~ng~-----------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 154 ------SKVVLVDSDSFQINANGT-----------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred ------ceEEEEcccceeeccCCc-----------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHh
Confidence 678888754322111110 111346899999999865 21112234578999999999999998
Q ss_pred C-CCCCCCCCHH-----HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc--CC
Q 001143 1045 L-QVPYMGLSEL-----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE--NP 1116 (1141)
Q Consensus 1045 G-k~Pf~~~~~~-----el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~--DP 1116 (1141)
| .+||.+.... .....|..+.....++. .......+.+.|- .-.++.+..+..+|+.. ++
T Consensus 217 ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~----------~~g~~p~P~~~P~--~~Lpp~vqAlF~qaF~~~~~~ 284 (637)
T COG4248 217 GGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQ----------RRGLKPPPRSIPL--SMLPPDVQALFQQAFTESGVA 284 (637)
T ss_pred cCCCCCCcccccCCCCCcchhhhhcceeeechhc----------cCCCCCCCCCCCh--hhcCHHHHHHHHHHhcccCCC
Confidence 6 9999863210 00112222221111100 0000001111111 13456788888999864 35
Q ss_pred CCCCCHHHHHHHHHh
Q 001143 1117 TERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~ 1131 (1141)
.-|||++..+..+-.
T Consensus 285 ~~RP~a~aW~aAl~a 299 (637)
T COG4248 285 TPRPTAKAWVAALDA 299 (637)
T ss_pred CCCCCHHHHHHHHHH
Confidence 689999887776544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.5e-06 Score=89.56 Aligned_cols=148 Identities=15% Similarity=0.102 Sum_probs=100.2
Q ss_pred cccCceEEEEEEECCccEEEEEEecccCCC-C-hHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCCCCCCCCCC
Q 001143 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGS-S-ADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSADGN 890 (1141)
Q Consensus 815 G~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~-~-~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkllg~~~~~~~~~~~~g~ 890 (1141)
|+||.+.|++....+..+-+|--....... . +-.. ..|.+|+..+.++. .-.+.++. ++....
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~----ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k-------- 93 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGR----PTIVREVAVIKELERAGVIVPKIV-FGEAVK-------- 93 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCc----hHHHHHHHHHHHHHHcCCCCCccc-eeeeec--------
Confidence 458888899988777666666422111110 0 0112 23479999998885 33355555 332111
Q ss_pred CccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCC
Q 001143 891 PEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1141)
Q Consensus 891 ~~~~~~~~~LVmEy~~g-gSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~ 969 (1141)
.....+.+||+|-++| .||.+++.+ ....+.+......++.+++..+.-||+.|+.|+|+.+.||+++.++
T Consensus 94 -~~~~~rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g---- 165 (216)
T PRK09902 94 -IEGEWRALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG---- 165 (216)
T ss_pred -cCCceEEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC----
Confidence 0123467899998764 489998765 2223567888889999999999999999999999999999998552
Q ss_pred CCCeEEEeecccccc
Q 001143 970 GKPVVKLCDFDRAVP 984 (1141)
Q Consensus 970 ~~~~vKL~DFGlA~~ 984 (1141)
...++++||.-++.
T Consensus 166 -~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 -KAEAGFLDLEKSRR 179 (216)
T ss_pred -CeeEEEEEhhccch
Confidence 14599999997653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.6e-08 Score=97.76 Aligned_cols=127 Identities=17% Similarity=0.085 Sum_probs=62.5
Q ss_pred ccEEEeecCCCCccCccc---cCCcCCcEEEccCCCCCcCchhhcC-CCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001143 70 VEGLYLYKNVLNLIPKSV---GRYEKLRNLKFFGNEINLFPSEVGN-LLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1141)
Q Consensus 70 L~~L~Ls~N~Lt~iP~~l---~~L~~L~~L~Ls~N~L~~lP~~~~~-L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls 145 (1141)
+-.|+|+++.|..|++.. .....|+..+|++|.+..+|..|.. .+.++.|+|++|.+..+|..+..++.|+.|+++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLR 108 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccc
Confidence 334555555555444432 2222344445555555555555433 234555555555555555444455555555555
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccc
Q 001143 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK 200 (1141)
Q Consensus 146 ~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~ 200 (1141)
.|+++ ..|..+..|.+|.+|+..+|.+..||-++.--+++-...|.+|.+.
T Consensus 109 ~N~l~----~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~ 159 (177)
T KOG4579|consen 109 FNPLN----AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLG 159 (177)
T ss_pred cCccc----cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCccc
Confidence 54443 3344455566667777777777766665432223333344444444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1141 | ||||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 8e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-04 |
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 67/311 (21%), Positives = 111/311 (35%), Gaps = 76/311 (24%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
++ S L++ ++ D KV LKV S + R+F E L H ++ +
Sbjct: 19 NENHSGELWKGRWQGNDIVVKV--LKVRDWSTRKSRDF----NEECPRLRIFSHPNVLPV 72
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G + P H + ++ GS+ N L E V A+ A
Sbjct: 73 LG---------ACQSPPAPHP---TLITHWMPYGSLYNV---LHEGTNFVVDQSQAVKFA 117
Query: 935 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
D+A + LH+ I + S +++ID + ++ D SF
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARISMADVK---FSFQSP- 166
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
+ P W+APE L+ KP + D+WS+ LL EL+T +VP+
Sbjct: 167 -----------GRMYAPAWVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 1052 LSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110
LS +EI + G RP + H + + +
Sbjct: 214 LSNMEIGMKVALEGLRPTIPP------GISPH---------------------VSKLMKI 246
Query: 1111 CTEENPTERPT 1121
C E+P +RP
Sbjct: 247 CMNEDPAKRPK 257
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 55/291 (18%), Positives = 98/291 (33%), Gaps = 66/291 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
+R + + + D+++ F EV RH +V G A +P H
Sbjct: 60 IRLIDIERDNEDQLKAF----KREVMAYRQTRHENVVLFMG----------ACMSPPHL- 104
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
AI KG ++ + + + + V IAQ++ + LH+K I+H+D+K
Sbjct: 105 ---AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
S+N+ D V + DF L S R G +APE
Sbjct: 158 SKNVFYD--------NGKVVITDFG----LFSISGVLQAGRREDKLRIQN-GWLCHLAPE 204
Query: 1016 VLRAMHKPNL-----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 1070
++R + + D+++ G + EL + P+ I + G +P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--- 261
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
+++ + D+ C ERPT
Sbjct: 262 -----------------------NLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 69/268 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV ++ L H IV++YG + + ME+V G + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPP--------------RMVMEFVPCGDLYHRLLDKA 116
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKL 976
+ + L + D+A + + +++ I+HRD++S NI + + A K+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAKV 170
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF + + +H+ +G +WMAPE + A + Y + D +S+
Sbjct: 171 ADFGLS---QQSVHSV----------SGLLGNFQWMAPETIGAEEES--YTEKADTYSFA 215
Query: 1037 CLLLELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093
+L +LT + P+ S +I + + + G RP + + C
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE------DCPPR----------- 258
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERPT 1121
L +V C +P +RP
Sbjct: 259 ----------LRNVIELCWSGDPKKRPH 276
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 65/312 (20%), Positives = 108/312 (34%), Gaps = 72/312 (23%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G ++R + + A K + I N E ++ L+H I+ +
Sbjct: 16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV----RQEAKLFAMLKHPNIIAL 71
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G + + ME+ +GG + + K + + + A
Sbjct: 72 RG----------VCLKEPNL----CLVMEFARGGPLNRVLSG------KRIPPDILVNWA 111
Query: 935 QDVAAALVELHSKH---IMHRDIKSENILIDLERKKAD-GKPVVKLCDFDRAVPLRSFLH 990
+A + LH + I+HRD+KS NILI + + D ++K+ DF
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---------- 161
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1050
HR G WMAPEV+R + D+WSYG LL ELLT +VP+
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIR--ASM--FSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 1051 GLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1109
G+ L + + + + +C E +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPS------TCPEP---------------------FAKLME 248
Query: 1110 RCTEENPTERPT 1121
C +P RP+
Sbjct: 249 DCWNPDPHSRPS 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 73/310 (23%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G ++ R ++ +D A K+ L A+ + F L EV ++ LRH IV
Sbjct: 46 GAGSFGTVHRAEWHGSDVAVKI--LMEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G A P + +I EY+ GS+ + K + + + L +A
Sbjct: 100 MG----------AVTQPPNL----SIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMA 143
Query: 935 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
DVA + LH+++ I+HR++KS N+L+D K VK+CDF +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------KKYTVKVCDFGLS---------- 186
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1052
+ + GTP WMAPEVLR +P + D++S+G +L EL TLQ P+ L
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLR--DEP--SNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 1053 SELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111
+ ++ + KR + + + + + C
Sbjct: 243 NPAQVVAAVGFKCKRLEIPR------NLNPQ---------------------VAAIIEGC 275
Query: 1112 TEENPTERPT 1121
P +RP+
Sbjct: 276 WTNEPWKRPS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 65/288 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L V + +++ F EV +L RH I+ G S+ L
Sbjct: 51 VKMLNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMG--YSTA----------PQL 94
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
AI ++ +G S+ +++ E +K + IA+ A + LH+K I+HRD+K
Sbjct: 95 ---AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
S NI + VK+ DF A + G+ WMAPE
Sbjct: 148 SNNIFL-------HEDNTVKIGDFGLA---TEKSRWSGSHQFEQLS-----GSILWMAPE 192
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDEL 1073
V+R M N Y + D++++G +L EL+T Q+PY ++ + I + + P L
Sbjct: 193 VIR-MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---S 248
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
+ +C + + + C ++ ERP+
Sbjct: 249 KVRSNCPKR---------------------MKRLMAECLKKKRDERPS 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 83/312 (26%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ + + K+ + D A K ++ S E + F E+R L + H IV++
Sbjct: 17 GRGAFGVVCKAKWRAKDVAIKQ--IE----SESERKAFI----VELRQLSRVNHPNIVKL 66
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
YG + + MEY +GGS+ N + + + A+
Sbjct: 67 YG--ACLNPV--------------CLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWC 108
Query: 935 QDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
+ + LHS K ++HRD+K N+L+ G V+K+CDF A +++ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------AGGTVLKICDFGTACDIQTHMTN 162
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
G+ WMAPEV Y + D++S+G +L E++T + P+
Sbjct: 163 NK-------------GSAAWMAPEVFE--GSN--YSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 1052 LS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1109
+ I + G RP L + + + +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIK------NLPKP---------------------IESLMT 238
Query: 1110 RCTEENPTERPT 1121
RC ++P++RP+
Sbjct: 239 RCWSKDPSQRPS 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 66/276 (23%), Positives = 102/276 (36%), Gaps = 64/276 (23%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
C+ E+ +L L H +++ Y I L I +E G + I
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMI 123
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + + + + + +AL +HS+ +MHRDIK N+ I A G VV
Sbjct: 124 KHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----ATG--VV 175
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
KL D R F AH VGTP +M+PE + Y + DIWS
Sbjct: 176 KLGDLGLG---RFFSSKTTAAH-------SLVGTPYYMSPERIH--ENG--YNFKSDIWS 221
Query: 1035 YGCLLLELLTLQVPYMG--LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092
GCLL E+ LQ P+ G ++ + I+ P L + S
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD------------HYS----- 264
Query: 1093 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L + C +P +RP +Y++
Sbjct: 265 ---------EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 56/296 (18%), Positives = 101/296 (34%), Gaps = 60/296 (20%)
Query: 848 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--IFMEYV 905
++ EV+ L L H IV G + P I ME+
Sbjct: 43 RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 906 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965
G+++ +IEK + + LAL + + + + +HSK +++RD+K NI +
Sbjct: 103 DKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156
Query: 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025
VK+ DF L++ GT R+M+PE + +
Sbjct: 157 --DTK--QVKIGDFGLVTSLKNDGKRTRS-----------KGTLRYMSPEQIS--SQD-- 197
Query: 1026 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 1085
YG EVD+++ G +L ELL + E + ++D
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF-----ETSKFFTDLRDGIISDIF------------ 240
Query: 1086 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 1140
+ ++ + P +RP ++ V + S + R
Sbjct: 241 -DKK--------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 71/290 (24%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
L+ + E + F+ E ML L+H IV Y W + G + ++
Sbjct: 59 LQDRKLTKSERQRFK----EEAEMLKGLQHPNIVRFYDS-----WESTVKG--KKCIV-- 105
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 956
+ E + G++K Y+++ K + + + L LH++ I+HRD+K
Sbjct: 106 -LVTELMTSGTLKTYLKRFKVMKIKVLRS-----WCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
+NI I G VK+ D + +GTP +MAPE+
Sbjct: 160 DNIFIT----GPTG--SVKIGDL------------GLATLKRASFAKAVIGTPEFMAPEM 201
Query: 1017 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEA 1075
Y VD++++G +LE+ T + PY +I+ + G +P D++
Sbjct: 202 YE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 1076 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
PE + + C +N ER + DL
Sbjct: 257 ------------------PEVK----EII----EGCIRQNKDERYSIKDL 280
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 822 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881
+ ++ L + R F L EV+++ L H +++ G +
Sbjct: 26 AIKVTHRETGEVMVMKELI--RFDEETQRTF----LKEVKVMRCLEHPNVLKFIG--VLY 77
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 941
K + L EY+KGG+++ I+ + + A+D+A+ +
Sbjct: 78 K---------DKRL---NFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGI 999
LHS +I+HRD+ S N L+ + V + DF R + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENK-------NVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 1000 PAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSEL 1055
VG P WMAPE++ + Y +VD++S+G +L E++ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMIN--GRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 1056 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115
+ ++ +C + RC + +
Sbjct: 231 DFGLNVRGFLDR------YCPPNCPPS---------------------FFPITVRCCDLD 263
Query: 1116 PTERPTAGDLYEMF 1129
P +RP+ L
Sbjct: 264 PEKRPSFVKLEHWL 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 56/286 (19%), Positives = 93/286 (32%), Gaps = 75/286 (26%)
Query: 853 EYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 911
E + L EV L +HS +V + W + H+L I EY GGS+
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSA-----WAE------DDHML---IQNEYCNGGSLA 99
Query: 912 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID--------- 962
+ I + + + V L +HS ++H DIK NI I
Sbjct: 100 DAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 963 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
E A K + K+ D + S P V G R++A EVL+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHVTRISS--------------PQVEEGDSRFLANEVLQ- 203
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1079
+ + + DI++ ++ + + I+ G+ PR+ L
Sbjct: 204 ENYT--HLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IRQGRLPRIPQVL------ 252
Query: 1080 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
S ++ + +P RP+A L
Sbjct: 253 -------SQE--------------FTELLKVMIHPDPERRPSAMAL 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 58/268 (21%), Positives = 92/268 (34%), Gaps = 61/268 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L IV +YG W+ IFME ++GGS+ I+++
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWV--------------NIFMELLEGGSLGQLIKQMG 145
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E L LH++ I+H D+K++N+L+ +DG LCD
Sbjct: 146 CLPEDRALY-----YLGQALEGLEYLHTRRILHGDVKADNVLLS-----SDGS-RAALCD 194
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A+ L+ + D GT MAPEV+ +VDIWS C+
Sbjct: 195 FGHALCLQPDGLGKSLLTG-----DYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCM 245
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
+L +L P+ + I P E P
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----------------------EIP---- 279
Query: 1099 ETLS-FLVDVFRRCTEENPTERPTAGDL 1125
+ + + + P R +A +L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 66/288 (22%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
EV +L ++H IV+ + L I M+Y +GG + I
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSL--------------YIVMDYCEGGDLFKRI 114
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L + AL +H + I+HRDIKS+NI + DG V
Sbjct: 115 NA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-----KDG--TV 164
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
+L DF A R T +A C+GTP +++PE+ +KP Y + DIW+
Sbjct: 165 QLGDFGIA---RVLNSTVELAR-------ACIGTPYYLSPEICE--NKP--YNNKSDIWA 210
Query: 1035 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1094
GC+L EL TL+ + S + I G P ++ S
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY----S---------------- 250
Query: 1095 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSRS 1141
L + + + NP +RP+ + E F+A+ S
Sbjct: 251 -------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 72/279 (25%), Positives = 106/279 (37%), Gaps = 66/279 (23%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EV +L L+H IV Y I L I MEY +GG + + I
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRT---------NTTLY---IVMEYCEGGDLASVI 98
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENILIDLERKKAD 969
K ++ +++ + L + + AL E H + ++HRD+K N+ +D
Sbjct: 99 TKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD------- 150
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1029
GK VKL DF A R H A VGTP +M+PE + Y +
Sbjct: 151 GKQNVKLGDFGLA---RILNHDTSFAK-------TFVGTPYYMSPEQMN--RMS--YNEK 196
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1089
DIWS GCLL EL L P+ S+ E+ I+ GK R+ S
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY----S----------- 241
Query: 1090 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L ++ R RP+ ++ E
Sbjct: 242 ------------DELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 55/276 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKNYI 914
EV +L +L H +V Y WL + ++ I MEY + G++ + I
Sbjct: 52 EVMLLASLNHQYVVRYYAA-----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + + + AL +HS+ I+HRD+K NI ID V
Sbjct: 107 HS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-----ESRN--V 155
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVLRAMHKPNLYGLEV 1030
K+ DF A + L + + +P +GT ++A EVL + Y ++
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGH-YNEKI 212
Query: 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1090
D++S G + E++ G+ + I ++
Sbjct: 213 DMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVS------------------------- 245
Query: 1091 FEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1125
E P + + R + +P +RP A L
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/274 (22%), Positives = 96/274 (35%), Gaps = 48/274 (17%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EV+ L L H IV + + + L I M+ + ++K+++
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL--YIQMQLCRKENLKDWM 106
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + L I +A A+ LHSK +MHRD+K NI D VV
Sbjct: 107 NG--RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VV 157
Query: 975 KLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
K+ DF A+ T VGT +M+PE + Y +VDI
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDI 213
Query: 1033 WSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1091
+S G +L ELL P+ E ++ K P L
Sbjct: 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL---------------------- 248
Query: 1092 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ +V + +P ERP A ++
Sbjct: 249 --FTQKYPCEYVMV---QDMLSPSPMERPEAINI 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 53/285 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ LRH I+ +D H Q + Y + GS+ +Y++
Sbjct: 52 ELYNTVMLRHENILGFIA----------SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 99
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 970
+ L I +A+ L LH + I HRD+KS+NIL+ +G
Sbjct: 100 ----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-----KNG 150
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE- 1029
+ D AV + + + VGT R+MAPEVL + +
Sbjct: 151 --QCCIADLGLAVMHSQSTNQLDVGNNPR------VGTKRYMAPEVLD--ETIQVDCFDS 200
Query: 1030 ---VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1086
VDIW++G +L E+ V + + + + P D + V
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--------VCV 252
Query: 1087 SGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
TL+ L + + C +NP+ R TA + +
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 19/220 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS-PGV 128
L L L P R L+++ + P + GLE L + + + P
Sbjct: 86 LELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPA- 144
Query: 129 NGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
++ L L+EL + ++P + E GL L L + IR LP
Sbjct: 145 ---SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPAS 201
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA-NNKLVELPSGLYLLQRLENLDLS 241
I L NL+ L + + + L I +L L L + L P L+ L L
Sbjct: 202 IANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 242 N-NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + L +L LD+ + L+ L+L+ LS ++PS I
Sbjct: 262 DCSNLLTL-PLDIHRLTQLEKLDLRGCVNLS--RLPSLIA 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-27
Identities = 36/198 (18%), Positives = 67/198 (33%), Gaps = 18/198 (9%)
Query: 93 LRNLKFFG-NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP 151
NL F G + + + N + ++ +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQ-IETRTGRALKATA 72
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKA 211
+L + L + + P + LS+L+ + + + LP +
Sbjct: 73 DLLEDAT----QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAG 128
Query: 212 LISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--------GSLDLCLMHNLQNL 262
L +L +A N L LP+ + L RL L + LT L S + + NLQ+L
Sbjct: 129 LETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 263 NLQYNKLLSYCQVPSWIC 280
L++ + S +P+ I
Sbjct: 189 RLEWTGIRS---LPASIA 203
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 43/185 (23%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L + +P S+ + L++LK + ++ + +L LE L
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEEL--------- 234
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEIGCLS 187
L+G L G L +L + S + LP +I L+
Sbjct: 235 ------DLRGCTALR-----------NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 188 NLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
LE+LDL LP+ I L A + V + +L +R
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ---------------HRPV 322
Query: 247 SLGSL 251
+ +
Sbjct: 323 ARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 9/93 (9%), Positives = 19/93 (20%), Gaps = 5/93 (5%)
Query: 179 LPPEIGCLSNLEQLDLS-FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
S E L ++ + + A+ +
Sbjct: 4 SHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQ---RHYNADRNRWHSAWRQANSNNPQI 60
Query: 238 LDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKL 269
+ L + L+ L L+ L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPL 93
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 64/286 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ + L+H IV+ G + IFME V GGS+ +
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSE-----------NGFIK---IFMEQVPGGSLSALLRSKW 114
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + + + Q + L LH I+HRDIK +N+LI+ G V+K+ D
Sbjct: 115 GPLKDNEQT-IGFYTKQ-ILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISD 166
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F + L P + GT ++MAPE++ P YG DIWS GC
Sbjct: 167 FGTSKRLAGI----------NPCTETFTGTLQYMAPEIID--KGPRGYGKAADIWSLGCT 214
Query: 1039 LLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
++E+ T + P+ L E + M K P + + + A
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA------------------- 255
Query: 1097 ELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSISSRS 1141
+F+ +C E +P +R A DL F+ +S ++
Sbjct: 256 ----KAFI----LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 81/299 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV L ++H I++ G A+ + + + + GS+ ++++
Sbjct: 68 EVYSLPGMKHENILQFIG----------AEKRGTSVDVDLWLITAFHEKGSLSDFLKA-- 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDIKSENILIDLERKKA 968
VS IA+ +A L LH I HRDIKS+N+L+
Sbjct: 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----N 166
Query: 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYG 1027
+ + DF A+ + + VGT R+MAPEVL A++
Sbjct: 167 NL--TACIADFGLALKFEAGKSAGDTHGQ--------VGTRRYMAPEVLEGAINFQRDAF 216
Query: 1028 LEVDIWSYGCLLLELLTLQVPYMGL----------------SELEIHDLI-QMGKRPRLT 1070
L +D+++ G +L EL + G S ++ +++ KRP L
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
D +H ++ L + C + + R +AG + E
Sbjct: 277 D------YWQKHAG----------------MAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 64/281 (22%), Positives = 96/281 (34%), Gaps = 75/281 (26%)
Query: 855 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
L EV + +H C V + W +G L + E G S++ +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----W---EEGG---ILY---LQTELC-GPSLQQH 146
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
E + +D AL LHS+ ++H D+K NI + G
Sbjct: 147 CEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-----PRG--R 195
Query: 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
KL DF V L + +V G PR+MAPE+L+ YG D++
Sbjct: 196 CKLGDFGLLVELGTAGAG-----------EVQEGDPRYMAPELLQ-----GSYGTAADVF 239
Query: 1034 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092
S G +LE+ +++P+ G L Q P T L S
Sbjct: 240 SLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGL----S-------------- 278
Query: 1093 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVAR 1132
E L V E +P R TA L + + +
Sbjct: 279 -SE--------LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 44/228 (19%), Positives = 82/228 (35%), Gaps = 28/228 (12%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
E M H I+ + + + + +H + + + K G++ N IE
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRER-------GAKHEAW---LLLPFFKRGTLWNEIE 122
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+L + G ++ L++ + L +H+K HRD+K NIL+ +G
Sbjct: 123 RLKDKGN-FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----DEG--QPV 174
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWS 1034
L D + A T + APE+ + + D+WS
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSV--QSHCVIDERTDVWS 231
Query: 1035 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-----PRLTDELEAL 1076
GC+L ++ + PY + + + L + PR + L L
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQL 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 855 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 116
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 117 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 163
Query: 973 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1020
++KL DF A ++ + GT +M PE ++ M
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 210
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1080
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 249
Query: 1081 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1127
H + E P + L DV + C + +P +R + +L
Sbjct: 250 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 1032
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1091
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1092 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 855 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 97
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 98 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 144
Query: 973 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1020
++KL DF A ++ + GT +M PE ++ M
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 191
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1080
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 230
Query: 1081 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1127
H + E P + L DV + C + +P +R + +L
Sbjct: 231 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 78/316 (24%), Positives = 115/316 (36%), Gaps = 79/316 (25%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 881
C A K L+ C +S DE+ E++ + H IV Y
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--------EKHVSVKLALFI 933
W + M+ + GGSV + I+ + G E ++ I
Sbjct: 88 LW----------------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-----I 126
Query: 934 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 993
++V L LH +HRD+K+ NIL+ DG V++ DF + L +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-----EDGS--VQIADFGVSAFLATGGDITR 179
Query: 994 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1053
R VGTP WMAPEV M + Y + DIWS+G +EL T PY
Sbjct: 180 NKVR-----KTFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 1054 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR---- 1109
+++ L P L E + E L FR
Sbjct: 232 PMKVLMLTLQNDPPSL----------------------ETGVQDKEMLKKYGKSFRKMIS 269
Query: 1110 RCTEENPTERPTAGDL 1125
C +++P +RPTA +L
Sbjct: 270 LCLQKDPEKRPTAAEL 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +RH I+ AD Q + +Y + GS+ +Y++
Sbjct: 81 EIYQTVLMRHENILGFIA----------ADIKGTGSWTQLYLITDYHENGSLYDYLKS-- 128
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSENILIDLERKKADG 970
+ K L +A + L LH++ I HRD+KS+NIL+
Sbjct: 129 ----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------K 177
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGL 1028
+ D AV S + I VGT R+M PEVL N +
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTR------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 1029 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1088
D++S+G +L E+ V + E ++ + P D E V
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI--------VCIKK 283
Query: 1089 S--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
F + E L + + C NP R TA + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-33
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 855 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 144
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 145 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 191
Query: 973 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1020
++KL DF A ++ + G +M PE ++ M
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GAVNYMPPEAIKDMSSSRENG 238
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1080
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 277
Query: 1081 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1127
H + E P + L DV + C + +P +R + +L
Sbjct: 278 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-32
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 1032
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1091
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1092 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 63/323 (19%), Positives = 102/323 (31%), Gaps = 59/323 (18%)
Query: 824 RCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882
R K + L+ C ++ E+ + H IV I+
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQG-------ELHVSKLFNHPNIVPYRATFIADN 99
Query: 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAA 940
L + ++ GS K+ I G E ++ +I Q V A
Sbjct: 100 EL--------------WVVTSFMAYGSAKDLICTHFMDGMNELAIA-----YILQGVLKA 140
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1000
L +H +HR +K+ +ILI DGK V L S +
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-----VDGK--VYLSGLRSN---LSMISHGQRQRVVHD 190
Query: 1001 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1060
P V W++PEVL+ + Y + DI+S G EL VP+ + ++
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 1061 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV--------------D 1106
G P L D ++S + ++ +
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 1107 VFR----RCTEENPTERPTAGDL 1125
F +C + NP RP+A L
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTL 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 66/299 (22%), Positives = 103/299 (34%), Gaps = 81/299 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ LRH I+ AD Q + +Y + GS+ +Y+ + +
Sbjct: 86 EIYQTVMLRHENILGFIA----------ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 970
V+V+ + +A A+ L LH + I HRD+KS+NIL+
Sbjct: 136 ------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------K 182
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR----AMHKPNLY 1026
+ D AV S T IA VGT R+MAPEVL H
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEVLDDSINMKHFE--S 234
Query: 1027 GLEVDIWSYGCLLLELLTL----------QVPYMGL-----SELEIHDLI-QMGKRPRLT 1070
DI++ G + E+ Q+PY L S E+ ++ + RP +
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ + E L + + R C N R TA + +
Sbjct: 295 NRWQ----------------------SCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 51/301 (16%), Positives = 97/301 (32%), Gaps = 76/301 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+ + + H I + ++ + MEY GS+ Y+
Sbjct: 57 NIYRVPLMEHDNIARFIV---------GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-- 105
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH---------IMHRDIKSENILIDLERKKAD 969
+ +A V L LH++ I HRD+ S N+L+ D
Sbjct: 106 ----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----ND 156
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR---AMHKPNLY 1026
G + DF ++ L +V GT R+MAPEVL +
Sbjct: 157 G--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYMAPEVLEGAVNLRDXESA 212
Query: 1027 GLEVDIWSYGCLLLELLT-------------LQVPYMGL-----SELEIHDLI-QMGKRP 1067
+VD+++ G + E+ Q+ + + ++ L+ + +RP
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
+ + + E+ +A + L + C +++ R TA E
Sbjct: 273 KFPE------AWKENSLA---------------VRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 1128 M 1128
Sbjct: 312 R 312
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 72/270 (26%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+ ++ ++ IV W + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTE 110
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E ++ + ++ AL LHS ++HRDIKS+NIL+ DG VKL
Sbjct: 111 -TCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKL 157
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF + T + R VGTP WMAPEV+ YG +VDIWS G
Sbjct: 158 TDFGFCAQI-----TPEQSKR-----STMVGTPYWMAPEVV----TRKAYGPKVDIWSLG 203
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+ +E++ + PY+ + L LI P L +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------------------------ 239
Query: 1097 ELETLS-FLVDVFRRCTEENPTERPTAGDL 1125
E LS D RC E + +R +A +L
Sbjct: 240 --EKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 72/270 (26%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EV ++ +H +VEMY W + ME+++GG++ + + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELW----------------VLMEFLQGGALTDIVSQ 135
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E+ ++ + + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 136 VRLN-EEQIAT-----VCEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 182
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF + + + R VGTP WMAPEV+ Y EVDIWS G
Sbjct: 183 SDFGFCAQI-----SKDVPKR-----KSLVGTPYWMAPEVISRSL----YATEVDIWSLG 228
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+++E++ + PY S ++ ++ P+L +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS------------------------ 264
Query: 1097 ELETLS-FLVDVFRRCTEENPTERPTAGDL 1125
+S L D R +P ER TA +L
Sbjct: 265 --HKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 80/311 (25%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 889
A K+ L+ ++I+ E+ +L + + YG K + W
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQ-------EITVLSQCDSPYVTKYYGSYLKDTKLW------ 96
Query: 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 949
I MEY+ GGS + + + E ++ I +++ L LHS+
Sbjct: 97 ----------IIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
+HRDIK+ N+L+ G+ VKL DF A L T R + VGTP
Sbjct: 141 IHRDIKAANVLLS-----EHGE--VKLADFGVAGQL-----TDTQIKR-----NTFVGTP 183
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1069
WMAPEV+ K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 184 FWMAPEVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 1070 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM- 1128
+ KP L + C + P+ RPTA +L +
Sbjct: 240 EGN------------------YSKP---------LKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 1129 FVARTSSSISS 1139
F+ R + S
Sbjct: 273 FILRNAKKTSY 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 65/291 (22%), Positives = 106/291 (36%), Gaps = 64/291 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
+KV + DE + E+ ML H I YG ++ + L
Sbjct: 54 IKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGA-----FIKKNPPGMDDQLW- 103
Query: 898 SAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME+ GSV + I+ E+ ++ +I +++ L LH ++HRDIK
Sbjct: 104 --LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-----YICREILRGLSHLHQHKVIHRDIK 156
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+N+L+ + + VKL DF + L + R + +GTP WMAPE
Sbjct: 157 GQNVLLT-----ENAE--VKLVDFGVSAQL-----DRTVGRR-----NTFIGTPYWMAPE 199
Query: 1016 VLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
V+ P+ Y + D+WS G +E+ P + + LI PRL
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL----- 254
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ K C +N ++RP L
Sbjct: 255 ------------KSKKWSKK---------FQSFIESCLVKNHSQRPATEQL 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 75/298 (25%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 889
AAAKV K S +E+ ++ E+ +L H IV++ G + W
Sbjct: 47 AAAKVIETK----SEEELEDYI----VEIEILATCDHPYIVKLLGAYYHDGKLW------ 92
Query: 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKH 948
I +E+ GG+V + +L E + + + + AL LHSK
Sbjct: 93 ----------IMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
I+HRD+K+ N+L+ +G ++L DF + L R D +GT
Sbjct: 138 IIHRDLKAGNVLMT-----LEGD--IRLADFGVSAKNLKTL-----QKR-----DSFIGT 180
Query: 1009 PRWMAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1067
P WMAPEV + K Y + DIWS G L+E+ ++ P+ L+ + + I P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
L + S + D + ++NP RP+A L
Sbjct: 241 TL----------------LTPSKWSVE---------FRDFLKIALDKNPETRPSAAQL 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 48/210 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
EV + LRH I+ +YG+ + ++ +EY G+V ++K
Sbjct: 59 EVEIQSHLRHPNILRLYGYFHDAT----------------RVYLILEYAPLGTVYRELQK 102
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ ++A AL HSK ++HRDIK EN+L+ + G+ +K+
Sbjct: 103 -----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----SAGE--LKI 150
Query: 977 CDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
DF +V S C GT ++ PE++ ++ +VD+WS
Sbjct: 151 ADFGWSVHAPSSRRTDLC-------------GTLDYLPPEMIEG----RMHDEKVDLWSL 193
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
G L E L + P+ + E + I +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 68/271 (25%), Positives = 100/271 (36%), Gaps = 72/271 (26%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+ ++ +V+ YG K + W I MEY GSV + I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW----------------IVMEYCGAGSVSDIIRL 117
Query: 917 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
++T E ++ I Q L LH +HRDIK+ NIL++ +G K
Sbjct: 118 RNKTLTEDEIAT-----ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-----TEGH--AK 165
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
L DF A L T +A R + +GTP WMAPEV+ + Y DIWS
Sbjct: 166 LADFGVAGQL-----TDTMAKR-----NTVIGTPFWMAPEVI----QEIGYNCVADIWSL 211
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1095
G +E+ + PY + + +I P
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP----------------------- 248
Query: 1096 AELETLS-FLVDVFRRCTEENPTERPTAGDL 1125
E S D ++C ++P +R TA L
Sbjct: 249 ---ELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 55/274 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E++++ +++ + G I++ ++ EY++ S+ + E
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNY---------------DEVYIIYEYMENDSILKFDEY 136
Query: 917 ---LSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKP 972
L + + +++ I + V + +H+ K+I HRD+K NIL+D +G+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-----KNGR- 190
Query: 973 VVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031
VKL DF + + + GT +M PE ++ + G +VD
Sbjct: 191 -VKLSDFGESEYMVDKKIKGSR-------------GTYEFMPPEFF--SNESSYNGAKVD 234
Query: 1032 IWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1090
IWS G L + VP+ +S +E+ + I+ + ++ + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 1091 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124
F E D + +NP ER T+ D
Sbjct: 294 FLSNEDI--------DFLKLFLRKNPAERITSED 319
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 33/303 (10%), Positives = 69/303 (22%), Gaps = 56/303 (18%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH----------KISSKWLPSAD 888
LKV A+ R+ L E + S+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 889 GNPEHHLLQSAIF--MEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVEL 944
+ + M ++ L + + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
SK ++H +N+ I DG+ + L D + +
Sbjct: 211 QSKGLVHGHFTPDNLFIM-----PDGR--LMLGDVSALWKVGTRGPASS----------- 252
Query: 1005 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 1064
+ E L + ++ W G + + L +P+ ++ +
Sbjct: 253 --VPVTYAPREFLN--ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 1065 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124
R TD L + + + R + R +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK-------------------TLIGRFLNFDRRRRLLPLE 349
Query: 1125 LYE 1127
E
Sbjct: 350 AME 352
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 29/219 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
D L L L+ +P+ L +L N + P +L L + +
Sbjct: 70 DRQAHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLKSLLVDNNNLKA- 125
Query: 127 GVNGFALNKL-KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC 185
L+ L L+ L +S L L E+ L + V + S++ LP
Sbjct: 126 ------LSDLPPLLEYLGVSNNQ-----LEKLPELQNSSFLKIIDVDNNSLKKLPDLPP- 173
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
+LE + N+++ LP E+ L L ++ NN L +LP L LE++ NN L
Sbjct: 174 --SLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKKLPD---LPLSLESIVAGNNIL 227
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L +L + L + N L + +P +LE
Sbjct: 228 EELP--ELQNLPFLTTIYADNNLLKT---LPDLP-PSLE 260
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 49/234 (20%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
+E L + N L +P + L+ + N + P +L + ++
Sbjct: 131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEEL- 188
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L L + L ++ L + + + LP E+ L
Sbjct: 189 ---PELQNLPFLTAIYADN--------NSLKKLPDLPLSLESIVAGNNILEELP-ELQNL 236
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L + N +K LP L+ +L V +N L +LP L Q L LD+S N +
Sbjct: 237 PFLTTIYADNNLLKTLPDLPPSLE---ALNVRDNYLTDLPE---LPQSLTFLDVSENIFS 290
Query: 247 -------SLGSLDLC---------LMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+L L+ L +L+ LN+ NKL+ +P+ LE
Sbjct: 291 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE---LPALP-PRLE 340
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 41/233 (17%), Positives = 76/233 (32%), Gaps = 29/233 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+Y N+L +P L L N + P +L L+ + S
Sbjct: 242 IYADNNLLKTLPDLPP---SLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 298
Query: 133 LNKLKGLKELELSKVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFSIRYLPPEIG 184
L L E+ + P L L E+ A L +L + +P
Sbjct: 299 LYYLN-ASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQ 357
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
NL+QL + +N ++ P ++ L N+ L E+P L Q L+ L + N
Sbjct: 358 ---NLKQLHVEYNPLREFPDIPESVEDLRM----NSHLAEVPE---LPQNLKQLHVETNP 407
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
L + ++++L + +++ + + D
Sbjct: 408 LREFPDI----PESVEDLRMNSERVV---DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 39/199 (19%), Positives = 66/199 (33%), Gaps = 31/199 (15%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
+ + L +P + +E P G + +++
Sbjct: 16 PLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD-------- 67
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
+ ELEL+ LS + L L S+ LP L +L
Sbjct: 68 --CLDRQAHELELNN--------LGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLL 117
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+ + + LP L L V+NN+L +LP L L+ +D+ NN L L
Sbjct: 118 VDNNNLKALSDLP------PLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPD 170
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L +L+ + N+L
Sbjct: 171 ----LPPSLEFIAAGNNQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-16
Identities = 38/208 (18%), Positives = 73/208 (35%), Gaps = 42/208 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
S+E L + N L +P+ L L N + NL L +I S
Sbjct: 258 SLEALNVRDNYLTDLPELPQ---SLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL-- 312
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFS 175
+ L+EL +S ++P P L L+E+ + L +L V +
Sbjct: 313 ----CDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNP 368
Query: 176 IRYLPPEIGCL----------------SNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
+R P + NL+QL + N ++ P ++ L++ +
Sbjct: 369 LREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVE---DLRMNS 425
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLT 246
++V+ + +LE+ ++
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 20/106 (18%), Positives = 40/106 (37%), Gaps = 18/106 (16%)
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLY------ 230
++ P + L++ + + +P E +K+ A ++ P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 231 -------LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ L+L+N L+SL L +L++L N L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPE----LPPHLESLVASCNSL 103
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 69/303 (22%), Positives = 111/303 (36%), Gaps = 74/303 (24%)
Query: 859 EVRMLGALRHSCIVEMYG-----HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
E+++L IV YG +IS I ME++ GGS+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEIS-------------------ICMEHMDGGSLDQV 121
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKP 972
++K E+ + ++ V L L KH IMHRD+K NIL++ +
Sbjct: 122 LKKAGRIPEQILGK-----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE------ 170
Query: 973 VVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031
+KLCDF + L S ++ VGT +M+PE L + Y ++ D
Sbjct: 171 -IKLCDFGVSGQLIDSMANS-------------FVGTRSYMSPERL----QGTHYSVQSD 212
Query: 1032 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1091
IWS G L+E+ + P E+ + + + + + G
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT-PGRPLNKFGMDS 271
Query: 1092 EKPEAELETLSFLV-----------------DVFRRCTEENPTERPTAGDLYEM-FVART 1133
P A E L ++V D +C +NP ER L F+ R+
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 1134 SSS 1136
+
Sbjct: 332 DAE 334
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 56/276 (20%)
Query: 859 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
EV + L H IV+ K + L + E KG V +++K+
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGK---EESDTGQAEFL---LLTELCKGQLV-EFLKKM 127
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVK 975
G +S L I A+ +H + I+HRD+K EN+L+ G +K
Sbjct: 128 ESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-----NQG--TIK 178
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAM-HKPNLYGLEVDI 1032
LCDF A + + A R + TP + PE++ + P G + DI
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP--IGEKQDI 236
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1091
W+ GC+L L Q P+ ++L I + + +L
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSL--------------- 281
Query: 1092 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
R + NP ER + ++
Sbjct: 282 ----------------IRAMLQVNPEERLSIAEVVH 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 48/210 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ + LRH I+ MY + + I+ +E+ G + ++K
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDR---------------KRIYLMLEFAPRGELYKELQK 107
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ + +++A AL H + ++HRDIK EN+L+ G +K+
Sbjct: 108 -----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----YKG--ELKI 155
Query: 977 CDFDRAV-PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
DF +V T C GT ++ PE++ + +VD+W
Sbjct: 156 ADFGWSVHAPSLRRRTMC-------------GTLDYLPPEMIEG----KTHDEKVDLWCA 198
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
G L E L P+ S E H I
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/295 (22%), Positives = 108/295 (36%), Gaps = 70/295 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++ + D F L E R+L H IV + G + ++ P +
Sbjct: 144 VKSCR-ETLPPDLKAKF----LQEARILKQYSHPNIVRLIG--VCTQKQP---------I 187
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME V+GG ++ + VK L + D AA + L SK +HRD+
Sbjct: 188 Y---IVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N L+ + V+K+ DF + ++ R +P +W APE
Sbjct: 241 ARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPV--------KWTAPE 285
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
L Y E D+WS+G LL E +L PY LS + + ++ G R L
Sbjct: 286 ALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------LP 335
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
C + + + +C P +RP+ +Y+
Sbjct: 336 CPELCPDA---------------------VFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-27
Identities = 28/218 (12%), Positives = 76/218 (34%), Gaps = 27/218 (12%)
Query: 71 EGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-------K 122
Y+ + E + + + NL L +++ K
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKT----EDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 123 ISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSV--CHFS 175
+ + L L ++ + ++ L++ + + + + +
Sbjct: 265 LPT------FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGL-YLLQR 234
+ + + L L+ +N+++ L SL +A N++ E+P+ ++
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 235 LENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKLLS 271
+ENL ++N+L + D + + ++ YN++ S
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-25
Identities = 43/241 (17%), Positives = 76/241 (31%), Gaps = 37/241 (15%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLF--------PSEVGNLLGLE 117
VE L N L IP + + F NEI + +
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 118 CL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTK 168
+ QI + + L + L P+ S+ LT
Sbjct: 437 SINLSNNQISKFPKEL----FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 169 LSVCHFSIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--- 223
+ + + L + L L +DLS+N PT+ L + N +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGN 552
Query: 224 ----ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
E P G+ L L L + +N + ++ + N+ L+++ N +S S++
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIR---KVNEKITPNISVLDIKDNPNISI--DLSYV 607
Query: 280 C 280
C
Sbjct: 608 C 608
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-25
Identities = 37/235 (15%), Positives = 75/235 (31%), Gaps = 38/235 (16%)
Query: 69 SVEGLYLYKNVLNL-IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ + + I KS K + N I V L L +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEI 183
N + + + + K + LK LT + V + + LP +
Sbjct: 220 --AENICEAWENENSEYAQQYKTED--------LKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 184 GCLSNLEQLDLSFNKMKYLP---------TEICYLKALISLKVANNKLVEL--PSGLYLL 232
L ++ ++++ N+ + + + + + N L + L +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 233 QRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++L L+ N+L + GS L +LNL YN++ +P+ C
Sbjct: 330 KKLGMLECLYNQLEGKLPAFGSE-----IKLASLNLAYNQITE---IPANFCGFT 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 31/239 (12%), Positives = 77/239 (32%), Gaps = 46/239 (19%)
Query: 75 LYKNVLNLIPKSVGRYEKLRNLKFFGNEINL---FPSEVGNLLGLECLQI---------K 122
Y + L +++ + P+ + L ++ + + +
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNC--PNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSV-----LTLLS-----------EIA 161
+ + ++ + + P S+ L +L
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVA 218
L L++ + I +P G +E L + NK+KY+P + + + ++ +
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410
Query: 219 NNKL--------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++ L + + +++LSNN+++ L ++NL N L
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-20
Identities = 33/213 (15%), Positives = 71/213 (33%), Gaps = 30/213 (14%)
Query: 78 NVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGVNGF-- 131
+ + + + + ++ N+I+ FP E+ L + + ++ N
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 132 ---ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
L ++L K+ TL L + LS FS P +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY----LVGID-LSYNSFS--KFPTQP 532
Query: 184 GCLSNLEQLDLSFNK-------MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
S L+ + + ++ P I +L L++ +N + ++ + +
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNIS 590
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LD+ +N S+ +C L Y+K
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-16
Identities = 31/203 (15%), Positives = 63/203 (31%), Gaps = 25/203 (12%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--------NLFPSEVGNLLGLECL 119
+V + L N ++ + L ++ GN + N L +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 120 QI---KISS-PGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLS 170
+ K++ + F L L ++LS K P +P + L
Sbjct: 494 DLRFNKLTKLS--DDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR-DAQ 550
Query: 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP-SGL 229
R P I +L QL + N ++ + +I + L + +N + + S +
Sbjct: 551 GNRTL-REWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDLSYV 607
Query: 230 YLLQRLENLDLSNNRLTSLGSLD 252
L ++ + D
Sbjct: 608 CPYIEAGMYMLFYDKTQDIRGCD 630
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-12
Identities = 25/241 (10%), Positives = 63/241 (26%), Gaps = 73/241 (30%)
Query: 65 GGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL-----KFFGNEINLFPSEVGNLLGLEC 118
+ V GL L + +P ++G+ +L L NE P + + E
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
Q + + + S + + S+ +
Sbjct: 138 KQK-----MRMHYQKTFVDYDPREDFSDL----IKDCINSD--------------PQQKS 174
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
+ Q+ +N + + + L +L
Sbjct: 175 IKKSSRITLKDTQIGQL-----------------------SNNITFVSKAVMRLTKLRQF 211
Query: 239 DLSNNRLTS-----------------LGSLDLCL--MHNLQNLNLQYNKLLSYCQVPSWI 279
+ N+ + + DL + +L ++ + L+ ++P+++
Sbjct: 212 YMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT--KLPTFL 269
Query: 280 C 280
Sbjct: 270 K 270
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-12
Identities = 28/192 (14%), Positives = 59/192 (30%), Gaps = 32/192 (16%)
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ PGV +LN + L L +VP I L L L++ +
Sbjct: 71 AQPGV---SLNSNGRVTGLSLEGFGASGRVPD---------AIGQLTELEVLALGSHGEK 118
Query: 178 -----YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL------VELP 226
+ P I + EQ Y T + Y + + + +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMH--YQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+ + + +N +T + S + + L+ + + ++ +W N E
Sbjct: 177 KSSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235
Query: 287 GKDSSNDDFISS 298
+ + D +
Sbjct: 236 QQYKTEDLKWDN 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 32/200 (16%), Positives = 66/200 (33%), Gaps = 40/200 (20%)
Query: 854 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
Y + L ++ Y + S + E G++ N
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQN--------------GSVLVGELYSYGTLLNA 157
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI----DLERKKAD 969
I T EK + L + A + + ++H I+H DIK +N ++ + + D
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217
Query: 970 GKPVVKLCDFDRAVPLRSF-----LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
+ L D +++ ++ F C T + E+L +KP
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKC-------------ETSGFQCVEMLS--NKP- 261
Query: 1025 LYGLEVDIWSYGCLLLELLT 1044
+ ++D + + +L
Sbjct: 262 -WNYQIDYFGVAATVYCMLF 280
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 44/261 (16%)
Query: 867 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 926
+ V++ S P + I M+ + ++K+++ + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDRE 162
Query: 927 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVP 984
+ L I +A A+ LHSK +MHRD+K NI D VVK+ DF A+
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VVKVGDFGLVTAMD 215
Query: 985 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
T VGT +M+PE + + Y +VDI+S G +L ELL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN----YSHKVDIFSLGLILFELLY 271
Query: 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104
M + I D+ K P L + +
Sbjct: 272 SFSTQMERVRI-ITDVRN-LKFPLL------------------------FTQKYPQEHMM 305
Query: 1105 VDVFRRCTEENPTERPTAGDL 1125
V + +PTERP A D+
Sbjct: 306 V---QDMLSPSPTERPEATDI 323
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-27
Identities = 34/210 (16%), Positives = 72/210 (34%), Gaps = 21/210 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+ N + I K++ R KL+ + F + V + + + +
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL---S 486
Query: 133 LNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCH----------FSIRYLPP 181
+ LK L ++EL +T L + L L L++ L
Sbjct: 487 WSNLKDLTDVELY----NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ ++ + +N ++ P + + L L +NK+ L + +L +L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA-FGTNVKLTDLK 601
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L N++ + ++ L +NKL
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 6e-25
Identities = 38/239 (15%), Positives = 75/239 (31%), Gaps = 36/239 (15%)
Query: 73 LYLY-KNVLNLIPKSVGRYEKLRNLKFFGNEI----------NLFPSEVGNLLGLECLQI 121
+ LY + +P + +L++L N + ++ +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 122 ---KISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + L K+ L L+ K + L LT L + + I
Sbjct: 556 GYNNLEEFPASAS-LQKMVKLGLLDCVHNK-------VRHLEAFGTNVKLTDLKLDYNQI 607
Query: 177 RYLPPEIG-CLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPSGL---- 229
+P + +E L S NK+KY+P + + S+ + NK+ +
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 230 --YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
Y + LS N + + + + L N + S +P +GN
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS---IPENSLKPKDGN 723
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-24
Identities = 38/242 (15%), Positives = 75/242 (30%), Gaps = 41/242 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPS--EVGNLLGLECLQI---KISSP 126
L L N + IP+ + +++ L F N++ P+ ++ + + KI S
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 127 GVNGFALNKLKGLKELE--------LSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
G N + K P A ++ + + + +
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPT--------ELFATGSPISTIILSNNLMTS 711
Query: 179 LPPE--------IGCLSNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG 228
+P L +DL FNK+ L + L L ++ V+ N P+
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQ 771
Query: 229 LYLLQRLENLDLSNNRLTS----LGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+L+ + + R L + +L L + N + V +
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQ 828
Query: 283 LE 284
L
Sbjct: 829 LY 830
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 3e-21
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 47/247 (19%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLFPSEVG------NLLGLECL 119
+ VEGL N L IP + + ++ F N+I + + +
Sbjct: 619 DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 120 QI---KISSPGVNGFAL-----------NKLKGLKELELSKVPPRPSVLTLLSE------ 159
+ +I FA N + + E L LL+
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 160 ----------IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKM-------KYL 202
L L+ + V + P + S L+ + + +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 203 PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262
PT I +LI L++ +N + ++ L +L LD+++N S+ +C
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 263 NLQYNKL 269
L Y+K
Sbjct: 857 VLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-20
Identities = 32/218 (14%), Positives = 74/218 (33%), Gaps = 19/218 (8%)
Query: 65 GGDNSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL---LGLECLQ 120
+ V GL L +P ++G+ +L+ L F + + G+ + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT-------KLSVCH 173
L+ + L +L + + E+ +K + ++
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQ-----DAINRNPEMKPIKKDSRISLKDTQIGNLT 434
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I ++ I L+ L+ + + + Y + + A + L+
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY---AKQYENEELSWSNLK 491
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +++L N + L + LQ+LN+ N+ +S
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 24/191 (12%), Positives = 56/191 (29%), Gaps = 30/191 (15%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKL 169
L L K P A+ +L LK L V R L+ + ++
Sbjct: 328 LSLAGFGAKGRVPD----AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 170 SVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
+ + + L+ +MK + + + N++ +
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCL-------------------MHNLQNLNLQYNKL 269
+ L +L+ + +N+ T + +L ++ L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503
Query: 270 LSYCQVPSWIC 280
++ Q+P ++
Sbjct: 504 MT--QLPDFLY 512
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 19/165 (11%), Positives = 44/165 (26%), Gaps = 34/165 (20%)
Query: 166 LTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK-------- 216
+T LS+ F + +P IG L+ L+ L + + +
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 217 ------------------------VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
N ++ + + + + NR+T +
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISK-A 443
Query: 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
+ + LQ + + W N + + + + S
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 53/233 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I +E +++ Y+E+ + + + Q + L LHS +I+HRD+K NI
Sbjct: 95 IAIELC-AATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 960 LIDLERKKADGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
LI A GK + DF S GT W+A
Sbjct: 150 LIS--MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-------------GTEGWIA 194
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE+L K N VDI+S GC+ +++ P+ + + + L+ L E
Sbjct: 195 PEMLSEDCKEN-PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
E A ++ + +P +RP+A +
Sbjct: 254 KH-----------------EDVIAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 66/273 (24%), Positives = 100/273 (36%), Gaps = 79/273 (28%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EVR L LRH ++ G + + W + MEY GS + +E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAW----------------LVMEYC-LGSASDLLEV 146
Query: 917 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ E ++ + L LHS +++HRD+K+ NIL+ G VK
Sbjct: 147 HKKPLQEVEIAA-----VTHGALQGLAYLHSHNMIHRDVKAGNILLS-----EPGL--VK 194
Query: 976 LCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
L DF A + SF VGTP WMAPEV+ AM Y +VD+
Sbjct: 195 LGDFGSASIMAPANSF-----------------VGTPYWMAPEVILAM-DEGQYDGKVDV 236
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1092
WS G +EL + P ++ + I + P L +
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-----------------GHWS 279
Query: 1093 KPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+ + C ++ P +RPT+ L
Sbjct: 280 EY---------FRNFVDSCLQKIPQDRPTSEVL 303
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 38/256 (14%), Positives = 78/256 (30%), Gaps = 31/256 (12%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP- 891
V ++ I+ + + +R+L +++ +++ I L
Sbjct: 107 EVHVPY-FTERPPSNAIKQMK-EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 892 --------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAAL 941
+ S F+ +++ + E L H + L + V L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1001
LH ++H ++ +I++D G V L F+ V + +
Sbjct: 225 ASLHHYGLVHTYLRPVDIVLD-----QRGG--VFLTGFEHLVRDGASAVSPI-------- 269
Query: 1002 PDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1060
P A +L H P L D W+ G + + +P + L +
Sbjct: 270 -GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328
Query: 1061 IQMGKRPRLTDELEAL 1076
I + + AL
Sbjct: 329 I-FRSCKNIPQPVRAL 343
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 33/212 (15%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ L H +V + L D + MEY +GG ++ Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPND--------LPLLAMEYCEGGDLRKYLNQFE 113
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + D+++AL LH I+HRD+K ENI++ + + K+ D
Sbjct: 114 NCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG----PQRLIHKIID 167
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
+ + GT +++APE+L Y + VD WS+G
Sbjct: 168 LGYAKELDQGELCTEFV-------------GTLQYLAPELLEQ----KKYTVTVDYWSFG 210
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1068
L E +T P++ + K
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/234 (24%), Positives = 83/234 (35%), Gaps = 52/234 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDI 954
I ME + K Y S E+ + I AL L I+HRDI
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHLKENLKIIHRDI 152
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
K NIL+D G +KLCDF + L IA G +MAP
Sbjct: 153 KPSNILLD-----RSGN--IKLCDFGISGQL-----VDSIAKT------RDAGCRPYMAP 194
Query: 1015 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDEL 1073
E + Y + D+WS G L EL T + PY S + + G P+L++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
E S P +F+ C ++ ++RP +L +
Sbjct: 255 EREFS---------------PSFI----NFV----NLCLTKDESKRPKYKELLK 285
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
A ++ + + + + + E+ +L L H CI+++ + +
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 213
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 214 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1010
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 264 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 306
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 1065
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 307 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 57/302 (18%), Positives = 113/302 (37%), Gaps = 72/302 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK ++ +I F L E + H + ++ G +S + L
Sbjct: 56 VKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVG--VSL------RSRAKGRL 103
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDI 954
+ + ++K G + ++ + ++ + D+A + L S++ +HRD+
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGT----P 1009
+ N ++ + V + DF + R I + D G P
Sbjct: 164 AARNCMLAEDM-------TVCVADFGLS--------------RKIYSGDYYRQGCASKLP 202
Query: 1010 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1067
+W+A E L NLY + D+W++G + E++T Q PY G+ EI++ + G R
Sbjct: 203 VKWLALESLAD----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
++P E + + D+ +C +P +RP+ L
Sbjct: 258 -----------------------LKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 1128 MF 1129
Sbjct: 292 EL 293
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 49/191 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
EV++ L+H I+E+Y + + ++ +E G + Y++
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDS---------------NYVYLVLEMCHNGEMNRYLKN 104
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K S A + ++ LHS I+HRD+ N+L+ +K+
Sbjct: 105 RV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------IKI 153
Query: 977 CDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
DF A L+ +T C GTP +++PE+ + +GLE D+W
Sbjct: 154 ADFGLATQLKMPHEKHYTLC-------------GTPNYISPEIATR----SAHGLESDVW 196
Query: 1034 SYGCLLLELLT 1044
S GC+ LL
Sbjct: 197 SLGCMFYTLLI 207
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 73/302 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T+K+ SS EI F L E + H ++ + G + + P
Sbjct: 67 VKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLG--VCIEMSSQGIPKP---- 116
Query: 896 LQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
+ + ++K G + Y+ ETG KH+ ++ L D+A + L +++ +HRD+
Sbjct: 117 ---MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGTP---- 1009
+ N ++ + V + DF + + I + D G
Sbjct: 174 AARNCMLRDDM-------TVCVADFGLS--------------KKIYSGDYYRQGRIAKMP 212
Query: 1010 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1067
+W+A E L +Y + D+W++G + E+ T PY G+ E++D + G R
Sbjct: 213 VKWIAIESLAD----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267
Query: 1068 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
++PE + L L ++ C +P +RPT L
Sbjct: 268 -----------------------LKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
Query: 1128 MF 1129
Sbjct: 302 QL 303
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 8e-26
Identities = 33/236 (13%), Positives = 73/236 (30%), Gaps = 40/236 (16%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNP---------EHHLLQSAIFMEYVKGGS 909
+R+L +++ +++ I L + S F+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 910 VKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
++ + E L H + L + V L LH ++H ++ +I++D
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----- 240
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL-------RAM 1020
G V L F+ V + + + + + PE+
Sbjct: 241 QRGG--VFLTGFEHLVRDGARVVSS--------------VSRGFEPPELEARRATISYHR 284
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1076
+ L D W+ G ++ + +P + L + I + + AL
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-FRSCKNIPQPVRAL 339
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 108
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 109 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 156
Query: 977 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
DF + C GTP ++APEVL + EVD+W
Sbjct: 157 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 199
Query: 1034 SYGCLLLELLT 1044
S GC++ LL
Sbjct: 200 SIGCIMYTLLV 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 54/233 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIK 955
I ME + K Y + + + E + IA + AL LHSK ++HRD+K
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGK-----IAVSIVKALEHLHSKLSVIHRDVK 137
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
N+LI+ A G+ VK+CDF + L + A D+ G +MAPE
Sbjct: 138 PSNVLIN-----ALGQ--VKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPE 179
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELE 1074
+ Y ++ DIWS G ++EL L+ PY + + + P+L +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD-- 237
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
F E + F +C ++N ERPT +L +
Sbjct: 238 ---------------KFSA-----EFVDFT----SQCLKKNSKERPTYPELMQ 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 47/241 (19%), Positives = 88/241 (36%), Gaps = 54/241 (22%)
Query: 900 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
I +E ++++ +E +S+ K + + + +A+ + LHS I+HRD+K +
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 958 NILIDLERKKADGKPV------VKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDV 1004
NIL+ + + + + DF R+ L+
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS----------- 193
Query: 1005 CVGTPRWMAPEVLRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1061
GT W APE+L + +DI+S GC+ +L+ G + I
Sbjct: 194 --GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSRESNI 250
Query: 1062 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121
G L+ + H+ + EA D+ + + +P +RPT
Sbjct: 251 IRGIF-----SLDEMKCLHDRSLI--------AEAT--------DLISQMIDHDPLKRPT 289
Query: 1122 A 1122
A
Sbjct: 290 A 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 134
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 182
Query: 977 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
DF + C GTP ++APEVL + EVD+W
Sbjct: 183 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 225
Query: 1034 SYGCLLLELLT 1044
S GC++ LL
Sbjct: 226 SIGCIMYTLLV 236
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 43/202 (21%), Positives = 78/202 (38%), Gaps = 16/202 (7%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L L N + L L +++ + NL L L + +I
Sbjct: 135 YSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIEDIS 193
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L + +T ++ +A + L L + + I L P + LS
Sbjct: 194 ----PLASLTSLHYFTAYV-----NQITDITPVANMTRLNSLKIGNNKITDLSP-LANLS 243
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
L L++ N++ + + L L L V +N++ ++ L L +L +L L+NN+L +
Sbjct: 244 QLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDISV-LNNLSQLNSLFLNNNQLGN 301
Query: 248 LGSLDLCLMHNLQNLNLQYNKL 269
+ + NL L L N +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 37/207 (17%), Positives = 78/207 (37%), Gaps = 24/207 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS 125
L K + + + E + L G ++ + L LE L + +I+
Sbjct: 23 EGIRAVLQKASVTDVV-TQEELESITKLVVAGEKVASIQ-GIEYLTNLEYLNLNGNQITD 80
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS---IRYLPPE 182
L+ L L L + +++I+ L+ LT L + + I + P
Sbjct: 81 IS----PLSNLVKLTNLYIGT--------NKITDISALQNLTNLRELYLNEDNISDISP- 127
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
+ L+ + L+L N + + + L L V +K+ ++ + L L +L L+
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNY 186
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++ + L + +L N++
Sbjct: 187 NQIEDISPLA--SLTSLHYFTAYVNQI 211
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-22
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 19/203 (9%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L + ++ + + + L +L N+I S + +L L +I+
Sbjct: 158 NYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIE-DISPLASLTSLHYFTAYVNQITDIT 215
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
+ + L L++ + +T LS +A L LT L + I + + L+
Sbjct: 216 ----PVANMTRLNSLKIGN-----NKITDLSPLANLSQLTWLEIGTNQISDINA-VKDLT 265
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLT 246
L+ L++ N++ + + L L SL + NN+L + L L L LS N +T
Sbjct: 266 KLKMLNVGSNQISDIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 247 SLGSLDLCLMHNLQNLNLQYNKL 269
+ L + + + + +
Sbjct: 325 DIRPLA--SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-20
Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 10/141 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L L K + +T + L+ +TKL V + + I L+NLE
Sbjct: 16 FPDADLAEGIRAVLQK-----ASVTDVVTQEELESITKLVVAGEKVASIQG-IEYLTNLE 69
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L+ N++ + + L L +L + NK+ ++ + L L L L L+ + ++ +
Sbjct: 70 YLNLNGNQITDIS-PLSNLVKLTNLYIGTNKITDISA-LQNLTNLRELYLNEDNISDISP 127
Query: 251 LDLCLMHNLQNLNLQYNKLLS 271
L + + +LNL N LS
Sbjct: 128 LAN--LTKMYSLNLGANHNLS 146
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 2e-16
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 21/180 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L L N + I + L + N+I V N+ L L +I SP
Sbjct: 182 LSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP- 238
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L LE+ + ++ ++ + L L L+V I + + LS
Sbjct: 239 -----LANLSQLTWLEIGT-----NQISDINAVKDLTKLKMLNVGSNQISDISV-LNNLS 287
Query: 188 NLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L L L+ N++ I L L +L ++ N + ++ L L ++++ D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK 346
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 958
I ME + + K E+ + + + AL L KH ++HRD+K N
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+D G+ +KLCDF + L A D G +MAPE +
Sbjct: 156 ILLD-----ERGQ--IKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERID 197
Query: 1019 AMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEAL 1076
Y + D+WS G L+EL T Q PY ++ E+ + + P L
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH---- 253
Query: 1077 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
GF + C ++ +RP L E
Sbjct: 254 ------------MGFSGD---------FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+++ N L +P L+ L N++ P+ L L +++S P
Sbjct: 126 LWIFGNQLTSLPVLPP---GLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLP----- 177
Query: 132 ALNKLKGLKELELSK-----VPPRPSVLTLLSEI--------AGLKCLTKLSVCHFSIRY 178
GL+EL +S +P PS L L A L +L V +
Sbjct: 178 --MLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS 235
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
LP L++L +S N++ LP L+SL V N+L LP L L +
Sbjct: 236 LPVLPS---ELKELMVSGNRLTSLPMLPS---GLLSLSVYRNQLTRLPESLIHLSSETTV 289
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+L N L+ L + + + ++ + +
Sbjct: 290 NLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 34/218 (15%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L + ++ L +P + + L N + P+ L LE +++S P
Sbjct: 40 NGNAVLNVGESGLTTLPDCLPA--HITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSLP 97
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L LT L + L KL + + LP
Sbjct: 98 V----LPPGLLELSIFSNP--------LTHLPAL--PSGLCKLWIFGNQLTSLPVLPP-- 141
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L++L +S N++ LP L L NN+L LP L L+ L +S+N+L
Sbjct: 142 -GLQELSVSDNQLASLPALPSELC---KLWAYNNQLTSLPM---LPSGLQELSVSDNQLA 194
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
SL + L L L N+L +P+ L+
Sbjct: 195 SLPT----LPSELYKLWAYNNRL---TSLPALP-SGLK 224
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 37/198 (18%), Positives = 64/198 (32%), Gaps = 26/198 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+ Y N L +P L+ L N++ P+ L L +++S P
Sbjct: 166 LWAYNNQLTSLPMLPS---GLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLP----- 217
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
GLKEL +S LT L L +L V + LP L
Sbjct: 218 --ALPSGLKELIVSGNR-----LTSLPV--LPSELKELMVSGNRLTSLPMLPS---GLLS 265
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L + N++ LP + +L + ++ + N L E + + + + +
Sbjct: 266 LSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQAL--REITSAPGYSGPIIRFDMA 323
Query: 252 D---LCLMHNLQNLNLQY 266
L +
Sbjct: 324 GASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-17
Identities = 38/145 (26%), Positives = 56/145 (38%), Gaps = 22/145 (15%)
Query: 136 LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLS 195
G L + + S LT L + +T L + ++ LP L L++S
Sbjct: 39 NNGNAVLNVGE-----SGLTTLPD-CLPAHITTLVIPDNNLTSLPALPP---ELRTLEVS 89
Query: 196 FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255
N++ LP L L L LPSG L L + N+LTSL L
Sbjct: 90 GNQLTSLPVLPPGLLELSIFSNPLTHLPALPSG------LCKLWIFGNQLTSLPV----L 139
Query: 256 MHNLQNLNLQYNKLLSYCQVPSWIC 280
LQ L++ N+L S +P+
Sbjct: 140 PPGLQELSVSDNQLAS---LPALPS 161
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 6/65 (9%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
C L V + L LP L + L + +N LTSL + L L+ L +
Sbjct: 35 RACLNNGNAVLNVGESGLTTLPDC--LPAHITTLVIPDNNLTSLPA----LPPELRTLEV 88
Query: 265 QYNKL 269
N+L
Sbjct: 89 SGNQL 93
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 61/235 (25%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY++G ++ YIE +SV A+ + + H I+HRDIK +NI
Sbjct: 88 LVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 960 LIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
LID ++ +K+ DF +A+ + + + +GT ++ +PE
Sbjct: 143 LID-----SNKT--LKIFDFGIAKAL-----------SETSLTQTNHVLGTVQYFSPEQA 184
Query: 1018 RAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
+ G DI+S G +L E+L + P+ G + + I I+ + D +
Sbjct: 185 K--------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIK-----HIQDSV 229
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1127
+ + ++ QS L +V R TE++ R T ++ +
Sbjct: 230 PNVTTDVRKDIPQS----------------LSNVILRATEKDKANRYKTIQEMKD 268
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
A K+ + + + + + E+ +L L H CI+++ + +
Sbjct: 39 AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 88
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 89 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 138
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1010
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 139 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 181
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 1065
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 182 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 41/203 (20%), Positives = 74/203 (36%), Gaps = 15/203 (7%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVN 129
L L N + + + L N I+ G G + + + KI+ +
Sbjct: 85 LDLNNNYVQELLVG----PSIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITM--LR 136
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189
++ L+L + A L L++ + I + ++ + L
Sbjct: 137 DLDEGCRSRVQYLDLKL--NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKL 193
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
+ LDLS NK+ ++ E + + + NNKLV + L Q LE+ DL N
Sbjct: 194 KTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 250 SLDLCLMHN-LQNLNLQYNKLLS 271
D + +Q + Q K L+
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLT 276
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/296 (17%), Positives = 97/296 (32%), Gaps = 72/296 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ L + +F M+ L H +V YG + +
Sbjct: 45 LKVLDKA--HRNYSESF----FEAASMMSKLSHKHLVLNYG--VCVCGDENI-------- 88
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ E+VK GS+ Y++K + +++ L +A+ +AAA+ L ++H ++
Sbjct: 89 ----LVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 956 SENILIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
++NIL+ E + G P +KL D + + D+ W+ P
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS--------------ITVLPKDILQERIPWVPP 186
Query: 1015 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
E + P L D WS+G L E+ + P L + + L
Sbjct: 187 E---CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ------L 237
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
A + ++ C + P RP+ +
Sbjct: 238 PAPKAAELA-----------------------NLINNCMDYEPDHRPSFRAIIRDL 270
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + + K + + ++A F ++ A+ +H +HRDIK +NIL+
Sbjct: 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM- 1020
D G ++L DF + LR+ V VGTP +++PE+L+A+
Sbjct: 196 D-----RCGH--IRLADFGSCLKLRADGTVRS---------LVAVGTPDYLSPEILQAVG 239
Query: 1021 --HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1067
YG E D W+ G E+ Q P+ S E + I K
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 44/215 (20%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 912
E ++ +V++ + Q + MEY+ GG
Sbjct: 117 WEERDIMAFANSPWVVQL------------------FYAFQDDRYLYMVMEYMPGG---- 154
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+ ++ V K A F +V AL +HS +HRD+K +N+L+D G
Sbjct: 155 --DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH- 206
Query: 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
+KL DF + + C D VGTP +++PEVL++ YG E D
Sbjct: 207 -LKLADFGTCMKMNKEGMVRC---------DTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1067
WS G L E+L P+ S + + I K
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-24
Identities = 53/275 (19%), Positives = 88/275 (32%), Gaps = 88/275 (32%)
Query: 859 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E + L + H IV+++ G+P + I MEYV G S+K +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEH------TDRHGDPVGY-----IVMEYVGGQSLKRSKGQ 177
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ V A+ ++ AL LHS +++ D+K ENI++ E+ +KL
Sbjct: 178 -------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKL 222
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV---DIW 1033
D I + GTP + APE++R DI+
Sbjct: 223 IDLG-------------AV-SRINSFGYLYGTPGFQAPEIVR--------TGPTVATDIY 260
Query: 1034 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1093
+ G L L G + + + D L
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGLPEDDP---VLKTYDSYGRL----------------- 300
Query: 1094 PEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1127
RR + +P +R TA ++
Sbjct: 301 --------------LRRAIDPDPRQRFTTAEEMSA 321
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/255 (21%), Positives = 92/255 (36%), Gaps = 39/255 (15%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--------------- 876
A K+ K+ + ++ + EVR++ L H I +Y
Sbjct: 55 AIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 877 ------HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 930
K++ S + ++ I E+ + KL
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
I + + +AL LH++ I HRDIK EN L + +KL DF + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFS-----TNKSFEIKLVDFGLSKEFYKLNN 225
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1050
GTP ++APEVL ++ YG + D WS G LL LL VP+
Sbjct: 226 GEYYGMTTK------AGTPYFVAPEVLNTTNES--YGPKCDAWSAGVLLHLLLMGAVPFP 277
Query: 1051 GLSELEIHDLIQMGK 1065
G+++ + + K
Sbjct: 278 GVNDADTISQVLNKK 292
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 30/234 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L L + L+ +P ++ ++ L+ N + P +L L+ ++S+ P
Sbjct: 59 NQFSELQLNRLNLSSLPDNLPP--QITVLEITQNALISLPELPASLEYLDACDNRLSTLP 116
Query: 127 GVNGFALNKLKGLKELELS-----KVPPRPSVLTLLS-------EI-AGLKCLTKLSVCH 173
LK L++ +P P++L ++ + L LSV +
Sbjct: 117 -------ELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRN 169
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL----ISLKVANNKLVELPSGL 229
+ +LP +LE LD+S N ++ LP I + N++ +P +
Sbjct: 170 NQLTFLPELPE---SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITHIPENI 226
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L + L +N L+S L + + + + L
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 5e-20
Identities = 33/208 (15%), Positives = 63/208 (30%), Gaps = 24/208 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PG 127
S+E L N L+ +P+ L++L N++ + P L + +++ P
Sbjct: 101 SLEYLDACDNRLSTLPELPA---SLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLP- 156
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L+ L + LT L E + L L V + LP
Sbjct: 157 ------ELPTSLEVLSVRNNQ-----LTFLPE--LPESLEALDVSTNLLESLPAVPVRNH 203
Query: 188 NLEQ----LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ E+ N++ ++P I L ++ + +N L L + +
Sbjct: 204 HSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIR--ESLSQQTAQPDYHG 261
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
D + L
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-18
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 21/153 (13%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
A +K + + R ++LL E + ++L + ++ LP + +
Sbjct: 32 AWDKWEKQALPGEN----RNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLP--PQITV 84
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L+++ N + LP L+ L +N+L LP L L++LD+ NN+LT L
Sbjct: 85 LEITQNALISLPELPASLE---YLDACDNRLSTLPE---LPASLKHLDVDNNQLTMLPE- 137
Query: 252 DLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L L+ +N N+L +P +LE
Sbjct: 138 ---LPALLEYINADNNQL---TMLPELP-TSLE 163
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 10/96 (10%)
Query: 192 LDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGL--YLLQRLENLDLSNNRLTSL 248
+ +N + + + E S L L+ + L L+ L+SL
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSL 74
Query: 249 GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L + L + N L+S +P +LE
Sbjct: 75 PD---NLPPQITVLEITQNALIS---LPELP-ASLE 103
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ +K S DE F E + + L H +V+ YG + SK P +
Sbjct: 37 VKMIKEGSMSEDE---F----FQEAQTMMKLSHPKLVKFYG--VCSK------EYPIY-- 79
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ G + NY+ K + L + DV + L S +HRD+
Sbjct: 80 ----IVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L+D + VK+ DF R L ++ G P +W A
Sbjct: 132 ARNCLVDRDL-------CVKVSDFGMT---RYVLDDQYVSSVGTKFPV--------KWSA 173
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PEV Y + D+W++G L+ E+ +L ++PY + E+ + G R
Sbjct: 174 PEVFHY----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------ 223
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L + + + C E P +RPT L
Sbjct: 224 LYRPHLA--------------SDT-------IYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 200
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 201 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 256
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 316
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273
RLENL L +N + +L L H L+NL L +N
Sbjct: 317 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNS 355
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE- 159
E S + + I + + V GF L K + S + L
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN-----STMRKLPAA 63
Query: 160 -IAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLK 216
+ + + L++ I + +++L + FN ++YLP + + L L
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 217 VANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 24/189 (12%)
Query: 95 NLKFFGNEINLFPSEVG------NLLGLECLQI---KISSPGVNGFALNKLKGLKELELS 145
+ F+ I++ +V L + + + + L+ + ++ L L+
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK--LPAALLDSFRQVELLNLN 77
Query: 146 KVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
+ + A + KL + +IRYLPP + + L L L N + L
Sbjct: 78 D-----LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 203 PTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
P I L +L ++NN L + + L+NL LS+NRLT +DL L+ +L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSLF 189
Query: 261 NLNLQYNKL 269
+ N+ YN L
Sbjct: 190 HANVSYNLL 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 900 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
+ E V G V LSE A F QD+ + LH + I+HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSE--------DQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 958 NILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
N+L+ DG +K+ DF + + L GTP +MAP
Sbjct: 167 NLLVG-----EDG--HIKIADFGVSNEFKGSDALLSNTV-------------GTPAFMAP 206
Query: 1015 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-----RPR 1068
E L K + G +D+W+ G L + Q P+M + +H I+ +P
Sbjct: 207 ESLSETRKI--FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD 264
Query: 1069 LTDELEAL 1076
+ ++L+ L
Sbjct: 265 IAEDLKDL 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 76/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T K +S F L E + H IV++ G + ++ NP
Sbjct: 48 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIG--VITE-------NP---- 89
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 90 --VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 144 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 185
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 186 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 235
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L +C P L + +C +P+ RP +L
Sbjct: 236 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 859 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
EV ML + H ++E+ + +L+ E ++GGS+ ++I K
Sbjct: 60 EVEMLYQCQGHRNVLELIE---------FFEEEDRFYLV-----FEKMRGGSILSHIHK- 104
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
+H + A + QDVA+AL LH+K I HRD+K ENIL E VK+C
Sbjct: 105 ----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL--CEHPNQVSP--VKIC 156
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYG 1036
DFD ++ I+ + P G+ +MAPEV+ A + ++Y D+WS G
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
+L LL+ P++G + E++ +E P+
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK----------YEFPDK 263
Query: 1097 ELETLSFLV-DVFRRCTEENPTERPTAGDL 1125
+ +S D+ + + +R +A +
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 35 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 78
Query: 892 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 79 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1006
I+HR++K EN+L+ KA G VKL DF A+ + H
Sbjct: 126 IVHRNLKPENLLLA---SKAKGAA-VKLADFGLAIEVNDSEAWHGFA------------- 168
Query: 1007 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 169 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 890
A K+ SA+E++ + L EV +L + H I+++ + + N
Sbjct: 46 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD---------TYETN 96
Query: 891 PEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
L+ + +K G + +Y+ LSE K I + + + LH
Sbjct: 97 TFFFLV-----FDLMKKGELFDYLTEKVTLSE--------KETRKIMRALLEVICALHKL 143
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1005
+I+HRD+K ENIL+ D +KL DF + L L C
Sbjct: 144 NIVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLREVC------------ 184
Query: 1006 VGTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
GTP ++APE++ N YG EVD+WS G ++ LL P+ ++ + +I
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 1064 GK 1065
G
Sbjct: 244 GN 245
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 51/301 (16%), Positives = 107/301 (35%), Gaps = 83/301 (27%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ L+ +S + L E ++ ++ + + + G I +
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLG--ICLT-------ST---- 90
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+Q + + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 91 VQ--LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1068
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 1069 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L C + + R+C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMRKCWMIDADSRPKFRELIIE 272
Query: 1129 F 1129
F
Sbjct: 273 F 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/297 (18%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T++ S ++ F + E ++ L H +V++YG + + P
Sbjct: 37 IKTIREGAMSEED---F----IEEAEVMMKLSHPKLVQLYG--VCLEQAPIC-------- 79
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ E+++ G + +Y+ + + L + DV + L ++HRD+
Sbjct: 80 ----LVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L+ + V+K+ DF R L + G P +W +
Sbjct: 132 ARNCLVGENQ-------VIKVSDFGMT---RFVLDDQYTSSTGTKFPV--------KWAS 173
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PEV + Y + D+WS+G L+ E+ + ++PY S E+ + I G R
Sbjct: 174 PEVFSF----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------ 223
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L + + C E P +RP L
Sbjct: 224 LYKPRLA--------------STH-------VYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 77/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++LK S D F L E ++ L+H +V +Y + ++ P +
Sbjct: 42 VKSLKQGSMSPDA---F----LAEANLMKQLQHQRLVRLYA--VVTQ-------EPIY-- 83
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ ++ L +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ NIL+ K+ DF A R A G P +W A
Sbjct: 137 AANILVSDTL-------SCKIADFGLA---RLIEDNEYTAREGAKFPI--------KWTA 178
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE + + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R
Sbjct: 179 PEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------ 228
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ +C PE L + R C +E P +RPT L +
Sbjct: 229 MVRPDNC--------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 82/300 (27%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T K + D F + E ++ L H IV++ G I + P
Sbjct: 45 VKTCKK-DCTLDNKEKF----MSEAVIMKNLDHPHIVKLIG--IIEE-------EP---- 86
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ I ME G + +Y+E+ + + V + + + A+ L S + +HRDI
Sbjct: 87 --TWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
NIL+ VKL DF + R +P +WM+
Sbjct: 141 VRNILVASPE-------CVKLGDFGLS---RYIEDEDYYKASVTRLPI--------KWMS 182
Query: 1014 PEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1069
PE + + D+W + + E+L+ + P+ L ++ +++ G R
Sbjct: 183 PESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--- 232
Query: 1070 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L C P L + RC + +P++RP +L
Sbjct: 233 ---LPKPDLC--------------PPV-------LYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/237 (21%), Positives = 80/237 (33%), Gaps = 71/237 (29%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M + G + + + + ++ A+ I + + +AL H+ HRD+K ENI
Sbjct: 111 VDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----GIPAPDVCVGTPRWMAPE 1015
L+ AD L DF IA + VGT +MAPE
Sbjct: 166 LVS-----ADDF--AYLVDFG-------------IASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 1016 VLRAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1071
DI++ C+L E LT PY G D + +
Sbjct: 206 RFS--------ESHATYRADIYALTCVLYECLTGSPPYQG-------DQLSV-------- 242
Query: 1072 ELEALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCTEENPTER-PTAGDL 1125
H ++ S +P + V R +NP +R T GDL
Sbjct: 243 ---MGA--HINQAIPRPSTV-RPGIPVAFD------AVIARGMAKNPEDRYVTCGDL 287
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 56/233 (24%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K NI
Sbjct: 93 IVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
+I A VK+ DF A + ++ + +GT ++++PE R
Sbjct: 148 MIS-----ATNA--VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQAR- 192
Query: 1020 MHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1075
G V D++S GC+L E+LT + P+ G S + + Q + ++
Sbjct: 193 -------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQ-----HVREDPIP 238
Query: 1076 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1127
S ++ L V + +NP R TA ++
Sbjct: 239 P-SARHEGLSAD----------------LDAVVLKALAKNPENRYQTAAEMRA 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y GG + + K E + ++A F ++ A+ +H H +HRDIK +NIL+
Sbjct: 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D +G ++L DF + L G V VGTP +++PE+L+AM
Sbjct: 209 D-----MNGH--IRLADFGSCLKLME---------DGTVQSSVAVGTPDYISPEILQAME 252
Query: 1022 KPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1067
YG E D WS G + E+L + P+ S +E + I K
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 77/303 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 65 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 108
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 953
I ME + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 109 F---ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165
Query: 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1009
I + N L+ G+ V K+ DF A R I
Sbjct: 166 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRASYYRKGGCAML 207
Query: 1010 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 208 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 1067 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126
++ +C P + + +C + P +RP +
Sbjct: 264 ------MDPPKNC--------------PGP-------VYRIMTQCWQHQPEDRPNFAIIL 296
Query: 1127 EMF 1129
E
Sbjct: 297 ERI 299
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 3e-23
Identities = 68/443 (15%), Positives = 133/443 (30%), Gaps = 49/443 (11%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 206
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 207 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 262
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV---PSWICCNLEGN-- 286
RLENL L +N + +L L H L+NL L +N + ++
Sbjct: 323 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQ 379
Query: 287 --GKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLT 344
D + + Y +L+ S E ++ S+ T++S S S
Sbjct: 380 HCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHY 439
Query: 345 ARKSSKQWKRHHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEE 404
+ + + Q A L + Q + L L +E +
Sbjct: 440 ITQQGGVPLQGNEQLEAEVNELRAE---------VQQLTNEQIQQEQLLQGLHAEIDTNL 490
Query: 405 ASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDEC 464
+ D + + +L + + E +E
Sbjct: 491 RRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALE 550
Query: 465 SKHDSSSLSTANGATEQDEGSSS 487
+ D+ A E
Sbjct: 551 KQLDNKRAKQAELRQETSLKRQK 573
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE- 159
E S + + I + + V GF L K + S + L
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN-----STMRKLPAA 69
Query: 160 -IAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLK 216
+ + + L++ I + +++L + FN ++YLP + + L L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 217 VANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 77/299 (25%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A K+ R V SS ++ EV +L L H I+++Y +
Sbjct: 66 AIKIIRKTSVSTSSNSKLLE-------EVAVLKLLDHPNIMKLYDFFEDKR--------- 109
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
++L+ ME KGG + + I + A I + V + + LH +I+H
Sbjct: 110 NYYLV-----MECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1009
RD+K EN+L LE K+ D +K+ DF + + GT
Sbjct: 160 RDLKPENLL--LESKEKDAL--IKIVDFGLSAVFENQKKMKERL-------------GTA 202
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1069
++APEVLR Y + D+WS G +L LL P+ G ++ EI ++ GK
Sbjct: 203 YYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---- 253
Query: 1070 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTAGDLYE 1127
+ E + +S D+ ++ + + R +A E
Sbjct: 254 ---------------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A KV I EV +L L H I++++ + +
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFE---------ILEDSS 94
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1009
RD+K ENIL++ + K D +K+ DF + + + + GT
Sbjct: 145 RDLKPENILLESKEKDCD----IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E R+L A+ +V++ + L +++ MEYV GG + +++ +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNL---------YMV-----MEYVAGGEMFSHLRR 134
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
S A F A + LHS +++RD+K EN+LID G +++
Sbjct: 135 -----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-----QQGY--IQV 182
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF A ++ T C GTP +APE++ + K Y VD W+ G
Sbjct: 183 TDFGFAKRVKGRTWTLC-------------GTPEALAPEII--LSKG--YNKAVDWWALG 225
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
L+ E+ P+ ++I++ I GK
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 77/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ +K S DE F + E +++ L H +V++YG + +K P
Sbjct: 53 IKMIKEGSMSEDE---F----IEEAKVMMNLSHEKLVQLYG--VCTK------QRPIF-- 95
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 96 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L++ + VVK+ DF + R L + G P RW
Sbjct: 148 ARNCLVNDQG-------VVKVSDFGLS---RYVLDDEYTSSVGSKFPV--------RWSP 189
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PEVL + + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 190 PEVLMY----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------ 239
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L E + + C E ERPT L
Sbjct: 240 LYRPHLA--------------SEK-------VYTIMYSCWHEKADERPTFKILLSNI 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 77/299 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK G + + +F LGE ++G H I+ + G + SK+ P
Sbjct: 78 IKTLKA-GYTEKQRVDF----LGEAGIMGQFSHHNIIRLEG--VISKYKPMM-------- 122
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 123 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1014
+ NIL++ V K+ DF + L G IP RW AP
Sbjct: 175 ARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTTSGGKIPI--------RWTAP 219
Query: 1015 EVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1070
E + Y D+WS+G ++ E++T + PY LS E+ I G R
Sbjct: 220 EAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 268
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L C P A + + +C ++ RP D+ +
Sbjct: 269 --LPTPMDC--------------PSA-------IYQLMMQCWQQERARRPKFADIVSIL 304
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 76/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +E F L E ++ ++H +V++ G + ++ P +
Sbjct: 43 VKTLKEDTMEVEE---F----LKEAAVMKEIKHPNLVQLLG--VCTR------EPPFY-- 85
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+
Sbjct: 86 ----IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L+ +VK+ DF + R AH G P +W A
Sbjct: 139 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFPI--------KWTA 180
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE L N + ++ D+W++G LL E+ T PY G+ ++++L++ R
Sbjct: 181 PESLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ 230
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+E C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 231 MERPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 56/218 (25%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 912
E ++ L H V++Y Q + Y K G +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFT------------------FQDDEKLYFGLSYAKNGELLK 119
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
YI K F ++ +AL LH K I+HRD+K ENIL++ D
Sbjct: 120 YIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----EDMH- 168
Query: 973 VVKLCDFDRA-----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
+++ DF A ++ ++ GT ++++PE+L K
Sbjct: 169 -IQITDFGTAKVLSPESKQARANSFV-------------GTAQYVSPELLT--EKS--AC 210
Query: 1028 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
D+W+ GC++ +L+ P+ +E I I +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK S + L E +++ LRH +V++Y
Sbjct: 213 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 254
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 255 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 308 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 351
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 352 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 401
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
C PE+ L D+ +C + P ERPT L
Sbjct: 402 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 51/236 (21%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A KV I EV +L L H I++++ S
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFEILEDSS--------- 94
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1009
RD+K ENIL LE K+ D +K+ DF + + + + GT
Sbjct: 145 RDLKPENIL--LESKEKDCD--IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
E +KGG + + I + +K S + A + + + LH++ ++HRD+K NIL
Sbjct: 95 TELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 962 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
++ +++CDF A LR L T C T ++APEVL
Sbjct: 150 ---VDESGNPESIRICDFGFAKQLRAENGLLMTPC-------------YTANFVAPEVL- 192
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGK 1065
+ Y DIWS G LL +LT P+ + EI I GK
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 69/267 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ +L H I+ +Y + + +L+ ME GG + +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNT---------DIYLV-----MELCTGGELFERVVH-- 99
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
++ A I +DV +A+ H ++ HRD+K EN L + + +KL D
Sbjct: 100 ---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP----LKLID 152
Query: 979 FDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
F A + + T GTP +++P+VL LYG E D WS G
Sbjct: 153 FGLAARFKPGKMMRTKV-------------GTPYYVSPQVLE-----GLYGPECDEWSAG 194
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
++ LL P+ ++ E+ I+ G F PE
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIREGT-------------------------FTFPEK 229
Query: 1097 ELETLSFLV-DVFRRCTEENPTERPTA 1122
+ +S + RR ++P +R T+
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITS 256
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 89/313 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++LK S + I + E+ +L L H IV+ G I ++ GN
Sbjct: 55 VKSLKP-ESGGNHIADL----KKEIEILRNLYHENIVKYKG--ICTE----DGGNG---- 99
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
++ + ME++ GS+K Y+ K + +++K L A + + L S+ +HRD+
Sbjct: 100 IK--LIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L++ E VK+ DF +A+ +T P W
Sbjct: 154 ARNVLVESEH-------QVKIGDFGLTKAIETDKEYYT---VKDDRDSPV--------FW 195
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 1056
APE L + + + D+WS+G L ELLT + ++
Sbjct: 196 YAPECLMQ----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116
+ + ++ GKR L +C P+ + + R+C E P
Sbjct: 252 LVNTLKEGKR------LPCPPNC--------------PDE-------VYQLMRKCWEFQP 284
Query: 1117 TERPTAGDLYEMF 1129
+ R + +L E F
Sbjct: 285 SNRTSFQNLIEGF 297
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 71/296 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ LK G + + R+F L E ++G H I+ + G + ++ G
Sbjct: 82 IKALKA-GYTERQRRDF----LSEASIMGQFDHPNIIRLEG--VVTR------GRLAM-- 126
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ ++ + ++ + + + V A + L +HRD+
Sbjct: 127 ----IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1014
+ N+L+D V K+ DF + L G IP RW AP
Sbjct: 179 ARNVLVDSNL-------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPI--------RWTAP 223
Query: 1015 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
E + A + D+WS+G ++ E+L + PY ++ ++ ++ G R L
Sbjct: 224 EAI-AFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR------L 273
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
A C P A L + C ++ +RP + +
Sbjct: 274 PAPMGC--------------PHA-------LHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 66/295 (22%), Positives = 127/295 (43%), Gaps = 72/295 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +E L E ++ ++H +V++ G + ++ E
Sbjct: 250 VKTLKEDTMEVEEF-------LKEAAVMKEIKHPNLVQLLG--VCTR---------EPPF 291
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HR++
Sbjct: 292 Y---IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N L+ +VK+ DF + R AH G P +W APE
Sbjct: 346 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFP------IKWTAPE 389
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
L N + ++ D+W++G LL E+ T PY G+ ++++L++ R +E
Sbjct: 390 SLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ME 439
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 440 RPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L +L H I++++ +++ ME +GG + I
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYH---------NMYIV-----METCEGGELLERIVSAQ 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
G K +S + + + AL HS+H++H+D+K ENIL + +K+ D
Sbjct: 116 ARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSP--IKIID 170
Query: 979 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
F A +S GT +MAPEV + + DIWS G
Sbjct: 171 FGLAELFKSDEHSTNAA-------------GTALYMAPEVFK-----RDVTFKCDIWSAG 212
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
++ LLT +P+ G S E+ +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKE 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKN 912
E++++ L H +V ++ Q + ++ + GG ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYS------------------FQDEEDMFMVVDLLLGGDLRY 104
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
++++ E+ V LFI + + AL L ++ I+HRD+K +NIL+D G
Sbjct: 105 HLQQNVHFKEETV----KLFICE-LVMALDYLQNQRIIHRDMKPDNILLD-----EHGH- 153
Query: 973 VVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030
V + DF+ A +P + + T GT +MAPE+ K Y V
Sbjct: 154 -VHITDFNIAAMLPRETQITTMA-------------GTKPYMAPEMFS-SRKGAGYSFAV 198
Query: 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
D WS G ELL + PY S +++
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 91/314 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 44 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 87
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 88 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ NIL++ E VK+ DF + +P P W
Sbjct: 142 TRNILVENEN-------RVKIGDFGLTKVLPQDKEFFK---VKEPGESPI--------FW 183
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 1055
APE L + + + D+WS+G +L EL T +
Sbjct: 184 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 1056 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115
+ +L++ R L C P+ + + C N
Sbjct: 240 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 272
Query: 1116 PTERPTAGDLYEMF 1129
+RP+ DL
Sbjct: 273 VNQRPSFRDLALRV 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 58 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 101
Query: 892 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 102 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1006
I+HR++K EN+L+ + K A VKL DF A+ + H
Sbjct: 149 IVHRNLKPENLLLASKAKGAA----VKLADFGLAIEVNDSEAWHGFA------------- 191
Query: 1007 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 192 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 71/297 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
+++L + ++ F L E ++ L H ++ + G I
Sbjct: 54 IKSLSR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIG--IMLPPEGLP-------- 98
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + Y+ G + +I +++ +VK + VA + L + +HRD+
Sbjct: 99 ---HVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N ++D VK+ DF A + + HR +P +W A
Sbjct: 152 ARNCMLDESF-------TVKVADFGLARDILDREYYSVQQHRHARLPV--------KWTA 196
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
E L + + + D+WS+G LL ELLT PY + ++ + G+R
Sbjct: 197 LESL----QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L C P++ L V ++C E +P RPT L
Sbjct: 247 LPQPEYC--------------PDS-------LYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 891
A K+ + S +++ + E +L + H I+ + S + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID---------SYESSS 173
Query: 892 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
L+ + ++ G + +Y+ LSE K I + + A+ LH+ +
Sbjct: 174 FMFLV-----FDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLEAVSFLHANN 220
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1006
I+HRD+K ENIL+ D ++L DF + L L C
Sbjct: 221 IVHRDLKPENILL-------DDNMQIRLSDFGFSCHLEPGEKLRELC------------- 260
Query: 1007 GTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 1064
GTP ++APE+L+ YG EVD+W+ G +L LL P+ ++ + +I G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 1065 K 1065
+
Sbjct: 321 Q 321
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV++L L H I+++Y + +L+ E GG + + I
Sbjct: 76 EVQLLKQLDHPNIMKLYE---------FFEDKGYFYLV-----GEVYTGGELFDEIIS-- 119
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
K S A I + V + + +H I+HRD+K EN+L++ + K A+ +++ D
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN----IRIID 172
Query: 979 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
F + + + GT ++APEVL Y + D+WS G
Sbjct: 173 FGLSTHFEASKKMKDKI-------------GTAYYIAPEVLH-----GTYDEKCDVWSTG 214
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+L LL+ P+ G +E +I ++ GK
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 43/209 (20%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E ML + H I+ M+G ++ + ++ M+Y++GG + + + K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQI---------FMI-----MDYIEGGELFSLLRK 99
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ +A F A +V AL LHSK I++RD+K ENIL+D +G +K+
Sbjct: 100 -----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----KNGH--IKI 147
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
DF A + +T C GTP ++APEV+ KP Y +D WS+G
Sbjct: 148 TDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS--TKP--YNKSIDWWSFG 190
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
L+ E+L P+ + ++ ++ I +
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 77/303 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 106 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 149
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 953
I +E + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 150 F---ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206
Query: 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1009
I + N L+ G+ V K+ DF A R I
Sbjct: 207 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRAGYYRKGGCAML 248
Query: 1010 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 249 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 1067 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126
+ P+ + + +C + P +RP +
Sbjct: 305 ------------------------MDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 1127 EMF 1129
E
Sbjct: 338 ERI 340
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 56/215 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
EVR++ L H IV+++ I ++ ++ MEY GG V +Y+
Sbjct: 64 EVRIMKILNHPNIVKLF-EVIETE---------------KTLYLIMEYASGGEVFDYLVA 107
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++ E K A + + +A+ H K I+HRD+K+EN+L+D +
Sbjct: 108 HGRMKE--------KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------- 152
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1030
+K+ DF + L C G P + APE+ + Y G EV
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC-------------GAPPYAAPELFQG----KKYDGPEV 195
Query: 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
D+WS G +L L++ +P+ G + E+ + + GK
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 915
E+ +L ++H IV + S+ ++L M+ V GG + + I
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTT---------HYYL-----VMQLVSGGELFDRILERG 101
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+E K A + Q V +A+ LH I+HRD+K EN+L + + K +
Sbjct: 102 VYTE--------KDASLVIQQVLSAVKYLHENGIVHRDLKPENLL--YLTPEENSK--IM 149
Query: 976 LCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
+ DF + + + T C GTP ++APEVL KP Y VD WS
Sbjct: 150 ITDFGLSKMEQNGIMSTAC-------------GTPGYVAPEVLA--QKP--YSKAVDCWS 192
Query: 1035 YGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
G + LL P+ +E ++ + I+ G
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 71/297 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 58 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 102
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 103 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N ++D + VK+ DF R + + + +P +WMA
Sbjct: 156 ARNCMLDEKF-------TVKVADFGLARDMYDKEYYSVHNKTGAKLPV--------KWMA 200
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 201 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 250
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L C P+ L +V +C RP+ +L
Sbjct: 251 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-22
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 71/296 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLKV G + + R+F LGE ++G H I+ + G + +K P
Sbjct: 78 IKTLKV-GYTEKQRRDF----LGEASIMGQFDHPNIIRLEG--VVTKSKPVM-------- 122
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ +++ K + +V + + + +A+ + L +HRD+
Sbjct: 123 ----IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1014
+ NILI+ V K+ DF L G IP RW +P
Sbjct: 175 ARNILINSNL-------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--------RWTSP 219
Query: 1015 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1073
E + + D+WSYG +L E+++ + PY +S ++ + G R L
Sbjct: 220 EAI----AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------L 269
Query: 1074 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
C P A L + C +++ RP + +
Sbjct: 270 PPPMDC--------------PAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 91/314 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 75 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 118
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 119 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ NIL++ E VK+ DF + +P + P W
Sbjct: 173 TRNILVENEN-------RVKIGDFGLTKVLPQDKEYYK---VKEPGESPI--------FW 214
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 1055
APE L + + + D+WS+G +L EL T +
Sbjct: 215 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 1056 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115
+ +L++ R L C P+ + + C N
Sbjct: 271 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 303
Query: 1116 PTERPTAGDLYEMF 1129
+RP+ DL
Sbjct: 304 VNQRPSFRDLALRV 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-22
Identities = 46/221 (20%), Positives = 76/221 (34%), Gaps = 24/221 (10%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEVGNLLGLECLQI---K 122
S+ L L +N L+ +L+ N + + L L+ L
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHST 410
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ A L+ L L++S GL L L + S +
Sbjct: 411 LKRVTEFS-AFLSLEKLLYLDISYTNTKIDFD--------GIFLGLTSLNTLKMAGNSFK 461
Query: 178 YLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
+NL LDLS +++ + + L L L +++N L+ L S Y L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
L LD S NR+ + + +L NL N + C+
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-19
Identities = 46/225 (20%), Positives = 80/225 (35%), Gaps = 33/225 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-----------------SEVGNLLG 115
+ L + + + K ++L ++ FP S +
Sbjct: 290 MSLAGVSIKYLEDVPKHF-KWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348
Query: 116 LECLQI------KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
L L +S G ++ L+ L+LS + + + GL+ L L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS----FNGAIIMSANFMGLEELQHL 404
Query: 170 SVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVE-- 224
H +++ + L L LD+S+ K I L +L +LK+A N +
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
Query: 225 LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + L LDLS +L + +H LQ LN+ +N L
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-16
Identities = 45/247 (18%), Positives = 83/247 (33%), Gaps = 43/247 (17%)
Query: 132 ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGC 185
+ + L+ L+LS + GL L+ L + I+ P
Sbjct: 51 SFSNFSELQWLDLSRCEIETIED--------KAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 186 LSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKL--VELPSGLYLLQRLENLDLSN 242
L++LE L K+ L + I L L L VA+N + +LP+ L L ++DLS
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 243 NRLTSLGSLDLCLMHNLQN----LNLQYNKL-----------------LSYCQ----VPS 277
N + ++ DL + L++ N + L +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 278 WICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSS 337
NL G ++++E ++E +V+ E + S V
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR-LTYTNDFSDDIVKF 281
Query: 338 SNSRSLT 344
+++
Sbjct: 282 HCLANVS 288
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-16
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
+ + ++ L S L+ LDLS +++ + + + L L +L + N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
G L LENL +L SL S + + L+ LN+ +N +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 38/219 (17%), Positives = 73/219 (33%), Gaps = 28/219 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N + + P S L NL ++ S G L+ L+ L + I S
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 128 VNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L L ++LS + + L L E + L + I ++ +
Sbjct: 145 LPAY-FSNLTNLVHVDLSYNYIQTITV--NDLQFLRENPQV--NLSLDMSLNPIDFIQDQ 199
Query: 183 IGCLSNLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKLVELPS----------GLY 230
L +L L N + T + L L ++ + + + GL
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ E L+ S + + N+ ++L +
Sbjct: 260 DVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-12
Identities = 33/212 (15%), Positives = 67/212 (31%), Gaps = 30/212 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-----GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
++ + L N + I + + +L N I+ + + L L ++
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 123 --ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+S + L L GL L L E + L
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLI-----------LGEFKDERNLEIFEPSIM------ 255
Query: 181 PEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
E C +++ L++ + L + ++ +A + L + ++L
Sbjct: 256 -EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK-WQSLS 313
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ +L +LDL L++L L NK
Sbjct: 314 IIRCQLKQFPTLDL---PFLKSLTLTMNKGSI 342
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
L P I + N+ K+ +P +I + ++ ++ N L L S L+
Sbjct: 4 LNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LDLS + ++ +H+L NL L N + S
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-22
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 76/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T K +S F L E + H IV++ G +
Sbjct: 423 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENPVW----------- 466
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 467 ----IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 519 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 560
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 561 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 610
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L +C P L + +C +P+ RP +L
Sbjct: 611 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-22
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
N++ + N L I + KL ++ N+I + NL L L + +I+
Sbjct: 68 NNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQIT 125
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
L L L LELS ++ +S ++GL L +LS + + L P +
Sbjct: 126 DI----DPLKNLTNLNRLELSSNT-----ISDISALSGLTSLQQLSFGN-QVTDLKP-LA 174
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ LE+LD+S NK+ + + L L SL NN++ ++ L +L L+ L L+ N+
Sbjct: 175 NLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQ 232
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
L +G+L NL +L+L N++
Sbjct: 233 LKDIGTLASL--TNLTDLDLANNQI 255
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++ L L N L I ++ L +L N+I+ + L L L++ +IS
Sbjct: 221 TNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQIS 278
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L L L LEL++ L +S I+ LK LT L++ +I + P +
Sbjct: 279 NI----SPLAGLTALTNLELNENQ-----LEDISPISNLKNLTYLTLYFNNISDISP-VS 328
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L++L NK+ + + L + L +N++ +L L L R+ L L++
Sbjct: 329 SLTKLQRLFFYNNKVSDVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA 386
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
T+ ++ ++ N L P+ I
Sbjct: 387 WTNA-PVNYKANVSIPNTVKNVTGALI---APATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 32/181 (17%), Positives = 72/181 (39%), Gaps = 17/181 (9%)
Query: 91 EKLRNLKFFGNEINLFP--SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148
+ + +++ + L+ ++ I S + L L ++ S
Sbjct: 24 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID----GVEYLNNLTQINFSN-- 77
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICY 208
+ LT ++ + L L + + + I + P + L+NL L L N++ + +
Sbjct: 78 ---NQLTDITPLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP-LKN 132
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L L L++++N + ++ + L L L+ L N L + L+ L++ NK
Sbjct: 133 LTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVTDLKP---LANLTTLERLDISSNK 188
Query: 269 L 269
+
Sbjct: 189 V 189
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-19
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L + L K + +T L +T L I+ + + L+NL
Sbjct: 18 FTDTALAEKMKTVLGK-----TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-VEYLNNLT 71
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
Q++ S N++ + + L L+ + + NN++ ++ L L L L L NN++T +
Sbjct: 72 QINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDI-- 127
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NL L L N +
Sbjct: 128 DPLKNLTNLNRLELSSNTI 146
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-14
Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 16/201 (7%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L L N ++ I + L NL+ N++ + NL L L + IS
Sbjct: 268 TELKLGANQISNIS-PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS 325
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
++ L L+ L + ++ +S +A L + LS H I L P + L+
Sbjct: 326 ----PVSSLTKLQRLFFYN-----NKVSDVSSLANLTNINWLSAGHNQISDLTP-LANLT 375
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
+ QL L+ P ++ + + P+ + D++ N +
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY 435
Query: 248 LGSLDLCLMHNLQNLNLQYNK 268
+ +
Sbjct: 436 TNEVS-YTFSQPVTIGKGTTT 455
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 29/182 (15%), Positives = 57/182 (31%), Gaps = 14/182 (7%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
++ L L +N L I + + L L + N I+ S V +L L+ L K+S
Sbjct: 287 TALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDI-SPVSSLTKLQRLFFYNNKVS 344
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+L L + L ++ L+ +A L +T+L + + P
Sbjct: 345 DVS----SLANLTNINWLSAGHNQ-----ISDLTPLANLTRITQLGLNDQAWTNAPVNYK 395
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
++ + P I + + N Y + +
Sbjct: 396 ANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTT 455
Query: 245 LT 246
+
Sbjct: 456 FS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-11
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234
I + L+ + L + + L + +L+ + + G+ L
Sbjct: 13 PINQIFT-DTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI-DGVEYLNN 69
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ SNN+LT + L + L ++ + N++
Sbjct: 70 LTQINFSNNQLTDITPLK--NLTKLVDILMNNNQI 102
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R + EI EV +L + H ++ ++
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIER-------EVSILRQVLHHNVITLHD---------VY 84
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
+ + L+ +E V GG + +++ ++ +S + A + + + LH+K
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVC 1005
I H D+K ENI++ K P +KL DF A +
Sbjct: 135 KIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------ 179
Query: 1006 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-21
Identities = 66/234 (28%), Positives = 95/234 (40%), Gaps = 18/234 (7%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
IE + + + L L P + + L+ L F N+ SEV +L LE
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEV-DLPSLE 350
Query: 118 CLQI---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174
L + +S G + LK L+LS V+T+ S GL+ L L H
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 175 SIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVE--LPSGL 229
+++ + L NL LD+S + I L +L LK+A N E LP
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L+ L LDLS +L L + +LQ LN+ N+L S VP I L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS---VPDGIFDRL 517
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-21
Identities = 37/208 (17%), Positives = 70/208 (33%), Gaps = 15/208 (7%)
Query: 69 SVEGLYLYKN--VLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++E L L+ I + + I N G + L++ +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLEL--VNC 314
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEI 183
F KLK LK L + + L L L + + +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG--LYLLQRLENLDLS 241
++L+ LDLSFN + + + L+ L L ++ L ++ L+ L LD+S
Sbjct: 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ + + +L+ L + N
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-17
Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 32/230 (13%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----Q 120
S + L L N L + + +L+ L EI +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
I+ + G A + L L++L + P I LK L +L+V H
Sbjct: 88 IQSLALG----AFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNL 135
Query: 176 IRYL--PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKAL----ISLKVANNKLVELPSG 228
I+ P L+NLE LDLS NK++ + + L + +SL ++ N + + G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 229 LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
+ RL L L NN + ++ + + L+ L + + +
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-16
Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 19/212 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECLQI--------- 121
L L N +N I + +L L N N+ + + L GLE ++
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+ + ++E L+ + + L L ++ S+ +I +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTNVSSFSLVSVTIERVKD 299
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLS 241
+ L+L K PT LK+L L +NK S + L LE LDLS
Sbjct: 300 FSY-NFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLS 355
Query: 242 NNRLTSLG--SLDLCLMHNLQNLNLQYNKLLS 271
N L+ G S +L+ L+L +N +++
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-14
Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 24/192 (12%)
Query: 69 SVEGLYLYKNVLNLI---PKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---- 121
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 122 --KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI- 176
++S V L+ L L++S + GL L L + S
Sbjct: 408 LKQMSEFSV----FLSLRNLIYLDISHTH-----TRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-LLQ 233
P+I L NL LDLS +++ L L +L L +A+N+L +P G++ L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
Query: 234 RLENLDLSNNRL 245
L+ + L N
Sbjct: 519 SLQKIWLHTNPW 530
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK S + L E +++ LRH +V++Y
Sbjct: 296 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 337
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 338 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 391 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 434
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 435 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 484
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
C PE+ L D+ +C + P ERPT L
Sbjct: 485 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 83/318 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T+ +S E F L E ++ +V + G + S+ P
Sbjct: 60 IKTVNE-AASMRERIEF----LNEASVMKEFNCHHVVRLLG--VVSQGQP---------T 103
Query: 896 LQSAIFMEYVKGGSVKNYI-----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950
L + ME + G +K+Y+ + S+ + +A ++A + L++ +
Sbjct: 104 L---VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-- 1008
HRD+ + N ++ + VK+ DF R I D
Sbjct: 161 HRDLAARNCMVAEDF-------TVKIGDFGMT--------------RDIYETDYYRKGGK 199
Query: 1009 ---P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 1063
P RWM+PE L K ++ D+WS+G +L E+ TL + PY GLS ++ +
Sbjct: 200 GLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 1064 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123
G +KP+ L ++ R C + NP RP+
Sbjct: 256 GGL------------------------LDKPD---NCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 1124 DLYEMFVARTSSSISSRS 1141
++ S
Sbjct: 289 EIISSIKEEMEPGFREVS 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGV 128
LYL KN L +P+ + + L+ L+ NEI V L + +++ + S G+
Sbjct: 105 LYLSKNQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
A +K L + ++ T ++ I LT+L + I +
Sbjct: 163 ENGAFQGMKKLSYIRIAD--------TNITTIPQGLPPSLTELHLDGNKITKVDAASLKG 214
Query: 186 LSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NL +L LSFN + + L L + NNKLV++P GL + ++ + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 245 LTSLGSLDLCL------MHNLQNLNLQYNKL 269
++++GS D C + ++L N +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 24/207 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGV 128
+ L +PK + L N+I + + NL L L + KIS +
Sbjct: 36 VQCSDLGLEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--I 91
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
+ A L L+ L LSK L E+ K L +L V I + +
Sbjct: 92 SPGAFAPLVKLERLYLSK--------NQLKELPEKMPKTLQELRVHENEITKVRKSVFNG 143
Query: 186 LSNLEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
L+ + ++L N +K + +K L +++A+ + +P G L L L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDG 201
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++T + + L ++NL L L +N +
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSI 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 3/87 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L NL L L NK+ + L L L ++ N+L ELP + + L+ L + N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENE 132
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T + ++ + + L N L S
Sbjct: 133 ITKVRKSVFNGLNQMIVVELGTNPLKS 159
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 28 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + L+ L L N+L
Sbjct: 86 NKISKISPGAFAPLVKLERLYLSKNQL 112
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 23/140 (16%), Positives = 44/140 (31%), Gaps = 20/140 (14%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISS-P 126
L+L N + + + L L N I+ + N L L + K+ P
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 256
Query: 127 GVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--L 179
G L K ++ + L S + + + +S+ ++Y +
Sbjct: 257 G----GLADHKYIQVVYLHNNNISAIGS--NDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 180 PPEI-GCLSNLEQLDLSFNK 198
P C+ + L K
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 915
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 976 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1029
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 1030 VDIWSYGCLLLELLT 1044
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R L EI EV +L +RH I+ ++
Sbjct: 34 AAKFIKKRRLSSSRRGVSREEIER-------EVNILREIRHPNIITLHD---------IF 77
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 944
+ + L+ +E V GG + +++ E L+E A + + + L
Sbjct: 78 ENKTDVVLI-----LELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAP 1002
HSK I H D+K ENI+ L K P +KL DF A + +
Sbjct: 125 HSKRIAHFDLKPENIM--LLDKNVPN-PRIKLIDFGIAHKIEAGNEFKNIF--------- 172
Query: 1003 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1062
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 173 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 1063 MGK 1065
Sbjct: 225 AVN 227
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 96/315 (30%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + ++F E +L L+H IV+ YG + P L
Sbjct: 50 VKALK--DPTLAARKDF----QREAELLTNLQHEHIVKFYG--VCGDGDP---------L 92
Query: 896 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 944
+ + EY+K G + + ++ + + + L IA +A+ +V L
Sbjct: 93 I---MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
S+H +HRD+ + N L+ +VK+ DF + R + + D
Sbjct: 150 ASQHFVHRDLATRNCLVGANL-------LVKIGDFGMS--------------RDVYSTDY 188
Query: 1005 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 1054
P RWM PE + +Y E D+WS+G +L E+ T + P+ LS
Sbjct: 189 YRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1114
E+ + I G+ LE C P+ + DV C +
Sbjct: 242 TEVIECITQGRV------LERPRVC--------------PKE-------VYDVMLGCWQR 274
Query: 1115 NPTERPTAGDLYEMF 1129
P +R ++Y++
Sbjct: 275 EPQQRLNIKEIYKIL 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 55/299 (18%), Positives = 102/299 (34%), Gaps = 78/299 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + L E ++ L + IV M G I E +
Sbjct: 49 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIG--ICEA---------ESWM 93
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 94 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+ + K+ DF +A+ + A P +W
Sbjct: 145 ARNVLLVTQH-------YAKISDFGLSKALRADENYYK---AQTHGKWPV--------KW 186
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1070
APE + + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 187 YAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---- 238
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ C P + D+ C + RP +
Sbjct: 239 --MGCPAGC--------------PRE-------MYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + +I+ + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 97 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG +K+ DF + + +T C GTP ++APE+L
Sbjct: 152 D-----KDGH--IKIADFGMCKENMLGDAKTNTFC-------------GTPDYIAPEILL 191
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 192 GQK----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 46/174 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+++++GG + + K E + + F ++A AL LHS I++RD+K ENIL+
Sbjct: 105 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D +G +KL DF +A ++ C GT +
Sbjct: 160 D-----EEGH--IKLTDFGLSKESIDHEKKA-------YSFC-------------GTVEY 192
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
MAPEV+ + D WS+G L+ E+LT +P+ G E +I K
Sbjct: 193 MAPEVVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 90/313 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L+ G D+ R+F E+++L AL IV+ G
Sbjct: 57 VKQLQHSGP--DQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQS---------- 100
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
L+ + MEY+ G +++++++ + L + + + L S+ +HRD+
Sbjct: 101 LR--LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ NIL++ E VK+ DF + +PL + P W
Sbjct: 155 ARNILVESEA-------HVKIADFGLAKLLPLDKDYYV---VREPGQSPI--------FW 196
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSEL--------------E 1056
APE L N++ + D+WS+G +L EL T +E
Sbjct: 197 YAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116
+ +L++ G+R L A +C P + ++ + C +P
Sbjct: 253 LLELLEEGQR------LPAPPAC--------------PAE-------VHELMKLCWAPSP 285
Query: 1117 TERPTAGDLYEMF 1129
+RP+ L
Sbjct: 286 QDRPSFSALGPQL 298
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 98.7 bits (245), Expect = 3e-21
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 22/236 (9%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL 113
P G +S + L K+ + E+L + + + SE+ +
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESC 371
Query: 114 LGLECLQIKISSPGVNGFA-----------------LNKLKGLKELELSKVPPRPSVLTL 156
L+ L+ + + + LK + + + + S L
Sbjct: 372 KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 157 LSEIAG--LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214
+ + + L + H + L + L + LDLS N+++ LP + L+ L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEV 490
Query: 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ ++N L + G+ L RL+ L L NNRL ++ L L LNLQ N L
Sbjct: 491 LQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 26/219 (11%), Positives = 61/219 (27%), Gaps = 3/219 (1%)
Query: 72 GLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF 131
L +++ E+ F + + LL ++ + + +G
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGR 293
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
L +L + + + T G + + + L +
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANN-KLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+LS K L +E+ K L L+ N L+ + + L L + ++L +
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 251 LDLC--LMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
+D + + + +L
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 49/301 (16%), Positives = 105/301 (34%), Gaps = 83/301 (27%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ L+ +S + L E ++ ++ + + + G ++S
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ----------- 92
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 93 ----LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1068
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 1069 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L C + + +C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMVKCWMIDADSRPKFRELIIE 272
Query: 1129 F 1129
F
Sbjct: 273 F 273
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 77/297 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T+K S + L E ++ L+H +V+++ + +K P +
Sbjct: 217 VKTMKPGSMSVEAF-------LAEANVMKTLQHDKLVKLHA--VVTK-------EPIY-- 258
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I E++ GS+ ++ L + + + +A + + ++ +HRD++
Sbjct: 259 ----IITEFMAKGSLLDF---LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ NIL+ V K+ DF A R A G P +W A
Sbjct: 312 AANILVSASL-------VCKIADFGLA---RVIEDNEYTAREGAKFPI--------KWTA 353
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE + + ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R
Sbjct: 354 PEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------ 403
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ +C PE L ++ RC + P ERPT + +
Sbjct: 404 MPRPENC--------------PEE-------LYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-21
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 69/272 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L +L H I++++ K +L+ E+ +GG + I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK---------YFYLV-----TEFYEGGELFEQIIN-- 139
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
A I + + + + LH +I+HRDIK ENIL LE K + +K+ D
Sbjct: 140 ---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL--LENKNSLLN--IKIVD 192
Query: 979 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
F + L GT ++APEVL+ Y + D+WS G
Sbjct: 193 FGLSSFFSKDYKLRDRL-------------GTAYYIAPEVLK-----KKYNEKCDVWSCG 234
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096
++ LL P+ G ++ +I ++ GK +
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGK-------------------------YYFDFN 269
Query: 1097 ELETLSFLV-DVFRRCTEENPTERPTAGDLYE 1127
+ + +S ++ + + +R TA +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D DG +K+ DF T C GTP +
Sbjct: 139 D-----KDGH--IKITDFGLCKEGISDGATM-------KTFC-------------GTPEY 171
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+APEVL N YG VD W G ++ E++ ++P+ + +LI M +
Sbjct: 172 LAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-21
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 46/174 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY+ GG + +E+ E A F +++ AL LH K I++RD+K ENI++
Sbjct: 100 LEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
+ G VKL DF HT C GT +
Sbjct: 155 N-----HQGH--VKLTDFGLCKESIHDGTVT-------HTFC-------------GTIEY 187
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
MAPE+L + + VD WS G L+ ++LT P+ G + + D I K
Sbjct: 188 MAPEILMR----SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 78/299 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 42 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 85
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME GG + ++ + + V + V+ + L K+ +HRD+
Sbjct: 86 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 138 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 179
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1070
APE + K + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 180 YAPECI-NFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+E C P L + C +RP + +
Sbjct: 232 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 915
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 976 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1029
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 1030 VDIWSYGCLLLELLT 1044
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-21
Identities = 25/205 (12%), Positives = 64/205 (31%), Gaps = 12/205 (5%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KIS 124
S+E L+ N ++ + S G+ +N+ N+I + G ++ L + +I
Sbjct: 100 SIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L+ L L + + + L L + + ++ PE
Sbjct: 158 TVNFAEL-AASSDTLEHLNLQY-----NFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQ 211
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
+ + + L NK+ + + + + L + N + + ++
Sbjct: 212 SAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCC 296
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 19/140 (13%)
Query: 133 LNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNL 189
N+ K K + L + S + +L + + + + + L
Sbjct: 9 GNRYKIEKVTDSSLKQALA--------SLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
E L+LS N + ++ L L +L + NN + EL +E L +NN ++
Sbjct: 61 ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNIS--- 112
Query: 250 SLDLCLMHNLQNLNLQYNKL 269
+ +N+ L NK+
Sbjct: 113 RVSCSRGQGKKNIYLANNKI 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 33/251 (13%), Positives = 73/251 (29%), Gaps = 32/251 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++E L L N + + V + KL+ L N++ E + G+ + + K+
Sbjct: 169 DTLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227
Query: 125 S-PGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
AL + L+ +L + + +V +++ L
Sbjct: 228 LIEK----ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--------QTVAKQTVKKL 275
Query: 180 PPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--------ELPSGLY 230
+ + + LP + LI+LK + L+ L
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAP--FADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDS 290
R +D + ++ L + L L+G + +
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 291 SNDDFISSSAE 301
+ + E
Sbjct: 394 VGQIELQHATE 404
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-21
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 13/219 (5%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVG--NLLG 115
IE + + + L L P + L+ L F N+ SEV +L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLK--SLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 116 LECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
L+ + +S G + LK L+LS V+T+ S GL+ L L H +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 176 IRYLPPE--IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVE--LPSGLY 230
++ + L NL LD+S + L +L LK+A N E LP
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLS +L L + +LQ LN+ +N
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-19
Identities = 55/219 (25%), Positives = 81/219 (36%), Gaps = 29/219 (13%)
Query: 69 SVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----Q 120
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLT--KLSVCH 173
+K S L+ L L++S GL L K++
Sbjct: 408 LKQMSEFS---VFLSLRNLIYLDISHTHTRVAFN--------GIFNGLSSLEVLKMAGNS 456
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYL 231
F +LP L NL LDLS +++ L PT L +L L +++N L +
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 232 LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L L+ LD S N + + +L +L LNL N
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-18
Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 13/197 (6%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
L+ I + + I + G + L++ + F KLK L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL--VNCKFGQFPTLKLKSL 327
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEIGCLSNLEQLDLSF 196
K L + + L L L + + + ++L+ LDLSF
Sbjct: 328 KRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 197 NKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGSLDLC 254
N + + + L+ L L ++ L ++ S L+ L LD+S+ +
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 255 LMHNLQNLNLQYNKLLS 271
+ +L+ L + N
Sbjct: 443 GLSSLEVLKMAGNSFQE 459
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-17
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 32/238 (13%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-----Q 120
S + L L N L +L S + +L+ L EI + +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSV--CH 173
I+ + G A + L L++L + P I LK L +L+V
Sbjct: 88 IQSLALG----AFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNL 135
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKAL----ISLKVANNKLVELPSG 228
LP L+NLE LDLS NK++ + T++ L + +SL ++ N + + G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 229 LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEG 285
+ RL L L NN + ++ + + L+ L + + + + LEG
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-16
Identities = 44/251 (17%), Positives = 85/251 (33%), Gaps = 32/251 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFF-------GNEINLFPSEVGNLLGLECLQIK-- 122
L L N + ++ + L + N +N + L L ++
Sbjct: 154 LDLSSNKIQSIYCTDLR---VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL--- 179
S V + L GL+ L R + + L+ L L++ F + YL
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 180 ----PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRL 235
CL+N+ L ++ + + Y L++ N K + P+ L+ L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCKFGQFPTLK--LKSL 327
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC-------NLEGNGK 288
+ L ++N+ + S +L+ L+L N L +L NG
Sbjct: 328 KRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 289 DSSNDDFISSS 299
+ + +F+
Sbjct: 386 ITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-13
Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LY 230
+ +P + + + LDLSFN +++L L L ++ ++ + G
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L L+ N + SL + +LQ L L
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-06
Identities = 16/53 (30%), Positives = 23/53 (43%), Gaps = 2/53 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++P L +NLDLS N L LGS LQ L+L ++ +
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 53/240 (22%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R K +I EV +L ++H ++ ++
Sbjct: 40 AAKFIKKRRTKSSRRGVSREDIER-------EVSILKEIQHPNVITLHE---------VY 83
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
+ + L+ +E V GG + +++ + ++ ++ + A + + + LHS
Sbjct: 84 ENKTDVILI-----LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL 133
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1005
I H D+K ENI+ L + P +K+ DF A + +
Sbjct: 134 QIAHFDLKPENIM--LLDRNVPK-PRIKIIDFGLAHKIDFGNEFKNIF------------ 178
Query: 1006 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E +
Sbjct: 179 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 80/297 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 49 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 90
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 91 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ + V K+ DF + + +P +W A
Sbjct: 145 ARNVLVSEDN-------VAKVSDFGLT---KE-ASS---TQDTGKLPV--------KWTA 182
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 183 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 232
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
++A C P A + +V + C + RP+ L E
Sbjct: 233 MDAPDGC--------------PPA-------VYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 49/179 (27%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++Y+ GG + ++ + + + ++ AL LH I++RDIK ENIL+
Sbjct: 138 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 962 DLERKKADGKPVVKLCDF-----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
D ++G V L DF +RA + C GT
Sbjct: 193 D-----SNGH--VVLTDFGLSKEFVADETERA-------YDFC-------------GTIE 225
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE----LEIHDLIQMGK 1065
+MAP+++R + VD WS G L+ ELLT P+ E EI I +
Sbjct: 226 YMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 47/223 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME ++GG + ++ E G++ + + A I +D+ A+ LHS +I HRD+K EN+L
Sbjct: 105 MECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL- 160
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
K+ D V+KL DF A L T C TP ++APEVL
Sbjct: 161 -YTSKEKD--AVLKLTDFGFAKETTQNALQTPC-------------YTPYYVAPEVLGPE 204
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1080
Y D+WS G ++ LL P+ + I + +
Sbjct: 205 K----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------KRRIRLGQ 249
Query: 1081 EHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTA 1122
+ P E +S + R + +PTER T
Sbjct: 250 ----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 71/311 (22%), Positives = 115/311 (36%), Gaps = 89/311 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK S ++F E +L L+H IV +G + ++ P L
Sbjct: 76 VKALKEA--SESARQDF----QREAELLTMLQHQHIVRFFG--VCTEGRP---------L 118
Query: 896 LQSAIFMEYVKGGSVKNY----------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 945
L + EY++ G + + + + + + L +A VAA +V L
Sbjct: 119 L---MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1005
H +HRD+ + N L+ VVK+ DF + R I + D
Sbjct: 176 GLHFVHRDLATRNCLVGQGL-------VVKIGDFGMS--------------RDIYSTDYY 214
Query: 1006 -VGT----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIH 1058
VG P RWM PE + + E D+WS+G +L E+ T + P+ LS E
Sbjct: 215 RVGGRTMLPIRWMPPESI----LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 1059 DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118
D I G+ LE +C P + + R C + P +
Sbjct: 271 DCITQGRE------LERPRAC--------------PPE-------VYAIMRGCWQREPQQ 303
Query: 1119 RPTAGDLYEMF 1129
R + D++
Sbjct: 304 RHSIKDVHARL 314
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 72 VKMLK-DDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 117
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 118 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 173 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 211
Query: 1004 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1056
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116
+ L++ G R +KP + L + R C P
Sbjct: 268 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 300
Query: 1117 TERPTAGDLYEMF 1129
++RPT L E
Sbjct: 301 SQRPTFKQLVEDL 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 97/320 (30%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK +S E+R+ L E +L + H ++++YG + P L
Sbjct: 58 VKMLKE-NASPSELRDL----LSEFNVLKQVNHPHVIKLYGA--------CSQDGP---L 101
Query: 896 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 936
L + +EY K GS++ + L E+ +++ + A
Sbjct: 102 L---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
++ + L ++HRD+ + NIL+ A+G+ +K+ DF +
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILV------AEGR-KMKISDFGLS-------------- 197
Query: 997 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1049
R + D V P +WMA E L ++Y + D+WS+G LL E++TL PY
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFD----HIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1109
G+ + +L++ G R E+P+ + +
Sbjct: 254 PGIPPERLFNLLKTGHR------------------------MERPD---NCSEEMYRLML 286
Query: 1110 RCTEENPTERPTAGDLYEMF 1129
+C ++ P +RP D+ +
Sbjct: 287 QCWKQEPDKRPVFADISKDL 306
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME + GG + I+K +KH S A +I + + +A+ +H ++HRD+K EN+L
Sbjct: 85 MELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF 139
Query: 962 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ +K+ DF A L T C T + APE+L
Sbjct: 140 ----TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-------------FTLHYAAPELLN 182
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-------YMGLSELEIHDLIQMGK 1065
N Y D+WS G +L +L+ QVP S +EI I+ G
Sbjct: 183 Q----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-21
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 80/297 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 221 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 262
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 263 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ + V K+ DF S +P +W A
Sbjct: 317 ARNVLVSEDN-------VAKVSDFGLTKEASS-------TQDTGKLPV--------KWTA 354
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 355 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 404
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
++A C P A + DV + C + RPT L E
Sbjct: 405 MDAPDGC--------------PPA-------VYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R + EI EV +L + H I+ ++
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIER-------EVSILRQVLHPNIITLHD---------VY 84
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 944
+ + L+ +E V GG + +++ E LSE + A + + + L
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAP 1002
H+K I H D+K ENI++ K P +KL DF A +
Sbjct: 132 HTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--------- 179
Query: 1003 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1062
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 1063 MGK 1065
Sbjct: 232 AVS 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 67/313 (21%), Positives = 114/313 (36%), Gaps = 91/313 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + + E+ +L L H I++ G A
Sbjct: 65 VKALKA-DAGPQHRSGW----KQEIDILRTLYHEHIIKYKG--CCED----AGAAS---- 109
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
LQ + MEYV GS+++Y+ + + + L AQ + + LH++H +HRD+
Sbjct: 110 LQ--LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+D +R +VK+ DF +AVP + P W
Sbjct: 162 ARNVLLDNDR-------LVKIGDFGLAKAVPEGHEYYR---VREDGDSPV--------FW 203
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 1056
APE L+ + D+WS+G L ELLT + ++ L
Sbjct: 204 YAPECLKE----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116
+ +L++ G+R L C P + + + C E
Sbjct: 260 LTELLERGER------LPRPDKC--------------PAE-------VYHLMKNCWETEA 292
Query: 1117 TERPTAGDLYEMF 1129
+ RPT +L +
Sbjct: 293 SFRPTFENLIPIL 305
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 71/297 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 122 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 166
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 167 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N ++D + VK+ DF A + G +P +WMA
Sbjct: 220 ARNCMLDEKF-------TVKVADFGLARDMYDKEFDSVHNKTGAKLPV--------KWMA 264
Query: 1014 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1072
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 265 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 314
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
L C P+ L +V +C RP+ +L
Sbjct: 315 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 72/313 (23%), Positives = 120/313 (38%), Gaps = 90/313 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK ++ ++ + + E+ M+ + +H I+ + G ++ +
Sbjct: 106 VKMLK-SDATEKDLSDL----ISEMEMMKMIGKHKNIINLLG--ACTQ---------DGP 149
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
L + +EY G+++ Y S E+ +S K + A VA +
Sbjct: 150 LY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L SK +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 207 LASKKCIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RDIHHID 245
Query: 1004 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1056
T P +WMAPE L +Y + D+WS+G LL E+ TL PY G+ E
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116
+ L++ G R +KP + L + R C P
Sbjct: 302 LFKLLKEGHR------------------------MDKPS---NCTNELYMMMRDCWHAVP 334
Query: 1117 TERPTAGDLYEMF 1129
++RPT L E
Sbjct: 335 SQRPTFKQLVEDL 347
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 53/198 (26%)
Query: 859 EVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIE 915
EV +L + ++ + W D + + +E + + ++I
Sbjct: 96 EVVLLKKVSSGFSGVIRLLD------WFERPD-----SFV---LILERPEPVQDLFDFIT 141
Query: 916 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
L E +LA V A+ H+ ++HRDIK ENILIDL R +
Sbjct: 142 ERGALQE--------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----- 188
Query: 973 VVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1030
+KL DF A+ + GT + PE +R + Y G
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY----HRYHGRSA 230
Query: 1031 DIWSYGCLLLELLTLQVP 1048
+WS G LL +++ +P
Sbjct: 231 AVWSLGILLYDMVCGDIP 248
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-20
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D ++G +K+ DF T C GTP +
Sbjct: 155 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 187
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 188 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-20
Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 71 EGLYLYKNVLN-LIPKSV-GRYEKLRNLKFFGNEIN-LFPSEVGNLLG-LECLQI---KI 123
E L L N + +P + L+ L NE + P + NL L L +
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
S P + N L+EL L K+PP S + L + LS + S
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH-------LSFNYLSGT 433
Query: 178 YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL 235
+P +G LS L L L N ++ +P E+ Y+K L +L + N L E+PSGL L
Sbjct: 434 -IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 236 ENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ LSNNRLT G + + + NL L L N +P+ +
Sbjct: 493 NWISLSNNRLT--GEIPKWIGRLENLAILKLSNNSF--SGNIPAELG 535
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-17
Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 27/211 (12%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N + IP +G L L N N P+ + G + + G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK--IAANFIA-GKRY 575
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYL----PPEIGC 185
+ KE + ++L L L+ + C+ + R P
Sbjct: 576 VYIKNDGMKKECHGAG-----NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 186 LSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
++ LD+S+N + Y+P EI + L L + +N + +P + L+ L LDLS+N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 244 RLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+L ++ +L L ++L N L
Sbjct: 691 KLDGRIPQAMSAL-----TMLTEIDLSNNNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-16
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 26/233 (11%)
Query: 68 NSVEGLYLYKNVLNL----IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-- 121
+ V + L LN+ + S+ L +L + IN S L L +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL- 179
+S P +L GLK L +S + L +++G L L V S +
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSS-----NTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 180 ---PPEI---GCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYL 231
L+ L +S NK+ + + L L V++N +P L
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGD 221
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++LD+S N+L+ S + L+ LN+ N+ +P +L+
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF--VGPIPPLPLKSLQ 272
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-15
Identities = 54/237 (22%), Positives = 84/237 (35%), Gaps = 51/237 (21%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFF---GNEIN-LFPSEVGNLLGLECLQIKI 123
S+E L L N ++ + LK GN+I+ V + LE L +
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDV-- 207
Query: 124 SSPGVNGF-----ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKL--S 170
N F L L+ L++S I+ L L S
Sbjct: 208 ---SSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR---------AISTCTELKLLNIS 255
Query: 171 VCHFS--IRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICY-LKALISLKVANNKLV-EL 225
F I PP L +L+ L L+ NK +P + L L ++ N +
Sbjct: 256 SNQFVGPI---PPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSL---DLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
P LE+L LS+N + G L L M L+ L+L +N+ ++P +
Sbjct: 311 PPFFGSCSLLESLALSSNNFS--GELPMDTLLKMRGLKVLDLSFNEFSG--ELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-14
Identities = 38/220 (17%), Positives = 72/220 (32%), Gaps = 45/220 (20%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N L IP + L + N + P +G L L L++ S+ N
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL--SN---NS 525
Query: 131 F------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
F L + L L+L+ +P + + K K++ + +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIP---------AAMF--KQSGKIAANFIAGK- 573
Query: 179 LPPEIGCLSNLEQLDLSFNKMKY---LPTEICYLKALISLKVANNKLV-ELPSGLYLLQR 234
I ++ + N +++ ++ L + +
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633
Query: 235 LENLDLSNNRLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+ LD+S N L+ +GS+ L LNL +N +
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSM-----PYLFILNLGHNDI 668
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-14
Identities = 47/220 (21%), Positives = 75/220 (34%), Gaps = 43/220 (19%)
Query: 73 LYLYKNVLNL-IPKSVG-RYEKLRNLKFFGNEIN-LFPSEV---GNLLGLECLQIKISSP 126
L + N L+ S G + L L N I+ L+ L I
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI----- 185
Query: 127 GVNGFA----LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTK--LSVCHF 174
N + +++ L+ L++S +P + L +S
Sbjct: 186 SGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP----------FLGDCSALQHLDISGNKL 235
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLY-L 231
S I + L+ L++S N+ +P LK+L L +A NK E+P L
Sbjct: 236 SGD-FSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 232 LQRLENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKL 269
L LDLS N G++ L++L L N
Sbjct: 293 CDTLTGLDLSGNHFY--GAVPPFFGSCSLLESLALSSNNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-11
Identities = 51/243 (20%), Positives = 79/243 (32%), Gaps = 59/243 (24%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSP 126
+ L+L N L+ IP S+G KLR+LK + N + P E+ + LE L +
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL----- 473
Query: 127 GVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSV--C 172
N L+ L + LS ++P I L+ L L +
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP---------KWIGRLENLAILKLSNN 524
Query: 173 HFS--IRYLPPEIGCLSNLEQLDLSFNK---------------MKY------LPTEICYL 209
FS I P E+G +L LDL+ N + I
Sbjct: 525 SFSGNI---PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581
Query: 210 KALISLKVANNKLV---ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
A N L L L ++++ S ++ L++ Y
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 267 NKL 269
N L
Sbjct: 642 NML 644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-08
Identities = 35/187 (18%), Positives = 55/187 (29%), Gaps = 36/187 (19%)
Query: 65 GGDNSVEGLYLYKNVLNL---IPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQ 120
D + + N+L + + R N + L
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS--IRY 178
+ S N L G + P + + + L L S I
Sbjct: 639 M--SY--------NMLSG----YI------PKEIGSMPYLFILN----LGHNDISGSI-- 672
Query: 179 LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLE 236
P E+G L L LDLS NK+ +P + L L + ++NN L +P +
Sbjct: 673 -PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG-QFETFP 730
Query: 237 NLDLSNN 243
NN
Sbjct: 731 PAKFLNN 737
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 118 VKMLKD-DATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 163
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 164 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 219 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 257
Query: 1004 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1056
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116
+ L++ G R +KP + L + R C P
Sbjct: 314 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 346
Query: 1117 TERPTAGDLYEMF 1129
++RPT L E
Sbjct: 347 SQRPTFKQLVEDL 359
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-20
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME+V GG + +I+K + A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 103 MEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D +G KL DF T C GTP +
Sbjct: 158 D-----HEGH--CKLADFGMCKEGICNGVTT-------ATFC-------------GTPDY 190
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+APE+L+ M YG VD W+ G LL E+L P+ +E ++ + I +
Sbjct: 191 IAPEILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 24/216 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
S L L N L +P V + +L L N ++ + G L+
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 122 KISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI---AGLKCLTKLSVCHFSIR 177
+ + L+ L+ L+ L +SE L+ L L + H R
Sbjct: 89 GVITMSS----NFLGLEQLEHLDFQHSN-----LKQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 178 YLPPEI-GCLSNLEQLDLSFNKM-KYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
I LS+LE L ++ N + +I L+ L L ++ +L +L + L
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L++S+N SL + +++LQ L+ N +
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 51/188 (27%), Positives = 76/188 (40%), Gaps = 13/188 (6%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
L+ N++ +L L L L + +S G + LK L+LS
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS--- 86
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI 206
V+T+ S GL+ L L H +++ + L NL LD+S + I
Sbjct: 87 -FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 207 CY-LKALISLKVANNKLVE--LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L +L LK+A N E LP L+ L LDLS +L L + +LQ LN
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 264 LQYNKLLS 271
+ +N S
Sbjct: 206 MSHNNFFS 213
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 53/235 (22%), Positives = 79/235 (33%), Gaps = 41/235 (17%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECL-----Q 120
+ L L N L+ +LK+ N + S L LE L
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 112
Query: 121 IK-ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCH- 173
+K +S L+ L L++S T GL L L +
Sbjct: 113 LKQMSEFS----VFLSLRNLIYLDISH--------THTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 174 FSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
P+I L NL LDLS +++ L L +L L +++N L + Y
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 232 -LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L L+ LD S N + + +L +L LNL N + C C
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN---------DFACTCEH 266
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 25/117 (21%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGC---LSNLEQLDLSFNKMKYLPTEICYLKALISLKV 217
L LTKLS+ + + ++L+ LDLSFN + + + L+ L L
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF 108
Query: 218 ANNKLVELPSG--LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
++ L ++ L+ L LD+S+ + + +L+ L + N
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 57/205 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--ME-YVKGGSVKNYIE 915
E+ +L + H+ I+++ ++ ME + G + +I+
Sbjct: 79 EIAILSRVEHANIIKVL-DIFENQ---------------GFFQLVMEKHGSGLDLFAFID 122
Query: 916 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+L E LA +I + + +A+ L K I+HRDIK ENI+I
Sbjct: 123 RHPRLDE--------PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-------AEDF 167
Query: 973 VVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1029
+KL DF A L +T C GT + APEVL N Y G E
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC-------------GTIEYCAPEVLMG----NPYRGPE 210
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSE 1054
+++WS G L L+ + P+ L E
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCELEE 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 56/301 (18%), Positives = 103/301 (34%), Gaps = 83/301 (27%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ ++ S + + +G+L H+ IV + G S
Sbjct: 47 IKVIED-KSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSSLQ----------- 90
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ +Y+ GS+ +++ + + +L L +A + L ++HR++
Sbjct: 91 ----LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ V++ DF A +P D +
Sbjct: 143 ARNVLLKSPS-------QVQVADFGVA--------------DLLPPDDKQLLYSEAKTPI 181
Query: 1010 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1068
+WMA E + Y + D+WSYG + EL+T PY GL E+ DL++ G+R
Sbjct: 182 KWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-- 235
Query: 1069 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
L C + V +C + RPT +L
Sbjct: 236 ----LAQPQIC--------------TID-------VYMVMVKCWMIDENIRPTFKELANE 270
Query: 1129 F 1129
F
Sbjct: 271 F 271
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-20
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 18/219 (8%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
V+ + + + + L+P S ++ + L L N + + LQ
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+ S G L LK L L++S R + + + + L++ IR +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDIS----RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVK 426
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
I LE LD+S N + +L L L ++ NKL LP L L + +
Sbjct: 427 TCI--PQTLEVLDVSNNNLDSFSL---FLPRLQELYISRNKLKTLPDAS-LFPVLLVMKI 480
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
S N+L S+ + +LQ + L N C ++
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-20
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 17/214 (7%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYE--KLRNLKFFGNEINLFPSEV-GNLLGLECLQI-- 121
D ++ GL + + + +G+ E +R L + S V L ++ + +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
K+ V LK L+ L+LS+ L + L L + +R +
Sbjct: 320 SKVFL--VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 181 PEIG---CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
L NL LD+S N +P + + + L +++ + + + + Q LE
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTC--IPQTLEV 435
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LD+SNN L S + LQ L + NKL +
Sbjct: 436 LDVSNNNLDSFSL----FLPRLQELYISRNKLKT 465
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 37/242 (15%), Positives = 80/242 (33%), Gaps = 17/242 (7%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L L N + I L+ L + IN + +L LE L + +
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 124 SSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLP 180
SS ++ L LK L L L + S L L L + + + +
Sbjct: 87 SS--LSSSWFGPLSSLKYLNLMGNPY----QTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 181 PE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLY-LLQRLEN 237
L++L +L++ ++ ++ + ++ + L + ++ L +L +
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
L+L + L L + + + L + S +F
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 298 SS 299
+
Sbjct: 261 CT 262
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-15
Identities = 27/152 (17%), Positives = 52/152 (34%), Gaps = 18/152 (11%)
Query: 139 LKELELSKVPPR-PSVLTLL------------SEIAGLKCLTKLSVCHFSIRYLPPEI-G 184
+ + +P + + L ++ L L + I + +
Sbjct: 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFY 71
Query: 185 CLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL--LQRLENLDLS 241
L +LE LDLS N + L + L +L L + N L L L+ L +
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131
Query: 242 -NNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
+ + +D + +L L ++ L +Y
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 29/213 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------KISSP 126
LY+ KN L IP ++ L L+ N I P G GL + + +
Sbjct: 107 LYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPK--GVFSGLRNMNCIEMGGNPLENS 162
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI- 183
G A + LK L L +S+ L+ I + L +L + H I+ + E
Sbjct: 163 GFEPGAFDGLK-LNYLRISE--------AKLTGIPKDLPETLNELHLDHNKIQAIELEDL 213
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
S L +L L N+++ + L L L + NNKL +P+GL L+ L+ + L
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHT 273
Query: 243 NRLTSLGSLDLCLMH------NLQNLNLQYNKL 269
N +T +G D C + ++L N +
Sbjct: 274 NNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 47/233 (20%), Positives = 89/233 (38%), Gaps = 49/233 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L L N ++ + K + L L N+I+ +
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK------------------ 96
Query: 128 VNGFALNKLKGLKELELSK-----VPPR-PSVLTLL-------SEI-----AGLKCLTKL 169
A + L+ L++L +SK +PP PS L L ++ +GL+ + +
Sbjct: 97 ----AFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 170 SVCHFSIRYLPPEIGCLS--NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
+ + E G L L +S K+ +P ++ + L L + +NK+ +
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQAIEL 210
Query: 228 G-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
L +L L L +N++ + + L + L+ L+L NKL VP+ +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR---VPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLL 232
++ +P EI + LDL N + L + L+ L +L + NNK+ ++ L
Sbjct: 44 GLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++L+ L +S N L + L +L L + N++
Sbjct: 102 RKLQKLYISKNHLVEIPPN---LPSSLVELRIHDNRI 135
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
GC +L + S +K +P EI L + NN + EL LQ L L L N
Sbjct: 30 GCHCHLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + LQ L + N L
Sbjct: 88 NKISKIHEKAFSPLRKLQKLYISKNHL 114
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-20
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 51/237 (21%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AA + T K+ ++ E R+ L+H IV ++
Sbjct: 40 AAMIINTKKLSARDHQKLER-------EARICRLLKHPNIVRLHDSISEEG--------- 83
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
H+L+ + V GG + I ++ S A Q + A++ H ++H
Sbjct: 84 HHYLI-----FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGT 1008
R++K EN+L+ + K A VKL DF A+ + GT
Sbjct: 134 RNLKPENLLLASKLKGAA----VKLADFGLAIEVEGEQQAWFGFA-------------GT 176
Query: 1009 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
P +++PEVLR + YG VD+W+ G +L LL P+ + ++ I+ G
Sbjct: 177 PGYLSPEVLRK----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E + L+H IVE+ S +++ E++ G + I K
Sbjct: 76 EASICHMLKHPHIVELLETYSSDG---------MLYMV-----FEFMDGADLCFEIVK-R 120
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
S +A + + AL H +I+HRD+K +L+ K + P VKL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA---SKENSAP-VKLGG 176
Query: 979 FDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
F A+ L GTP +MAPEV++ YG VD+W
Sbjct: 177 FGVAIQLGESGLVAGGRV-------------GTPHFMAPEVVKR----EPYGKPVDVWGC 219
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
G +L LL+ +P+ G ++ + + I GK
Sbjct: 220 GVILFILLSGCLPFYG-TKERLFEGIIKGK 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGN 890
AAK + + EI + E+ +L + ++ ++ +
Sbjct: 58 AAKFLKKRRRGQDCRAEILH-------EIAVLELAKSCPRVINLHE---------VYENT 101
Query: 891 PEHHLLQSAIFMEYVKGGS-----VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 945
E L+ +EY GG + E +SE + + + + + LH
Sbjct: 102 SEIILI-----LEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPD 1003
+I+H D+K +NIL L G +K+ DF + + L
Sbjct: 149 QNNIVHLDLKPQNIL--LSSIYPLGD--IKIVDFGMSRKIGHACELREIM---------- 194
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
GTP ++APE+L + P D+W+ G + LLT P++G E + I
Sbjct: 195 ---GTPEYLAPEILN--YDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 1064 GK 1065
Sbjct: 248 VN 249
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-20
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 15/214 (7%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
++E LYL N ++ I G EKL+ L F N I L ++ +L L +
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ F + L + L + ++ L + + P
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST----IQSLWLGTFEDMDDEDISP 245
Query: 182 EI---GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ C ++E ++L + + + L L + L ELPSGL L L+
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKK 305
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L LS N+ +L + +L +L+++ N
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-18
Identities = 41/211 (19%), Positives = 75/211 (35%), Gaps = 36/211 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KI 123
SVE + L K+ N+ + + L+ L ++ PS + L L+ L + K
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
+ + + L L + + +
Sbjct: 314 E--NLCQISASNFPSLTHLSIKG-------------------------NTKRLELGTGCL 346
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKLVELPSG-LYLLQRLENLD 239
L NL +LDLS + ++ L+ L L+ + N+ + L + +LE LD
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ RL + +H L+ LNL ++ L
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-17
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 24/223 (10%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLK---FFGNEINLFPSEV-GNLLGLECL---- 119
++ L L + + + L +L+ NE +E LE L
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 120 -QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI 176
++K+ L LK L LS S+L + SE GL L L++
Sbjct: 410 TRLKVKDAQS---PFQNLHLLKVLNLSH-----SLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 177 RYLPPE----IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
+ + L LE L LSF + + LK + + +++N+L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
+ L+L++N ++ + L ++ + +NL+ N L C
Sbjct: 522 HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-15
Identities = 20/107 (18%), Positives = 42/107 (39%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
L + + L NL LDL+ ++ ++ + L +L + N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + L++L ++S+ + L L++L L N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-15
Identities = 42/213 (19%), Positives = 63/213 (29%), Gaps = 38/213 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
NS E L NVL + + R L L +I +
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED----------------- 75
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPE-I 183
L L L+ + L ++E A G K L L I + +
Sbjct: 76 -----TFQSQHRLDTLVLTA-----NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 184 GCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP----SGLYLLQRLENL 238
LE L L N + + + + L L NN + L S L L L
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-L 184
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L+ N + + Q+LN + L
Sbjct: 185 NLNGNDIAGIEPGAFDSAV-FQSLNFGGTQNLL 216
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
+ + + +P + + L+ + N L + + L L LDL+
Sbjct: 10 EKEVNKTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ + H L L L N L+
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIF 95
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-20
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 46/174 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D + G + L DF T C GTP +
Sbjct: 173 D-----SQGH--IVLTDFGLCKENIEHNSTT-------STFC-------------GTPEY 205
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+APEVL Y VD W G +L E+L P+ + E++D I
Sbjct: 206 LAPEVLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 48/190 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 915
E+ +L L H I+++ + E L+ +E V GG + + I
Sbjct: 98 EIGVLLRLSHPNIIKLKE------IFETPT---EISLV-----LELVTGGELFDRIVEKG 143
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
SE + A + + A+ LH I+HRD+K EN+L D +K
Sbjct: 144 YYSE--------RDAADAVKQILEAVAYLHENGIVHRDLKPENLL--YATPAPDAP--LK 191
Query: 976 LCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033
+ DF + + + T C GTP + APE+LR YG EVD+W
Sbjct: 192 IADFGLSKIVEHQVLMKTVC-------------GTPGYCAPEILRGCA----YGPEVDMW 234
Query: 1034 SYGCLLLELL 1043
S G + LL
Sbjct: 235 SVGIITYILL 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 90/314 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK G++ E R + E+++L + H +V + G +K P
Sbjct: 62 VKMLKE-GATHSEHRAL----MSELKILIHIGHHLNVVNLLG--ACTK--------PGGP 106
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
L+ + +E+ K G++ Y + + ++++ + + VA +
Sbjct: 107 LM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L S+ +HRD+ + NIL+ ++ VVK+CDF A R I
Sbjct: 164 LASRKCIHRDLAARNILL------SEKN-VVKICDFGLA--------------RDIYKDP 202
Query: 1004 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-L 1055
V P +WMAPE + +Y ++ D+WS+G LL E+ +L PY G+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 1056 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115
E ++ G R P+ T + C
Sbjct: 259 EFCRRLKEGTR------------------------MRAPD---YTTPEMYQTMLDCWHGE 291
Query: 1116 PTERPTAGDLYEMF 1129
P++RPT +L E
Sbjct: 292 PSQRPTFSELVEHL 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-20
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 34/221 (15%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECL-----QIKIS 124
L L KN ++ + + L L NEI L E L + + +
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 125 SPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
+ + + L+ L L + V PS L+ LT L + + +I +
Sbjct: 446 TRN----SFALVPSLQRLMLRRVALKNVDSSPSPFQ------PLRNLTILDLSNNNIANI 495
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEICY---------LKALISLKVANNKLVELPSGL 229
+ + L LE LDL N + L L L L + +N E+P +
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 230 YL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L L+ +DL N L +L + +L++LNLQ N +
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-19
Identities = 54/233 (23%), Positives = 87/233 (37%), Gaps = 33/233 (14%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-------QIKI 123
L L N LN + S +L N I LF + L + L + I
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 124 SS---PGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTK--LSVCH 173
S P ++ F+ LK L+ L + + + GL L LS
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS--------NMFTGLINLKYLSLSNSF 364
Query: 174 FSIRYLPPEIG---CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG- 228
S+R L E S L L+L+ NK+ + ++ +L L L + N++ + +G
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 229 -LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
L+ + + LS N+ L L+ +LQ L L+ L + PS
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-19
Identities = 53/227 (23%), Positives = 81/227 (35%), Gaps = 37/227 (16%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++ L L N L L + RY +L +L N I+ E
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE----------------- 67
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSIRYLPPE-I 183
KL LK L L L+ LS+ A LT+L + SI+ +
Sbjct: 68 -----LCQKLPMLKVLNLQHNE-----LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPS---GLYLLQRLENLD 239
NL LDLS N + L+ L L ++NNK+ L S ++ L+ L+
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
LS+N++ + L L L +L + +C L
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP--SLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-18
Identities = 45/218 (20%), Positives = 79/218 (36%), Gaps = 21/218 (9%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-----Q 120
+ + ++ + S + L +L N+I + + L+ L+ L
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 121 IKISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
+ + F L L L+K + S + L+ L L +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD-----AFSWLGHLEVL-DLGLNEIG 418
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKL---VELPSGLYL 231
E L N+ ++ LS+NK L + +L L + L PS
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLSNN + ++ L + L+ L+LQ+N L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-17
Identities = 44/230 (19%), Positives = 78/230 (33%), Gaps = 36/230 (15%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L N + + +LK ++ L N QIK SPG
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLK----KLELS----SN-------QIKEFSPG- 189
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG---C 185
+ + L L L+ V PS+ L + LS+ + +
Sbjct: 190 ---CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 186 LSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG----------LYLLQR 234
+NL LDLS+N + + +L L + N + L S L L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+S L + + L++LN++ N + + S + L
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG---IKSNMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-17
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 27/250 (10%)
Query: 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GN 101
+ ++ + L E + S+ L L + L+ + K NL N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 102 EIN-LFPSEVGNLLGLECL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRP 151
+N + L LE I+ +L+ L ++ L L K
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH----SLHGLFNVRYLNLKRSFTKQSISL 314
Query: 152 SVLTLL--SEIAGLKCLTKLSVCHFSIRYLPPEIGC-LSNLEQLDLSFNKMK--YLPTEI 206
+ L + LKCL L++ I + + L NL+ L LS + L E
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 207 CYLKALISLKV---ANNKLVELPSG-LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQN 261
A L + NK+ ++ S L LE LDL N + L + + N+
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 262 LNLQYNKLLS 271
+ L YNK L
Sbjct: 435 IYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-16
Identities = 47/216 (21%), Positives = 78/216 (36%), Gaps = 28/216 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPG 127
L L N L L K+ L L N I + + L L + +SS
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-- 135
Query: 128 VNGFALNKLKGLKELELS-----KVPPRP-SVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+L+ L+EL LS + + S L KL + I+ P
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS-------LKKLELSSNQIKEFSP 188
Query: 182 E-IGCLSNLEQLDLSFNKMKYLPTEI----CYLKALISLKVANNKLVELPSGLYL---LQ 233
+ L L L+ ++ TE ++ +L ++N++L + +L
Sbjct: 189 GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L LDLS N L +G+ + L+ L+YN +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-14
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 139 LKELELSKVPPR-PSVLTLL------------SEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
L+L++VP P+ +T+L + LT L V +I L PE
Sbjct: 11 CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 185 CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
L L+ L+L N++ L + + L L + +N + ++ + + L LDLS+
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+S + NLQ L L NK+
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKI 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-12
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
C + E D S K+ +P ++ + L + +N+L LP+ +L +LD+ N
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
++ L + L+ LNLQ+N+L
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNEL 85
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 56/192 (29%), Positives = 75/192 (39%), Gaps = 50/192 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 915
E+ +LRH IV I + HL AI MEY GG + I
Sbjct: 66 EIINHRSLRHPNIVRFK-EVILTP----------THL---AIIMEYASGGELYERICNAG 111
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ SE A F Q + + + HS I HRD+K EN L+D P +K
Sbjct: 112 RFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLK 158
Query: 976 LCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDI 1032
+CDF ++ L S + GTP ++APEVL Y G D+
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV-------------GTPAYIAPEVLLR----QEYDGKIADV 201
Query: 1033 WSYGCLLLELLT 1044
WS G L +L
Sbjct: 202 WSCGVTLYVMLV 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 836 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK S + + +F + EV + +L H ++ +YG + P
Sbjct: 51 VKCLKPDVLSQPEAMDDF----IREVNAMHSLDHRNLIRLYG--VVL-------TPP--- 94
Query: 895 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
++ + E GS+ + + K + H + A VA + L SK +HRD+
Sbjct: 95 -MK--MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 955 KSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
+ N+L+ + +VK+ DF RA+P + P W
Sbjct: 148 AARNLLL-------ATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVP------FAWC 191
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI-QMGKRPRLT 1070
APE L+ + D W +G L E+ T Q P++GL+ +I I + G+R
Sbjct: 192 APESLKT----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---- 243
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1130
L C P+ + +V +C P +RPT L + +
Sbjct: 244 --LPRPEDC--------------PQD-------IYNVMVQCWAHKPEDRPTFVALRDFLL 280
Query: 1131 ARTSSSISSR 1140
+ + +
Sbjct: 281 EAQPTDMRAE 290
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
+R A +KL DF A S L T C TP ++APEVL
Sbjct: 195 TSKRPNAI----LKLTDFGFAKETTSHNSLTTPC-------------YTPYYVAPEVL-- 235
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 1065
P Y D+WS G ++ LL P+ + I+MG+
Sbjct: 236 --GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 56/194 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
E++ L RH I+++Y IS+ + F MEYV GG + +YI
Sbjct: 61 EIQNLKLFRHPHIIKLY-QVISTP---------------TDFFMVMEYVSGGELFDYICK 104
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++ E A + Q + +A+ H ++HRD+K EN+L+D
Sbjct: 105 HGRVEE--------MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN------- 149
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1030
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 192
Query: 1031 DIWSYGCLLLELLT 1044
DIWS G +L LL
Sbjct: 193 DIWSCGVILYALLC 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 37/155 (23%)
Query: 900 IFMEY-VKGGSVKNYIE---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ +E + + +YI L E + V AA+ HS+ ++HRDIK
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGE--------GPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 956 SENILIDLERKKADGKPVVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
ENILIDL R KL DF A+ GT + P
Sbjct: 167 DENILIDLRRGC------AKLIDFGSGALLHDEPYTDFD-------------GTRVYSPP 207
Query: 1015 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVP 1048
E + + Y L +WS G LL +++ +P
Sbjct: 208 EWISR----HQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-19
Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 850 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 909
R E L E ++L + +V + A + L + + GG
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA----------YAYETKDALCL----VLTLMNGGD 270
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
+K +I + G+ A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 271 LKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-----DH 322
Query: 970 GKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
G +++ D A VP + GT +MAPEV++ Y
Sbjct: 323 GH--IRISDLGLAVHVPEGQTIKGRV-------------GTVGYMAPEVVKNER----YT 363
Query: 1028 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
D W+ GCLL E++ Q P+ + + + +R E
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEE 407
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 2e-19
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D ++G +K+ DF T C GTP +
Sbjct: 476 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 508
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 509 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 97/320 (30%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK +SAD +F E ++ + IV++ G A G P +
Sbjct: 82 VKMLKE-EASADMQADF----QREAALMAEFDNPNIVKLLG--------VCAVGKP---M 125
Query: 896 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 936
+ EY+ G + + ++S G +S L IA+
Sbjct: 126 C---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLS-------------- 221
Query: 997 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1049
R I + D P RWM PE + N Y E D+W+YG +L E+ + PY
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESI----FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1109
G++ E+ ++ G PE L ++ R
Sbjct: 278 YGMAHEEVIYYVRDGNI------------------------LACPE---NCPLELYNLMR 310
Query: 1110 RCTEENPTERPTAGDLYEMF 1129
C + P +RP+ ++ +
Sbjct: 311 LCWSKLPADRPSFCSIHRIL 330
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 60/314 (19%), Positives = 107/314 (34%), Gaps = 95/314 (30%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK + F E + L+H +V + G + +K P
Sbjct: 44 IKTLKD-KAEGPLREEF----RHEAMLRARLQHPNVVCLLG--VVTK------DQP---- 86
Query: 896 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 944
++ Y G + + T + + + + +AA + L
Sbjct: 87 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
S H++H+D+ + N+L+ + VK+ D R + A D
Sbjct: 145 SSHHVVHKDLATRNVLVYDKL-------NVKISDLGLF--------------REVYAADY 183
Query: 1005 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 1054
P RWMAPE + +YG ++ DIWSYG +L E+ + PY G S
Sbjct: 184 YKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1114
++ ++I+ + L C P + + C E
Sbjct: 237 QDVVEMIRNRQV------LPCPDDC--------------PAW-------VYALMIECWNE 269
Query: 1115 NPTERPTAGDLYEM 1128
P+ RP D++
Sbjct: 270 FPSRRPRFKDIHSR 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
AK +KV G+ ++ E+ +L RH I+ ++ S + E
Sbjct: 34 MAKF--VKVKGTDQVLVKK-------EISILNIARHRNILHLHE---------SFESMEE 75
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
++ E++ G + E+++ + + ++ ++ Q V AL LHS +I H
Sbjct: 76 LVMI-----FEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSHNIGHF 126
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DI+ ENI+ + +++ +K+ +F +A L+ G + P +
Sbjct: 127 DIRPENII--YQTRRSS---TIKIIEFGQARQLKP----------GDNFRLLF-TAPEYY 170
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
APEV + H D+WS G L+ LL+ P++ + +I + I +
Sbjct: 171 APEVHQ--HDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 38/233 (16%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL------Q 120
+ + ++L+ N ++ +P + L L N + + L LE L Q
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
++ P + L L L L + L E+ GL L L + +
Sbjct: 93 LRSVDPA----TFHGLGRLHTLHLDR--------CGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-L 232
++ LP + L NL L L N++ +P L +L L + N++ + + L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
RL L L N L++L + L + LQ L L N W+C C
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN---------PWVCDCRAR 244
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
++ +P I + +++ L N++ ++P + L L + +N L + + L
Sbjct: 22 GLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79
Query: 233 QRLENLDLSNN-RLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLS+N +L S+ + L L+L L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 3/82 (3%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGS 250
++ +P I A + + N++ +P+ + L L L +N L + +
Sbjct: 16 TSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 251 LDLCLMHNLQNLNLQYNKLLSY 272
+ L+ L+L N L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRS 95
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 33/168 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 960
MEY GG + ++ + E+ S A F ++ +AL LHS+ +++RD+K EN++
Sbjct: 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 961 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 282 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 321
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
N YG VD W G ++ E++ ++P+ ++ +LI M +
Sbjct: 322 ED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-19
Identities = 48/243 (19%), Positives = 75/243 (30%), Gaps = 26/243 (10%)
Query: 64 RGGDNSVEGLYLYKNVL--NLIPKSVGRYEKLRNLKFFGNEIN-------LFPSEVGNLL 114
GG S+E L + + + L+ L I L + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKV--PPRPSVLTLLSEIAGLKCLTKLSVC 172
L ++++ L L L V R + L L + L LS+
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG-LKVLSIA 157
Query: 173 HFSIRYLP-PEIGCLSNLEQLDLSFNKM---KYLPTEICY--LKALISLKVANNKLVELP 226
++ L LDLS N + L + +C L L + N +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 227 ----SGLYLLQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKLLSYCQVPSWICC 281
+ +L+ LDLS+N L C L +LNL + L VP +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPA 274
Query: 282 NLE 284
L
Sbjct: 275 KLS 277
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 20/190 (10%)
Query: 93 LRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF---ALNKLKGLKELELSK--- 146
LRN+ + + + +E+ L + I+ F + L L+LS
Sbjct: 128 LRNVSW--ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL----SNLEQLDLSFNKMKYL 202
+ R + L L L++ + + L L+ LDLS N ++
Sbjct: 186 LGERGLISALCPL--KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 203 PTEI--CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
+ L SL ++ L ++P GL +L LDLS NRL S D + +
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLKQVPKGL--PAKLSVLDLSYNRLDRNPSPD--ELPQVG 299
Query: 261 NLNLQYNKLL 270
NL+L+ N L
Sbjct: 300 NLSLKGNPFL 309
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-19
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 27/245 (11%)
Query: 68 NSVEGLYLYKNVLNLIPK---SVGRYEKLRNLKFFGNEINLFPS----EVGNLLGLECLQ 120
NS++ + N + L+ + + + L N + S + N L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 121 -IKISSPG----VNGFALNKLKGLKELELSKVPPRPSVLTL----LSEI-----AGLKC- 165
+ +S G + G N + + L + + AGL
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLIL-AHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 166 -LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+ L + H + L + L +L+ L+L++NK+ + E L L L ++ N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 223 VELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281
EL S Y L ++ +DL N + + + LQ L+L+ N L + +PS
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDI 386
Query: 282 NLEGN 286
L GN
Sbjct: 387 FLSGN 391
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-16
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 21/213 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
V + L KN + +I ++ EKL+ L N + + ++ + K+ +
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-IPSIPDIFLSGNKLVTLP 397
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC-- 185
N + L E L + L + + L L + +
Sbjct: 398 KINLTANLIH-LSENRLENLDI-------LYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 186 LSNLEQLDLSFNKMKYLP-TEIC-----YLKALISLKVANNKLVELPSGLYL-LQRLENL 238
+LEQL L N ++ TE+C L L L + +N L LP G++ L L L
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L++NRLT L D L NL+ L++ N+LL+
Sbjct: 510 SLNSNRLTVLSHND--LPANLEILDISRNQLLA 540
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 41/240 (17%), Positives = 77/240 (32%), Gaps = 49/240 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEV-GNLLGLECLQI--- 121
++ L L N +N I + L NL+ N + S L + + +
Sbjct: 291 DLKVLNLAYNKINKIADEA--FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ + L+ L+ L+L L+ I + + + + + LP
Sbjct: 349 HIAI--IQDQTFKFLEKLQTLDLRD--------NALTTIHFIPSIPDIFLSGNKLVTLPK 398
Query: 182 E----------------------IGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKV 217
+ + +L+ L L+ N+ + +L L +
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 218 ANNKLVEL------PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
N L L L+ L L++N L SL + L+ L+L N+L
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-14
Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 17/194 (8%)
Query: 112 NLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLT 167
L E L + I + V + L+ L+ LEL + + LT+ E L L
Sbjct: 22 VLNTTERLLLSFNYIRT--VTASSFPFLEQLQLLELGS---QYTPLTIDKEAFRNLPNLR 76
Query: 168 KLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLV 223
L + I +L P+ L +L +L L F + LKAL L ++ N++
Sbjct: 77 ILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
Query: 224 ELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCLMH--NLQNLNLQYNKLLSYCQVPSWI 279
L L L+++D S+N++ + +L + L +L N L S V
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196
Query: 280 CCNLEGNGKDSSND 293
C N N D
Sbjct: 197 CMNPFRNMVLEILD 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 25/123 (20%), Positives = 52/123 (42%), Gaps = 8/123 (6%)
Query: 165 CLTKLSVCHF-SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+++ F ++ +P L+ E+L LSFN ++ + +L+ L L++ +
Sbjct: 4 FDGRIAFYRFCNLTQVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 223 -VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + + L L LDL ++++ L + +L L L + LS +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG-LSDAVLKDGYF 119
Query: 281 CNL 283
NL
Sbjct: 120 RNL 122
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+E L L +N + I L L+ F N + P+ L L+ L + I
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPP 181
S + +A N++ L+ L+L ++ L+ +SE A GL L L++ ++R +P
Sbjct: 149 ES--IPSYAFNRIPSLRRLDLGELKR----LSYISEGAFEGLSNLRYLNLAMCNLREIP- 201
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLD 239
+ L L++LDLS N + + L L L + +++ + + LQ L ++
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L++N LT L +H+L+ ++L +N W C C++
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN---------PWNCNCDI 297
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 28/216 (12%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+ L L++N + +I + L L+ N I G GL L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI--GAFNGLANLNTLELFDN 122
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-S 175
++++ + A L LKEL L + I + L +L +
Sbjct: 123 RLTT--IPNGAFVYLSKLKELWLRN--------NPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQ 233
+ Y+ LSNL L+L+ ++ +P + L L L ++ N L + G L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L + +++ + + +L +NL +N L
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-16
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECL-----Q 120
N + + L +P + R L N+I + + +L LE L
Sbjct: 42 SNQFSKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
I+ G A N L L LEL L+ I L L +L + +
Sbjct: 100 IRTIEIG----AFNGLANLNTLELFD--------NRLTTIPNGAFVYLSKLKELWLRNNP 147
Query: 176 IRYLPPEI-GCLSNLEQLDLS-FNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLL 232
I +P + +L +LDL ++ Y+ L L L +A L E+P+ L L
Sbjct: 148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPL 206
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+L+ LDLS N L+++ + +LQ L + +++
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 6e-19
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++ + GG + ++ + S F A ++ L +H++ +++RD+K NIL+
Sbjct: 271 LDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
D G V++ D A H GT +MAPEVL+
Sbjct: 326 D-----EHGH--VRISDLGLACDFSKKKPHASV-------------GTHGYMAPEVLQKG 365
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1063
Y D +S GC+L +LL P+ + H++ +M
Sbjct: 366 VA---YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 8e-19
Identities = 53/299 (17%), Positives = 99/299 (33%), Gaps = 78/299 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 368 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 411
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME GG + ++ + + V + V+ + L K+ +HR++
Sbjct: 412 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 464 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 505
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1070
APE + + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 506 YAPECINF----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 557
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+E C P L + C +RP + +
Sbjct: 558 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 72/316 (22%), Positives = 115/316 (36%), Gaps = 93/316 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK + E + E+++L L H IV + G G P
Sbjct: 58 VKMLKP-SAHLTEREAL----MSELKVLSYLGNHMNIVNLLGA--------CTIGGP--- 101
Query: 895 LLQSAIFMEYVKGGSVKNY-------------IEKLSETGEKHVSVKLALFIAQDVAAAL 941
L + EY G + N+ + E E + ++ L + VA +
Sbjct: 102 TL---VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1001
L SK+ +HRD+ + NIL+ R + K+CDF A R I
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLA--------------RDIKN 197
Query: 1002 PDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 1054
V P +WMAPE + +Y E D+WSYG L EL +L PY G+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI----FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 1055 -LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113
+ + +I+ G R PE + + D+ + C +
Sbjct: 254 DSKFYKMIKEGFR------------------------MLSPE---HAPAEMYDIMKTCWD 286
Query: 1114 ENPTERPTAGDLYEMF 1129
+P +RPT + ++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-19
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N L LIP V L L N+I + + +L L+ L++ +
Sbjct: 85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-- 142
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPE 182
++ A + L L++L L K L+ I + L L L + H +I +
Sbjct: 143 ISHRAFSGLNSLEQLTLEK--------CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 183 I-GCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239
L L+ L++S + + Y L SL + + L +P + L L L+
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LS N ++++ L + LQ + L +L
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L + N L I L L + P+E +L GL L++ I
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
Query: 124 SSPGVNGFALNKLKGLKELELSKVP----PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
++ + ++ +L LK LE+S P P+ L L+ LT LS+ H ++ +
Sbjct: 189 NA--IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-------LTSLSITHCNLTAV 239
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLE 236
P + L L L+LS+N + + + L L +++ +L + L L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
L++S N+LT+L + NL+ L L N C C L
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSN---------PLACDCRLL 339
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 48/204 (23%), Positives = 74/204 (36%), Gaps = 22/204 (10%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
R L N I L E + LE L++ +S+ V A N L L+ L L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA--VEPGAFNNLFNLRTLGLRS-- 89
Query: 149 PRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
L I GL LTKL + I L + L NL+ L++ N + Y+
Sbjct: 90 ------NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143
Query: 203 PTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
L +L L + L +P+ L L L L L + + ++ ++ L+
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 261 NLNLQYNKLLSYCQVPSWICCNLE 284
L + + L NL
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLT 227
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-11
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+P I + LDL N++K L + L L++ N + + G L
Sbjct: 22 RFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL 79
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L +NRL + + NL L++ NK+
Sbjct: 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ V +P G+ LDL NR+ +L + +L+ L L N +
Sbjct: 20 RKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 89/312 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK + ADE + E++++ L +H IV + G G P
Sbjct: 81 VKMLKS-TAHADEKEAL----MSELKIMSHLGQHENIVNLLGA--------CTHGGP--- 124
Query: 895 LLQSAIFMEYVKGGSVKNY---------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 945
+L + EY G + N+ + S + L + VA + L
Sbjct: 125 VL---VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1005
SK+ +HRD+ + N+L+ +G V K+ DF A R I
Sbjct: 182 SKNCIHRDVAARNVLL------TNGH-VAKIGDFGLA--------------RDIMNDSNY 220
Query: 1006 VGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG-LSELEI 1057
+ P +WMAPE + +Y ++ D+WSYG LL E+ +L PY G L +
Sbjct: 221 IVKGNARLPVKWMAPESI----FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 1058 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117
+ L++ G + +P + + + C PT
Sbjct: 277 YKLVKDGYQ------------------------MAQPA---FAPKNIYSIMQACWALEPT 309
Query: 1118 ERPTAGDLYEMF 1129
RPT +
Sbjct: 310 HRPTFQQICSFL 321
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 34/162 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1017
D ++G +KL D+ + G+ D C GTP ++APE+L
Sbjct: 144 D-----SEGH--IKLTDY-------------GMCKEGLRPGDTTSTFC-GTPNYIAPEIL 182
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1059
R YG VD W+ G L+ E++ + P+ + + D
Sbjct: 183 RG----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M + GG ++ +I + E A+F + + L LH ++I++RD+K EN+L+
Sbjct: 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG V++ D AV L++ GTP +MAPE+L
Sbjct: 323 D-----DDGN--VRISDLGLAVELKAGQTKTKGYA-------------GTPGFMAPELLL 362
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL----EIHDLIQMGK 1065
Y VD ++ G L E++ + P+ E E+ +
Sbjct: 363 GEE----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 43/217 (19%), Positives = 68/217 (31%), Gaps = 38/217 (17%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF 131
L N L + V + L L N + S L L+C K +
Sbjct: 111 LNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL---- 164
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
+ L L+ S + +T L +++ K L +L+ +I L + L
Sbjct: 165 DVTPQTQLTTLDCSF-----NKITEL-DVSQNKLLNRLNCDTNNITKLD--LNQNIQLTF 216
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL--- 248
LD S NK+ + + L L + N L EL L +L L L +
Sbjct: 217 LDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVST--LSKLTTLHCIQTDLLEIDLT 272
Query: 249 ----------------GSLDLCLMHNLQNLNLQYNKL 269
LD+ L L+ Q +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-17
Identities = 39/171 (22%), Positives = 65/171 (38%), Gaps = 18/171 (10%)
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI 160
+ + FP + N ++ + + + +L L L+ S +T ++ I
Sbjct: 10 SFNDWFPDD--NFASEVAAAFEMQA--TDTISEEQLATLTSLDCHN-----SSITDMTGI 60
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L LTKL +I L + +NL L NK+ L + L L L N
Sbjct: 61 EKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTN 116
Query: 221 KLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
KL +L L L+ + N LT +D+ L L+ NK ++
Sbjct: 117 KLTKLDVSQ--NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT 162
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 37/221 (16%), Positives = 74/221 (33%), Gaps = 32/221 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ L N + + V + + L L N I + + L L K++
Sbjct: 170 TQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLT 225
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHF-SIRYL 179
+ L L + S P ++ LS++ L C L ++ + H + Y
Sbjct: 226 E-----IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280
Query: 180 ---------PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY 230
++ + L LD + L + L+ L + N +L EL +
Sbjct: 281 QAEGCRKIKELDVTHNTQLYLLDCQAAGITELD--LSQNPKLVYLYLNNTELTELD--VS 336
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L++L N + S + + L N + ++
Sbjct: 337 HNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTIT 375
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 33/198 (16%), Positives = 59/198 (29%), Gaps = 20/198 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF 131
L N L I V +L N + S + L L C+Q +
Sbjct: 217 LDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLE-----I 269
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
L L + + L ++ L L I L + L
Sbjct: 270 DLTHNTQLIYFQAEGCRK----IKEL-DVTHNTQLYLLDCQAAGITELD--LSQNPKLVY 322
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L L+ ++ L + + L SL N + + S + + L N + + ++
Sbjct: 323 LYLNNTELTELD--VSHNTKLKSLSCVNAHIQDFSS-VGKIPALNNNFEAEGQTITMPKE 379
Query: 252 DLCLMHNLQNLNLQYNKL 269
L N + + + L
Sbjct: 380 TLTN--NSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 27/194 (13%), Positives = 61/194 (31%), Gaps = 25/194 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
N L + S KL L ++ + + L+ + +
Sbjct: 238 FDCSVNPLTELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL---- 291
Query: 132 ALNKLKGLKELELSK-------VPPRPSVLTL------LSEI--AGLKCLTKLSVCHFSI 176
+ L L+ + P ++ L L+E+ + L LS + I
Sbjct: 292 DVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHI 351
Query: 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
+ +G + L + + +P E +L ++ V+ + L + + + +
Sbjct: 352 QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDG 409
Query: 237 N-LDLSNNRLTSLG 249
D + N +T
Sbjct: 410 GVYDQATNTITWEN 423
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+E L L +N + I L L+ F N + + PS L L+
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA--FEYLSKLRELWLRNN 157
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYL 179
I S + +A N++ L L+L ++ L +SE A GL L L++ +I+ +
Sbjct: 158 PIES--IPSYAFNRVPSLMRLDLGELKK----LEYISEGAFEGLFNLKYLNLGMCNIKDM 211
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
P + L LE+L++S N + L +L L V N+++ + L L
Sbjct: 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L+L++N L+SL + L L+L +N W C C++
Sbjct: 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHN---------PWNCDCDI 308
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 24/214 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+ L L +N + +I L L+ N I L L L++ +
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-SIR 177
+ + A L L+EL L + I + L +L + +
Sbjct: 136 TV--IPSGAFEYLSKLRELWLRN--------NPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 178 YLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRL 235
Y+ L NL+ L+L +K +P + L L L+++ N E+ G + L L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + N++++ + + +L LNL +N L
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-12
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+ +P I SN L+L N ++ + + +L L L++ N + ++ G L
Sbjct: 65 GLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGL 122
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L+L +N LT + S + L+ L L+ N +
Sbjct: 123 ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 42/259 (16%), Positives = 97/259 (37%), Gaps = 24/259 (9%)
Query: 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYL 75
GP+ + + I + DD+ + + + + NS++ +
Sbjct: 1 GPLGSETITVPTPIKQIFS-------DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIA 53
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVNGFA 132
+ + + + + + L GN++ + NL L L + K+ ++
Sbjct: 54 NNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVKD--LSS-- 107
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L LK LK L L + ++ ++ + L L L + + I + + L+ L+ L
Sbjct: 108 LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTL 161
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
L N++ + + L L +L ++ N + +L L L+ L+ L+L + +
Sbjct: 162 SLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPINH 219
Query: 253 LCLMHNLQNLNLQYNKLLS 271
+ + L++
Sbjct: 220 QSNLVVPNTVKNTDGSLVT 238
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 81/307 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
++ +K +S D+ R+F GE+ +L L H I+ + G +
Sbjct: 57 IKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGA--------CEHRGYLY- 102
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
+ +EY G++ ++ ++ + +S + L A DVA +
Sbjct: 103 -----LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L K +HRD+ + NIL+ V K+ DF + R +P
Sbjct: 158 LSQKQFIHRDLAARNILVGENY-------VAKIADFGLS---RGQEVYVKKTMGRLPV-- 205
Query: 1004 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 1062
RWMA E L ++Y D+WSYG LL E+++L PY G++ E+++ +
Sbjct: 206 ------RWMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 1063 MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122
G R LE +C + + D+ R+C E P ERP+
Sbjct: 256 QGYR------LEKPLNC--------------DDE-------VYDLMRQCWREKPYERPSF 288
Query: 1123 GDLYEMF 1129
+
Sbjct: 289 AQILVSL 295
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 6e-18
Identities = 49/236 (20%), Positives = 74/236 (31%), Gaps = 51/236 (21%)
Query: 62 GNRGGDNSVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLF----PSEVGNLL 114
V L L L IP S+ L L G N P + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI--NNLVGPIPPAIAKLT 101
Query: 115 GLECLQIKISSPGVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAG 162
L L I L+++K L L+ S +PP S L L I
Sbjct: 102 QLHYLYI-----THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT- 155
Query: 163 LKCLTKLSVCHFS--IRYLPPEIGCLSNLEQ-LDLSFNKMK-YLPTEICYLKALISLKVA 218
S I P G S L + +S N++ +P L L + ++
Sbjct: 156 ------FDGNRISGAI---PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 219 NNKLV-ELPSGLYLLQRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKL 269
N L + + + + L+ N L +G NL L+L+ N++
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS-----KNLNGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 47/202 (23%), Positives = 75/202 (37%), Gaps = 49/202 (24%)
Query: 83 IPKSVGRYEKLRNLKFFGNEIN---LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
+ + + ++ NL G + PS + NL L L I +N L G
Sbjct: 42 LCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI---------GGINNLVG- 91
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKL--SVCHFS--IRYLPPEIGCLSNLEQLDLS 195
+PP IA L L L + + S I P + + L LD S
Sbjct: 92 ------PIPP---------AIAKLTQLHYLYITHTNVSGAI---PDFLSQIKTLVTLDFS 133
Query: 196 FNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL-ENLDLSNNRLT-----S 247
+N + LP I L L+ + N++ +P +L ++ +S NRLT +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 248 LGSLDLCLMHNLQNLNLQYNKL 269
+L NL ++L N L
Sbjct: 194 FANL------NLAFVDLSRNML 209
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 8e-15
Identities = 51/211 (24%), Positives = 75/211 (35%), Gaps = 47/211 (22%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L N L+ +P S+ L + F GN I+ P G+ L + IS
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF-TSMTISR----- 183
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK--LSVCHFS--IRYLPPEIGCL 186
N+L G K+PP A L L LS G
Sbjct: 184 ---NRLTG-------KIPP---------TFANLN-LAFVDLSRNMLEGDA---SVLFGSD 220
Query: 187 SNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNR 244
N +++ L+ N + L ++ K L L + NN++ LP GL L+ L +L++S N
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 245 LT----SLGSLDLCLMHNLQNLNLQYNKLLS 271
L G+L NK L
Sbjct: 280 LCGEIPQGGNLQ-----RFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 40/202 (19%), Positives = 68/202 (33%), Gaps = 55/202 (27%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKL-RNLKFFGNEIN-LFPSEVGNLLGLECLQI---- 121
++ G+ N ++ IP S G + KL ++ N + P NL L + +
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208
Query: 122 ---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLT-LLSEIAGLKCLTKLSVCH--FS 175
S K +++ L+K + L L ++ K L L + +
Sbjct: 209 LEGDASV------LFGSDKNTQKIHLAK-----NSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 176 --IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLL 232
+ P + L L L++SF N L E+P G L
Sbjct: 258 GTL---PQGLTQLKFLHSLNVSF-----------------------NNLCGEIPQGG-NL 290
Query: 233 QRLENLDLSNNRLTSLGSLDLC 254
QR + +NN+ L C
Sbjct: 291 QRFDVSAYANNKCLCGSPLPAC 312
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 46/168 (27%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D ++G +KL D+ D T C GTP +
Sbjct: 187 D-----SEGH--IKLTDYGMCKEGLRPGDTT-------STFC-------------GTPNY 219
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1059
+APE+LR YG VD W+ G L+ E++ + P+ + + D
Sbjct: 220 IAPEILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ L H ++ ++ + + E L +E++ GG + ++++
Sbjct: 98 EISIMNQLHHPKLINLHD---------AFEDKYEMVL-----ILEFLSGGEL---FDRIA 140
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
K ++ ++ Q L +H I+H DIK ENI+ E KKA VK+ D
Sbjct: 141 AEDYKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKPENIM--CETKKAS---SVKIID 194
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A L T + APE++ +P G D+W+ G L
Sbjct: 195 FGLATKLNP----------DEIVKVTT-ATAEFAAPEIVD--REP--VGFYTDMWAIGVL 239
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGK 1065
LL+ P+ G +LE ++
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-18
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 38/207 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++ + LRH +V ++ + + + E ++ E++ GG + +
Sbjct: 204 EIQTMSVLRHPTLVNLHD---------AFEDDNEMVMI-----YEFMSGGELFEKV--AD 247
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E +S A+ + V L +H + +H D+K ENI+ +R +KL D
Sbjct: 248 EHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-----LKLID 300
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F L GT + APEV KP G D+WS G L
Sbjct: 301 FGLTAHLDP----------KQSVKVTT-GTAEFAAPEVAE--GKP--VGYYTDMWSVGVL 345
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGK 1065
LL+ P+ G ++ E ++
Sbjct: 346 SYILLSGLSPFGGENDDETLRNVKSCD 372
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 54/242 (22%), Positives = 86/242 (35%), Gaps = 58/242 (23%)
Query: 848 EIRNFEYSCLGEVRMLGALRHSCIVEMY----GHKISSKWLPSADGNPEHHLLQSAIFME 903
E S E+ +L L+H ++ + H WL +
Sbjct: 57 EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL----------------LFD 100
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLAL-----FIAQDVAAALVELHSKHIMHRDIKSEN 958
Y + + + I+ + V+L + Q + + LH+ ++HRD+K N
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYLHANWVLHRDLKPAN 158
Query: 959 ILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-A 1013
IL+ E + VK+ D A PL+ D V T W A
Sbjct: 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKPLAD-----------LDPVVVT-FWYRA 203
Query: 1014 PEVL-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1072
PE+L A H Y +DIW+ GC+ ELLT + + E P D+
Sbjct: 204 PELLLGARH----YTKAIDIWAIGCIFAELLTSEPIFHCRQE------DIKTSNPYHHDQ 253
Query: 1073 LE 1074
L+
Sbjct: 254 LD 255
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 1e-17
Identities = 43/289 (14%), Positives = 100/289 (34%), Gaps = 19/289 (6%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
NS++ + + + + + + + L GN++ + NL L L + KI
Sbjct: 43 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIK 100
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
++ L LK LK L L + ++ ++ + L L L + + I + +
Sbjct: 101 D--LSS--LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LS 150
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L+ L L N++ + + L L +L ++ N + +L L L+ L+ L+L +
Sbjct: 151 RLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQE 208
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDV 304
+ + + L++ + + E +F + + +
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPEFTNEVSFIFY 266
Query: 305 YEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWK 353
+ + + + S + + A K
Sbjct: 267 QPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPK 315
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 3e-13
Identities = 25/117 (21%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 155 TLLSEIAGLKCLTKLSVCHFSIRYL--PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
T + +I + + + + L++++Q+ + + +K + I YL +
Sbjct: 9 TPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-QGIQYLPNV 67
Query: 213 ISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + NKL ++ L L+ L L L N++ L SL L++L+L++N +
Sbjct: 68 TKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIKDLSSLKDL--KKLKSLSLEHNGI 121
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 11/81 (13%), Positives = 27/81 (33%), Gaps = 4/81 (4%)
Query: 189 LEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248
+ + +K + I + + + L ++ + +N+ + S+
Sbjct: 1 MGETITVSTPIKQIFP-DDAFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIKSV 58
Query: 249 GSLDLCLMHNLQNLNLQYNKL 269
+ N+ L L NKL
Sbjct: 59 QGIQYL--PNVTKLFLNGNKL 77
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 17/204 (8%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
GL L N + + + K+ L+ GN + S + L ++ L + +I+
Sbjct: 66 IGLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV- 122
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L+ L L + +T +S +AGL L LS+ + + L P + LS
Sbjct: 123 ---TPLAGLSNLQVLYLDL-----NQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLS 173
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
L L NK+ + + L LI + + NN++ ++ S L L + L+N +T+
Sbjct: 174 KLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDV-SPLANTSNLFIVTLTNQTITN 231
Query: 248 LGSLDLCLMHNLQNLNLQYNKLLS 271
+ + ++
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L ++ K S +T A L +T LS + + + L+NL
Sbjct: 13 FPDPALANAIKIAAGK-----SNVTDTVTQADLDGITTLSAFGTGVTTIEG-VQYLNNLI 66
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L N++ L + L + L+++ N L + S + LQ ++ LDL++ ++T +
Sbjct: 67 GLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDVT- 123
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NLQ L L N++
Sbjct: 124 -PLAGLSNLQVLYLDLNQI 141
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 58/194 (29%), Positives = 84/194 (43%), Gaps = 56/194 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
E++ L RH I+++Y IS+ S IF MEYV GG + +YI
Sbjct: 66 EIQNLKLFRHPHIIKLY-QVISTP---------------SDIFMVMEYVSGGELFDYICK 109
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+L E K + + Q + + + H ++HRD+K EN+L+D
Sbjct: 110 NGRLDE--------KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN------- 154
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1030
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 197
Query: 1031 DIWSYGCLLLELLT 1044
DIWS G +L LL
Sbjct: 198 DIWSSGVILYALLC 211
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 57/194 (29%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
E+ L LRH I+++Y I++ + I +EY GG + +YI
Sbjct: 59 EISYLKLLRHPHIIKLY-DVITTP---------------TDIVMVIEYA-GGELFDYIVE 101
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++++E Q + A+ H I+HRD+K EN+L+D
Sbjct: 102 KKRMTE--------DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------- 146
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1030
VK+ DF + + +FL T C G+P + APEV+ LY G EV
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSC-------------GSPNYAAPEVING----KLYAGPEV 189
Query: 1031 DIWSYGCLLLELLT 1044
D+WS G +L +L
Sbjct: 190 DVWSCGIVLYVMLV 203
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 30/182 (16%), Positives = 72/182 (39%), Gaps = 14/182 (7%)
Query: 91 EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149
+ N + N+ +++ +L + I ++ + G + +K+L ++
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTG--IEYAHNIKDLTINN--- 75
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEIC 207
T + I+GL L +L + + P + L++L LD+S + + T+I
Sbjct: 76 --IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 208 YLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
L + S+ ++ N + L L L++L++ + + ++ L L
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQ 191
Query: 268 KL 269
+
Sbjct: 192 TI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 24/148 (16%), Positives = 53/148 (35%), Gaps = 9/148 (6%)
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S + K L + S + A + LT +++ + ++ L I
Sbjct: 11 SQDNVNIPDSTFKAYLNGLLGQ----SSTANI--TEAQMNSLTYITLANINVTDLTG-IE 63
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
N++ L ++ I L L L++ + + L L L LD+S++
Sbjct: 64 YAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ + + +++L YN ++
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAIT 150
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 23/184 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L ++ I ++ + L + + + + ++ L +P
Sbjct: 28 GLLGQSSTANITEA--QMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNYNP- 83
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLT--LLSEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
++ L L+ L + +T + ++GL LT L + H + I
Sbjct: 84 -----ISGLSNLERLRIMG-----KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L + +DLS+N + L L SL + + + + G+ +L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQT 192
Query: 245 LTSL 248
+
Sbjct: 193 IGGK 196
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 50/213 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 914
E+ ++ L H+ ++++Y + + + L MEYV GG + + I
Sbjct: 136 EISVMNQLDHANLIQLYD---------AFESKNDIVL-----VMEYVDGGELFDRIIDES 181
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L+E + + + + +H +I+H D+K ENIL + A +
Sbjct: 182 YNLTE--------LDTILFMKQICEGIRHMHQMYILHLDLKPENIL--CVNRDAK---QI 228
Query: 975 KLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
K+ DF A R L GTP ++APEV+ + D+
Sbjct: 229 KIIDFGLARRYKPREKLKVNF-------------GTPEFLAPEVVN--YDF--VSFPTDM 271
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1065
WS G + LL+ P++G ++ E + I +
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 36/151 (23%), Positives = 52/151 (34%), Gaps = 33/151 (21%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY G E L EK V A + L LHS+ I+H+DIK N+
Sbjct: 85 MVMEYCVCGMQ----EMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140
Query: 960 LIDLERKKADGKPVVKLCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
L+ +K+ T G+P + P
Sbjct: 141 LLTTGGT-------LKISALGVAEALHPFAADDTCRTSQ-------------GSPAFQPP 180
Query: 1015 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLT 1044
E+ + + G +VDIWS G L + T
Sbjct: 181 EIANGLD---TFSGFKVDIWSAGVTLYNITT 208
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 104/324 (32%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK + + E + E++M+ L H IV + G P
Sbjct: 80 VKMLKE-KADSSEREAL----MSELKMMTQLGSHENIVNLLGA--------CTLSGP--- 123
Query: 895 LLQSAIFMEYVKGGSVKNY------------------IEKLSETGEKHVSVKLALFIAQD 936
+ + EY G + NY E ++ + L A
Sbjct: 124 IY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VA + L K +HRD+ + N+L+ + VVK+CDF A
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVKICDFGLA-------------- 219
Query: 997 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1049
R I + V P +WMAPE L +Y ++ D+WSYG LL E+ +L PY
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFE----GIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 1050 MGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLV 1105
G+ + + LIQ G + ++P E+
Sbjct: 276 PGIPVDANFYKLIQNGFK------------------------MDQPFYATEEIY------ 305
Query: 1106 DVFRRCTEENPTERPTAGDLYEMF 1129
+ + C + +RP+ +L
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFL 329
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 45/203 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H I+E+ + HH + + EY + +K Y++K
Sbjct: 83 EVSLLKELQHRNIIEL--KSV------------IHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + + F+ Q + + HS+ +HRD+K +N+L+ + V+K+ D
Sbjct: 128 DVSMRVI----KSFLYQ-LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP--VLKIGD 180
Query: 979 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1033
F RA +P+R F H + T W PE+L Y VDIW
Sbjct: 181 FGLARAFGIPIRQFTHE--------------IIT-LWYRPPEILLGSRH---YSTSVDIW 222
Query: 1034 SYGCLLLELLTLQVPYMGLSELE 1056
S C+ E+L + G SE++
Sbjct: 223 SIACIWAEMLMKTPLFPGDSEID 245
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 57/207 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 916
E+RML L+H +V + + + + EY +V + +++
Sbjct: 52 EIRMLKQLKHPNLVNLL--------------EVFRR--KRRLHLVFEYCDH-TVLHELDR 94
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+H+ VK Q A+ H + +HRD+K ENILI V+KL
Sbjct: 95 YQRGVPEHL-VKS--ITWQ-TLQAVNFCHKHNCIHRDVKPENILIT-----KHS--VIKL 143
Query: 977 CDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 1030
CDF R P + V T RW +PE+L YG V
Sbjct: 144 CDFGFARLLTGPSDYYDDE--------------VAT-RWYRSPELLVGDTQ----YGPPV 184
Query: 1031 DIWSYGCLLLELLTLQVPYM-GLSELE 1056
D+W+ GC+ ELL+ P G S+++
Sbjct: 185 DVWAIGCVFAELLSGV-PLWPGKSDVD 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 57/207 (27%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+++L LRH +V + K +L +F E+V ++ + +E
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYL---------------VF-EFVDH-TILDDLEL 116
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ V V+ ++ Q + + HS +I+HRDIK ENIL+ G VVKL
Sbjct: 117 FPNGLDYQV-VQK--YLFQ-IINGIGFCHSHNIIHRDIKPENILVS-----QSG--VVKL 165
Query: 977 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 1030
CDF R P + V T RW APE+L + YG V
Sbjct: 166 CDFGFARTLAAPGEVYDD--------------EVAT-RWYRAPELLVGDVK----YGKAV 206
Query: 1031 DIWSYGCLLLELLTLQVPYM-GLSELE 1056
D+W+ GCL+ E+ + P G S+++
Sbjct: 207 DVWAIGCLVTEMFMGE-PLFPGDSDID 232
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 52/162 (32%), Positives = 69/162 (42%), Gaps = 15/162 (9%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
L L + S L L +L L + + LT L L L L + H
Sbjct: 36 LHLSENLLYTFSLA----TLMPYTRLTQLNLDR-----AELTKLQVDGTLPVLGTLDLSH 86
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-L 231
++ LP L L LD+SFN++ LP L L L + N+L LP GL
Sbjct: 87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 232 LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+LE L L+NN LT L G L+ + NL L LQ N L +
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLN--GLENLDTLLLQENSLYT 186
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 47/222 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L+L +N+L + Y +L L E+
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-------------------- 71
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
L L L+LS + +L L LT L V + LP L
Sbjct: 72 ----VDGTLPVLGTLDLS----HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
L++L L N++K LP + L L +ANN L ELP+GL L+ L+ L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L ++ G H L L N P W+C C +
Sbjct: 184 LYTIPKGFFGS---HLLPFAFLHGN--------P-WLCNCEI 213
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+++ +++ + LP ++ K L ++ N L + RL L+L
Sbjct: 8 KVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LT L + L L+L +N+L S
Sbjct: 66 ELTKLQVDG--TLPVLGTLDLSHNQLQS 91
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 6e-16
Identities = 34/123 (27%), Positives = 53/123 (43%), Gaps = 31/123 (25%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIA 995
L HS++++HRD+K +N+LI+ +G +KL +F RA +P+R +
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLIN-----RNG--ELKLANFGLARAFGIPVRCYSA----- 160
Query: 996 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 1053
V T W P+VL Y +D+WS GC+ EL P G
Sbjct: 161 ---------EVVT-LWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 1054 ELE 1056
+
Sbjct: 208 VDD 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 6/113 (5%)
Query: 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK 216
+ GL K ++ S+ L LS ++ + + ++ L + + L L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS-QKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELH 69
Query: 217 VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+++N++ +L S L L +LE L ++ NRL +L + L L L N+L
Sbjct: 70 LSHNQISDL-SPLKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 40/202 (19%), Positives = 77/202 (38%), Gaps = 29/202 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L K + + S ++N + I + + L+ L QI SP
Sbjct: 24 QNLGKQSVTDL-VSQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP- 80
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC--LTKLSVCHFSIRYLPPEIGC 185
L L L+EL +++ L + G+ L++L + + +R +
Sbjct: 81 -----LKDLTKLEELSVNR--------NRLKNLNGIPSACLSRLFLDNNELRDTDS-LIH 126
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L NLE L + NK+K + + +L L L + N++ GL L+++ +DL+ +
Sbjct: 127 LKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKC 184
Query: 246 TSLGSLDLCLMHNLQNLNLQYN 267
+ + L N +
Sbjct: 185 V---NEPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
+L G++ S + L+ + L +L + H I L P + L+ LE+L
Sbjct: 37 QKELSGVQNFNGDN-----SNIQSLAGMQFFTNLKELHLSHNQISDLSP-LKDLTKLEEL 90
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
++ N++K L L L + NN+L + L L+ LE L + NN+L S+ L
Sbjct: 91 SVNRNRLKNL--NGIPSACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSIVMLG 147
Query: 253 LCLMHNLQNLNLQYNKL 269
+ L+ L+L N++
Sbjct: 148 --FLSKLEVLDLHGNEI 162
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 40/193 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ ++H +V++ + + D E L + +EYV +V +
Sbjct: 82 ELQIMRIVKHPNVVDLKAF-----FYSNGDKKDEVFLN---LVLEYV-PETVYRASRHYA 132
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + + + L++ Q + +L +HS I HRDIK +N+L+D V+KL D
Sbjct: 133 KLKQTMPMLLIKLYMYQ-LLRSLAYIHSIGICHRDIKPQNLLLDPP------SGVLKLID 185
Query: 979 FDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIW 1033
F A + + +C R+ APE+ A + Y +DIW
Sbjct: 186 FGSAKILIAGEPNVS------------YICS---RYYRAPELIFGATN----YTTNIDIW 226
Query: 1034 SYGCLLLELLTLQ 1046
S GC++ EL+ Q
Sbjct: 227 STGCVMAELMQGQ 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 67/286 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ +H +VE+ G S+DG+ L ++ Y+ GS+ + +
Sbjct: 80 EIKVMAKCQHENLVELLGF--------SSDGD--DLCL---VY-VYMPNGSLLDRL--SC 123
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
G +S + IAQ A + LH H +HRDIKS NIL+D K+ D
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-----EAFTA--KISD 176
Query: 979 FD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
F RA + + R + VGT +MAPE LR + + DI+S+G
Sbjct: 177 FGLARASEKFAQTV---MTSR------I-VGTTAYMAPEALRG----EIT-PKSDIYSFG 221
Query: 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE--LEA-----LGSCHEHEVAQSGS 1089
+LLE++T + L+ + K +E +E + V
Sbjct: 222 VVLLEIITGLPA-VDEHREP-QLLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEA--- 275
Query: 1090 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1135
+ V +C E +RP + ++ T+S
Sbjct: 276 --------------MYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
A+ E+V K + L++ + ++ + + AL HS IMHRD+K N
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTD---YDI----RFYMYE-ILKALDYCHSMGIMHRDVKPHN 160
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
++ID E +K ++L D+ A + R V + R+ PE+L
Sbjct: 161 VMIDHEHRK------LRLIDWGLA---EFYHPGQEYNVR--------VAS-RYFKGPELL 202
Query: 1018 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048
Y +D+WS GC+L ++ + P
Sbjct: 203 VDYQM---YDYSLDMWSLGCMLASMIFRKEP 230
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 42/238 (17%), Positives = 76/238 (31%), Gaps = 50/238 (21%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEVGNLLG-------LECLQI 121
L L N L+ + S ++ L +L F GN L + + + L
Sbjct: 105 LDLSYNYLSNLSSSW--FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 122 KISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
L L+ELE+ P L ++ ++ L +
Sbjct: 163 TKIQRK----DFAGLTFLEELEIDASDLQSYEP--KSL------KSIQNVSHLILHMKQH 210
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLP-TEIC--------YLKALISLKVANNKLVELP 226
L S++E L+L + +E+ ++K+ + L ++
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVM 270
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L + L L+ S N+L S+ + +LQ + L N W C C
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCSCPR 319
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 6/115 (5%)
Query: 161 AGLKCLTKLSV-CHF-SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKV 217
A L C S+ +P + ++ LDLS N++ Y+ L +L +
Sbjct: 26 ASLSCDRNGICKGSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVL 83
Query: 218 ANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+N + + L LE+LDLS N L++L S + +L LNL N +
Sbjct: 84 TSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 46/206 (22%)
Query: 849 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 908
+ + E++++ L H IV + + S + E +L + ++YV
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYV-PE 137
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
+V S + + + L++ Q + +L +HS I HRDIK +N+L+D +
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHSFGICHRDIKPQNLLLDPD---- 192
Query: 969 DGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAM 1020
V+KLCDF R P S+ +C R+ APE+ A
Sbjct: 193 --TAVLKLCDFGSAKQLVRGEPNVSY---------------ICS---RYYRAPELIFGAT 232
Query: 1021 HKPNLYGLEVDIWSYGCLLLELLTLQ 1046
Y +D+WS GC+L ELL Q
Sbjct: 233 D----YTSSIDVWSAGCVLAELLLGQ 254
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 31/218 (14%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QI 121
S + L L N L + + +L+ L EI +L L L I
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 122 KISSPGVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + G + L L++L + + P I LK L +L+V H I
Sbjct: 89 QSLALGA----FSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNLI 136
Query: 177 RYLPPEIGC--LSNLEQLDLSFNKMKYLPTEI-CYLKAL----ISLKVANNKLVELPSGL 229
+ L+NLE LDLS NK++ + L + +SL ++ N + + G
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
+ RL+ L L N+L S+ + +LQ + L N
Sbjct: 197 FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 4/113 (3%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA 218
L L + I+ + LS+L L L+ N ++ L L +L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKL 269
L L + L+ L+ L++++N + S + + NL++L+L NK+
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 3/100 (3%)
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYL-L 232
+R+L L+ LDLS +++ + L L +L + N + L G + L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ L L SL + + + L+ LN+ +N + S+
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ + LDLSFN +++L + L L ++ ++ + G Y L L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ SL G+ +LQ L L S
Sbjct: 88 IQSLALGAFSGL--SSLQKLVAVETNLAS 114
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 49/203 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L L+HS IV++Y + H + + E++ +K ++
Sbjct: 50 EISILKELKHSNIVKLY--------------DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E K F+ Q + + H + ++HRD+K +N+LI+ +G +K+ D
Sbjct: 95 GGLESVT-AKS--FLLQ-LLNGIAYCHDRRVLHRDLKPQNLLIN-----REG--ELKIAD 143
Query: 979 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1033
F RA +P+R + H + T W AP+VL K Y +DIW
Sbjct: 144 FGLARAFGIPVRKYTH--------------EIVT-LWYRAPDVLMGSKK---YSTTIDIW 185
Query: 1034 SYGCLLLELLTLQVPYMGLSELE 1056
S GC+ E++ + G+SE +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 53/205 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ +L L H IV + + H + + E+++ +K +++
Sbjct: 69 EISLLKELHHPNIVSLI--------------DVIHS--ERCLTLVFEFMEK-DLKKVLDE 111
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ +K+ ++ Q + + H I+HRD+K +N+LI+ +DG +KL
Sbjct: 112 NKTGLQDSQ-IKI--YLYQ-LLRGVAHCHQHRILHRDLKPQNLLIN-----SDG--ALKL 160
Query: 977 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 1031
DF RA +P+RS+ H V T W AP+VL K Y VD
Sbjct: 161 ADFGLARAFGIPVRSYTH--------------EVVT-LWYRAPDVLMGSKK---YSTSVD 202
Query: 1032 IWSYGCLLLELLTLQVPYMGLSELE 1056
IWS GC+ E++T + + G+++ +
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 27/195 (13%), Positives = 43/195 (22%), Gaps = 73/195 (37%)
Query: 859 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L + + + H + E+++GGS
Sbjct: 81 RTLRLSRIDKPGVARVLDVVH---------TRAGG-------LVVAEWIRGGS------- 117
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
L E + S A+ Q +AAA H + + + DG V
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-----IDGDVV--- 169
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036
+ P M + DI G
Sbjct: 170 -----------------------------LAYPATMPDANPQD-----------DIRGIG 189
Query: 1037 CLLLELLTLQVPYMG 1051
L LL + P
Sbjct: 190 ASLYALLVNRWPLPE 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 45/126 (35%), Positives = 65/126 (51%), Gaps = 38/126 (30%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RA--VPLRSFLHTCCIA 995
L LH I+HRD+K N+L+D +G V+KL DF ++ P R++ H
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-----ENG--VLKLADFGLAKSFGSPNRAYTH----- 171
Query: 996 HRGIPAPDVCVGTPRWM-APEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM- 1050
V T RW APE+L R YG+ VD+W+ GC+L ELL +VP++
Sbjct: 172 ---------QVVT-RWYRAPELLFGARM------YGVGVDMWAVGCILAELLL-RVPFLP 214
Query: 1051 GLSELE 1056
G S+L+
Sbjct: 215 GDSDLD 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 49/203 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 50 EVSLLKDLKHANIVTL--HDI------------IHTEKSLTLVFEYLDK-DLKQYLDDCG 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
H VKL F+ Q + L H + ++HRD+K +N+LI+ G +KL D
Sbjct: 95 NIINMHN-VKL--FLFQ-LLRGLAYCHRQKVLHRDLKPQNLLIN-----ERG--ELKLAD 143
Query: 979 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1033
F RA +P +++ + V T W P++L Y ++D+W
Sbjct: 144 FGLARAKSIPTKTYDN--------------EVVT-LWYRPPDILLGSTD---YSTQIDMW 185
Query: 1034 SYGCLLLELLTLQVPYMGLSELE 1056
GC+ E+ T + + G + E
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEE 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 48/164 (29%), Positives = 67/164 (40%), Gaps = 44/164 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
E+V ++ Y++K G ++K + Q L LH+ I+HRD+K ENIL+
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIKD--LMRQ-FLRGLDFLHANCIVHRDLKPENILV 153
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEV 1016
+ G VKL DF A R + TP W APEV
Sbjct: 154 T-----SGG--TVKLADFGLA---RIY---------SYQMA----LTPVVVTLWYRAPEV 190
Query: 1017 LRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 1056
L L Y VD+WS GC+ E+ + P G SE +
Sbjct: 191 L-------LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEAD 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-14
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 56/216 (25%)
Query: 849 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 908
IR E + L R L H +V + + + + E L + E+V
Sbjct: 59 IR--EVAVL---RHLETFEHPNVVRL--FDV----CTVSRTDRETKLT---LVFEHVDQ- 103
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
+ Y++K+ E G ++K + Q + L LHS ++HRD+K +NIL+ +
Sbjct: 104 DLTTYLDKVPEPGVPTETIKD--MMFQ-LLRGLDFLHSHRVVHRDLKPQNILVT-----S 155
Query: 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKP 1023
G +KL DF A R + T W APEVL
Sbjct: 156 SG--QIKLADFGLA---RIY---------SFQMA----LTSVVVTLWYRAPEVL------ 191
Query: 1024 NL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
L Y VD+WS GC+ E+ + + G S+++
Sbjct: 192 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-14
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 55/212 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK---GGSVKNYIE 915
E+++L L+H +V + +K P +L+ ++ + G + N +
Sbjct: 66 EIKILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLV-----FDFCEHDLAGLLSNVLV 119
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
K + + K + + L +H I+HRD+K+ N+LI DG V+K
Sbjct: 120 KFTLSEIKR-------VMQM-LLNGLYYIHRNKILHRDMKAANVLIT-----RDG--VLK 164
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNL---- 1025
L DF A R+F + T R W PE+L L
Sbjct: 165 LADFGLA---RAF---------SLAKNSQPNRYTNRVVTLWYRPPELL-------LGERD 205
Query: 1026 YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 1056
YG +D+W GC++ E+ T P M G +E
Sbjct: 206 YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQH 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 60/229 (26%)
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
S E + + ++++ + + VA + L S+ +HRD+ + NIL+ +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--- 230
Query: 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-----P-RWMAPEVLRAMHK 1022
VVK+CDF A R I V P +WMAPE +
Sbjct: 231 ----VVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPETIFD--- 269
Query: 1023 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCH 1080
+Y ++ D+WS+G LL E+ +L PY G+ + E ++ G R + A
Sbjct: 270 -RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPDYTT 322
Query: 1081 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ C P++RPT +L E
Sbjct: 323 PE---------------------MYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 52/207 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ L+H IV + + + H + + E++ +K Y++ +
Sbjct: 53 EISLMKELKHENIVRL--YDV------------IHTENKLTLVFEFMDN-DLKKYMDSRT 97
Query: 919 ETGEKH----VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
VK F Q + L H I+HRD+K +N+LI+ G +
Sbjct: 98 VGNTPRGLELNLVKY--FQWQ-LLQGLAFCHENKILHRDLKPQNLLIN-----KRG--QL 147
Query: 975 KLCDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLE 1029
KL DF RA +P+ +F V T W AP+VL Y
Sbjct: 148 KLGDFGLARAFGIPVNTFSS--------------EVVT-LWYRAPDVLMGSRT---YSTS 189
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSELE 1056
+DIWS GC+L E++T + + G ++ E
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 53/241 (21%), Positives = 82/241 (34%), Gaps = 53/241 (21%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E + + + S+ L A + L LH I+H D+K ENIL+ K G+ +
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-----KQQGRSGI 241
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034
K+ DF + ++T I R AP+V +G YG+ +D+WS
Sbjct: 242 KVIDFGSSCYEHQRVYT-YIQSRFYRAPEVILGAR----------------YGMPIDMWS 284
Query: 1035 YGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEH 1082
GC+L ELLT G E + L+ KR + +
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 1083 EVAQSGSGFEKP-------------------EAELETLSFLVDVFRRCTEENPTERPTAG 1123
GS + +D ++C E +P R T G
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 1124 D 1124
Sbjct: 405 Q 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 36/242 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEK---------LRNLKFFGNEINLFPSEV----GNLL 114
L L L + + +EK + L GN ++
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP-SVLTL----LSEI-----AGLK 164
++ L + S + F K + L + + +
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKL 222
L +L++ I + L++L +L+LS N + + + + L L L ++ N +
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 223 VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC- 280
L +L L L+ L L N+L S+ + +LQ + L N W C
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCS 410
Query: 281 CN 282
C
Sbjct: 411 CP 412
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 33/232 (14%), Positives = 69/232 (29%), Gaps = 31/232 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEV-GNLLGLECL---- 119
++E L L + L+ S ++ L +L+ N I + P+ N+ L
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 120 -QIKISSPGV-NGFALNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
++K F L+ + L + +T L +
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 176 IRYLPPEI----GCLSNLEQL----------DLSFNKMKYLPTEICY---LKALISLKVA 218
+ + + ++ L K + + ++
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+K+ L ++ LE L L+ N + + + +L LNL N L
Sbjct: 284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 30/150 (20%), Positives = 60/150 (40%), Gaps = 14/150 (9%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSN 188
+ ++L+ L+ L++ + + ++ GL L L + + L L+N
Sbjct: 49 SFSRLQDLQFLKVEQQ----TPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLAN 104
Query: 189 LEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVEL-PSGL-YLLQRLENLDLSNN 243
LE L L+ + L L +L L + +N + ++ P+ ++R LDL+ N
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
++ S+ L + L L L
Sbjct: 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 35/149 (23%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 144 LSKVPPRPSVLTLL-------SEI-----AGLKCLTKLSVCHFSIRYLPPEIGC--LSNL 189
L +VP P+ + + +E+ + L+ L L V + + LS+L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 190 EQLDLSFNKMKYLPTEICY-LKALISLKVANNKL--VELPSGLYL-LQRLENLDLSNNRL 245
L L +N+ L T L L L + L L + L LE L L +N +
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 246 TSLGSLDL-CLMHNLQNLNLQYNKLLSYC 273
+ M L+L +NK+ S C
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 43/243 (17%), Positives = 72/243 (29%), Gaps = 52/243 (21%)
Query: 73 LYLYKNVLNL-IPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSP 126
L + + L I + R L LK N+ + L LE L + +
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI--G 184
++G L L+ L L +I+ + P
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDN---------------------------NIKKIQPASFFL 151
Query: 185 CLSNLEQLDLSFNKMKYLPTEICY---LKALISLKVANNKLVELPSGLYL---------L 232
+ LDL+FNK+K + E K L++++ L ++
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSN 292
+ LDLS N + + +Q L + + S N KD N
Sbjct: 212 TSITTLDLSGNGFKESMAKRFF--DAIAGTKIQSLILSNSYNMGSSFGHT---NFKDPDN 266
Query: 293 DDF 295
F
Sbjct: 267 FTF 269
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 66/251 (26%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERKKADGKP 972
+ L T + VS+ L AQ + AL+ L + I+H D+K ENIL+ +
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-----CNPKRS 198
Query: 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032
+K+ DF + L ++ I R +P+V +G P Y L +D+
Sbjct: 199 AIKIVDFGSSCQLGQRIYQY-IQSRFYRSPEVLLGMP----------------YDLAIDM 241
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKR-------------- 1066
WS GC+L+E+ T + + G +E++ ++ +
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 1067 -------------PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113
P LG + + + D+ R +
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG---ESGHTVADYLKFKDLILRMLD 358
Query: 1114 ENPTERPTAGD 1124
+P R
Sbjct: 359 YDPKTRIQPYY 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 67/288 (23%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L ++ L L H IV++ + + +L + MEYV ++
Sbjct: 67 LQIMQDLAVLHHPNIVQLQ-SYFYT---LGERDRRDIYL---NVVMEYV-PDTLHRCCRN 118
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + +F+ Q + ++ LH S ++ HRDIK N+L++ +ADG +
Sbjct: 119 YYRRQVAPPPILIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVN----EADG--TL 171
Query: 975 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLE 1029
KLCDF A P + C + R+ APE+ H Y
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--------------S-RYYRAPELIFGNQH----YTTA 212
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1089
VDIWS GC+ E++ + + G + I + LG + +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-----------VRVLGCPSREVLRKLNP 261
Query: 1090 G-------------FEK--PEAELETLSFLVDVFRRCTEENPTERPTA 1122
+ + L+ D+ + P ER
Sbjct: 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 33/127 (25%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVA 218
+ K L ++ + + I L P+ L +L L L NK+ LP + L +L L +
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
NK+ L + L L L L +N+L ++ + +Q ++L N P
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN--------P- 163
Query: 278 WIC-CNL 283
+IC C+L
Sbjct: 164 FICDCHL 170
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ ++ L N +K +P K L + ++NN++ EL + L+ L +L L N+
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T L + +LQ L L NK+
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINC 118
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 29/138 (21%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-L 209
+VL L L K++ + I + S + ++ L+ N+++ + ++ L
Sbjct: 45 TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGL 104
Query: 210 KALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
++L +L + +N++ + + ++ L + L L +N++T++ G+ D +H+L LNL
Sbjct: 105 ESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD--TLHSLSTLNLLA 162
Query: 267 NKLLSYCQVPSWIC-CNL 283
N + C C L
Sbjct: 163 N---------PFNCNCYL 171
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 18/88 (20%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+L L+ N+ L + L L + +NNK+ ++ G + + + L++N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
RL ++ + +L+ L L+ N++
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRITC 119
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 47/168 (27%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 94 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL- 149
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
K+ + +KL DF G A E
Sbjct: 150 -YTSKRPNAI--LKLTDF------------------GF-------------AKETTG--- 172
Query: 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 1065
Y D+WS G ++ LL P+ + I+MG+
Sbjct: 173 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 64/209 (30%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 143 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 181
Query: 1004 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1059
+ V T R+ APEV+ M Y VDIWS GC++ E++ V + G ++ +
Sbjct: 182 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
Query: 1060 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1095
+ K + E L + + +
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS--FEKLFPDVLFPADSEHNKLKASQ 294
Query: 1096 AELETLSFLVDVFRRCTEENPTERPTAGD 1124
A D+ + + ++R + +
Sbjct: 295 A--------RDLLSKMLVIDASKRISVDE 315
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LH +++HRD+K N+LI+ ++ +K+CDF A R +
Sbjct: 128 LHGSNVIHRDLKPSNLLIN-----SNCD--LKVCDFGLA---RIIDESAADNSEPTGQQS 177
Query: 1004 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1059
V T RW APEV+ K Y +D+WS GC+L EL + + G
Sbjct: 178 GMVEFVAT-RWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 1060 LI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVDVFRR 1110
LI +G P ++L + S E +S + P + + L +R
Sbjct: 234 LIFGIIGT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL----QR 288
Query: 1111 CTEENPTERPTA 1122
+P +R TA
Sbjct: 289 MLVFDPAKRITA 300
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 43/216 (19%), Positives = 78/216 (36%), Gaps = 21/216 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEI-NLFPSEV-GNLLGLECLQI---- 121
+ L L +I K + L ++ N++ + ++V NL L ++I
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCH-FSIRY 178
+ +N A L L+ L +S + + L ++ L + +I
Sbjct: 91 NLLY--INPEAFQNLPNLQYLLISN-----TGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 179 LPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKLVELPSG-LYLLQR 234
+ G L L+ N ++ + L L + NN L ELP+ +
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG 203
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 204 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 239
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 19/112 (16%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 166 LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNK-MKYLPTEI-CYLKALISLKVAN-NK 221
+L +R + +LE++++S N ++ + ++ L L +++ N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 222 LVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ + + L L+ L +SN + L + L++Q N +
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 10/54 (18%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
+K+ E+PS L + L +L + +L+ + + N +L
Sbjct: 18 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 53/318 (16%), Positives = 110/318 (34%), Gaps = 85/318 (26%)
Query: 849 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--------- 899
+ E+ ++ L H I+++ + ++ P +
Sbjct: 40 VLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99
Query: 900 ---------------IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAA 940
+ MEYV ++ ++ +G +S ++I Q + A
Sbjct: 100 HKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS----IYIYQ-LFRA 153
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA---VPLRSFLHTCCIAHR 997
+ +HS I HRDIK +N+L++ + D +KLCDF A +P + C
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSK----DN--TLKLCDFGSAKKLIPSEPSVAYIC---- 203
Query: 998 GIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1056
+ R+ APE+ M Y +D+WS GC+ EL+ + + G + ++
Sbjct: 204 ----------S-RFYRAPEL---MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
Query: 1057 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF------EKPEAELETL------SFL 1104
I ++ +G+ + ++ + + + + S
Sbjct: 250 QLVRI-----------IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 1105 VDVFRRCTEENPTERPTA 1122
+D+ + P R
Sbjct: 299 IDLLEQILRYEPDLRINP 316
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 36/237 (15%), Positives = 66/237 (27%), Gaps = 71/237 (29%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILI------------------DLERKKADGKPVV 974
++ AL L + H D+K ENIL+ + +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIP---------APDVCVGTPRWMAPEVLRAMHKPNL 1025
KL DF A AP+V +
Sbjct: 202 KLIDFGCA----------TFKSDYHGSIINTRQYRAPEVILNLG---------------- 235
Query: 1026 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPR----L 1069
+ + D+WS+GC+L EL T + + +E +++ + +
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295
Query: 1070 TDELEALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124
+ L S + P ++ D + +PT RP+ +
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 156 LLSEIAGLKCLTK---LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
L+ + A + L + + I + L + +D S N+++ L L+ L
Sbjct: 8 LIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRRL 66
Query: 213 ISLKVANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
+L V NN++ + GL L L L L+NN L LG LD L + +L L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 1/89 (1%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLV 71
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+NNR+ +G + +L L L N L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 28/137 (20%), Positives = 48/137 (35%), Gaps = 16/137 (11%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGL----KCLTKLSVCHFSIRYLPPEIGCLSN 188
+EL+L + I L + IR L L
Sbjct: 15 YTNAVRDRELDLRG--------YKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRR 65
Query: 189 LEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRL 245
L+ L ++ N++ + L L L + NN LVEL L L+ L L + N +
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
Query: 246 TSLGSLDLCLMHNLQNL 262
T+ L +++ + +
Sbjct: 126 TNKKHYRLYVIYKVPQV 142
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 69/278 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L RH +V + G + N +L I+ +Y++ G++K ++ S
Sbjct: 85 EIETLSFCRHPHLVSLIGF--------CDERN--EMIL---IY-KYMENGNLKRHLYG-S 129
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ +S + L I A L LH++ I+HRD+KS NIL+ D V K+ D
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITD 182
Query: 979 FD--RAVPLRSFLH--TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 1032
F + H T V GT ++ PE L D+
Sbjct: 183 FGISKKGTELDQTHLST------------VVKGTLGYIDPEYFIKGR------LTEKSDV 224
Query: 1033 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL------GSCHEHEVAQ 1086
+S+G +L E+L + + E+ +L + +LE + + +
Sbjct: 225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK 284
Query: 1087 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124
D +C + +RP+ GD
Sbjct: 285 -----------------FGDTAVKCLALSSEDRPSMGD 305
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 26/130 (20%), Positives = 53/130 (40%), Gaps = 15/130 (11%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKL 222
+L I + + L + L LS N + +I L + +L++ N +
Sbjct: 27 KVELHGMIPPIEKMDATLSTLKACKHLALSTNNI----EKISSLSGMENLRILSLGRNLI 82
Query: 223 VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV------P 276
++ + + LE L +S N++ SL ++ NL+ L + NK+ ++ ++
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSGIEKL--VNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 277 SWICCNLEGN 286
L GN
Sbjct: 141 KLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 30/138 (21%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L+ LK K L LS + + +S ++G++ L LS+ I+ + LE+L
Sbjct: 44 LSTLKACKHLALST-----NNIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEEL 98
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
+S+N++ L SG+ L L L +SNN++T+ G +D
Sbjct: 99 WISYNQIASL------------------------SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 253 -LCLMHNLQNLNLQYNKL 269
L + L++L L N L
Sbjct: 135 KLAALDKLEDLLLAGNPL 152
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 21/112 (18%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 1001
LHS ++HRD+K NIL++ A+ VK+ DF R+ +
Sbjct: 125 LHSGGLLHRDMKPSNILLN-----AECH--VKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 1002 PDVCVGTP--------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
+ P RW APE+L K Y +D+WS GC+L E+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILC 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 46/200 (23%), Positives = 77/200 (38%), Gaps = 56/200 (28%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS +++HRD+K N+ I+ E +K+ DF A R +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLV------LKIGDFGLA--------------RIMDPHY 175
Query: 1004 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1055
+ T +W +P +L + + Y +D+W+ GC+ E+LT + + G EL
Sbjct: 176 SHKGHLSEGLVT-KWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231
Query: 1056 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--------EKPEAELETL-----S 1102
E LI LE++ HE + + S +P L L
Sbjct: 232 EQMQLI-----------LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 1103 FLVDVFRRCTEENPTERPTA 1122
VD + +P +R TA
Sbjct: 281 EAVDFLEQILTFSPMDRLTA 300
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 8e-12
Identities = 37/196 (18%), Positives = 63/196 (32%), Gaps = 7/196 (3%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L L L + H IR L + +LE LD+S N+++ + + +L L ++ N
Sbjct: 74 FLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCP--MASLRHLDLSFN 131
Query: 221 KLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
LP L +L L LS + L L + +H L + + + S
Sbjct: 132 DFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 279 ICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSS 338
N + S M V L+ E+ +
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM--TFLSELTRGP 249
Query: 339 NSRSLTARKSSKQWKR 354
++T + WK
Sbjct: 250 TLLNVTLQHIETTWKC 265
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 39/223 (17%), Positives = 77/223 (34%), Gaps = 36/223 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QIKISS 125
++ V +++ ++ ++ + L S
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG----LKCLTKLSVCHFSIRYLPP 181
+ LK L+ L L + L ++A + L L V S+
Sbjct: 370 FQG----CSTLKRLQTLILQRNG-----LKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
Query: 182 EIGC--LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ C ++ L+LS N + C + L + NN+++ +P + LQ L+ L+
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 240 LSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+++N+L S+ G D +LQ + L N W C
Sbjct: 480 VASNQLKSVPDGVFDRL--TSLQYIWLHDNP---------WDC 511
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLS 241
+ L LS N + L +L L L++++N++ L ++L Q LE LD+S
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 242 NNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+NRL ++ + +L++L+L +N
Sbjct: 109 HNRLQNISCCPMA-----SLRHLDLSFNDFDV 135
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 35/182 (19%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL-----LGLECLQIK 122
S L +NV + + + ++L+ L N + F L + +
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L LS L+ F R LPP
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSS--------------------NMLTGSVF--RCLPP- 450
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
++ LDL N++ +P ++ +L+AL L VA+N+L +P G++ L L+ + L
Sbjct: 451 -----KVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505
Query: 242 NN 243
+N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 28/232 (12%), Positives = 66/232 (28%), Gaps = 21/232 (9%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECLQIKISSPGVN 129
L L N +++P + L L F + L L C+ + + S +
Sbjct: 126 LDLSFNDFDVLPVC-KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSIRYLPPEIGC 185
G L+ L V S+ ++ ++ L+ + + + + L +
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 186 LS-NLEQLDLSFNKMKYLPTEIC------YLKALISLKVANNKLVELPSGLYL------L 232
L+ L+++ ++ + + + L + N + E L
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ L + N + + L + V +
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 15/51 (29%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L +P L R + L LS N ++ L D+ + L+ L L +N++
Sbjct: 40 NRNLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 43/224 (19%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 980
+A + AL LH + H D+K ENIL +K+ +++ DF
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 981 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040
A HT +A R P+V + + D+WS GC+L
Sbjct: 188 SATFDHEH-HTTIVATRHYRPPEVILELG----------------WAQPCDVWSIGCILF 230
Query: 1041 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1088
E + E +I ++ + + G E + G
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK----GGLVWDENSSDG 286
Query: 1089 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 1124
++ L++ L D+ RR E +P +R T +
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS ++HRD+K N+ ++ D + +K+ DF A R +
Sbjct: 142 IHSAGVVHRDLKPGNLAVN-----EDCE--LKILDFGLA--------------RHA-DAE 179
Query: 1004 VC--VGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1060
+ V T RW APEV+ + Y VDIWS GC++ E+LT + + G L+
Sbjct: 180 MTGYVVT-RWYRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235
Query: 1061 I--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDV 1107
I G + ++ L QS + P+A D+
Sbjct: 236 ILKVTGVPGT--EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA--------ADL 285
Query: 1108 FRRCTEENPTERPTAGD 1124
+ E + +R TA
Sbjct: 286 LEKMLELDVDKRLTAAQ 302
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 40/224 (17%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 980
+A + ++ LHS + H D+K ENIL ++ P +K+ DF
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 981 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040
A T ++ R AP+V + + D+WS GC+L+
Sbjct: 183 SATYDDEHHST-LVSTRHYRAPEVILALG----------------WSQPCDVWSIGCILI 225
Query: 1041 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1088
E + E +IQ ++ + E + +G
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH----DRLDWDEHSSAG 281
Query: 1089 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 1124
+ L+ L D+ ++ E +P +R T +
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 64/209 (30%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 180 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 218
Query: 1004 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1059
+ V T R+ APEV+ M Y VDIWS GC++ E++ ++ + G ++ +
Sbjct: 219 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 1060 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1095
+ K LT L + + +
Sbjct: 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQ 331
Query: 1096 AELETLSFLVDVFRRCTEENPTERPTAGD 1124
A D+ + +P +R + D
Sbjct: 332 A--------RDLLSKMLVIDPAKRISVDD 352
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 27/86 (31%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
S LDLS N + L E L L SL +++N L + S + L LDLS+N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +L + L+ L L N +
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHI 124
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 38/165 (23%), Positives = 57/165 (34%), Gaps = 25/165 (15%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCL 186
+ +L L L LS + L +S A + L L + + L + L
Sbjct: 57 EWTPTRLTNLHSLLLSH-----NHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL 111
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG----LYLLQRLENLDLS 241
LE L L N + + + L L ++ N++ P L +L LDLS
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171
Query: 242 NNRLTSLGSLDLCLMHNL--QNLNLQYNKLLSYCQVPSWIC-CNL 283
+N+L L DL + L L N C C L
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNN---------PLECDCKL 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 48/195 (24%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS I+HRD+K N+ ++ D + +K+ DF A +
Sbjct: 148 IHSADIIHRDLKPSNLAVN-----EDCE--LKILDFGLARHTADEM-------------T 187
Query: 1004 VCVGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1061
V T RW APE++ Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 188 GYVAT-RWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243
Query: 1062 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 1109
+G + L+ + S QS + K P A VD+
Sbjct: 244 RLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA--------VDLLE 293
Query: 1110 RCTEENPTERPTAGD 1124
+ + +R TA
Sbjct: 294 KMLVLDSDKRITAAQ 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 48/195 (24%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+H+ I+HRD+K N+ ++ D + +K+ DF A S +
Sbjct: 144 IHAAGIIHRDLKPGNLAVN-----EDCE--LKILDFGLARQADSEMTG------------ 184
Query: 1004 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1061
V T RW APEV+ + Y VDIWS GC++ E++T + + G L+ I
Sbjct: 185 -YVVT-RWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239
Query: 1062 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 1109
G P + ++ L S + EK P A V++
Sbjct: 240 KVTGTPPA--EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA--------VNLLE 289
Query: 1110 RCTEENPTERPTAGD 1124
+ + +R TAG+
Sbjct: 290 KMLVLDAEQRVTAGE 304
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218
A ++ L L C + + NLE L L + + + L L L+++
Sbjct: 22 TPAAVRELV-LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-LPKLPKLKKLELS 79
Query: 219 NNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
N++ L L L +L+LS N+L + +L+ L + L++L+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L L K E L L + N L+ + S L L +L+ L+LS N
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSEN 81
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC------NLEGN 286
R+ + + NL +LNL NKL + +L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 32/131 (24%), Positives = 56/131 (42%), Gaps = 8/131 (6%)
Query: 136 LKGLKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
++EL L + L +E L LS+ + + + + L L++L+L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAE---FVNLEFLSLINVGLISVSN-LPKLPKLKKLEL 78
Query: 195 SFNK-MKYLPTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSL 251
S N+ L L L L ++ NKL ++ + L L+ L++LDL N +T+L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY 138
Query: 252 DLCLMHNLQNL 262
+ L L
Sbjct: 139 RESVFKLLPQL 149
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 22/117 (18%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 1001
+H I+HRD+K N L++ D VK+CDF R + +
Sbjct: 145 IHESGIIHRDLKPANCLLN-----QDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 1002 PDVCVGTPRWM----------APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048
+ + APE++ Y +DIWS GC+ ELL +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 45/232 (19%), Positives = 72/232 (31%), Gaps = 65/232 (28%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPA 1001
+HS I+HRD+K N L++ D VK+CDF R V ++
Sbjct: 172 VHSAGILHRDLKPANCLVN-----QDCS--VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 1002 PDVCVGTP--------------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046
++ RW APE++ Y +D+WS GC+ ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN---YTEAIDVWSIGCIFAELLNMI 281
Query: 1047 VP----------------YMGLSELEIHDLIQMGKRPRLTDEL----EALGSCHEHEVAQ 1086
LS + D+L LG+ E ++
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 1087 SGSGFEKPEAELETLSF-----LVDVFRRCTEE-----------NPTERPTA 1122
E + + L + F + + NP +R T
Sbjct: 342 LEK--EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL-L 232
+ ++P ++ L++S N + L ++I L L L +++N++ L ++
Sbjct: 11 GLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN 68
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
Q LE LDLS+N+L + NL++L+L +N +
Sbjct: 69 QELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDA 104
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 40/179 (22%), Positives = 75/179 (41%), Gaps = 13/179 (7%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
+ ++ + +L F N + E G+L LE L + ++
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
++K L++L++S+ ++ + L + S L I CL
Sbjct: 365 KIAEMTTQMKSLQQLDISQNS-----VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 187 -SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
++ LDL NK+K +P ++ L+AL L VA+N+L +P G++ L L+ + L N
Sbjct: 420 PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 42/226 (18%), Positives = 70/226 (30%), Gaps = 36/226 (15%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L + +N + L + KLR L N I V
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV----------------- 64
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGC 185
+ L+ L+LS + L +S L L + + LP E G
Sbjct: 65 -----FKFNQELEYLDLSH-----NKLVKIS-CHPTVNLKHLDLSFNAFDALPICKEFGN 113
Query: 186 LSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYL----LQRLENLDL 240
+S L+ L LS ++ I +L L V E L + L +
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+N + + + + NL+ N++ + C I L+ N
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 36/241 (14%), Positives = 73/241 (30%), Gaps = 44/241 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF- 131
L L L + + + E + L + I P F
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 132 -----ALNKLKGLKELELSKVPPR---PSVLTLLSEIAGLKCLTKLSVCHFSIRYL---- 179
++ + L+ + V L++L+++ L+ L++ + +
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEI------CYLKALISLKVANNKLVELPSGLYL-- 231
++ + + +S K++ LKAL +V ++ S +Y
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 232 -----------------------LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
+ +LD SNN LT + + L+ L LQ N+
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 269 L 269
L
Sbjct: 360 L 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 13/51 (25%), Positives = 28/51 (54%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+ +P L Q+ L++S N ++ L + D+ + L+ L + +N++
Sbjct: 9 KNGLIHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L N L+ +P + +L L+ L L +++ G+ F
Sbjct: 42 LDLQSNKLSSLPSKA--FHRLTKLRL---------------LYLNDNKLQTLPAGI--F- 81
Query: 133 LNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
+LK L+ L ++ +P L L +L + ++ LPP + L
Sbjct: 82 -KELKNLETLWVTDNKLQALPIG--------VFDQLVNLAELRLDRNQLKSLPPRVFDSL 132
Query: 187 SNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
+ L L L +N+++ LP + L +L L++ NN+L +P G + L L+ L L NN+
Sbjct: 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 245 LTSLGSLDLCLMHNLQNLNLQYN 267
L + + L+ L LQ N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
++ ++LDL NK+ LP++ L L L + +NKL LP+G++ L+ LE L +++N+
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +L + NL L L N+L S
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLKS 123
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 29/105 (27%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LH ++HRD+ NIL+ + + +CDF+ A R A
Sbjct: 150 LHEAGVVHRDLHPGNILLA-----DNND--ITICDFNLA--------------REDTADA 188
Query: 1004 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
V RW APE++ + VD+WS GC++ E+
Sbjct: 189 NKTHYVTH-RWYRAPELVMQFKG---FTKLVDMWSAGCVMAEMFN 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 49/226 (21%)
Query: 926 SVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984
+ I++ + L +H + I+H DIK EN+L+++ + +K+ D A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNA-- 185
Query: 985 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044
C + T + +PEVL +G DIWS CL+ EL+T
Sbjct: 186 --------CWYDEHYTNS---IQTREYRSPEVLLGAP----WGCGADIWSTACLIFELIT 230
Query: 1045 LQVPYMGLSELEI------------------HDLIQMGKRPRL--TDELEALGSCHE--- 1081
+ L++ GK R
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 1082 --HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
+V F K EA+ + D + +P +R AG L
Sbjct: 291 PLEDVLTEKYKFSKDEAKE-----ISDFLSPMLQLDPRKRADAGGL 331
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 32/207 (15%), Positives = 71/207 (34%), Gaps = 25/207 (12%)
Query: 93 LRNLKFFGNEINLFPSEV-GNLLGLECLQI----KISSPGVNGFALNKLKGLKELELSKV 147
+ LK + PS NL + + + + + + L + +E+
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ--LESHSFYNLSKVTHIEIRNT 90
Query: 148 PPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEIGC--LSNLEQLDLSFN-KMKYL 202
LT + A L L L + + ++ P L+++ N M +
Sbjct: 91 RN----LTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 203 PTEICY--LKALISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--GSLDLCLMH 257
P ++LK+ NN + + +L+ + L+ N LT + + +
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG-GVYS 205
Query: 258 NLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++ + + +PS +L+
Sbjct: 206 GPSLLDVSQTSVTA---LPSKGLEHLK 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 20/110 (18%), Positives = 44/110 (40%), Gaps = 7/110 (6%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA-NNKLV 223
V I+ +P + + L L ++ +P+ L + + V+ + L
Sbjct: 13 EEDFRVTCKDIQRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 224 ELPSGLYL-LQRLENLDLSNNR-LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L S + L ++ ++++ N R LT + L + L+ L + L
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+HS +++HRD+K N+L++ +K+CDF A R
Sbjct: 144 IHSANVLHRDLKPSNLLLN-----TTCD--LKICDFGLA--------------RVADPDH 182
Query: 1004 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1055
V T RW APE++ Y +DIWS GC+L E+L+ + + G L
Sbjct: 183 DHTGFLTEYVAT-RWYRAPEIMLNSKG---YTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 1056 EIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVD 1106
+ + I +G + ++L + + S K P A+ + L L
Sbjct: 239 DQLNHILGILGSPSQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL-- 294
Query: 1107 VFRRCTEENPTERPTA 1122
+ NP +R
Sbjct: 295 --DKMLTFNPHKRIEV 308
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 4/107 (3%)
Query: 163 LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
+K L L + L LE L + + + L L L++++N++
Sbjct: 19 VKELV-LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRV 76
Query: 223 VELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
L L +L+LS N++ L +++ L + NL++L+L
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
S++++L L ++ E + L L N L + + L L +L+ L+LS+N
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDN 74
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
R++ + NL +LNL NK+
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 31/127 (24%), Positives = 56/127 (44%), Gaps = 6/127 (4%)
Query: 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198
+KEL L R + L + L LS + + + + L+ L++L+LS N+
Sbjct: 19 VKELVLDNS--RSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-LPKLNKLKKLELSDNR 75
Query: 199 MKYLPTEIC-YLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCL 255
+ + L L ++ NK+ +L + L L+ L++LDL N +T+L +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135
Query: 256 MHNLQNL 262
L L
Sbjct: 136 FKLLPQL 142
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 9/125 (7%)
Query: 154 LTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYL 209
L LS+ GL LT L++ + ++ L + L+ L L L+ N++ LP + +L
Sbjct: 47 LATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHL 106
Query: 210 KALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
L L + N+L LPSG++ L +L+ L L+ N+L S+ G+ D + NLQ L+L
Sbjct: 107 TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD--KLTNLQTLSLST 164
Query: 267 NKLLS 271
N+L S
Sbjct: 165 NQLQS 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 26/165 (15%)
Query: 116 LECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLS 170
+ ++ N ++ V L + L L +S
Sbjct: 24 ANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLHDIS 79
Query: 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGL 229
L+NL L L+ N+++ LP + L L L + N+L LP G+
Sbjct: 80 ALK-----------ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV 128
Query: 230 Y-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ L L L+L++N+L SL G D + NL L+L YN+L S
Sbjct: 129 FDKLTNLTYLNLAHNQLQSLPKGVFD--KLTNLTELDLSYNQLQS 171
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L + T+ L ++ + N+ + + G+ L + L L N
Sbjct: 16 DAFAETIKANLKKKSVTDAVTQN-ELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGN 73
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L + +L + NL L L N+L S
Sbjct: 74 KLHDISALK--ELTNLTYLILTGNQLQS 99
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSP 126
L K + + + + ++I + N+ L K+
Sbjct: 20 ETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI 78
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI- 183
L +L L L L+ + L L L L +L + ++ LP +
Sbjct: 79 SA----LKELTNLTYLILTG-----NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
L+NL L+L+ N+++ LP + L L L ++ N+L LP G++ L +L++L L
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLY 189
Query: 242 NNRLTSL--GSLDLCLMHNLQNL 262
N+L S+ G D L +L
Sbjct: 190 QNQLKSVPDGVFD-----RLTSL 207
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 50/254 (19%), Positives = 72/254 (28%), Gaps = 64/254 (25%)
Query: 929 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLE-----------------RKKADG 970
I Q V L LH+K I+H DIK ENIL+ +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV------------CVGTPRWMAPEVLR 1018
V L + L + D+ + T ++ + EVL
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----LIQM----GKRP--- 1067
Y DIWS C+ EL T + S E + + GK P
Sbjct: 267 GSG----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 1068 ----RLTDE----------LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113
+ + E + L EV + + EA D E
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG-----FTDFLLPMLE 377
Query: 1114 ENPTERPTAGDLYE 1127
P +R TA +
Sbjct: 378 LIPEKRATAAECLR 391
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRL 245
++ +L L N+ +P E+ K L + ++NN++ L + + + +L L LS NRL
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 246 TSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ + D + +L+ L+L N +
Sbjct: 91 RCIPPRTFD--GLKSLRLLSLHGNDISV 116
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVEL 225
T+L + +P E+ +L +DLS N++ L + + L++L ++ N+L +
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 226 PSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYC 273
P + L+ L L L N ++ + G+ + L +L + N L YC
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL--SALSHLAIGANPL--YC 140
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 74/314 (23%), Positives = 113/314 (35%), Gaps = 88/314 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + E F EV M+ H ++ + G L
Sbjct: 59 VKRLKEERTQGGE-LQF----QTEVEMISMAVHRNLLRLRGF--------CMTPT--ERL 103
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHR 952
L ++ Y+ GSV + + + E + + IA A L LH I+HR
Sbjct: 104 L---VY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 953 DIKSENILID--LERKKAD-GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
D+K+ NIL+D E D G + KL D+ + + T V GT
Sbjct: 159 DVKAANILLDEEFEAVVGDFG--LAKLMDYK-----DTHVTT-----------AV-RGTI 199
Query: 1010 RWMAPEVLRAMH-----KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----- 1059
+APE K D++ YG +LLEL+T Q + D
Sbjct: 200 GHIAPEY--LSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 1060 ----LIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1114
L++ K L D +L+ G+ + EV Q L+ V CT+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQ-----------------LIQVALLCTQS 291
Query: 1115 NPTERPTAGDLYEM 1128
+P ERP ++ M
Sbjct: 292 SPMERPKMSEVVRM 305
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + + SVK A+ + A + +H K +++RDIK +N LI K +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM--I 150
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 1030
+ DF + + H IP + GT R+M+ H G E
Sbjct: 151 YVVDFGMV---KFYRDPVTKQH--IPYREKKNLSGTARYMS----INTHL----GREQSR 197
Query: 1031 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1073
D+ + G + + L +P+ GL + + ++ I K+ EL
Sbjct: 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + S+K L +A + + + +HSK+ +HRD+K +N L+ L +K +V
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK----GNLV 147
Query: 975 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 1030
+ DF A R+ H ++ + GT R+ + H G+E
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNL------TGTARYAS----INTHL----GIEQS 193
Query: 1031 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1073
D+ S G +L+ +P+ GL ++ + ++ I K + L
Sbjct: 194 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 45/212 (21%), Positives = 76/212 (35%), Gaps = 36/212 (16%)
Query: 93 LRNLKFFGNEIN------LFPSEVGNLLGLECLQI---KISSPGVN--GFALNKLKGLKE 141
L+ L N + L + LE LQ+ +S+ L KE
Sbjct: 115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174
Query: 142 LELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLD 193
L +S + + +L + L+ L KL C + R L + ++L +L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEAL-KLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 194 LSFNK-----MKYL-PTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
L NK M L P + L +L + + +L L + L+ L L+
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 243 NRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
N L G+ LC L+ L++L ++
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 25/162 (15%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL--------SVCHFSIRYLPPEI 183
L L L+EL LS + L LL E L +L S+ S L +
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCE-GLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 184 GCLSNLEQLDLSFNK-----MKYLPTEICYLKA-LISLKVANNKL-----VELPSGLYLL 232
+ ++L +S N ++ L + L +LK+ + + +L +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 233 QRLENLDLSNNRLTSLGSLDLCLM-----HNLQNLNLQYNKL 269
L L L +N+L +G +LC L+ L + +
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-06
Identities = 38/168 (22%), Positives = 55/168 (32%), Gaps = 33/168 (19%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSI-----RYLP 180
L + LKEL L+ LL E L L L V S +
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCE--TLLEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 181 PEIGCLSNLEQLDLSFNKM---------KYLPTEICYLKALISLKVANNKLVE-----LP 226
+ L +L +S N++ + L L+ L +A+ + + L
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR---VLWLADCDVSDSSCSSLA 391
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
+ L L LDLSNN L G L L + L+ L L
Sbjct: 392 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 36/144 (25%)
Query: 139 LKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLDL 194
++ L++ LL + + + +L C + + + + L +L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVV-RLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 195 SFNK-----MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
N+ + + L L+ + K+ + L L N LT G
Sbjct: 64 RSNELGDVGVHCV---------LQGLQTPSCKI-------------QKLSLQNCCLTGAG 101
Query: 250 SLDLCLM----HNLQNLNLQYNKL 269
L LQ L+L N L
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLL 125
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 12/95 (12%)
Query: 187 SNLEQLDLSFNKMKYLP-TEIC-YLKALISLKVANNKL-----VELPSGLYLLQRLENLD 239
+++ LD+ ++ E+ L+ +++ + L ++ S L + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 240 LSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L +N L +G + L +Q L+LQ L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 97
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 29/162 (17%), Positives = 54/162 (33%), Gaps = 9/162 (5%)
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEI- 206
R L L + G + LT+L + + +++L + L L L + + ++++ +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 207 CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
+ L L ++ N L L L+ L LS N L C + LQ +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH----CS-CALRWLQRWEEEG 131
Query: 267 NKLLSYCQVPSWICCNLEGNGKDS-SNDDFISSSAEMDVYEG 307
+ ++ L S V G
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVG 173
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 6e-08
Identities = 92/647 (14%), Positives = 172/647 (26%), Gaps = 209/647 (32%)
Query: 393 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 452
D S EE II D L LF
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTL--------RLFWT-------------------- 70
Query: 453 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 512
L S +E + + K + + +
Sbjct: 71 LLSKQEEMVQK----------FVEEVLRINYKFLMSPIKTEQR-----QPSMMTRMYIEQ 115
Query: 513 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG--YEQTPHLDSREVIL 570
R + N +Q ++ Y+ R +P+++L E P + +L
Sbjct: 116 RDRL---YNDNQVFAK--------------YNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 571 VDR-----KSDEELDAIALSAQALV---------LHLKQLNGLTKDGVIEPVDNLQIALL 616
+D K+ + + + L+LK N + + V+E + L
Sbjct: 155 IDGVLGSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCN--SPETVLEMLQKL----- 205
Query: 617 LALFVSDHFGGSDRSG--------IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 668
L + SD S I R+ + Y +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----------------- 248
Query: 669 ILDAVEDI-VLS--DL-C-------EKSLRSIKSKRNSVVVPIGSVQFGVCRH--RAVLL 715
+L V++ + +L C K + S + + + + +++LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 716 KYLCDRVE--PPVPC-----------ELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDAC 761
KYL R + P E +R L + W + K + I ++
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVL 366
Query: 762 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDE--AGKSVS 819
P + R+ ++ ++ F S H P L F + S K
Sbjct: 367 EPAEYRK------------MFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 820 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879
SL + K T+ + + E + H IV+ Y I
Sbjct: 414 YSL-------VEKQPKESTISI----PSIYLELKVKLENEYAL-----HRSIVDHY--NI 455
Query: 880 SSKWLPSADGNPE----------HHLLQ----------SAIFMEYVKGGSVKNYIE-KLS 918
+ P HHL +F+++ ++E K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFLEQKIR 508
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965
+ L Q ++ + +I D K E ++ +
Sbjct: 509 HDSTAWNASGSILNTLQQ-----LKFYKPYICDNDPKYERLVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 1e-05
Identities = 104/643 (16%), Positives = 190/643 (29%), Gaps = 203/643 (31%)
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
P + +EQ D +N + + L+ + L+ L+EL +L
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLELRPAKNVL 154
Query: 233 QRLENLDLSNNRLTSLGS------LDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
++ + LGS LD+CL + +Q ++ W+ NL
Sbjct: 155 --IDGV---------LGSGKTWVALDVCLSYKVQCKM--------DFKI-FWL--NL--- 189
Query: 287 GKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTAR 346
+S + + ML+ + T S +S ++ R
Sbjct: 190 KNCNSPETVLE-----------MLQK------------LLYQIDPNWTSRSDHSSNIKLR 226
Query: 347 KSS-KQWKRHHLQQRARQERL------NNSRKWRG-EGHAQ---TSMKEGQRYKSGNLDA 395
S + R L+ + + L N++ W + T+ R+K D
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT-----RFKQ-VTDF 280
Query: 396 LASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLES 455
L++ T + I LD L E ++LL D + + L E +
Sbjct: 281 LSAATTTH-----ISLDHHSMTLT--PDEVKSLLLKYLDCRPQD---LPREVLTTNPR-- 328
Query: 456 TGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV-CKTKRHS-DRDLDNPKPCKSR 513
LS + +D ++ +N K V C + L+ +P + R
Sbjct: 329 ---------------RLSII-AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 514 KSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGY-EQTPHLDSREVI--- 569
+ + S+ P A P + L+ D V+
Sbjct: 373 ----------KMFDR---LSV---FPP---SA--HIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 570 ----LVDRKSDEE--------LDAIALSAQALVLH---LKQLNGLTK----DGVIEPVDN 610
LV+++ E L+ LH + N D + +D
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
Query: 611 LQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCT--CSTGNSDSANTSQKQ 668
+ H + + R ++R F+ + +A+ S
Sbjct: 472 Y-----FYSHIGHHLKNIEHPERMTLFRMVFL--DFR--FLEQKIRHDSTAWNASGS--- 519
Query: 669 ILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPC 728
IL+ ++ L+ K Y+CD P
Sbjct: 520 ILNTLQQ----------LKFYK-------------------------PYICD--NDPKYE 542
Query: 729 ELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD-IREEA 770
LV LDF P ++ K +R+ + A + I EEA
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRIALMA--EDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 69/519 (13%), Positives = 139/519 (26%), Gaps = 179/519 (34%)
Query: 576 DEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVE 635
D E + ++ + + + V ++ ++L + D V
Sbjct: 8 DFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA---VS 62
Query: 636 RTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD---LCEKSLRSIKSK 692
T + F S + VE+++ + L IK++
Sbjct: 63 GTLRL---------FWTLLSKQEE--------MVQKFVEEVLRINYKFLMSP----IKTE 101
Query: 693 RNSVVVPIGSVQFGVCRHRA-----VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 747
+ + + + R R V KY R++P + +L + L+ +P +L+
Sbjct: 102 QRQPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKN--VLI 155
Query: 748 K----KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAP---------FSTESDH 794
G +W + +D C + ++ + D + F ++ L +P + D
Sbjct: 156 DGVLGSGKTW--VALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 795 SPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL----KVCGSSADEIR 850
+ S D S L + ++ L + K L V +A
Sbjct: 212 NWTSRSDHSSNIKLRI--HSIQAELRRLLKSK-------PYENCLLVLLNVQ--NAKAWN 260
Query: 851 NFEYSCLGEVRML--------------GALRHSCIVEM-------YGHKISSKW------ 883
F SC ++L H + + K+
Sbjct: 261 AFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 884 -LPS--ADGNPEHHLLQSAIFMEYVKGG-----------------SVKNYIEKLSETGEK 923
LP NP + +I E ++ G +++ + L +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 924 HVSVKLALF-----I----------------AQDVAAALV-------------------- 942
+ +L++F I V L
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 943 -----------ELHSKHIMHRDIKSENILIDLERKKADG 970
LH + H +I DL D
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 38/110 (34%), Positives = 62/110 (56%), Gaps = 7/110 (6%)
Query: 167 TKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVE 224
T L + S++ LP + L++L QL L NK++ LP + L +L L ++ N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 225 LPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LP+G++ L +L+ L L+ N+L SL G D + L++L L N+L S
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDK--LTQLKDLRLYQNQLKS 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L LT+L + ++ LP + L++L L+LS N+++ LP + L L L +
Sbjct: 50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT 109
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
N+L LP G++ L +L++L L N+L S+ G D + +LQ + L N
Sbjct: 110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD--RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I + LDL N +K LP + L +L L + NKL LP+G++ L L
Sbjct: 23 PTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N+L SL G D + L+ L L N+L S
Sbjct: 81 LNLSTNQLQSLPNGVFDK--LTQLKELALNTNQLQS 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 17/87 (19%), Positives = 40/87 (45%), Gaps = 7/87 (8%)
Query: 190 EQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLT 246
+L L+ N++ + ++ + L L+ L++ N+L + + ++ L L N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 247 SL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ +H L+ LNL N++
Sbjct: 92 EISNKMFL--GLHQLKTLNLYDNQISC 116
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + ++ S+K L IA + + + +HSK++++RD+K EN LI K +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV--I 149
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 1030
+ DF A + ++ H IP + GT R+M+ H G E
Sbjct: 150 HIIDFALA---KEYIDPETKKH--IPYREHKSLTGTARYMS----INTHL----GKEQSR 196
Query: 1031 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1073
D+ + G + + L +P+ GL + E + I KR + L
Sbjct: 197 RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + +S+K L +A + + +HSK +HRDIK +N L+ L R+ V
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQV 145
Query: 975 KLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 1030
+ DF A R + H ++ + GT R+ + H G+E
Sbjct: 146 YIIDFGLAKKYRDTSTHQHIPYRENKNL------TGTARYAS----VNTHL----GIEQS 191
Query: 1031 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1073
D+ S G +L+ L +P+ GL ++ + ++ I K + L
Sbjct: 192 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L L +L + + LP + L+ L LDL N++ LP+ + L L L +
Sbjct: 62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
NKL ELP G+ L L +L L N+L S+ G+ D + +L + L N
Sbjct: 122 NKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFD--RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I +N + L L N++ L L L L + +N+L LP G++ L +L
Sbjct: 35 PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LDL N+LT L D + +L+ L + NKL
Sbjct: 93 LDLGTNQLTVLPSAVFDR--LVHLKELFMCCNKLTE 126
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 31/169 (18%), Positives = 60/169 (35%), Gaps = 27/169 (15%)
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++K+ E K S K L ++ + L +H +H DIK+ N+L++ +
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-----Q 192
Query: 974 VKLCDFDRAVPLRSFLHTCCIAHRGIP-APDVC-VGTPRWMAPEVLRAMHKPNLYGLEV- 1030
V L D+ A + H+ P C GT + + H G+
Sbjct: 193 VYLVDYGLA---YRYCPEGV--HKAYAADPKRCHDGTIEFTS----IDAHN----GVAPS 239
Query: 1031 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1073
D+ G +++ LT +P+ + I+ + +
Sbjct: 240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 31/168 (18%)
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
L + + +S + L +A + AL LH +H ++ +ENI +D E + V L
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-----QVTL 202
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVC----VGTPRWMAPEVLRAMHKPNLYGLEV-- 1030
+ A + C + + + + G +++ +HK G
Sbjct: 203 AGYGFA---FRY----CPSGKHVAYVEGSRSPHEGDLEFIS----MDLHK----GCGPSR 247
Query: 1031 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1073
D+ S G +L+ L +P+ +E + + +P
Sbjct: 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP 295
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
S+ +L+L NK++ LP + L L L ++ N++ LP G++ L +L L L N+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L SL G D + L+ L L N+L S
Sbjct: 88 LQSLPNGVFDK--LTQLKELALDTNQLKS 114
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 6/86 (6%)
Query: 186 LSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
L+ L +L LS N+++ LP + L L L + NKL LP+G++ L +L+ L L N
Sbjct: 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYN 267
+L S+ G D + +LQ + L N
Sbjct: 111 QLKSVPDGIFD--RLTSLQKIWLHTN 134
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 45/238 (18%), Positives = 75/238 (31%), Gaps = 49/238 (20%)
Query: 68 NSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
+SV+ + L N + + +++ + L +F E+ L L
Sbjct: 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI--PEALRLL--- 86
Query: 123 ISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCH------- 173
AL K L + LS P + L+ ++ L L + +
Sbjct: 87 -------LQALLKCPKLHTVRLSDNAFGPT-AQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138
Query: 174 -------FSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNK 221
+ + L + N+ MK + L ++K+ N
Sbjct: 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198
Query: 222 L------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN--LQNLNLQYNKL 269
+ L GL Q L+ LDL +N T LGS L L L+ L L L
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 19/100 (19%), Positives = 28/100 (28%), Gaps = 17/100 (17%)
Query: 187 SNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL-----VELPSGLYLL--QR 234
L+ LDL N L + L L + + L + L
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
Query: 235 LENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L+ L L N + L + L L L N+
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 25/134 (18%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 926 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF---DRA 982
L + + L +H +H DIK+ N+L+ + V L D+ R
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-----QVYLADYGLSYRY 203
Query: 983 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV----DIWSYGCL 1038
P + +G GT + + HK G+ + D+ G
Sbjct: 204 CPNGNHKQYQENPRKGH------NGTIEFTS----LDAHK----GVALSRRSDVEILGYC 249
Query: 1039 LLELLTLQVPYMGL 1052
+L L ++P+
Sbjct: 250 MLRWLCGKLPWEQN 263
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 3e-05
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 24/168 (14%)
Query: 110 VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
+ + L L+IK ++ LK LE+ SV+ + + L L KL
Sbjct: 168 LDAMPLLNNLKIKGTNNL--SIGKKPRPNLKSLEIISGGLPDSVVEDILG-SDLPNLEKL 224
Query: 170 SVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSG 228
+ Y G ++ F+K + L L + + + +
Sbjct: 225 VLYVGVEDY-----GFDGDMNVFRPLFSKDR--------FPNLKWLGIVDAEEQNVVVEM 271
Query: 229 LY---LLQRLENLDLSNNRLTSLGSLDLC----LMHNLQNLNLQYNKL 269
+L +LE +D+S LT G+ L + +L+ +N++YN L
Sbjct: 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 5/95 (5%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL + + L + L + L +L+LSNNRL L +
Sbjct: 132 LDLKGLRSDPDLVA---QNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDM 188
Query: 252 DLCL--MHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ NL+ LNL N+L S ++ LE
Sbjct: 189 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1141 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.98 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.92 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.92 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.83 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.82 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.69 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.63 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.63 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.54 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.52 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.5 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.46 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.27 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.14 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.06 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.01 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.89 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.8 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.75 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.75 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.62 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.62 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.2 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.9 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.66 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.91 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.72 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.66 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.13 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.84 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.48 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.15 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.76 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 82.96 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 80.32 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=465.44 Aligned_cols=261 Identities=25% Similarity=0.332 Sum_probs=214.8
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+.++++|++.++||+|+||+||+|++. +..||+|+.... .......+. +.+|+.+|++++|||||++++++.
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~----~~~E~~il~~l~HpnIV~~~~~~~ 93 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS--RMSSKEREE----SRREVAVLANMKHPNIVQYRESFE 93 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECT--TSCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehH--HCCHHHHHH----HHHHHHHHHHCCCCCCCcEEEEEE
Confidence 446789999999999999999999985 667888875433 333333334 489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+++. .|||||||+||+|.++|.. .+...+++.+++.|+.||+.||+|||++|||||||||+||
T Consensus 94 ~~~~--------------~yiVmEy~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 94 ENGS--------------LYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp ETTE--------------EEEEEECCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred ECCE--------------EEEEEeCCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 7653 4999999999999999976 3345689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+|+.+...... ....+||+.|||||++.+ ..|+.++|||||||++
T Consensus 157 Ll~~~-------g~vKl~DFGla~~~~~~~~~----------~~~~~GT~~YmAPE~l~~----~~y~~~~DiwSlGvil 215 (350)
T 4b9d_A 157 FLTKD-------GTVQLGDFGIARVLNSTVEL----------ARACIGTPYYLSPEICEN----KPYNNKSDIWALGCVL 215 (350)
T ss_dssp EECTT-------CCEEECSTTEESCCCHHHHH----------HHHHHSCCTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEcccccceeecCCccc----------ccccCCCccccCHHHHCC----CCCCcHHHHHHHHHHH
Confidence 99987 88999999999876432211 123579999999999986 5789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|||++|+.||.+.+..++...+..+..+.++. ..++++.+||.+||+.||++|
T Consensus 216 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~R 268 (350)
T 4b9d_A 216 YELCTLKHAFEAGSMKNLVLKIISGSFPPVSL---------------------------HYSYDLRSLVSQLFKRNPRDR 268 (350)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHccCChhHC
Confidence 99999999999988888888887666543321 456679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||++|+++|+|+..
T Consensus 269 ~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 269 PSVNSILEKGFIAK 282 (350)
T ss_dssp CCHHHHHTSHHHHT
T ss_pred cCHHHHhcCHHhhc
Confidence 99999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=459.84 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=216.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..|++.++||+|+||+||+|++. +..||+|+...... ...+. +.+|+.+|++++|||||+++++|.+.+.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~----~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRREL----LFNEVVIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGG----GHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHH----HHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45999999999999999999985 66788887654321 11223 3799999999999999999999987664
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.|||||||+||+|.+++.+ ..+++.++..|+.||+.||+|||++|||||||||+|||++.
T Consensus 146 --------------~~ivmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 146 --------------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp --------------EEEEECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred --------------EEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 4999999999999999975 36999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||++|||+
T Consensus 206 ~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyeml 264 (346)
T 4fih_A 206 D-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMV 264 (346)
T ss_dssp T-------CCEEECCCTTCEECCSSSC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecCcCceecCCCCC----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 8899999999987643211 1235679999999999976 57899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||.+.+..++...|.....+.+... ...++++.+||.+||+.||++|||++
T Consensus 265 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~dli~~~L~~dP~~R~ta~ 319 (346)
T 4fih_A 265 DGEPPYFNEPPLKAMKMIRDNLPPRLKNL-------------------------HKVSPSLKGFLDRLLVRDPAQRATAA 319 (346)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSSCCCCSCG-------------------------GGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCCcc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999888888888766544332210 14567899999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001143 1124 DLYEMFVARTSS 1135 (1141)
Q Consensus 1124 ElL~~L~~~~~s 1135 (1141)
|+++|+|+....
T Consensus 320 e~l~Hp~~~~~~ 331 (346)
T 4fih_A 320 ELLKHPFLAKAG 331 (346)
T ss_dssp HHTTCGGGGGCC
T ss_pred HHhcCHhhcCCC
Confidence 999999998654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=443.20 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=203.5
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
|++.++||+|+||+||+|.+..+...|+++.+..........+. +.+|+.+|++++|||||++++++.+...
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~----~~~E~~il~~l~HpnIV~~~~~~~~~~~---- 99 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTVK---- 99 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEEEEET----
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHH----HHHHHHHHHhCCCCCCCcEEEEEeeccC----
Confidence 37888999999999999999755444444444433333343344 4899999999999999999999875211
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeec-c
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL-E 964 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NILld~-~ 964 (1141)
.....|||||||+||+|.+++++ ...+++..++.|+.||+.||+|||+++ ||||||||+|||++. +
T Consensus 100 ------~~~~~~lvmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~ 168 (290)
T 3fpq_A 100 ------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp ------TEEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTT
T ss_pred ------CCcEEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCC
Confidence 12256999999999999999986 246999999999999999999999998 999999999999974 4
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+|
T Consensus 169 -------g~vKl~DFGla~~~~~~------------~~~~~~GTp~YmAPE~~~~-----~y~~~~DiwSlGvilyellt 224 (290)
T 3fpq_A 169 -------GSVKIGDLGLATLKRAS------------FAKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp -------SCEEECCTTGGGGCCTT------------SBEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEEeCcCCEeCCCC------------ccCCcccCccccCHHHcCC-----CCCcHHHHHHHHHHHHHHHH
Confidence 78999999999753321 1124579999999999864 58999999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 Gk~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||.+.. ..++...+..+..+... ....++++.+||.+||+.||++|||++
T Consensus 225 g~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~ 278 (290)
T 3fpq_A 225 SEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSIK 278 (290)
T ss_dssp SSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCcHHHHHHHHHcCCCCCCC--------------------------CccCCHHHHHHHHHHccCChhHCcCHH
Confidence 999997644 44455555544332111 113456799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001143 1124 DLYEMFVARTS 1134 (1141)
Q Consensus 1124 ElL~~L~~~~~ 1134 (1141)
|+++|+|++..
T Consensus 279 e~l~Hp~~~~~ 289 (290)
T 3fpq_A 279 DLLNHAFFQEE 289 (290)
T ss_dssp HHHTSGGGC--
T ss_pred HHhcCccccCC
Confidence 99999999754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=448.97 Aligned_cols=260 Identities=21% Similarity=0.254 Sum_probs=215.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..++|++.++||+|+||+||+|++. +..+|+|+...... .......++.+|+.+|++++|||||+++++|.++
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 4568999999999999999999984 66788887643211 1112223458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. .|||||||+||+|.+++++ .+.+++.+++.|+.||+.||+|||++||+||||||+|||+
T Consensus 105 ~~--------------~yivmEy~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl 165 (311)
T 4aw0_A 105 EK--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 165 (311)
T ss_dssp SE--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CE--------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE
Confidence 64 4999999999999999986 2469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ..|+.++||||+||++|+
T Consensus 166 ~~~-------g~vKl~DFGla~~~~~~~~~--------~~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilye 226 (311)
T 4aw0_A 166 NED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQ 226 (311)
T ss_dssp CTT-------SCEEECCCTTCEECCTTTTC--------CCBCCCCSCGGGCCHHHHHH----SCBCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEEcCCceecCCCCCc--------ccccCcccCcccCCHHHHcC----CCCCcHHHHHHHHHHHHH
Confidence 987 88999999999876432211 12235679999999999987 578999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|+.||.+.+..++...|..+... ++. ..++++++||.+||+.||++|||
T Consensus 227 ml~G~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~dli~~lL~~dp~~R~t 278 (311)
T 4aw0_A 227 LVAGLPPFRAGNEGLIFAKIIKLEYD-FPE---------------------------KFFPKARDLVEKLLVLDATKRLG 278 (311)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCC-CCT---------------------------TCCHHHHHHHHHHSCSSGGGSTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCC-CCc---------------------------ccCHHHHHHHHHHccCCHhHCcC
Confidence 99999999998888888887665421 111 34567999999999999999999
Q ss_pred HHH------HHHHHHhhcC
Q 001143 1122 AGD------LYEMFVARTS 1134 (1141)
Q Consensus 1122 a~E------lL~~L~~~~~ 1134 (1141)
++| |++|+||+.-
T Consensus 279 ~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 279 CEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp SGGGTCHHHHHTSGGGTTC
T ss_pred hHHHcCCHHHHCCCCcCCC
Confidence 987 5888998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=440.28 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=207.9
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.+.++|++.++||+|+||+||+|++.+ .||||+++ .........+.| .+|+.+|++++|||||++++++.++.
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~--~~~~~~~~~~~f----~~E~~il~~l~HpNIV~l~g~~~~~~ 105 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILK--VVDPTPEQFQAF----RNEVAVLRKTRHVNILLFMGYMTKDN 105 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECC--CSSCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEE--ecCCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEECCe
Confidence 346788999999999999999999865 57888754 333344444444 89999999999999999999875422
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.+||||||+||+|.++++. ...++++.++..|+.||+.||+|||+++||||||||+|||++
T Consensus 106 ---------------~~iVmEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~ 166 (307)
T 3omv_A 106 ---------------LAIVTQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH 166 (307)
T ss_dssp ---------------CEEEEECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE
T ss_pred ---------------EEEEEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC
Confidence 3899999999999999975 234699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +++||+|||+|+........ ......+||+.|||||++.+.. ...|+.++|||||||++|||
T Consensus 167 ~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~GT~~ymAPE~l~~~~-~~~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 167 EG-------LTVKIGDFGLATVKSRWSGS--------QQVEQPTGSVLWMAPEVIRMQD-NNPFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp TT-------EEEEECCCSSCBC--------------------CCCCTTSCCHHHHHCCS-SCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccCceecccCCcc--------eeecccccCCCccCHHHhhccC-CCCCCcHHHhHhHHHHHHHH
Confidence 88 89999999999765432111 1123457999999999997522 24689999999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHhCCCC-CchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1043 LTLQVPYMGLSELE-IHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~e-l~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+||+.||.+.+..+ +...+..+..+ .+. .....+++.+.+|+.+||+.||++||
T Consensus 231 ltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~------------------------~~~~~~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 231 MTGELPYSHINNRDQIIFMVGRGYASPDLS------------------------KLYKNCPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHTTCCCCCST------------------------TSCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCCcc------------------------cccccchHHHHHHHHHHcCCCHhHCc
Confidence 99999998765544 33444433222 111 01125677899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
||.||+++++....
T Consensus 287 s~~ei~~~Le~l~~ 300 (307)
T 3omv_A 287 LFPQILSSIELLQH 300 (307)
T ss_dssp CHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHhc
Confidence 99999999887543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=436.68 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=199.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+.+|++.+.||+|+||+||+|++. +..||+|+...... .. .....++.+|+.++++++|||||++++++.+.
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--AK---SDMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--CC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 3678999999999999999999974 67788887543221 11 12223458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. .|+||||+ +|+|.+++.+ ...+++.+++.|+.||+.||+|||++||+||||||+|||+
T Consensus 86 ~~--------------~~ivmEy~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl 145 (275)
T 3hyh_A 86 DE--------------IIMVIEYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL 145 (275)
T ss_dssp SE--------------EEEEEECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE
T ss_pred CE--------------EEEEEeCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE
Confidence 53 49999999 5899999976 3479999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+...... .....+||+.|||||++.+ ...++.++||||+||++|+
T Consensus 146 ~~~-------~~vkl~DFGla~~~~~~~-----------~~~~~~GT~~Y~APE~~~~---~~y~~~~~DiwSlGvily~ 204 (275)
T 3hyh_A 146 DEH-------LNVKIADFGLSNIMTDGN-----------FLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYV 204 (275)
T ss_dssp CTT-------CCEEECCSSCC--------------------------CTTSCHHHHSS---SSCCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeecCCCeecCCCC-----------ccCCeeECcccCChhhhcC---CCCCCChhhhHHHHHHHHH
Confidence 887 889999999997654321 1124579999999999986 2234689999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|+||+.||.+.+..++...+..+..+ ++ ...++++.+||.+||+.||++|||
T Consensus 205 lltg~~PF~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dP~~R~s 256 (275)
T 3hyh_A 205 MLCRRLPFDDESIPVLFKNISNGVYT-LP---------------------------KFLSPGAAGLIKRMLIVNPLNRIS 256 (275)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCC-CC---------------------------TTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHccCChhHCcC
Confidence 99999999988888887777655432 11 034567999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
++|+++|+|++..
T Consensus 257 ~~eil~hpw~k~~ 269 (275)
T 3hyh_A 257 IHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHCHHHHTT
T ss_pred HHHHHcCcccccC
Confidence 9999999999854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=461.34 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=216.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..|++.++||+|+||.||+|++. +..||+|+...... ...+ .+.+|+.+|++++|||||+++++|.+.+.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~----~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRE----LLFNEVVIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGG----GHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHH----HHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence 45999999999999999999985 66788887654321 1122 34799999999999999999999987653
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+|||||||+||+|.++++. ..+++.++..|+.||+.||+|||++|||||||||+||||+.
T Consensus 223 --------------~~iVmEy~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~ 282 (423)
T 4fie_A 223 --------------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 282 (423)
T ss_dssp --------------EEEEEECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT
T ss_pred --------------EEEEEeCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC
Confidence 4999999999999999975 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||++|||+
T Consensus 283 ~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyeml 341 (423)
T 4fie_A 283 D-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMV 341 (423)
T ss_dssp T-------CCEEECCCTTCEECCSSCC----------CBCCCEECTTTCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecCccceECCCCCc----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 8899999999986543211 1235679999999999976 57899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||.+.+..+++..|.....+.+... ...++++.+||.+||+.||++|||+.
T Consensus 342 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~dli~~~L~~dP~~R~ta~ 396 (423)
T 4fie_A 342 DGEPPYFNEPPLKAMKMIRDNLPPRLKNL-------------------------HKVSPSLKGFLDRLLVRDPAQRATAA 396 (423)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSCT-------------------------TSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCccc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999888888888766544332210 14567799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001143 1124 DLYEMFVARTSS 1135 (1141)
Q Consensus 1124 ElL~~L~~~~~s 1135 (1141)
|+++|+|+....
T Consensus 397 ell~Hp~~~~~~ 408 (423)
T 4fie_A 397 ELLKHPFLAKAG 408 (423)
T ss_dssp HHTTCGGGGGCC
T ss_pred HHhcCHHhcCCC
Confidence 999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=439.51 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=212.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
.-++|.+.++||+|+||+||+|++. +..||||+. +. ......++| .+|+++|++++|||||+++|
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l--~~--~~~~~~~~f----~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KD--ASDNARKDF----HREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEE--CS--CCHHHHHHH----HHHHHHHTTCCCTTBCCEEE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEe--CC--CChHHHHHH----HHHHHHHHhCCCCCCccEEE
Confidence 3467999999999999999999874 345677764 32 233333444 89999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKH 948 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~--------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g 948 (1141)
++.+.+. .+||||||++|+|.++++.... .....+++.++..|+.||+.||+|||+++
T Consensus 83 ~~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 83 VCVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp EECSSSS--------------EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeeCCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9987653 4999999999999999986321 22357999999999999999999999999
Q ss_pred ccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc
Q 001143 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1141)
Q Consensus 949 IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1028 (1141)
||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||++.+ ..|+.
T Consensus 149 iiHRDlKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~~--------~~~~~~gt~~ymAPE~~~~----~~~~~ 209 (299)
T 4asz_A 149 FVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----RKFTT 209 (299)
T ss_dssp CCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCEE--------ETTTEEECGGGCCHHHHHH----CCCCH
T ss_pred cccCccCHhhEEECCC-------CcEEECCcccceecCCCCcee--------ecCceecChhhcCHHHHcC----CCCCc
Confidence 9999999999999988 889999999998654322111 1123468999999999987 67899
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|||||||++|||+| |+.||.+.+..++...+..+..+..+. .+++++.+|
T Consensus 210 k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~l 262 (299)
T 4asz_A 210 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPQEVYEL 262 (299)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHH
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHH
Confidence 9999999999999999 899999988888888887776544332 456679999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+||+.||++||||.||++.+...
T Consensus 263 i~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 263 MLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999998877654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=439.13 Aligned_cols=264 Identities=21% Similarity=0.323 Sum_probs=215.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 874 (1141)
..++.++++.++||+|+||+||+|++. +..||||+ ++.... ....+. |.+|+.++++++|||||++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~--l~~~~~-~~~~~~----f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAE-GPLREE----FRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEE--CCC-CC-C-CHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEE--ECcccC-hHHHHH----HHHHHHHHHhCCCCCCCCc
Confidence 345677899999999999999999973 34567766 432221 222233 4899999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~y 943 (1141)
+|++.+.+.+ +||||||++|+|.+++...... ....+++.++..|+.||+.||+|
T Consensus 95 ~g~~~~~~~~--------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 160 (308)
T 4gt4_A 95 LGVVTKDQPL--------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 160 (308)
T ss_dssp EEEECSSSSC--------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHH
T ss_pred ceEEEECCEE--------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 9999876544 9999999999999999753211 12369999999999999999999
Q ss_pred HHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 944 LHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
||+++||||||||+||||+.+ +++||+|||+|+.+...... .......||+.|||||++.+
T Consensus 161 LH~~~iiHRDLK~~NILl~~~-------~~~Ki~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~---- 221 (308)
T 4gt4_A 161 LSSHHVVHKDLATRNVLVYDK-------LNVKISDLGLFREVYAADYY--------KLLGNSLLPIRWMAPEAIMY---- 221 (308)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-------GCEEECCSCCBCGGGGGGCB--------CSSSSSCBCGGGCCHHHHHH----
T ss_pred HHhCCCCCCCccccceEECCC-------CCEEECCcccceeccCCCce--------eEecccccCCcccCHHHHhC----
Confidence 999999999999999999988 88999999999865432211 11234569999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 001143 1024 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1102 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1141)
..|+.++|||||||++|||+| |+.||.+.+..++...+..+..++.+. .+++
T Consensus 222 ~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~ 274 (308)
T 4gt4_A 222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD---------------------------DCPA 274 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCH
T ss_pred CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cchH
Confidence 678999999999999999999 899999999888888887666544321 4567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+.+|+.+||+.||++||||.||+++|...
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 799999999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=442.42 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=209.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
...+|.+.++||+|+||+||+|++. +..||||+. +. ......++| .+|+++|++++|||||++++
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l--~~--~~~~~~~~f----~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KE--ASESARQDF----QREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEE--SC--CSHHHHHHH----HHHHHHHTTCCCTTBCCEEE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEE--Cc--CCHHHHHHH----HHHHHHHHhCCCCCCCcEEE
Confidence 4467899999999999999999974 455777764 32 233334444 89999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------TGEKHVSVKLALFIAQDVAAALVELHS 946 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~----------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs 946 (1141)
++.+... .+||||||++|+|.++++.... ....++++.+++.|+.||+.||+|||+
T Consensus 111 ~~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 111 VCTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp EECSSSS--------------EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 9987553 4999999999999999976321 123469999999999999999999999
Q ss_pred CCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001143 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1141)
Q Consensus 947 ~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1026 (1141)
++||||||||+|||++.+ +++||+|||+|+.+...... .......||+.|||||++.+ ..|
T Consensus 177 ~~iiHRDLKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~gt~~ymAPE~~~~----~~~ 237 (329)
T 4aoj_A 177 LHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RKF 237 (329)
T ss_dssp TTCCCSCCCGGGEEEETT-------TEEEECCCC------------------------CCCCGGGCCHHHHTT----CCC
T ss_pred CCeecccccHhhEEECCC-------CcEEEcccccceeccCCCcc--------eecCcccccccccChhhhcC----CCC
Confidence 999999999999999988 89999999999865432211 11224569999999999986 678
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 001143 1027 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1105 (1141)
Q Consensus 1027 s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1105 (1141)
+.++|||||||++|||+| |+.||.+.+..++...+..+.++..+. .+++++.
T Consensus 238 ~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~~~ 290 (329)
T 4aoj_A 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR---------------------------ACPPEVY 290 (329)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHH
T ss_pred CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cccHHHH
Confidence 999999999999999999 899999988888888887766544332 4567799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1106 DVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1106 dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
+|+.+||+.||++||||.||+++|.....
T Consensus 291 ~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 291 AIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999877543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=446.05 Aligned_cols=257 Identities=24% Similarity=0.256 Sum_probs=207.8
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
.+.++|++.+.||+|+||+||+|++. +..||+|+...... ...... ++.+|+.+|++++|||||+++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~----~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL--KVRDRV----RTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE--EEEECC----------CCCCCCCCTTEECEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc--ChHHHH----HHHHHHHHHHHCCCCCCCeEEEE
Confidence 34578999999999999999999872 45689988643221 111112 23789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+.+++. .|||||||+||+|.+++++ ...+++.+++.|+.||+.||+|||++||+||||||+
T Consensus 95 ~~~~~~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 155 (304)
T 3ubd_A 95 FQTEGK--------------LYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPE 155 (304)
T ss_dssp EEETTE--------------EEEEECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG
T ss_pred EEECCE--------------EEEEEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 987654 4999999999999999986 246999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.+||+|||+|+...... ......+||+.|||||++.+ ..|+.++|||||||
T Consensus 156 NILl~~~-------g~vKl~DFGla~~~~~~~----------~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGv 214 (304)
T 3ubd_A 156 NILLDEE-------GHIKLTDFGLSKESIDHE----------KKAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGV 214 (304)
T ss_dssp GEEECTT-------SCEEEESSEEEEC---------------CCCCSCCCCGGGCCHHHHHT----SCCCTHHHHHHHHH
T ss_pred HeEEcCC-------CCEEecccccceeccCCC----------ccccccccCcccCCHHHhcc----CCCCCCCcccchHH
Confidence 9999988 889999999997543321 11234679999999999986 57899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++|||+||+.||.+.+..++...|..+..+ ++ ...++++.+||.+||+.||+
T Consensus 215 ilyemltG~~PF~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dP~ 266 (304)
T 3ubd_A 215 LMFEMLTGTLPFQGKDRKETMTMILKAKLG-MP---------------------------QFLSPEAQSLLRMLFKRNPA 266 (304)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-CC---------------------------CcCCHHHHHHHHHHcccCHH
Confidence 999999999999998888888887655432 11 14566799999999999999
Q ss_pred CCCC-----HHHHHHHHHhhc
Q 001143 1118 ERPT-----AGDLYEMFVART 1133 (1141)
Q Consensus 1118 ~RPS-----a~ElL~~L~~~~ 1133 (1141)
+||| ++|+++|+||+.
T Consensus 267 ~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 267 NRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp GSTTCSTTTHHHHHTSGGGTT
T ss_pred HCCCCCcCCHHHHHcCccccC
Confidence 9998 589999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=444.56 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=205.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+..|++.++||+|+||.||+|++. +..||+|+.+.+.. ..+|+.++++++|||||++++++.+.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3567899999999999999999985 56788887653321 14799999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. .|||||||+||+|.+++++ ...+++.+++.|+.||+.||+|||++|||||||||+|||+
T Consensus 123 ~~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 183 (336)
T 4g3f_A 123 PW--------------VNIFMELLEGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183 (336)
T ss_dssp TE--------------EEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE
T ss_pred CE--------------EEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 53 4999999999999999986 2469999999999999999999999999999999999999
Q ss_pred ecccccCCCCC-eEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 962 DLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~~~~~~~~~~-~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
+.+ + .+||+|||+|+.+....... ........+||+.|||||++.+ ..|+.++|||||||++|
T Consensus 184 ~~~-------g~~vKl~DFGla~~~~~~~~~~-----~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvily 247 (336)
T 4g3f_A 184 SSD-------GSRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCMML 247 (336)
T ss_dssp CTT-------SCCEEECCCTTCEEC-----------------CCCCCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEeeCCCCeEccCCCccc-----ceecCCccccCccccCHHHHCC----CCCCcHHHHHHHHHHHH
Confidence 877 5 59999999998765422110 0112234579999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
||+||+.||.+.+..++...|.....+.. .....+++.+.+||.+||+.||.+||
T Consensus 248 emltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~ 302 (336)
T 4g3f_A 248 HMLNGCHPWTQYFRGPLCLKIASEPPPIR-------------------------EIPPSCAPLTAQAIQEGLRKEPVHRA 302 (336)
T ss_dssp HHHHSSCSSTTTCCSCCHHHHHHSCCGGG-------------------------GSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHCcCCCCCCCHHHHHHHHHcCCCCch-------------------------hcCccCCHHHHHHHHHHccCCHhHCc
Confidence 99999999988766666666654432110 00115667899999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
|+.|+++++..
T Consensus 303 sa~el~~~l~~ 313 (336)
T 4g3f_A 303 SAMELRRKVGK 313 (336)
T ss_dssp CHHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 99999887644
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=436.67 Aligned_cols=292 Identities=16% Similarity=0.199 Sum_probs=214.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||+||+|++. +..||+|+. +.........+ ++.+|+.+|++++|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i--~~~~~~~~~~~----~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI--PNAFDVVTNAK----RTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEE--TTTTSSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEE--CccccchHHHH----HHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 47999999999999999999985 566777774 33333333333 34799999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+ ....++|||||||+ |+|.+++.. ...+++.+++.|++||+.||+|||++|||||||||+|||++.
T Consensus 128 ~--------~~~~~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 128 Y--------GEFKSVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE 193 (398)
T ss_dssp T--------TTCCCEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred c--------ccCCEEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC
Confidence 2 12236799999996 789999865 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+.+...... ........+||+.|||||++.+ ...++.++||||+||++|||+
T Consensus 194 ~-------~~~Ki~DFGla~~~~~~~~~------~~~~~~~~~GT~~Y~APEv~~~---~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 194 N-------CELKIGDFGMARGLCTSPAE------HQYFMTEYVATRWYRAPELMLS---LHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp T-------CCEEECCCTTCBCC-------------CCCCCSSCCCCTTCCHHHHTT---CSCCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecceeeecccCccc------cccccccceeChHhcCHHHhcC---CCCCCChhheehhHHHHHHHH
Confidence 7 88999999999865432111 1112335689999999999876 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++||.+.+..+....|............................... ........++++.+||.+||++||.+||
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 9999999988888777774322221111111100000000000000000 0111124567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
|+.|+++|+|+..
T Consensus 338 ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 338 SAAAALRHPFLAK 350 (398)
T ss_dssp CHHHHTTSGGGTT
T ss_pred CHHHHhcCHhhCc
Confidence 9999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=426.60 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=208.8
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkll 875 (1141)
+.++|++.++||+|+||+||+|++.+ ..||||+.. .. ......+.+ .+|+.+|.++. |||||+++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~--~~-~~~~~~~~~----~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EG-ATHSEHRAL----MSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEEC--TT-CCHHHHHHH----HHHHHHHHHHCCCTTBCCEE
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEc--cc-cChHHHHHH----HHHHHHHHHcCCCCcEEEEE
Confidence 34679999999999999999999843 246666543 22 223333444 89999999996 59999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHH
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVEL 944 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~yL 944 (1141)
|++.+.+. ..+||||||++|+|.++|+..... ....+++.++..|+.||+.||+||
T Consensus 135 g~~~~~~~-------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL 201 (353)
T 4ase_A 135 GACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 201 (353)
T ss_dssp EEECCTTS-------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCC-------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence 99865321 249999999999999999864321 134589999999999999999999
Q ss_pred HHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC
Q 001143 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024 (1141)
Q Consensus 945 Hs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1024 (1141)
|+++||||||||+|||++.+ +.+||+|||+|+.+....... ......||+.|||||++.+ .
T Consensus 202 H~~~iiHRDLK~~NILl~~~-------~~vKi~DFGlar~~~~~~~~~--------~~~~~~gt~~ymAPE~l~~----~ 262 (353)
T 4ase_A 202 ASRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDYV--------RKGDARLPLKWMAPETIFD----R 262 (353)
T ss_dssp HHTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTSE--------EETTEEECGGGCCHHHHHH----C
T ss_pred hhCCeecCccCccceeeCCC-------CCEEECcchhhhhcccCCCce--------eeccccccccccCHHHHhc----C
Confidence 99999999999999999988 889999999998654322110 1124568999999999987 6
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 001143 1025 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1102 (1141)
Q Consensus 1025 ~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1141)
.|+.++|||||||++|||+| |+.||.+... .++...+..+.++..+. .+++
T Consensus 263 ~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~ 315 (353)
T 4ase_A 263 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTP 315 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCH
T ss_pred CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc---------------------------cCCH
Confidence 78999999999999999998 8999987653 44556666665544332 4566
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
++.+++.+||+.||++||||.||++||...
T Consensus 316 ~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 316 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 799999999999999999999999998654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=418.20 Aligned_cols=277 Identities=24% Similarity=0.287 Sum_probs=192.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||+||+|++. +..||+|+..... .....+ ++.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~----~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELARE----KVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHH----HHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 46899999999999999999985 6677888754331 222223 34899999999999999999999876442
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.... .......+.|+|||||+||+|.++++.. ......++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 78 ~~~~--~~~~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 78 TEKL--QPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp -----------CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred cccc--cccCCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC
Confidence 1000 0011223579999999999999999762 11223567778999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecccccccccccccccc--ccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI--AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~--~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+ +.+||+|||+|+.+......... ...........+||+.|||||++.+ ..|+.++|||||||++||
T Consensus 154 ~-------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 154 D-------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG----NSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp T-------CCEEECCCCCC--------------------------CCCTTSCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred C-------CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC----CCCCCHHHHHHHHHHHHH
Confidence 7 78999999999876543211100 0000111234579999999999986 578999999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ ||.+.... .....+.....|.. ....++.+.+||.+||+.||.+||
T Consensus 223 ll~---Pf~~~~~~~~~~~~~~~~~~p~~---------------------------~~~~~~~~~~li~~~L~~dP~~Rp 272 (299)
T 4g31_A 223 LLY---PFSTQMERVRTLTDVRNLKFPPL---------------------------FTQKYPCEYVMVQDMLSPSPMERP 272 (299)
T ss_dssp HHS---CCSSHHHHHHHHHHHHTTCCCHH---------------------------HHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred Hcc---CCCCccHHHHHHHHHhcCCCCCC---------------------------CcccCHHHHHHHHHHcCCChhHCc
Confidence 996 78642211 12222332222211 113345578899999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|+.|+++|+|++.-
T Consensus 273 s~~eil~h~~~~~~ 286 (299)
T 4g31_A 273 EAINIIENAVFEDL 286 (299)
T ss_dssp CHHHHHTSGGGCCC
T ss_pred CHHHHhcCHhhCCC
Confidence 99999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=417.02 Aligned_cols=268 Identities=25% Similarity=0.297 Sum_probs=200.1
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
.+|.+.++||+|+||+||+|+++++.||||+.... ..+.+ ....|+..+.+++|||||++++++.+++.
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~-------~~~~~--~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-- 71 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhhH--HHHHHHHHHhcCCCCCCCcEEEEEEecCC--
Confidence 35889999999999999999999999999986422 11122 12456777778899999999999986432
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCC
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSE 957 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--------gIvHrDLKP~ 957 (1141)
...+.|||||||++|+|.++++. ..+++..+.+|+.|++.||+|||++ +||||||||+
T Consensus 72 --------~~~~~~lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~ 137 (303)
T 3hmm_A 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGG
T ss_pred --------CceEEEEEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcc
Confidence 12357999999999999999986 3699999999999999999999987 9999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC--CCCCCchhhHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSY 1035 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVWSL 1035 (1141)
|||++.+ +++||+|||+|+......... .......+||+.|||||++.+... ...++.++|||||
T Consensus 138 NILl~~~-------~~~Ki~DFGla~~~~~~~~~~------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 138 NILVKKN-------GTCCIADLGLAVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp GEEECTT-------SCEEECCCTTCEEEETTTTEE------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred cEEECCC-------CCEEEEeCCCCccccCCCCce------eeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 9999988 899999999998765432211 011234579999999999976321 1236789999999
Q ss_pred HHHHHHHHhCCCCCCCC---------------CHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 001143 1036 GCLLLELLTLQVPYMGL---------------SELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1099 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~---------------~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1141)
||++|||+||..||... ...++...+ ....+|.++.... ...
T Consensus 205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~----------------------~~~ 262 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ----------------------SCE 262 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG----------------------SSH
T ss_pred HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCcccc----------------------chH
Confidence 99999999997765321 112222222 2222233222111 115
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1100 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1100 ~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.++.+.+|+.+||+.||++||||.||++.|....
T Consensus 263 ~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 263 ALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 6678999999999999999999999999987643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=412.58 Aligned_cols=286 Identities=19% Similarity=0.167 Sum_probs=198.4
Q ss_pred CCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEe
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~ 879 (1141)
+.|++.++||+|+||+||+|+++ +..||+|+. .... .. .++.+|+++|+.+ +|||||+++++|.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i--~~~~----~~----~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL--IPTS----HP----IRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEE--CTTS----CH----HHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEE--cccc----CH----HHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 46999999999999999999863 345666653 2211 11 1237899999998 6999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.+ +.|+||||++||+|.++++ .+++.+++.|+.||+.||+|||++||+||||||+||
T Consensus 91 ~~~--------------~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNi 148 (361)
T 4f9c_A 91 KND--------------HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNF 148 (361)
T ss_dssp ETT--------------EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ECC--------------EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHe
Confidence 765 4599999999999999984 389999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeecccccccccccccccc------------------ccCCCCCCCCccCCCcccchhhhcccc
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI------------------AHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~------------------~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1021 (1141)
|++.+. +.+||+|||+|+........... ...........+||+.|+|||++.+
T Consensus 149 Ll~~~~------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 220 (361)
T 4f9c_A 149 LYNRRL------KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-- 220 (361)
T ss_dssp EEETTT------TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT--
T ss_pred EEeCCC------CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC--
Confidence 998652 68999999999765432110000 0000011234579999999999976
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC-CCCch----------------------hHHhhhc
Q 001143 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGK-RPRLT----------------------DELEALG 1077 (1141)
Q Consensus 1022 ~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~-~~~~el~~~I~~~~-~p~l~----------------------~~l~~~~ 1077 (1141)
...|+.++||||+||++|||++|+.||.. .+..+....|.... .+... .......
T Consensus 221 -~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 221 -CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp -CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred -CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 23588999999999999999999999954 34444444442110 00000 0000000
Q ss_pred cCccccccc----cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1078 SCHEHEVAQ----SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1078 ~~~~~~~~~----~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.. ...... ..............++++.+||.+||++||++|||++|+++|+||+.
T Consensus 300 ~~-~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 300 GM-DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cc-cccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00 000000 00000000011245678999999999999999999999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=434.76 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=215.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.+.||+|+||+||+|++. +..+|+|+.... .....+. +.+|+.+|++++|||||+++++|.+..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~----~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHH----HHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHH----HHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 568999999999999999999984 567788875422 2222333 479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
++|||||||+||+|.++|.. ....+++.++..|+.||+.||+|||++||+||||||+|||++
T Consensus 228 --------------~~~iv~E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~ 289 (573)
T 3uto_A 228 --------------EMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 289 (573)
T ss_dssp --------------EEEEEEECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEeecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhcccc
Confidence 35999999999999999864 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+. .+.+||+|||+|+.+...... ...+||+.|||||++.+ ..|+.++||||+||++|||
T Consensus 290 ~~~-----~~~vKl~DFG~a~~~~~~~~~-----------~~~~GT~~y~APEv~~~----~~y~~~~DiWSlGvilyem 349 (573)
T 3uto_A 290 TKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYIL 349 (573)
T ss_dssp SSS-----CCCEEECCCSSCEECCTTSEE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred CCC-----CCCEEEeeccceeEccCCCce-----------eeeEECccccCHHHhCC----CCCCcHHHHHHHHHHHHHH
Confidence 542 268999999999876542211 23569999999999987 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..+.+..|........... ....++++.+||.+||+.||.+|||+
T Consensus 350 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~dli~~~L~~dp~~R~t~ 405 (573)
T 3uto_A 350 LSGLSPFGGENDDETLRNVKSCDWNMDDSA------------------------FSGISEDGKDFIRKLLLADPNTRMTI 405 (573)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCSGG------------------------GTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HHCCCCCCCcCHHHHHHHHHhCCCCCCccc------------------------ccCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999888888888765543211110 11456779999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
.|+++|+|+...
T Consensus 406 ~e~l~Hpw~~~~ 417 (573)
T 3uto_A 406 HQALEHPWLTPG 417 (573)
T ss_dssp HHHHHSTTTSCC
T ss_pred HHHhcCcCcCCC
Confidence 999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=437.65 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=206.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+.++++|++.++||+|+||.||+|++. +..+|+|+......... ...........++.+++.++|||||+++++|.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~--~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh--hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 567899999999999999999999984 66788887543211000 00111111134567778889999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.+. +|||||||+||+|.++|.+ ...+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 263 ~~~~--------------lylVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 263 TPDK--------------LSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp CSSE--------------EEEEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred ECCE--------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 7664 4999999999999999986 24699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
||+.+ +++||+|||+|+.+... .....+||+.|||||++.. +..|+.++|||||||++
T Consensus 324 Lld~~-------G~vKL~DFGlA~~~~~~------------~~~t~~GTp~YmAPEvl~~---~~~y~~~vDiWSLGvil 381 (689)
T 3v5w_A 324 LLDEH-------GHVRISDLGLACDFSKK------------KPHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCML 381 (689)
T ss_dssp EECTT-------SCEEECCCTTCEECSSC------------CCCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHH
T ss_pred EEeCC-------CCEEecccceeeecCCC------------CCCCccCCcCccCHHHHhC---CCCCCcHHHHHHHHHHH
Confidence 99988 89999999999765431 1234579999999999964 24689999999999999
Q ss_pred HHHHhCCCCCCCC---CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1040 LELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~---~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|||++|++||.+. ...++...+..... .++ ...++++++||.+||+.||
T Consensus 382 YEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~S~~a~dLI~~lL~~dP 433 (689)
T 3v5w_A 382 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELP---------------------------DSFSPELRSLLEGLLQRDV 433 (689)
T ss_dssp HHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSCG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHhhcCCCC-CCC---------------------------ccCCHHHHHHHHHHccCCH
Confidence 9999999999753 23334444333221 111 1456779999999999999
Q ss_pred CCCCC-----HHHHHHHHHhhc
Q 001143 1117 TERPT-----AGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RPS-----a~ElL~~L~~~~ 1133 (1141)
.+|++ ++||++|+||+.
T Consensus 434 ~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 434 NRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp GGCTTCSSSTHHHHTTSGGGTT
T ss_pred hHCCCCCCCCHHHHhcCccccC
Confidence 99998 899999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=384.54 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=213.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+.+|++.+.||+|+||.||+|++ .+..||+|+.... .......+. +.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT--QLNPTSLQK----LFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG--GSCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhh--cCCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4467899999999999999999998 5677888876433 223333333 4799999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.+ ..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 86 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 86 EK--------------TLYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL 146 (328)
T ss_dssp SS--------------EEEEEECCCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CC--------------EEEEEEECCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence 55 35999999999999999976 246999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||++........ .....||+.|+|||++.+. ...+.++|||||||++|
T Consensus 147 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ 205 (328)
T 3fe3_A 147 LDAD-------MNIKIADFGFSNEFTVGGK-----------LDAFCGAPPYAAPELFQGK---KYDGPEVDVWSLGVILY 205 (328)
T ss_dssp ECTT-------SCEEECSTTCCGGGSSSCG-----------GGTTSSSGGGCCHHHHHTC---CCCSHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeccCceecCCCCc-----------cccccCCcceeCcccccCC---CcCCchhhhhhhHHHHH
Confidence 9887 7899999999976543211 1234699999999999862 23358999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|+.||.+.+..++...+..+.... + ...++++.+|+.+||..||.+||
T Consensus 206 ell~g~~pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~s~~~~~li~~~L~~dP~~R~ 257 (328)
T 3fe3_A 206 TLVSGSLPFDGQNLKELRERVLRGKYRI-P---------------------------FYMSTDCENLLKRFLVLNPIKRG 257 (328)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHCCSSTTTSC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCC-C---------------------------CCCCHHHHHHHHHHCCCChhHCc
Confidence 9999999999988888777776543321 1 03456789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|++|+++|+|+...
T Consensus 258 t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 258 TLEQIMKDRWINAG 271 (328)
T ss_dssp CHHHHTTCTTTTTT
T ss_pred CHHHHhcCHhhcCC
Confidence 99999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=378.99 Aligned_cols=259 Identities=25% Similarity=0.434 Sum_probs=211.8
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.++||+|+||+||+|.+ .+..||+|+...... . ..+ .+.+|+.++++++||||+++++++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~--~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--P--KKE----LIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--S--CHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--c--HHH----HHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 45799999999999999999987 466788887654422 1 112 2378999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 91 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 91 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (297)
T ss_dssp --------------EEEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence 34999999999999999976 2589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 209 (297)
T 3fxz_A 151 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (297)
T ss_dssp TT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCGGGCCHHHHHC----SCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCceecCCccc----------ccCCccCCcCccChhhhcC----CCCCcHHHHHHHHHHHHHH
Confidence 87 7899999999876543211 1224569999999999986 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.........+.....+.... ....+..+.+++.+||+.||.+|||+
T Consensus 210 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (297)
T 3fxz_A 210 IEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLEMDVEKRGSA 264 (297)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSC-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhHCcCH
Confidence 99999998877766555543333222110 11456679999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001143 1123 GDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s~~ 1137 (1141)
.|+++|+|++.....
T Consensus 265 ~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 265 KELLQHQFLKIAKPL 279 (297)
T ss_dssp HHHTTCGGGGGCCCG
T ss_pred HHHhhChhhcccCcc
Confidence 999999999876544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=385.33 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=212.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.|++.+.||+|+||.||+|++. +..+|+|+........... ......+.+|+.++++++||||+++++++.+..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 88 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENRT- 88 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-
Confidence 45999999999999999999985 6678888865433221110 011123479999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 89 -------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 150 (361)
T 2yab_A 89 -------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (361)
T ss_dssp -------------EEEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC
Confidence 35999999999999999864 347999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++. ....+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 151 ~~~---~~~~vkl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~~ll 212 (361)
T 2yab_A 151 KNI---PIPHIKLIDFGLAHEIEDGV-----------EFKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 212 (361)
T ss_dssp TTS---SSCCEEECCCSSCEECCTTC-----------CCCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CCC---CccCEEEEecCCceEcCCCC-----------ccccCCCCccEECchHHcC----CCCCccccHHHHHHHHHHHH
Confidence 520 11279999999997654321 1123469999999999876 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+.+..+....+..+........ ....+..+.+||.+||..||.+|||+.
T Consensus 213 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~ 268 (361)
T 2yab_A 213 SGASPFLGDTKQETLANITAVSYDFDEEF------------------------FSQTSELAKDFIRKLLVKETRKRLTIQ 268 (361)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhcCCCCCchh------------------------ccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 99999998888887777765543221111 114566799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|+..
T Consensus 269 e~l~hp~~~~ 278 (361)
T 2yab_A 269 EALRHPWITP 278 (361)
T ss_dssp HHHTSTTTSC
T ss_pred HHhcCcCcCC
Confidence 9999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=382.82 Aligned_cols=259 Identities=24% Similarity=0.299 Sum_probs=207.8
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
...+++|++.++||+|+||.||+|++. +..+|+|+.+... .........+.+|..++..+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH-----hcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 456789999999999999999999985 5678888865321 11111123347899999988 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.. ..|+||||++||+|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 94 ~~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 94 QTPD--------------RLFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 8755 35999999999999999976 2469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+|+...... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 155 ILl~~~-------g~ikL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 213 (353)
T 3txo_A 155 VLLDHE-------GHCKLADFGMCKEGICNG----------VTTATFCGTPDYIAPEILQE----MLYGPAVDWWAMGVL 213 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCSCC-------------------CCGGGCCHHHHHH----HHCTTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEccccceeecccCC----------ccccccCCCcCeEChhhcCC----CCcCCccCCCcchHH
Confidence 999987 889999999997532211 11224579999999999986 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||++|+.||.+.+..++...+....... + ...+..+.++|.+||+.||.+
T Consensus 214 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 214 LYEMLCGHAPFEAENEDDLFEAILNDEVVY-P---------------------------TWLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-C---------------------------CCCCHHHHHHHHHHhhhCHHH
Confidence 999999999999988888888776543211 1 034556899999999999999
Q ss_pred CCCH------HHHHHHHHhhc
Q 001143 1119 RPTA------GDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa------~ElL~~L~~~~ 1133 (1141)
||++ .|+++|+||..
T Consensus 266 R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTT
T ss_pred ccCCcccCCHHHHhhCCcccC
Confidence 9999 99999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=377.52 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=210.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
++++|++.+.||+|+||.||+|++. +..+|+|+...... ........+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 4678999999999999999999984 66788887643211 0111122347899999999999999999999875
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+ ..|+||||++||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 138 (337)
T 1o6l_A 78 D--------------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138 (337)
T ss_dssp S--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE
Confidence 5 35999999999999999976 2469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 139 ~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 197 (337)
T 1o6l_A 139 DKD-------GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp CTT-------SCEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeccchhhcccCCC----------cccccccChhhCChhhhcC----CCCCchhhcccchhHHHH
Confidence 987 8899999999975322111 1224569999999999876 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP- 1120 (1141)
|++|+.||.+.+..++...+...... ++ ...++++.++|.+||+.||.+||
T Consensus 198 ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP~~R~g 249 (337)
T 1o6l_A 198 MMCGRLPFYNQDHERLFELILMEEIR-FP---------------------------RTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHHhcC
Confidence 99999999988877777766543221 11 13456799999999999999999
Q ss_pred ----CHHHHHHHHHhhc
Q 001143 1121 ----TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 ----Sa~ElL~~L~~~~ 1133 (1141)
++.|+++|+||..
T Consensus 250 ~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 250 GGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSTTTHHHHHTSGGGTT
T ss_pred CCCCCHHHHHcCCCcCC
Confidence 9999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=375.29 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=211.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|.+. +..+|+|+.... ...... +.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVL----VKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHH----HHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHH----HHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 467999999999999999999985 456777765422 222233 379999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||++|++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 75 --------------~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 75 --------------ELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp --------------EEEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 35999999999999999864 234699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+. .+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 137 ~~~-----~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 196 (321)
T 1tki_A 137 TRR-----SSTIKIIEFGQARQLKPGDN-----------FRLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp SSS-----CCCEEECCCTTCEECCTTCE-----------EEEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHHH
T ss_pred cCC-----CCCEEEEECCCCeECCCCCc-----------cccccCChhhcCcHHhcC----CCCCchhhHHHHHHHHHHH
Confidence 631 17899999999976543211 123468999999999976 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|..||.+....+....+...........+ ...+.++.+++.+||..||.+|||+
T Consensus 197 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~Rpt~ 252 (321)
T 1tki_A 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAF------------------------KEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCcCCCHHHHHHHHHcCCCCCChhhh------------------------ccCCHHHHHHHHHHcCCChhHCcCH
Confidence 9999999988888877777655443222111 1456779999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
.|+++|+|+...
T Consensus 253 ~e~l~hp~~~~~ 264 (321)
T 1tki_A 253 SEALQHPWLKQK 264 (321)
T ss_dssp HHHHHSHHHHSC
T ss_pred HHHhcChhhccC
Confidence 999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=366.04 Aligned_cols=284 Identities=19% Similarity=0.242 Sum_probs=206.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.++||+|+||+||+|.+. +..+|+|+..... ......+. +.+|+.++++++||||+++++++.+..
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSS----ALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHH----HHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC--CcCCcchH----HHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 468999999999999999999984 5668888765443 22222233 379999999999999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||++ ++|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 75 --------------KLTLVFEFCD-QDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp --------------EEEEEEECCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecCC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 3499999998 567666654 234699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 136 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 195 (292)
T 3o0g_A 136 RN-------GELKLANFGLARAFGIPVR----------CYSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------SCEEECCCTTCEECCSCCS----------CCCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCCccc----------cccCCccccCCcChHHHcC---CCCcCchHHHHHHHHHHHHH
Confidence 87 7899999999976543211 1224468999999999876 23478999999999999999
Q ss_pred HhCCCC-CCCCCHHHHHHHHHhCCCCCchhHHhhhccCc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1043 LTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1043 LTGk~P-f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
++|..| |.+.+..+....+...........+....... ....................+..+.+|+.+||+.||++||
T Consensus 196 ~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 275 (292)
T 3o0g_A 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC
Confidence 998777 45555555555542211111111111000000 0000000000011111225677899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
|++|+++|+||..
T Consensus 276 t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 276 SAEEALQHPYFSD 288 (292)
T ss_dssp CHHHHHTSGGGTT
T ss_pred CHHHHhcCccccc
Confidence 9999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=378.90 Aligned_cols=260 Identities=25% Similarity=0.312 Sum_probs=212.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+. +..+|+|+.... .......+. +.+|+.++++++||||+++++++.+..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~----~~~E~~il~~l~hpnIv~~~~~~~~~~- 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK--KLSARDFQK----LEREARICRKLQHPNIVRLHDSIQEES- 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcc--cCCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 46999999999999999999985 567888876533 223333333 489999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..|+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 102 -------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 102 -------------FHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp -------------EEEEEECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred -------------EEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 34999999999999999864 346999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+. ..+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 164 ~~----~~~~~kl~DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll 224 (362)
T 2bdw_A 164 KA----KGAAVKLADFGLAIEVNDSE-----------AWHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYILL 224 (362)
T ss_dssp SS----TTCCEEECCCTTCBCCTTCC-----------SCCCSCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEeecCcceEecCCc-----------ccccCCCCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 52 12569999999997654321 1123569999999999976 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+.+..++...+..+........+ ...++++.+||.+||+.||.+|||+.
T Consensus 225 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (362)
T 2bdw_A 225 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEW------------------------DTVTPEAKSLIDSMLTVNPKKRITAD 280 (362)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTGG------------------------GGSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCcccc------------------------cCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999988887777777655432111100 14567799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|+..
T Consensus 281 e~l~hp~~~~ 290 (362)
T 2bdw_A 281 QALKVPWICN 290 (362)
T ss_dssp HHTTSHHHHT
T ss_pred HHhcCcccCC
Confidence 9999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=371.13 Aligned_cols=287 Identities=19% Similarity=0.248 Sum_probs=208.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.-.++|++.++||+|+||+||+|++ .+..+|+|+..... ... .....+.+|+.++++++||||+++++++.+.
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA--EDE----GIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc--ccc----hhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 4467899999999999999999998 46678888765332 111 1223347999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. .++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 92 RC--------------LTLVFEFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp SC--------------EEEEEECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEcCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 53 499999998 588888865 23469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 212 (311)
T 3niz_A 153 NSD-------GALKLADFGLARAFGIPVR----------SYTHEVVTLWYRAPDVLMG---SKKYSTSVDIWSIGCIFAE 212 (311)
T ss_dssp CTT-------CCEEECCCTTCEETTSCCC-------------CCCCCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccCcCceecCCCcc----------cccCCcccCCcCCHHHhcC---CCCCCchHHhHHHHHHHHH
Confidence 887 7899999999976543211 1123468999999999875 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCcc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|++|+.||.+....+....+.. ...+. +..+........ ...................++++.+||.+||+.||.+
T Consensus 213 ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 213 MITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp HHHSSCSCCCSSTTTHHHHHHHHHCCCC-TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred HHhCCCCCCCCChHHHHHHHHHHHCCCC-hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 9999999987665554444422 11111 111110000000 0000000000001112245678999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001143 1119 RPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~s 1135 (1141)
|||++|+++|+||+.-.
T Consensus 292 Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 292 RISARDAMNHPYFKDLD 308 (311)
T ss_dssp SCCHHHHHTSGGGTTSC
T ss_pred CCCHHHHhcCcccccCC
Confidence 99999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.90 Aligned_cols=261 Identities=28% Similarity=0.460 Sum_probs=204.7
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
....+|++.++||+|+||+||+|++.+..+|+|+.... .......+.+ .+|+.++++++||||+++++++.+..
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ--DFHAERVNEF----LREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCC--CCSHHHHHHH----HHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCC--CCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 44678999999999999999999999999999986533 2233333444 89999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 960 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NIL 960 (1141)
.+ ++||||+++++|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+|||
T Consensus 108 ~~--------------~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIl 171 (309)
T 3p86_A 108 NL--------------SIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171 (309)
T ss_dssp CC--------------EEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEE
T ss_pred ce--------------EEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEE
Confidence 43 999999999999999975211 124999999999999999999999999 999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 172 l~~~-------~~~kL~Dfg~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 172 VDKK-------YTVKVCDFGLSRLKASTF----------LSSKSAAGTPEWMAPEVLRD----EPSNEKSDVYSFGVILW 230 (309)
T ss_dssp ECTT-------CCEEECCCC---------------------------CCTTSCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EeCC-------CcEEECCCCCCccccccc----------cccccCCCCccccChhhhcC----CCCCchhhHHHHHHHHH
Confidence 9887 789999999997543211 11224569999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|++|+.||.+....+....+... ....++ ...++.+.+||.+||+.||.+|
T Consensus 231 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dP~~R 283 (309)
T 3p86_A 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---------------------------RNLNPQVAAIIEGCWTNEPWKR 283 (309)
T ss_dssp HHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhC
Confidence 999999999988877766655322 211111 1455679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.++++.+....
T Consensus 284 ps~~~ll~~L~~~~ 297 (309)
T 3p86_A 284 PSFATIMDLLRPLI 297 (309)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999876554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=388.11 Aligned_cols=261 Identities=25% Similarity=0.311 Sum_probs=210.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||+||+|.+. +..+|+|+...+ .......+. +.+|+.++++++||||+++++++.+.+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~--~~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~- 83 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK--KLSARDHQK----LEREARICRLLKHPNIVRLHDSISEEG- 83 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESC--SCHHHHHHH----HHHHHHHHHHCCBTTBCCEEEEEECSS-
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcc--cCCHHHHHH----HHHHHHHHHhCCCcCCCeEEEEEEECC-
Confidence 46999999999999999999984 566777775433 222222333 489999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 84 -------------~~~lv~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~ 145 (444)
T 3soa_A 84 -------------HHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145 (444)
T ss_dssp -------------EEEEEECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred -------------EEEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 34999999999999999976 346999999999999999999999999999999999999985
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+. ..+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 146 ~~----~~~~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGvilyell 207 (444)
T 3soa_A 146 KL----KGAAVKLADFGLAIEVEGEQQ----------AWFGFAGTPGYLSPEVLRK----DPYGKPVDLWACGVILYILL 207 (444)
T ss_dssp SS----TTCCEEECCCSSCBCCCTTCC----------BCCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred cC----CCCcEEEccCceeEEecCCCc----------eeecccCCcccCCHHHhcC----CCCCCccccHHHHHHHHHHH
Confidence 31 126899999999976543211 1123569999999999976 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+.+..++...+..+........+ ...++++.+||.+||+.||.+|||+.
T Consensus 208 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~Rpta~ 263 (444)
T 3soa_A 208 VGYPPFWDEDQHRLYQQIKAGAYDFPSPEW------------------------DTVTPEAKDLINKMLTINPSKRITAA 263 (444)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCCCCCTTTT------------------------TTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hCCCCCCCccHHHHHHHHHhCCCCCCcccc------------------------ccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 999999988888888777665432211100 14566799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|+..
T Consensus 264 e~L~hp~~~~ 273 (444)
T 3soa_A 264 EALKHPWISH 273 (444)
T ss_dssp HHHHSCTTHH
T ss_pred HHhcCccccC
Confidence 9999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=372.02 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=211.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.++++|++.+.||+|+||.||+|++. +..+|+|+...... ........+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 45788999999999999999999984 66788888643210 011112234789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 78 AQ--------------QIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 55 35999999999999999986 346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~-------g~~kL~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 194 (318)
T 1fot_A 139 LDKN-------GHIKITDFGFAKYVPDV-------------TYTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIY 194 (318)
T ss_dssp ECTT-------SCEEECCCSSCEECSSC-------------BCCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeecCcceecCCc-------------cccccCCccccCHhHhcC----CCCCcccchhhhHHHHH
Confidence 9887 88999999999764321 123469999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
||++|+.||.+.+..+....+...... ++ ...+.++.++|.+||..||.+||
T Consensus 195 ell~g~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 195 EMLAGYTPFYDSNTMKTYEKILNAELR-FP---------------------------PFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSCTTTCT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHhccCHHHcC
Confidence 999999999988877777766544321 11 03456799999999999999999
Q ss_pred -----CHHHHHHHHHhhc
Q 001143 1121 -----TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 -----Sa~ElL~~L~~~~ 1133 (1141)
+++++++|+|+..
T Consensus 247 ~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 247 GNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp TSSTTTTHHHHTSGGGSS
T ss_pred CCcCCCHHHHhcCccccC
Confidence 9999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=372.81 Aligned_cols=260 Identities=25% Similarity=0.274 Sum_probs=203.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
....++|++.+.||+|+||.||+|++ .+..+|+|+.+............ .+.+|+.++++++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA----HTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHH----HHHHHHHHHHhCCCCCccceeE
Confidence 34567899999999999999999997 45678888764322111111222 2378999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++...+. .|+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||
T Consensus 89 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp 149 (327)
T 3a62_A 89 AFQTGGK--------------LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149 (327)
T ss_dssp EEECSSC--------------EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred EEEcCCE--------------EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence 9987553 4999999999999999976 24689999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 150 ~Nill~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG 208 (327)
T 3a62_A 150 ENIMLNHQ-------GHVKLTDFGLCKESIHDGT----------VTHTFCGTIEYMAPEILMR----SGHNRAVDWWSLG 208 (327)
T ss_dssp TTEEECTT-------SCEEECCCSCC--------------------CTTSSCCTTSCHHHHTT----SCCCTHHHHHHHH
T ss_pred HHeEECCC-------CcEEEEeCCcccccccCCc----------cccccCCCcCccCHhhCcC----CCCCCcccchhHH
Confidence 99999887 7899999999875332111 1124469999999999976 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|++|+|++|+.||.+.+..+....+...... ++ ...+..+.++|.+||+.||
T Consensus 209 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~L~~dp 260 (327)
T 3a62_A 209 ALMYDMLTGAPPFTGENRKKTIDKILKCKLN-LP---------------------------PYLTQEARDLLKKLLKRNA 260 (327)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CC---------------------------TTSCHHHHHHHHHHSCSCG
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHHhcCH
Confidence 9999999999999988777777666543321 11 1345679999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhc
Q 001143 1117 TERP-----TAGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RP-----Sa~ElL~~L~~~~ 1133 (1141)
.+|| ++.|+++|+|+..
T Consensus 261 ~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 261 ASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp GGSTTSSTTTHHHHHHSGGGSS
T ss_pred hhccCCCCCCHHHHHcCCcccC
Confidence 9999 8999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=372.72 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=211.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
+.|++.+.||+|+||.||+|.+. +..+|+|+.......... ...+ .+.+|+.++++++||||+++++++.+.
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE----DIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHH----HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHH----HHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 35899999999999999999985 667888876543322111 1122 347999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 87 ~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll 147 (326)
T 2y0a_A 87 T--------------DVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147 (326)
T ss_dssp S--------------EEEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE
Confidence 4 35999999999999999864 3469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.++. ....+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 148 ~~~~~---~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ 209 (326)
T 2y0a_A 148 LDRNV---PKPRIKIIDFGLAHKIDFGN-----------EFKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYI 209 (326)
T ss_dssp SCSSS---SSCCEEECCCTTCEECCTTS-----------CCCCCCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred ecCCC---CCCCEEEEECCCCeECCCCC-----------ccccccCCcCcCCceeecC----CCCCcHHHHHHHHHHHHH
Confidence 87620 11379999999997654321 1123469999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|..||.+....+....+........... ....+..+.+||.+||+.||.+|||
T Consensus 210 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rpt 265 (326)
T 2y0a_A 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEY------------------------FSNTSALAKDFIRRLLVKDPKKRMT 265 (326)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHCcCCCCCCCHHHHHHHHHhcCCCcCccc------------------------cccCCHHHHHHHHHHccCChhhCCC
Confidence 9999999998877777666654433221111 1145667999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.|+++|+|+...
T Consensus 266 ~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 266 IQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHSTTTSCC
T ss_pred HHHHhcCCCccCC
Confidence 9999999999743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.16 Aligned_cols=259 Identities=25% Similarity=0.285 Sum_probs=209.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+++|++.+.||+|+||.||+|.+.. ..+|+|+.... ..........+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH-----HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc-----ccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 457789999999999999999999854 45788875422 11222233456899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil 141 (279)
T 3fdn_A 81 AT--------------RVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141 (279)
T ss_dssp SS--------------EEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred CC--------------EEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence 54 359999999999999999762 46999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 142 i~~~-------~~~~l~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 198 (279)
T 3fdn_A 142 LGSA-------GELKIADFGWSVHAPSSR------------RTDLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCY 198 (279)
T ss_dssp ECTT-------SCEEECSCCEESCC--------------------CCCCTTCCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEeccccccCCccc------------ccccCCCCCccCHhHhcc----CCCCccchhHhHHHHHH
Confidence 9887 789999999885433211 123468999999999876 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|..||......+....+....... + ...+..+.+|+.+||+.||.+||
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 199 EFLVGKPPFEANTYQETYKRISRVEFTF-P---------------------------DFVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHTCCCC-C---------------------------TTSCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHCCCCCCCCcHHHHHHHHHhCCCCC-C---------------------------CcCCHHHHHHHHHHhccChhhCC
Confidence 9999999999877777666664433211 0 13456789999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001143 1121 TAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~s~ 1136 (1141)
|+.|+++|+|+...+.
T Consensus 251 s~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 251 MLREVLEHPWITANSS 266 (279)
T ss_dssp CHHHHHHCHHHHHHCS
T ss_pred CHHHHhhCccccCCcc
Confidence 9999999999986443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=364.68 Aligned_cols=283 Identities=19% Similarity=0.240 Sum_probs=206.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+++|++.+.||+|+||+||+|++. +..+|+|+...... .. .....+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DE----GIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GG----CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--cc----ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 468999999999999999999984 66788887643321 11 111234789999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 --------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 75 --------------LVLVFEHLD-QDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp --------------EEEEEECCS-EEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------EEEEEEecC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 499999998 599998875 2346999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 136 E-------GELKIADFGLARAFGIPVR----------KYTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeECccccccCcccc----------ccccccccccccCchheeC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999999976542211 1123468999999999875 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+|+.||.+.+..+....+.. ...+... .+....... ....................++++.+|+.+||+.||++|||
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 274 (288)
T 1ob3_A 196 NGTPLFPGVSEADQLMRIFRILGTPNSK-NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (288)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTT-TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHHHCCCChh-hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC
Confidence 99999998777665554422 1111100 000000000 00000000000001111245678999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.|+++|+|+..
T Consensus 275 ~~e~l~hp~f~~ 286 (288)
T 1ob3_A 275 AKQALEHAYFKE 286 (288)
T ss_dssp HHHHHTSGGGGC
T ss_pred HHHHhcCcchhh
Confidence 999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=374.01 Aligned_cols=266 Identities=25% Similarity=0.313 Sum_probs=209.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.|++.+.||+|+||+||+|.+. +..+|+|+........ .....+ .+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE----DLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHH----HHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45999999999999999999984 6778888865332110 001122 3479999999999999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..|+||||++|++|.+++...... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 100 --------------~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~ 164 (351)
T 3c0i_A 100 --------------MLYMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164 (351)
T ss_dssp --------------EEEEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEe
Confidence 349999999999999888753322 34689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+. ....+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 165 ~~~----~~~~vkl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 226 (351)
T 3c0i_A 165 SKE----NSAPVKLGGFGVAIQLGESGL----------VAGGRVGTPHFMAPEVVKR----EPYGKPVDVWGCGVILFIL 226 (351)
T ss_dssp SSS----TTCCEEECCCTTCEECCTTSC----------BCCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEecCcceeEecCCCe----------eecCCcCCcCccCHHHHcC----CCCCchHhhHHHHHHHHHH
Confidence 652 124599999999976543211 1123469999999999976 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+. ..+....+..+.....+..+ ...+..+.+||.+||+.||++|||+
T Consensus 227 l~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~s~ 281 (351)
T 3c0i_A 227 LSGCLPFYGT-KERLFEGIIKGKYKMNPRQW------------------------SHISESAKDLVRRMLMLDPAERITV 281 (351)
T ss_dssp HHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCc-HHHHHHHHHcCCCCCCcccc------------------------ccCCHHHHHHHHHHCCCChhHCcCH
Confidence 9999999874 44455555444332221111 1456679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.|+++|+|+..
T Consensus 282 ~e~l~hp~~~~ 292 (351)
T 3c0i_A 282 YEALNHPWLKE 292 (351)
T ss_dssp HHHHTSHHHHT
T ss_pred HHHhcChhhcC
Confidence 99999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.85 Aligned_cols=265 Identities=25% Similarity=0.297 Sum_probs=213.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|.+. +..+|+|+..... ......+. +.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQK----LEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHH----HHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 467999999999999999999985 5678888865432 23333333 379999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 79 --------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 139 (284)
T 3kk8_A 79 --------------FHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139 (284)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred --------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence 34999999999999998876 24699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.++ ..+.+||+|||.+........ .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 140 ~~~----~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 200 (284)
T 3kk8_A 140 SKA----KGAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYIL 200 (284)
T ss_dssp SSS----TTCCEEECCCTTCEECCSSCB-----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEeeceeeEEcccCcc-----------ccCCCCCcCCcCchhhcC----CCCCcccchHHHHHHHHHH
Confidence 652 124599999999976543211 123468999999999976 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|..||.+....+....+..+........ ....++.+.+++.+||+.||.+|||+
T Consensus 201 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 256 (284)
T 3kk8_A 201 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------------------------WDTVTPEAKSLIDSMLTVNPKKRITA 256 (284)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCCchhHHHHHHHhccccCCchh------------------------hcccCHHHHHHHHHHcccChhhCCCH
Confidence 999999998887777777655443211100 01455679999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001143 1123 GDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s~~ 1137 (1141)
.|+++|+|+......
T Consensus 257 ~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 257 DQALKVPWICNRERV 271 (284)
T ss_dssp HHHTTSHHHHSCCCG
T ss_pred HHHhcCccccCChhH
Confidence 999999999865443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=373.93 Aligned_cols=256 Identities=23% Similarity=0.289 Sum_probs=212.8
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+++|++.+.||+|+||.||+|++. +..+|+|+..... .........+.+|+.++++++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH-----hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 355788999999999999999999984 6678888764321 111111234478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.. ..|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 112 ~~~--------------~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 172 (350)
T 1rdq_E 112 DNS--------------NLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCC--------------EEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence 655 359999999999999999862 3699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 173 ll~~~-------g~~kL~DFg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 228 (350)
T 1rdq_E 173 LIDQQ-------GYIQVTDFGFAKRVKGR-------------TWTLCGTPEALAPEIILS----KGYNKAVDWWALGVLI 228 (350)
T ss_dssp EECTT-------SCEEECCCTTCEECSSC-------------BCCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEcccccceeccCC-------------cccccCCccccCHHHhcC----CCCCCcCCEecccHhH
Confidence 99887 88999999999765331 113469999999999986 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|..||.+.+..++...+..+... ++ ...+..+.++|.+||+.||.+|
T Consensus 229 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~lL~~dp~~R 280 (350)
T 1rdq_E 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR-FP---------------------------SHFSSDLKDLLRNLLQVDLTKR 280 (350)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTCCHHHHHHHHHHSCSCTTTC
T ss_pred hHHhhCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhc
Confidence 9999999999988888877777654321 11 0345679999999999999999
Q ss_pred CC-----HHHHHHHHHhhc
Q 001143 1120 PT-----AGDLYEMFVART 1133 (1141)
Q Consensus 1120 PS-----a~ElL~~L~~~~ 1133 (1141)
|+ ++++++|+|+..
T Consensus 281 ~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 281 FGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TTSSTTTTHHHHTSGGGTT
T ss_pred cCCccCCHHHHHhCcCcCC
Confidence 98 999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=376.12 Aligned_cols=259 Identities=25% Similarity=0.323 Sum_probs=209.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
...+.+|++.+.||+|+||.||+|++. +..+|+|+.+.... ........+..|..++..+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 345789999999999999999999985 56678887543211 0111112346899999877 899999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.. ..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 88 ~~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 148 (345)
T 1xjd_A 88 QTKE--------------NLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 148 (345)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhh
Confidence 8755 35999999999999999986 2469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 149 Ill~~~-------g~vkL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 207 (345)
T 1xjd_A 149 ILLDKD-------GHIKIADFGMCKENMLGD----------AKTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVL 207 (345)
T ss_dssp EEECTT-------SCEEECCCTTCBCCCCTT----------CCBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEeEChhhhhcccCC----------CcccCCCCCcccCChhhhcC----CCCCChhhhHHHHHH
Confidence 999987 889999999997532211 11234579999999999986 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||++|+.||.+.+..++...+...... ++ ...+.++.+||.+||+.||.+
T Consensus 208 l~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dp~~ 259 (345)
T 1xjd_A 208 LYEMLIGQSPFHGQDEEELFHSIRMDNPF-YP---------------------------RWLEKEAKDLLVKLFVREPEK 259 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------cccCHHHHHHHHHHhcCCHhH
Confidence 99999999999988888777777554321 11 034567999999999999999
Q ss_pred CCCHH-HHHHHHHhhc
Q 001143 1119 RPTAG-DLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~-ElL~~L~~~~ 1133 (1141)
||++. ++++|+||..
T Consensus 260 R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 260 RLGVRGDIRQHPLFRE 275 (345)
T ss_dssp SBTTBSCGGGSGGGTT
T ss_pred cCCChHHHHcCccccC
Confidence 99998 9999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=367.80 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=209.4
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|+..++||+|+||.||+|++. +..||+|+...... ...+. +.+|+.++++++||||+++++++....
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~--- 115 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRREL----LFNEVVIMRDYQHFNVVEMYKSYLVGE--- 115 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHH----HHHHHHHHTTCCCTTBCCEEEEEEETT---
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHH----HHHHHHHHHhCCCCCcceEEEEEEECC---
Confidence 788899999999999999984 67788888654321 11222 378999999999999999999998654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 116 -----------~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~- 177 (321)
T 2c30_A 116 -----------ELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD- 177 (321)
T ss_dssp -----------EEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-
T ss_pred -----------EEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-
Confidence 35999999999999998864 369999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 178 ------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~g 237 (321)
T 2c30_A 178 ------GRVKLSDFGFCAQISKDVP----------KRKSLVGTPYWMAPEVISR----SLYATEVDIWSLGIMVIEMVDG 237 (321)
T ss_dssp ------CCEEECCCTTCEECCSSSC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHHHS
T ss_pred ------CcEEEeeeeeeeecccCcc----------ccccccCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999999876543211 1124469999999999976 5678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001143 1046 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125 (1141)
Q Consensus 1046 k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~El 1125 (1141)
+.||......+....+.....+.+.. ....++.+.+++.+||+.||.+|||+.|+
T Consensus 238 ~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 238 EPPYFSDSPVQAMKRLRDSPPPKLKN-------------------------SHKVSPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp SCTTTTSCHHHHHHHHHHSSCCCCTT-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCcCc-------------------------cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999887777766665544333221 01455679999999999999999999999
Q ss_pred HHHHHhhcCC
Q 001143 1126 YEMFVARTSS 1135 (1141)
Q Consensus 1126 L~~L~~~~~s 1135 (1141)
++|+|+....
T Consensus 293 l~hp~~~~~~ 302 (321)
T 2c30_A 293 LDHPFLLQTG 302 (321)
T ss_dssp HTSGGGGGCC
T ss_pred hcChhhccCC
Confidence 9999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=362.23 Aligned_cols=285 Identities=22% Similarity=0.282 Sum_probs=206.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.++||+|+||+||+|.+. +..+|+|+... ........+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE--SEDDPVIKK----IALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--CCC-HHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeec--cccchHHHH----HHHHHHHHHHhCCCCCccchhheeecCC
Confidence 468999999999999999999985 56677776532 222222223 3479999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 76 --------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 76 --------------RLHLVFEYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136 (311)
T ss_dssp --------------EEEEEEECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence 34999999999999988764 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.+........ ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 196 (311)
T 4agu_A 137 KH-------SVIKLCDFGFARLLTGPSD----------YYDDEVATRWYRSPELLVG---DTQYGPPVDVWAIGCVFAEL 196 (311)
T ss_dssp TT-------SCEEECCCTTCEECC----------------------GGGCCHHHHHT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCchhccCccc----------ccCCCcCCccccChHHHhc---CCCCCcchhhHHHHHHHHHH
Confidence 87 7899999999976543211 1123468999999999875 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC---ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
++|+.||.+....+....+........+......... .....................+..+.+|+.+||+.||.+|
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 9999999988777665555332222222111111000 0000000000000000112566779999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||++|+++|+|+..-
T Consensus 277 pt~~ell~hp~f~~~ 291 (311)
T 4agu_A 277 LTCEQLLHHPYFENI 291 (311)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred CCHHHHhcChHHHhc
Confidence 999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.31 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=203.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-.+|++.+.||+|+||.||+|++. +..+|+|+...... ......+ ++.+|+.++++++||||+++++++.+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLK----RFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHH----HHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHH----HHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 357999999999999999999984 56788887643321 2223233 3489999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||++|++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 85 --------------~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 145 (294)
T 4eqm_A 85 --------------CYYLVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145 (294)
T ss_dssp --------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred --------------eEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 34999999999999999976 23699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++........ .......||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 146 ~~-------~~~kl~Dfg~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 205 (294)
T 4eqm_A 146 SN-------KTLKIFDFGIAKALSETSL---------TQTNHVLGTVQYFSPEQAKG----EATDECTDIYSIGIVLYEM 205 (294)
T ss_dssp TT-------SCEEECCCSSSTTC----------------------CCSSCCHHHHHT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEeCCCccccccccc---------cccCccccCccccCHhHhcC----CCCCchHhHHHHHHHHHHH
Confidence 87 7899999999976543211 11223469999999999986 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-C
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-T 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-S 1121 (1141)
++|+.||.+....+..........+...... ....++.+.+++.+||..||.+|| +
T Consensus 206 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 206 LVGEPPFNGETAVSIAIKHIQDSVPNVTTDV-----------------------RKDIPQSLSNVILRATEKDKANRYKT 262 (294)
T ss_dssp HHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS-----------------------CTTSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred HhCCCCCCCCChHHHHHHHhhccCCCcchhc-----------------------ccCCCHHHHHHHHHHhcCCHhHcccc
Confidence 9999999987776655444444333322111 014567799999999999999999 6
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
++++.+.+...
T Consensus 263 ~~~l~~~l~~~ 273 (294)
T 4eqm_A 263 IQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHHHHTS
T ss_pred HHHHHHHHHHH
Confidence 77777766554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=356.27 Aligned_cols=260 Identities=23% Similarity=0.285 Sum_probs=208.0
Q ss_pred CCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||+|.+... .+++|+..... .. ..+. +.+|+.++++++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~--~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~- 79 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VE--DVDR----FKQEIEIMKSLDHPNIIRLYETFEDNT- 79 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CS--CHHH----HHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cc--hHHH----HHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 3589999999999999999998654 45666543221 11 1223 378999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+||++..
T Consensus 80 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 141 (277)
T 3f3z_A 80 -------------DIYLVMELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT 141 (277)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred -------------eEEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEec
Confidence 34999999999999999876 246899999999999999999999999999999999999932
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ ...+.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 142 ~----~~~~~~~l~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 142 D----SPDSPLKLIDFGLAARFKPGK-----------MMRTKVGTPYYVSPQVLEG-----LYGPECDEWSAGVMMYVLL 201 (277)
T ss_dssp S----STTCCEEECCCTTCEECCTTS-----------CBCCCCSCTTTCCHHHHTT-----CBCTTHHHHHHHHHHHHHH
T ss_pred C----CCCCcEEEEecccceeccCcc-----------chhccCCCCCccChHHhcc-----cCCchhhehhHHHHHHHHH
Confidence 2 111789999999997654321 1123468999999999865 4789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||......+....+..+......... ...++.+.+++.+||+.||.+|||+.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dp~~R~s~~ 257 (277)
T 3f3z_A 202 CGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------------------LNVSPQAESLIRRLLTKSPKQRITSL 257 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCchhh------------------------hcCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999988877777777655443222111 14566799999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001143 1124 DLYEMFVARTSSS 1136 (1141)
Q Consensus 1124 ElL~~L~~~~~s~ 1136 (1141)
++++|+|+.....
T Consensus 258 ~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 258 QALEHEWFEKQLS 270 (277)
T ss_dssp HHTTSHHHHHHHC
T ss_pred HHhcCHHHhcccc
Confidence 9999999976433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=369.62 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=206.1
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeee
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 877 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~ 877 (1141)
.+..+.+|++.+.||+|+||.||+|++. +..+|+|+...... ......+. +.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~----~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDW----VQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHH----HHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHH----HHHHHHHHHhcCCCCccCeEEEE
Confidence 3456788999999999999999999985 56678887653321 12222333 47899999988 79999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+.+.. ..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 79 ~~~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 139 (345)
T 3a8x_A 79 FQTES--------------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139 (345)
T ss_dssp EECSS--------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EEeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 98655 35999999999999999976 236999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 140 NIll~~~-------g~~kL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ 198 (345)
T 3a8x_A 140 NVLLDSE-------GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGV 198 (345)
T ss_dssp GEEECTT-------SCEEECCGGGCBCSCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHH
T ss_pred HEEECCC-------CCEEEEeccccccccCCCC----------cccccCCCccccCccccCC----CCCChHHhHHHHHH
Confidence 9999887 8899999999975322111 1224579999999999986 56789999999999
Q ss_pred HHHHHHhCCCCCCCC---------CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 001143 1038 LLLELLTLQVPYMGL---------SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1108 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~---------~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1108 (1141)
++|||++|+.||... ....+...+..... .++ ...+..+.++|
T Consensus 199 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li 250 (345)
T 3a8x_A 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP---------------------------RSLSVKAASVL 250 (345)
T ss_dssp HHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHH
T ss_pred HHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHH
Confidence 999999999999642 12223333322211 111 14556799999
Q ss_pred HHhcccCCCCCCCH------HHHHHHHHhhc
Q 001143 1109 RRCTEENPTERPTA------GDLYEMFVART 1133 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa------~ElL~~L~~~~ 1133 (1141)
.+||+.||.+||++ .|+++|+||..
T Consensus 251 ~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 251 KSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999995 89999999964
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=354.75 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=199.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+.+|++.++||+|+||.||+|.+.+..+|+|+.+....... ......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI----SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH----HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 467899999999999999999999999999998654322111 1122334899999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCee
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH---IMHRDIKSENIL 960 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g---IvHrDLKP~NIL 960 (1141)
. ++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+
T Consensus 81 ~--------------~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil 140 (271)
T 3dtc_A 81 L--------------CLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140 (271)
T ss_dssp C--------------EEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred e--------------EEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence 3 999999999999998853 46999999999999999999999999 899999999999
Q ss_pred eeccccc-CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 961 IDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 961 ld~~~~~-~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
++..... ....+.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 204 (271)
T 3dtc_A 141 ILQKVENGDLSNKILKITDFGLAREWHRTT------------KMSAAGAYAWMAPEVIRA----SMFSKGSDVWSYGVLL 204 (271)
T ss_dssp ESSCCSSSCCSSCCEEECCCCC-------------------------CCGGGSCHHHHHH----CCCSHHHHHHHHHHHH
T ss_pred EecccccccccCcceEEccCCccccccccc------------ccCCCCccceeCHHHhcc----CCCCchhhHHHHHHHH
Confidence 9863110 0113789999999997544321 113468999999999986 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||.+.........+........ .....++.+.+++.+||+.||.+|
T Consensus 205 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~R 258 (271)
T 3dtc_A 205 WELLTGEVPFRGIDGLAVAYGVAMNKLALP--------------------------IPSTCPEPFAKLMEDCWNPDPHSR 258 (271)
T ss_dssp HHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--------------------------CCcccCHHHHHHHHHHhcCCcccC
Confidence 999999999998776665555433321110 001455679999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
||+.|+++++..
T Consensus 259 ps~~e~l~~L~~ 270 (271)
T 3dtc_A 259 PSFTNILDQLTT 270 (271)
T ss_dssp CCHHHHHHHHHC
T ss_pred cCHHHHHHHHhc
Confidence 999999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=371.27 Aligned_cols=259 Identities=24% Similarity=0.286 Sum_probs=209.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
...+.+|++.++||+|+||.||+|++.. ..+|+|+...... ........+..|..++..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 4567899999999999999999999965 4577777543211 0111123347899999888 799999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.. ..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 151 (353)
T 2i0e_A 91 QTMD--------------RLYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151 (353)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EcCC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 8655 35999999999999999986 2369999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+|+...... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 152 Ill~~~-------g~vkL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 210 (353)
T 2i0e_A 152 VMLDSE-------GHIKIADFGMCKENIWDG----------VTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVL 210 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCCCCTT----------CCBCCCCSCGGGCCHHHHTT----CCBSTHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEEeCCcccccccCC----------cccccccCCccccChhhhcC----CCcCCcccccchHHH
Confidence 999987 889999999997532211 11224569999999999976 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||++|+.||.+.+..++...+...... ++ ...+.++.+||.+||..||.+
T Consensus 211 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 211 LYEMLAGQAPFEGEDEDELFQSIMEHNVA-YP---------------------------KSMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSCTTS
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHH
Confidence 99999999999988888877777554321 11 134567999999999999999
Q ss_pred CC-----CHHHHHHHHHhhc
Q 001143 1119 RP-----TAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RP-----Sa~ElL~~L~~~~ 1133 (1141)
|| ++.++++|+||..
T Consensus 263 R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTT
T ss_pred cCCCCCCCHHHHhcCccccC
Confidence 99 4799999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=368.20 Aligned_cols=292 Identities=21% Similarity=0.250 Sum_probs=204.1
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+++|++.++||+|+||+||+|.+. +..+|+|+.... .......+.+ .+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE--HEEEGVPGTA----IREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCC--C--------C----HHHHHHGGGCCCTTBCCEEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccc--ccccccchhH----HHHHHHHHHcCCCCcceEEEEEe
Confidence 455778999999999999999999874 556777764322 2222222333 78999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.. ..++||||++ ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 104 ~~~--------------~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 104 HNH--------------RLHLIFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp ETT--------------EEEEEEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCC--------------EEEEEEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 755 3499999998 699999976 34699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.++ ....+.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++
T Consensus 164 ll~~~~--~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 164 LLSVSD--ASETPVLKIGDFGLARAFGIPIR----------QFTHEIITLWYRPPEILLG---SRHYSTSVDIWSIACIW 228 (329)
T ss_dssp EEEC-------CCEEEECCTTHHHHHC---------------------CCTTCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEecCC--CCccceEEECcCCCccccCCccc----------ccCCCcCCccccCHHHhcC---CCCCCcHHHHHHHHHHH
Confidence 996541 11226799999999976543211 1123468999999999876 23578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|+|++|+.||.+....+....+.. ...+... .+....... ....................++++.+||.+||+.||
T Consensus 229 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 307 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT-TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307 (329)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT-TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred HHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh-hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence 999999999998777665555422 1111111 000000000 000000000000001112356789999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001143 1117 TERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~s 1135 (1141)
.+|||+.|+++|+||....
T Consensus 308 ~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 308 VKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GGSCCHHHHHTSGGGSSSC
T ss_pred hhCCCHHHHhCCcccCCCC
Confidence 9999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=353.97 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=210.0
Q ss_pred CCCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..++|++.+.||+|+||.||+|.+ .+..+|+|+.... ... .+. +.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMS---EED----FIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBC---HHH----HHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccC---HHH----HHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 346799999999999999999998 5666888876422 111 123 379999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 79 ~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 140 (269)
T 4hcu_A 79 P--------------ICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 140 (269)
T ss_dssp S--------------EEEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred c--------------eEEEEEeCCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc
Confidence 3 4999999999999999975 234699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 200 (269)
T 4hcu_A 141 EN-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEV 200 (269)
T ss_dssp GG-------GCEEECCTTGGGGBCCHHHH---------STTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEeccccccccccccccc---------cccCcccccccCCHHHhcC----CCCCchhhhHHHHHHHHHH
Confidence 87 78999999999765432211 1123357889999999976 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |+.||......+....+..+..+..+. ..++.+.+++.+||+.||.+|||
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps 253 (269)
T 4hcu_A 201 FSEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRPA 253 (269)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hcCCCCCCCCCCHHHHHHHHhcCccCCCCC---------------------------cCCHHHHHHHHHHccCCcccCcC
Confidence 99 999999888877777765543322211 34567999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.++++++.....
T Consensus 254 ~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 254 FSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=376.61 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=203.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+.+|++.+.||+|+||.||+|.+ .+..||+|+..... ........++.+|+.+++.++||||+++++++.
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL-----LKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH-----ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34578899999999999999999998 56678888764221 111122234589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
... ..++||||+ +|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 80 ~~~--------------~~~lv~E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 139 (336)
T 3h4j_B 80 TPT--------------DIVMVIEYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139 (336)
T ss_dssp CSS--------------EEEEEECCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred eCC--------------EEEEEEECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence 655 359999999 6899998876 24699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++....... ......||+.|+|||++.+. ...+.++|||||||++
T Consensus 140 ll~~~-------~~~kl~DFG~s~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il 198 (336)
T 3h4j_B 140 LLDDN-------LNVKIADFGLSNIMTDGN-----------FLKTSCGSPNYAAPEVINGK---LYAGPEVDVWSCGIVL 198 (336)
T ss_dssp EECTT-------CCEEECCSSCTBTTTTSB-----------TTCCCTTSTTTSCGGGSCCS---GGGCHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEEeccceeccCCc-----------ccccccCCcCcCCHHHHcCC---CCCCCccchhHHHHHH
Confidence 99987 789999999997654321 11234699999999998762 2236899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||.+....+....+..+. ... +...++.+.+||.+||+.||.+|
T Consensus 199 ~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------------~~~---p~~~s~~~~~li~~~L~~dP~~R 250 (336)
T 3h4j_B 199 YVMLVGRLPFDDEFIPNLFKKVNSCV-------------------------YVM---PDFLSPGAQSLIRRMIVADPMQR 250 (336)
T ss_dssp HHHHHSSCSSBCSSSTTCBCCCCSSC-------------------------CCC---CTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHHHhCCCCCCCccHHHHHHHHHcCC-------------------------CCC---cccCCHHHHHHHHHHcCCChhHC
Confidence 99999999997643222111110000 000 11456779999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||++|+++|+|+...
T Consensus 251 pt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 251 ITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCHHHHTTCHHHHTT
T ss_pred cCHHHHHhChhhccC
Confidence 999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=365.56 Aligned_cols=261 Identities=19% Similarity=0.322 Sum_probs=208.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
...+|++.+.||+|+||.||+|.+. +..||+|+.... ......+. +.+|+.++++++||||+++++++
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRD----FLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHH----HHHHHHHHHhCCCCCCCcEEEEE
Confidence 4567999999999999999999984 233777765422 12333333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.... ++||||+++++|.++++. ....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 120 ~~~~~~--------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 181 (325)
T 3kul_A 120 TRGRLA--------------MIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN 181 (325)
T ss_dssp CGGGCC--------------EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EeCCcc--------------EEEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 765543 999999999999999965 23469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+++.......... ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 182 Ill~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 243 (325)
T 3kul_A 182 VLVDSN-------LVCKVSDFGLSRVLEDDPDAAY-------TTTGGKIPIRWTAPEAIAF----RTFSSASDVWSFGVV 243 (325)
T ss_dssp EEECTT-------CCEEECCCSSCEECC----CCE-------ECC---CCGGGSCHHHHHH----CEECHHHHHHHHHHH
T ss_pred EEECCC-------CCEEECCCCcccccccCcccee-------eccCCCCcccccCHhHhcC----CCCCcHHHHHHHHHH
Confidence 999887 7899999999987544221110 1112346788999999986 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++ |..||.+....++...+..+..+..+. .++..+.+++.+||..||.
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 296 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM---------------------------GCPHALHQLMLDCWHKDRA 296 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC---------------------------CcCHHHHHHHHHHccCChh
Confidence 999999 999999888887777776554332211 4566799999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+|||+.++++.+.....
T Consensus 297 ~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 297 QRPRFSQIVSVLDALIR 313 (325)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999877543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=362.35 Aligned_cols=291 Identities=21% Similarity=0.224 Sum_probs=207.8
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeEe
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkllg~~~ 879 (1141)
..+|++.++||+|+||+||+|++ .+..||+|+........... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG---GLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS---CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc---ccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 46899999999999999999996 46778888865443211110 1111225677777666 4999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... ......++||||+. ++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 85 ~~~~---------~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 151 (308)
T 3g33_A 85 TSRT---------DREIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151 (308)
T ss_dssp ECCS---------SSEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTE
T ss_pred ccCC---------CCceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 6431 12335799999997 699999976 2333599999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 152 l~~~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 209 (308)
T 3g33_A 152 LVTSG-------GTVKLADFGLARIYSYQM-----------ALTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIF 209 (308)
T ss_dssp EECTT-------SCEEECSCSCTTTSTTCC-----------CSGGGGCCCSSCCHHHHHT----SCCCSTHHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeCccccccCCCc-----------ccCCccccccccCchHHcC----CCCCchHHHHHHHHHH
Confidence 99887 789999999997653321 1224568999999999976 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||.+.+..+....+...........+..........+ ...............++.+.+||.+||+.||++|
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 288 (308)
T 3g33_A 210 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF-PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR 288 (308)
T ss_dssp HHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS-CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc-CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccC
Confidence 999999999998887776655532111111111100000000000 0000000111122566789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||+.|+++|+|+...
T Consensus 289 ~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 289 ISAFRALQHSYLHKD 303 (308)
T ss_dssp CCHHHHHTSTTC---
T ss_pred CCHHHHhcCccccCC
Confidence 999999999999754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=384.07 Aligned_cols=284 Identities=17% Similarity=0.236 Sum_probs=205.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.++||+|+||+||+|.+. +..||+|+.. .........+ ++.+|+.+++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~--~~~~~~~~~~----~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEE--SGGGSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEEC--ccccChHHHH----HHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 578999999999999999999985 5567777654 2222223333 3479999999999999999999997644
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ....+.|+||||++ ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 135 ~~--------~~~~~~~lv~E~~~-~~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 135 TL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp ST--------TTCCEEEEEEECCS-EEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cc--------ccCCeEEEEEeCCC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 22 12346799999997 567776643 489999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 199 ~~-------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el 256 (464)
T 3ttj_A 199 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 256 (464)
T ss_dssp TT-------SCEEECCCCCC-----CC-----------CC----CCCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEEEEeeeecCCCc-----------ccCCCcccccccCHHHHcC----CCCCHHHHHHHHHHHHHHH
Confidence 87 789999999997654311 1224579999999999987 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCC---------------CCchhhhhhHHHHHHH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---------------EKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~L~dL 1107 (1141)
++|+.||.+.+..+....+......+.+..+....... .......... .........+.++.+|
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 335 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 335 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH-HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh-hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHH
Confidence 99999999988777666663322222222111110000 0000000000 0011112336789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
|.+||++||.+|||++|+++|+|+..
T Consensus 336 l~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 336 LSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHcCCChhhCCCHHHHhcChhhhh
Confidence 99999999999999999999999973
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=382.03 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=211.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..++|++.++||+|+||.||+|++. +..+|+|+..... .........+.+|+.+++.++|||||++++++.+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh-----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3567999999999999999999985 5567888754211 11111112347899999999999999999999875
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. +.|+||||++||+|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 142 ~--------------~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl 201 (410)
T 3v8s_A 142 R--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201 (410)
T ss_dssp S--------------EEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE
Confidence 5 34999999999999999975 258999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+........ .....+||+.|+|||++.+......++.++|||||||++||
T Consensus 202 ~~~-------g~ikL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilye 265 (410)
T 3v8s_A 202 DKS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265 (410)
T ss_dssp CTT-------SCEEECCCTTCEECCTTSEE---------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeccceeEeeccCCcc---------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHH
Confidence 987 88999999999765432211 11245799999999999863322337899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~-- 1118 (1141)
|++|+.||.+.+..+....+..... ...+. ....+.++.+||.+||..+|.+
T Consensus 266 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~lL~~~~~rlg 320 (410)
T 3v8s_A 266 MLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRLG 320 (410)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-------------------------TCCCCHHHHHHHHHHSSCGGGCTT
T ss_pred HHhCCCCCCCCChhhHHHHHHhccccccCCC-------------------------cccccHHHHHHHHHHccChhhhCC
Confidence 9999999998888777776643210 00000 0145667999999999999988
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
||+++||++|+||+..
T Consensus 321 R~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 321 RNGVEEIKRHLFFKND 336 (410)
T ss_dssp SSCHHHHHTSGGGCCS
T ss_pred CCCHHHHhcCccccCC
Confidence 9999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.40 Aligned_cols=268 Identities=24% Similarity=0.245 Sum_probs=203.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHH
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRM 862 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~------------------~~~~~~~~~~~~Ei~i 862 (1141)
..+.+|++.+.||+|+||.||+|++. +..+|+|+.......... .........+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 44678999999999999999999984 567888876533211100 0001112345899999
Q ss_pred HhhCCCCCccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 001143 863 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 863 L~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+++++||||+++++++.+.. ....++||||+++++|.+++. ...+++..++.++.||+.||.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~------------~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~ 151 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPN------------EDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIE 151 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSS------------SSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCC------------CCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHH
Confidence 99999999999999987632 125699999999999877543 247999999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||++||+||||||+|||++.+ +.+||+|||++......... .....||+.|+|||++.+..
T Consensus 152 ~lH~~~ivH~Dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~- 213 (298)
T 2zv2_A 152 YLHYQKIIHRDIKPSNLLVGED-------GHIKIADFGVSNEFKGSDAL----------LSNTVGTPAFMAPESLSETR- 213 (298)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-------SCEEECCCTTCEECSSSSCE----------ECCCCSCGGGCCGGGCCTTC-
T ss_pred HHHHCCeeccCCCHHHEEECCC-------CCEEEecCCCcccccccccc----------ccCCcCCccccChhhhccCC-
Confidence 9999999999999999999887 78999999999765432111 12346999999999987521
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1102 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1141)
...++.++|||||||++|+|++|+.||...........+......... ....++
T Consensus 214 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~ 267 (298)
T 2zv2_A 214 KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD--------------------------QPDIAE 267 (298)
T ss_dssp CCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------------------------SSCCCH
T ss_pred CCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC--------------------------ccccCH
Confidence 112478999999999999999999999887766666555433221100 014456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+.++|.+||+.||.+|||+.|+++|+|+.
T Consensus 268 ~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 268 DLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 799999999999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=370.16 Aligned_cols=261 Identities=24% Similarity=0.280 Sum_probs=203.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+++|++.+.||+|+||.||+|.+. +..+|+|+...+.. ....+ .+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPE----NIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHH----HHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3678999999999999999999985 66788887653321 11122 347999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 78 ~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll 138 (323)
T 3tki_A 78 N--------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138 (323)
T ss_dssp S--------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--------------eEEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE
Confidence 5 34999999999999998854 3469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++..+...... .......||+.|+|||++.+. ..++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ 200 (323)
T 3tki_A 139 DER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKRR---EFHAEPVDVWSCGIVLTA 200 (323)
T ss_dssp CTT-------CCEEECCCTTCEECEETTEE--------CCBCSCCSCGGGSCHHHHHCS---SBCHHHHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEEeeccceeccCCcc--------cccCCCccCcCccCcHHhccC---CCCCCcccHHHHHHHHHH
Confidence 887 78999999999765432211 111245699999999999762 234689999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++|+.||...... .............. .....+..+.+|+.+||+.||.+||
T Consensus 201 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~ 254 (323)
T 3tki_A 201 MLAGELPWDQPSDSCQEYSDWKEKKTYLN--------------------------PWKKIDSAPLALLHKILVENPSARI 254 (323)
T ss_dssp HHHSSCSCSSSCTTSHHHHHHHTTCTTST--------------------------TGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHhCCCCCCCCchHHHHHHHHhcccccCC--------------------------ccccCCHHHHHHHHHHccCChhhCc
Confidence 99999999764432 12222211111000 0114566789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|+.|+++|+|+...
T Consensus 255 t~~eil~h~~~~~~ 268 (323)
T 3tki_A 255 TIPDIKKDRWYNKP 268 (323)
T ss_dssp CHHHHTTCTTTTCC
T ss_pred CHHHHhhChhhccc
Confidence 99999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=377.28 Aligned_cols=259 Identities=21% Similarity=0.338 Sum_probs=203.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
...+.+|++.++||+|+||.||+|++. +..+|+|+.+..... .....+ .+.+|..++.++ +|||||++++++
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~----~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDID----WVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CC----HHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHH----HHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 345788999999999999999999985 456788876533221 112222 237899999887 799999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.. ..++||||++||+|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 123 ~~~~--------------~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~N 183 (396)
T 4dc2_A 123 QTES--------------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 183 (396)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EECC--------------EEEEEEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 8755 35999999999999999986 2469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+|+...... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 184 ILl~~~-------g~ikL~DFGla~~~~~~~----------~~~~~~~gt~~Y~aPE~l~~----~~~~~~~DiwslGvl 242 (396)
T 4dc2_A 184 VLLDSE-------GHIKLTDYGMCKEGLRPG----------DTTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVL 242 (396)
T ss_dssp EEECTT-------SCEEECCCTTCBCCCCTT----------CCBCCCCBCGGGCCHHHHTT----CCBCTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEeecceeeecccCC----------CccccccCCcccCCchhhcC----CCCChHHHHHHHHHH
Confidence 999988 889999999997532211 11234579999999999986 568899999999999
Q ss_pred HHHHHhCCCCCCCCC---------HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 001143 1039 LLELLTLQVPYMGLS---------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1109 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~---------~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~ 1109 (1141)
+|||++|+.||.... ...+...+..... .++ ...+.++.+||.
T Consensus 243 lyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li~ 294 (396)
T 4dc2_A 243 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP---------------------------RSLSVKAASVLK 294 (396)
T ss_dssp HHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHH
T ss_pred HHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-CCC---------------------------CcCCHHHHHHHH
Confidence 999999999996421 1223333322211 111 145567999999
Q ss_pred HhcccCCCCCCCH------HHHHHHHHhhc
Q 001143 1110 RCTEENPTERPTA------GDLYEMFVART 1133 (1141)
Q Consensus 1110 ~cL~~DP~~RPSa------~ElL~~L~~~~ 1133 (1141)
+||+.||.+||++ +|+++|+||..
T Consensus 295 ~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 295 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred HHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 9999999999984 89999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=368.01 Aligned_cols=284 Identities=19% Similarity=0.259 Sum_probs=209.8
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----CCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----HSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----HpNIVkllg~ 877 (1141)
-++|++.++||+|+||+||+|++ .+..+|+|+... ....... +..|+.+++++. ||||++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~----~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRS----AKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHH----HHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhh----hHHHHHHHHHhcccCCCCCCeecccce
Confidence 35799999999999999999998 466788887541 1222223 368999999986 9999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+...+ +.++||||+ +++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+
T Consensus 105 ~~~~~--------------~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 166 (360)
T 3llt_A 105 FMYYD--------------HMCLIFEPL-GPSLYEIITR---NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166 (360)
T ss_dssp EEETT--------------EEEEEECCC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eeECC--------------eeEEEEcCC-CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcc
Confidence 98654 459999999 8999999986 23345999999999999999999999999999999999
Q ss_pred Ceeeeccccc------------------CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcc
Q 001143 958 NILIDLERKK------------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019 (1141)
Q Consensus 958 NILld~~~~~------------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1019 (1141)
|||++..... ....+.+||+|||+++..... .....||+.|+|||++.+
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------------HGSIINTRQYRAPEVILN 233 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------------CCSCCSCGGGCCHHHHTT
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-------------CcCccCcccccCcHHHcC
Confidence 9999751000 001278999999999754321 123468999999999986
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccc-cccCCC--C-----
Q 001143 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQSGSG--F----- 1091 (1141)
Q Consensus 1020 ~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~~~~~--~----- 1091 (1141)
..++.++|||||||++|+|++|+.||.+....+....+.....+................. ...... +
T Consensus 234 ----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 309 (360)
T 3llt_A 234 ----LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENAS 309 (360)
T ss_dssp ----CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCS
T ss_pred ----CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCccccc
Confidence 5688999999999999999999999998887777766644443333222211110000000 000000 0
Q ss_pred ----------CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1092 ----------EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1092 ----------~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
..+......++.+.+||.+||+.||.+|||+.|+++|+|++
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 310 SINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred chhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00111112336788999999999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=374.68 Aligned_cols=297 Identities=19% Similarity=0.214 Sum_probs=210.2
Q ss_pred CCCCCceEeeeeccc--CceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 803 GSFPSLSSCDEAGKS--VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~G--sfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
....+|++.++||+| +||.||+|++. +..||+|+..... ......+ .+.+|+.++++++|||||++++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVT----FLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHH----HHHHHHHHHHhCCCCCCCcEeEEE
Confidence 345679999999999 99999999985 6678888765432 2233333 347899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.+ ..++||||+++++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 96 ~~~~--------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 158 (389)
T 3gni_B 96 IADN--------------ELWVVTSFMAYGSAKDLICT---HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH 158 (389)
T ss_dssp EETT--------------EEEEEEECCTTCBHHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EECC--------------EEEEEEEccCCCCHHHHHhh---hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 8755 34999999999999999976 223469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||.+............ .........||+.|+|||++.+. ...++.++|||||||+
T Consensus 159 Ill~~~-------~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 159 ILISVD-------GKVYLSGLRSNLSMISHGQRQRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGIT 226 (389)
T ss_dssp EEECTT-------CCEEECCGGGCEECEETTEECSC---BCCCCTTCTTTGGGSCHHHHSTT--SSCBCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEcccccceeeccccccccc---cccccccccccccccCHHHHhcc--CCCCCcHhHHHHHHHH
Confidence 999887 78999999998764332211100 11123345799999999999762 1457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC-------------ccccccc-----cCCCCCCchhhhhh
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-------------HEHEVAQ-----SGSGFEKPEAELET 1100 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-------------~~~~~~~-----~~~~~~~~~~~~~~ 1100 (1141)
+|+|++|+.||.+.+..+....+..+..+.+.......... ....... ..............
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 99999999999876554443333222221111000000000 0000000 00000000112245
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1101 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1101 ~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
++.+.+||.+||+.||.+|||+.|+++|+|+...
T Consensus 307 s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 6789999999999999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=368.39 Aligned_cols=266 Identities=25% Similarity=0.359 Sum_probs=217.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~ 882 (1141)
.+|++.+.||+|+||.||+|.+. +..||||+...............+...+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 46999999999999999999984 67899998765544344455555566678999999999 7999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||++|++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 174 --------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 174 --------------FMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234 (365)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 45999999999999999976 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC--CCCCCchhhHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVWSLGviL~ 1040 (1141)
.+ +.+||+|||++..+..... .....||+.|+|||++.+... ...++.++|||||||++|
T Consensus 235 ~~-------~~ikl~DfG~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 235 DN-------MQIRLSDFGFSCHLEPGEK-----------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp TT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred CC-------CCEEEEecCcccccCCCcc-----------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence 87 7899999999876543211 123469999999999875321 235789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|..||...........+..+........+ ...+..+.+++.+||+.||.+||
T Consensus 297 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rp 352 (365)
T 2y7j_A 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW------------------------DDRSSTVKDLISRLLQVDPEARL 352 (365)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH------------------------SSSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc------------------------ccCCHHHHHHHHHHcCCChhHCc
Confidence 999999999887777766666554432211110 13456799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
|+.|+++|+|+.
T Consensus 353 s~~ell~hp~f~ 364 (365)
T 2y7j_A 353 TAEQALQHPFFE 364 (365)
T ss_dssp CHHHHHHSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=369.54 Aligned_cols=262 Identities=23% Similarity=0.366 Sum_probs=208.8
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccc
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 873 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~---------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVk 873 (1141)
..++|++.+.||+|+||.||+|++.+ ..+|+|+.+ .. ......+. +.+|+.+++++ +||||++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD-ATEKDLSD----LVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECC--TT-CBHHHHHH----HHHHHHHHHHSCCCTTBCC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEec--CC-cCHHHHHH----HHHHHHHHHHhcCCCCEee
Confidence 34679999999999999999998731 236666643 21 12233333 48999999999 8999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHH
Q 001143 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 874 llg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+++++.+.+.+ |+||||+++|+|.+++...... ....+++.+++.++.||+.||+
T Consensus 152 ~~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 217 (370)
T 2psq_A 152 LLGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 217 (370)
T ss_dssp EEEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEccCCCE--------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 99999876544 9999999999999999863211 1235899999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||++||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 218 ~LH~~~ivHrDlkp~NIll~~~-------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~--- 279 (370)
T 2psq_A 218 YLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFD--- 279 (370)
T ss_dssp HHHHTTEECSCCCGGGEEECTT-------CCEEECCCSSCEETTCCCTT--------CTTTTTTSCGGGCCHHHHHT---
T ss_pred HHHhCCeeccccchhhEEECCC-------CCEEEccccCCcccCcccce--------ecccCCCcccceECHhHhcC---
Confidence 9999999999999999999887 78999999999765432211 11123357889999999976
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1141)
..++.++|||||||++|||++ |..||.+....++...+..+..+..+. .++
T Consensus 280 -~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 331 (370)
T 2psq_A 280 -RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCT 331 (370)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TSC
T ss_pred -CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCC
Confidence 568999999999999999999 999999877777776665554332221 455
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1102 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
..+.+++.+||+.||.+|||+.|+++++...
T Consensus 332 ~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 6799999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=363.65 Aligned_cols=284 Identities=21% Similarity=0.253 Sum_probs=205.2
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
...+|++.++||+|+||+||+|++.+..||+|++... ...... ..+|+.++++++||||+++++++.....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-----DKQSWQ----NEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-----GHHHHH----HHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecC-----chHHHH----HHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3567999999999999999999999999999986532 122222 2579999999999999999999986432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccC
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRD 953 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~----------gIvHrD 953 (1141)
.....++||||+++|+|.++++. ..+++..++.|+.||+.||.|||+. ||+|||
T Consensus 93 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~D 156 (322)
T 3soc_A 93 ----------VDVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156 (322)
T ss_dssp ----------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSC
T ss_pred ----------CCceEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCC
Confidence 12356999999999999999976 3599999999999999999999999 999999
Q ss_pred CCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC-CCCCCchhhH
Q 001143 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDI 1032 (1141)
Q Consensus 954 LKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDV 1032 (1141)
|||+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+... ...++.++||
T Consensus 157 lkp~Nill~~~-------~~~kL~DFg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 221 (322)
T 3soc_A 157 IKSKNVLLKNN-------LTACIADFGLALKFEAGKSA--------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221 (322)
T ss_dssp CSGGGEEECTT-------CCEEECCCTTCEEECTTSCC--------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred CChHhEEECCC-------CeEEEccCCcccccccccCc--------cccccCccCccccCHhhcccccccCcCCCccchh
Confidence 99999999887 78999999999765432211 11223569999999999875211 1234578999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001143 1033 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111 (1141)
Q Consensus 1033 WSLGviL~ELLTGk~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~c 1111 (1141)
|||||++|||++|+.||.+....... ........+............ ...............+..+.+|+.+|
T Consensus 222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~c 295 (322)
T 3soc_A 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK------KKRPVLRDYWQKHAGMAMLCETIEEC 295 (322)
T ss_dssp HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc------cCCCCccccccccchHHHHHHHHHHH
Confidence 99999999999999999753221100 000001111111110000000 00000000001124567799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 001143 1112 TEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1112 L~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
|+.||++|||+.|+++.+....
T Consensus 296 l~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 296 WDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=363.06 Aligned_cols=288 Identities=21% Similarity=0.314 Sum_probs=196.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
+..+|++.++||+|+||.||+|.+. +..+|+|+...... ....+ .+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPS----TAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST---TCSCH----HHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHH----HHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 3568999999999999999999874 66788887654321 11112 237899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
+ ..++||||++ ++|.+++...... ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 76 ~--------------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl 140 (317)
T 2pmi_A 76 N--------------KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLL 140 (317)
T ss_dssp T--------------EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred C--------------eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeE
Confidence 4 3599999998 6999998763321 2235899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 200 (317)
T 2pmi_A 141 INKR-------GQLKLGDFGLARAFGIPVN----------TFSSEVVTLWYRAPDVLMG---SRTYSTSIDIWSCGCILA 200 (317)
T ss_dssp ECTT-------CCEEECCCSSCEETTSCCC----------CCCCCCSCCTTCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcCccceecCCCcc----------cCCCCcccccccCchHhhC---CCCCCcHHHHHHHHHHHH
Confidence 9887 7899999999976543211 1123468999999999875 235789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHh--CCCCC-chhHHhhhccCcccccccc-CCCCC---CchhhhhhHHHHHHHHHHhcc
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQM--GKRPR-LTDELEALGSCHEHEVAQS-GSGFE---KPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~--~~~p~-l~~~l~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
+|++|+.||.+.+..+....+.. +..+. ............ ...... ..... .+......+.++.+||.+||+
T Consensus 201 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence 99999999998877776655532 11111 100000000000 000000 00000 000011356789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001143 1114 ENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.||++|||+.|+++|+|+...
T Consensus 280 ~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 280 LNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp SSGGGSCCHHHHTTSGGGGGG
T ss_pred CCcccCCCHHHHhCChhhhcc
Confidence 999999999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.73 Aligned_cols=260 Identities=22% Similarity=0.258 Sum_probs=210.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+++|++.+.||+|+||.||+|.+. +..+|+|+..... .........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-----LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-----cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 345678999999999999999999985 4457777754221 111222334589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 85 ~~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 145 (284)
T 2vgo_A 85 DRK--------------RIYLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145 (284)
T ss_dssp CSS--------------EEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred cCC--------------EEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 654 359999999999999999762 3689999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 202 (284)
T 2vgo_A 146 LMGYK-------GELKIADFGWSVHAPSLR------------RRTMCGTLDYLPPEMIEG----KTHDEKVDLWCAGVLC 202 (284)
T ss_dssp EECTT-------CCEEECCCTTCEECSSSC------------BCCCCSCGGGCCHHHHTT----CCBCTTHHHHHHHHHH
T ss_pred EEcCC-------CCEEEecccccccCcccc------------cccccCCCCcCCHHHhcc----CCCCcccchhhHHHHH
Confidence 99887 789999999986543211 123468999999999886 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|..||......+....+...... ++ ...+..+.++|.+||+.||.+|
T Consensus 203 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R 254 (284)
T 2vgo_A 203 YEFLVGMPPFDSPSHTETHRRIVNVDLK-FP---------------------------PFLSDGSKDLISKLLRYHPPQR 254 (284)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTTCCC-CC---------------------------TTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHCCCCCCCCCHhHHHHHHhccccC-CC---------------------------CcCCHHHHHHHHHHhhcCHhhC
Confidence 9999999999887776665555432211 10 1345678999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001143 1120 PTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s~ 1136 (1141)
||+.++++|+|+.....
T Consensus 255 ps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 255 LPLKGVMEHPWVKANSR 271 (284)
T ss_dssp CCHHHHHTCHHHHHHCC
T ss_pred CCHHHHhhCHHHHhhcc
Confidence 99999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=373.43 Aligned_cols=293 Identities=19% Similarity=0.251 Sum_probs=201.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~ 881 (1141)
..+|++.++||+|+||.||+|.+. +..||+|+.. .........+.+ .+|+.++.++. ||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~~----~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQRT----FREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEEC--C--CCHHHHHHH----HHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEec--ccccChHHHHHH----HHHHHHHHhccCCCCCCeeeeEEecC
Confidence 468999999999999999999985 5667777643 222333333333 79999999997 99999999998753
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. ...|+||||++ ++|..+++. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 82 ~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 82 ND------------RDVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TS------------SCEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CC------------CEEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 31 24699999997 699999875 369999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecccccccccccccccc-----------ccCCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~-----------~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1030 (1141)
+.+ +.+||+|||+|+.+......... ...........+||+.|+|||++.+ ...++.++
T Consensus 143 ~~~-------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~ 212 (388)
T 3oz6_A 143 NAE-------CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG---STKYTKGI 212 (388)
T ss_dssp CTT-------CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT---CCCCCTHH
T ss_pred cCC-------CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC---CCCCCChh
Confidence 887 88999999999865431110000 0001112234579999999999875 24688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccc----cc----cCCCCCC--ch----
Q 001143 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEV----AQ----SGSGFEK--PE---- 1095 (1141)
Q Consensus 1031 DVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~----~~----~~~~~~~--~~---- 1095 (1141)
|||||||++|||++|++||.+.+..+....+.. ...|... .+........... .. ....... +.
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNE-DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH-HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhh
Confidence 999999999999999999998887776666532 2222211 1111000000000 00 0000000 00
Q ss_pred -----hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1096 -----AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1096 -----~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.....++++.+|+.+||+.||.+|||++|+++|+|+..
T Consensus 292 ~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp HHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred cccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence 00144678999999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=362.73 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=210.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.|++.+.||+|+||.||+|++. +..+|+|+........... ......+.+|+.++++++||||+++++++.+..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 88 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYENRT- 88 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 35899999999999999999984 6678888865443221110 001123479999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 89 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~ 150 (321)
T 2a2a_A 89 -------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (321)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEec
Confidence 35999999999999999975 346999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++. ....+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 151 ~~~---~~~~~kl~Dfg~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 212 (321)
T 2a2a_A 151 KNI---PIPHIKLIDFGLAHEIEDGV-----------EFKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 212 (321)
T ss_dssp TTS---SSCCEEECCCTTCEECCTTC-----------CCCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CCC---CcCCEEEccCccceecCccc-----------cccccCCCCCccCcccccC----CCCCCccccHHHHHHHHHHH
Confidence 621 11279999999997654321 1123468999999999876 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+....+....+.......... .....+..+.++|.+||+.||.+|||+.
T Consensus 213 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 268 (321)
T 2a2a_A 213 SGASPFLGDTKQETLANITSVSYDFDEE------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQ 268 (321)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCHH------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhcccccChh------------------------hhcccCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999887777776665443321111 1114556799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|+..
T Consensus 269 e~l~hp~~~~ 278 (321)
T 2a2a_A 269 EALRHPWITP 278 (321)
T ss_dssp HHHHSTTTSC
T ss_pred HHhcCccccC
Confidence 9999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.97 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=201.6
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
..|++.+.||+|+||.||+|.+......++++.+..........+.+ .+|+.++++++||||+++++++.....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 99 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRFYDSWESTVK-- 99 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEEEESS--
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHH----HHHHHHHHhCCCCCeeeeeeeeccccC--
Confidence 34899999999999999999986555444443343333333333444 899999999999999999999875321
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeee-
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILID- 962 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NILld- 962 (1141)
.....++||||+++++|.+++.. ...+++..++.|+.||+.||.|||++| |+||||||+|||++
T Consensus 100 --------~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~ 166 (290)
T 1t4h_A 100 --------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 166 (290)
T ss_dssp --------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred --------CCceEEEEEEecCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC
Confidence 12356999999999999999976 246899999999999999999999999 99999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 167 ~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l 222 (290)
T 1t4h_A 167 PT-------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp TT-------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCcccccccc------------cccccCCcCcCCHHHHhc-----cCCCcchHHHHHHHHHHH
Confidence 44 789999999986543211 123458999999998864 478999999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|+.||..... .+....+..+..+.. .....++.+.+++.+||+.||.+|||
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps 276 (290)
T 1t4h_A 223 ATSEYPYSECQNAAQIYRRVTSGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYS 276 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HhCCCCCCCcCcHHHHHHHHhccCCccc--------------------------cCCCCCHHHHHHHHHHccCChhhCCC
Confidence 999999987443 334444433322211 11134467999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.|+++|+|+...
T Consensus 277 ~~ell~h~~f~~~ 289 (290)
T 1t4h_A 277 IKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHTSGGGC--
T ss_pred HHHHhhCcccccC
Confidence 9999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=366.94 Aligned_cols=291 Identities=22% Similarity=0.267 Sum_probs=211.7
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 799 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 799 ~~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
.+....+++|++.+.||+|+||.||+|++. +..||+|+.... .......+ .+.+|+.++++++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~ 91 (331)
T 4aaa_A 18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKK----IAMREIKLLKQLRHENLVNLLE 91 (331)
T ss_dssp -CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC--SSCHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC--CCchHHHH----HHHHHHHHHhhCCCCCEeeEEE
Confidence 455667889999999999999999999985 567888875422 22222223 3479999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++.+.. ..++||||+++++|..++.. ...+++..+..|+.||+.||.|||++||+||||||
T Consensus 92 ~~~~~~--------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 152 (331)
T 4aaa_A 92 VCKKKK--------------RWYLVFEFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152 (331)
T ss_dssp EEEETT--------------EEEEEEECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EeecCC--------------EEEEEEecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcCh
Confidence 998655 34999999999888887654 34699999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|||++.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++||||||
T Consensus 153 ~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG 212 (331)
T 4aaa_A 153 ENILVSQS-------GVVKLCDFGFARTLAAPGE----------VYDDEVATRWYRAPELLVG---DVKYGKAVDVWAIG 212 (331)
T ss_dssp GGEEECTT-------SCEEECCCTTC----------------------CCCCCTTCCHHHHTT---CTTCCTHHHHHHHH
T ss_pred heEEEcCC-------CcEEEEeCCCceeecCCcc----------ccCCCcCCccccCcccccC---CCCcchHHHHHHHH
Confidence 99999887 7899999999976543211 1123468999999999875 23678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHh---hhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE---ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
|++|+|++|+.||.+....+....+........+.... ..........................++.+.+|+.+||+
T Consensus 213 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 292 (331)
T 4aaa_A 213 CLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292 (331)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhc
Confidence 99999999999999877766554442222111111111 100000000000000000111122567889999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001143 1114 ENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.||.+|||+.|+++|+|+...
T Consensus 293 ~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 293 IDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp SSGGGSCCGGGGGGSHHHHGG
T ss_pred cCcccCCCHHHHhcCchhccC
Confidence 999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=372.56 Aligned_cols=259 Identities=23% Similarity=0.287 Sum_probs=203.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HhhCCCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIVkllg~~ 878 (1141)
.....+|++.+.||+|+||.||+|++. +..+|+|+......... ..... +.+|..+ ++.++||||+++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~----~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKH----IMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHH----HHHHHHHHHHhCCCCCCCCEEEEE
Confidence 455778999999999999999999985 45678887654322111 11222 2567776 4678999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.+ ..|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 109 ~~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 169 (373)
T 2r5t_A 109 QTAD--------------KLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169 (373)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence 8755 45999999999999999976 2468999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 170 Ill~~~-------g~ikL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 228 (373)
T 2r5t_A 170 ILLDSQ-------GHIVLTDFGLCKENIEHN----------STTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAV 228 (373)
T ss_dssp EEECTT-------SCEEECCCCBCGGGBCCC----------CCCCSBSCCCCCCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEeeCccccccccCC----------CccccccCCccccCHHHhCC----CCCCchhhhHHHHHH
Confidence 999987 889999999997532211 11234579999999999976 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||++|..||.+.+..++...+...... ++ ...+..+.+||.+||+.||.+
T Consensus 229 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~lL~~dp~~ 280 (373)
T 2r5t_A 229 LYEMLYGLPPFYSRNTAEMYDNILNKPLQ-LK---------------------------PNITNSARHLLEGLLQKDRTK 280 (373)
T ss_dssp HHHHHHSSCTTCCSBHHHHHHHHHHSCCC-CC---------------------------SSSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhcccC-CC---------------------------CCCCHHHHHHHHHHcccCHHh
Confidence 99999999999988887777776543221 10 134567999999999999999
Q ss_pred CCCH----HHHHHHHHhhc
Q 001143 1119 RPTA----GDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa----~ElL~~L~~~~ 1133 (1141)
||++ .++++|+||..
T Consensus 281 R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 281 RLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp STTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHhCCccccC
Confidence 9986 69999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=370.78 Aligned_cols=268 Identities=21% Similarity=0.331 Sum_probs=212.8
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 874 (1141)
.....+|++.++||+|+||.||+|.+. +..||+|+.. .. ........ +.+|+.++++++||||+++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EV-CSEQDELD----FLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECC--SS-CCHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecc--cc-cChhhHHH----HHHHHHHHHhCCCCCCCeE
Confidence 345678999999999999999999963 3357777642 21 12233333 3789999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHr 952 (1141)
++++.+.... ++||||+++|+|.++++..... ....+++..++.|+.||+.||.|||++||+||
T Consensus 140 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 205 (367)
T 3l9p_A 140 IGVSLQSLPR--------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205 (367)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEecCCCC--------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 9999865543 9999999999999999874321 22459999999999999999999999999999
Q ss_pred CCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001143 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032 (1141)
Q Consensus 953 DLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1032 (1141)
||||+|||++.++ ....+||+|||+++.+...... .......||+.|+|||++.+ ..++.++||
T Consensus 206 Dlkp~NIll~~~~----~~~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dv 269 (367)
T 3l9p_A 206 DIAARNCLLTCPG----PGRVAKIGDFGMARDIYRAGYY--------RKGGCAMLPVKWMPPEAFME----GIFTSKTDT 269 (367)
T ss_dssp CCCGGGEEESCSS----TTCCEEECCCHHHHHHHHHSSC--------TTCCGGGSCGGGCCHHHHHH----CCCCHHHHH
T ss_pred CCChhhEEEecCC----CCceEEECCCcccccccccccc--------ccCCCcCCcccEECHHHhcC----CCCCcHHHH
Confidence 9999999998541 1146999999999754332111 11223468999999999976 568899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001143 1033 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111 (1141)
Q Consensus 1033 WSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~c 1111 (1141)
|||||++|||++ |..||.+....++...+..+..+..+. .++..+.+|+.+|
T Consensus 270 wslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~ 322 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMTQC 322 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHH
Confidence 999999999998 999999888888877776655433221 4456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 001143 1112 TEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1112 L~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
|+.||.+|||+.+|++++++..
T Consensus 323 l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 323 WQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHHHHHh
Confidence 9999999999999999998864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.30 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=204.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|.+.++||+|+||.||+|.+. +..+++|+........ ..+. +.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV---PMEQ----IEAEIEVLKSLDHPNIIKIFEVFEDYH- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS---CHHH----HHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch---hHHH----HHHHHHHHHhCCCchHHhHHHheecCC-
Confidence 46999999999999999999985 5567777765432211 1223 378999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++...... ...+++..++.|+.||+.||+|||++||+||||||+||+++.
T Consensus 94 -------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 94 -------------NMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159 (285)
T ss_dssp -------------EEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred -------------eEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEec
Confidence 359999999999999999764333 346999999999999999999999999999999999999964
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+. ..+.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 160 ~~----~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 160 TS----PHSPIKIIDFGLAELFKSDE-----------HSTNAAGTALYMAPEVFKR-----DVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp SS----TTCCEEECCCCCCCC---------------------CTTGGGCCHHHHTT-----CCCHHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEEeeecceecCCcc-----------cCcCcccccCcCChHHhcc-----CCCcccCeehHHHHHHHHH
Confidence 31 12679999999997654321 1123468999999999864 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||.+....+....+.......... ....++.+.+++.+||+.||.+|||+.
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ 274 (285)
T 3is5_A 220 TGCLPFTGTSLEEVQQKATYKEPNYAVE-------------------------CRPLTPQAVDLLKQMLTKDPERRPSAA 274 (285)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCC---------------------------CCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHhhhccCCcccccc-------------------------cCcCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999999877776665554332211100 002456789999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|++.
T Consensus 275 e~l~hp~f~~ 284 (285)
T 3is5_A 275 QVLHHEWFKQ 284 (285)
T ss_dssp HHHTSGGGGC
T ss_pred HHhcCHHhhc
Confidence 9999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=374.66 Aligned_cols=260 Identities=21% Similarity=0.279 Sum_probs=209.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.+.|++.+.||+|+||.||+|.+. +..+|+|+.... ...... .+.+|+.++++++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~----~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----TVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHH----HHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHH----HHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 457999999999999999999985 556777775422 122222 3479999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 122 --------------~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 183 (387)
T 1kob_A 122 --------------EMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 183 (387)
T ss_dssp --------------EEEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEe
Confidence 35999999999999998864 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+.. +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 184 ~~~~-----~~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el 243 (387)
T 1kob_A 184 TKKA-----SSVKIIDFGLATKLNPDEI-----------VKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYVL 243 (387)
T ss_dssp STTC-----CCEEECCCTTCEECCTTSC-----------EEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred cCCC-----CceEEEecccceecCCCcc-----------eeeeccCCCccCchhccC----CCCCCcccEeeHhHHHHHH
Confidence 5421 6799999999976543211 113468999999999976 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|..||.+.+..+....+.......... .....++++.+||.+||+.||.+|||+
T Consensus 244 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~ 299 (387)
T 1kob_A 244 LSGLSPFAGEDDLETLQNVKRCDWEFDED------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTV 299 (387)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHCCCCCCSS------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999887777766665443211100 001456779999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
.|+++|+|+...
T Consensus 300 ~ell~hp~~~~~ 311 (387)
T 1kob_A 300 HDALEHPWLKGD 311 (387)
T ss_dssp HHHHTSTTTSSC
T ss_pred HHHhhCccccCC
Confidence 999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=369.20 Aligned_cols=285 Identities=20% Similarity=0.241 Sum_probs=205.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|.+. +..||+|+ +..........+ ++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~--~~~~~~~~~~~~----~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAK----RAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEE--CSSTTSSHHHHH----HHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEE--eCccccCHHHHH----HHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 457999999999999999999985 55666665 333222333233 3489999999999999999999987653
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ......|+||||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 98 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 98 TL--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162 (367)
T ss_dssp ST--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred cc--------ccCceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc
Confidence 22 1223459999999 7999999875 3689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++..... ....++|+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 163 ~~-------~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 163 ED-------CELKILDFGLARQADSE-------------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp TT-------CCEEECCCTTCEECCSS-------------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEeeecccccccc-------------cCcCcCCCCcCCHHHHhC---CCCCChhhhHHHHHHHHHHH
Confidence 87 78999999999764321 123468999999999875 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
++|+.||.+.+..+....+.. ...+. .................. .............++.+.+|+.+||+.||.+
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~ 298 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPP-AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCC-HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCC-HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhH
Confidence 999999998887776665533 22222 111111100000000000 0000011111245678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
|||+.|+++|+|+..-
T Consensus 299 R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 299 RVTAGEALAHPYFESL 314 (367)
T ss_dssp SCCHHHHHHSGGGTTT
T ss_pred CCCHHHHhcChHHHhh
Confidence 9999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=372.15 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=207.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+++|++.+.||+|+||.||+|.+. +..+|+|+...... ........+.+|+.++++++|||||++++++.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-----VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455788999999999999999999985 45588887543211 11111234479999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.. ..|+||||++||+|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 86 ~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 146 (384)
T 4fr4_A 86 DEE--------------DMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI 146 (384)
T ss_dssp CSS--------------EEEEEECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred eCC--------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 755 34999999999999999975 34699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+++.+.... ......||+.|+|||++.+.. ...++.++|||||||++
T Consensus 147 ll~~~-------g~vkL~DFG~a~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~DiwSlG~il 207 (384)
T 4fr4_A 147 LLDEH-------GHVHITDFNIAAMLPRET-----------QITTMAGTKPYMAPEMFSSRK-GAGYSFAVDWWSLGVTA 207 (384)
T ss_dssp EECTT-------SCEEECCCTTCEECCTTC-----------CBCCCCSCGGGCCGGGTCCCS-SCCBCTTHHHHHHHHHH
T ss_pred EECCC-------CCEEEeccceeeeccCCC-----------ceeccCCCccccCCeeeccCC-CCCCCccceeechHHHH
Confidence 99987 889999999997654321 112456999999999987421 24578999999999999
Q ss_pred HHHHhCCCCCCCC---CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1040 LELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~---~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|+|++|+.||... ...+....+...... .+ ...+..+.+||.+||+.||
T Consensus 208 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP 259 (384)
T 4fr4_A 208 YELLRGRRPYHIRSSTSSKEIVHTFETTVVT-YP---------------------------SAWSQEMVSLLKKLLEPNP 259 (384)
T ss_dssp HHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhhcccC-CC---------------------------CcCCHHHHHHHHHHhcCCH
Confidence 9999999999743 233333333322211 10 1445679999999999999
Q ss_pred CCCCC-HHHHHHHHHhhc
Q 001143 1117 TERPT-AGDLYEMFVART 1133 (1141)
Q Consensus 1117 ~~RPS-a~ElL~~L~~~~ 1133 (1141)
.+||+ ++++++|+|+..
T Consensus 260 ~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 260 DQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp GGSCCSHHHHHTSGGGTT
T ss_pred hHhcccHHHHHcChhhhc
Confidence 99998 999999999964
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=361.99 Aligned_cols=264 Identities=23% Similarity=0.372 Sum_probs=211.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
...+|++.+.||+|+||.||+|++.+ ..+|+|+.... ......+ .+.+|+.++++++||||+++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQA----DFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc---cCHHHHH----HHHHHHHHHHhCCCCCEEEEEE
Confidence 35679999999999999999999854 56777764321 1222233 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-------------------CCCCCCHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQDV 937 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-------------------~~~~Ls~~~i~~Ia~QI 937 (1141)
++.+.... ++||||+++++|.+++...... ....+++.+++.|+.||
T Consensus 118 ~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 118 VCAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred EEccCCce--------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 99865543 9999999999999999863211 12579999999999999
Q ss_pred HHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhh
Q 001143 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017 (1141)
Q Consensus 938 a~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 1017 (1141)
+.||.|||++||+||||||+|||++.+ +.+||+|||++......... .......+|+.|+|||++
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESI 248 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHH
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCC-------CeEEEeecCCCcccccCccc--------cccCCCcccceecChhhh
Confidence 999999999999999999999999987 78999999999765432211 111234578999999999
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchh
Q 001143 1018 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096 (1141)
Q Consensus 1018 ~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1141)
.+ ..++.++|||||||++|+|++ |..||.+....++...+..+..+..+.
T Consensus 249 ~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------- 299 (343)
T 1luf_A 249 FY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE------------------------- 299 (343)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-------------------------
T ss_pred cc----CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCC-------------------------
Confidence 86 568899999999999999999 999999888877777766554432221
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1097 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1097 ~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.++..+.+++.+||+.||.+|||+.++++++.....
T Consensus 300 --~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 300 --NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 445679999999999999999999999999887654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=383.01 Aligned_cols=258 Identities=24% Similarity=0.322 Sum_probs=204.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
....+|++.++||+|+||.||+|.+. +..||+|+....... ...... .+.+|+.+++.++||||+++++++.+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVA----HTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHH----HHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 35678999999999999999999984 567888876533211 111222 23789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NI 959 (1141)
.+ ..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||+ +||+||||||+||
T Consensus 220 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 220 HD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280 (446)
T ss_dssp TT--------------EEEEEECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGE
T ss_pred CC--------------EEEEEEeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHE
Confidence 55 34999999999999999976 2469999999999999999999998 9999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+|+....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 281 ll~~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 339 (446)
T 4ejn_A 281 MLDKD-------GHIKITDFGLCKEGIKDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVM 339 (446)
T ss_dssp EECSS-------SCEEECCCCCCCTTCC---------------CCSSSCGGGCCHHHHHT----SCCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEccCCCceeccCCCc----------ccccccCCccccCHhhcCC----CCCCCccchhhhHHHH
Confidence 99987 7899999999975332111 1224579999999999976 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|||++|+.||.+.+..++...+...... ++ ...++++.+||.+||+.||.+|
T Consensus 340 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 340 YEMMCGRLPFYNQDHEKLFELILMEEIR-FP---------------------------RTLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------ccCCHHHHHHHHHHcccCHHHh
Confidence 9999999999988877777766543321 11 1345679999999999999999
Q ss_pred C-----CHHHHHHHHHhhc
Q 001143 1120 P-----TAGDLYEMFVART 1133 (1141)
Q Consensus 1120 P-----Sa~ElL~~L~~~~ 1133 (1141)
| +++|+++|+||..
T Consensus 392 ~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp TTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHhCccccC
Confidence 9 9999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=364.97 Aligned_cols=275 Identities=23% Similarity=0.242 Sum_probs=207.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~-~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.+|++.+.||+|+||.||+|.+. +..+|+|+....... ......+ .+.+|+.++++++||||+++++++.+..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE----RIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHH----HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHH----HHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 35999999999999999999985 456788876433111 1112222 3489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------------------------------cCCCCCCH
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------------------------TGEKHVSV 927 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------------------------------~~~~~Ls~ 927 (1141)
..++||||++|++|.+++..... .....+++
T Consensus 102 --------------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 102 --------------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp --------------EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred --------------eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 35999999999999998852111 01223577
Q ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccC
Q 001143 928 KLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007 (1141)
Q Consensus 928 ~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~G 1007 (1141)
..++.|+.||+.||+|||++||+||||||+|||++.++. +.+||+|||++..+...... .........|
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-----~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g 236 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS-----FEIKLVDFGLSKEFYKLNNG------EYYGMTTKAG 236 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS-----CCEEECCCTTCEEGGGTTCC--------------CC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCC-----ceEEEeeccccccccccCcc------ccccccccCC
Confidence 889999999999999999999999999999999986521 48999999999765432211 0011224569
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcccccccc
Q 001143 1008 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 1087 (1141)
Q Consensus 1008 T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~ 1087 (1141)
|+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+....+....+..........
T Consensus 237 t~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------- 298 (345)
T 3hko_A 237 TPYFVAPEVLNTT--NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP---------------- 298 (345)
T ss_dssp CGGGCCHHHHTCS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG----------------
T ss_pred CccccCchhhccC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc----------------
Confidence 9999999998652 2467899999999999999999999999888777666664433221110
Q ss_pred CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001143 1088 GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1088 ~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~s 1135 (1141)
.....++.+.+||.+||+.||.+|||+.|+++|+|+...+
T Consensus 299 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 299 --------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp --------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred --------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 0014567799999999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=383.23 Aligned_cols=262 Identities=27% Similarity=0.331 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||+||+|++. +..+|+|+........ .... .+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~- 94 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTS----TILREVELLKKLDHPNIMKLFEILEDSS- 94 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHH----HHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHH----HHHHHHHHHHhCCCCCcCeEEEEEEcCC-
Confidence 45999999999999999999985 6678888864322111 1122 3479999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 95 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 95 -------------SFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred -------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 34999999999999999876 246999999999999999999999999999999999999965
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
.. ..+.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 157 ~~----~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 157 KE----KDCDIKIIDFGLSTCFQQNT-----------KMKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp SS----TTCCEEECSCSCTTTBCCC---------------CCTTGGGGCCGGGGGS-----CCCHHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEEECCcCeECCCCC-----------ccCCCcCCCCCCCHHHhCC-----CCCchhhHHHHHHHHHHHH
Confidence 31 12679999999997654321 1123469999999999875 4889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+.+..++...+..+........+ ...++.+.+||.+||+.||.+|||+.
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~t~~ 272 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQW------------------------RTISDDAKDLIRKMLTFHPSLRITAT 272 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCSGGG------------------------GGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCccc------------------------CCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999998888888777655433211100 14567799999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001143 1124 DLYEMFVARTSSS 1136 (1141)
Q Consensus 1124 ElL~~L~~~~~s~ 1136 (1141)
|+++|+|++....
T Consensus 273 ~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 273 QCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHCHHHHHTCC
T ss_pred HHhcCHhhccCcc
Confidence 9999999986543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=354.33 Aligned_cols=265 Identities=26% Similarity=0.357 Sum_probs=211.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
...++|++.+.||+|+||.||+|.+. +..+++|+.... .......+. +.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQM----LVSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECT--TCCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcc--cCCHHHHHH----HHHHHHHHHhcCCCCCCeEEEEEec
Confidence 34678999999999999999999985 566777775433 223333333 4899999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCC
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIK 955 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g-----IvHrDLK 955 (1141)
.. ....++||||+++++|.+++...... ...+++..++.++.||+.||.|||++| |+|||||
T Consensus 77 ~~------------~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 77 RT------------NTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp GG------------GTEEEEEEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred CC------------CceEEEEEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 22 12469999999999999999864332 346999999999999999999999999 9999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
|+||+++.+ +.+||+|||.+......... .....||+.|+|||++.+ ..++.++|||||
T Consensus 144 p~NIl~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~sl 202 (279)
T 2w5a_A 144 PANVFLDGK-------QNVKLGDFGLARILNHDTSF----------AKTFVGTPYYMSPEQMNR----MSYNEKSDIWSL 202 (279)
T ss_dssp GGGEEECSS-------SCEEECCCCHHHHC---CHH----------HHHHHSCCTTCCHHHHHC----C-CCHHHHHHHH
T ss_pred hhhEEEcCC-------CCEEEecCchheeecccccc----------ccccCCCccccChHHhcc----CCCCchhhHHHH
Confidence 999999887 78999999998765432111 012358999999999976 567899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|+++|+|++|+.||......++...+..+..+.++. ..+..+.+++.+||+.|
T Consensus 203 G~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~ 255 (279)
T 2w5a_A 203 GCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLK 255 (279)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc---------------------------ccCHHHHHHHHHHcCCC
Confidence 999999999999999887777777776655433221 34567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 001143 1116 PTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~~ 1134 (1141)
|.+|||+.|+++++|+...
T Consensus 256 p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 256 DYHRPSVEEILENPLILEH 274 (279)
T ss_dssp GGGSCCHHHHHTSTTCCGG
T ss_pred cccCCCHHHHHhChhhhhh
Confidence 9999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=363.97 Aligned_cols=300 Identities=16% Similarity=0.201 Sum_probs=211.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+.+|++.++||+|+||.||+|++. +..+|+|+..... ....... .+.+|+.++++++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPI----TALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS--CSSSSCH----HHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc--ccccchH----HHHHHHHHHHhccCCCcccHhheeec
Confidence 34678999999999999999999984 5667777643332 1211112 23689999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.... ........++||||++ ++|.+.+.. ....+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 156 (351)
T 3mi9_A 88 KASP------YNRCKGSIYLVFDFCE-HDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 156 (351)
T ss_dssp C--------------CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cccc------cccCCceEEEEEeccC-CCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 4321 0111235799999998 588887764 2346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++.+...... .........||+.|+|||++.+ ...++.++|||||||++|
T Consensus 157 ~~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 220 (351)
T 3mi9_A 157 ITRD-------GVLKLADFGLARAFSLAKNS------QPNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMA 220 (351)
T ss_dssp ECTT-------SCEEECCCTTCEECCCCSSS------SCCCCCSSCSCGGGCCHHHHTT---CCSCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEccchhcccccccccc------cccccCCcccccCccCchhhcC---CCCCCcHhHHHHHHHHHH
Confidence 9887 78999999999765432211 1112234568999999999875 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc-cccccccCCCCCCch---hhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|++|+.||.+....+....+........+..+....... ............... .....++.+.+||.+||+.||
T Consensus 221 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 300 (351)
T 3mi9_A 221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300 (351)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCCh
Confidence 9999999999887776665553221111111111000000 000000000000000 011235678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001143 1117 TERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~s 1135 (1141)
++|||++|+++|+|+....
T Consensus 301 ~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 301 AQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp GGSCCHHHHHTSGGGGSSS
T ss_pred hhCCCHHHHhCCCCcCCCC
Confidence 9999999999999997643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.04 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=200.5
Q ss_pred eEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~ 886 (1141)
...+.||+|+||.||+|.+. +..+|+|+.... .....+. +.+|+.++++++||||+++++++.+..
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 159 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEE----VKNEISVMNQLDHANLIQLYDAFESKN---- 159 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHH----HHHHHHHHHhCCCCCCCeEEEEEEECC----
Confidence 44778999999999999984 567888876532 2233333 489999999999999999999998654
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccc
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~ 966 (1141)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+..+..
T Consensus 160 ----------~~~lv~E~~~~~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 225 (373)
T 2x4f_A 160 ----------DIVLVMEYVDGGELFDRIID----ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225 (373)
T ss_dssp ----------EEEEEEECCTTCEEHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT
T ss_pred ----------EEEEEEeCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC
Confidence 35999999999999998875 1246999999999999999999999999999999999999954311
Q ss_pred cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001143 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1046 (1141)
Q Consensus 967 ~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk 1046 (1141)
+.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 226 -----~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~ 285 (373)
T 2x4f_A 226 -----KQIKIIDFGLARRYKPREK-----------LKVNFGTPEFLAPEVVNY----DFVSFPTDMWSVGVIAYMLLSGL 285 (373)
T ss_dssp -----TEEEECCCSSCEECCTTCB-----------CCCCCSSCTTCCHHHHTT----CBCCHHHHHHHHHHHHHHHHHSS
T ss_pred -----CcEEEEeCCCceecCCccc-----------cccccCCCcEeChhhccC----CCCCcHHhHHHHHHHHHHHHhCC
Confidence 7899999999976543211 123469999999999875 56789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL 1126 (1141)
.||.+.+..+....+.......... .....++++.+||.+||+.||.+|||+.|++
T Consensus 286 ~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 286 SPFLGDNDAETLNNILACRWDLEDE------------------------EFQDISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCSCSG------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHhccCCCChh------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 9999888777776665443221110 0114567799999999999999999999999
Q ss_pred HHHHhhc
Q 001143 1127 EMFVART 1133 (1141)
Q Consensus 1127 ~~L~~~~ 1133 (1141)
+|+|+..
T Consensus 342 ~hp~~~~ 348 (373)
T 2x4f_A 342 KHPWLSD 348 (373)
T ss_dssp HSHHHHC
T ss_pred cCcCcCC
Confidence 9999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.67 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=209.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+++|++.+.||+|+||.||+|++.+..+|+|++... .......+.+ .+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVR--DWSTRKSRDF----NEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCT--TCCHHHHHHH----HHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccc--ccCHHHHHHH----HHHHHHHHhcCCCchhheEEEEccC
Confidence 345778999999999999999999999999999987643 2233333344 8999999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCe
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENI 959 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NI 959 (1141)
.. ...++||||+++++|.+++.. .....+++..++.|+.||+.||.|||++| |+||||||+||
T Consensus 80 ~~------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Ni 144 (271)
T 3kmu_A 80 PA------------PHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSV 144 (271)
T ss_dssp TS------------SSCEEEEECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGE
T ss_pred CC------------CCeEeeecccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceE
Confidence 21 134999999999999999975 23336999999999999999999999999 99999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.++|+|||++..... ....||+.|+|||++.+.. ...++.++|||||||++
T Consensus 145 l~~~~-------~~~~l~~~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~-~~~~~~~~Di~slG~il 201 (271)
T 3kmu_A 145 MIDED-------MTARISMADVKFSFQS---------------PGRMYAPAWVAPEALQKKP-EDTNRRSADMWSFAVLL 201 (271)
T ss_dssp EECTT-------SCEEEEGGGSCCTTSC---------------TTCBSCGGGSCHHHHHSCG-GGSCHHHHHHHHHHHHH
T ss_pred EEcCC-------cceeEEeccceeeecc---------------cCccCCccccChhhhccCC-CCCCCchhhHHHHHHHH
Confidence 99887 7899998888653221 1235899999999987622 12334589999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++|+.||.+....+....+.. ...+..+ ...++.+.+++.+||+.||.+
T Consensus 202 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 254 (271)
T 3kmu_A 202 WELVTREVPFADLSNMEIGMKVALEGLRPTIP---------------------------PGISPHVSKLMKICMNEDPAK 254 (271)
T ss_dssp HHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCCccccChHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhh
Confidence 999999999998777766555432 2222211 145667999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
|||+.++++.+....
T Consensus 255 Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 255 RPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHhh
Confidence 999999999887643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=367.17 Aligned_cols=258 Identities=24% Similarity=0.280 Sum_probs=193.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
...++|++.++||+|+||+||+|++. +..||+|+.... ... .+. +.+|+.++++++||||+++++++.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG--AAI---DEN----VQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS--TTS---CHH----HHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC--ccc---cHH----HHHHHHHHHhCCCCCCCcEEEEEee
Confidence 34678999999999999999999984 566888875422 111 122 3789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 88 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 88 PT--------------HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp SS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred CC--------------EEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 55 35999999999999999976 236999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCC-chhhHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG-LEVDIWSYGCLL 1039 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s-~ksDVWSLGviL 1039 (1141)
++.+.. +.+||+|||+++...... ......||+.|+|||++.+ ..++ .++|||||||++
T Consensus 149 l~~~~~-----~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il 208 (361)
T 3uc3_A 149 LDGSPA-----PRLKICDFGYSKSSVLHS-----------QPKSTVGTPAYIAPEVLLR----QEYDGKIADVWSCGVTL 208 (361)
T ss_dssp ECSSSS-----CCEEECCCCCC--------------------------CTTSCHHHHHC----SSCCHHHHHHHHHHHHH
T ss_pred EcCCCC-----ceEEEeecCccccccccC-----------CCCCCcCCCCcCChhhhcC----CCCCCCeeeeehhHHHH
Confidence 986621 459999999986432211 1123469999999999976 3343 459999999999
Q ss_pred HHHHhCCCCCCCCCH----HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1040 LELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~----~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|+|++|+.||.+... ......+...... ++. ....++.+.+||.+||+.|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-IPD-------------------------DIRISPECCHLISRIFVAD 262 (361)
T ss_dssp HHHHHSSCSCC----CCCHHHHHHHHHTTCCC-CCT-------------------------TSCCCHHHHHHHHHHSCSC
T ss_pred HHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC-CCC-------------------------cCCCCHHHHHHHHHHccCC
Confidence 999999999976432 2222322221110 000 0134567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 001143 1116 PTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~~ 1134 (1141)
|.+|||+.|+++|+|+...
T Consensus 263 P~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 263 PATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp TTTSCCHHHHHTSHHHHTT
T ss_pred hhHCcCHHHHHhCcchhcC
Confidence 9999999999999999643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.80 Aligned_cols=267 Identities=23% Similarity=0.270 Sum_probs=204.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|++ .+..+|+|+...... ...... .++.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHH----HHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHH----HHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 46799999999999999999997 456778887643321 122222 34489999999999999999999987643
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ....|+||||++|++|.++++. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 86 ~~----------~~~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 86 PA----------GPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150 (311)
T ss_dssp TT----------EEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred CC----------CcccEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 21 2245999999999999999976 23699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++..+...... ........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 151 AT-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp TT-------SCEEECCCSCC-------------------------CCTTCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeccCcccccccccc-------cccccccCcCcccCCHHHhcC----CCCCchHhHHHHHHHHHHH
Confidence 87 78999999999765432211 011223468999999999986 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+....+....+.......... .....+.++.+++.+||+.||.+||++
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~ 268 (311)
T 3ork_A 213 LTGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRYQT 268 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCHHH------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HhCCCCCCCCChHHHHHHHhcCCCCCccc------------------------ccCCCCHHHHHHHHHHHhcCHhhChhh
Confidence 99999999887776655544333221110 011456779999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.+++.+.|++.
T Consensus 269 ~~~l~~~l~~~ 279 (311)
T 3ork_A 269 AAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999988864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=383.42 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=206.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..|++.++||+|+||+||+|++. +..+|+|+...... ...... .+.+|+.+++.++|||||++++++.+..
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~- 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNS----KLLEEVAVLKLLDHPNIMKLYDFFEDKR- 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTH----HHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc--CchHHH----HHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 35999999999999999999985 55678887643321 111122 3479999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++|+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 110 -------------~~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 110 -------------NYYLVMECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 34999999999999998876 246999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
.. ..+.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|+
T Consensus 172 ~~----~~~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~-----~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 172 KE----KDALIKIVDFGLSAVFENQKK-----------MKERLGTAYYIAPEVLRK-----KYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp SS----TTCCEEECCCTTCEECBTTBC-----------BCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCcEEEEECCCCeECCCCcc-----------ccccCCCcCeeCHHHHcc-----cCCCchhHHHHHHHHHHHH
Confidence 41 125699999999976543211 123469999999999864 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+....++...+..+........+ ...++.+.+||.+||+.||.+|||+.
T Consensus 232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~~ 287 (494)
T 3lij_A 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPEW------------------------KNVSEGAKDLIKQMLQFDSQRRISAQ 287 (494)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCSGGG------------------------TTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCchhc------------------------ccCCHHHHHHHHHHCCCChhhCccHH
Confidence 999999998888888877665443211110 14566799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|++.
T Consensus 288 e~l~hp~~~~ 297 (494)
T 3lij_A 288 QALEHPWIKE 297 (494)
T ss_dssp HHHTCHHHHH
T ss_pred HHhcCccccc
Confidence 9999999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=364.72 Aligned_cols=284 Identities=19% Similarity=0.214 Sum_probs=204.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.++||+|+||+||+|++. +..+|+|+...... ...... +.+|+.++++++||||+++++++....
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCT----AIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCC----CCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchh----HHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 468999999999999999999985 56688887543221 111112 257999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 134 (324)
T 3mtl_A 74 S--------------LTLVFEYLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134 (324)
T ss_dssp C--------------EEEEEECCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC
T ss_pred E--------------EEEEecccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC
Confidence 3 499999997 6999998762 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 135 ~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 194 (324)
T 3mtl_A 135 ER-------GELKLADFGLARAKSIPTK----------TYDNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFYEM 194 (324)
T ss_dssp TT-------CCEEECSSSEEECC----------------------CGGGCCHHHHTT---CCCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccCcccccccCCcc----------ccccccCcccccChhhhcC---CCCCCcHHHHHHHHHHHHHH
Confidence 87 7899999999975433211 1123468999999999875 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcc-ccccccCC-CCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
++|+.||.+.+..+....+...........+........ ........ ...........+.++.+||.+||+.||.+||
T Consensus 195 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 274 (324)
T 3mtl_A 195 ATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274 (324)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence 999999998887776665533211111111110000000 00000000 0000111124567899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|++|+++|+||...
T Consensus 275 t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 275 SAEDAMKHPFFLSL 288 (324)
T ss_dssp CHHHHTTSGGGGGG
T ss_pred CHHHHhcChhhhhc
Confidence 99999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=377.29 Aligned_cols=298 Identities=18% Similarity=0.196 Sum_probs=194.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.++||+|+||+||+|.+. +..||+|+. ..........+. +.+|+.+|++++|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i--~~~~~~~~~~~~----~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKR----ILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEE--CSTTSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEe--chhhcCHHHHHH----HHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 367999999999999999999885 556777764 332333333334 489999999999999999999986533
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ......|+||||+. ++|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 126 ~---------~~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 126 V---------EKFDELYVVLEIAD-SDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190 (458)
T ss_dssp T---------TTCCCEEEEECCCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred c---------ccCceEEEEEeccc-cchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC
Confidence 1 12235799999985 899999875 34699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccc-----------------cCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~-----------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
.+ +.+||+|||+|+............ ..........+||+.|+|||++.. ...
T Consensus 191 ~~-------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~ 260 (458)
T 3rp9_A 191 QD-------CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL---QEN 260 (458)
T ss_dssp TT-------CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT---CCC
T ss_pred CC-------CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC---CCC
Confidence 87 889999999998764322110000 000011234578999999998754 256
Q ss_pred CCchhhHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHH-HhCCCCCchhHH
Q 001143 1026 YGLEVDIWSYGCLLLELLT-----------LQVPYMGLSE--------------------LEIHDLI-QMGKRPRLTDEL 1073 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLT-----------Gk~Pf~~~~~--------------------~el~~~I-~~~~~p~l~~~l 1073 (1141)
++.++|||||||++|||++ |+++|.+.+. .+....+ .....+.. ..+
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~-~~~ 339 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE-EDI 339 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCH-HHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCH-HHH
Confidence 8999999999999999999 6777765431 1122222 11111111 111
Q ss_pred hhhccCcccccc---ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1074 EALGSCHEHEVA---QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1074 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
............ ...............+.++.+||.+||.+||.+|||++|+++|+|+..-
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 340 EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 110000000000 0000011111112457789999999999999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=365.72 Aligned_cols=287 Identities=22% Similarity=0.244 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|++. +..+|+|+....... .........+.+|+.++++++||||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc---hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 567999999999999999999985 567888875432211 111122234579999999999999999999997655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 86 ~~--------------~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 146 (346)
T 1ua2_A 86 NI--------------SLVFDFME-TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 146 (346)
T ss_dssp CC--------------EEEEECCS-EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred ce--------------EEEEEcCC-CCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc
Confidence 43 99999998 589888864 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 147 ~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 206 (346)
T 1ua2_A 147 EN-------GVLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAEL 206 (346)
T ss_dssp TT-------CCEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEecccceeccCCcc----------cCCcccccccccCchHhhC---CCCCCchhhhHhHHHHHHHH
Confidence 87 7899999999976543211 1223468999999999875 23578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|.+||.+....+....+... ..+... .+...........................+.++.+||.+||+.||.+|||
T Consensus 207 l~g~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 285 (346)
T 1ua2_A 207 LLRVPFLPGDSDLDQLTRIFETLGTPTEE-QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCTT-TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHCCCCCCCCCHHHHHHHHHHHcCCCChh-hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC
Confidence 9999999988777766555322 211111 11000000000000000000001111245678999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.|+++|+|+...
T Consensus 286 ~~ell~h~~f~~~ 298 (346)
T 1ua2_A 286 ATQALKMKYFSNR 298 (346)
T ss_dssp HHHHHTSGGGTSS
T ss_pred HHHHhcChhhhcC
Confidence 9999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=363.96 Aligned_cols=261 Identities=24% Similarity=0.279 Sum_probs=187.9
Q ss_pred CceEe---eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001143 807 SLSSC---DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1141)
Q Consensus 807 ~y~i~---~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~ 880 (1141)
+|++. +.||+|+||+||+|.+. +..+|+|+.... ... .+.+|+.+++.+. ||||+++++++.+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~----~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEA----NTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHH----HHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhh----hHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 45554 78999999999999985 566888875321 112 2368999999997 9999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+++++|.+++.. ...+++.++..|+.||+.||.|||++||+||||||+|||
T Consensus 78 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 138 (325)
T 3kn6_A 78 QL--------------HTFLVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138 (325)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEEccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence 55 34999999999999999986 346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.++ ....+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~~----~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~ 200 (325)
T 3kn6_A 139 FTDEN----DNLEIKIIDFGFARLKPPDNQ----------PLKTPCFTLHYAAPELLNQ----NGYDESCDLWSLGVILY 200 (325)
T ss_dssp EEC--------CEEEECCCTTCEECCC------------------------------------CCCCHHHHHHHHHHHHH
T ss_pred EecCC----CcccEEEeccccceecCCCCC----------cccccCCCcCccCHHHhcC----CCCCCccchHHHHHHHH
Confidence 97652 114799999999975433211 1123468999999999876 56889999999999999
Q ss_pred HHHhCCCCCCCCCH-------HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1041 ELLTLQVPYMGLSE-------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~-------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
+|++|+.||.+... .++...+..+....... .....++++.+||.+||+
T Consensus 201 ~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 201 TMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE------------------------AWKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp HHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH------------------------HHHTSCHHHHHHHHHHHC
T ss_pred HHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc------------------------cccCCCHHHHHHHHHHCC
Confidence 99999999975332 33444444333221111 112456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCCCCC
Q 001143 1114 ENPTERPTAGDLYEMFVARTSSSISS 1139 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~s~~ss 1139 (1141)
.||.+|||+.|+++|+|+......++
T Consensus 257 ~dP~~Rpt~~ell~h~w~~~~~~~~~ 282 (325)
T 3kn6_A 257 VDPNKRLKMSGLRYNEWLQDGSQLSS 282 (325)
T ss_dssp CCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred CChhHCCCHHHHhcChhhccCccCCC
Confidence 99999999999999999987655443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=381.78 Aligned_cols=260 Identities=23% Similarity=0.274 Sum_probs=212.1
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+.+|.+.+.||+|+||.||+|++. +..||+|+..... .........+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~-----~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK-----IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH-----HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh-----ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345678999999999999999999984 6778888864321 111122234589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
... ..++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 87 ~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI 147 (476)
T 2y94_A 87 TPS--------------DIFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147 (476)
T ss_dssp CSS--------------EEEEEEECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred ECC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence 654 35999999999999999864 34699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++....... ......||+.|+|||++.+. ...+.++|||||||++
T Consensus 148 ll~~~-------~~vkL~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil 206 (476)
T 2y94_A 148 LLDAH-------MNAKIADFGLSNMMSDGE-----------FLRTSCGSPNYAAPEVISGR---LYAGPEVDIWSSGVIL 206 (476)
T ss_dssp EECTT-------CCEEECCCSSCEECCTTC-----------CBCCCCSCSTTCCHHHHTTC---CBCSHHHHHHHHHHHH
T ss_pred EEecC-------CCeEEEeccchhhccccc-----------cccccCCCcCeEChhhccCC---CCCCCcceehhhHHHH
Confidence 99887 789999999997654321 11234699999999999862 2346899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||.+....++...+..+.... + ...++.+.+||.+||+.||.+|
T Consensus 207 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~s~~~~~Li~~~L~~dP~~R 258 (476)
T 2y94_A 207 YALLCGTLPFDDDHVPTLFKKICDGIFYT-P---------------------------QYLNPSVISLLKHMLQVDPMKR 258 (476)
T ss_dssp HHHHHSSCSSCCSSSHHHHHHHHTTCCCC-C---------------------------TTCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhCCCCCCCCCHHHHHHHHhcCCcCC-C---------------------------ccCCHHHHHHHHHHcCCCchhC
Confidence 99999999999877777776665443211 0 0345678999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||+.|+++|+|+...
T Consensus 259 pt~~eil~hp~~~~~ 273 (476)
T 2y94_A 259 ATIKDIREHEWFKQD 273 (476)
T ss_dssp CCHHHHHTCHHHHTT
T ss_pred cCHHHHHhCHHhhhc
Confidence 999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=351.18 Aligned_cols=265 Identities=24% Similarity=0.304 Sum_probs=208.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|++. +..+|+|+........... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--GVSREEIEREVNILREIRHPNIITLHDIFENKT- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--chHHHHHHHHHHHHHhCCCCCeeehhheecCCC-
Confidence 35899999999999999999985 6778888865443221111 001123479999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 82 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 143 (283)
T 3bhy_A 82 -------------DVVLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143 (283)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred -------------eEEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec
Confidence 35999999999999999976 246999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++ .....+||+|||.+........ .....||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 144 ~~---~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 144 KN---VPNPRIKLIDFGIAHKIEAGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp SS---SSSCCEEECCCTTCEECC-------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC---CCCCceEEEecccceeccCCCc-----------ccccCCCcCccCcceecC----CCCCcchhhhhHHHHHHHHH
Confidence 62 1113799999999976543211 123458999999999876 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+....+....+.......... .....+..+.+++.+||..||.+|||+.
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 261 (283)
T 3bhy_A 206 SGASPFLGETKQETLTNISAVNYDFDEE------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIA 261 (283)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTCCCCCHH------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred HCCCCCCCcchHHHHHHhHhcccCCcch------------------------hcccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 9999999877777666665443221111 1114566799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|+..
T Consensus 262 ~~l~h~~~~~ 271 (283)
T 3bhy_A 262 QSLEHSWIKA 271 (283)
T ss_dssp HHHHCHHHHH
T ss_pred HHHhCHHHHH
Confidence 9999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.29 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=207.4
Q ss_pred CCCceEeeeecccCceEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~-~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.++|++.+.||+|+||.||+|.+.+. .+|+|+.... ... .+. +.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMS---EDE----FFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCc---HHH----HHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 46799999999999999999998654 6888876432 111 123 3789999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||+++.
T Consensus 78 --------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~ 139 (268)
T 3sxs_A 78 --------------IYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR 139 (268)
T ss_dssp --------------EEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT
T ss_pred --------------eEEEEEccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC
Confidence 49999999999999999762 235999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+......... ......+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~~l~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 199 (268)
T 3sxs_A 140 D-------LCVKVSDFGMTRYVLDDQYV---------SSVGTKFPVKWSAPEVFHY----FKYSSKSDVWAFGILMWEVF 199 (268)
T ss_dssp T-------CCEEECCTTCEEECCTTCEE---------ECCSCCCCGGGCCHHHHHH----SEEETTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccCccceecchhhhh---------cccCCCcCcccCCHHHHhc----cCCchhhhhHHHHHHHHHHH
Confidence 7 78999999999765432211 1112346788999999976 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||......+....+..+.....+. ..++.+.+++.+||+.||.+|||+
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~ 252 (268)
T 3sxs_A 200 SLGKMPYDLYTNSEVVLKVSQGHRLYRPH---------------------------LASDTIYQIMYSCWHELPEKRPTF 252 (268)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHTTCSSGGGSCCH
T ss_pred cCCCCCccccChHHHHHHHHcCCCCCCCC---------------------------cChHHHHHHHHHHcCCChhhCcCH
Confidence 9 999999887777766665544322211 345579999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.|+++++....
T Consensus 253 ~~ll~~L~~l~ 263 (268)
T 3sxs_A 253 QQLLSSIEPLR 263 (268)
T ss_dssp HHHHHHHGGGC
T ss_pred HHHHHHHHHhh
Confidence 99999997654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=365.81 Aligned_cols=257 Identities=24% Similarity=0.260 Sum_probs=203.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~ 881 (1141)
.++|++.+.||+|+||.||+|.+. +..+|+|+..... . .. .+|++++.++ +||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~------~~----~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--R------DP----TEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--C------CC----HHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--C------Ch----HHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 346999999999999999999985 5668888754221 1 11 4788888888 799999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~--------------~~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~ 149 (342)
T 2qr7_A 89 K--------------YVYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149 (342)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEE
Confidence 5 45999999999999999975 3469999999999999999999999999999999999998
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
..+. ...+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 150 ~~~~---~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 212 (342)
T 2qr7_A 150 VDES---GNPESIRICDFGFAKQLRAENG----------LLMTPCYTANFVAPEVLER----QGYDAACDIWSLGVLLYT 212 (342)
T ss_dssp SSSS---CSGGGEEECCCTTCEECBCTTC----------CBCCSSCCSSCCCHHHHHH----HHHHHHHHHHHHHHHHHH
T ss_pred ecCC---CCcCeEEEEECCCcccCcCCCC----------ceeccCCCccccCHHHhcC----CCCCCccCeeeHhHHHHH
Confidence 5431 1114699999999976543211 1123468999999999976 347789999999999999
Q ss_pred HHhCCCCCCC---CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1042 LLTLQVPYMG---LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~---~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|++|..||.+ ....++...+..+........ ....++++.+||.+||..||++
T Consensus 213 ll~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~ 268 (342)
T 2qr7_A 213 MLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY------------------------WNSVSDTAKDLVSKMLHVDPHQ 268 (342)
T ss_dssp HHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT------------------------TTTSCHHHHHHHHHHTCSSTTT
T ss_pred HhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc------------------------cccCCHHHHHHHHHHCCCChhH
Confidence 9999999975 345556666655443211100 0145677999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
|||+.|+++|+|+..
T Consensus 269 R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 269 RLTAALVLRHPWIVH 283 (342)
T ss_dssp SCCHHHHTTSHHHHT
T ss_pred CcCHHHHhcCCeecC
Confidence 999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=350.81 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=205.8
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
....+|++.+.||+|+||.||+|.+.+ ..+|+|+.... ... .+. +.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMS---EDE----FIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBC---HHH----HHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCC---HHH----HHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 345689999999999999999999864 46888876422 111 123 37999999999999999999999765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. .++||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||++
T Consensus 92 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili 153 (283)
T 3gen_A 92 RP--------------IFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153 (283)
T ss_dssp SS--------------EEEEECCCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred CC--------------eEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE
Confidence 53 49999999999999999752 2369999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 154 ~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~ 213 (283)
T 3gen_A 154 NDQ-------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWE 213 (283)
T ss_dssp CTT-------SCEEECSTTGGGGBCCHHHH---------STTSTTSCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEccccccccccccccc---------cccCCccCcccCCHHHhcc----CCCCchhhHHHHHHHHHH
Confidence 887 78999999999765432211 1112347888999999986 468899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |+.||......+....+..+.....+. ..++.+.+++.+||+.||.+||
T Consensus 214 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 214 IYSLGKMPYERFTNSETAEHIAQGLRLYRPH---------------------------LASEKVYTIMYSCWHEKADERP 266 (283)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGSC
T ss_pred HHhCCCCCccccChhHHHHHHhcccCCCCCC---------------------------cCCHHHHHHHHHHccCChhHCc
Confidence 998 999999888777777765544332211 3345799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
|+.++++++...
T Consensus 267 s~~~ll~~L~~~ 278 (283)
T 3gen_A 267 TFKILLSNILDV 278 (283)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=356.55 Aligned_cols=290 Identities=20% Similarity=0.234 Sum_probs=207.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.++||+|+||+||+|.+. +..||+|+....... ...+ .+.+|+.++++++||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVD----VQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHH----HHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHH----HHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 46999999999999999999996 667888876432211 1122 23789999999999999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
...++||||+++++|.+++.... ....+++..++.|+.||+.||.|||++||+||||||+|||+..
T Consensus 82 ------------~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 147 (319)
T 4euu_A 82 ------------RHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (319)
T ss_dssp ------------CCEEEEEECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred ------------ceEEEEEeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEec
Confidence 14599999999999999998632 2234999999999999999999999999999999999999822
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc----CCCCCCchhhHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~~s~ksDVWSLGviL 1039 (1141)
.. ...+.+||+|||+++....... .....||+.|+|||++.... ....++.++|||||||++
T Consensus 148 ~~---~~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 148 GE---DGQSVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp CT---TSCEEEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred cC---CCCceEEEccCCCceecCCCCc-----------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 10 1127899999999976543221 12346899999999986311 125678999999999999
Q ss_pred HHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1040 LELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|||++|+.||.... ..+....+..+..+............... + ..... .........+..+.+++.+||+.|
T Consensus 214 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~-~~~~~-~~~~~~~~~~~~l~~ll~~~L~~d 290 (319)
T 4euu_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID-W-SGDMP-VSCSLSRGLQVLLTPVLANILEAD 290 (319)
T ss_dssp HHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEE-E-ESSCC-TTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccc-c-CccCC-cccccchhHHHHhHHHHHHhccCC
Confidence 99999999996422 23344444433332221111100000000 0 00000 011122367788999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001143 1116 PTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~ 1133 (1141)
|++|||++|+++|+.-..
T Consensus 291 P~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 291 QEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTTSCCHHHHHHHHHHHT
T ss_pred hhhhccHHHhhhccHHHh
Confidence 999999999999997653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=351.55 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=193.8
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..++|++.+.||+|+||+||+|++ .+..+|+|+.... .. ...... .+..+...++.++||||+++++++.+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~-~~~~~~---~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VN-SQEQKR---LLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----C-HHHHHH---HHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc--cC-cHHHHH---HHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 356799999999999999999998 5667788875422 11 122121 124455557888999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 960 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NIL 960 (1141)
+. .++||||++ ++|.+++...... ...+++..++.|+.||+.||.|||++ ||+||||||+||+
T Consensus 79 ~~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil 142 (290)
T 3fme_A 79 GD--------------VWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 142 (290)
T ss_dssp SS--------------EEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCE
T ss_pred CC--------------EEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEE
Confidence 53 499999997 6998888764333 35799999999999999999999998 9999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||++........ .....||+.|+|||++........++.++|||||||++|
T Consensus 143 ~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 204 (290)
T 3fme_A 143 INAL-------GQVKMCDFGISGYLVDDVA-----------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204 (290)
T ss_dssp ECTT-------CCEEBCCC--------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecCCccccccccc-----------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH
Confidence 9887 7899999999976543211 123358999999999853323456889999999999999
Q ss_pred HHHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLTGk~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|++|+.||... ..............+.... ...+..+.+++.+||+.||.+|
T Consensus 205 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~R 258 (290)
T 3fme_A 205 ELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA--------------------------DKFSAEFVDFTSQCLKKNSKER 258 (290)
T ss_dssp HHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT--------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHCCCCccccCchHHHHHHHhccCCCCccc--------------------------ccCCHHHHHHHHHHhhcChhhC
Confidence 999999999753 3333333332222221110 1445679999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||+.|+++|+|+...
T Consensus 259 pt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 259 PTYPELMQHPFFTLH 273 (290)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHHhCcccccC
Confidence 999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=349.46 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=194.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
...+|++.+.||+|+||.||+|.+.. ....++++..... ......+ .+.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~ 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVRE----KFLQEALTMRQFDHPHIVKLIGVITE 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHH----HHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHH----HHHHHHHHHHhCCCCccceEEEEEcc
Confidence 34679999999999999999999843 2233333333322 1222223 34899999999999999999999753
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
. ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 88 ~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 148 (281)
T 1mp8_A 88 N---------------PVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148 (281)
T ss_dssp S---------------SCEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C---------------ccEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEE
Confidence 2 23899999999999999975 1336999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 149 ~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~ 208 (281)
T 1mp8_A 149 VSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMW 208 (281)
T ss_dssp EEET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEECccccccccCccccc---------ccccCCCcccccChhhccc----CCCCCccCchHHHHHHH
Confidence 9987 78999999999765432111 1123347789999999976 56889999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|++ |..||.+....+....+..+..+..+ ...++.+.+++.+||+.||.+|
T Consensus 209 ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~R 261 (281)
T 1mp8_A 209 EILMHGVKPFQGVKNNDVIGRIENGERLPMP---------------------------PNCPPTLYSLMTKCWAYDPSRR 261 (281)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhC
Confidence 9997 99999887776666666554432221 1455679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001143 1120 PTAGDLYEMFVAR 1132 (1141)
Q Consensus 1120 PSa~ElL~~L~~~ 1132 (1141)
||+.|+++++...
T Consensus 262 ps~~~l~~~l~~~ 274 (281)
T 1mp8_A 262 PRFTELKAQLSTI 274 (281)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=359.67 Aligned_cols=280 Identities=24% Similarity=0.281 Sum_probs=200.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.+|++.+.||+|+||.||+|++. +..||+|+..... .....+. +.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREK----VMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHH----HHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHH----HHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 356899999999999999999984 6678888865432 1122233 489999999999999999999986543
Q ss_pred CCC-----------C--------------------------------CCCCCccccceEEEEEeeccCCCHHHHHHHhhh
Q 001143 883 WLP-----------S--------------------------------ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE 919 (1141)
Q Consensus 883 ~~~-----------~--------------------------------~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~ 919 (1141)
... . ............++||||+++++|.+++....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~- 156 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC- 156 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-
Confidence 100 0 00000111234799999999999999998622
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccc--cC
Q 001143 920 TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HR 997 (1141)
Q Consensus 920 ~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~--~~ 997 (1141)
.....++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++............ ..
T Consensus 157 -~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 228 (332)
T 3qd2_B 157 -SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-------DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228 (332)
T ss_dssp -SGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-------CCEEECCCTTCEECSCC-----------
T ss_pred -CccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-------CCEEEeecCcccccccchhhcccccccc
Confidence 22346777899999999999999999999999999999999887 789999999998765432110000 00
Q ss_pred CCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhc
Q 001143 998 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1077 (1141)
Q Consensus 998 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~ 1077 (1141)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..|+.. .......+.....+.
T Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~--------- 293 (332)
T 3qd2_B 229 AYATHTGQVGTKLYMSPEQIHG----NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL--------- 293 (332)
T ss_dssp ---CCCSCC-CGGGSCHHHHHC----CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---------
T ss_pred ccccccccCCCcCccChHHhcC----CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---------
Confidence 0112234569999999999986 5688999999999999999998766531 122223333222211
Q ss_pred cCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1078 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1078 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.....++.+.+++.+||+.||.+|||+.|+++|+|+..
T Consensus 294 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 ------------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp ------------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ------------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11244566899999999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=380.84 Aligned_cols=268 Identities=22% Similarity=0.287 Sum_probs=211.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-----hHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-----ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~-----~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
..+|++.++||+|+||+||+|.+. +..+|+|+......... ....+.....+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 457999999999999999999984 56788888653321110 01112233455899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+.+.. ..++||||++||+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+
T Consensus 115 ~~~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 175 (504)
T 3q5i_A 115 FEDKK--------------YFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175 (504)
T ss_dssp EECSS--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEcCC--------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHH
Confidence 98655 35999999999999999876 246999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.++ ....+||+|||++....... ......||+.|+|||++.+ .++.++||||+||
T Consensus 176 Nil~~~~~----~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~ 235 (504)
T 3q5i_A 176 NILLENKN----SLLNIKIVDFGLSSFFSKDY-----------KLRDRLGTAYYIAPEVLKK-----KYNEKCDVWSCGV 235 (504)
T ss_dssp GEEESSTT----CCSSEEECCCTTCEECCTTS-----------CBCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHH
T ss_pred HEEEecCC----CCccEEEEECCCCEEcCCCC-----------ccccccCCcCCCCHHHhcc-----CCCchHHHHHHHH
Confidence 99998752 11369999999997654321 1123469999999999864 5789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++|+|++|..||.+.+..++...+..+........+ ...++++.+||.+||++||.
T Consensus 236 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~ 291 (504)
T 3q5i_A 236 IMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW------------------------KNISDEAKELIKLMLTYDYN 291 (504)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc------------------------CCCCHHHHHHHHHHcCCChh
Confidence 999999999999998888888887665543221111 14567799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001143 1118 ERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~s 1135 (1141)
+|||+.|+++|+|++...
T Consensus 292 ~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 292 KRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp TSCCHHHHHTSHHHHHTC
T ss_pred HCCCHHHHhcCHhhhhch
Confidence 999999999999997543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=381.53 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=211.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||+|++. +..+|+|+........ ....+. +.+|+.++++++||||+++++++.+..
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~- 99 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKES----LLREVQLLKQLDHPNIMKLYEFFEDKG- 99 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHH----HHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHH----HHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 46999999999999999999984 6678888865332211 112223 379999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+.+++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 100 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 161 (484)
T 3nyv_A 100 -------------YFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161 (484)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred -------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEec
Confidence 34999999999999999875 346999999999999999999999999999999999999954
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
.. ..+.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 162 ~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 162 KS----KDANIRIIDFGLSTHFEASKK-----------MKDKIGTAYYIAPEVLHG-----TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp SS----TTCCEEECCTTHHHHBCCCCS-----------HHHHTTGGGTCCHHHHHT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCcEEEEeeeeeEEcccccc-----------cccCCCCccccCceeecC-----CCCCcceeHHHHHHHHHHH
Confidence 21 127899999999976543211 123469999999999875 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+.+..++...+..+........+ ...++.+.+||.+||+.||.+|||+.
T Consensus 222 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~~ 277 (484)
T 3nyv_A 222 SGCPPFNGANEYDILKKVEKGKYTFELPQW------------------------KKVSESAKDLIRKMLTYVPSMRISAR 277 (484)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGG------------------------GGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCCccc------------------------ccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 999999998888888877665432211100 14567799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001143 1124 DLYEMFVARTS 1134 (1141)
Q Consensus 1124 ElL~~L~~~~~ 1134 (1141)
|+++|+|+...
T Consensus 278 e~l~h~~~~~~ 288 (484)
T 3nyv_A 278 DALDHEWIQTY 288 (484)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhChhhccc
Confidence 99999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=366.17 Aligned_cols=258 Identities=24% Similarity=0.273 Sum_probs=193.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.|++.+.||+|+||.||+|++. +..||+|+.... ...+. +.+|+.++++++||||+++++++.+..
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~- 121 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKI----VRTEIGVLLRLSHPNIIKLKEIFETPT- 121 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSS-
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc------hhHHH----HHHHHHHHHhCCCCCCcceeeeEecCC-
Confidence 45999999999999999999995 456788875422 11222 378999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 122 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~ 183 (349)
T 2w4o_A 122 -------------EISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183 (349)
T ss_dssp -------------EEEEEECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESS
T ss_pred -------------eEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEec
Confidence 35999999999999999865 346999999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
.. ..+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 184 ~~----~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 184 PA----PDAPLKIADFGLSKIVEHQV-----------LMKTVCGTPGYCAPEILRG----CAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp SS----TTCCEEECCCC---------------------------CGGGSCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEccCccccccCccc-----------ccccccCCCCccCHHHhcC----CCCCcccchHHHHHHHHHHH
Confidence 21 12789999999997643311 1123468999999999986 56889999999999999999
Q ss_pred hCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|..||......+ ....+.......... .....+..+.+||.+||+.||++|||+
T Consensus 245 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (349)
T 2w4o_A 245 CGFEPFYDERGDQFMFRRILNCEYYFISP------------------------WWDEVSLNAKDLVRKLIVLDPKKRLTT 300 (349)
T ss_dssp HSSCTTCCTTCHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred hCCCCCCCCcccHHHHHHHHhCCCccCCc------------------------hhhhCCHHHHHHHHHHccCChhhCcCH
Confidence 9999997655443 444544333221110 001456679999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001143 1123 GDLYEMFVARTSS 1135 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s 1135 (1141)
.|+++|+|+....
T Consensus 301 ~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 301 FQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHSTTTTSTT
T ss_pred HHHhcCcccCCCc
Confidence 9999999997654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=355.15 Aligned_cols=251 Identities=26% Similarity=0.278 Sum_probs=194.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~ 882 (1141)
++|++.++||+|+||+||+|++. +..||+|+.. ............ ..|+..+.++ +||||+++++++.+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~----~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM--SPFRGPKDRARK----LAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEES--SSCCSHHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEec--ccccChHHHHHH----HHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 45999999999999999999985 6677888643 222233322222 5666666555 8999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 131 --------------~~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 131 --------------ILYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 359999999 58999998762 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|||
T Consensus 192 ~~-------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 192 PR-------GRCKLGDFGLLVELGTAG-----------AGEVQEGDPRYMAPELLQG-----SYGTAADVFSLGLTILEV 248 (311)
T ss_dssp GG-------GCEEECCCTTCEECC-----------------CCCCCGGGCCGGGGGT-----CCSTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccceeeeecccCC-----------CCcccCCCccccCHhHhcC-----CCCchhhHHHHHHHHHHH
Confidence 87 789999999987654321 1123459999999999874 578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|..|+.+. .....+..+..+ +......+..+.+++.+||+.||++|||+
T Consensus 249 ~~g~~~~~~~---~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 299 (311)
T 3p1a_A 249 ACNMELPHGG---EGWQQLRQGYLP--------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATA 299 (311)
T ss_dssp HHTCCCCSSH---HHHHHHTTTCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCc---cHHHHHhccCCC--------------------------cccccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 9997766542 222333222211 11112456789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.|+++|+|++.
T Consensus 300 ~ell~hp~~~~ 310 (311)
T 3p1a_A 300 EALLALPVLRQ 310 (311)
T ss_dssp HHHHTSGGGSC
T ss_pred HHHHhCccccC
Confidence 99999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=347.57 Aligned_cols=260 Identities=23% Similarity=0.258 Sum_probs=203.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
....+|++.+.||+|+||.||+|.+. +..+++|+..... .........+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34678999999999999999999985 6778888865321 1111223345899999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 83 ~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 143 (276)
T 2h6d_A 83 PT--------------DFFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143 (276)
T ss_dssp SS--------------EEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE
T ss_pred CC--------------eEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE
Confidence 54 359999999999999999762 36899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||.+....... ......||+.|+|||++.+. ...+.++||||||+++|
T Consensus 144 ~~~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~~l~ 202 (276)
T 2h6d_A 144 LDAH-------MNAKIADFGLSNMMSDGE-----------FLRTSCGSPNYAAPEVISGR---LYAGPEVDIWSCGVILY 202 (276)
T ss_dssp ECTT-------SCEEECCCCGGGCCCC------------------------CCTGGGTTS---CCCHHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccccccCCCc-----------ceecccCCccccCHHHHcCC---CCCCccchHHHHHHHHH
Confidence 9887 789999999987654321 11234589999999998761 23368999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|+.||......+....+..+.... + ...+..+.+++.+||+.||.+||
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~l~~li~~~l~~~p~~Rp 254 (276)
T 2h6d_A 203 ALLCGTLPFDDEHVPTLFKKIRGGVFYI-P---------------------------EYLNRSVATLLMHMLQVDPLKRA 254 (276)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhCCCCCCCCcHHHHHHHhhcCcccC-c---------------------------hhcCHHHHHHHHHHccCChhhCC
Confidence 9999999998877766666665433211 0 03455689999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001143 1121 TAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~s 1135 (1141)
|+.|+++|+|+....
T Consensus 255 s~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 255 TIKDIREHEWFKQDL 269 (276)
T ss_dssp CHHHHHHSHHHHTTC
T ss_pred CHHHHHhChhhccCc
Confidence 999999999997653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=349.42 Aligned_cols=262 Identities=22% Similarity=0.238 Sum_probs=200.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~ 882 (1141)
.+|++.+.||+|+||+||+|.+. +..+|+|+.... ......... +.+|+..+.++ +||||+++++++.+.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQN----ALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--CTTSHHHHH----HHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccc--ccccHHHHH----HHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 56999999999999999999985 677888876533 222233333 37899999999 8999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++...... ...+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 85 --------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~ 149 (289)
T 1x8b_A 85 --------------HMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149 (289)
T ss_dssp --------------EEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------eEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEc
Confidence 349999999999999999864332 24699999999999999999999999999999999999998
Q ss_pred ccccc------------CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001143 963 LERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030 (1141)
Q Consensus 963 ~~~~~------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1030 (1141)
.++.. ......+||+|||.+...... ....||+.|+|||++.+ ...++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~gt~~y~aPE~~~~---~~~~~~~~ 212 (289)
T 1x8b_A 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--------------QVEEGDSRFLANEVLQE---NYTHLPKA 212 (289)
T ss_dssp --------------------CCCEEECCCTTCEETTCS--------------CCCCCCGGGCCHHHHTT---CCTTHHHH
T ss_pred CCCCCcccccccccccccCCceEEEEcccccccccCCc--------------cccCCCccccChhHhcC---CCCCCchh
Confidence 54200 012257999999998765431 12358999999999976 23566899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1031 DVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
|||||||++|+|++|.+|+.... ....+..+..+.++. ..++.+.+++.+
T Consensus 213 Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~ 262 (289)
T 1x8b_A 213 DIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQ---------------------------VLSQEFTELLKV 262 (289)
T ss_dssp HHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSS---------------------------CCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHH
Confidence 99999999999999988765432 233343333322211 445679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcCC
Q 001143 1111 CTEENPTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1111 cL~~DP~~RPSa~ElL~~L~~~~~s 1135 (1141)
||+.||.+|||+.|+++|+|+...+
T Consensus 263 ~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 263 MIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HTCSSGGGSCCHHHHHTCTTC----
T ss_pred HhCCCcccCCCHHHHhhChHhhhhc
Confidence 9999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=350.99 Aligned_cols=260 Identities=21% Similarity=0.280 Sum_probs=210.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+....+|.+.+.||+|+||.||+|.+. +..+|+|+...... ......+. +.+|+.++++++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREK----MSMEISIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHH----HHHHHHHHHhCCCCCEeeeeeeec
Confidence 455678999999999999999999985 55678887653321 12223333 478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 86 DND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146 (294)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCC--------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 654 34999999999999999876 23699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||.+........ ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 147 l~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 205 (294)
T 2rku_A 147 FLNED-------LEVKIGDFGLATKVEYDGE----------RKKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCIM 205 (294)
T ss_dssp EECTT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCCSSCCHHHHTT----SCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEeccCceecccCcc----------ccccccCCCCcCCcchhcc----CCCCchhhHHHHHHHH
Confidence 99887 7899999999976542211 1123468999999999876 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||......+....+...... ++ ...+..+.+++.+||+.||++|
T Consensus 206 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 206 YTLLVGKPPFETSCLKETYLRIKKNEYS-IP---------------------------KHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTTCCC-CC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhhccCC-Cc---------------------------cccCHHHHHHHHHHcccChhhC
Confidence 9999999999887766665555433211 10 0345568999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||+.|+++|+|+...
T Consensus 258 ps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 258 PTINELLNDEFFTSG 272 (294)
T ss_dssp CCGGGGGGSHHHHTS
T ss_pred cCHHHHhhChheecC
Confidence 999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=354.66 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=185.2
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+++|++.+.||+|+||.||+|++ .+..+|+|+..... ........++.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 467899999999999999999997 46678888864321 11112223458999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 84 ~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili 145 (278)
T 3cok_A 84 N--------------YVYLVLEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145 (278)
T ss_dssp S--------------EEEEEEECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred C--------------eEEEEEecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 4 34999999999999999875 23469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 146 ~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 204 (278)
T 3cok_A 146 TRN-------MNIKIADFGLATQLKMPHE----------KHYTLCGTPNYISPEIATR----SAHGLESDVWSLGCMFYT 204 (278)
T ss_dssp CTT-------CCEEECCCTTCEECC------------------------------------------CTHHHHHHHHHHH
T ss_pred cCC-------CCEEEEeecceeeccCCCC----------cceeccCCCCcCCcchhcC----CCCCchhhHHHHHHHHHH
Confidence 887 7899999999976543211 1113468999999999876 567889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|+.||......+....+..... .. ....+.++.+++.+||+.||.+|||
T Consensus 205 l~~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~---~~~~~~~~~~li~~~l~~dp~~Rps 256 (278)
T 3cok_A 205 LLIGRPPFDTDTVKNTLNKVVLADY-------------------------EM---PSFLSIEAKDLIHQLLRRNPADRLS 256 (278)
T ss_dssp HHHSSCSSCCCSCC-----CCSSCC-------------------------CC---CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhCCCCCCChhHHHHHHHHhhccc-------------------------CC---ccccCHHHHHHHHHHcccCHhhCCC
Confidence 9999999976543322222111000 00 0134567999999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001143 1122 AGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s~ 1136 (1141)
+.++++|+|+.....
T Consensus 257 ~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 257 LSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHHTTSTTTC----
T ss_pred HHHHhcCccccCCCC
Confidence 999999999986544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=367.22 Aligned_cols=295 Identities=18% Similarity=0.186 Sum_probs=208.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.++||+|+||+||+|.+ .+..||+|+...... .. .+|+.+++.++||||+++++++....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~----~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YK----NRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SC----CHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hH----HHHHHHHHHcCCCCccchhheeeecC
Confidence 45799999999999999999998 456788886542211 11 47999999999999999999986532
Q ss_pred CCCC-----------CCC-------------CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 001143 883 WLPS-----------ADG-------------NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVA 938 (1141)
Q Consensus 883 ~~~~-----------~~g-------------~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa 938 (1141)
.... ..+ .......+.++||||++ ++|.+.+...... ...+++..++.|+.||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLF 151 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHH
Confidence 1000 000 00012335789999998 6998888764433 35799999999999999
Q ss_pred HHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001143 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018 (1141)
Q Consensus 939 ~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1018 (1141)
.||.|||++||+||||||+|||++.+. +.+||+|||+|+.+.... ......||+.|+|||++.
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~------~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKD------NTLKLCDFGSAKKLIPSE-----------PSVAYICSRFYRAPELML 214 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTT------TEEEECCCTTCEECCTTS-----------CCCCCCCCSSCCCHHHHT
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCC------CcEEEEECCCCcccCCCC-----------CCcCcccCCCccCHHHhc
Confidence 999999999999999999999998421 789999999997654321 112346899999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1019 ~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
+ ...++.++|||||||++|+|++|+.||.+.+..+....+ .....+................+.......-.....
T Consensus 215 ~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 215 G---ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp T---CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred C---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 6 235789999999999999999999999988777765555 333333322211111000000000000000000011
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
...+.++.+|+.+||+.||.+|||+.|+++|+||..
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 245678999999999999999999999999999963
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=362.51 Aligned_cols=285 Identities=17% Similarity=0.209 Sum_probs=204.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|.+. +..||+|+.... .......+. +.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT--TSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc--cCChHHHHH----HHHHHHHHHhcCCCCccceEEeecccc
Confidence 578999999999999999999984 566777775422 223333333 379999999999999999999987644
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ......++||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 98 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 98 SL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp ST--------TTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cc--------ccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 21 12336799999997 688888753 589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 162 ~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 219 (371)
T 2xrw_A 162 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 219 (371)
T ss_dssp TT-------SCEEECCCCC---------------------------CTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEEeeccccccccc-----------ccCCceecCCccCHHHhcC----CCCCchHhHHHHHHHHHHH
Confidence 87 789999999997643211 1123468999999999986 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC-----------ccccccccCCC---CCCchhhhhhHHHHHHHH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-----------HEHEVAQSGSG---FEKPEAELETLSFLVDVF 1108 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-----------~~~~~~~~~~~---~~~~~~~~~~~~~L~dLI 1108 (1141)
++|+.||.+.+..+....+........+......... ....+...... ..........+..+.+||
T Consensus 220 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 299 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299 (371)
T ss_dssp HHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHH
Confidence 9999999988877766666443333322221111000 00000000000 000111223477899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1109 RRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.+||+.||.+|||++|+++|+|+..
T Consensus 300 ~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 300 SKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHCcCChhhCCCHHHHhCCcchhh
Confidence 9999999999999999999999964
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=364.66 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=210.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~---------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 874 (1141)
.++|.+.++||+|+||.||+|++.+ ..+|+|+.+.. ......+. +.+|+++++++ +||||+++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD----LISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHH----HHHHHHHHHHhcCCchhhhh
Confidence 4579999999999999999999732 35777775422 22333333 37999999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~y 943 (1141)
++++.+.+.. ++||||+++++|.+++...... ....+++..++.|+.||+.||.|
T Consensus 141 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 206 (382)
T 3tt0_A 141 LGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206 (382)
T ss_dssp EEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred eeeeccCCce--------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 9999876544 9999999999999999873211 12459999999999999999999
Q ss_pred HHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 944 LHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
||++||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 207 LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~---- 267 (382)
T 3tt0_A 207 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD---- 267 (382)
T ss_dssp HHHTTCCCSCCCGGGEEECTT-------CCEEECSCSCCCCSSCCCTT--------CCCTTCCCGGGGSCHHHHHS----
T ss_pred HHhCCEecCCCCcceEEEcCC-------CcEEEcccCccccccccccc--------ccccCCCCCcceeCHHHhcC----
Confidence 999999999999999999887 78999999999765432211 11223457889999999986
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 001143 1024 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1102 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1141)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. .+++
T Consensus 268 ~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 320 (382)
T 3tt0_A 268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NCTN 320 (382)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SCCH
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCH
Confidence 568899999999999999999 999999888877777776554433221 4456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
++.+|+.+||+.||.+|||+.|+++++...
T Consensus 321 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 321 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 799999999999999999999999998765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=377.04 Aligned_cols=269 Identities=20% Similarity=0.276 Sum_probs=200.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|.+.+.||+|+||.||+|.+. +..+|+|+...+...............+.+|+.++++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 357999999999999999999984 56788888765432222211112222357999999999999999999998542
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 213 --------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 213 --------------DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273 (419)
T ss_dssp --------------EEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred --------------ceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence 24899999999999888754 34799999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.++ ....+||+|||+++...... ......||+.|+|||++.+.. ...++.++|||||||++|+|
T Consensus 274 ~~~----~~~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~~l 337 (419)
T 3i6u_A 274 SQE----EDCLIKITDFGHSKILGETS-----------LMRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFIC 337 (419)
T ss_dssp SSS----SSCCEEECCSSTTTSCC----------------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHH
T ss_pred cCC----CcceEEEeecccceecCCCc-----------cccccCCCCCccCceeeecCC-CCCCCchhhhHhHHHHHHHH
Confidence 542 12569999999997654321 112456999999999985321 24678899999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|+.||...... .+...+..+.....+... ...++.+.+|+.+||+.||.+|||
T Consensus 338 ltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rps 393 (419)
T 3i6u_A 338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW------------------------AEVSEKALDLVKKLLVVDPKARFT 393 (419)
T ss_dssp HHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHCCCCCCCCcchHHHHHHHhcCCCCCCchhh------------------------cccCHHHHHHHHHHccCChhHCcC
Confidence 9999999764322 234444444433222211 145677999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.|+++|+|+..
T Consensus 394 ~~e~l~hp~~~~ 405 (419)
T 3i6u_A 394 TEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHSGGGCC
T ss_pred HHHHhCCcccCC
Confidence 999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=372.90 Aligned_cols=267 Identities=24% Similarity=0.265 Sum_probs=210.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..++|++.++||+|+||.||+|++. +..+|+|+..... .........+.+|..++.+++||||+++++++.+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 3568999999999999999999984 6678888754211 11111223457899999999999999999999875
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. +.|+||||++||+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 134 ~--------------~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl 195 (412)
T 2vd5_A 134 N--------------YLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195 (412)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee
Confidence 5 359999999999999999762 2369999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc---CCCCCCchhhHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVWSLGvi 1038 (1141)
+.+ +++||+|||+|+........ .....+||+.|+|||++.... ....++.++|||||||+
T Consensus 196 d~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 196 DRC-------GHIRLADFGSCLKLRADGTV---------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp CTT-------SCEEECCCTTCEECCTTSCE---------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred cCC-------CCEEEeechhheeccCCCcc---------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 987 88999999999765432111 112357999999999987321 12457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|||++|+.||.+.+..+....+.... ...+ +......+.++++||.+||. +|.
T Consensus 260 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------p~~~~~~s~~~~dli~~lL~-~p~ 314 (412)
T 2vd5_A 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSL------------------------PLVDEGVPEEARDFIQRLLC-PPE 314 (412)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC------------------------C----CCCHHHHHHHHTTSS-CGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC------------------------CccccCCCHHHHHHHHHHcC-Chh
Confidence 999999999999888877776664311 0000 00111456779999999999 999
Q ss_pred CC---CCHHHHHHHHHhhcC
Q 001143 1118 ER---PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~R---PSa~ElL~~L~~~~~ 1134 (1141)
+| |+++|+++|+||..-
T Consensus 315 ~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 315 TRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp GCTTTTTHHHHHTSGGGTTC
T ss_pred hcCCCCCHHHHhcCCCcCCC
Confidence 98 699999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=368.61 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=207.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|++. +..||+|+.+ .. ......+.+ .+|+.++++++||||+++++++....
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ET-LPPDLKAKF----LQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECC--TT-SCHHHHTTT----THHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcc--cc-CCHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 457999999999999999999995 5667777643 21 222333344 79999999999999999999997655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 186 ~~--------------~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~ 247 (377)
T 3cbl_A 186 PI--------------YIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247 (377)
T ss_dssp SC--------------EEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred Cc--------------EEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc
Confidence 43 9999999999999999762 23589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 248 ~~-------~~~kl~DfG~s~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el 308 (377)
T 3cbl_A 248 EK-------NVLKISDFGMSREEADGVYAA--------SGGLRQVPVKWTAPEALNY----GRYSSESDVWSFGILLWET 308 (377)
T ss_dssp TT-------CCEEECCGGGCEECTTSEEEC--------CSSCCEEEGGGSCHHHHHH----CEEEHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEECcCCCceecCCCceee--------cCCCCCCCcCcCCHhHhcc----CCCCchhhHHHHHHHHHHH
Confidence 87 789999999997543321110 1112235778999999986 4678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |..||.+....+....+..+.....+. .+++.+.+++.+||+.||.+|||
T Consensus 309 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rps 361 (377)
T 3cbl_A 309 FSLGASPYPNLSNQQTREFVEKGGRLPCPE---------------------------LCPDAVFRLMEQCWAYEPGQRPS 361 (377)
T ss_dssp HTTSCCSSTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCchhCcC
Confidence 98 999999888777777666554433221 34567999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
+.++++.+...
T Consensus 362 ~~~i~~~L~~i 372 (377)
T 3cbl_A 362 FSTIYQELQSI 372 (377)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999988654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=360.91 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=206.3
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCCh-HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..|++.+.||+|+||+||+|++ .+..||+|+.... .... ...+ .+.+|+.++++++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESC--SSCHHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccc--cccchHHHH----HHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3489999999999999999997 4566777765432 2122 2223 3489999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 128 --------------~~~lv~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 188 (348)
T 1u5q_A 128 --------------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 188 (348)
T ss_dssp --------------EEEEEEECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred --------------eEEEEEecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 3499999997 7888888642 34699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++...... ....||+.|+|||++.+.. ...++.++|||||||++|||
T Consensus 189 ~~-------~~~kL~DfG~a~~~~~~--------------~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~el 246 (348)
T 1u5q_A 189 EP-------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 246 (348)
T ss_dssp TT-------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHHTTS-SCCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeccCceecCCC--------------CcccCCcceeCHhhhcccc-CCCCCcHHHHHHHHHHHHHH
Confidence 87 88999999999654321 1346899999999986321 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..+....+.....+.... ...++.+.+||.+||+.||.+|||+
T Consensus 247 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dP~~Rps~ 300 (348)
T 1u5q_A 247 AERKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTS 300 (348)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCC--------------------------CCCCHHHHHHHHHHcccChhhCcCH
Confidence 99999998877766655554443322110 1345678999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001143 1123 GDLYEMFVARTSS 1135 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s 1135 (1141)
.++++|+|+....
T Consensus 301 ~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 301 EVLLKHRFVLRER 313 (348)
T ss_dssp HHHTTCHHHHSCC
T ss_pred HHHhhChhhhccC
Confidence 9999999997643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=352.32 Aligned_cols=275 Identities=23% Similarity=0.328 Sum_probs=198.5
Q ss_pred CCCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
..+|++.++||+|+||+||+|++ .+..+|+|+... ......+.+ .+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDF----EREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC----CCHHHHHHH----HHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc----CCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEE
Confidence 45799999999999999999985 456677776532 223333444 8999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
...+. ...++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 144 (295)
T 3ugc_A 81 YSAGR------------RNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 144 (295)
T ss_dssp CHHHH------------TSCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ecCCC------------CceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhh
Confidence 65321 1349999999999999999762 2359999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||++.......... .......++..|+|||++.+ ..++.++||||||++
T Consensus 145 il~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 145 ILVENE-------NRVKIGDFGLTKVLPQDKEFF-------KVKEPGESPIFWYAPESLTE----SKFSVASDVWSFGVV 206 (295)
T ss_dssp EEEEET-------TEEEECCCCSCC--------------------CTTCGGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CeEEEccCcccccccCCccee-------eeccCCCCccceeCcHHhcC----CCCChHHHHHHHHHH
Confidence 999987 789999999997654322110 11123347788999999987 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|..||... ..+....+.......... .... . .......... ...+++++.+++.+||+.||.+
T Consensus 207 l~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~-----~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~ 275 (295)
T 3ugc_A 207 LYELFTYIEKSKSP-PAEFMRMIGNDKQGQMIV-FHLI-----E-LLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQ 275 (295)
T ss_dssp HHHHHHTTCTTCSH-HHHHHHHHCTTCCTHHHH-HHHH-----H-HHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHhcccccCCC-hHHHHhhhcCccccchhH-HHHH-----H-HHhccCcCCC---CcCcCHHHHHHHHHHcCCChhh
Confidence 99999999998642 222222221111100000 0000 0 0000000001 1256778999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
|||+.|+++.+...
T Consensus 276 Rps~~el~~~L~~l 289 (295)
T 3ugc_A 276 RPSFRDLALRVDQI 289 (295)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHH
Confidence 99999999988654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=376.98 Aligned_cols=267 Identities=23% Similarity=0.280 Sum_probs=210.1
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.++||+|+||+||+|++.. ..+|+|+..... .........+.+|+.++..++||||+++++++.+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-----hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 4679999999999999999999854 567777754211 111111123478999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..|+||||++||+|.+++.+. ...+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 148 --------------~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 148 --------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209 (437)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc
Confidence 359999999999999999751 34699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~E 1041 (1141)
.+ +.+||+|||+|+........ .....+||+.|+|||++.... ....++.++|||||||++||
T Consensus 210 ~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~e 273 (437)
T 4aw2_A 210 MN-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273 (437)
T ss_dssp TT-------SCEEECCCTTCEECCTTSCE---------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEcchhhhhhcccCCCc---------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHH
Confidence 87 88999999999765432211 112357999999999987321 12457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~-- 1118 (1141)
|++|+.||.+.+..+....+.... ...++ ......++++.+||.+||..+|++
T Consensus 274 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~~~~~~s~~~~dLi~~lL~~~~~r~~ 329 (437)
T 4aw2_A 274 MLYGETPFYAESLVETYGKIMNHKERFQFP------------------------TQVTDVSENAKDLIRRLICSREHRLG 329 (437)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTHHHHCCCC------------------------SSCCCSCHHHHHHHHTTSSCGGGCTT
T ss_pred HHhCCCCCCCCChhHHHHhhhhccccccCC------------------------cccccCCHHHHHHHHHHhcccccccC
Confidence 999999999888877776664211 00000 000135677999999999988888
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
||+++|+++|+||..-
T Consensus 330 r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 330 QNGIEDFKKHPFFSGI 345 (437)
T ss_dssp TTTTHHHHTSGGGTTC
T ss_pred CCCHHHHhCCCccCCC
Confidence 9999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=351.80 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=207.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
..+|.+.+.||+|+||.||+|.+. +..+|+|+.. .. ......+.+ .+|+.++++++||||++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~~----~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--EN-ASPSELRDL----LSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECC--TT-CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEE
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEecc--CC-CCHHHHHHH----HHHHHHHhhCCCCceeeEEEE
Confidence 467999999999999999999872 2456777643 21 223333344 899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-------------------CCCCCCHHHHHHHHHHHH
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQDVA 938 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-------------------~~~~Ls~~~i~~Ia~QIa 938 (1141)
+.+.... ++||||+++++|.+++...... ....+++..++.++.||+
T Consensus 95 ~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 160 (314)
T 2ivs_A 95 CSQDGPL--------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160 (314)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHH
T ss_pred EecCCce--------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHH
Confidence 9865543 9999999999999999863221 123589999999999999
Q ss_pred HHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001143 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018 (1141)
Q Consensus 939 ~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1018 (1141)
.||.|||++||+||||||+||+++.+ +.+||+|||++.......... ......+|+.|+|||++.
T Consensus 161 ~~l~~lH~~~ivH~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 161 QGMQYLAEMKLVHRDLAARNILVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEETT-------TEEEECCCTTCEECTTTSCEE--------CSSCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHCCCcccccchheEEEcCC-------CCEEEccccccccccccccce--------eccCCCCcccccChhhhc
Confidence 99999999999999999999999987 789999999997654322110 112335788999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1019 AMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1019 ~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
+ ..++.++|||||||++|+|++ |..||.+....++...+..+..+..+
T Consensus 226 ~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------- 274 (314)
T 2ivs_A 226 D----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERP--------------------------- 274 (314)
T ss_dssp H----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------------------------
T ss_pred C----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCC---------------------------
Confidence 6 567899999999999999999 99999887776666666554432221
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
...++.+.+++.+||+.||.+|||+.++++++...
T Consensus 275 ~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 275 DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 14556799999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=351.24 Aligned_cols=265 Identities=24% Similarity=0.363 Sum_probs=199.3
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhh--CCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||+||+|++.+..||+|++... ....+ .+|.+++.. ++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-------DEKSW----FRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-------GHHHH----HHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-------cchhh----HHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 457999999999999999999999999999986422 11222 456666655 78999999999976532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCC
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDI 954 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--------s~gIvHrDL 954 (1141)
. .....++||||+++|+|.++++. ..+++..++.|+.||+.||+||| ++||+||||
T Consensus 76 ~----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 139 (301)
T 3q4u_A 76 H----------SSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139 (301)
T ss_dssp T----------TEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCC
T ss_pred C----------CCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCC
Confidence 1 12356999999999999999954 36999999999999999999999 999999999
Q ss_pred CCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC--CCCchhhH
Q 001143 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDI 1032 (1141)
Q Consensus 955 KP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksDV 1032 (1141)
||+|||++.+ +.+||+|||+++.......... .......||+.|+|||++.+..... .++.++||
T Consensus 140 kp~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv 206 (301)
T 3q4u_A 140 KSKNILVKKN-------GQCCIADLGLAVMHSQSTNQLD------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206 (301)
T ss_dssp CGGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred ChHhEEEcCC-------CCEEEeeCCCeeeccccccccc------ccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence 9999999987 7899999999976543222110 0112346999999999997632111 34579999
Q ss_pred HHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHH-hCCCCCchhHHhhhccCccccccccCCCCCCchh
Q 001143 1033 WSYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096 (1141)
Q Consensus 1033 WSLGviL~ELLTG----------k~Pf~~~~-----~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1141)
|||||++|||++| +.||.... .......+. ....+.++.. ..
T Consensus 207 wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 264 (301)
T 3q4u_A 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR----------------------WF 264 (301)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------GG
T ss_pred HHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChh----------------------hc
Confidence 9999999999999 88885421 122222221 1122221110 11
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1097 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1097 ~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
....+..+.+++.+||+.||.+|||+.|+++.+..
T Consensus 265 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 265 SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 12567889999999999999999999999998865
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=352.00 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=206.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.+|++.+.||+|+||.||+|.+. +..+|+|+....... ........+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR----RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH----HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc----ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 468999999999999999999984 556788876533211 10112234589999999999999999999985422
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
....++||||++++ |.+++.. .....+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 80 ------------~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~ 143 (305)
T 2wtk_C 80 ------------KQKMYMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143 (305)
T ss_dssp --------------CEEEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred ------------CCeEEEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc
Confidence 12459999999865 8888765 2345799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.+......... .......||+.|+|||++.+.. ..++.++||||||+++|+|
T Consensus 144 ~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~il~~l 206 (305)
T 2wtk_C 144 TG-------GTLKISALGVAEALHPFAAD--------DTCRTSQGSPAFQPPEIANGLD--TFSGFKVDIWSAGVTLYNI 206 (305)
T ss_dssp TT-------CCEEECCCTTCEECCTTCSS--------CEECCCCSCGGGCCHHHHTCCS--CEESHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEeeccccccccCccccc--------cccccCCCCCCCcChhhccCcc--cCCcchhhHHHHHHHHHHH
Confidence 87 78999999999765432111 0112345899999999987521 2346899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+....+....+..+.... + ...+..+.+++.+||..||.+|||+
T Consensus 207 ~~g~~p~~~~~~~~~~~~i~~~~~~~-~---------------------------~~~~~~l~~li~~~l~~dp~~Rps~ 258 (305)
T 2wtk_C 207 TTGLYPFEGDNIYKLFENIGKGSYAI-P---------------------------GDCGPPLSDLLKGMLEYEPAKRFSI 258 (305)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCC-C---------------------------SSSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhCCCCCCCchHHHHHHHHhcCCCCC-C---------------------------CccCHHHHHHHHHHccCChhhCCCH
Confidence 99999999877777766665443211 0 0345678999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001143 1123 GDLYEMFVARTSS 1135 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s 1135 (1141)
.|+++|+|+....
T Consensus 259 ~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 259 RQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHSHHHHSCC
T ss_pred HHHhcCcccccCC
Confidence 9999999997653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=342.95 Aligned_cols=257 Identities=21% Similarity=0.343 Sum_probs=208.7
Q ss_pred CCCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
...+|++.+.||+|+||.||+|.+ .+..+++|+..... .. .+. +.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MS---EED----FIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BC---HHH----HHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CC---HHH----HHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 346799999999999999999998 45578888764321 11 123 379999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 77 ~~--------------~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~ 138 (267)
T 3t9t_A 77 PI--------------CLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 138 (267)
T ss_dssp SC--------------EEEECCCTTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred Ce--------------EEEEeCCCCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC
Confidence 43 9999999999999999762 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 139 ~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 198 (267)
T 3t9t_A 139 EN-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEV 198 (267)
T ss_dssp GG-------GCEEECCTTGGGGBCCHHHH---------STTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccccccccccccccc---------ccccccccccccChhhhcC----CCccchhchhhhHHHHHHH
Confidence 87 78999999999765432111 1123357889999999976 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |+.||......+....+..+..+..+. ..+..+.+++.+||+.||.+|||
T Consensus 199 ~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps 251 (267)
T 3t9t_A 199 FSEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRPA 251 (267)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hccCCCCCCCCCHHHHHHHHhcCCcCCCCc---------------------------cCcHHHHHHHHHHccCChhhCcC
Confidence 99 899999887777776665543322111 34567899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.++++++.....
T Consensus 252 ~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 252 FSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=357.76 Aligned_cols=260 Identities=21% Similarity=0.280 Sum_probs=211.0
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+....+|.+.+.||+|+||.||+|.+. +..+++|+...... ......+. +.+|+.++++++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREK----MSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEEe
Confidence 455678999999999999999999985 45678887653321 12233333 478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.+ ..++||||+++++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 172 (335)
T 2owb_A 112 DND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172 (335)
T ss_dssp CSS--------------EEEEEECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred cCC--------------eEEEEEecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence 654 34999999999999999876 24699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 173 l~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 231 (335)
T 2owb_A 173 FLNED-------LEVKIGDFGLATKVEYDGE----------RKKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCIM 231 (335)
T ss_dssp EECTT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCCSSCCHHHHHT----SCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeccCceecccCcc----------cccccCCCccccCHHHhcc----CCCCchhhHHHHHHHH
Confidence 99887 7899999999976543211 1123468999999999976 5578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||......+....+...... ++ ...+..+.+||.+||+.||.+|
T Consensus 232 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~dp~~R 283 (335)
T 2owb_A 232 YTLLVGKPPFETSCLKETYLRIKKNEYS-IP---------------------------KHINPVAASLIQKMLQTDPTAR 283 (335)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHHTCCC-CC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCcCCCCCCCHHHHHHHHhcCCCC-CC---------------------------ccCCHHHHHHHHHHccCChhHC
Confidence 9999999999887766665555433211 10 0344568999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001143 1120 PTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~ 1134 (1141)
||+.|+++|+|+...
T Consensus 284 ps~~ell~~~~~~~~ 298 (335)
T 2owb_A 284 PTINELLNDEFFTSG 298 (335)
T ss_dssp CCGGGGGGSHHHHTS
T ss_pred cCHHHHhcCccccCC
Confidence 999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=361.41 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=204.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
..++|++.+.||+|+||.||+|++. +..||+|+.... ......+. +.+|+.++.++ +||||++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA----LMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHH----HHHHHHHHHhhcCCcceeeee
Confidence 3567999999999999999999853 256777775321 22233333 48999999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC----------------------------------
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG---------------------------------- 921 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~---------------------------------- 921 (1141)
+++.+.+. ..++||||+++|+|.++++......
T Consensus 93 ~~~~~~~~-------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (359)
T 3vhe_A 93 GACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS 159 (359)
T ss_dssp EEECSTTS-------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred eeeecCCC-------------ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence 99876432 2499999999999999998632100
Q ss_pred ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeE
Q 001143 922 ---------------------------EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974 (1141)
Q Consensus 922 ---------------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~v 974 (1141)
...+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~ 232 (359)
T 3vhe_A 160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-------NVV 232 (359)
T ss_dssp ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-------GCE
T ss_pred ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-------CcE
Confidence 1128999999999999999999999999999999999999987 789
Q ss_pred EEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001143 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS 1053 (1141)
Q Consensus 975 KL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~ 1053 (1141)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 233 kl~Dfg~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 233 KICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp EECCCGGGSCTTSCTTC--------EEC--CEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEEeccceeeecccccc--------hhccccCCCceeEChhhhcC----CCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 99999999765332111 01223468899999999986 568899999999999999998 999998755
Q ss_pred HH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1054 EL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1054 ~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.. .....+..+..+..+. ..++++.+++.+||+.||.+|||+.|+++|+...
T Consensus 301 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 301 IDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CSHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 33 3344444433322211 3456799999999999999999999999998764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=362.18 Aligned_cols=279 Identities=23% Similarity=0.314 Sum_probs=206.4
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
....+|++.+.||+|+||.||+|.+. +..+|+|+..... .....+ .+.+|+.++++++||||+++++++..
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRN----QIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHH----HHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHH----HHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 34567999999999999999999996 6678888765331 223233 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NI 959 (1141)
.+ ..++||||+++++|.+++.. ...+++..+..|+.||+.||.|||++ ||+||||||+||
T Consensus 103 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 163 (360)
T 3eqc_A 103 DG--------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163 (360)
T ss_dssp TT--------------EEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CC--------------EEEEEEECCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHE
Confidence 55 35999999999999999976 23699999999999999999999996 999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 164 l~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 164 LVNSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSL 220 (360)
T ss_dssp EECTT-------CCEEECCCCCCHHHHHHC----------------CCCCTTCCHHHHTT----CCCSHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCCccccccc------------ccCCCCCCCeECHHHHcC----CCCCchhhHHHHHHHH
Confidence 99987 789999999986543211 123468999999999976 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCC---CCchhHHhhhccCcc----------------ccccccCCCCCCchhhhhh
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHE----------------HEVAQSGSGFEKPEAELET 1100 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~---p~l~~~l~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 1100 (1141)
|+|++|+.||......+....+..... ...+........... ...... .. ........
T Consensus 221 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~ 297 (360)
T 3eqc_A 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PP--PKLPSGVF 297 (360)
T ss_dssp HHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHS-CC--CCCCTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc-CC--CCCCcccc
Confidence 999999999988766554433311100 000000000000000 000000 00 00011135
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1101 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1101 ~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+.++.+||.+||+.||.+|||+.|+++|+|+..
T Consensus 298 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 298 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 678999999999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=374.47 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=208.3
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
...+|++.++||+|+||.||+|.+.+..||+|+.+... ..+. +.+|+.+|++++||||+++++++.+...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~------~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT------TSHH----HHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch------HHHH----HHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 45679999999999999999999999999999864221 2233 3799999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++|+|.++++. .+...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 261 -------------~~~iv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 324 (450)
T 1k9a_A 261 -------------GLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 324 (450)
T ss_dssp -------------CEEEEEECCTTCBHHHHHHH---HCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred -------------ceEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC
Confidence 35999999999999999986 23335799999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|||+
T Consensus 325 ~-------~~~kl~DfG~a~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~ 380 (450)
T 1k9a_A 325 D-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 380 (450)
T ss_dssp T-------SCEEECCCTTCEECC-------------------CCCTTTSCHHHHHS----SCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeCCCcccccccc-------------cCCCCCcceeCHHHhcC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 789999999997533211 12247889999999976 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||.+....++...+..+..+..+. .+++.+.++|.+||+.||.+|||+
T Consensus 381 t~g~~P~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~Rpt~ 433 (450)
T 1k9a_A 381 SFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYDVMKNCWHLDAATRPTF 433 (450)
T ss_dssp TTTCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHCcCH
Confidence 8 999998877666666665554332221 456779999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.++++.+....
T Consensus 434 ~~l~~~L~~i~ 444 (450)
T 1k9a_A 434 LQLREQLEHIR 444 (450)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999887654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=353.62 Aligned_cols=272 Identities=26% Similarity=0.325 Sum_probs=197.8
Q ss_pred CCCceEe-eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 805 FPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~-~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
-+.|++. +.||+|+||.||+|.+ .+..+|+|+..... . ...+ .+.+|+.++.++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~--~~~~----~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--G--HIRS----RVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--S--CCHH----HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--c--hhHH----HHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3568885 7899999999999987 46778888864321 1 1122 337899999985 79999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.+ ..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 143 (316)
T 2ac3_A 83 ED--------------RFYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143 (316)
T ss_dssp TT--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CC--------------EEEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 55 35999999999999999976 246899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC-CCCCCchhhHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVWSLGviL 1039 (1141)
++.++ ....+||+|||++............ .........||+.|+|||++.+... ...++.++|||||||++
T Consensus 144 ~~~~~----~~~~~kl~Dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 144 CEHPN----QVSPVKICDFDLGSGIKLNGDCSPI---STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp ESCSS----SSCSEEECCTTCCC----------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred EccCC----CcCceEEEEccCccccccCCccccc---cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 98762 1134999999998765432111000 0111123459999999999864110 02367899999999999
Q ss_pred HHHHhCCCCCCCCCH---------------HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1040 LELLTLQVPYMGLSE---------------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~---------------~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
|+|++|+.||.+... ..+...+..+....... .....+..+
T Consensus 217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~ 272 (316)
T 2ac3_A 217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK------------------------DWAHISCAA 272 (316)
T ss_dssp HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHH------------------------HHTTSCHHH
T ss_pred HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCch------------------------hcccCCHHH
Confidence 999999999976431 22334443332211110 011456679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+|+.+||+.||.+|||+.|+++|+|+...
T Consensus 273 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 999999999999999999999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=352.02 Aligned_cols=259 Identities=24% Similarity=0.248 Sum_probs=206.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++. +..+|+|+..... ....+. +.+|+.++++++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSS----LENEIAVLKKIKHENIVTLEDIYESTT- 79 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------H----HHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHH----HHHHHHHHHhCCCCCeeehhhhcccCC-
Confidence 46899999999999999999984 6678888765321 111222 378999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++..
T Consensus 80 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~ 141 (304)
T 2jam_A 80 -------------HYYLVMQLVSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141 (304)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESS
T ss_pred -------------EEEEEEEcCCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 35999999999999999876 236899999999999999999999999999999999999932
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
. ...+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 142 ~----~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 142 P----EENSKIMITDFGLSKMEQNGI------------MSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp S----STTCCEEBCSCSTTCCCCCBT------------THHHHSCCCBCCTTTBSS----CSCCHHHHHHHHHHHHHHHH
T ss_pred C----CCCCCEEEccCCcceecCCCc------------cccccCCCCccChHHhcc----CCCCchhhHHHHHHHHHHHH
Confidence 1 111789999999986533211 123458999999999876 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||......+....+..+....... .....+..+.+++.+||..||.+|||+.
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 257 (304)
T 2jam_A 202 CGYPPFYEETESKLFEKIKEGYYEFESP------------------------FWDDISESAKDFICHLLEKDPNERYTCE 257 (304)
T ss_dssp HSSCTTTTSCHHHHHHHHHHCCCCCCTT------------------------TTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 9999999887777777765544321100 0014566799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001143 1124 DLYEMFVARTSS 1135 (1141)
Q Consensus 1124 ElL~~L~~~~~s 1135 (1141)
|+++|+|+....
T Consensus 258 ~~l~h~~~~~~~ 269 (304)
T 2jam_A 258 KALSHPWIDGNT 269 (304)
T ss_dssp HHHTSHHHHSSC
T ss_pred HHhcCccccCCC
Confidence 999999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=370.15 Aligned_cols=298 Identities=18% Similarity=0.223 Sum_probs=202.1
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||.||+|.+.. ..||+|+. ..........+. +.+|+.++++++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~--~~~~~~~~~~~~----~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKR----ILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEE--CSTTTSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEe--CchhcChHHHHH----HHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 4679999999999999999999854 45666654 333333333333 489999999999999999999987643
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. .....|+||||++ ++|.++++. ...+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 99 ~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 163 (432)
T 3n9x_A 99 LL---------KFDELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163 (432)
T ss_dssp TT---------TCCCEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CC---------cCCeEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC
Confidence 21 1235799999996 699999975 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecccccccccccccccccc------------CCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH------------RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1030 (1141)
.+ +.+||+|||+|+............. .........+||+.|+|||++.. ...++.++
T Consensus 164 ~~-------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~~ 233 (432)
T 3n9x_A 164 QD-------CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL---QENYTKSI 233 (432)
T ss_dssp TT-------CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT---CSCCCTHH
T ss_pred CC-------CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc---CCCCCccc
Confidence 87 8899999999987643221100000 00011235579999999999754 25688999
Q ss_pred hHHHHHHHHHHHHhC-----------CCCCCCCC-----------------HHHHHHHH-HhCCCCCchhHHhhhccCcc
Q 001143 1031 DIWSYGCLLLELLTL-----------QVPYMGLS-----------------ELEIHDLI-QMGKRPRLTDELEALGSCHE 1081 (1141)
Q Consensus 1031 DVWSLGviL~ELLTG-----------k~Pf~~~~-----------------~~el~~~I-~~~~~p~l~~~l~~~~~~~~ 1081 (1141)
|||||||++|||++| .++|.+.+ ..+....+ .....|... .+........
T Consensus 234 DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~-~~~~~~~~~~ 312 (432)
T 3n9x_A 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED-DLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHH-HHHTCCCHHH
T ss_pred ccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHH-HHHhccCHHH
Confidence 999999999999984 44443322 11222222 222222211 1111000000
Q ss_pred ccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1082 HEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1082 ~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
..... ..............++++.+||.+||+.||.+|||++|+++|+|+..-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 00000 000000011112467789999999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=355.16 Aligned_cols=267 Identities=20% Similarity=0.317 Sum_probs=192.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~-----~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
...+|++.+.||+|+||.||+|.+... .+|+|+.+.. .......+. +.+|+.++++++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD--IIASSDIEE----FLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHH----HHHHHHHHTTCCCTTBCCCCEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc--ccCHHHHHH----HHHHHHHHHHCCCCceehhhcee
Confidence 356799999999999999999987443 5777775422 212233333 48999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
...... ......++||||+++++|.+++...... ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~--------~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~ 166 (323)
T 3qup_A 95 LRSRAK--------GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR 166 (323)
T ss_dssp ECC---------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred eccccc--------cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcc
Confidence 764421 1123458999999999999999763321 1225999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||
T Consensus 167 NIli~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 227 (323)
T 3qup_A 167 NCMLAED-------MTVCVADFGLSRKIYSGDYY--------RQGCASKLPVKWLALESLAD----NLYTVHSDVWAFGV 227 (323)
T ss_dssp GEEECTT-------SCEEECCCCC-------------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEEcCC-------CCEEEeeccccccccccccc--------cccccccCcccccCchhhcC----CCCCCccchhhHHH
Confidence 9999887 78999999999765432211 11123347889999999987 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|+|++ |+.||.+....+....+..+..+..+ ...+..+.+++.+||+.||
T Consensus 228 il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp 280 (323)
T 3qup_A 228 TMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP---------------------------PECMEEVYDLMYQCWSADP 280 (323)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHTTCSSG
T ss_pred HHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC---------------------------CccCHHHHHHHHHHccCCh
Confidence 9999999 99999987777766666544432221 1445679999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 001143 1117 TERPTAGDLYEMFV 1130 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~ 1130 (1141)
.+|||+.++++.+.
T Consensus 281 ~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 281 KQRPSFTCLRMELE 294 (323)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hhCcCHHHHHHHHH
Confidence 99999555554443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.77 Aligned_cols=272 Identities=25% Similarity=0.348 Sum_probs=216.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 878 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~-~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~ 878 (1141)
...++|++.+.||+|+||.||+|.+. +..+|+|+....... ......+.....+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34678999999999999999999984 567888886543211 122333444556689999999996 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.... ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 154 (298)
T 1phk_A 94 ETNT--------------FFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154 (298)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCC--------------eEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 7654 45999999999999999976 2469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLG 1036 (1141)
|+++.+ +.+||+|||.+....... ......||+.|+|||++.+.. ....++.++||||||
T Consensus 155 il~~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 216 (298)
T 1phk_A 155 ILLDDD-------MNIKLTDFGFSCQLDPGE-----------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216 (298)
T ss_dssp EEECTT-------CCEEECCCTTCEECCTTC-----------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred EEEcCC-------CcEEEecccchhhcCCCc-----------ccccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence 999887 789999999997654321 112346899999999986321 124578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+++|+|++|..||......+....+..+....... .....+..+.+++.+||+.||
T Consensus 217 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 217 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc------------------------cccccCHHHHHHHHHHccCCc
Confidence 99999999999998877777666665443221110 001456779999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001143 1117 TERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~s 1135 (1141)
.+|||+.|+++|+|+....
T Consensus 273 ~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 273 QKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp GGSCCHHHHTTSGGGCTTC
T ss_pred ccCCCHHHHHhChHhhhcc
Confidence 9999999999999997543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=358.91 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=196.3
Q ss_pred CCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC--CCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkllg~~~~~~ 882 (1141)
..|++.+.||+|+||.||+|.+ .+..+|+|+.... .......+.+ .+|+.++.+++| |||+++++++....
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE--EADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECT--TCCHHHHHHH----HHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecc--ccchHHHHHH----HHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 4699999999999999999987 4556888876543 2233333444 799999999976 99999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++|||| .+++|.+++.. ...+++.++..|+.||+.||.|||++||+||||||+|||++
T Consensus 83 --------------~~~lv~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~ 142 (343)
T 3dbq_A 83 --------------YIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 142 (343)
T ss_dssp --------------EEEEEECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred --------------EEEEEEeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE
Confidence 35999995 57899999986 34699999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1035 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVWSL 1035 (1141)
. +.+||+|||+++........ .......||+.|+|||++.+.. ....++.++|||||
T Consensus 143 ~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 143 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp T--------TEEEECCCSSSCCC--------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred C--------CcEEEeecccccccCccccc--------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 3 67999999999765432111 1122456999999999986421 12467899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1036 GCLLLELLTLQVPYMGLSEL-EIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~~-el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
||++|+|++|+.||...... .....+.. ......+ ...+..+.+|+.+||+
T Consensus 207 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~L~ 259 (343)
T 3dbq_A 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 259 (343)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc---------------------------ccCCHHHHHHHHHHcC
Confidence 99999999999999764322 22222211 1111100 0234568999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001143 1114 ENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.||.+|||+.|+++|+|+...
T Consensus 260 ~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 260 RDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp SSTTTSCCHHHHHTSHHHHSC
T ss_pred CChhHCCCHHHHHhCcccccc
Confidence 999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=357.97 Aligned_cols=257 Identities=19% Similarity=0.313 Sum_probs=200.9
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--ccE----EEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS--ADA----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~--~~v----AvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
...+|++.++||+|+||+||+|++.. ..+ ++|. +.... ..... ..+.+|+.++++++||||++++++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~--~~~~~-~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREAT-SPKAN----KEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEE--C--------CH----HHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEee--ccccc-CHHHH----HHHHHHHHHHHhCCCCCEeEEEEE
Confidence 45679999999999999999999843 333 3443 22111 11122 334899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+.+.. .++||||+++|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 86 ~~~~~---------------~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~ 146 (327)
T 3poz_A 86 CLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146 (327)
T ss_dssp EESSS---------------EEEEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EecCC---------------eEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChh
Confidence 87543 3899999999999999976 2346999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||
T Consensus 147 NIll~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~ 207 (327)
T 3poz_A 147 NVLVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGV 207 (327)
T ss_dssp GEEEEET-------TEEEECCTTHHHHHTTTCC---------------CCCGGGSCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEECCC-------CCEEEccCcceeEccCCccc--------ccccCCCccccccChHHhcc----CCCCchhhhhhhHH
Confidence 9999987 78999999999865432211 11123357889999999987 57889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|||++ |+.||.+....++...+..+.....+ ...+..+.+++.+||+.||
T Consensus 208 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 208 TVWELMTFGSKPYDGIPASEISSILEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---------------------------TTBCHHHHHHHHHHTCSCG
T ss_pred HHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC---------------------------ccCCHHHHHHHHHHcCCCh
Confidence 9999999 99999987776666666554432221 1345679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
.+|||+.|+++++...
T Consensus 261 ~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 261 DSRPKFRELIIEFSKM 276 (327)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHH
Confidence 9999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=370.70 Aligned_cols=284 Identities=23% Similarity=0.254 Sum_probs=206.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.++||+|+||.||+|++. +..||+|+..... ... .+|+.++++++|||||++++++.....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~----~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFK----NRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--------TSC----CHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--------hhH----HHHHHHHHHcCCCCccceeeEEeccCC
Confidence 36999999999999999999994 5677887653221 111 479999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.....+.++||||++ ++|.+.+...... ...+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 122 --------~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~ 191 (420)
T 1j1b_A 122 --------KKDEVYLNLVLDYVP-ETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191 (420)
T ss_dssp --------TTTEEEEEEEEECCC-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET
T ss_pred --------CCcceeEEeehhccc-ccHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC
Confidence 012335689999998 5787777653332 357999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+. +.+||+|||+++.+.... ......||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 192 ~~------~~~kl~DFG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell 251 (420)
T 1j1b_A 192 DT------AVLKLCDFGSAKQLVRGE-----------PNVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELL 251 (420)
T ss_dssp TT------TEEEECCCTTCEECCTTC-----------CCCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHH
T ss_pred CC------CeEEeccchhhhhcccCC-----------CceeeeeCCCcCCHHHHcC---CCCCCchhhhHHHHHHHHHHH
Confidence 52 578999999997653311 1123468999999999875 236889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhcc-CccccccccCCCCCC-chhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGS-CHEHEVAQSGSGFEK-PEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+.+..+....+ .....+... .+..... .....+..... ... .......+.++.+||.+||+.||.+||
T Consensus 252 ~G~~pf~~~~~~~~l~~i~~~lg~p~~~-~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~ 329 (420)
T 1j1b_A 252 LGQPIFPGDSGVDQLVEIIKVLGTPTRE-QIREMNPNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329 (420)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCHH-HHHHHCSCCCCCCCCCCCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHH-HHHhhChhhhhhccCccCC-CCHHHhcCCCCCHHHHHHHHHhccCChhHCC
Confidence 999999987766655444 333333222 1111100 00000000000 000 001124567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
|+.|+++|+||..
T Consensus 330 t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 330 TPLEACAHSFFDE 342 (420)
T ss_dssp CHHHHHTSGGGGG
T ss_pred CHHHHhCCHhhcc
Confidence 9999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=366.59 Aligned_cols=285 Identities=22% Similarity=0.241 Sum_probs=204.2
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.+|++.++||+|+||+||+|++. ...+|+|...... ... .+|+.+++.++||||+++++++......
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~--------~~~----~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK--------RFK----NRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT--------TSC----CHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc--------chH----HHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 46999999999999999999984 3446666542111 011 3799999999999999999998764321
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee-c
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID-L 963 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld-~ 963 (1141)
......++||||+++ ++...+..... ....+++..++.|+.||+.||.|||++||+||||||+|||++ .
T Consensus 108 --------~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~ 177 (394)
T 4e7w_A 108 --------KDEVFLNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP 177 (394)
T ss_dssp --------SSCEEEEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred --------CCceEEEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCC
Confidence 123356899999985 55555543222 234799999999999999999999999999999999999998 4
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+...... ......||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 178 ~-------~~~kL~DFG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell 236 (394)
T 4e7w_A 178 S-------GVLKLIDFGSAKILIAGE-----------PNVSYICSRYYRAPELIFG---ATNYTTNIDIWSTGCVMAELM 236 (394)
T ss_dssp T-------TEEEECCCTTCEECCTTC-----------CCCSSCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeeCCCcccccCCC-----------CCcccccCcCccCHHHHcC---CCCCCcHHHHHHHHHHHHHHH
Confidence 5 789999999997653321 1123468999999999875 245889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|+.||.+.+..+....+ .....+................+................++++.+||.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (394)
T 4e7w_A 237 QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316 (394)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence 999999988776655554 3333333221111100000000000000000000112356789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.|+++|+||..
T Consensus 317 ~e~l~hp~f~~ 327 (394)
T 4e7w_A 317 IEALCHPFFDE 327 (394)
T ss_dssp HHHHTSGGGST
T ss_pred HHHhcChhhhh
Confidence 99999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=365.65 Aligned_cols=285 Identities=20% Similarity=0.233 Sum_probs=193.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|.+. +..||+|+ +..........+. +.+|+.+++.++||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~--~~~~~~~~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEE--CSSTTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEE--eCccccCHHHHHH----HHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 367999999999999999999985 45566665 4332223333333 479999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ......++||||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 166 (367)
T 2fst_X 102 SL--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166 (367)
T ss_dssp SG--------GGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cc--------ccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC
Confidence 21 1123459999999 6899998864 3699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 167 ~~-------~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 223 (367)
T 2fst_X 167 ED-------CELKILDFGLARHTADE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 223 (367)
T ss_dssp TT-------CCEEECC----------------------------CCCTTCCHHHHTT---CCSCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccccccccc-------------CCCcCcCcCccChHHHcC---CcCCCchhhHHHHHHHHHHH
Confidence 87 78999999999754321 123468999999999875 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
++|+.||.+.+..+....+......+....+............+... ...........++.+.+||.+||+.||.+|
T Consensus 224 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R 303 (367)
T 2fst_X 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303 (367)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence 99999999888777666553321111111111110000000000000 000111112456789999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.|+++|+|+..
T Consensus 304 ~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 304 ITAAQALAHAYFAQ 317 (367)
T ss_dssp CCHHHHHTSGGGTT
T ss_pred cCHHHHhcChhhhh
Confidence 99999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=355.19 Aligned_cols=268 Identities=25% Similarity=0.394 Sum_probs=208.4
Q ss_pred CCCCCCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccc
Q 001143 797 CSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 873 (1141)
Q Consensus 797 ~~~~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVk 873 (1141)
...++...+.+|++.+.||+|+||.||+|++. +..+.++++.+.... .....+. +.+|+.+++++ +||||++
T Consensus 16 ~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~----~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRD----FAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CH----HHHHHHHHTTCCCCTTBCC
T ss_pred CcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHH----HHHHHHHHHhccCCCchhh
Confidence 34567778899999999999999999999874 444433444343211 1222233 47999999999 8999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHH
Q 001143 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 874 llg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+++++.+.+ ..++||||+++++|.+++..... .....+++..++.++.||+.||.
T Consensus 91 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 156 (327)
T 1fvr_A 91 LLGACEHRG--------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156 (327)
T ss_dssp EEEEEEETT--------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred hceeeeeCC--------------ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 999998655 34999999999999999976320 11246999999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||++||+||||||+|||++.+ +.+||+|||+++...... ......+++.|+|||++.+
T Consensus 157 ~LH~~~ivH~dlkp~NIl~~~~-------~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~--- 215 (327)
T 1fvr_A 157 YLSQKQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYV-----------KKTMGRLPVRWMAIESLNY--- 215 (327)
T ss_dssp HHHHTTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEEC-----------CC----CCTTTCCHHHHHH---
T ss_pred HHHhCCccCCCCccceEEEcCC-------CeEEEcccCcCccccccc-----------cccCCCCCccccChhhhcc---
Confidence 9999999999999999999887 789999999986432211 1123357889999999976
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1141)
..++.++|||||||++|+|++ |..||.+....+....+..+..+..+ ...+
T Consensus 216 -~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 267 (327)
T 1fvr_A 216 -SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCD 267 (327)
T ss_dssp -CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC---------------------------TTBC
T ss_pred -ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC---------------------------CCCC
Confidence 457899999999999999998 99999988777766665444322111 1455
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1102 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+.+++.+||..||.+|||+.|+++++...
T Consensus 268 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 268 DEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 6799999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=370.11 Aligned_cols=262 Identities=24% Similarity=0.274 Sum_probs=194.6
Q ss_pred CCCceEe-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhh-CCCCCccceeeeEec
Q 001143 805 FPSLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~-~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIVkllg~~~~ 880 (1141)
+.+|.+. ++||+|+||+||+|.+. +..||+|+.. . . .. +.+|+.++.+ .+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~--~---~----~~----~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--D---C----PK----ARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE--C---S----HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC--c---c----hh----HHHHHHHHHHhcCCCCcceEeEEEee
Confidence 5678776 78999999999999985 5668888753 1 1 11 2578888754 489999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ....+.|+||||++||+|.+++.. .+...+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 127 ~~----------~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil 193 (400)
T 1nxk_A 127 LY----------AGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193 (400)
T ss_dssp EE----------TTEEEEEEEEECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cc----------cCCcEEEEEEEeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEE
Confidence 11 012256999999999999999975 22346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+. ..+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 194 l~~~~----~~~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 254 (400)
T 1nxk_A 194 YTSKR----PNAILKLTDFGFAKETTSHN-----------SLTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_dssp ESSSS----TTCCEEECCCTTCEECC----------------------CTTCCGGGSCC----CCSSSHHHHHHHHHHHH
T ss_pred EecCC----CCccEEEEecccccccCCCC-----------ccccCCCCCCccCHhhcCC----CCCCCcccHHHHHHHHH
Confidence 98731 12789999999997543211 1124468999999999865 57889999999999999
Q ss_pred HHHhCCCCCCCCCHHH----HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~e----l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|++|..||.+..... ....+..+..... .+. ....+.++.+||.+||+.||
T Consensus 255 ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-----------------------~~~-~~~~s~~~~~li~~~L~~dP 310 (400)
T 1nxk_A 255 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-----------------------NPE-WSEVSEEVKMLIRNLLKTEP 310 (400)
T ss_dssp HHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC-----------------------TTT-TTTSCHHHHHHHHTTSCSSG
T ss_pred HHHhCCCCCCCCccccccHHHHHHHHcCcccCC-----------------------Ccc-cccCCHHHHHHHHHHCCCCh
Confidence 9999999997643221 2233322221100 000 01456779999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001143 1117 TERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~s 1135 (1141)
.+|||+.|+++|+|+....
T Consensus 311 ~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 311 TQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp GGSCCHHHHHHSHHHHTTT
T ss_pred hHCcCHHHHhcCccccCCC
Confidence 9999999999999998643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=372.26 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=209.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
...+|++.++||+|+||.||+|.+. +..||+|+.+.. . ...+.+ .+|+.+|++++|||||++++++.. .
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~---~~~~~~----~~E~~~l~~l~h~~iv~l~~~~~~-~ 255 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--S---MSVEAF----LAEANVMKTLQHDKLVKLHAVVTK-E 255 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--S---BCHHHH----HHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--C---ccHHHH----HHHHHHHhhCCCCCEeeEEEEEeC-C
Confidence 3457999999999999999999985 566888875422 1 122333 899999999999999999999863 2
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++|+|.++++... ...+++..+..|+.||+.||.|||++||+||||||+|||++
T Consensus 256 --------------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~ 318 (454)
T 1qcf_A 256 --------------PIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 318 (454)
T ss_dssp --------------SCEEEECCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC
T ss_pred --------------ccEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC
Confidence 2399999999999999997521 23588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++........ ......+|+.|+|||++.. ..++.++|||||||++|||
T Consensus 319 ~~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~el 378 (454)
T 1qcf_A 319 AS-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEI 378 (454)
T ss_dssp TT-------CCEEECSTTGGGGBCCHHHH---------TTCSSSSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeCCCceEcCCCcee---------ccCCCcccccccCHHHhcc----CCCCcHHHHHhHHHHHHHH
Confidence 87 78999999999865432111 1112346789999999986 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |+.||.+....++...+..+.....+. .+++.+.+||.+||+.||++|||
T Consensus 379 ~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dp~~RPt 431 (454)
T 1qcf_A 379 VTYGRIPYPGMSNPEVIRALERGYRMPRPE---------------------------NCPEELYNIMMRCWKNRPEERPT 431 (454)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhHCcC
Confidence 99 999999888888777776554332211 45667999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001143 1122 AGDLYEMFVARTSS 1135 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s 1135 (1141)
+.+|++.+......
T Consensus 432 ~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 432 FEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHHHTSSSS
T ss_pred HHHHHHHHHHHHhc
Confidence 99999998776443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=351.14 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=210.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-+.|++.+.||+|+||.||+|.+. +..+|+|+...... ....+. +.+|+.++++++||||+++++++....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIED----IQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHH----HHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 456999999999999999999984 66788888654322 122233 479999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 94 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 153 (303)
T 3a7i_A 94 --------------KLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153 (303)
T ss_dssp --------------EEEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence 34999999999999999864 4699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 154 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 212 (303)
T 3a7i_A 154 EH-------GEVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIEL 212 (303)
T ss_dssp TT-------SCEEECCCTTCEECBTTBC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCcccc----------ccCccCCCcCccCHHHHhc----CCCCchhhhHHHHHHHHHH
Confidence 87 7899999999976543211 1123468999999999976 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||......+....+.....+.+. ...+..+.+++.+||+.||.+|||+
T Consensus 213 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp~~Rps~ 265 (303)
T 3a7i_A 213 ARGEPPHSELHPMKVLFLIPKNNPPTLE---------------------------GNYSKPLKEFVEACLNKEPSFRPTA 265 (303)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCC---------------------------SSCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccCCCCCCCcCHHHHHHHhhcCCCCCCc---------------------------cccCHHHHHHHHHHcCCChhhCcCH
Confidence 9999999887776666655444332221 1345679999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001143 1123 GDLYEMFVARTSS 1135 (1141)
Q Consensus 1123 ~ElL~~L~~~~~s 1135 (1141)
.++++|+|+....
T Consensus 266 ~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 266 KELLKHKFILRNA 278 (303)
T ss_dssp HHHTTCHHHHHHC
T ss_pred HHHhhChhhhcCC
Confidence 9999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.34 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=201.2
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~---~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
...+|++.+.||+|+||.||+|.+.. . .+|+|+. ... ......+. +.+|+.++++++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~--~~~-~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKD-CTLDNKEK----FMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEEC--CTT-SCHHHHHH----HHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEec--ccc-cCchHHHH----HHHHHHHHHhCCCCCcceEEEEE
Confidence 45679999999999999999998743 2 2666653 321 12233333 48999999999999999999997
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.. .++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 143 (281)
T 3cc6_A 83 EEEP---------------TWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN 143 (281)
T ss_dssp CSSS---------------CEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred cCCC---------------CEEEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccce
Confidence 6432 28999999999999999762 2358999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|+++.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||++
T Consensus 144 il~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 203 (281)
T 3cc6_A 144 ILVASP-------ECVKLGDFGLSRYIEDEDYY---------KASVTRLPIKWMSPESINF----RRFTTASDVWMFAVC 203 (281)
T ss_dssp EEEEET-------TEEEECCCCGGGCC------------------CCCCCGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CcEEeCccCCCccccccccc---------ccccCCCCcceeCchhhcc----CCCCchhccHHHHHH
Confidence 999987 78999999999765432111 1123357889999999976 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++ |+.||......+....+..+..+..+. ..++.+.+++.+||..||.
T Consensus 204 l~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD---------------------------LCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHccCCch
Confidence 999998 999998766666665555443322211 3456799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+|||+.|+++++...
T Consensus 257 ~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 257 DRPRFTELVCSLSDV 271 (281)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=349.04 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=208.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
...+|++.+.||+|+||.||+|.+. +..+|+|+.. .. ........ +.+|+.++++++||||+++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EA-ASMRERIE----FLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECC--TT-SCHHHHHH----HHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecc--cc-cCHHHHHH----HHHHHHHHHhcCCCCEeeeEE
Confidence 3457999999999999999999874 3456776643 21 12222333 479999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMH 951 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvH 951 (1141)
++.+.... ++||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+|
T Consensus 96 ~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 161 (322)
T 1p4o_A 96 VVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161 (322)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred EEccCCcc--------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99765543 9999999999999999764321 1235799999999999999999999999999
Q ss_pred cCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001143 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031 (1141)
Q Consensus 952 rDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1031 (1141)
|||||+||+++.+ +.+||+|||++.......... ......+|+.|+|||++.+ ..++.++|
T Consensus 162 ~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~D 222 (322)
T 1p4o_A 162 RDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSD 222 (322)
T ss_dssp SCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEE--------GGGSSEECGGGCCHHHHHH----CCCCHHHH
T ss_pred CCCccceEEEcCC-------CeEEECcCccccccccccccc--------cccCCCCCCCccChhhhcc----CCCCchhh
Confidence 9999999999987 789999999997654322110 1112357889999999986 56889999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1032 IWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1032 VWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
||||||++|+|++ |..||.+....+....+..+..+..+ ...+..+.+++.+
T Consensus 223 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~ 275 (322)
T 1p4o_A 223 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP---------------------------DNCPDMLFELMRM 275 (322)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHH
Confidence 9999999999999 89999988777777666554432221 1455679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 001143 1111 CTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1111 cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
||+.||.+|||+.|+++++...
T Consensus 276 ~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 276 CWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HTCSSGGGSCCHHHHHHHHGGG
T ss_pred HcCCCcccCcCHHHHHHHHHHh
Confidence 9999999999999999998765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=389.58 Aligned_cols=259 Identities=24% Similarity=0.292 Sum_probs=211.1
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~ 878 (1141)
...+.+|++.++||+|+||.||+|++. +..+|+|+.+.... ........+..|..++..+ +||||+++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-----HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 346789999999999999999999985 45588887653211 0111122347899999888 699999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.+ ..||||||++||+|.++++.. ..+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 412 ~~~~--------------~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~N 472 (674)
T 3pfq_A 412 QTMD--------------RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472 (674)
T ss_dssp BCSS--------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTT
T ss_pred EeCC--------------EEEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhh
Confidence 8655 359999999999999999862 469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+|+...... .......||+.|+|||++.+ ..|+.++|||||||+
T Consensus 473 ILl~~~-------g~ikL~DFGla~~~~~~~----------~~~~~~~GT~~Y~APE~l~~----~~~~~~~DvwSlGvi 531 (674)
T 3pfq_A 473 VMLDSE-------GHIKIADFGMCKENIWDG----------VTTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVL 531 (674)
T ss_dssp EEECSS-------SCEEECCCTTCEECCCTT----------CCBCCCCSCSSSCCHHHHTC----CCBSTHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEeecceeeccccCC----------cccccccCCCcccCHhhhcC----CCCCccceEechHHH
Confidence 999988 889999999997532211 11234579999999999976 578999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||++|+.||.+.+..++...|...... ++ ...+.++.+||.+||+.||.+
T Consensus 532 lyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~dP~~ 583 (674)
T 3pfq_A 532 LYEMLAGQAPFEGEDEDELFQSIMEHNVA-YP---------------------------KSMSKEAVAICKGLMTKHPGK 583 (674)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHSSCCC-CC---------------------------TTSCHHHHHHHHHHSCSSSTT
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhCCCC-CC---------------------------ccCCHHHHHHHHHHccCCHHH
Confidence 99999999999998888888877654321 11 145567999999999999999
Q ss_pred CCCH-----HHHHHHHHhhc
Q 001143 1119 RPTA-----GDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa-----~ElL~~L~~~~ 1133 (1141)
||++ +||++|+||..
T Consensus 584 R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 584 RLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp CTTCSTTHHHHHHSSGGGSS
T ss_pred CCCCCCCcHHHHhcCccccC
Confidence 9997 99999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.05 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=206.2
Q ss_pred CCCceEee-eecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~-~LG~GsfG~Vy~a~~----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..+|.+.+ .||+|+||.||+|.+ .+..+|+|+.... ......+. +.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEE----MMREAQIMHQLDNPYIVRLIGVCQ 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHH----HHHHHHHHHhCCCCCEeEEEEEec
Confidence 35677776 999999999999986 3455777775422 12333333 489999999999999999999984
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.. ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||
T Consensus 81 ~~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 141 (287)
T 1u59_A 81 AE---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 141 (287)
T ss_dssp SS---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CC---------------CcEEEEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheE
Confidence 32 24999999999999999864 234699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 203 (287)
T 1u59_A 142 LLVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTM 203 (287)
T ss_dssp EEEET-------TEEEECCCTTCEECTTCSCEE-------CCCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEECcccceeeeccCccee-------eccccccccccccCHHHhcc----CCCCchhhHHHHHHHH
Confidence 99987 789999999998664322110 11123357899999999976 4578999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++ |+.||......+....+..+..+..+. ..++.+.+++.+||..||.+
T Consensus 204 ~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~ 256 (287)
T 1u59_A 204 WEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWED 256 (287)
T ss_dssp HHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGG
T ss_pred HHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC---------------------------CcCHHHHHHHHHHcCCChhh
Confidence 99999 999998877777777666554332221 45567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
||++.+++++++..
T Consensus 257 Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 257 RPDFLTVEQRMRAC 270 (287)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999998875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=381.88 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=208.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
+....+|++.++||+|+||.||+|++. +..+|+|+...... ........+.+|+.++++++|||||++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 345678999999999999999999984 66788887643211 11111233478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.. ..|+||||++||+|.+++.. .+...+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 255 ~~~--------------~l~lVmEy~~gg~L~~~l~~---~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI 317 (576)
T 2acx_A 255 TKD--------------ALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317 (576)
T ss_dssp CSS--------------EEEEEECCCCSCBHHHHHHS---SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred eCC--------------EEEEEEEcCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence 655 35999999999999999875 2334599999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 318 Lld~~-------g~vKL~DFGla~~~~~~~~-----------~~~~~GT~~Y~APEvl~~----~~~~~~~DiwSLGvil 375 (576)
T 2acx_A 318 LLDDH-------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLL 375 (576)
T ss_dssp EECTT-------SCEEECCCTTCEECCTTCC-----------EECCCSCGGGCCHHHHTT----CEESSHHHHHHHHHHH
T ss_pred EEeCC-------CCeEEEecccceecccCcc-----------ccccCCCccccCHHHHcC----CCCCccchHHHHHHHH
Confidence 99987 8899999999976543211 113469999999999986 5678999999999999
Q ss_pred HHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1040 LELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|||++|+.||.+.. ..++...+..... .++ ...+.++.+||.+||+.|
T Consensus 376 yeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~s~~~~dLI~~lL~~d 427 (576)
T 2acx_A 376 YEMIAGQSPFQQRKKKIKREEVERLVKEVPE-EYS---------------------------ERFSPQARSLCSQLLCKD 427 (576)
T ss_dssp HHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSS
T ss_pred HHHHhCCCCCcccccchhHHHHHHHhhcccc-cCC---------------------------ccCCHHHHHHHHHhccCC
Confidence 99999999998643 2334444432211 111 145667999999999999
Q ss_pred CCCCC-----CHHHHHHHHHhhc
Q 001143 1116 PTERP-----TAGDLYEMFVART 1133 (1141)
Q Consensus 1116 P~~RP-----Sa~ElL~~L~~~~ 1133 (1141)
|.+|| +++|+++|+||..
T Consensus 428 P~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 428 PAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp GGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHcCCCCCCCHHHHHhChhhcc
Confidence 99999 8999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=357.76 Aligned_cols=289 Identities=18% Similarity=0.220 Sum_probs=209.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|.+. +..||+|+.. .. ......+ .+.+|+.++++++||||+++++++.....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~-~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--PF-EHQTYCQ----RTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--CT-TCHHHHH----HHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEec--cc-cCcHHHH----HHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 57999999999999999999985 4456666543 21 1222223 34799999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. .....++||||++ ++|.++++. ..+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 100 ~---------~~~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 100 E---------QMKDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163 (364)
T ss_dssp T---------TCCCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------ccceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence 1 2235699999997 699999875 35999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++......... ........||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 164 ~-------~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 164 T-------CDLKICDFGLARVADPDHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp T-------CCEEECCCTTCEECCGGGCB-------CCTTCCCCSCGGGCCHHHHHT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEeCcceEecCCCCCc-------cccccccccccCCCCCHHhcC---CCCCCcchhHHHHHHHHHHHH
Confidence 7 78999999999765432211 011224579999999998765 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcccc-ccc--cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQ--SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+....+....+...........+.......... ... ..............+.++.+||.+||+.||.+||
T Consensus 227 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 306 (364)
T 3qyz_A 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306 (364)
T ss_dssp HSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC
Confidence 9999998877666655553221111111111100000000 000 0000001111124567899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|+.|+++|+|+...
T Consensus 307 t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 307 EVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcCcchhhc
Confidence 99999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.46 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=203.8
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
....+|++.+.||+|+||.||+|.+. +..+|+|+..... ..+. +.+|+.++++++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQE----IIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHH----HHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHH----HHHHHHHHHhCCCCCCccEEEEEEe
Confidence 34567999999999999999999985 6678888765321 1122 3789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 96 ~~--------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil 157 (314)
T 3com_A 96 NT--------------DLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157 (314)
T ss_dssp TT--------------EEEEEEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence 54 349999999999999999741 346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||.+........ ......||+.|+|||++.+ ..++.++||||||+++|
T Consensus 158 ~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 216 (314)
T 3com_A 158 LNTE-------GHAKLADFGVAGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNCVADIWSLGITAI 216 (314)
T ss_dssp ECTT-------CCEEECCCTTCEECBTTBS----------CBCCCCSCGGGCCHHHHSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccchhhhhhcc----------ccCccCCCCCccChhhcCC----CCCCccccHHHHHHHHH
Confidence 9887 7899999999976543211 1123468999999999876 46789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|+.||...........+.....+.... ....+..+.+++.+||..||.+||
T Consensus 217 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rp 271 (314)
T 3com_A 217 EMAEGKPPYADIHPMRAIFMIPTNPPPTFRK-------------------------PELWSDNFTDFVKQCLVKSPEQRA 271 (314)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhCCCCCCCCChHHHHHHHhcCCCcccCC-------------------------cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999998777665554443333222110 113456799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001143 1121 TAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~s 1135 (1141)
|+.++++|+|+....
T Consensus 272 t~~~ll~~~~~~~~~ 286 (314)
T 3com_A 272 TATQLLQHPFVRSAK 286 (314)
T ss_dssp CHHHHTTSHHHHTCC
T ss_pred CHHHHHhCHHHhcCC
Confidence 999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=364.08 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=203.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
...+.+|++.++||+|+||.||+|++ .+..+|+|+.+...........+.+ .+|+.+++++ +||||++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~----~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGC----CCHHHHHHHHHTCTTBCCEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHH----HHHHHHHHHccCCCceeEEE
Confidence 44568899999999999999999998 5677899986432111111112223 6799999999 699999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLK 955 (1141)
+++.... ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|||||
T Consensus 126 ~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk 186 (355)
T 1vzo_A 126 YAFQTET--------------KLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK 186 (355)
T ss_dssp EEEEETT--------------EEEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred EEEeeCc--------------eEEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 9998655 34999999999999999976 2369999999999999999999999999999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
|+|||++.+ +.+||+|||+++........ ......||+.|+|||++.+. ...++.++|||||
T Consensus 187 p~NIll~~~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 187 LENILLDSN-------GHVVLTDFGLSKEFVADETE---------RAYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSL 248 (355)
T ss_dssp GGGEEECTT-------SCEEESCSSEEEECCGGGGG---------GGCGGGSCCTTCCHHHHTTC--C---CTHHHHHHH
T ss_pred HHHEEECCC-------CcEEEeeCCCCeecccCCCC---------cccCcccCcCccChhhhcCC--CCCCCchhhHHHH
Confidence 999999887 78999999999765432111 11234699999999999752 1346899999999
Q ss_pred HHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001143 1036 GCLLLELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1111 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~c 1111 (1141)
||++|+|++|+.||.... ...+...+.....+ .+ ...+..+.+||.+|
T Consensus 249 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~ 300 (355)
T 1vzo_A 249 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-YP---------------------------QEMSALAKDLIQRL 300 (355)
T ss_dssp HHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC-CC---------------------------cccCHHHHHHHHHH
Confidence 999999999999996432 22333333222111 10 14456789999999
Q ss_pred cccCCCCCC-----CHHHHHHHHHhhc
Q 001143 1112 TEENPTERP-----TAGDLYEMFVART 1133 (1141)
Q Consensus 1112 L~~DP~~RP-----Sa~ElL~~L~~~~ 1133 (1141)
|..||.+|| ++.|+++|+|+..
T Consensus 301 L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 301 LMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred hhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999 9999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.35 Aligned_cols=269 Identities=24% Similarity=0.369 Sum_probs=204.7
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
...+|++.+.||+|+||.||+|++ .+..+|+|+..... . ..+. +.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~---~~~~----~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--D---EEEE----IKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--S---TTHH----HHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--c---cHHH----HHHHHHHHHhccCCCCeeeeeeEEee
Confidence 456799999999999999999998 56778888865331 1 1123 37899999999 79999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.... ......++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 93 ~~~~--------~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl 161 (326)
T 2x7f_A 93 KNPP--------GMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161 (326)
T ss_dssp CC----------CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred ccCc--------cccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEE
Confidence 4310 1123579999999999999999862 2346899999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL 1039 (1141)
++.+ +.+||+|||++........ ......||+.|+|||++.... ....++.++|||||||++
T Consensus 162 ~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 224 (326)
T 2x7f_A 162 LTEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224 (326)
T ss_dssp ECTT-------CCEEECCCTTTC-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeCcCceecCcCcc----------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence 9877 7899999999876543111 112346899999999986321 124678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|..||...........+.....+.... ...+..+.++|.+||..||.+|
T Consensus 225 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~R 278 (326)
T 2x7f_A 225 IEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS--------------------------KKWSKKFQSFIESCLVKNHSQR 278 (326)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------SCSCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhCCCCCCCCcHHHHHHHhhcCccccCCc--------------------------cccCHHHHHHHHHHhccChhhC
Confidence 99999999998877666555554433222110 1345679999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001143 1120 PTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s 1135 (1141)
||+.++++|+|+....
T Consensus 279 ps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 279 PATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCHHHHHTSHHHHCCT
T ss_pred CCHHHHhhChHHhhCc
Confidence 9999999999997543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=348.70 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=197.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~---------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 874 (1141)
..++|++.+.||+|+||+||+|.+.. ..+++|+.... .... ...+.+|+.++++++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~----~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNY----SESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGG----HHHHHHHHHHHHTSCCTTBCCE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHH----HHHHHHHHHHHHhCCCCCEeEE
Confidence 45679999999999999999998743 34777775321 1122 2334899999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL 954 (1141)
++++.+.+.. ++||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||
T Consensus 78 ~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 139 (289)
T 4fvq_A 78 YGVCVCGDEN--------------ILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENTLIHGNV 139 (289)
T ss_dssp EEEECCTTCC--------------EEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEeCCCC--------------EEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCc
Confidence 9999875543 8999999999999999862 234999999999999999999999999999999
Q ss_pred CCCCeeeeccccc-CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHH
Q 001143 955 KSENILIDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1033 (1141)
Q Consensus 955 KP~NILld~~~~~-~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVW 1033 (1141)
||+|||++.+... ....+.+||+|||.+....... ...||+.|+|||++.+. ..++.++|||
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~y~aPE~~~~~---~~~~~~~Diw 202 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--------------ILQERIPWVPPECIENP---KNLNLATDKW 202 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH--------------HHHHTTTTSCHHHHHCG---GGCCHHHHHH
T ss_pred CcceEEEecCCcccccccceeeeccCcccccccCcc--------------ccCCcCcccCHHHhCCC---CCCCchhHHH
Confidence 9999999877210 0111239999999986543211 23478899999998752 3578999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1034 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1034 SLGviL~ELLTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
||||++|+|++| .+||................. .+. ..+..+.+++.+||
T Consensus 203 slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~l~~li~~~l 253 (289)
T 4fvq_A 203 SFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ--LPA---------------------------PKAAELANLINNCM 253 (289)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCC---------------------------CSSCTTHHHHHHHS
T ss_pred HHHHHHHHHHcCCCCCccccchHHHHHHhhccCC--CCC---------------------------CCCHHHHHHHHHHc
Confidence 999999999995 555655444443333222111 000 12334889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCCC
Q 001143 1113 EENPTERPTAGDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~~~~~s~~ 1137 (1141)
+.||.+|||+.++++++....++..
T Consensus 254 ~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 254 DYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp CSSGGGSCCHHHHHHHHHTCC----
T ss_pred CCChhHCcCHHHHHHHHHHhcCCCC
Confidence 9999999999999999988766544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.14 Aligned_cols=263 Identities=24% Similarity=0.410 Sum_probs=195.2
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
-.+|++.++||+|+||+||+|++.+ .+|+|+.+.. .......+.+ .+|+.++++++||||++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~--- 92 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP--- 92 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCS--SCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEecc--CCCHHHHHHH----HHHHHHHHhCCCCcEEEEEeeccCC---
Confidence 4569999999999999999999765 4888876543 3333444444 8999999999999999999975432
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..++||||+++++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||+++.+
T Consensus 93 ------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~ 156 (289)
T 3og7_A 93 ------------QLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED 156 (289)
T ss_dssp ------------SCEEEEECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred ------------ccEEEEEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 23899999999999999864 23469999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+.+||+|||++......... .......||+.|+|||++... ....++.++||||||+++|+|++
T Consensus 157 -------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el~~ 220 (289)
T 3og7_A 157 -------NTVKIGDFGLATEKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ-DSNPYSFQSDVYAFGIVLYELMT 220 (289)
T ss_dssp -------TEEEECCCC--------------------------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEccceecccccccccc--------ccccccCCCccccCchhhccc-CCCCCCcccchHHHHHHHHHHHH
Confidence 78999999999754432111 112234689999999998632 12567889999999999999999
Q ss_pred CCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 Gk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||.+....+ +...+..+....... .....+++.+.+++.+||+.||.+|||+.
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 277 (289)
T 3og7_A 221 GQLPYSNINNRDQIIEMVGRGSLSPDLS-----------------------KVRSNCPKRMKRLMAECLKKKRDERPSFP 277 (289)
T ss_dssp SSCTTSSCCCHHHHHHHHHHTSCCCCTT-----------------------SSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCccccchHHHHHHHhcccccCcchh-----------------------hccccCCHHHHHHHHHHccCChhhCCCHH
Confidence 999998754433 444444333221110 00114567899999999999999999999
Q ss_pred HHHHHHHhh
Q 001143 1124 DLYEMFVAR 1132 (1141)
Q Consensus 1124 ElL~~L~~~ 1132 (1141)
++++.+...
T Consensus 278 ell~~L~~l 286 (289)
T 3og7_A 278 RILAEIEEL 286 (289)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHH
Confidence 999988754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=356.29 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=202.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC--cc----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS--AD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~--~~----vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
....+|++.++||+|+||+||+|.+.. .. +++|+.. ... .....+.+ .+|+.++++++||||+++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~--~~~-~~~~~~~~----~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKS-GRQSFQAV----TDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEEC--CTT-SCSCBCSC----CHHHHHHHTCCCTTBCCEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecc--ccc-cHHHHHHH----HHHHHHHhcCCCCCcCeEEE
Confidence 345689999999999999999999843 33 4555432 111 11112223 68999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++.+. ..++||||+++|+|.+++... ...+++..+..|+.||+.||.|||++||+||||||
T Consensus 83 ~~~~~---------------~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 83 LCPGS---------------SLQLVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp EECBS---------------SEEEEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred EEcCC---------------ccEEEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 88632 248999999999999998751 24689999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++||||||
T Consensus 144 ~Nil~~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 204 (325)
T 3kex_A 144 RNVLLKSP-------SQVQVADFGVADLLPPDDKQ--------LLYSEAKTPIKWMALESIHF----GKYTHQSDVWSYG 204 (325)
T ss_dssp TTEEESSS-------SCEEECSCSGGGGSCCCTTC--------CC-----CCTTTSCHHHHHH----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CeEEECCCCcccccCccccc--------ccccCCCCcccccChHHhcc----CCCChhhHhHHhH
Confidence 99999887 78999999999875432211 11224468889999999986 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1037 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1037 viL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|++|+|++ |..||.+....++...+..+..+..+. ..+..+.+++.+||..|
T Consensus 205 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~d 257 (325)
T 3kex_A 205 VTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMID 257 (325)
T ss_dssp HHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT---------------------------TBCTTTTHHHHHHTCSC
T ss_pred HHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC---------------------------cCcHHHHHHHHHHcCCC
Confidence 99999999 999998877666666665544332221 23345788999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 001143 1116 PTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~ 1132 (1141)
|.+|||+.++++++...
T Consensus 258 p~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 258 ENIRPTFKELANEFTRM 274 (325)
T ss_dssp TTTSCCHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHH
Confidence 99999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=350.80 Aligned_cols=270 Identities=25% Similarity=0.348 Sum_probs=205.2
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
|...++||+|+||.||+|.+.+..+|+|+.............+ .+.+|+.++++++||||+++++++.+....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--- 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ----QFDQEIKVMAKCQHENLVELLGFSSDGDDL--- 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHH----HHHHHHHHHHHCCCTTBCCEEEEECSSSSC---
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHH----HHHHHHHHHHhcCCCCeEEEEEEEecCCce---
Confidence 5667999999999999999999999999865332222222223 348999999999999999999999865543
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 106 -----------~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~--- 169 (307)
T 2nru_A 106 -----------CLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA--- 169 (307)
T ss_dssp -----------EEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---
T ss_pred -----------EEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---
Confidence 99999999999999997532 23469999999999999999999999999999999999999887
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~ 1047 (1141)
+.+||+|||++......... .......||+.|+|||++.+ .++.++||||||+++|+|++|..
T Consensus 170 ----~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-----~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 170 ----FTAKISDFGLARASEKFAQT--------VMTSRIVGTTAYMAPEALRG-----EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp ----CCEEECCCTTCEECCSCSSC--------EECSSCCSCGGGCCHHHHTT-----EECTHHHHHHHHHHHHHHHHCCC
T ss_pred ----CcEEEeeccccccccccccc--------ccccccCCCcCcCChHHhcC-----CCCccchhHHHHHHHHHHHHCCC
Confidence 78999999999765432211 01123468999999999865 36789999999999999999999
Q ss_pred CCCCCCHHH----HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1048 PYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1048 Pf~~~~~~e----l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
||......+ +...+... ...+..... .. ........+..+.+++.+||+.||.+|||+.
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----------~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 295 (307)
T 2nru_A 233 AVDEHREPQLLLDIKEEIEDE-EKTIEDYID-----------KK-----MNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295 (307)
T ss_dssp SBCTTBSSSBTTHHHHHHHTT-SCCHHHHSC-----------SS-----CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CcccCcchHHHHHHHHHhhhh-hhhhhhhcc-----------cc-----ccccchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 997643322 12222111 111111000 00 0111235678899999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001143 1124 DLYEMFVARTS 1134 (1141)
Q Consensus 1124 ElL~~L~~~~~ 1134 (1141)
++++++.....
T Consensus 296 ~l~~~L~~l~~ 306 (307)
T 2nru_A 296 KVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHhc
Confidence 99999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.11 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=196.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..+..+|++.+.||+|+||.||+|++.+..+|+|+.. . ....+. +.+|+.++++++||||+++++++.+.
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~--~----~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~ 73 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE--S----ESERKA----FIVELRQLSRVNHPNIVKLYGACLNP 73 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECS--S----TTHHHH----HHHHHHHHHHCCCTTBCCEEEBCTTT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEec--C----hhHHHH----HHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 3456789999999999999999999999888888743 1 122333 37999999999999999999987532
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCC
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---KHIMHRDIKSEN 958 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs---~gIvHrDLKP~N 958 (1141)
.++||||+++++|.+++... .....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus 74 ----------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 74 ----------------VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp ----------------TEEEEECCTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred ----------------cEEEEEcCCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 28999999999999999752 112247899999999999999999999 899999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.++ ..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||+
T Consensus 136 Ill~~~~------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~i 192 (307)
T 2eva_A 136 LLLVAGG------TVLKICDFGTACDIQTHM-------------TNNKGSAAWMAPEVFEG----SNYSEKCDVFSWGII 192 (307)
T ss_dssp EEEETTT------TEEEECCCCC-------------------------CCTTSSCHHHHTC----CCCCTHHHHHHHHHH
T ss_pred EEEeCCC------CEEEEccccccccccccc-------------ccCCCCCceEChhhhCC----CCCCcHHHHHHHHHH
Confidence 9998762 248999999986543211 12358999999999976 568899999999999
Q ss_pred HHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1039 LLELLTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~--~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|+|++|+.||.... .......+..+..+... ...+..+.+++.+||+.||
T Consensus 193 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp 245 (307)
T 2eva_A 193 LWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI---------------------------KNLPKPIESLMTRCWSKDP 245 (307)
T ss_dssp HHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB---------------------------TTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc---------------------------cccCHHHHHHHHHHhcCCh
Confidence 999999999997532 22333333333322211 1445679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
.+|||+.++++++...
T Consensus 246 ~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 246 SQRPSMEEIVKIMTHL 261 (307)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHH
Confidence 9999999999988764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=355.54 Aligned_cols=268 Identities=21% Similarity=0.280 Sum_probs=201.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||.||+|.+. +..||+|+...................+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 46999999999999999999985 467888875433211111111111223479999999999999999999986432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 89 --------------YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp --------------EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred --------------eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 4999999999999998864 347999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++ ....+||+|||++......... ....||+.|+|||++.+.. ...++.++|||||||++|+|+
T Consensus 150 ~~----~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 150 QE----EDCLIKITDFGHSKILGETSLM-----------RTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp SS----SSCCEEECCCTTCEECCCCHHH-----------HHHHSCCTTCCHHHHHHTT-TTTCTTHHHHHHHHHHHHHHH
T ss_pred CC----CCCeEEEccCccceeccccccc-----------ccccCCcCccCchhhccCC-CCCCCchhhHHHHHHHHHHHH
Confidence 52 1146999999999765432111 1235899999999985311 246789999999999999999
Q ss_pred hCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|..||...... .+...+..+.....+. .....+..+.+++.+||..||.+|||+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~ 269 (322)
T 2ycf_A 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPE------------------------VWAEVSEKALDLVKKLLVVDPKARFTT 269 (322)
T ss_dssp HSSCSSCSTTCSSCHHHHHHHTCCCCCHH------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hCCCCCcccchHHHHHHHHHhCccccCch------------------------hhhhcCHHHHHHHHHHcccCHhhCCCH
Confidence 999999754322 2334444433322221 111456779999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
.++++|+|+..
T Consensus 270 ~~~l~h~~~~~ 280 (322)
T 2ycf_A 270 EEALRHPWLQD 280 (322)
T ss_dssp HHHHTSGGGCC
T ss_pred HHHhhCcCcCC
Confidence 99999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=350.96 Aligned_cols=260 Identities=21% Similarity=0.334 Sum_probs=201.9
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCc------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSA------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
....+|++.+.||+|+||.||+|.+... .+|+|+.... ........ +.+|+.++++++||||+++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVD----FLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHTCCCTTBCCEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHHH----HHHHHHHHHhCCCCCCCcEEE
Confidence 3456799999999999999999987432 3777765422 12233333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++..... .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||
T Consensus 114 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 114 VISKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp EECSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCCC--------------cEEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 9876543 4999999999999999975 234699999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|||++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||
T Consensus 176 ~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 237 (333)
T 1mqb_A 176 RNILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 237 (333)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CcEEECCCCcchhhccccccc-------cccCCCCccccccCchhccc----CCCCchhhhHHHH
Confidence 99999887 789999999997654321110 01112346889999999976 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1037 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1037 viL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|++|+|++ |+.||.+....++...+..+..+..+ ...+..+.+++.+||+.|
T Consensus 238 ~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 238 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---------------------------MDCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---------------------------TTCBHHHHHHHHHHTCSS
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc---------------------------ccCCHHHHHHHHHHcCCC
Confidence 99999999 99999888877777776554332211 144567999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 001143 1116 PTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~ 1132 (1141)
|.+||++.++++++...
T Consensus 291 p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 291 RARRPKFADIVSILDKL 307 (333)
T ss_dssp TTTSCCHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHH
Confidence 99999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=362.97 Aligned_cols=259 Identities=21% Similarity=0.353 Sum_probs=195.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
...+|++.+.||+|+||.||+|++. +..||+|+.+.. ......+. +.+|+.++++++||||+++++++
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG---YTEKQRRD----FLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT---CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc---cCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEE
Confidence 3567999999999999999999864 445777764322 12333333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+.... ++||||+++++|.++++. ....+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 116 ~~~~~~--------------~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 177 (373)
T 2qol_A 116 TKSKPV--------------MIVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177 (373)
T ss_dssp CSSSSC--------------EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeCCce--------------EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 865543 999999999999999975 23469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+++......... .......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 178 Ill~~~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 178 ILINSN-------LVCKVSDFGLGRVLEDDPEAA-------YTTRGGKIPIRWTSPEAIAY----RKFTSASDVWSYGIV 239 (373)
T ss_dssp EEECTT-------CCEEECCC-----------------------------CTTSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECcCccccccccCCccc-------eeccCCCcCCCccChhhhcc----CCcCchhcHHHHHHH
Confidence 999887 789999999997654322110 01112235788999999986 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|||++ |+.||......++...+..+.....+ ..++..+.+++.+||+.||.
T Consensus 240 l~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~ 292 (373)
T 2qol_A 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---------------------------MDCPAALYQLMLDCWQKDRN 292 (373)
T ss_dssp HHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC---------------------------TTCBHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------ccccHHHHHHHHHHhCcChh
Confidence 999998 99999988877777666543222111 14556799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+||++.++++.+...
T Consensus 293 ~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 293 NRPKFEQIVSILDKL 307 (373)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999988654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=345.52 Aligned_cols=300 Identities=21% Similarity=0.238 Sum_probs=206.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|.+. +..+|+|+.... .....+.+ .+|+.++++++||||+++++++.....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHA----LREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHH----HHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHH----HHHHHHHHhcCCCCeeEEEEecccccc
Confidence 57999999999999999999986 566777765422 23333333 799999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
....+..........++||||++ ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 10000001122346799999998 699998854 46899999999999999999999999999999999999974
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++ +.+||+|||++......... ........+|..|+|||++.+ ...++.++|||||||++|+|+
T Consensus 156 ~~------~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 156 ED------LVLKIGDFGLARIMDPHYSH-------KGHLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp TT------TEEEECCCTTCBCC---------------CCCGGGSCCTTCCHHHHHC---TTCCCHHHHHHHHHHHHHHHH
T ss_pred CC------CeEEEccCccccccCCCccc-------ccccccccccccccCcHHhcC---cccCCchhhhHhHHHHHHHHH
Confidence 32 68999999999765432111 011223457999999999865 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCC-C-CCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G-FEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+|+.||.+....+....+............................ . ..........+.++.+++.+||+.||.+|||
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 9999999887776666654333222221111110000000000000 0 0001111246778999999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001143 1122 AGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s~ 1136 (1141)
+.|+++|+|+.....
T Consensus 300 ~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 300 AEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHTSHHHHTTCC
T ss_pred HHHHhCCcccccccC
Confidence 999999999986543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.27 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=206.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.+.||+|+||.||+|.+. +..+|+|+.. .. ....+.+ .+|+.++++++||||+++++++.+.
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~---~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--ED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEEC--SC---STHHHHH----HHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecC--cC---HHHHHHH----HHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3567999999999999999999996 4556666643 21 1223333 7999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. .++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 82 ~~--------------~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~ 144 (288)
T 3kfa_A 82 PP--------------FYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 144 (288)
T ss_dssp SS--------------EEEEEECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE
T ss_pred CC--------------EEEEEEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE
Confidence 53 4999999999999999976 334569999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.+......... ......+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 145 ~~~-------~~~~l~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 204 (288)
T 3kfa_A 145 GEN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWE 204 (288)
T ss_dssp CGG-------GCEEECCCCGGGTSCSSSSE---------EETTEEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEccCccceeccCCccc---------cccCCccccCcCChhhhcc----CCCCchhhHHHHHHHHHH
Confidence 887 78999999999765432211 1123347889999999986 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |..||.+....+....+.....+..+ ...++.+.+++.+||..||.+||
T Consensus 205 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp~~Rp 257 (288)
T 3kfa_A 205 IATYGMSPYPGIDLSQVYELLEKDYRMERP---------------------------EGCPEKVYELMRACWQWNPSDRP 257 (288)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHhccCCCCCC---------------------------CCCCHHHHHHHHHHhCCChhhCc
Confidence 999 99999887766666665544332211 14556799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001143 1121 TAGDLYEMFVA 1131 (1141)
Q Consensus 1121 Sa~ElL~~L~~ 1131 (1141)
|+.++++.+..
T Consensus 258 s~~~~~~~l~~ 268 (288)
T 3kfa_A 258 SFAEIHQAFET 268 (288)
T ss_dssp CHHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 99999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=350.88 Aligned_cols=264 Identities=21% Similarity=0.213 Sum_probs=200.1
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~ 882 (1141)
.+|++.+.||+|+||.||+|++ .+..||+|+...... .+. +.+|+.+++++ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~----~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQ----LHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCC----HHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHH----HHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 5799999999999999999997 566788887653321 112 37899999999 8999999999988754
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 79 --------------~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~ 139 (330)
T 2izr_A 79 --------------YNAMVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG 139 (330)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred --------------ccEEEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence 349999999 89999999862 34799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.++. .....+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 140 ~~~~--~~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 140 RPGN--KTQQVIHIIDFALAKEYIDPETKKH---IPYREHKSLTGTARYMSINTHLG----KEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CGGG--TCTTSEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred cCCC--CCCceEEEEEcccceeeecCCCCcc---ccccccCCcCCCccccChHHHcC----CCCCchhHHHHHHHHHHHH
Confidence 7721 1112399999999987544221110 01112235679999999999986 5688999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1043 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
++|+.||.+.. ..+....+.....+..... .....+ ++.+++..||..||.+|
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~~p-~~~~li~~~l~~~p~~R 266 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKIGDTKRATPIEV-----------------------LCENFP-EMATYLRYVRRLDFFEK 266 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-----------------------HTTTCH-HHHHHHHHHHHCCTTCC
T ss_pred hcCCCCccccccccHHHHHHHHHhhhccCCHHH-----------------------HhccCh-HHHHHHHHHHhCCCCCC
Confidence 99999998743 3333333322111100000 001234 79999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
|++++|++.+..
T Consensus 267 P~~~~l~~~l~~ 278 (330)
T 2izr_A 267 PDYDYLRKLFTD 278 (330)
T ss_dssp CCHHHHHHHHHH
T ss_pred CCHHHHHHHHHH
Confidence 999999987753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=347.26 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=198.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...+|++.++||+|+||+||+|.+. +..+|+|+. .. ......+.+ .+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~--~~--~~~~~~~~~----~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--IR--FDEETQRTF----LKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEE--SC--CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEe--cc--CCHHHHHHH----HHHHHHHHhCCCcCcccEEEEEecC
Confidence 3567999999999999999999985 556666654 21 233333444 8999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.++++. ....+++.++..|+.||+.||+|||++||+||||||+|||+
T Consensus 80 ~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~ 141 (310)
T 3s95_A 80 K--------------RLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141 (310)
T ss_dssp T--------------EEEEEEECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred C--------------eeEEEEEecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence 5 34999999999999999976 23469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeecccccccccccccccc----ccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~----~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
+.+ +.+||+|||+++........... ............||+.|+|||++.+ ..++.++|||||||
T Consensus 142 ~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~ 210 (310)
T 3s95_A 142 REN-------KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING----RSYDEKVDVFSFGI 210 (310)
T ss_dssp CTT-------SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHH
T ss_pred CCC-------CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC----CCCCcHHHHHHHHH
Confidence 887 78999999999865432211000 0000001124569999999999976 56889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++|+|++|..||.......... ........... ....+++.+.+++.+||+.||+
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~~------~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dP~ 265 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMDF------GLNVRGFLDRY-------------------CPPNCPPSFFPITVRCCDLDPE 265 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTTS------SBCHHHHHHHT-------------------CCTTCCTTHHHHHHHHTCSSGG
T ss_pred HHHHHhcCCCCCcchhhhHHHH------hhhhhcccccc-------------------CCCCCCHHHHHHHHHHccCChh
Confidence 9999999999986432110000 00000000000 0013445689999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+|||+.++++.+...
T Consensus 266 ~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 266 KRPSFVKLEHWLETL 280 (310)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=354.41 Aligned_cols=292 Identities=19% Similarity=0.193 Sum_probs=200.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+++|++.+.||+|+||.||+|++. +..+|+|+....... .. +..+|+..+..++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~----~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RN----RELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CC----HHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cH----HHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 34678999999999999999999985 567888875432111 11 12578888888999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCC
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSEN 958 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--s~gIvHrDLKP~N 958 (1141)
... ........++||||++ ++|...+..... ....+++..+..++.||+.||.||| ++||+||||||+|
T Consensus 91 ~~~-------~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~N 161 (360)
T 3e3p_A 91 LGE-------RDRRDIYLNVVMEYVP-DTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161 (360)
T ss_dssp ECS-------SCTTCEEEEEEEECCS-CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGG
T ss_pred ccc-------ccccceeEEEEeeccc-ccHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHH
Confidence 332 1112335789999998 566666654322 3457899999999999999999999 9999999999999
Q ss_pred eeeec-ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 959 ILIDL-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 959 ILld~-~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
||++. + +.+||+|||++....... ......||+.|+|||++.+ ...++.++|||||||
T Consensus 162 Ill~~~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 162 VLVNEAD-------GTLKLCDFGSAKKLSPSE-----------PNVAYICSRYYRAPELIFG---NQHYTTAVDIWSVGC 220 (360)
T ss_dssp EEEETTT-------TEEEECCCTTCBCCCTTS-----------CCCSTTSCGGGCCHHHHTT---CSSCCTHHHHHHHHH
T ss_pred EEEeCCC-------CcEEEeeCCCceecCCCC-----------CcccccCCcceeCHHHHcC---CCCCCcHHHHHHHHH
Confidence 99986 5 789999999997654321 1123468999999999865 235789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc-cccccccCCCCCC----chhhhhhHHHHHHHHHHhc
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEK----PEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~L~dLI~~cL 1112 (1141)
++|+|++|+.||.+.+..+....+...........+....... ...... ...... +......+.++.+||.+||
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L 299 (360)
T 3e3p_A 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN-SKGIPWSNVFSDHSLKDAKEAYDLLSALL 299 (360)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGC-CCCCCHHHHTTTCCCTTHHHHHHHHHHHT
T ss_pred HHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccc-cccCCcccccchhhccccHHHHHHHHHHh
Confidence 9999999999999887777666553322222111111110000 000000 000000 0011135788999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 001143 1113 EENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
+.||.+|||+.|+++|+|+...
T Consensus 300 ~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 300 QYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccCccccCCHHHHhcCcccccc
Confidence 9999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.80 Aligned_cols=267 Identities=21% Similarity=0.308 Sum_probs=202.9
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 800 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 800 ~~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
.+.....+|++.+.||+|+||.||+|++ .+..+|+|+............. .....+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI-EKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHH-CCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHH-HHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 3445567899999999999999999998 4667888875443322222211 111345899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIK 955 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLK 955 (1141)
+.+.. ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+|||||
T Consensus 92 ~~~~~----------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dik 151 (287)
T 4f0f_A 92 MHNPP----------------RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151 (287)
T ss_dssp ETTTT----------------EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCS
T ss_pred ecCCC----------------eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCC
Confidence 86432 799999999999998864 2347999999999999999999999999 9999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1035 (1141)
|+|||++.++. .....+||+|||+++..... .....||+.|+|||++.+. ...++.++|||||
T Consensus 152 p~Nil~~~~~~--~~~~~~kl~Dfg~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~--~~~~~~~~Di~sl 214 (287)
T 4f0f_A 152 SPNIFLQSLDE--NAPVCAKVADFGLSQQSVHS-------------VSGLLGNFQWMAPETIGAE--EESYTEKADTYSF 214 (287)
T ss_dssp GGGEEESCCCT--TCSCCEEECCCTTCBCCSSC-------------EECCCCCCTTSCGGGSSCS--SCEECHHHHHHHH
T ss_pred cceEEEeccCC--CCceeEEeCCCCcccccccc-------------ccccCCCccccCchhhccC--CCCcCchhhHHHH
Confidence 99999987621 12234999999998643321 1234689999999998431 2457899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHH--HHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1036 GCLLLELLTLQVPYMGLSELE--IHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~~e--l~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
||++|+|++|+.||......+ ....+.. ...+..+ ...++.+.+++.+||
T Consensus 215 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l 267 (287)
T 4f0f_A 215 AMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---------------------------EDCPPRLRNVIELCW 267 (287)
T ss_dssp HHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC---------------------------TTSCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHh
Confidence 999999999999997654332 2333322 2111111 145667999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 001143 1113 EENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~~ 1131 (1141)
+.||.+|||+.|+++.+..
T Consensus 268 ~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 268 SGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CSSGGGSCCHHHHHHHHHT
T ss_pred cCChhhCcCHHHHHHHHHh
Confidence 9999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=357.70 Aligned_cols=261 Identities=20% Similarity=0.247 Sum_probs=204.2
Q ss_pred CceEe-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001143 807 SLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1141)
Q Consensus 807 ~y~i~-~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~ 882 (1141)
.|.+. +.||+|+||.||+|.+. +..+|+|+...... ....... +.+|+.++.++. ||||+++++++.+..
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~----~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAE----ILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHH----HHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHH----HHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 36676 89999999999999985 67788887654321 2222223 379999999995 799999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 103 --------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 103 --------------EIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165 (327)
T ss_dssp --------------EEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred --------------eEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe
Confidence 35999999999999988753 2335799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
... ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 166 ~~~----~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 226 (327)
T 3lm5_A 166 SIY----PLGDIKIVDFGMSRKIGHACE-----------LREIMGTPEYLAPEILNY----DPITTATDMWNIGIIAYML 226 (327)
T ss_dssp CBT----TBCCEEECCGGGCEEC--------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEeeCccccccCCccc-----------cccccCCcCccCCeeecC----CCCCchhhHHHHHHHHHHH
Confidence 721 117899999999976543211 123469999999999976 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+....+....+.......... .....+..+.++|.+||+.||.+|||+
T Consensus 227 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~ 282 (327)
T 3lm5_A 227 LTHTSPFVGEDNQETYLNISQVNVDYSEE------------------------TFSSVSQLATDFIQSLLVKNPEKRPTA 282 (327)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HhCCCCCCCCCchHHHHHHHhcccccCch------------------------hhcccCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999887777666654433221110 001456679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
+|+++|+|++.
T Consensus 283 ~~ll~h~~~~~ 293 (327)
T 3lm5_A 283 EICLSHSWLQQ 293 (327)
T ss_dssp HHHTTCGGGCC
T ss_pred HHHhCCHhhcc
Confidence 99999999964
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=347.39 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=204.7
Q ss_pred CCCCceEeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~-------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
...+|++.+.||+|+||.||+|++ .+..+|+|+.... ......+. +.+|+.+++++ +||||++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREA----LMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHHH----HHHHHHHHhhcccCCCeeeEE
Confidence 346799999999999999999986 2356777775422 22233333 48999999999 899999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------cCCCCCCHHHHHHHHHHHHHHHH
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-------------~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+++...+.. ++||||+++++|.+++..... .....+++..++.++.||+.||.
T Consensus 94 ~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 94 GACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp EEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCc--------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 999875543 999999999999999986321 11235899999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||++||+||||||+||+++.+ +.+||+|||++......... .......+|+.|+|||++.+
T Consensus 160 ~lH~~~i~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--- 221 (313)
T 1t46_A 160 FLASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNY--------VVKGNARLPVKWMAPESIFN--- 221 (313)
T ss_dssp HHHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTS--------EECSSSEECGGGCCHHHHHH---
T ss_pred HHHHCCeecCCCccceEEEcCC-------CCEEEccccccccccccccc--------eeccCCCCcceeeChHHhcC---
Confidence 9999999999999999999887 78999999999765432211 01123457889999999876
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1100 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1141)
..++.++||||||+++|+|++ |..||.+..... ....+.....+..+ ...
T Consensus 222 -~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 273 (313)
T 1t46_A 222 -CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---------------------------EHA 273 (313)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TTS
T ss_pred -CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc---------------------------ccC
Confidence 568899999999999999999 999998755433 33333332221111 144
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1101 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1101 ~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+..+.+++.+||+.||.+|||+.|+++++....
T Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 567999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=373.40 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=207.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.++||+|+||.||+|.+. +..||+|+ ++.... ..+.+ .+|+.+|++++|||||++++++....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~--~~~~~~---~~~~~----~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTM---EVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEE--CCSSSS---CHHHH----HHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEE--ecCccc---chHHH----HHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 456999999999999999999996 45566665 333221 22333 79999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.+ ++||||+++|+|.++++. .....+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 290 ~~--------------~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 352 (495)
T 1opk_A 290 PF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352 (495)
T ss_dssp SC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cE--------------EEEEEccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC
Confidence 43 999999999999999976 2334699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++........ ......+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 353 ~~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlG~~l~el 412 (495)
T 1opk_A 353 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 412 (495)
T ss_dssp GG-------GCEEECCTTCEECCTTCCEE---------CCTTCCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeecccceeccCCcee---------ecCCCcCCcceeCHhHHhc----CCCCcHHhHHhHHHHHHHH
Confidence 87 78999999999865432111 1123346789999999986 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |..||.+.+..++...+..+.....+ ..+++.+.+||.+||+.||.+|||
T Consensus 413 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs 465 (495)
T 1opk_A 413 ATYGMSPYPGIDLSQVYELLEKDYRMERP---------------------------EGCPEKVYELMRACWQWNPSDRPS 465 (495)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCcChhHCcC
Confidence 99 99999987776666666544332211 145667999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.+|++.+....
T Consensus 466 ~~el~~~L~~~~ 477 (495)
T 1opk_A 466 FAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTSC
T ss_pred HHHHHHHHHHHH
Confidence 999999887653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.70 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=202.8
Q ss_pred CCCCceEeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~-------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
...+|++.+.||+|+||.||+|.+ .+..+|+|+..... ..... ..+.+|+.+++++ +||||++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~----~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSER----EALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------C----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHH----HHHHHHHHHHHhhcCCCCeeeEE
Confidence 456899999999999999999997 23357777754221 11222 2348999999999 899999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------CCCCCCHHHHHHHHHHH
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------GEKHVSVKLALFIAQDV 937 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~------------------~~~~Ls~~~i~~Ia~QI 937 (1141)
+++...+.. ++||||+++|+|.+++...... ....+++..++.|+.||
T Consensus 116 ~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 116 GACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred EEEeeCCcc--------------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 999875543 9999999999999999763210 01348999999999999
Q ss_pred HHHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhh
Q 001143 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017 (1141)
Q Consensus 938 a~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 1017 (1141)
+.||.|||++||+||||||+|||++.+ +.+||+|||++......... .......||+.|+|||++
T Consensus 182 ~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 182 AKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNY--------VVRGNARLPVKWMAPESL 246 (344)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTS--------EEETTEEECGGGCCHHHH
T ss_pred HHHHHHHHhCCcccCCCChhhEEEcCC-------CcEEeCCCccCcccccCccc--------eeccCccCccCccCHHHh
Confidence 999999999999999999999999987 78999999999765432211 011234578899999999
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhCCCCCchhHHhhhccCccccccccCCCCCCch
Q 001143 1018 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1095 (1141)
Q Consensus 1018 ~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 1095 (1141)
.+ ..++.++|||||||++|+|+| |..||.+...... ...+..+..+..+
T Consensus 247 ~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------- 297 (344)
T 1rjb_A 247 FE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP------------------------- 297 (344)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC-------------------------
T ss_pred cc----CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC-------------------------
Confidence 76 568899999999999999998 9999987654333 3333333222111
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1096 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1096 ~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
...++.+.+++.+||..||.+|||+.++++++.....
T Consensus 298 --~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 298 --FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1345679999999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=353.00 Aligned_cols=297 Identities=20% Similarity=0.224 Sum_probs=207.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..+|++.+.||+|+||.||+|.+. +..+|+|+.. . ......... +.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~-~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--P-FDKPLFALR----TLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--C-CSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeec--c-cccchHHHH----HHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 467999999999999999999986 5667777653 2 122222233 479999999999999999999876532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. .....++||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 83 ~~---------~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~ 146 (353)
T 2b9h_A 83 FE---------NFNEVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146 (353)
T ss_dssp ST---------TCCCEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cC---------ccceEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc
Confidence 11 1235699999997 799999875 3699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++........................||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 147 ~~-------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 216 (353)
T 2b9h_A 147 SN-------CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAEL 216 (353)
T ss_dssp TT-------CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS---CCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc---CCCccchhhHHHHHHHHHHH
Confidence 87 789999999998765322111000000111223468999999998764 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHH-hCCCCCchhHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
++|+.||.+.+..+....+. ....+........................ .........++++.+||.+||+.||.+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 296 (353)
T 2b9h_A 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296 (353)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGG
T ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCccc
Confidence 99999999877665544442 11111111000000000000000000000 001111256778999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
|||+.|+++|+|+...
T Consensus 297 Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 297 RITAKEALEHPYLQTY 312 (353)
T ss_dssp SCCHHHHHTSGGGTTT
T ss_pred CCCHHHHhcCcccccc
Confidence 9999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.73 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=201.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
...|++.++||+|+||+||+|.+. +..++++++.+... ......+.+ .+|+.++++++||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHH----HHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHH----HHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 346899999999999999999863 33344444444432 223333334 7999999999999999999986543
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. ..++||||+++++|.++++. ....+++..+..|+.||+.||.|||++||+||||||+||++
T Consensus 99 ~~-------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~ 161 (298)
T 3f66_A 99 EG-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161 (298)
T ss_dssp SS-------------CCEEEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC-------------ceEEEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence 21 24899999999999999974 23468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++......... ........+|+.|+|||.+.+ ..++.++||||||+++|+
T Consensus 162 ~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 162 DEK-------FTVKVADFGLARDMYDKEYYS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWE 224 (298)
T ss_dssp CTT-------CCEEECSCGGGCCCSCGGGCB------C-----CCBCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEECcccccccccccchhc------cccccCCCCCccccChHHhcC----CCCChHHHHHHHHHHHHH
Confidence 887 789999999997654422111 111223457889999999976 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |.+||......+....+..+..+..+. ..++.+.+++.+||+.||.+||
T Consensus 225 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp HHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCccCCHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChhhCc
Confidence 999 677777666555555554443322111 3456799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
|+.|+++.+....
T Consensus 278 s~~ell~~L~~~~ 290 (298)
T 3f66_A 278 SFSELVSRISAIF 290 (298)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999887653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=349.37 Aligned_cols=282 Identities=20% Similarity=0.233 Sum_probs=202.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeE
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 878 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~ 878 (1141)
....++|++.++||+|+||.||+|.+ .+..+|+|+.... . .+. +.+|+.++++++ ||||+++++++
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~----~~~E~~~l~~l~~~~~i~~~~~~~ 100 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----K---KKK----IKREIKILENLRGGPNIITLADIV 100 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----C---HHH----HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----c---hHH----HHHHHHHHHHcCCCCCEEEeeeee
Confidence 33456799999999999999999987 4667888875311 1 122 379999999997 99999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+... ...++||||+++++|.++++. +++..++.++.||+.||+|||++||+||||||+|
T Consensus 101 ~~~~~------------~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 160 (330)
T 3nsz_A 101 KDPVS------------RTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 160 (330)
T ss_dssp ECTTT------------CCEEEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred ccCCC------------CceEEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 86321 245999999999999988743 8999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.++ ..+||+|||+++...... ......||+.|+|||++.+ ...++.++|||||||+
T Consensus 161 il~~~~~------~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~i 220 (330)
T 3nsz_A 161 VMIDHEH------RKLRLIDWGLAEFYHPGQ-----------EYNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCM 220 (330)
T ss_dssp EEEETTT------TEEEECCCTTCEECCTTC-----------CCCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHH
T ss_pred EEEcCCC------CEEEEEeCCCceEcCCCC-----------ccccccccccccChhhhcC---CCcCCchhhHHHHHHH
Confidence 9998662 389999999997654321 1123468999999999875 2467899999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHH-HhCCCCCchhHHhhhccCcc--------ccccccCCCCCCchhhhhhHHHHHHHH
Q 001143 1039 LLELLTLQVPYMGL-SELEIHDLI-QMGKRPRLTDELEALGSCHE--------HEVAQSGSGFEKPEAELETLSFLVDVF 1108 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~-~~~el~~~I-~~~~~p~l~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~L~dLI 1108 (1141)
+|+|++|+.||... ...+....+ .....+.............. ...................++++.+||
T Consensus 221 l~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 300 (330)
T 3nsz_A 221 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 300 (330)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHH
T ss_pred HHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHH
Confidence 99999999999542 332222222 11111000000000000000 000000000001111224678899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1109 RRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+||++||.+|||++|+++|+||...
T Consensus 301 ~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 301 DKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHhcCCcccCCCHHHHhcCccHhhh
Confidence 99999999999999999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=352.88 Aligned_cols=260 Identities=19% Similarity=0.322 Sum_probs=199.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEE--EecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKV--RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI--~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
....+|++.++||+|+||.||+|.+. +..+++|+ +.+.... .....+. +.+|+.++++++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKE----ILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHH----HHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHH----HHHHHHHHHhCCCCCeeEEEEEE
Confidence 34578999999999999999999984 34443332 2222111 1112223 47999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.... .++||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 87 ~~~~---------------~~~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 147 (327)
T 3lzb_A 87 LTST---------------VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147 (327)
T ss_dssp ESSS---------------EEEEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ecCC---------------ceEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHH
Confidence 7543 38999999999999999762 3469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 148 Il~~~~-------~~~kL~DfG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 208 (327)
T 3lzb_A 148 VLVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVT 208 (327)
T ss_dssp EEEEET-------TEEEECCTTC------------------------CCCGGGSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccCcceeEccCcccc--------ccccCCCccccccCHHHHcC----CCCChHHHHHHHHHH
Confidence 999887 78999999999765432211 11123347889999999987 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++ |..||.+....++...+..+.....+. ..+..+.+++.+||+.||.
T Consensus 209 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 261 (327)
T 3lzb_A 209 VWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMRKCWMIDAD 261 (327)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChh
Confidence 999999 999999877776666665544332211 3456799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+|||+.|+++.+...
T Consensus 262 ~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 262 SRPKFRELIIEFSKM 276 (327)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999988764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.85 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=206.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..+.|++.+.||+|+||.||+|.+. +..+++|+.... .....+. +.+|+.++++++||||+++++++...
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELED----YIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHH----HHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHH----HHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 3467999999999999999999995 566777775422 1112233 37899999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 89 ~--------------~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~ 150 (302)
T 2j7t_A 89 G--------------KLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM 150 (302)
T ss_dssp ---------------CEEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred C--------------eEEEEEEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE
Confidence 4 349999999999999998752 2469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ 1040 (1141)
+.+ +.+||+|||++........ ......||+.|+|||++.... ....++.++||||||+++|
T Consensus 151 ~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~ 213 (302)
T 2j7t_A 151 TLE-------GDIRLADFGVSAKNLKTLQ----------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213 (302)
T ss_dssp CTT-------SCEEECCCHHHHHHHHHHH----------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEEECCCCcccccccc----------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHH
Confidence 877 7899999998754322110 112346899999999985211 1256789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|+.||...+.......+.....+.... ....+..+.+++.+||+.||.+||
T Consensus 214 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rp 268 (302)
T 2j7t_A 214 EMAQIEPPHHELNPMRVLLKIAKSDPPTLLT-------------------------PSKWSVEFRDFLKIALDKNPETRP 268 (302)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHhcCCCCCccCCHHHHHHHHhccCCcccCC-------------------------ccccCHHHHHHHHHHcccChhhCC
Confidence 9999999999877766665554443322110 114556799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001143 1121 TAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~s 1135 (1141)
|+.++++|+|+....
T Consensus 269 s~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 269 SAAQLLEHPFVSSIT 283 (302)
T ss_dssp CHHHHTTSTTTTTCC
T ss_pred CHHHHhcChHHhhhc
Confidence 999999999997543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=360.56 Aligned_cols=251 Identities=22% Similarity=0.266 Sum_probs=198.5
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCCh----HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA----DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~----~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
.+|++.+.||+|+||.||+|.+ .+..||+|+.......... ...+. +.+|+.++++++||||+++++++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK----VTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEE----EEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHH----HHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4699999999999999999987 4566888876543221110 11222 368999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCC-CHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~gg-SL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
+.+ ..++||||+.+| +|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 100 ~~~--------------~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 160 (335)
T 3dls_A 100 NQG--------------FFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160 (335)
T ss_dssp CSS--------------EEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eCC--------------EEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHH
Confidence 655 349999999766 99999875 3469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||+
T Consensus 161 Ill~~~-------~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~i 219 (335)
T 3dls_A 161 IVIAED-------FTIKLIDFGSAAYLERGKL-----------FYTFCGTIEYCAPEVLMG---NPYRGPELEMWSLGVT 219 (335)
T ss_dssp EEECTT-------SCEEECCCTTCEECCTTCC-----------BCEECSCGGGCCHHHHTT---CCBCSHHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEeecccceECCCCCc-----------eeccCCCccccChhhhcC---CCCCCCcccchhHHHH
Confidence 999887 7899999999976543211 123468999999999976 1234789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|..||..... .+.... .. ....++++.+||.+||+.||.+
T Consensus 220 l~el~~g~~pf~~~~~-----~~~~~~--------------------------~~---~~~~~~~l~~li~~~L~~dP~~ 265 (335)
T 3dls_A 220 LYTLVFEENPFCELEE-----TVEAAI--------------------------HP---PYLVSKELMSLVSGLLQPVPER 265 (335)
T ss_dssp HHHHHHSSCSCSSGGG-----GTTTCC--------------------------CC---SSCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCchhhHHH-----HHhhcc--------------------------CC---CcccCHHHHHHHHHHccCChhh
Confidence 9999999999975211 000000 00 0134567999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
|||+.++++|+|+...
T Consensus 266 Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 266 RTTLEKLVTDPWVTQP 281 (335)
T ss_dssp SCCHHHHHHCTTTTCC
T ss_pred CcCHHHHhcCccccCC
Confidence 9999999999998653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.87 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=200.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
....+|++.+.||+|+||.||+|.+.+..+|+|+.... ...+. +.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC------C--HH----HHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch------hHHHH----HHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 45678999999999999999999999999999985421 12223 378999999999999999999875432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ..++||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 88 ~-------------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (278)
T 1byg_A 88 G-------------GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 151 (278)
T ss_dssp --------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-------------ceEEEEecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe
Confidence 1 2499999999999999997631 22489999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 152 ~~-------~~~~l~Dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 207 (278)
T 1byg_A 152 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 207 (278)
T ss_dssp TT-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccccccccccc-------------cCCCccccccCHHHhCC----CCCCchhcHHHHHHHHHHH
Confidence 87 789999999987543211 12347889999999976 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |..||......+....+..+..+..+ ...++.+.+++.+||+.||.+|||
T Consensus 208 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rps 260 (278)
T 1byg_A 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------------------------DGCPPAVYEVMKNCWHLDAAMRPS 260 (278)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------ccCCHHHHHHHHHHhcCChhhCCC
Confidence 98 99999877666666555443322211 145667999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
+.|+++.+...
T Consensus 261 ~~~l~~~L~~i 271 (278)
T 1byg_A 261 FLQLREQLEHI 271 (278)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999988664
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=376.39 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=209.0
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
....++|++.++||+|+||.||+|++. +..+|+|+..... .........+.+|+.++++++||||+++++++.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR-----LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH-----hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 345678999999999999999999984 6678888764321 111111234478999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.. ..|+||||++||+|.+++..... ....+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 256 ~~~--------------~l~lVmE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NI 320 (543)
T 3c4z_A 256 TKT--------------DLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320 (543)
T ss_dssp CSS--------------EEEEEECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred eCC--------------EEEEEEEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHE
Confidence 655 35999999999999999975321 134699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+++.+..... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 321 Ll~~~-------g~vkL~DFGla~~~~~~~~----------~~~~~~GT~~Y~APE~l~~----~~~~~~~DiwSlGvil 379 (543)
T 3c4z_A 321 LLDDD-------GNVRISDLGLAVELKAGQT----------KTKGYAGTPGFMAPELLLG----EEYDFSVDYFALGVTL 379 (543)
T ss_dssp EECTT-------SCEEECCCTTCEECCTTCC----------CBCCCCSCTTTSCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EEeCC-------CCEEEeecceeeeccCCCc----------ccccccCCccccChhhhcC----CCCChHHhcCcchHHH
Confidence 99987 8899999999976543211 1123479999999999986 5688999999999999
Q ss_pred HHHHhCCCCCCCCC----HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1040 LELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~----~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|||++|+.||.+.. ..++...+...... .+ ...+..+.+||.+||+.|
T Consensus 380 yelltG~~PF~~~~~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~lL~~d 431 (543)
T 3c4z_A 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVT-YP---------------------------DKFSPASKDFCEALLQKD 431 (543)
T ss_dssp HHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC-CC---------------------------TTSCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCccchhHHHHHHHHhhcccC-CC---------------------------cccCHHHHHHHHHhccCC
Confidence 99999999997642 34444444332211 10 145667999999999999
Q ss_pred CCCCCC-----HHHHHHHHHhhc
Q 001143 1116 PTERPT-----AGDLYEMFVART 1133 (1141)
Q Consensus 1116 P~~RPS-----a~ElL~~L~~~~ 1133 (1141)
|.+||+ ++++++|+||+.
T Consensus 432 P~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 432 PEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp GGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HhHCCCCcccCHHHHHcCccccC
Confidence 999996 589999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=345.22 Aligned_cols=263 Identities=24% Similarity=0.288 Sum_probs=204.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.+.||+|+||.||+|.+. +..+|+|+...... ....+ .+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPE----NIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHH----HHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhH----HHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 356999999999999999999985 66788887654321 11222 3479999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 79 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 139 (276)
T 2yex_A 79 --------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (276)
T ss_dssp --------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc
Confidence 34999999999999988754 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.+......... .......||+.|+|||++.+. ..++.++||||||+++|+|
T Consensus 140 ~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l 201 (276)
T 2yex_A 140 ER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKRR---EFHAEPVDVWSCGIVLTAM 201 (276)
T ss_dssp TT-------CCEEECCCTTCEECEETTEE--------CCBCCCCSCGGGCCGGGGTCS---SBCHHHHHHHHHHHHHHHH
T ss_pred cC-------CCEEEeeCCCccccCCCcch--------hcccCCccccCccChHHHhcC---CCCCCcchHHHHHHHHHHH
Confidence 87 78999999999765432111 011234689999999998751 2346899999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|+.||...... .....+...... .. .....+..+.+++.+||+.||.+|||
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 255 (276)
T 2yex_A 202 LAGELPWDQPSDSCQEYSDWKEKKTY-LN-------------------------PWKKIDSAPLALLHKILVENPSARIT 255 (276)
T ss_dssp HHSSCCCSCSCTTSHHHHHHHTTCTT-ST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCchHHHHHHHhhhcccc-cC-------------------------chhhcCHHHHHHHHHHCCCCchhCCC
Confidence 9999999765432 122222211110 00 00145667899999999999999999
Q ss_pred HHHHHHHHHhhcCCCC
Q 001143 1122 AGDLYEMFVARTSSSI 1137 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s~~ 1137 (1141)
+.|+++|+|+......
T Consensus 256 ~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 256 IPDIKKDRWYNKPLKK 271 (276)
T ss_dssp HHHHTTCTTTTCCCC-
T ss_pred HHHHhcCccccChhhc
Confidence 9999999999865443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=346.84 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=201.3
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
...+|.+.+.||+|+||.||+|.+.. ..+|+|+.. .........+.+ .+|+.++++++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK--LDNSSQREIEEF----LSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-----CCCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEe--ccccchhHHHHH----HHHHHHHhcCCCCCeeeeeEEE
Confidence 34579999999999999999998732 257777643 223333333444 8999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
.+.... .....++||||+++++|.+++..... .....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 106 ~~~~~~---------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~ 176 (313)
T 3brb_A 106 IEMSSQ---------GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176 (313)
T ss_dssp EC----------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGG
T ss_pred eecccc---------CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc
Confidence 864321 12346999999999999999964321 23457999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
||+++.+ +.+||+|||++......... .......+++.|+|||++.+ ..++.++||||||+
T Consensus 177 NIli~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 237 (313)
T 3brb_A 177 NCMLRDD-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGV 237 (313)
T ss_dssp GEEECTT-------SCEEECSCSCC------------------------CCGGGSCHHHHHS----SCCCHHHHHHHHHH
T ss_pred eEEEcCC-------CcEEEeecCcceeccccccc--------CcccccCCCccccCchhhcC----CCccchhhhHHHHH
Confidence 9999887 78999999999765432111 11123457889999999976 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|+|++ |..||.+....+....+..+..+..+. ..++.+.+++.+||..||
T Consensus 238 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp 290 (313)
T 3brb_A 238 TMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE---------------------------DCLDELYEIMYSCWRTDP 290 (313)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT---------------------------TCCHHHHHHHHHTTCSSG
T ss_pred HHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCCh
Confidence 9999999 899998877766666665544332221 455679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
.+|||+.++++++...
T Consensus 291 ~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 291 LDRPTFSVLRLQLEKL 306 (313)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHH
Confidence 9999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=357.87 Aligned_cols=282 Identities=19% Similarity=0.202 Sum_probs=205.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|.+.+.||+|+||.||+|.+. +..||+|+.. .........+ ++.+|+.++++++||||+++++++.....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAK----RAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--STTSSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEec--ccccchhHHH----HHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 57999999999999999999985 5667777653 2222333233 34799999999999999999999986543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. ......++||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 116 ~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 179 (371)
T 4exu_A 116 L--------RNFYDFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179 (371)
T ss_dssp S--------TTCCCCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred c--------ccceeEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC
Confidence 2 12234599999997 788877632 5999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 180 ~-------~~~kL~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 180 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp T-------CCEEECSTTCC---------------------CTTCCCTTSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecCcccccccC-------------cCCcccCccccCHHHhcC---CCCCCcHHhHHHHHHHHHHHH
Confidence 7 78999999999754321 123468999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|+.||.+.+..+....+.. ...+. ................... ............++.+.+||.+||+.||.+|
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (371)
T 4exu_A 237 TGKTLFKGKDYLDQLTQILKVTGVPG-TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 315 (371)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCC-HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCc-HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence 99999998877776655532 22221 1111110000000000000 0000011112457789999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.|+++|+|+..
T Consensus 316 pt~~ell~hp~f~~ 329 (371)
T 4exu_A 316 LTAAQALTHPFFEP 329 (371)
T ss_dssp CCHHHHHTSGGGTT
T ss_pred CCHHHHhcCccccc
Confidence 99999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=342.82 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=203.0
Q ss_pred CCCceEee-eecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 805 FPSLSSCD-EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 805 ~~~y~i~~-~LG~GsfG~Vy~a~~~----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..+|++.+ .||+|+||.||+|.+. +..+|+|+.... .......+ .+.+|+.++++++||||+++++++.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKD----ELLAEANVMQQLDNPYIVRMIGICE 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHH----HHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc--ccCHHHHH----HHHHHHHHHHhCCCCCEEEEEEEEC
Confidence 45789988 9999999999999752 456777775432 11222223 3489999999999999999999984
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
. . ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~-~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni 148 (291)
T 1xbb_A 89 A-E--------------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 148 (291)
T ss_dssp S-S--------------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred C-C--------------CcEEEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceE
Confidence 3 2 24899999999999999986 34699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 149 l~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 210 (291)
T 1xbb_A 149 LLVTQ-------HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLM 210 (291)
T ss_dssp EEEET-------TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHH
T ss_pred EEeCC-------CcEEEccCCcceeeccCCCccc-------ccccCCCCceeeChHHhcc----CCCChhhhHHHHHHHH
Confidence 99987 7899999999976543221100 1112346789999999976 4577899999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++ |+.||.+....++...+..+..+..+. ..+..+.+++.+||+.||.+
T Consensus 211 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~ 263 (291)
T 1xbb_A 211 WEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVEN 263 (291)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhh
Confidence 99999 999999888877777766554433221 45567999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
||++.++++.+..
T Consensus 264 Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 264 RPGFAAVELRLRN 276 (291)
T ss_dssp SCCHHHHHHHHHH
T ss_pred CcCHHHHHHHHHH
Confidence 9999999988754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=340.70 Aligned_cols=267 Identities=16% Similarity=0.176 Sum_probs=203.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~ 881 (1141)
-.+|++.+.||+|+||.||+|.+ .+..+|+|+..... ..+. +.+|+.+++++ +|+||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~----~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQ----LRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCC----HHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHH----HHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 35699999999999999999996 56778888754221 1122 36899999999 799999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..++||||+ +++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||+
T Consensus 79 ~--------------~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 139 (298)
T 1csn_A 79 L--------------HNVLVIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139 (298)
T ss_dssp T--------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred c--------------eeEEEEEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe
Confidence 4 349999999 89999999862 2369999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.++. .....+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~~~--~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~e 210 (298)
T 1csn_A 140 GRPNS--KNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMY 210 (298)
T ss_dssp CCSSS--TTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred ccCCC--CCCCeEEEEECcccccccccccccc---ccccCccCCCCCcccCCchhhcC----CCCChHHHHHHHHHHHHH
Confidence 87621 1224599999999987654321110 01112335579999999999876 567899999999999999
Q ss_pred HHhCCCCCCCC---CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1042 LLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1042 LLTGk~Pf~~~---~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|++|+.||.+. ...+....+......... +......++.+.+++.+||+.||.+
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~ 267 (298)
T 1csn_A 211 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----------------------RELCAGFPEEFYKYMHYARNLAFDA 267 (298)
T ss_dssp HHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHHCCTTC
T ss_pred HHcCCCCcchhhccccHHHHHHHHhhccCccH-----------------------HHHHhhCcHHHHHHHHHHhcCCccc
Confidence 99999999863 233333333221110000 0011145678999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
||++.+|++.+...
T Consensus 268 RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 268 TPDYDYLQGLFSKV 281 (298)
T ss_dssp CCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHH
Confidence 99999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=365.29 Aligned_cols=281 Identities=22% Similarity=0.249 Sum_probs=203.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC------CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL------RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L------~HpNIVkllg 876 (1141)
..+|++.++||+|+||.||+|.+. +..||+|+... ....... +.+|+.+++.+ .|+||+++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~----~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQ----AAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHH----HHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHH----HHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 346999999999999999999985 45677777532 1222222 36788887776 5789999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++.... +.++||||+. ++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||
T Consensus 167 ~~~~~~--------------~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp 228 (429)
T 3kvw_A 167 NFTFRN--------------HICMTFELLS-MNLYELIKK---NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228 (429)
T ss_dssp EEEETT--------------EEEEEECCCC-CBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSG
T ss_pred ecccCC--------------eEEEEEeccC-CCHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 998655 4599999996 799999986 2334599999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|||++.++. ..+||+|||++...... .....||+.|+|||++.+ ..++.++||||||
T Consensus 229 ~NILl~~~~~-----~~vkL~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG 286 (429)
T 3kvw_A 229 ENILLKQQGR-----SGIKVIDFGSSCYEHQR-------------VYTYIQSRFYRAPEVILG----ARYGMPIDMWSLG 286 (429)
T ss_dssp GGEEESSTTS-----CCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHHT----BCCCTHHHHHHHH
T ss_pred HHeEEccCCC-----cceEEeecccceecCCc-------------ccccCCCCCccChHHHhC----CCCCchHHHHhHH
Confidence 9999987721 23999999998653321 123468999999999986 5688999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCc----cccc--------------------cccC---C
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH----EHEV--------------------AQSG---S 1089 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~----~~~~--------------------~~~~---~ 1089 (1141)
|++|||++|..||.+.+..+....+...........+....... .... .... .
T Consensus 287 ~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (429)
T 3kvw_A 287 CILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRG 366 (429)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEEC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccC
Confidence 99999999999999888777665553222211111111100000 0000 0000 0
Q ss_pred CCCCch----hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1090 GFEKPE----AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1090 ~~~~~~----~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
...... .....++.+.+||.+||++||++|||+.|+++|+|++..
T Consensus 367 ~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 367 PPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp STTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred CccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 000000 011235779999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=348.95 Aligned_cols=285 Identities=20% Similarity=0.229 Sum_probs=205.9
Q ss_pred CCCceEeeeecccCceEEEEEEE---CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC------Ccccee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS------CIVEMY 875 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~---~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp------NIVkll 875 (1141)
..+|++.+.||+|+||.||+|.+ .+..||+|+... .....+ .+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~----~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCE----AARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHH----HHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhH----HHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 35799999999999999999987 356788887531 122222 337899999888655 499999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLK 955 (1141)
+++...+ +.++||||+ +++|.+++.. .+...+++..+..++.||+.||+|||++||+|||||
T Consensus 84 ~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 145 (339)
T 1z57_A 84 EWFEHHG--------------HICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK 145 (339)
T ss_dssp EEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred cccccCC--------------cEEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 9988655 459999999 7999999976 333468999999999999999999999999999999
Q ss_pred CCCeeeeccccc------------CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 956 SENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 956 P~NILld~~~~~------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
|+|||++..... ....+.+||+|||++...... .....||+.|+|||++.+
T Consensus 146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~---- 208 (339)
T 1z57_A 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------------HSTLVSTRHYRAPEVILA---- 208 (339)
T ss_dssp GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-------------CCSSCSCGGGCCHHHHTT----
T ss_pred HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-------------cccccCCccccChHHhhC----
Confidence 999999763100 000267999999998753321 123468999999999976
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcc-c--c------------ccccC
Q 001143 1024 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-H--E------------VAQSG 1088 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~-~--~------------~~~~~ 1088 (1141)
..++.++|||||||++|||++|..||...+..+....+.....+.............. . . .....
T Consensus 209 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (339)
T 1z57_A 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288 (339)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC
Confidence 5688999999999999999999999998777665555433222211111111000000 0 0 00000
Q ss_pred CCC-CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1089 SGF-EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1089 ~~~-~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
... .........++.+.+|+.+||+.||.+|||+.|+++|+|+..
T Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 000 000001245778999999999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=354.37 Aligned_cols=295 Identities=16% Similarity=0.164 Sum_probs=207.3
Q ss_pred CCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCCh---HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~---~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+|++.+.||+|+||.||+|.+ .+..+|+|+.......... .........+.+|+.++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 35799999999999999999987 4667888876433221110 1111222445899999999999999999999865
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
... ......++||||++ ++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~---------~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 101 FEE---------PAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCT---------TTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred ccC---------CCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 321 12336799999998 789888874 2346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||++....... ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 167 ~~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 225 (362)
T 3pg1_A 167 LADN-------NDITICDFNLAREDTADA-----------NKTHYVTHRWYRAPELVMQ---FKGFTKLVDMWSAGCVMA 225 (362)
T ss_dssp ECTT-------CCEEECCTTC--------------------------CGGGCCHHHHTT---CTTCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEecCccccccccc-----------ccceecccceecCcHHhcC---CCCCCcHhHHHhHHHHHH
Confidence 9887 789999999997533211 1123468999999999875 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHH-HhCCCCCchhHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|++|+.||.+....+....+ .....+........................ .........++.+.+||.+||+.||
T Consensus 226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 999999999988777666555 333333332211100000000000000000 0011122456779999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+|||+.|+++|+|+..-
T Consensus 306 ~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 306 QRRISTEQALRHPYFESL 323 (362)
T ss_dssp GGSCCHHHHHTSGGGTTT
T ss_pred hhCCCHHHHHcCchhhhc
Confidence 999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=349.78 Aligned_cols=271 Identities=21% Similarity=0.337 Sum_probs=209.4
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCc
Q 001143 799 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI 871 (1141)
Q Consensus 799 ~~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI 871 (1141)
.+......+|++.+.||+|+||.||+|++. +..+|+|+.. .. ........ +.+|+.++++++||||
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~h~~i 95 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EV-CSEQDELD----FLMEALIISKFNHQNI 95 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECC--SS-CCHHHHHH----HHHHHHHHHHCCCTTB
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEec--cc-cchhhHHH----HHHHHHHHhhCCCCCC
Confidence 344455678999999999999999999842 3457777643 21 12233333 4799999999999999
Q ss_pred cceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 001143 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHI 949 (1141)
Q Consensus 872 Vkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gI 949 (1141)
+++++++.+.... ++||||+++++|.+++...... ....+++..++.++.||+.||.|||++||
T Consensus 96 v~~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 161 (327)
T 2yfx_A 96 VRCIGVSLQSLPR--------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161 (327)
T ss_dssp CCEEEEECSSSSC--------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CeEEEEEcCCCCc--------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe
Confidence 9999999875543 9999999999999999873221 11358999999999999999999999999
Q ss_pred cccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCch
Q 001143 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1029 (1141)
Q Consensus 950 vHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1029 (1141)
+||||||+|||++.++ ....+||+|||++......... .......||+.|+|||++.+ ..++.+
T Consensus 162 ~H~dlkp~NIli~~~~----~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~ 225 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPG----PGRVAKIGDFGMARDIYRASYY--------RKGGCAMLPVKWMPPEAFME----GIFTSK 225 (327)
T ss_dssp CCSCCCGGGEEESCSS----TTCCEEECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHH----CCCCHH
T ss_pred ecCcCCHhHEEEecCC----CcceEEECcccccccccccccc--------ccCCCcCCCcceeCHhHhcC----CCCCch
Confidence 9999999999998541 1157999999999754332111 11223458899999999976 568899
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 001143 1030 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1108 (1141)
Q Consensus 1030 sDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1108 (1141)
+||||||+++|+|++ |..||......+....+..+..+..+. ..+..+.+++
T Consensus 226 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li 278 (327)
T 2yfx_A 226 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIM 278 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHH
Confidence 999999999999998 999999877777777665554332211 4456799999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1109 RRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.+||+.||.+|||+.++++++++..
T Consensus 279 ~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 279 TQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=360.05 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=197.3
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkllg~~~~~~ 882 (1141)
..|++.+.||+|+||.||+|.+. +..+|+|+.... .......+.+ .+|+.++.+++ ||||+++++++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE--EADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECT--TCCHHHHHHH----HHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecc--cccHHHHHHH----HHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 35999999999999999999874 566888876543 2233333444 89999999996 599999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||| +.+++|.+++.. ...+++.++..|+.||+.||.|||++||+||||||+|||++
T Consensus 130 --------------~~~lv~E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 189 (390)
T 2zmd_A 130 --------------YIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189 (390)
T ss_dssp --------------EEEEEEE-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES
T ss_pred --------------EEEEEEe-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE
Confidence 3599999 557899999986 34689999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1035 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVWSL 1035 (1141)
. +.+||+|||+++.+...... ......+||+.|+|||++.+.. ....++.++|||||
T Consensus 190 ~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 190 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp S--------SCEEECCCSSSCCC-----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred C--------CeEEEEecCccccccCCCcc--------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 3 67999999999765432111 1122456999999999987521 11358899999999
Q ss_pred HHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1036 GCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~-~el~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
||++|+|++|+.||..... ......+..... ...+ ...+..+.+||.+||+
T Consensus 254 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~L~ 306 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 306 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC---------------------------ccchHHHHHHHHHHcc
Confidence 9999999999999976432 223333322111 0000 0224568999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001143 1114 ENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.||.+|||+.|+++|+|+...
T Consensus 307 ~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 307 RDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp SSTTTSCCHHHHHTSHHHHSC
T ss_pred cChhhCCCHHHHhhCcCcccc
Confidence 999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=344.02 Aligned_cols=260 Identities=26% Similarity=0.321 Sum_probs=209.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++. +..+++|+....... ....+. +.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTST----ILREVELLKKLDHPNIMKLFEILEDSS- 94 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHH----HHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHH----HHHHHHHHHhccCCCccEEEEEEeCCC-
Confidence 46999999999999999999984 677888886543221 122223 379999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 95 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 95 -------------SFYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (287)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred -------------eEEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEec
Confidence 34999999999999998875 236999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++ ..+.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 157 ~~----~~~~~kL~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 157 KE----KDCDIKIIDFGLSTCFQQNT-----------KMKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp SS----TTCCEEECSTTGGGTBCCCS-----------SCSCHHHHHTTCCHHHHTT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC----CcccEEEeccCcceeecCCC-----------ccccccCcccccChHHhcC-----CCCCchhhHhHHHHHHHHH
Confidence 42 12579999999987543321 1123358899999999875 4789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|..||.+....+....+..+........ ....+..+.+++.+||..||.+|||+.
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ 272 (287)
T 2wei_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQ------------------------WRTISDDAKDLIRKMLTFHPSLRITAT 272 (287)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGG------------------------GTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCchh------------------------hhhcCHHHHHHHHHHcccChhhCcCHH
Confidence 99999998887777776655443211100 014566799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001143 1124 DLYEMFVARTS 1134 (1141)
Q Consensus 1124 ElL~~L~~~~~ 1134 (1141)
|+++|+|+...
T Consensus 273 ell~hp~~~~~ 283 (287)
T 2wei_A 273 QCLEHPWIQKY 283 (287)
T ss_dssp HHHHSHHHHHH
T ss_pred HHhcCHHHhcc
Confidence 99999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=344.75 Aligned_cols=267 Identities=25% Similarity=0.419 Sum_probs=199.3
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
....+.+|++.+.||+|+||.||+|.+ .+..+|+|+..... .......+. +.+|+.++++++||||+++++++
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARAD----CIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS-SCCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh-ccCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEE
Confidence 455678899999999999999999997 46678888764322 122233333 47999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 102 ~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 166 (310)
T 2wqm_A 102 IEDN--------------ELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166 (310)
T ss_dssp EETT--------------EEEEEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EcCC--------------cEEEEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHH
Confidence 8655 349999999999999999764332 3469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|+++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||++
T Consensus 167 Il~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i 225 (310)
T 2wqm_A 167 VFITAT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCL 225 (310)
T ss_dssp EEECTT-------SCEEECCC----------------------------CCSSCCHHHHTT----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEEeccceeeecCCCc----------cccccCCCeeEeChHHhCC----CCCCchhhHHHHHHH
Confidence 999877 7899999999876543211 1123468999999999876 568899999999999
Q ss_pred HHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1039 LLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~--~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|+|++|+.||.+. ...+....+.....+.... ...+.++.+++.+||..||
T Consensus 226 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp 279 (310)
T 2wqm_A 226 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS--------------------------DHYSEELRQLVNMCINPDP 279 (310)
T ss_dssp HHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT--------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc--------------------------cccCHHHHHHHHHHcCCCh
Confidence 99999999999753 2333444444333222110 1455679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+|||+.++++++.....
T Consensus 280 ~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 280 EKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHHH
Confidence 999999999999877643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=350.37 Aligned_cols=278 Identities=23% Similarity=0.330 Sum_probs=193.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
....+|++.+.||+|+||.||+|.+ .+..||+|+..... . ....+ .+.+|+.++++++||||+++++++..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~-~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--C-QTSMD----ELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEES
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--c-chhHH----HHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 3457899999999999999999987 45667777643221 1 11222 34789999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~---~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
.+. .++||||+++++|.+++...... ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 85 ~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ 150 (303)
T 2vwi_A 85 KDE--------------LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAG 150 (303)
T ss_dssp SSC--------------EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred cCC--------------cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChh
Confidence 553 49999999999999999754322 2346999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
||+++.+ +.+||+|||++.......... .........||+.|+|||++.+. ..++.++|||||||
T Consensus 151 Nil~~~~-------~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~ 215 (303)
T 2vwi_A 151 NILLGED-------GSVQIADFGVSAFLATGGDIT-----RNKVRKTFVGTPCWMAPEVMEQV---RGYDFKADIWSFGI 215 (303)
T ss_dssp GEEECTT-------CCEEECCCHHHHHCC--------------------CCCTTCCHHHHHHH---HCCCTHHHHHHHHH
T ss_pred hEEEcCC-------CCEEEEeccchheeccCCCcc-----chhhhcccCCCccccCHHHhccc---cCCCchhhHHHHHH
Confidence 9999887 789999999987654321110 00112245689999999998652 24679999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++|+|++|+.||.................+........ +......+..+.+++.+||+.||.
T Consensus 216 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~ 277 (303)
T 2vwi_A 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD------------------KEMLKKYGKSFRKMISLCLQKDPE 277 (303)
T ss_dssp HHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHhCCCCCccCchhhHHHHHhccCCCcccccccc------------------chhhhhhhHHHHHHHHHHccCChh
Confidence 99999999999987665554443333333222211100 000114556799999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+|||+.++++|+|+...
T Consensus 278 ~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 278 KRPTAAELLRHKFFQKA 294 (303)
T ss_dssp GSCCHHHHHTSTTC---
T ss_pred hCcCHHHHhhChhhhcC
Confidence 99999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=366.83 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=203.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
..+|++.++||+|+||.||+|.+.+ ..||+|+.+ ..... .+.+ .+|+.+|++++||||+++++++.+ ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~---~~~~----~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMS---PEAF----LQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECC--TTSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEec--cCCCC---HHHH----HHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 4579999999999999999999965 457777643 22211 2233 799999999999999999999864 22
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++|+|.++++.. ....+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 253 --------------~~iv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 315 (452)
T 1fmk_A 253 --------------IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 315 (452)
T ss_dssp --------------CEEEECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred --------------eEEEehhhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC
Confidence 38999999999999999752 1235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++........ ......+++.|+|||++.+ ..++.++|||||||++|||+
T Consensus 316 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~ 375 (452)
T 1fmk_A 316 N-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELT 375 (452)
T ss_dssp G-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEECCCccceecCCCcee---------cccCCcccccccCHhHHhc----CCCCccccHHhHHHHHHHHH
Confidence 7 78999999999765432111 1123347889999999986 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||.+....++...+..+.....+. .+++.+.++|.+||+.||++|||+
T Consensus 376 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rpt~ 428 (452)
T 1fmk_A 376 TKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPTF 428 (452)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCH
Confidence 9 999999888888777776554332221 456679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
+++++.+....
T Consensus 429 ~~l~~~L~~~~ 439 (452)
T 1fmk_A 429 EYLQAFLEDYF 439 (452)
T ss_dssp HHHHHHHHTTT
T ss_pred HHHHHHHHHHh
Confidence 99999887654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=348.48 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=207.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl 874 (1141)
.++|++.+.||+|+||.||+|++. +..||+|+.. .. ......+. +.+|+.+++++ +||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD-ATEKDLSD----LVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECC--TT-CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeec--cC-CcHHHHHH----HHHHHHHHHHhhcCCCEeeE
Confidence 467999999999999999999974 3457777643 21 12233333 47999999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~y 943 (1141)
++++.+.+.+ ++||||+++++|.+++...... ....+++..++.++.||+.||.|
T Consensus 107 ~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 172 (334)
T 2pvf_A 107 LGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172 (334)
T ss_dssp EEEECSSSCC--------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEccCCce--------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 9999865543 9999999999999999863211 12348999999999999999999
Q ss_pred HHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 944 LHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+
T Consensus 173 LH~~~ivH~Dlkp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 233 (334)
T 2pvf_A 173 LASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYYK--------KTTNGRLPVKWMAPEALFD---- 233 (334)
T ss_dssp HHHTTEECSCCSGGGEEECTT-------CCEEECCCTTCEECTTTSSEE--------CCSCCCCCGGGCCHHHHHH----
T ss_pred HHhCCeeCCCCccceEEEcCC-------CCEEEcccccccccccccccc--------ccCCCCcccceeChHHhcC----
Confidence 999999999999999999887 789999999997654322110 1123357889999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 001143 1024 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1102 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1141)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. .++.
T Consensus 234 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 286 (334)
T 2pvf_A 234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCTN 286 (334)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCH
T ss_pred CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCc---------------------------cCCH
Confidence 457899999999999999999 999999888777777665544332211 4456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1103 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1103 ~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+.+++.+||+.||.+|||+.|+++++...
T Consensus 287 ~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 799999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=353.98 Aligned_cols=273 Identities=23% Similarity=0.294 Sum_probs=203.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
...+|++.+.||+|+||.||+|++. +..+|+|+.... .....+.+ .+|+.++++++||||+++++++.+.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEF----ETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHHH----HHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHHH----HHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4568999999999999999999974 567788764322 12223333 79999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ++||||+++++|.+++.... .....+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 109 ~~--------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 109 EM--------------ILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173 (321)
T ss_dssp CC--------------EEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC
T ss_pred eE--------------EEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC
Confidence 33 99999999999999886421 1223699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 174 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el 234 (321)
T 2qkw_B 174 EN-------FVPKITDFGISKKGTELDQT--------HLSTVVKGTLGYIDPEYFIK----GRLTEKSDVYSFGVVLFEV 234 (321)
T ss_dssp TT-------CCEEECCCTTCEECSSSSCC--------CCBCCCEEETTTCCHHHHHH----CBCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeccccccccccccc--------ccccccCCCccccCHHHhcC----CCCCcccchHhHHHHHHHH
Confidence 87 78999999999764332111 11123458999999999976 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHH----hCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQ----MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~----~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
++|+.||.+....+....+. ......+. .... ...........+..+.+++.+||+.||++
T Consensus 235 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 299 (321)
T 2qkw_B 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLE------------QIVD---PNLADKIRPESLRKFGDTAVKCLALSSED 299 (321)
T ss_dssp HHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC------------SSSS---SSCTTCSCHHHHHHHHHHHHHHTCSSGGG
T ss_pred HhCCCcccccCcHHHHHHHHHhhhccccccHH------------HhcC---hhhccccCHHHHHHHHHHHHHHcCCCccc
Confidence 99999997543221110000 00000000 0000 00011122367788999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
|||+.|+++++....
T Consensus 300 Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 300 RPSMGDVLWKLEYAL 314 (321)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHh
Confidence 999999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=345.05 Aligned_cols=267 Identities=24% Similarity=0.364 Sum_probs=196.1
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC--CCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||.||+|++.+..||+|++... . ...+ .+|.+++..+ +||||+++++++.....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~-~~~~----~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT------E-EASW----FRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG------G-HHHH----HHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEecc------c-cchh----hhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 46999999999999999999999999999986422 1 1111 4566666554 89999999999876421
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCC
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIK 955 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--------gIvHrDLK 955 (1141)
.....++||||+++++|.++++. ..+++..++.++.||+.||.|||++ ||+|||||
T Consensus 106 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 106 ----------SWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp ----------GGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred ----------CCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 12356999999999999999976 3699999999999999999999998 99999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC--CCchhhHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGLEVDIW 1033 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~--~s~ksDVW 1033 (1141)
|+|||++.+ +.+||+|||+++.+....... ........||+.|+|||++.+...... ++.++|||
T Consensus 170 p~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diw 236 (337)
T 3mdy_A 170 SKNILVKKN-------GTCCIADLGLAVKFISDTNEV------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236 (337)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHH
T ss_pred hHHEEECCC-------CCEEEEeCCCceeeccccccc------cCCCCCCccCcceeChhhcccccCCccccCccccchH
Confidence 999999887 789999999997654322110 111224569999999999976321111 01249999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHH-hCCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1034 SYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1034 SLGviL~ELLTG----------k~Pf~~~~-----~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
||||++|||++| +.||.... .......+. ....+..+.. ...
T Consensus 237 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~ 294 (337)
T 3mdy_A 237 SFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR----------------------WSS 294 (337)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------GGG
T ss_pred HHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccccc----------------------chh
Confidence 999999999999 66665321 122222221 1111111111 011
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
..+++.+.+++.+||+.||.+|||+.|+++++.....
T Consensus 295 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 295 DECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 2677889999999999999999999999999977543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=341.12 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=203.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.++|++.+.||+|+||.||+|.+.+ ..+|+|+.... ... .+. +.+|+.++++++||||+++++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~- 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMS---PDA----FLAEANLMKQLQHQRLVRLYAVVTQEP- 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--ccc---HHH----HHHHHHHHHhCCCcCcceEEEEEcCCC-
Confidence 4679999999999999999999864 46888875422 111 223 379999999999999999999876422
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 82 --------------~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~ 144 (279)
T 1qpc_A 82 --------------IYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144 (279)
T ss_dssp --------------CEEEEECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred --------------cEEEEecCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC
Confidence 38999999999999998642 1125899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.+......... ......+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 145 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 204 (279)
T 1qpc_A 145 T-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIV 204 (279)
T ss_dssp T-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEECCCcccccccCcccc---------cccCCCCccCccChhhhcc----CCCCchhhhHHHHHHHHHHH
Confidence 7 78999999999765432211 1123347889999999976 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+ |+.||.+....+....+..+..+..+ ...+..+.+++.+||..||++|||+
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rps~ 257 (279)
T 1qpc_A 205 THGRIPYPGMTNPEVIQNLERGYRMVRP---------------------------DNCPEELYQLMRLCWKERPEDRPTF 257 (279)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCcccCHHHHHHHHhcccCCCCc---------------------------ccccHHHHHHHHHHhccChhhCCCH
Confidence 9 99999988777776666544332211 1445679999999999999999999
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.++++.+..
T Consensus 258 ~~l~~~l~~ 266 (279)
T 1qpc_A 258 DYLRSVLED 266 (279)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999987754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=348.22 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=203.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
...+|++.+.||+|+||.||+|.+.. ..+|+|+.... ......+. +.+|+.+++++ +||||++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEA----LMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc---cChHHHHH----HHHHHHHHHhhcCCCCeeeEE
Confidence 45789999999999999999999843 25777775322 12233333 48999999999 899999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---------CCCCCCHHHHHHHHHHHHHHHHHHHH
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------GEKHVSVKLALFIAQDVAAALVELHS 946 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~---------~~~~Ls~~~i~~Ia~QIa~gL~yLHs 946 (1141)
+++.+.+.. ++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+
T Consensus 117 ~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 117 GACTHGGPV--------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp EEECSSSSC--------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCce--------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 999865543 9999999999999999764321 12358999999999999999999999
Q ss_pred CCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCC
Q 001143 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1141)
Q Consensus 947 ~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1026 (1141)
+||+||||||+|||++.+ +.+||+|||++......... .......+|+.|+|||++.+ ..+
T Consensus 183 ~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 243 (333)
T 2i1m_A 183 KNCIHRDVAARNVLLTNG-------HVAKIGDFGLARDIMNDSNY--------IVKGNARLPVKWMAPESIFD----CVY 243 (333)
T ss_dssp TTEECSCCSGGGCEEEGG-------GEEEBCCCGGGCCGGGCTTS--------EECSSCEECGGGSCHHHHHH----CCC
T ss_pred CCcccCCcccceEEECCC-------CeEEECccccccccccccce--------eecCCCCCCccccCHHHhcc----CCC
Confidence 999999999999999987 78999999999765432211 01123457889999999886 568
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1027 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1027 s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
+.++|||||||++|+|++ |..||.+....... ..+.....+..+ ...+..+
T Consensus 244 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l 296 (333)
T 2i1m_A 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP---------------------------AFAPKNI 296 (333)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TTCCHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------CCCCHHH
Confidence 899999999999999999 99999875543333 332322221111 1345679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+++.+||+.||.+|||+.|+++++...
T Consensus 297 ~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 297 YSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999988654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=369.42 Aligned_cols=270 Identities=13% Similarity=0.109 Sum_probs=191.4
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHH---HHhhCCCCCcccee----
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR---MLGALRHSCIVEMY---- 875 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~---iL~~L~HpNIVkll---- 875 (1141)
..+|++.+.||+|+||.||+|++ .+..||+|+....... .....+. +.+|+. ++++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~----~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQ----MKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHH----HHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHH----HHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 45799999999999999999996 4778999986543221 1222333 378994 55555799999998
Q ss_pred ---eeEecCCCC---CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 001143 876 ---GHKISSKWL---PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSK 947 (1141)
Q Consensus 876 ---g~~~~~~~~---~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~ 947 (1141)
+++...+.. ....++........|+||||+ +|+|.+++...... ....+++..++.|+.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 444432110 000001111122468999999 58999999863221 113455688889999999999999999
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc------
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------ 1021 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------ 1021 (1141)
||+||||||+|||++.+ +.+||+|||+|+...... ....| +.|+|||++.+..
T Consensus 226 ~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~~ 284 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGARV-------------VSSVS-RGFEPPELEARRATISYHR 284 (377)
T ss_dssp TEECSCCCGGGEEECTT-------CCEEECCGGGCEETTCEE-------------ECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred CeecCCCCHHHEEEcCC-------CCEEEEechhheecCCcc-------------cCCCC-cCccChhhhcccccccccc
Confidence 99999999999999987 789999999997533211 13357 9999999998720
Q ss_pred -CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 001143 1022 -KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1100 (1141)
Q Consensus 1022 -~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1141)
....++.++|||||||++|||++|+.||.+....+....+... . ...
T Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------------~---------~~~ 332 (377)
T 3byv_A 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-----------------------C---------KNI 332 (377)
T ss_dssp CCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS-----------------------C---------CCC
T ss_pred cccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh-----------------------c---------cCC
Confidence 0015789999999999999999999999754322111111000 0 144
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1101 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1101 ~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
++.+.+||.+||+.||.+|||+.|+++|+|+..
T Consensus 333 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 333 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 567999999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=358.41 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=193.8
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
..|++.++||+|+||.||+|.+. +..+.++++.++... .....+.+ .+|+.++++++||||+++++++....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~----~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHH----HHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHH----HHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 34789999999999999999873 233444444444322 22333444 89999999999999999999875432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. ..++||||+++++|.++++. ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 164 ~-------------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 226 (373)
T 3c1x_A 164 G-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226 (373)
T ss_dssp S-------------CCEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred C-------------CeEEEEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC
Confidence 1 23899999999999999975 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++.+....... ........+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 227 ~~-------~~~kL~DFG~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 227 EK-------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp TT-------CCEEECCC---------------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccccccccccccc------ccccCCCCCcccccChHHhcC----CCCCcHHHHHHHHHHHHHH
Confidence 87 789999999997654321110 011123457889999999986 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |.+||......+....+..+..+..+ ..++..+.+++.+||+.||++|||
T Consensus 290 lt~~~~p~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~~~~l~~li~~cl~~dp~~RPs 342 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFDITVYLLQGRRLLQP---------------------------EYCPDPLYEVMLKCWHPKAEMRPS 342 (373)
T ss_dssp HTTSCCSCTTSCSSCHHHHHHTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCcCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCcC
Confidence 99 78888766555555555444332211 145567999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
+.|+++++....
T Consensus 343 ~~ell~~L~~i~ 354 (373)
T 3c1x_A 343 FSELVSRISAIF 354 (373)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.55 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=198.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+++|.....||+|+||.||+|.+. +..||+|+.... . ....+. +.+|+.++++++||||+++++++...
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~--~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--D--SRYSQP----LHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--C--C---HH----HHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--c--hHHHHH----HHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 3455666679999999999999984 455677764322 1 122233 37999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+ ..++||||+++++|.+++... .+...+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 92 ~--------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 155 (295)
T 2clq_A 92 G--------------FIKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155 (295)
T ss_dssp T--------------EEEEEEECCSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------cEEEEEEeCCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE
Confidence 4 349999999999999999762 223457899999999999999999999999999999999999
Q ss_pred ec-ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 962 DL-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 962 d~-~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
+. + +.+||+|||++........ ......||+.|+|||++.+.. ..++.++||||||+++|
T Consensus 156 ~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~il~ 216 (295)
T 2clq_A 156 NTYS-------GVLKISDFGTSKRLAGINP----------CTETFTGTLQYMAPEIIDKGP--RGYGKAADIWSLGCTII 216 (295)
T ss_dssp ETTT-------CCEEECCTTTCEESCC---------------CCCCCCGGGCCHHHHHHGG--GGCSHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccccccCCCCC----------cccccCCCccccChhhhcCCC--CCCCcHHHHHHHHHHHH
Confidence 87 4 7899999999976543211 112346899999999987521 23679999999999999
Q ss_pred HHHhCCCCCCCCCHHH-H-HHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1041 ELLTLQVPYMGLSELE-I-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~e-l-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|++|+.||....... . .........+.++ ...+..+.+++.+||+.||++
T Consensus 217 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 217 EMATGKPPFYELGEPQAAMFKVGMFKVHPEIP---------------------------ESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp HHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC---------------------------TTSCHHHHHHHHHTTCSSTTT
T ss_pred HHHHCCCCccCCCchhHHHHhhcccccccccc---------------------------ccCCHHHHHHHHHHccCChhh
Confidence 9999999997543222 1 1111111111111 145567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCC
Q 001143 1119 RPTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~s~ 1136 (1141)
|||+.++++|+|+.....
T Consensus 270 Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 270 RACANDLLVDEFLKVSSK 287 (295)
T ss_dssp SCCHHHHHTSGGGCC---
T ss_pred CCCHHHHhcChhhhhccc
Confidence 999999999999986544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=348.42 Aligned_cols=274 Identities=23% Similarity=0.353 Sum_probs=202.2
Q ss_pred CCCCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
...+|++.+.||+|+||.||+|++ .+..+|+|+.... .....+. +.+|+.++++++||||++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~ 92 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRD----FQREIQILKALHSDFIVKYRGV 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHH----HHHHHHHHHTCCCTTBCCEEEE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHH----HHHHHHHHHhcCCCceeEEEEE
Confidence 346799999999999999999995 3556777765321 2333333 4899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
+..... ...++||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+
T Consensus 93 ~~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 156 (327)
T 3lxl_A 93 SYGPGR------------QSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156 (327)
T ss_dssp EECSSS------------CEEEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EecCCC------------ceEEEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh
Confidence 874321 2469999999999999999763 235999999999999999999999999999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.+||+|||++........... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 157 NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 157 NILVESE-------AHVKIADFGLAKLLPLDKDYYV-------VREPGQSPIFWYAPESLSD----NIFSRQSDVWSFGV 218 (327)
T ss_dssp GEEEEET-------TEEEECCGGGCEECCTTCSEEE-------CSSCCCSCGGGSCHHHHHH----CEEEHHHHHHHHHH
T ss_pred hEEECCC-------CCEEEcccccceecccCCccce-------eeccCCccccccCHHHhcc----CCCChHHhHHHHHH
Confidence 9999887 8899999999986543221110 1123458889999999976 45789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
++|+|++|+.||...... ....... ...+......... ...... .....+++.+.+++.+||+.||
T Consensus 219 il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 219 VLYELFTYCDKSCSPSAE-FLRMMGCERDVPALSRLLELL---------EEGQRL---PAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp HHHHHHTTTCGGGSHHHH-HHHHCC----CCHHHHHHHHH---------HTTCCC---CCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHhCCCCCccccch-hhhhcccccccccHHHHHHHh---------hcccCC---CCCCcccHHHHHHHHHHcCCCh
Confidence 999999999998753221 1111100 0000000000000 000000 0112566789999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
.+|||+.|+++++...
T Consensus 286 ~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 286 QDRPSFSALGPQLDML 301 (327)
T ss_dssp GGSCCHHHHHHHHHHC
T ss_pred hhCcCHHHHHHHHHHH
Confidence 9999999999988765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=346.12 Aligned_cols=287 Identities=21% Similarity=0.235 Sum_probs=207.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkllg~~ 878 (1141)
..+|++.+.||+|+||.||+|++. +..||+|+......... .... +.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~----~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLS----TIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCT----HHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCch----hhHHHHHHHhhhccCCCCeEeeeeee
Confidence 367999999999999999999983 56788888654432111 1112 25677777666 899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
..... ......++||||++ ++|.+++.. .....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 84 ~~~~~---------~~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~N 150 (326)
T 1blx_A 84 TVSRT---------DRETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150 (326)
T ss_dssp EEEEC---------SSEEEEEEEEECCS-CBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred eeccc---------CCCceEEEEEecCC-CCHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHH
Confidence 73210 01235699999998 699999976 233459999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|+++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 151 ili~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 208 (326)
T 1blx_A 151 ILVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCI 208 (326)
T ss_dssp EEECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred eEEcCC-------CCEEEecCcccccccCCCC-----------ccccccccceeCHHHHhc----CCCCcchhHHHHHHH
Confidence 999887 7899999999976543211 123468999999999976 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++|+.||.+....+....+... ..+... .+....... ...................+..+.+|+.+||..||.
T Consensus 209 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (326)
T 1blx_A 209 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE-DWPRDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286 (326)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG-GSCTTCSSC-GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc-cCccccccc-hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence 99999999999987776665555321 111111 100000000 000000000001111225677899999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+|||+.|+++|+|+...
T Consensus 287 ~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 287 KRISAYSALSHPYFQDL 303 (326)
T ss_dssp TSCCHHHHHTSGGGTTC
T ss_pred cCCCHHHHhcCcccccc
Confidence 99999999999999743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=341.94 Aligned_cols=273 Identities=23% Similarity=0.329 Sum_probs=197.9
Q ss_pred CCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
..|++.++||+|+||.||+|++ .+..+|+|+..... .....+ .+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIA----DLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHH----HHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHH----HHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3489999999999999999995 46678888764332 111122 3479999999999999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... ...++||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 94 ~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni 157 (302)
T 4e5w_A 94 EDGG------------NGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 157 (302)
T ss_dssp C---------------CCEEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cCCC------------ceEEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheE
Confidence 6421 1458999999999999999652 24699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+++.+ +.+||+|||++.......... .......||..|+|||++.+ ..++.++||||||+++
T Consensus 158 l~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 219 (302)
T 4e5w_A 158 LVESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDRDSPVFWYAPECLMQ----SKFYIASDVWSFGVTL 219 (302)
T ss_dssp EEEET-------TEEEECCCTTCEECCTTCCEE-------ECCCCTTCCGGGCCHHHHHH----CEEEHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEECcccccccccCCCcce-------eccCCCCCCccccCCeeecC----CCCCcchhHHHHHHHH
Confidence 99887 789999999997654432110 11223458889999999976 4577999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|..|+.. ................. .... .. ......... .....++.+.+++.+||+.||.+|
T Consensus 220 ~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~--~~~~----~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R 287 (302)
T 4e5w_A 220 HELLTYCDSDSS--PMALFLKMIGPTHGQMT--VTRL----VN-TLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNR 287 (302)
T ss_dssp HHHHTTTCGGGS--HHHHHHHHHCSCCGGGH--HHHH----HH-HHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred HHHHHccCCCcc--hhhHHhhccCCcccccC--HHHH----HH-HHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCC
Confidence 999999998753 22111111111000000 0000 00 000000000 112556789999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001143 1120 PTAGDLYEMFVA 1131 (1141)
Q Consensus 1120 PSa~ElL~~L~~ 1131 (1141)
||+.++++.+..
T Consensus 288 ps~~~ll~~L~~ 299 (302)
T 4e5w_A 288 TSFQNLIEGFEA 299 (302)
T ss_dssp CCHHHHHHHHHH
T ss_pred CCHHHHHHHHHH
Confidence 999999998864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=349.35 Aligned_cols=274 Identities=21% Similarity=0.260 Sum_probs=203.4
Q ss_pred CCCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
...+|++.+.||+|+||.||+|++ .+..+|+|+...... .... ..+.+|+.++++++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT---QGGE----LQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CC----CHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC---chHH----HHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 346799999999999999999987 467788887543211 1111 13479999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCe
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENI 959 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---gIvHrDLKP~NI 959 (1141)
.. ++||||+++++|.+++.... .....+++..+..|+.||+.||.|||++ ||+||||||+||
T Consensus 101 ~~--------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 101 ER--------------LLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CC--------------EEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred ce--------------EEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 43 89999999999999998632 2234699999999999999999999999 999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 166 l~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 225 (326)
T 3uim_A 166 LLDEE-------FEAVVGDFGLAKLMDYKDTH---------VTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVML 225 (326)
T ss_dssp EECTT-------CCEEECCCSSCEECCSSSSC---------EECCCCSCGGGCCHHHHHH----SEECHHHHHHHHHHHH
T ss_pred EECCC-------CCEEeccCccccccCccccc---------ccccccCCcCccCHHHhcc----CCCCccccchhHHHHH
Confidence 99887 78999999999765432211 1123458999999999976 4578999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 001143 1040 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1114 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~-----~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~ 1114 (1141)
|+|++|+.||... ........+......... ..... ...........+..+.+++.+||+.
T Consensus 226 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~ 291 (326)
T 3uim_A 226 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL-----------EALVD---VDLQGNYKDEEVEQLIQVALLCTQS 291 (326)
T ss_dssp HHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS-----------TTSSC---TTCTTSCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhCCCcccccccccccchhHHHHHHHHhhchhh-----------hhhcC---hhhccccCHHHHHHHHHHHHHHhCc
Confidence 9999999999521 000011111110000000 00000 0001112236678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 001143 1115 NPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1115 DP~~RPSa~ElL~~L~~~~ 1133 (1141)
||.+|||+.||+++++...
T Consensus 292 dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 292 SPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CGGGSCCHHHHHHHHHTSS
T ss_pred CCccCCCHHHHHHHhcCcc
Confidence 9999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=344.51 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=203.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
..+|++.+.||+|+||.||+|++. +..+|+|+.... ......+. +.+|+.++.++ +||||+++++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA----LMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHH----HHHHHHHHHhcccCCCeeeEEE
Confidence 467999999999999999999862 356777775422 22233333 48999999999 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 945 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~yLH 945 (1141)
++...+. ..++||||+++++|.+++...... ....+++..++.++.||+.||.|||
T Consensus 99 ~~~~~~~-------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 165 (316)
T 2xir_A 99 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165 (316)
T ss_dssp EECCTTS-------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCC-------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH
Confidence 9875432 249999999999999999762210 0123899999999999999999999
Q ss_pred HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 946 s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
++||+||||||+||+++.+ +.+||+|||+++........ .......||+.|+|||++.+ ..
T Consensus 166 ~~~i~H~dikp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~ 226 (316)
T 2xir_A 166 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 226 (316)
T ss_dssp HTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTS--------EEETTEEECGGGCCHHHHHH----CC
T ss_pred hCCcccccCccceEEECCC-------CCEEECCCccccccccCccc--------eeccCCCcceeecCchhhcc----cc
Confidence 9999999999999999887 78999999999765432111 01123457889999999976 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLT-LQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1141)
++.++|||||||++|+|++ |..||.+.... .....+..+.....+. ..++.
T Consensus 227 ~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 279 (316)
T 2xir_A 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 279 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCC---------------------------CCCHH
Confidence 8899999999999999998 99999765432 3344444433222111 34567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+++.+||+.||.+|||+.|+++++...
T Consensus 280 l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 280 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=337.85 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=200.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|.+. +..+|+|+..... +.+ .+|+.++++++||||+++++++.....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKA----EREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGG----HHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHH----HHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 46899999999999999999985 6778888765321 123 689999999999999999998865221
Q ss_pred CCCCC--CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 884 LPSAD--GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 884 ~~~~~--g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.+... ..........++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 10000 00001233579999999999999999862 23469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 156 ~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 156 VDT-------KQVKIGDFGLVTSLKNDG-----------KRTRSKGTLRYMSPEQISS----QDYGKEVDLYALGLILAE 213 (284)
T ss_dssp EET-------TEEEECCCTTCEESSCCS-----------CCCCCCSCCTTSCHHHHHC----SCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECcchhheeccccc-----------cccccCCcccccChhhhcc----CCCcchhhhHHHHHHHHH
Confidence 987 789999999987654321 1123458999999999976 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|..||.. .......+.....+ ...+..+.+++.+||+.||.+|||
T Consensus 214 l~~~~~~~~~--~~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rps 261 (284)
T 2a19_B 214 LLHVCDTAFE--TSKFFTDLRDGIIS------------------------------DIFDKKEKTLLQKLLSKKPEDRPN 261 (284)
T ss_dssp HHSCCSSHHH--HHHHHHHHHTTCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhcCCcchh--HHHHHHHhhccccc------------------------------ccCCHHHHHHHHHHccCChhhCcC
Confidence 9999988742 12222222221110 034456899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001143 1122 AGDLYEMFVARTSS 1135 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s 1135 (1141)
+.|++++++....+
T Consensus 262 ~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 262 TSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHHHHHHTC-
T ss_pred HHHHHHHHHHHhhC
Confidence 99999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=336.86 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=200.8
Q ss_pred CceEeeeecccCceEEEEEEECC--c---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFGS--A---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~~--~---~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.|.+.++||+|+||+||+|.+.. . .+|+|+. .. .......+.+ .+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~--~~-~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEE--TT-CCSHHHHHHH----HHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeec--cc-cccHHHHHHH----HHHHHHHHhCCCCCeeeEEEEEecC
Confidence 46778999999999999998732 2 3566654 32 2223333444 7999999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. ..++||||+.+++|.+++.. ....+++..+..|+.||+.||.|||++||+||||||+||++
T Consensus 95 ~~-------------~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili 157 (298)
T 3pls_A 95 EG-------------LPHVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157 (298)
T ss_dssp SS-------------CCEEEECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC-------------CcEEEEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 32 23899999999999999975 23468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++........ .........+|+.|+|||.+.+ ..++.++||||||+++|+
T Consensus 158 ~~~-------~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 158 DES-------FTVKVADFGLARDILDREYY------SVQQHRHARLPVKWTALESLQT----YRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp CTT-------CCEEECCTTSSCTTTTGGGG------CSCCSSCTTCGGGGSCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeCcCCCcccccCCccc------ccccCcCCCCCccccChhhhcc----CCCChhhchhhHHHHHHH
Confidence 887 78999999999765432211 1112234468899999999976 568899999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++| .+||......+....+........+. ..++.+.+++.+||+.||.+||
T Consensus 221 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 221 LLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE---------------------------YCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp HHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhhCCCCCCccCCHHHHHHHhhcCCCCCCCc---------------------------cchHHHHHHHHHHccCChhhCc
Confidence 9994 55566656655666555444322211 3456799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
|+.++++.+...
T Consensus 274 s~~~ll~~l~~~ 285 (298)
T 3pls_A 274 TFRVLVGEVEQI 285 (298)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999988764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=358.88 Aligned_cols=290 Identities=21% Similarity=0.257 Sum_probs=186.4
Q ss_pred ceE-eeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 808 LSS-CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 808 y~i-~~~LG~GsfG~Vy~a~~~----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
|++ .++||+|+||+||+|++. +..+|+|+.. ..... . .+.+|+.++++++||||+++++++....
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~--~~~~~----~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGIS----M----SACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECS--SSSCC----H----HHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEEC--CCCCC----H----HHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 555 568999999999999974 4567777643 22111 1 2368999999999999999999986532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
. ...++||||++ ++|.+++...... ....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 92 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~N 158 (405)
T 3rgf_A 92 D------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPAN 158 (405)
T ss_dssp T------------TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred C------------CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHH
Confidence 1 25699999997 6898888643321 12259999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||+..+. ...+.+||+|||+|+........ ........||+.|+|||++.+ ...++.++|||||||+
T Consensus 159 Ill~~~~---~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~i 225 (405)
T 3rgf_A 159 ILVMGEG---PERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCI 225 (405)
T ss_dssp EEECCSS---TTTTCEEECCTTCCC-----------------------CCCTTCCHHHHTT---CCSCCHHHHHHHHHHH
T ss_pred eEEecCC---CCCCcEEEEECCCceecCCCCcc-------cccCCCceecCcccCchhhcC---CCcccchhhhHHHHHH
Confidence 9994320 11278999999999765432111 011224569999999999876 2358899999999999
Q ss_pred HHHHHhCCCCCCCCCH---------HHHHHHH-HhCCCCCchhHHhhhccCcccc-cc-ccC-CCCCCch-------hhh
Q 001143 1039 LLELLTLQVPYMGLSE---------LEIHDLI-QMGKRPRLTDELEALGSCHEHE-VA-QSG-SGFEKPE-------AEL 1098 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~---------~el~~~I-~~~~~p~l~~~l~~~~~~~~~~-~~-~~~-~~~~~~~-------~~~ 1098 (1141)
+|+|++|+.||.+... .+....+ .....+.... +.......... .. ... ..+.... ...
T Consensus 226 l~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (405)
T 3rgf_A 226 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD-WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304 (405)
T ss_dssp HHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTT-CGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTC
T ss_pred HHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhh-cchhhcCcchhhhhhhccccCCCcchhhhhHhhcCC
Confidence 9999999999976443 1222222 2222221110 00000000000 00 000 0000000 000
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1099 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1099 ~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
..+..+.+||.+||++||.+|||++|+++|+||...
T Consensus 305 ~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp CTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 124568999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=351.88 Aligned_cols=282 Identities=19% Similarity=0.203 Sum_probs=204.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|.+.+.||+|+||.||+|.+. +..||+|+.. .........+ ++.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAK----RAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEES--STTSSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEec--ccccchHHHH----HHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 57999999999999999999985 5667777643 2222322233 34799999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. ......++||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 98 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 98 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161 (353)
T ss_dssp G--------GGCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT
T ss_pred c--------ccceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC
Confidence 2 12234599999997 68877653 25999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 162 ~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 162 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp T-------CCEEECSTTCTTC---------------------CCSBCCSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeecccccCCCCC-------------ccccccCcCcCCHHHHhC---cCCCCchhhHHHHHHHHHHHH
Confidence 7 78999999999754321 123468999999999875 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|+.||.+.+..+....+.. ...+. ................+ ..............+..+.+||.+||+.||.+|
T Consensus 219 ~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 297 (353)
T 3coi_A 219 TGKTLFKGKDYLDQLTQILKVTGVPG-TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297 (353)
T ss_dssp HSSCSSBSSCHHHHHHHHHHHHCBCC-HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCC-HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccC
Confidence 99999998777666555532 12111 11110000000000000 000000111112567789999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
||+.|+++|+|+..
T Consensus 298 pt~~e~l~hp~f~~ 311 (353)
T 3coi_A 298 LTAAQALTHPFFEP 311 (353)
T ss_dssp CCHHHHHTSGGGTT
T ss_pred CCHHHHhcCcchhh
Confidence 99999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=353.21 Aligned_cols=279 Identities=14% Similarity=0.130 Sum_probs=199.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHh----HHhHHHHHHHHhhCCCCCccc
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNF----EYSCLGEVRMLGALRHSCIVE 873 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~----~~~~~~Ei~iL~~L~HpNIVk 873 (1141)
-.+|++.++||+|+||.||+|.+.. ..+|+|+....... ...+.+.+ ...+..|+..+..++||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4579999999999999999999843 57889886533110 00011100 112346777788889999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 001143 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 953 (1141)
Q Consensus 874 llg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrD 953 (1141)
+++++..... ...+.++||||+ |++|.+++.. ....+++..++.|+.||+.||.|||++||+|||
T Consensus 113 ~~~~~~~~~~----------~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrD 177 (364)
T 3op5_A 113 YWGSGLHDKN----------GKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177 (364)
T ss_dssp EEEEEEEEET----------TEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEeeeeeccC----------CcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEec
Confidence 9999876321 123569999999 8999999976 234699999999999999999999999999999
Q ss_pred CCCCCeeee--cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001143 954 IKSENILID--LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031 (1141)
Q Consensus 954 LKP~NILld--~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1031 (1141)
|||+|||++ .+ +.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|
T Consensus 178 lkp~Nill~~~~~-------~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~D 243 (364)
T 3op5_A 178 IKASNLLLNYKNP-------DQVYLVDYGLAYRYCPEGVHKA---YAADPKRCHDGTIEFTSIDAHNG----VAPSRRGD 243 (364)
T ss_dssp CCGGGEEEESSCT-------TCEEECCCTTCEESSGGGCCCC---SSCCSSCCCCCCTTTCCHHHHTT----CCCCHHHH
T ss_pred CCHHHEEEecCCC-------CeEEEEECCcceecccCCcccc---cccCcccccCCCCCccCHHHhCC----CCCCchhh
Confidence 999999998 44 7899999999987654321110 01111234569999999999986 56899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1032 IWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1032 VWSLGviL~ELLTGk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
||||||++|||++|+.||.+... ............+.+....... .. ....+.++.+++..
T Consensus 244 i~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~----------~~~~~~~~~~li~~ 305 (364)
T 3op5_A 244 LEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKC--------FP----------AANAPGEIAKYMET 305 (364)
T ss_dssp HHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHH--------SC----------TTCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHh--------cc----------cccCHHHHHHHHHH
Confidence 99999999999999999985322 2222222111111111111100 00 01446789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 001143 1111 CTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1111 cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
||..||.+||++.+|++.+..
T Consensus 306 cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 306 VKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHTCCTTCCCCHHHHHHHHHH
T ss_pred HhcCCCCCCCCHHHHHHHHHH
Confidence 999999999999999988754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.41 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=198.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~---~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
...+|++.+.||+|+||+||+|++. +. .+|+|+....... .....+ .+.+|+.++++++||||+++++++
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMD----DFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHH----HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHH----HHHHHHHHHHhCCCCCcccEEEEE
Confidence 3467999999999999999999863 22 3566654322111 112223 348999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.... .++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 91 ~~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 151 (291)
T 1u46_A 91 LTPP---------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 151 (291)
T ss_dssp CSSS---------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ccCC---------------ceeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence 7543 38999999999999999762 2358999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|+++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||++
T Consensus 152 ili~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 213 (291)
T 1u46_A 152 LLLATR-------DLVKIGDFGLMRALPQNDDHY-------VMQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGVT 213 (291)
T ss_dssp EEEEET-------TEEEECCCTTCEECCC-CCEE-------EC-----CCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccccccccccccccch-------hhhccCCCCceeeCchhhcC----CCCCchhhHHHHHHH
Confidence 999887 789999999997654322110 01123457889999999976 457899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++ |+.||.+....+....+......... ....+..+.+++.+||..||.
T Consensus 214 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~ 267 (291)
T 1u46_A 214 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--------------------------PEDCPQDIYNVMVQCWAHKPE 267 (291)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--------------------------CcCcCHHHHHHHHHHccCCcc
Confidence 999999 99999988877776666443221100 014566799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001143 1118 ERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~s 1135 (1141)
+|||+.++++++......
T Consensus 268 ~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 268 DRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp GSCCHHHHHHHHHHHC--
T ss_pred cCcCHHHHHHHHHHhCcc
Confidence 999999999998876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=352.66 Aligned_cols=286 Identities=22% Similarity=0.220 Sum_probs=200.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--------CCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--------HSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--------HpNIVkl 874 (1141)
..+|++.++||+|+||+||+|++. +..||+|+... .....+ .+.+|+.++++++ ||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTE----TALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHH----HHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchH----HHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 367999999999999999999984 56677877531 122223 3478999999885 7889999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccC
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRD 953 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrD 953 (1141)
++++..... ...+.++||||+ +++|.+++.. .....+++..++.|+.||+.||.|||++ ||+|||
T Consensus 107 ~~~~~~~~~----------~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrD 172 (397)
T 1wak_A 107 LDDFKISGV----------NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTD 172 (397)
T ss_dssp EEEEEEEET----------TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCC
T ss_pred ecceeecCC----------CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 999874211 123569999999 5777777765 2334699999999999999999999998 999999
Q ss_pred CCCCCeeeecccc------------------------------------------cCCCCCeEEEeeccccccccccccc
Q 001143 954 IKSENILIDLERK------------------------------------------KADGKPVVKLCDFDRAVPLRSFLHT 991 (1141)
Q Consensus 954 LKP~NILld~~~~------------------------------------------~~~~~~~vKL~DFGlA~~l~~~~~~ 991 (1141)
|||+|||++.++. .......+||+|||.+......
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--- 249 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--- 249 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---
Confidence 9999999986520 0001137999999999765431
Q ss_pred cccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH-HhC
Q 001143 992 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLI-QMG 1064 (1141)
Q Consensus 992 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~------~~el~~~I-~~~ 1064 (1141)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+ ..+....+ ...
T Consensus 250 ----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 315 (397)
T 1wak_A 250 ----------FTEDIQTRQYRSLEVLIG----SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315 (397)
T ss_dssp ----------SCSCCSCGGGCCHHHHHT----SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH
T ss_pred ----------CccCCCCCcccCChhhcC----CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc
Confidence 123468999999999986 568899999999999999999999997543 22222222 111
Q ss_pred CCCCchhHHhhhccCcccccccc-----CCCCCC----------chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001143 1065 KRPRLTDELEALGSCHEHEVAQS-----GSGFEK----------PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129 (1141)
Q Consensus 1065 ~~p~l~~~l~~~~~~~~~~~~~~-----~~~~~~----------~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L 1129 (1141)
..++.. ...........+... ...... .......+..+.+||.+||+.||++|||+.|+++|+
T Consensus 316 ~~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 316 GKVPRK--LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CSCCHH--HHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred CCCChH--HhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 111111 000000000000000 000000 011235677899999999999999999999999999
Q ss_pred Hhh
Q 001143 1130 VAR 1132 (1141)
Q Consensus 1130 ~~~ 1132 (1141)
|+.
T Consensus 394 ~~~ 396 (397)
T 1wak_A 394 WLN 396 (397)
T ss_dssp GGG
T ss_pred ccc
Confidence 986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.33 Aligned_cols=287 Identities=19% Similarity=0.209 Sum_probs=211.9
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHH---------HHHhHHhHHHHHHHHhhCCCCCccc
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE---------IRNFEYSCLGEVRMLGALRHSCIVE 873 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~---------~~~~~~~~~~Ei~iL~~L~HpNIVk 873 (1141)
....+|++.+.||+|+||.||+|.+.+..+|+|+............ .......+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 3467899999999999999999999888999998764422111000 0000033489999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHh---hhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q 001143 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL---SETGEKHVSVKLALFIAQDVAAALVELHS-KHI 949 (1141)
Q Consensus 874 llg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~---~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gI 949 (1141)
+++++.+.+ ..++||||+++++|.+++... .......+++..++.++.||+.||.|||+ +||
T Consensus 108 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i 173 (348)
T 2pml_X 108 CEGIITNYD--------------EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI 173 (348)
T ss_dssp CSEEEESSS--------------EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCE
T ss_pred EEEEEeeCC--------------eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCE
Confidence 999998654 459999999999999883210 01224579999999999999999999999 999
Q ss_pred cccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCc-
Q 001143 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL- 1028 (1141)
Q Consensus 950 vHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~- 1028 (1141)
+||||||+||+++.+ +.+||+|||.+....... .....||+.|+|||++.+. ..++.
T Consensus 174 ~H~dl~p~Nil~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~---~~~~~~ 231 (348)
T 2pml_X 174 CHRDVKPSNILMDKN-------GRVKLSDFGESEYMVDKK------------IKGSRGTYEFMPPEFFSNE---SSYNGA 231 (348)
T ss_dssp ECCCCCGGGEEECTT-------SCEEECCCTTCEECBTTE------------ECSSCSCGGGCCGGGGSSC---CCEEHH
T ss_pred eecCCChHhEEEcCC-------CcEEEecccccccccccc------------ccCCCCCcCccCchhhcCC---CCCCcc
Confidence 999999999999887 789999999997654321 1234689999999998762 24445
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 001143 1029 EVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLTGk~Pf~~~~~-~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|||||||++|+|++|..||..... .+....+..+.... +..... .................+..+.+|
T Consensus 232 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~l 302 (348)
T 2pml_X 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY-PLDRNH--------FLYPLTNKKSTCSNNFLSNEDIDF 302 (348)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCC-CCSSSS--------STTTTCC--------CCCHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCC-ccchhh--------hhccccccccccchhhcCHHHHHH
Confidence 99999999999999999999987655 55666665443221 100000 000000000001112566789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
+.+||+.||.+|||+.|+++|+|+...
T Consensus 303 i~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 303 LKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHccCChhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=344.23 Aligned_cols=270 Identities=22% Similarity=0.323 Sum_probs=198.0
Q ss_pred ceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 808 LSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
|++.++||+|+||+||++.+ .+..+|+|+.... ......+. +.+|+.++++++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSG----WKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHH----HHHHHHHHHhCCCcchhhEEEEEecC
Confidence 49999999999999999876 4567888876432 22233333 48999999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. ...++||||+++++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||++
T Consensus 106 ~~------------~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~ 167 (318)
T 3lxp_A 106 GA------------ASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167 (318)
T ss_dssp TT------------TEEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC------------ceEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence 31 256999999999999999865 249999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 168 ~~~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 168 DND-------RLVKIGDFGLAKAVPEGHEYY-------RVREDGDSPVFWYAPECLKE----YKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp CTT-------CCEEECCGGGCEECCTTCSEE-------EC---CCCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECCcccccccccccccc-------ccccCCCCCceeeChHHhcC----CCCCcHHHHHHHHHHHHH
Confidence 887 789999999998764422110 01123458889999999986 457799999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|..||..... ....... .... ....... ........... ....++..+.+|+.+||+.||.+|||
T Consensus 230 ll~g~~p~~~~~~-~~~~~~~-~~~~--~~~~~~~-----~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps 297 (318)
T 3lxp_A 230 LLTHCDSSQSPPT-KFLELIG-IAQG--QMTVLRL-----TELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPT 297 (318)
T ss_dssp HHTTTCGGGSHHH-HHHHHHC-SCCH--HHHHHHH-----HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhCCCcccccch-hhhhhhc-cccc--chhHHHH-----HHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcC
Confidence 9999999975221 1111110 0000 0000000 00000000000 11256678999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001143 1122 AGDLYEMFVAR 1132 (1141)
Q Consensus 1122 a~ElL~~L~~~ 1132 (1141)
+.|+++.+...
T Consensus 298 ~~ell~~L~~l 308 (318)
T 3lxp_A 298 FENLIPILKTV 308 (318)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999887654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=349.27 Aligned_cols=269 Identities=22% Similarity=0.307 Sum_probs=206.1
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.....+|++.+.||+|+||.||+|.+.+ .+++|+..... ......+.+ .+|+.++++++||||+++++++.+.
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~--~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIER--DNEDQLKAF----KREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCS--CCCCCCCCC----CTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCC--CCHHHHHHH----HHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3457889999999999999999999876 47888754432 222222333 6899999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. .++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 102 ~~--------------~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~ 163 (319)
T 2y4i_B 102 PH--------------LAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY 163 (319)
T ss_dssp SC--------------EEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE
T ss_pred Cc--------------eEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE
Confidence 53 4999999999999999864 23468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-----CCCCCCchhhHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-----KPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-----~~~~~s~ksDVWSLG 1036 (1141)
+ + +.+||+|||++......... ..........||+.|+|||++.+.. ....++.++||||||
T Consensus 164 ~-~-------~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG 230 (319)
T 2y4i_B 164 D-N-------GKVVITDFGLFSISGVLQAG-----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230 (319)
T ss_dssp C----------CCEECCCSCCC---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH
T ss_pred e-C-------CCEEEeecCCcccccccccc-----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH
Confidence 7 3 67999999998754322111 0111223445899999999987522 123578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|++|+|++|+.||......+....+..+..+.... ...+..+.+++.+||..||
T Consensus 231 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 231 TIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------------------------IGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp HHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC--------------------------SSCCTTHHHHHHHHHCSST
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc--------------------------CCCCHHHHHHHHHHhcCCh
Confidence 99999999999999887777776665554433211 0234458999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
.+|||+.++++.+.....
T Consensus 285 ~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 285 EERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TTSCCHHHHHHHHTTC--
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=345.45 Aligned_cols=295 Identities=19% Similarity=0.217 Sum_probs=198.0
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
+...+++|++.+.||+|+||.||+|++.+..||+|++.... ...+ ....|+..+..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~--~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-------RQNF--INEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-------HHHH--HHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-------hhhH--HHHHHHHHHHhccCcchhhheecccc
Confidence 34568899999999999999999999999999999875321 1122 01234444456799999999987654
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------Cccc
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMH 951 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---------gIvH 951 (1141)
... ......++||||+++|+|.+++.. ...++..+..|+.||+.||.|||++ ||+|
T Consensus 79 ~~~---------~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH 143 (336)
T 3g2f_A 79 VTA---------DGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISH 143 (336)
T ss_dssp ECT---------TSCEEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEEC
T ss_pred ccc---------CCCceEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceee
Confidence 221 112356899999999999999976 2468999999999999999999999 9999
Q ss_pred cCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC---CCCCc
Q 001143 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGL 1028 (1141)
Q Consensus 952 rDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~---~~~s~ 1028 (1141)
|||||+|||++.+ +.+||+|||+++.+......... ..........||+.|+|||++.+.... ..++.
T Consensus 144 ~Dikp~Nill~~~-------~~~kL~DFG~a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 144 RDLNSRNVLVKND-------GTCVISDFGLSMRLTGNRLVRPG--EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp SSCSGGGEEECTT-------SCEEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred cccccceEEEcCC-------CcEEEeeccceeecccccccCcc--ccccccccCCCccceeCchhhcCCccccccccccc
Confidence 9999999999887 78999999999865432211000 001112244699999999998752110 23557
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCH-HH--HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 001143 1029 EVDIWSYGCLLLELLTLQVPYMGLSE-LE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1105 (1141)
Q Consensus 1029 ksDVWSLGviL~ELLTGk~Pf~~~~~-~e--l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1105 (1141)
++|||||||++|||++|..||..... .+ ..........+............ .........+. .....++.+.
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~l~ 289 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE--KQRPKFPEAWK---ENSLAVRSLK 289 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS--CCCCCCCTTCC---CCSHHHHHHH
T ss_pred ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccc--ccCCCCCcccc---cccchHHHHH
Confidence 89999999999999999776643211 00 00000111111111100000000 00000000000 0124677899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1106 DVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1106 dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+||.+||+.||.+|||+.|+++.+....
T Consensus 290 ~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 290 ETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 9999999999999999999999887653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.41 Aligned_cols=278 Identities=21% Similarity=0.293 Sum_probs=196.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++. +..+|+|+.... ....+. +.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLST----ILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHH----HHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 36899999999999999999984 667888875421 222333 4799999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+... -.........++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 77 ~~~~-~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 77 FVKP-MTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCC-------CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hhhh-hcccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 1000 0011123467999999999999999985 2346889999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccc----cCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~----~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+ +.+||+|||.+............. ...........||+.|+|||++.+ ...++.++|||||||++
T Consensus 152 ~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 152 S-------RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG---TGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp T-------SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS---CSCCCTHHHHHHHHHHH
T ss_pred C-------CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC---CCCCcchhhHHHHHHHH
Confidence 7 789999999997654321100000 000111234568999999999875 23578999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|+|++ ||... ...+....+..... .++ +......+..+.+++.+||+.||.+
T Consensus 222 ~~l~~---p~~~~~~~~~~~~~~~~~~~-~~~-----------------------~~~~~~~~~~~~~li~~~l~~dp~~ 274 (303)
T 1zy4_A 222 FEMIY---PFSTGMERVNILKKLRSVSI-EFP-----------------------PDFDDNKMKVEKKIIRLLIDHDPNK 274 (303)
T ss_dssp HHHHS---CCSSHHHHHHHHHHHHSTTC-CCC-----------------------TTCCTTTSHHHHHHHHHHTCSSGGG
T ss_pred HHHHh---ccCCchhHHHHHHhcccccc-ccC-----------------------ccccccchHHHHHHHHHHHhcCccc
Confidence 99998 56432 22223333332211 111 0011145567899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
|||+.++++|+|+...
T Consensus 275 Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 275 RPGARTLLNSGWLPVK 290 (303)
T ss_dssp SCCHHHHHHSSCSCCC
T ss_pred CcCHHHHhCCCCcCCC
Confidence 9999999999999643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.51 Aligned_cols=263 Identities=24% Similarity=0.263 Sum_probs=195.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 802 ~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
...+.+|++.+.||+|+||.||+|.+. +..+|+|+..... .. .......+.+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~---~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--SS---DPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--GG---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--cc---CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 345789999999999999999999985 5567777643221 11 1122334589999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
..+ ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 105 ~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI 165 (309)
T 2h34_A 105 IDG--------------QLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165 (309)
T ss_dssp ETT--------------EEEEEEECCCCEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eCC--------------eEEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence 655 34999999999999999986 23699999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 166 l~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 225 (309)
T 2h34_A 166 LVSAD-------DFAYLVDFGIASATTDEKLT---------QLGNTVGTLYYMAPERFSE----SHATYRADIYALTCVL 225 (309)
T ss_dssp EECTT-------SCEEECSCCC-------------------------CCGGGCCGGGTCC--------CCCHHHHHHHHH
T ss_pred EEcCC-------CCEEEecCccCccccccccc---------cccccCCCcCccCHHHHcC----CCCCchHhHHHHHHHH
Confidence 99887 78999999998765432111 1123468999999999876 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1040 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|+|++|+.||.+.....+...+.... +.... .....+..+.+++.+||+.||.+|
T Consensus 226 ~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~R 280 (309)
T 2h34_A 226 YECLTGSPPYQGDQLSVMGAHINQAI-PRPST------------------------VRPGIPVAFDAVIARGMAKNPEDR 280 (309)
T ss_dssp HHHHHSSCSSCSCHHHHHHHHHHSCC-CCGGG------------------------TSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCCCCCCCchHHHHHHHhccCC-CCccc------------------------cCCCCCHHHHHHHHHhccCCHHHH
Confidence 99999999998765543333333221 11100 011455679999999999999999
Q ss_pred C-CHHHHHHHHHhhc
Q 001143 1120 P-TAGDLYEMFVART 1133 (1141)
Q Consensus 1120 P-Sa~ElL~~L~~~~ 1133 (1141)
| +++++++.+....
T Consensus 281 p~s~~~l~~~l~~~l 295 (309)
T 2h34_A 281 YVTCGDLSAAAHAAL 295 (309)
T ss_dssp CSSHHHHHHHHHHTC
T ss_pred HHhHHHHHHHHHHHH
Confidence 9 9999999887653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=370.03 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=208.3
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
...+|++.++||+|+||.||+|.+.+ ..||+|+.+.. ... .+.+ .+|+.+|++++||||+++++++.+ .
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~---~~~~----~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEAF----LQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT--SSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC--CCC---HHHH----HHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 34569999999999999999999965 46888875432 111 2233 799999999999999999999864 2
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .+|||||+++|+|.++++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 335 ~--------------~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 397 (535)
T 2h8h_A 335 P--------------IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 397 (535)
T ss_dssp S--------------CEEEECCCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred c--------------ceEeeehhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc
Confidence 2 399999999999999997521 23589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||
T Consensus 398 ~~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlGv~l~el 457 (535)
T 2h8h_A 398 EN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTEL 457 (535)
T ss_dssp GG-------GCEEECCTTSTTTCCCHHHH---------TTCSTTSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEcccccceecCCCcee---------cccCCcCcccccCHHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 87 78999999999765432111 1112346789999999986 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++ |+.||.+....++...+..+.....+. .++..+.+||.+||+.||++|||
T Consensus 458 ~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RPt 510 (535)
T 2h8h_A 458 TTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPT 510 (535)
T ss_dssp TTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhHCcC
Confidence 99 999999888888777776554332211 45667999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001143 1122 AGDLYEMFVARTS 1134 (1141)
Q Consensus 1122 a~ElL~~L~~~~~ 1134 (1141)
+.+|++.+.....
T Consensus 511 ~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 511 FEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHHTSSC
T ss_pred HHHHHHHHHHHhh
Confidence 9999998876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=343.40 Aligned_cols=283 Identities=18% Similarity=0.193 Sum_probs=202.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCC------cccee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC------IVEMY 875 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN------IVkll 875 (1141)
..+|++.+.||+|+||+||+|.+.. ..||+|+... .....+. +.+|+.++++++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~----~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREA----ARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHH----HHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhH----HHHHHHHHHHHhhcCCCCceeEEEee
Confidence 4679999999999999999999842 4688887542 1222233 378999999887655 88888
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLK 955 (1141)
+++.... +.++||||+ +++|.+++.. .....+++..++.|+.||+.||.|||++||+|||||
T Consensus 89 ~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk 150 (355)
T 2eu9_A 89 DWFNFHG--------------HMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150 (355)
T ss_dssp EEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred eeeeeCC--------------eEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 8887654 459999999 5778777765 233469999999999999999999999999999999
Q ss_pred CCCeeeecccc------------cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC
Q 001143 956 SENILIDLERK------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1141)
Q Consensus 956 P~NILld~~~~------------~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1023 (1141)
|+|||++.... .....+.+||+|||+++..... .....||+.|+|||++.+
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~---- 213 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-------------HTTIVATRHYRPPEVILE---- 213 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-------------CCSSCSCGGGCCHHHHTT----
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-------------ccCCcCCCcccCCeeeec----
Confidence 99999943210 0011278999999999753321 123468999999999976
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCC----------
Q 001143 1024 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---------- 1093 (1141)
Q Consensus 1024 ~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---------- 1093 (1141)
..++.++|||||||++|+|++|..||......+....+.....+........... ...+......+..
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 291 (355)
T 2eu9_A 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK--QKYFYKGGLVWDENSSDGRYVKE 291 (355)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccc--hhhhcccccccccccchhccccc
Confidence 5688999999999999999999999998777665554433222211111111000 0000000000000
Q ss_pred --------chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1094 --------PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1094 --------~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.......+..+.+||.+||+.||++|||+.|+++|+|+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp HCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred cCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcC
Confidence 0001134668999999999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=342.90 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=203.2
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhh--CCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++.+..+|+|++... .... +.+|++++.. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~----~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERS----WFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-------GHHH----HHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-------hHHH----HHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 46999999999999999999999999999986421 1222 3678888877 689999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCC
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDIK 955 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--------s~gIvHrDLK 955 (1141)
.....++||||+++++|.+++.+ ..+++..++.++.||+.||.||| ++||+|||||
T Consensus 111 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 111 ----------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp ----------SCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred ----------ccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 12256999999999999999976 35999999999999999999999 8999999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC--CCCchhhHH
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDIW 1033 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksDVW 1033 (1141)
|+|||++.+ +.+||+|||++........... .......||+.|+|||++.+..... .++.++|||
T Consensus 175 p~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~ 241 (342)
T 1b6c_B 175 SKNILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241 (342)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHH
T ss_pred HHHEEECCC-------CCEEEEECCCceeccccccccc------cccccCCcCcccCCHhhhcccccccccccCCcccHH
Confidence 999999887 7899999999976544221100 0122446999999999997632111 233789999
Q ss_pred HHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1034 SYGCLLLELLTL----------QVPYMGL-----SELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1034 SLGviL~ELLTG----------k~Pf~~~-----~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
||||++|+|++| ..||... ....+...+.. ...+.++..+ ..
T Consensus 242 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 299 (342)
T 1b6c_B 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QS 299 (342)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GT
T ss_pred HHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc----------------------cc
Confidence 999999999999 7888653 22333333322 2222222111 11
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
...++.+.+|+.+||+.||.+|||+.++++++....
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 300 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 256778999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=370.32 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=198.7
Q ss_pred CCceEee-eecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 806 PSLSSCD-EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 806 ~~y~i~~-~LG~GsfG~Vy~a~~~----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.++.+.+ +||+|+||.||+|.+. +..||+|+. +... .....+.+ .+|+.+|++++|||||++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~--~~~~-~~~~~~~~----~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGT-EKADTEEM----MREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEEC--CCCC-SSTTHHHH----HHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEc--CCCC-ChHHHHHH----HHHHHHHHhCCCCCEeeEEEEecc
Confidence 4456666 8999999999999873 334666664 3221 11223334 899999999999999999999874
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
+ ..++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 408 ~---------------~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 408 E---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp S---------------SEEEEEECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C---------------CeEEEEEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 2 24999999999999999864 2346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++.+....... .......+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 469 l~~~-------~~vkL~DFGla~~~~~~~~~~-------~~~~~~~~~~~y~APE~~~~----~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 469 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp EEET-------TEEEECCCSTTTTCC---------------------CCTTSCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEEeeccCcccccCCCcee-------eeccCCCCccceeCHhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9987 889999999997654322110 01112346789999999976 57889999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
||++ |+.||.+....++...+..+..+..+. .+++++.+||.+||+.||++|
T Consensus 531 ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp HHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSTTTS
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHC
Confidence 9998 999999888888887776665433221 456779999999999999999
Q ss_pred CCHHHHHHHHH
Q 001143 1120 PTAGDLYEMFV 1130 (1141)
Q Consensus 1120 PSa~ElL~~L~ 1130 (1141)
|++.+|++.+.
T Consensus 584 Ps~~~l~~~L~ 594 (613)
T 2ozo_A 584 PDFLTVEQRMR 594 (613)
T ss_dssp CCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99999976653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=349.09 Aligned_cols=281 Identities=20% Similarity=0.255 Sum_probs=203.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CC-----Cccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HS-----CIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----NIVkllg 876 (1141)
..+|++.++||+|+||+||+|.+. +..||+|+... ...... .+..|+.+++.++ |+ +|+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~----~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLN----QAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHH----HHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHH----HHHHHHHHHHHHHhcccccceeEEEeee
Confidence 578999999999999999999985 55677777542 122222 3367888888885 55 4899999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDI 954 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--s~gIvHrDL 954 (1141)
++.... +.++||||++ ++|.+++.. .....+++..++.++.||+.||.||| +.||+||||
T Consensus 124 ~~~~~~--------------~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl 185 (382)
T 2vx3_A 124 HFMFRN--------------HLCLVFEMLS-YNLYDLLRN---TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185 (382)
T ss_dssp EEEETT--------------EEEEEEECCC-CBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred eeccCC--------------ceEEEEecCC-CCHHHHHhh---cCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence 988654 4599999996 699999986 22346999999999999999999999 579999999
Q ss_pred CCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001143 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034 (1141)
Q Consensus 955 KP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1034 (1141)
||+|||++.+.. +.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||
T Consensus 186 kp~NIll~~~~~-----~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwS 243 (382)
T 2vx3_A 186 KPENILLCNPKR-----SAIKIVDFGSSCQLGQR-------------IYQYIQSRFYRSPEVLLG----MPYDLAIDMWS 243 (382)
T ss_dssp SGGGEEESSTTS-----CCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHTT----CCCCTHHHHHH
T ss_pred CcccEEEecCCC-----CcEEEEeccCceecccc-------------cccccCCccccChHHHcC----CCCCcHHHHHH
Confidence 999999964321 78999999999765321 123468999999999986 56889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhcc-------Cccccc-----cccCCCCCCc--------
Q 001143 1035 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-------CHEHEV-----AQSGSGFEKP-------- 1094 (1141)
Q Consensus 1035 LGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~-------~~~~~~-----~~~~~~~~~~-------- 1094 (1141)
|||++|||++|+.||.+.+..+....+................. .....+ ......+..+
T Consensus 244 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (382)
T 2vx3_A 244 LGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNI 323 (382)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHH
Confidence 99999999999999998887776666633222221111111000 000000 0000000000
Q ss_pred ----------------hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1095 ----------------EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1095 ----------------~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
.......+.+.+||.+||++||++|||++|+++|+|+...
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 324 LGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0011234579999999999999999999999999999754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.97 Aligned_cols=263 Identities=17% Similarity=0.160 Sum_probs=194.7
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-++|++.+.||+|+||.||+|++ .+..+|+|+...... ... +.+|+.+++.++|++++..+..+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~----~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQ----LHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCC----HHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chH----HHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 36799999999999999999997 466788887543321 112 378999999999888887777664422
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee-
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI- 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl- 961 (1141)
...++||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 78 -------------~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 78 -------------DYNVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp -------------TEEEEEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred -------------CceEEEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 1459999999 89999999752 3469999999999999999999999999999999999999
Q ss_pred --ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 962 --DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 962 --d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
+.+ +.+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++
T Consensus 140 ~~~~~-------~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 140 LGKKG-------NLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVL 205 (296)
T ss_dssp CGGGT-------TCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCGGGCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred ccCCC-------CeEEEecCccceeccCcccCcc---CCCCcccccCCCccccchHHhcC----CCCCchhHHHHHHHHH
Confidence 444 7899999999987654322110 01112234579999999999986 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHH---HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1040 LELLTLQVPYMGLSEL---EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~~---el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|+|++|+.||.+.... +....+.....+... +......++.+.+++.+||+.||
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p 262 (296)
T 4hgt_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCT
T ss_pred HHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----------------------hhhhccCCHHHHHHHHHHHhcCC
Confidence 9999999999764321 112221111000000 00011446789999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
++|||+.++++.+...
T Consensus 263 ~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 263 DDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TCCCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHH
Confidence 9999999999887553
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=346.27 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=183.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHhhCCCCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkllg~~~ 879 (1141)
...++|++.+.||+|+||.||+|.+. +..||+|+.... . .......+ ..|+. +++.++||||+++++++.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~-~~~~~~~~----~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--V-DEKEQKQL----LMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC--C-CHHHHHHH----HHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc--c-CchHHHHH----HHHHHHHHHcCCCCcEeeeeeEEE
Confidence 34678999999999999999999985 667888876432 1 22222222 45665 667779999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSEN 958 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~N 958 (1141)
..+ ..++||||++ ++|.+++..........+++..+..++.|++.||.|||++ ||+||||||+|
T Consensus 92 ~~~--------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~N 156 (327)
T 3aln_A 92 REG--------------DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156 (327)
T ss_dssp CSS--------------EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGG
T ss_pred eCC--------------ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHH
Confidence 654 3499999998 5898888754444456799999999999999999999999 99999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||++........ .....||+.|+|||++........++.++|||||||+
T Consensus 157 Ill~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 157 ILLDRS-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp EEEETT-------TEEEECCCSSSCC-----------------------------------------CCSHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccCCCceecccccc-----------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 999887 8899999999976543211 1123589999999998532223567899999999999
Q ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++|+.||...... +....+..+..+.+.. ......+..+.+|+.+||+.||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~ 275 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN-----------------------SEEREFSPSFINFVNLCLTKDES 275 (327)
T ss_dssp HHHHHHSCCCSSCC-------CCCCCSCCCCCCC-----------------------CSSCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC-----------------------cccccCCHHHHHHHHHHhhCChh
Confidence 99999999999764321 1111111111111100 00014567799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001143 1118 ERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~ 1133 (1141)
+|||+.++++|+|+..
T Consensus 276 ~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 276 KRPKYKELLKHPFILM 291 (327)
T ss_dssp GSCCHHHHTTSHHHHH
T ss_pred hCcCHHHHHhChHHHH
Confidence 9999999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=372.44 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=199.0
Q ss_pred eeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
++||+|+||.||+|.+. +..||||+.+.. .......+ .+.+|+.++++++|||||++++++....
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 443 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKD----ELLAEANVMQQLDNPYIVRMIGICEAES----- 443 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGG--GGCGGGHH----HHHHHHHHHHHCCCTTBCCEEEEEESSS-----
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccc--cCCHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEecCC-----
Confidence 48999999999999762 356788875432 11222223 3489999999999999999999986432
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.++||||+++|+|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 444 ----------~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~--- 505 (635)
T 4fl3_A 444 ----------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 505 (635)
T ss_dssp ----------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---
T ss_pred ----------EEEEEEccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---
Confidence 3899999999999999976 3469999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 1046 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk 1046 (1141)
+.+||+|||+++.+....... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |+
T Consensus 506 ----~~~kL~DFGla~~~~~~~~~~-------~~~~~~~~t~~y~APE~~~~----~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 506 ----HYAKISDFGLSKALRADENYY-------KAQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp ----TEEEECCTTHHHHTTC--------------------CGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----CCEEEEEcCCccccccCcccc-------ccccCCCCceeeeChhhhcC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 789999999998654322110 01123346889999999976 568899999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL 1126 (1141)
.||.+....++...+..+..+..+. .+++++.+||.+||+.||++||++.+|+
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~~l~ 623 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 623 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999988888888777665443321 4566799999999999999999999999
Q ss_pred HHHHh
Q 001143 1127 EMFVA 1131 (1141)
Q Consensus 1127 ~~L~~ 1131 (1141)
+.+..
T Consensus 624 ~~L~~ 628 (635)
T 4fl3_A 624 LRLRN 628 (635)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=334.05 Aligned_cols=263 Identities=17% Similarity=0.160 Sum_probs=197.6
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-++|++.+.||+|+||.||+|++ .+..+|+|+...... . +. +.+|+.+++.++|++++..+.++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~----~~----~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--H----PQ----LHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--C----CH----HHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--h----hH----HHHHHHHHHHhhcCCCCCccccccCCC
Confidence 46799999999999999999997 567788887543321 1 12 378999999999888777776664322
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
...++||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 78 -------------~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 78 -------------DYNVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp -------------TEEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred -------------CceEEEEEec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 1459999999 89999999752 34699999999999999999999999999999999999995
Q ss_pred ---cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 963 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 963 ---~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
.+ +.+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++
T Consensus 140 ~~~~~-------~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 140 LGKKG-------NLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVL 205 (296)
T ss_dssp CGGGT-------TCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred cCCCC-------CeEEEeeCCCcccccccccccc---cccccccccccccccCChhhhcC----CCCCcchhhHHHHHHH
Confidence 33 7899999999987654322110 01112235579999999999986 5688999999999999
Q ss_pred HHHHhCCCCCCCCCH---HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1040 LELLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|+|++|+.||.+... .+....+......... +......++.+.+++.+||+.||
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp 262 (296)
T 3uzp_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCT
T ss_pred HHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----------------------HHHHhhCCHHHHHHHHHHHhcCc
Confidence 999999999976322 1122222111000000 00011456779999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
.+|||+.++++.+...
T Consensus 263 ~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 263 DDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TCCCCHHHHHHHHHHH
T ss_pred CcCCCHHHHHHHHHHH
Confidence 9999999999887654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=338.09 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=195.7
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkllg~~~~~~ 882 (1141)
.+|++.+.||+|+||.||+|.+. +..+|+|+..... ......+.+ .+|+.++.+++ ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~----~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHHH----HHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHHH----HHHHHHHHhccccCCceEEEEEEeecCC
Confidence 45999999999999999999874 5668888865432 233333444 89999999996 699999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 --------------~~~lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 102 --------------YIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 161 (313)
T ss_dssp --------------EEEEEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred --------------EEEEEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE
Confidence 3599999 457899999986 34689999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1035 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVWSL 1035 (1141)
. +.+||+|||++......... .......||+.|+|||++.+.. ....++.++|||||
T Consensus 162 ~--------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 162 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp T--------TEEEECCCSSSCC----------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred C--------CeEEEeeccccccccCcccc--------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 4 68999999999765432111 1112346899999999987521 11367899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHHh-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1036 GCLLLELLTLQVPYMGLSEL-EIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~~~-el~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
||++|+|++|+.||...... .....+.. ......+ ...+..+.+++.+||+
T Consensus 226 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~ 278 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 278 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc---------------------------ccchHHHHHHHHHHcc
Confidence 99999999999999764322 22222211 1111000 0234578999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCC
Q 001143 1114 ENPTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~~~s 1135 (1141)
.||.+|||+.|+++|+|+....
T Consensus 279 ~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 279 RDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp SSTTTSCCHHHHHTSHHHHCC-
T ss_pred CCcccCcCHHHHhcCccccCCC
Confidence 9999999999999999998654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=345.81 Aligned_cols=288 Identities=18% Similarity=0.234 Sum_probs=202.8
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----------CCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSC 870 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpN 870 (1141)
...+|++.+.||+|+||+||+|++ .+..+|+|+... .....+. +.+|+.+++++. |||
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~----~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEA----AEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHH----HHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----Cccchhh----hhHHHHHHHHhhcccccchhccccch
Confidence 456899999999999999999997 466778887542 1222233 378999988886 899
Q ss_pred ccceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q 001143 871 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HI 949 (1141)
Q Consensus 871 IVkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gI 949 (1141)
|+++++++..... .....++||||+ +++|.+++... ....+++..+..|+.||+.||.|||++ ||
T Consensus 88 i~~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~i 153 (373)
T 1q8y_A 88 ILKLLDHFNHKGP----------NGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCGI 153 (373)
T ss_dssp BCCCCEEEEEEET----------TEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred HHHHHHHhhccCC----------CCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 9999999876331 123569999999 79999999862 234599999999999999999999998 99
Q ss_pred cccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCch
Q 001143 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1029 (1141)
Q Consensus 950 vHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1029 (1141)
+||||||+|||++.++. ....+.+||+|||++...... .....||+.|+|||++.+ ..++.+
T Consensus 154 vH~Dikp~NIll~~~~~-~~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~----~~~~~~ 215 (373)
T 1q8y_A 154 IHTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEH-------------YTNSIQTREYRSPEVLLG----APWGCG 215 (373)
T ss_dssp ECSCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBC-------------CCSCCSCGGGCCHHHHHT----CCCCTH
T ss_pred EecCCChHHeEEeccCC-CcCcceEEEcccccccccCCC-------------CCCCCCCccccCcHHHhC----CCCCch
Confidence 99999999999965421 012258999999999765431 113468999999999986 568899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH-HhCCCCCchhHHhhhccCc-----cccccccCCCCC-----
Q 001143 1030 VDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLI-QMGKRPRLTDELEALGSCH-----EHEVAQSGSGFE----- 1092 (1141)
Q Consensus 1030 sDVWSLGviL~ELLTGk~Pf~~~~------~~el~~~I-~~~~~p~l~~~l~~~~~~~-----~~~~~~~~~~~~----- 1092 (1141)
+|||||||++|+|++|+.||.+.. ..+....+ .....++ ..+....... ............
T Consensus 216 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (373)
T 1q8y_A 216 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP--SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 293 (373)
T ss_dssp HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC--HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCC--HHHHhccchhhhhcCCcchhcccccccccchh
Confidence 999999999999999999997543 22222222 1111111 1110000000 000000000000
Q ss_pred -----CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1093 -----KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1093 -----~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
........+.++.+||.+||+.||.+|||+.|+++|+|+...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 000113567889999999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=346.73 Aligned_cols=280 Identities=13% Similarity=0.089 Sum_probs=196.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCCh-HHHHH----hHHhHHHHHHHHhhCCCCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSA-DEIRN----FEYSCLGEVRMLGALRHSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-----~~~vAvKI~~l~~~~~~~-~~~~~----~~~~~~~Ei~iL~~L~HpNIVkl 874 (1141)
-.+|++.+.||+|+||.||+|.+. +..+|+|+..... ... .+.+. ....+.+|+.++..++||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC---CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCC--cchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 457999999999999999999984 4567777754321 111 11111 11234688999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL 954 (1141)
++++..... .....++||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++||+||||
T Consensus 114 ~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 177 (345)
T 2v62_A 114 YGSGLTEFK----------GRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDI 177 (345)
T ss_dssp EEEEEEESS----------SCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ecccccccC----------CCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCc
Confidence 999876210 123569999999 8999999875 237999999999999999999999999999999
Q ss_pred CCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHH
Q 001143 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1034 (1141)
Q Consensus 955 KP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1034 (1141)
||+|||++.++. +.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++||||
T Consensus 178 kp~NIll~~~~~-----~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~s 245 (345)
T 2v62_A 178 KAANLLLGYKNP-----DQVYLADYGLSYRYCPNGNHKQ---YQENPRKGHNGTIEFTSLDAHKG----VALSRRSDVEI 245 (345)
T ss_dssp SGGGEEEESSST-----TSEEECCCTTCEESSGGGCCCC---CCCCGGGCSCSCTTTCCHHHHHT----CCCCHHHHHHH
T ss_pred CHHHEEEccCCC-----CcEEEEeCCCceeccccccccc---chhccccccCCCccccCHHHhcC----CCCCchhhHHH
Confidence 999999987621 3899999999987653221100 00111134569999999999986 56889999999
Q ss_pred HHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001143 1035 YGCLLLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1112 (1141)
Q Consensus 1035 LGviL~ELLTGk~Pf~~~--~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL 1112 (1141)
|||++|+|++|+.||.+. ......... ....+.++...... . .....+.++.+++.+||
T Consensus 246 lG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----------~-------~~~~~~~~l~~li~~~l 306 (345)
T 2v62_A 246 LGYCMLRWLCGKLPWEQNLKDPVAVQTAK-TNLLDELPQSVLKW-----------A-------PSGSSCCEIAQFLVCAH 306 (345)
T ss_dssp HHHHHHHHHHSSCTTGGGTTCHHHHHHHH-HHHHHTTTHHHHHH-----------S-------CTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCccccccccHHHHHHH-HhhcccccHHHHhh-----------c-------cccccHHHHHHHHHHHh
Confidence 999999999999999642 222222111 11111111111100 0 00145667999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhc
Q 001143 1113 EENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1113 ~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
..||.+|||+.+|++.+....
T Consensus 307 ~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 307 SLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCCTTCCCCHHHHHHHHCTTC
T ss_pred hcCcccCCCHHHHHHHHhccC
Confidence 999999999999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=338.13 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=187.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+.+|++.+.||+|+||.||+|.+. +..+|+|+.... . .......+ +..+..+++.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~-~~~~~~~~---~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--G-NKEENKRI---LMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETT--S-CHHHHHHH---HHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccc--c-cchHHHHH---HHHHHHHHHhcCCCceeeEEEEEec
Confidence 45778999999999999999999984 667888876432 1 12222221 2445556778899999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIvHrDLKP~NI 959 (1141)
.+ ..++||||+ ++.+..+.... ...+++..+..++.||+.||.|||++ ||+||||||+||
T Consensus 96 ~~--------------~~~lv~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 96 NT--------------DVFIAMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp SS--------------EEEEEECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred CC--------------cEEEEEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 54 359999999 56666665531 34699999999999999999999995 999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGvi 1038 (1141)
+++.+ +.+||+|||++....... ......||+.|+|||++.... ....++.++|||||||+
T Consensus 157 l~~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 157 LLDER-------GQIKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp EECTT-------SCEEECCCTTC-------------------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCchhccCCc-----------cccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 99887 789999999987553321 112345899999999985321 12467899999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~-~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++|+.||... ...+....+.....+..+.. ...+..+.+++.+||+.||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~dp~ 273 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH-------------------------MGFSGDFQSFVKDCLTKDHR 273 (318)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS-------------------------SCCCHHHHHHHHHHTCSCTT
T ss_pred HHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc-------------------------CCCCHHHHHHHHHHccCChh
Confidence 99999999999763 34445555544433322110 03456799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001143 1118 ERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~ 1133 (1141)
+|||+.++++|+|+..
T Consensus 274 ~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 274 KRPKYNKLLEHSFIKR 289 (318)
T ss_dssp TSCCHHHHTTSHHHHH
T ss_pred HCcCHHHHhhCHHHHh
Confidence 9999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=352.11 Aligned_cols=290 Identities=20% Similarity=0.225 Sum_probs=206.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.++||+|+||+||+|++. +..||+|+....... ...+ .+.+|+.++++++||||+++++++.....
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVD----VQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHH----HHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHH----HHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 46999999999999999999985 667888876432111 1122 23789999999999999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
...++||||+++++|.++++... ....+++..++.|+.||+.||+|||++||+||||||+|||+..
T Consensus 82 ------------~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 147 (396)
T 4eut_A 82 ------------RHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (396)
T ss_dssp ------------CCEEEEECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred ------------CeeEEEEecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEee
Confidence 14599999999999999997532 1234999999999999999999999999999999999999822
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC----CCCCCchhhHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK----PNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~----~~~~s~ksDVWSLGviL 1039 (1141)
. ..+.+.+||+|||+++....... .....||+.|+|||++.+... ...++.++|||||||++
T Consensus 148 ~---~~~~~~~kL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 148 G---EDGQSVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp C---TTSCEEEEECCGGGCEECCCGGG-----------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred c---CCCceeEEEecCCCceEccCCCc-----------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 1 01126799999999976543221 113469999999999864210 02456899999999999
Q ss_pred HHHHhCCCCCCC----CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1040 LELLTLQVPYMG----LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~----~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
|||++|+.||.. ....+....+..+..+............... + ....+ .........+..+.+++.+||+.|
T Consensus 214 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~-~~~~~-~~~~l~~~~~~~l~~ll~~~L~~d 290 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID-W-SGDMP-VSCSLSRGLQVLLTPVLANILEAD 290 (396)
T ss_dssp HHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEE-E-ESSCC-TTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcc-c-CccCC-cccccchHHHhhchHHHHHhhccC
Confidence 999999999963 2233455555544443322111100000000 0 00000 011122367788999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001143 1116 PTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~~~ 1133 (1141)
|++||++.|+++++....
T Consensus 291 P~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 291 QEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp TTTSCCHHHHHHHHHHHH
T ss_pred hhhhccHHHHHHHHHHHh
Confidence 999999999999886643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=339.69 Aligned_cols=273 Identities=21% Similarity=0.280 Sum_probs=183.8
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~ 882 (1141)
.+|++.++||+|+||.||+|++ .+..+|+|+.... .....+. +.+|+.++.++. ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRA----IIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHH----HHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHH----HHHHHHHHHHhccCCChhhccccccccc
Confidence 3699999999999999999998 5667888875322 2233333 379999999996 999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 960 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NIL 960 (1141)
.. ........++||||+. |+|.+++..... ...+++..++.|+.||+.||.|||++| |+||||||+|||
T Consensus 100 ~~------~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl 170 (337)
T 3ll6_A 100 EE------SDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170 (337)
T ss_dssp TT------STTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCE
T ss_pred cc------cccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEE
Confidence 21 1122345799999996 799999876432 346999999999999999999999999 999999999999
Q ss_pred eecccccCCCCCeEEEeecccccccccccccccccc--CCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~--~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
++.+ +.+||+|||+++............. ..........||+.|+|||++... ....++.++|||||||+
T Consensus 171 ~~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 171 LSNQ-------GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-SNFPIGEKQDIWALGCI 242 (337)
T ss_dssp ECTT-------SCEEBCCCTTCBCCSSCC-------------------------------CC-TTSCSSHHHHHHHHHHH
T ss_pred ECCC-------CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-ccCCCChHHhHHHHHHH
Confidence 9987 7899999999986544221110000 000111234589999999998421 12567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|+.||............ ..... ....+..+.+|+.+||+.||.+
T Consensus 243 l~el~~g~~p~~~~~~~~~~~~~---~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~ 292 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIVNGK---YSIPP---------------------------HDTQYTVFHSLIRAMLQVNPEE 292 (337)
T ss_dssp HHHHHHSSCCC---------------CCCCT---------------------------TCCSSGGGHHHHHHHSCSSGGG
T ss_pred HHHHHhCCCCCcchhHHHhhcCc---ccCCc---------------------------ccccchHHHHHHHHHccCChhh
Confidence 99999999999754332221110 00000 0022344889999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
|||+.|++++++...
T Consensus 293 Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 293 RLSIAEVVHQLQEIA 307 (337)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999997753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=344.66 Aligned_cols=278 Identities=15% Similarity=0.120 Sum_probs=197.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC----------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG----------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~----------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 874 (1141)
-.+|++.+.||+|+||.||+|++. +..+|+|+.... +. +.+|+.++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~----~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GR----LFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------ST----HHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------ch----HHHHHHHHHHhcccchhhh
Confidence 367999999999999999999985 467888886422 12 3789999999999999984
Q ss_pred eeeEecCCCC--CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 001143 875 YGHKISSKWL--PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1141)
Q Consensus 875 lg~~~~~~~~--~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHr 952 (1141)
++.+...... +...+.........++||||+ +++|.+++... ....+++..++.|+.||+.||.|||++||+||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~ 183 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENEYVHG 183 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred hhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 4332211000 000000000112569999999 89999999862 12469999999999999999999999999999
Q ss_pred CCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhH
Q 001143 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1032 (1141)
Q Consensus 953 DLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1032 (1141)
||||+|||++.++. ..+||+|||+++.+......... .........||+.|+|||++.+ ..++.++||
T Consensus 184 Dikp~NIl~~~~~~-----~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di 251 (352)
T 2jii_A 184 NVTAENIFVDPEDQ-----SQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHEGDLEFISMDLHKG----CGPSRRSDL 251 (352)
T ss_dssp CCCGGGEEEETTEE-----EEEEECCGGGCBCSSGGGCCCCC---CTTSSCTTCSCTTTCCHHHHTT----CCCCHHHHH
T ss_pred CCCHHHEEEcCCCC-----ceEEEecCcceeeccCCCccccc---cccccccccCCccccCHHHHcc----CCCCchhhH
Confidence 99999999998721 28999999999876543211100 0111234479999999999986 568899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 001143 1033 WSYGCLLLELLTLQVPYMGLS--ELEIHDLIQ--MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1108 (1141)
Q Consensus 1033 WSLGviL~ELLTGk~Pf~~~~--~~el~~~I~--~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI 1108 (1141)
|||||++|+|++|+.||.... ...+..... ....+.+... .. .....+..+.+++
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~------~~~~~~~~l~~li 310 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP---------------CG------HWIRPSETLQKYL 310 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECT---------------TS------CEECCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhh---------------cc------ccCCCcHHHHHHH
Confidence 999999999999999997642 333332221 1111111000 00 0013457799999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1109 RRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1109 ~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+||..||.+|||+.++++.+...
T Consensus 311 ~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 311 KVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999988664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=335.99 Aligned_cols=278 Identities=18% Similarity=0.179 Sum_probs=201.3
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.-.+|++.+.||+|+||.||+|++ .+..+|+|+.... .....+. +.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREE----AQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHH----HHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHH----HHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 345799999999999999999997 4667888875432 2233333 37999999999999999999998742
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
.. .....++||||+++++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~----------~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~ 167 (317)
T 2buj_A 99 RG----------AKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL 167 (317)
T ss_dssp ET----------TEEEEEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred cC----------CCceeEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 11 123569999999999999999874333 3579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||.+.............. .........||+.|+|||++.+.. ...++.++|||||||++|+
T Consensus 168 ~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~e 238 (317)
T 2buj_A 168 GDE-------GQPVLMDLGSMNQACIHVEGSRQAL-TLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLYA 238 (317)
T ss_dssp CTT-------SCEEECCCSSCEESCEEEESHHHHH-HHHHHHHHHSCGGGCCGGGSSCCS-EEEECTHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEecCcchhcccccccccccc-cccccccccCCcccCCHhHhccCC-CcCCCchhhHHHHHHHHHH
Confidence 887 7899999999875432111000000 000001234799999999986521 1235789999999999999
Q ss_pred HHhCCCCCCCCCH--HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1042 LLTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~--~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
|++|+.||..... ......+....... . ....+..+.+++.+||+.||.+|
T Consensus 239 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~---~~~~~~~l~~li~~~l~~dp~~R 291 (317)
T 2buj_A 239 MMFGEGPYDMVFQKGDSVALAVQNQLSIP------------------------Q---SPRHSSALWQLLNSMMTVDPHQR 291 (317)
T ss_dssp HHHSSCTTHHHHHTTSCHHHHHHCC--CC------------------------C---CTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHhCCCChhhhhcccchhhHHhhccCCCC------------------------c---cccCCHHHHHHHHHHhhcChhhC
Confidence 9999999953100 01111111110000 0 01455679999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001143 1120 PTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s~ 1136 (1141)
||+.++++++.......
T Consensus 292 ps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 292 PHIPLLLSQLEALQPPA 308 (317)
T ss_dssp CCHHHHHHHHHHTCCCC
T ss_pred CCHHHHHHHhhhcCCCC
Confidence 99999999998875543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=345.93 Aligned_cols=264 Identities=25% Similarity=0.279 Sum_probs=176.3
Q ss_pred CCCceEee-eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHH-HHHhhCCCCCccceeeeEec
Q 001143 805 FPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEV-RMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~~-~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpNIVkllg~~~~ 880 (1141)
.++|.+.+ +||+|+||+||+|.+. +..+|+|+.... ... .+|+ ..++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~--------~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA--------RQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH--------HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH--------HHHHHHHHHhcCCCChHHHHHHHhh
Confidence 45798855 6999999999999985 677888875321 111 2333 33566789999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
... .....++||||+++|+|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 94 ~~~----------~~~~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIl 160 (336)
T 3fhr_A 94 MHH----------GKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160 (336)
T ss_dssp EET----------TEEEEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccC----------CCceEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 221 12246999999999999999976 33346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.++ ..+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 161 l~~~~----~~~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~ 220 (336)
T 3fhr_A 161 YTSKE----KDAVLKLTDFGFAKETTQNA------------LQTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 220 (336)
T ss_dssp ESCSS----TTCCEEECCCTTCEEC--------------------------------------CHHHHHHHHHHHHHHHH
T ss_pred EEecC----CCceEEEeccccceeccccc------------cccCCCCcCccChhhhCC----CCCCchhhHHHHHHHHH
Confidence 97641 12679999999997543211 123468999999999865 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|..||...........+....... ......+ .....+..+.+|+.+||+.||.+||
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp 280 (336)
T 3fhr_A 221 ILLCGFPPFYSNTGQAISPGMKRRIRLG-------------------QYGFPNP-EWSEVSEDAKQLIRLLLKTDPTERL 280 (336)
T ss_dssp HHHHSSCCC----------------------------------------CCCTT-TSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHCCCCCCCccchhhhhhHHHhhhcc-------------------ccccCch-hhccCCHHHHHHHHHHCCCChhHCc
Confidence 9999999997644332211110000000 0000000 0014567799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|+.|+++|+|+...
T Consensus 281 t~~ell~hp~~~~~ 294 (336)
T 3fhr_A 281 TITQFMNHPWINQS 294 (336)
T ss_dssp CHHHHHHSHHHHTG
T ss_pred CHHHHhcCcccccc
Confidence 99999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=338.20 Aligned_cols=253 Identities=22% Similarity=0.258 Sum_probs=190.5
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC----CCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL----RHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L----~HpNIVkllg~~ 878 (1141)
..+|++.+.||+|+||.||+|++ .+..+|+|+..... ............+.+|+.++.++ +||||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNR--VLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTT--TC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccc--ccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 45799999999999999999988 45568888754322 11111001112236799999988 899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEee-ccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEY-VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy-~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~ 957 (1141)
...+.. ++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 108 ~~~~~~--------------~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 168 (312)
T 2iwi_A 108 ETQEGF--------------MLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDE 168 (312)
T ss_dssp -----C--------------EEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGG
T ss_pred ecCCeE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChh
Confidence 765533 999999 789999999976 236999999999999999999999999999999999
Q ss_pred Ceeee-cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 958 NILID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 958 NILld-~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
||+++ .+ +.+||+|||++....... .....||+.|+|||++.+. ...+.++||||||
T Consensus 169 Nil~~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG 226 (312)
T 2iwi_A 169 NILIDLRR-------GCAKLIDFGSGALLHDEP------------YTDFDGTRVYSPPEWISRH---QYHALPATVWSLG 226 (312)
T ss_dssp GEEEETTT-------TEEEECCCSSCEECCSSC------------BCCCCSCTTTSCHHHHHHS---CBCHHHHHHHHHH
T ss_pred hEEEeCCC-------CeEEEEEcchhhhcccCc------------ccccCCcccccCceeeecC---CCCCccchHHHHH
Confidence 99998 55 789999999997654321 1234589999999998762 2334689999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
|++|+|++|+.||... .+.. .... .++ ...+..+.++|.+||+.||
T Consensus 227 ~il~~l~~g~~pf~~~--~~~~----~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p 272 (312)
T 2iwi_A 227 ILLYDMVCGDIPFERD--QEIL----EAEL-HFP---------------------------AHVSPDCCALIRRCLAPKP 272 (312)
T ss_dssp HHHHHHHHSSCSCCSH--HHHH----HTCC-CCC---------------------------TTSCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHCCCCCCCh--HHHh----hhcc-CCc---------------------------ccCCHHHHHHHHHHccCCh
Confidence 9999999999999742 1111 1110 000 1445678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001143 1117 TERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~~~ 1134 (1141)
++|||+.|+++|+|+...
T Consensus 273 ~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 273 SSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TTSCCHHHHHHSTTTCC-
T ss_pred hhCcCHHHHhcChhhcCc
Confidence 999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.62 Aligned_cols=274 Identities=23% Similarity=0.321 Sum_probs=199.3
Q ss_pred CCCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~------~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
..+|++.+.||+|+||.||+|++ .+..||+|+.... .....+.+ .+|+.++++++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDF----EREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHH----HHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCCeeeEEEEE
Confidence 45699999999999999999985 3566777775321 22333334 8999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
..... ...++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 112 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N 175 (326)
T 2w1i_A 112 YSAGR------------RNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175 (326)
T ss_dssp CC----------------CCEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EecCC------------CceEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence 65321 1349999999999999999762 2469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|+++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++||||||++
T Consensus 176 Ili~~~-------~~~kL~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 237 (326)
T 2w1i_A 176 ILVENE-------NRVKIGDFGLTKVLPQDKEYYK-------VKEPGESPIFWYAPESLTE----SKFSVASDVWSFGVV 237 (326)
T ss_dssp EEEEET-------TEEEECCCTTCEECCSSCSEEE-------CSSCCSCCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEecCcchhhccccccccc-------cccCCCCceeEECchhhcC----CCCCchhhHHHHHHH
Confidence 999987 7899999999976544221100 1123357888999999976 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchh-HHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|+|++|..||... ..+....+.......... .+.. .......... ...++.++.+++.+||..||.
T Consensus 238 l~el~tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~ 305 (326)
T 2w1i_A 238 LYELFTYIEKSKSP-PAEFMRMIGNDKQGQMIVFHLIE--------LLKNNGRLPR---PDGCPDEIYMIMTECWNNNVN 305 (326)
T ss_dssp HHHHHHTTCGGGSH-HHHHHHHHCTTCCTHHHHHHHHH--------HHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHHHhcCCCCCCC-HHHHHHhhccccchhhhHHHHHH--------HhhcCCCCCC---CCcccHHHHHHHHHHcCCChh
Confidence 99999999998642 112222211111000000 0000 0000000000 125667899999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+|||+.|+++.+...
T Consensus 306 ~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 306 QRPSFRDLALRVDQI 320 (326)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999987654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=342.02 Aligned_cols=253 Identities=21% Similarity=0.232 Sum_probs=197.2
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEec
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkllg~~~~ 880 (1141)
..+|++.+.||+|+||.||+|.+ .+..||+|+........... . ....++.+|+.++++++ ||||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~-~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-L-PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE-C-TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh-h-hhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 46799999999999999999998 45668888765442211000 0 00112368999999996 6999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~g-gSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.+ ..++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 120 ~~--------------~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 180 (320)
T 3a99_A 120 PD--------------SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180 (320)
T ss_dssp SS--------------EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CC--------------cEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHE
Confidence 55 34999999976 899999976 24689999999999999999999999999999999999
Q ss_pred eee-cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 960 LID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 960 Lld-~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|++ .+ +.+||+|||++....... .....||+.|+|||++.+. ..++.++|||||||+
T Consensus 181 ll~~~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~---~~~~~~~Di~slG~i 238 (320)
T 3a99_A 181 LIDLNR-------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGIL 238 (320)
T ss_dssp EEETTT-------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHHS---CBCHHHHHHHHHHHH
T ss_pred EEeCCC-------CCEEEeeCcccccccccc------------ccCCCCCccCCChHHhccC---CCCCccchHHhHHHH
Confidence 998 44 789999999997654321 1134589999999998762 234688999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|+.||... .+ +...... . ....+.++.++|.+||+.||.+
T Consensus 239 l~el~~g~~pf~~~--~~----~~~~~~~-~---------------------------~~~~~~~~~~li~~~l~~dp~~ 284 (320)
T 3a99_A 239 LYDMVCGDIPFEHD--EE----IIRGQVF-F---------------------------RQRVSSECQHLIRWCLALRPSD 284 (320)
T ss_dssp HHHHHHSSCSCCSH--HH----HHHCCCC-C---------------------------SSCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHCCCCCCCh--hh----hhccccc-c---------------------------cccCCHHHHHHHHHHccCChhh
Confidence 99999999999752 11 1111100 0 0134567999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
|||+.|+++|+|+...
T Consensus 285 Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 285 RPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SCCHHHHHTSGGGSSC
T ss_pred CcCHHHHhcCHhhcCc
Confidence 9999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=365.95 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=203.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
..+|++.+.||+|+||.||+|.+.. ...+++++..+.. ......+ .+.+|+.++++++||||+++++++.+.
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~----~~~~E~~~l~~l~HpnIv~l~~~~~~~ 463 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVRE----KFLQEALTMRQFDHPHIVKLIGVITEN 463 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHH----HHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4579999999999999999999843 2334444434322 1222223 348999999999999999999998532
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
..++||||+++|+|.++++. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 464 ---------------~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl 524 (656)
T 2j0j_A 464 ---------------PVWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524 (656)
T ss_dssp ---------------SCEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ---------------ceEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE
Confidence 23899999999999999975 23368999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 525 ~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 584 (656)
T 2j0j_A 525 SSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMWE 584 (656)
T ss_dssp EET-------TEEEECCCCCCCSCCC-------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEecCCCeecCCCcce---------eccCCCCCcceeCHHHhcC----CCCCchhhHHHHHHHHHH
Confidence 987 88999999999765432111 1123357889999999976 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |..||.+....+....+..+..+..+. .+++.+.+++.+||..||.+||
T Consensus 585 llt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~RP 637 (656)
T 2j0j_A 585 ILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSRRP 637 (656)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCChhHCc
Confidence 997 999999888887777776554433221 4556799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
|+.++++.+...
T Consensus 638 s~~el~~~L~~i 649 (656)
T 2j0j_A 638 RFTELKAQLSTI 649 (656)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999988653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=347.16 Aligned_cols=278 Identities=14% Similarity=0.076 Sum_probs=182.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC--CCCCcccee-----
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMY----- 875 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkll----- 875 (1141)
...|++.++||+|+||+||+|.+. +..+|+|+...... ......+ .+.+|+.++..+ +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~----~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELE----RLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHH----HHHHHHHHHHHHHC----------CBCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHH----HHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 345999999999999999999985 56688887654321 1112222 336775444444 699988765
Q ss_pred --eeEecCCCCC---CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHH------HHHHHHHHHHHHHH
Q 001143 876 --GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA------LFIAQDVAAALVEL 944 (1141)
Q Consensus 876 --g~~~~~~~~~---~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i------~~Ia~QIa~gL~yL 944 (1141)
+++...+.-. ..++.........++||||++ ++|.+++.... ..+++..+ ..++.||+.||+||
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 3433322100 000000111245799999998 89999998632 13444455 67789999999999
Q ss_pred HHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCC
Q 001143 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024 (1141)
Q Consensus 945 Hs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1024 (1141)
|++||+||||||+|||++.+ +.+||+|||+|+....... ...+|+.|+|||++.+. ..
T Consensus 211 H~~~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~~-------------~~~~t~~y~aPE~~~~~--~~ 268 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIMPD-------GRLMLGDVSALWKVGTRGP-------------ASSVPVTYAPREFLNAS--TA 268 (371)
T ss_dssp HHTTEEETTCSGGGEEECTT-------SCEEECCGGGEEETTCEEE-------------GGGSCGGGCCHHHHTCS--EE
T ss_pred HHCCCccCcCCHHHEEECCC-------CCEEEEecceeeecCCCcc-------------CccCCcCCcChhhccCC--CC
Confidence 99999999999999999987 7899999999976543210 23467999999999641 13
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1025 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1025 ~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
.++.++|||||||++|+|++|+.||.+....... .. ..... ..........+. ....++.+
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~---~~~~~--------------~~~~~~~~~~~~-~~~~~~~~ 329 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-SW---KRPSL--------------RVPGTDSLAFGS-CTPLPDFV 329 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-CC---CBCCT--------------TSCCCCSCCCTT-SSCCCHHH
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-ch---hhhhh--------------hhccccccchhh-ccCCCHHH
Confidence 5789999999999999999999999765321100 00 00000 000000000110 11556789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
.+||.+||+.||++|||+.|+++|+|+..
T Consensus 330 ~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 330 KTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=343.05 Aligned_cols=256 Identities=14% Similarity=0.145 Sum_probs=191.4
Q ss_pred CCCceEeeeecccCceEEEEEE-------ECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccce
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCK-------FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEM 874 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~-------~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl 874 (1141)
-.+|.+.++||+|+||+||+|. ..+..+|+|+.... . ...+ .+|+.++..++ |+||+++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~---~~~~----~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----N---PWEF----YIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----C---HHHH----HHHHHHHHHSCGGGGGGBCCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----C---hhHH----HHHHHHHHHhhhhhhhhhhhh
Confidence 4569999999999999999994 25678888885421 1 1223 67888888886 9999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 001143 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1141)
Q Consensus 875 lg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDL 954 (1141)
++++...+. .++||||+++|+|.+++..........+++..++.|+.||+.||+|||++||+||||
T Consensus 133 ~~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDi 198 (365)
T 3e7e_A 133 YSAHLFQNG--------------SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDI 198 (365)
T ss_dssp EEEEECSSC--------------EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred heeeecCCC--------------cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCC
Confidence 999987553 499999999999999998755444567999999999999999999999999999999
Q ss_pred CCCCeeeecccc----cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchh
Q 001143 955 KSENILIDLERK----KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1030 (1141)
Q Consensus 955 KP~NILld~~~~----~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1030 (1141)
||+|||++.... .....+.+||+|||+|+.+....... ......||+.|+|||++.+ ..++.++
T Consensus 199 Kp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~ 266 (365)
T 3e7e_A 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--------IFTAKCETSGFQCVEMLSN----KPWNYQI 266 (365)
T ss_dssp SGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE--------EECCSSCTTSCCCHHHHTT----CCBSTHH
T ss_pred CHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCc--------eeeeecCCCCCCChHHhcC----CCCCccc
Confidence 999999987100 00112789999999997654221110 1123469999999999986 5688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1031 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1031 DVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
|||||||++|||++|+.||........ ........ ....+.+.+++..
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~~-------------------------~~~~~~~~-------~~~~~~~~~~~~~ 314 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGEC-------------------------KPEGLFRR-------LPHLDMWNEFFHV 314 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTEE-------------------------EECSCCTT-------CSSHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCce-------------------------eechhccc-------cCcHHHHHHHHHH
Confidence 999999999999999999864211000 00000000 0235568899999
Q ss_pred hcccCCCCCC-CHHHHHHHH
Q 001143 1111 CTEENPTERP-TAGDLYEMF 1129 (1141)
Q Consensus 1111 cL~~DP~~RP-Sa~ElL~~L 1129 (1141)
||+.+|.+|+ ++.++.+.+
T Consensus 315 ~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 315 MLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp HHCCCCTTCCCCHHHHHHHH
T ss_pred HcCCCCCCcchHHHHHHHHH
Confidence 9999999994 566555443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=352.06 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=190.6
Q ss_pred CceEeeeecccCceE-EEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~-Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~ 884 (1141)
+|.+.++||+|+||+ ||++.+.+..||||+..... ...+ .+|+.+++++ +|||||++++++.+..
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~~----~~E~~~l~~l~~HpnIv~l~~~~~~~~-- 91 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSFA----DREVQLLRESDEHPNVIRYFCTEKDRQ-- 91 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEEC----HHHHHHHHHSCCCTTBCCEEEEEEETT--
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHHH----HHHHHHHHhccCCCCcCeEEEEEecCC--
Confidence 589999999999998 55556678889999753211 1122 6899999999 7999999999988655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..|+||||++ |+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||++.+
T Consensus 92 ------------~~~lv~E~~~-g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~ 154 (432)
T 3p23_A 92 ------------FQYIAIELCA-ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154 (432)
T ss_dssp ------------EEEEEEECCS-EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCC
T ss_pred ------------EEEEEEECCC-CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecC
Confidence 3499999997 6999999751 2245556678999999999999999999999999999999643
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+ ..+...+||+|||+|+........ ........||+.|+|||++.+.. ...++.++|||||||++|||++
T Consensus 155 ~--~~~~~~~kL~DFG~a~~~~~~~~~-------~~~~~~~~gt~~y~APE~l~~~~-~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 155 N--AHGKIKAMISDFGLCKKLAVGRHS-------FSRRSGVPGTEGWIAPEMLSEDC-KENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp B--TTTBCCEEECCTTEEECC-------------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHT
T ss_pred C--CCCceeEEEecccceeeccCCCcc-------eeeccccCCCcCccChhhhhccc-ccCCCcHHHHHHHHHHHHHHHc
Confidence 1 122357899999999765432111 01122456999999999987421 2456789999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 -Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|..||......+....+........ ......+..+.+||.+||+.||.+|||+.
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 279 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDCL-------------------------HPEKHEDVIARELIEKMIAMDPQKRPSAK 279 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTTS-------------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcchhhHHHHHHHhccCCcccc-------------------------CccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence 9999975443332222111110000 00114566689999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+||..
T Consensus 280 evl~hp~f~~ 289 (432)
T 3p23_A 280 HVLKHPFFWS 289 (432)
T ss_dssp HHHTSTTTCC
T ss_pred HHHhCccccC
Confidence 9999999853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=346.00 Aligned_cols=261 Identities=19% Similarity=0.218 Sum_probs=195.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC-CccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIVkllg~~~~~ 881 (1141)
.++|++.++||+|+||.||+|.+. +..||+|+....... .. +.+|+.+++.++|+ +|+.+..++...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~----~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQ----LLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CC----HHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HH----HHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 467999999999999999999984 677888876543211 12 36899999999864 555554444433
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. ..+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 76 ~--------------~~~lvme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 136 (483)
T 3sv0_A 76 D--------------YNVLVMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (483)
T ss_dssp T--------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence 3 459999999 89999999752 3469999999999999999999999999999999999999
Q ss_pred e---cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 962 D---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 962 d---~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
+ .+ +.+||+|||+++.+....... ...........||+.|+|||++.+ ..++.++|||||||+
T Consensus 137 ~~~~~~-------~~vkL~DFGla~~~~~~~~~~---~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 137 GLGRRA-------NQVYIIDFGLAKKYRDTSTHQ---HIPYRENKNLTGTARYASVNTHLG----IEQSRRDDLESLGYV 202 (483)
T ss_dssp CCGGGT-------TCEEECCCTTCEECBCTTTCC---BCCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHH
T ss_pred ecCCCC-------CeEEEEeCCcceeccCCcccc---ccccccccccCCCccccCHHHhcC----CCCChHHHHHHHHHH
Confidence 4 44 789999999998765432111 001112235679999999999986 568899999999999
Q ss_pred HHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001143 1039 LLELLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1115 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~---~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~D 1115 (1141)
+|||++|+.||.+... .+.+..+.......... .....++.++.+|+..||+.|
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-----------------------~l~~~~p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE-----------------------ALCRGYPTEFASYFHYCRSLR 259 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-----------------------HHHTTSCHHHHHHHHHHHTCC
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHH-----------------------HHhcCCcHHHHHHHHHHhcCC
Confidence 9999999999986433 23333322111000000 011145678999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 001143 1116 PTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1116 P~~RPSa~ElL~~L~~ 1131 (1141)
|++||++.+|++.+..
T Consensus 260 P~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 260 FDDKPDYSYLKRLFRD 275 (483)
T ss_dssp TTCCCCHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHH
Confidence 9999999999887654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=347.00 Aligned_cols=270 Identities=21% Similarity=0.280 Sum_probs=188.0
Q ss_pred ceEeeeecccCceEEEEE-EECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRC-KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a-~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~~~ 885 (1141)
|.+.++||+|+||+||.+ ...+..||+|+...+. .+ .+.+|+.+++++ +|||||++++++.+..
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-------~~----~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--- 82 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CD----IALMEIKLLTESDDHPNVIRYYCSETTDR--- 82 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-------HH----HHHHHHHHHHHHTTSTTBCCEEEEEECSS---
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-------HH----HHHHHHHHHHhccCCCCcCeEEEEEecCC---
Confidence 567889999999999755 4467889999764321 12 236899999876 8999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE--KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~--~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||++ |+|.+++........ ...++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 83 -----------~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~ 150 (434)
T 2rio_A 83 -----------FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150 (434)
T ss_dssp -----------EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEC
T ss_pred -----------eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 3599999996 699999975211110 01133456789999999999999999999999999999976
Q ss_pred ccc------cCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc---CCCCCCchhhHHH
Q 001143 964 ERK------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWS 1034 (1141)
Q Consensus 964 ~~~------~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVWS 1034 (1141)
++. .....+.+||+|||+++......... ........||+.|+|||++.+.. ....++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred CcccccccccCCCceEEEEcccccceecCCCCccc------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 420 01123689999999998764422110 00112346999999999997521 1246789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1035 YGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1035 LGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
|||++|||++ |+.||......+ ..+..+.... .. . ........+.++.++|.+||+
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~-~~-------------------~-~~~~~~~~~~~~~~li~~~L~ 281 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSL-DE-------------------M-KCLHDRSLIAEATDLISQMID 281 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCC-CC-------------------C-TTCCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCc-cc-------------------c-cccccccchHHHHHHHHHHhh
Confidence 9999999999 999997644332 1222211110 00 0 000012567789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 001143 1114 ENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1114 ~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.||.+|||+.++++|+|+.
T Consensus 282 ~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 282 HDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp SSGGGSCCHHHHHTSGGGS
T ss_pred CChhhCCCHHHHHhCCccC
Confidence 9999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=321.71 Aligned_cols=245 Identities=22% Similarity=0.251 Sum_probs=181.6
Q ss_pred CCCceEe-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH-hhCCCCCccceeeeEec
Q 001143 805 FPSLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~-~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIVkllg~~~~ 880 (1141)
+.+|.+. +.||+|+||.||+|.+. +..+|+|+.... .. +.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~----~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PK----ARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HH----HHHHHHHHHHhccCCCchhHHhhhhh
Confidence 5678887 78999999999999984 567888875311 11 25788888 55589999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ......++||||+++++|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 83 ~~----------~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 149 (299)
T 3m2w_A 83 LY----------AGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149 (299)
T ss_dssp EE----------TTEEEEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hc----------CCCceEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 11 012256999999999999999986 33346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+. ..+.+||+|||++..... ..++.++|||||||++|
T Consensus 150 ~~~~~----~~~~~kl~Dfg~a~~~~~------------------------------------~~~~~~~DiwslG~il~ 189 (299)
T 3m2w_A 150 YTSKR----PNAILKLTDFGFAKETTG------------------------------------EKYDKSCDMWSLGVIMY 189 (299)
T ss_dssp ESSSS----TTCCEEECCCTTCEECTT------------------------------------CGGGGHHHHHHHHHHHH
T ss_pred EecCC----CCCcEEEecccccccccc------------------------------------ccCCchhhHHHHHHHHH
Confidence 98731 127899999998853211 23458999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCc-hhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP-EAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|++|+.||.+....+....+... .. . .....+ ......++++.+++.+||+.||.+|
T Consensus 190 el~tg~~pf~~~~~~~~~~~~~~~----~~---------------~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 248 (299)
T 3m2w_A 190 ILLCGYPPFYSNHGLAISPGMKTR----IR---------------M--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 248 (299)
T ss_dssp HHHHSSCSCCC-------CCSCCS----SC---------------T--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHCCCCCCCCcchhhhHHHHHH----Hh---------------h--ccccCCchhcccCCHHHHHHHHHHcccChhhC
Confidence 999999999764432221110000 00 0 000011 1112567789999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001143 1120 PTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s~ 1136 (1141)
||+.|+++|+|+.....
T Consensus 249 ps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 249 MTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CCHHHHHTSHHHHTGGG
T ss_pred CCHHHHhcChhhccccc
Confidence 99999999999976543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=335.87 Aligned_cols=274 Identities=17% Similarity=0.102 Sum_probs=186.2
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---------CCCcccee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---------HSCIVEMY 875 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---------HpNIVkll 875 (1141)
..+|++.++||+|+||+||+|++.+..||+|+...................+.+|+.+++.++ |||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 457999999999999999999999999999987654321100000011122368888888775 66666665
Q ss_pred eeE-----------------ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 001143 876 GHK-----------------ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVA 938 (1141)
Q Consensus 876 g~~-----------------~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa 938 (1141)
+.+ .+.... ..+........+.|+||||+++|++.+.+.+ ..+++..++.|+.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~-~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGS-ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCC-SSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccc-cccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 553 321000 0000000012357999999999976655532 3689999999999999
Q ss_pred HHHHHHH-HCCccccCCCCCCeeeeccccc-------------CCCCCeEEEeeccccccccccccccccccCCCCCCCC
Q 001143 939 AALVELH-SKHIMHRDIKSENILIDLERKK-------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004 (1141)
Q Consensus 939 ~gL~yLH-s~gIvHrDLKP~NILld~~~~~-------------~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~ 1004 (1141)
.||+||| ++||+||||||+|||++.++.. ......+||+|||+|+..... .
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------------~ 236 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------------I 236 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------------E
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------------c
Confidence 9999999 9999999999999999876200 000128999999999765421 3
Q ss_pred ccCCCcccchhhhccccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhC-CCCCchhHHhhhccCcc
Q 001143 1005 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL-LLELLTLQVPYMGLSE-LEIHDLIQMG-KRPRLTDELEALGSCHE 1081 (1141)
Q Consensus 1005 ~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi-L~ELLTGk~Pf~~~~~-~el~~~I~~~-~~p~l~~~l~~~~~~~~ 1081 (1141)
..||+.|+|||++.+ .. +.++||||+|++ .+++++|..||.+... ......+... ....
T Consensus 237 ~~gt~~y~aPE~~~g----~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 298 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTG----DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT------------- 298 (336)
T ss_dssp EECCCCTTCSGGGCC----CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS-------------
T ss_pred EEEeecccChhhhcC----CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc-------------
Confidence 469999999999986 22 789999998777 7778889998853111 1122222211 1100
Q ss_pred ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhh
Q 001143 1082 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY-EMFVAR 1132 (1141)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL-~~L~~~ 1132 (1141)
..........++++.+||.+||+.| |++|++ +|+|++
T Consensus 299 ---------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 ---------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ---------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ---------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0011122367889999999999976 999999 999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=338.92 Aligned_cols=269 Identities=14% Similarity=0.117 Sum_probs=188.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC-CCcccee------
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMY------ 875 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkll------ 875 (1141)
...|.+.++||+|+||+||+|.+. +..||||+...... ......+. +.+|+.+++.++| +|.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~----~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQ----MKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHH----HHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHH----HHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 345889999999999999999985 77899998653221 11112233 4799999999976 3322211
Q ss_pred ---eeEecCCCC---CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 001143 876 ---GHKISSKWL---PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--TGEKHVSVKLALFIAQDVAAALVELHSK 947 (1141)
Q Consensus 876 ---g~~~~~~~~---~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~--~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~ 947 (1141)
+.....+.. ....+.........+++|+++ +++|.++++.... .....+++..++.|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111111000 000000111234568888877 5899999864321 2244688899999999999999999999
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc------
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------ 1021 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------ 1021 (1141)
||+||||||+|||++.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 231 ~iiHrDiKp~NILl~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGASA-------------VSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp TEECSCCCGGGEEECTT-------CCEEECCGGGCEETTEEE-------------CCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred CcccCCcccceEEEecC-------CeEEEEeccceeecCCcc-------------ccCCC-CceeCchhhhccccccccc
Confidence 99999999999999988 789999999987654321 13357 9999999994321
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 001143 1022 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101 (1141)
Q Consensus 1022 ~~~~~s~ksDVWSLGviL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1141)
....++.++|||||||++|||++|+.||......+....+. ... ...+
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-----------------------~~~---------~~~~ 337 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF-----------------------RSC---------KNIP 337 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG-----------------------SSC---------CCCC
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH-----------------------hhc---------ccCC
Confidence 23457889999999999999999999997643221111100 000 0345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1102 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+.+||.+||+.||.+||++.++++|+|+.
T Consensus 338 ~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 6799999999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=356.33 Aligned_cols=290 Identities=19% Similarity=0.181 Sum_probs=198.6
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 801 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 801 ~~~~~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
+...+.+|++.++||+|+||+||+|.+ .+..||+|+.... ......+. +.+|+.++++++||||+++++++
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~----~~~Ei~iL~~L~HpnIV~l~~v~ 81 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRER----WCLEIQIMKKLNHPNVVSAREVP 81 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHH----HHHHHHHHHHCCBTTBCCEEECC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHH----HHHHHHHHHhCCCCCCCceeeee
Confidence 344568899999999999999999997 4567888864321 22333333 48999999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
...... ......++||||++|++|.+++... .....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 82 ~~~~~~--------~~~~~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~N 151 (676)
T 3qa8_A 82 DGLQKL--------APNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151 (676)
T ss_dssp TTTCCC--------CTTSSCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTT
T ss_pred cccccc--------cCCCeEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 652211 1122458999999999999999762 222358999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|+++.++ ....+||+|||.+....... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 152 ILl~~~g----~~~~vKL~DFG~a~~~~~~~-----------~~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSLGvi 212 (676)
T 3qa8_A 152 IVLQPGP----QRLIHKIIDLGYAKELDQGE-----------LCTEFVGTLQYLAPELLEQ----KKYTVTVDYWSFGTL 212 (676)
T ss_dssp EEEECCS----SSCEEEECSCCCCCBTTSCC-----------CCCCCCSCCTTCSSCSSCC----SCCSTTHHHHHHHHH
T ss_pred eEeecCC----CceeEEEccccccccccccc-----------ccccccCCcccCChHHhcc----CCCCchhHHHHHHHH
Confidence 9998652 12469999999997654321 1123468999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCCCC-CchhhhhhHHHHHHHHHHhcccCC
Q 001143 1039 LLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE-KPEAELETLSFLVDVFRRCTEENP 1116 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~dLI~~cL~~DP 1116 (1141)
+|+|++|..||......... ..+........ ................. ........++.+.+++.+||.+||
T Consensus 213 LyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~------~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP 286 (676)
T 3qa8_A 213 AFECITGFRPFLPNWQPVQWHGKVREKSNEHI------VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ 286 (676)
T ss_dssp HHHHHSSCSSCCSSCHHHHSSTTCC------C------CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSC
T ss_pred HHHHHHCCCCCCcccchhhhhhhhhcccchhh------hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCH
Confidence 99999999999764332111 00000000000 00000000000000000 111223578899999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001143 1117 TERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1117 ~~RPSa~ElL~~L~~~ 1132 (1141)
++|||+.|+++|+||.
T Consensus 287 ~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 287 RQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp C---CCTTCCCCTTHH
T ss_pred hhCcCHHHHhcCHHHH
Confidence 9999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=310.75 Aligned_cols=230 Identities=14% Similarity=0.079 Sum_probs=176.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.+.||+|+||.||+|++. +..||+|+..... .......+. +.+|+.++.+++||||+++++++.+.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~----~~~e~~~l~~l~hp~iv~~~~~~~~~~- 104 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQE----TLSRTLRLSRIDKPGVARVLDVVHTRA- 104 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-CSCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc-ccCHHHHHH----HHHHHHHHhcCCCCCcceeeEEEEECC-
Confidence 56999999999999999999996 5677787754221 111222333 489999999999999999999998755
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..|+||||++|++|.++++. .....++.+|+.||+.||+|||++||+||||||+|||++.
T Consensus 105 -------------~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~ 164 (286)
T 3uqc_A 105 -------------GGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164 (286)
T ss_dssp -------------EEEEEEECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET
T ss_pred -------------cEEEEEEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC
Confidence 34999999999999999853 2456678999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+++| |++ .++.++|||||||++|+|+
T Consensus 165 ~-------g~~kl~~~~------------------------------~~~-----------~~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 165 D-------GDVVLAYPA------------------------------TMP-----------DANPQDDIRGIGASLYALL 196 (286)
T ss_dssp T-------SCEEECSCC------------------------------CCT-----------TCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecc------------------------------ccC-----------CCCchhHHHHHHHHHHHHH
Confidence 7 788887544 222 2458999999999999999
Q ss_pred hCCCCCCCCCHHHHHH---HHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHD---LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~---~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+.+..+... .......+. ........++.+.+++.+||+.||.+|
T Consensus 197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R- 251 (286)
T 3uqc_A 197 VNRWPLPEAGVRSGLAPAERDTAGQPIE------------------------PADIDRDIPFQISAVAARSVQGDGGIR- 251 (286)
T ss_dssp HSEECSCCCSBCCCSEECCBCTTSCBCC------------------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-
T ss_pred HCCCCCCcCCcchhhHHHHHHhccCCCC------------------------hhhcccCCCHHHHHHHHHHcccCCccC-
Confidence 9999998644321110 000000000 001112566789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001143 1121 TAGDLYEMFVARTS 1134 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~~ 1134 (1141)
|+.|+++.+.....
T Consensus 252 s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 252 SASTLLNLMQQATA 265 (286)
T ss_dssp CHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHhc
Confidence 99999999887543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=344.63 Aligned_cols=242 Identities=22% Similarity=0.247 Sum_probs=186.6
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.+|++.++||+|+||.||+|.+. +..|++|+.. .. ....... .+.+|+.++++++|||||++++++...+
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~--~~-~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV--HS-GDAEAQA----MAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESC--SS-CCHHHHH----HHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeC--cc-CCHHHHH----HHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 67999999999999999999984 5667777642 21 1222223 3479999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. .....||||||++|++|.+++.. .+++.+++.|+.||+.||.|||++||+||||||+|||++
T Consensus 153 ~~---------~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~ 216 (681)
T 2pzi_A 153 RH---------GDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216 (681)
T ss_dssp TT---------SCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CC---------CCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe
Confidence 21 12235999999999999887643 699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ .+||+|||+++..... ....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 217 ~~--------~~kl~DFG~a~~~~~~--------------~~~~gt~~y~aPE~~~~-----~~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 217 EE--------QLKLIDLGAVSRINSF--------------GYLYGTPGFQAPEIVRT-----GPTVATDIYTVGRTLAAL 269 (681)
T ss_dssp SS--------CEEECCCTTCEETTCC--------------SCCCCCTTTSCTTHHHH-----CSCHHHHHHHHHHHHHHH
T ss_pred CC--------cEEEEecccchhcccC--------------CccCCCccccCHHHHcC-----CCCCceehhhhHHHHHHH
Confidence 63 6999999999765331 23469999999999876 237899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|..||.+.... ..+. .......++.+.++|.+||+.||.+||+.
T Consensus 270 ~~g~~~~~~~~~~---------~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~ 315 (681)
T 2pzi_A 270 TLDLPTRNGRYVD---------GLPE-------------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTT 315 (681)
T ss_dssp HSCCCEETTEECS---------SCCT-------------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HhCCCCCcccccc---------cccc-------------------------cccccccCHHHHHHHhhhccCChhhCCCH
Confidence 9999888642100 0000 00111344678999999999999999987
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
.+.+.+.|+
T Consensus 316 ~~~l~~~l~ 324 (681)
T 2pzi_A 316 AEEMSAQLT 324 (681)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777766654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=341.63 Aligned_cols=296 Identities=21% Similarity=0.193 Sum_probs=244.6
Q ss_pred CcccccCCCCCccccCCCCCCC--CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCc
Q 001143 18 IKEKLPSEANKINNEKNGSVND--DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLR 94 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~--l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~ 94 (1141)
.++.|.+..|++++..+..+.. +++|++|+|++|++++.+|..++.+ ++|++|+|++|+++ .+|..|.++++|+
T Consensus 369 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 445 (768)
T 3rgz_A 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC---SELVSLHLSFNYLSGTIPSSLGSLSKLR 445 (768)
T ss_dssp TCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGC---TTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred CCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcC---CCCCEEECcCCcccCcccHHHhcCCCCC
Confidence 4556666666666555555554 6677788888887777777766555 78888888888887 6677888888888
Q ss_pred EEEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc
Q 001143 95 NLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1141)
Q Consensus 95 ~L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls 172 (1141)
.|+|++|+++ .+|..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.+ .+.+|..++.+++|+.|+++
T Consensus 446 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l---~~~~p~~~~~l~~L~~L~L~ 522 (768)
T 3rgz_A 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL---TGEIPKWIGRLENLAILKLS 522 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC---CSCCCGGGGGCTTCCEEECC
T ss_pred EEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCcc---CCcCChHHhcCCCCCEEECC
Confidence 8888888887 67888888888888888888855 6777888888888888888544 45667788888888888888
Q ss_pred CCCCC-ccCccccCCCCCCEEEccCCccc-cccccc--------------------------------------------
Q 001143 173 HFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEI-------------------------------------------- 206 (1141)
Q Consensus 173 ~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~iP~~l-------------------------------------------- 206 (1141)
+|+++ .+|..++.+++|++|+|++|.++ .+|..+
T Consensus 523 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (768)
T 3rgz_A 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602 (768)
T ss_dssp SSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGG
T ss_pred CCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccch
Confidence 88888 67888888888888888888887 666543
Q ss_pred --------------------------cCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCC
Q 001143 207 --------------------------CYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNL 259 (1141)
Q Consensus 207 --------------------------~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L 259 (1141)
+.+++|+.|+|++|+|+ .||.+++++++|+.|+|++|+|+|.+|..|..+++|
T Consensus 603 ~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L 682 (768)
T 3rgz_A 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682 (768)
T ss_dssp GGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred hhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCC
Confidence 34578999999999998 889999999999999999999999999999999999
Q ss_pred CEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcccccccCCCCCCCCCCCCcCCCC-CCCc
Q 001143 260 QNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESD-AGSR 326 (1141)
Q Consensus 260 ~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~~~~~~~~~~l~~~~~~sf~~n~-~~~~ 326 (1141)
+.|||++|++++ .+|..+..+..+..+++++|.+.|.+|. ...+.+|...+|.||+ +|+.
T Consensus 683 ~~LdLs~N~l~g--~ip~~l~~l~~L~~L~ls~N~l~g~iP~-----~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 683 NILDLSSNKLDG--RIPQAMSALTMLTEIDLSNNNLSGPIPE-----MGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CEEECCSSCCEE--CCCGGGGGCCCCSEEECCSSEEEEECCS-----SSSGGGSCGGGGCSCTEEEST
T ss_pred CEEECCCCcccC--cCChHHhCCCCCCEEECcCCcccccCCC-----chhhccCCHHHhcCCchhcCC
Confidence 999999999998 6999999999999999999999999984 4567889999999995 6743
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=331.00 Aligned_cols=274 Identities=20% Similarity=0.231 Sum_probs=242.2
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~~ 95 (1141)
+.++.|.+..|++++..+..|.++++|++|+|++|++++.+|..++.+ ++|++|+|++|.++ .+|..|..+++|++
T Consensus 394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 470 (768)
T 3rgz_A 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL---SKLRDLKLWLNMLEGEIPQELMYVKTLET 470 (768)
T ss_dssp CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC---TTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcC---CCCCEEECCCCcccCcCCHHHcCCCCceE
Confidence 479999999999999999999999999999999999999999887666 99999999999998 78999999999999
Q ss_pred EEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001143 96 LKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1141)
Q Consensus 96 L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1141)
|+|++|+|+ .+|..|.++++|++|+|++|++. .+|..+..+++|++|+|++| .+.+.+|..+..+++|+.|++++
T Consensus 471 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N---~l~~~~p~~l~~l~~L~~L~Ls~ 547 (768)
T 3rgz_A 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN---SFSGNIPAELGDCRSLIWLDLNT 547 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS---CCEEECCGGGGGCTTCCEEECCS
T ss_pred EEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCC---cccCcCCHHHcCCCCCCEEECCC
Confidence 999999998 78999999999999999999966 78889999999999999995 45678889999999999999999
Q ss_pred CCCC-ccCccc---------------------------------------------------------------------
Q 001143 174 FSIR-YLPPEI--------------------------------------------------------------------- 183 (1141)
Q Consensus 174 N~L~-~iP~~l--------------------------------------------------------------------- 183 (1141)
|.++ .+|..+
T Consensus 548 N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~ 627 (768)
T 3rgz_A 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627 (768)
T ss_dssp SEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCS
T ss_pred CccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchh
Confidence 9987 666543
Q ss_pred -cCCCCCCEEEccCCccc-cccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCC
Q 001143 184 -GCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260 (1141)
Q Consensus 184 -~~l~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~ 260 (1141)
+.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|+ .||..++++++|+.|||++|+|+|.+|..+..+++|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 33578999999999999 89999999999999999999998 8999999999999999999999999999999999999
Q ss_pred EEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 261 NLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 261 ~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
.|+|++|+|+| +||..-............++.+||.
T Consensus 708 ~L~ls~N~l~g--~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 708 EIDLSNNNLSG--PIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp EEECCSSEEEE--ECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred EEECcCCcccc--cCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999999 6786533222222222344456654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=288.91 Aligned_cols=272 Identities=20% Similarity=0.202 Sum_probs=237.7
Q ss_pred cccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc---CccccCCcCCcEEE
Q 001143 21 KLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI---PKSVGRYEKLRNLK 97 (1141)
Q Consensus 21 ~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i---P~~l~~L~~L~~L~ 97 (1141)
.+....++|+.++...+ ++|++|+|++|+|+...+..|+ ++++|++|+|++|.|+.+ |..+..+++|++|+
T Consensus 11 ~l~c~~~~l~~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 11 EIRCNSKGLTSVPTGIP---SSATRLELESNKLQSLPHGVFD---KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp EEECCSSCCSSCCSCCC---TTCCEEECCSSCCCCCCTTTTT---TCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred EEEcCCCCcccCCCCCC---CCCCEEECCCCccCccCHhHhh---ccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 57778888998887544 6899999999999977665554 459999999999999865 56788899999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc--cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF--ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 98 Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~--~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
|++|.|+.+|..+.++++|+.|+|++|.+..++. .+..+++|++|++++|.+ ....+..+..+++|+.|++++|.
T Consensus 85 Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l---~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 85 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT---RVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp CCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCC---EECSTTTTTTCTTCCEEECTTCE
T ss_pred CCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcC---CccchhhcccCcCCCEEECCCCc
Confidence 9999999999999999999999999999877764 799999999999999654 44556778999999999999999
Q ss_pred CCc--cCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcc
Q 001143 176 IRY--LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSL 251 (1141)
Q Consensus 176 L~~--iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~ 251 (1141)
++. +|..+..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|+|++.+|.
T Consensus 162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (306)
T 2z66_A 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241 (306)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSS
T ss_pred cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHH
Confidence 985 688999999999999999999976 6789999999999999999998865 678899999999999999999998
Q ss_pred cccCCC-CCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCccc
Q 001143 252 DLCLMH-NLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAE 301 (1141)
Q Consensus 252 ~l~~L~-~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~~ 301 (1141)
.+..++ +|+.|+|++|+|+|.|++++...|......+....+.+.|..|.
T Consensus 242 ~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 242 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp SCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred HHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 999985 99999999999999988887777777776666667777777664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-29 Score=282.29 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=214.3
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+. +++|++|+|++|.|+.+|..+. ++|+.
T Consensus 51 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---l~~L~~L~Ls~n~l~~l~~~~~--~~L~~ 125 (330)
T 1xku_A 51 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP---LVKLERLYLSKNQLKELPEKMP--KTLQE 125 (330)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT---CTTCCEEECCSSCCSBCCSSCC--TTCCE
T ss_pred CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcC---CCCCCEEECCCCcCCccChhhc--ccccE
Confidence 457888899999999998888999999999999999999887776654 4889999999999998887765 68999
Q ss_pred EEccCCCCCcCch-hhcCCCCCCEEEccCCCCC---CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001143 96 LKFFGNEINLFPS-EVGNLLGLECLQIKISSPG---VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1141)
Q Consensus 96 L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~---~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~L 171 (1141)
|+|++|+|+.++. .|.++++|+.|+|++|.+. ..+..+..+++|++|++++|.+.. +|..+. ++|+.|++
T Consensus 126 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~----l~~~~~--~~L~~L~l 199 (330)
T 1xku_A 126 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT----IPQGLP--PSLTELHL 199 (330)
T ss_dssp EECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS----CCSSCC--TTCSEEEC
T ss_pred EECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc----CCcccc--ccCCEEEC
Confidence 9999999987754 4888999999999998876 445678889999999999876653 444432 78899999
Q ss_pred cCCCCCcc-CccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCC
Q 001143 172 CHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249 (1141)
Q Consensus 172 s~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~ 249 (1141)
++|+++.+ |..+..+++|+.|+|++|.|+.++ ..+..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|++++
T Consensus 200 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~ 279 (330)
T 1xku_A 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 279 (330)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccC
Confidence 99999866 567888999999999999998765 4788889999999999999999988888999999999999999988
Q ss_pred cccccCC------CCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCC
Q 001143 250 SLDLCLM------HNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSND 293 (1141)
Q Consensus 250 p~~l~~L------~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n 293 (1141)
+..|+.. +.|..|++++|++..+.-.|..+.+......+++++|
T Consensus 280 ~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp TTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred hhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 8777643 6788999999998765444555555555555554443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=294.93 Aligned_cols=280 Identities=19% Similarity=0.143 Sum_probs=198.1
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCc
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLR 94 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~ 94 (1141)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|.+.+.++. ..|.++++|++|+|++|.++.+ |..|.++++|+
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~--~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 106 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGLSSLIILKLDYNQFLQLETGAFNGLANLE 106 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECT--TTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCC
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECc--ccccccccCCEEeCCCCccCccChhhccCcccCC
Confidence 35788889999999988888888999999999999888765533 2234558888888888888866 66788888888
Q ss_pred EEEccCCCCCc-Cchh--hcCCCCCCEEEccCCCCCCC-ccc-ccCCCCCCEEECCCCCCCCCcccc-------------
Q 001143 95 NLKFFGNEINL-FPSE--VGNLLGLECLQIKISSPGVN-GFA-LNKLKGLKELELSKVPPRPSVLTL------------- 156 (1141)
Q Consensus 95 ~L~Ls~N~L~~-lP~~--~~~L~~L~~L~Ls~N~l~~~-~~~-~~~L~~L~~L~Ls~N~ln~~~~~l------------- 156 (1141)
+|+|++|+|+. +|.. |.++++|++|+|++|.+..+ |.. +.++++|++|++++|.+.......
T Consensus 107 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~ 186 (455)
T 3v47_A 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186 (455)
T ss_dssp EEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEE
T ss_pred EEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccc
Confidence 88888888874 4444 78888888888888887665 433 778888888888887654332110
Q ss_pred ------------------------------------------hhhhc---------------------------------
Q 001143 157 ------------------------------------------LSEIA--------------------------------- 161 (1141)
Q Consensus 157 ------------------------------------------p~~l~--------------------------------- 161 (1141)
|..+.
T Consensus 187 l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~ 266 (455)
T 3v47_A 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266 (455)
T ss_dssp CTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCT
T ss_pred cccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcc
Confidence 00000
Q ss_pred ------CCCCCcEEEccCCCCCcc-CccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcC-CcCccCC
Q 001143 162 ------GLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLL 232 (1141)
Q Consensus 162 ------~L~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L 232 (1141)
..++|+.|++++|.++.+ |..++.+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+..+
T Consensus 267 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 346 (455)
T 3v47_A 267 FTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENL 346 (455)
T ss_dssp TTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTC
T ss_pred cccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCc
Confidence 013455555555555533 55567777777777777777755 45677777777777777777755 4556667
Q ss_pred CCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCch-hhhhcccCCCCCCCCCCcccCcc
Q 001143 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS-WICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 233 ~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~-~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
++|+.|+|++|+|++++|..|..+++|+.|+|++|++++ +|. .+........+++.+|.+.|..|
T Consensus 347 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 347 DKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS---VPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC---CCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccCCEEECCCCcccccChhhccccccccEEECCCCcccc---CCHhHhccCCcccEEEccCCCcccCCC
Confidence 777777777777777777777777777777777777776 443 33455566677777777776655
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=282.27 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=175.8
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1141)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+|..+. ++|++|
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~--~~L~~L 128 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL---RKLQKLYISKNHLVEIPPNLP--SSLVEL 128 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTC---TTCCEEECCSSCCCSCCSSCC--TTCCEE
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCc---CCCCEEECCCCcCCccCcccc--ccCCEE
Confidence 456777777777777777777777777777777777777666555433 777777777777777776554 567777
Q ss_pred EccCCCCCcCchh-hcCCCCCCEEEccCCCCC---CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc
Q 001143 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPG---VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~---~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls 172 (1141)
+|++|+|+.+|.. |.++++|+.|+|++|.++ ..+..+..+ +|++|++++|.+.. +|..+. ++|+.|+++
T Consensus 129 ~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~----l~~~~~--~~L~~L~l~ 201 (332)
T 2ft3_A 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG----IPKDLP--ETLNELHLD 201 (332)
T ss_dssp ECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS----CCSSSC--SSCSCCBCC
T ss_pred ECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc----cCcccc--CCCCEEECC
Confidence 7777777766543 667777777777777754 344455556 77777777755543 333332 567777777
Q ss_pred CCCCCccC-ccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 173 HFSIRYLP-PEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 173 ~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
+|.++.++ ..+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|+++++
T Consensus 202 ~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~~ 281 (332)
T 2ft3_A 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGV 281 (332)
T ss_dssp SSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCCT
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccCh
Confidence 77777654 46677777777777777777654 35777777777777777777777777777777777777777777776
Q ss_pred ccccCC------CCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCC
Q 001143 251 LDLCLM------HNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSN 292 (1141)
Q Consensus 251 ~~l~~L------~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~ 292 (1141)
..|..+ +.|+.|++++|++....-.|..+........+.+.+
T Consensus 282 ~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~ 329 (332)
T 2ft3_A 282 NDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329 (332)
T ss_dssp TSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC--
T ss_pred hHccccccccccccccceEeecCcccccccCcccccccchhhhhhccc
Confidence 666543 467777777777764323444444444444444433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=289.64 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=225.3
Q ss_pred cccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEE
Q 001143 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLK 97 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~ 97 (1141)
...+....++|+.++.... .+++.|+|++|+|++..+..|..+ ++|++|+|++|.|+.++ ..|.++++|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l---~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~ 118 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS---TNTRLLNLHENQIQIIKVNSFKHL---RHLEILQLSRNHIRTIEIGAFNGLANLNTLE 118 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC---TTCSEEECCSCCCCEECTTTTSSC---SSCCEEECCSSCCCEECGGGGTTCSSCCEEE
T ss_pred CCEEEeCCCCcCcCCCCCC---CCCcEEEccCCcCCeeCHHHhhCC---CCCCEEECCCCcCCccChhhccCCccCCEEE
Confidence 4467777888999887554 688999999999999888766554 99999999999999886 5799999999999
Q ss_pred ccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEEccCC
Q 001143 98 FFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHF 174 (1141)
Q Consensus 98 Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~-~l~~L~~L~~L~Ls~N 174 (1141)
|++|+|+.+|. .|.++++|+.|+|++|.+..++. .|..+++|++|+|++| +....++. .|.++++|+.|+|++|
T Consensus 119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~---~~l~~i~~~~~~~l~~L~~L~L~~n 195 (440)
T 3zyj_A 119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL---KRLSYISEGAFEGLSNLRYLNLAMC 195 (440)
T ss_dssp CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC---TTCCEECTTTTTTCSSCCEEECTTS
T ss_pred CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC---CCcceeCcchhhcccccCeecCCCC
Confidence 99999999876 58999999999999999887775 7999999999999984 33444444 6889999999999999
Q ss_pred CCCccCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCccc
Q 001143 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLD 252 (1141)
Q Consensus 175 ~L~~iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~ 252 (1141)
+|+.+|. +..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+.++++|+.|+|++|+|+++++..
T Consensus 196 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 274 (440)
T 3zyj_A 196 NLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274 (440)
T ss_dssp CCSSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhH
Confidence 9999985 78999999999999999976 67899999999999999999977 567888999999999999999999988
Q ss_pred ccCCCCCCEEEccCCcCCCCCCCchhhhhccc
Q 001143 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1141)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1141)
|..+++|+.|+|++|+|.|+|.+-+...|...
T Consensus 275 ~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~~~ 306 (440)
T 3zyj_A 275 FTPLHHLERIHLHHNPWNCNCDILWLSWWIKD 306 (440)
T ss_dssp TSSCTTCCEEECCSSCEECSSTTHHHHHHHHT
T ss_pred hccccCCCEEEcCCCCccCCCCchHHHHHHHh
Confidence 99999999999999999999998765555443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=289.89 Aligned_cols=248 Identities=20% Similarity=0.225 Sum_probs=215.8
Q ss_pred CCCCEEEccCCCCCC--CCcccccCCCCCCCccEEEeec-CCCC-ccCccccCCcCCcEEEccCCCCC-cCchhhcCCCC
Q 001143 41 DDDSVIDVSGKTVDF--PLIESYGNRGGDNSVEGLYLYK-NVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLG 115 (1141)
Q Consensus 41 ~~L~~LdLs~N~Ls~--~~p~~~~~l~~L~~L~~L~Ls~-N~Lt-~iP~~l~~L~~L~~L~Ls~N~L~-~lP~~~~~L~~ 115 (1141)
..++.|+|++|+|++ .+|..++.+ ++|++|+|++ |.++ .+|..|.++++|++|+|++|+|+ .+|..|.++++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l---~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 126 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANL---PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC---TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred ceEEEEECCCCCccCCcccChhHhCC---CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCC
Confidence 579999999999998 788777655 9999999994 8887 78889999999999999999998 78999999999
Q ss_pred CCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCC-CCcEEEccCCCCC-ccCccccCCCCCCEE
Q 001143 116 LECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLK-CLTKLSVCHFSIR-YLPPEIGCLSNLEQL 192 (1141)
Q Consensus 116 L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~-~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L 192 (1141)
|++|+|++|.+. .+|..+..+++|++|++++|. +.+.+|..+..++ +|+.|++++|+++ .+|..+..+. |+.|
T Consensus 127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR---ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC---CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc---ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence 999999999966 788889999999999999954 4557788899998 9999999999999 7788888887 9999
Q ss_pred EccCCccc-cccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 193 DLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 193 ~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+|++|+|+ .+|..+..+++|+.|+|++|+++..++.+..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|++++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 99999998 56788999999999999999998665568889999999999999998888899999999999999999997
Q ss_pred CCCCchhhhhcccCCCCCCCCCC-cccC
Q 001143 272 YCQVPSWICCNLEGNGKDSSNDD-FISS 298 (1141)
Q Consensus 272 ~~~iP~~~~~~l~~~~l~~~~n~-l~~~ 298 (1141)
.+|.. ..+.....+.+.+|. +|+.
T Consensus 283 --~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 283 --EIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp --ECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred --cCCCC-ccccccChHHhcCCCCccCC
Confidence 47765 556667778888887 4543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=299.75 Aligned_cols=133 Identities=16% Similarity=0.092 Sum_probs=117.7
Q ss_pred CCCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcC
Q 001143 14 PEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEK 92 (1141)
Q Consensus 14 ~~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~ 92 (1141)
+-|++++.|++..|+|+.|.+.+|.++++|++|||++|+|+++.+..|+ +|++|++|+|++|+|+.+|. .|.++++
T Consensus 49 ~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~---~L~~L~~L~Ls~N~l~~l~~~~f~~L~~ 125 (635)
T 4g8a_A 49 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ---SLSHLSTLILTGNPIQSLALGAFSGLSS 125 (635)
T ss_dssp SSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT---TCTTCCEEECTTCCCCEECGGGGTTCTT
T ss_pred CCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhc---CCCCCCEEEccCCcCCCCCHHHhcCCCC
Confidence 3456799999999999999999999999999999999999998887665 45999999999999999986 5899999
Q ss_pred CcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCC
Q 001143 93 LRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPP 149 (1141)
Q Consensus 93 L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~N~l 149 (1141)
|++|+|++|+|+.+|. .|++|++|++|+|++|.+.. .|..+..+++|++|+|++|.+
T Consensus 126 L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 126 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp CCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 9999999999998876 48999999999999999765 456788899999999988764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=283.70 Aligned_cols=247 Identities=17% Similarity=0.183 Sum_probs=223.9
Q ss_pred CCcccccCCCCCccc--cCCCCCCCCCCCCEEEccC-CCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcC
Q 001143 17 PIKEKLPSEANKINN--EKNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEK 92 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~--i~~~~f~~l~~L~~LdLs~-N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~ 92 (1141)
..+..|.+..|+|++ ..+..|.++++|++|+|++ |++++.+|..|+.+ ++|++|+|++|.|+ .+|..|.++++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l---~~L~~L~Ls~n~l~~~~p~~~~~l~~ 126 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL---TQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC---TTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcC---CCCCEEECcCCeeCCcCCHHHhCCCC
Confidence 368889999999998 6778999999999999995 99999999887665 99999999999998 78999999999
Q ss_pred CcEEEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCcEE
Q 001143 93 LRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169 (1141)
Q Consensus 93 L~~L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~-~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L 169 (1141)
|++|+|++|.|+ .+|..|.++++|++|+|++|.+. .+|..+..++ +|++|++++|. +.+.+|..+..++ |+.|
T Consensus 127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~---l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR---LTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE---EEEECCGGGGGCC-CSEE
T ss_pred CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe---eeccCChHHhCCc-ccEE
Confidence 999999999998 78999999999999999999987 7888999998 99999999954 4567788888887 9999
Q ss_pred EccCCCCC-ccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCC
Q 001143 170 SVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 170 ~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
++++|+++ .+|..+..+++|+.|+|++|+|+..+..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 99999999 5577889999999999999999966666889999999999999998 889999999999999999999999
Q ss_pred CCcccccCCCCCCEEEccCCcCCC
Q 001143 248 LGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
.+|.. ..+++|+.|++++|+.-|
T Consensus 283 ~ip~~-~~l~~L~~l~l~~N~~lc 305 (313)
T 1ogq_A 283 EIPQG-GNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp ECCCS-TTGGGSCGGGTCSSSEEE
T ss_pred cCCCC-ccccccChHHhcCCCCcc
Confidence 88854 889999999999999444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-28 Score=288.99 Aligned_cols=255 Identities=20% Similarity=0.249 Sum_probs=223.9
Q ss_pred cccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEE
Q 001143 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLK 97 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~ 97 (1141)
...+....++++.++.... ++|++|+|++|+|++..+..|+.+ ++|++|+|++|.|+.++ ..|.++++|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 129 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP---SNTRYLNLMENNIQMIQADTFRHL---HHLEVLQLGRNSIRQIEVGAFNGLASLNTLE 129 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC---TTCSEEECCSSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcEEEECCCCcCccCCCCC---CCccEEECcCCcCceECHHHcCCC---CCCCEEECCCCccCCcChhhccCcccCCEEE
Confidence 4567777888888876443 689999999999999988776555 99999999999999886 5799999999999
Q ss_pred ccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEEccCC
Q 001143 98 FFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHF 174 (1141)
Q Consensus 98 Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~-~l~~L~~L~~L~Ls~N 174 (1141)
|++|+|+.+|.. |.++++|+.|+|++|.+..++. .|..+++|++|++++| +....++. .|.++++|+.|+|++|
T Consensus 130 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~---~~l~~i~~~~~~~l~~L~~L~L~~n 206 (452)
T 3zyi_A 130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL---KKLEYISEGAFEGLFNLKYLNLGMC 206 (452)
T ss_dssp CCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC---TTCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC---CCccccChhhccCCCCCCEEECCCC
Confidence 999999988765 8889999999999999887775 7999999999999983 33444544 6889999999999999
Q ss_pred CCCccCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCccc
Q 001143 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLD 252 (1141)
Q Consensus 175 ~L~~iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~ 252 (1141)
+|+.+|. +..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..
T Consensus 207 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 207 NIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CCSSCCC-CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS
T ss_pred ccccccc-ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH
Confidence 9999874 78999999999999999966 77899999999999999999976 677888999999999999999999988
Q ss_pred ccCCCCCCEEEccCCcCCCCCCCchhhhhcc
Q 001143 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283 (1141)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l 283 (1141)
|..+++|+.|+|++|+|.|+|.+-+...|..
T Consensus 286 ~~~l~~L~~L~L~~Np~~CdC~~~~l~~~l~ 316 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPWNCDCDILWLAWWLR 316 (452)
T ss_dssp STTCTTCCEEECCSSCEECSTTTHHHHHHHH
T ss_pred hccccCCCEEEccCCCcCCCCCchHHHHHHH
Confidence 9999999999999999999999875554443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=291.16 Aligned_cols=276 Identities=19% Similarity=0.159 Sum_probs=223.2
Q ss_pred CCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCC
Q 001143 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKL 93 (1141)
Q Consensus 15 ~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L 93 (1141)
.++.+..|.+..|+|+.+.+..|.++++|++|+|++|.|++..|..|+. +++|++|+|++|+|+.+|. .|.++++|
T Consensus 30 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L 106 (477)
T 2id5_A 30 IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN---LFNLRTLGLRSNRLKLIPLGVFTGLSNL 106 (477)
T ss_dssp CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT---CTTCCEEECCSSCCCSCCTTSSTTCTTC
T ss_pred CCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhC---CccCCEEECCCCcCCccCcccccCCCCC
Confidence 3457999999999999999999999999999999999999988876654 4999999999999999986 47899999
Q ss_pred cEEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001143 94 RNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1141)
Q Consensus 94 ~~L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~L 171 (1141)
++|+|++|+|+.+ |..|.++++|+.|+|++|.+..++ ..|..+++|+.|+|++|.+... .+..|.++++|+.|+|
T Consensus 107 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~l~~L~~L~l 183 (477)
T 2id5_A 107 TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI---PTEALSHLHGLIVLRL 183 (477)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC---CHHHHTTCTTCCEEEE
T ss_pred CEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc---ChhHhcccCCCcEEeC
Confidence 9999999999966 667999999999999999977654 5799999999999999766432 3446888999999999
Q ss_pred cCCCCCccCc-cccCCCCCCEEEccCCccc-cccccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCC
Q 001143 172 CHFSIRYLPP-EIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSL 248 (1141)
Q Consensus 172 s~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~ 248 (1141)
++|.++.++. .|..+++|+.|+|++|.+. .+|..+....+|+.|+|++|+|+.+| ..+..+++|+.|+|++|+|+++
T Consensus 184 ~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 263 (477)
T 2id5_A 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263 (477)
T ss_dssp ESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCcc
Confidence 9999997654 6788888888888887654 66766666667788888888777776 3566677777888887777777
Q ss_pred CcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 249 GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 249 ~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
++..|..+++|+.|+|++|++++. .|..+.....+..+++++|.+...
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~ 311 (477)
T 2id5_A 264 EGSMLHELLRLQEIQLVGGQLAVV--EPYAFRGLNYLRVLNVSGNQLTTL 311 (477)
T ss_dssp CTTSCTTCTTCCEEECCSSCCSEE--CTTTBTTCTTCCEEECCSSCCSCC
T ss_pred ChhhccccccCCEEECCCCccceE--CHHHhcCcccCCEEECCCCcCcee
Confidence 777777777777777777777762 455555566666666776666543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-28 Score=288.09 Aligned_cols=272 Identities=18% Similarity=0.183 Sum_probs=185.1
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~ 95 (1141)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..+..|+ ++++|++|+|++|+|+.+ |..|.++++|+.
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 132 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT---GLSNLTKLDISENKIVILLDYMFQDLYNLKS 132 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSST---TCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCccccc---CCCCCCEEECCCCccccCChhHccccccCCE
Confidence 4788888999999999889999999999999999999887766554 448899999999988866 456888888999
Q ss_pred EEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001143 96 LKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1141)
Q Consensus 96 L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1141)
|+|++|.|+.+ |..|.++++|+.|+|++|.++.++. .+..+++|+.|+|++|.+.. ..+..|..+++|+.|++++
T Consensus 133 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~---~~~~~~~~l~~L~~L~l~~ 209 (477)
T 2id5_A 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA---IRDYSFKRLYRLKVLEISH 209 (477)
T ss_dssp EEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE---ECTTCSCSCTTCCEEEEEC
T ss_pred EECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE---eChhhcccCcccceeeCCC
Confidence 99999988866 5568888888888888888777664 57888888888888865533 2233566666666666666
Q ss_pred CCCC-ccCccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCCCc
Q 001143 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 174 N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
|.+. .+|..+....+|+.|+|++|+|+.+| ..+..+++|+.|+|++|+|+.+| ..+..+++|+.|+|++|+|++++|
T Consensus 210 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 289 (477)
T 2id5_A 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289 (477)
T ss_dssp CTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECT
T ss_pred CccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECH
Confidence 5433 45554444456666666666666555 34555666666666666666543 334556666666666666666655
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCCch-hhhhcccCCCCCCCCCCccc
Q 001143 251 LDLCLMHNLQNLNLQYNKLLSYCQVPS-WICCNLEGNGKDSSNDDFIS 297 (1141)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N~L~~~~~iP~-~~~~~l~~~~l~~~~n~l~~ 297 (1141)
..|..+++|+.|+|++|+|+. +|. .+.....+..+++.+|.+.|
T Consensus 290 ~~~~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 290 YAFRGLNYLRVLNVSGNQLTT---LEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp TTBTTCTTCCEEECCSSCCSC---CCGGGBSCGGGCCEEECCSSCEEC
T ss_pred HHhcCcccCCEEECCCCcCce---eCHhHcCCCcccCEEEccCCCccC
Confidence 556666666666666666655 332 22333344445555555443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=277.07 Aligned_cols=267 Identities=18% Similarity=0.157 Sum_probs=194.9
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~L 96 (1141)
.++.|.+..|+|+.+.+..|.++++|++|+|++|++++.+|..|+.+ ++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCC---CCCCEEECCCCccCcCCHHHhcCCCCCcEE
Confidence 57777777777777777777777777777777777777766655443 7777777777777777765 4677777777
Q ss_pred EccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCC---------------cccchhhh
Q 001143 97 KFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPS---------------VLTLLSEI 160 (1141)
Q Consensus 97 ~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~---------------~~~lp~~l 160 (1141)
+|++|.|+.+ |..|.++++|+.|+|++|.++.++ +..+++|+.|++++|.+... ...+|..
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~- 223 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGP- 223 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECC-
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccccccCCCCcceEEECCCCeeeecccc-
Confidence 7777777766 344777777777777777766554 34444554444444333211 1111221
Q ss_pred cCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEe
Q 001143 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239 (1141)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~ 239 (1141)
..++|+.|++++|.++.+ ..+..+++|+.|+|++|.|+.+ |..+..+++|+.|+|++|+|+.+|..+..+++|+.|+
T Consensus 224 -~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~ 301 (390)
T 3o6n_A 224 -VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLD 301 (390)
T ss_dssp -CCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEE
T ss_pred -ccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEE
Confidence 235788889999998876 4678889999999999999855 7788889999999999999998888888889999999
Q ss_pred CCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 240 Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
|++|+|+++++ .+..+++|+.|+|++|+++. +| +........+++.+|.+.|.
T Consensus 302 L~~n~l~~~~~-~~~~l~~L~~L~L~~N~i~~---~~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 302 LSHNHLLHVER-NQPQFDRLENLYLDHNSIVT---LK--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CCSSCCCCCGG-GHHHHTTCSEEECCSSCCCC---CC--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCcceecCc-cccccCcCCEEECCCCccce---eC--chhhccCCEEEcCCCCccch
Confidence 99999987765 67788899999999999886 44 44455667788888888764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=305.58 Aligned_cols=272 Identities=16% Similarity=0.157 Sum_probs=169.6
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCC-CCC-CCcccccCC---CCCCCccEEEeecCCCCccCc--ccc
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT-VDF-PLIESYGNR---GGDNSVEGLYLYKNVLNLIPK--SVG 88 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~-Ls~-~~p~~~~~l---~~L~~L~~L~Ls~N~Lt~iP~--~l~ 88 (1141)
-+.++.|.+..|++.+..+..|.++++|++|+|++|+ +++ .+|..++.+ ..+++|++|+|++|+|+.||. .|.
T Consensus 248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~ 327 (636)
T 4eco_A 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327 (636)
T ss_dssp CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHT
T ss_pred cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhc
Confidence 3578899999999999889999999999999999998 998 777766542 233678888888888888887 788
Q ss_pred CCcCCcEEEccCCCCC-cCchhhcCCCCCCEEEccCCCCCCCcccccCCCC-CCEEECCCCCCCCCcccchhhhcC----
Q 001143 89 RYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKG-LKELELSKVPPRPSVLTLLSEIAG---- 162 (1141)
Q Consensus 89 ~L~~L~~L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~-L~~L~Ls~N~ln~~~~~lp~~l~~---- 162 (1141)
++++|+.|+|++|+|+ .+| .|+++++|+.|+|++|.+..+|..+..+++ |++|++++|.+. .+|..+..
T Consensus 328 ~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~----~lp~~~~~~~l~ 402 (636)
T 4eco_A 328 KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK----YIPNIFDAKSVS 402 (636)
T ss_dssp TCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS----SCCSCCCTTCSS
T ss_pred cCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc----ccchhhhhcccC
Confidence 8888888888888887 777 677777777777777776666666777777 777777775543 33433333
Q ss_pred -----------------------------CCCCcEEEccCCCCCccCccc-cCCCCCCEEEccCCccccccccccCC---
Q 001143 163 -----------------------------LKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYL--- 209 (1141)
Q Consensus 163 -----------------------------L~~L~~L~Ls~N~L~~iP~~l-~~l~~L~~L~Ls~N~L~~iP~~l~~l--- 209 (1141)
+++|+.|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.+|..+...
T Consensus 403 ~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~ 482 (636)
T 4eco_A 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482 (636)
T ss_dssp CEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTE
T ss_pred ccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccc
Confidence 334444444444444444432 23445555555555555444332221
Q ss_pred -----CCCCEEEccCCCCCcCCcCcc--CCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEcc------CCcCCCCCCCc
Q 001143 210 -----KALISLKVANNKLVELPSGLY--LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ------YNKLLSYCQVP 276 (1141)
Q Consensus 210 -----~~L~~L~Ls~N~L~~IP~~l~--~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls------~N~L~~~~~iP 276 (1141)
++|+.|+|++|+|+.||..++ .+++|+.|+|++|+|+++ |..+..+++|+.|+|+ +|++.+ .+|
T Consensus 483 ~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~i-p~~~~~l~~L~~L~Ls~N~~ls~N~l~~--~~p 559 (636)
T 4eco_A 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLR--EWP 559 (636)
T ss_dssp ECTTGGGCCEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSSC-CCGGGGCSSCCEEECCSCBCTTCCBCCC--CCC
T ss_pred cccccCCccEEECcCCcCCccChhhhhccCCCcCEEECCCCCCCCc-ChhhhcCCCCCEEECCCCcccccCcccc--cCh
Confidence 145555555555555555544 455555555555555552 3344455555555552 333333 345
Q ss_pred hhhhhcccCCCCCCCCCCc
Q 001143 277 SWICCNLEGNGKDSSNDDF 295 (1141)
Q Consensus 277 ~~~~~~l~~~~l~~~~n~l 295 (1141)
..+.....+..+++++|.+
T Consensus 560 ~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 560 EGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp TTGGGCSSCCEEECCSSCC
T ss_pred HHHhcCCCCCEEECCCCcC
Confidence 5555444555555555554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=275.59 Aligned_cols=224 Identities=19% Similarity=0.176 Sum_probs=190.1
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEE
Q 001143 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL 119 (1141)
Q Consensus 40 l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L 119 (1141)
...++.|+|++|+|+. +|..++.+ ++|++|+|++|.|+.+|..|.++++|++|+|++|+|+.+|..|+++++|++|
T Consensus 80 ~~~l~~L~L~~n~l~~-lp~~l~~l---~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 80 QPGRVALELRSVPLPQ-FPDQAFRL---SHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLREL 155 (328)
T ss_dssp STTCCEEEEESSCCSS-CCSCGGGG---TTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEE
T ss_pred ccceeEEEccCCCchh-cChhhhhC---CCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEE
Confidence 4689999999999994 55555544 8999999999999999999999999999999999999999999999999999
Q ss_pred EccCCC-CCCCcccccC---------CCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCC
Q 001143 120 QIKISS-PGVNGFALNK---------LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189 (1141)
Q Consensus 120 ~Ls~N~-l~~~~~~~~~---------L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L 189 (1141)
+|++|+ ++.+|..+.. +++|++|+|++|.+. .+|..+..+++|+.|+|++|+++.+|..++.+++|
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~----~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L 231 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR----SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKL 231 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC----CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTC
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC----cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCC
Confidence 999966 7777776554 888888888886554 66777888888888888888888888888888888
Q ss_pred CEEEccCCccc-cccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCC
Q 001143 190 EQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 190 ~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
+.|+|++|++. .+|..++.+++|+.|+|++|++. .+|..+.++++|+.|+|++|++.+.+|..+..|++|+.+++..|
T Consensus 232 ~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp CEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred CEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 88888888776 77888888888888888887665 77888888888888888888888888888888888888888888
Q ss_pred cCCC
Q 001143 268 KLLS 271 (1141)
Q Consensus 268 ~L~~ 271 (1141)
.+..
T Consensus 312 ~~~~ 315 (328)
T 4fcg_A 312 LQAQ 315 (328)
T ss_dssp GSCC
T ss_pred HHHH
Confidence 7665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=311.47 Aligned_cols=271 Identities=16% Similarity=0.154 Sum_probs=187.6
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCC-CCC-CCcccccCC----CCCCCccEEEeecCCCCccCc--ccc
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT-VDF-PLIESYGNR----GGDNSVEGLYLYKNVLNLIPK--SVG 88 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~-Ls~-~~p~~~~~l----~~L~~L~~L~Ls~N~Lt~iP~--~l~ 88 (1141)
++++.|.+..|++....+..|.++++|+.|+|++|+ |++ .+|..++.+ ..+++|++|+|++|.|+.||. .|.
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~ 570 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQ 570 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHT
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhh
Confidence 478899999999888888999999999999999998 988 777766533 355689999999999999988 889
Q ss_pred CCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCC-CCEEECCCCCCCCCcccchhhhcCCC---
Q 001143 89 RYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKG-LKELELSKVPPRPSVLTLLSEIAGLK--- 164 (1141)
Q Consensus 89 ~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~-L~~L~Ls~N~ln~~~~~lp~~l~~L~--- 164 (1141)
++++|+.|+|++|+|+.|| .|+++++|+.|+|++|.+..+|..+..+++ |+.|+|++|.+. .+|..+..+.
T Consensus 571 ~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~----~lp~~~~~~~~~~ 645 (876)
T 4ecn_A 571 KMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK----YIPNIFNAKSVYV 645 (876)
T ss_dssp TCTTCCEEECTTSCCCBCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC----SCCSCCCTTCSSC
T ss_pred cCCCCCEEECCCCCcccch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC----cCchhhhccccCC
Confidence 9999999999999999888 888889999999998888888888888888 888888887654 3344443332
Q ss_pred ----------------------------CCcEEEccCCCCCccCccc-cCCCCCCEEEccCCccccccccccCC------
Q 001143 165 ----------------------------CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYL------ 209 (1141)
Q Consensus 165 ----------------------------~L~~L~Ls~N~L~~iP~~l-~~l~~L~~L~Ls~N~L~~iP~~l~~l------ 209 (1141)
+|+.|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.+|..+...
T Consensus 646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~ 725 (876)
T 4ecn_A 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725 (876)
T ss_dssp EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCT
T ss_pred CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccccccc
Confidence 4455555555555555443 24555566666666555555443332
Q ss_pred --CCCCEEEccCCCCCcCCcCcc--CCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccC------CcCCCCCCCchhh
Q 001143 210 --KALISLKVANNKLVELPSGLY--LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY------NKLLSYCQVPSWI 279 (1141)
Q Consensus 210 --~~L~~L~Ls~N~L~~IP~~l~--~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~------N~L~~~~~iP~~~ 279 (1141)
++|+.|+|++|+|+.||..++ .+++|+.|+|++|+|+++ |..+..+++|+.|+|++ |++.+ .+|..+
T Consensus 726 nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~l-p~~l~~L~~L~~L~Ls~N~~ls~N~l~~--~ip~~l 802 (876)
T 4ecn_A 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRDAEGNRILR--QWPTGI 802 (876)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSSC-CCGGGGCTTCCEEECCCCBCTTCCBCCC--CCCTTG
T ss_pred ccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCcc-chhhhcCCCCCEEECCCCCCcccccccc--cChHHH
Confidence 256666666666665555555 556666666666666653 33555566666666544 34443 355555
Q ss_pred hhcccCCCCCCCCCCc
Q 001143 280 CCNLEGNGKDSSNDDF 295 (1141)
Q Consensus 280 ~~~l~~~~l~~~~n~l 295 (1141)
..+..+..+++++|.+
T Consensus 803 ~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 803 TTCPSLIQLQIGSNDI 818 (876)
T ss_dssp GGCSSCCEEECCSSCC
T ss_pred hcCCCCCEEECCCCCC
Confidence 5555555555555555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=304.96 Aligned_cols=270 Identities=17% Similarity=0.173 Sum_probs=228.7
Q ss_pred CCcccccCCCCCcccc-----------------CCCCCC--CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeec
Q 001143 17 PIKEKLPSEANKINNE-----------------KNGSVN--DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK 77 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i-----------------~~~~f~--~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~ 77 (1141)
+.++.|.+..|+|++. -+..+. ++++|++|+|++|++.+.+|..++.+ ++|++|+|++
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~ 282 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL---PEMQLINVAC 282 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC---SSCCEEECTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC---CCCCEEECcC
Confidence 4788899999999994 567777 99999999999999999999776554 9999999999
Q ss_pred CC-CC--ccCccccCC------cCCcEEEccCCCCCcCch--hhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECC
Q 001143 78 NV-LN--LIPKSVGRY------EKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELS 145 (1141)
Q Consensus 78 N~-Lt--~iP~~l~~L------~~L~~L~Ls~N~L~~lP~--~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls 145 (1141)
|+ |+ .+|..++++ ++|++|+|++|+|+.+|. .|+++++|+.|+|++|.+. .+| .+..+++|++|+++
T Consensus 283 n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~ 361 (636)
T 4eco_A 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361 (636)
T ss_dssp CTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC
T ss_pred CCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC
Confidence 98 88 489888876 899999999999999998 8999999999999999987 888 89999999999999
Q ss_pred CCCCCCCcccchhhhcCCCC-CcEEEccCCCCCccCccccCCC--CCCEEEccCCccc-ccccccc-------CCCCCCE
Q 001143 146 KVPPRPSVLTLLSEIAGLKC-LTKLSVCHFSIRYLPPEIGCLS--NLEQLDLSFNKMK-YLPTEIC-------YLKALIS 214 (1141)
Q Consensus 146 ~N~ln~~~~~lp~~l~~L~~-L~~L~Ls~N~L~~iP~~l~~l~--~L~~L~Ls~N~L~-~iP~~l~-------~l~~L~~ 214 (1141)
+|.+. .+|..+..+++ |+.|++++|+|+.+|..+..+. +|+.|+|++|+|+ .+|..+. .+++|+.
T Consensus 362 ~N~l~----~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~ 437 (636)
T 4eco_A 362 YNQIT----EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437 (636)
T ss_dssp SSEEE----ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE
T ss_pred CCccc----cccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE
Confidence 96543 78888999999 9999999999999998877655 8999999999988 5677777 7778888
Q ss_pred EEccCCCCCcCCcCccC-CCCCCEEeCCCCCCCCCCcccccCCC-------CCCEEEccCCcCCCCCCCchhhh--hccc
Q 001143 215 LKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMH-------NLQNLNLQYNKLLSYCQVPSWIC--CNLE 284 (1141)
Q Consensus 215 L~Ls~N~L~~IP~~l~~-L~~L~~L~Ls~N~Lt~~~p~~l~~L~-------~L~~L~Ls~N~L~~~~~iP~~~~--~~l~ 284 (1141)
|+|++|+|+.+|..++. +++|+.|+|++|+|+.+++..+..+. +|+.|+|++|+++. +|..+. .+..
T Consensus 438 L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~---lp~~~~~~~l~~ 514 (636)
T 4eco_A 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK---LSDDFRATTLPY 514 (636)
T ss_dssp EECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCB---CCGGGSTTTCTT
T ss_pred EECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCc---cChhhhhccCCC
Confidence 99999988888877654 88888888888888876665554433 88888888888885 787776 6677
Q ss_pred CCCCCCCCCCccc
Q 001143 285 GNGKDSSNDDFIS 297 (1141)
Q Consensus 285 ~~~l~~~~n~l~~ 297 (1141)
...+++++|.+.+
T Consensus 515 L~~L~Ls~N~l~~ 527 (636)
T 4eco_A 515 LVGIDLSYNSFSK 527 (636)
T ss_dssp CCEEECCSSCCSS
T ss_pred cCEEECCCCCCCC
Confidence 7778888887776
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=306.44 Aligned_cols=270 Identities=17% Similarity=0.169 Sum_probs=200.2
Q ss_pred CCcccccCCCCCcccc-----------------CCCCCC--CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeec
Q 001143 17 PIKEKLPSEANKINNE-----------------KNGSVN--DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK 77 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i-----------------~~~~f~--~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~ 77 (1141)
++++.|.+..|+|++. -|..+. ++++|++|+|++|++.+.+|..++.+ ++|+.|+|++
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L---~~L~~L~Ls~ 524 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL---PELQSLNIAC 524 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC---SSCCEEECTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC---CCCCEEECcC
Confidence 4789999999999991 345555 99999999999999999999887666 9999999999
Q ss_pred CC-CCc--cCccccCCc-------CCcEEEccCCCCCcCch--hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001143 78 NV-LNL--IPKSVGRYE-------KLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1141)
Q Consensus 78 N~-Lt~--iP~~l~~L~-------~L~~L~Ls~N~L~~lP~--~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls 145 (1141)
|+ |+. +|..|++++ +|+.|+|++|+|+.||. .|+++++|+.|+|++|.+..+| .+..+++|+.|+|+
T Consensus 525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCCBCC-CCCTTSEESEEECC
T ss_pred CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcccch-hhcCCCcceEEECc
Confidence 98 884 898777665 99999999999999999 8999999999999999998888 89999999999999
Q ss_pred CCCCCCCcccchhhhcCCCC-CcEEEccCCCCCccCccccCCCC--CCEEEccCCccccc-c---cccc--CCCCCCEEE
Q 001143 146 KVPPRPSVLTLLSEIAGLKC-LTKLSVCHFSIRYLPPEIGCLSN--LEQLDLSFNKMKYL-P---TEIC--YLKALISLK 216 (1141)
Q Consensus 146 ~N~ln~~~~~lp~~l~~L~~-L~~L~Ls~N~L~~iP~~l~~l~~--L~~L~Ls~N~L~~i-P---~~l~--~l~~L~~L~ 216 (1141)
+|.+. .+|..+.++++ |+.|+|++|+|+.+|..+..++. |+.|+|++|+|+.. | ..+. .+++|+.|+
T Consensus 604 ~N~l~----~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~ 679 (876)
T 4ecn_A 604 YNQIE----EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679 (876)
T ss_dssp SSCCS----CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEE
T ss_pred CCccc----cchHHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEE
Confidence 97664 67888999999 99999999999999987766543 77777777766522 2 1222 223555666
Q ss_pred ccCCCCCcCCcCcc-CCCCCCEEeCCCCCCCCCCcccccCC-------CCCCEEEccCCcCCCCCCCchhhh--hcccCC
Q 001143 217 VANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLM-------HNLQNLNLQYNKLLSYCQVPSWIC--CNLEGN 286 (1141)
Q Consensus 217 Ls~N~L~~IP~~l~-~L~~L~~L~Ls~N~Lt~~~p~~l~~L-------~~L~~L~Ls~N~L~~~~~iP~~~~--~~l~~~ 286 (1141)
|++|+|+.+|..++ .+++|+.|+|++|+|+.+++..+..+ ++|+.|+|++|+|+. +|..+. .+..+.
T Consensus 680 Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~---lp~~l~~~~l~~L~ 756 (876)
T 4ecn_A 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS---LSDDFRATTLPYLS 756 (876)
T ss_dssp CCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCC---CCGGGSTTTCTTCC
T ss_pred ccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCcc---chHHhhhccCCCcC
Confidence 66666655555544 45555555555555554444332221 155555555555553 555544 444455
Q ss_pred CCCCCCCCccc
Q 001143 287 GKDSSNDDFIS 297 (1141)
Q Consensus 287 ~l~~~~n~l~~ 297 (1141)
.+++++|.+.+
T Consensus 757 ~L~Ls~N~L~~ 767 (876)
T 4ecn_A 757 NMDVSYNCFSS 767 (876)
T ss_dssp EEECCSSCCSS
T ss_pred EEEeCCCCCCc
Confidence 55555555544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=290.58 Aligned_cols=276 Identities=18% Similarity=0.161 Sum_probs=230.3
Q ss_pred CCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCC
Q 001143 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKL 93 (1141)
Q Consensus 15 ~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L 93 (1141)
-++.++.|.+..|+|+.+.+..|.++++|++|||++|+|++..|..|+. +++|++|+|++|+|+.+ |..|.++++|
T Consensus 31 l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~---l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 107 (606)
T 3t6q_A 31 LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS---QHRLDTLVLTANPLIFMAETALSGPKAL 107 (606)
T ss_dssp SCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTT---CTTCCEEECTTCCCSEECTTTTSSCTTC
T ss_pred CCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccC---ccccCeeeCCCCcccccChhhhcccccc
Confidence 4557999999999999999999999999999999999999988877655 49999999999999976 6689999999
Q ss_pred cEEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc--EE
Q 001143 94 RNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT--KL 169 (1141)
Q Consensus 94 ~~L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~--~L 169 (1141)
++|+|++|+|+.+ |..|+++++|++|+|++|.+..++ ..+..+++|++|++++|.+. ...|..|+.+++|+ .|
T Consensus 108 ~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~l~L 184 (606)
T 3t6q_A 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH---YLSKEDMSSLQQATNLSL 184 (606)
T ss_dssp CEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC---EECHHHHHTTTTCCSEEE
T ss_pred cEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc---ccChhhhhhhcccceeEE
Confidence 9999999999988 677999999999999999988764 45666999999999996654 44466788889998 89
Q ss_pred EccCCCCCccCccccCCC----------------------------------------------------CCCEEEccCC
Q 001143 170 SVCHFSIRYLPPEIGCLS----------------------------------------------------NLEQLDLSFN 197 (1141)
Q Consensus 170 ~Ls~N~L~~iP~~l~~l~----------------------------------------------------~L~~L~Ls~N 197 (1141)
++++|.++.+++...... +|+.|+|++|
T Consensus 185 ~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n 264 (606)
T 3t6q_A 185 NLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264 (606)
T ss_dssp ECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTC
T ss_pred ecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecC
Confidence 999999997654332222 5778888888
Q ss_pred ccccccc-cccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCc
Q 001143 198 KMKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1141)
Q Consensus 198 ~L~~iP~-~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1141)
.++.+|. .|..+++|+.|+|++|+++.+|..+..+++|+.|+|++|++++++|..+..+++|+.|++++|.+.+ .+|
T Consensus 265 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~--~~~ 342 (606)
T 3t6q_A 265 YFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL--ELG 342 (606)
T ss_dssp CCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCC--BCC
T ss_pred ccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccc--ccc
Confidence 8887754 4888899999999999999999889889999999999999998888888899999999999998875 354
Q ss_pred hh-hhhcccCCCCCCCCCCcccC
Q 001143 277 SW-ICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 277 ~~-~~~~l~~~~l~~~~n~l~~~ 298 (1141)
.. +........++++.|.+.+.
T Consensus 343 ~~~~~~l~~L~~L~l~~n~l~~~ 365 (606)
T 3t6q_A 343 TGCLENLENLRELDLSHDDIETS 365 (606)
T ss_dssp SSTTTTCTTCCEEECCSSCCCEE
T ss_pred hhhhhccCcCCEEECCCCccccc
Confidence 43 55556666777777766543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=292.64 Aligned_cols=267 Identities=18% Similarity=0.165 Sum_probs=165.8
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~L 96 (1141)
.+..|.+..|+|+.+.+..|.++++|++|+|++|.|++.+|..|+.+ ++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCC---CCCCEEEeeCCCCCCCCHHHhccCCCCCEE
Confidence 46666666666666666666666666666666666666665544333 6666666666666666554 4566666666
Q ss_pred EccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCC---------------cccchhhh
Q 001143 97 KFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPS---------------VLTLLSEI 160 (1141)
Q Consensus 97 ~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~---------------~~~lp~~l 160 (1141)
+|++|.|+.+ |..|+++++|+.|+|++|.++.++ +..+++|+.|++++|.+..+ +..+|..+
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~ 230 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPV 230 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSC
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCccccccCCchhheeeccCCccccccccc
Confidence 6666666654 334666666666666666655443 33444444444444333211 00111111
Q ss_pred cCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEe
Q 001143 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239 (1141)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~ 239 (1141)
.++|+.|+|++|.++.+ ..++.+++|+.|+|++|.|+.+ |..|+.+++|+.|+|++|+|+.+|..+..+++|+.|+
T Consensus 231 --~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~ 307 (597)
T 3oja_B 231 --NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLD 307 (597)
T ss_dssp --CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEE
T ss_pred --CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEE
Confidence 13566666666666653 4566777777777777777744 6677777777777777777777777777777777777
Q ss_pred CCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 240 Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
|++|+|+++++ .+..+++|+.|+|++|+|++ +| +..+..+..+++++|.+.|.
T Consensus 308 Ls~N~l~~i~~-~~~~l~~L~~L~L~~N~l~~---~~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 308 LSHNHLLHVER-NQPQFDRLENLYLDHNSIVT---LK--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CCSSCCCCCGG-GHHHHTTCSEEECCSSCCCC---CC--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCCccCc-ccccCCCCCEEECCCCCCCC---cC--hhhcCCCCEEEeeCCCCCCh
Confidence 77777776544 56777777777777777766 33 33344556666777776654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=278.39 Aligned_cols=272 Identities=17% Similarity=0.165 Sum_probs=229.1
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~ 95 (1141)
+++..+.+..|.|+.++...|.++++|++|+|++|.|++..+..|+. +++|++|+|++|.|+.+|+ .|.++++|++
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAY---AHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTT---CTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccC---CCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 46788889999999999999999999999999999999888766654 5999999999999998864 5899999999
Q ss_pred EEccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhh-------------h
Q 001143 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSE-------------I 160 (1141)
Q Consensus 96 L~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~-------------l 160 (1141)
|+|++|+|+.+|.. |.++++|++|+|++|.+..++ ..+..+++|++|++++|.+.......... +
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEE
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccccc
Confidence 99999999999877 589999999999999977765 56999999999999998775442111101 1
Q ss_pred cCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEe
Q 001143 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLD 239 (1141)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~ 239 (1141)
...++|+.|++++|.++.+|.. .+++|+.|+|++|.|+.+ ..+..+++|+.|+|++|.|+.+ |..+..+++|+.|+
T Consensus 202 ~~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVVRGP--VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278 (390)
T ss_dssp ECCSSCSEEECCSSCCCEEECC--CCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred CCCCcceEEECCCCeeeecccc--ccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEE
Confidence 2224566666677776666543 357899999999999987 4789999999999999999966 88899999999999
Q ss_pred CCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 240 Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
|++|+|++++. .+..+++|+.|+|++|+++. +|..+..+.....+++.+|.+...
T Consensus 279 L~~n~l~~~~~-~~~~l~~L~~L~L~~n~l~~---~~~~~~~l~~L~~L~L~~N~i~~~ 333 (390)
T 3o6n_A 279 ISNNRLVALNL-YGQPIPTLKVLDLSHNHLLH---VERNQPQFDRLENLYLDHNSIVTL 333 (390)
T ss_dssp CCSSCCCEEEC-SSSCCTTCCEEECCSSCCCC---CGGGHHHHTTCSEEECCSSCCCCC
T ss_pred CCCCcCcccCc-ccCCCCCCCEEECCCCccee---cCccccccCcCCEEECCCCcccee
Confidence 99999999754 67889999999999999986 888888888888899998887654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=273.55 Aligned_cols=223 Identities=22% Similarity=0.213 Sum_probs=204.9
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
.+++.|+|++|.|+.||..++++++|++|+|++|.|+.+|..|+++++|++|+|++|.+..+|..+..+++|++|+|++|
T Consensus 81 ~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n 160 (328)
T 4fcg_A 81 PGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRAC 160 (328)
T ss_dssp TTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEE
T ss_pred cceeEEEccCCCchhcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCC
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999994
Q ss_pred CCCCCcccchhhhc---------CCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEcc
Q 001143 148 PPRPSVLTLLSEIA---------GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~---------~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls 218 (1141)
+..+.+|..+. ++++|+.|+|++|+|+.+|..++.+++|+.|+|++|+|+.+|..++.+++|+.|+|+
T Consensus 161 ---~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls 237 (328)
T 4fcg_A 161 ---PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLR 237 (328)
T ss_dssp ---TTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECT
T ss_pred ---CCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECc
Confidence 44556666554 499999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCc
Q 001143 219 NNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDF 295 (1141)
Q Consensus 219 ~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l 295 (1141)
+|++. .+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+ .+|.++..+.....+.+..+.+
T Consensus 238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~--~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS--RLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC--CCCGGGGGSCTTCEEECCGGGS
T ss_pred CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh--hccHHHhhccCceEEeCCHHHH
Confidence 99886 789999999999999999999999999999999999999999999988 6999998877776666554433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=288.32 Aligned_cols=268 Identities=18% Similarity=0.136 Sum_probs=193.6
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1141)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|+|+.||.. .+++|++|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~lp~~--~l~~L~~L 95 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN---QELEYLDLSHNKLVKISCH--PTVNLKHL 95 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTC---TTCCEEECCSSCCCEEECC--CCCCCSEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcc---cCCCEEecCCCceeecCcc--ccCCccEE
Confidence 589999999999999999999999999999999999999888777555 9999999999999999877 89999999
Q ss_pred EccCCCCCc--CchhhcCCCCCCEEEccCCCCCCCcccccCCCCC--CEEECCCCCC-----------------------
Q 001143 97 KFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL--KELELSKVPP----------------------- 149 (1141)
Q Consensus 97 ~Ls~N~L~~--lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L--~~L~Ls~N~l----------------------- 149 (1141)
+|++|+|+. +|..|+++++|++|+|++|.+.. ..+..+++| ++|++++|.+
T Consensus 96 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK--SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp ECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred eccCCccccccchhhhccCCcceEEEecCcccch--hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 999999985 57899999999999999988653 223334444 4444444332
Q ss_pred --------------------------------------------------------------------------------
Q 001143 150 -------------------------------------------------------------------------------- 149 (1141)
Q Consensus 150 -------------------------------------------------------------------------------- 149 (1141)
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~ 253 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence
Q ss_pred ---CCCcccchhhh-----------------------------------------------------cCCCCCcEEEccC
Q 001143 150 ---RPSVLTLLSEI-----------------------------------------------------AGLKCLTKLSVCH 173 (1141)
Q Consensus 150 ---n~~~~~lp~~l-----------------------------------------------------~~L~~L~~L~Ls~ 173 (1141)
+.+.+.+|..+ ..+++|+.|++++
T Consensus 254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~ 333 (520)
T 2z7x_B 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333 (520)
T ss_dssp EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCS
T ss_pred eecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeEC
Confidence 00111222222 4556666777777
Q ss_pred CCCCc-cCccccCCCCCCEEEccCCcccc---ccccccCCCCCCEEEccCCCCCc-CCcC-ccCCCCCCEEeCCCCCCCC
Q 001143 174 FSIRY-LPPEIGCLSNLEQLDLSFNKMKY---LPTEICYLKALISLKVANNKLVE-LPSG-LYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 174 N~L~~-iP~~l~~l~~L~~L~Ls~N~L~~---iP~~l~~l~~L~~L~Ls~N~L~~-IP~~-l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
|+++. +|..++.+++|++|+|++|+|+. +|..++.+++|+.|+|++|+++. +|.. +..+++|+.|+|++|+|++
T Consensus 334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 77664 56666667777777777777763 34556667777777777777765 6654 5556677777777777766
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcc
Q 001143 248 LGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFI 296 (1141)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~ 296 (1141)
..|..+. ++|+.|+|++|+++. +|..+........+++.+|.+.
T Consensus 414 ~~~~~l~--~~L~~L~Ls~N~l~~---ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 414 TIFRCLP--PRIKVLDLHSNKIKS---IPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp GGGGSCC--TTCCEEECCSSCCCC---CCGGGGGCTTCCEEECCSSCCC
T ss_pred chhhhhc--ccCCEEECCCCcccc---cchhhhcCCCCCEEECCCCcCC
Confidence 5554432 577777777777764 7776666666777777777666
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=288.52 Aligned_cols=270 Identities=19% Similarity=0.136 Sum_probs=198.3
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+. +++|++|+|++|+|+.||.. .+++|++
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~---l~~L~~L~Ls~N~l~~lp~~--~l~~L~~ 125 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF---NQDLEYLDVSHNRLQNISCC--PMASLRH 125 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTT---CTTCCEEECTTSCCCEECSC--CCTTCSE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCC---CCCCCEEECCCCcCCccCcc--ccccCCE
Confidence 358999999999999999999999999999999999999988876654 49999999999999999987 8999999
Q ss_pred EEccCCCCCcC--chhhcCCCCCCEEEccCCCCCCCcccccCCCCC--CEEECCCCCC--CC------------------
Q 001143 96 LKFFGNEINLF--PSEVGNLLGLECLQIKISSPGVNGFALNKLKGL--KELELSKVPP--RP------------------ 151 (1141)
Q Consensus 96 L~Ls~N~L~~l--P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L--~~L~Ls~N~l--n~------------------ 151 (1141)
|+|++|+|+.+ |..|+++++|++|+|++|.+... .+..+++| ++|++++|.+ ..
T Consensus 126 L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l 203 (562)
T 3a79_B 126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203 (562)
T ss_dssp EECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEE
T ss_pred EECCCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEe
Confidence 99999999976 47899999999999999986642 34444444 6666665544 10
Q ss_pred --------------------------------------------------------------------------------
Q 001143 152 -------------------------------------------------------------------------------- 151 (1141)
Q Consensus 152 -------------------------------------------------------------------------------- 151 (1141)
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l 283 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEE
T ss_pred cCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEE
Confidence
Q ss_pred ----Ccccchhhh-----------------------------------------------------cCCCCCcEEEccCC
Q 001143 152 ----SVLTLLSEI-----------------------------------------------------AGLKCLTKLSVCHF 174 (1141)
Q Consensus 152 ----~~~~lp~~l-----------------------------------------------------~~L~~L~~L~Ls~N 174 (1141)
+.+.+|..+ ..+++|+.|++++|
T Consensus 284 ~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n 363 (562)
T 3a79_B 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363 (562)
T ss_dssp EEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred eccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCC
Confidence 001223222 45666777777777
Q ss_pred CCCc-cCccccCCCCCCEEEccCCccccc---cccccCCCCCCEEEccCCCCCc-CCcC-ccCCCCCCEEeCCCCCCCCC
Q 001143 175 SIRY-LPPEIGCLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVE-LPSG-LYLLQRLENLDLSNNRLTSL 248 (1141)
Q Consensus 175 ~L~~-iP~~l~~l~~L~~L~Ls~N~L~~i---P~~l~~l~~L~~L~Ls~N~L~~-IP~~-l~~L~~L~~L~Ls~N~Lt~~ 248 (1141)
+++. +|..++.+++|++|+|++|+|+.+ |..+..+++|+.|+|++|+++. +|.. +..+++|+.|+|++|+|++.
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence 7774 566667777777777777777744 3456677777777777777764 6654 45567777777777777665
Q ss_pred CcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCccc
Q 001143 249 GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297 (1141)
Q Consensus 249 ~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~ 297 (1141)
.|..+. ++|+.|+|++|+++. ||..+........+++++|.+..
T Consensus 444 ~~~~l~--~~L~~L~L~~N~l~~---ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 444 VFRCLP--PKVKVLDLHNNRIMS---IPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp GGSSCC--TTCSEEECCSSCCCC---CCTTTTSSCCCSEEECCSSCCCC
T ss_pred hhhhhc--CcCCEEECCCCcCcc---cChhhcCCCCCCEEECCCCCCCC
Confidence 553332 577777777777764 77766666666777777777663
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=285.88 Aligned_cols=82 Identities=16% Similarity=0.111 Sum_probs=61.6
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCcCCc
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEKLR 94 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~--iP~~l~~L~~L~ 94 (1141)
+.++.|.+..|+|+.+.+..|.++++|++|||++|+|+. +|.. .+++|++|+|++|.|+. +|..|.++++|+
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-----~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 118 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH-----PTVNLKHLDLSFNAFDALPICKEFGNMSQLK 118 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC-----CCCCCSEEECCSSCCSSCCCCGGGGGCTTCC
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc-----ccCCccEEeccCCccccccchhhhccCCcce
Confidence 368888888888888888888888888888888888874 3432 34778888888888775 456777777777
Q ss_pred EEEccCCCCC
Q 001143 95 NLKFFGNEIN 104 (1141)
Q Consensus 95 ~L~Ls~N~L~ 104 (1141)
+|+|++|.|+
T Consensus 119 ~L~L~~n~l~ 128 (520)
T 2z7x_B 119 FLGLSTTHLE 128 (520)
T ss_dssp EEEEEESSCC
T ss_pred EEEecCcccc
Confidence 7777777653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-27 Score=261.33 Aligned_cols=247 Identities=20% Similarity=0.210 Sum_probs=204.0
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcC-chhhcCCCCCCEEE
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQ 120 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~l-P~~~~~L~~L~~L~ 120 (1141)
.+++++++++++.++.. + .++|++|+|++|.|+.+|. .|.++++|++|+|++|.|+.+ |..|.++++|++|+
T Consensus 13 ~~~~~c~~~~l~~ip~~-~-----~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 86 (285)
T 1ozn_A 13 KVTTSCPQQGLQAVPVG-I-----PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86 (285)
T ss_dssp SCEEECCSSCCSSCCTT-C-----CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CeEEEcCcCCcccCCcC-C-----CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEe
Confidence 36788888888865432 1 2678888888888888764 588888888888888888866 66788888888888
Q ss_pred ccCCC-CCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCC
Q 001143 121 IKISS-PGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFN 197 (1141)
Q Consensus 121 Ls~N~-l~~~-~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N 197 (1141)
|++|. ++.+ +..+..+++|++|++++|.+.. ..|..|.++++|+.|++++|+++.+|. .+..+++|+.|+|++|
T Consensus 87 l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 163 (285)
T 1ozn_A 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE---LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (285)
T ss_dssp CCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC---CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCCCccccCHHHhcCCcCCCEEECCCCcCCE---ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence 88886 7766 5678888899999999866543 335678889999999999999998876 4789999999999999
Q ss_pred ccccccc-cccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCC
Q 001143 198 KMKYLPT-EICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV 275 (1141)
Q Consensus 198 ~L~~iP~-~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~i 275 (1141)
+|+.+|. .+..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..+..+++|+.|+|++|+|.|.|++
T Consensus 164 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred cccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence 9998875 588999999999999999966 88899999999999999999999998899999999999999999998887
Q ss_pred chhhhhcccCCCCCCCCCCcccCccc
Q 001143 276 PSWICCNLEGNGKDSSNDDFISSSAE 301 (1141)
Q Consensus 276 P~~~~~~l~~~~l~~~~n~l~~~~~~ 301 (1141)
.+...|..... ...+.+.|..|.
T Consensus 244 ~~~~~~l~~~~---~~~~~~~c~~p~ 266 (285)
T 1ozn_A 244 RPLWAWLQKFR---GSSSEVPCSLPQ 266 (285)
T ss_dssp HHHHHHHHHCC---SEECCCBEEESG
T ss_pred HHHHHHHHhcc---cccCccccCCch
Confidence 76555544332 445666666654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-26 Score=263.53 Aligned_cols=242 Identities=19% Similarity=0.230 Sum_probs=211.3
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L 96 (1141)
.+..+.+..+.++.++.... ++|++|+|++|+|++..+..|+. +++|++|+|++|.|+.+ |..|.++++|++|
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEIKDGDFKN---LKNLHTLILINNKISKISPGAFAPLVKLERL 105 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCC---TTCCEEECCSSCCCCBCTTTTTT---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCeEEEecCCCccccCccCC---CCCeEEECCCCcCCEeChhhhcc---CCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence 46677888888988875443 68999999999999988766654 49999999999999987 7789999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
+|++|+|+.+|..+. ++|+.|++++|.++.++. .+..+++|++|++++|.+.. .+..+..+.++++|+.|++++|.
T Consensus 106 ~Ls~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 106 YLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS-SGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp ECCSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG-GGBCTTGGGGCTTCCEEECCSSC
T ss_pred ECCCCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc-cCcChhhccCCCCcCEEECCCCc
Confidence 999999999998775 899999999999887764 68999999999999977632 33556788999999999999999
Q ss_pred CCccCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCCCcccc
Q 001143 176 IRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDL 253 (1141)
Q Consensus 176 L~~iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p~~l 253 (1141)
++.+|..+. ++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.++. .+
T Consensus 183 l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~l 259 (330)
T 1xku_A 183 ITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG-GL 259 (330)
T ss_dssp CCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT-TT
T ss_pred cccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCCh-hh
Confidence 999988664 8999999999999966 678999999999999999999775 478889999999999999997654 78
Q ss_pred cCCCCCCEEEccCCcCCC
Q 001143 254 CLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 254 ~~L~~L~~L~Ls~N~L~~ 271 (1141)
..+++|+.|+|++|+|++
T Consensus 260 ~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 260 ADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp TTCSSCCEEECCSSCCCC
T ss_pred ccCCCcCEEECCCCcCCc
Confidence 999999999999999987
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-27 Score=286.40 Aligned_cols=82 Identities=21% Similarity=0.137 Sum_probs=70.9
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC--ccccCCcCCc
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP--KSVGRYEKLR 94 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP--~~l~~L~~L~ 94 (1141)
+.++.|.+..|+|+.+.+..|.++++|++|||++|+|+.. |.. .+++|++|+|++|+|+.+| ..|.++++|+
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~-----~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~ 149 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI-SCC-----PMASLRHLDLSFNDFDVLPVCKEFGNLTKLT 149 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEE-CSC-----CCTTCSEEECCSSCCSBCCCCGGGGGCTTCC
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCcc-Ccc-----ccccCCEEECCCCCccccCchHhhcccCccc
Confidence 4799999999999999999999999999999999999854 432 4589999999999998764 6788999999
Q ss_pred EEEccCCCCC
Q 001143 95 NLKFFGNEIN 104 (1141)
Q Consensus 95 ~L~Ls~N~L~ 104 (1141)
+|+|++|+|+
T Consensus 150 ~L~L~~n~l~ 159 (562)
T 3a79_B 150 FLGLSAAKFR 159 (562)
T ss_dssp EEEEECSBCC
T ss_pred EEecCCCccc
Confidence 9999888875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=289.20 Aligned_cols=279 Identities=17% Similarity=0.128 Sum_probs=184.6
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~ 95 (1141)
+.+..|.+..|+|+.+.+..|.++++|++|||++|+|++..|..|+. +++|++|+|++|.|+.+ |..|.++++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~---l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 108 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHG---LHHLSNLILTGNPIQSFSPGSFSGLTSLEN 108 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT---CTTCCEEECTTCCCCCCCTTSSTTCTTCCE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhc---hhhcCEeECCCCcccccChhhcCCcccCCE
Confidence 45777777777777777777777777777777777777766655543 37777777777777765 556777777777
Q ss_pred EEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCCCCCccc-----------------
Q 001143 96 LKFFGNEINLFP-SEVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPPRPSVLT----------------- 155 (1141)
Q Consensus 96 L~Ls~N~L~~lP-~~~~~L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~N~ln~~~~~----------------- 155 (1141)
|+|++|.|+.+| ..|+++++|++|+|++|.+.. +|..+.++++|++|++++|.+......
T Consensus 109 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l 188 (606)
T 3vq2_A 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188 (606)
T ss_dssp EECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEEC
T ss_pred EEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeec
Confidence 777777776664 456777777777777777553 466677777777777666654321100
Q ss_pred --------------------------------------------------------------------------------
Q 001143 156 -------------------------------------------------------------------------------- 155 (1141)
Q Consensus 156 -------------------------------------------------------------------------------- 155 (1141)
T Consensus 189 ~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred cCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence
Q ss_pred -----------------------------------------------------c--------------------hhhhcC
Q 001143 156 -----------------------------------------------------L--------------------LSEIAG 162 (1141)
Q Consensus 156 -----------------------------------------------------l--------------------p~~l~~ 162 (1141)
+ +..+..
T Consensus 269 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhcc
Confidence 0 001223
Q ss_pred CCCCcEEEccCCCCCcc---CccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCC--cCccCCCCCCE
Q 001143 163 LKCLTKLSVCHFSIRYL---PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP--SGLYLLQRLEN 237 (1141)
Q Consensus 163 L~~L~~L~Ls~N~L~~i---P~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP--~~l~~L~~L~~ 237 (1141)
+++|+.|++++|+++.+ |..+..+++|+.|+|++|.++.+|..+..+++|+.|+|++|+++.++ ..+..+++|+.
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 44556666666666543 55666777788888888887777777777777777777777777553 36667777777
Q ss_pred EeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCc
Q 001143 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299 (1141)
Q Consensus 238 L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~ 299 (1141)
|+|++|++++.+|..+..+++|+.|++++|++++. .+|..+........+++++|.+.+..
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~ 489 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN-TLSNVFANTTNLTFLDLSKCQLEQIS 489 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG-EECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCc-chHHhhccCCCCCEEECCCCcCCccC
Confidence 77777777777776777777777777777777651 14555555566666666666665543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=279.36 Aligned_cols=244 Identities=18% Similarity=0.212 Sum_probs=138.2
Q ss_pred ccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEEccC
Q 001143 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFG 100 (1141)
Q Consensus 22 L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~Ls~ 100 (1141)
.....|+++.++...+ ++|++|+|++|+|++..+..|. ++++|++|+|++|.|+.++ ..|.++++|++|+|++
T Consensus 36 c~~~~~~l~~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 36 CKGSSGSLNSIPSGLT---EAVKSLDLSNNRITYISNSDLQ---RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp EECCSTTCSSCCTTCC---TTCCEEECTTSCCCEECTTTTT---TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eeCCCCCccccccccc---ccCcEEECCCCcCcccCHHHhc---cCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 4444455555544322 2455555555555544443332 2255555555555555442 3355555555555555
Q ss_pred CCCCcCchh-hcCCCCCCEEEccCCCCCCCcc--cccCCCCCCEEECCCCCCCCCcccc-hhhhcCCCCCcEEEccCCCC
Q 001143 101 NEINLFPSE-VGNLLGLECLQIKISSPGVNGF--ALNKLKGLKELELSKVPPRPSVLTL-LSEIAGLKCLTKLSVCHFSI 176 (1141)
Q Consensus 101 N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~~~--~~~~L~~L~~L~Ls~N~ln~~~~~l-p~~l~~L~~L~~L~Ls~N~L 176 (1141)
|+|+.+|.. |.++++|++|+|++|.++.+|. .+..+++|++|++++|. ....+ +..|.++++|+.|++++|++
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD---TFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS---SCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc---cccccCHHHccCCCCCCEEECCCCCc
Confidence 555555443 4555555555555555544443 44555555555555531 11122 23445555555555555555
Q ss_pred Ccc-CccccCCCCCCEEEccCCccccccccc-cCCCCCCEEEccCCCCCc------------------------------
Q 001143 177 RYL-PPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVE------------------------------ 224 (1141)
Q Consensus 177 ~~i-P~~l~~l~~L~~L~Ls~N~L~~iP~~l-~~l~~L~~L~Ls~N~L~~------------------------------ 224 (1141)
+.+ |..+..+++|+.|+|++|+++.+|..+ ..+++|+.|+|++|+++.
T Consensus 187 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l 266 (353)
T 2z80_A 187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266 (353)
T ss_dssp CEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHH
T ss_pred CccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcch
Confidence 533 444555555555555555555444332 234555555555555543
Q ss_pred --CCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 225 --LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 225 --IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
+|..+..+++|+.|+|++|+|+.+++..|..+++|+.|+|++|+|.|.|+
T Consensus 267 ~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 267 FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 45667789999999999999998887667999999999999999999653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-27 Score=265.65 Aligned_cols=241 Identities=18% Similarity=0.235 Sum_probs=200.3
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L 96 (1141)
.+..+.+..++++.++...+ ++|++|+|++|+|++..+..|.. +++|++|+|++|.|+.+ |..|.++++|++|
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEIS---PDTTLLDLQNNDISELRKDDFKG---LQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCC---TTCCEEECCSSCCCEECTTTTTT---CTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred cCCEEECCCCCccccCCCCC---CCCeEEECCCCcCCccCHhHhhC---CCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 36777888888888876543 68899999999999887766654 48999999999999977 6678999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
+|++|+|+.+|..+. ++|++|+|++|.++.++. .+..+++|++|++++|.+.. .+..|..+..+ +|+.|++++|+
T Consensus 108 ~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~l-~L~~L~l~~n~ 183 (332)
T 2ft3_A 108 YISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN-SGFEPGAFDGL-KLNYLRISEAK 183 (332)
T ss_dssp ECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG-GGSCTTSSCSC-CCSCCBCCSSB
T ss_pred ECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc-CCCCcccccCC-ccCEEECcCCC
Confidence 999999999988766 889999999999887775 58889999999999976532 23456677777 89999999999
Q ss_pred CCccCccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcccc
Q 001143 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDL 253 (1141)
Q Consensus 176 L~~iP~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l 253 (1141)
++.+|..+. ++|+.|+|++|.|+.++ ..+..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|+|+.+++ .+
T Consensus 184 l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~l 260 (332)
T 2ft3_A 184 LTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPA-GL 260 (332)
T ss_dssp CSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCT-TG
T ss_pred CCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecCh-hh
Confidence 999888654 78999999999999765 678889999999999999997754 68889999999999999996654 68
Q ss_pred cCCCCCCEEEccCCcCCC
Q 001143 254 CLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 254 ~~L~~L~~L~Ls~N~L~~ 271 (1141)
..+++|+.|+|++|++++
T Consensus 261 ~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 261 PDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp GGCTTCCEEECCSSCCCB
T ss_pred hcCccCCEEECCCCCCCc
Confidence 889999999999999987
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-27 Score=286.06 Aligned_cols=136 Identities=21% Similarity=0.203 Sum_probs=106.2
Q ss_pred cCCCCCcEEEccCCCCCc-cCc---cccCCCCCCEEEccCCcccccc---ccccCCCCCCEEEccCCCCCcCCcCccCCC
Q 001143 161 AGLKCLTKLSVCHFSIRY-LPP---EIGCLSNLEQLDLSFNKMKYLP---TEICYLKALISLKVANNKLVELPSGLYLLQ 233 (1141)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~-iP~---~l~~l~~L~~L~Ls~N~L~~iP---~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~ 233 (1141)
..+++|+.|++++|+++. +|. .++.+++|+.|+|++|+|+.+| ..+..+++|+.|+|++|+|+.+|..+..++
T Consensus 331 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~ 410 (549)
T 2z81_A 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPE 410 (549)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCT
T ss_pred hcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccc
Confidence 357889999999999884 332 3677888889999988888775 347888888888888888888888888888
Q ss_pred CCCEEeCCCCCCCCCCccc-----------------ccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcc
Q 001143 234 RLENLDLSNNRLTSLGSLD-----------------LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFI 296 (1141)
Q Consensus 234 ~L~~L~Ls~N~Lt~~~p~~-----------------l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~ 296 (1141)
+|+.|+|++|+|+.++... +..+++|+.|+|++|+|+. ||.. ........++++.|.+.
T Consensus 411 ~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~---ip~~-~~l~~L~~L~Ls~N~l~ 486 (549)
T 2z81_A 411 KMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT---LPDA-SLFPVLLVMKISRNQLK 486 (549)
T ss_dssp TCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSS---CCCG-GGCTTCCEEECCSSCCC
T ss_pred cccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCc---CCCc-ccCccCCEEecCCCccC
Confidence 8888888888777654321 1368899999999999986 7873 45667888889999888
Q ss_pred cCcc
Q 001143 297 SSSA 300 (1141)
Q Consensus 297 ~~~~ 300 (1141)
+..+
T Consensus 487 ~~~~ 490 (549)
T 2z81_A 487 SVPD 490 (549)
T ss_dssp CCCT
T ss_pred CcCH
Confidence 7655
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=284.89 Aligned_cols=278 Identities=14% Similarity=0.103 Sum_probs=191.3
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~ 95 (1141)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|++++..|..|+.+ ++|++|+|++|.|+.+ |..|.++++|++
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~L~~n~i~~l~~~~~~~l~~L~~ 133 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP---KALKHLFFIQTGISSIDFIPLHNQKTLES 133 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSC---TTCCEEECTTSCCSCGGGSCCTTCTTCCE
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhccc---ccccEeeccccCcccCCcchhccCCcccE
Confidence 479999999999999999999999999999999999999888776554 9999999999999988 567999999999
Q ss_pred EEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCCC-cccccCCCCCC--EEECCCCCCCCCcccch--------------
Q 001143 96 LKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVN-GFALNKLKGLK--ELELSKVPPRPSVLTLL-------------- 157 (1141)
Q Consensus 96 L~Ls~N~L~~lP-~~~~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~--~L~Ls~N~ln~~~~~lp-------------- 157 (1141)
|+|++|+|+.++ ..+..+++|++|+|++|.+..+ +..+..+++|+ .|++++|.+........
T Consensus 134 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~ 213 (606)
T 3t6q_A 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213 (606)
T ss_dssp EECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCS
T ss_pred EECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCch
Confidence 999999999763 3455699999999999997766 45788999999 88999876543221110
Q ss_pred --------------------------------hhhcCCC--CCcEEEccCCCCCccCc-cccCCCCCCEEEccCCccccc
Q 001143 158 --------------------------------SEIAGLK--CLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL 202 (1141)
Q Consensus 158 --------------------------------~~l~~L~--~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~i 202 (1141)
..+..+. +|+.|++++|.++.+|. .|..+++|++|+|++|+|+.+
T Consensus 214 ~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~l 293 (606)
T 3t6q_A 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293 (606)
T ss_dssp CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCC
T ss_pred hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCC
Confidence 0000000 45556666666665543 356666666666666666666
Q ss_pred cccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCc-ccccCCCCCCEEEccCCcCCCCCCCchhhh
Q 001143 203 PTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1141)
Q Consensus 203 P~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p-~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1141)
|..++.+++|++|+|++|+++.+ |..+..+++|+.|+|++|.+++..+ ..+..+++|+.|++++|.+++....|..+.
T Consensus 294 p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 373 (606)
T 3t6q_A 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373 (606)
T ss_dssp CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTT
T ss_pred ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcc
Confidence 66666666666666666666644 4455556666666666666653332 235566666666666666654211234444
Q ss_pred hcccCCCCCCCCCCccc
Q 001143 281 CNLEGNGKDSSNDDFIS 297 (1141)
Q Consensus 281 ~~l~~~~l~~~~n~l~~ 297 (1141)
.......+.++.|.+.+
T Consensus 374 ~l~~L~~L~l~~n~l~~ 390 (606)
T 3t6q_A 374 NLSHLQSLNLSYNEPLS 390 (606)
T ss_dssp TCTTCCEEECCSCSCEE
T ss_pred cCCCCCEEECCCCcCCc
Confidence 44445555555554433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=286.97 Aligned_cols=265 Identities=15% Similarity=0.088 Sum_probs=147.5
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l~~L~~L~~ 95 (1141)
++++.+.+..|.++.++ .+..+++|+.|+|++|.+ +.+|. + .+++|++|+|++|... .+ .+..+++|++
T Consensus 285 ~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l-~~lp~-~----~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~ 354 (606)
T 3vq2_A 285 ANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQL-KQFPT-L----DLPFLKSLTLTMNKGSISF--KKVALPSLSY 354 (606)
T ss_dssp TTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCC-SSCCC-C----CCSSCCEEEEESCSSCEEC--CCCCCTTCCE
T ss_pred CCCCEEEecCccchhhh--hccccccCCEEEcccccC-ccccc-C----CCCccceeeccCCcCccch--hhccCCCCCE
Confidence 35667777777777765 677777778888887777 44443 2 3355666666665332 22 3445555666
Q ss_pred EEccCCCCCcC---chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccch-hhhcCCCCCcEEEc
Q 001143 96 LKFFGNEINLF---PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSV 171 (1141)
Q Consensus 96 L~Ls~N~L~~l---P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp-~~l~~L~~L~~L~L 171 (1141)
|+|++|+|+.+ |..+..+++|+.|+|++|.+..+|..+..+++|+.|++++|.+. +..| ..+..+++|+.|++
T Consensus 355 L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~---~~~~~~~~~~l~~L~~L~l 431 (606)
T 3vq2_A 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLK---RVTEFSAFLSLEKLLYLDI 431 (606)
T ss_dssp EECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEE---STTTTTTTTTCTTCCEEEC
T ss_pred EECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccC---CccChhhhhccccCCEEEC
Confidence 66666655533 45555556666666665555555555555555666666553322 1222 34555555555555
Q ss_pred cCCCCCc-cCccccCCCCCCEEEccCCcccc--ccccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCC
Q 001143 172 CHFSIRY-LPPEIGCLSNLEQLDLSFNKMKY--LPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 172 s~N~L~~-iP~~l~~l~~L~~L~Ls~N~L~~--iP~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
++|.++. +|..+..+++|++|+|++|+++. +|..++.+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|++++
T Consensus 432 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 511 (606)
T 3vq2_A 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511 (606)
T ss_dssp TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCC
Confidence 5555553 34445555555555555555553 455555555555555555555533 3445555555555555555555
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcc-cCCCCCCCCCCccc
Q 001143 248 LGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL-EGNGKDSSNDDFIS 297 (1141)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l-~~~~l~~~~n~l~~ 297 (1141)
.+|..|..+++|+.|+|++|+|+. +|..+.... ....+++.+|.+.|
T Consensus 512 ~~~~~~~~l~~L~~L~l~~N~l~~---~p~~~~~l~~~L~~l~l~~N~~~c 559 (606)
T 3vq2_A 512 LDSSHYNQLYSLSTLDCSFNRIET---SKGILQHFPKSLAFFNLTNNSVAC 559 (606)
T ss_dssp EEGGGTTTCTTCCEEECTTSCCCC---EESCGGGSCTTCCEEECCSCCCCC
T ss_pred cCHHHccCCCcCCEEECCCCcCcc---cCHhHhhhcccCcEEEccCCCccc
Confidence 555555555555555555555553 554444333 24455555555544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-26 Score=259.57 Aligned_cols=263 Identities=18% Similarity=0.178 Sum_probs=210.3
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1141)
+.++.|.+..|+|+.+.+ |.++++|++|+|++|.++.. + . +.++++|++|+|++|.++.+|. +..+++|+.|
T Consensus 66 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~-~-~---~~~l~~L~~L~l~~n~i~~~~~-~~~l~~L~~L 137 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI-S-A---LQNLTNLRELYLNEDNISDISP-LANLTKMYSL 137 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-G---GTTCTTCSEEECTTSCCCCCGG-GTTCTTCCEE
T ss_pred CCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc-h-H---HcCCCcCCEEECcCCcccCchh-hccCCceeEE
Confidence 478999999999999877 99999999999999999874 2 2 4556999999999999998876 8899999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001143 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1141)
+|++|.....+..+..+++|+.|++++|.+...+. +..+++|++|++++|.+... +. +..+++|+.|++++|.+
T Consensus 138 ~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~----~~-~~~l~~L~~L~l~~n~l 211 (347)
T 4fmz_A 138 NLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDI----SP-LASLTSLHYFTAYVNQI 211 (347)
T ss_dssp ECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCCC----GG-GGGCTTCCEEECCSSCC
T ss_pred ECCCCCCcccccchhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCccccc----cc-ccCCCccceeecccCCC
Confidence 99999655444458899999999999999777766 88899999999998766433 22 66778888888888888
Q ss_pred CccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCC
Q 001143 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1141)
Q Consensus 177 ~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L 256 (1141)
+.++. +..+++|+.|+|++|+++.+|. +..+++|+.|+|++|.++.++ .+..+++|+.|+|++|+++++ + .+..+
T Consensus 212 ~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~-~-~~~~l 286 (347)
T 4fmz_A 212 TDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI-S-VLNNL 286 (347)
T ss_dssp CCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC-G-GGGGC
T ss_pred CCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC-h-hhcCC
Confidence 87655 6778888888888888887766 777888888888888888774 577788888888888888876 2 57778
Q ss_pred CCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 257 HNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 257 ~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
++|+.|+|++|++++ ..|..+........+++.+|.+.+..|
T Consensus 287 ~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 287 SQLNSLFLNNNQLGN--EDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp TTCSEEECCSSCCCG--GGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CCCCEEECcCCcCCC--cChhHhhccccCCEEEccCCccccccC
Confidence 888888888888876 355666666777777777777766544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=271.73 Aligned_cols=268 Identities=16% Similarity=0.134 Sum_probs=220.4
Q ss_pred cccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccC-ccccCCcCCcEEEc
Q 001143 21 KLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIP-KSVGRYEKLRNLKF 98 (1141)
Q Consensus 21 ~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP-~~l~~L~~L~~L~L 98 (1141)
.+....++++.++. + .++|++|||++|+|++..|..|+.+ ++|++|+|++|.++ .+| ..|.++++|++|+|
T Consensus 14 ~~~c~~~~l~~lp~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 14 NAICINRGLHQVPE--L--PAHVNYVDLSLNSIAELNETSFSRL---QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp EEECCSSCCSSCCC--C--CTTCCEEECCSSCCCEECTTTTSSC---TTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred ccCcCCCCcccCCC--C--CCccCEEEecCCccCcCChhHhccC---ccccEEECcCCcccceECcccccccccCCEEeC
Confidence 35566778888876 2 2789999999999999888776555 99999999999997 675 57999999999999
Q ss_pred cCCCCCcC-chhhcCCCCCCEEEccCCCCCC-Ccc--cccCCCCCCEEECCCCCCCCCcccchhh-hcCCCCCcEEEccC
Q 001143 99 FGNEINLF-PSEVGNLLGLECLQIKISSPGV-NGF--ALNKLKGLKELELSKVPPRPSVLTLLSE-IAGLKCLTKLSVCH 173 (1141)
Q Consensus 99 s~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~-~~~--~~~~L~~L~~L~Ls~N~ln~~~~~lp~~-l~~L~~L~~L~Ls~ 173 (1141)
++|+|+.+ |..|+++++|++|+|++|.+.. .+. .+..+++|++|+|++|.+... .|.. +.++++|+.|++++
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---~~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI---QPASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC---CCCGGGGGCTTCCEEECTT
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc---CcccccCCCCcccEEeCCC
Confidence 99999966 7889999999999999999775 333 389999999999999766433 3444 78899999999999
Q ss_pred CCCCcc-CccccCC------------------------------------------------------------------
Q 001143 174 FSIRYL-PPEIGCL------------------------------------------------------------------ 186 (1141)
Q Consensus 174 N~L~~i-P~~l~~l------------------------------------------------------------------ 186 (1141)
|+++.+ |..+..+
T Consensus 164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~ 243 (455)
T 3v47_A 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243 (455)
T ss_dssp CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEE
T ss_pred CcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceee
Confidence 998855 3333222
Q ss_pred -------------------------------CCCCEEEccCCcccc-ccccccCCCCCCEEEccCCCCCcC-CcCccCCC
Q 001143 187 -------------------------------SNLEQLDLSFNKMKY-LPTEICYLKALISLKVANNKLVEL-PSGLYLLQ 233 (1141)
Q Consensus 187 -------------------------------~~L~~L~Ls~N~L~~-iP~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~ 233 (1141)
++|+.|+|++|+|+. +|..++.+++|+.|+|++|+|+.+ |..+..++
T Consensus 244 L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 323 (455)
T 3v47_A 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT 323 (455)
T ss_dssp EECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred EeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcc
Confidence 245555555555553 466788899999999999999976 66888999
Q ss_pred CCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 234 ~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
+|+.|+|++|+|++++|..|..+++|+.|+|++|++++ ..|..+........+++.+|.+.+..+
T Consensus 324 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~ 388 (455)
T 3v47_A 324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA--LGDQSFLGLPNLKELALDTNQLKSVPD 388 (455)
T ss_dssp TCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE--ECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc--cChhhccccccccEEECCCCccccCCH
Confidence 99999999999999999999999999999999999988 257778888888889999998876443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-26 Score=284.03 Aligned_cols=278 Identities=22% Similarity=0.155 Sum_probs=202.2
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCC--cccccCCCCCCCccEEEeecCCCCcc-CccccCCcCC
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPL--IESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKL 93 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~--p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L 93 (1141)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|.++... ...|..+ ..++|+.|+|++|+++.+ |..|..+++|
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 407 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL-AHSPLHILNLTKNKISKIESDAFSWLGHL 407 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGG-TTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhccc-ccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence 36777778888888888888888888888888877654322 2222221 124677888888888765 4567888888
Q ss_pred cEEEccCCCCC-cCc-hhhcCCCCCCEEEccCCCCCC-CcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEE
Q 001143 94 RNLKFFGNEIN-LFP-SEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLS 170 (1141)
Q Consensus 94 ~~L~Ls~N~L~-~lP-~~~~~L~~L~~L~Ls~N~l~~-~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~ 170 (1141)
+.|+|++|.|+ .+| ..|.++++|+.|+|++|.+.. .+..|..+++|+.|++++|.+... +.+|..|.++++|+.|+
T Consensus 408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~p~~~~~l~~L~~L~ 486 (680)
T 1ziw_A 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV-DSSPSPFQPLRNLTILD 486 (680)
T ss_dssp CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCT-TCSSCTTTTCTTCCEEE
T ss_pred CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccc-ccCCcccccCCCCCEEE
Confidence 88888888886 565 567788888888888888443 345677788888888888665332 45677788888888888
Q ss_pred ccCCCCCccCc-cccCCCCCCEEEccCCccccccc---------cccCCCCCCEEEccCCCCCcCCcC-ccCCCCCCEEe
Q 001143 171 VCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPT---------EICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239 (1141)
Q Consensus 171 Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~---------~l~~l~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~ 239 (1141)
+++|+|+.+|+ .+..+++|++|+|++|+|+.++. .+..+++|+.|+|++|+|+.||.. +.++++|+.|+
T Consensus 487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 566 (680)
T 1ziw_A 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeE
Confidence 88888887755 46788888888888888876532 267788888888888888888754 66788888888
Q ss_pred CCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhh-hcccCCCCCCCCCCcccC
Q 001143 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 240 Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~-~~l~~~~l~~~~n~l~~~ 298 (1141)
|++|+|+++++..|..+++|+.|+|++|+|++. .|..+. .......+++.+|.+.|.
T Consensus 567 Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV--EKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBC--CHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred CCCCCCCcCCHhHhCCCCCCCEEECCCCcCCcc--ChhHhcccccccCEEEccCCCcccC
Confidence 888888888887778888888888888888872 333333 455566677777766554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=298.48 Aligned_cols=259 Identities=19% Similarity=0.168 Sum_probs=181.2
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~ 95 (1141)
+.++.|.+..|+|+.+.+..|.++++|+.|+|++|+|++..+..|.. +++|++|+|++|.|+.+ |..|..+++|+.
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG---LDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTT---CSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcC---CCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 47888999999999999999999999999999999999888876654 48999999999999877 667999999999
Q ss_pred EEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcc-----------------------------------------cc
Q 001143 96 LKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGF-----------------------------------------AL 133 (1141)
Q Consensus 96 L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~~-----------------------------------------~~ 133 (1141)
|+|++|+|+.++. .|.++++|+.|+|++|.++.++. .+
T Consensus 343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~ 422 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFL 422 (844)
T ss_dssp EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHH
T ss_pred EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhh
Confidence 9999999997754 58889999999999998765542 01
Q ss_pred cCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc------CccccCCCCCCEEEccCCcccccc-ccc
Q 001143 134 NKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL------PPEIGCLSNLEQLDLSFNKMKYLP-TEI 206 (1141)
Q Consensus 134 ~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~i------P~~l~~l~~L~~L~Ls~N~L~~iP-~~l 206 (1141)
..+++|++|+|++|.+...... ..+..+++|+.|+|++|.++.+ |..|..+++|+.|+|++|+|+.+| ..|
T Consensus 423 ~~l~~L~~L~Ls~N~l~~~~~~--~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 500 (844)
T 3j0a_A 423 LRVPHLQILILNQNRFSSCSGD--QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500 (844)
T ss_dssp TTCTTCCEEEEESCCCCCCCSS--SSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSS
T ss_pred hcCCccceeeCCCCcccccccc--cccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHc
Confidence 1233333333333332211110 0122334444444444444322 123556667777777777777554 446
Q ss_pred cCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhccc
Q 001143 207 CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1141)
Q Consensus 207 ~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1141)
..+++|+.|+|++|+|+.+|..... ++|+.|+|++|+|++.+|..| .+|+.|+|++|+|.|.|++.+...|...
T Consensus 501 ~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~~f~~~~~~ 574 (844)
T 3j0a_A 501 SHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNH 574 (844)
T ss_dssp SSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCCSHHHHHHH
T ss_pred cchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccHHHHHHHHh
Confidence 6777777777777777777655444 677777777777777777543 4677888888888888877666655443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=284.75 Aligned_cols=271 Identities=17% Similarity=0.170 Sum_probs=223.6
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L 96 (1141)
++..+.+..|.++.+++..|.++++|++|+|++|.|++.++..|+.+ ++|++|+|++|.|+.+|+ .|.++++|++|
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA---HTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCC---CCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 56778888999999999999999999999999999999888766544 999999999999998865 57999999999
Q ss_pred EccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchh-------------hhc
Q 001143 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLS-------------EIA 161 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~-------------~l~ 161 (1141)
+|++|.|+.+|.. |+++++|++|+|++|.+..++ ..|..+++|++|+|++|.+......... .+.
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~ 208 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 208 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEE
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcccccc
Confidence 9999999999877 689999999999999977665 4799999999999999877544211100 112
Q ss_pred CCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeC
Q 001143 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDL 240 (1141)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~L 240 (1141)
...+|+.|++++|.++.+|..+ .++|+.|+|++|.|+.+ ..++.+++|+.|+|++|.|+.+ |..++.+++|+.|+|
T Consensus 209 ~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 285 (597)
T 3oja_B 209 IPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285 (597)
T ss_dssp CCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEEC
T ss_pred CCchhheeeccCCccccccccc--CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEEC
Confidence 2344556666666666554432 36788999999988875 5788899999999999999855 788999999999999
Q ss_pred CCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 241 s~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
++|+|+++++ .+..+++|+.|+|++|+++. +|..+..+..+..+++.+|.+.+.
T Consensus 286 s~N~l~~l~~-~~~~l~~L~~L~Ls~N~l~~---i~~~~~~l~~L~~L~L~~N~l~~~ 339 (597)
T 3oja_B 286 SNNRLVALNL-YGQPIPTLKVLDLSHNHLLH---VERNQPQFDRLENLYLDHNSIVTL 339 (597)
T ss_dssp TTSCCCEEEC-SSSCCTTCCEEECCSSCCCC---CGGGHHHHTTCSEEECCSSCCCCC
T ss_pred CCCCCCCCCc-ccccCCCCcEEECCCCCCCc---cCcccccCCCCCEEECCCCCCCCc
Confidence 9999999754 67789999999999999986 888888888888888888887654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-25 Score=256.49 Aligned_cols=261 Identities=19% Similarity=0.236 Sum_probs=225.0
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1141)
+.+..|.+..|+++.++ .|..+++|++|+|++|++++..+ + .++++|++|+|++|.++.+| .|..+++|++|
T Consensus 44 ~~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~~--~---~~l~~L~~L~L~~n~i~~~~-~~~~l~~L~~L 115 (347)
T 4fmz_A 44 ESITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDISP--L---SNLVKLTNLYIGTNKITDIS-ALQNLTNLREL 115 (347)
T ss_dssp TTCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCG-GGTTCTTCSEE
T ss_pred ccccEEEEeCCccccch--hhhhcCCccEEEccCCccccchh--h---hcCCcCCEEEccCCcccCch-HHcCCCcCCEE
Confidence 46788999999999885 48899999999999999997654 4 45599999999999999986 58999999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001143 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1141)
+|++|.|+.+|. +..+++|+.|++++|........+..+++|++|++++|.+.... . +..+++|+.|++++|.+
T Consensus 116 ~l~~n~i~~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~----~-~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 116 YLNEDNISDISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT----P-IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp ECTTSCCCCCGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCG----G-GGGCTTCSEEECTTSCC
T ss_pred ECcCCcccCchh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCch----h-hccCCCCCEEEccCCcc
Confidence 999999999877 88999999999999974444445999999999999997664332 2 78899999999999999
Q ss_pred CccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCC
Q 001143 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1141)
Q Consensus 177 ~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L 256 (1141)
+.++. +..+++|+.|++++|.++.++. +..+++|+.|+|++|+++.+|. +..+++|+.|+|++|+++++ ..+..+
T Consensus 190 ~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l 264 (347)
T 4fmz_A 190 EDISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDL 264 (347)
T ss_dssp CCCGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred ccccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcC
Confidence 98876 8899999999999999998766 8889999999999999998876 88899999999999999987 368899
Q ss_pred CCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 257 HNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 257 ~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
++|+.|++++|+++. +| .+........+++.+|.+.+..+
T Consensus 265 ~~L~~L~l~~n~l~~---~~-~~~~l~~L~~L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 265 TKLKMLNVGSNQISD---IS-VLNNLSQLNSLFLNNNQLGNEDM 304 (347)
T ss_dssp TTCCEEECCSSCCCC---CG-GGGGCTTCSEEECCSSCCCGGGH
T ss_pred CCcCEEEccCCccCC---Ch-hhcCCCCCCEEECcCCcCCCcCh
Confidence 999999999999987 54 46666778888888888765543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=278.76 Aligned_cols=142 Identities=18% Similarity=0.167 Sum_probs=112.4
Q ss_pred hhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccc--ccccCCCCCCEEEccCCCCCc-CCcCccCCC
Q 001143 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVE-LPSGLYLLQ 233 (1141)
Q Consensus 157 p~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP--~~l~~l~~L~~L~Ls~N~L~~-IP~~l~~L~ 233 (1141)
|..+.++++|+.|++++|.++.+|..+..+++|+.|+|++|.++.++ ..+..+++|+.|+|++|.++. +|..+..++
T Consensus 366 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 445 (570)
T 2z63_A 366 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445 (570)
T ss_dssp EHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred cccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCC
Confidence 34566778899999999999888777888899999999999888653 367888888888888888874 566777888
Q ss_pred CCCEEeCCCCCCC-CCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 234 RLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 234 ~L~~L~Ls~N~Lt-~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
+|+.|+|++|+++ +..|..+..+++|+.|+|++|++++ ..|..+........+++.+|.+.+..+
T Consensus 446 ~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~ 511 (570)
T 2z63_A 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ--LSPTAFNSLSSLQVLNMASNQLKSVPD 511 (570)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE--ECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCcEEECcCCcCccccchhhhhcccCCCEEECCCCcccc--CChhhhhcccCCCEEeCCCCcCCCCCH
Confidence 8888888888887 4566678888888888888888887 246677777777778888887766543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=279.70 Aligned_cols=132 Identities=16% Similarity=0.108 Sum_probs=106.7
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCc
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLR 94 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~ 94 (1141)
++.+..|.+..|+|+.+.+.+|.++++|++|||++|+|++..+..|+ ++++|++|+|++|.|+.+| ..|.++++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ---SLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTT---TCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCccccc---CchhCCEEeCcCCcCCccCHhhhcCccccc
Confidence 45688888889999988888899999999999999988887776554 4488888888888888775 5688888888
Q ss_pred EEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCCC
Q 001143 95 NLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPPR 150 (1141)
Q Consensus 95 ~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~--~~~~~~~L~~L~~L~Ls~N~ln 150 (1141)
+|+|++|+|+.+|. .|+++++|++|+|++|.+.. +|..+.++++|++|++++|.+.
T Consensus 104 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp EEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred cccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 88888888887765 58888888888888888665 5677888888888888877643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-28 Score=295.29 Aligned_cols=194 Identities=15% Similarity=0.112 Sum_probs=129.7
Q ss_pred eEeeeecccCceEEEEEE--ECCccEEEEEEecccCCC--ChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEecCCC
Q 001143 809 SSCDEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCGS--SADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~--~~~~~vAvKI~~l~~~~~--~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~~~~ 883 (1141)
......+.|+.|.+..++ +-+..+++|++..+.... .....+.-.+.+.+|+++|+++ .|+||++++++++++..
T Consensus 237 ~w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 237 HWQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp EEECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred hhhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 344456777777766654 368889999986543222 2222233334568999999999 69999999999998764
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.||||||++|++|.++|.+ ..+++.. +|+.||+.||+|+|++|||||||||+|||++.
T Consensus 317 --------------~yLVMEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~ 374 (569)
T 4azs_A 317 --------------GWLVMEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA 374 (569)
T ss_dssp --------------EEEEEECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT
T ss_pred --------------EEEEEecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC
Confidence 4999999999999999986 3456654 58899999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+....... .....+||+.|||||++.+ .+..++|+||+|+++++|.
T Consensus 375 d-------g~vKL~DFGlAr~~~~~~~----------~~~t~vGTp~YmAPE~l~g-----~~~~~~d~~s~g~~~~~l~ 432 (569)
T 4azs_A 375 R-------QHARLIDFGSIVTTPQDCS----------WPTNLVQSFFVFVNELFAE-----NKSWNGFWRSAPVHPFNLP 432 (569)
T ss_dssp T-------SCEEECCCTTEESCC---C----------CSHHHHHHHHHHHHHHC----------------------CCCC
T ss_pred C-------CCEEEeecccCeeCCCCCc----------cccCceechhhccHHHhCC-----CCCCcccccccccchhhhc
Confidence 7 8899999999976543211 1234679999999999876 3567899999999988776
Q ss_pred hCC
Q 001143 1044 TLQ 1046 (1141)
Q Consensus 1044 TGk 1046 (1141)
++.
T Consensus 433 ~~~ 435 (569)
T 4azs_A 433 QPW 435 (569)
T ss_dssp TTH
T ss_pred ccc
Confidence 553
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-25 Score=268.39 Aligned_cols=254 Identities=18% Similarity=0.118 Sum_probs=192.2
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1141)
+.++.|.+..|+|+.++ .|..+++|++|+|++|+|++. | ++.+++|++|+|++|.|+.+| +.++++|++|
T Consensus 42 ~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~n~l~~~-~-----~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L 111 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDMT--GIEKLTGLTKLICTSNNITTL-D-----LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYL 111 (457)
T ss_dssp TTCCEEECCSSCCCCCT--TGGGCTTCSEEECCSSCCSCC-C-----CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEE
T ss_pred CCCCEEEccCCCcccCh--hhcccCCCCEEEccCCcCCeE-c-----cccCCCCCEEECcCCCCceee--cCCCCcCCEE
Confidence 35778888888888874 688888899999999988875 2 345588899999999888885 8888889999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCC
Q 001143 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1141)
+|++|+|+.+| ++++++|+.|++++|.++.++ +..+++|++|++++|.. .+.+ .+..+++|+.|++++|+|
T Consensus 112 ~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~~---~~~~--~~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 112 NCDTNKLTKLD--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKK---ITKL--DVTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp ECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCSC---CCCC--CCTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCeec--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCCCc---cccc--ccccCCcCCEEECCCCcc
Confidence 99999888876 888889999999888877764 77888899999888632 3333 367788889999999988
Q ss_pred CccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCC
Q 001143 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1141)
Q Consensus 177 ~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L 256 (1141)
+.+| ++.+++|+.|+|++|+|+.++ ++.+++|+.|+|++|+|+.+| ++.+++|+.|+|++|+|+++++. .+
T Consensus 183 ~~l~--l~~l~~L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~---~l 253 (457)
T 3bz5_A 183 TELD--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVS---TL 253 (457)
T ss_dssp CCCC--CTTCTTCCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCT---TC
T ss_pred ceec--cccCCCCCEEECcCCcCCeec--cccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHH---HC
Confidence 8887 778888999999999988774 788888999999999998887 77888899999999999887654 44
Q ss_pred CCCCEEEccCCcCCCC--------CCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 257 HNLQNLNLQYNKLLSY--------CQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 257 ~~L~~L~Ls~N~L~~~--------~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
++|+.|++++|+|..+ ..+|. ........+++++|.+.+..|
T Consensus 254 ~~L~~L~l~~n~L~~L~l~~n~~~~~~~~--~~l~~L~~L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 254 SKLTTLHCIQTDLLEIDLTHNTQLIYFQA--EGCRKIKELDVTHNTQLYLLD 303 (457)
T ss_dssp TTCCEEECTTCCCSCCCCTTCTTCCEEEC--TTCTTCCCCCCTTCTTCCEEE
T ss_pred CCCCEEeccCCCCCEEECCCCccCCcccc--cccccCCEEECCCCcccceec
Confidence 5555555554444331 02331 222445555566665554443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-26 Score=283.00 Aligned_cols=259 Identities=17% Similarity=0.162 Sum_probs=223.3
Q ss_pred CCcccccCCCCC--ccccCCCCCCCC--CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccC-ccccCC
Q 001143 17 PIKEKLPSEANK--INNEKNGSVNDD--DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIP-KSVGRY 90 (1141)
Q Consensus 17 ~~l~~L~~~~N~--i~~i~~~~f~~l--~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP-~~l~~L 90 (1141)
+.++.|.+..|. +..+....|..+ ++|+.|+|++|++++..|..|.. +++|++|+|++|.++ .+| ..|.++
T Consensus 353 ~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~~l 429 (680)
T 1ziw_A 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW---LGHLEVLDLGLNEIGQELTGQEWRGL 429 (680)
T ss_dssp TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT---CTTCCEEECCSSCCEEECCSGGGTTC
T ss_pred cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC---CCCCCEEeCCCCcCccccCcccccCc
Confidence 368888888886 566666777655 58999999999999998876654 499999999999997 577 579999
Q ss_pred cCCcEEEccCCCCCcC-chhhcCCCCCCEEEccCCCC---CCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC
Q 001143 91 EKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSP---GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL 166 (1141)
Q Consensus 91 ~~L~~L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l---~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L 166 (1141)
++|++|+|++|+++.+ +..|..+++|+.|++++|.+ ...|..+..+++|+.|++++|.+.. ..+..|.++++|
T Consensus 430 ~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~---i~~~~~~~l~~L 506 (680)
T 1ziw_A 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN---INDDMLEGLEKL 506 (680)
T ss_dssp TTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCC---CCTTTTTTCTTC
T ss_pred ccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCc---CChhhhcccccc
Confidence 9999999999999866 56799999999999999985 4677889999999999999976653 334568999999
Q ss_pred cEEEccCCCCCccCc---------cccCCCCCCEEEccCCccccccc-cccCCCCCCEEEccCCCCCcCCcCc-cCCCCC
Q 001143 167 TKLSVCHFSIRYLPP---------EIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSGL-YLLQRL 235 (1141)
Q Consensus 167 ~~L~Ls~N~L~~iP~---------~l~~l~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~IP~~l-~~L~~L 235 (1141)
+.|++++|+++.++. .+..+++|+.|+|++|+|+.+|. .|..+++|+.|+|++|+|+.+|... ..+++|
T Consensus 507 ~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 586 (680)
T 1ziw_A 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586 (680)
T ss_dssp CEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCC
Confidence 999999999997632 27889999999999999999986 5899999999999999999998764 679999
Q ss_pred CEEeCCCCCCCCCCccccc-CCCCCCEEEccCCcCCCCCCC-chhhhh
Q 001143 236 ENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKLLSYCQV-PSWICC 281 (1141)
Q Consensus 236 ~~L~Ls~N~Lt~~~p~~l~-~L~~L~~L~Ls~N~L~~~~~i-P~~~~~ 281 (1141)
+.|+|++|+|+++++..+. .+++|+.|+|++|+|.|.|+. .+...|
T Consensus 587 ~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~ 634 (680)
T 1ziw_A 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634 (680)
T ss_dssp CEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECC
T ss_pred CEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHH
Confidence 9999999999999998787 789999999999999999985 544444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=282.48 Aligned_cols=178 Identities=20% Similarity=0.212 Sum_probs=136.4
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCc
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLR 94 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~ 94 (1141)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..|..|+. +++|++|+|++|+|+.+|.. |.++++|+
T Consensus 25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~---l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 101 (549)
T 2z81_A 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS---LGSLEHLDLSDNHLSSLSSSWFGPLSSLK 101 (549)
T ss_dssp CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT---CTTCCEEECTTSCCCSCCHHHHTTCTTCC
T ss_pred CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc---cccCCEEECCCCccCccCHHHhccCCCCc
Confidence 357999999999999999999999999999999999999988876654 49999999999999988764 99999999
Q ss_pred EEEccCCCCCc--CchhhcCCCCCCEEEccCCC-CCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEE
Q 001143 95 NLKFFGNEINL--FPSEVGNLLGLECLQIKISS-PGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLS 170 (1141)
Q Consensus 95 ~L~Ls~N~L~~--lP~~~~~L~~L~~L~Ls~N~-l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~ 170 (1141)
+|+|++|.|+. +|..|+++++|++|+|++|. ++.++ ..+.++++|++|++++|.+. +..|..+..+++|+.|+
T Consensus 102 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~l~~l~~L~~L~ 178 (549)
T 2z81_A 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR---NYQSQSLKSIRDIHHLT 178 (549)
T ss_dssp EEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC---EECTTTTTTCSEEEEEE
T ss_pred EEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc---ccChhhhhccccCceEe
Confidence 99999999985 47789999999999999998 67666 47899999999999996654 33455555544444444
Q ss_pred ccCCCCCccCccc-cCCCCCCEEEccCCcc
Q 001143 171 VCHFSIRYLPPEI-GCLSNLEQLDLSFNKM 199 (1141)
Q Consensus 171 Ls~N~L~~iP~~l-~~l~~L~~L~Ls~N~L 199 (1141)
++.|.+..+|..+ ..+++|++|+|++|++
T Consensus 179 l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 179 LHLSESAFLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EECSBSTTHHHHHHHSTTTBSEEEEESCBC
T ss_pred cccCcccccchhhHhhcccccEEEccCCcc
Confidence 4444444333322 2333444444444433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=254.13 Aligned_cols=246 Identities=20% Similarity=0.224 Sum_probs=210.7
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcEEEccCCCCCcC---chhhcCCCCCCE
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNLKFFGNEINLF---PSEVGNLLGLEC 118 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~L~Ls~N~L~~l---P~~~~~L~~L~~ 118 (1141)
-+.+++++++++..+... . ++|++|+|++|.|+.+|.. |.++++|++|+|++|+|+.+ |..+..+++|++
T Consensus 9 ~~~l~c~~~~l~~ip~~~---~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 9 GTEIRCNSKGLTSVPTGI---P---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTEEECCSSCCSSCCSCC---C---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCEEEcCCCCcccCCCCC---C---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 468999999999765432 1 6899999999999999875 78999999999999999865 678889999999
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc-CccccCCCCCCEEEccCC
Q 001143 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFN 197 (1141)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N 197 (1141)
|+|++|.+..++..+..+++|++|++++|.+..... +..+..+++|+.|++++|.++.+ |..+..+++|+.|+|++|
T Consensus 83 L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 83 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE--FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTT--TTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EECCCCccccChhhcCCCCCCCEEECCCCccccccc--chhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 999999998899889999999999999965533221 14688999999999999999955 667899999999999999
Q ss_pred cccc--ccccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 198 KMKY--LPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 198 ~L~~--iP~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
.++. +|..+..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..+..+++|+.|+|++|++++ .
T Consensus 161 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~ 238 (306)
T 2z66_A 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT--S 238 (306)
T ss_dssp EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB--C
T ss_pred ccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcc--c
Confidence 9985 789999999999999999999977 7788899999999999999999998889999999999999999998 3
Q ss_pred Cchhhhhc-ccCCCCCCCCCCcccC
Q 001143 275 VPSWICCN-LEGNGKDSSNDDFISS 298 (1141)
Q Consensus 275 iP~~~~~~-l~~~~l~~~~n~l~~~ 298 (1141)
.|..+... .....+++.+|.+.|.
T Consensus 239 ~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 239 KKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp SSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CHHHHHhhhccCCEEEccCCCeecc
Confidence 55555444 2566666777766554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=264.49 Aligned_cols=259 Identities=20% Similarity=0.243 Sum_probs=192.6
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1141)
+.++.|.+..|+|+.+.+ |.++++|++|+|++|.+++..+ + +++++|++|+|++|.++.+|. +.++++|++|
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~---~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L 139 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L---ANLTNLTGLTLFNNQITDIDP-LKNLTNLNRL 139 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCGG-GTTCTTCSEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--h---cCCCCCCEEECCCCCCCCChH-HcCCCCCCEE
Confidence 478888888999888876 8888899999999998887665 4 445888888888888888765 7888888888
Q ss_pred EccCCCCCcCch--------------------hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccc
Q 001143 97 KFFGNEINLFPS--------------------EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTL 156 (1141)
Q Consensus 97 ~Ls~N~L~~lP~--------------------~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~l 156 (1141)
+|++|.|+.+|. .+.++++|+.|++++|.+..++ .+..+++|++|++++|.+.....
T Consensus 140 ~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-- 216 (466)
T 1o6v_A 140 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDITP-- 216 (466)
T ss_dssp EEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG--
T ss_pred ECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCCh-hhccCCCCCEEEecCCccccccc--
Confidence 888888776542 2566788888888888877765 37888888888888866544321
Q ss_pred hhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCC
Q 001143 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1141)
Q Consensus 157 p~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~ 236 (1141)
++.+++|+.|++++|+++.++ .+..+++|+.|+|++|.++.++. +..+++|+.|+|++|+++.+|. +..+++|+
T Consensus 217 ---~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~ 290 (466)
T 1o6v_A 217 ---LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALT 290 (466)
T ss_dssp ---GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCS
T ss_pred ---ccccCCCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccC
Confidence 566777888888888877764 46777778888888887776654 7777777888888777777765 66777777
Q ss_pred EEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 237 ~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
.|+|++|+++++++ +..+++|+.|+|++|++++ ++. +........+.+.+|.+.+.
T Consensus 291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~---~~~-~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISD---ISP-VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC---CGG-GGGCTTCCEEECCSSCCCCC
T ss_pred eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC---chh-hccCccCCEeECCCCccCCc
Confidence 77777777777655 6677777777777777776 333 44555566666666665544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=263.79 Aligned_cols=260 Identities=22% Similarity=0.263 Sum_probs=225.7
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
.+..|.+..+.++.++ .+..+++|++|||++|.+++..+ + +++++|++|+|++|.++.+|. +.++++|++|+
T Consensus 47 ~l~~L~l~~~~i~~l~--~~~~l~~L~~L~Ls~n~l~~~~~--~---~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~ 118 (466)
T 1o6v_A 47 QVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITP--L---KNLTKLVDILMNNNQIADITP-LANLTNLTGLT 118 (466)
T ss_dssp TCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred cccEEecCCCCCccCc--chhhhcCCCEEECCCCccCCchh--h---hccccCCEEECCCCccccChh-hcCCCCCCEEE
Confidence 5778888899998876 48889999999999999998765 4 455999999999999998877 99999999999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc--------------------cccCCCCCCEEECCCCCCCCCcccch
Q 001143 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF--------------------ALNKLKGLKELELSKVPPRPSVLTLL 157 (1141)
Q Consensus 98 Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~--------------------~~~~L~~L~~L~Ls~N~ln~~~~~lp 157 (1141)
|++|.|+.+|. +.++++|+.|+|++|.+..++. .+..+++|++|++++|.+...
T Consensus 119 L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~----- 192 (466)
T 1o6v_A 119 LFNNQITDIDP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI----- 192 (466)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-----
T ss_pred CCCCCCCCChH-HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC-----
Confidence 99999999876 9999999999999998666542 256778899999999776543
Q ss_pred hhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCE
Q 001143 158 SEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237 (1141)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 237 (1141)
..+..+++|+.|++++|.++.+++ ++.+++|+.|+|++|+++.++ .+..+++|+.|+|++|.++.++. +..+++|+.
T Consensus 193 ~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~ 269 (466)
T 1o6v_A 193 SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP-LSGLTKLTE 269 (466)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSE
T ss_pred hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccchh-hhcCCCCCE
Confidence 247889999999999999998755 788999999999999999885 68899999999999999998875 888999999
Q ss_pred EeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 238 L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
|+|++|+++++++ +..+++|+.|+|++|++++ ++. +........+++..|.+.+..+
T Consensus 270 L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~---~~~-~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 270 LKLGANQISNISP--LAGLTALTNLELNENQLED---ISP-ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC---CGG-GGGCTTCSEEECCSSCCSCCGG
T ss_pred EECCCCccCcccc--ccCCCccCeEEcCCCcccC---chh-hcCCCCCCEEECcCCcCCCchh
Confidence 9999999999876 8899999999999999987 554 5666778888888888877654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-24 Score=258.86 Aligned_cols=184 Identities=19% Similarity=0.112 Sum_probs=129.5
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEE
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L 96 (1141)
+.++.|.+..|+|+.++ |..+++|++|+|++|+|++. + ++++++|++|+|++|+|+.+| +..+++|++|
T Consensus 64 ~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~~-~-----~~~l~~L~~L~L~~N~l~~l~--~~~l~~L~~L 132 (457)
T 3bz5_A 64 TGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTNL-D-----VTPLTKLTYLNCDTNKLTKLD--VSQNPLLTYL 132 (457)
T ss_dssp TTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCC-C-----CTTCTTCCEEECCSSCCSCCC--CTTCTTCCEE
T ss_pred CCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCcee-e-----cCCCCcCCEEECCCCcCCeec--CCCCCcCCEE
Confidence 47888999999999884 88899999999999999885 2 355689999999999999886 8888999999
Q ss_pred EccCCCCCcCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 97 KFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
+|++|+|+.+| ++++++|+.|++++|. ++.+ .+..+++|++|++++|.+.. +| +..+++|+.|++++|+
T Consensus 133 ~l~~N~l~~l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~----l~--l~~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 133 NCARNTLTEID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE----LD--VSQNKLLNRLNCDTNN 202 (457)
T ss_dssp ECTTSCCSCCC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC----CC--CTTCTTCCEEECCSSC
T ss_pred ECCCCccceec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce----ec--cccCCCCCEEECcCCc
Confidence 99999998775 6777777777777774 4444 36667777777777765543 22 4455555566666555
Q ss_pred CCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcC
Q 001143 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1141)
Q Consensus 176 L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~I 225 (1141)
|+.++ ++.+++|+.|+|++|+|+.+| ++.+++|+.|+|++|+|+.+
T Consensus 203 l~~~~--l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 203 ITKLD--LNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CSCCC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC
T ss_pred CCeec--cccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCc
Confidence 55542 455555555555555555554 55555555555555555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=265.26 Aligned_cols=245 Identities=20% Similarity=0.164 Sum_probs=198.3
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCC-CCCccccc----CCCCCCCccEEEeecCCCC-ccCccc--cC
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVD-FPLIESYG----NRGGDNSVEGLYLYKNVLN-LIPKSV--GR 89 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls-~~~p~~~~----~l~~L~~L~~L~Ls~N~Lt-~iP~~l--~~ 89 (1141)
.++.+.+..|++ .++...... |+.|+|++|.|+ ..+|..+. .+.++++|++|+|++|.|+ .+|..+ ..
T Consensus 44 ~L~~l~l~~n~l-~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE-ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT-CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc-ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 467777777888 444322222 888899999884 44555443 0013489999999999998 688876 89
Q ss_pred CcCCcEEEccCCCCCcCchhhcCC-----CCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhh--c
Q 001143 90 YEKLRNLKFFGNEINLFPSEVGNL-----LGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEI--A 161 (1141)
Q Consensus 90 L~~L~~L~Ls~N~L~~lP~~~~~L-----~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l--~ 161 (1141)
+++|++|+|++|+|+.+|..++.+ ++|++|+|++|+++.++ ..+..+++|++|+|++|.+....+ +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-LISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH-HHHHSCTT
T ss_pred CCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH-HHHHHHhc
Confidence 999999999999999888888877 99999999999987777 689999999999999976532221 34444 8
Q ss_pred CCCCCcEEEccCCCCCccC---cc-ccCCCCCCEEEccCCcccccc--ccccCCCCCCEEEccCCCCCcCCcCccCCCCC
Q 001143 162 GLKCLTKLSVCHFSIRYLP---PE-IGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPSGLYLLQRL 235 (1141)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~iP---~~-l~~l~~L~~L~Ls~N~L~~iP--~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L 235 (1141)
.+++|+.|+|++|+|+.+| .. +..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.||..+. ++|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L 276 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKL 276 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCc
Confidence 8999999999999999543 33 367899999999999999654 456678999999999999999999888 889
Q ss_pred CEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 236 ~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+.|+|++|+|+++ |. +..+++|+.|+|++|+|++
T Consensus 277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 9999999999999 43 8999999999999999986
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=262.05 Aligned_cols=248 Identities=17% Similarity=0.132 Sum_probs=205.7
Q ss_pred cccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001143 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1141)
+..+.+..+++.......+..+++|++|||++|+|++..|..|+.+ ++|++|+|++|.|+.+++ |..+++|++|+|
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~L 87 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF---TKLELLNLSSNVLYETLD-LESLSTLRTLDL 87 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTC---TTCCEEECTTSCCEEEEE-ETTCTTCCEEEC
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCC---CcCCEEECCCCcCCcchh-hhhcCCCCEEEC
Confidence 4445566677777767777888899999999999999888777655 999999999999987765 899999999999
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001143 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1141)
Q Consensus 99 s~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1141)
++|+|+.+|. +++|+.|++++|.+..++. ..+++|++|++++|.+... .+..+..+++|+.|++++|.|+.
T Consensus 88 s~n~l~~l~~----~~~L~~L~l~~n~l~~~~~--~~~~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 88 NNNYVQELLV----GPSIETLHAANNNISRVSC--SRGQGKKNIYLANNKITML---RDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp CSSEEEEEEE----CTTCCEEECCSSCCSEEEE--CCCSSCEEEECCSSCCCSG---GGBCTGGGSSEEEEECTTSCCCE
T ss_pred cCCccccccC----CCCcCEEECCCCccCCcCc--cccCCCCEEECCCCCCCCc---cchhhhccCCCCEEECCCCCCCc
Confidence 9999987763 3899999999999877664 4478899999999766543 34467788999999999999996
Q ss_pred c-Cccc-cCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCC
Q 001143 179 L-PPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1141)
Q Consensus 179 i-P~~l-~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L 256 (1141)
+ |..+ ..+++|++|+|++|.|+.+|.. ..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|+++++ .+..+
T Consensus 159 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~-~~~~l 236 (317)
T 3o53_A 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEK-ALRFS 236 (317)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEECC-CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECT-TCCCC
T ss_pred ccHHHHhhccCcCCEEECCCCcCcccccc-cccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhh-HhhcC
Confidence 6 4555 4789999999999999988644 35899999999999999998889999999999999999998755 78899
Q ss_pred CCCCEEEccCCcCCCCCCCchhhhhc
Q 001143 257 HNLQNLNLQYNKLLSYCQVPSWICCN 282 (1141)
Q Consensus 257 ~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1141)
++|+.|+|++|++.|. .+|.++..+
T Consensus 237 ~~L~~L~l~~N~~~~~-~~~~~~~~~ 261 (317)
T 3o53_A 237 QNLEHFDLRGNGFHCG-TLRDFFSKN 261 (317)
T ss_dssp TTCCEEECTTCCCBHH-HHHHHHHTC
T ss_pred CCCCEEEccCCCccCc-CHHHHHhcc
Confidence 9999999999999852 255555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=259.58 Aligned_cols=250 Identities=20% Similarity=0.187 Sum_probs=208.5
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcC-chhhcCCCC
Q 001143 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLF-PSEVGNLLG 115 (1141)
Q Consensus 38 ~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~l-P~~~~~L~~ 115 (1141)
..++...+.|+++|+++.++.. +. ++|++|+|++|.|+.+|. .|.++++|+.|+|++|+|+.+ |..|.++++
T Consensus 28 ~~C~~~~~c~~~~~~l~~iP~~-~~-----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 101 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLNSIPSG-LT-----EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101 (353)
T ss_dssp CEECTTSEEECCSTTCSSCCTT-CC-----TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CCCCCCeEeeCCCCCccccccc-cc-----ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCC
Confidence 3445566799999999976543 22 589999999999999976 799999999999999999977 566999999
Q ss_pred CCEEEccCCCCCCCccc-ccCCCCCCEEECCCCCCCCCcccchh--hhcCCCCCcEEEccCC-CCCcc-CccccCCCCCC
Q 001143 116 LECLQIKISSPGVNGFA-LNKLKGLKELELSKVPPRPSVLTLLS--EIAGLKCLTKLSVCHF-SIRYL-PPEIGCLSNLE 190 (1141)
Q Consensus 116 L~~L~Ls~N~l~~~~~~-~~~L~~L~~L~Ls~N~ln~~~~~lp~--~l~~L~~L~~L~Ls~N-~L~~i-P~~l~~l~~L~ 190 (1141)
|++|+|++|.++.++.. +.++++|++|++++|.+. .+|. .+..+++|+.|++++| .++.+ |..+..+++|+
T Consensus 102 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~----~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~ 177 (353)
T 2z80_A 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK----TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177 (353)
T ss_dssp CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS----SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc----ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence 99999999998888865 899999999999997665 3444 6889999999999999 58877 45789999999
Q ss_pred EEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCcCcc-CCCCCCEEeCCCCCCCCCCc------------------
Q 001143 191 QLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGS------------------ 250 (1141)
Q Consensus 191 ~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~~l~-~L~~L~~L~Ls~N~Lt~~~p------------------ 250 (1141)
.|+|++|+++.+ |..+..+++|+.|+|++|+++.+|..+. .+++|+.|+|++|++++.++
T Consensus 178 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~ 257 (353)
T 2z80_A 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257 (353)
T ss_dssp EEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEE
T ss_pred EEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccc
Confidence 999999999965 8899999999999999999998887655 48999999999999998653
Q ss_pred -------------ccccCCCCCCEEEccCCcCCCCCCCchhh-hhcccCCCCCCCCCCcccCcc
Q 001143 251 -------------LDLCLMHNLQNLNLQYNKLLSYCQVPSWI-CCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 251 -------------~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~-~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
..+..+++|+.|+|++|+++. +|..+ ........+++.+|.+.|..+
T Consensus 258 ~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~---i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 258 NVKITDESLFQVMKLLNQISGLLELEFSRNQLKS---VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp SCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC---CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccccCcchhhhHHHHhcccCCCEEECCCCCCCc---cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 245677788888888888875 67664 455666677777777766554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-25 Score=244.18 Aligned_cols=212 Identities=26% Similarity=0.254 Sum_probs=153.9
Q ss_pred CccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECC
Q 001143 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELS 145 (1141)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls 145 (1141)
+|++|+|++|.|+.+|. .|.++++|++|+|++|+|+.++. .|.++++|++|+|++|.++.++ ..+.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555665555555543 45555556666666665554433 4555556666666655544443 345566666666666
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEEccCCCCCc--cCccccCCCCCCEEEccCCcccccc-ccccCCCCCC----EEEcc
Q 001143 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--LPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALI----SLKVA 218 (1141)
Q Consensus 146 ~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~--iP~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~----~L~Ls 218 (1141)
+|.+.... +..+..+++|+.|++++|+++. +|..+..+++|+.|+|++|+|+.+| ..+..+++|+ .|+|+
T Consensus 109 ~n~l~~~~---~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls 185 (276)
T 2z62_A 109 ETNLASLE---NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (276)
T ss_dssp TSCCCCST---TCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECC
T ss_pred CCCccccC---chhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecC
Confidence 64443322 2246778889999999999986 6888999999999999999999775 5676666666 89999
Q ss_pred CCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcc
Q 001143 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283 (1141)
Q Consensus 219 ~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l 283 (1141)
+|+|+.+|.......+|+.|+|++|+|+++++..|..+++|+.|+|++|+|+|.|+--.++..++
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~~l~~~~ 250 (276)
T 2z62_A 186 LNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 250 (276)
T ss_dssp SSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTHHHHHHH
T ss_pred CCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchHHHHHHH
Confidence 99999998888887899999999999999999888999999999999999999886434444333
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=284.13 Aligned_cols=273 Identities=19% Similarity=0.161 Sum_probs=182.9
Q ss_pred CCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCC-cccccCCCCCCCccEEEeecCCCCcc-CccccCCcC
Q 001143 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPL-IESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEK 92 (1141)
Q Consensus 15 ~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~-p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~ 92 (1141)
.++.+..|++..|+|+.+.+..|.++.+|++|||++|.+.+.+ |..| ++|++|++|+|++|.|+.+ |..|.++++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f---~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~ 98 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF---RNLPNLRILDLGSSKIYFLHPDAFQGLFH 98 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTT---SSCTTCCEEECTTCCCCEECTTSSCSCSS
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHh---cCCCCCCEEECCCCcCcccCHhHccCCcc
Confidence 4567999999999999999999999999999999999776665 5555 4559999999999999976 778999999
Q ss_pred CcEEEccCCCCCc-Cchh--hcCCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhcCC--CC
Q 001143 93 LRNLKFFGNEINL-FPSE--VGNLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIAGL--KC 165 (1141)
Q Consensus 93 L~~L~Ls~N~L~~-lP~~--~~~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L--~~ 165 (1141)
|++|+|++|.|+. +|.. |.+|++|+.|+|++|.+...+ ..|.++++|++|+|++|.+... .|..+..+ ++
T Consensus 99 L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~---~~~~l~~l~~~~ 175 (844)
T 3j0a_A 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV---CEHELEPLQGKT 175 (844)
T ss_dssp CCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC---CSGGGHHHHHCS
T ss_pred cCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee---CHHHcccccCCc
Confidence 9999999999984 5665 899999999999999976653 4799999999999999776543 33344443 55
Q ss_pred CcEEEccCCCCC-ccCccccCCCC------CCEEEccCCccc-cccccccC-----------------------------
Q 001143 166 LTKLSVCHFSIR-YLPPEIGCLSN------LEQLDLSFNKMK-YLPTEICY----------------------------- 208 (1141)
Q Consensus 166 L~~L~Ls~N~L~-~iP~~l~~l~~------L~~L~Ls~N~L~-~iP~~l~~----------------------------- 208 (1141)
|+.|++++|.+. .+|..++.+++ |+.|+|++|.++ .+|..+..
T Consensus 176 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~ 255 (844)
T 3j0a_A 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255 (844)
T ss_dssp SCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTG
T ss_pred cceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCC
Confidence 666666666555 33444443333 555555555443 22221111
Q ss_pred ---------CCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchh
Q 001143 209 ---------LKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1141)
Q Consensus 209 ---------l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~ 278 (1141)
.++|+.|+|++|.++.+ |..+..+++|+.|+|++|+|++++|..|..+++|+.|+|++|+++.. .|..
T Consensus 256 ~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~ 333 (844)
T 3j0a_A 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL--YSSN 333 (844)
T ss_dssp GGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCC--CSCS
T ss_pred ChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCcc--CHHH
Confidence 13455555555555533 34444455555555555555555555555555555555555555441 2334
Q ss_pred hhhcccCCCCCCCCCCc
Q 001143 279 ICCNLEGNGKDSSNDDF 295 (1141)
Q Consensus 279 ~~~~l~~~~l~~~~n~l 295 (1141)
+........++++.|.+
T Consensus 334 ~~~l~~L~~L~L~~N~i 350 (844)
T 3j0a_A 334 FYGLPKVAYIDLQKNHI 350 (844)
T ss_dssp CSSCTTCCEEECCSCCC
T ss_pred hcCCCCCCEEECCCCCC
Confidence 44444444444444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=275.68 Aligned_cols=229 Identities=17% Similarity=0.141 Sum_probs=187.1
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCC
Q 001143 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGL 116 (1141)
Q Consensus 37 f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L 116 (1141)
....++|++|||++|+|++.+|..|+.+ ++|++|+|++|.|+.+++ |..+++|++|+|++|.|+.+|.. ++|
T Consensus 30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~~----~~L 101 (487)
T 3oja_A 30 RQSAWNVKELDLSGNPLSQISAADLAPF---TKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG----PSI 101 (487)
T ss_dssp STTGGGCCEEECCSSCCCCCCGGGGTTC---TTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEEC----TTC
T ss_pred cccCCCccEEEeeCCcCCCCCHHHHhCC---CCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCCC----CCc
Confidence 3455589999999999998888777555 899999999999986655 88899999999999999877643 889
Q ss_pred CEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc-cCcccc-CCCCCCEEEc
Q 001143 117 ECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY-LPPEIG-CLSNLEQLDL 194 (1141)
Q Consensus 117 ~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~-iP~~l~-~l~~L~~L~L 194 (1141)
+.|+|++|.+..++. ..+++|+.|+|++|.+.. ..|..++.+++|+.|+|++|.|+. +|..+. .+++|+.|+|
T Consensus 102 ~~L~L~~N~l~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L 176 (487)
T 3oja_A 102 ETLHAANNNISRVSC--SRGQGKKNIYLANNKITM---LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (487)
T ss_dssp CEEECCSSCCCCEEE--CCCSSCEEEECCSSCCCS---GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CEEECcCCcCCCCCc--cccCCCCEEECCCCCCCC---CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence 999999999887764 357889999999966543 345577888999999999999995 466665 7899999999
Q ss_pred cCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 195 SFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 195 s~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
++|.|+.+|. +..+++|+.|+|++|+|+.+|+.+..+++|+.|+|++|+|+++++ .+..+++|+.|+|++|++.|. .
T Consensus 177 s~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-~l~~l~~L~~L~l~~N~l~c~-~ 253 (487)
T 3oja_A 177 QYNFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEK-ALRFSQNLEHFDLRGNGFHCG-T 253 (487)
T ss_dssp TTSCCCEEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECT-TCCCCTTCCEEECTTCCBCHH-H
T ss_pred CCCccccccc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccch-hhccCCCCCEEEcCCCCCcCc-c
Confidence 9999998864 446889999999999999998888889999999999999998765 688889999999999999852 2
Q ss_pred Cchhhhh
Q 001143 275 VPSWICC 281 (1141)
Q Consensus 275 iP~~~~~ 281 (1141)
+|.++..
T Consensus 254 ~~~~~~~ 260 (487)
T 3oja_A 254 LRDFFSK 260 (487)
T ss_dssp HHHHHTT
T ss_pred hHHHHHh
Confidence 5555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-24 Score=258.09 Aligned_cols=243 Identities=19% Similarity=0.189 Sum_probs=206.9
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEEccCCCCCcCc-hhhcCCCCCCEE
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECL 119 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~Ls~N~L~~lP-~~~~~L~~L~~L 119 (1141)
....+++++++|+.++.. +. ++|+.|+|++|+|+.++ ..|.++++|++|+|++|+|+.++ ..|.++++|+.|
T Consensus 44 ~~~~v~c~~~~l~~iP~~-~~-----~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L 117 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDG-IS-----TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL 117 (440)
T ss_dssp TSCEEECCSCCCSSCCSC-CC-----TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEE
T ss_pred CCCEEEeCCCCcCcCCCC-CC-----CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEE
Confidence 467899999999976543 32 67999999999999886 57999999999999999999875 679999999999
Q ss_pred EccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC-CCCCccCc-cccCCCCCCEEEccC
Q 001143 120 QIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH-FSIRYLPP-EIGCLSNLEQLDLSF 196 (1141)
Q Consensus 120 ~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~-N~L~~iP~-~l~~l~~L~~L~Ls~ 196 (1141)
+|++|+++.++. .|..+++|++|+|++|.+. ...+..|.++++|+.|+|++ |.++.+|. .|..+++|+.|+|++
T Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~---~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~ 194 (440)
T 3zyj_A 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194 (440)
T ss_dssp ECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC---EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTT
T ss_pred ECCCCcCCeeCHhHhhccccCceeeCCCCccc---ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCC
Confidence 999999888875 6999999999999997654 22334788999999999999 56777766 689999999999999
Q ss_pred CccccccccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCC
Q 001143 197 NKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV 275 (1141)
Q Consensus 197 N~L~~iP~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~i 275 (1141)
|+|+.+| .+..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|+. +
T Consensus 195 n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~ 270 (440)
T 3zyj_A 195 CNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL---L 270 (440)
T ss_dssp SCCSSCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC---C
T ss_pred CcCcccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc---c
Confidence 9999998 588999999999999999977 7788899999999999999999999999999999999999999997 4
Q ss_pred chh-hhhcccCCCCCCCCCCccc
Q 001143 276 PSW-ICCNLEGNGKDSSNDDFIS 297 (1141)
Q Consensus 276 P~~-~~~~l~~~~l~~~~n~l~~ 297 (1141)
|.. +..+..+..+++.+|.+.|
T Consensus 271 ~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 271 PHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTTTSSCTTCCEEECCSSCEEC
T ss_pred ChhHhccccCCCEEEcCCCCccC
Confidence 433 3334445555555555543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-27 Score=264.01 Aligned_cols=241 Identities=17% Similarity=0.119 Sum_probs=211.5
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
.++++.|.+..|+|+.+.+..|.++++|++|+|++|+|++.++ + ..+++|++|+|++|.|+.+|. +++|+.
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~---~~l~~L~~L~Ls~n~l~~l~~----~~~L~~ 103 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--L---ESLSTLRTLDLNNNYVQELLV----GPSIET 103 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--E---TTCTTCCEEECCSSEEEEEEE----CTTCCE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--h---hhcCCCCEEECcCCccccccC----CCCcCE
Confidence 3479999999999999999999999999999999999997664 4 555999999999999998863 379999
Q ss_pred EEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhh-cCCCCCcEEEccC
Q 001143 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCH 173 (1141)
Q Consensus 96 L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l-~~L~~L~~L~Ls~ 173 (1141)
|+|++|+|+.++.. .+++|+.|+|++|.++.++. .+..+++|++|+|++|.+.. ..|..+ ..+++|+.|+|++
T Consensus 104 L~l~~n~l~~~~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~~l~~L~~L~L~~ 178 (317)
T 3o53_A 104 LHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT---VNFAELAASSDTLEHLNLQY 178 (317)
T ss_dssp EECCSSCCSEEEEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE---EEGGGGGGGTTTCCEEECTT
T ss_pred EECCCCccCCcCcc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc---ccHHHHhhccCcCCEEECCC
Confidence 99999999987643 47899999999999887754 78899999999999976543 334455 4789999999999
Q ss_pred CCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCC-CCCccc
Q 001143 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT-SLGSLD 252 (1141)
Q Consensus 174 N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt-~~~p~~ 252 (1141)
|+|+.+|.. ..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+++ +.++.+
T Consensus 179 N~l~~~~~~-~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 257 (317)
T 3o53_A 179 NFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (317)
T ss_dssp SCCCEEECC-CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred CcCcccccc-cccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCHHHH
Confidence 999988654 469999999999999999998899999999999999999999999999999999999999999 777888
Q ss_pred ccCCCCCCEEEccCC-cCCC
Q 001143 253 LCLMHNLQNLNLQYN-KLLS 271 (1141)
Q Consensus 253 l~~L~~L~~L~Ls~N-~L~~ 271 (1141)
+..+++|+.|++++| .+++
T Consensus 258 ~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 258 FSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp HHTCHHHHHHHHHHHHHHHS
T ss_pred HhccccceEEECCCchhccC
Confidence 999999999999954 4554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=274.32 Aligned_cols=236 Identities=17% Similarity=0.125 Sum_probs=209.0
Q ss_pred CCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCc
Q 001143 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLR 94 (1141)
Q Consensus 15 ~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~ 94 (1141)
..+++..|.+..|+|+.+.+..|.++++|++|+|++|.|++.+| ++.+++|++|+|++|.|+.+|.. ++|+
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-----l~~l~~L~~L~Ls~N~l~~l~~~----~~L~ 102 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-----LESLSTLRTLDLNNNYVQELLVG----PSIE 102 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-----CTTCTTCCEEECCSSEEEEEEEC----TTCC
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-----cccCCCCCEEEecCCcCCCCCCC----CCcC
Confidence 44579999999999999999999999999999999999998765 45569999999999999988743 7899
Q ss_pred EEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhc-CCCCCcEEEcc
Q 001143 95 NLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIA-GLKCLTKLSVC 172 (1141)
Q Consensus 95 ~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~-~L~~L~~L~Ls 172 (1141)
.|+|++|.|+.+|.. .+++|+.|+|++|.++.+ |..+..+++|++|+|++|.+. +..|..+. .+++|+.|+|+
T Consensus 103 ~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---~~~~~~l~~~l~~L~~L~Ls 177 (487)
T 3oja_A 103 TLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID---TVNFAELAASSDTLEHLNLQ 177 (487)
T ss_dssp EEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCC---EEEGGGGGGGTTTCCEEECT
T ss_pred EEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCC---CcChHHHhhhCCcccEEecC
Confidence 999999999988653 578999999999997776 457899999999999996554 44566665 79999999999
Q ss_pred CCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCC-CCCcc
Q 001143 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT-SLGSL 251 (1141)
Q Consensus 173 ~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt-~~~p~ 251 (1141)
+|.|+.+|. +..+++|+.|+|++|.|+.+|..+..+++|+.|+|++|.|+.||..+..+++|+.|+|++|.++ +.+|.
T Consensus 178 ~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 178 YNFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp TSCCCEEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred CCccccccc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 999998865 4569999999999999999998899999999999999999999999999999999999999998 66677
Q ss_pred cccCCCCCCEEEcc
Q 001143 252 DLCLMHNLQNLNLQ 265 (1141)
Q Consensus 252 ~l~~L~~L~~L~Ls 265 (1141)
++..++.|+.|+++
T Consensus 257 ~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 257 FFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHTTCHHHHHHHHH
T ss_pred HHHhCCCCcEEecc
Confidence 88899999988887
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=247.36 Aligned_cols=249 Identities=20% Similarity=0.192 Sum_probs=207.7
Q ss_pred ccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEc
Q 001143 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKF 98 (1141)
Q Consensus 20 ~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~L 98 (1141)
..+....+.|+.++... .++|++|+|++|+|++..+..|+.+ ++|++|+|++|.|+.+ |..|.++++|++|+|
T Consensus 14 ~~~~c~~~~l~~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 87 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI---PAASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (285)
T ss_dssp CEEECCSSCCSSCCTTC---CTTCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eEEEcCcCCcccCCcCC---CCCceEEEeeCCcCCccCHHHcccC---CCCCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence 45777888898887543 4689999999999999887766554 9999999999999987 678999999999999
Q ss_pred cCCC-CCcC-chhhcCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 99 FGNE-INLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 99 s~N~-L~~l-P~~~~~L~~L~~L~Ls~N~l~~~-~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
++|. ++.+ |..|.++++|++|+|++|.+..+ +..+..+++|++|++++|.+... .+..|..+++|+.|++++|+
T Consensus 88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~l~~n~ 164 (285)
T 1ozn_A 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL---PDDTFRDLGNLTHLFLHGNR 164 (285)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC---CTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccccc---CHhHhccCCCccEEECCCCc
Confidence 9997 8887 67799999999999999997776 46789999999999999766432 23458899999999999999
Q ss_pred CCccCc-cccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCccc
Q 001143 176 IRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLD 252 (1141)
Q Consensus 176 L~~iP~-~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~ 252 (1141)
|+.+|. .+..+++|+.|+|++|.|+.+ |..+..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|.++...+..
T Consensus 165 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 244 (285)
T 1ozn_A 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence 998876 589999999999999999966 7889999999999999999998875 4888999999999999998655421
Q ss_pred ccCCCCCCEEEccCCcCCCCCCCchhhh
Q 001143 253 LCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1141)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1141)
.-+..|+.+..+.|.+.| ..|..+.
T Consensus 245 -~~~~~l~~~~~~~~~~~c--~~p~~l~ 269 (285)
T 1ozn_A 245 -PLWAWLQKFRGSSSEVPC--SLPQRLA 269 (285)
T ss_dssp -HHHHHHHHCCSEECCCBE--EESGGGT
T ss_pred -HHHHHHHhcccccCcccc--CCchHhC
Confidence 111234455577788877 5776544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=265.19 Aligned_cols=292 Identities=21% Similarity=0.141 Sum_probs=220.8
Q ss_pred cCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCC
Q 001143 23 PSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGN 101 (1141)
Q Consensus 23 ~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N 101 (1141)
+-...+++.|+.+- -.++++|||++|+|+++.+..|..+ ++|++|+|++|+|+.||+ .|.+|++|++|+|++|
T Consensus 37 ~c~~~~l~~vP~~l---p~~~~~LdLs~N~i~~l~~~~f~~l---~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N 110 (635)
T 4g8a_A 37 QCMELNFYKIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 110 (635)
T ss_dssp ECTTSCCSSCCSSS---CTTCCEEECTTSCCCEECTTTTTTC---TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ECCCCCcCccCCCC---CcCCCEEEeeCCCCCCCCHHHHhCC---CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC
Confidence 34456788887532 2489999999999999888776555 999999999999999975 6999999999999999
Q ss_pred CCCcCch-hhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc
Q 001143 102 EINLFPS-EVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179 (1141)
Q Consensus 102 ~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~i 179 (1141)
+|+.+|. .|.+|++|++|+|++|+++.++. .|.++++|++|+|++|.+... .+|..++.+++|+.|++++|+|+.+
T Consensus 111 ~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~--~~~~~~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 111 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--KLPEYFSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC--CCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC--CCchhhccchhhhhhcccCcccccc
Confidence 9999975 58999999999999999888775 699999999999999776432 3466777888888888888876533
Q ss_pred Cc-cc---------------------------------------------------------------------------
Q 001143 180 PP-EI--------------------------------------------------------------------------- 183 (1141)
Q Consensus 180 P~-~l--------------------------------------------------------------------------- 183 (1141)
+. .+
T Consensus 189 ~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~ 268 (635)
T 4g8a_A 189 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 268 (635)
T ss_dssp CGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred ccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccc
Confidence 21 00
Q ss_pred --------------------------------------------------------------------------------
Q 001143 184 -------------------------------------------------------------------------------- 183 (1141)
Q Consensus 184 -------------------------------------------------------------------------------- 183 (1141)
T Consensus 269 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l 348 (635)
T 4g8a_A 269 KFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL 348 (635)
T ss_dssp CCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBC
T ss_pred cccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccc
Confidence
Q ss_pred -------------------cCCCCCCEEEccCCccc--------------------------------------------
Q 001143 184 -------------------GCLSNLEQLDLSFNKMK-------------------------------------------- 200 (1141)
Q Consensus 184 -------------------~~l~~L~~L~Ls~N~L~-------------------------------------------- 200 (1141)
..+++|+.|++++|.+.
T Consensus 349 ~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~ 428 (635)
T 4g8a_A 349 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQ 428 (635)
T ss_dssp TTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECT
T ss_pred hhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhh
Confidence 01234444555554432
Q ss_pred ------------------------------cc-cccccCCCCCCEEEccCCCCC--cCCcCccCCCCCCEEeCCCCCCCC
Q 001143 201 ------------------------------YL-PTEICYLKALISLKVANNKLV--ELPSGLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 201 ------------------------------~i-P~~l~~l~~L~~L~Ls~N~L~--~IP~~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
.+ |..+..+++|+.|+|++|++. .+|..+..+++|+.|+|++|+|++
T Consensus 429 ~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~ 508 (635)
T 4g8a_A 429 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 508 (635)
T ss_dssp TSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred hccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCC
Confidence 11 122334567889999999764 358888999999999999999999
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcccccccCCCCCCCCCCCCcCCCCC-CCc
Q 001143 248 LGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDA-GSR 326 (1141)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~~~~~~~~~~l~~~~~~sf~~n~~-~~~ 326 (1141)
++|..|.++++|+.|+|++|+|++. .|..+..+..+..+++++|.+.+..|..-. .....-.....++|+. |.+
T Consensus 509 l~~~~f~~l~~L~~L~Ls~N~l~~l--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~---~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 509 LSPTAFNSLSSLQVLNMSHNNFFSL--DTFPYKCLNSLQVLDYSLNHIMTSKKQELQ---HFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCBC--CCGGGTTCTTCCEEECTTSCCCBCCSSCTT---CCCTTCCEEECTTCCBCCSG
T ss_pred cChHHHcCCCCCCEEECCCCcCCCC--ChhHHhCCCCCCEEECCCCcCCCCCHHHHH---hhhCcCCEEEeeCCCCcccC
Confidence 9999999999999999999999983 355566777888999999999887664110 0011223345677776 754
Q ss_pred c
Q 001143 327 H 327 (1141)
Q Consensus 327 ~ 327 (1141)
.
T Consensus 584 ~ 584 (635)
T 4g8a_A 584 E 584 (635)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-26 Score=255.60 Aligned_cols=226 Identities=19% Similarity=0.096 Sum_probs=190.8
Q ss_pred cccccCCCCCccccCCCCCC--------CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCC
Q 001143 19 KEKLPSEANKINNEKNGSVN--------DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY 90 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~--------~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L 90 (1141)
++.|.+..|+|+.+...... ++++|++|+|++|+|++.+|..+- ++.+++|++|+|++|+|+.+|..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL-EATGPDLNILNLRNVSWATRDAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS-SCCSCCCSEEEEESCBCSSSSSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH-HhcCCCccEEEccCCCCcchhHHHHHH
Confidence 77888999999765433322 689999999999999998887541 245699999999999999888888877
Q ss_pred -----cCCcEEEccCCCCCcCc-hhhcCCCCCCEEEccCCCCCC---Cccc--ccCCCCCCEEECCCCCCCCCcccchhh
Q 001143 91 -----EKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGV---NGFA--LNKLKGLKELELSKVPPRPSVLTLLSE 159 (1141)
Q Consensus 91 -----~~L~~L~Ls~N~L~~lP-~~~~~L~~L~~L~Ls~N~l~~---~~~~--~~~L~~L~~L~Ls~N~ln~~~~~lp~~ 159 (1141)
++|++|+|++|+|+.++ ..|+++++|+.|+|++|++.. .+.. +..+++|++|+|++|.+..........
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 223 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHH
Confidence 89999999999999876 789999999999999999543 2333 389999999999998775433322344
Q ss_pred hcCCCCCcEEEccCCCCCccC--ccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCE
Q 001143 160 IAGLKCLTKLSVCHFSIRYLP--PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237 (1141)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~iP--~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 237 (1141)
+..+++|+.|++++|+|+.++ ..+..+++|+.|+|++|+|+.+|..+. ++|+.|+|++|+|+.+|. +..+++|+.
T Consensus 224 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~p~-~~~l~~L~~ 300 (312)
T 1wwl_A 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVGN 300 (312)
T ss_dssp HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCSCCC-TTTSCEEEE
T ss_pred HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCCChh-HhhCCCCCE
Confidence 568899999999999999754 356778999999999999999999887 899999999999999987 899999999
Q ss_pred EeCCCCCCCCC
Q 001143 238 LDLSNNRLTSL 248 (1141)
Q Consensus 238 L~Ls~N~Lt~~ 248 (1141)
|+|++|+|++.
T Consensus 301 L~L~~N~l~~~ 311 (312)
T 1wwl_A 301 LSLKGNPFLDS 311 (312)
T ss_dssp EECTTCTTTCC
T ss_pred EeccCCCCCCC
Confidence 99999999864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=258.18 Aligned_cols=225 Identities=22% Similarity=0.233 Sum_probs=200.4
Q ss_pred CCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCC
Q 001143 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKL 93 (1141)
Q Consensus 15 ~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L 93 (1141)
.++.+..|.+..|+|+.+.+..|.++++|++|+|++|+|++..+..|. ++++|++|+|++|+|+.+|.. |..+++|
T Consensus 73 ~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 149 (452)
T 3zyi_A 73 IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN---GLASLNTLELFDNWLTVIPSGAFEYLSKL 149 (452)
T ss_dssp CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT---TCTTCCEEECCSSCCSBCCTTTSSSCTTC
T ss_pred CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhcc---CcccCCEEECCCCcCCccChhhhcccCCC
Confidence 345799999999999999999999999999999999999998887665 459999999999999999764 8899999
Q ss_pred cEEEccCCCCCcCch-hhcCCCCCCEEEccCCC-CCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEE
Q 001143 94 RNLKFFGNEINLFPS-EVGNLLGLECLQIKISS-PGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLS 170 (1141)
Q Consensus 94 ~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~-l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~ 170 (1141)
++|+|++|+|+.+|. .|.++++|+.|+|++|+ ++.++. .|.++++|++|+|++|.+... | .+..+++|+.|+
T Consensus 150 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~----~-~~~~l~~L~~L~ 224 (452)
T 3zyi_A 150 RELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM----P-NLTPLVGLEELE 224 (452)
T ss_dssp CEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC----C-CCTTCTTCCEEE
T ss_pred CEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc----c-cccccccccEEE
Confidence 999999999998866 58899999999999854 777765 699999999999999877543 3 478899999999
Q ss_pred ccCCCCCcc-CccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCcC-ccCCCCCCEEeCCCCCCCC
Q 001143 171 VCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 171 Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+..
T Consensus 225 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 999999977 66889999999999999999966 67799999999999999999988755 5679999999999998764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-24 Score=264.94 Aligned_cols=240 Identities=23% Similarity=0.204 Sum_probs=154.1
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
++..|.+..|+|+.++. .+++|++|||++|+|+++.+ .+++|++|+|++|.|+.+|. .+++|+.|+
T Consensus 62 ~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~-------~l~~L~~L~Ls~N~l~~l~~---~l~~L~~L~ 127 (622)
T 3g06_A 62 HITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV-------LPPGLLELSIFSNPLTHLPA---LPSGLCKLW 127 (622)
T ss_dssp TCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCCCC-------CCTTCCEEEECSCCCCCCCC---CCTTCCEEE
T ss_pred CCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcCCC-------CCCCCCEEECcCCcCCCCCC---CCCCcCEEE
Confidence 45555555555555544 34555555555555554322 22555555555555555554 344555555
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001143 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1141)
Q Consensus 98 Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1141)
|++|+|+.+|.. +++|+.|+|++|.++.+|. .+.+|+.|++++|.+.. +| ..+++|+.|++++|+|+
T Consensus 128 L~~N~l~~lp~~---l~~L~~L~Ls~N~l~~l~~---~~~~L~~L~L~~N~l~~----l~---~~~~~L~~L~Ls~N~l~ 194 (622)
T 3g06_A 128 IFGNQLTSLPVL---PPGLQELSVSDNQLASLPA---LPSELCKLWAYNNQLTS----LP---MLPSGLQELSVSDNQLA 194 (622)
T ss_dssp CCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC----CC---CCCTTCCEEECCSSCCS
T ss_pred CCCCCCCcCCCC---CCCCCEEECcCCcCCCcCC---ccCCCCEEECCCCCCCC----Cc---ccCCCCcEEECCCCCCC
Confidence 555555555543 2555666666665555443 23455555555544432 22 23467777788888877
Q ss_pred ccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCC
Q 001143 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1141)
Q Consensus 178 ~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~ 257 (1141)
.+|.. +++|+.|+|++|.|+.+|.. +++|+.|+|++|+|+.|| ..+++|+.|+|++|+|+.+++ .++
T Consensus 195 ~l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~lp~----~~~ 261 (622)
T 3g06_A 195 SLPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTSLPM----LPS 261 (622)
T ss_dssp CCCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC----CCT
T ss_pred CCCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCcCCc----ccc
Confidence 77653 36777777777777777653 367888888888888887 345778888888888887665 567
Q ss_pred CCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 258 NLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 258 ~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
+|+.|+|++|+|+. ||..+..+..+..+++.+|.+.+..+
T Consensus 262 ~L~~L~Ls~N~L~~---lp~~l~~l~~L~~L~L~~N~l~~~~~ 301 (622)
T 3g06_A 262 GLLSLSVYRNQLTR---LPESLIHLSSETTVNLEGNPLSERTL 301 (622)
T ss_dssp TCCEEECCSSCCCS---CCGGGGGSCTTCEEECCSCCCCHHHH
T ss_pred cCcEEeCCCCCCCc---CCHHHhhccccCEEEecCCCCCCcCH
Confidence 88888888888885 78877777777888888888876654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-24 Score=252.93 Aligned_cols=123 Identities=19% Similarity=0.116 Sum_probs=60.1
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEE
Q 001143 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120 (1141)
Q Consensus 41 ~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~ 120 (1141)
++|++|+|++|++++ +|+ ++++++|++|+|++|+|+.+|..+ ++|++|+|++|+|+.+| .|+++++|+.|+
T Consensus 131 ~~L~~L~L~~n~l~~-lp~----~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPE----LQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIY 201 (454)
T ss_dssp TTCCEEECCSSCCSS-CCC----CTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEE
T ss_pred CCCCEEECcCCCCCC-Ccc----cCCCCCCCEEECCCCcCcccCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEE
Confidence 355555555555554 331 233355555555555555555432 24555555555555555 355555555555
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccC
Q 001143 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180 (1141)
Q Consensus 121 Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP 180 (1141)
+++|.+..+|..+ .+|++|++++|.+. .+| .++.+++|+.|++++|+++.+|
T Consensus 202 l~~N~l~~l~~~~---~~L~~L~l~~n~l~----~lp-~~~~l~~L~~L~l~~N~l~~l~ 253 (454)
T 1jl5_A 202 ADNNSLKKLPDLP---LSLESIVAGNNILE----ELP-ELQNLPFLTTIYADNNLLKTLP 253 (454)
T ss_dssp CCSSCCSSCCCCC---TTCCEEECCSSCCS----SCC-CCTTCTTCCEEECCSSCCSSCC
T ss_pred CCCCcCCcCCCCc---CcccEEECcCCcCC----ccc-ccCCCCCCCEEECCCCcCCccc
Confidence 5555544443322 24455555543332 223 2444444445555444444444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=241.62 Aligned_cols=207 Identities=26% Similarity=0.237 Sum_probs=143.7
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSK 146 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~ 146 (1141)
++|+.|++++|.|+.+|..+. ++|+.|+|++|+|+.+ |..|.++++|+.|+|++|.++.++.. ..+++|++|+|++
T Consensus 10 ~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~ 86 (290)
T 1p9a_G 10 ASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSH 86 (290)
T ss_dssp TTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCEEECCS
T ss_pred CCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCEEECCC
Confidence 444444444444444444332 2444444444444433 23344444444444444444443332 4455555555555
Q ss_pred CCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCc
Q 001143 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVE 224 (1141)
Q Consensus 147 N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~ 224 (1141)
|.+. .+|..+..+++|+.|+|++|+|+.+|. .|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+.
T Consensus 87 N~l~----~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 87 NQLQ----SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp SCCS----SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred CcCC----cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 4432 445566778889999999999998864 688999999999999999988754 6789999999999999999
Q ss_pred CCcCc-cCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhc
Q 001143 225 LPSGL-YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1141)
Q Consensus 225 IP~~l-~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1141)
+|..+ ..+++|+.|+|++|+|+.+++ .+..+++|+.|+|++|+|.|.|.+.....|.
T Consensus 163 l~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~~~~L~~l~L~~Np~~C~c~~~~l~~wl 220 (290)
T 1p9a_G 163 LPAGLLNGLENLDTLLLQENSLYTIPK-GFFGSHLLPFAFLHGNPWLCNCEILYFRRWL 220 (290)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCCCSEEECCSCCBCCSGGGHHHHHHH
T ss_pred cCHHHhcCcCCCCEEECCCCcCCccCh-hhcccccCCeEEeCCCCccCcCccHHHHHHH
Confidence 98765 569999999999999998766 6777889999999999999988776544443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.3e-24 Score=233.85 Aligned_cols=201 Identities=26% Similarity=0.352 Sum_probs=147.4
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEE
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECL 119 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~~-~~~L~~L~~L 119 (1141)
+++.+++++|+|+.++ ..+. ++|++|+|++|+|+.+|. .|.++++|++|+|++|+|+.+|.. |.++++|++|
T Consensus 17 ~~~~l~~~~~~l~~ip-~~~~-----~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIP-SNIP-----ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL 90 (270)
T ss_dssp TTTEEECTTSCCSSCC-SCCC-----TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEE
T ss_pred CCCEEEccCCCCCccC-CCCC-----CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEE
Confidence 3455666666665432 2111 345566666666655543 455566666666666666555443 3445555555
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCc
Q 001143 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1141)
Q Consensus 120 ~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~ 198 (1141)
+|++|.++.++ +..|..+++|+.|++++|+++.+|. .|..+++|++|+|++|+
T Consensus 91 ~l~~n~l~~~~--------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 91 WVTDNKLQALP--------------------------IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ECCSSCCCCCC--------------------------TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCC--------------------------HhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 55554433322 2346778889999999999997755 57899999999999999
Q ss_pred ccccccc-ccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 199 MKYLPTE-ICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 199 L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
|+.+|.. |..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 9988755 7889999999999999998875 47789999999999999999999889999999999999999999886
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-23 Score=260.33 Aligned_cols=230 Identities=22% Similarity=0.162 Sum_probs=199.1
Q ss_pred CCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCc
Q 001143 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLR 94 (1141)
Q Consensus 15 ~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~ 94 (1141)
..++++.|.+..|+|+.++. .+++|++|+|++|+|++..+ .+++|+.|+|++|+|+.||.. +++|+
T Consensus 79 ~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~-------~l~~L~~L~L~~N~l~~lp~~---l~~L~ 144 (622)
T 3g06_A 79 LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLTSLPVL---PPGLQ 144 (622)
T ss_dssp CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCCCCC-------CCTTCCEEECCSSCCSCCCCC---CTTCC
T ss_pred cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCCCCC-------CCCCcCEEECCCCCCCcCCCC---CCCCC
Confidence 34589999999999999876 78999999999999998654 237899999999999999975 47899
Q ss_pred EEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001143 95 NLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1141)
Q Consensus 95 ~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1141)
+|+|++|+|+.+|.. +++|+.|+|++|.++.+| ..+++|+.|++++|.+.. +|.. +++|+.|++++|
T Consensus 145 ~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~~----l~~~---~~~L~~L~L~~N 211 (622)
T 3g06_A 145 ELSVSDNQLASLPAL---PSELCKLWAYNNQLTSLP---MLPSGLQELSVSDNQLAS----LPTL---PSELYKLWAYNN 211 (622)
T ss_dssp EEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC----CCCC---CTTCCEEECCSS
T ss_pred EEECcCCcCCCcCCc---cCCCCEEECCCCCCCCCc---ccCCCCcEEECCCCCCCC----CCCc---cchhhEEECcCC
Confidence 999999999999863 578999999999999888 567899999999987754 3332 478999999999
Q ss_pred CCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCccccc
Q 001143 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1141)
Q Consensus 175 ~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~ 254 (1141)
.|+.+|.. +++|+.|+|++|+|+.+| ..+++|+.|+|++|+|+.||. .+++|+.|+|++|+|+.++ ..|.
T Consensus 212 ~l~~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~~lp-~~l~ 281 (622)
T 3g06_A 212 RLTSLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLTRLP-ESLI 281 (622)
T ss_dssp CCSSCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCCSCC-GGGG
T ss_pred cccccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCCcCC-HHHh
Confidence 99999864 589999999999999998 456899999999999999997 6788999999999999765 5799
Q ss_pred CCCCCCEEEccCCcCCCCCCCchhhhhcc
Q 001143 255 LMHNLQNLNLQYNKLLSYCQVPSWICCNL 283 (1141)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l 283 (1141)
.+++|+.|+|++|+|++ .+|..+....
T Consensus 282 ~l~~L~~L~L~~N~l~~--~~~~~l~~L~ 308 (622)
T 3g06_A 282 HLSSETTVNLEGNPLSE--RTLQALREIT 308 (622)
T ss_dssp GSCTTCEEECCSCCCCH--HHHHHHHHHH
T ss_pred hccccCEEEecCCCCCC--cCHHHHHhcc
Confidence 99999999999999998 4666666544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-23 Score=244.85 Aligned_cols=203 Identities=21% Similarity=0.175 Sum_probs=150.6
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
++.++.|.+..|+|+.++. .+.+|++|+|++|++++.. .. .++|++|+|++|+|+.+| .|.++++|++
T Consensus 90 ~~~L~~L~l~~n~l~~lp~----~~~~L~~L~l~~n~l~~l~-~~------~~~L~~L~L~~n~l~~lp-~~~~l~~L~~ 157 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNLKALS-DL------PPLLEYLGVSNNQLEKLP-ELQNSSFLKI 157 (454)
T ss_dssp CTTCSEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCCC-SC------CTTCCEEECCSSCCSSCC-CCTTCTTCCE
T ss_pred cCCCCEEEccCCcCCcccc----ccCCCcEEECCCCccCccc-CC------CCCCCEEECcCCCCCCCc-ccCCCCCCCE
Confidence 3568888888888888653 2478888888888887643 11 157888888888888888 5888888888
Q ss_pred EEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 96 L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
|+|++|+|+.+|..+ .+|++|+|++|.++.+| .+..+++|++|++++|.+.. +|.. .++|+.|++++|.
T Consensus 158 L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~----l~~~---~~~L~~L~l~~n~ 226 (454)
T 1jl5_A 158 IDVDNNSLKKLPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK----LPDL---PLSLESIVAGNNI 226 (454)
T ss_dssp EECCSSCCSCCCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS----CCCC---CTTCCEEECCSSC
T ss_pred EECCCCcCcccCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc----CCCC---cCcccEEECcCCc
Confidence 888888888887654 58888888888877777 58888888888888876643 2322 2478888888888
Q ss_pred CCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCC
Q 001143 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248 (1141)
Q Consensus 176 L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~ 248 (1141)
++.+|. ++.+++|+.|+|++|+|+.+|.. +++|+.|+|++|+++.+|..+ ++|+.|+|++|+++++
T Consensus 227 l~~lp~-~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~l~~~~---~~L~~L~ls~N~l~~l 292 (454)
T 1jl5_A 227 LEELPE-LQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTDLPELP---QSLTFLDVSENIFSGL 292 (454)
T ss_dssp CSSCCC-CTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSEE
T ss_pred CCcccc-cCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccccCccc---CcCCEEECcCCccCcc
Confidence 888874 78888888888888888877753 356777777777777766532 5566666666666653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-23 Score=229.68 Aligned_cols=221 Identities=19% Similarity=0.174 Sum_probs=185.0
Q ss_pred ccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccC
Q 001143 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFG 100 (1141)
Q Consensus 22 L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~ 100 (1141)
+.....+++.++.... ++|++|+|++|+|++..+..|.. +++|++|+|++|.|+.++. .|.++++|++|+|++
T Consensus 12 ~~c~~~~l~~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~---l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 85 (276)
T 2z62_A 12 YQCMELNFYKIPDNLP---FSTKNLDLSFNPLRHLGSYSFFS---FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (276)
T ss_dssp EECTTSCCSSCCSSSC---TTCCEEECTTCCCCEECTTTTTT---CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred EEecCCCccccCCCCC---CCccEEECCCCcccccCHhHhcc---ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence 3445566666665332 57999999999999888766654 4999999999999998865 689999999999999
Q ss_pred CCCCcCc-hhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001143 101 NEINLFP-SEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1141)
Q Consensus 101 N~L~~lP-~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1141)
|.|+.++ ..|.++++|+.|++++|.+..++. .+..+++|++|++++|.+... .+|..|.++++|+.|++++|+|+.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--KLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC--CCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee--cCchhhccCCCCCEEECCCCCCCc
Confidence 9999775 668999999999999999777765 699999999999999766432 357789999999999999999998
Q ss_pred cCc-cccCCCCCC----EEEccCCccccccccccCCCCCCEEEccCCCCCcCCcC-ccCCCCCCEEeCCCCCCCCCCc
Q 001143 179 LPP-EIGCLSNLE----QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 179 iP~-~l~~l~~L~----~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
+|. .+..+.+|+ .|+|++|.|+.+|.......+|+.|+|++|+|+.+|.. +..+++|+.|+|++|++++..+
T Consensus 164 ~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp ECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 754 666666666 89999999999988777777999999999999999866 4679999999999999986543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-23 Score=231.22 Aligned_cols=202 Identities=21% Similarity=0.225 Sum_probs=177.8
Q ss_pred CCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCcEEEccCCCCCcCchhhcCCC
Q 001143 36 SVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFGNEINLFPSEVGNLL 114 (1141)
Q Consensus 36 ~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~ 114 (1141)
.+.++++++.|++++|+|+.+++..+ ++|+.|+|++|.|+.++ ..|.++++|+.|+|++|.|+.+|.. +.++
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~~~------~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~ 77 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLP 77 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSCCC------TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCT
T ss_pred cccccCCccEEECCCCCCCcCCCCCC------CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCC
Confidence 46778899999999999997654322 67899999999999774 5799999999999999999988764 7899
Q ss_pred CCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEE
Q 001143 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLD 193 (1141)
Q Consensus 115 ~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~ 193 (1141)
+|+.|+|++|.++.+|..+..+++|++|+|++|.+... .|..|.++++|+.|+|++|+|+.+|.. |..+++|+.|+
T Consensus 78 ~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL---PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp TCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCC---CSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCccc---CHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 99999999999999999899999999999999766533 245789999999999999999988764 68899999999
Q ss_pred ccCCcccccccc-ccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCC
Q 001143 194 LSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 194 Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
|++|+|+.+|.. +..+++|+.|+|++|+|+.||..++.+.+|+.|+|++|.+..
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccC
Confidence 999999999865 577999999999999999999999999999999999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=235.78 Aligned_cols=191 Identities=23% Similarity=0.311 Sum_probs=114.4
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
++|++|+|++|.++.+| .+..+++|++|+|++|.|+.++. +.++++|+.|+|++|.++.++ .+..+++|++|++++|
T Consensus 41 ~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~l~~n 117 (308)
T 1h6u_A 41 DGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLTST 117 (308)
T ss_dssp HTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG-GGTTCTTCCEEECTTS
T ss_pred CCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch-hhcCCCCCCEEECCCC
Confidence 44444444444444443 34444444444444444444443 444444444444444444433 3444555555555554
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~ 227 (1141)
.+... + .+..+++|+.|++++|+++.+|. +..+++|+.|+|++|+|+.++. +..+++|+.|+|++|+|+.+|.
T Consensus 118 ~l~~~----~-~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 118 QITDV----T-PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp CCCCC----G-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred CCCCc----h-hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh
Confidence 44321 2 25666677777777777776654 6667777777777777776655 6677777777777777776654
Q ss_pred CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+..+++|+.|+|++|+|+++++ +..+++|+.|+|++|++++
T Consensus 191 -l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp -GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred -hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 6667777777777777776654 6677777777777777765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=235.68 Aligned_cols=227 Identities=19% Similarity=0.124 Sum_probs=182.7
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccc--cCCcCCcEEEccCCCCCc-Cc----hhhcC
Q 001143 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSV--GRYEKLRNLKFFGNEINL-FP----SEVGN 112 (1141)
Q Consensus 41 ~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~~l--~~L~~L~~L~Ls~N~L~~-lP----~~~~~ 112 (1141)
..++.|+++++.++...-..+..+..+++|++|+|++|.++ .+|..+ ..+++|++|+|++|.|+. +| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 35788999998886422111111122367999999999998 557777 899999999999999984 33 34568
Q ss_pred CCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccc-hhhhcCCCCCcEEEccCCCCCccCcc----ccCC
Q 001143 113 LLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTL-LSEIAGLKCLTKLSVCHFSIRYLPPE----IGCL 186 (1141)
Q Consensus 113 L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~l-p~~l~~L~~L~~L~Ls~N~L~~iP~~----l~~l 186 (1141)
+++|++|+|++|.+..++ ..+..+++|++|+|++|.+....+.. +..+..+++|++|+|++|+|+.+|.. +..+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 999999999999977665 67899999999999997653321111 12346889999999999999977653 4788
Q ss_pred CCCCEEEccCCccccc-cccccCC---CCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEE
Q 001143 187 SNLEQLDLSFNKMKYL-PTEICYL---KALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262 (1141)
Q Consensus 187 ~~L~~L~Ls~N~L~~i-P~~l~~l---~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L 262 (1141)
++|++|+|++|+|+.+ |..++.+ ++|++|+|++|+|+.||..+. ++|+.|+|++|+|++++. +..+++|+.|
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L 299 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRAPQ--PDELPEVDNL 299 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSCCC--TTSCCCCSCE
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCCch--hhhCCCccEE
Confidence 9999999999999965 8888776 699999999999999998886 799999999999999843 7889999999
Q ss_pred EccCCcCCC
Q 001143 263 NLQYNKLLS 271 (1141)
Q Consensus 263 ~Ls~N~L~~ 271 (1141)
+|++|+|+.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 999999975
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-24 Score=259.99 Aligned_cols=201 Identities=19% Similarity=0.176 Sum_probs=144.6
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~ 888 (1141)
...++||+|+||.||+|.+.+..+++|....+..............++.+|+.++++++||||+++..++......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~---- 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK---- 414 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT----
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc----
Confidence 4567999999999999998899999998655432222222223345568999999999999999655555443322
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecccccC
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~~ 968 (1141)
|+||||++|++|.++++. +..|+.||+.||+|||++||+||||||+|||++.
T Consensus 415 ----------~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----- 466 (540)
T 3en9_A 415 ----------RIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----- 466 (540)
T ss_dssp ----------EEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----
T ss_pred ----------EEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----
Confidence 999999999999999753 5689999999999999999999999999999975
Q ss_pred CCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001143 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1048 (1141)
Q Consensus 969 ~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~P 1048 (1141)
.+||+|||+|+............ ........||+.|||||++.... ..|+..+|+|+..+-..+.+.++.+
T Consensus 467 ----~~kL~DFGla~~~~~~~~~~~~~---~~~~~~~~GT~~y~APEv~~~~~--~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 467 ----DLYIIDFGLGKISNLDEDKAVDL---IVFKKAVLSTHHEKFDEIWERFL--EGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp ----SEEECCCTTCEECCCHHHHHHHH---HHHHHHHHHHCGGGHHHHHHHHH--HHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ----eEEEEECccCEECCCccccccch---hhhhhhhcCCCCcCCHHHHHHHH--HHHHHHHhHHHHHHHHHHHHHhccc
Confidence 49999999998765422110000 00012456999999999997522 2466788999999988888877766
Q ss_pred CC
Q 001143 1049 YM 1050 (1141)
Q Consensus 1049 f~ 1050 (1141)
|.
T Consensus 538 Y~ 539 (540)
T 3en9_A 538 YV 539 (540)
T ss_dssp CC
T ss_pred cC
Confidence 63
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-22 Score=218.75 Aligned_cols=199 Identities=23% Similarity=0.299 Sum_probs=163.1
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNL 96 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~L 96 (1141)
....+.+..++|+.++.... ++|+.|+|++|+|++..+..|+. +++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~---l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP---ADTKKLDLQSNKLSSLPSKAFHR---LTKLRLLYLNDNKLQTLPAGIFKELKNLETL 90 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC---TTCSEEECCSSCCSCCCTTSSSS---CTTCCEEECCSSCCSCCCTTTTSSCTTCCEE
T ss_pred CCCEEEccCCCCCccCCCCC---CCCCEEECcCCCCCeeCHHHhcC---CCCCCEEECCCCccCeeChhhhcCCCCCCEE
Confidence 45678899999999876443 68999999999999888766654 49999999999999999875 6889999999
Q ss_pred EccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 97 ~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
+|++|.|+.+|.. |.++++|+.|+|++|.++.++ +..|..+++|+.|+|++|.
T Consensus 91 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------------~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 91 WVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLP--------------------------PRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCC--------------------------TTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCCHhHcccccCCCEEECCCCccCeeC--------------------------HHHhCcCcCCCEEECCCCc
Confidence 9999999988754 678888988888888765443 2245667778888888888
Q ss_pred CCccCcc-ccCCCCCCEEEccCCccccccc-cccCCCCCCEEEccCCCCCcCCcC-ccCCCCCCEEeCCCCCCCCC
Q 001143 176 IRYLPPE-IGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSL 248 (1141)
Q Consensus 176 L~~iP~~-l~~l~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~Lt~~ 248 (1141)
|+.+|.. |..+++|+.|+|++|+|+.+|. .|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+...
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 8877664 6788889999999998887764 477888999999999999888764 66788999999999987654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=229.61 Aligned_cols=209 Identities=21% Similarity=0.237 Sum_probs=182.3
Q ss_pred CCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCC
Q 001143 24 SEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI 103 (1141)
Q Consensus 24 ~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L 103 (1141)
+..++++.+ ..+.++++|+.|+|++|+++.. + .+ ..+++|++|+|++|.|+.+|. +..+++|++|+|++|+|
T Consensus 26 l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~l-~-~~---~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 26 AGKSNVTDT--VTQADLDGITTLSAFGTGVTTI-E-GV---QYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPL 97 (308)
T ss_dssp TTCSSTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TG---GGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCC
T ss_pred hCCCCcCce--ecHHHcCCcCEEEeeCCCccCc-h-hh---hccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcC
Confidence 334444443 3455688999999999999874 3 24 445999999999999999987 99999999999999999
Q ss_pred CcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccc
Q 001143 104 NLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183 (1141)
Q Consensus 104 ~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l 183 (1141)
+.+| .+..+++|+.|+|++|.++.++. +..+++|++|++++|.+... +. +..+++|+.|++++|+++.+|. +
T Consensus 98 ~~~~-~~~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~----~~-l~~l~~L~~L~l~~n~l~~~~~-l 169 (308)
T 1h6u_A 98 KNVS-AIAGLQSIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNI----SP-LAGLTNLQYLSIGNAQVSDLTP-L 169 (308)
T ss_dssp SCCG-GGTTCTTCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCC----GG-GGGCTTCCEEECCSSCCCCCGG-G
T ss_pred CCch-hhcCCCCCCEEECCCCCCCCchh-hcCCCCCCEEECCCCccCcC----cc-ccCCCCccEEEccCCcCCCChh-h
Confidence 9986 69999999999999999888875 89999999999999777543 32 7889999999999999998877 8
Q ss_pred cCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 184 ~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
..+++|+.|+|++|+|+.+|. +..+++|+.|+|++|+|+.+|+ +..+++|+.|+|++|++++.+.
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEECCCE
T ss_pred cCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeecCCe
Confidence 999999999999999998876 8899999999999999998874 8899999999999999998765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-21 Score=214.32 Aligned_cols=185 Identities=21% Similarity=0.266 Sum_probs=142.0
Q ss_pred CccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
+.+++++++|.|+.+|..+. ++|+.|+|++|.|+.++. .|.++++|++|+|++|.++.++
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~----------------- 75 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS----------------- 75 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC-----------------
T ss_pred CCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC-----------------
Confidence 45677777777777776654 467777777777776543 4666666666666666543322
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcC
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL 225 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~I 225 (1141)
|..|..+++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+
T Consensus 76 ---------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 76 ---------AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp ---------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ---------HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 2346667778888888888887754 568889999999999999988755 67899999999999999988
Q ss_pred Cc-CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCC-CCCchhhhh
Q 001143 226 PS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY-CQVPSWICC 281 (1141)
Q Consensus 226 P~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~-~~iP~~~~~ 281 (1141)
|. .+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|. |.+.....|
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~ 204 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQW 204 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHH
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccHHHHHH
Confidence 76 578899999999999999999998899999999999999999986 554433333
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=228.29 Aligned_cols=203 Identities=17% Similarity=0.116 Sum_probs=170.2
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc-cC----ccccCCcCCcEEEccCCCCCcCc-hhhcCC
Q 001143 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL-IP----KSVGRYEKLRNLKFFGNEINLFP-SEVGNL 113 (1141)
Q Consensus 40 l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~-iP----~~l~~L~~L~~L~Ls~N~L~~lP-~~~~~L 113 (1141)
+++|++|+|++|++++..|..+.. ..+++|++|+|++|.++. +| ..+..+++|++|+|++|+|+.+| ..|+++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~-~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLE-ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSS-CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred cCceeEEEeeCCEeccchhhhhhh-ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 456999999999999998876511 455999999999999984 33 24568999999999999999775 678999
Q ss_pred CCCCEEEccCCCCCC---Cc--ccccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEEccCCCCCcc-CccccCC
Q 001143 114 LGLECLQIKISSPGV---NG--FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHFSIRYL-PPEIGCL 186 (1141)
Q Consensus 114 ~~L~~L~Ls~N~l~~---~~--~~~~~L~~L~~L~Ls~N~ln~~~~~lp~-~l~~L~~L~~L~Ls~N~L~~i-P~~l~~l 186 (1141)
++|++|+|++|++.. ++ ..+..+++|++|+|++|.+..... .+. .+..+++|++|+|++|+|+.+ |..++.+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTG-VCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHH-HHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHH-HHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 999999999999643 22 234789999999999987743322 233 357889999999999999976 8877776
Q ss_pred ---CCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCC
Q 001143 187 ---SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 187 ---~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
++|++|+|++|+|+.+|..+. ++|+.|+|++|+|+.+|. +..+++|+.|+|++|+|+.
T Consensus 248 ~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSCCC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCCch-hhhCCCccEEECcCCCCCC
Confidence 699999999999999998886 799999999999999876 7889999999999999984
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-22 Score=216.38 Aligned_cols=192 Identities=15% Similarity=0.139 Sum_probs=126.0
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-CCccCc-cccCCcCCcEEEccC-CCCCcCch-hhcCCCCCC
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-LNLIPK-SVGRYEKLRNLKFFG-NEINLFPS-EVGNLLGLE 117 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~-Lt~iP~-~l~~L~~L~~L~Ls~-N~L~~lP~-~~~~L~~L~ 117 (1141)
+|++|+|++|+|++..+..|+. +++|++|+|++|. ++.+|. .|.++++|++|+|++ |+|+.+|. .|.++++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~---l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSN---LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTT---CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred cccEEEEeCCcceEECHHHccC---CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 5566666666665555443332 3556666666664 555543 455566666666665 56655542 355555555
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc---EEEccCC-CCCccCc-cccCCCCCC-E
Q 001143 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT---KLSVCHF-SIRYLPP-EIGCLSNLE-Q 191 (1141)
Q Consensus 118 ~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~---~L~Ls~N-~L~~iP~-~l~~l~~L~-~ 191 (1141)
.|+|++|.++.+| . |..+++|+ .|++++| +++.+|. .|..+++|+ .
T Consensus 109 ~L~l~~n~l~~lp---------------------------~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~ 160 (239)
T 2xwt_C 109 FLGIFNTGLKMFP---------------------------D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160 (239)
T ss_dssp EEEEEEECCCSCC---------------------------C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEE
T ss_pred EEeCCCCCCcccc---------------------------c-cccccccccccEEECCCCcchhhcCcccccchhcceeE
Confidence 5555555544333 2 44555555 7888888 7887765 467788888 8
Q ss_pred EEccCCccccccccccCCCCCCEEEccCCC-CCcCCc-CccCC-CCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCC
Q 001143 192 LDLSFNKMKYLPTEICYLKALISLKVANNK-LVELPS-GLYLL-QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 192 L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~-L~~IP~-~l~~L-~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
|+|++|+|+.+|......++|+.|+|++|+ |+.+|. .+..+ ++|+.|+|++|+|+++++. .+++|+.|++++|
T Consensus 161 L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 161 LKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp EECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred EEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 888888888887665555788888888884 887754 45667 8888888888888877764 5677888888776
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=223.46 Aligned_cols=192 Identities=24% Similarity=0.301 Sum_probs=97.7
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSK 146 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~ 146 (1141)
++|+.|++++|.++.++ .+..+++|++|+|++|.|+.++ .+.++++|++|+|++|.++.++. .+..+++|++|++++
T Consensus 41 ~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHDIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp TTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCCch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 55666666666665554 3555666666666666666543 45556666666666555444332 234444444444444
Q ss_pred CCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCc
Q 001143 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVE 224 (1141)
Q Consensus 147 N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~ 224 (1141)
|.+. ...+..|..+++|+.|++++|+|+.+|.. +..+++|+.|+|++|+|+.+|.. ++.+++|+.|+|++|+|+.
T Consensus 119 n~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 119 NQLQ---SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp SCCC---CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CcCC---ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 3322 11122344455555555555555544332 34555555555555555544332 3445555555555555554
Q ss_pred CCcC-ccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 225 LPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 225 IP~~-l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+|.. +..+++|+.|+|++|.+++. +++|++|++..|.++|
T Consensus 196 ~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g 236 (272)
T 3rfs_A 196 VPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSG 236 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGG
T ss_pred cCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCC
Confidence 4332 34455555555555544432 2345555555555555
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.8e-22 Score=214.06 Aligned_cols=180 Identities=17% Similarity=0.206 Sum_probs=140.2
Q ss_pred CccEEEeecCCCCccCc-cccCCcCCcEEEccCCC-CCcCch-hhcCCCCCCEEEccC-CCCCCCcccccCCCCCCEEEC
Q 001143 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE-INLFPS-EVGNLLGLECLQIKI-SSPGVNGFALNKLKGLKELEL 144 (1141)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~-L~~lP~-~~~~L~~L~~L~Ls~-N~l~~~~~~~~~L~~L~~L~L 144 (1141)
+|++|+|++|+|+.+|. .|.++++|++|+|++|. |+.+|. .|.++++|++|+|++ |.++.++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~-------------- 97 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID-------------- 97 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC--------------
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC--------------
Confidence 45666666666665554 45566666666666664 555543 355555555555554 4433222
Q ss_pred CCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCC---EEEccCC-ccccccc-cccCCCCCC-EEEcc
Q 001143 145 SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE---QLDLSFN-KMKYLPT-EICYLKALI-SLKVA 218 (1141)
Q Consensus 145 s~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~---~L~Ls~N-~L~~iP~-~l~~l~~L~-~L~Ls 218 (1141)
+..|.++++|+.|++++|+++.+|. +..+++|+ +|+|++| +|+.+|. .|..+++|+ .|+|+
T Consensus 98 ------------~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 98 ------------PDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp ------------TTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred ------------HHHhCCCCCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence 2467788999999999999999987 88889998 9999999 9998875 588999999 99999
Q ss_pred CCCCCcCCcCccCCCCCCEEeCCCCC-CCCCCcccccCC-CCCCEEEccCCcCCCCCCCchh
Q 001143 219 NNKLVELPSGLYLLQRLENLDLSNNR-LTSLGSLDLCLM-HNLQNLNLQYNKLLSYCQVPSW 278 (1141)
Q Consensus 219 ~N~L~~IP~~l~~L~~L~~L~Ls~N~-Lt~~~p~~l~~L-~~L~~L~Ls~N~L~~~~~iP~~ 278 (1141)
+|+|+.||...+..++|+.|+|++|+ |+++++..|..+ ++|+.|+|++|+++. +|..
T Consensus 165 ~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~---l~~~ 223 (239)
T 2xwt_C 165 NNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA---LPSK 223 (239)
T ss_dssp SCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC---CCCT
T ss_pred CCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc---CChh
Confidence 99999999887777899999999995 999999889999 999999999999987 6654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-23 Score=245.28 Aligned_cols=237 Identities=19% Similarity=0.164 Sum_probs=193.5
Q ss_pred CCCCCCCCCCEEEccCCCCCCCCccccc-CCCCCCCccEEEeecCCCC----ccCccc-------cCCcCCcEEEccCCC
Q 001143 35 GSVNDDDDDSVIDVSGKTVDFPLIESYG-NRGGDNSVEGLYLYKNVLN----LIPKSV-------GRYEKLRNLKFFGNE 102 (1141)
Q Consensus 35 ~~f~~l~~L~~LdLs~N~Ls~~~p~~~~-~l~~L~~L~~L~Ls~N~Lt----~iP~~l-------~~L~~L~~L~Ls~N~ 102 (1141)
..+..+++|++|+|++|+|+...+..+. .+..+++|++|+|++|.+. .+|..+ ..+++|++|+|++|.
T Consensus 26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 3456778999999999999877554432 2455699999999997665 445544 788999999999999
Q ss_pred CCc-----CchhhcCCCCCCEEEccCCCCCCCc-----ccccCC---------CCCCEEECCCCCCC-CCcccchhhhcC
Q 001143 103 INL-----FPSEVGNLLGLECLQIKISSPGVNG-----FALNKL---------KGLKELELSKVPPR-PSVLTLLSEIAG 162 (1141)
Q Consensus 103 L~~-----lP~~~~~L~~L~~L~Ls~N~l~~~~-----~~~~~L---------~~L~~L~Ls~N~ln-~~~~~lp~~l~~ 162 (1141)
|+. +|..+.++++|+.|+|++|.++..+ ..+..+ ++|++|+|++|.+. .....+...+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 986 7888999999999999999976433 234444 89999999998765 223333367888
Q ss_pred CCCCcEEEccCCCCC------ccCccccCCCCCCEEEccCCcc-----ccccccccCCCCCCEEEccCCCCCc-----CC
Q 001143 163 LKCLTKLSVCHFSIR------YLPPEIGCLSNLEQLDLSFNKM-----KYLPTEICYLKALISLKVANNKLVE-----LP 226 (1141)
Q Consensus 163 L~~L~~L~Ls~N~L~------~iP~~l~~l~~L~~L~Ls~N~L-----~~iP~~l~~l~~L~~L~Ls~N~L~~-----IP 226 (1141)
+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.| ..+|..+..+++|+.|+|++|.|+. +|
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 999999999999998 2354788999999999999999 4688999999999999999999983 47
Q ss_pred cCc--cCCCCCCEEeCCCCCCCC----CCcccc-cCCCCCCEEEccCCcCCC
Q 001143 227 SGL--YLLQRLENLDLSNNRLTS----LGSLDL-CLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 227 ~~l--~~L~~L~~L~Ls~N~Lt~----~~p~~l-~~L~~L~~L~Ls~N~L~~ 271 (1141)
..+ +.+++|+.|+|++|+|++ ..|..+ .++++|+.|+|++|++++
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 777 448999999999999998 345455 678999999999999997
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.2e-22 Score=240.77 Aligned_cols=188 Identities=19% Similarity=0.236 Sum_probs=106.7
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEc
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI 121 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~L 121 (1141)
+|+.|+|++|+|++ +|..+ + ++|++|+|++|+|+.|| ..+++|++|+|++|+|+.||. |.+ +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~---~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--P---PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--C---TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhH--c---CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch-hhc--CCCEEEC
Confidence 55555555555554 22211 1 44555555555555555 234455555555555555554 433 4555555
Q ss_pred cCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccc
Q 001143 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY 201 (1141)
Q Consensus 122 s~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~ 201 (1141)
++|.++.+| . .+++|+.|+|++|+|+.+|. .+++|+.|+|++|+|+.
T Consensus 128 s~N~l~~lp---------------------------~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 128 DNNQLTMLP---------------------------E---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CSSCCSCCC---------------------------C---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC
T ss_pred CCCcCCCCC---------------------------C---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC
Confidence 444444333 2 35566666666666666665 45666666777776666
Q ss_pred ccccccCCCCCCEEEccCCCCCcCCcCccCCCCC-------CEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 202 LPTEICYLKALISLKVANNKLVELPSGLYLLQRL-------ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 202 iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L-------~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
+|. |. ++|+.|+|++|+|+.||. +.. +| +.|+|++|+|+.+++ .+..+++|+.|+|++|+|++ .
T Consensus 175 lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~-~l~~l~~L~~L~L~~N~l~~--~ 245 (571)
T 3cvr_A 175 LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRITHIPE-NILSLDPTCTIILEDNPLSS--R 245 (571)
T ss_dssp CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCCCCCG-GGGGSCTTEEEECCSSSCCH--H
T ss_pred cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcceecCH-HHhcCCCCCEEEeeCCcCCC--c
Confidence 666 44 667777777777666666 443 45 777777777776544 45557777777777777766 4
Q ss_pred Cchhhhhcc
Q 001143 275 VPSWICCNL 283 (1141)
Q Consensus 275 iP~~~~~~l 283 (1141)
+|..+....
T Consensus 246 ~p~~l~~l~ 254 (571)
T 3cvr_A 246 IRESLSQQT 254 (571)
T ss_dssp HHHHHHHHH
T ss_pred CHHHHHHhh
Confidence 566555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=216.58 Aligned_cols=200 Identities=22% Similarity=0.238 Sum_probs=174.3
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
.++..+++..+.++.+ ..+..+++|+.|++++|.++.++. +..+++|++|+|++|.+..++ .+..+++|++|++++|
T Consensus 19 ~~l~~l~l~~~~~~~~-~~~~~l~~L~~L~l~~~~i~~~~~-l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L~~n 95 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA-VTQNELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLHDIS-ALKELTNLTYLILTGN 95 (272)
T ss_dssp HHHHHHHHTCSCTTSE-ECHHHHTTCCEEECTTSCCCCCTT-GGGCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECTTS
T ss_pred HHHHHHHhcCcccccc-cccccccceeeeeeCCCCcccccc-cccCCCCcEEECCCCCCCCch-hhcCCCCCCEEECCCC
Confidence 4567778888877755 346678899999999999998864 889999999999999988765 7899999999999997
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcC
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL 225 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~I 225 (1141)
.+.. ..+..|..+++|+.|++++|+++.+|.. +..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+
T Consensus 96 ~l~~---~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 96 QLQS---LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp CCCC---CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ccCc---cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 6643 3344678999999999999999988664 78999999999999999988654 68899999999999999988
Q ss_pred CcC-ccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCC
Q 001143 226 PSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273 (1141)
Q Consensus 226 P~~-l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~ 273 (1141)
|.. +..+++|+.|+|++|+|+++++..+..+++|+.|+|++|+|.|.|
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 655 578999999999999999999988999999999999999999843
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-21 Score=235.48 Aligned_cols=182 Identities=22% Similarity=0.224 Sum_probs=143.8
Q ss_pred CCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001143 92 KLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1141)
Q Consensus 92 ~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~L 171 (1141)
+|+.|+|++|.|+.||..+. ++|+.|+|++|.++.+| ..+++|++|+|++|.+.. +|. +.+ +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~----ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALISLP---ELPASLEYLDACDNRLST----LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC----CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCC----cch-hhc--CCCEEEC
Confidence 56666666666666665542 56666666666666555 345667777777755543 344 443 8999999
Q ss_pred cCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcc
Q 001143 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251 (1141)
Q Consensus 172 s~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~ 251 (1141)
++|+|+.+|. .+++|+.|+|++|+|+.||. .+++|+.|+|++|+|+.||. +. ++|+.|+|++|+|+.+++
T Consensus 128 s~N~l~~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~~lp~- 197 (571)
T 3cvr_A 128 DNNQLTMLPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLESLPA- 197 (571)
T ss_dssp CSSCCSCCCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCSSCCC-
T ss_pred CCCcCCCCCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCCchhh-
Confidence 9999999988 68999999999999999987 67899999999999999998 66 899999999999997765
Q ss_pred cccCCCCC-------CEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCccc
Q 001143 252 DLCLMHNL-------QNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAE 301 (1141)
Q Consensus 252 ~l~~L~~L-------~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~~ 301 (1141)
|.. +| +.|+|++|+|+. ||..+..+..+..+++++|.+.+..|.
T Consensus 198 -~~~--~L~~~~~~L~~L~Ls~N~l~~---lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 198 -VPV--RNHHSEETEIFFRCRENRITH---IPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp -CC----------CCEEEECCSSCCCC---CCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred -HHH--hhhcccccceEEecCCCccee---cCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 544 67 999999999996 999888888889999999999887653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=5.6e-23 Score=243.60 Aligned_cols=252 Identities=17% Similarity=0.097 Sum_probs=144.3
Q ss_pred CCcccccCCCCCccccCCCCC-CCCC----CCCEEEccCCCCCC----CCcccccCCCCCCCccEEEeecCCCCcc-Ccc
Q 001143 17 PIKEKLPSEANKINNEKNGSV-NDDD----DDSVIDVSGKTVDF----PLIESYGNRGGDNSVEGLYLYKNVLNLI-PKS 86 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f-~~l~----~L~~LdLs~N~Ls~----~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~ 86 (1141)
+.++.|.+..|+|+......+ ..+. +|++|+|++|+|+. .++..+. .+++|++|+|++|.|+.. +..
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~---~~~~L~~L~Ls~n~i~~~~~~~ 132 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR---TLPTLQELHLSDNLLGDAGLQL 132 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTT---SCTTCCEEECCSSBCHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHc---cCCceeEEECCCCcCchHHHHH
Confidence 357777777777765433222 2233 57777777777763 3344443 337777777777777632 222
Q ss_pred c-----cCCcCCcEEEccCCCCCc-----CchhhcCCCCCCEEEccCCCCCCCcc-ccc-----CCCCCCEEECCCCCCC
Q 001143 87 V-----GRYEKLRNLKFFGNEINL-----FPSEVGNLLGLECLQIKISSPGVNGF-ALN-----KLKGLKELELSKVPPR 150 (1141)
Q Consensus 87 l-----~~L~~L~~L~Ls~N~L~~-----lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~~-----~L~~L~~L~Ls~N~ln 150 (1141)
+ ..+++|+.|+|++|.|+. ++..+..+++|+.|+|++|.++..+. .+. .+++|++|++++|.+.
T Consensus 133 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~ 212 (461)
T 1z7x_W 133 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCB
T ss_pred HHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCc
Confidence 2 224567777777777763 34556666777777777776544321 121 2456777777775543
Q ss_pred CCc-ccchhhhcCCCCCcEEEccCCCCCcc------CccccCCCCCCEEEccCCcccc-----ccccccCCCCCCEEEcc
Q 001143 151 PSV-LTLLSEIAGLKCLTKLSVCHFSIRYL------PPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVA 218 (1141)
Q Consensus 151 ~~~-~~lp~~l~~L~~L~~L~Ls~N~L~~i------P~~l~~l~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls 218 (1141)
... ..++..+..+++|+.|++++|.++.. +..+..+++|+.|+|++|.|+. ++..+..+++|+.|+|+
T Consensus 213 ~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls 292 (461)
T 1z7x_W 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292 (461)
T ss_dssp TTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECT
T ss_pred HHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECC
Confidence 221 12455566666777777777766632 1122346667777777777664 56666666667777777
Q ss_pred CCCCCc-----CCcCccC-CCCCCEEeCCCCCCCCC----CcccccCCCCCCEEEccCCcCCC
Q 001143 219 NNKLVE-----LPSGLYL-LQRLENLDLSNNRLTSL----GSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 219 ~N~L~~-----IP~~l~~-L~~L~~L~Ls~N~Lt~~----~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+|.++. ++..+.. .++|+.|+|++|.+++. .+..+..+++|+.|+|++|+++.
T Consensus 293 ~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 355 (461)
T 1z7x_W 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355 (461)
T ss_dssp TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred CCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccc
Confidence 776652 1222221 24666666666666654 23344555666666666666554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-22 Score=233.06 Aligned_cols=234 Identities=15% Similarity=0.113 Sum_probs=192.7
Q ss_pred CCcccccCCCCCccccCC----CCCCCCCCCCEEEccCC---CCCCCCccccc----CCCCCCCccEEEeecCCCCc---
Q 001143 17 PIKEKLPSEANKINNEKN----GSVNDDDDDSVIDVSGK---TVDFPLIESYG----NRGGDNSVEGLYLYKNVLNL--- 82 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~----~~f~~l~~L~~LdLs~N---~Ls~~~p~~~~----~l~~L~~L~~L~Ls~N~Lt~--- 82 (1141)
+.++.|.+..|+|+.... ..|..+++|++|+|++| ++++.+|..+. .+..+++|++|+|++|.|+.
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 468999999999988754 34889999999999996 45556665442 12456999999999999986
Q ss_pred --cCccccCCcCCcEEEccCCCCCc-----CchhhcCC---------CCCCEEEccCCCCC--CCc---ccccCCCCCCE
Q 001143 83 --IPKSVGRYEKLRNLKFFGNEINL-----FPSEVGNL---------LGLECLQIKISSPG--VNG---FALNKLKGLKE 141 (1141)
Q Consensus 83 --iP~~l~~L~~L~~L~Ls~N~L~~-----lP~~~~~L---------~~L~~L~Ls~N~l~--~~~---~~~~~L~~L~~ 141 (1141)
+|..|..+++|++|+|++|.|+. ++..+..+ ++|+.|+|++|.++ .++ ..+..+++|++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 78889999999999999999973 33444445 99999999999986 334 35778999999
Q ss_pred EECCCCCCC--CCcccchhhhcCCCCCcEEEccCCCC-----CccCccccCCCCCCEEEccCCcccc-----ccccc--c
Q 001143 142 LELSKVPPR--PSVLTLLSEIAGLKCLTKLSVCHFSI-----RYLPPEIGCLSNLEQLDLSFNKMKY-----LPTEI--C 207 (1141)
Q Consensus 142 L~Ls~N~ln--~~~~~lp~~l~~L~~L~~L~Ls~N~L-----~~iP~~l~~l~~L~~L~Ls~N~L~~-----iP~~l--~ 207 (1141)
|+|++|.+. +....+|..+..+++|+.|+|++|.| ..+|..+..+++|+.|+|++|.|+. +|..+ +
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 271 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhc
Confidence 999997764 21123444788999999999999999 4578888999999999999999983 57777 4
Q ss_pred CCCCCCEEEccCCCCCc-----CCcCc-cCCCCCCEEeCCCCCCCCCCc
Q 001143 208 YLKALISLKVANNKLVE-----LPSGL-YLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 208 ~l~~L~~L~Ls~N~L~~-----IP~~l-~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
.+++|+.|+|++|.|+. +|..+ .++++|+.|+|++|++++..+
T Consensus 272 ~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred cCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 49999999999999996 89888 568999999999999998875
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.84 E-value=7e-22 Score=228.22 Aligned_cols=247 Identities=13% Similarity=0.119 Sum_probs=190.4
Q ss_pred ccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCc----ccccCCCCCC-CccEEEeecCCCCcc-CccccCC-----
Q 001143 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLI----ESYGNRGGDN-SVEGLYLYKNVLNLI-PKSVGRY----- 90 (1141)
Q Consensus 22 L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p----~~~~~l~~L~-~L~~L~Ls~N~Lt~i-P~~l~~L----- 90 (1141)
+.+..|++++..+..+....+|++|||++|+|++..+ ..+..+ + +|++|+|++|.|+.. +..|..+
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~---~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 79 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANT---PASVTSLNLSGNSLGFKNSDELVQILAAIP 79 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTC---CTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhC---CCceeEEECcCCCCCHHHHHHHHHHHhccC
Confidence 3466788888777777777789999999999988776 555444 7 899999999999865 4456554
Q ss_pred cCCcEEEccCCCCCcCc-hh----hcCC-CCCCEEEccCCCCCCCcc-c----ccC-CCCCCEEECCCCCCCCCc-ccch
Q 001143 91 EKLRNLKFFGNEINLFP-SE----VGNL-LGLECLQIKISSPGVNGF-A----LNK-LKGLKELELSKVPPRPSV-LTLL 157 (1141)
Q Consensus 91 ~~L~~L~Ls~N~L~~lP-~~----~~~L-~~L~~L~Ls~N~l~~~~~-~----~~~-L~~L~~L~Ls~N~ln~~~-~~lp 157 (1141)
++|++|+|++|.|+..+ .. +..+ ++|+.|+|++|.++..+. . +.. .++|++|+|++|.+.... ..++
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 159 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI 159 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence 88999999999998553 33 4455 899999999999776664 2 334 368999999997664322 2455
Q ss_pred hhhcCCC-CCcEEEccCCCCCccCc-----cccCC-CCCCEEEccCCcccc-----ccccccCC-CCCCEEEccCCCCCc
Q 001143 158 SEIAGLK-CLTKLSVCHFSIRYLPP-----EIGCL-SNLEQLDLSFNKMKY-----LPTEICYL-KALISLKVANNKLVE 224 (1141)
Q Consensus 158 ~~l~~L~-~L~~L~Ls~N~L~~iP~-----~l~~l-~~L~~L~Ls~N~L~~-----iP~~l~~l-~~L~~L~Ls~N~L~~ 224 (1141)
..+..++ +|+.|+|++|+|+..+. .+..+ ++|+.|+|++|.|+. ++..+..+ ++|+.|+|++|.|+.
T Consensus 160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 6666676 89999999999986543 33445 599999999999986 67777764 589999999999986
Q ss_pred CC-----cCccCCCCCCEEeCCCCCCCCCCcc-------cccCCCCCCEEEccCCcCCC
Q 001143 225 LP-----SGLYLLQRLENLDLSNNRLTSLGSL-------DLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 225 IP-----~~l~~L~~L~~L~Ls~N~Lt~~~p~-------~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
++ ..+..+++|+.|+|++|.++++.+. .+..+++|+.||+++|++..
T Consensus 240 ~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 240 PSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp CCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 54 3446688999999999997776654 46678889999999999876
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-20 Score=215.54 Aligned_cols=233 Identities=17% Similarity=0.137 Sum_probs=165.5
Q ss_pred ccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCc-cccCCcCCc-EEEc
Q 001143 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPK-SVGRYEKLR-NLKF 98 (1141)
Q Consensus 22 L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt-~iP~-~l~~L~~L~-~L~L 98 (1141)
+....++|+.|+.+. ..+++.|+|++|+|+.+.+..|. +|++|++|+|++|++. .+|. .|.++++|. .+++
T Consensus 14 v~C~~~~Lt~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~---~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 14 FLCQESKVTEIPSDL---PRNAIELRFVLTKLRVIQKGAFS---GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EEEESTTCCSCCTTC---CTTCSEEEEESCCCSEECTTSST---TCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred EEecCCCCCccCcCc---CCCCCEEEccCCcCCCcCHHHHc---CCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 455667788776543 24678888888888876665554 4488888888888874 4664 477787755 4666
Q ss_pred cCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccch-hhhcCCC-CCcEEEccCC
Q 001143 99 FGNEINLF-PSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLL-SEIAGLK-CLTKLSVCHF 174 (1141)
Q Consensus 99 s~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp-~~l~~L~-~L~~L~Ls~N 174 (1141)
++|+|+.+ |..|.++++|+.|++++|.+..++. .+....++..|++.++ +....+| ..|..+. .|+.|+|++|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~---~~i~~l~~~~f~~~~~~l~~L~L~~N 164 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN---INIHTIERNSFVGLSFESVILWLNKN 164 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC---TTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc---cccccccccchhhcchhhhhhccccc
Confidence 77888877 4557788888888888888776654 4556667777777652 2233333 2455553 5788889999
Q ss_pred CCCccCccccCCCCCCEEEccC-Cccccccc-cccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCC-CCCCCCCcc
Q 001143 175 SIRYLPPEIGCLSNLEQLDLSF-NKMKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN-NRLTSLGSL 251 (1141)
Q Consensus 175 ~L~~iP~~l~~l~~L~~L~Ls~-N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~-N~Lt~~~p~ 251 (1141)
+|+.||.......+|+.|+|++ |.++.||. .|..+++|+.|+|++|+|+.||... +.+|+.|.+.+ |.++.+|
T Consensus 165 ~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l~~~~l~~lP-- 240 (350)
T 4ay9_X 165 GIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNLKKLP-- 240 (350)
T ss_dssp CCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECTTCTTCCCCC--
T ss_pred cccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhccCCCcCcCC--
Confidence 9988888777778888888874 77888875 4678888999999999998888643 45666666544 4566655
Q ss_pred cccCCCCCCEEEccCC
Q 001143 252 DLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 252 ~l~~L~~L~~L~Ls~N 267 (1141)
.+..+++|+.+++++|
T Consensus 241 ~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 241 TLEKLVALMEASLTYP 256 (350)
T ss_dssp CTTTCCSCCEEECSCH
T ss_pred CchhCcChhhCcCCCC
Confidence 3778888888888754
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=8.4e-20 Score=199.84 Aligned_cols=176 Identities=22% Similarity=0.271 Sum_probs=140.8
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEE
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECL 119 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L 119 (1141)
+.+.+|+++|+++..++. +. ++|+.|+|++|.|+.++. .|.++++|++|+|++|+|+.++. .|.++++|+.|
T Consensus 15 ~~~~l~~~~~~l~~~p~~-~~-----~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 88 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSG-IP-----ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL 88 (251)
T ss_dssp GGTEEECTTCCCSSCCSC-CC-----TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCeEEecCCCCccccCCC-CC-----CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEE
Confidence 567899999999865543 22 578999999999997754 68899999999999999997754 47888888888
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCc
Q 001143 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNK 198 (1141)
Q Consensus 120 ~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~ 198 (1141)
+|++|.++.++ +..|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+
T Consensus 89 ~L~~n~l~~~~--------------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 142 (251)
T 3m19_A 89 GLANNQLASLP--------------------------LGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQ 142 (251)
T ss_dssp ECTTSCCCCCC--------------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcccccC--------------------------hhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCc
Confidence 88888765444 22455677788888888888877664 5788889999999999
Q ss_pred cccccc-cccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCC
Q 001143 199 MKYLPT-EICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLG 249 (1141)
Q Consensus 199 L~~iP~-~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~ 249 (1141)
|+.+|. .|..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|++++..
T Consensus 143 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 143 LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 988765 58888999999999999987765 6777899999999999998763
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=210.91 Aligned_cols=170 Identities=21% Similarity=0.235 Sum_probs=87.3
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
++|+.|++++|.++.+|. +..+++|+.|+|++|+|+.++. +.++++|+.|+|++|.++.++. +..+++|++|++++|
T Consensus 46 ~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~n 122 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS-LKDLKKLKSLSLEHN 122 (291)
T ss_dssp HTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG-GTTCTTCCEEECTTS
T ss_pred CcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh-hccCCCCCEEECCCC
Confidence 555666666665555542 5555566666666666655544 5555555555555555444332 444444444444443
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~ 227 (1141)
.+... ..+..+++|+.|++++|+++.+ ..+..+++|+.|+|++|+|+.++. +..+++|+.|+|++|+|+.+|.
T Consensus 123 ~i~~~-----~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l~~ 195 (291)
T 1h6t_A 123 GISDI-----NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLRA 195 (291)
T ss_dssp CCCCC-----GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCGG
T ss_pred cCCCC-----hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCChh
Confidence 33221 1344455555555555555544 334555555555555555554443 5555555555555555555542
Q ss_pred CccCCCCCCEEeCCCCCCCCC
Q 001143 228 GLYLLQRLENLDLSNNRLTSL 248 (1141)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Lt~~ 248 (1141)
+..+++|+.|+|++|+++..
T Consensus 196 -l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 196 -LAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp -GTTCTTCSEEEEEEEEEECC
T ss_pred -hccCCCCCEEECcCCcccCC
Confidence 44555555555555555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-22 Score=238.67 Aligned_cols=279 Identities=16% Similarity=0.123 Sum_probs=143.9
Q ss_pred CcccccCCCCCccccC----CCCCCCCCCCCEEEccCCCCCCCCcccc-cCCCCCC-CccEEEeecCCCC-----ccCcc
Q 001143 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPLIESY-GNRGGDN-SVEGLYLYKNVLN-----LIPKS 86 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~----~~~f~~l~~L~~LdLs~N~Ls~~~p~~~-~~l~~L~-~L~~L~Ls~N~Lt-----~iP~~ 86 (1141)
+++.|.+..|+|+... +..+..+++|++|||++|.|+...+..+ ..+.... +|++|+|++|.|+ .+|..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 4555666666655332 2334455666666666666654332222 1121111 4666666666665 23555
Q ss_pred ccCCcCCcEEEccCCCCCcC-chhh-----cCCCCCCEEEccCCCCCCC-----cccccCCCCCCEEECCCCCCCCCcc-
Q 001143 87 VGRYEKLRNLKFFGNEINLF-PSEV-----GNLLGLECLQIKISSPGVN-----GFALNKLKGLKELELSKVPPRPSVL- 154 (1141)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~l-P~~~-----~~L~~L~~L~Ls~N~l~~~-----~~~~~~L~~L~~L~Ls~N~ln~~~~- 154 (1141)
|..+++|++|+|++|.|+.. +..+ ..+++|+.|+|++|.++.. +..+..+++|++|++++|.+.....
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 188 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 188 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHH
Confidence 66666666666666666521 2211 1244566666666654432 2344555666666666644321100
Q ss_pred cchhhhc-CCCCCcEEEccCCCCCc-----cCccccCCCCCCEEEccCCccccc-----ccc-ccCCCCCCEEEccCCCC
Q 001143 155 TLLSEIA-GLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKYL-----PTE-ICYLKALISLKVANNKL 222 (1141)
Q Consensus 155 ~lp~~l~-~L~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~~i-----P~~-l~~l~~L~~L~Ls~N~L 222 (1141)
.+...+. .+++|+.|++++|.++. +|..+..+++|+.|+|++|.|+.. ... +..+++|+.|+|++|+|
T Consensus 189 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l 268 (461)
T 1z7x_W 189 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268 (461)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCC
Confidence 0111111 24466666666666664 344555566666666666666522 122 22456666666666666
Q ss_pred Cc-----CCcCccCCCCCCEEeCCCCCCCCCCcccccC-----CCCCCEEEccCCcCCCCC--CCchhhhhcccCCCCCC
Q 001143 223 VE-----LPSGLYLLQRLENLDLSNNRLTSLGSLDLCL-----MHNLQNLNLQYNKLLSYC--QVPSWICCNLEGNGKDS 290 (1141)
Q Consensus 223 ~~-----IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~-----L~~L~~L~Ls~N~L~~~~--~iP~~~~~~l~~~~l~~ 290 (1141)
+. +|..+..+++|+.|+|++|.++...+..+.. .++|+.|+|++|.+++.. .+|..+........+++
T Consensus 269 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 348 (461)
T 1z7x_W 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348 (461)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEc
Confidence 63 5555555666666666666665443333322 246666666666665421 13444444555556666
Q ss_pred CCCCcc
Q 001143 291 SNDDFI 296 (1141)
Q Consensus 291 ~~n~l~ 296 (1141)
+.|.+.
T Consensus 349 s~n~i~ 354 (461)
T 1z7x_W 349 SNNRLE 354 (461)
T ss_dssp CSSBCH
T ss_pred cCCccc
Confidence 665544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-21 Score=221.96 Aligned_cols=195 Identities=16% Similarity=0.123 Sum_probs=94.3
Q ss_pred CccEEEeecCCCCccCccccCCcCCcEEEccCCCCC-c-CchhhcCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECC
Q 001143 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN-L-FPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELS 145 (1141)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~-~-lP~~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L~~L~Ls 145 (1141)
+|+.|+|++|.++.++..+..+++|+.|+|++|.|+ . +|..+..+++|+.|+|++|.++ ..+..+..+++|++|+++
T Consensus 71 ~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~ 150 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150 (336)
T ss_dssp TCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred cceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC
Confidence 445555555555544434444555555555555554 1 4444555555555555555433 223344445555555555
Q ss_pred CCCCCCCcc-cchhhhcCCCCCcEEEccCC-CCCc--cCccccCCC-CCCEEEccCCc--cc--cccccccCCCCCCEEE
Q 001143 146 KVPPRPSVL-TLLSEIAGLKCLTKLSVCHF-SIRY--LPPEIGCLS-NLEQLDLSFNK--MK--YLPTEICYLKALISLK 216 (1141)
Q Consensus 146 ~N~ln~~~~-~lp~~l~~L~~L~~L~Ls~N-~L~~--iP~~l~~l~-~L~~L~Ls~N~--L~--~iP~~l~~l~~L~~L~ 216 (1141)
+|. .+.. .++..+.++++|+.|++++| .++. +|..+..++ +|+.|+|++|. ++ .+|..+..+++|+.|+
T Consensus 151 ~~~--~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 151 GCS--GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp TCB--SCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCC--CCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 531 1111 23334445555555555555 5552 344445555 55555555552 32 3444455555555555
Q ss_pred ccCCC-CC-cCCcCccCCCCCCEEeCCCCCCCCCCcc---cccCCCCCCEEEccCC
Q 001143 217 VANNK-LV-ELPSGLYLLQRLENLDLSNNRLTSLGSL---DLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 217 Ls~N~-L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~---~l~~L~~L~~L~Ls~N 267 (1141)
|++|. ++ ..+..+..+++|+.|+|++|. ++.+. .+..+++|+.|++++|
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence 55555 33 334455555555555555553 22222 3445555555555555
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-21 Score=225.53 Aligned_cols=251 Identities=16% Similarity=0.111 Sum_probs=190.7
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-----ccccCCc-CCcEEEccCCCCCcC-chhhcCC----
Q 001143 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-----KSVGRYE-KLRNLKFFGNEINLF-PSEVGNL---- 113 (1141)
Q Consensus 45 ~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-----~~l~~L~-~L~~L~Ls~N~L~~l-P~~~~~L---- 113 (1141)
.++|++|++++.+|..+... ++|++|+|++|.|+.++ ..|..++ +|++|+|++|.|+.. +..|..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~---~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIP---HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSC---TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred ccccccccchHHHHHHHhCC---CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhcc
Confidence 57899999999999876554 67999999999999876 5678898 899999999999965 5566664
Q ss_pred -CCCCEEEccCCCCCCCccc-----ccCC-CCCCEEECCCCCCCCCccc-chhhhcCC-CCCcEEEccCCCCC-----cc
Q 001143 114 -LGLECLQIKISSPGVNGFA-----LNKL-KGLKELELSKVPPRPSVLT-LLSEIAGL-KCLTKLSVCHFSIR-----YL 179 (1141)
Q Consensus 114 -~~L~~L~Ls~N~l~~~~~~-----~~~L-~~L~~L~Ls~N~ln~~~~~-lp~~l~~L-~~L~~L~Ls~N~L~-----~i 179 (1141)
++|++|+|++|.++..+.. +..+ ++|++|+|++|.+...... +...+..+ ++|+.|+|++|+|+ .+
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 9999999999998765542 5555 8999999999776443322 22334553 69999999999999 34
Q ss_pred CccccCCC-CCCEEEccCCccccc-cc----cccCC-CCCCEEEccCCCCCc-----CCcCccCC-CCCCEEeCCCCCCC
Q 001143 180 PPEIGCLS-NLEQLDLSFNKMKYL-PT----EICYL-KALISLKVANNKLVE-----LPSGLYLL-QRLENLDLSNNRLT 246 (1141)
Q Consensus 180 P~~l~~l~-~L~~L~Ls~N~L~~i-P~----~l~~l-~~L~~L~Ls~N~L~~-----IP~~l~~L-~~L~~L~Ls~N~Lt 246 (1141)
+..+..++ +|+.|+|++|+|+.. +. .+..+ ++|+.|+|++|.|+. +|..+..+ ++|+.|+|++|+|+
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 45556665 999999999999854 33 34455 599999999999986 67777764 58999999999999
Q ss_pred CCCcc----cccCCCCCCEEEccCCcCCCCC-----CCchhhhhcccCCCCCCCCCCcccC
Q 001143 247 SLGSL----DLCLMHNLQNLNLQYNKLLSYC-----QVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 247 ~~~p~----~l~~L~~L~~L~Ls~N~L~~~~-----~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
+.++. .+..+++|+.|+|++|.+.... .++..+........+++.+|.+...
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 98763 3567899999999999976521 0111222233345566666665544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=216.23 Aligned_cols=183 Identities=22% Similarity=0.214 Sum_probs=133.9
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchh-hc-CCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001143 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE-VG-NLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1141)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~-~~-~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ 148 (1141)
+.+++++|.|+.||..+.. .|+.|+|++|+|+.++.. |. ++++|+.|+|++|+++.++
T Consensus 21 ~~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~------------------ 80 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFIS------------------ 80 (361)
T ss_dssp TEEECCSSCCSSCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEEC------------------
T ss_pred CEEEeCCCCcCccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccC------------------
Confidence 4666777777777665443 466677777777666443 33 5566665555555543322
Q ss_pred CCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCC
Q 001143 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP 226 (1141)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP 226 (1141)
+..|.++++|+.|+|++|+|+.+|. .|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|
T Consensus 81 --------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 81 --------SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp --------TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred --------hhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 2345667777777777788776655 567888888888888888866 567888888999999999998888
Q ss_pred cCc----cCCCCCCEEeCCCCCCCCCCcccccCCCC--CCEEEccCCcCCCCCCCchhhhh
Q 001143 227 SGL----YLLQRLENLDLSNNRLTSLGSLDLCLMHN--LQNLNLQYNKLLSYCQVPSWICC 281 (1141)
Q Consensus 227 ~~l----~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~--L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1141)
..+ ..+++|+.|+|++|+|+++++..|..++. |+.|+|++|+|.|.|.+-+++..
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~~~~~ 213 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSH 213 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHHHHHHHH
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCcHHHHHH
Confidence 766 46899999999999999999888888887 48899999999999887665443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=9.7e-20 Score=209.41 Aligned_cols=221 Identities=19% Similarity=0.085 Sum_probs=180.3
Q ss_pred CCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccE-EEeecCCCCccC-ccccCCcC
Q 001143 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEG-LYLYKNVLNLIP-KSVGRYEK 92 (1141)
Q Consensus 15 ~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~-L~Ls~N~Lt~iP-~~l~~L~~ 92 (1141)
.++++++|.+..|+|+.|++++|.++++|++|||++|++.+.+|. +.|.+|++|++ +.++.|+|+.+| ..|..+++
T Consensus 28 l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~--~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~ 105 (350)
T 4ay9_X 28 LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA--DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPN 105 (350)
T ss_dssp CCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT--TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTT
T ss_pred cCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh--hHhhcchhhhhhhcccCCcccccCchhhhhccc
Confidence 345799999999999999999999999999999999999876664 23455577665 677889999985 56899999
Q ss_pred CcEEEccCCCCCcCch-hhcCCCCCCEEEccC-CCCCCCcc-cccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCcE
Q 001143 93 LRNLKFFGNEINLFPS-EVGNLLGLECLQIKI-SSPGVNGF-ALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168 (1141)
Q Consensus 93 L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~-N~l~~~~~-~~~~L~-~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~ 168 (1141)
|++|+|++|+|+.+|. .+....++..|++.. |.+..++. .|..+. .|+.|+|++|.+. .+|.......+|+.
T Consensus 106 L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~----~i~~~~f~~~~L~~ 181 (350)
T 4ay9_X 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ----EIHNSAFNGTQLDE 181 (350)
T ss_dssp CCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC----EECTTSSTTEEEEE
T ss_pred cccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc----CCChhhccccchhH
Confidence 9999999999998865 466778888999966 45776664 566665 6899999996654 56666667778999
Q ss_pred EEcc-CCCCCccCc-cccCCCCCCEEEccCCccccccccccCCCCCCEEEccC-CCCCcCCcCccCCCCCCEEeCCCCC
Q 001143 169 LSVC-HFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN-NKLVELPSGLYLLQRLENLDLSNNR 244 (1141)
Q Consensus 169 L~Ls-~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~-N~L~~IP~~l~~L~~L~~L~Ls~N~ 244 (1141)
|++. +|.++.||. .|..+++|+.|+|++|+|+.||... +.+|+.|.+.+ +.++.+| .+..+++|+.++++++.
T Consensus 182 l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp EECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred HhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 9997 588999987 5689999999999999999998642 55677777654 4788999 48889999999998753
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=202.43 Aligned_cols=191 Identities=24% Similarity=0.226 Sum_probs=168.7
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
.++..+.+..+.++.+. .+..+++|+.|++++|.|+.+|. +..+++|+.|+|++|.++.++. +..+++|++|++++|
T Consensus 24 ~~~~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 24 AETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHHHHTTCSCTTSEE-CHHHHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred HHHHHHHhcCCCccccc-chhhcCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCC
Confidence 34555667777776552 35678899999999999999975 8999999999999999988887 999999999999997
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~ 227 (1141)
.+.. +| .+..+++|+.|++++|+|+.+ +.+..+++|+.|+|++|+|+.+ ..+..+++|+.|+|++|+|+.++.
T Consensus 101 ~l~~----~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 101 KVKD----LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CCCC----GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred cCCC----Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 7654 33 488999999999999999988 4688999999999999999988 679999999999999999998876
Q ss_pred CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+..+++|+.|+|++|+|++++ .+..+++|+.|++++|+++.
T Consensus 174 -l~~l~~L~~L~L~~N~i~~l~--~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEEEEEEC
T ss_pred -hcCCCccCEEECCCCcCCCCh--hhccCCCCCEEECcCCcccC
Confidence 899999999999999999874 48999999999999999986
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-20 Score=226.49 Aligned_cols=192 Identities=19% Similarity=0.204 Sum_probs=114.9
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEcc
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls 122 (1141)
+..++|+.+.++..++. . .|++|+.|+|++|.|+.+| .|..|++|+.|+|++|+|+.+|. |..|++|+.|+|+
T Consensus 23 l~~l~l~~~~i~~~~~~--~---~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVTQ--N---ELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHTTCSCTTSEECH--H---HHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECC
T ss_pred HHHHhccCCCcccccch--h---cCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECc
Confidence 33444555555544331 2 2356666666666666665 36666666666666666666654 6666666666666
Q ss_pred CCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccc
Q 001143 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL 202 (1141)
Q Consensus 123 ~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~i 202 (1141)
+|.+..++ .+..|++|+.|+|++|.+..+ ..+..|++|+.|+|++|+|+.+ ..+..+++|+.|+|++|+|+.+
T Consensus 96 ~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l-----~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 96 ENKIKDLS-SLKDLKKLKSLSLEHNGISDI-----NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp SSCCCCCT-TSTTCTTCCEEECTTSCCCCC-----GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCC
T ss_pred CCCCCCCh-hhccCCCCCEEEecCCCCCCC-----ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCc
Confidence 66655544 355555566666655544332 2355666666666666666665 4456666666666666666655
Q ss_pred cccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 203 PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 203 P~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
+. +..+++|+.|+|++|+|+.+| .+..|++|+.|+|++|+|++.+.
T Consensus 169 ~~-l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 169 VP-LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp GG-GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEECCSEEEECCCC
T ss_pred hh-hccCCCCCEEECcCCCCCCCh-HHccCCCCCEEEccCCcCcCCcc
Confidence 44 666666666666666666664 46666666666666666665544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=212.07 Aligned_cols=242 Identities=18% Similarity=0.178 Sum_probs=197.5
Q ss_pred CCcccccCCCCCccccCCCCCCCC--CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCcC
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDD--DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEK 92 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l--~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~--iP~~l~~L~~ 92 (1141)
.....+++..|++. +..+..+ .+++.|+|++|.+++.++.. ..+++|++|+|++|.++. +|..+..+++
T Consensus 47 ~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~----~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~ 119 (336)
T 2ast_B 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEH----FSPFRVQHMDLSNSVIEVSTLHGILSQCSK 119 (336)
T ss_dssp TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSC----CCCBCCCEEECTTCEECHHHHHHHHTTBCC
T ss_pred hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhh----ccCCCCCEEEccCCCcCHHHHHHHHhhCCC
Confidence 35778888888776 4556666 89999999999999987763 345999999999999983 7888999999
Q ss_pred CcEEEccCCCCC-cCchhhcCCCCCCEEEccCC-CCCC--CcccccCCCCCCEEECCCC-CCCCCcccchhhhcCCC-CC
Q 001143 93 LRNLKFFGNEIN-LFPSEVGNLLGLECLQIKIS-SPGV--NGFALNKLKGLKELELSKV-PPRPSVLTLLSEIAGLK-CL 166 (1141)
Q Consensus 93 L~~L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N-~l~~--~~~~~~~L~~L~~L~Ls~N-~ln~~~~~lp~~l~~L~-~L 166 (1141)
|++|+|++|.++ .+|..++.+++|+.|+|++| .++. ++..+..+++|++|++++| .+.. ..++..+..++ +|
T Consensus 120 L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~--~~~~~~~~~l~~~L 197 (336)
T 2ast_B 120 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE--KHVQVAVAHVSETI 197 (336)
T ss_dssp CSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH--HHHHHHHHHSCTTC
T ss_pred CCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh--HHHHHHHHhcccCC
Confidence 999999999998 67888999999999999999 5763 5667889999999999996 5432 12567788899 99
Q ss_pred cEEEccCC--CCC--ccCccccCCCCCCEEEccCCc-cc-cccccccCCCCCCEEEccCCC-CC-cCCcCccCCCCCCEE
Q 001143 167 TKLSVCHF--SIR--YLPPEIGCLSNLEQLDLSFNK-MK-YLPTEICYLKALISLKVANNK-LV-ELPSGLYLLQRLENL 238 (1141)
Q Consensus 167 ~~L~Ls~N--~L~--~iP~~l~~l~~L~~L~Ls~N~-L~-~iP~~l~~l~~L~~L~Ls~N~-L~-~IP~~l~~L~~L~~L 238 (1141)
+.|++++| .++ .+|..+..+++|+.|+|++|. ++ ..+..+..+++|+.|+|++|. ++ .....+.++++|+.|
T Consensus 198 ~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L 277 (336)
T 2ast_B 198 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 277 (336)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEE
Confidence 99999999 454 567778889999999999999 66 667889999999999999995 33 112357889999999
Q ss_pred eCCCCCCCCCCcccccCCC-CCCEEEccCCcCCC
Q 001143 239 DLSNNRLTSLGSLDLCLMH-NLQNLNLQYNKLLS 271 (1141)
Q Consensus 239 ~Ls~N~Lt~~~p~~l~~L~-~L~~L~Ls~N~L~~ 271 (1141)
+|++| ++ ...+..+. .|..|++++|++++
T Consensus 278 ~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~ 307 (336)
T 2ast_B 278 QVFGI-VP---DGTLQLLKEALPHLQINCSHFTT 307 (336)
T ss_dssp ECTTS-SC---TTCHHHHHHHSTTSEESCCCSCC
T ss_pred eccCc-cC---HHHHHHHHhhCcceEEecccCcc
Confidence 99999 44 32343332 36667799999998
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-19 Score=190.75 Aligned_cols=124 Identities=19% Similarity=0.209 Sum_probs=102.7
Q ss_pred hcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCccccccc-cccCCCCCCEEEccCCCCCcC-CcCccCCCCCC
Q 001143 160 IAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVEL-PSGLYLLQRLE 236 (1141)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~ 236 (1141)
|..+++|+.|+|++|+|+.++. .|..+++|++|+|++|+|+.+|. .|..+++|++|+|++|+|+.+ |..+..+++|+
T Consensus 53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 132 (220)
T 2v70_A 53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132 (220)
T ss_dssp GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence 4455667777777777776654 67888888888888888887754 588899999999999999977 67888899999
Q ss_pred EEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcc
Q 001143 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283 (1141)
Q Consensus 237 ~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l 283 (1141)
.|+|++|+|++++|..|..+++|+.|+|++|+|.|.|++.+...|..
T Consensus 133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~~~ 179 (220)
T 2v70_A 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLGEWLR 179 (220)
T ss_dssp EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHHHHHHHH
T ss_pred EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchHHHHHHHH
Confidence 99999999999999899999999999999999999888765555544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.4e-20 Score=204.23 Aligned_cols=152 Identities=16% Similarity=0.145 Sum_probs=112.5
Q ss_pred CceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCCh----H------HHHHhHHhHHHHHHHHhhCCCCCcccee
Q 001143 807 SLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA----D------EIRNFEYSCLGEVRMLGALRHSCIVEMY 875 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~----~------~~~~~~~~~~~Ei~iL~~L~HpNIVkll 875 (1141)
-|.+.+.||+|+||.||+|.+ .+..+|+|+.+........ . ........+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 367889999999999999999 4667888886533211100 0 00011234589999999999 4 6666
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLK 955 (1141)
+++.. + ..++||||++|++|.+ +.. .....++.||+.||.|||++||+|||||
T Consensus 168 ~~~~~-~--------------~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~giiHrDlk 220 (282)
T 1zar_A 168 KVYAW-E--------------GNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRGIVHGDLS 220 (282)
T ss_dssp CEEEE-E--------------TTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEec-c--------------ceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCCCEeCCCC
Confidence 65543 2 2299999999999987 311 2345799999999999999999999999
Q ss_pred CCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcc
Q 001143 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019 (1141)
Q Consensus 956 P~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1019 (1141)
|+|||++ + +.+||+|||+|+. +..|+|||++..
T Consensus 221 p~NILl~-~-------~~vkl~DFG~a~~-----------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 221 QYNVLVS-E-------EGIWIIDFPQSVE-----------------------VGEEGWREILER 253 (282)
T ss_dssp TTSEEEE-T-------TEEEECCCTTCEE-----------------------TTSTTHHHHHHH
T ss_pred HHHEEEE-C-------CcEEEEECCCCeE-----------------------CCCCCHHHHHHH
Confidence 9999999 6 7899999999853 334789999864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.8e-19 Score=218.20 Aligned_cols=188 Identities=20% Similarity=0.180 Sum_probs=163.0
Q ss_pred cCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCC
Q 001143 23 PSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNE 102 (1141)
Q Consensus 23 ~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~ 102 (1141)
.+..+.++.+. .+..+.+|+.|+|++|.|+... .+ ..|++|+.|+|++|.|+.+|. |..+++|+.|+|++|.
T Consensus 27 ~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~l~--~l---~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 27 NLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQ--GI---QYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCCCT--TG---GGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSC
T ss_pred hccCCCccccc--chhcCCCCCEEECcCCCCCCCh--HH---ccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCC
Confidence 34445555443 3568889999999999998753 24 455999999999999999876 9999999999999999
Q ss_pred CCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc
Q 001143 103 INLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182 (1141)
Q Consensus 103 L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~ 182 (1141)
|+.+| .|..|++|+.|+|++|.+..++ .+..|++|+.|+|++|.+..+ ..+..|++|+.|+|++|+|+.+++
T Consensus 99 l~~l~-~l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l-----~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 99 IKDLS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI-----TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp CCCCT-TSTTCTTCCEEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC-----GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCCCh-hhccCCCCCEEEecCCCCCCCc-cccCCCccCEEECCCCccCCc-----hhhcccCCCCEEECcCCcCCCchh-
Confidence 99887 6999999999999999988875 589999999999999877654 468899999999999999998866
Q ss_pred ccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc
Q 001143 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1141)
Q Consensus 183 l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~ 227 (1141)
+..+++|+.|+|++|+|+.+| .+..+++|+.|+|++|+|+..|.
T Consensus 171 l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 171 LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEECCSEEEECCCC
T ss_pred hccCCCCCEEECcCCCCCCCh-HHccCCCCCEEEccCCcCcCCcc
Confidence 899999999999999999985 69999999999999999987664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-21 Score=236.96 Aligned_cols=195 Identities=22% Similarity=0.204 Sum_probs=143.5
Q ss_pred CCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCC-------------CC-cCchhhcCCCCCCEEE-
Q 001143 56 PLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNE-------------IN-LFPSEVGNLLGLECLQ- 120 (1141)
Q Consensus 56 ~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~-------------L~-~lP~~~~~L~~L~~L~- 120 (1141)
....++.++..++.|+.|+|++|+|+.||.+|+++++|+.|++++|. +. .+|..+++|++|+.|+
T Consensus 337 ~~~~~~~d~~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~ 416 (567)
T 1dce_A 337 RPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP 416 (567)
T ss_dssp CSEEEEECCSTTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCG
T ss_pred CchhhhcccccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcc
Confidence 33444544556688889999999999899889999999999987775 22 3355556666666665
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccc
Q 001143 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK 200 (1141)
Q Consensus 121 Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~ 200 (1141)
++.|.+ .+|..+.+++|. +..+|. ..|+.|+|++|+|+.+|. ++.+++|+.|+|++|+|+
T Consensus 417 l~~n~~----------~~L~~l~l~~n~----i~~l~~-----~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 417 MRAAYL----------DDLRSKFLLENS----VLKMEY-----ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp GGHHHH----------HHHHHHHHHHHH----HHHHHH-----TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC
T ss_pred hhhccc----------chhhhhhhhccc----ccccCc-----cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc
Confidence 443321 122233333321 122222 247888888888888886 888888888888888888
Q ss_pred cccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCC-cccccCCCCCCEEEccCCcCCC
Q 001143 201 YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG-SLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 201 ~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~-p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
.||..|+.+++|+.|+|++|+|+.|| .++.|++|+.|+|++|+|++++ |..|..|++|+.|+|++|+|++
T Consensus 477 ~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 477 ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 88888888888888888888888888 7888888888888888888886 7788888888888888888887
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-18 Score=184.53 Aligned_cols=162 Identities=20% Similarity=0.229 Sum_probs=132.5
Q ss_pred cEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccC
Q 001143 94 RNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1141)
Q Consensus 94 ~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1141)
+.+++++|.|+.||..+. ++|+.|+|++|.+..++ +..|..+++|+.|+|++
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~--------------------------~~~~~~l~~L~~L~Ls~ 65 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIP--------------------------PGAFSPYKKLRRIDLSN 65 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEEC--------------------------TTSSTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcC--------------------------HhHhhCCCCCCEEECCC
Confidence 567888888888877654 55666666655544332 23567788888888888
Q ss_pred CCCCcc-CccccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 174 FSIRYL-PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 174 N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
|+|+.+ |..|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++
T Consensus 66 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 66 NQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp SCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 998866 67889999999999999999988865 57899999999999999977 5678889999999999999999999
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCCchhhhhcc
Q 001143 251 LDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283 (1141)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l 283 (1141)
..|..+++|+.|+|++|+|.|.|.+.+...|..
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~c~c~l~~l~~~l~ 178 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFICDCHLKWLADYLH 178 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred HHHhCCCCCCEEEeCCCCcCCCCccHHHHHHHH
Confidence 889999999999999999999998765555533
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.4e-19 Score=198.19 Aligned_cols=82 Identities=26% Similarity=0.391 Sum_probs=39.6
Q ss_pred CCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCC
Q 001143 164 KCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243 (1141)
Q Consensus 164 ~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N 243 (1141)
++|+.|+|++|+|+.+| .+..+++|+.|+|++|+|+.+| .+..+++|+.|+|++|+|+.+ ..+..+++|+.|+|++|
T Consensus 106 ~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N 182 (263)
T 1xeu_A 106 ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQ 182 (263)
T ss_dssp SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEE
T ss_pred CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCC
Confidence 34445555555554443 2444555555555555555443 344445555555555555444 33444445555555555
Q ss_pred CCCCC
Q 001143 244 RLTSL 248 (1141)
Q Consensus 244 ~Lt~~ 248 (1141)
++++.
T Consensus 183 ~~~~~ 187 (263)
T 1xeu_A 183 KCVNE 187 (263)
T ss_dssp EEECC
T ss_pred cccCC
Confidence 54444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.9e-19 Score=195.10 Aligned_cols=168 Identities=25% Similarity=0.232 Sum_probs=126.6
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
.++..|+|++|.++.++ .+..+++|+.|+|++|.|+.+| .+..++ +|++|+|++|
T Consensus 19 ~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~-----------------------~L~~L~L~~N 73 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA-GMQFFT-----------------------NLKELHLSHN 73 (263)
T ss_dssp HHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT-TGGGCT-----------------------TCCEEECCSS
T ss_pred HHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch-HHhhCC-----------------------CCCEEECCCC
Confidence 34445555555555554 3445555555555555555554 344444 4555555554
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~ 227 (1141)
.+.. +|. +..+++|+.|+|++|+|+.+|.... ++|++|+|++|+|+.+| .+..+++|+.|+|++|+|+.+|
T Consensus 74 ~i~~----~~~-l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~~- 144 (263)
T 1xeu_A 74 QISD----LSP-LKDLTKLEELSVNRNRLKNLNGIPS--ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSIV- 144 (263)
T ss_dssp CCCC----CGG-GTTCSSCCEEECCSSCCSCCTTCCC--SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBCG-
T ss_pred ccCC----Chh-hccCCCCCEEECCCCccCCcCcccc--CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCCh-
Confidence 3332 222 6778889999999999998876433 99999999999999986 5999999999999999999997
Q ss_pred CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 228 ~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++
T Consensus 145 ~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 145 MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 688999999999999999998 479999999999999999987
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=182.78 Aligned_cols=165 Identities=21% Similarity=0.255 Sum_probs=71.5
Q ss_pred EEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCC
Q 001143 72 GLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPR 150 (1141)
Q Consensus 72 ~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln 150 (1141)
.+++++|.++.+|..+. ++|++|+|++|+|+.+|.. |.++++|++|+|++|+++.++..
T Consensus 11 ~v~c~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~------------------ 70 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG------------------ 70 (208)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT------------------
T ss_pred EEEecCCCccCCCCCCC--CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh------------------
Confidence 44555555555554332 2455555555555544332 34445555555544443332211
Q ss_pred CCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcCCcC
Q 001143 151 PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG 228 (1141)
Q Consensus 151 ~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~~ 228 (1141)
.|..+++|++|+|++|+|+.+|.. +..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+|..
T Consensus 71 --------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 71 --------VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp --------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred --------hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 122333344444444444433322 34444444444444444443322 34444444444444444444332
Q ss_pred -ccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 229 -LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 229 -l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+..+++|+.|+|++|.+++ .+++|++|+++.|.+++
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSG 179 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTT
T ss_pred HhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCc
Confidence 3334444444444443332 22344444444454444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.7e-18 Score=183.76 Aligned_cols=154 Identities=23% Similarity=0.234 Sum_probs=128.6
Q ss_pred CcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEcc
Q 001143 93 LRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1141)
Q Consensus 93 L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls 172 (1141)
.+.+++++|.++.+|..+. ++|+.|+|++|.+..+ .|..|.++++|+.|+|+
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~--------------------------~~~~~~~l~~L~~L~L~ 72 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKL--------------------------EPGVFDSLINLKELYLG 72 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCC--------------------------CTTTTTTCTTCCEEECC
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCcc--------------------------CHHHhhCccCCcEEECC
Confidence 5668888888888876553 5666666655553332 24467778889999999
Q ss_pred CCCCCccCc-cccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 173 HFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 173 ~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
+|+|+.+|. .|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+.||..+..+++|+.|+|++|+|+++++
T Consensus 73 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 73 SNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCH
Confidence 999998875 468899999999999999988754 688999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCEEEccCCcCCCCCC
Q 001143 251 LDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
..|..+++|+.|+|++|+|.|.|+
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHhCCCCCCEEEeeCCCccCCcc
Confidence 889999999999999999999775
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-18 Score=180.56 Aligned_cols=176 Identities=17% Similarity=0.163 Sum_probs=105.7
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEEEc
Q 001143 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQI 121 (1141)
Q Consensus 44 ~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~~L~~L~~L~Ls~N~L~~lP~~-~~~L~~L~~L~L 121 (1141)
+.+++++++++..+... .++|++|+|++|.|+.+|.. |..+++|++|+|++|+|+.+|.. |.++++|++|+|
T Consensus 10 ~~v~c~~~~l~~~p~~~------~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI------PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TEEECCSSCCSSCCSCC------CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCccCCCCCC------CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence 56777788777654321 25678888888888877653 67788888888888888877654 567788888887
Q ss_pred cCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCccc
Q 001143 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMK 200 (1141)
Q Consensus 122 s~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~ 200 (1141)
++|.++.++.. .|..+++|+.|++++|+|+.+|.. +..+++|+.|+|++|+|+
T Consensus 84 s~n~l~~~~~~--------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 84 STNQLQSLPNG--------------------------VFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp CSSCCCCCCTT--------------------------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCcCCccCHh--------------------------HhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 77775544421 233344455555555555544332 445555555555555555
Q ss_pred ccccc-ccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCC
Q 001143 201 YLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1141)
Q Consensus 201 ~iP~~-l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~ 257 (1141)
.+|.. +..+++|+.|+|++|.+. +.+++|+.|+++.|+++|.+|..++.++
T Consensus 138 ~~~~~~~~~l~~L~~L~l~~N~~~------~~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 138 SVPDGVFDRLTSLQYIWLHDNPWD------CTCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSCCBC------CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred eeCHHHhccCCCccEEEecCCCee------cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence 44433 445555555555555443 2234555556666666665555555444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-17 Score=179.33 Aligned_cols=153 Identities=22% Similarity=0.243 Sum_probs=118.2
Q ss_pred ccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcC-chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001143 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1141)
Q Consensus 70 L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ 148 (1141)
.+.++.++|.++.||..+. ++|++|+|++|+|+.+ |..|.++++|+.|+|++|.++.++.
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~----------------- 81 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPV----------------- 81 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-----------------
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcCh-----------------
Confidence 4567788888888877654 5788888888888766 5567777777777777776544431
Q ss_pred CCCCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc
Q 001143 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1141)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~ 227 (1141)
..|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|+.+|.
T Consensus 82 ---------~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 82 ---------GVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp ---------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred ---------hhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCH
Confidence 2345667788888888888877654 578889999999999999888888889999999999999998864
Q ss_pred -CccCCCCCCEEeCCCCCCCCCCc
Q 001143 228 -GLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 228 -~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
.+..+++|+.|+|++|.+++..+
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHhCCCCCCEEEeeCCCccCCcc
Confidence 46778999999999999887654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-19 Score=222.57 Aligned_cols=218 Identities=16% Similarity=0.075 Sum_probs=90.2
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCC--CccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCE
Q 001143 41 DDDSVIDVSGKTVDFPLIESYGNRGGDN--SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLEC 118 (1141)
Q Consensus 41 ~~L~~LdLs~N~Ls~~~p~~~~~l~~L~--~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~ 118 (1141)
+.++.|+|++|.+.......+..+ .|. +|..++++.|++...|..|..++.|+.|+|++|.|..||..+++|++|+.
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~l~~l-~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~ 251 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQALLQHK-KLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTR 251 (727)
T ss_dssp --------------------------------------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSC
T ss_pred CccceEEeeCCCCCcchhhHhhcC-ccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCE
Confidence 457778888887776432211111 111 12233344444444455677777777888888877777777777777777
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCc
Q 001143 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198 (1141)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~ 198 (1141)
|+|++|.++.+|..|..|++|++|+|++|.+. .+|..|+.|++|+.|+|++|.|+.||..|+.|++|+.|+|++|.
T Consensus 252 L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~----~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 252 LYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT----SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS----SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSC
T ss_pred EEeeCCcCcccChhhhCCCCCCEEeCcCCcCC----ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCc
Confidence 77777777666666666667777777665443 44566666666777777777666666666666677777777777
Q ss_pred cc-cccccccCCC-CCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCC--------CCCCCCcccccCCCCCCEEEccCC
Q 001143 199 MK-YLPTEICYLK-ALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN--------RLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 199 L~-~iP~~l~~l~-~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N--------~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
|+ .+|..+..+. .+..|+|++|.++ .+|. .|..|+|+.| .|++..+..+..+..+....+++|
T Consensus 328 l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~N 401 (727)
T 4b8c_D 328 LEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYN 401 (727)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C-----------------------------------------
T ss_pred cCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccccccchhhcccccceeeeecc
Confidence 66 3444444332 1223566666665 4443 2344445554 333333333344444444455555
Q ss_pred cC
Q 001143 268 KL 269 (1141)
Q Consensus 268 ~L 269 (1141)
-+
T Consensus 402 il 403 (727)
T 4b8c_D 402 TL 403 (727)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.8e-18 Score=177.90 Aligned_cols=108 Identities=20% Similarity=0.270 Sum_probs=67.8
Q ss_pred hcCCCCCcEEEccCCCCCc-cCccccCCCCCCEEEccCCccc-cccccccCCCCCCEEEccCCC-CCcCCcCccCCCCCC
Q 001143 160 IAGLKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNK-LVELPSGLYLLQRLE 236 (1141)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~-iP~~l~~l~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~-L~~IP~~l~~L~~L~ 236 (1141)
+..+++|+.|++++|+++. .|..++.+++|++|+|++|+|+ ..|..+..+++|+.|+|++|+ ++.+| .+..+++|+
T Consensus 84 l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~ 162 (197)
T 4ezg_A 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELK 162 (197)
T ss_dssp GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCC
T ss_pred hhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCC
Confidence 4455566666666666663 4555666666666666666666 345666666667777777665 66665 466666677
Q ss_pred EEeCCCCCCCCCCcccccCCCCCCEEEccCCcCC
Q 001143 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270 (1141)
Q Consensus 237 ~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~ 270 (1141)
.|+|++|++++++ .+..+++|+.|++++|++.
T Consensus 163 ~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 163 SLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp EEECTTBCCCCCT--TGGGCSSCCEEEECBC---
T ss_pred EEECCCCCCcChH--HhccCCCCCEEEeeCcccC
Confidence 7777777776654 4666677777777777654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.1e-20 Score=225.36 Aligned_cols=203 Identities=18% Similarity=0.180 Sum_probs=158.8
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-------------CC-ccCccccCCcCCcEEE-ccCC
Q 001143 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-------------LN-LIPKSVGRYEKLRNLK-FFGN 101 (1141)
Q Consensus 37 f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~-------------Lt-~iP~~l~~L~~L~~L~-Ls~N 101 (1141)
+..+++|+.|+|++|+|+ .+|+.++.+ ++|+.|++++|. +. .+|..+.+|++|+.|+ ++.|
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l---~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n 420 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESC---KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHH---HHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHH---HHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhc
Confidence 367889999999999998 567777766 899999997774 33 5567789999999999 7888
Q ss_pred CCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc
Q 001143 102 EINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181 (1141)
Q Consensus 102 ~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~ 181 (1141)
.+..++. +.+++|.++.++. ..|+.|+|++|.+.. +|. |+.+++|+.|+|++|+|+.+|.
T Consensus 421 ~~~~L~~----------l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~----lp~-~~~l~~L~~L~Ls~N~l~~lp~ 480 (567)
T 1dce_A 421 YLDDLRS----------KFLLENSVLKMEY-----ADVRVLHLAHKDLTV----LCH-LEQLLLVTHLDLSHNRLRALPP 480 (567)
T ss_dssp HHHHHHH----------HHHHHHHHHHHHH-----TTCSEEECTTSCCSS----CCC-GGGGTTCCEEECCSSCCCCCCG
T ss_pred ccchhhh----------hhhhcccccccCc-----cCceEEEecCCCCCC----CcC-ccccccCcEeecCcccccccch
Confidence 7654443 2334444333332 136777777765543 454 7788889999999999998898
Q ss_pred cccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcC--CcCccCCCCCCEEeCCCCCCCCCCccc---ccCC
Q 001143 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGSLD---LCLM 256 (1141)
Q Consensus 182 ~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~I--P~~l~~L~~L~~L~Ls~N~Lt~~~p~~---l~~L 256 (1141)
.++.+++|+.|+|++|+|+.|| .++.+++|+.|+|++|+|+.+ |..++.|++|+.|+|++|+|++.+|.. +..+
T Consensus 481 ~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~l 559 (567)
T 1dce_A 481 ALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559 (567)
T ss_dssp GGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHC
T ss_pred hhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHC
Confidence 8999999999999999999888 888999999999999999877 888999999999999999999887732 3347
Q ss_pred CCCCEEEc
Q 001143 257 HNLQNLNL 264 (1141)
Q Consensus 257 ~~L~~L~L 264 (1141)
++|+.|++
T Consensus 560 p~L~~L~l 567 (567)
T 1dce_A 560 PSVSSILT 567 (567)
T ss_dssp TTCSEEEC
T ss_pred cccCccCC
Confidence 88888875
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-17 Score=174.78 Aligned_cols=150 Identities=19% Similarity=0.249 Sum_probs=89.1
Q ss_pred CCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
++|++|+|++|.|+.+| .+..+++|++|+|++|.++.++ .+..+++|++|+|++|.++
T Consensus 44 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~-------------------- 101 (197)
T 4ezg_A 44 NSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVT-------------------- 101 (197)
T ss_dssp HTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCB--------------------
T ss_pred CCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccC--------------------
Confidence 45555555555555555 4555555555555555554443 3444555555555444432
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCc-cCccccCCCCCCEEEccCCc-cccccccccCCCCCCEEEccCCCCCcC
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANNKLVEL 225 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~-iP~~l~~l~~L~~L~Ls~N~-L~~iP~~l~~l~~L~~L~Ls~N~L~~I 225 (1141)
...|..++.+++|+.|++++|+++. .|..++.+++|+.|+|++|. ++.+| .+..+++|+.|+|++|+++.+
T Consensus 102 ------~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~ 174 (197)
T 4ezg_A 102 ------SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY 174 (197)
T ss_dssp ------GGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC
T ss_pred ------cccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh
Confidence 2233445566666666777776663 45566677777777777776 66665 566777777777777777766
Q ss_pred CcCccCCCCCCEEeCCCCCCCC
Q 001143 226 PSGLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 226 P~~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
| .+..+++|+.|+|++|++.+
T Consensus 175 ~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 175 R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp T-TGGGCSSCCEEEECBC----
T ss_pred H-HhccCCCCCEEEeeCcccCC
Confidence 6 56667777777777777653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-17 Score=192.41 Aligned_cols=173 Identities=22% Similarity=0.228 Sum_probs=123.7
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-cc-CCcCCcEEEccCCCCCcCc-hhhcCCCCCCEE
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VG-RYEKLRNLKFFGNEINLFP-SEVGNLLGLECL 119 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~-l~-~L~~L~~L~Ls~N~L~~lP-~~~~~L~~L~~L 119 (1141)
-+++++++|+|+.++.. +. ..|+.|+|++|+|+.+|.. |. ++++|+.|+|++|+|+.++ ..|.++++|+.|
T Consensus 20 ~~~l~c~~~~l~~iP~~-~~-----~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 20 SNILSCSKQQLPNVPQS-LP-----SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TTEEECCSSCCSSCCSS-CC-----TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCEEEeCCCCcCccCcc-CC-----CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE
Confidence 36899999999875432 32 4689999999999988764 55 8999999999999999886 458888898888
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc-CccccCCCCCCEEEccCCc
Q 001143 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNK 198 (1141)
Q Consensus 120 ~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~ 198 (1141)
+|++|++..++. ..|.++++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+
T Consensus 94 ~Ls~N~l~~~~~--------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 147 (361)
T 2xot_A 94 DLSSNHLHTLDE--------------------------FLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147 (361)
T ss_dssp ECCSSCCCEECT--------------------------TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCCH--------------------------HHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCc
Confidence 888887655442 2345556666666666666655 4456677777777777777
Q ss_pred cccccccc----cCCCCCCEEEccCCCCCcCCc-CccCCCC--CCEEeCCCCCCCC
Q 001143 199 MKYLPTEI----CYLKALISLKVANNKLVELPS-GLYLLQR--LENLDLSNNRLTS 247 (1141)
Q Consensus 199 L~~iP~~l----~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~--L~~L~Ls~N~Lt~ 247 (1141)
|+.+|..+ ..+++|+.|+|++|+|+.+|. .+..++. |+.|+|++|.+..
T Consensus 148 l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 77776554 457777777777777777763 4445555 3677888887763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.2e-17 Score=181.90 Aligned_cols=142 Identities=15% Similarity=0.123 Sum_probs=103.7
Q ss_pred ceEeeeecccCceEEEEEEE--CCcc--EEEEEEecccCCCChH----------------HHHHhHHhHHHHHHHHhhCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKF--GSAD--AAAKVRTLKVCGSSAD----------------EIRNFEYSCLGEVRMLGALR 867 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~--~~~~--vAvKI~~l~~~~~~~~----------------~~~~~~~~~~~Ei~iL~~L~ 867 (1141)
|++.+.||+|+||.||+|.+ .+.. +|+|+.+......... ........+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 68899999999999999998 6778 9999865432111100 00111234589999999998
Q ss_pred CCCc--cceeeeEecCCCCCCCCCCCccccceEEEEEeeccC-C----CHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 001143 868 HSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-G----SVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 940 (1141)
Q Consensus 868 HpNI--Vkllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~g-g----SL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~g 940 (1141)
|+++ +.+++. . ..+|||||+.+ | +|.++... .++..+..++.||+.|
T Consensus 129 ~~~i~~p~~~~~--~----------------~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~ 182 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----------------KNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVEN 182 (258)
T ss_dssp HTTCCCCCEEEE--E----------------TTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc--C----------------CCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHH
Confidence 8764 333332 1 12899999942 3 77766432 2345678899999999
Q ss_pred HHHHH-HCCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 941 LVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 941 L~yLH-s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
|.||| +.||+||||||+|||++. .++|+|||+|..
T Consensus 183 l~~lH~~~givHrDlkp~NILl~~---------~~~liDFG~a~~ 218 (258)
T 1zth_A 183 VKRLYQEAELVHADLSEYNIMYID---------KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHHTSCEECSSCSTTSEEESS---------SEEECCCTTCEE
T ss_pred HHHHHHHCCEEeCCCCHHHEEEcC---------cEEEEECccccc
Confidence 99999 999999999999999974 499999999964
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.8e-18 Score=216.00 Aligned_cols=152 Identities=20% Similarity=0.108 Sum_probs=52.6
Q ss_pred CCccEEEeecCCCCccCccccCCcC-----CcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEE
Q 001143 68 NSVEGLYLYKNVLNLIPKSVGRYEK-----LRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKEL 142 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP~~l~~L~~-----L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L 142 (1141)
+.++.|.|.+|.+..+|..+....+ +..++++.|.+...|..|..+++|+.|+|++|.+..+|..+..+++|++|
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L 252 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRL 252 (727)
T ss_dssp -------------------------------------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCC
T ss_pred CccceEEeeCCCCCcchhhHhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEE
Confidence 4578889988888877654432222 22233333444433444555555665555555555555444444444444
Q ss_pred ECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCC
Q 001143 143 ELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222 (1141)
Q Consensus 143 ~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L 222 (1141)
+|++|.+. .+|..|++|++|+.|+|++|.|+.||..|+.|++|++|+|++|.|+.||..|+.+++|+.|+|++|.|
T Consensus 253 ~Ls~N~l~----~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 253 YLNGNSLT----ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp BCTTSCCS----CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCC
T ss_pred EeeCCcCc----ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCcc
Confidence 44443332 33444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred C
Q 001143 223 V 223 (1141)
Q Consensus 223 ~ 223 (1141)
+
T Consensus 329 ~ 329 (727)
T 4b8c_D 329 E 329 (727)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-16 Score=170.36 Aligned_cols=149 Identities=21% Similarity=0.255 Sum_probs=122.3
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCC
Q 001143 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149 (1141)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~l 149 (1141)
+.+++++|.|+.||..+. ++|+.|+|++|+|+.+|. .|.++++|+.|+|++|.+..+
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~-------------------- 71 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-------------------- 71 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE--------------------
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc--------------------
Confidence 679999999999998775 589999999999998865 688888888888887775433
Q ss_pred CCCcccchhhhcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCc
Q 001143 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS 227 (1141)
Q Consensus 150 n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~ 227 (1141)
.|..|.++++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.
T Consensus 72 ------~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 72 ------APDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp ------CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred ------CHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 244567777888888888888888764 57788889999999988866 5678888899999999999988765
Q ss_pred -CccCCCCCCEEeCCCCCCCC
Q 001143 228 -GLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 228 -~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
.+..+++|+.|+|++|.+..
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEEC
T ss_pred HHHhCCCCCCEEEeCCCCcCC
Confidence 47778899999999998865
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.5e-16 Score=169.24 Aligned_cols=148 Identities=18% Similarity=0.207 Sum_probs=91.1
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc--cccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEE
Q 001143 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQ 120 (1141)
Q Consensus 44 ~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~--~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~ 120 (1141)
+.|++++|+|+.+ |..+. ..+++|+|++|+|+.++. .|..+++|+.|+|++|+|+.++. .|.++++|++|+
T Consensus 14 ~~l~~s~n~l~~i-P~~~~-----~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 87 (220)
T 2v70_A 14 TTVDCSNQKLNKI-PEHIP-----QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87 (220)
T ss_dssp TEEECCSSCCSSC-CSCCC-----TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CEeEeCCCCcccC-ccCCC-----CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEE
Confidence 4666777766653 32222 345667777777766532 35666667777777777665543 466666666666
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCcc-CccccCCCCCCEEEccCCcc
Q 001143 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKM 199 (1141)
Q Consensus 121 Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L 199 (1141)
|++|.++.++ +..|.++++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|
T Consensus 88 Ls~N~l~~~~--------------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 141 (220)
T 2v70_A 88 LTSNRLENVQ--------------------------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141 (220)
T ss_dssp CCSSCCCCCC--------------------------GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCC
T ss_pred CCCCccCccC--------------------------HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcC
Confidence 6666544433 23455566666666666666655 44566667777777777777
Q ss_pred ccc-cccccCCCCCCEEEccCCCCC
Q 001143 200 KYL-PTEICYLKALISLKVANNKLV 223 (1141)
Q Consensus 200 ~~i-P~~l~~l~~L~~L~Ls~N~L~ 223 (1141)
+.+ |..|..+++|+.|+|++|.++
T Consensus 142 ~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 142 TTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CEECHHHhcCCCCCCEEEecCcCCc
Confidence 655 556666777777777777665
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-16 Score=165.10 Aligned_cols=137 Identities=18% Similarity=0.272 Sum_probs=114.5
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCcc--ccCCCCCCEEEccCCccccc-cccccCCCCCCEEE
Q 001143 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLK 216 (1141)
Q Consensus 140 ~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~--l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~ 216 (1141)
+.|++++|.+. .+|..+.. +|+.|+|++|+|+.+|.. ++.+++|+.|+|++|+|+.+ |..|..+++|++|+
T Consensus 11 ~~l~~s~~~l~----~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 84 (192)
T 1w8a_A 11 TTVDCTGRGLK----EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TEEECTTSCCS----SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CEEEcCCCCcC----cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence 45666664442 34443322 789999999999988763 88999999999999999976 78899999999999
Q ss_pred ccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhc
Q 001143 217 VANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1141)
Q Consensus 217 Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1141)
|++|+|+.+|. .+..+++|+.|+|++|+|++++|..|..+++|+.|+|++|+|+|.|++.+...|.
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l 151 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL 151 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHH
Confidence 99999997754 5788999999999999999999999999999999999999999988766544443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.1e-16 Score=162.46 Aligned_cols=139 Identities=20% Similarity=0.234 Sum_probs=117.2
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEcc
Q 001143 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVA 218 (1141)
Q Consensus 140 ~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls 218 (1141)
+.+++++|.+. .+|..+ .++|+.|+|++|+|+.+|..|..+++|+.|+|++|+|+.++ ..|..+++|+.|+|+
T Consensus 13 ~~l~~~~~~l~----~ip~~~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 13 TVVRCSNKGLK----VLPKGI--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp TEEECTTSCCS----SCCSCC--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCCC----cCCCCC--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 45566654443 334333 24789999999999999999999999999999999999886 568999999999999
Q ss_pred CCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhccc
Q 001143 219 NNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1141)
Q Consensus 219 ~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1141)
+|+|+.+|. .|..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.+.+...|...
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~ 153 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKS 153 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHh
Confidence 999998864 688899999999999999999998899999999999999999999987665555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.5e-16 Score=175.84 Aligned_cols=100 Identities=13% Similarity=0.153 Sum_probs=79.7
Q ss_pred CCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCcccccc-ccccCCCCCC-EEEccCCCCCcCC-cCccCCCCCCEE
Q 001143 163 LKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALI-SLKVANNKLVELP-SGLYLLQRLENL 238 (1141)
Q Consensus 163 L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~-~L~Ls~N~L~~IP-~~l~~L~~L~~L 238 (1141)
+++|+.|+|++|+++.||. .|..+++|+.|+|.+| ++.|+ .+|..+++|+ .|+|.+ +++.|+ ..|.+|++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 6788888888888888866 5778888888888887 77775 4577788888 888887 777774 566678888888
Q ss_pred eCCCCCCCCCCcccccCCCCCCEEEc
Q 001143 239 DLSNNRLTSLGSLDLCLMHNLQNLNL 264 (1141)
Q Consensus 239 ~Ls~N~Lt~~~p~~l~~L~~L~~L~L 264 (1141)
+|++|+++.+.+..|.++++|+.|+.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 88888888888888888888888764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-17 Score=201.66 Aligned_cols=277 Identities=14% Similarity=-0.042 Sum_probs=152.6
Q ss_pred CCcccccCCCCCccccCC----CCCCCCCCCCEEEccCCCCCCCCcccc------------------------cCCCCCC
Q 001143 17 PIKEKLPSEANKINNEKN----GSVNDDDDDSVIDVSGKTVDFPLIESY------------------------GNRGGDN 68 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~----~~f~~l~~L~~LdLs~N~Ls~~~p~~~------------------------~~l~~L~ 68 (1141)
+.++.|.+..|.++.+.. ..+.++++|+.|+|++|.+++ ++..+ ..+..++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~ 270 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccc
Confidence 367777777777764432 234466777777777776654 22222 2333445
Q ss_pred CccEEEeecCCCCccCccccCCcCCcEEEccCCCCC--cCchhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECC
Q 001143 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN--LFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELS 145 (1141)
Q Consensus 69 ~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~--~lP~~~~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls 145 (1141)
+|+.|+++++....+|..+..+++|+.|+|++|.++ .++..+.++++|+.|+|+++. -..++..+..+++|++|+++
T Consensus 271 ~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 271 KLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp TCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred cccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence 555555555544556666666777777777777765 223335667777777776222 11122234556677777777
Q ss_pred C--------CCCCCCcc-cchhhhcCCCCCcEEEccCCCCC-ccCccccC-CCCCCEEEcc----CCcccccc------c
Q 001143 146 K--------VPPRPSVL-TLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGC-LSNLEQLDLS----FNKMKYLP------T 204 (1141)
Q Consensus 146 ~--------N~ln~~~~-~lp~~l~~L~~L~~L~Ls~N~L~-~iP~~l~~-l~~L~~L~Ls----~N~L~~iP------~ 204 (1141)
+ +..+.... .++..+..+++|+.|+++.|+++ ..+..++. +++|+.|+|+ .|.++..| .
T Consensus 351 ~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~ 430 (592)
T 3ogk_B 351 RGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRS 430 (592)
T ss_dssp CCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHH
T ss_pred cCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHH
Confidence 2 00111111 12222344667777777667666 23344433 6677777774 56666432 2
Q ss_pred cccCCCCCCEEEccCC--CCC-cCCcCccC-CCCCCEEeCCCCCCCCC-CcccccCCCCCCEEEccCCcCCCCCCCchhh
Q 001143 205 EICYLKALISLKVANN--KLV-ELPSGLYL-LQRLENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279 (1141)
Q Consensus 205 ~l~~l~~L~~L~Ls~N--~L~-~IP~~l~~-L~~L~~L~Ls~N~Lt~~-~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~ 279 (1141)
.+..+++|+.|+|++| .++ ..+..++. +++|+.|+|++|++++. .+..+..+++|+.|+|++|+++. ..++...
T Consensus 431 ~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~ 509 (592)
T 3ogk_B 431 LLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE-RAIAAAV 509 (592)
T ss_dssp HHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH-HHHHHHH
T ss_pred HHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH-HHHHHHH
Confidence 2455667777777643 354 22333332 66677777777777642 23344666777777777777643 1133333
Q ss_pred hhcccCCCCCCCCCCc
Q 001143 280 CCNLEGNGKDSSNDDF 295 (1141)
Q Consensus 280 ~~~l~~~~l~~~~n~l 295 (1141)
.....+..+.+++|.+
T Consensus 510 ~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 510 TKLPSLRYLWVQGYRA 525 (592)
T ss_dssp HHCSSCCEEEEESCBC
T ss_pred HhcCccCeeECcCCcC
Confidence 3344455555555543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.63 E-value=7e-18 Score=206.29 Aligned_cols=245 Identities=12% Similarity=-0.032 Sum_probs=128.4
Q ss_pred CcccccCCCCCccccCCC----CCCCCCCCCEEEccCCCCCCCCcccccC-CCCCCCccEEEeecCCCCccCccccCCcC
Q 001143 18 IKEKLPSEANKINNEKNG----SVNDDDDDSVIDVSGKTVDFPLIESYGN-RGGDNSVEGLYLYKNVLNLIPKSVGRYEK 92 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~----~f~~l~~L~~LdLs~N~Ls~~~p~~~~~-l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~ 92 (1141)
+++.|.+..|.++..... .+.++++|+.|+|++|.+++.....+.. +.++++|+.|+|++|.++.+|..+.++++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~ 244 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAAN 244 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhH
Confidence 455555555555433211 2334556666666666665322211110 12235666666666666555555555555
Q ss_pred CcEEEccCCCCC----cCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcE
Q 001143 93 LRNLKFFGNEIN----LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168 (1141)
Q Consensus 93 L~~L~Ls~N~L~----~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~ 168 (1141)
|+.|+++.+... ..+..+..+++|+.|+++++....++..+..+++|++|+|++|.+.. ..++..+..+++|+.
T Consensus 245 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~--~~~~~~~~~~~~L~~ 322 (592)
T 3ogk_B 245 LEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLET--EDHCTLIQKCPNLEV 322 (592)
T ss_dssp CCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCH--HHHHHHHTTCTTCCE
T ss_pred HHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCH--HHHHHHHHhCcCCCE
Confidence 666655532211 22233445555555555555555566667778888888888865321 122233566777777
Q ss_pred EEccCCCCC--ccCccccCCCCCCEEEcc-----------CCccc--cccccccCCCCCCEEEccCCCCC-cCCcCccC-
Q 001143 169 LSVCHFSIR--YLPPEIGCLSNLEQLDLS-----------FNKMK--YLPTEICYLKALISLKVANNKLV-ELPSGLYL- 231 (1141)
Q Consensus 169 L~Ls~N~L~--~iP~~l~~l~~L~~L~Ls-----------~N~L~--~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~- 231 (1141)
|+++ |.+. .++..+..+++|+.|+|+ .|.++ .++..+..+++|+.|+|+.|+++ ..+..++.
T Consensus 323 L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~ 401 (592)
T 3ogk_B 323 LETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401 (592)
T ss_dssp EEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHH
T ss_pred Eecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhh
Confidence 7776 3333 233333456667777776 35555 23333344666666666666665 33344443
Q ss_pred CCCCCEEeCC----CCCCCCCCc-----ccccCCCCCCEEEcc
Q 001143 232 LQRLENLDLS----NNRLTSLGS-----LDLCLMHNLQNLNLQ 265 (1141)
Q Consensus 232 L~~L~~L~Ls----~N~Lt~~~p-----~~l~~L~~L~~L~Ls 265 (1141)
+++|+.|+|+ .|++++.+. ..+..+++|+.|+|+
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~ 444 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFY 444 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEe
Confidence 5666666664 556665421 123445555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=155.15 Aligned_cols=134 Identities=20% Similarity=0.132 Sum_probs=83.6
Q ss_pred CCccEEEeecCCCC--ccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001143 68 NSVEGLYLYKNVLN--LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt--~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls 145 (1141)
++|+.|+|++|.|+ .+|..+..+++|++|+|++|.|+.+ ..|..+++|++|+|++|.+..
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~----------------- 85 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFG----------------- 85 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCS-----------------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCch-----------------
Confidence 55666777777666 6666666666677777777666655 445555555555555554332
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEEccCCCCCccC--ccccCCCCCCEEEccCCccccccc----cccCCCCCCEEEccC
Q 001143 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP--PEIGCLSNLEQLDLSFNKMKYLPT----EICYLKALISLKVAN 219 (1141)
Q Consensus 146 ~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP--~~l~~l~~L~~L~Ls~N~L~~iP~----~l~~l~~L~~L~Ls~ 219 (1141)
. +|..+..+++|+.|++++|.|+.+| ..+..+++|+.|+|++|.|+.+|. .+..+++|+.|++++
T Consensus 86 ------~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 86 ------G---LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp ------C---CCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ------H---HHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 1 3334444666666666666666654 456666677777777777766654 566667777777777
Q ss_pred CCCCcCCcC
Q 001143 220 NKLVELPSG 228 (1141)
Q Consensus 220 N~L~~IP~~ 228 (1141)
|.+..+|.+
T Consensus 157 n~~~~~~~~ 165 (168)
T 2ell_A 157 REDQEAPDS 165 (168)
T ss_dssp TTSCBCCSS
T ss_pred CChhhcccc
Confidence 776666654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.2e-15 Score=154.11 Aligned_cols=136 Identities=17% Similarity=0.098 Sum_probs=99.4
Q ss_pred CCCCCEEEccCCCCC-CCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCc-CchhhcCCCCCC
Q 001143 40 DDDDSVIDVSGKTVD-FPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINL-FPSEVGNLLGLE 117 (1141)
Q Consensus 40 l~~L~~LdLs~N~Ls-~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~-lP~~~~~L~~L~ 117 (1141)
.++|+.|+|++|+|+ +.+|..+..+ ++|++|+|++|.|+.+ ..|..+++|++|+|++|+|+. +|..+.++++|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l---~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEF---VNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGG---GGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred cccCCEEECCCCCCChhhHHHHHHhC---CCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 378999999999998 6777766555 8999999999999988 778999999999999999997 787787899999
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc----cccCCCCCCEEE
Q 001143 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP----EIGCLSNLEQLD 193 (1141)
Q Consensus 118 ~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~----~l~~l~~L~~L~ 193 (1141)
.|+|++|.++.++. +..+..+++|+.|++++|.++.+|. .+..+++|++|+
T Consensus 99 ~L~Ls~N~l~~~~~-------------------------~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 153 (168)
T 2ell_A 99 HLNLSGNKLKDIST-------------------------LEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153 (168)
T ss_dssp EEECBSSSCCSSGG-------------------------GGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEET
T ss_pred EEeccCCccCcchh-------------------------HHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEec
Confidence 99999888776551 1233444455555555555554444 445555555555
Q ss_pred ccCCccccccc
Q 001143 194 LSFNKMKYLPT 204 (1141)
Q Consensus 194 Ls~N~L~~iP~ 204 (1141)
+++|.+..+|.
T Consensus 154 l~~n~~~~~~~ 164 (168)
T 2ell_A 154 GYDREDQEAPD 164 (168)
T ss_dssp TEETTSCBCCS
T ss_pred CCCCChhhccc
Confidence 55555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5.1e-14 Score=165.12 Aligned_cols=228 Identities=10% Similarity=0.079 Sum_probs=176.6
Q ss_pred CCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCc
Q 001143 27 NKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINL 105 (1141)
Q Consensus 27 N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~ 105 (1141)
|+++.|...+|.+. +|+.++|..| ++.+....|.+ .+|+.+.|.+ .++.|+. .|.++++|+.|+|++|+|+.
T Consensus 122 ~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~----~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~ 194 (401)
T 4fdw_A 122 NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN----STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK 194 (401)
T ss_dssp TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT----CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE
T ss_pred CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC----CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE
Confidence 57888999999985 7999998876 77666655543 3689999986 5888864 68889999999999999999
Q ss_pred CchhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cc
Q 001143 106 FPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EI 183 (1141)
Q Consensus 106 lP~~~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l 183 (1141)
||......++|+.+.|..| +..++ ..|.++.+|+.|.+..| +...-..+|.+ .+|+.+.+ .|.++.|+. .|
T Consensus 195 I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~----l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF 267 (401)
T 4fdw_A 195 LPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN----VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAF 267 (401)
T ss_dssp ECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT----CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTT
T ss_pred echhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC----ccCcccccccc-CCccEEEe-CCCccEEChhHh
Confidence 9877555789999999855 55444 57889999999999862 22222345666 67888888 566777744 77
Q ss_pred cCCCCCCEEEccCCccc-----ccc-ccccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcccccCC
Q 001143 184 GCLSNLEQLDLSFNKMK-----YLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1141)
Q Consensus 184 ~~l~~L~~L~Ls~N~L~-----~iP-~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L 256 (1141)
..+++|+.|.|.+|.+. .|+ ..|..+++|+.+.|. |.++.|+. .|.+|++|+.|+|.+| ++.+.+..|.++
T Consensus 268 ~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~ 345 (401)
T 4fdw_A 268 YYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT 345 (401)
T ss_dssp TTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred hCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence 88899999999888876 564 567888999999998 55888854 5556899999999655 888888888888
Q ss_pred CCCCEEEccCCcCCC
Q 001143 257 HNLQNLNLQYNKLLS 271 (1141)
Q Consensus 257 ~~L~~L~Ls~N~L~~ 271 (1141)
+|+.|++++|.+..
T Consensus 346 -~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 346 -GIKEVKVEGTTPPQ 359 (401)
T ss_dssp -CCCEEEECCSSCCB
T ss_pred -CCCEEEEcCCCCcc
Confidence 89999999987665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3.6e-15 Score=172.75 Aligned_cols=150 Identities=18% Similarity=0.148 Sum_probs=100.0
Q ss_pred ceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCCh--------------HHHHHhHHhHHHHHHHHhhCCCCCcc
Q 001143 808 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA--------------DEIRNFEYSCLGEVRMLGALRHSCIV 872 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~~--------------~~~~~~~~~~~~Ei~iL~~L~HpNIV 872 (1141)
|++.+.||+|++|.||+|.+ .+..+|+|+++........ ...........+|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999987 5778999997643222110 00111111234566666666544432
Q ss_pred ceeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 001143 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1141)
Q Consensus 873 kllg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHr 952 (1141)
-..-+... ..+|||||++|++|..+. ....+..++.||+.+|.|||++|||||
T Consensus 177 vp~p~~~~----------------~~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH~~gIVHr 229 (397)
T 4gyi_A 177 VPEPIAQS----------------RHTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLAKHGLIHG 229 (397)
T ss_dssp CCCEEEEE----------------TTEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CCeeeecc----------------CceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 11111110 127999999988875432 112346788999999999999999999
Q ss_pred CCCCCCeeeecccccCCCC---CeEEEeecccccc
Q 001143 953 DIKSENILIDLERKKADGK---PVVKLCDFDRAVP 984 (1141)
Q Consensus 953 DLKP~NILld~~~~~~~~~---~~vKL~DFGlA~~ 984 (1141)
||||.|||++.++...... ..+.|+||+.+..
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999998874211111 1489999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=6.1e-14 Score=164.51 Aligned_cols=237 Identities=9% Similarity=0.074 Sum_probs=184.7
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
.+..+.+..| |+.|...+|.+. +|+.|+|.. .++.+....| .++++|+.|+|++|+++.||.......+|+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF---~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~ 209 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIF---YYCYNLKKADLSKTKITKLPASTFVYAGIEEVL 209 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTT---TTCTTCCEEECTTSCCSEECTTTTTTCCCSEEE
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHh---hCcccCCeeecCCCcceEechhhEeecccCEEE
Confidence 4677776544 999999999994 799999986 6776655544 555899999999999999987644568899999
Q ss_pred ccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCC
Q 001143 98 FFGNEINLFPS-EVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1141)
Q Consensus 98 Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1141)
|.+| ++.|+. .|.++++|+.|.|..| +..++ ..|.+ .+|+.+.|.. ++...-..+|.+|++|+.|.+.+|.
T Consensus 210 lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~----~i~~I~~~aF~~c~~L~~l~l~~~~ 282 (401)
T 4fdw_A 210 LPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPN----GVTNIASRAFYYCPELAEVTTYGST 282 (401)
T ss_dssp CCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEET----TCCEECTTTTTTCTTCCEEEEESSC
T ss_pred eCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCC----CccEEChhHhhCCCCCCEEEeCCcc
Confidence 9854 888855 4888999999999876 44444 46666 7899999954 3333334578899999999998887
Q ss_pred CC-----ccCc-cccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCC
Q 001143 176 IR-----YLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 176 L~-----~iP~-~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
+. .|+. .|..+++|+.|.|. |.++.|+ .+|..+++|+.|.|..| ++.|+ ..|.++ +|+.|+|++|.+..
T Consensus 283 ~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 283 FNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp CCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred ccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 76 5644 77889999999998 5688886 56778899999999555 88885 556678 99999999999998
Q ss_pred CCcccccCCC-CCCEEEccCCcCC
Q 001143 248 LGSLDLCLMH-NLQNLNLQYNKLL 270 (1141)
Q Consensus 248 ~~p~~l~~L~-~L~~L~Ls~N~L~ 270 (1141)
+.+..|..++ .+..|++..|.+.
T Consensus 360 l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 360 VFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cccccccCCCCCccEEEeCHHHHH
Confidence 8888888885 7888888877653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=6.2e-15 Score=154.86 Aligned_cols=87 Identities=24% Similarity=0.328 Sum_probs=43.0
Q ss_pred CCCCcEEEccCCCCCcc-CccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEe
Q 001143 163 LKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLD 239 (1141)
Q Consensus 163 L~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~ 239 (1141)
+++|+.|+|++|+|+.+ |..|..+++|++|+|++|+|+.+| ..|..+++|+.|+|++|+|+.+ |..+..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 33344444444444433 334444555555555555555433 2344555555555555555533 44455555555555
Q ss_pred CCCCCCCCCC
Q 001143 240 LSNNRLTSLG 249 (1141)
Q Consensus 240 Ls~N~Lt~~~ 249 (1141)
|++|.+++..
T Consensus 133 L~~N~l~c~c 142 (192)
T 1w8a_A 133 LASNPFNCNC 142 (192)
T ss_dssp CTTCCBCCSG
T ss_pred eCCCCccCcC
Confidence 5555555443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-14 Score=147.76 Aligned_cols=129 Identities=27% Similarity=0.322 Sum_probs=106.7
Q ss_pred CCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCcccccccc-ccCCCCCCEEE
Q 001143 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLK 216 (1141)
Q Consensus 139 L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~ 216 (1141)
.+.+++++|.+. .+|..+ .++|+.|++++|+++.+|. .+..+++|++|+|++|+|+.+|.. +..+++|+.|+
T Consensus 9 ~~~l~~~~~~l~----~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (177)
T 2o6r_A 9 GTEIRCNSKGLT----SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY 82 (177)
T ss_dssp TTEEECCSSCCS----SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCEEEecCCCCc----cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE
Confidence 345666654443 233322 3578999999999998866 468899999999999999988754 68899999999
Q ss_pred ccCCCCCcCCcC-ccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCC
Q 001143 217 VANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273 (1141)
Q Consensus 217 Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~ 273 (1141)
|++|+|+.+|.. +..+++|+.|+|++|+|+++++..+..+++|+.|+|++|+|.|.|
T Consensus 83 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 83 LHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 999999988765 578999999999999999999877899999999999999999854
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.54 E-value=6.7e-15 Score=147.45 Aligned_cols=127 Identities=25% Similarity=0.249 Sum_probs=89.6
Q ss_pred CCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccc-ccccccCCCCCCEE
Q 001143 137 KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY-LPTEICYLKALISL 215 (1141)
Q Consensus 137 ~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~-iP~~l~~l~~L~~L 215 (1141)
++|+.|++++|.+.. +.+|..+..+++|+.|++++|.|+.+ ..++.+++|++|+|++|.|+. +|..+..+++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~--~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBT--TBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCCh--hHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 445566666533210 24555566677777777777777766 566777778888888888775 66666677778888
Q ss_pred EccCCCCCcCC--cCccCCCCCCEEeCCCCCCCCCCc---ccccCCCCCCEEEccC
Q 001143 216 KVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGS---LDLCLMHNLQNLNLQY 266 (1141)
Q Consensus 216 ~Ls~N~L~~IP--~~l~~L~~L~~L~Ls~N~Lt~~~p---~~l~~L~~L~~L~Ls~ 266 (1141)
+|++|+|+.+| ..+..+++|+.|+|++|++++.++ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88888887654 677777888888888888877776 4677778888877763
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=4.6e-14 Score=145.43 Aligned_cols=107 Identities=27% Similarity=0.324 Sum_probs=98.5
Q ss_pred CcEEEccCCCCCccCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCcC-ccCCCCCCEEeCCCC
Q 001143 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243 (1141)
Q Consensus 166 L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N 243 (1141)
.+.|++++|+|+.+|..+. ++|+.|+|++|+|+.+ |..|..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 5789999999999998764 8999999999999987 66799999999999999999999776 468999999999999
Q ss_pred CCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 244 ~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
+|+++++..|..+++|+.|+|++|+|+|.|+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999999889999999999999999999764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.5e-14 Score=146.95 Aligned_cols=125 Identities=23% Similarity=0.269 Sum_probs=58.6
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCC
Q 001143 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPP 149 (1141)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~l 149 (1141)
+.+++++|.|++||..+. ++|+.|+|++|+|+.+|..|.++++|+.|+|++|.++.++. .|.++++|++|+|++|.+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 455556666666655443 35666666666666565555555555555555555443331 233333333333333222
Q ss_pred CCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCccc
Q 001143 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMK 200 (1141)
Q Consensus 150 n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~ 200 (1141)
.. ..|..|.++++|+.|+|++|+|+.+|. .|..+++|+.|+|++|.+.
T Consensus 91 ~~---i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 91 RC---IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CB---CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CE---eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 11 112234444445555555555554433 2344444555555554443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.51 E-value=4.5e-16 Score=190.16 Aligned_cols=180 Identities=13% Similarity=0.013 Sum_probs=93.7
Q ss_pred cCCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc---------cCCCCCcc
Q 001143 111 GNLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV---------CHFSIRYL 179 (1141)
Q Consensus 111 ~~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~L---------s~N~L~~i 179 (1141)
..+++|+.|+|++|.++... ..+..+++|++|++++| + ....++.....+++|+.|++ ..|.++..
T Consensus 286 ~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~--~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-I--EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp HHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-G--HHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred HhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-c--CHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 35678888888888744321 23557778888888764 1 11122222334677777766 33444421
Q ss_pred -Cccc-cCCCCCCEEEccCCccc-ccccccc-CCCCCCEEEcc--C----CCCCcCCc------CccCCCCCCEEeCCCC
Q 001143 180 -PPEI-GCLSNLEQLDLSFNKMK-YLPTEIC-YLKALISLKVA--N----NKLVELPS------GLYLLQRLENLDLSNN 243 (1141)
Q Consensus 180 -P~~l-~~l~~L~~L~Ls~N~L~-~iP~~l~-~l~~L~~L~Ls--~----N~L~~IP~------~l~~L~~L~~L~Ls~N 243 (1141)
...+ ..+++|+.|.++.|.++ ..+..+. .+++|+.|+|+ + |.++..|. -+..+++|+.|+|++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~- 441 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG- 441 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-
Confidence 1122 23566777766666666 2233333 36667777776 3 45554332 133456666666655
Q ss_pred CCCCCCcccccC-CCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCc
Q 001143 244 RLTSLGSLDLCL-MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDF 295 (1141)
Q Consensus 244 ~Lt~~~p~~l~~-L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l 295 (1141)
.++......+.. +++|+.|+|++|.++.. .++........+..+++.++.+
T Consensus 442 ~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~-~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL-GMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp SCCHHHHHHHHHHCTTCCEEEEESCCSSHH-HHHHHHHHCTTCCEEEEESCSC
T ss_pred cccHHHHHHHHHhchhccEeeccCCCCcHH-HHHHHHhcCCCcCEEECcCCCC
Confidence 454443334433 56666666666665431 1111112334445555555554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.4e-14 Score=149.60 Aligned_cols=103 Identities=25% Similarity=0.260 Sum_probs=42.4
Q ss_pred CcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccc-cCCCCCCEEEccCCCCCcCCc--CccCCCCCCEEeCCC
Q 001143 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPS--GLYLLQRLENLDLSN 242 (1141)
Q Consensus 166 L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l-~~l~~L~~L~Ls~N~L~~IP~--~l~~L~~L~~L~Ls~ 242 (1141)
|+.|++++|.|+.+ ..+..+++|++|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++
T Consensus 44 L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~ 122 (176)
T 1a9n_A 44 FDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 122 (176)
T ss_dssp CSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCS
T ss_pred CCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecC
Confidence 33333333333333 23333444444444444444333222 334444444444444444433 344444444444444
Q ss_pred CCCCCCCcc---cccCCCCCCEEEccCCcC
Q 001143 243 NRLTSLGSL---DLCLMHNLQNLNLQYNKL 269 (1141)
Q Consensus 243 N~Lt~~~p~---~l~~L~~L~~L~Ls~N~L 269 (1141)
|.++..++. .+..+++|+.|++++|.+
T Consensus 123 N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 123 NPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp SGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 444433321 244444455555544443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.2e-14 Score=148.25 Aligned_cols=134 Identities=19% Similarity=0.175 Sum_probs=104.2
Q ss_pred hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccc-cCCC
Q 001143 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLS 187 (1141)
Q Consensus 109 ~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l-~~l~ 187 (1141)
.+.++++|+.|+|++|.++.++......++|++|++++|.+... ..|..+++|+.|++++|+|+.+|+.+ ..++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~-----~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-----DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE-----CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred hcCCcCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc-----cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 35677888888888888777755333334888888888766532 46778888888888888888887654 7888
Q ss_pred CCCEEEccCCccccccc--cccCCCCCCEEEccCCCCCcCCcC----ccCCCCCCEEeCCCCCCCC
Q 001143 188 NLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLVELPSG----LYLLQRLENLDLSNNRLTS 247 (1141)
Q Consensus 188 ~L~~L~Ls~N~L~~iP~--~l~~l~~L~~L~Ls~N~L~~IP~~----l~~L~~L~~L~Ls~N~Lt~ 247 (1141)
+|++|+|++|+|+.+|. .+..+++|+.|+|++|.++.+|.. +..+++|+.||++.|.+..
T Consensus 89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 88888888888888876 788888888888888888888775 7778888888888887653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.7e-14 Score=142.00 Aligned_cols=56 Identities=18% Similarity=0.198 Sum_probs=26.3
Q ss_pred CCccEEEeecCCCC--ccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCC
Q 001143 68 NSVEGLYLYKNVLN--LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKIS 124 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt--~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N 124 (1141)
++|+.|+|++|.++ .+|..+..+++|++|+|++|.|+.+ ..++++++|++|+|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n 74 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDN 74 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSS
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCC
Confidence 34555555555554 4444445555555555555555444 33333444444443333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-13 Score=141.37 Aligned_cols=91 Identities=31% Similarity=0.366 Sum_probs=66.4
Q ss_pred hcCCCCCcEEEccCCCCCccCcc-ccCCCCCCEEEccCCcccccccc-ccCCCCCCEEEccCCCCCcCCcCc-cCCCCCC
Q 001143 160 IAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGL-YLLQRLE 236 (1141)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~~l-~~L~~L~ 236 (1141)
|..+++|++|++++|+|+.+|.. +..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+|..+ ..+++|+
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 127 (177)
T 2o6r_A 48 FDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQ 127 (177)
T ss_dssp TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccC
Confidence 34455666666666766666543 56777788888888888766543 577888888888888888777654 5688888
Q ss_pred EEeCCCCCCCCCCc
Q 001143 237 NLDLSNNRLTSLGS 250 (1141)
Q Consensus 237 ~L~Ls~N~Lt~~~p 250 (1141)
.|+|++|.+++..|
T Consensus 128 ~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 128 KIWLHTNPWDCSCP 141 (177)
T ss_dssp EEECCSSCBCCCHH
T ss_pred EEEecCCCeeccCc
Confidence 88888888887665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=9.2e-14 Score=143.90 Aligned_cols=107 Identities=26% Similarity=0.346 Sum_probs=98.1
Q ss_pred CcEEEccCCCCCccCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCcCc-cCCCCCCEEeCCCC
Q 001143 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGL-YLLQRLENLDLSNN 243 (1141)
Q Consensus 166 L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~~l-~~L~~L~~L~Ls~N 243 (1141)
-+.+++++|+|+.+|..+. ++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.||..+ ..+++|+.|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 4689999999999999765 8999999999999977 667999999999999999999998764 68999999999999
Q ss_pred CCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 244 ~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
+|+++++..|..+++|+.|+|++|+|.+.|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9999999789999999999999999999654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.4e-16 Score=166.14 Aligned_cols=109 Identities=19% Similarity=0.131 Sum_probs=48.0
Q ss_pred cccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCC
Q 001143 86 SVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC 165 (1141)
Q Consensus 86 ~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~ 165 (1141)
.|..+++|++|+|++|.|+.+| .+.++++|+.|+|++|.++.+|..+..+++|++|++++|.+.. +| .+..+++
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~----l~-~~~~l~~ 116 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS----LS-GIEKLVN 116 (198)
T ss_dssp HHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC----HH-HHHHHHH
T ss_pred HHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc----CC-ccccCCC
Confidence 4444444444444444444444 4444444444444444433333222222233333333322211 12 2444455
Q ss_pred CcEEEccCCCCCccCc--cccCCCCCCEEEccCCccc
Q 001143 166 LTKLSVCHFSIRYLPP--EIGCLSNLEQLDLSFNKMK 200 (1141)
Q Consensus 166 L~~L~Ls~N~L~~iP~--~l~~l~~L~~L~Ls~N~L~ 200 (1141)
|+.|++++|+|+.+|. .+..+++|+.|+|++|.++
T Consensus 117 L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 5555555555554432 4455555555555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-16 Score=166.65 Aligned_cols=110 Identities=26% Similarity=0.263 Sum_probs=83.4
Q ss_pred hhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCc--CccCCCCCC
Q 001143 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS--GLYLLQRLE 236 (1141)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~--~l~~L~~L~ 236 (1141)
.+..+++|+.|++++|.|+.+|..+..+++|++|+|++|+|+.+| .+..+++|+.|+|++|+|+.+|. .+..+++|+
T Consensus 65 ~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~ 143 (198)
T 1ds9_A 65 SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143 (198)
T ss_dssp CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCC
Confidence 455667777777777777777776666778888888888888776 57777888888888888887654 677788888
Q ss_pred EEeCCCCCCCCCCccc----------ccCCCCCCEEEccCCcCCC
Q 001143 237 NLDLSNNRLTSLGSLD----------LCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 237 ~L~Ls~N~Lt~~~p~~----------l~~L~~L~~L~Ls~N~L~~ 271 (1141)
.|+|++|++++.+|.. +..+++|+.|| +|+++.
T Consensus 144 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp EEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred EEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 8888888887776532 77788888876 677654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-15 Score=186.78 Aligned_cols=131 Identities=13% Similarity=0.083 Sum_probs=92.5
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-CCCc--cCccccCCcCCcEEEccCCCCCcC-----chh
Q 001143 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNL--IPKSVGRYEKLRNLKFFGNEINLF-----PSE 109 (1141)
Q Consensus 38 ~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N-~Lt~--iP~~l~~L~~L~~L~Ls~N~L~~l-----P~~ 109 (1141)
..+++|+.|+|++|.+++..+..+. ..+++|++|+|++| .++. ++..+.++++|++|+|++|.|+.. +.-
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~--~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~ 179 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIA--KSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHF 179 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHH--HHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGS
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHH--HhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHH
Confidence 4677899999999988876665553 12489999999988 6664 555556888999999999987632 222
Q ss_pred hcCCCCCCEEEccCCCCCCCc-----ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC
Q 001143 110 VGNLLGLECLQIKISSPGVNG-----FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1141)
Q Consensus 110 ~~~L~~L~~L~Ls~N~l~~~~-----~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1141)
...+++|+.|+|++|. ..++ ..+..+++|++|++++| .....+|..+..+++|+.|+++.+
T Consensus 180 ~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~---~~~~~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 180 PDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRA---VPLEKLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTT---SCHHHHHHHHHHCTTCSEEECSBC
T ss_pred hhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCC---CcHHHHHHHHhcCCcceEcccccc
Confidence 3467799999999887 2222 22345789999999885 233446667777777887775444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.8e-13 Score=154.06 Aligned_cols=99 Identities=16% Similarity=0.110 Sum_probs=85.3
Q ss_pred CCCCCEEECCCCCCCCCcccch-hhhcCCCCCcEEEccCCCCCccCc-cccCCCCCC-EEEccCCcccccc-ccccCCCC
Q 001143 136 LKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLE-QLDLSFNKMKYLP-TEICYLKA 211 (1141)
Q Consensus 136 L~~L~~L~Ls~N~ln~~~~~lp-~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~-~L~Ls~N~L~~iP-~~l~~l~~ 211 (1141)
+++|+.|+|++|.+. .+| ..|.+|.+|+.|+|.+| ++.|+. .|.++++|+ .|+|.+ .++.|+ .+|..+++
T Consensus 225 ~~~L~~l~L~~n~i~----~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~ 298 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT----TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDN 298 (329)
T ss_dssp CTTCCEEECTTBCCC----EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTT
T ss_pred cCCCeEEECCCCCcc----eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCcc
Confidence 789999999985543 343 47899999999999998 888866 789999999 999998 888885 67899999
Q ss_pred CCEEEccCCCCCcCCc-CccCCCCCCEEeC
Q 001143 212 LISLKVANNKLVELPS-GLYLLQRLENLDL 240 (1141)
Q Consensus 212 L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~L 240 (1141)
|+.|+|++|+++.|+. .|.++++|+.|+.
T Consensus 299 L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 299 LRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9999999999999965 6677999999874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=8.7e-13 Score=150.69 Aligned_cols=130 Identities=20% Similarity=0.171 Sum_probs=107.0
Q ss_pred EEEccCC-CCCccCccccCCCCCCEEEccC-Ccccccc-ccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCC
Q 001143 168 KLSVCHF-SIRYLPPEIGCLSNLEQLDLSF-NKMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNN 243 (1141)
Q Consensus 168 ~L~Ls~N-~L~~iP~~l~~l~~L~~L~Ls~-N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N 243 (1141)
.++++++ +|+.||. |..+++|+.|+|++ |+|+.+| ..|+.|++|+.|+|++|+|+.+| ..|.+|++|+.|+|++|
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 5788988 9999999 99999999999996 9999887 67999999999999999999775 46788999999999999
Q ss_pred CCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 244 ~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
+|+++++..|..++ |+.|+|++|+|.|.|++.+...|.. .....+..+.+.|..|
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~-~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEE-EGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHH-TTCSSCGGGCCCCSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHH-hCcccccccCCCCCCC
Confidence 99999997777776 9999999999999988765544433 3333333344555444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=128.22 Aligned_cols=101 Identities=17% Similarity=0.229 Sum_probs=64.1
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEEEc
Q 001143 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQI 121 (1141)
Q Consensus 44 ~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~Ls~N~L~~lP~~-~~~L~~L~~L~L 121 (1141)
+.||+++|+|+.++. .+. ++|++|+|++|+|+.+ |..|.++++|++|+|++|+|+.+|.. |.++++|+.|+|
T Consensus 15 ~~l~~~~n~l~~iP~-~~~-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L 88 (174)
T 2r9u_A 15 TLVNCQNIRLASVPA-GIP-----TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDL 88 (174)
T ss_dssp SEEECCSSCCSSCCS-CCC-----TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cEEEeCCCCCCccCC-CcC-----CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEEC
Confidence 566777776654332 221 5666777777777666 34566667777777777777766554 456777777777
Q ss_pred cCCCCCCCccc-ccCCCCCCEEECCCCCCC
Q 001143 122 KISSPGVNGFA-LNKLKGLKELELSKVPPR 150 (1141)
Q Consensus 122 s~N~l~~~~~~-~~~L~~L~~L~Ls~N~ln 150 (1141)
++|++..++.. |..+++|++|+|++|++.
T Consensus 89 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 89 NDNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 77776666543 666777777777776554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=126.53 Aligned_cols=104 Identities=23% Similarity=0.323 Sum_probs=75.9
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEccCCCCCcCchh-hcCCCCCCEEE
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQ 120 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~Ls~N~L~~lP~~-~~~L~~L~~L~ 120 (1141)
.+.||+++|+|+.++.. + . ++|++|+|++|+|+.+ |..|.++++|++|+|++|+|+.+|.. |.++++|++|+
T Consensus 11 ~~~l~~s~n~l~~ip~~-~--~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 84 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTG-I--P---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLS 84 (170)
T ss_dssp TTEEECTTSCCSSCCSC-C--C---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCEEEeCCCCcCccCcc-C--C---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEE
Confidence 46788888888764432 2 1 5678888888888877 44577888888888888888877654 57788888888
Q ss_pred ccCCCCCCCcc-cccCCCCCCEEECCCCCCCCC
Q 001143 121 IKISSPGVNGF-ALNKLKGLKELELSKVPPRPS 152 (1141)
Q Consensus 121 Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~ 152 (1141)
|++|+++.++. .|..+++|++|+|++|++...
T Consensus 85 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 85 LNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 88888777665 477788888888888776543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.1e-12 Score=152.26 Aligned_cols=164 Identities=20% Similarity=0.170 Sum_probs=88.1
Q ss_pred CCcEEEccCCCCCcC-----chhhc-CCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCccc-chhhh-c
Q 001143 92 KLRNLKFFGNEINLF-----PSEVG-NLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLT-LLSEI-A 161 (1141)
Q Consensus 92 ~L~~L~Ls~N~L~~l-----P~~~~-~L~~L~~L~Ls~N~l~~~~--~~~~~L~~L~~L~Ls~N~ln~~~~~-lp~~l-~ 161 (1141)
.|+.|+|++|.|+.. ...+. +.++|+.|+|++|.++..+ .....+.+|+.|+|++|.+...... +...+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 455566666655522 11121 1245555555555543322 1122334455555555443221111 11122 2
Q ss_pred CCCCCcEEEccCCCCCc-----cCccccCCCCCCEEEccCCcccc-----ccccccCCCCCCEEEccCCCCCc-----CC
Q 001143 162 GLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVANNKLVE-----LP 226 (1141)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~~-----IP 226 (1141)
..++|+.|+|++|.|+. ++..+..+++|++|+|++|.|+. |+..+...++|+.|+|++|.|+. ++
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 35567777777777753 33444566777777777777762 34556666777777777777762 33
Q ss_pred cCccCCCCCCEEeCCCCCCCCCCcccccC
Q 001143 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1141)
Q Consensus 227 ~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~ 255 (1141)
..+...++|+.|+|++|.|+......+..
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 44445667777777777777555444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=3.1e-12 Score=148.53 Aligned_cols=157 Identities=20% Similarity=0.250 Sum_probs=104.5
Q ss_pred CCccEEEeecCCCCccC-cc----cc-CCcCCcEEEccCCCCCc--CchhhcCCCCCCEEEccCCCCCCCcc-cc-----
Q 001143 68 NSVEGLYLYKNVLNLIP-KS----VG-RYEKLRNLKFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNGF-AL----- 133 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~iP-~~----l~-~L~~L~~L~Ls~N~L~~--lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~----- 133 (1141)
+.|+.|+|++|.|+... .. +. ..++|+.|+|++|.|+. +..-+..+++|+.|+|++|.++..+. .+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45667777777766322 11 22 22467777777777652 12212335567777777776654432 11
Q ss_pred cCCCCCCEEECCCCCCCCC-cccchhhhcCCCCCcEEEccCCCCCc-----cCccccCCCCCCEEEccCCcccc-----c
Q 001143 134 NKLKGLKELELSKVPPRPS-VLTLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----L 202 (1141)
Q Consensus 134 ~~L~~L~~L~Ls~N~ln~~-~~~lp~~l~~L~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~~-----i 202 (1141)
...++|++|+|++|.+... ...++..+..+++|+.|+|++|.|+. ++..+...++|+.|+|++|.|+. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2456788888888655321 12355566788899999999999884 34566778899999999999983 4
Q ss_pred cccccCCCCCCEEEccCCCCCc
Q 001143 203 PTEICYLKALISLKVANNKLVE 224 (1141)
Q Consensus 203 P~~l~~l~~L~~L~Ls~N~L~~ 224 (1141)
+..+...++|+.|+|++|.|+.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHhCCCCCEEeccCCCCCH
Confidence 5566778999999999999984
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-09 Score=127.17 Aligned_cols=244 Identities=12% Similarity=0.101 Sum_probs=118.6
Q ss_pred cCCCCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-------------
Q 001143 12 KSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN------------- 78 (1141)
Q Consensus 12 ~~~~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N------------- 78 (1141)
+.+.. +++.+.+. ++|+.|...+|.++.+|+.++|..+ ++.+....| .++.+|+.+.+..+
T Consensus 67 F~~c~-~L~~i~lp-~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF---~~c~~L~~i~~p~~l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 67 FQGCR-KVTEIKIP-STVREIGEFAFENCSKLEIINIPDS-VKMIGRCTF---SGCYALKSILLPLMLKSIGVEAFKGCD 140 (394)
T ss_dssp TTTCT-TEEEEECC-TTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTT---TTCTTCCCCCCCTTCCEECTTTTTTCC
T ss_pred hhCCC-CceEEEeC-CCccCcchhHhhCCCCCcEEEeCCC-ceEccchhh---cccccchhhcccCceeeecceeeeccc
Confidence 44433 45566554 4577777777777777777777644 333322222 22344444333222
Q ss_pred --------CCCccC-ccccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001143 79 --------VLNLIP-KSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1141)
Q Consensus 79 --------~Lt~iP-~~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ 148 (1141)
.++.+. ..|.++++|+.+.|.++ +..|+. .|.++++|+.+.+..|-...-...|.++..|+.+.+..+.
T Consensus 141 ~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~~~~I~~~~F~~~~~L~~i~~~~~~ 219 (394)
T 4fs7_A 141 FKEITIPEGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRNLKIIRDYCFAECILLENMEFPNSL 219 (394)
T ss_dssp CSEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCTTCCBCCCCTTC
T ss_pred ccccccCccccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCCceEeCchhhccccccceeecCCCc
Confidence 111222 23556667777777644 444543 4667777777777655322223456666666665554321
Q ss_pred CC------------------CCcccchhhhcCCCCCcEEEccCCCCCccCcccc---------------------CCCCC
Q 001143 149 PR------------------PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG---------------------CLSNL 189 (1141)
Q Consensus 149 ln------------------~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~---------------------~l~~L 189 (1141)
.. .....-...|.++..|+.+.+..+...--...+. .+.+|
T Consensus 220 ~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L 299 (394)
T 4fs7_A 220 YYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSL 299 (394)
T ss_dssp CEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTTTTCTTC
T ss_pred eEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeeccccccccccc
Confidence 10 0000011234556666666665553321122233 34444
Q ss_pred CEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEcc
Q 001143 190 EQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265 (1141)
Q Consensus 190 ~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls 265 (1141)
+.+.+..| ++.|+ .+|..+++|+.++|.++ ++.|+ .+|.++.+|+.++|..| ++.+....|.++.+|+.++|.
T Consensus 300 ~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 300 TEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp CEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred cccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 44444332 44443 23444555555555422 44443 23344555555555444 454544455555555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.06 E-value=1.9e-10 Score=131.31 Aligned_cols=104 Identities=21% Similarity=0.179 Sum_probs=89.5
Q ss_pred CEEEccCC-ccccccccccCCCCCCEEEccC-CCCCcCC-cCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccC
Q 001143 190 EQLDLSFN-KMKYLPTEICYLKALISLKVAN-NKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1141)
Q Consensus 190 ~~L~Ls~N-~L~~iP~~l~~l~~L~~L~Ls~-N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~ 266 (1141)
..+++++| +|+.||. |..+++|+.|+|++ |+|+.+| ..|.+|++|+.|+|++|+|++++|..|..|++|+.|+|++
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 45789998 9999999 99999999999996 9999887 5688999999999999999999999999999999999999
Q ss_pred CcCCCCCCCchhhhhcccCCCCCCCCCCccc
Q 001143 267 NKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297 (1141)
Q Consensus 267 N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~ 297 (1141)
|+|++ +|......+.+..+.+.+|.+.|
T Consensus 90 N~l~~---~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALES---LSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SCCSC---CCSTTTCSCCCCEEECCSSCCCC
T ss_pred Cccce---eCHHHcccCCceEEEeeCCCccC
Confidence 99997 77655544446666666666554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=3.9e-10 Score=123.34 Aligned_cols=140 Identities=14% Similarity=0.112 Sum_probs=106.5
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~ 883 (1141)
+..|++...++.|+.+.||++...+..+++|+....... . ... +.+|+.+++.+. |..+.++++++...+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~-~---~~~----~~~E~~~l~~l~~~~~vP~v~~~~~~~~- 83 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG-T---TYD----VEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT-S---TTC----HHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC-C---HHH----HHHHHHHHHHHhcCCCCCeEEEEEecCC-
Confidence 456889999999999999999887788889886432111 1 112 378999999885 778889998877543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----------------- 946 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs----------------- 946 (1141)
..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 84 -------------~~~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 84 -------------WSNLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred -------------ceEEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 3499999999999876521 112234778899999999998
Q ss_pred ------------------------------------------CCccccCCCCCCeeeecccccCCCCCeEEEeeccccc
Q 001143 947 ------------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 947 ------------------------------------------~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
..++|||++|.||+++.+ ..+.|+||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~lIDwe~a~ 212 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-------KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-------cEEEEEEchhcc
Confidence 458999999999999764 456799999763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.01 E-value=1e-08 Score=119.47 Aligned_cols=247 Identities=8% Similarity=0.076 Sum_probs=154.3
Q ss_pred ccCCCCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCC---CCCCCcccccCCCCCCCccEEEeecCCCCccCc-c
Q 001143 11 QKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT---VDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-S 86 (1141)
Q Consensus 11 ~~~~~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~---Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~ 86 (1141)
++.+....++.+.+- +.++.|...+|.++.+|+.+.++.|. ++.+-... |.++.+|+.+.+..+ ++.|+. .
T Consensus 58 aF~~~~~~L~sI~iP-~svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~a---F~~c~~L~~i~~~~~-~~~I~~~a 132 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIP-DTVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQA---FMFCSELTDIPILDS-VTEIDSEA 132 (394)
T ss_dssp TTTTCCSCCCEEEEC-TTCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTT---TTTCTTCCBCGGGTT-CSEECTTT
T ss_pred hccCCCCcCEEEEEC-CCeeEEhHHHhhCCccCceEeecCCCCCeeeEechhh---chhcccceeeccCCc-cceehhhh
Confidence 344432246666554 45999999999999999999998874 44333333 344466776666554 666654 4
Q ss_pred ccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCCCc-----------------------ccccCCCCCCEE
Q 001143 87 VGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNG-----------------------FALNKLKGLKEL 142 (1141)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~-----------------------~~~~~L~~L~~L 142 (1141)
|..+.+|+.+.|.. .++.|+. .|.++.+|+.+.+..+- ..++ ..|..+.+|...
T Consensus 133 F~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~~-~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 133 FHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDSV-TAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTI 210 (394)
T ss_dssp TTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEE
T ss_pred hhhhcccccccccc-eeeeecccceeccccccccccccee-eEeccccccccceeEEEECCcccccccchhhhcccccee
Confidence 66667777777753 3444433 35556666666654332 2222 233333444333
Q ss_pred ECCCCCCC-------------------------CCcccch--------hhhcCCCCCcEEEccCCCCCcc-CccccCCCC
Q 001143 143 ELSKVPPR-------------------------PSVLTLL--------SEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSN 188 (1141)
Q Consensus 143 ~Ls~N~ln-------------------------~~~~~lp--------~~l~~L~~L~~L~Ls~N~L~~i-P~~l~~l~~ 188 (1141)
....+... ...-.+| .+|.++..|+.+.+.++.. .| ...|.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~ 289 (394)
T 4gt6_A 211 TSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPA 289 (394)
T ss_dssp EECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTT
T ss_pred cccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccc-eecCcccccccc
Confidence 32221100 0000112 3466777788887765543 34 335677888
Q ss_pred CCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccC
Q 001143 189 LEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1141)
Q Consensus 189 L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~ 266 (1141)
|+.+.+. +.++.|+ ..|..+.+|+.+.|..| ++.|. .+|.++.+|+.+.|..+ ++.+....|.++.+|+.+++.+
T Consensus 290 L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 290 LQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred cccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 8888885 5677776 45777888999988754 77775 45666888999988654 7888888888899999998888
Q ss_pred Cc
Q 001143 267 NK 268 (1141)
Q Consensus 267 N~ 268 (1141)
|.
T Consensus 367 ~~ 368 (394)
T 4gt6_A 367 SR 368 (394)
T ss_dssp CH
T ss_pred ce
Confidence 74
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.1e-08 Score=118.97 Aligned_cols=137 Identities=10% Similarity=0.016 Sum_probs=93.4
Q ss_pred CccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCC----
Q 001143 28 KINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE---- 102 (1141)
Q Consensus 28 ~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~---- 102 (1141)
+++.|...+|.++.+|+.++|.. .++.+-... |.++++|+.++|.+| ++.|+. .|.++.+|+.+.+..+-
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~a---F~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~ 132 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFA---FENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIG 132 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTT---TTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEEC
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhH---hhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeec
Confidence 58999999999999999999975 477655544 456699999999876 888875 58888888887776441
Q ss_pred -----------------CCcC-chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCC
Q 001143 103 -----------------INLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLK 164 (1141)
Q Consensus 103 -----------------L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~ 164 (1141)
+..+ ...|.++++|+.+.+..+....-...|.++.+|+.+.+..+ ....-...|.++.
T Consensus 133 ~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~I~~~~F~~c~~L~~i~l~~~----~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 133 VEAFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMETLHNGLFSGCGKLKSIKLPRN----LKIIRDYCFAECI 208 (394)
T ss_dssp TTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCBCCCCTT----CCEECTTTTTTCT
T ss_pred ceeeecccccccccCccccccchhhhcccCCCcEEecCCccceeccccccCCCCceEEEcCCC----ceEeCchhhcccc
Confidence 1112 12366777888888875554444456777888888877652 2212223455666
Q ss_pred CCcEEEccC
Q 001143 165 CLTKLSVCH 173 (1141)
Q Consensus 165 ~L~~L~Ls~ 173 (1141)
.|+.+.+..
T Consensus 209 ~L~~i~~~~ 217 (394)
T 4fs7_A 209 LLENMEFPN 217 (394)
T ss_dssp TCCBCCCCT
T ss_pred ccceeecCC
Confidence 666555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.4e-08 Score=113.08 Aligned_cols=239 Identities=13% Similarity=0.058 Sum_probs=141.0
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
+++++.+. ..|+.|...+|.++.+|+.++|..+ ++.+-...|. ++ +|+.+.+..| ++.|+.......+|+.+.
T Consensus 47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~---~c-~l~~i~~~~~-l~~I~~~aF~~~~L~~i~ 119 (379)
T 4h09_A 47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFA---DT-KLQSYTGMER-VKKFGDYVFQGTDLDDFE 119 (379)
T ss_dssp GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTT---TC-CCCEEEECTT-CCEECTTTTTTCCCSEEE
T ss_pred CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhc---CC-CCceEECCce-eeEeccceeccCCccccc
Confidence 45555543 4689999999999999999999754 7655555554 33 6888888765 888876543445899999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCC---------------------------
Q 001143 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPR--------------------------- 150 (1141)
Q Consensus 98 Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln--------------------------- 150 (1141)
|.++ ++.+......-.+|+.+.+..+-...-...|..+.+|+.+.+..+...
T Consensus 120 lp~~-~~~i~~~~F~~~~l~~~~~~~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (379)
T 4h09_A 120 FPGA-TTEIGNYIFYNSSVKRIVIPKSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE 198 (379)
T ss_dssp CCTT-CCEECTTTTTTCCCCEEEECTTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred CCCc-cccccccccccceeeeeeccceeeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence 8764 444444322233555555543332222234555555555544432210
Q ss_pred -----CCcccchhhhcCCCCCcEEEccCCCCCccC-ccccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCC
Q 001143 151 -----PSVLTLLSEIAGLKCLTKLSVCHFSIRYLP-PEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLV 223 (1141)
Q Consensus 151 -----~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~ 223 (1141)
.........+..+..|+.+.+..+ +..++ ..+..+.+|+.+.+..+ ++.|. ..+..+.+|+.+.+.. .++
T Consensus 199 ~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~ 275 (379)
T 4h09_A 199 FTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVK 275 (379)
T ss_dssp EECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCS
T ss_pred cccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cce
Confidence 001111123444555666665443 33343 24566667777777654 55553 3455666777777753 366
Q ss_pred cCCc-CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCC
Q 001143 224 ELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 224 ~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
.|+. .+.++.+|+.+.|.+|.++.+....|.++.+|+.+.|..|
T Consensus 276 ~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 276 TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 6643 3445677777777777777666667777777777777544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.4e-09 Score=125.75 Aligned_cols=153 Identities=17% Similarity=0.179 Sum_probs=81.0
Q ss_pred hhhcCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhc--CCCCCcEEEccC--CC------C
Q 001143 108 SEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCH--FS------I 176 (1141)
Q Consensus 108 ~~~~~L~~L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~--~L~~L~~L~Ls~--N~------L 176 (1141)
..+..+++|+.|+|++|. +.. +. + .+++|+.|+|..+.++ ......++ .+++|+.|+|+. |. +
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l~l-~~-~-~~~~L~~L~L~~~~l~---~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~ 239 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNLSI-GK-K-PRPNLKSLEIISGGLP---DSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM 239 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTCBC-CS-C-BCTTCSEEEEECSBCC---HHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG
T ss_pred HHHhcCCCCcEEEEeCCCCcee-cc-c-cCCCCcEEEEecCCCC---hHHHHHHHHccCCCCcEEEEeccccccccchhH
Confidence 334555566666665552 221 11 2 2556666666553321 12122232 466666666542 11 1
Q ss_pred CccCccc--cCCCCCCEEEccCCccc-cccccc---cCCCCCCEEEccCCCCCc-----CCcCccCCCCCCEEeCCCCCC
Q 001143 177 RYLPPEI--GCLSNLEQLDLSFNKMK-YLPTEI---CYLKALISLKVANNKLVE-----LPSGLYLLQRLENLDLSNNRL 245 (1141)
Q Consensus 177 ~~iP~~l--~~l~~L~~L~Ls~N~L~-~iP~~l---~~l~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L 245 (1141)
..+...+ ..+++|+.|+|.+|.+. ..+..+ ..+++|+.|+|+.|.|+. |+..+.++++|+.|+|++|.|
T Consensus 240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 1121112 24677888888777776 222222 246778888888877763 455555677778888877777
Q ss_pred CCCCcccccC-CCCCCEEEccCCc
Q 001143 246 TSLGSLDLCL-MHNLQNLNLQYNK 268 (1141)
Q Consensus 246 t~~~p~~l~~-L~~L~~L~Ls~N~ 268 (1141)
+...-..+.. + ...+++++|+
T Consensus 320 ~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 320 SDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp CHHHHHHHHHHC--CSEEECCSBC
T ss_pred CHHHHHHHHHHc--CCEEEecCCc
Confidence 6433222332 2 3456777665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.7e-07 Score=109.07 Aligned_cols=232 Identities=10% Similarity=0.120 Sum_probs=150.4
Q ss_pred CccccCCCCCCCCC-CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC---CCccCc-cccCCcCCcEEEccCCC
Q 001143 28 KINNEKNGSVNDDD-DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV---LNLIPK-SVGRYEKLRNLKFFGNE 102 (1141)
Q Consensus 28 ~i~~i~~~~f~~l~-~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~---Lt~iP~-~l~~L~~L~~L~Ls~N~ 102 (1141)
.++.|...+|.+.. .|+.+.|-.+ ++.+-...| .++++|+.+.+..|. ++.|+. +|.++.+|+.+.+.++
T Consensus 50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF---~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~- 124 (394)
T 4gt6_A 50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAF---YNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS- 124 (394)
T ss_dssp EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTT---TTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-
T ss_pred eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHh---hCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-
Confidence 48899999999985 6999999764 766555544 566999999998874 778865 6888999999988765
Q ss_pred CCcCch-hhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCC---------CCC-cccch--------hhhcCC
Q 001143 103 INLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP---------RPS-VLTLL--------SEIAGL 163 (1141)
Q Consensus 103 L~~lP~-~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~l---------n~~-~~~lp--------~~l~~L 163 (1141)
++.|+. .|.++.+|+.+.+..+....-...|..+.+|+.+.+..+-- +.+ .-.+| ..|..+
T Consensus 125 ~~~I~~~aF~~c~~L~~i~lp~~~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c 204 (394)
T 4gt6_A 125 VTEIDSEAFHHCEELDTVTIPEGVTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSEC 204 (394)
T ss_dssp CSEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTC
T ss_pred cceehhhhhhhhcccccccccceeeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhc
Confidence 777755 48899999999997655444446788899999998865310 000 00111 123344
Q ss_pred CCCcEEEccCCCCC-----------------------------ccCc--------cccCCCCCCEEEccCCccccc-ccc
Q 001143 164 KCLTKLSVCHFSIR-----------------------------YLPP--------EIGCLSNLEQLDLSFNKMKYL-PTE 205 (1141)
Q Consensus 164 ~~L~~L~Ls~N~L~-----------------------------~iP~--------~l~~l~~L~~L~Ls~N~L~~i-P~~ 205 (1141)
..|..+....+... .+|. .|..+.+|+.+.+..+.. .| ...
T Consensus 205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~a 283 (394)
T 4gt6_A 205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVV-SIGTGA 283 (394)
T ss_dssp TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCC-EECTTT
T ss_pred cccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccc-eecCcc
Confidence 44443332222111 1121 244555666666654433 33 244
Q ss_pred ccCCCCCCEEEccCCCCCcCCcC-ccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCC
Q 001143 206 ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 206 l~~l~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
|.++++|+.+.+. +.++.|+.. |.++.+|+.++|..| ++.+....|.++.+|+.+.|..|
T Consensus 284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 6667777777774 556666543 445777777777654 66666667777777777777544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.75 E-value=8.9e-09 Score=111.49 Aligned_cols=134 Identities=14% Similarity=0.114 Sum_probs=91.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCC--ccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IVkllg~~~~~ 881 (1141)
+..|.+....+.|..+.||++... +..+++|+.... .... +.+|+.+++.+.+.+ +.+++++....
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~----~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNE----LQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSC----HHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchh----hhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 445666555556777999999764 456888885321 1112 368999998885434 56688876643
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH------------- 948 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g------------- 948 (1141)
+ ..++||||++|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 88 ~--------------~~~~v~e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~ 140 (264)
T 1nd4_A 88 G--------------RDWLLLGEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHR 140 (264)
T ss_dssp S--------------CEEEEEECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHH
T ss_pred C--------------CCEEEEEecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 3 249999999998873 11 111 1245666777777777643
Q ss_pred ---------------------------------------------ccccCCCCCCeeeecccccCCCCCeEEEeeccccc
Q 001143 949 ---------------------------------------------IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 949 ---------------------------------------------IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
++|||++|.||+++.+ ..+.|+|||.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~liD~~~a~ 213 (264)
T 1nd4_A 141 IERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-------RFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-------cEEEEEcchhcc
Confidence 9999999999999765 456799999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.3e-08 Score=116.76 Aligned_cols=148 Identities=15% Similarity=0.179 Sum_probs=103.9
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkllg~~~~~~~~~~ 886 (1141)
.-.+.|+.|.++.||++...+..+++|+..... ........ .+.+|+.+++.+. +..+++++.++.+....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~-~~~~~~~~----~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~-- 113 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPK-SKLLPSAH----AIEREYRVMDALAGTDVPVAKMYALCEDESVI-- 113 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT--
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCC-CCCCCcHH----HHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc--
Confidence 346789999999999998877777777542001 00011112 2378999999986 55688888887654211
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-------------------- 946 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-------------------- 946 (1141)
...++||||++|..+.+.. ...++..+...++.+++.+|..||+
T Consensus 114 ---------g~~~~vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3dxp_A 114 ---------GRAFYIMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQR 177 (359)
T ss_dssp ---------SSCEEEEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHH
T ss_pred ---------CCeEEEEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHH
Confidence 1348999999987764311 1247788889999999999999997
Q ss_pred --------------------------------------CCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 947 --------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 947 --------------------------------------~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
.+++|||+++.|||++.+.. ..+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-----~v~~viDwe~a~~ 248 (359)
T 3dxp_A 178 QIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-----RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-----CEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-----cEEEEECcccccc
Confidence 36899999999999987521 2468999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.62 E-value=2.2e-08 Score=112.31 Aligned_cols=197 Identities=18% Similarity=0.211 Sum_probs=118.8
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCC--ccceeeeEecCCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSC--IVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpN--IVkllg~~~~~~~~~~~~ 888 (1141)
+.++.|.+..||++. ..+++|+... ..... .+.+|+++++.+. +.. +.+++.......
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~------~~~~~----~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~------ 86 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH------SRGST----NLFNEVNILKRIHNKLPLPIPEVVFTGMPSE------ 86 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS------HHHHH----HHHHHHHHHHHHTTSSSSCCCCEEEECCCCS------
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC------cchHH----HHHHHHHHHHHHHhcCCCCCCceEeecCCCC------
Confidence 458999999999864 5677887431 12222 3478999998884 433 344444332211
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 946 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs---------------------- 946 (1141)
.....|+|||+++|.+|...... .++..+...++.|++..|..||+
T Consensus 87 -----~~~~~~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 87 -----TYQMSFAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp -----SCSCSCEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred -----CCCcceEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 11233899999999888654332 37778888888888888888886
Q ss_pred ------------------------------------CCccccCCCCCCeeeecccccCCCCCeEEEeecccccccccccc
Q 001143 947 ------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990 (1141)
Q Consensus 947 ------------------------------------~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~ 990 (1141)
..++|+|++|.||+++.+. ...+.|+||+.+..-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-----~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-----NTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-----TEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-----CCEEEEEeCCCCccCChHHH
Confidence 1379999999999998731 15688999998864322110
Q ss_pred ccccccC-CCCCC---CCccCCCcccc-hhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001143 991 TCCIAHR-GIPAP---DVCVGTPRWMA-PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1050 (1141)
Q Consensus 991 ~~~~~~~-~~~~~---~~~~GT~~Y~A-PE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~Pf~ 1050 (1141)
....... ....+ ........+.. |+.... .....+.|++|.++|.+.+|..+|.
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r------~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK------YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH------HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH------HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0000000 00000 00000001112 333221 1134689999999999999987763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.62 E-value=2.3e-08 Score=115.48 Aligned_cols=81 Identities=20% Similarity=0.228 Sum_probs=57.4
Q ss_pred CCCCCcEEEccCCCCCc-cCccc---cCCCCCCEEEccCCcccc-----ccccccCCCCCCEEEccCCCCCc-CCcCccC
Q 001143 162 GLKCLTKLSVCHFSIRY-LPPEI---GCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVANNKLVE-LPSGLYL 231 (1141)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~-iP~~l---~~l~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~~-IP~~l~~ 231 (1141)
.+++|+.|+|.+|.++. .+..+ ..+++|+.|+|+.|.|+. ++..+..+++|+.|+|++|.|+. .-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 46788999998888872 22222 357889999999999883 45556678899999999998872 1122222
Q ss_pred -CCCCCEEeCCCCC
Q 001143 232 -LQRLENLDLSNNR 244 (1141)
Q Consensus 232 -L~~L~~L~Ls~N~ 244 (1141)
+ ...++++.|+
T Consensus 330 al--g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL--PMKIDVSDSQ 341 (362)
T ss_dssp HC--CSEEECCSBC
T ss_pred Hc--CCEEEecCCc
Confidence 2 3668999887
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.48 E-value=3.1e-06 Score=97.47 Aligned_cols=241 Identities=11% Similarity=0.093 Sum_probs=161.9
Q ss_pred cccCCCCCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccC
Q 001143 10 TQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGR 89 (1141)
Q Consensus 10 ~~~~~~~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~ 89 (1141)
.++.+.. +|+.+.+. ++++.|...+|.+. +|+.+.+..+ ++.+....|. + .+|+.+.|..+ ++.+......
T Consensus 63 ~aF~~C~-~L~~I~lp-~~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~---~-~~L~~i~lp~~-~~~i~~~~F~ 133 (379)
T 4h09_A 63 ANFNSCY-NMTKVTVA-STVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQ---G-TDLDDFEFPGA-TTEIGNYIFY 133 (379)
T ss_dssp TTTTTCT-TCCEEEEC-TTCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTT---T-CCCSEEECCTT-CCEECTTTTT
T ss_pred HHhhCCC-CCCEEEeC-CcceEechhhhcCC-CCceEECCce-eeEeccceec---c-CCcccccCCCc-cccccccccc
Confidence 3445544 67777775 45889999999987 6777777644 5444333332 2 36888888665 5555443222
Q ss_pred CcCCcEEEccCCCCCcC-chhhcCCCCCCEEEccC------------------------------------CCCCCCccc
Q 001143 90 YEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKI------------------------------------SSPGVNGFA 132 (1141)
Q Consensus 90 L~~L~~L~Ls~N~L~~l-P~~~~~L~~L~~L~Ls~------------------------------------N~l~~~~~~ 132 (1141)
-.+|+.+.+..+ ++.+ ...|.++.+|+.+.+.. +........
T Consensus 134 ~~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 212 (379)
T 4h09_A 134 NSSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYG 212 (379)
T ss_dssp TCCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTT
T ss_pred cceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecc
Confidence 234555554432 3333 22344455555444332 222222335
Q ss_pred ccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCcccccc-ccccCCC
Q 001143 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLK 210 (1141)
Q Consensus 133 ~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~ 210 (1141)
+....+|+.+.+.. +....-...|.++..|+.+.+..+ ++.|.. .+.++.+|+.+.+.. .++.++ ..|..++
T Consensus 213 f~~~~~l~~i~~~~----~~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~ 286 (379)
T 4h09_A 213 FSYGKNLKKITITS----GVTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCS 286 (379)
T ss_dssp TTTCSSCSEEECCT----TCCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCT
T ss_pred cccccccceeeecc----ceeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceecccccccccc
Confidence 66677888888865 233333456788999999999776 777754 678889999999965 477776 4578899
Q ss_pred CCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCC
Q 001143 211 ALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 211 ~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
+|+.+.+.+|.++.|+ ..|.++.+|+.+.|..| ++.+....|.++.+|+.+.+..|
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 9999999999999996 45667999999999765 88888888999999999988655
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-07 Score=98.96 Aligned_cols=115 Identities=14% Similarity=0.069 Sum_probs=81.7
Q ss_pred chhhhcCCCCCcEEEccCC-CCCc-----cCccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCCc
Q 001143 156 LLSEIAGLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE 224 (1141)
Q Consensus 156 lp~~l~~L~~L~~L~Ls~N-~L~~-----iP~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~~ 224 (1141)
+...+...+.|+.|+|++| .|+. +...+...++|++|+|++|.|+ .|...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445666777888888888 7762 3344566678888888888886 244556666788888888888872
Q ss_pred -----CCcCccCCCCCCEEeC--CCCCCCCCCc----ccccCCCCCCEEEccCCcCC
Q 001143 225 -----LPSGLYLLQRLENLDL--SNNRLTSLGS----LDLCLMHNLQNLNLQYNKLL 270 (1141)
Q Consensus 225 -----IP~~l~~L~~L~~L~L--s~N~Lt~~~p----~~l~~L~~L~~L~Ls~N~L~ 270 (1141)
|...+...++|+.|+| ++|.|+.... ..+...++|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4666777778888888 7788875432 23445578888888888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.32 E-value=9.2e-08 Score=105.60 Aligned_cols=78 Identities=24% Similarity=0.203 Sum_probs=39.1
Q ss_pred CCCCCCEEEccCCccccc---cccccCCCCCCEEEccCCCCCcCCcCccCCC--CCCEEeCCCCCCCCCCc-------cc
Q 001143 185 CLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQ--RLENLDLSNNRLTSLGS-------LD 252 (1141)
Q Consensus 185 ~l~~L~~L~Ls~N~L~~i---P~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~--~L~~L~Ls~N~Lt~~~p-------~~ 252 (1141)
++++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+.+ ..+..+. +|+.|+|++|.|++..| ..
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 455555555555555533 23444555555555555555544 2233333 55556666665554332 12
Q ss_pred ccCCCCCCEEE
Q 001143 253 LCLMHNLQNLN 263 (1141)
Q Consensus 253 l~~L~~L~~L~ 263 (1141)
+..+++|+.||
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 44555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.20 E-value=4.6e-07 Score=94.33 Aligned_cols=89 Identities=15% Similarity=0.114 Sum_probs=56.1
Q ss_pred hhhcCCCCCcEEEccCCCCCc-----cCccccCCCCCCEEEccCCcccc-----ccccccCCCCCCEEEc--cCCCCCc-
Q 001143 158 SEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKV--ANNKLVE- 224 (1141)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~L--s~N~L~~- 224 (1141)
..+...++|++|+|++|.|+. +...+...++|++|+|++|.|+. |...+...++|+.|+| ++|.|+.
T Consensus 59 ~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 59 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 345555666777777776652 23334445667777777777762 4556666677777777 6677762
Q ss_pred ----CCcCccCCCCCCEEeCCCCCCC
Q 001143 225 ----LPSGLYLLQRLENLDLSNNRLT 246 (1141)
Q Consensus 225 ----IP~~l~~L~~L~~L~Ls~N~Lt 246 (1141)
|...+...++|+.|+|++|.+.
T Consensus 139 g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 139 VEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3444555567777777777664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.18 E-value=2.7e-07 Score=101.93 Aligned_cols=97 Identities=22% Similarity=0.142 Sum_probs=68.2
Q ss_pred EECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccC---ccccCCCCCCEEEccCCccccccccccCCC--CCCEEE
Q 001143 142 LELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP---PEIGCLSNLEQLDLSFNKMKYLPTEICYLK--ALISLK 216 (1141)
Q Consensus 142 L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP---~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~--~L~~L~ 216 (1141)
++++.|..+.+...++-...++++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.+ ..+..++ +|+.|+
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~ 226 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELW 226 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEE
Confidence 455554333232223323356888999999999998653 4557889999999999999976 3444444 899999
Q ss_pred ccCCCCC-cCCc-------CccCCCCCCEEe
Q 001143 217 VANNKLV-ELPS-------GLYLLQRLENLD 239 (1141)
Q Consensus 217 Ls~N~L~-~IP~-------~l~~L~~L~~L~ 239 (1141)
|++|.|. .+|. .+..+++|+.||
T Consensus 227 L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 227 LDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp CTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred ccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 9999997 5652 255688888875
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=2.8e-06 Score=83.48 Aligned_cols=72 Identities=19% Similarity=0.166 Sum_probs=62.3
Q ss_pred CEEEccCCCCC--cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCC
Q 001143 213 ISLKVANNKLV--ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286 (1141)
Q Consensus 213 ~~L~Ls~N~L~--~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~ 286 (1141)
..++.+++.|+ .||..+. .+|+.|+|++|+|+.+++..|..+++|+.|+|++|+|.|.|.+-+...|.....
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~ 84 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRP 84 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSS
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCc
Confidence 47888999998 8887655 569999999999999999999999999999999999999999877777665543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=3.4e-05 Score=86.58 Aligned_cols=138 Identities=16% Similarity=0.141 Sum_probs=87.7
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCC---CccceeeeEecCCCCCCC
Q 001143 811 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS---CIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---NIVkllg~~~~~~~~~~~ 887 (1141)
.+.++.|....||+. +..+++|+.. ...... .+.+|+++|..+.+. .+.+++.+.....
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~------~~~~~~----~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----- 85 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK------SQQGAD----ELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----- 85 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES------SHHHHH----HHHHHHHHHHHHTTTCSSBCCCEEEEEECTT-----
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC------CchHHH----HHHHHHHHHHHHHhcCCCCCCCeEeecccCC-----
Confidence 356789999999988 5778888732 122222 347999999999642 3556666654211
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------------------- 947 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-------------------- 947 (1141)
...++||||++|.+|...... .++..+...++.++...|..||+.
T Consensus 86 --------g~~~~v~e~i~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 86 --------GNPFVGYRKVQGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp --------SCEEEEEECCCSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred --------CceEEEEeccCCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 124899999999887653211 234444445555555555555532
Q ss_pred ----------------------------------------CccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 948 ----------------------------------------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 948 ----------------------------------------gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
.++|+|++|.||+++.+. .....+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~---~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS---RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC---SSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC---CCCceEEEEehhhcCC
Confidence 459999999999998620 0013458999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=7.9e-05 Score=81.29 Aligned_cols=134 Identities=15% Similarity=0.124 Sum_probs=87.4
Q ss_pred ceEeeeecccCce-EEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001143 808 LSSCDEAGKSVSS-SLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1141)
Q Consensus 808 y~i~~~LG~GsfG-~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~ 883 (1141)
|+. +.+..|.+| .||+.... +..+.+|+... .....+ .+|...|+.+. +--+.++++++.+.+
T Consensus 27 ~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~----~~E~~~l~~l~~~vPVP~v~~~~~~~~- 93 (272)
T 4gkh_A 27 YRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDV----TDEMVRLNWLTAFMPLPTIKHFIRTPD- 93 (272)
T ss_dssp CEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHH----HHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred CeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHH----HHHHHHHHHhccCCCcCeEEEEEEECC-
Confidence 443 344556665 68987653 45678887542 122233 68999998884 444678888776543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------------- 947 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---------------- 947 (1141)
..++|||+++|.++.+..... ......+..+++..|..||+.
T Consensus 94 -------------~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~ 151 (272)
T 4gkh_A 94 -------------DAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLA 151 (272)
T ss_dssp -------------EEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHH
T ss_pred -------------eEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchh
Confidence 349999999998887765431 112233455555555555531
Q ss_pred ------------------------------------------CccccCCCCCCeeeecccccCCCCCeEEEeeccccc
Q 001143 948 ------------------------------------------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 948 ------------------------------------------gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
.++|||+.+.|||++.+ ..+-|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-------~~~~viDwe~a~ 222 (272)
T 4gkh_A 152 QAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-------KLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred hHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-------eEEEEEECcccc
Confidence 27899999999999865 456799999873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00016 Score=82.28 Aligned_cols=86 Identities=10% Similarity=-0.013 Sum_probs=51.9
Q ss_pred eEeeee-cccCceEEEEEEEC--------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C--CCccceee
Q 001143 809 SSCDEA-GKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYG 876 (1141)
Q Consensus 809 ~i~~~L-G~GsfG~Vy~a~~~--------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H--pNIVkllg 876 (1141)
...+.| +.|....+|+.... +..+++|+........ ..... .+.+|+.+++.+. + -.+.+++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~----~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTY----RLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCC----CHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchh----HHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 445778 89999999998764 5566777643211000 00011 2367888888884 3 35677887
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 910 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL 910 (1141)
+..+.... ...++||||++|..+
T Consensus 98 ~~~~~~~~-----------g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 98 IETTGDVL-----------GTPFFLMDYVEGVVP 120 (357)
T ss_dssp EECSSTTT-----------SSCEEEEECCCCBCC
T ss_pred EccCCCcc-----------CCceEEEEecCCCCh
Confidence 76543211 123899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0016 Score=72.94 Aligned_cols=30 Identities=20% Similarity=0.339 Sum_probs=26.2
Q ss_pred CCccccCCCCCCeeeecccccCCCCCeEEEeeccccc
Q 001143 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 947 ~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
.+++|||+++.||+++.+ +.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-------~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-------EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-------GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-------CcEEEEehhhcc
Confidence 579999999999999765 579999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00083 Score=77.80 Aligned_cols=82 Identities=12% Similarity=0.005 Sum_probs=45.4
Q ss_pred EeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C-CC-ccceeeeEecCCCC
Q 001143 810 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-SC-IVEMYGHKISSKWL 884 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-pN-IVkllg~~~~~~~~ 884 (1141)
-.+.||.|.++.||++.. .+..+++|.......... ........++..|.++++.+. + |. +.+++.+. ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~-~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVG-ESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT-
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccC-CCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCc-
Confidence 457899999999999954 456788886431110000 000001123367888888773 2 33 44555432 111
Q ss_pred CCCCCCCccccceEEEEEeeccCC
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGG 908 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~gg 908 (1141)
.++||||++|.
T Consensus 110 -------------~~lvmE~l~g~ 120 (397)
T 2olc_A 110 -------------AVTVMEDLSHL 120 (397)
T ss_dssp -------------TEEEECCCTTS
T ss_pred -------------cEEEEEeCCCc
Confidence 28999999863
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0011 Score=64.83 Aligned_cols=55 Identities=18% Similarity=0.234 Sum_probs=27.8
Q ss_pred EEEccCCCCC-CCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCC
Q 001143 45 VIDVSGKTVD-FPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEIN 104 (1141)
Q Consensus 45 ~LdLs~N~Ls-~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~ 104 (1141)
.+|.++++|+ ..+|..+. .+|++|+|++|+|+.||. .|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp-----~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP-----VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC-----TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC-----cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5556666555 12222111 345555666665555554 2455555555555555553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.001 Score=69.75 Aligned_cols=87 Identities=13% Similarity=0.069 Sum_probs=38.9
Q ss_pred CCCCCCCCEEEccCC-CCCCCCc-ccccCCCCCCCccEEEeecCCCC-----ccCccccCCcCCcEEEccCCCCC-----
Q 001143 37 VNDDDDDSVIDVSGK-TVDFPLI-ESYGNRGGDNSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEIN----- 104 (1141)
Q Consensus 37 f~~l~~L~~LdLs~N-~Ls~~~p-~~~~~l~~L~~L~~L~Ls~N~Lt-----~iP~~l~~L~~L~~L~Ls~N~L~----- 104 (1141)
+.+.+.|+.|+|++| +|...-. .....+..-+.|+.|+|++|.|+ .|-..+..-+.|+.|+|++|+|+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344556666666654 5532100 00111122245666666666655 12223333344666666666655
Q ss_pred cCchhhcCCCCCCEEEccC
Q 001143 105 LFPSEVGNLLGLECLQIKI 123 (1141)
Q Consensus 105 ~lP~~~~~L~~L~~L~Ls~ 123 (1141)
.|-+.+..-+.|+.|+|++
T Consensus 117 ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HHHHHTTTTCCCSEEECCC
T ss_pred HHHHHHhhCCceeEEECCC
Confidence 1223333334455555543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0019 Score=66.60 Aligned_cols=82 Identities=11% Similarity=0.066 Sum_probs=45.5
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-CCcc-CccccCC----cCCcEEEccCCC-CCcC-chhhcC
Q 001143 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-LNLI-PKSVGRY----EKLRNLKFFGNE-INLF-PSEVGN 112 (1141)
Q Consensus 41 ~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~-Lt~i-P~~l~~L----~~L~~L~Ls~N~-L~~l-P~~~~~ 112 (1141)
..|+.||||++.|+. ..+..+.++++|+.|+|+++. ||.- =..+..+ ++|+.|+|+++. ||.- =..+.+
T Consensus 61 ~~L~~LDLs~~~Itd---~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~ 137 (176)
T 3e4g_A 61 YKIQAIDATDSCIMS---IGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHH 137 (176)
T ss_dssp CCEEEEEEESCCCCG---GGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGG
T ss_pred ceEeEEeCcCCCccH---HHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhc
Confidence 467777777776553 233344556777777777763 5521 1234443 257777777753 6521 123455
Q ss_pred CCCCCEEEccCCC
Q 001143 113 LLGLECLQIKISS 125 (1141)
Q Consensus 113 L~~L~~L~Ls~N~ 125 (1141)
+++|+.|+|++..
T Consensus 138 ~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 138 FRNLKYLFLSDLP 150 (176)
T ss_dssp CTTCCEEEEESCT
T ss_pred CCCCCEEECCCCC
Confidence 6666666665544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0074 Score=66.98 Aligned_cols=71 Identities=13% Similarity=0.117 Sum_probs=42.7
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCCCCCCCC
Q 001143 811 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADG 889 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~~~~~~g 889 (1141)
.+.|+.|....+|++ ..+.+|+..... ....+. .+|+.+++.+. +.-..+++++..+.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~-----~~~~~r----~~E~~~l~~l~~~g~~P~~~~~~~~~-------- 81 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT-----EEYINR----ANEAVAAREAAKAGVSPEVLHVDPAT-------- 81 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC---------CCCH----HHHHHHHHHHHHTTSSCCEEEECTTT--------
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc-----cceeCH----HHHHHHHHHHHHcCCCCceEEEECCC--------
Confidence 688999999999998 677888764211 111111 46777777764 22224555543211
Q ss_pred CCccccceEEEEEeec-cCCCH
Q 001143 890 NPEHHLLQSAIFMEYV-KGGSV 910 (1141)
Q Consensus 890 ~~~~~~~~~~LVmEy~-~ggSL 910 (1141)
.++||||+ +|.+|
T Consensus 82 --------~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 82 --------GVMVTRYIAGAQTM 95 (301)
T ss_dssp --------CCEEEECCTTCEEC
T ss_pred --------CEEEEeecCCCccC
Confidence 17899999 65443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0015 Score=68.47 Aligned_cols=110 Identities=16% Similarity=0.164 Sum_probs=73.8
Q ss_pred hhcCCCCCcEEEccCC-CCCc-----cCccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCC----
Q 001143 159 EIAGLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV---- 223 (1141)
Q Consensus 159 ~l~~L~~L~~L~Ls~N-~L~~-----iP~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~---- 223 (1141)
.+.+-+.|+.|+|++| +|.. |-..+..-+.|+.|+|++|+|. .|-..+..-+.|+.|+|++|.|+
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455567888888875 7662 3334555578888888888887 34455666678899999999887
Q ss_pred -cCCcCccCCCCCCEEeCCCCCCCCCC-------cccccCCCCCCEEEccCCc
Q 001143 224 -ELPSGLYLLQRLENLDLSNNRLTSLG-------SLDLCLMHNLQNLNLQYNK 268 (1141)
Q Consensus 224 -~IP~~l~~L~~L~~L~Ls~N~Lt~~~-------p~~l~~L~~L~~L~Ls~N~ 268 (1141)
.|-..+..-+.|+.|+|++|....+. ...+..-+.|..|+|+.|.
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 33445555566899999876432222 2234455788888887664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0068 Score=70.77 Aligned_cols=32 Identities=9% Similarity=0.351 Sum_probs=27.1
Q ss_pred HHCCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 945 Hs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
+...++|||++|.|||++.+ + ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-------~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-------S-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-------C-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCC-------C-CEEEeCccccc
Confidence 35679999999999999865 3 99999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.17 E-value=0.017 Score=64.41 Aligned_cols=150 Identities=15% Similarity=0.131 Sum_probs=77.3
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C-CCccceeeeEecCCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-SCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-pNIVkllg~~~~~~~~~~ 886 (1141)
.-.+.|+.|....+|+....+..+++|+.... .....+ ..|+.++..+. + -.+.+++... +...+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~------~~~~~l----~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~-- 91 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKR------VEKNDL----PFFLGLMQHLAAKGLSCPLPLPRK-DGELL-- 91 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC---------CCHH----HHHHHHHHHHHHTTCCCCCBCCBT-TCCSC--
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCC------CCHHHH----HHHHHHHHHHHHCCCCCCcccCCC-CCCEE--
Confidence 44577888999999999887667888876421 011122 46777777664 2 1133333211 00000
Q ss_pred CCCCCccccceEEEEEeeccCCCHH-----------HH---HHHhhhc-CCC---CCC---HHHHHH------------H
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSVK-----------NY---IEKLSET-GEK---HVS---VKLALF------------I 933 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL~-----------~~---I~~~~~~-~~~---~Ls---~~~i~~------------I 933 (1141)
.......++||+|++|..+. .. ++..... ... ... +..... +
T Consensus 92 -----~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 92 -----GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp -----EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred -----EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 00012458999999975421 11 2221100 000 011 111000 0
Q ss_pred HHHHHHHHHHHHH-------CCccccCCCCCCeeeecccccCCCCCeEEEeeccccc
Q 001143 934 AQDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 934 a~QIa~gL~yLHs-------~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
...+...+++++. .+++|+|+.+.|||++.+ ..+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~-------~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-------ELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCC-------ceEEEecchhcc
Confidence 1123445566653 369999999999999865 345799999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.045 Score=61.52 Aligned_cols=76 Identities=12% Similarity=0.040 Sum_probs=55.2
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC---CCCccceeeeEecCCCCCC
Q 001143 810 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKWLPS 886 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkllg~~~~~~~~~~ 886 (1141)
-.+.|+.|.+..+|+....+..+.+|+.... .... +..|++.|+.|. ...+++++++....+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-------~~~~----~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g---- 104 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-------YRSM----FRAEADQLALLAKTNSINVPLVYGIGNSQG---- 104 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-------GHHH----HHHHHHHHHHHHHTTSSBCCCEEEEEECSS----
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-------cHHH----HHHHHHHHHHHHhhCCCCcceEEEEeecCC----
Confidence 4577899999999999877778888875421 1222 378988888874 356788888765432
Q ss_pred CCCCCccccceEEEEEeeccCCCH
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGSV 910 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggSL 910 (1141)
..++||||++|..+
T Consensus 105 ----------~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 ----------HSFLLLEALNKSKN 118 (312)
T ss_dssp ----------EEEEEEECCCCCCC
T ss_pred ----------ceEEEEEeccCCCC
Confidence 35999999998753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0024 Score=65.80 Aligned_cols=33 Identities=12% Similarity=0.105 Sum_probs=15.4
Q ss_pred CCcEEEccCCCCCcc-CccccCCCCCCEEEccCC
Q 001143 165 CLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFN 197 (1141)
Q Consensus 165 ~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N 197 (1141)
.|+.|+++++.|+.. -..+..+++|+.|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 355555555554421 122344555555555554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.02 Score=64.25 Aligned_cols=35 Identities=34% Similarity=0.468 Sum_probs=26.5
Q ss_pred CCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 947 ~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
..++|||+.+.|||++.+. .+...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~---~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPER---EGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTS---CGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCc---CCCCCeEEEeCCCcCc
Confidence 4799999999999997631 0014689999998854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.057 Score=63.98 Aligned_cols=73 Identities=18% Similarity=0.130 Sum_probs=45.7
Q ss_pred EeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCc-cceeeeEecCCCCCC
Q 001143 810 SCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPS 886 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~~~--~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkllg~~~~~~~~~~ 886 (1141)
-.+.|+.|-...+|++...+ ..+.+|+..-.. .. .. +. .+|..++..|...++ .++++.+. +
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~--~i-dR----~~E~~vl~~L~~~gl~P~ll~~~~--~---- 176 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE--II-NR----EREKKISCILYNKNIAKKIYVFFT--N---- 176 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS--CS-CH----HHHHHHHHHHTTSSSBCCEEEEET--T----
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh--hc-CH----HHHHHHHHHHHhcCCCCCEEEEeC--C----
Confidence 35678889999999999876 677888753211 00 00 01 478888888864344 56666552 1
Q ss_pred CCCCCccccceEEEEEeeccCCC
Q 001143 887 ADGNPEHHLLQSAIFMEYVKGGS 909 (1141)
Q Consensus 887 ~~g~~~~~~~~~~LVmEy~~ggS 909 (1141)
.+||||++|.+
T Consensus 177 ------------G~v~e~I~G~~ 187 (458)
T 2qg7_A 177 ------------GRIEEFMDGYA 187 (458)
T ss_dssp ------------EEEEECCCSEE
T ss_pred ------------eEEEEeeCCcc
Confidence 46999998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.30 E-value=0.018 Score=65.73 Aligned_cols=29 Identities=24% Similarity=0.398 Sum_probs=24.1
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
+++|+|+++.|||++.+ .+.|+||..|..
T Consensus 213 ~l~HgDl~~~Nil~~~~--------~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--------CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC---------CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCC--------cEEEEEecCCCC
Confidence 59999999999999754 489999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.89 E-value=0.037 Score=63.92 Aligned_cols=143 Identities=17% Similarity=0.225 Sum_probs=77.7
Q ss_pred eeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecC
Q 001143 812 DEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 881 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~---------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~ 881 (1141)
+.|..|-...+|++... +..+.+++. .. ........ .+|..+++.+. +.-..++++.+.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~-g~----~~~~~~~~----~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLY-GA----ILQGVDSL----VLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEEC-C-------CCHHHH----HHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEEC-CC----ccchHHHH----HHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 56777888889998864 245666653 11 11111222 57888888874 3334666665431
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHH--------------HHHHHhhhcC---CCCC--CHHHHHHHHHHHHH---
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVK--------------NYIEKLSETG---EKHV--SVKLALFIAQDVAA--- 939 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~--------------~~I~~~~~~~---~~~L--s~~~i~~Ia~QIa~--- 939 (1141)
.+||||++|..|. ..+.+..... .+.. -+.++.++..++..
T Consensus 126 -----------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~ 188 (379)
T 3feg_A 126 -----------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPP 188 (379)
T ss_dssp -----------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCC
T ss_pred -----------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccC
Confidence 4899999875432 1222211111 1112 24566666655422
Q ss_pred ----------------HHHHHHH--------CCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 940 ----------------ALVELHS--------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 940 ----------------gL~yLHs--------~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
.+..|.+ ..++|+|+.+.||+++.+. ...+.+.++||..|..
T Consensus 189 ~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~---~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 189 TGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEP---ENADSLMLVDFEYSSY 254 (379)
T ss_dssp CSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC------CCEEECCCTTCEE
T ss_pred cccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCC---CccCcEEEEecccCCc
Confidence 2333332 2599999999999997641 0114789999998853
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.23 Score=54.43 Aligned_cols=75 Identities=19% Similarity=0.117 Sum_probs=48.9
Q ss_pred eEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-C--CCccceeeeEecCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGHKISSKWL 884 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H--pNIVkllg~~~~~~~~ 884 (1141)
.-.+.+|.|..+.||+.+.. ++.+.+|+..-... .... .+..|++.|+.|. . --+++++++..
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~----~~~~----~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----- 84 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP----ALDG----LFRAEALGLDWLGRSFGSPVPQVAGWDD----- 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC----CCTT----HHHHHHHHHHHHTCSTTCCSCCEEEEET-----
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc----chhh----HHHHHHHHHHHHHhhCCCCcceEEeccC-----
Confidence 55788999999999999974 56788886432211 1111 2368999888874 2 23455555421
Q ss_pred CCCCCCCccccceEEEEEeeccCCC
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGS 909 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggS 909 (1141)
.++||||++++.
T Consensus 85 -------------~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 -------------RTLAMEWVDERP 96 (288)
T ss_dssp -------------TEEEEECCCCCC
T ss_pred -------------ceEEEEeecccC
Confidence 179999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.34 E-value=0.28 Score=52.01 Aligned_cols=99 Identities=15% Similarity=0.104 Sum_probs=61.2
Q ss_pred CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeeeecccccCCCCCeEEEeecccccccc
Q 001143 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1141)
Q Consensus 908 gSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~ 986 (1141)
-||.+.++.+ ..++++++++.++.|.+.+|.-+-. +.-..+=+-|..|++..+ |.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-------G~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-------GAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-------SCEEECC-C------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-------Cceeccc-cccc---
Confidence 3899999863 3589999999999999998877622 111122233577788776 5565543 1110
Q ss_pred ccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 987 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
.....+.|||... ...+.+.=|||+|++||..+--
T Consensus 98 -------------------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -------------------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ----------------------------CCSS-----SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -------------------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhc
Confidence 0122366777753 2346889999999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.22 E-value=0.23 Score=58.13 Aligned_cols=71 Identities=15% Similarity=0.227 Sum_probs=45.5
Q ss_pred EeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001143 810 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 879 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~~---------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~ 879 (1141)
-.+.|+.|....||++... +..+.+|+.... .. ...+ .+|..+++.+. +.-..++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~--~~~l----i~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET--ESHL----VAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC--HHHH----HHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc--HHHH----HHHHHHHHHHHhCCCCCcEEEEeC
Confidence 3467888999999999874 356778776211 11 0122 46888888875 333356666542
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGG 908 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~gg 908 (1141)
+ .+||||++|.
T Consensus 147 ~------------------g~v~e~l~G~ 157 (429)
T 1nw1_A 147 G------------------GRLEEYIPSR 157 (429)
T ss_dssp T------------------EEEECCCCEE
T ss_pred C------------------CEEEEEeCCc
Confidence 1 5899999863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.48 E-value=0.23 Score=55.17 Aligned_cols=29 Identities=28% Similarity=0.287 Sum_probs=24.0
Q ss_pred CCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 947 ~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
..++|||+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--------~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--------GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--------SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--------CCEEEECCCCCc
Confidence 4589999999999997 3 388999998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.32 E-value=0.34 Score=56.64 Aligned_cols=73 Identities=8% Similarity=0.086 Sum_probs=45.4
Q ss_pred EeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001143 810 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 879 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~~---------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~ 879 (1141)
-.+.|..|-...+|+.... +..+.+++.... ....-+. .+|..+++.+. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-----t~~~idR----~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-----VGKFYDS----KVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-----C-CCCCH----HHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-----cchhcCH----HHHHHHHHHHHhcCCCCCEEEEcC
Confidence 3466778889999999876 466777764211 1111111 47888888774 333456665332
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCC
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGS 909 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggS 909 (1141)
+ ++||||++|..
T Consensus 145 --~----------------~~I~efI~G~~ 156 (424)
T 3mes_A 145 --E----------------GRIEEFIDGEP 156 (424)
T ss_dssp --T----------------EEEEECCCSEE
T ss_pred --C----------------CEEEEEeCCcc
Confidence 1 78999999854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.83 E-value=0.35 Score=54.56 Aligned_cols=31 Identities=26% Similarity=0.454 Sum_probs=26.6
Q ss_pred CCccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 947 ~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-------~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-------ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-------GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-------CeEEEEECCCCee
Confidence 369999999999999876 5699999988754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.76 E-value=1.8 Score=49.99 Aligned_cols=35 Identities=29% Similarity=0.357 Sum_probs=25.8
Q ss_pred ccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 949 IvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
++|+|+.+.|||+..+.. ......+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~-~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE-NSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGG-GCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcc-cCcCCeEEEechHhccC
Confidence 689999999999954311 11226799999998854
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=82.96 E-value=0.4 Score=53.27 Aligned_cols=43 Identities=30% Similarity=0.422 Sum_probs=37.6
Q ss_pred ccchhhhhHHHHHHhhhccCCCCccccccccccc----CCCCcceeEEe
Q 001143 704 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDF----QPHAWNTILVK 748 (1141)
Q Consensus 704 ~~g~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~~----~~~~~~~~~~~ 748 (1141)
..|+|++-|.||-.||-.++ ||+|.|.||..- ..|||..+-+-
T Consensus 177 ~~G~C~d~A~l~val~Ra~G--IPAR~VsGy~~~~~~~~~HAW~Evyl~ 223 (293)
T 3isr_A 177 RAGVCRDFAHLGIALCRALS--IPARYFTGYAFKLNPPDFHACFEAYIG 223 (293)
T ss_dssp CEECHHHHHHHHHHHHHHTT--CCEEEEEEEETTCSSCCEEEEEEEEET
T ss_pred CcEehHHHHHHHHHHHHHCC--CCEEEEEEECCCCCCCCeEEEEEEEEC
Confidence 47999999999999999999 999999999863 47999776653
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=80.32 E-value=0.64 Score=51.34 Aligned_cols=41 Identities=20% Similarity=0.467 Sum_probs=36.8
Q ss_pred ccchhhhhHHHHHHhhhccCCCCcccccccccccCCCCcceeEEee
Q 001143 704 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKK 749 (1141)
Q Consensus 704 ~~g~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~~~~~~~~~~~~~~ 749 (1141)
..|+|++-|.||-.||-.++ ||+|.|-|| ..|||..+-+..
T Consensus 139 r~G~C~d~A~lf~al~Ra~G--IpAR~V~Gy---~~HaW~Evy~~g 179 (295)
T 2f4m_A 139 RCGRCGEWANCFTLCCRALG--FEARYVWDY---TDHVWTEVYSPS 179 (295)
T ss_dssp CEESHHHHHHHHHHHHHHTT--CCEEEEEET---TTEEEEEEEETT
T ss_pred CCEeeHHHHHHHHHHHHHCC--CCEEEEcCC---CCEEEEEEEECC
Confidence 57999999999999999999 999999998 799997766543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1141 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 65/315 (20%), Positives = 123/315 (39%), Gaps = 64/315 (20%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G ++++ K+ D A K+ L V + +++ F EV +L RH I+
Sbjct: 17 GSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLF 69
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G+ + + I ++ +G S+ +++ + E + + IA
Sbjct: 70 MGYSTAPQLA---------------IVTQWCEGSSLYHHLHII----ETKFEMIKLIDIA 110
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+ A + LH+K I+HRD+KS NI + VK+ DF A + +
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL-------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1054
G+ WMAPEV+R M N Y + D++++G +L EL+T Q+PY ++
Sbjct: 164 EQ--------LSGSILWMAPEVIR-MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1114
+ + +G+ D + +C + + + C ++
Sbjct: 215 RDQIIFM-VGRGYLSPDLSKVRSNCPKA---------------------MKRLMAECLKK 252
Query: 1115 NPTERPTAGDLYEMF 1129
ERP +
Sbjct: 253 KRDERPLFPQILASI 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 67/314 (21%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G +++ + A + + S +E+ ++ + E+ +L + H IV++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDY----MVEIDILASCDHPNIVKL 74
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
L I +E+ GG+V + +L E+ ++ +
Sbjct: 75 LDAFYYENNL--------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVC 116
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+ AL LH I+HRD+K+ NIL DG +KL DF +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFT-----LDG--DIKLADFGVS----------AK 159
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1053
R I D +GTP WMAPEV+ K Y + D+WS G L+E+ ++ P+ L+
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 1054 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113
+ + I + P L +P S D ++C E
Sbjct: 220 PMRVLLKIAKSEPPTL----------------------AQPS---RWSSNFKDFLKKCLE 254
Query: 1114 ENPTERPTAGDLYE 1127
+N R T L +
Sbjct: 255 KNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 70/318 (22%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G + + S + L + E + + EV +L L+H IV
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRY 68
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
Y I L I MEY +GG + + I K ++ +++ + L +
Sbjct: 69 YDRIIDRT---------NTTLY---IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVM 115
Query: 935 QDVAAALVELHSKH-----IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 989
+ AL E H + ++HRD+K N+ +D GK VKL DF A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-------GKQNVKLGDFGLA------- 161
Query: 990 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1049
I + VGTP +M+PE + M Y + DIWS GCLL EL L P+
Sbjct: 162 ---RILNHDTSFAKAFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPF 214
Query: 1050 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1109
S+ E+ I+ GK R+ + L ++
Sbjct: 215 TAFSQKELAGKIREGKFRRIPYRY--------------------SDE-------LNEIIT 247
Query: 1110 RCTEENPTERPTAGDLYE 1127
R RP+ ++ E
Sbjct: 248 RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 67/317 (21%), Positives = 115/317 (36%), Gaps = 73/317 (23%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ ++++ L+ + E + F E ML L+H IV
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRF 73
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
Y W + G L+ E + G++K Y+++ K + +K+
Sbjct: 74 YDS-----WESTVKGKKCIVLV-----TELMTSGTLKTYLKR-----FKVMKIKVLRSWC 118
Query: 935 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHT 991
+ + L LH++ I+HRD+K +NI I VK+ D A R SF
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFIT------GPTGSVKIGDLGLATLKRASFAKA 172
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1051
GTP +MAPE+ Y VD++++G +LE+ T + PY
Sbjct: 173 VI-------------GTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 1052 LSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110
+I+ + G +P D++ PE + ++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAI------------------PEVK--------EIIEG 248
Query: 1111 CTEENPTERPTAGDLYE 1127
C +N ER + DL
Sbjct: 249 CIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 70/294 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + L E ++ L + IV M G + W+
Sbjct: 39 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAESWM----------- 83
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 84 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N+L+ + K+ DF + LR+ + +W APE
Sbjct: 135 ARNVLL-------VTQHYAKISDFGLSKALRADENYYKAQTH-------GKWPVKWYAPE 180
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
+ + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 181 CINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC- 235
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
P + D+ C + RP +
Sbjct: 236 -------------------PRE-------MYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 66/311 (21%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A K+ L++ + ++I E+++L IV YG S +
Sbjct: 34 MARKLIHLEIKPAIRNQIIR-------ELQVLHECNSPYIVGFYGAFYSDGEI------- 79
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IM 950
+I ME++ GGS+ ++K + ++ ++ V L L KH IM
Sbjct: 80 -------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
HRD+K NIL++ + +KLCDF + L + VGT
Sbjct: 128 HRDVKPSNILVN-------SRGEIKLCDFGVSGQLIDSMAN------------SFVGTRS 168
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI--------- 1061
+M+PE L+ H Y ++ DIWS G L+E+ + P E+ +
Sbjct: 169 YMSPERLQGTH----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 1062 ------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEE 1114
+ RP + +++ E+ P+ S D +C +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 1115 NPTERPTAGDL 1125
NP ER L
Sbjct: 285 NPAERADLKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 59/272 (21%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++ LRHS +V++ G + K L I EY+ GS+ +Y+
Sbjct: 50 EASVMTQLRHSNLVQLLGVIVEEK----------GGLY---IVTEYMAKGSLVDYLRS-- 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
G + L + DV A+ L + +HRD+ + N+L+ D V K+ D
Sbjct: 95 -RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-----EDN--VAKVSD 146
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F S T +W APE LR + + D+WS+G L
Sbjct: 147 FGLTKEASSTQDTGK-------------LPVKWTAPEALREKK----FSTKSDVWSFGIL 189
Query: 1039 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097
L E+ + +VPY + ++ ++ G + D P A
Sbjct: 190 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--------------------PPA- 228
Query: 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ +V + C + RP+ L E
Sbjct: 229 ------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 7e-36
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 64/299 (21%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGN 890
A + SA+E++ + L EV +L + H I+++ ++ +
Sbjct: 32 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF------ 85
Query: 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950
+ + +K G + +Y+ + + +S K I + + + LH +I+
Sbjct: 86 --------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
HRD+K ENIL+ D +KL DF + L GTP
Sbjct: 133 HRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKL-----------REVCGTPS 174
Query: 1011 WMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1068
++APE++ N YG EVD+WS G ++ LL P+ ++ + +I G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 1069 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
+ E + + D+ R P +R TA +
Sbjct: 235 GSPEWDDYSDT------------------------VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-36
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 71/298 (23%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV + E E+ EV + LRH I+ +YG+ + +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY------------- 82
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ +EY G+V ++K + ++A AL HSK ++HRDIK EN
Sbjct: 83 -LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+L+ +K+ DF +V S T GT ++ PE++
Sbjct: 137 LLL-------GSAGELKIADFGWSVHAPSSRRTT------------LCGTLDYLPPEMIE 177
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
+ +VD+WS G L E L + P+ + E + I D +
Sbjct: 178 GRM----HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFV----- 227
Query: 1079 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 1135
E D+ R + NP++RP ++ E ++ SS
Sbjct: 228 ---------------TEG-------ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (337), Expect = 6e-35
Identities = 66/289 (22%), Positives = 100/289 (34%), Gaps = 67/289 (23%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K S + + EVR L LRH ++ G + EH
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----------EHTAW-- 91
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY G + +K + + L LHS +++HRD+K+ N
Sbjct: 92 -LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+ +VKL DF A PA GTP WMAPEV+
Sbjct: 146 ILL-------SEPGLVKLGDF-------------GSASIMAPANSFV-GTPYWMAPEVIL 184
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
AM + Y +VD+WS G +EL + P ++ + I + P L
Sbjct: 185 AMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG------ 237
Query: 1079 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
E + C ++ P +RPT+ L +
Sbjct: 238 -------------HWSEY-------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 69/295 (23%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
A K+ +K + I+ E+ + L H +V+ YGH+
Sbjct: 34 AVKIVDMKRAVDCPENIKK-------EICINKMLNHENVVKFYGHRREGNIQ-------- 78
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
+F+EY GG + + IE + + A + A +V LH I HR
Sbjct: 79 ------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DIK EN+L+ D + +K+ DF L T + + GT ++
Sbjct: 128 DIKPENLLL-------DERDNLKISDFG--------LATVFRYNNRERLLNKMCGTLPYV 172
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1072
APE+L+ + + VD+WS G +L +L ++P+ S+ K+ L
Sbjct: 173 APELLK---RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 226
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
P +++ S + + + ENP+ R T D+ +
Sbjct: 227 --------------------NPWKKID--SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 133 bits (335), Expect = 2e-34
Identities = 48/270 (17%), Positives = 83/270 (30%), Gaps = 64/270 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++ + LRH +V ++ + + E++ GG + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEM--------------VMIYEFMSGGELFEKVAD-- 116
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+S A+ + V L +H + +H D+K ENI+ +KL D
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-----TKRSNELKLID 169
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F L GT + APEV G D+WS G L
Sbjct: 170 FGLTAHLDPKQSVKV-----------TTGTAEFAAPEVAEGKP----VGYYTDMWSVGVL 214
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
LL+ P+ G ++ E ++ + ++
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCD-------------------------WNMDDSAF 249
Query: 1099 ETLSF-LVDVFRRCTEENPTERPTAGDLYE 1127
+S D R+ +P R T E
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 4e-34
Identities = 66/268 (24%), Positives = 102/268 (38%), Gaps = 68/268 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ ++ IV + L + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDEL--------------WVVMEYLAGGSLTDVVTE-- 110
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + ++ AL LHS ++HRDIKS+NIL+ DG VKL D
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKLTD 159
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F + VGTP WMAPEV+ YG +VDIWS G +
Sbjct: 160 FGFCAQITPEQSKR----------STMVGTPYWMAPEVVTRKA----YGPKVDIWSLGIM 205
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
+E++ + PY+ + L LI P L +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-------------------------- 239
Query: 1099 ETLS-FLVDVFRRCTEENPTERPTAGDL 1125
E LS D RC + + +R +A +L
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-34
Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 69/287 (24%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
G+ + + E +++ L + IV + G + + + M
Sbjct: 47 GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM---------------LVM 87
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
E GG + ++ + + V + V+ + L K+ +HRD+ + N+L+
Sbjct: 88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL- 142
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
+ K+ DF + L + G +W APE +
Sbjct: 143 ------VNRHYAKISDFGLSKALGADDSYYTARSAG-------KWPLKWYAPECINFRK- 188
Query: 1023 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1081
+ D+WSYG + E L+ Q PY + E+ I+ GKR E
Sbjct: 189 ---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------- 237
Query: 1082 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
P L + C +RP + +
Sbjct: 238 ------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 1e-33
Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 65/284 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ L H ++ ++ + + +E++ GG + + I
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEM--------------VLILEFLSGGELFDRIAA-- 119
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ +S + + L +H I+H DIK ENI+ + VK+ D
Sbjct: 120 --EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE-----TKKASSVKIID 172
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A L T + APE++ G D+W+ G L
Sbjct: 173 FGLATKLNPDEIVKV-----------TTATAEFAAPEIVDREP----VGFYTDMWAIGVL 217
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
LL+ P+ G +LE ++ +E E
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCD-------------------------WEFDEDAF 252
Query: 1099 ETLSF-LVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 1140
++S D + ++ P +R T D E ++ S+++SR
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 2e-33
Identities = 55/315 (17%), Positives = 119/315 (37%), Gaps = 69/315 (21%)
Query: 828 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
G + ++TLK G + + R+F L E ++G H ++ + G S +
Sbjct: 51 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPV--- 102
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
I E+++ GS+ +++ + + +V + + + +AA + L
Sbjct: 103 -----------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007
+ +HRD+ + NIL++ ++ V K+ DF + L
Sbjct: 148 NYVHRDLAARNILVN-----SNL--VCKVSDFGLSRFLEDDTSDPTYTSAL-----GGKI 195
Query: 1008 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1066
RW APE ++ + D+WSYG ++ E+++ + PY ++ ++ + I+ R
Sbjct: 196 PIRWTAPEAIQYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 1067 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126
++ S L + C +++ RP G +
Sbjct: 252 L---------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 1127 EMF--VARTSSSISS 1139
+ R +S+ +
Sbjct: 285 NTLDKMIRNPNSLKA 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 73/295 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++LK S D E ++ L+H +V +Y
Sbjct: 42 VKSLKQGSMSPDAFLA-------EANLMKQLQHQRLVRLYAVVTQEPIY----------- 83
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ ++++ +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ K+ DF A I A + +W APE
Sbjct: 137 AANILV-------SDTLSCKIADFGLA---------RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
+ + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 181 AINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
PE L + R C +E P +RPT L +
Sbjct: 236 -------------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 73/294 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ +K S DE E +++ L H +V++YG + +
Sbjct: 33 IKMIKEGSMSEDEFIE-------EAKVMMNLSHEKLVQLYGVCTKQRPIF---------- 75
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 76 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N L+ + + VVK+ DF + + +T + RW PE
Sbjct: 128 ARNCLV-------NDQGVVKVSDFGLSRYVLDDEYTSSVG---------SKFPVRWSPPE 171
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
VL + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 172 VLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 220
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
+P E + + C E ERPT L
Sbjct: 221 -----------------YRPHLASEK---VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 58/295 (19%), Positives = 98/295 (33%), Gaps = 37/295 (12%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ S + E E+ LRH I+ AD Q
Sbjct: 31 VKIFSSREERSWFRE----AEIYQTVMLRHENILGFIA----------ADNKDNGTWTQL 76
Query: 899 AIFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956
+ +Y + GS+ +Y+ + ++ G +++ A +A + I HRD+KS
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
+NIL+ + D AV S T IA VGT R+MAPEV
Sbjct: 137 KNILV-------KKNGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEV 183
Query: 1017 LR--AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1074
L K DI++ G + E+ + ++ + P + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ E L + + R C N R TA + +
Sbjct: 244 VVCEQKLRP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 58/286 (20%), Positives = 97/286 (33%), Gaps = 39/286 (13%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
G ++ + L E+++L L H I+ + + ++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--------------SLVF 79
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
++++ + H L LH I+HRD+K N+L+D
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
V+KL DF A S V T + APE+L
Sbjct: 135 -------ENGVLKLADFGLAKSFGSPNRAYTH----------QVVTRWYRAPELLFGARM 177
Query: 1023 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1082
YG+ VD+W+ GC+L ELL G S+L+ I ++ + S ++
Sbjct: 178 ---YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 1083 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
+S G L+D+ + NP R TA +M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-32
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 70/292 (23%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K F L E +++ LRH +V++Y
Sbjct: 46 IKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPIY-------------- 87
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I EY+ GS+ ++++ K++ + + +A +A+ + + + +HRD+++ N
Sbjct: 88 -IVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 143
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+ V K+ DF A + +T A +W APE
Sbjct: 144 ILV-------GENLVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAAL 187
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1077
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R E
Sbjct: 188 YGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 239
Query: 1078 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
PE+ L D+ +C + P ERPT L
Sbjct: 240 ----------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-32
Identities = 56/316 (17%), Positives = 99/316 (31%), Gaps = 64/316 (20%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G + R ++ + +K + EV + +L H ++ +
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
YG ++ + E GS+ + + K + H + A
Sbjct: 77 YGVVLTPPMK---------------MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYA 117
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
VA + L SK +HRD+ + N+L+ +VK+ DF L +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYVM 170
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 1053
W APE L+ + D W +G L E+ T Q P++GL+
Sbjct: 171 QEH-------RKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 1054 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113
+I I +PE + + +V +C
Sbjct: 220 GSQILHKIDKEGER-----------------------LPRPEDCPQD---IYNVMVQCWA 253
Query: 1114 ENPTERPTAGDLYEMF 1129
P +RPT L +
Sbjct: 254 HKPEDRPTFVALRDFL 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 7e-32
Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 84/306 (27%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
+SAD +F E ++ + IV++ G K + + E
Sbjct: 55 ASADMQADF----QREAALMAEFDNPNIVKLLGVCAVGKPM--------------CLLFE 96
Query: 904 YVKGGSVKNYIEKL-------------------SETGEKHVSVKLALFIAQDVAAALVEL 944
Y+ G + ++ + S G +S L IA+ VAA + L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
+ +HRD+ + N L+ VVK+ DF + + S + +
Sbjct: 157 SERKFVHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGN-------- 201
Query: 1005 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQM 1063
RWM PE + Y E D+W+YG +L E+ + + PY G++ E+ ++
Sbjct: 202 DAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 1064 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123
G + P L ++ R C + P +RP+
Sbjct: 258 GNILACPENC--------------------PLE-------LYNLMRLCWSKLPADRPSFC 290
Query: 1124 DLYEMF 1129
++ +
Sbjct: 291 SIHRIL 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 7e-32
Identities = 52/316 (16%), Positives = 105/316 (33%), Gaps = 74/316 (23%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G + + + D A ++T++ S ++ E ++ L H +V++
Sbjct: 14 GSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIE-------EAEVMMKLSHPKLVQL 65
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
YG + + + E+++ G + +Y+ + + L +
Sbjct: 66 YGVCLEQAPI--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMC 107
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
DV + L ++HRD+ + N L+ V+K+ DF + +T
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVG-------ENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 1053
+W +PEV Y + D+WS+G L+ E+ + ++PY S
Sbjct: 161 G---------TKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 1054 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113
E+ + I G R + + + C +
Sbjct: 208 NSEVVEDISTGFRLYKPRLAS---------------------------THVYQIMNHCWK 240
Query: 1114 ENPTERPTAGDLYEMF 1129
E P +RP L
Sbjct: 241 ERPEDRPAFSRLLRQL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 8e-32
Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 69/292 (23%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K E+ F L E ++ ++H +V++ G
Sbjct: 47 VKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPPF-------------- 88
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+ + N
Sbjct: 89 YIITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+ + +VK+ DF + + +T +W APE L
Sbjct: 146 CLVG-----ENH--LVKVADFGLSRLMTGDTYTAHAG---------AKFPIKWTAPESLA 189
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALG 1077
+ ++ D+W++G LL E+ T + PY G+ ++++L++ R
Sbjct: 190 YNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235
Query: 1078 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
E+PE E + ++ R C + NP++RP+ ++++ F
Sbjct: 236 --------------ERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 66/287 (22%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ N E ++ L H V++Y + L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-------------- 83
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ Y K G + YI K F ++ +AL LH K I+HRD+K EN
Sbjct: 84 YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+ + +++ DF A + VGT ++++PE+L
Sbjct: 139 ILL-------NEDMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
D+W+ GC++ +L+ P+ +E I I + ++
Sbjct: 184 EKS----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFF---- 234
Query: 1079 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1125
P+A D+ + + T+R ++
Sbjct: 235 ---------------PKA--------RDLVEKLLVLDATKRLGCEEM 258
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-30
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 36/270 (13%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+++L RH I+ + + P ++ + ++ G + ++
Sbjct: 56 EIKILLRFRHENIIGINDIIRA----------PTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+H+S + + L +HS +++HRD+K N+L+ + +K+CD
Sbjct: 104 ----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-------NTTCDLKICD 152
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A V T + APE++ Y +DIWS GC+
Sbjct: 153 FGLARVADPDHDHTGFLTE-------YVATRWYRAPEIMLNSKG---YTKSIDIWSVGCI 202
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
L E+L+ + + G L+ + I ++L + + S K
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 1099 ETLSF---LVDVFRRCTEENPTERPTAGDL 1125
+ +D+ + NP +R
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 71/314 (22%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ + RC S+ + +KV G+ ++ E+ +L RH I+ +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-------EISILNIARHRNILHL 66
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
+ S + L + E++ G + I ++ + +
Sbjct: 67 HESFESMEEL--------------VMIFEFISGLDIFERINT----SAFELNEREIVSYV 108
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
V AL LHS +I H DI+ ENI+ +K+ +F +A L+ +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQ-----TRRSSTIKIIEFGQARQLKPGDNF--- 160
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1054
+ P + APEV + D+WS G L+ LL+ P++ +
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDV----VSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 1055 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTE 1113
+I + I + + E + +S +D R
Sbjct: 209 QQIIENIMNAE-------------------------YTFDEEAFKEISIEAMDFVDRLLV 243
Query: 1114 ENPTERPTAGDLYE 1127
+ R TA + +
Sbjct: 244 KERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 54/265 (20%)
Query: 862 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 921
A + IV + + LL I ME + GG + + I+ G
Sbjct: 58 HWRASQCPHIVRIVDVYENL-------YAGRKCLL---IVMECLDGGELFSRIQD---RG 104
Query: 922 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 981
++ + + A I + + A+ LHS +I HRD+K EN+L ++KL DF
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGF 160
Query: 982 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041
A S + TP ++APEVL Y D+WS G ++
Sbjct: 161 AKETTSHNSLTTPCY-----------TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYI 205
Query: 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101
LL P+ L I ++ R +E P E +
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRM---------------------GQYEFPNPEWSEV 244
Query: 1102 SF-LVDVFRRCTEENPTERPTAGDL 1125
S + + R + PT+R T +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 72/299 (24%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A ++T K C +S F L E + H IV++ G I+ +
Sbjct: 36 LAVAIKTCKNC-TSDSVREKF----LQEALTMRQFDHPHIVKLIGV-ITENPVW------ 83
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
I ME G ++++++ + + + + A ++ AL L SK +H
Sbjct: 84 --------IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RDI + N+L+ VKL DF + + + +W
Sbjct: 132 RDIAARNVLVS-------SNDCVKLGDFGLSRYMEDSTYYKA---------SKGKLPIKW 175
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1070
MAPE + + D+W +G + E+L P+ G+ ++ I+ G+R +
Sbjct: 176 MAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 1071 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
P L + +C +P+ RP +L
Sbjct: 232 PNC--------------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 3e-30
Identities = 58/280 (20%), Positives = 96/280 (34%), Gaps = 64/280 (22%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
+ E S E+ +L ++H IV + S L + M+ V
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL--------------YLIMQLVS 90
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG + + I + + + + A + V A+ LH I+HRD+K EN+L
Sbjct: 91 GGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-- 143
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
D + + DF + G C GTP ++APEVL Y
Sbjct: 144 --DEDSKIMISDF----------GLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP----Y 186
Query: 1027 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1086
VD WS G + LL P+ ++ ++ + I +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--------------------- 225
Query: 1087 SGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 1125
+E + +S D R E++P +R T
Sbjct: 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 68/319 (21%), Positives = 116/319 (36%), Gaps = 81/319 (25%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882
R K A ++ +K +S D+ R+F GE+ +L L H I+ + G
Sbjct: 30 RIKKDGLRMDAAIKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHRG 84
Query: 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----------LSETGEKHVSVKLAL 931
+L + +EY G++ +++ K ++ + +S + L
Sbjct: 85 YL--------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 932 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
A DVA + L K +HRD+ + NIL+ V K+ DF + ++
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVG-------ENYVAKIADFGLSRGQEVYVKK 183
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 1050
RWMA E L Y D+WSYG LL E+++L PY
Sbjct: 184 TM-----------GRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWEIVSLGGTPYC 228
Query: 1051 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110
G++ E+++ + G R + + D+ R+
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCD---------------------------DEVYDLMRQ 261
Query: 1111 CTEENPTERPTAGDLYEMF 1129
C E P ERP+ +
Sbjct: 262 CWREKPYERPSFAQILVSL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 6e-30
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 31/286 (10%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
+E F + L E+++L L+H +V + + + + + +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY------LVFD 97
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
+ + L ++ + Q + L +H I+HRD+K+ N+LI
Sbjct: 98 FCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT- 151
Query: 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023
DG V+KL DF A ++ + V T + PE+L
Sbjct: 152 ----RDG--VLKLADFGLARAFSLAKNSQPNRYTNR------VVTLWYRPPELLLGERD- 198
Query: 1024 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1083
YG +D+W GC++ E+ T G +E LI + + + +E
Sbjct: 199 --YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 1084 VAQSGSGFEKPEAELETLSFL----VDVFRRCTEENPTERPTAGDL 1125
+ G ++ + +D+ + +P +R + D
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 1e-29
Identities = 65/294 (22%), Positives = 104/294 (35%), Gaps = 60/294 (20%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+KV + +F E + AL H IV +Y +
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA----------ETPAGPLP 86
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K N
Sbjct: 87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
I+I VK+ DF A + ++ +GT ++++PE R
Sbjct: 142 IMIS-------ATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQYLSPEQAR 187
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
D++S GC+L E+LT + P+ G S + +
Sbjct: 188 GDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------- 233
Query: 1079 CHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERP-TAGDLYEMFV 1130
P A E LS L V + +NP R TA ++ V
Sbjct: 234 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 76/292 (26%)
Query: 859 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-- 915
E+ M+ + +H I+ + G L + +EY G+++ Y++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPL--------------YVIVEYASKGNLREYLQAR 113
Query: 916 ---------KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
S E+ +S K + A VA + L SK +HRD+ + N+L+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---- 169
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
V+K+ DF A + + + +WMAPE L Y
Sbjct: 170 ---EDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDRI----Y 214
Query: 1027 GLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 1085
+ D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC------------ 262
Query: 1086 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF---VARTS 1134
L + R C P++RPT L E VA TS
Sbjct: 263 --------TNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 69/295 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK + + LGE ++G H I+ + G K +
Sbjct: 41 IKTLKAGYTEKQRVD-----FLGEAGIMGQFSHHNIIRLEGVISKYKPMM---------- 85
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 86 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ + V K+ DF + L G RW APE
Sbjct: 138 ARNILV-------NSNLVCKVSDFGLSRVLEDDPEATYTTSGG-------KIPIRWTAPE 183
Query: 1016 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLSELEIHDLIQMGKRPRLTDELE 1074
+ + D+WS+G ++ E++T LS E+ I G R
Sbjct: 184 AISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 231
Query: 1075 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
++ S + + +C ++ RP D+ +
Sbjct: 232 -------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-29
Identities = 61/298 (20%), Positives = 105/298 (35%), Gaps = 66/298 (22%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
+ E+ F L E ++ H ++ + G + E L + +
Sbjct: 67 TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL----------RSEGSPL---VVLP 109
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
Y+K G ++N+I + +VK + VA + L SK +HRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-- 163
Query: 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023
D K VK+ DF A + G +WMA E L+
Sbjct: 164 -----DEKFTVKVADFGLARDMYDKEFDSVHNKTG------AKLPVKWMALESLQTQK-- 210
Query: 1024 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1082
+ + D+WS+G LL EL+T PY ++ +I + G+R +
Sbjct: 211 --FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--------- 259
Query: 1083 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSR 1140
P+ L +V +C RP+ +L A S+ I
Sbjct: 260 -----------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 9e-29
Identities = 40/271 (14%), Positives = 86/271 (31%), Gaps = 49/271 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++ ++ + + ++++ + ME + +
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGA---------EGDYNV----MVMELLGPSLEDLFNFC-- 96
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ S+K L +A + + + +HSK+ +HRD+K +N L+ L +V + D
Sbjct: 97 ---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG----KKGNLVYIID 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A R I + GT R+ + + D+ S G +
Sbjct: 150 FGLAKKYRDARTHQHIPY---RENKNLTGTARYASINTHLGIE----QSRRDDLESLGYV 202
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
L+ +P+ GL + +++ +E L + E
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE--------------- 247
Query: 1099 ETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
C ++P L ++F
Sbjct: 248 -----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 65/296 (21%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
AAK +K + + EV +L ++H ++ ++ + +
Sbjct: 39 AAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV-------- 88
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
+ +E V GG + +++ + ++ ++ + A + + + LHS I H
Sbjct: 89 ------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
D+K ENI++ + KP +K+ DF A + GTP ++
Sbjct: 138 DLKPENIMLL---DRNVPKPRIKIIDFGLAHKIDFGNEFKN-----------IFGTPEFV 183
Query: 1013 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1072
APE++ GLE D+WS G + LL+ P++G ++ E +
Sbjct: 184 APEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------- 232
Query: 1073 LEALGSCHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDLYE 1127
+E + S D RR ++P +R T D +
Sbjct: 233 ------------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 47/288 (16%), Positives = 98/288 (34%), Gaps = 70/288 (24%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
+S + L E ++ ++ + + + G ++S +
Sbjct: 49 ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ---------------LIT 89
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
+ + G + +Y+ + + ++ + L +A + L + ++HRD+ + N+L+
Sbjct: 90 QLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
VK+ DF A L + + +WMA E +
Sbjct: 146 -------TPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALESILHRI- 189
Query: 1023 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1081
Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 190 ---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------------- 232
Query: 1082 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+P + + +C + RP +L F
Sbjct: 233 ----------PQPPICTIDV---YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 81/291 (27%)
Query: 859 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 916
E++M+ L H IV + G S + + EY G + NY+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPI--------------YLIFEYCCYGDLLNYLRSK 135
Query: 917 -----------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
E ++ + L A VA + L K +HRD+ + N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ VVK+CDF A + S + + +WMAPE L
Sbjct: 196 LV-------THGKVVKICDFGLARDIMSDSNYVVRGN--------ARLPVKWMAPESLFE 240
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE-IHDLIQMGKRPRLTDELEALG 1077
Y ++ D+WSYG LL E+ +L PY G+ + LIQ G +
Sbjct: 241 GI----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---- 292
Query: 1078 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
E + + + C + +RP+ +L
Sbjct: 293 ----------------TEE-------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 61/264 (23%), Positives = 92/264 (34%), Gaps = 68/264 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+ + A H + M+ + + L MEY+ GG + +I+
Sbjct: 53 KRVLSLAWEHPFLTHMFCTFQTKENL--------------FFVMEYLNGGDLMYHIQS-- 96
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ A F A ++ L LHSK I++RD+K +NIL+D +K+ D
Sbjct: 97 ---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-------KDGHIKIAD 146
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F GTP ++APE+L Y VD WS+G L
Sbjct: 147 FGMCKENMLGDAKTN----------TFCGTPDYIAPEILLGQK----YNHSVDWWSFGVL 192
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
L E+L Q P+ G E E+ I+M P LE EA
Sbjct: 193 LYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLE-------------------KEA-- 230
Query: 1099 ETLSFLVDVFRRCTEENPTERPTA 1122
D+ + P +R
Sbjct: 231 ------KDLLVKLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 6e-28
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 38/268 (14%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+R L H +V ++ S+ + + E+V L
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSR---------TDRETKLTLVFEHVDQD----LTTYLD 106
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ E V + + + L LHS ++HRD+K +NIL+ + G+ +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-----SSGQIKLADFG 161
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
R + L + T + APEVL Y VD+WS GC+
Sbjct: 162 LARIYSFQMALTSVV-------------VTLWYRAPEVLLQSS----YATPVDLWSVGCI 204
Query: 1039 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097
E+ + + G S+++ I + P D + + ++S EK +
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 1098 LETLSFLVDVFRRCTEENPTERPTAGDL 1125
++ L D+ +C NP +R +A
Sbjct: 265 IDEL--GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (280), Expect = 1e-27
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 33/230 (14%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ + + G S+++ ++ + SVK A+ + A + +H K +++RDIK +N
Sbjct: 77 VLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
LI K + + DF R + I + GT R+M+
Sbjct: 133 LIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPY---REKKNLSGTARYMSINT--- 184
Query: 1020 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1079
H D+ + G + + L +P+ GL + + + L L +
Sbjct: 185 -HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 1080 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
E P L +F
Sbjct: 244 FPEE--------------------FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 53/300 (17%), Positives = 103/300 (34%), Gaps = 71/300 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T+ S + I L E ++ +V + G +
Sbjct: 55 IKTVNEAASMRERIE-----FLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------- 99
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHV-----SVKLALFIAQDVAAALVELHSKHIM 950
+ ME + G +K+Y+ L + S+ + +A ++A + L++ +
Sbjct: 100 ----VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
HRD+ + N ++ VK+ DF + + R
Sbjct: 156 HRDLAARNCMVA-------EDFTVKIGDFG--------MTRDIYETDYYRKGGKGLLPVR 200
Query: 1011 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1069
WM+PE L+ ++ D+WS+G +L E+ TL + PY GLS ++ + G
Sbjct: 201 WMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 1070 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
D + L ++ R C + NP RP+ ++
Sbjct: 257 PDNCPDM---------------------------LFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (274), Expect = 6e-27
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)
Query: 850 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 909
+ + E+ +L L+HS IV++Y + K L + E++
Sbjct: 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV--------------LVFEHLDQDL 86
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
K E + A + + H + ++HRD+K +N+LI+
Sbjct: 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------- 134
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1029
+ +K+ DF A + + T + AP+VL K Y
Sbjct: 135 REGELKIADFGLARAFGIPVRKYT----------HEIVTLWYRAPDVLMGSKK---YSTT 181
Query: 1030 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1089
+DIWS GC+ E++ + G+SE + I + + +++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 1090 GFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1125
E+ L+ L +D+ + + +P +R TA
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-26
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 31/268 (11%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ L H IV + + S + E +L + ++YV +
Sbjct: 63 ELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYVPETVYRVARHYSR 114
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
++ + V + +L +HS I HRDIK +N+L+D V+KLCD
Sbjct: 115 A--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------PDTAVLKLCD 166
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A L RG P + A Y +D+WS GC+
Sbjct: 167 FGSAKQLV----------RGEPNVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCV 212
Query: 1039 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097
L ELL Q + G S ++ I ++ P E + E + Q +
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 1098 LETLSFLVDVFRRCTEENPTERPTAGDL 1125
T + + R E PT R T +
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-26
Identities = 56/287 (19%), Positives = 102/287 (35%), Gaps = 76/287 (26%)
Query: 859 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 916
E+++L L H IV + G + EY G + N++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPT--------------LVITEYCCYGDLLNFLRRK 121
Query: 917 ------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964
+ E E + ++ L + VA + L SK+ +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179
Query: 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
+ K+CDF A +++ + + +WMAPE +
Sbjct: 180 -----HGRITKICDFGLARDIKNDSNYVVKGN--------ARLPVKWMAPESIFNCV--- 223
Query: 1025 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEH 1082
Y E D+WSYG L EL +L ++ + +I+ G R + A
Sbjct: 224 -YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE------ 276
Query: 1083 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1129
+ D+ + C + +P +RPT + ++
Sbjct: 277 ---------------------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (266), Expect = 1e-25
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+KV E ML + H I+ M+G ++ +
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-------------- 79
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ M+Y++GG + + + K A F A +V AL LHSK I++RD+K EN
Sbjct: 80 FMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+D +G +K+ DF A + +T C GTP ++APEV+
Sbjct: 135 ILLD-----KNGH--IKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 174
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEA 1075
Y +D WS+G L+ E+L P+ + ++ ++ I + P ++++
Sbjct: 175 TKP----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 1076 L 1076
L
Sbjct: 231 L 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 51/279 (18%), Positives = 99/279 (35%), Gaps = 39/279 (13%)
Query: 848 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 907
E + + E+ +L L H IV++ + L + E++
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--------------LVFEFLH- 84
Query: 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
++ + + + + + L + L HS ++HRD+K +N+LI
Sbjct: 85 ---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------ 135
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
+ + +KL DF A + T V T + APE+L Y
Sbjct: 136 -NTEGAIKLADFGLARAFGVPVRTYT----------HEVVTLWYRAPEILLGCKY---YS 181
Query: 1028 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 1087
VDIWS GC+ E++T + + G SE++ I + S +++ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 1088 GSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1125
+ + L + + +P +R +A
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-25
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+R+L +RH ++ + + M ++ G + ++
Sbjct: 67 ELRLLKHMRHENVIGLLDVFT--------PDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + F+ + L +H+ I+HRD+K N+ + + +K+ D
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------NEDCELKILD 164
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A S + T + APEV+ + Y VDIWS GC+
Sbjct: 165 FGLARQADSEMTGYV-------------VTRWYRAPEVILNWMR---YTQTVDIWSVGCI 208
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE- 1097
+ E++T + + G L+ I + ++ L S + EK +
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 1098 -LETLS-FLVDVFRRCTEENPTERPTAGDL 1125
L S V++ + + +R TAG+
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (263), Expect = 6e-25
Identities = 46/265 (17%), Positives = 86/265 (32%), Gaps = 66/265 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+ ++ IV M + L + ++ + GG + ++ +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKL--------------SFILDLMNGGDLHYHLSQHG 102
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E F A ++ L +H++ +++RD+K NIL+ D V++ D
Sbjct: 103 VFSEAD-----MRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------DEHGHVRISD 150
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
A + GT +MAPEVL+ Y D +S GC+
Sbjct: 151 LGLACDFSKKKPHASV------------GTHGYMAPEVLQKGVA---YDSSADWFSLGCM 195
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
L +LL P+ + H++ +M + E+ S S PE
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------ELPDSFS----PELR- 237
Query: 1099 ETLSFLVDVFRRCTEENPTERPTAG 1123
+ + + R
Sbjct: 238 -------SLLEGLLQRDVNRRLGCL 255
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 7e-25
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 68/285 (23%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ ++ + E R+L RH + + + L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC------------- 81
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN
Sbjct: 82 -FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+++ D +K+ DF S T GTP ++APEVL
Sbjct: 136 LML-------DKDGHIKITDFGLCKEGISDGATMKT----------FCGTPEYLAPEVLE 178
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1078
YG VD W G ++ E++ ++P+ + +LI M + R L
Sbjct: 179 DND----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLS---- 229
Query: 1079 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123
PEA + +++P +R G
Sbjct: 230 ---------------PEA--------KSLLAGLLKKDPKQRLGGG 251
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 77/272 (28%)
Query: 859 EVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIE 915
EV +L + S ++ + + +E + + ++I
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSF--------------VLILERPEPVQDLFDFIT 102
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + +LA V A+ H+ ++HRDIK ENILIDL R + +K
Sbjct: 103 E-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE------LK 151
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
L DF L+ ++T GT + PE +R +G +WS
Sbjct: 152 LIDFGSGALLKDTVYTD------------FDGTRVYSPPEWIRYHRY---HGRSAAVWSL 196
Query: 1036 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1095
G LL +++ +P+ E+ + R R++ E +
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFF---RQRVSSECQ--------------------- 232
Query: 1096 AELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127
+ R C P++RPT ++
Sbjct: 233 ----------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-24
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+R+L ++H ++ + ++ L + ++ G + N ++
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSL---------EEFNDVYLVTHLMGADLNNIVKC-- 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ ++ F+ + L +HS I+HRD+K N+ ++ +K+ D
Sbjct: 116 ----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-------EDCELKILD 164
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A + T + APE++ Y VDIWS GC+
Sbjct: 165 FGLARHTDDEMTGYVA-------------TRWYRAPEIMLNWMH---YNQTVDIWSVGCI 208
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
+ ELLT + + G ++ LI + L+ + S QS + K
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 1099 ETLSF---LVDVFRRCTEENPTERPTAGDL 1125
+ VD+ + + +R TA
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-24
Identities = 50/313 (15%), Positives = 108/313 (34%), Gaps = 45/313 (14%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ ++F+ K ++ +++ + L E+ +L L+H IV +
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRL 66
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
+ S K L + E+ ++K ++ + ++
Sbjct: 67 HDVLHSDKKLT--------------LVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+ L HS++++HRD+K +N+LI + +KL +F
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLI-------NRNGELKLANFG----------LARA 150
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLS 1053
+ V T + P+VL Y +D+WS GC+ EL P + G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 1054 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCT 1112
+ I ++ ++ +++ + L+ D+ +
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 1113 EENPTERPTAGDL 1125
+ NP +R +A +
Sbjct: 268 KCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (251), Expect = 1e-23
Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 51/278 (18%)
Query: 859 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+++L LR I+ + +P A+ E+V K + L
Sbjct: 79 EIKILENLRGGPNIITLADIVK----------DPVSRTP--ALVFEHVNNTDFKQLYQTL 126
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
++ F ++ AL HS IMHRD+K N++ID E +K ++L
Sbjct: 127 TD--------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK------LRLI 172
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037
D+ A V + + PE+ + +Y +D+WS GC
Sbjct: 173 DWGLAEFYHPGQEYNV-----------RVASRYFKGPEL---LVDYQMYDYSLDMWSLGC 218
Query: 1038 LLLELLTLQVPYM-GLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1095
+L ++ + P+ G + I ++ L D ++ + +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 1096 AELETLSF--------LVDVFRRCTEENPTERPTAGDL 1125
E S +D + + R TA +
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 8e-23
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 66/292 (22%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGNP 891
A KV A + E ++L +R S +V ++ + L
Sbjct: 56 AMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHYAFQTETKLH------ 105
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+ ++Y+ GG + ++ + E V + + ++ AL LH I++
Sbjct: 106 --------LILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLGIIY 152
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RDIK ENIL+D V L DF + + G +
Sbjct: 153 RDIKLENILLD-------SNGHVVLTDFGLSKEFVADETERAYDFCGTI---------EY 196
Query: 1012 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1071
MAP+++R + VD WS G L+ ELLT P+ E I
Sbjct: 197 MAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---- 250
Query: 1072 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123
+P E + D+ +R ++P +R G
Sbjct: 251 --------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 1e-22
Identities = 61/283 (21%), Positives = 103/283 (36%), Gaps = 71/283 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-- 916
E+++L + H V L A P L+ + +E+ K G++ Y+
Sbjct: 66 ELKILIHIGHHLNV---------VNLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKR 113
Query: 917 ---------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
+ + ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----- 168
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
K VVK+CDF A + +WMAPE + Y
Sbjct: 169 --EKNVVKICDFGLARDIYKDPDYVRKGD--------ARLPLKWMAPETIFDRV----YT 214
Query: 1028 LEVDIWSYGCLLLELLTLQV-PYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVA 1085
++ D+WS+G LL E+ +L PY G+ E ++ G R R D
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT----------- 263
Query: 1086 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1128
PE + C P++RPT +L E
Sbjct: 264 --------PE--------MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 47/281 (16%), Positives = 92/281 (32%), Gaps = 52/281 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ + H I+ + K L + ME + + +L
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ--------DVYLVMELMDANLCQVIQMELD 117
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ ++ + + LHS I+HRD+K NI++ +K+ D
Sbjct: 118 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------KSDCTLKILD 162
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038
F A + V T + APEV+ M Y VDIWS GC+
Sbjct: 163 FGLARTAGTSFMMTPY-----------VVTRYYRAPEVILGMG----YKENVDIWSVGCI 207
Query: 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1098
+ E++ ++ + G ++ + + + ++ L + V +L
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 1099 ETLSF--------------LVDVFRRCTEENPTERPTAGDL 1125
S D+ + +P +R + D
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 4e-21
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 43/229 (18%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ L E R+L A+ +V++ + L + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ S A F A + LHS +++RD+K EN
Sbjct: 131 HLRRI-------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+LI D + +++ DF A ++ T C GTP +APE++
Sbjct: 172 LLI-------DQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIIL 211
Query: 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1067
+ Y VD W+ G L+ E+ P+ ++I++ I GK
Sbjct: 212 SKG----YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 4e-17
Identities = 48/290 (16%), Positives = 96/290 (33%), Gaps = 46/290 (15%)
Query: 859 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+++L + + + G K L +H + + + V +N +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDH-----FNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVK 975
+ + + + + I++ + L +H + I+H DIK EN+L+++ + +K
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIK 172
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1035
+ D A T + +PEVL +G DIWS
Sbjct: 173 IADLGNACWYDEHYTNSI-------------QTREYRSPEVLLGAP----WGCGADIWST 215
Query: 1036 GCLLLELLTLQVPYMG-------------------LSELEIHDLIQMGKRPRLTDELEAL 1076
CL+ EL+T + L EL + L + L
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 1077 GSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 1125
+ + + + + + + D + +P +R AG L
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 7e-14
Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 17/197 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNG 130
L N ++ I +G L L GN++ + + NL L+ +IS+
Sbjct: 202 LIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLA--- 257
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
L+ L L EL+L ++ +S +AGL + + I L NL
Sbjct: 258 -PLSGLTKLTELKLGANQ-----ISNISPLAGLTA-LTNLELNENQLEDISPISNLKNLT 310
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L L FN + + + L L L ANNK+ ++ S L L + L +N+++ L
Sbjct: 311 YLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDVSS-LANLTNINWLSAGHNQISDL-- 366
Query: 251 LDLCLMHNLQNLNLQYN 267
L + + L L
Sbjct: 367 TPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 3e-11
Identities = 37/176 (21%), Positives = 73/176 (41%), Gaps = 16/176 (9%)
Query: 96 LKFFGNEINLFPSEVG--NLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSV 153
L N+I+ NL L ++ G L L L +L+L+ +
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN-----NQ 252
Query: 154 LTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213
++ L+ ++GL LT+L + I + P G + + I LK L
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISPLAGLTAL--TNLELNENQLEDISPISNLKNLT 310
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + N + ++ + L +L+ L +NN+++ + SL + N+ L+ +N++
Sbjct: 311 YLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDVSSL--ANLTNINWLSAGHNQI 363
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 1e-07
Identities = 28/163 (17%), Positives = 60/163 (36%), Gaps = 10/163 (6%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
++ G ++ L L N ++ + + KL LK N+I+ G L
Sbjct: 231 LKDIGTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAG--LTAL 287
Query: 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ + ++ LK L L L + ++ +S ++ L L +L + +
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYF-----NNISDISPVSSLTKLQRLFFANNKVS 342
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
+ L+N+ L N++ L + L + L + +
Sbjct: 343 D-VSSLANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 25/112 (22%), Positives = 49/112 (43%), Gaps = 4/112 (3%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + L+NLE L + N++ + + L L L + N+L ++ + L
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGT-LAS 239
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L L +LDL+NN++++L L + L L L N++ + +
Sbjct: 240 LTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTN 289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 15/98 (15%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L+ + L + ++ L + +L+ + + G+ L L ++ SNN+L
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQL 78
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
T + L + L ++ + N++ + +
Sbjct: 79 TDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTG 114
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 65.2 bits (157), Expect = 1e-11
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 10/93 (10%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ S + +LE+L++S NK+ LP L+ L + N L E+P L
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAEVPE---L 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
Q L+ L + N L + ++++L +
Sbjct: 323 PQNLKQLHVEYNPLREFPD----IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.0 bits (146), Expect = 3e-10
Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 7/74 (9%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265
+L L V+NNKL+ELP+ L RLE L S N L + L NL+ L+++
Sbjct: 280 CDLPPSLEELNVSNNKLIELPA---LPPRLERLIASFNHLAEVPEL----PQNLKQLHVE 332
Query: 266 YNKLLSYCQVPSWI 279
YN L + +P +
Sbjct: 333 YNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 12/100 (12%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
N EQ +++ ++++ C + L++ N L LP L LE+L S N LT
Sbjct: 20 GNGEQREMAVSRLR-----DCLDRQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT 71
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
L L +L++L + N L + +P + N
Sbjct: 72 ELPE----LPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 107
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 1e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 7/99 (7%)
Query: 185 CL-SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
CL +L+L+ + LP +L+ SL + N L ELP L Q L++L + NN
Sbjct: 35 CLDRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLTELPE---LPQSLKSLLVDNN 88
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
L +L L L + + N I
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDV 127
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
+L + + + LP +LE L S N + LP LK SL V NN L L
Sbjct: 40 AHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLK---SLLVDNNNLKAL 93
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
LL+ L + +L L + + ++ N +L+ L N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.7 bits (144), Expect = 2e-11
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 3/112 (2%)
Query: 154 LTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213
LT+L + L +T L + H +R LPP + L LE L S N ++ + + L L
Sbjct: 10 LTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQ 68
Query: 214 SLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L + NN+L + L RL L+L N L + L L +++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.8 bits (139), Expect = 1e-10
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ L + LDLS N+++ LP + L+ L L+ ++N L + L RL+ L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGV-ANLPRLQELL 71
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L NNRL ++ L L LNLQ N L + + L
Sbjct: 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 1e-10
Identities = 48/238 (20%), Positives = 86/238 (36%), Gaps = 37/238 (15%)
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLG-LECLQIKISSPGVNGFALN 134
+ + P + KL L N++ P ++ L L + +I+ + F
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
Query: 135 KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
+ EL P S G+K L+ + + +I +P G +L +L L
Sbjct: 124 NQMIVVEL---GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHL 178
Query: 195 SFNKMK-YLPTEICYLKALISLK------------------------VANNKLVELPSGL 229
NK+ + L L L + NNKLV++P GL
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMH------NLQNLNLQYNKLLSYCQVPSWICC 281
+ ++ + L NN ++++GS D C + ++L N + + PS C
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.3 bits (124), Expect = 1e-07
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 16/210 (7%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLK 137
L +PK + L N+I + + NL L L + + ++ A L
Sbjct: 22 LEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 79
Query: 138 GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSF 196
L+ L LSK + L L E +L V I + + L+ + ++L
Sbjct: 80 KLERLYLSK-----NQLKELPEKMPKTL-QELRVHENEITKVRKSVFNGLNQMIVVELGT 133
Query: 197 NKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253
N +K +K L +++A+ + +P GL L L L N++T + + L
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASL 191
Query: 254 CLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++NL L L +N + + +L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 28/148 (18%), Positives = 51/148 (34%), Gaps = 11/148 (7%)
Query: 166 LTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLV 223
L + + I + + L NL L L NK+ + P L L L ++ N+L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 224 ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI---- 279
ELP + + L+ L + N +T + ++ + + L N L S
Sbjct: 93 ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 280 ---CCNLEGNGKDSSNDDFISSSAEMDV 304
+ + S E+ +
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHL 178
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 3/101 (2%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 64
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
N+++ + + L+ L L N+L + L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL 105
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.3 bits (140), Expect = 4e-10
Identities = 27/197 (13%), Positives = 59/197 (29%), Gaps = 65/197 (32%)
Query: 850 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 909
S E R L L+ + ++Y + +A+ ME +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAWE------------------GNAVLMELIDAKE 96
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
+ + + + + + + + + I+H D+ N+L+
Sbjct: 97 LYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVS------- 137
Query: 970 GKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
+ + + DF ++V + R L DV ++ +
Sbjct: 138 -EEGIWIIDFPQSVEVGEEGWREIL-----------ERDVRN---------IITYFSRT- 175
Query: 1025 LYGLEVDIWSYGCLLLE 1041
Y E DI S +L+
Sbjct: 176 -YRTEKDINSAIDRILQ 191
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 7e-09
Identities = 15/102 (14%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 188 NLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDL 240
+++ LD+ ++ + L+ +++ + L ++ S L + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+N L +G + + +Q L + C +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 20/90 (22%), Positives = 27/90 (30%), Gaps = 23/90 (25%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
S L L L+ + ++ L + L L LDLSNN
Sbjct: 367 PGSVLRVLWLADCDVS------------------DSSCSSLAATLLANHSLRELDLSNNC 408
Query: 245 LTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L G L L + L+ L L
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYW 438
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 9e-08
Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 10/128 (7%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
L +L + L + + Q L ++ P ++ + L ++ L
Sbjct: 1 LNELK--PEQVEQLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAATL 57
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCL--MHNLQNLNLQYNKL-----LSYCQVPSW 278
+ L +L+LSNNRL L + + NL+ LNL N+L L +
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 279 ICCNLEGN 286
L+GN
Sbjct: 118 EELWLDGN 125
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 8e-06
Identities = 24/95 (25%), Positives = 40/95 (42%), Gaps = 3/95 (3%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV---ELPSGLYLLQRLE 236
P++ + L+ + L + L+SL ++NN+L ++ S + L+
Sbjct: 35 DPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N L S LD L+ L L N L
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 16/60 (26%), Positives = 24/60 (40%), Gaps = 3/60 (5%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLSYCQVPS 277
N LP GL L+ L +L++S N L G + + NK L +P+
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLC--GEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.4 bits (103), Expect = 6e-05
Identities = 25/84 (29%), Positives = 36/84 (42%), Gaps = 1/84 (1%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLY 230
S+ + ++G NL LDL N++ LP + LK L SL V+ N L
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 231 LLQRLENLDLSNNRLTSLGSLDLC 254
LQR + +NN+ L C
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 3e-04
Identities = 14/58 (24%), Positives = 20/58 (34%), Gaps = 1/58 (1%)
Query: 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
L LP + L L L++SFN + + L+ ANNK
Sbjct: 247 NGLDLRNNRIYGT-LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 16/70 (22%), Positives = 24/70 (34%), Gaps = 2/70 (2%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
E+ + + + + L LP L + L LS N L + L L LNL
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 265 QYNKLLSYCQ 274
+L
Sbjct: 63 DRAELTKLQV 72
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 12/58 (20%), Positives = 21/58 (36%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ L NL+ L L N + +P L + N + LY + L++
Sbjct: 165 AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQD 222
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 46/236 (19%), Positives = 82/236 (34%), Gaps = 7/236 (2%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
+ + ++L+ N + ++ S L L N + + L L +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
+ GL L + GL L L + +++ LP +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 187 S-NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNN 243
NL L L N++ +P L +L L + N++ + P L RL L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299
L++L + L + LQ L L N + C+ + L+ S+ + S
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKF--RGSSSEVPCSL 264
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 11/100 (11%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
+L+ ++ K + + ++ + ++ N + L + + LE + S+
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+ + L L+ KL + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 9/78 (11%), Positives = 21/78 (26%), Gaps = 4/78 (5%)
Query: 210 KALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM----HNLQNLNLQ 265
K+L + + + L ++ + LS N + + + L +L+
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 266 YNKLLSYCQVPSWICCNL 283
L
Sbjct: 68 DIFTGRVKDEIPEALRLL 85
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 1/94 (1%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL+ + T + +I+ + + + + + + R++++DLSN+ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 252 D-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L LQNL+L+ +L NL
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 24/140 (17%), Positives = 41/140 (29%), Gaps = 25/140 (17%)
Query: 142 LELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY 201
L+L+ P V L + + + E ++ +DLS +
Sbjct: 5 LDLTGKNLHPDVTGRLLS----QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS---- 56
Query: 202 LPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQN 261
++ L L +L+NL L RL+ L NL
Sbjct: 57 -----------------VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 99
Query: 262 LNLQYNKLLSYCQVPSWICC 281
LNL S + + +
Sbjct: 100 LNLSGCSGFSEFALQTLLSS 119
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 3e-04
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 1/102 (0%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLV 70
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+NNR+ +G + +L L L N L+ +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 112
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 23/134 (17%), Positives = 46/134 (34%), Gaps = 1/134 (0%)
Query: 151 PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLK 210
++ ++ +L + + I + L + +D S N+++ L +
Sbjct: 5 AELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
Query: 211 ALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L N L L L L+NN L LG LD + +L L + N +
Sbjct: 65 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124
Query: 270 LSYCQVPSWICCNL 283
+ ++ +
Sbjct: 125 TNKKHYRLYVIYKV 138
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
I + + + + L ++ + +N+ + S+ + + N+ L L NK
Sbjct: 23 FAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGNK 79
Query: 269 LLSYCQVPSWICCNL 283
L + +
Sbjct: 80 LTDIKPLANLKNLGW 94
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
+ L L +LK +NK+ ++ L L L + L NN+++ + L NL + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSPLANT--SNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L I + + + + + L + L +T++ + +NL L L+ N+
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTIEGVQYL--NNLIGLELKDNQ 74
Query: 269 LLSYCQVPSWICCNL 283
+ + +
Sbjct: 75 ITDLAPLKNLTKITE 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 0.001
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKL 222
+ ++ LP ++ S LD+S ++ LP+ L+ L L+ + L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNL 235
Query: 223 VELPS 227
+LP+
Sbjct: 236 KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 11/39 (28%), Positives = 16/39 (41%)
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.003
Identities = 10/64 (15%), Positives = 23/64 (35%), Gaps = 2/64 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
+K+ E+PS L + L +L + +L+ + + N +L + +
Sbjct: 17 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 279 ICCN 282
Sbjct: 75 SNLP 78
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 10/74 (13%), Positives = 25/74 (33%), Gaps = 3/74 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L + + + + S L ++ L + S+ ++ +NL +N N+
Sbjct: 17 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSIDGVEYL--NNLTQINFSNNQ 73
Query: 269 LLSYCQVPSWICCN 282
L + +
Sbjct: 74 LTDITPLKNLTKLV 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1141 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.93 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.65 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.63 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.34 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.14 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.31 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.14 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.86 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.43 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.37 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.71 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.69 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.53 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.02 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=436.76 Aligned_cols=257 Identities=24% Similarity=0.286 Sum_probs=215.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
++++|++.+.||+|+||+||+|++. +..+|+|+..... .........+.+|+.++++++|||||++++++.++
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 4778999999999999999999985 5668888754221 11122334558999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. .|+|||||++|+|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 79 ~~--------------~~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 79 TR--------------VYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEeecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence 53 4999999999999999976 2469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+...... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~-------~~~kl~DFG~a~~~~~~~------------~~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvilye 196 (263)
T d2j4za1 140 GSA-------GELKIADFGWSVHAPSSR------------RTTLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCYE 196 (263)
T ss_dssp CTT-------SCEEECCCCSCSCCCCCC------------CEETTEEGGGCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEeecccceeeecCCCc------------ccccCCCCcccCHHHHcC----CCCCchhhhhhHhHHHHH
Confidence 987 789999999997654321 123469999999999986 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|+.||.+.+..++...+...... ++ ...++++.+|+.+||+.||++|||
T Consensus 197 ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 197 FLVGKPPFEANTYQETYKRISRVEFT-FP---------------------------DFVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTTCCC-CC---------------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCC-CC---------------------------ccCCHHHHHHHHHHccCCHhHCcC
Confidence 99999999988888877777554321 11 135567999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001143 1122 AGDLYEMFVARTSS 1135 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s 1135 (1141)
++|+++|+|+...+
T Consensus 249 ~~eil~hp~~~~~s 262 (263)
T d2j4za1 249 LREVLEHPWITANS 262 (263)
T ss_dssp HHHHHTCHHHHHHC
T ss_pred HHHHHcCcCcCCcC
Confidence 99999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=435.83 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=214.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.+|++.++||+|+||+||+|++. +..||+|+...... . ..+. +.+|+.++++++|||||++++++.+.+.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~--~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--P--KKEL----IINEILVMRENKNPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--S--CHHH----HHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--h--HHHH----HHHHHHHHHhCCCCCEeeEeEEEEECCE
Confidence 46999999999999999999974 77788888654421 1 1223 4799999999999999999999987653
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.|+|||||+||+|.+++.+ ..+++.+++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 92 --------------~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 92 --------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp --------------EEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred --------------EEEEEEecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 4999999999999998865 36999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+.+..... .....+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 152 ~-------~~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyeml 210 (293)
T d1yhwa1 152 D-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEMI 210 (293)
T ss_dssp T-------CCEEECCCTTCEECCSTTC----------CBCCCCSCGGGCCHHHHSS----SCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CcEeeccchhheeeccccc----------cccccccCCCccChhhhcC----CCCCchhceehHhHHHHHHh
Confidence 7 7899999999987543211 1224579999999999986 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||.+.+..+....+.....+.+.. ....++.+++||.+||+.||.+|||++
T Consensus 211 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ 265 (293)
T d1yhwa1 211 EGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLDMDVEKRGSAK 265 (293)
T ss_dssp HSSCTTTTSCHHHHHHHHHHHCSCCCSS-------------------------GGGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------cccCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999999887777666554433332211 114567799999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 001143 1124 DLYEMFVARTSSSIS 1138 (1141)
Q Consensus 1124 ElL~~L~~~~~s~~s 1138 (1141)
|+++|+|++.....+
T Consensus 266 eil~Hp~~~~~~~~~ 280 (293)
T d1yhwa1 266 ELLQHQFLKIAKPLS 280 (293)
T ss_dssp HHTTCGGGGGCCCGG
T ss_pred HHhcCHhhCCCCCCC
Confidence 999999998655443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=430.84 Aligned_cols=260 Identities=27% Similarity=0.365 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||+||+|++. +..||+|+... ........+. +.+|++++++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~--~~~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY--GSMTEAEKQM----LVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--TTSCHHHHHH----HHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEECh--hhCCHHHHHH----HHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 367999999999999999999985 55678887543 2333343344 489999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCC
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSE 957 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g-----IvHrDLKP~ 957 (1141)
. ...|+|||||+||+|.+++.+.... ...+++..++.|+.||+.||+|||+++ |+||||||+
T Consensus 77 ~------------~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 77 N------------TTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred C------------CEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 1 1459999999999999999764433 347999999999999999999999876 999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1037 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1037 (1141)
|||++.+ +.+||+|||+|+.+..... ......||+.|+|||++.+ ..|+.++|||||||
T Consensus 144 NIll~~~-------~~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGv 202 (269)
T d2java1 144 NVFLDGK-------QNVKLGDFGLARILNHDTS----------FAKAFVGTPYYMSPEQMNR----MSYNEKSDIWSLGC 202 (269)
T ss_dssp GEEECTT-------SCEEECCHHHHHHC---------------------CCCSCCCHHHHTT----CCCCHHHHHHHHHH
T ss_pred hcCcCCC-------CcEEEeeccceeecccCCC----------ccccCCCCcccCCHHHHcC----CCCChHHHHHhhCH
Confidence 9999987 7899999999987643211 1224579999999999976 57899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1038 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1038 iL~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++|||+||+.||.+.+..++...+..+..+.++. ..++++.+||.+||+.||.
T Consensus 203 ilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHcCCChh
Confidence 9999999999999988888888877665443321 4556799999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001143 1118 ERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~ 1131 (1141)
+|||++|+++|+|.
T Consensus 256 ~Rps~~ell~hp~i 269 (269)
T d2java1 256 HRPSVEEILENPLI 269 (269)
T ss_dssp GSCCHHHHHTSTTC
T ss_pred HCcCHHHHHhCCcC
Confidence 99999999999983
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=431.31 Aligned_cols=261 Identities=24% Similarity=0.276 Sum_probs=205.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.++||+|+||+||+|++. +..+|+|+...+.. ....+ ++.+|+.++++++|||||++++++.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~----~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPE----NIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHH----HHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 568999999999999999999985 66788888653321 11222 3489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .|+||||++||+|.++++. ...+++.+++.|+.||+.||+|||++||+||||||+|||++
T Consensus 77 ~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 77 I--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp E--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred e--------------eEEEEeccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 3 4999999999999999854 34799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ...++.++|||||||++|||
T Consensus 138 ~~-------~~~KL~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~---~~~~~~~~DiwSlGvilyem 199 (271)
T d1nvra_ 138 ER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAM 199 (271)
T ss_dssp TT-------CCEEECCCTTCEECEETTEE--------CCBCCCCSCGGGSCTHHHHC---SSBCHHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccchhheeeccCCcc--------ccccceeeCcCccCHhHhcC---CCCCCCceeeeHhHHHHHHH
Confidence 87 78999999999876432211 11224579999999999976 12346889999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
++|+.||....... ....+........ .....++++.+|+.+||+.||++|||
T Consensus 200 l~G~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 253 (271)
T d1nvra_ 200 LAGELPWDQPSDSCQEYSDWKEKKTYLN--------------------------PWKKIDSAPLALLHKILVENPSARIT 253 (271)
T ss_dssp HHSSCSCSSSSTTSHHHHHHHTTCTTST--------------------------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCC--------------------------ccccCCHHHHHHHHHHcCCChhHCcC
Confidence 99999997644322 2222222111100 01145677899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001143 1122 AGDLYEMFVARTSS 1135 (1141)
Q Consensus 1122 a~ElL~~L~~~~~s 1135 (1141)
++|+++|+|++..-
T Consensus 254 ~~eil~hpwf~~~l 267 (271)
T d1nvra_ 254 IPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHHTTCTTTTCCC
T ss_pred HHHHhcCHhhCcCC
Confidence 99999999997543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=428.68 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=214.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.|++.++||+|+||+||+|++. +..+|+|+.... .....+.+ .+|+.+|++++|||||++++++.+.+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~----~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGT----HHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHH----HHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 35899999999999999999985 556777775422 22333444 799999999999999999999987653
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++|||||+||+|.+++.+. ...+++.++..|+.||+.||+|||++||+||||||+|||++.
T Consensus 84 --------------~~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 84 --------------LWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp --------------EEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred --------------EEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence 49999999999999998752 346999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1042 (1141)
+ +.+||+|||+|+........ .....||+.|+|||++.... ....|+.++|||||||++|||
T Consensus 146 ~-------~~~Kl~DFG~a~~~~~~~~~----------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 146 D-------GDIKLADFGVSAKNTRTIQR----------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp T-------SCEEECCCTTCEECHHHHHH----------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEechhhhccCCCccc----------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence 7 78999999999765432111 12346999999999986432 235688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..++...+..+..+.+... ...++++.+||.+||+.||.+|||+
T Consensus 209 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~ 263 (288)
T d2jfla1 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQP-------------------------SRWSSNFKDFLKKCLEKNVDARWTT 263 (288)
T ss_dssp HHSSCTTTTSCGGGHHHHHHHSCCCCCSSG-------------------------GGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCCCCcc-------------------------ccCCHHHHHHHHHHccCChhHCcCH
Confidence 999999998888777777766554433210 1456789999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
+|+++|+|+...
T Consensus 264 ~ell~hp~~~~~ 275 (288)
T d2jfla1 264 SQLLQHPFVTVD 275 (288)
T ss_dssp HHHTTSGGGCCC
T ss_pred HHHhcCcccCCC
Confidence 999999999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=421.22 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=202.2
Q ss_pred ceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 808 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~~~~--~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
|++.++||+|+||+||+|++..+ .||+|+. ..........+. +.+|+++|++++|||||++++++.+...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i--~~~~~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~~-- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTVK-- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEE--EGGGSCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEEESS--
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEE--chhhCCHHHHHH----HHHHHHHHHhCCCCCeeeEEEEEeeccc--
Confidence 47888999999999999999654 4555554 333333333444 4899999999999999999999875321
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCeeeec
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL 963 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IvHrDLKP~NILld~ 963 (1141)
.....|+||||+++|+|.+++.+ ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 83 --------~~~~~~ivmE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 83 --------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp --------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred --------cCCEEEEEEeCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 12356999999999999999976 246999999999999999999999998 999999999999964
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+. +.+||+|||+|+...... ....+||+.|+|||++.+ .++.++|||||||++|||+
T Consensus 150 ~~------~~~Kl~DFGla~~~~~~~------------~~~~~GT~~Y~aPE~~~~-----~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 150 PT------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp TT------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC------CCEEEeecCcceeccCCc------------cCCcccCccccCHHHhCC-----CCCCcCchhhHHHHHHHHH
Confidence 21 789999999997543211 124579999999999864 5889999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~-~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
+|+.||.+.. ..++...+..+..+.. .....++++.+||.+||++||++|||+
T Consensus 207 ~g~~Pf~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~ 260 (270)
T d1t4ha_ 207 TSEYPYSECQNAAQIYRRVTSGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSI 260 (270)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HCCCCCCCcccHHHHHHHHHcCCCCcc--------------------------cCccCCHHHHHHHHHHccCCHhHCcCH
Confidence 9999997644 4445555554433211 111345679999999999999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
+|+++|+|++
T Consensus 261 ~ell~Hp~fk 270 (270)
T d1t4ha_ 261 KDLLNHAFFQ 270 (270)
T ss_dssp HHHHTSGGGC
T ss_pred HHHhCCcccC
Confidence 9999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=421.05 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=206.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.++|++.++||+|+||+||+|++++ .||||+.+.. .......+.+ .+|+.++++++|||||++++++.+.
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~--~~~~~~~~~~----~~E~~~l~~l~HpnIv~~~~~~~~~-- 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP-- 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCS--SCCTTHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcc--cCCHHHHHHH----HHHHHHHHhCCCCCEeeeeEEEecc--
Confidence 35679999999999999999998765 5888875433 3333444444 8999999999999999999987532
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++||||||||+|||++.
T Consensus 77 -------------~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~ 139 (276)
T d1uwha_ 77 -------------QLAIVTQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE 139 (276)
T ss_dssp -------------SCEEEEECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred -------------EEEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC
Confidence 23899999999999999975 2346999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+........ .......||+.|||||++.+.. ...|+.++|||||||++|||+
T Consensus 140 ~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~-~~~~~~~sDiwS~Gv~l~el~ 203 (276)
T d1uwha_ 140 D-------LTVKIGDFGLATVKSRWSGS--------HQFEQLSGSILWMAPEVIRMQD-KNPYSFQSDVYAFGIVLYELM 203 (276)
T ss_dssp T-------SSEEECCCCCSCC--------------------CCCCGGGCCHHHHTTCS-SCCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccccceeeccccCCc--------ccccccccCcccCCHHHHhccc-CCCCCchhhhhhhHHHHHHHH
Confidence 7 88999999999765432211 1123456999999999997532 245889999999999999999
Q ss_pred hCCCCCCCCCHHH-HHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 TLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~e-l~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
||+.||.+.+... +...+..+..++... .....+++++.+|+.+||+.||++||||
T Consensus 204 tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~-----------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~ 260 (276)
T d1uwha_ 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLS-----------------------KVRSNCPKAMKRLMAECLKKKRDERPLF 260 (276)
T ss_dssp HSSCTTTTCCCHHHHHHHHHHTSCCCCGG-----------------------GSCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCChHHHHHHHHhcCCCCCcch-----------------------hccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 9999998765544 444444443322111 0111566789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
+||+++++...
T Consensus 261 ~~il~~Le~l~ 271 (276)
T d1uwha_ 261 PQILASIELLA 271 (276)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=425.01 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=210.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh-HHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.|++.++||+|+||+||+|++. +..||||+.... .... ...+ .+.+|+.+|++++|||||++++++.+.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECC--SSCHHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchh--hccCHHHHH----HHHHHHHHHHHCCCCCEeeEEEEEEECC-
Confidence 3899999999999999999985 556777775432 2222 2223 3489999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+.|+|||||++|+|..++.. ..++++.+++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 89 -------------~~~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 150 (309)
T d1u5ra_ 89 -------------TAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (309)
T ss_dssp -------------EEEEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred -------------EEEEEEEecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC
Confidence 34999999999999777654 347999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+..... ....||+.|||||++.+.. ...|+.++|||||||++|||+
T Consensus 151 ~-------~~~Kl~DFG~a~~~~~~--------------~~~~GT~~Y~APE~~~~~~-~~~y~~~~DiwSlGvilyel~ 208 (309)
T d1u5ra_ 151 P-------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 208 (309)
T ss_dssp T-------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHTTTT-SCCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecccccccCCC--------------CccccCccccCHHHHhccC-CCCcCchhhhhhHHHHHHHHH
Confidence 7 89999999999754321 1346999999999987522 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||.+....+....+.....+.+.. ...++++.+||.+||+.||.+|||++
T Consensus 209 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ 262 (309)
T d1u5ra_ 209 ERKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSE 262 (309)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCCC--------------------------CCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 9999999888877777665554433221 14566799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001143 1124 DLYEMFVARTSS 1135 (1141)
Q Consensus 1124 ElL~~L~~~~~s 1135 (1141)
|+++|+|+....
T Consensus 263 ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 263 VLLKHRFVLRER 274 (309)
T ss_dssp HHTTCHHHHSCC
T ss_pred HHHhCHHhcCCC
Confidence 999999997543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=421.83 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=215.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.|++.++||+|+||+||+|++. +..||+|+........... ......+.+|+.+|++++|||||++++++.+..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT- 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 35999999999999999999985 6678888865432221111 111223489999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+.|+|||||+||+|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 87 -------------~~~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 87 -------------DVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 34999999999999999976 246999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
++. ....+|++|||+|........ .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 149 ~~~---~~~~vkl~DfG~a~~~~~~~~-----------~~~~~~t~~y~APE~~~~----~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 149 RNV---PKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SSS---SSCCEEECCCTTCEECTTSCB-----------CSCCCCCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred CCC---cccceEecchhhhhhcCCCcc-----------ccccCCCCcccCHHHHcC----CCCCCcccchhhhHHHHHHH
Confidence 621 124699999999976543221 124468999999999986 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
+|+.||.+.+..+....+..+........ ....++.+++||.+||+.||.+|||++
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ 266 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDEY------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQ 266 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCchh------------------------cCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999999888888877766543322111 114567799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+|++.
T Consensus 267 eil~hp~~~~ 276 (293)
T d1jksa_ 267 DSLQHPWIKP 276 (293)
T ss_dssp HHHHSTTTCC
T ss_pred HHhcCcccCC
Confidence 9999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=422.56 Aligned_cols=258 Identities=21% Similarity=0.254 Sum_probs=209.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.+.||+|+||+||+|++. +..||+|+..... .........+.+|+.++++++|||||++++++.+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH-----IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH-----ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 367999999999999999999984 6678888764321 111112234589999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~--------------~~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 82 K--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp E--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEEccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 3 4999999999999999876 24699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+|+.+...... ......+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 143 ~~-------~~vkl~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 143 ED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TT-------SCEEECCCTTCEECC------------------CCCCGGGCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------ceEEecccccceecccCCcc--------cccccccCCccccCceeecc----CCCCcccceehhhHHHHHH
Confidence 87 78999999999876432211 11224569999999999986 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..++...+..+... ++ ...++++.+||.+||+.||.+|||+
T Consensus 204 l~g~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dP~~R~t~ 255 (288)
T d1uu3a_ 204 VAGLPPFRAGNEYLIFQKIIKLEYD-FP---------------------------EKFFPKARDLVEKLLVLDATKRLGC 255 (288)
T ss_dssp HHSSCSSCCSSHHHHHHHHHTTCCC-CC---------------------------TTCCHHHHHHHHTTSCSSGGGSTTS
T ss_pred hhCCCCCCCcCHHHHHHHHHcCCCC-CC---------------------------ccCCHHHHHHHHHHccCCHhHCcCH
Confidence 9999999988888887777654321 11 1345679999999999999999999
Q ss_pred HH------HHHHHHhhc
Q 001143 1123 GD------LYEMFVART 1133 (1141)
Q Consensus 1123 ~E------lL~~L~~~~ 1133 (1141)
+| +++|+||..
T Consensus 256 ~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 256 EEMEGYGPLKAHPFFES 272 (288)
T ss_dssp GGGTCHHHHHTSGGGTT
T ss_pred HHHcCCHHHHcCCccCC
Confidence 88 567777754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-46 Score=420.00 Aligned_cols=263 Identities=20% Similarity=0.340 Sum_probs=203.2
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
...+|++.++||+|+||+||+|++.. ..++|+++.+... ......+.| .+|+.+|++++|||||++++++.+
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHH----HHHHHHHHhCCCCCCccEEEEEee
Confidence 35679999999999999999999842 3345666555432 223333444 899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.+.+ ++|||||++|+|.+++.. ....+++.++..|+.||+.||.|||+++|+||||||+|||
T Consensus 99 ~~~~--------------~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 99 STPV--------------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL 160 (299)
T ss_dssp SSSC--------------EEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCEE--------------EEEEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEE
Confidence 6544 999999999999998875 2346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +++||+|||+|+.+........ ........||+.|+|||++.+ ..++.++|||||||++|
T Consensus 161 l~~~-------~~~Kl~DFGla~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~----~~~~~~sDvwS~Gvvl~ 224 (299)
T d1jpaa_ 161 VNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSALGGKIPIRWTAPEAIQY----RKFTSASDVWSYGIVMW 224 (299)
T ss_dssp ECTT-------CCEEECCC----------------------------CGGGSCHHHHHS----CCCCHHHHHHHHHHHHH
T ss_pred ECCC-------CcEEECCcccceEccCCCCcce-----eeecccccCCccccCHHHHhc----CCCCcccccccchHHHH
Confidence 9987 8899999999987654221110 011112357999999999886 57899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
||+| |+.||.+....++...+..+..+..+. .+++.+.+|+.+||+.||++|
T Consensus 225 el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 225 EVMSYGERPYWDMTNQDVINAIEQDYRLPPPM---------------------------DCPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhHC
Confidence 9998 899999888888888876655443221 456679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001143 1120 PTAGDLYEMFVAR 1132 (1141)
Q Consensus 1120 PSa~ElL~~L~~~ 1132 (1141)
|||.||+++|...
T Consensus 278 Ps~~ei~~~L~~~ 290 (299)
T d1jpaa_ 278 PKFGQIVNTLDKM 290 (299)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=428.21 Aligned_cols=280 Identities=23% Similarity=0.300 Sum_probs=203.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
-++|++.++||+|+||+||+|++. +..||+|+.+.+ .. .... .++.+|+.+|++++|||||+++++|.+..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~-~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IK-PAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC--CC-TTHH----HHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh--hC-HHHH----HHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357999999999999999999985 566777775433 21 1222 23489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 961 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvHrDLKP~NILl 961 (1141)
+.|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 78 --------------~~~iVmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl 138 (322)
T d1s9ja_ 78 --------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138 (322)
T ss_dssp --------------EEEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred --------------EEEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence 45999999999999999976 2469999999999999999999997 599999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+.+.... ....+||+.|+|||++.+ ..|+.++||||+||++||
T Consensus 139 ~~~-------~~vkl~DFGla~~~~~~~------------~~~~~GT~~Y~APEvl~~----~~y~~~~DiWSlGvil~e 195 (322)
T d1s9ja_ 139 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 195 (322)
T ss_dssp CTT-------CCEEECCCCCCHHHHHHT------------C---CCSSCCCCHHHHHC----SCCCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeCCCccccCCCc------------cccccCCccccCchHHcC----CCCCcHHHHHHHHHHHHH
Confidence 887 889999999998654321 124579999999999987 578999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH---HhCCCCCchhHHhhhccCccccccccC-------------CCCCCchhhhhhHHHHH
Q 001143 1042 LLTLQVPYMGLSELEIHDLI---QMGKRPRLTDELEALGSCHEHEVAQSG-------------SGFEKPEAELETLSFLV 1105 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I---~~~~~p~l~~~l~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~L~ 1105 (1141)
|++|+.||.+.+..+..... ..+.....+.................. ............+.++.
T Consensus 196 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 275 (322)
T d1s9ja_ 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275 (322)
T ss_dssp HHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHH
Confidence 99999999865433221111 111100000000000000000000000 00000001113467899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1106 DVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1106 dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+||.+||+.||.+||||+|+++|+|++.
T Consensus 276 dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 276 DFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 9999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=424.05 Aligned_cols=260 Identities=22% Similarity=0.212 Sum_probs=199.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
.|++.+.||+|+||+||+|++. +..||+|+...... . ... ..+.+|+.+|++++|||||++++++.+++
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~-~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 80 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--E-GKE----GSMENEIAVLHKIKHPNIVALDDIYESGG-- 80 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh--h-hHH----HHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 4999999999999999999985 56688887543321 1 111 23478999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
..|+|||||+||+|.+++.. ...+++.++..|+.||+.||+|||++||+||||||+|||+...
T Consensus 81 ------------~~~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~ 143 (307)
T d1a06a_ 81 ------------HLYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143 (307)
T ss_dssp ------------EEEEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred ------------EEEEEEeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc
Confidence 34999999999999999975 3579999999999999999999999999999999999999642
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
. ..+.+||+|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++
T Consensus 144 ~----~~~~vkl~DFG~a~~~~~~~-----------~~~~~~GT~~y~APE~~~~----~~~~~~~DiwSlGvilyell~ 204 (307)
T d1a06a_ 144 D----EDSKIMISDFGLSKMEDPGS-----------VLSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVIAYILLC 204 (307)
T ss_dssp S----TTCCEEECCC-----------------------------CTTSCHHHHTT----CCCCTHHHHHHHHHHHHHHHH
T ss_pred C----CCceEEEeccceeEEccCCC-----------eeeeeeeCccccCcHHHcC----CCCCcHHHhhhhhHHHHHHHh
Confidence 1 12789999999997654321 1124569999999999986 568999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
|+.||.+....++...+..+....... .....++++.+||.+||+.||++|||++|
T Consensus 205 g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 205 GYPPFYDENDAKLFEQILKAEYEFDSP------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp SSCSCCCSSHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCc------------------------cccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999888888777776544322110 00145678999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001143 1125 LYEMFVARTSS 1135 (1141)
Q Consensus 1125 lL~~L~~~~~s 1135 (1141)
+++|+|+....
T Consensus 261 il~hp~~~~~~ 271 (307)
T d1a06a_ 261 ALQHPWIAGDT 271 (307)
T ss_dssp HHHSTTTTSSC
T ss_pred HhcCHhhCCCC
Confidence 99999997544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-46 Score=427.14 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=214.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.++||+|+||.||+|++. +..||+|+.... .....+. +.+|+.+|++++|||||++++++.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHH----HHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHH----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 568999999999999999999985 567788875322 2233333 489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.|+|||||+||+|.+++.+ ....+++..+..|+.||+.||+|||++|||||||||+|||++
T Consensus 97 --------------~~~ivmE~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~ 158 (350)
T d1koaa2 97 --------------EMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 158 (350)
T ss_dssp --------------EEEEEECCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeec
Confidence 34999999999999999854 234699999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+.. +.+||+|||+|+.+..... .....||+.|||||++.+ ..++.++|||||||++|+|
T Consensus 159 ~~~~-----~~vkL~DFG~a~~~~~~~~-----------~~~~~gT~~Y~aPEv~~~----~~~~~~~DiwSlGvilyel 218 (350)
T d1koaa2 159 TKRS-----NELKLIDFGLTAHLDPKQS-----------VKVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYIL 218 (350)
T ss_dssp STTS-----CCEEECCCTTCEECCTTSC-----------EEEECSCTTTCCHHHHHT----CCBCHHHHHHHHHHHHHHH
T ss_pred cCCC-----CeEEEeecchheecccccc-----------cceecCcccccCHHHHcC----CCCChhHhhhhhhHHHHHH
Confidence 5421 6899999999987654221 124569999999999986 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..++...+.......... .....++++++||.+||+.||++|||+
T Consensus 219 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~ 274 (350)
T d1koaa2 219 LSGLSPFGGENDDETLRNVKSCDWNMDDS------------------------AFSGISEDGKDFIRKLLLADPNTRMTI 274 (350)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCSCCG------------------------GGGGCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999888888887776544321111 111456789999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
+|+++|+|+...
T Consensus 275 ~eil~hp~~~~~ 286 (350)
T d1koaa2 275 HQALEHPWLTPG 286 (350)
T ss_dssp HHHHHSTTTSCT
T ss_pred HHHhcCcccCCC
Confidence 999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=410.49 Aligned_cols=255 Identities=21% Similarity=0.358 Sum_probs=201.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.++|++.++||+|+||+||+|++. +..||||+. +..... .+++ .+|+.++++++|||||+++|++.+.+.
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i--~~~~~~---~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMS---EEDF----IEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEEC--CSSSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEE--CCCcCc---HHHH----HHHHHHHHhcCCCCcccccceeccCCc
Confidence 467999999999999999999985 456788764 332222 2334 799999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
+ ++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++|+||||||+|||++.
T Consensus 75 ~--------------~lv~E~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~ 136 (263)
T d1sm2a_ 75 I--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136 (263)
T ss_dssp C--------------EEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG
T ss_pred e--------------EEEEEecCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC
Confidence 4 999999999999999875 2346899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+........ ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 137 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp G-------GCEEECSCC---------------------------CTTSCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCeEecccchheeccCCCce---------eecceecCcccCChHHhcC----CCCCchhhhcchHHHHHHHH
Confidence 8 78999999999765432211 1123468999999999986 57899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
| |.+||...+..++...+..+..+..+. .+++++.+|+.+||+.||++|||+
T Consensus 197 t~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~p~~Rps~ 249 (263)
T d1sm2a_ 197 SEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWKERPEDRPAF 249 (263)
T ss_dssp TTSCCTTCSCCHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------ccCHHHHHHHHHHccCCHhHCcCH
Confidence 9 577777777777777776665443321 345679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001143 1123 GDLYEMFVART 1133 (1141)
Q Consensus 1123 ~ElL~~L~~~~ 1133 (1141)
+||+++|....
T Consensus 250 ~~il~~L~~i~ 260 (263)
T d1sm2a_ 250 SRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=422.87 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=214.9
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
.++++|++.+.||+|+||.||+|++. +..||+|+...... .......++.+|+.+|++++|||||++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 35789999999999999999999984 66788887643211 111122345799999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.+. .|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 77 ~~~--------------~~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 77 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred ccc--------------cccceeccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 664 4999999999999999986 346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+|+....... .....+||+.|+|||++.+ ..|+.++||||+||++|
T Consensus 138 l~~~-------g~vkl~DFG~a~~~~~~~~----------~~~~~~GT~~Y~aPE~~~~----~~y~~~~DiwSlGvily 196 (337)
T d1o6la_ 138 LDKD-------GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTT-------SCEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ecCC-------CCEEEeecccccccccCCc----------ccccceeCHHHhhhhhccC----CCCChhhcccchhhHHH
Confidence 9988 8899999999976543211 1224579999999999987 57899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
||++|++||.+.+..++...+..+... ++. ..++++.+||.+||++||.+||
T Consensus 197 eml~G~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 197 EMMCGRLPFYNQDHERLFELILMEEIR-FPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHCCCCCCCcCHHHHHHHHhcCCCC-CCc---------------------------cCCHHHHHHHHhhccCCchhhc
Confidence 999999999998888887777654421 111 4556799999999999999999
Q ss_pred C-----HHHHHHHHHhhc
Q 001143 1121 T-----AGDLYEMFVART 1133 (1141)
Q Consensus 1121 S-----a~ElL~~L~~~~ 1133 (1141)
+ ++|+++|+||..
T Consensus 249 ~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TCSTTTHHHHHTSGGGTT
T ss_pred ccccccHHHHHcCccccc
Confidence 4 999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-46 Score=419.46 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=213.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
++++|++.++||+|+||+||+|++. +..||+|+...... ........+.+|+.++++++|||||++++++.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 5788999999999999999999985 66788888643211 1111223458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+ ..|+||||++||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~--------------~~~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl 137 (316)
T d1fota_ 77 Q--------------QIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137 (316)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred C--------------eeeeEeeecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE
Confidence 5 34999999999999999876 4568999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+...... ....||+.|+|||++.+ ..|+.++|||||||++|+
T Consensus 138 ~~~-------g~vkL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~l~~----~~y~~~~DiwSlGvilye 193 (316)
T d1fota_ 138 DKN-------GHIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIYE 193 (316)
T ss_dssp CTT-------SCEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEEEecCccceEecccc-------------ccccCcccccCHHHHcC----CCCCchhhccccchhHHH
Confidence 987 889999999997654321 23569999999999976 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 1120 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP- 1120 (1141)
|++|+.||.+.+..++...+..+.... + ...++++.+++.+||..||.+|+
T Consensus 194 mltG~~Pf~~~~~~~~~~~i~~~~~~~-p---------------------------~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 194 MLAGYTPFYDSNTMKTYEKILNAELRF-P---------------------------PFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHCCCCC-C---------------------------TTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred HHhCCCCCCCcCHHHHHHHHHcCCCCC-C---------------------------CCCCHHHHHHHHHHhhhCHHhccc
Confidence 999999999988888887776544321 1 13456799999999999999996
Q ss_pred ----CHHHHHHHHHhhc
Q 001143 1121 ----TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 ----Sa~ElL~~L~~~~ 1133 (1141)
|++++++|+|++.
T Consensus 246 ~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 246 NLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp SSTTTTHHHHTSGGGSS
T ss_pred cchhhHHHHHcCccccc
Confidence 9999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.4e-46 Score=411.11 Aligned_cols=268 Identities=25% Similarity=0.366 Sum_probs=220.4
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~--~~~~vAvKI~~l~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~ 880 (1141)
.++|++.+.||+|+||+||+|++ .+..+|+|+........ .....+....++.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 46778888865443322 22344555567789999999997 9999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
++. .||||||++||+|.++++. ...+++.+++.|+.||+.||+|||++||+||||||+|||
T Consensus 82 ~~~--------------~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 82 NTF--------------FFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Ccc--------------eEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence 664 4999999999999999976 246999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhcccc--CCCCCCchhhHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLGvi 1038 (1141)
++.+ +.+||+|||+|+.+.... ......||+.|+|||++.+.. ....++.++||||+||+
T Consensus 143 l~~~-------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi 204 (277)
T d1phka_ 143 LDDD-------MNIKLTDFGFSCQLDPGE-----------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204 (277)
T ss_dssp ECTT-------CCEEECCCTTCEECCTTC-----------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred EcCC-------CCeEEccchheeEccCCC-----------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence 9887 889999999998764321 112356999999999987532 23457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|+|++|+.||.+.+..+....+..+....... .....++++++|+.+||+.||.+
T Consensus 205 lyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~~p~~ 260 (277)
T d1phka_ 205 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQPQK 260 (277)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSGGG
T ss_pred hhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc------------------------ccccCCHHHHHHHHHHccCChhH
Confidence 999999999999988887777776554321110 01156678999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001143 1119 RPTAGDLYEMFVART 1133 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~ 1133 (1141)
|||++||++|+|++.
T Consensus 261 R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 261 RYTAEEALAHPFFQQ 275 (277)
T ss_dssp SCCHHHHTTSGGGCT
T ss_pred CcCHHHHHcCHHHHH
Confidence 999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-46 Score=427.12 Aligned_cols=260 Identities=21% Similarity=0.279 Sum_probs=213.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
++.|++.++||+|+||.||+|++. +..||+|+.... .....+ .+.+|+.+|++++|||||+++++|.+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----TVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHH----HHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHH----HHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 456999999999999999999984 667888875432 222223 3479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.|+|||||+||+|.+++.. ...++++.+++.|+.||+.||+|||++||+||||||+|||++
T Consensus 100 --------------~~~ivmE~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~ 161 (352)
T d1koba_ 100 --------------EMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 161 (352)
T ss_dssp --------------EEEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccc
Confidence 34999999999999987754 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.... +.+||+|||+|+.+..... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 162 ~~~~-----~~vkL~DFGla~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilyel 221 (352)
T d1koba_ 162 TKKA-----SSVKIIDFGLATKLNPDEI-----------VKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYVL 221 (352)
T ss_dssp STTC-----CCEEECCCTTCEECCTTSC-----------EEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred ccCC-----CeEEEeecccceecCCCCc-----------eeeccCcccccCHHHHcC----CCCCCccchHHHHHHHHHH
Confidence 4321 7899999999987654221 124568999999999986 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..+....+..+....... .....++++.+||.+||+.||.+|||+
T Consensus 222 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~ 277 (352)
T d1koba_ 222 LSGLSPFAGEDDLETLQNVKRCDWEFDED------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTV 277 (352)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHCCCCCCSS------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999988888887776554322110 001456789999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
.|+++|+|++..
T Consensus 278 ~eil~Hp~~~~~ 289 (352)
T d1koba_ 278 HDALEHPWLKGD 289 (352)
T ss_dssp HHHHTSTTTSSC
T ss_pred HHHhcCHhhCCC
Confidence 999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=416.49 Aligned_cols=283 Identities=22% Similarity=0.227 Sum_probs=205.6
Q ss_pred EeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 810 SCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 810 i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
..++||+|+||+||+|++. +..||+|+.+..... .....+..++.+|+.++++++|||||++++++.+.+.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~--- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC---
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh---hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce---
Confidence 4689999999999999984 567888875433211 11122334458999999999999999999999876644
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
|+||||+.++++..+.. ....+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 76 -----------~ivmE~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~--- 136 (299)
T d1ua2a_ 76 -----------SLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--- 136 (299)
T ss_dssp -----------EEEEECCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---
T ss_pred -----------eehhhhhcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---
Confidence 99999999776665543 24579999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1047 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTGk~ 1047 (1141)
+.+||+|||+|+....... .....+||+.|+|||++.+ ...|+.++|||||||++|||++|++
T Consensus 137 ----~~~KL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 137 ----GVLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ----CCEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ----CccccccCccccccCCCcc----------cccceecChhhccHHHHcc---CCCCChhhhhhhcchHHHHHHhCcC
Confidence 8899999999976543211 1224579999999999875 2467899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001143 1048 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1127 (1141)
Q Consensus 1048 Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~ 1127 (1141)
||.+.+..+....+...........+...........................++++.+||.+||+.||++||||+|+++
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 99988887777666432111111111100000000000000000011111245678999999999999999999999999
Q ss_pred HHHhhcC
Q 001143 1128 MFVARTS 1134 (1141)
Q Consensus 1128 ~L~~~~~ 1134 (1141)
|+|++..
T Consensus 280 Hp~f~~~ 286 (299)
T d1ua2a_ 280 MKYFSNR 286 (299)
T ss_dssp SGGGTSS
T ss_pred CHhhCCC
Confidence 9999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=408.67 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=207.2
Q ss_pred CCceEeee-ecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 806 PSLSSCDE-AGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 806 ~~y~i~~~-LG~GsfG~Vy~a~~~----~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
++|.+.+. ||+|+||+||+|.+. +..||||+. +.. ......+.+ .+|+.+|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l--~~~-~~~~~~~~~----~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQG-TEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEE--CSS-CCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEE--Chh-cCHHHHHHH----HHHHHHHHhCCCCCEeeEeeeecc
Confidence 45778884 999999999999873 224666664 332 223334444 899999999999999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
+ ..|+||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 81 ~---------------~~~lvmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 81 E---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp S---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred C---------------eEEEEEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 3 24899999999999998754 2346999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+|+.+....... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 142 l~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 142 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp EEET-------TEEEECCCTTCEECTTCSCEE-------CCCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred eccC-------Cceeeccchhhhccccccccc-------ccccccccCccccChHHHhC----CCCCccchhhcchHHHH
Confidence 9987 899999999998765432211 11224468999999999986 56889999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
||+| |+.||.+.+..++...+..+.++..+. .+++++.+||.+||+.||++|
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCCHhHC
Confidence 9998 899999888888888887766554332 456679999999999999999
Q ss_pred CCHHHHHH---HHHhhc
Q 001143 1120 PTAGDLYE---MFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~---~L~~~~ 1133 (1141)
||+.+|++ ++|+..
T Consensus 257 Ps~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 257 PDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHh
Confidence 99999955 455543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=406.68 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=199.7
Q ss_pred eeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCCCC
Q 001143 812 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1141)
Q Consensus 812 ~~LG~GsfG~Vy~a~~~~----~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~~~ 887 (1141)
++||+|+||+||+|.+.. ..||+|+.+.. .......+ ++.+|+.+|++++|||||++++++..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~----~~~~E~~il~~l~HpnIv~~~g~~~~~~----- 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKD----ELLAEANVMQQLDNPYIVRMIGICEAES----- 81 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHH----HHHHHHHHHHTCCCTTBCCEEEEEESSS-----
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh--hCCHHHHH----HHHHHHHHHHhCCCCCCceEEEEeccCC-----
Confidence 479999999999998732 35777765322 22222233 3489999999999999999999986432
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccccc
Q 001143 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1141)
Q Consensus 888 ~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~~~ 967 (1141)
.+|||||+++|+|.++++. ...+++..+..|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 82 ----------~~lvmE~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~--- 143 (277)
T d1xbba_ 82 ----------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 143 (277)
T ss_dssp ----------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---
T ss_pred ----------EEEEEEcCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---
Confidence 3899999999999999976 3469999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 001143 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 1046 (1141)
Q Consensus 968 ~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-Gk 1046 (1141)
+.+||+|||+|+.+........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+
T Consensus 144 ----~~~kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~----~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 144 ----HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp ----TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ----Ccccccchhhhhhccccccccc-------cccccCCCceecCchhhcC----CCCCchhhhccchhhhhHHhhCCC
Confidence 8999999999987544321110 1123468999999999987 568899999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001143 1047 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1126 (1141)
Q Consensus 1047 ~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL 1126 (1141)
.||.+.+..++...+..+.++..+. .+++++.+|+.+||+.||++|||+++|+
T Consensus 209 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999988888888887766554332 4566799999999999999999999995
Q ss_pred ---HHHHh
Q 001143 1127 ---EMFVA 1131 (1141)
Q Consensus 1127 ---~~L~~ 1131 (1141)
+++|+
T Consensus 262 ~~L~~~~~ 269 (277)
T d1xbba_ 262 LRLRNYYY 269 (277)
T ss_dssp HHHHHHHH
T ss_pred HHhhCHHh
Confidence 45554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-45 Score=409.87 Aligned_cols=256 Identities=23% Similarity=0.414 Sum_probs=207.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
+.++|++.++||+|+||+||+|++. +..||||+ ++.... ..+++ .+|+.+|++++|||||++++++.+.
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~--i~~~~~---~~~~~----~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTM---EVEEF----LKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEE--CCTTCS---CHHHH----HHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEE--ECCccc---hHHHH----HHHHHHHHhCCCCCEecCCccEeeC
Confidence 3467999999999999999999995 45567765 333221 22334 8999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+.+ ++||||+++|+|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 86 ~~~--------------~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl 148 (287)
T d1opja_ 86 PPF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 148 (287)
T ss_dssp SSC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred Cee--------------EEEeecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE
Confidence 544 999999999999999976 334579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+........ ......||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 149 ~~~-------~~~Kl~DFG~a~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~----~~~~~k~DiwS~Gv~l~e 208 (287)
T d1opja_ 149 GEN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWE 208 (287)
T ss_dssp CGG-------GCEEECCCCCTTTCCSSSSE---------EETTEEECGGGCCHHHHHH----CCCSHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEEccccceeecCCCCce---------eeccccccccccChHHHcC----CCCCchhhhhhHHHHHHH
Confidence 988 78999999999865442211 1123458899999999987 578999999999999999
Q ss_pred HHhCCCC-CCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTGk~P-f~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++|..| |.+.+..++.+.+..+..+..+. .+++++.+|+.+||+.||++||
T Consensus 209 ll~~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rp 261 (287)
T d1opja_ 209 IATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDRP 261 (287)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCcchHHHHHHHHhcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhHCc
Confidence 9996555 55566666666666554433221 4566799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
|++||++.+...
T Consensus 262 s~~ei~~~L~~~ 273 (287)
T d1opja_ 262 SFAEIHQAFETM 273 (287)
T ss_dssp CHHHHHHHHHHT
T ss_pred CHHHHHHHHHHH
Confidence 999999877543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=416.74 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=213.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.+.||+|+||+||+|.+. +..+|+|+.+.+ . .... .+.+|+.+|++++|||||++++++.+.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~-~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----G-TDQV----LVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----T-HHHH----HHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC----c-ccHH----HHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 578999999999999999999985 566788875432 1 2222 2479999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .|+|||||+||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++
T Consensus 75 ~--------------~~lvmE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~ 136 (321)
T d1tkia_ 75 E--------------LVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp E--------------EEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred E--------------EEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeec
Confidence 3 4999999999999999964 233699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+.. ..+||+|||+++....... .....+|+.|+|||.+.+ ..++.++||||+||++|+|
T Consensus 137 ~~~~-----~~ikl~DFG~~~~~~~~~~-----------~~~~~~t~~y~ape~~~~----~~~~~~~DiWSlGvily~l 196 (321)
T d1tkia_ 137 TRRS-----STIKIIEFGQARQLKPGDN-----------FRLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp SSSC-----CCEEECCCTTCEECCTTCE-----------EEEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHHH
T ss_pred CCCc-----eEEEEcccchhhccccCCc-----------ccccccccccccchhccC----CCCCchhhcccHHHHHHHH
Confidence 6522 6899999999976543221 123468999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||.+.+..++...|..+........+ ...++++.+||.+||..||.+|||+
T Consensus 197 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~ 252 (321)
T d1tkia_ 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAF------------------------KEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCChhhc------------------------cCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999998888888887665433221111 1456779999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001143 1123 GDLYEMFVARTS 1134 (1141)
Q Consensus 1123 ~ElL~~L~~~~~ 1134 (1141)
+|+++|+|+...
T Consensus 253 ~eil~hp~~~~~ 264 (321)
T d1tkia_ 253 SEALQHPWLKQK 264 (321)
T ss_dssp HHHHHSHHHHSC
T ss_pred HHHhcCHhhccC
Confidence 999999999643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=402.28 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=210.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
.++|++.++||+|+||+||+|+++ +..||||+.+.. ... .+++ .+|+.++++++|||||+++|++.++..
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~---~~~~----~~Ev~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMS---EDEF----IEEAKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSC---HHHH----HHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCC---HHHH----HHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence 468999999999999999999995 447888875532 222 2234 799999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+++|+|..++.. ....+++..+.+|+.||++||+|||++||+||||||+|||++.
T Consensus 74 --------------~~iv~Ey~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~ 135 (258)
T d1k2pa_ 74 --------------IFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135 (258)
T ss_dssp --------------EEEEEECCTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT
T ss_pred --------------eEEEEEccCCCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC
Confidence 4999999999999999765 2346899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~ksDiwS~G~~l~el~ 195 (258)
T d1k2pa_ 136 Q-------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEIY 195 (258)
T ss_dssp T-------CCEEECCCSSCCBCSSSSCC---------CCCCSCCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CcEEECcchhheeccCCCce---------eecccCCCCCcCCcHHhcC----CCCCcceeecccchhhHhHH
Confidence 7 78999999999765442211 1223568999999999987 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
| |+.||.+.+..++...+..+.++..+. ..++++.+||.+||+.||++|||+
T Consensus 196 t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPt~ 248 (258)
T d1k2pa_ 196 SLGKMPYERFTNSETAEHIAQGLRLYRPH---------------------------LASEKVYTIMYSCWHEKADERPTF 248 (258)
T ss_dssp TTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred hcCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------------------cccHHHHHHHHHHccCCHhHCcCH
Confidence 8 899999988888888887665543321 345679999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1123 GDLYEMFV 1130 (1141)
Q Consensus 1123 ~ElL~~L~ 1130 (1141)
++|++|+.
T Consensus 249 ~eil~~L~ 256 (258)
T d1k2pa_ 249 KILLSNIL 256 (258)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 99999984
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-45 Score=418.53 Aligned_cols=255 Identities=24% Similarity=0.275 Sum_probs=213.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+++|++.++||+|+||.||+|++. +..+|+|+...... .......++.+|+.+|++++|||||++++++.+
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 44689999999999999999999985 67788887542211 111112345899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
.. ..++||||+.||+|..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 113 ~~--------------~~~~v~e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL 173 (350)
T d1rdqe_ 113 NS--------------NLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SS--------------EEEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cc--------------ccccccccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcc
Confidence 65 34999999999999999976 246999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+|+.+.... ....||+.|||||++.+ ..++.++|||||||++|
T Consensus 174 l~~~-------g~ikL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvily 229 (350)
T d1rdqe_ 174 IDQQ-------GYIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred cCCC-------CCEEeeeceeeeeccccc-------------ccccCccccCCHHHHcC----CCCCccccccchhHHHH
Confidence 9887 889999999998654321 23469999999999986 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
||+||+.||.+.+..++...+..+..... ...++++.+||.+||+.||.+|+
T Consensus 230 emltG~~Pf~~~~~~~~~~~i~~~~~~~p----------------------------~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 230 EMAAGYPPFFADQPIQIYEKIVSGKVRFP----------------------------SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------------------------TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHHhCCCCCCCcCHHHHHHHHhcCCCCCC----------------------------ccCCHHHHHHHHHHhhhCHHhcc
Confidence 99999999999888888777765443211 14556799999999999999994
Q ss_pred -----CHHHHHHHHHhhc
Q 001143 1121 -----TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 -----Sa~ElL~~L~~~~ 1133 (1141)
|++++++|+||+.
T Consensus 282 ~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 282 GNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TSSTTTTHHHHTSGGGTT
T ss_pred ccccccHHHHHcCccccC
Confidence 9999999999964
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=405.77 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=204.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+.++|++.++||+|+||.||+|+++ +..||||+.. ..... .+.+ .+|+.++++++|||||++++++.++.
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~--~~~~~---~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~ 81 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMS---PDAF----LAEANLMKQLQHQRLVRLYAVVTQEP 81 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEEC--TTSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEc--cCcCC---HHHH----HHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 3468999999999999999999996 4568888753 22211 2233 89999999999999999999875432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.++||||+++|+|.+++.... ..++++..++.|+.||+.||.|||+++|+||||||+|||++
T Consensus 82 ---------------~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~ 143 (272)
T d1qpca_ 82 ---------------IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143 (272)
T ss_dssp ---------------CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred ---------------eEEEEEeCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee
Confidence 389999999999999875421 23599999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||+|+.+...... ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 144 ~~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~~~~----~~~~~~sDvwS~Gvvl~el 203 (272)
T d1qpca_ 144 DT-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEI 203 (272)
T ss_dssp TT-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHHH
T ss_pred cc-------cceeeccccceEEccCCccc---------cccccCCcccccChHHHhC----CCCCchhhhhhhHHHHHHH
Confidence 87 88999999999876542211 1223468999999999986 5688999999999999999
Q ss_pred HhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1043 LTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1043 LTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+|| .+||......++...+..+..+..+. .+++++.+|+.+||+.||++|||
T Consensus 204 lt~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~P~~Rpt 256 (272)
T d1qpca_ 204 VTHGRIPYPGMTNPEVIQNLERGYRMVRPD---------------------------NCPEELYQLMRLCWKERPEDRPT 256 (272)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------cChHHHHHHHHHHcCCCHhHCcC
Confidence 995 55666667777777776655443321 45567999999999999999999
Q ss_pred HHHHHHHH
Q 001143 1122 AGDLYEMF 1129 (1141)
Q Consensus 1122 a~ElL~~L 1129 (1141)
++||++.|
T Consensus 257 ~~ei~~~L 264 (272)
T d1qpca_ 257 FDYLRSVL 264 (272)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-45 Score=422.66 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=203.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
++++|++.++||+|+||.||+|++. +..||+|+...... ..........+...|+.+++.++|||||++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc--chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 5789999999999999999999984 66788887542211 0111111111113457778888999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+ ..|+||||++||+|.+++.+ ...+++..++.|+.||+.||.|||++|||||||||+|||+
T Consensus 80 ~--------------~~~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 80 D--------------KLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence 5 34999999999999999976 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+.+.... .....||+.|+|||++.. ...|+.++|||||||++||
T Consensus 141 ~~~-------g~iKl~DFGla~~~~~~~------------~~~~~GT~~y~APE~~~~---~~~~~~~~DiwSlGvilye 198 (364)
T d1omwa3 141 DEH-------GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFK 198 (364)
T ss_dssp CSS-------SCEEECCCTTCEECSSSC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEeeeceeeecCCCc------------ccccccccccchhHHhhc---CCCCCcccchhHHHHHHHH
Confidence 987 889999999997654321 224569999999999864 2468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|+||+.||.+....+.............. .....++++.+||.+||+.||.+|||
T Consensus 199 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 199 LLRGHSPFRQHKTKDKHEIDRMTLTMAVE-------------------------LPDSFSPELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp HHHSSCSSCSSCSSCHHHHHHHSSSCCCC-------------------------CCSSSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------CCCCCCHHHHHHHHHHcccCHHHhCC
Confidence 99999999865433322222211111100 00145677999999999999999999
Q ss_pred -----HHHHHHHHHhhc
Q 001143 1122 -----AGDLYEMFVART 1133 (1141)
Q Consensus 1122 -----a~ElL~~L~~~~ 1133 (1141)
|+|+++|+||+.
T Consensus 254 ~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 254 CLGRGAQEVKESPFFRS 270 (364)
T ss_dssp TSSSTHHHHHTSGGGTT
T ss_pred CcccCHHHHHcCccccC
Confidence 799999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=400.32 Aligned_cols=257 Identities=21% Similarity=0.331 Sum_probs=201.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.++|++.+.||+|+||.||+|++.. ..++||++.++... .....+. +.+|+.++++++|||||++++++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~----~~~E~~~l~~l~HpnIv~l~~~~~~- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREK----FLQEALTMRQFDHPHIVKLIGVITE- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHH----HHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3579999999999999999999843 34667776654322 2233333 4899999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. .++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||++
T Consensus 80 ~~--------------~~iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll 141 (273)
T d1mp8a_ 80 NP--------------VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 141 (273)
T ss_dssp SS--------------CEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred Ce--------------EEEEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee
Confidence 22 3999999999999998765 23469999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+........ ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 142 ~~~-------~~~Kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~apE~l~~----~~~~~~~DiwSlGvil~e 201 (273)
T d1mp8a_ 142 SSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMWE 201 (273)
T ss_dssp EET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEccchhheeccCCcce---------eccceecCcccchhhHhcc----CCCCCccccccchHHHHH
Confidence 988 88999999999765432211 1223468999999999986 578999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++ |.+||.+.+..++...+..+..++.+. .+++.+.+||.+||..||++||
T Consensus 202 ~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dp~~Rp 254 (273)
T d1mp8a_ 202 ILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSRRP 254 (273)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCc
Confidence 998 899999888888888877665544321 4567799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001143 1121 TAGDLYEMFVAR 1132 (1141)
Q Consensus 1121 Sa~ElL~~L~~~ 1132 (1141)
|+.||++++...
T Consensus 255 s~~ei~~~L~~i 266 (273)
T d1mp8a_ 255 RFTELKAQLSTI 266 (273)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=412.75 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=201.5
Q ss_pred CCCceEeeeecccCceEEEEEEECCc-------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~-------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
.++|++.++||+|+||+||+|++.+. .||+|+. .... ...... .+.+|+.++.++ +|||||++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~--~~~~-~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKA-DSSERE----ALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEE--CC-------CH----HHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEe--cccc-CHHHHH----HHHHHHHHHHHhcCCCcEeEEEE
Confidence 46799999999999999999997432 3555543 2211 112222 347999999998 8999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh------------------cCCCCCCHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------TGEKHVSVKLALFIAQDVA 938 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~------------------~~~~~Ls~~~i~~Ia~QIa 938 (1141)
++.+.+.+ ++|||||++|+|.++++.... .....+++..++.|+.||+
T Consensus 109 ~~~~~~~~--------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 174 (325)
T d1rjba_ 109 ACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174 (325)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred EEeeCCeE--------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHH
Confidence 99876644 999999999999999975321 1123589999999999999
Q ss_pred HHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001143 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018 (1141)
Q Consensus 939 ~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1018 (1141)
.||+|||+++||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||++.
T Consensus 175 ~gl~yLH~~~IiHRDlKp~Nill~~~-------~~~Kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 175 KGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPESLF 239 (325)
T ss_dssp HHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHHHH
T ss_pred HHHHHHHhCCeeeccCchhccccccC-------CeEEEeeccccccccCCCcee--------eeccccCCCccCChHHHc
Confidence 99999999999999999999999988 899999999997654432111 112345899999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhCCCCCchhHHhhhccCccccccccCCCCCCchh
Q 001143 1019 AMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1096 (1141)
Q Consensus 1019 ~~~~~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1141)
+ ..++.++|||||||++|||+| |+.||.+.+..+.. ..+..+.++..+
T Consensus 240 ~----~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p-------------------------- 289 (325)
T d1rjba_ 240 E----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP-------------------------- 289 (325)
T ss_dssp H----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--------------------------
T ss_pred C----CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--------------------------
Confidence 7 578999999999999999998 89999876554443 444444333221
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001143 1097 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1131 (1141)
Q Consensus 1097 ~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~ 1131 (1141)
..+++++.+||.+||+.||++|||++||++||--
T Consensus 290 -~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 290 -FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1456779999999999999999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=399.71 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=200.1
Q ss_pred CCCceEeeeecccCceEEEEEEECCc------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSA------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~ 878 (1141)
.+.|++.++||+|+||.||+|.+... .||||+. ... ........ +.+|+.++++++|||||+++|++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~--~~~-~~~~~~~~----~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAG-YTEKQRVD----FLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEE--CTT-CCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEE--Ccc-cChHHHHH----HHHHHHHHHhcCCCCEeeeeEEE
Confidence 45799999999999999999987432 3666654 322 22333333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
.+... .++||||+.++++.+++.. ....+++.++..|+.||+.||+|||+++|+||||||+|
T Consensus 79 ~~~~~--------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N 140 (283)
T d1mqba_ 79 SKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 140 (283)
T ss_dssp CSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ecCCc--------------eEEEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccccccCccccce
Confidence 86553 4999999999999998875 23469999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
|||+.+ +.+||+|||+|+.+....... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 141 ILl~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~----~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 141 ILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFGIV 202 (283)
T ss_dssp EEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CeEEEcccchhhcccCCCccc-------eEeccCCCCccccCHHHHcc----CCCCCcccccccHHH
Confidence 999987 899999999998754322110 11223458999999999976 678999999999999
Q ss_pred HHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001143 1039 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1039 L~ELLTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
+|||+++ .+||...+..++...+..+.++..+. .++..+.+|+.+||+.||+
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~p~ 255 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM---------------------------DCPSAIYQLMMQCWQQERA 255 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCBHHHHHHHHHHTCSSTT
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhccCCCCCch---------------------------hhHHHHHHHHHHHCcCCHh
Confidence 9999995 55566667777777776665443321 4556799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001143 1118 ERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~ 1132 (1141)
+||||.||++.+...
T Consensus 256 ~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 256 RRPKFADIVSILDKL 270 (283)
T ss_dssp TSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999988653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=413.37 Aligned_cols=256 Identities=26% Similarity=0.334 Sum_probs=209.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHh-hCCCCCccceeeeEecC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpNIVkllg~~~~~ 881 (1141)
+++|++.++||+|+||+||+|++. +..||+|+...... ..+.....+..|+.++. .++|||||++++++.+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 478999999999999999999994 66778887543211 01111122356777665 68999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
+. .|+||||+++|+|.++++. ...+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~~--------------~yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 76 EN--------------LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred Cc--------------eeEEEeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 54 4999999999999999986 2468999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+|+....... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 195 (320)
T d1xjda_ 137 DKD-------GHIKIADFGMCKENMLGDA----------KTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLLYE 195 (320)
T ss_dssp CTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred cCC-------Cceeccccchhhhcccccc----------cccccCCCCCcCCHHHHcC----CCCCchhhhhhhhHHHHH
Confidence 987 8899999999976543211 1224569999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
|++|+.||.+.+..++...+..+.. .++. ..++++.+||.+||+.||.+|||
T Consensus 196 mltG~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 196 MLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGSBT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHhcccCCCCCcC
Confidence 9999999999888888887765432 1111 34567999999999999999999
Q ss_pred HH-HHHHHHHhhc
Q 001143 1122 AG-DLYEMFVART 1133 (1141)
Q Consensus 1122 a~-ElL~~L~~~~ 1133 (1141)
+. |+++|+|++.
T Consensus 248 ~~~~l~~hpff~~ 260 (320)
T d1xjda_ 248 VRGDIRQHPLFRE 260 (320)
T ss_dssp TBSCGGGSGGGTT
T ss_pred HHHHHHhCchhcc
Confidence 95 8999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=400.10 Aligned_cols=283 Identities=19% Similarity=0.280 Sum_probs=208.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.++||+|+||+||+|++. ++.||+|+..... ... ....++.+|+.++++++|||||++++++.+..
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cCh----HHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 468999999999999999999985 6678888864332 111 12234589999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
+.|+||||+. +++.+++.. .....+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 75 --------------~~~iv~e~~~-~~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 75 --------------KLYLVFEFLH-QDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp --------------EEEEEEECCS-EEHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred --------------ceeEEEeecC-Cchhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec
Confidence 4599999997 455555543 2345699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.|+....... ......||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~apE~~~~---~~~~~~~~DiwSlGvily~m 196 (298)
T d1gz8a_ 137 TE-------GAIKLADFGLARAFGVPVR----------TYTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEM 196 (298)
T ss_dssp TT-------SCEEECSTTHHHHHCCCSB----------CTTCCBCCCTTCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred cc-------CcceeccCCcceeccCCcc----------cceeecccceeeehhhhcc---ccCCCccccccccchhhhHH
Confidence 87 7899999999976543221 1224579999999999876 23567999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHh--CCCCCchhHHhhhccCccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCC
Q 001143 1043 LTLQVPYMGLSELEIHDLIQM--GKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~--~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
++|+.||.+.+..+....+.. +....... ........ .......... .......++++.+|+.+||+.||.
T Consensus 197 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 272 (298)
T d1gz8a_ 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVW--PGVTSMPD--YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272 (298)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS--TTGGGSTT--CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTT
T ss_pred hhCCCCCCCCCHHHHHHHHHHhcCCCchhhc--cccccccc--cccccccccccchhhhccCCCHHHHHHHHHHccCChh
Confidence 999999998877766555422 12111111 00000000 0000000001 111224567899999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001143 1118 ERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~s 1135 (1141)
+|||++|+++|+|++.-.
T Consensus 273 ~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 273 KRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TSCCHHHHHTSGGGTTCC
T ss_pred HCcCHHHHhCCHhhccCC
Confidence 999999999999997543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-44 Score=399.42 Aligned_cols=283 Identities=19% Similarity=0.221 Sum_probs=208.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~-~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+++|++.++||+|+||+||+|++. +..||+|+...... .. ....++.+|+.+|++++|||||++++++...+.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DE----GIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GG----CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--Ch----HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 468999999999999999999985 57788888654321 11 122344899999999999999999999987664
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.++||||+.++.+..+.+. ...+++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 75 --------------~~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 75 --------------LVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp --------------EEEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------eeEEEEeehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC
Confidence 4999999987666655443 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||.|........ ......|++.|+|||.+.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~----------~~~~~~~~~~y~~pE~~~~---~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 136 E-------GELKIADFGLARAFGIPVR----------KYTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEecccccceecccCcc----------ccceecccchhhhHHHHhC---CCCCCcceeehhcCcHHHHHH
Confidence 8 8899999999976543221 1123468999999999876 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhC-CCCCchhHHhhhccCcc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1121 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~-~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPS 1121 (1141)
+|+.||.+.+..+....+... ..+... .+........ ...................++.+.+|+.+||+.||++|||
T Consensus 196 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s 274 (286)
T d1ob3a_ 196 NGTPLFPGVSEADQLMRIFRILGTPNSK-NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (286)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTT-TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCChh-hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC
Confidence 999999988777766555221 111111 1110000000 0000000111111122355678999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001143 1122 AGDLYEMFVART 1133 (1141)
Q Consensus 1122 a~ElL~~L~~~~ 1133 (1141)
++|+++|+|++.
T Consensus 275 ~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 275 AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHTSGGGGC
T ss_pred HHHHhcCcccCc
Confidence 999999999973
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-43 Score=393.59 Aligned_cols=264 Identities=24% Similarity=0.286 Sum_probs=202.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.+.||+|+||+||+|++. +..||+|+...... ...... .++.+|+.++++++|||||++++++...+.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~----~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHH----HHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHH----HHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 46999999999999999999985 66788887543221 122222 345899999999999999999999886442
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
.....|+||||++|++|.+++.. ...+++.+++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 82 ----------~~~~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 82 ----------AGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146 (277)
T ss_dssp ----------SSEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred ----------CCceEEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc
Confidence 12346999999999999999876 246999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.++++|||.+......... .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 147 ~-------~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 147 T-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp T-------SCEEECCCTTCEECC-----------------------TTCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred c-------ccceeehhhhhhhhcccccc-------ccccccccCcccccCHHHHcC----CCCCcceecccchHHHHHHH
Confidence 8 78999999998754332211 112234579999999999976 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-CH
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TA 1122 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP-Sa 1122 (1141)
||+.||.+.+..+....+.......... .....++++.++|.+||+.||.+|| |+
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa 264 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRYQTA 264 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCGGG------------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCCch------------------------hccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence 9999999888877766654433221110 0014567899999999999999999 78
Q ss_pred HHHHHHHHh
Q 001143 1123 GDLYEMFVA 1131 (1141)
Q Consensus 1123 ~ElL~~L~~ 1131 (1141)
+++++.+..
T Consensus 265 ~~l~~~l~r 273 (277)
T d1o6ya_ 265 AEMRADLVR 273 (277)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 888776554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=396.73 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=204.8
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
+.++|++.++||+|+||.||+|+++++.||||+.+ .. ...+.+ .+|+.++++++|||||+++|++.+...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~--~~----~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--ND----ATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECC--CC----C--HHH----HHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEEC--cH----HHHHHH----HHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 45689999999999999999999999999988743 21 122334 799999999999999999999864321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
..++||||+++|+|.+++.... ...+++..+++|+.||+.||.|||+++|+||||||+|||++.
T Consensus 75 -------------~~~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~ 138 (262)
T d1byga_ 75 -------------GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 138 (262)
T ss_dssp -------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -------------cEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC
Confidence 2399999999999999997522 235899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 139 ~-------~~~kl~dfg~s~~~~~~~-------------~~~~~~~~y~aPE~l~~----~~~t~~sDIwSfG~il~el~ 194 (262)
T d1byga_ 139 D-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 194 (262)
T ss_dssp T-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEeecccccceecCCCC-------------ccccccccCCChHHHhC----CCCChHHHHHhHHHHHHHHH
Confidence 8 889999999997543311 13357899999999987 57899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1044 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1044 T-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
| |++||...+..++...+..+.++.++. ..++++.+|+.+||+.||.+||||
T Consensus 195 t~~~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dP~~Rps~ 247 (262)
T d1byga_ 195 SFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYEVMKNCWHLDAAMRPSF 247 (262)
T ss_dssp TTSCCSCTTSCGGGHHHHHTTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcccCHhHCcCH
Confidence 8 799998888778888887666554432 445679999999999999999999
Q ss_pred HHHHHHHHhh
Q 001143 1123 GDLYEMFVAR 1132 (1141)
Q Consensus 1123 ~ElL~~L~~~ 1132 (1141)
.+++++|...
T Consensus 248 ~~l~~~L~~i 257 (262)
T d1byga_ 248 LQLREQLEHI 257 (262)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=401.95 Aligned_cols=255 Identities=20% Similarity=0.327 Sum_probs=204.0
Q ss_pred CCceEeeeecccCceEEEEEEECCc------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEe
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSA------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~------~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~ 879 (1141)
.+|++.++||+|+||+||+|.+..+ .||+|. ++... .....+ .+.+|+.++++++|||||++++++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~--~~~~~-~~~~~~----~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREAT-SPKANK----EILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEE--ECC-----CTHH----HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEE--ecccc-CHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 5799999999999999999998532 245544 32211 112223 3489999999999999999999997
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
+.. .++||||+.+++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 82 ~~~---------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 82 TST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp SSS---------------EEEEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCC---------------eeEEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence 643 3789999999999998875 245799999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.+ +.+||+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 143 ll~~~-------~~~kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 143 LVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp EEEET-------TEEEECCCSHHHHTTTTCC----------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHH
T ss_pred eeCCC-------CCeEeeccccceeccccccc--------ccccccccCccccChHHHhc----CCCChhhhhhhHHHHH
Confidence 99988 89999999999875432211 11123468999999999987 5789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1040 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1040 ~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
|||+| |+.||.+.+..++...+..+.++..+. .+++.+.+|+.+||+.||.+
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TBCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHhCCCChhh
Confidence 99999 899999887777777777665543321 45567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001143 1119 RPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~ 1132 (1141)
|||+.||++++...
T Consensus 257 RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 257 RPKFRELIIEFSKM 270 (317)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999998654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=402.17 Aligned_cols=265 Identities=25% Similarity=0.428 Sum_probs=212.3
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 800 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 800 ~~~~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
++..++++|++.++||+|+||.||+|++. +..++|||++++.... ....+.+ .+|+.+|.++ +|||||++++
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~----~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDF----AGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHH----HHHHHHHTTCCCCTTBCCEEE
T ss_pred CCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHH----HHHHHHHHhccCCCCEeeEEE
Confidence 45567899999999999999999999984 4455666666543222 2223334 8999999999 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALVELH 945 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~-----------~~~~~~Ls~~~i~~Ia~QIa~gL~yLH 945 (1141)
++.+.+. .++||||+++|+|.++++... ......+++..+..++.||+.||.|||
T Consensus 79 ~~~~~~~--------------~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH 144 (309)
T d1fvra_ 79 ACEHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144 (309)
T ss_dssp EEEETTE--------------EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCe--------------eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh
Confidence 9987653 499999999999999997521 122357999999999999999999999
Q ss_pred HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 946 s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
+++|+||||||+|||++.+ +.+||+|||+|+....... .....||..|+|||.+.+ ..
T Consensus 145 ~~~iiHrDlkp~NIL~~~~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~----~~ 202 (309)
T d1fvra_ 145 QKQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SV 202 (309)
T ss_dssp HTTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECC-----------C----CCTTTCCHHHHHH----CE
T ss_pred cCCccccccccceEEEcCC-------CceEEcccccccccccccc-----------ccceecCCcccchHHhcc----CC
Confidence 9999999999999999988 7899999999975443211 123458999999999987 57
Q ss_pred CCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1104 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1104 (1141)
++.++|||||||++|||++| .+||.+.+..++...+..+.++..+. .+++++
T Consensus 203 ~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~ 255 (309)
T d1fvra_ 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL---------------------------NCDDEV 255 (309)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT---------------------------TBCHHH
T ss_pred CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------cCCHHH
Confidence 89999999999999999996 56788888888887776655443321 456679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1105 VDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1105 ~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+||.+||+.||++||||.||+++|...
T Consensus 256 ~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 256 YDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-44 Score=399.19 Aligned_cols=288 Identities=20% Similarity=0.194 Sum_probs=208.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC---CCCCccceeeeE
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHK 878 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkllg~~ 878 (1141)
-++|++.++||+|+||+||+|++. +..||+|+.+...... ..... +.+|+.+++.+ +||||+++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~----~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLS----TIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCT----HHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHH----HHHHHHHHHHHhhcCCCCcceeeeee
Confidence 367999999999999999999984 3457888865443221 11112 25777777665 799999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCC
Q 001143 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1141)
Q Consensus 879 ~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~N 958 (1141)
..... ....+.+++|||++++.+..... .....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 80 ~~~~~---------~~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 80 TVSRT---------DRETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEEC---------SSEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ccccc---------ccCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 75321 12346799999998766554433 234579999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001143 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1038 (1141)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1038 (1141)
||++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..|+.++||||+||+
T Consensus 147 ILi~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~gT~~Y~APE~~~~----~~y~~~~DiwSlG~i 204 (305)
T d1blxa_ 147 ILVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCI 204 (305)
T ss_dssp EEECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEEcCC-------CCeeecchhhhhhhccccc-----------CCCcccChhhcCcchhcC----CCCChhehhhchHHH
Confidence 999987 7899999999875433221 124569999999999986 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1039 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1039 L~ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
+|||++|+.||.+.+..+....+...........+......... ..........+......++.+.+||.+||++||++
T Consensus 205 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG-GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhh-hhccccccchhhccccCCHHHHHHHHHHCcCChhH
Confidence 99999999999988887776665332111111111110000000 00011111111122255678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001143 1119 RPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1119 RPSa~ElL~~L~~~~~ 1134 (1141)
||||+|+++|+|++.-
T Consensus 284 R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 284 RISAYSALSHPYFQDL 299 (305)
T ss_dssp SCCHHHHHTSGGGTTC
T ss_pred CcCHHHHhcChhhcCc
Confidence 9999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=409.85 Aligned_cols=266 Identities=23% Similarity=0.243 Sum_probs=202.1
Q ss_pred CCCceEee-eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceeeeEec
Q 001143 805 FPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~~-~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg~~~~ 880 (1141)
+++|++.+ .||+|+||+||+|++. +..||+|+.. . . .. +.+|+.++.++ +|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~--~----~---~~----~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--D----C---PK----ARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE--C----S---HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC--C----c---HH----HHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 57898875 5999999999999984 5678888753 1 1 12 26899987655 79999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
... ...+.|+|||||+||+|.+++.+ .+...+++.+++.|+.||+.||+|||++||+||||||+|||
T Consensus 77 ~~~----------~~~~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIl 143 (335)
T d2ozaa1 77 LYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 143 (335)
T ss_dssp EET----------TEEEEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ccc----------CCCEEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccc
Confidence 210 12356999999999999999975 33457999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+. ..+.+||+|||+|+...... ......||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 144 l~~~~----~~~~~Kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~y~~~~DiwSlGvily 204 (335)
T d2ozaa1 144 YTSKR----PNAILKLTDFGFAKETTSHN-----------SLTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 204 (335)
T ss_dssp ESCSS----TTCCEEECCCTTCEECCCCC-----------CCCCCSCCCSSCCCCCCCG----GGGSHHHHHHHHHHHHH
T ss_pred ccccc----ccccccccccceeeeccCCC-----------ccccccCCcccCCcHHHcC----CCCCHHHHHHhhchhHH
Confidence 98642 22679999999997654321 1224569999999999876 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|+||+.||.+.+..+....+.... .... .+.. ......++++.+||.+||+.||++|
T Consensus 205 ~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~--------------------~~~~-~~~~~~s~~~~~li~~~L~~dP~~R 263 (335)
T d2ozaa1 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQY--------------------EFPN-PEWSEVSEEVKMLIRNLLKTEPTQR 263 (335)
T ss_dssp HHTTSSCSCEETTCC--------CCCSCSS--------------------SCCT-THHHHSCHHHHHHHHHHSCSSTTTS
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHHHhcCCC--------------------CCCC-cccccCCHHHHHHHHHHccCChhHC
Confidence 9999999997655433333221111 0000 0000 1112567789999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001143 1120 PTAGDLYEMFVARTSSS 1136 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~~s~ 1136 (1141)
||+.|+++|+|+.....
T Consensus 264 ~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 264 MTITEFMNHPWIMQSTK 280 (335)
T ss_dssp CCHHHHHHSHHHHTTTS
T ss_pred cCHHHHHcCHHhhCCCC
Confidence 99999999999976543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-43 Score=396.40 Aligned_cols=261 Identities=24% Similarity=0.385 Sum_probs=210.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~ 877 (1141)
-++|++.++||+|+||+||+|++.+ ..||||+. +.. ......+. +.+|+.++++++||||++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i--~~~-~~~~~~~~----~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEE-ASADMQAD----FQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEEC--CTT-CCHHHHHH----HHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEE--Chh-cChHHHHH----HHHHHHHHHhcCCCCcccceee
Confidence 4579999999999999999999743 45777764 321 22233333 4899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------------cCCCCCCHHHHHHHHHHHH
Q 001143 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVA 938 (1141)
Q Consensus 878 ~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-------------------~~~~~Ls~~~i~~Ia~QIa 938 (1141)
+...... ++||||+++|+|.++++.... .....+++..++.|+.||+
T Consensus 85 ~~~~~~~--------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 150 (301)
T d1lufa_ 85 CAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150 (301)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred eccCCce--------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHH
Confidence 9876544 999999999999999975211 1123589999999999999
Q ss_pred HHHHHHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhc
Q 001143 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018 (1141)
Q Consensus 939 ~gL~yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1018 (1141)
.||+|||+++||||||||+|||++.+ +.+||+|||+|+.+...... .......||+.|+|||.+.
T Consensus 151 ~gl~ylH~~~ivHrDlKp~NILld~~-------~~~Kl~DFGls~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 151 AGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHHH
T ss_pred HHhhhcccCCeEeeEEcccceEECCC-------CcEEEccchhheeccCCccc--------cccCCCCcCcCcCCHHHHc
Confidence 99999999999999999999999987 88999999999765433211 1122446889999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 001143 1019 AMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1097 (1141)
Q Consensus 1019 ~~~~~~~~s~ksDVWSLGviL~ELLTGk-~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1141)
+ ..++.++|||||||++|||++|. +||.+.+..++...+..+..+..+.
T Consensus 216 ~----~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~-------------------------- 265 (301)
T d1lufa_ 216 Y----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE-------------------------- 265 (301)
T ss_dssp H----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT--------------------------
T ss_pred c----CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCc--------------------------
Confidence 7 67899999999999999999985 6898888888888887766554332
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1098 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1098 ~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
.+++++.+|+.+||+.||++||||.||++.|...
T Consensus 266 -~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 266 -NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4556799999999999999999999999988754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=392.01 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=200.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
.+.++|++.+.||+|+||.||+|++.+ ..||+|+. +..... .+.| .+|+.++++++|||||++++++.++
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l--~~~~~~---~~~~----~~E~~~l~~l~h~nIv~~~g~~~~~ 84 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMS---PEAF----LQEAQVMKKLRHEKLVQLYAVVSEE 84 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEC--CTTSSC---HHHH----HHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEE--CcccCC---HHHH----HHHHHHHHhcccCCEeEEEEEEecC
Confidence 346789999999999999999999855 45777764 332222 2334 8999999999999999999998543
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
. .++||||+++|+|..++... ....+++.+++.|+.||+.||+|||++||+||||||+||||
T Consensus 85 ~---------------~~lv~Ey~~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll 146 (285)
T d1fmka3 85 P---------------IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146 (285)
T ss_dssp S---------------CEEEECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C---------------eEEEEEecCCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE
Confidence 2 28999999999999988652 12359999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +++||+|||+|+........ ......||+.|+|||++.. ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~S~Giil~e 206 (285)
T d1fmka3 147 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 206 (285)
T ss_dssp CGG-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEEcccchhhhccCCCce---------eeccccccccccChHHHhC----CCCCcHHhhhcchHHHHH
Confidence 988 88999999999765432211 1123468999999999987 578899999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1042 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1042 LLTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
|++| .+|+.+....++...+..+..+..+. .+++++.+||.+||+.||++||
T Consensus 207 l~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rp 259 (285)
T d1fmka3 207 LTTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERP 259 (285)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------ccCHHHHHHHHHHcccCHhHCc
Confidence 9995 55566667777777776655443321 4566799999999999999999
Q ss_pred CHHHHHHHHH
Q 001143 1121 TAGDLYEMFV 1130 (1141)
Q Consensus 1121 Sa~ElL~~L~ 1130 (1141)
|+++|++.+.
T Consensus 260 s~~~i~~~L~ 269 (285)
T d1fmka3 260 TFEYLQAFLE 269 (285)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHh
Confidence 9999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=391.17 Aligned_cols=259 Identities=23% Similarity=0.326 Sum_probs=197.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEec
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~---~~~vAvKI~~l~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~ 880 (1141)
..+|++.+.||+|+||.||+|++. +..+.|++|.++..... ....+ .+.+|+.+|++++|||||+++|++.+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~----~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD----DFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHH----HHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHH----HHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 467999999999999999999873 23333333334332211 12223 34899999999999999999999965
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
. . .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~-~--------------~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIl 143 (273)
T d1u46a_ 83 P-P--------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143 (273)
T ss_dssp S-S--------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred c-c--------------hheeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhc
Confidence 3 2 28999999999999988752 246999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+ +.+||+|||+++.+....... .......||..|+|||++.+ ..++.++|||||||++|
T Consensus 144 l~~~-------~~vkl~DfGl~~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 144 LATR-------DLVKIGDFGLMRALPQNDDHY-------VMQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGVTLW 205 (273)
T ss_dssp EEET-------TEEEECCCTTCEECCC-CCEE-------EC-----CCGGGCCHHHHHH----CEEEHHHHHHHHHHHHH
T ss_pred cccc-------cceeeccchhhhhcccCCCcc-------eecCccccCcccCCHHHHhC----CCCCcchhhhhhHHHHH
Confidence 9988 789999999998764432211 12234468889999999987 56889999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001143 1041 ELLT-LQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1118 (1141)
Q Consensus 1041 ELLT-Gk~Pf~~~~~~el~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~ 1118 (1141)
||+| |+.||.+.+..+....+.... .++.+ ..+++.+.+|+.+||+.||++
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~ 258 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRP---------------------------EDCPQDIYNVMVQCWAHKPED 258 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc---------------------------ccccHHHHHHHHHHcCCChhH
Confidence 9998 899999988888877774432 22211 145667999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001143 1119 RPTAGDLYEMFVA 1131 (1141)
Q Consensus 1119 RPSa~ElL~~L~~ 1131 (1141)
||||.||++.|..
T Consensus 259 RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 259 RPTFVALRDFLLE 271 (273)
T ss_dssp SCCHHHHHHHHHH
T ss_pred CcCHHHHHHHHHh
Confidence 9999999987754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=396.15 Aligned_cols=252 Identities=22% Similarity=0.247 Sum_probs=197.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISS 881 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkllg~~~~~ 881 (1141)
.+|++.++||+|+||+||+|++. +..||+|+........... ... ..++.+|+.++++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-~~~-~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPN-GTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE-CTT-CCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh-hhH-HHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 46999999999999999999984 6678888765432221110 000 112368999999996 99999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~g-gSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NIL 960 (1141)
+. .++||||+.+ +++.+++.. ...+++.+++.|+.||+.||+|||++||+||||||+|||
T Consensus 82 ~~--------------~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIl 142 (273)
T d1xwsa_ 82 DS--------------FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142 (273)
T ss_dssp SE--------------EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Ce--------------EEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceE
Confidence 53 4999999976 688888875 246999999999999999999999999999999999999
Q ss_pred eecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001143 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1040 (1141)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1040 (1141)
++.+. +.+||+|||+|+...... .....||+.|+|||++.+. ..++.++|||||||++|
T Consensus 143 l~~~~------~~vkl~DFG~a~~~~~~~------------~~~~~GT~~y~aPE~~~~~---~~~~~~~DiwSlGvily 201 (273)
T d1xwsa_ 143 IDLNR------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLY 201 (273)
T ss_dssp EETTT------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHHS---CBCHHHHHHHHHHHHHH
T ss_pred EecCC------CeEEECccccceeccccc------------ccccccCCCcCCHHHHcCC---CCCCcccccccceeeeh
Confidence 98542 689999999997643321 1245699999999999762 34567899999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1041 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1041 ELLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|++|+.||.+. . .+..+... ++ ...++++.+||.+||+.||++||
T Consensus 202 ell~g~~Pf~~~--~----~i~~~~~~-~~---------------------------~~~s~~~~~li~~~L~~dp~~R~ 247 (273)
T d1xwsa_ 202 DMVCGDIPFEHD--E----EIIRGQVF-FR---------------------------QRVSSECQHLIRWCLALRPSDRP 247 (273)
T ss_dssp HHHHSSCSCCSH--H----HHHHCCCC-CS---------------------------SCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHhhCCCCCCCc--h----HHhhcccC-CC---------------------------CCCCHHHHHHHHHHccCCHhHCc
Confidence 999999999752 1 12222110 00 13456799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
|++|+++|+|++.
T Consensus 248 s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 248 TFEEIQNHPWMQD 260 (273)
T ss_dssp CHHHHHTSGGGSS
T ss_pred CHHHHhcCHhhCC
Confidence 9999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-43 Score=391.20 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=196.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccceee
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~-------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkllg 876 (1141)
.++|++.++||+|+||.||+|++.+ +.||+|+. +.. ......+. +.+|+.++.++ +|||||.+++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l--~~~-~~~~~~~~----~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEG-ATHSEHRA----LMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEE--ccc-cCcHHHHH----HHHHHHHHHhhcCCCeEEEeee
Confidence 4679999999999999999999732 34667663 321 12233333 36888888777 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 945 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~yLH 945 (1141)
++...+. ..++|||||++|+|.++++..... ....+++.+++.|+.||+.||+|||
T Consensus 85 ~~~~~~~-------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH 151 (299)
T d1ywna1 85 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 151 (299)
T ss_dssp EECSTTS-------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred eeccCCC-------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 8765331 349999999999999999763221 1235899999999999999999999
Q ss_pred HCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCC
Q 001143 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1141)
Q Consensus 946 s~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1025 (1141)
+++||||||||+|||++.+ +++||+|||+|+........ .......||+.|+|||++.+ ..
T Consensus 152 ~~~ivHrDlKp~NILl~~~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~ 212 (299)
T d1ywna1 152 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 212 (299)
T ss_dssp HTTCCCSCCCGGGEEECGG-------GCEEECC------CCSCTTS--------CCTTSCCCGGGGCCHHHHHH----CC
T ss_pred hCCCcCCcCCccceeECCC-------CcEEEccCcchhhccccccc--------cccCceeeCccccchhHhhc----CC
Confidence 9999999999999999987 88999999999765432211 12234579999999999987 57
Q ss_pred CCchhhHHHHHHHHHHHHhC-CCCCCCCCHH-HHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 001143 1026 YGLEVDIWSYGCLLLELLTL-QVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1103 (1141)
Q Consensus 1026 ~s~ksDVWSLGviL~ELLTG-k~Pf~~~~~~-el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1141)
++.++|||||||++|||+|| .+||.+.... .+...+..+..+..+. ..+++
T Consensus 213 ~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 265 (299)
T d1ywna1 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 265 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHH
Confidence 89999999999999999996 5678765433 3445555555443321 44567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1104 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1104 L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
+.+++.+||+.||++|||++||++||...
T Consensus 266 l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 266 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=396.99 Aligned_cols=284 Identities=19% Similarity=0.227 Sum_probs=205.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||+||+|.+. +..||+|+.. .........+ ++.+|+.+|++++|||||+++++|...+.
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~--~~~~~~~~~~----~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAK----RAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECS--STTSSHHHHH----HHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEc--hhhcChHHHH----HHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 57999999999999999999985 6667777743 3223333333 34899999999999999999999987553
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. ....+.|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 92 L--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156 (346)
T ss_dssp T--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c--------cccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc
Confidence 2 1233569999999 5788888765 36999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+|++|||.|+..... .....||+.|+|||++.+ ...++.++||||+||++|+|+
T Consensus 157 ~-------~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 157 D-------CELKILDFGLARQADSE-------------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp T-------CCEEECCCTTCEECCSS-------------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHHH
T ss_pred c-------cccccccccceeccCCc-------------cccccccccccCHHHHcC---CCCCCccchhhcchHHHHHHH
Confidence 8 88999999999765431 124569999999999876 245689999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+.+..+....+........................... ............++++.+||.+||+.||.+||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (346)
T d1cm8a_ 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence 999999988777665555332222111111110000000000000 00001111124567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
||.|+++|+|++.
T Consensus 294 ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 294 TAGEALAHPYFES 306 (346)
T ss_dssp CHHHHHHSGGGTT
T ss_pred CHHHHhcChhhCc
Confidence 9999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=392.89 Aligned_cols=298 Identities=17% Similarity=0.200 Sum_probs=207.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecC
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~ 881 (1141)
++.+|++.++||+|+||+||+|++. +..||||+...+.. ... ...++.+|+.+|++++||||+++++++...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~----~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEG----FPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chH----HHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 4789999999999999999999984 66788887543322 111 223347999999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeee
Q 001143 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1141)
Q Consensus 882 ~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILl 961 (1141)
... ......+.++||||+.++.+..... ....+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 82 ~~~------~~~~~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl 150 (318)
T d3blha1 82 ASP------YNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150 (318)
T ss_dssp ---------------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ccc------ccccCceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee
Confidence 321 1112235799999998666554332 24579999999999999999999999999999999999999
Q ss_pred ecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001143 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1041 (1141)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1041 (1141)
+.+ +.+||+|||+++.+....... .......+||+.|+|||++.+ ...++.++||||+||++||
T Consensus 151 ~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~---~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 151 TRD-------GVLKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp CTT-------SCEEECCCTTCEECCC-----------CCCCCSCCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeeecceeeecccccccc------cccccceecCHHHhhHHHHcC---CCCCCcHHHcccCCceeee
Confidence 987 889999999997655432211 112234579999999999876 2468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCch----hhhhhHHHHHHHHHHhcccCCC
Q 001143 1042 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE----AELETLSFLVDVFRRCTEENPT 1117 (1141)
Q Consensus 1042 LLTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~L~dLI~~cL~~DP~ 1117 (1141)
|++|+.||.+.+..+....+.................................. .....++.+.+||.+||++||+
T Consensus 215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence 999999999877776665553321111111110000000000000000000000 0123356788999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001143 1118 ERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1118 ~RPSa~ElL~~L~~~~~ 1134 (1141)
+||||+|+++|+||+..
T Consensus 295 ~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 295 QRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TSCCHHHHHHSGGGSSS
T ss_pred HCcCHHHHHcChhhccC
Confidence 99999999999999854
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=396.77 Aligned_cols=285 Identities=22% Similarity=0.218 Sum_probs=205.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCC
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~ 884 (1141)
+|+..++||+|+||+||+|++. +..||+|+...+.. .. .+|+++|++++|||||+++++|......
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~----~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FK----NRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SC----CHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HH----HHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 5999999999999999999995 56688887543211 11 4799999999999999999998754311
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeecc
Q 001143 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1141)
Q Consensus 885 ~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~ 964 (1141)
....+.++||||++++ +...+.... .....+++.+++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 89 --------~~~~~~~lv~Ey~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 89 --------KDEVYLNLVLDYVPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp --------CSCCEEEEEEECCSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred --------CCceEEEEEEeccCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC
Confidence 1234679999999855 444443322 234579999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001143 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1044 (1141)
Q Consensus 965 ~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1044 (1141)
+ ..+||+|||+|+...... ......||+.|+|||.+.+ ...++.++||||+||++|||++
T Consensus 159 ~------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 159 T------AVLKLCDFGSAKQLVRGE-----------PNVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp T------CCEEECCCTTCEECCTTS-----------CCCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHHH
T ss_pred C------CceeEecccchhhccCCc-----------ccccccccccccChHHhhc---ccCCCcceeecccceEEEehhh
Confidence 2 479999999997654321 1124569999999999875 2468899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccC-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001143 1045 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1123 (1141)
Q Consensus 1045 Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ 1123 (1141)
|+.||...+..+....+...........+...... .....................++++.+||.+||++||++||||.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999988777766655332222222222111100 00000000000000001124567899999999999999999999
Q ss_pred HHHHHHHhhc
Q 001143 1124 DLYEMFVART 1133 (1141)
Q Consensus 1124 ElL~~L~~~~ 1133 (1141)
|+++|+||..
T Consensus 299 e~L~Hp~f~~ 308 (350)
T d1q5ka_ 299 EACAHSFFDE 308 (350)
T ss_dssp HHHTSGGGGG
T ss_pred HHhcCHhhcc
Confidence 9999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=388.68 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=206.9
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCccc
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 873 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~---------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVk 873 (1141)
+.++|++.++||+|+||.||+|++.+ ..||+|+ ++... .......+ .+|+..+.++ +|||||+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~--~~~~~-~~~~~~~~----~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDA-TEKDLSDL----ISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEEC--CCTTC-CHHHHHHH----HHHHHHHHHHCCCTTBCC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEE--ECccc-ChHHHHHH----HHHHHHHHHhcCCCeEEe
Confidence 34689999999999999999998632 2456655 33322 22333333 7899999888 7999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHH
Q 001143 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 874 llg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+++++.+++.. ++||||+++|+|.++|..... .....+++.+++.++.||+.||+
T Consensus 84 ~~~~~~~~~~~--------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 149 (299)
T d1fgka_ 84 LLGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME 149 (299)
T ss_dssp EEEEECSSSSC--------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccCCeE--------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHH
Confidence 99999876544 999999999999999975321 12346899999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||+++||||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||.+.+
T Consensus 150 ylH~~~ivHrDiKp~NiLl~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~--- 211 (299)
T d1fgka_ 150 YLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD--- 211 (299)
T ss_dssp HHHHTTCCCSCCSGGGEEECTT-------CCEEECSTTCCCCGGGCCTT--------CCCTTSCCGGGGSCHHHHHH---
T ss_pred HhhhCCEEeeeecccceeecCC-------CCeEeccchhhccccccccc--------cccccCCCChhhhhhhHhcC---
Confidence 9999999999999999999988 88999999999876542211 11234568999999999987
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1101 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1141)
..|+.++|||||||++|||++ |.+||.+.+..++...+..+..+..+. ..+
T Consensus 212 -~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~ 263 (299)
T d1fgka_ 212 -RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NCT 263 (299)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SCC
T ss_pred -CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cch
Confidence 678999999999999999998 799999888888887777665544331 445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1102 SFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1102 ~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
+++.+||.+||+.||.+||||.||++.|....
T Consensus 264 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 264 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 67999999999999999999999999987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-42 Score=384.87 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=201.1
Q ss_pred eEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 809 SSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 809 ~i~~~LG~GsfG~Vy~a~~~~---~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
.+.++||+|+||+||+|++.. +.++|+||.++.. ......+.+ .+|+++|++++|||||+++|++.+.+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~--- 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSE--- 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEEETT---
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHH----HHHHHHHHhCCCCCEeEEeEEEEecC---
Confidence 457899999999999999833 3344555545432 233444444 89999999999999999999976532
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeeccc
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~~~ 965 (1141)
...++|||||++|+|.++++. ....+++..+.+++.|++.||.|||+.+|+||||||+|||++.+
T Consensus 102 ----------~~~~lv~E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~- 166 (311)
T d1r0pa_ 102 ----------GSPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK- 166 (311)
T ss_dssp ----------TEEEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred ----------CceEEEEEEeecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-
Confidence 145999999999999999875 23467889999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001143 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1045 (1141)
Q Consensus 966 ~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1045 (1141)
+.+||+|||+++......... ........||+.|+|||.+.. ..++.++||||||+++|||+||
T Consensus 167 ------~~~kL~DFG~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~SfGivl~El~t~ 230 (311)
T d1r0pa_ 167 ------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTR 230 (311)
T ss_dssp ------CCEEECSSGGGCCTTTTTCCC------TTCTTCSSCCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ------CCEEEecccchhhcccccccc------ceecccccccccccChHHHhc----CCCCChhHhhhhHHHHHHHHHC
Confidence 789999999998765432111 112224568999999999886 5789999999999999999997
Q ss_pred CCCCCC-CCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001143 1046 QVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1124 (1141)
Q Consensus 1046 k~Pf~~-~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~E 1124 (1141)
..||.. .+..++...+..+.++..+. .+++.+.+|+.+||+.||++|||+.|
T Consensus 231 ~~p~~~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 231 GAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp SCCSCC------CHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 777654 33344555555555443221 44567999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001143 1125 LYEMFVARTSS 1135 (1141)
Q Consensus 1125 lL~~L~~~~~s 1135 (1141)
|++++.....+
T Consensus 284 i~~~L~~i~~~ 294 (311)
T d1r0pa_ 284 LVSRISAIFST 294 (311)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHh
Confidence 99998765443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-42 Score=384.45 Aligned_cols=264 Identities=21% Similarity=0.340 Sum_probs=213.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
+.++|++.++||+|+||+||+|.+. +..||||+. +.. ........ +.+|+.++++++|||||++++
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~--~~~-~~~~~~~~----~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEA-ASMRERIE----FLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC--CTT-SCHHHHHH----HHHHHHHGGGCCCTTBCCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEE--Ccc-cChHHHHH----HHHHHHHHHHcCCCCEeeeee
Confidence 3578999999999999999999874 346777763 322 22233333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-----~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvH 951 (1141)
++...... ++||||+++|+|.+++..... .....+++..+.+|+.||++||.|||+++|+|
T Consensus 91 ~~~~~~~~--------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 91 VVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred EEecCCce--------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 99865544 999999999999999875321 12235799999999999999999999999999
Q ss_pred cCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001143 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031 (1141)
Q Consensus 952 rDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1031 (1141)
|||||+|||++.+ +++||+|||+|+.+....... ......||+.|+|||.+.+ ..++.++|
T Consensus 157 rDlk~~NiLld~~-------~~~Kl~DFGla~~~~~~~~~~--------~~~~~~~t~~y~aPe~l~~----~~~~~~~D 217 (308)
T d1p4oa_ 157 RDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSD 217 (308)
T ss_dssp SCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEE--------GGGSSEECGGGCCHHHHHH----CCCCHHHH
T ss_pred ceEcCCceeecCC-------ceEEEeecccceeccCCccee--------eccceecccccCCHHHHcc----CCCCcccc
Confidence 9999999999987 889999999998765432211 1123358999999999987 57889999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001143 1032 IWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1110 (1141)
Q Consensus 1032 VWSLGviL~ELLTG-k~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~ 1110 (1141)
||||||++|||+|| ..||.+.+..+....+..+..+..+. .+++.+.++|.+
T Consensus 218 v~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~ 270 (308)
T d1p4oa_ 218 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRM 270 (308)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHH
T ss_pred cccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------------------cchHHHHHHHHH
Confidence 99999999999998 58898888888888776665544322 455679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 001143 1111 CTEENPTERPTAGDLYEMFVARTS 1134 (1141)
Q Consensus 1111 cL~~DP~~RPSa~ElL~~L~~~~~ 1134 (1141)
||+.||.+|||+.+|+++|.....
T Consensus 271 cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 271 CWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCChhHCcCHHHHHHHHHHhcC
Confidence 999999999999999998876533
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=380.89 Aligned_cols=284 Identities=19% Similarity=0.216 Sum_probs=210.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
+++|++.++||+|+||+||+|++. +..||||+.+... ....... ++.+|+.++++++|||||++++++.+..
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~----~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPS----SALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHH----HHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHH----HHHHHHHHHHhcCcCCEEeecccccccc
Confidence 368999999999999999999984 5668888865442 2222233 3489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
. .++||||+.+++|..+++. ...+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 75 ~--------------~~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 75 K--------------LTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp E--------------EEEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred c--------------eeEEeeecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 3 4999999999888887764 35789999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+||+|||.|+....... ......+++.|+|||++.+ ...++.++||||+||++|||
T Consensus 136 ~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~~~~~~~~pe~~~~---~~~~~~~~DiwSlG~il~el 195 (292)
T d1unla_ 136 RN-------GELKLANFGLARAFGIPVR----------CYSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------CCEEECCCTTCEECCSCCS----------CCCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred cC-------CceeeeecchhhcccCCCc----------cceeeccccchhhhhHhcc---CCCCCchhhccccchHHHHH
Confidence 87 7899999999976544221 1223457889999999876 23568999999999999999
Q ss_pred HhCCCCCC-CCCHHHHHHHHHhCCCCCchhHHhhhccC-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1043 LTLQVPYM-GLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1043 LTGk~Pf~-~~~~~el~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
++|+.||. +.+..+....+.....+.....+...... .....................++.+.+|+.+||+.||.+||
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence 99998864 44555555555322221111111100000 00000000111111122235567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
||+|+++|+||..
T Consensus 276 sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 276 SAEEALQHPYFSD 288 (292)
T ss_dssp CHHHHTTSGGGSS
T ss_pred CHHHHhcChhhcC
Confidence 9999999999963
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=383.42 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=206.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhC-CCCCcccee
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~-------~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkll 875 (1141)
+.++|++.++||+|+||.||+|++. +..||||+.+ ... .......+ .+|+.+++++ +|||||+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~--~~~-~~~~~~~~----~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSA-HLTEREAL----MSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC--TTC-CHHHHHHH----HHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEEC--ccc-CHHHHHHH----HHHHHHHHhccCCCCEEEEE
Confidence 3468999999999999999999873 2356776643 222 23333333 7999999999 699999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------cCCCCCCHHHHHHHHHHHHHHHH
Q 001143 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAALV 942 (1141)
Q Consensus 876 g~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~-------------~~~~~Ls~~~i~~Ia~QIa~gL~ 942 (1141)
+++.+...+ ++|||||++|+|.++++.... .....+++..+..|+.||+.||+
T Consensus 94 g~~~~~~~~--------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 94 GACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp EEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred EEEeeCCEE--------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 999876544 999999999999999986321 12346999999999999999999
Q ss_pred HHHHCCccccCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccC
Q 001143 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1141)
Q Consensus 943 yLHs~gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1022 (1141)
|||+++||||||||+||+++.+ +.+|++|||.++......... ......||+.|+|||++.+
T Consensus 160 ~LH~~~ivHrDLKp~NIl~~~~-------~~~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~--- 221 (311)
T d1t46a_ 160 FLASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN--- 221 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH---
T ss_pred HHHhCCeeeccccccccccccc-------CcccccccchheeccCCCcce--------EeeecccChHHcCHHHhcC---
Confidence 9999999999999999999987 899999999998654422111 1234578999999999986
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 001143 1023 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1100 (1141)
Q Consensus 1023 ~~~~s~ksDVWSLGviL~ELLT-Gk~Pf~~~~~~el-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1141)
..++.++|||||||++|||+| |++||.+.+..+. ...+..+.++..+. ..
T Consensus 222 -~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~ 273 (311)
T d1t46a_ 222 -CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE---------------------------HA 273 (311)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT---------------------------TS
T ss_pred -CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc---------------------------cc
Confidence 578999999999999999999 6666766555443 34445544433221 44
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1101 LSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1101 ~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
++.+.+||.+||+.||++||||+||++.|...
T Consensus 274 ~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 56799999999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=382.18 Aligned_cols=267 Identities=25% Similarity=0.278 Sum_probs=197.8
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~~~ 885 (1141)
.+|.+.++||+|+||.||+|++++..||||++..+ ..+.+ ....|+..+.+++|||||++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-------~~~~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhHH--HHHHHHHHHhhCCCCcCcceEEEEEeCCC--
Confidence 36899999999999999999999999999986422 11121 11345556667899999999999886432
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCC
Q 001143 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------KHIMHRDIKSE 957 (1141)
Q Consensus 886 ~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs--------~gIvHrDLKP~ 957 (1141)
...+.++||||+++|+|.+++++ ..+++..+.+++.|++.||.|||+ +||+||||||+
T Consensus 72 --------~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred --------cceEEEEEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 23367999999999999999986 359999999999999999999996 59999999999
Q ss_pred CeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCC--CCCCchhhHHHH
Q 001143 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP--NLYGLEVDIWSY 1035 (1141)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~--~~~s~ksDVWSL 1035 (1141)
||||+.+ +.+||+|||+++......... ........||+.|+|||++.+.... ..++.++|||||
T Consensus 138 NILl~~~-------~~~Kl~DFGl~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 138 NILVKKN-------GTCCIADLGLAVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp GEEECTT-------SCEEECCCTTCEEEETTTTEE------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ceEEcCC-------CCeEEEecCccccccCCCcce------eccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 9999987 899999999998765433221 1122345799999999998763211 125679999999
Q ss_pred HHHHHHHHhCCCCCCCCC---------------HHHHHHHHH-hCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 001143 1036 GCLLLELLTLQVPYMGLS---------------ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1099 (1141)
Q Consensus 1036 GviL~ELLTGk~Pf~~~~---------------~~el~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1141)
||++|||+||..||.... .......+. ...+|.++.. .....
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----------------------~~~~~ 262 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR----------------------WQSCE 262 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------GGGCH
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc----------------------cCChH
Confidence 999999999988774311 111111111 1111111111 11124
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001143 1100 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1132 (1141)
Q Consensus 1100 ~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~ 1132 (1141)
....+.+|+.+||+.||++|||+.||+++|...
T Consensus 263 ~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 263 ALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 567799999999999999999999999988654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=387.08 Aligned_cols=287 Identities=18% Similarity=0.234 Sum_probs=204.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||+||+|++. +..||||+.. ... .....+ ++.+|+.+|++++||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~--~~~-~~~~~~----~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFE-HQTYCQ----RTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEEC--CTT-CHHHHH----HHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEe--hhc-ChHHHH----HHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 35999999999999999999985 6677777743 221 222233 34899999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. .... +++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 81 ~---------~~~~-~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 81 E---------QMKD-VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp T---------TCCC-EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------ccce-EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence 1 1112 445556668999999975 36999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+||+|||+|+......... ......+||+.|+|||++.. ...++.++||||+||++|+|+
T Consensus 145 ~-------~~~kl~DfG~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 145 T-------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp T-------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEcccCceeeccCCCccc-------eeeccccccceechHHHhhc---CCCCCchhhhhccCceehHHh
Confidence 7 789999999997654432211 11234579999999999865 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh-CCCCCchhHHhhhccCcccc-cccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHE-VAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~-~~~p~l~~~l~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+|+.||.+.+..+....... ...+... ............ .... .............+.++.+|+.+||+.||.+|
T Consensus 208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 286 (345)
T d1pmea_ 208 SNRPIFPGKHYLDQLNHILGILGSPSQE-DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286 (345)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHH-HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hCCCCCCCCCHHHHHHHHhhhccCCChh-hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHC
Confidence 99999988776665544422 2222211 110000000000 0000 00000111112455679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001143 1120 PTAGDLYEMFVART 1133 (1141)
Q Consensus 1120 PSa~ElL~~L~~~~ 1133 (1141)
|||+|+++|+|+..
T Consensus 287 ~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 287 IEVEQALAHPYLEQ 300 (345)
T ss_dssp CCHHHHHTSGGGTT
T ss_pred cCHHHHhcCHhhcc
Confidence 99999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=386.51 Aligned_cols=284 Identities=17% Similarity=0.224 Sum_probs=202.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~ 882 (1141)
.++|++.++||+|+||+||+|++. +..||||+.... ......... +.+|+.++++++|||||+++++|....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~--~~~~~~~~~----~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST--TSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh--hcCHHHHHH----HHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 367999999999999999999985 677888875433 223333333 489999999999999999999997654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
.. ....+.|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~--------~~~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 90 TL--------EEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp ST--------TTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cc--------ccCceeEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence 21 233578999999975 4544443 2589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
.+ +.+|++|||.++...... ......||+.|+|||++.+ ..++.++||||+||++++|
T Consensus 154 ~~-------~~~kl~df~~~~~~~~~~-----------~~~~~~~t~~y~aPE~l~~----~~~~~~~DiwSlG~~l~el 211 (355)
T d2b1pa1 154 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 211 (355)
T ss_dssp TT-------CCEEECCCCC--------------------------CCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred cc-------cceeeechhhhhcccccc-----------ccccccccccccChhhhcC----CCCCCCcccccccchHHHH
Confidence 87 789999999987544321 1224468999999999986 5788999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCcccc---------------ccccCCCCCCchhhhhhHHHHHHH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE---------------VAQSGSGFEKPEAELETLSFLVDV 1107 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~L~dL 1107 (1141)
++|+.||.+.+.......+........+..+.......... ....... .........++++.+|
T Consensus 212 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDL 290 (355)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHH
T ss_pred hhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccc-ccccccccCCHHHHHH
Confidence 99999999887776665553322222222111110000000 0000000 0111223567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1108 FRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1108 I~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
|.+||++||++||||+|+++|+|+..
T Consensus 291 l~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 291 LSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=386.57 Aligned_cols=284 Identities=19% Similarity=0.236 Sum_probs=206.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeeeEecCCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~~~~~~~ 883 (1141)
++|++.++||+|+||+||+|++. +..||+|+. +.........+. +.+|+.+|++++|||||++++++.....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i--~~~~~~~~~~~~----~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEEC--SCTTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEE--CchhcChHHHHH----HHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 57999999999999999999985 566777764 333333333333 3799999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeeec
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld~ 963 (1141)
. .....++||+|+.||+|.++++. .++++.+++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~---------~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 92 L---------EEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156 (348)
T ss_dssp T---------TTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c---------ccCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc
Confidence 2 11123566777789999999854 36999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001143 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1043 (1141)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1043 (1141)
+ +.+|++|||.|....... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 157 ~-------~~~kl~dfg~a~~~~~~~-------------~~~~g~~~y~apE~~~~---~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 157 D-------CELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp T-------CCEEECCC----CCTGGG-------------SSSCHHHHTSCHHHHTT---CSCCCTTHHHHHHHHHHHHHH
T ss_pred c-------ccccccccchhcccCccc-------------ccccccccccCchhhcC---CccCCcccchhhhhHHHHHHH
Confidence 8 889999999986543321 23468999999999775 245689999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001143 1044 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERP 1120 (1141)
Q Consensus 1044 TGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~L~dLI~~cL~~DP~~RP 1120 (1141)
+|+.||.+.+.......+............................... ........++++.+||.+||+.||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 9999999888777666663332222111111000000000000000000 0111124567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001143 1121 TAGDLYEMFVART 1133 (1141)
Q Consensus 1121 Sa~ElL~~L~~~~ 1133 (1141)
||+|+++|+|+..
T Consensus 294 ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 294 TAAQALAHAYFAQ 306 (348)
T ss_dssp CHHHHHTSGGGTT
T ss_pred CHHHHhcCHhhCC
Confidence 9999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.2e-41 Score=381.74 Aligned_cols=282 Identities=19% Similarity=0.212 Sum_probs=202.9
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEe
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 879 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~ 879 (1141)
...++|++.++||+|+||+||+|++. +..||+|+.+ .. ..+. +.+|+.+|++++ ||||+++++++.
T Consensus 32 ~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~--~~-----~~~~----~~~Ei~il~~l~~hpnIv~~~~~~~ 100 (328)
T d3bqca1 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PV-----KKKK----IKREIKILENLRGGPNIITLADIVK 100 (328)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--SS-----CHHH----HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEC--HH-----HHHH----HHHHHHHHHhccCCCCCcEEEEEEE
Confidence 34578999999999999999999985 6677777743 21 1222 378999999995 999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCe
Q 001143 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1141)
Q Consensus 880 ~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NI 959 (1141)
.... ...++||||+++++|..+. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 101 ~~~~------------~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NI 160 (328)
T d3bqca1 101 DPVS------------RTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 160 (328)
T ss_dssp CTTT------------CSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ecCC------------CceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccce
Confidence 5321 2469999999999986653 2599999999999999999999999999999999999
Q ss_pred eeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001143 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1039 (1141)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1039 (1141)
|++.++ ..+||+|||+|+...... ......+|+.|+|||.+.+ ...++.++||||+||++
T Consensus 161 Li~~~~------~~vkl~DFG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~~l 220 (328)
T d3bqca1 161 MIDHEH------RKLRLIDWGLAEFYHPGQ-----------EYNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 220 (328)
T ss_dssp EEETTT------TEEEECCGGGCEECCTTC-----------CCCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEcCCC------CeeeecccccceeccCCC-----------cccccccCccccCcccccC---CCCCCcccchhhhhhhh
Confidence 998652 469999999997654321 1234568999999999876 24578999999999999
Q ss_pred HHHHhCCCCCCCCC-HHHHHHHHHhCCCCCchhHH-hhhccCcccccccc--------CCCCCCchhhhhhHHHHHHHHH
Q 001143 1040 LELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDEL-EALGSCHEHEVAQS--------GSGFEKPEAELETLSFLVDVFR 1109 (1141)
Q Consensus 1040 ~ELLTGk~Pf~~~~-~~el~~~I~~~~~p~l~~~l-~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~L~dLI~ 1109 (1141)
|+|++|+.||.... ..+....+............ .............. .............++++.+||.
T Consensus 221 ~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 300 (328)
T d3bqca1 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300 (328)
T ss_dssp HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHH
T ss_pred HHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHH
Confidence 99999999997543 22222222111100000000 00000000000000 0000111112356778999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 001143 1110 RCTEENPTERPTAGDLYEMFVARTSS 1135 (1141)
Q Consensus 1110 ~cL~~DP~~RPSa~ElL~~L~~~~~s 1135 (1141)
+||++||.+|||++|+++|+||+.-.
T Consensus 301 ~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 301 KLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred HHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999998643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=389.24 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=204.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCC-CCccceee
Q 001143 803 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 876 (1141)
Q Consensus 803 ~~~~~y~i~~~LG~GsfG~Vy~a~~-----~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkllg 876 (1141)
..+++|++.++||+|+||+||+|++ .+..||+|+++...........+. +.+|+.++++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~----~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGG----CCCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHH----HHHHHHHHHhccCCCeEEEeee
Confidence 4578899999999999999999987 356789998643321111112223 3789999999965 89999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
++.+... .++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||
T Consensus 97 ~~~~~~~--------------~~~v~e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp 157 (322)
T d1vzoa_ 97 AFQTETK--------------LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157 (322)
T ss_dssp EEEETTE--------------EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeccCCc--------------eeeeeecccccHHHHHHHh-----cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCc
Confidence 9987653 4999999999999999986 23578999999999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1036 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1036 (1141)
+|||++.+ +.+||+|||+|+.+....... .....|++.|+|||.+.+. ...++.++||||||
T Consensus 158 ~Nill~~~-------~~vkL~DFG~a~~~~~~~~~~---------~~~~~g~~~~~~pe~~~~~--~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 158 ENILLDSN-------GHVVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLG 219 (322)
T ss_dssp GGEEECTT-------SCEEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHH
T ss_pred cceeecCC-------CCEEEeeccchhhhccccccc---------ccccccccccchhHHhhcC--CcCCCchhhhHHHH
Confidence 99999987 789999999997654432211 1244689999999999752 23578899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001143 1037 CLLLELLTLQVPYMGLSELEIHDLIQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1113 (1141)
Q Consensus 1037 viL~ELLTGk~Pf~~~~~~el~~~I~~---~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~ 1113 (1141)
|++|+|++|+.||.+.+..+....+.. ...+..+ ...++++.+|+.+||+
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~---------------------------~~~s~~~~~li~~~l~ 272 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---------------------------QEMSALAKDLIQRLLM 272 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---------------------------TTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc---------------------------ccCCHHHHHHHHHHcc
Confidence 999999999999977544333222211 1111110 1456789999999999
Q ss_pred cCCCCCC-----CHHHHHHHHHhhc
Q 001143 1114 ENPTERP-----TAGDLYEMFVART 1133 (1141)
Q Consensus 1114 ~DP~~RP-----Sa~ElL~~L~~~~ 1133 (1141)
+||.+|| |++|+++|+|++.
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999 5899999999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-39 Score=360.83 Aligned_cols=268 Identities=16% Similarity=0.168 Sum_probs=192.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCCCCCccceeee-EecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH-KISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg~-~~~~~ 882 (1141)
++|++.++||+|+||.||+|++. +..||||+...+.. .+. +..|+++++.++|+|+|..+.. +.+.+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~----~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQ----LHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCC----HHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHH----HHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 36999999999999999999985 66888887654321 112 3689999999987766555544 44333
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+. ++|...+.. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 77 --------------~~~ivme~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 77 --------------YNVMVMELLG-PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp --------------EEEEEEECCC-CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred --------------EEEEEEEEcC-Cchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence 3589999995 777776654 235799999999999999999999999999999999999986
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
..+ ....+||+|||+|+.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 138 ~~~----~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 138 LGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp CGG----GTTCEEECCCSSCEECBCTTTCCB---CCCCBCCSCCCCSSSCCHHHHTT----BCCCHHHHHHHHHHHHHHH
T ss_pred ccC----CCceeeeeccCcceeccccccccc---eeccccCCcCCCccccCHHHHhC----CCCCChhhEEecCHHHHHH
Confidence 531 126799999999987654322111 11122345679999999999986 5689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001143 1043 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1122 (1141)
Q Consensus 1043 LTGk~Pf~~~~~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa 1122 (1141)
++|+.||......+....+...... .... ..+.....+++++.+++..||+.||++||++
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~----~~~~----------------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~ 266 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEK----KMST----------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHH----HHHS----------------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCH
T ss_pred HhCCCcccccchHHHHHHHHHhhcc----cCCC----------------ChhHhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999875544433222110000 0000 0001112566789999999999999999999
Q ss_pred HHH---HHHHHhhc
Q 001143 1123 GDL---YEMFVART 1133 (1141)
Q Consensus 1123 ~El---L~~L~~~~ 1133 (1141)
+++ +++++.+.
T Consensus 267 ~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 267 SYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHc
Confidence 865 55665543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-38 Score=351.13 Aligned_cols=264 Identities=17% Similarity=0.179 Sum_probs=198.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCC
Q 001143 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1141)
Q Consensus 806 ~~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~ 882 (1141)
.+|++.++||+|+||+||+|++. +..+|+|+..... . ... +.+|++.++.++ |+|++.+++++.+..
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~----~~~----~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--D----APQ----LRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--T----SCC----HHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--C----cHH----HHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 46999999999999999999985 5678888754321 1 112 368999999996 599999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCeeee
Q 001143 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1141)
Q Consensus 883 ~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP~NILld 962 (1141)
..++||||+ +++|.++++. ....+++.++..++.|++.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~~vme~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 75 --------------HNVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred --------------ccEEEEEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 349999999 6899999875 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001143 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1042 (1141)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1042 (1141)
... ....+.+||+|||+|+.+........ ..........||+.|||||++.+ ..++.++|||||||++|||
T Consensus 136 ~~~--~~~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 136 RPN--SKNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CSS--STTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred Ccc--cccCCceEEcccceeEEcccCccccc---eeecccCceEEchhhcCHHHhcC----CCCChHHHHHHhhHHHHHH
Confidence 531 11226799999999987654322111 11123345679999999999986 5689999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHhCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001143 1043 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1119 (1141)
Q Consensus 1043 LTGk~Pf~~~~---~~el~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLI~~cL~~DP~~R 1119 (1141)
+||+.||.+.. ..+....+.......... +.....++++.+++..|+..+|++|
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-----------------------~l~~~~p~~l~~ii~~~~~~~~~~r 263 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-----------------------ELCAGFPEEFYKYMHYARNLAFDAT 263 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-----------------------HHTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChH-----------------------HhcCCCCHHHHHHHHHHhcCCcccC
Confidence 99999997543 222333332111100000 0111456779999999999999999
Q ss_pred CCHHHHHHHHH
Q 001143 1120 PTAGDLYEMFV 1130 (1141)
Q Consensus 1120 PSa~ElL~~L~ 1130 (1141)
|+++.+.+.+.
T Consensus 264 P~y~~l~~~l~ 274 (293)
T d1csna_ 264 PDYDYLQGLFS 274 (293)
T ss_dssp CCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99888766543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-35 Score=339.99 Aligned_cols=282 Identities=20% Similarity=0.252 Sum_probs=189.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-----------CCCccc
Q 001143 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSCIVE 873 (1141)
Q Consensus 807 ~y~i~~~LG~GsfG~Vy~a~~~--~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpNIVk 873 (1141)
+|++.++||+|+||+||+|++. +..||||+.+.+ ....+. +.+|+.+++.++ |+||++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~----~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEA----AEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHH----HHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHH----HHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 5999999999999999999984 677888875422 122222 367888887775 578999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCC-HHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Q 001143 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMH 951 (1141)
Q Consensus 874 llg~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggS-L~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIvH 951 (1141)
+++++..... ...++||+++..+. ....... .....+++..++.++.||+.||+|||+ .||+|
T Consensus 85 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvH 149 (362)
T d1q8ya_ 85 LLDHFNHKGP------------NGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 149 (362)
T ss_dssp CCEEEEEEET------------TEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC
T ss_pred EEEEeeeccc------------cceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 9998875332 13466666665443 3333322 334579999999999999999999998 89999
Q ss_pred cCCCCCCeeeecccccCCCCCeEEEeeccccccccccccccccccCCCCCCCCccCCCcccchhhhccccCCCCCCchhh
Q 001143 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1031 (1141)
Q Consensus 952 rDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~l~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1031 (1141)
|||||+|||++.++. ......++++|||.+...... .....||+.|+|||++.+ ..++.++|
T Consensus 150 rDlKp~NIll~~~~~-~~~~~~~kl~dfg~s~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~D 211 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEH-------------YTNSIQTREYRSPEVLLG----APWGCGAD 211 (362)
T ss_dssp SCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBC-------------CCSCCSCGGGCCHHHHHT----CCCCTHHH
T ss_pred ccCChhHeeeeccCc-ccccceeeEeecccccccccc-------------cccccccccccChhhccc----cCCCcccc
Confidence 999999999987621 011135999999998754321 124569999999999886 56889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHH-HhCCCCCchhHHhhhccCc-----cccccccCCCCC------
Q 001143 1032 IWSYGCLLLELLTLQVPYMGLSEL------E-IHDLI-QMGKRPRLTDELEALGSCH-----EHEVAQSGSGFE------ 1092 (1141)
Q Consensus 1032 VWSLGviL~ELLTGk~Pf~~~~~~------e-l~~~I-~~~~~p~l~~~l~~~~~~~-----~~~~~~~~~~~~------ 1092 (1141)
|||+||++++|++|+.||...... + ....+ ..+..+. . ........ ............
T Consensus 212 iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS-Y--LLRNGKYTRTFFNSRGLLRNISKLKFWPLED 288 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH-H--HHHHCTTHHHHBCC--CBSSCCCCCBCCHHH
T ss_pred ccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCH-H--HhhcccccccccccchhhhccccccCCchhh
Confidence 999999999999999999753221 1 11111 1122111 1 10000000 000000000000
Q ss_pred ----CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001143 1093 ----KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1133 (1141)
Q Consensus 1093 ----~~~~~~~~~~~L~dLI~~cL~~DP~~RPSa~ElL~~L~~~~ 1133 (1141)
........++++.+|+.+||++||.+||||+|+|+|+||+.
T Consensus 289 ~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 289 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp HHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred hcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCC
Confidence 00111356788999999999999999999999999999983
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.93 E-value=5.5e-27 Score=262.39 Aligned_cols=248 Identities=20% Similarity=0.219 Sum_probs=210.4
Q ss_pred CCCCEEEccCCCCCCC--CcccccCCCCCCCccEEEeec-CCCC-ccCccccCCcCCcEEEccCCCCCcC-chhhcCCCC
Q 001143 41 DDDSVIDVSGKTVDFP--LIESYGNRGGDNSVEGLYLYK-NVLN-LIPKSVGRYEKLRNLKFFGNEINLF-PSEVGNLLG 115 (1141)
Q Consensus 41 ~~L~~LdLs~N~Ls~~--~p~~~~~l~~L~~L~~L~Ls~-N~Lt-~iP~~l~~L~~L~~L~Ls~N~L~~l-P~~~~~L~~ 115 (1141)
..++.|||++|+++|. +|..++.+ ++|++|+|++ |+++ .||.+|++|++|++|+|++|+|+.+ |..+.++.+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L---~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~ 126 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANL---PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC---TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcC---ccccccccccccccccccccccccccccchhhhccccccccccccccchhh
Confidence 3689999999999984 67767655 9999999986 8887 8999999999999999999999855 666889999
Q ss_pred CCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC-cEEEccCCCCC-ccCccccCCCCCCEE
Q 001143 116 LECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL-TKLSVCHFSIR-YLPPEIGCLSNLEQL 192 (1141)
Q Consensus 116 L~~L~Ls~N~-l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L-~~L~Ls~N~L~-~iP~~l~~l~~L~~L 192 (1141)
|+.+++++|. ...+|..+.+++.|+.+++++| ...+.+|..+..+..+ +.+++++|+++ ..|..+..+.. ..+
T Consensus 127 L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n---~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l 202 (313)
T d1ogqa_ 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGN---RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSS---CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEE
T ss_pred hcccccccccccccCchhhccCcccceeecccc---cccccccccccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998 6677889999999999999994 4556788888888776 88999999999 44667777654 479
Q ss_pred EccCCccc-cccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 193 DLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 193 ~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
++++|.+. .+|..++.+++|+.|++++|.++..|..++.+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|
T Consensus 203 ~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence 99999888 77888999999999999999998666688899999999999999999888899999999999999999998
Q ss_pred CCCCchhhhhcccCCCCCCCCCC-cccC
Q 001143 272 YCQVPSWICCNLEGNGKDSSNDD-FISS 298 (1141)
Q Consensus 272 ~~~iP~~~~~~l~~~~l~~~~n~-l~~~ 298 (1141)
.||.. ..+.....+.+.+|. +||.
T Consensus 283 --~iP~~-~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 283 --EIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp --ECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred --cCCCc-ccCCCCCHHHhCCCccccCC
Confidence 58853 444566677777776 4554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.93 E-value=3.8e-26 Score=255.52 Aligned_cols=250 Identities=16% Similarity=0.166 Sum_probs=216.0
Q ss_pred cccccCCCCCcccc--CCCCCCCCCCCCEEEccC-CCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCcCCc
Q 001143 19 KEKLPSEANKINNE--KNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLR 94 (1141)
Q Consensus 19 l~~L~~~~N~i~~i--~~~~f~~l~~L~~LdLs~-N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP-~~l~~L~~L~ 94 (1141)
+..|++..|++++. -+..+.++++|++|||++ |+++|.+|..++.+ ++|++|+|++|+|+.++ ..+..+..|+
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L---~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL---TQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC---TTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccc---cccchhhhccccccccccccccchhhhc
Confidence 66788889999874 357899999999999997 89999999887666 99999999999999764 5688999999
Q ss_pred EEEccCCCCC-cCchhhcCCCCCCEEEccCCCCC-CCcccccCCCCC-CEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001143 95 NLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGL-KELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1141)
Q Consensus 95 ~L~Ls~N~L~-~lP~~~~~L~~L~~L~Ls~N~l~-~~~~~~~~L~~L-~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~L 171 (1141)
.|++++|.+. .+|..|+++++|+.+++++|.+. .+|..+..+..| +.++++.| .+.+..|..+..+..+ .+++
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n---~l~~~~~~~~~~l~~~-~l~l 204 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN---RLTGKIPPTFANLNLA-FVDL 204 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS---EEEEECCGGGGGCCCS-EEEC
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccc---cccccccccccccccc-cccc
Confidence 9999999987 77999999999999999999955 678888888876 88999984 4555667777777655 7999
Q ss_pred cCCCCC-ccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCCCC
Q 001143 172 CHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLG 249 (1141)
Q Consensus 172 s~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~ 249 (1141)
.+|.+. .+|..+..+++|+.|++++|.++..+..++.+++|+.|+|++|+|+ .||.++++|++|+.|+|++|+|+|.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~i 284 (313)
T d1ogqa_ 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccC
Confidence 998887 6677889999999999999999966678999999999999999998 89999999999999999999999988
Q ss_pred cccccCCCCCCEEEccCCcCCCCCCCc
Q 001143 250 SLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1141)
Q Consensus 250 p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1141)
| .+.+|++|+.+++++|++.|..++|
T Consensus 285 P-~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 285 P-QGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp C-CSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred C-CcccCCCCCHHHhCCCccccCCCCC
Confidence 8 5788999999999999854434566
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2.2e-24 Score=239.95 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=213.9
Q ss_pred CCCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcE
Q 001143 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1141)
Q Consensus 16 ~~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~ 95 (1141)
+++++.|++..|+|+.+++.+|.++++|++|++++|.++...|..|.. +++|++|+|++|+|+.+|..+. ..|..
T Consensus 30 ~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~---l~~L~~L~l~~n~l~~l~~~~~--~~l~~ 104 (305)
T d1xkua_ 30 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP---LVKLERLYLSKNQLKELPEKMP--KTLQE 104 (305)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT---CTTCCEEECCSSCCSBCCSSCC--TTCCE
T ss_pred CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhC---CCccCEecccCCccCcCccchh--hhhhh
Confidence 457999999999999999999999999999999999999888876654 4999999999999999987654 47999
Q ss_pred EEccCCCCCcCchh-hcCCCCCCEEEccCCCCCCC---cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEc
Q 001143 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVN---GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1141)
Q Consensus 96 L~Ls~N~L~~lP~~-~~~L~~L~~L~Ls~N~l~~~---~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~L 171 (1141)
|++++|.+..++.. +.....+..+++..|..... +..+..+++|+.+++++|.+.. +|..+ +++|+.|++
T Consensus 105 L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~----l~~~~--~~~L~~L~l 178 (305)
T d1xkua_ 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT----IPQGL--PPSLTELHL 178 (305)
T ss_dssp EECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS----CCSSC--CTTCSEEEC
T ss_pred hhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc----cCccc--CCccCEEEC
Confidence 99999999988654 66788899999988874443 3468889999999999976643 34332 578999999
Q ss_pred cCCCCCc-cCccccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCC
Q 001143 172 CHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249 (1141)
Q Consensus 172 s~N~L~~-iP~~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~ 249 (1141)
++|.++. .+..+..++.++.|++++|.|+.+ |..+..+++|++|+|++|+|+.||.++..+++|+.|+|++|+|+.+.
T Consensus 179 ~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~ 258 (305)
T d1xkua_ 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 258 (305)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCccC
Confidence 9999884 466889999999999999999977 56788899999999999999999999999999999999999999987
Q ss_pred ccccc------CCCCCCEEEccCCcCCCCCCCchhhhh
Q 001143 250 SLDLC------LMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1141)
Q Consensus 250 p~~l~------~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1141)
...|. .+.+|+.|+|++|+|+.+.--|..+.+
T Consensus 259 ~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~ 296 (305)
T d1xkua_ 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296 (305)
T ss_dssp TTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred hhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcc
Confidence 65553 567899999999999764323444343
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.2e-23 Score=232.03 Aligned_cols=246 Identities=20% Similarity=0.200 Sum_probs=198.1
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEE
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQ 120 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~ 120 (1141)
...+++++++++.+ |..+. +++++|+|++|+|++||. .|.++++|++|++++|+|..++. .+.+++.+..+.
T Consensus 13 ~~~v~c~~~~L~~i-P~~ip-----~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~ 86 (284)
T d1ozna_ 13 KVTTSCPQQGLQAV-PVGIP-----AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86 (284)
T ss_dssp SCEEECCSSCCSSC-CTTCC-----TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CeEEEcCCCCCCcc-CCCCC-----CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccc
Confidence 34678888888855 43232 568999999999999985 58899999999999999997754 467788898887
Q ss_pred ccC-CCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCC
Q 001143 121 IKI-SSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFN 197 (1141)
Q Consensus 121 Ls~-N~l~~~-~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N 197 (1141)
... |.++.+ +..|.++++|++|++++|.+... .+..+..+.+|+.+++++|+|+.+|. .|..+++|+.|+|++|
T Consensus 87 ~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~---~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N 163 (284)
T d1ozna_ 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL---GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (284)
T ss_dssp CCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCC---CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cccccccccccchhhcccccCCEEecCCcccccc---cccccchhcccchhhhccccccccChhHhccccchhhcccccC
Confidence 754 446655 46789999999999999665333 34467778899999999999998865 6788999999999999
Q ss_pred cccccc-ccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCC
Q 001143 198 KMKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV 275 (1141)
Q Consensus 198 ~L~~iP-~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~i 275 (1141)
+|+.+| ..|..+++|+.|+|++|+++.+ |..|..+++|+.|++++|+++++++..|..+++|+.|+|++|+|.|.|++
T Consensus 164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred cccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 999885 6678899999999999999976 78888999999999999999999999999999999999999999998876
Q ss_pred chhhhhcccCCCCCCCCCCcccCcc
Q 001143 276 PSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 276 P~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
-+...|... .....+++.|..|
T Consensus 244 ~~l~~~l~~---~~~~~~~~~C~~p 265 (284)
T d1ozna_ 244 RPLWAWLQK---FRGSSSEVPCSLP 265 (284)
T ss_dssp HHHHHHHHH---CCSEECCCBEEES
T ss_pred hHHHHHHHh---CcCCCCceEeCCc
Confidence 444334332 2223345555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.2e-23 Score=228.16 Aligned_cols=208 Identities=24% Similarity=0.225 Sum_probs=145.8
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCcCchhhcCCCCCC
Q 001143 39 DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117 (1141)
Q Consensus 39 ~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~ 117 (1141)
+..++..+|+++++|+.+ |+.+. ++|++|+|++|+|+.+|. .|.++++|++|+|++|+|+.+|. ++.+++|+
T Consensus 8 ~~~~~~~v~C~~~~L~~i-P~~lp-----~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~ 80 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTAL-PPDLP-----KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLG 80 (266)
T ss_dssp CSTTCCEEECTTSCCSSC-CSCCC-----TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCC
T ss_pred ccCCCeEEEccCCCCCee-CcCcC-----cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccc
Confidence 344555566666666653 32221 356666666666666653 46666666666666666666653 34555666
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccC
Q 001143 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSF 196 (1141)
Q Consensus 118 ~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~ 196 (1141)
.|+|++|++...+ ..+.++++|+.|++++|.+..++. .+..+.+|+.|++++
T Consensus 81 ~L~Ls~N~l~~~~---------------------------~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~ 133 (266)
T d1p9ag_ 81 TLDLSHNQLQSLP---------------------------LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (266)
T ss_dssp EEECCSSCCSSCC---------------------------CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred ccccccccccccc---------------------------cccccccccccccccccccceeeccccccccccccccccc
Confidence 6665555544333 345566777777777777776644 557788888899999
Q ss_pred Ccccccccc-ccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001143 197 NKMKYLPTE-ICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1141)
Q Consensus 197 N~L~~iP~~-l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1141)
|.|+.+|.. +..+++|+.|++++|+|+.+|. .+..+++|+.|+|++|+|+.+++ .+..+++|+.|+|++|+|.|.|.
T Consensus 134 n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~-~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK-GFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccCh-hHCCCCCCCEEEecCCCCCCCcc
Confidence 988887644 5668889999999999988764 46678999999999999997655 67788999999999999999998
Q ss_pred Cchhhhh
Q 001143 275 VPSWICC 281 (1141)
Q Consensus 275 iP~~~~~ 281 (1141)
+-+...|
T Consensus 213 ~~~l~~w 219 (266)
T d1p9ag_ 213 ILYFRRW 219 (266)
T ss_dssp GHHHHHH
T ss_pred hHHHHHH
Confidence 7544444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=1.1e-22 Score=226.13 Aligned_cols=240 Identities=19% Similarity=0.229 Sum_probs=205.5
Q ss_pred ccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCcCCcEEEc
Q 001143 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKF 98 (1141)
Q Consensus 20 ~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~i-P~~l~~L~~L~~L~L 98 (1141)
..++-..++++.++.+-. +++++|||++|+|+.+.+.+|..+ ++|++|++++|.++.+ |..|.++++|+.|+|
T Consensus 13 ~~~~C~~~~L~~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l---~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 13 RVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEIKDGDFKNL---KNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp TEEECTTSCCCSCCCSCC---TTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCCCccCCCCC---CCCCEEECcCCcCCCcChhHhhcc---ccccccccccccccccchhhhhCCCccCEecc
Confidence 345666778998876432 579999999999998887666544 9999999999999988 457999999999999
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001143 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1141)
Q Consensus 99 s~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~-~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1141)
++|+|+.+|..+ ...|..|++..|.+..++. .+.....+..+....|.. ......+..+..+++|+.+++++|.++
T Consensus 87 ~~n~l~~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~-~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 87 SKNQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL-KSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp CSSCCSBCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC-CGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCCccCcCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccc-cccCCCccccccccccCccccccCCcc
Confidence 999999998765 3689999999999877664 577788899999988765 344455667889999999999999999
Q ss_pred ccCccccCCCCCCEEEccCCccc-cccccccCCCCCCEEEccCCCCCcC-CcCccCCCCCCEEeCCCCCCCCCCcccccC
Q 001143 178 YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1141)
Q Consensus 178 ~iP~~l~~l~~L~~L~Ls~N~L~-~iP~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~ 255 (1141)
.+|..+ +++|+.|++++|.++ ..+..+..++.++.|++++|.|+.+ |..+.++++|+.|+|++|+|+.+++ .|..
T Consensus 164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~-~l~~ 240 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG-GLAD 240 (305)
T ss_dssp SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT-TTTT
T ss_pred ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccccc-cccc
Confidence 998754 689999999999999 5578899999999999999999987 5667789999999999999998864 8999
Q ss_pred CCCCCEEEccCCcCCC
Q 001143 256 MHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 256 L~~L~~L~Ls~N~L~~ 271 (1141)
+++|++|+|++|+|+.
T Consensus 241 l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISA 256 (305)
T ss_dssp CSSCCEEECCSSCCCC
T ss_pred ccCCCEEECCCCccCc
Confidence 9999999999999987
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.9e-23 Score=224.65 Aligned_cols=195 Identities=19% Similarity=0.213 Sum_probs=161.3
Q ss_pred cccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEc
Q 001143 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1141)
Q Consensus 19 l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~L 98 (1141)
..++....++|+.|+++.. +++++|||++|+|++..+..|.. +++|++|+|++|+|+.+|. +..+++|++|+|
T Consensus 12 ~~~v~C~~~~L~~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~---l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L~L 84 (266)
T d1p9ag_ 12 HLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMP---YTRLTQLNLDRAELTKLQV-DGTLPVLGTLDL 84 (266)
T ss_dssp CCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTT---CTTCCEEECTTSCCCEEEC-CSCCTTCCEEEC
T ss_pred CeEEEccCCCCCeeCcCcC---cCCCEEECcCCcCCCcCHHHhhc---ccccccccccccccccccc-cccccccccccc
Confidence 4456788899999865432 57999999999999887776654 5999999999999999974 678999999999
Q ss_pred cCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCc
Q 001143 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1141)
Q Consensus 99 s~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1141)
++|+|+.+|..+.++++|+.|++++|.+..++. ..+..+.+|+.|++++|.++.
T Consensus 85 s~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~--------------------------~~~~~l~~l~~L~l~~n~l~~ 138 (266)
T d1p9ag_ 85 SHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL--------------------------GALRGLGELQELYLKGNELKT 138 (266)
T ss_dssp CSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCS--------------------------STTTTCTTCCEEECTTSCCCC
T ss_pred ccccccccccccccccccccccccccccceeec--------------------------cccccccccccccccccccce
Confidence 999999999999999999999998887554331 234556778888888888887
Q ss_pred cCc-cccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCC
Q 001143 179 LPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1141)
Q Consensus 179 iP~-~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt 246 (1141)
+|. .+..+++|+.|++++|+|+.+| ..|..+++|++|+|++|+|+.||.+++.+++|+.|+|++|.+.
T Consensus 139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred eccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence 765 4467888999999999998776 4577889999999999999999988888999999999999775
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=3.1e-22 Score=227.71 Aligned_cols=258 Identities=21% Similarity=0.235 Sum_probs=186.0
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
.+.+|.+..++|+.+. .+..+++|++|||++|+|++..+ +++|++|++|+|++|+|+.+++ +.++++|+.|+
T Consensus 45 ~l~~L~l~~~~I~~l~--gl~~L~nL~~L~Ls~N~l~~l~~-----l~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~ 116 (384)
T d2omza2 45 QVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITP-----LKNLTKLVDILMNNNQIADITP-LANLTNLTGLT 116 (384)
T ss_dssp TCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred CCCEEECCCCCCCCcc--ccccCCCCCEEeCcCCcCCCCcc-----ccCCcccccccccccccccccc-ccccccccccc
Confidence 5778888899998873 47788999999999999998643 4556999999999999998864 88899999999
Q ss_pred ccCCCCCcCc----------------------------------------------------------------hhhcCC
Q 001143 98 FFGNEINLFP----------------------------------------------------------------SEVGNL 113 (1141)
Q Consensus 98 Ls~N~L~~lP----------------------------------------------------------------~~~~~L 113 (1141)
+++|.++.++ ..+..+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 196 (384)
T d2omza2 117 LFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccc
Confidence 9988876321 224456
Q ss_pred CCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEE
Q 001143 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLD 193 (1141)
Q Consensus 114 ~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~ 193 (1141)
++++.|++++|.+..++. +..+.+|++|++++|.+... +.+..+++|+.|++++|.++.++. ++.+++|+.|+
T Consensus 197 ~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~-----~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~ 269 (384)
T d2omza2 197 TNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI-----GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELK 269 (384)
T ss_dssp TTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-----GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEE
T ss_pred cccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCCc-----chhhcccccchhccccCccCCCCc-ccccccCCEee
Confidence 778888888888666553 56677888888888765432 256778888888888888887754 67788888888
Q ss_pred ccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCC
Q 001143 194 LSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273 (1141)
Q Consensus 194 Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~ 273 (1141)
+++|+++.++. +..++.++.+.+++|.++.++ .+..+++|+.|+|++|+|+++++ +..+++|+.|+|++|+|+.
T Consensus 270 l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-- 343 (384)
T d2omza2 270 LGANQISNISP-LAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343 (384)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC--
T ss_pred ccCcccCCCCc-ccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC--
Confidence 88888876653 556666667777766666554 35556666666776666666543 5666666677776666665
Q ss_pred CCchhhhhcccCCCCCCCCCCcccC
Q 001143 274 QVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 274 ~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
+| .+..+..+..+++++|.+.+-
T Consensus 344 -l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 344 -VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp -CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred -Ch-hHcCCCCCCEEECCCCcCCCC
Confidence 44 344455566666666665543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=4e-22 Score=226.78 Aligned_cols=254 Identities=19% Similarity=0.244 Sum_probs=208.7
Q ss_pred CCcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC------------
Q 001143 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP------------ 84 (1141)
Q Consensus 17 ~~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP------------ 84 (1141)
++++.|.+..|+|+.+.+ |.++++|++|+|++|+|++..+ ++++++|+.|++++|.++.++
T Consensus 66 ~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~-----l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~ 138 (384)
T d2omza2 66 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-----LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138 (384)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEE
T ss_pred CCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc-----ccccccccccccccccccccccccccccccccc
Confidence 579999999999999974 9999999999999999987643 355699999999998876432
Q ss_pred ----------------------------------------------------ccccCCcCCcEEEccCCCCCcCchhhcC
Q 001143 85 ----------------------------------------------------KSVGRYEKLRNLKFFGNEINLFPSEVGN 112 (1141)
Q Consensus 85 ----------------------------------------------------~~l~~L~~L~~L~Ls~N~L~~lP~~~~~ 112 (1141)
..+..+++++.|++++|.++.++. +..
T Consensus 139 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~ 217 (384)
T d2omza2 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-LGI 217 (384)
T ss_dssp EEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-GGG
T ss_pred cccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc-ccc
Confidence 124556789999999999998764 567
Q ss_pred CCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEE
Q 001143 113 LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192 (1141)
Q Consensus 113 L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L 192 (1141)
.++|+.|++++|.+..++ .+..+++|+.|++++|.+.... .+..+++|+.|++++|.++.+++ +..++.++.+
T Consensus 218 ~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~-----~~~~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l 290 (384)
T d2omza2 218 LTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLA-----PLSGLTKLTELKLGANQISNISP-LAGLTALTNL 290 (384)
T ss_dssp CTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCG-----GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEE
T ss_pred cCCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCCC-----cccccccCCEeeccCcccCCCCc-cccccccccc
Confidence 889999999999988776 5788999999999997765432 37789999999999999998764 6788899999
Q ss_pred EccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCC
Q 001143 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1141)
Q Consensus 193 ~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1141)
+++.|.++.++ .+..+++++.|+|++|+|+.++ .+..+++|+.|+|++|+|++++ .|.++++|+.|+|++|++++
T Consensus 291 ~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~~l~--~l~~l~~L~~L~l~~N~l~~- 365 (384)
T d2omza2 291 ELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDVS--SLANLTNINWLSAGHNQISD- 365 (384)
T ss_dssp ECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCB-
T ss_pred ccccccccccc-ccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCCCCh--hHcCCCCCCEEECCCCcCCC-
Confidence 99999998765 4788899999999999999886 3788999999999999999764 58899999999999999987
Q ss_pred CCCchhhhhcccCCCCCCCCC
Q 001143 273 CQVPSWICCNLEGNGKDSSND 293 (1141)
Q Consensus 273 ~~iP~~~~~~l~~~~l~~~~n 293 (1141)
+++ +..+..+..+.+++|
T Consensus 366 --l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 366 --LTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp --CGG-GTTCTTCSEEECCCE
T ss_pred --Chh-hccCCCCCEeeCCCC
Confidence 554 444445555555443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=6.1e-22 Score=218.21 Aligned_cols=262 Identities=20% Similarity=0.191 Sum_probs=199.5
Q ss_pred ccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEcc-
Q 001143 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFF- 99 (1141)
Q Consensus 22 L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls- 99 (1141)
+.....+++.++..-. .++++|||++|+|+++.+..|.. +++|++|++++|+|+.++. .+..++.+..|+..
T Consensus 16 v~c~~~~L~~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~---l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 16 TSCPQQGLQAVPVGIP---AASQRIFLHGNRISHVPAASFRA---CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp EECCSSCCSSCCTTCC---TTCSEEECTTSCCCEECTTTTTT---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEcCCCCCCccCCCCC---CCCCEEECcCCcCCCCCHHHhhc---ccccccccccccccccccccccccccccccccccc
Confidence 4455666777765432 46799999999999877766654 4899999999999998865 46778888888765
Q ss_pred CCCCCcC-chhhcCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCC
Q 001143 100 GNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1141)
Q Consensus 100 ~N~L~~l-P~~~~~L~~L~~L~Ls~N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1141)
.|.++.+ |..|.++++|++|++++|.+..++ ..+..+.+|+.+++++|.+..+ .+..|..+++|+.|++++|+|+
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i---~~~~f~~~~~L~~L~l~~N~l~ 166 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL---PDDTFRDLGNLTHLFLHGNRIS 166 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC---CTTTTTTCTTCCEEECCSSCCC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccccc---ChhHhccccchhhcccccCccc
Confidence 6677777 566889999999999999976554 5678889999999999666432 2456888999999999999999
Q ss_pred ccCc-cccCCCCCCEEEccCCccccc-cccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEEeCCCCCCCCCCccccc
Q 001143 178 YLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1141)
Q Consensus 178 ~iP~-~l~~l~~L~~L~Ls~N~L~~i-P~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~ 254 (1141)
.+|+ .|..+++|+.|+|++|+++.+ |..|..+++|++|++++|+++.+| ..+..+++|+.|+|++|.+...-+. ..
T Consensus 167 ~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~ 245 (284)
T d1ozna_ 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RP 245 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HH
T ss_pred ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hH
Confidence 8854 678999999999999999966 788999999999999999999876 5677899999999999999865331 11
Q ss_pred CCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccC
Q 001143 255 LMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1141)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~ 298 (1141)
-+..++.+....+.+.| ..|..+. .....++..++++||
T Consensus 246 l~~~l~~~~~~~~~~~C--~~p~~l~---g~~l~~l~~~~l~gc 284 (284)
T d1ozna_ 246 LWAWLQKFRGSSSEVPC--SLPQRLA---GRDLKRLAANDLQGC 284 (284)
T ss_dssp HHHHHHHCCSEECCCBE--EESGGGT---TCBGGGSCGGGSCCC
T ss_pred HHHHHHhCcCCCCceEe--CCchHHc---CCccccCCHHHCCCc
Confidence 11234455666677776 5666554 233444555555553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=3e-21 Score=200.62 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=106.2
Q ss_pred ceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCC----------hHHHHHhHHhHHHHHHHHhhCCCCCccceee
Q 001143 808 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS----------ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1141)
Q Consensus 808 y~i~~~LG~GsfG~Vy~a~~-~~~~vAvKI~~l~~~~~~----------~~~~~~~~~~~~~Ei~iL~~L~HpNIVkllg 876 (1141)
+.+.++||+|+||+||+|++ ++..||+|+.+....... ............+|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 47899999999999999987 577899998654321100 0001112234467899999999999998876
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 001143 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1141)
Q Consensus 877 ~~~~~~~~~~~~g~~~~~~~~~~LVmEy~~ggSL~~~I~~~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIvHrDLKP 956 (1141)
+.. .++||||+++..+. .++...+..++.|++.||.|||++||+||||||
T Consensus 82 ~~~------------------~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 82 WEG------------------NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp EET------------------TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred ecC------------------CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCCh
Confidence 532 18999999875432 245556778999999999999999999999999
Q ss_pred CCeeeecccccCCCCCeEEEeecccccccc
Q 001143 957 ENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1141)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlA~~l~ 986 (1141)
+|||++++ .++|+|||.|+...
T Consensus 132 ~NILv~~~--------~~~liDFG~a~~~~ 153 (191)
T d1zara2 132 YNVLVSEE--------GIWIIDFPQSVEVG 153 (191)
T ss_dssp TSEEEETT--------EEEECCCTTCEETT
T ss_pred hheeeeCC--------CEEEEECCCcccCC
Confidence 99999864 58999999986543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1.2e-19 Score=193.25 Aligned_cols=205 Identities=21% Similarity=0.272 Sum_probs=145.5
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccC
Q 001143 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1141)
Q Consensus 44 ~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~ 123 (1141)
..++|+.+++++.++ +.. |.+|+.|++.+|.|+.++ .|..+++|++|+|++|+|+.++. +..+++|+.|++++
T Consensus 22 ~~~~l~~~~~~d~~~--~~~---l~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 22 IKIAAGKSNVTDTVT--QAD---LDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSG 94 (227)
T ss_dssp HHHHTTCSSTTSEEC--HHH---HHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCCcCC--HHH---cCCcCEEECCCCCCCcch-hHhcCCCCcEeecCCceeecccc-cccccccccccccc
Confidence 344566666665432 222 366677777777777663 46677777777777777766643 66677777777777
Q ss_pred CCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccc
Q 001143 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP 203 (1141)
Q Consensus 124 N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP 203 (1141)
|.++.++ .+..+++|+.|.++++..... ..+...+.+..+.++++.+...+ .+..+++|+.|++++|.++.++
T Consensus 95 n~~~~i~-~l~~l~~L~~l~l~~~~~~~~-----~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~~~ 167 (227)
T d1h6ua2 95 NPLKNVS-AIAGLQSIKTLDLTSTQITDV-----TPLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSDLT 167 (227)
T ss_dssp CCCSCCG-GGTTCTTCCEEECTTSCCCCC-----GGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCCCG
T ss_pred ccccccc-ccccccccccccccccccccc-----chhccccchhhhhchhhhhchhh-hhccccccccccccccccccch
Confidence 7665554 356677777777776544322 23556677888888888877543 3667788899999888888664
Q ss_pred ccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccC
Q 001143 204 TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1141)
Q Consensus 204 ~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~ 266 (1141)
. ++.+++|+.|+|++|+|+.+|. +.++++|+.|+|++|+|++++| +.++++|+.|+|++
T Consensus 168 ~-l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 168 P-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp G-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred h-hcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 3 7888889999999998888864 7888889999999999988765 78889999998874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=3.9e-18 Score=190.37 Aligned_cols=233 Identities=24% Similarity=0.206 Sum_probs=160.5
Q ss_pred CcccccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEE
Q 001143 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~ 97 (1141)
++..|++..+.|+.++. .+++|++|+|++|+|+.. |+.+ .+|+.|++++|+++.|+. +. +.|++|+
T Consensus 39 ~l~~LdLs~~~L~~lp~----~~~~L~~L~Ls~N~l~~l-p~~~------~~L~~L~l~~n~l~~l~~-lp--~~L~~L~ 104 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPE----LPPHLESLVASCNSLTEL-PELP------QSLKSLLVDNNNLKALSD-LP--PLLEYLG 104 (353)
T ss_dssp TCSEEECTTSCCSCCCS----CCTTCSEEECCSSCCSSC-CCCC------TTCCEEECCSSCCSCCCS-CC--TTCCEEE
T ss_pred CCCEEEeCCCCCCCCCC----CCCCCCEEECCCCCCccc-ccch------hhhhhhhhhhcccchhhh-hc--ccccccc
Confidence 46788999999998873 357899999999999954 5432 578999999999998864 21 3599999
Q ss_pred ccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcc-------------------cccCCCCCCEEECCCCCCCCCcc----
Q 001143 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-------------------ALNKLKGLKELELSKVPPRPSVL---- 154 (1141)
Q Consensus 98 Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~-------------------~~~~L~~L~~L~Ls~N~ln~~~~---- 154 (1141)
|++|.|+.+|. ++.+++|+.|++++|.+...+. .+..+..++.|.+.+|.......
T Consensus 105 L~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~ 183 (353)
T d1jl5a_ 105 VSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183 (353)
T ss_dssp CCSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTT
T ss_pred ccccccccccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccc
Confidence 99999999985 6789999999999887654442 24455667778877765432211
Q ss_pred -----------cchhhhcCCCCCcEEEccCCCCCccCccccC-----------------CCCCCEEEccCCccccc---c
Q 001143 155 -----------TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC-----------------LSNLEQLDLSFNKMKYL---P 203 (1141)
Q Consensus 155 -----------~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~-----------------l~~L~~L~Ls~N~L~~i---P 203 (1141)
.....+..++.|+.+++++|....+|..... ..++..+++..|.+..+ +
T Consensus 184 ~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~ 263 (353)
T d1jl5a_ 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263 (353)
T ss_dssp CCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0112345677888888888887766543211 12233333333333211 1
Q ss_pred cc--------------ccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcC
Q 001143 204 TE--------------ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1141)
Q Consensus 204 ~~--------------l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L 269 (1141)
.. ...+++|++|+|++|+|+.||.. +++|+.|+|++|+|+.++. .+.+|+.|+|++|+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~L~~l~~----~~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLAEVPE----LPQNLKQLHVEYNPL 336 (353)
T ss_dssp TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCC
T ss_pred chhcccccccCccccccccCCCCCEEECCCCccCccccc---cCCCCEEECCCCcCCcccc----ccCCCCEEECcCCcC
Confidence 10 11246788888888888888854 4678888888888887653 246788888888888
Q ss_pred CCC
Q 001143 270 LSY 272 (1141)
Q Consensus 270 ~~~ 272 (1141)
+.+
T Consensus 337 ~~l 339 (353)
T d1jl5a_ 337 REF 339 (353)
T ss_dssp SSC
T ss_pred CCC
Confidence 873
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=8.5e-19 Score=186.46 Aligned_cols=203 Identities=22% Similarity=0.257 Sum_probs=170.1
Q ss_pred ccCCCCCccccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCC
Q 001143 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGN 101 (1141)
Q Consensus 22 L~~~~N~i~~i~~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N 101 (1141)
+.+..++++.+ ..+.++.+|+.|+|++|+|+.. + .+ ..+++|++|+|++|+|+.+++ +..+++|++|++++|
T Consensus 24 ~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~~l-~-~l---~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 24 IAAGKSNVTDT--VTQADLDGITTLSAFGTGVTTI-E-GV---QYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGN 95 (227)
T ss_dssp HHTTCSSTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TG---GGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSC
T ss_pred HHhCCCCcCCc--CCHHHcCCcCEEECCCCCCCcc-h-hH---hcCCCCcEeecCCceeecccc-ccccccccccccccc
Confidence 44555666654 3567788999999999999864 2 24 455999999999999998854 899999999999999
Q ss_pred CCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc
Q 001143 102 EINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181 (1141)
Q Consensus 102 ~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~ 181 (1141)
.++.++ .+..+++|+.|.++.+...... .+.....+..+.++.+.+... ..+..+++|+.|++++|.++.++.
T Consensus 96 ~~~~i~-~l~~l~~L~~l~l~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~L~~L~l~~n~~~~~~~ 168 (227)
T d1h6ua2 96 PLKNVS-AIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITNI-----SPLAGLTNLQYLSIGNAQVSDLTP 168 (227)
T ss_dssp CCSCCG-GGTTCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECCSSCCCCC-----GGGGGCTTCCEEECCSSCCCCCGG
T ss_pred cccccc-cccccccccccccccccccccc-hhccccchhhhhchhhhhchh-----hhhccccccccccccccccccchh
Confidence 999886 4889999999999998865544 367788999999988655332 236678899999999999987654
Q ss_pred cccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCC
Q 001143 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242 (1141)
Q Consensus 182 ~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~ 242 (1141)
++.+++|+.|+|++|+|+.+|. +..+++|++|+|++|+|+.||+ +.++++|+.|+|++
T Consensus 169 -l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 169 -LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp -GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred -hcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEeeC
Confidence 8899999999999999999864 8899999999999999999974 88999999999974
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=6.5e-19 Score=185.67 Aligned_cols=180 Identities=21% Similarity=0.238 Sum_probs=93.3
Q ss_pred EEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCC
Q 001143 46 IDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS 125 (1141)
Q Consensus 46 LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~ 125 (1141)
.+++.+.+++.++. . +|.+|++|++++|.++.++ .+..+++|++|+|++|+|+.++. ++++++|++|++++|+
T Consensus 29 ~~l~~~~~~~~~~~--~---~L~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--N---ELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENK 101 (210)
T ss_dssp HHTTCSCTTSEECH--H---HHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred HHhCcCccCCccCH--H---HhcCccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCccc-cccCcccccccccccc
Confidence 34555666655443 1 2256677777777777664 36667777777777777776653 5666677777766666
Q ss_pred CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccccc
Q 001143 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE 205 (1141)
Q Consensus 126 l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~ 205 (1141)
++.++ .+..+++|+.|++++|.+... ..+..++.|+.+++++|.++.++ .+..+++|+.|++++|+++.++.
T Consensus 102 i~~l~-~l~~l~~L~~L~l~~~~~~~~-----~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~i~~- 173 (210)
T d1h6ta2 102 VKDLS-SLKDLKKLKSLSLEHNGISDI-----NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVP- 173 (210)
T ss_dssp CCCGG-GGTTCTTCCEEECTTSCCCCC-----GGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-
T ss_pred ccccc-ccccccccccccccccccccc-----ccccccccccccccccccccccc-ccccccccccccccccccccccc-
Confidence 55444 244444444444444332211 12344444555555555444332 23444444444444444444432
Q ss_pred ccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCC
Q 001143 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLS 241 (1141)
Q Consensus 206 l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls 241 (1141)
+.++++|+.|+|++|+|+.|| .+..|++|+.|+|+
T Consensus 174 l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 174 LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEE
T ss_pred ccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEcc
Confidence 444444444444444444443 24444444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.1e-18 Score=180.07 Aligned_cols=180 Identities=22% Similarity=0.273 Sum_probs=99.1
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEcc
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls 122 (1141)
+..++|+.+.+++.++. .. +.+|++|+|++|.|+.++ .+..+++|++|+|++|+|+.++. ++++++|+.|+++
T Consensus 20 ~i~~~l~~~~~~~~~~~--~~---l~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~ 92 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVSQ--TD---LDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMN 92 (199)
T ss_dssp HHHHHTTCSSTTSEECH--HH---HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECC
T ss_pred HHHHHhCCCCCCCccCH--HH---hcCCCEEECCCCCCCCcc-ccccCCCcCcCccccccccCccc-ccCCccccccccc
Confidence 33445666666665432 22 366777777777777764 46677777777777777777654 6777777777777
Q ss_pred CCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCccccc
Q 001143 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL 202 (1141)
Q Consensus 123 ~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~i 202 (1141)
+|.+..++. +.+++.|+ .|++++|.+..++ .+..+++|+.|++++|++..+
T Consensus 93 ~n~~~~~~~-l~~l~~L~---------------------------~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~ 143 (199)
T d2omxa2 93 NNQIADITP-LANLTNLT---------------------------GLTLFNNQITDID-PLKNLTNLNRLELSSNTISDI 143 (199)
T ss_dssp SSCCCCCGG-GTTCTTCS---------------------------EEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCC
T ss_pred ccccccccc-cccccccc---------------------------ccccccccccccc-ccchhhhhHHhhhhhhhhccc
Confidence 666544442 34444444 4444444444332 234444555555555555444
Q ss_pred cccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEE
Q 001143 203 PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262 (1141)
Q Consensus 203 P~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L 262 (1141)
| .+..+++|+.|++++|+++.++ .++++++|+.|+|++|+|+.++ .+..|++|+.|
T Consensus 144 ~-~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L 199 (199)
T d2omxa2 144 S-ALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199 (199)
T ss_dssp G-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred c-cccccccccccccccccccCCc-cccCCCCCCEEECCCCCCCCCc--cccCCCCCCcC
Confidence 3 3444555555555555555443 2445555555555555555432 24455555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.3e-18 Score=186.08 Aligned_cols=216 Identities=19% Similarity=0.109 Sum_probs=160.8
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCcCCcEEEccCCCCCc-Cc-hhhcCCCCCCEE
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINL-FP-SEVGNLLGLECL 119 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~-~l~~L~~L~~L~Ls~N~L~~-lP-~~~~~L~~L~~L 119 (1141)
.+++++++++|+.+++. + + +++++|+|++|+|+.||. .|.++++|++|+|++|.+.. +| ..|.++++++.|
T Consensus 10 ~~~i~c~~~~l~~iP~~-l--~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 10 NRVFLCQESKVTEIPSD-L--P---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SSEEEEESCSCSSCCSC-S--C---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred CCEEEEeCCCCCCcCCC-C--C---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 36788888888854433 2 1 468889999998888876 57888889999999888874 43 357788888888
Q ss_pred EccC-CCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCC-CCCCEEEcc
Q 001143 120 QIKI-SSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCL-SNLEQLDLS 195 (1141)
Q Consensus 120 ~Ls~-N~l~~~~-~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l-~~L~~L~Ls 195 (1141)
.+.. |++...+ ..|.++++|+.|++.+|.+.... ....+..+..|..+...++.+..++. .+..+ ..++.|+++
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~--~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~ 161 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP--DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 161 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCC--CCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cccccccccccccccccccccccccccchhhhcccc--cccccccccccccccccccccccccccccccccccceeeecc
Confidence 8754 4444443 56788888888888886654321 12234456667777778888887754 45544 478889999
Q ss_pred CCccccccccccCCCCCCEE-EccCCCCCcCCcC-ccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccC
Q 001143 196 FNKMKYLPTEICYLKALISL-KVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1141)
Q Consensus 196 ~N~L~~iP~~l~~l~~L~~L-~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~ 266 (1141)
+|+|+.++..+....+++.+ ++++|+|+.||.. |.++++|+.|+|++|+|+.+++..|.++++|+.|++.+
T Consensus 162 ~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 162 KNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp SSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 99999988777777776665 5688899999765 56799999999999999998887788888777776653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=9.8e-18 Score=176.49 Aligned_cols=166 Identities=21% Similarity=0.170 Sum_probs=145.3
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCE
Q 001143 39 DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLEC 118 (1141)
Q Consensus 39 ~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~ 118 (1141)
.+.+|+.|++++|+++.... + ..+++|++|+|++|+|+.++ .+..+++|++|+|++|+|+.+| .+.++++|+.
T Consensus 44 ~L~~L~~L~l~~~~i~~l~~--l---~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~ 116 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQG--I---QYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKS 116 (210)
T ss_dssp HHHTCCEEECTTSCCCCCTT--G---GGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCE
T ss_pred HhcCccEEECcCCCCCCchh--H---hhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc-cccccccccc
Confidence 46789999999999987542 3 44599999999999999987 4789999999999999999998 5899999999
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEEEccCCc
Q 001143 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198 (1141)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~ 198 (1141)
|++++|....++ .+..++.|+.+++++|.+... ..+..+++|+.+++++|+++.+++ +.++++|+.|+|++|+
T Consensus 117 L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~~-----~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 117 LSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI-----TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 189 (210)
T ss_dssp EECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC-----GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred cccccccccccc-ccccccccccccccccccccc-----cccccccccccccccccccccccc-ccCCCCCCEEECCCCC
Confidence 999999977665 588999999999999776432 346779999999999999998864 8999999999999999
Q ss_pred cccccccccCCCCCCEEEccC
Q 001143 199 MKYLPTEICYLKALISLKVAN 219 (1141)
Q Consensus 199 L~~iP~~l~~l~~L~~L~Ls~ 219 (1141)
|+.+| .+..+++|++|+|++
T Consensus 190 i~~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 190 ISDLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCBCG-GGTTCTTCSEEEEEE
T ss_pred CCCCh-hhcCCCCCCEEEccC
Confidence 99997 699999999999975
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.2e-17 Score=172.21 Aligned_cols=148 Identities=22% Similarity=0.304 Sum_probs=116.1
Q ss_pred CCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCccccCCCCCCEE
Q 001143 113 LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192 (1141)
Q Consensus 113 L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L 192 (1141)
+.+|+.|++++|.+..+. .+..+++|++|++++|.+.. ++ .++++++|+.|++++|.+..+|. +..+++|+.|
T Consensus 39 l~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~----~~-~l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~~L 111 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTD----IT-PLKNLTKLVDILMNNNQIADITP-LANLTNLTGL 111 (199)
T ss_dssp HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCC----CG-GGTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEE
T ss_pred hcCCCEEECCCCCCCCcc-ccccCCCcCcCccccccccC----cc-cccCCcccccccccccccccccc-cccccccccc
Confidence 344444444444444332 24455555566666544432 22 27788899999999999998864 8899999999
Q ss_pred EccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 193 ~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
++++|.+..++ .+..+++|+.|++++|++..+| .+..+++|+.|++++|+++++++ +.++++|+.|++++|+++.
T Consensus 112 ~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 112 TLFNNQITDID-PLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186 (199)
T ss_dssp ECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred ccccccccccc-ccchhhhhHHhhhhhhhhcccc-cccccccccccccccccccCCcc--ccCCCCCCEEECCCCCCCC
Confidence 99999998764 5888999999999999999886 58889999999999999999864 8999999999999999987
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=3.2e-17 Score=175.13 Aligned_cols=201 Identities=16% Similarity=0.167 Sum_probs=166.3
Q ss_pred cEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCch-hhcCCCCCCEEEccCCCCCC-Cc-ccccCCCCCCEEECCCC
Q 001143 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGV-NG-FALNKLKGLKELELSKV 147 (1141)
Q Consensus 71 ~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~-~~~~L~~L~~L~Ls~N~l~~-~~-~~~~~L~~L~~L~Ls~N 147 (1141)
+.++.+++.|+.+|..+. +++++|+|++|+|+.+|. .|.++++|++|+|++|.+.. ++ ..|.+++++++|.+..+
T Consensus 11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 678999999999998765 479999999999999976 48999999999999998654 33 56899999999998652
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCc--cccCCCCCCEEEccCCcccccc-ccccCCC-CCCEEEccCCCCC
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGCLSNLEQLDLSFNKMKYLP-TEICYLK-ALISLKVANNKLV 223 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~--~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~-~L~~L~Ls~N~L~ 223 (1141)
++.....+..|.++++|+.|++++|++..+|. .+..+..|..+..+++.+..++ ..+..++ .++.|++++|+|+
T Consensus 89 --n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 89 --NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp --TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred --ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 24455556678999999999999999987654 3355667777788888999886 4455554 8999999999999
Q ss_pred cCCcCccCCCCCCEE-eCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchh
Q 001143 224 ELPSGLYLLQRLENL-DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1141)
Q Consensus 224 ~IP~~l~~L~~L~~L-~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~ 278 (1141)
.++..++...++..+ ++++|+|+.+++..|.++++|++|+|++|+|+. +|.+
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~---l~~~ 219 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS---LPSY 219 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC---CCSS
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCc---cCHH
Confidence 999888887776555 678899999988889999999999999999987 6643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.70 E-value=7.7e-16 Score=171.51 Aligned_cols=231 Identities=23% Similarity=0.206 Sum_probs=163.7
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEc
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI 121 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~L 121 (1141)
++++|||++|+|+.. |+. +++|++|+|++|+|++||..+ .+|+.|++++|+++.|+.- .+.|++|++
T Consensus 39 ~l~~LdLs~~~L~~l-p~~------~~~L~~L~Ls~N~l~~lp~~~---~~L~~L~l~~n~l~~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLSSL-PEL------PPHLESLVASCNSLTELPELP---QSLKSLLVDNNNLKALSDL---PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCSCC-CSC------CTTCSEEECCSSCCSSCCCCC---TTCCEEECCSSCCSCCCSC---CTTCCEEEC
T ss_pred CCCEEEeCCCCCCCC-CCC------CCCCCEEECCCCCCcccccch---hhhhhhhhhhcccchhhhh---ccccccccc
Confidence 689999999999864 543 268999999999999999764 4799999999999988742 246999999
Q ss_pred cCCCCCCCcccccCCCCCCEEECCCCCCCCCccc---------------chhhhcCCCCCcEEEccCCCCCccCc-----
Q 001143 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLT---------------LLSEIAGLKCLTKLSVCHFSIRYLPP----- 181 (1141)
Q Consensus 122 s~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~---------------lp~~l~~L~~L~~L~Ls~N~L~~iP~----- 181 (1141)
++|.+..+|. +..+++|+.|+++++.+...... .+..+..++.++.|.+.+|.+..++.
T Consensus 106 ~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 106 SNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp CSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred cccccccccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 9999998885 67899999999998776433221 12235567778888888887654332
Q ss_pred --------------cccCCCCCCEEEccCCccccccccccC-----------------CCCCCEEEccCCCCCcC---Cc
Q 001143 182 --------------EIGCLSNLEQLDLSFNKMKYLPTEICY-----------------LKALISLKVANNKLVEL---PS 227 (1141)
Q Consensus 182 --------------~l~~l~~L~~L~Ls~N~L~~iP~~l~~-----------------l~~L~~L~Ls~N~L~~I---P~ 227 (1141)
.+..++.|+.|++++|.+..+|..... ...+..+++..|.+..+ |.
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~ 264 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 245577889999998887766543221 12344445444443322 11
Q ss_pred Cc--------------cCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCC
Q 001143 228 GL--------------YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSND 293 (1141)
Q Consensus 228 ~l--------------~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n 293 (1141)
.. ..+++|+.|+|++|+|+.++. .+++|+.|+|++|+|+. +|... .....+++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~L~~N~L~~---l~~~~---~~L~~L~L~~N 334 (353)
T d1jl5a_ 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAE---VPELP---QNLKQLHVEYN 334 (353)
T ss_dssp TCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC---CCCCC---TTCCEEECCSS
T ss_pred hhcccccccCccccccccCCCCCEEECCCCccCcccc----ccCCCCEEECCCCcCCc---ccccc---CCCCEEECcCC
Confidence 11 124689999999999997764 36789999999999986 55432 23455666666
Q ss_pred Ccc
Q 001143 294 DFI 296 (1141)
Q Consensus 294 ~l~ 296 (1141)
.+.
T Consensus 335 ~L~ 337 (353)
T d1jl5a_ 335 PLR 337 (353)
T ss_dssp CCS
T ss_pred cCC
Confidence 654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.65 E-value=8.5e-17 Score=166.71 Aligned_cols=171 Identities=17% Similarity=0.119 Sum_probs=102.5
Q ss_pred ccEEEeecCCCCccCccccCCcCCcEEEccCCCCCc-C-chhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINL-F-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 70 L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~-l-P~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
.+.++.++|+|++||..+. +++++|+|++|+|+. + +..|.++++|+.|+|++|.+..++
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~----------------- 70 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE----------------- 70 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBC-----------------
T ss_pred CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccc-----------------
Confidence 4567888888888887664 468888888888864 4 334566677766666666544332
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCCcccccc-ccccCCCCCCEEEccCCCCCcC
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVEL 225 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~L~Ls~N~L~~I 225 (1141)
+..|..+++|+.|+|++|+|+.+|+ .|.++++|++|+|++|+|+.|| ..|..+++|++|+|++|.+...
T Consensus 71 ---------~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 71 ---------PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp ---------TTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred ---------ccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 2345555666666666666666644 4566666666666666666664 3455666666666666666533
Q ss_pred CcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 226 P~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+....-...|+.+.+..|.++...|. .+..++.++|+.|.|.|
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p~---~l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKC 184 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSST---TTTTSBGGGSCTTTCCC
T ss_pred cchHHHhhhhhhhcccCCCeEeCCCh---hhcCCEeeecCHhhCcC
Confidence 22111112244455666666544443 33445566677777666
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.63 E-value=2.2e-16 Score=163.52 Aligned_cols=174 Identities=17% Similarity=0.186 Sum_probs=130.0
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc-cC-ccccCCcCCcEEEccCCCCCcC-chhhcCCCCCCE
Q 001143 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL-IP-KSVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLEC 118 (1141)
Q Consensus 42 ~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~-iP-~~l~~L~~L~~L~Ls~N~L~~l-P~~~~~L~~L~~ 118 (1141)
+.+++|+++|+|+.+++. +. +++++|+|++|+|+. ++ ..|.++++|+.|+|++|+|..+ +..|..+++|+.
T Consensus 9 ~~~~v~Cs~~~L~~iP~~-lp-----~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~ 82 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRD-IP-----LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp ETTEEECTTSCCSSCCSC-CC-----TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred cCCEEEEeCCCcCccCCC-CC-----CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccce
Confidence 356899999999976543 21 589999999999985 54 4588999999999999999977 456888999999
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCCCCCccCc-cccCCCCCCEEEccCC
Q 001143 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFN 197 (1141)
Q Consensus 119 L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~-~l~~l~~L~~L~Ls~N 197 (1141)
|+|++|++..++ |..|.++++|++|+|++|+|+.||+ .|..+++|++|+|++|
T Consensus 83 L~Ls~N~l~~l~--------------------------~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N 136 (192)
T d1w8aa_ 83 LQLGENKIKEIS--------------------------NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136 (192)
T ss_dssp EECCSCCCCEEC--------------------------SSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred eeeccccccccC--------------------------HHHHhCCCcccccccCCccccccCHHHhcCCccccccccccc
Confidence 999888866554 2356677788888888888887755 5678888999999988
Q ss_pred ccccccccccCCCCCCEEEccCCCCC-cCCcCccCCCCCCEEeCCCCCCCCCCc
Q 001143 198 KMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1141)
Q Consensus 198 ~L~~iP~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p 250 (1141)
.+...+........|+.+.+..|.++ ..|.. +..++.++|+.|.|+-..+
T Consensus 137 ~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 137 PFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp CBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCCCCC
T ss_pred ccccccchHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcCCCC
Confidence 88743322111223556667778777 55654 4556778899998876544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=5.6e-15 Score=142.44 Aligned_cols=110 Identities=31% Similarity=0.362 Sum_probs=92.8
Q ss_pred cEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCCcCccCCCCCCEEeCCCCCCC
Q 001143 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1141)
Q Consensus 167 ~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt 246 (1141)
++|+|++|+|+.+|. +..+++|++|+|++|+|+.+|+.++.+++|+.|+|++|+|+.+| .+..+++|+.|++++|+|+
T Consensus 1 R~L~Ls~n~l~~l~~-l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 1 RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp SEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCC
T ss_pred CEEEcCCCCCCCCcc-cccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCccC
Confidence 478999999998864 78889999999999999999888888999999999999999887 4888999999999999998
Q ss_pred CCCc-ccccCCCCCCEEEccCCcCCCCCCCchh
Q 001143 247 SLGS-LDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1141)
Q Consensus 247 ~~~p-~~l~~L~~L~~L~Ls~N~L~~~~~iP~~ 278 (1141)
.++. ..+..+++|+.|++++|+++....++..
T Consensus 79 ~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~ 111 (124)
T d1dcea3 79 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111 (124)
T ss_dssp SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred CCCCchhhcCCCCCCEEECCCCcCCcCccHHHH
Confidence 7764 4688889999999999998874444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=1.7e-14 Score=139.07 Aligned_cols=100 Identities=20% Similarity=0.119 Sum_probs=72.7
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccC
Q 001143 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1141)
Q Consensus 44 ~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~ 123 (1141)
++|||++|+|+.. +. + +++++|++|+|++|+|+.+|+.|..+++|+.|+|++|+|+.+|. +.++++|+.|++++
T Consensus 1 R~L~Ls~n~l~~l-~~-l---~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CH-L---EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG-VANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCSSC-CC-G---GGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCS
T ss_pred CEEEcCCCCCCCC-cc-c---ccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccCc-cccccccCeEECCC
Confidence 5788888888754 22 3 34478888888888888888778888888888888888888864 77888888888888
Q ss_pred CCCCCCcc--cccCCCCCCEEECCCCCC
Q 001143 124 SSPGVNGF--ALNKLKGLKELELSKVPP 149 (1141)
Q Consensus 124 N~l~~~~~--~~~~L~~L~~L~Ls~N~l 149 (1141)
|+++.++. .+..+++|+.|++++|++
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 88766552 345555555555555444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=5.9e-15 Score=148.96 Aligned_cols=112 Identities=19% Similarity=0.158 Sum_probs=57.7
Q ss_pred ccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC
Q 001143 87 VGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL 166 (1141)
Q Consensus 87 l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L 166 (1141)
+.+..+|+.|+|++|+|+.||..+..+++|+.|+|++|.+..++ .|..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~----------------------------~~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD----------------------------GFPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC----------------------------CCCCCSSC
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC----------------------------CcccCcch
Confidence 44555566666666666666544444555555555554433221 13334455
Q ss_pred cEEEccCCCCCccCccc-cCCCCCCEEEccCCccccccc--cccCCCCCCEEEccCCCCCcCC
Q 001143 167 TKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLVELP 226 (1141)
Q Consensus 167 ~~L~Ls~N~L~~iP~~l-~~l~~L~~L~Ls~N~L~~iP~--~l~~l~~L~~L~Ls~N~L~~IP 226 (1141)
+.|++++|+|+.+|..+ ..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|.++.+|
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~ 128 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCcccccc
Confidence 55555555555554432 345555555555555554432 3444555555555555555444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.48 E-value=6.3e-15 Score=165.78 Aligned_cols=235 Identities=17% Similarity=0.133 Sum_probs=173.4
Q ss_pred CCCCCCCCEEEccCCCCCCCCccccc-CCCCCCCccEEEeecCCCCcc----C-------ccccCCcCCcEEEccCCCCC
Q 001143 37 VNDDDDDSVIDVSGKTVDFPLIESYG-NRGGDNSVEGLYLYKNVLNLI----P-------KSVGRYEKLRNLKFFGNEIN 104 (1141)
Q Consensus 37 f~~l~~L~~LdLs~N~Ls~~~p~~~~-~l~~L~~L~~L~Ls~N~Lt~i----P-------~~l~~L~~L~~L~Ls~N~L~ 104 (1141)
+.....|+.|+|++|.|+..-...++ .+..+++|+.|+|+++.+..+ | ..+...++|+.|+|++|.|+
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence 45578899999999988654333222 345568999999998866532 2 23456788999999999997
Q ss_pred c-----CchhhcCCCCCCEEEccCCCCCCCcc--------------cccCCCCCCEEECCCCCCCCCc-ccchhhhcCCC
Q 001143 105 L-----FPSEVGNLLGLECLQIKISSPGVNGF--------------ALNKLKGLKELELSKVPPRPSV-LTLLSEIAGLK 164 (1141)
Q Consensus 105 ~-----lP~~~~~L~~L~~L~Ls~N~l~~~~~--------------~~~~L~~L~~L~Ls~N~ln~~~-~~lp~~l~~L~ 164 (1141)
. +...+..+++|+.|++++|.++.... .......|+.|.+++|.+.... ..+...+..++
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~ 186 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred cccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhh
Confidence 4 44556778999999999998643221 1235678999999997765332 23445567788
Q ss_pred CCcEEEccCCCCCc------cCccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCCc-----CCcC
Q 001143 165 CLTKLSVCHFSIRY------LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LPSG 228 (1141)
Q Consensus 165 ~L~~L~Ls~N~L~~------iP~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~~-----IP~~ 228 (1141)
.|+.|+|++|+|+. +...+..+++|+.|+|++|.|+ .+...+..+++|++|+|++|.|+. |-..
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 266 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHH
Confidence 99999999999873 2334677899999999999987 355678889999999999999983 2223
Q ss_pred ccC--CCCCCEEeCCCCCCCCCCcc----cc-cCCCCCCEEEccCCcCCC
Q 001143 229 LYL--LQRLENLDLSNNRLTSLGSL----DL-CLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 229 l~~--L~~L~~L~Ls~N~Lt~~~p~----~l-~~L~~L~~L~Ls~N~L~~ 271 (1141)
+.. ...|+.|+|++|+|+..... .+ .++++|+.|+|++|++..
T Consensus 267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 333 35799999999998753222 23 257899999999999976
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.4e-14 Score=143.27 Aligned_cols=106 Identities=17% Similarity=0.111 Sum_probs=65.6
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCCcCchh-hcCCCC
Q 001143 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE-VGNLLG 115 (1141)
Q Consensus 37 f~~l~~L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~-~~~L~~ 115 (1141)
|.+..+++.|||++|+|+.+ +..+.. +++|+.|+|++|.|++++ .|..+++|++|+|++|+|+.+|.. +..+++
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~---l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGAT---LDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGG---TTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred ccCcCcCcEEECCCCCCCcc-Cccccc---cccCCEEECCCCCCCccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 45666677777777777655 333333 367777777777777774 466777777777777777776554 345777
Q ss_pred CCEEEccCCCCCCCcc--cccCCCCCCEEECCCC
Q 001143 116 LECLQIKISSPGVNGF--ALNKLKGLKELELSKV 147 (1141)
Q Consensus 116 L~~L~Ls~N~l~~~~~--~~~~L~~L~~L~Ls~N 147 (1141)
|+.|+|++|++..++. .+..+++|++|++++|
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N 122 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSS
T ss_pred cccceeccccccccccccccccccccchhhcCCC
Confidence 7777777766655442 2344444444444443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=3.6e-13 Score=134.78 Aligned_cols=137 Identities=18% Similarity=0.116 Sum_probs=110.6
Q ss_pred CCCCCcEEEccCCCCCccCccccCCCCCCEEEccCC-cccccc-ccccCCCCCCEEEccCCCCCcCC-cCccCCCCCCEE
Q 001143 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN-KMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENL 238 (1141)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N-~L~~iP-~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~L 238 (1141)
.+...+.++++++++..+|..+..+++|+.|+|++| .|+.|+ ..|..+++|+.|+|++|+|+.|+ ..|..+++|+.|
T Consensus 6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 345567799999999999999999999999999876 599886 56889999999999999999995 557789999999
Q ss_pred eCCCCCCCCCCcccccCCCCCCEEEccCCcCCCCCCCchhhhhcccCCCCCCCCCCcccCcc
Q 001143 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1141)
Q Consensus 239 ~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~~~l~~~~n~l~~~~~ 300 (1141)
+|++|+|+.+++..|..+ +|+.|+|++|+|.|.|.+.+...|.. ........+.+.|..|
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~-~~~~~~~~~~~~C~~p 145 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEE-EGLGGVPEQKLQCHGQ 145 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHH-TTCSSCGGGCCCCSSS
T ss_pred eccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHH-hccCccCcCCcEECcC
Confidence 999999999998777655 79999999999999998766555443 3333333445555443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=8.8e-14 Score=152.72 Aligned_cols=218 Identities=16% Similarity=0.150 Sum_probs=122.4
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCcCCcEEEccCCCCC--cCchhhcCCCCCCEEEc
Q 001143 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN--LFPSEVGNLLGLECLQI 121 (1141)
Q Consensus 44 ~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt~iP~~l~~L~~L~~L~Ls~N~L~--~lP~~~~~L~~L~~L~L 121 (1141)
+.|||+++.+.... ++.+.. ..+..+.++...+...........+|++|||++|.++ .++.-+..+++|++|+|
T Consensus 3 ~~lDLs~~~l~~~~---l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLHPDV---TGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCCHHH---HHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCCchH---HHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 35677776664222 221100 1234555554444332233344456777777776665 24444566677777777
Q ss_pred cCCCCCC-CcccccCCCCCCEEECCCCC-CCCCcccchhhhcCCCCCcEEEccCC-CCC--ccCcccc-CCCCCCEEEcc
Q 001143 122 KISSPGV-NGFALNKLKGLKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHF-SIR--YLPPEIG-CLSNLEQLDLS 195 (1141)
Q Consensus 122 s~N~l~~-~~~~~~~L~~L~~L~Ls~N~-ln~~~~~lp~~l~~L~~L~~L~Ls~N-~L~--~iP~~l~-~l~~L~~L~Ls 195 (1141)
+++.+.. ....+..+++|++|+++++. ++. ..+...+.++++|+.|+++++ .++ .++..+. ..++|+.|+|+
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd--~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~ 156 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE--FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 156 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH--HHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccc--cccchhhHHHHhccccccccccccccccchhhhcccccccchhhhc
Confidence 7665432 22345666677777776631 210 112222345677777777764 444 2222232 23567777777
Q ss_pred CC--ccc--cccccccCCCCCCEEEccCC-CCC-cCCcCccCCCCCCEEeCCC-CCCCCCCcccccCCCCCCEEEccCC
Q 001143 196 FN--KMK--YLPTEICYLKALISLKVANN-KLV-ELPSGLYLLQRLENLDLSN-NRLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 196 ~N--~L~--~iP~~l~~l~~L~~L~Ls~N-~L~-~IP~~l~~L~~L~~L~Ls~-N~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
+. .++ .+..-+..+++|+.|+|++| .++ ..+..+.++++|+.|+|++ +.++......+.++++|+.|+++++
T Consensus 157 ~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 157 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 53 344 33334455777777777775 455 4456677777777777777 4666555556677777777777766
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.6e-14 Score=166.04 Aligned_cols=86 Identities=7% Similarity=0.065 Sum_probs=39.7
Q ss_pred CcccccCCCCCccccC----CCCCCCCCCCCEEEccCCCCCCCCccccc-CCC-CCCCccEEEeecCCCCc-----cCcc
Q 001143 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPLIESYG-NRG-GDNSVEGLYLYKNVLNL-----IPKS 86 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~----~~~f~~l~~L~~LdLs~N~Ls~~~p~~~~-~l~-~L~~L~~L~Ls~N~Lt~-----iP~~ 86 (1141)
+++.|.+..|.|+... ..++...++|+.|||++|+|+..-...+. .+. ...+|++|+|++|.|+. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 3445555555554322 12234555566666666655321101110 111 11345666666665542 2334
Q ss_pred ccCCcCCcEEEccCCCC
Q 001143 87 VGRYEKLRNLKFFGNEI 103 (1141)
Q Consensus 87 l~~L~~L~~L~Ls~N~L 103 (1141)
+..+++|++|+|++|.|
T Consensus 108 l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTSCTTCCEEECCSSBC
T ss_pred hhccccccccccccccc
Confidence 55555566666666554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=4.2e-15 Score=154.97 Aligned_cols=58 Identities=31% Similarity=0.280 Sum_probs=30.2
Q ss_pred CCcEEEccCCCCCccCccccCCCCCCEEEccCCcccccc--ccccCCCCCCEEEccCCCCC
Q 001143 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLV 223 (1141)
Q Consensus 165 ~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP--~~l~~l~~L~~L~Ls~N~L~ 223 (1141)
+|+.|++++|+|+.++ .+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|++.
T Consensus 94 ~L~~L~l~~N~i~~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 94 TLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HCCEEECSEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccccccccc-cccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 4555555555555543 2444555555555555555443 23455555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.34 E-value=2.1e-13 Score=153.06 Aligned_cols=232 Identities=15% Similarity=0.119 Sum_probs=171.6
Q ss_pred CcccccCCCCCccccC----CCCCCCCCCCCEEEccCCCCCCCC---cc----cccCCCCCCCccEEEeecCCCCc----
Q 001143 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPL---IE----SYGNRGGDNSVEGLYLYKNVLNL---- 82 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~----~~~f~~l~~L~~LdLs~N~Ls~~~---p~----~~~~l~~L~~L~~L~Ls~N~Lt~---- 82 (1141)
.++.|.+..|.|.... ...+...++|+.|+|+++.+.... +. .+..+..+++|+.|+|++|.++.
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccccc
Confidence 5788999999885533 245778899999999998665332 11 12233456899999999999974
Q ss_pred -cCccccCCcCCcEEEccCCCCCc-----Cch---------hhcCCCCCCEEEccCCCCCCCc-----ccccCCCCCCEE
Q 001143 83 -IPKSVGRYEKLRNLKFFGNEINL-----FPS---------EVGNLLGLECLQIKISSPGVNG-----FALNKLKGLKEL 142 (1141)
Q Consensus 83 -iP~~l~~L~~L~~L~Ls~N~L~~-----lP~---------~~~~L~~L~~L~Ls~N~l~~~~-----~~~~~L~~L~~L 142 (1141)
+...+...++|+.|+|++|.|+. +.. .....+.|+.|.+++|.++... ..+.....|+.|
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L 191 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred chhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccc
Confidence 33456678899999999999852 111 1245789999999999876433 346678899999
Q ss_pred ECCCCCCCCC--cccchhhhcCCCCCcEEEccCCCCCc-----cCccccCCCCCCEEEccCCcccc-----ccccccC--
Q 001143 143 ELSKVPPRPS--VLTLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICY-- 208 (1141)
Q Consensus 143 ~Ls~N~ln~~--~~~lp~~l~~L~~L~~L~Ls~N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~~-----iP~~l~~-- 208 (1141)
+|++|.+... ...+...+..+++|+.|+|++|.++. +...+..+++|++|+|++|.|+. +-..+..
T Consensus 192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~ 271 (344)
T d2ca6a1 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 271 (344)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred ccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhcc
Confidence 9999776432 11234457788999999999999873 34557788999999999999983 2233433
Q ss_pred CCCCCEEEccCCCCC-----cCCcCcc-CCCCCCEEeCCCCCCCCCC
Q 001143 209 LKALISLKVANNKLV-----ELPSGLY-LLQRLENLDLSNNRLTSLG 249 (1141)
Q Consensus 209 l~~L~~L~Ls~N~L~-----~IP~~l~-~L~~L~~L~Ls~N~Lt~~~ 249 (1141)
.+.|+.|+|++|+|+ .+...+. ++++|+.|+|++|++....
T Consensus 272 ~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 467999999999997 2455553 5788999999999998654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=5.4e-13 Score=146.29 Aligned_cols=221 Identities=19% Similarity=0.163 Sum_probs=143.5
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC--ccCccccCCcCCcEEEccCCCCC-cCchhhcCCCCCCEE
Q 001143 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN--LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL 119 (1141)
Q Consensus 43 L~~LdLs~N~Ls~~~p~~~~~l~~L~~L~~L~Ls~N~Lt--~iP~~l~~L~~L~~L~Ls~N~L~-~lP~~~~~L~~L~~L 119 (1141)
+..+.++...+...+...+ ...+|++|+|+++.++ .++.-+..+++|++|+|++|.++ ..+..++.+++|+.|
T Consensus 25 ~~~lrl~~~~~~~~~~~~~----~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 100 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAEHF----SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100 (284)
T ss_dssp CSEEECTTCEECSCCCSCC----CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ceEeeccccccccchhhhc----cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCc
Confidence 4566666665554333222 2357888888888776 24445677888888888888887 556678888888888
Q ss_pred EccCCC-CCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhc-CCCCCcEEEccCC--CCC--ccCccccCCCCCCE
Q 001143 120 QIKISS-PGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIA-GLKCLTKLSVCHF--SIR--YLPPEIGCLSNLEQ 191 (1141)
Q Consensus 120 ~Ls~N~-l~~~~--~~~~~L~~L~~L~Ls~N~ln~~~~~lp~~l~-~L~~L~~L~Ls~N--~L~--~iP~~l~~l~~L~~ 191 (1141)
+|+++. ++..+ ....++++|++|++++...- ....+...+. ..++|+.|+++++ .++ .+..-+..+++|+.
T Consensus 101 ~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~-~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~ 179 (284)
T d2astb2 101 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF-TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179 (284)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTC-CHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE
T ss_pred cccccccccccccchhhHHHHhcccccccccccc-ccccchhhhcccccccchhhhcccccccccccccccccccccccc
Confidence 888753 55332 23456888888888873210 1112222333 3467888888864 444 23333456788999
Q ss_pred EEccCC-ccc-cccccccCCCCCCEEEccCC-CCC-cCCcCccCCCCCCEEeCCCCCCCCCCcccccCCCCCCEEEccCC
Q 001143 192 LDLSFN-KMK-YLPTEICYLKALISLKVANN-KLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 192 L~Ls~N-~L~-~iP~~l~~l~~L~~L~Ls~N-~L~-~IP~~l~~L~~L~~L~Ls~N~Lt~~~p~~l~~L~~L~~L~Ls~N 267 (1141)
|+|++| .++ ..+..+..+++|++|+|+++ .++ .....++++++|+.|+++++--.+..+.....+++|+ +..+
T Consensus 180 L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~---i~~~ 256 (284)
T d2astb2 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCS 256 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSE---ESCC
T ss_pred cccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcccc---ccCc
Confidence 999885 466 45677888899999999984 676 3455678889999999988722222222223456654 4666
Q ss_pred cCCC
Q 001143 268 KLLS 271 (1141)
Q Consensus 268 ~L~~ 271 (1141)
+++.
T Consensus 257 ~ls~ 260 (284)
T d2astb2 257 HFTT 260 (284)
T ss_dssp CSCC
T ss_pred cCCC
Confidence 6665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=1.8e-14 Score=150.11 Aligned_cols=141 Identities=20% Similarity=0.123 Sum_probs=87.9
Q ss_pred ccEEEeecC--CCCccCccccCCcCCcEEEccCCCCCcCchhhcCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001143 70 VEGLYLYKN--VLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1141)
Q Consensus 70 L~~L~Ls~N--~Lt~iP~~l~~L~~L~~L~Ls~N~L~~lP~~~~~L~~L~~L~Ls~N~l~~~~~~~~~L~~L~~L~Ls~N 147 (1141)
++.++|+++ .++.+|..|..|++|+.|+|++|+|+.++ .|.+|++|+.|+|++|.++.++..+..+++|+.|++++|
T Consensus 25 ~~~~~l~~~~~~i~~l~~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N 103 (198)
T d1m9la_ 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYN 103 (198)
T ss_dssp CSCEECCBCCTTCCCCHHHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEE
T ss_pred cceeeeecccCchhhhhhHHhcccccceeECcccCCCCcc-cccCCccccChhhcccccccccccccccccccccccccc
Confidence 344444443 24455555566666666666666666554 355566666666666665555544444555666666665
Q ss_pred CCCCCcccchhhhcCCCCCcEEEccCCCCCccCc--cccCCCCCCEEEccCCcccccccc-----------ccCCCCCCE
Q 001143 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGCLSNLEQLDLSFNKMKYLPTE-----------ICYLKALIS 214 (1141)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~iP~--~l~~l~~L~~L~Ls~N~L~~iP~~-----------l~~l~~L~~ 214 (1141)
.+.. + ..+..+++|+.|++++|+|+.++. .+..+++|+.|+|++|.+...+.. +..+++|+.
T Consensus 104 ~i~~----l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~ 178 (198)
T d1m9la_ 104 QIAS----L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178 (198)
T ss_dssp ECCC----H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCE
T ss_pred cccc----c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCE
Confidence 5432 2 236667788888888888887753 578888999999999988744322 345666666
Q ss_pred EE
Q 001143 215 LK 216 (1141)
Q Consensus 215 L~ 216 (1141)
||
T Consensus 179 LD 180 (198)
T d1m9la_ 179 LD 180 (198)
T ss_dssp ES
T ss_pred eC
Confidence 65
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=1e-13 Score=159.10 Aligned_cols=107 Identities=12% Similarity=0.098 Sum_probs=81.4
Q ss_pred CcccccCCCCCccccC-CCCCCCCCCCCEEEccCCCCCCC----CcccccCCCCCCCccEEEeecCCCCc-----cCccc
Q 001143 18 IKEKLPSEANKINNEK-NGSVNDDDDDSVIDVSGKTVDFP----LIESYGNRGGDNSVEGLYLYKNVLNL-----IPKSV 87 (1141)
Q Consensus 18 ~l~~L~~~~N~i~~i~-~~~f~~l~~L~~LdLs~N~Ls~~----~p~~~~~l~~L~~L~~L~Ls~N~Lt~-----iP~~l 87 (1141)
+++.|++..|+|+... ...+..++++++|+|++|+|+.. +...+ ..+++|++|+|++|.|+. +...+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L---~~~~~L~~LdLs~N~i~~~~~~~l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL---RVNPALAELNLRSNELGDVGVHCVLQGL 79 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHH---HTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHH---hcCCCCCEEECcCCcCChHHHHHHHHHH
Confidence 5788999999998865 34467788999999999998732 22333 345899999999999973 23333
Q ss_pred c-CCcCCcEEEccCCCCCc-----CchhhcCCCCCCEEEccCCCCC
Q 001143 88 G-RYEKLRNLKFFGNEINL-----FPSEVGNLLGLECLQIKISSPG 127 (1141)
Q Consensus 88 ~-~L~~L~~L~Ls~N~L~~-----lP~~~~~L~~L~~L~Ls~N~l~ 127 (1141)
. ...+|+.|+|++|+|+. ++..+..+++|+.|+|++|.++
T Consensus 80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred hcCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 3 23479999999999973 4667888999999999998754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=1e-10 Score=116.61 Aligned_cols=105 Identities=22% Similarity=0.273 Sum_probs=80.2
Q ss_pred CCCEEECCCCCCCCCcccchhhhcCCCCCcEEEccCC-CCCccCc-cccCCCCCCEEEccCCcccccc-ccccCCCCCCE
Q 001143 138 GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALIS 214 (1141)
Q Consensus 138 ~L~~L~Ls~N~ln~~~~~lp~~l~~L~~L~~L~Ls~N-~L~~iP~-~l~~l~~L~~L~Ls~N~L~~iP-~~l~~l~~L~~ 214 (1141)
....++++++.+ ...|..+..+++|+.|++.+| .|+.|+. .|..+++|+.|+|++|+|+.|+ .+|..+++|++
T Consensus 9 ~~~~l~c~~~~~----~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 9 GSSGLRCTRDGA----LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp SSSCEECCSSCC----CTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CCCeEEecCCCC----ccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 344555555332 244556667788888888765 5887754 5788889999999999998884 56888889999
Q ss_pred EEccCCCCCcCCcCccCCCCCCEEeCCCCCCC
Q 001143 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1141)
Q Consensus 215 L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~Lt 246 (1141)
|+|++|+|+.||..+....+|+.|+|++|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhccccccccccCCCccc
Confidence 99999999988888777667899999999885
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=5.5e-09 Score=104.32 Aligned_cols=63 Identities=25% Similarity=0.237 Sum_probs=26.9
Q ss_pred CCCCCEEEccCCccccc---cccccCCCCCCEEEccCCCCCcCCc-CccCCCCCCEEeCCCCCCCCC
Q 001143 186 LSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSL 248 (1141)
Q Consensus 186 l~~L~~L~Ls~N~L~~i---P~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lt~~ 248 (1141)
+++|++|+|++|+|+.+ +..+..+++|+.|+|++|.|+.++. ......+|+.|+|++|.++..
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence 44444444444444433 1223344444444444444444432 111223345555555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.14 E-value=6e-08 Score=96.56 Aligned_cols=104 Identities=25% Similarity=0.166 Sum_probs=78.5
Q ss_pred CCcEEEccCCCCCccCccccCCCCCCEEEccCCccccccccccCCCCCCEEEccCCCCCcCC---cCccCCCCCCEEeCC
Q 001143 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP---SGLYLLQRLENLDLS 241 (1141)
Q Consensus 165 ~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~iP~~l~~l~~L~~L~Ls~N~L~~IP---~~l~~L~~L~~L~Ls 241 (1141)
..+.|+++++.. .| .+..+..+..|.+.+|.+..++.....+++|++|+|++|+|+.++ ..+..+++|+.|+|+
T Consensus 23 ~~~~Ldls~l~~--~~-~l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls 99 (162)
T d1koha1 23 SQQALDLKGLRS--DP-DLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS 99 (162)
T ss_dssp SSCCBCCCCCSS--CT-TTTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCT
T ss_pred hhCeeecccCCC--Cc-hhhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccc
Confidence 345566665442 22 344555566666666666666656667999999999999999774 445679999999999
Q ss_pred CCCCCCCCcccccCCCCCCEEEccCCcCCC
Q 001143 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1141)
Q Consensus 242 ~N~Lt~~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1141)
+|+|+.+.+..+.....|+.|+|++|+++.
T Consensus 100 ~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 100 GNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp TSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cCccccchhhhhhhccccceeecCCCCcCc
Confidence 999999887666666789999999999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.86 E-value=2.5e-05 Score=82.22 Aligned_cols=86 Identities=9% Similarity=0.056 Sum_probs=56.4
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEecCCC
Q 001143 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1141)
Q Consensus 805 ~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~~~~ 883 (1141)
++.|++.+..+.++.+.||+....+..+.+|+..-..... .. .+.+|...+..+. +--+.+++++...++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~----~~----~~~~E~~~l~~l~~~vpvP~vl~~~~~~~- 83 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT----TY----DVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS----TT----CHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc----hh----hHHHHHHHHHHHhccCCCCcEEEEEecCC-
Confidence 3466777776666667899998777778888753221111 11 2367888887774 444677777765443
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHH
Q 001143 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKN 912 (1141)
Q Consensus 884 ~~~~~g~~~~~~~~~~LVmEy~~ggSL~~ 912 (1141)
..++||++++|.++.+
T Consensus 84 -------------~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 84 -------------WSNLLMSEADGVLCSE 99 (263)
T ss_dssp -------------EEEEEEECCSSEEHHH
T ss_pred -------------ceEEEEEecccccccc
Confidence 3489999999877654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.43 E-value=4.2e-05 Score=75.75 Aligned_cols=106 Identities=17% Similarity=0.191 Sum_probs=65.0
Q ss_pred CCCCCcEEEccCC-CCCc-----cCccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCCc-----C
Q 001143 162 GLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----L 225 (1141)
Q Consensus 162 ~L~~L~~L~Ls~N-~L~~-----iP~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~~-----I 225 (1141)
+.+.|+.|+|+++ .++. +-..+...++|+.|+|++|.|+ .+-..+...+.|+.|+|++|.|+. |
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456677777653 3441 1223455566777777777776 223345556777888888887762 2
Q ss_pred CcCccCCCCCCEEeCCCCCCCCCCc-------ccccCCCCCCEEEccCC
Q 001143 226 PSGLYLLQRLENLDLSNNRLTSLGS-------LDLCLMHNLQNLNLQYN 267 (1141)
Q Consensus 226 P~~l~~L~~L~~L~Ls~N~Lt~~~p-------~~l~~L~~L~~L~Ls~N 267 (1141)
-..+...++|+.|+|++|++..+.. ..+..-++|+.|+++.+
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 3445566778888888887665432 22344577888888765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.37 E-value=6.9e-05 Score=74.13 Aligned_cols=37 Identities=16% Similarity=0.177 Sum_probs=17.1
Q ss_pred CCccEEEeecCCCCc-----cCccccCCcCCcEEEccCCCCC
Q 001143 68 NSVEGLYLYKNVLNL-----IPKSVGRYEKLRNLKFFGNEIN 104 (1141)
Q Consensus 68 ~~L~~L~Ls~N~Lt~-----iP~~l~~L~~L~~L~Ls~N~L~ 104 (1141)
+.|++|+|++|.|+. +-..+...+.|+.|+|++|.|+
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 445555555555541 1122333344555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.71 E-value=0.00023 Score=69.87 Aligned_cols=110 Identities=14% Similarity=0.096 Sum_probs=63.8
Q ss_pred hcCCCCCcEEEccC-CCCCc-----cCccccCCCCCCEEEccCCccc-----cccccccCCCCCCEEEccCCCCC-----
Q 001143 160 IAGLKCLTKLSVCH-FSIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV----- 223 (1141)
Q Consensus 160 l~~L~~L~~L~Ls~-N~L~~-----iP~~l~~l~~L~~L~Ls~N~L~-----~iP~~l~~l~~L~~L~Ls~N~L~----- 223 (1141)
..+.+.|+.|+|++ +.|+. +-..+...++|+.|+|++|.|+ .|-..+...+.|+.|++++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34556677777765 44541 1223445667777777777765 22234555667777777777775
Q ss_pred cCCcCccCCCCCCEEeC--CCCCCCCCC----cccccCCCCCCEEEccCCcC
Q 001143 224 ELPSGLYLLQRLENLDL--SNNRLTSLG----SLDLCLMHNLQNLNLQYNKL 269 (1141)
Q Consensus 224 ~IP~~l~~L~~L~~L~L--s~N~Lt~~~----p~~l~~L~~L~~L~Ls~N~L 269 (1141)
.|-..+...++|+.++| ++|.+.... ...+...++|+.|+++.|..
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 23355566667776544 455664321 22344667778887776643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.70 E-value=0.0012 Score=68.54 Aligned_cols=73 Identities=12% Similarity=0.074 Sum_probs=44.3
Q ss_pred eecccCc-eEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC--CCCccceeeeEecCCCCCCCC
Q 001143 813 EAGKSVS-SSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSAD 888 (1141)
Q Consensus 813 ~LG~Gsf-G~Vy~a~~~~-~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkllg~~~~~~~~~~~~ 888 (1141)
.+..|.+ +.||+....+ ..+.+|+..... ... +..|+..++.+. .-.+.+++++..+.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~~----l~~E~~~l~~L~~~gvpvP~v~~~~~~~~------ 79 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNE----LQDEAARLSWLATTGVPCAAVLDVVTEAG------ 79 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSC----HHHHHHHHHHHHTTTCCBCCEEEEEECSS------
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------HhH----HHHHHHHHHHHHhcCCCCCceeeeccccc------
Confidence 4455554 6789988754 446677643211 111 256788777663 334667777665433
Q ss_pred CCCccccceEEEEEeeccCCCH
Q 001143 889 GNPEHHLLQSAIFMEYVKGGSV 910 (1141)
Q Consensus 889 g~~~~~~~~~~LVmEy~~ggSL 910 (1141)
..++||+|++|.++
T Consensus 80 --------~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 80 --------RDWLLLGEVPGQDL 93 (255)
T ss_dssp --------CEEEEEECCSSEET
T ss_pred --------ceEEEEEeeecccc
Confidence 24899999987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.69 E-value=0.001 Score=74.60 Aligned_cols=29 Identities=21% Similarity=0.287 Sum_probs=25.0
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeecccccc
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~~ 984 (1141)
.++|||+.|.|||++++ .++|+||..|..
T Consensus 224 ~LiHGDl~~gNIlv~~~--------~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--------ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--------CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--------ceEEechhhccc
Confidence 58999999999999865 489999998753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.53 E-value=0.00046 Score=67.61 Aligned_cols=85 Identities=15% Similarity=0.167 Sum_probs=46.2
Q ss_pred CCCCCCCEEEccC-CCCCCCCc-ccccCCCCCCCccEEEeecCCCCc-----cCccccCCcCCcEEEccCCCCC-----c
Q 001143 38 NDDDDDSVIDVSG-KTVDFPLI-ESYGNRGGDNSVEGLYLYKNVLNL-----IPKSVGRYEKLRNLKFFGNEIN-----L 105 (1141)
Q Consensus 38 ~~l~~L~~LdLs~-N~Ls~~~p-~~~~~l~~L~~L~~L~Ls~N~Lt~-----iP~~l~~L~~L~~L~Ls~N~L~-----~ 105 (1141)
.+.++|+.|+|++ |.|+...- .....+...+.|++|+|++|.|+. |-..+...+.|+.|++++|.++ .
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456777777776 44542211 122223344667777777776652 2223445566777777777765 2
Q ss_pred CchhhcCCCCCCEEEcc
Q 001143 106 FPSEVGNLLGLECLQIK 122 (1141)
Q Consensus 106 lP~~~~~L~~L~~L~Ls 122 (1141)
+-..+...++|+.++|+
T Consensus 94 l~~~l~~~~~L~~l~L~ 110 (166)
T d1io0a_ 94 LVEALQSNTSLIELRID 110 (166)
T ss_dssp HHHGGGGCSSCCEEECC
T ss_pred HHHHHHhCccccEEeec
Confidence 23445555666655553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.91 E-value=0.037 Score=58.90 Aligned_cols=35 Identities=17% Similarity=0.094 Sum_probs=24.9
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEe
Q 001143 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRT 838 (1141)
Q Consensus 804 ~~~~y~i~~~LG~GsfG~Vy~a~~~~~~vAvKI~~ 838 (1141)
.+....-.+.|..|.--+.|+.+..+..+++|++.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~ 50 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYE 50 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESSCCEEEEEEC
T ss_pred CCCCceEeecCCCCcccCeEEEEECCCcEEEEEcC
Confidence 34455666778889889999999888889999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.51 E-value=0.032 Score=61.79 Aligned_cols=70 Identities=17% Similarity=0.270 Sum_probs=45.2
Q ss_pred eeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHhhCC-CCCccceeeeEec
Q 001143 811 CDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1141)
Q Consensus 811 ~~~LG~GsfG~Vy~a~~~~---------~~vAvKI~~l~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkllg~~~~ 880 (1141)
++.|+.|-.-.+|++.... ..+.+++.- . ... .. +. .+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~--~i-dr----~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PET--ES-HL----VAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCC--HH-HH----HHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cch--hh-HH----HHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 3678889999999998642 335555542 1 111 11 11 47888888885 5445677777642
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCC
Q 001143 881 SKWLPSADGNPEHHLLQSAIFMEYVKGG 908 (1141)
Q Consensus 881 ~~~~~~~~g~~~~~~~~~~LVmEy~~gg 908 (1141)
++||||++|.
T Consensus 117 ------------------g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ------------------GRLEEYIPSR 126 (395)
T ss_dssp ------------------EEEECCCCEE
T ss_pred ------------------ceEEEEeccc
Confidence 7899999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.02 E-value=0.048 Score=58.63 Aligned_cols=27 Identities=30% Similarity=0.288 Sum_probs=22.6
Q ss_pred CccccCCCCCCeeeecccccCCCCCeEEEeeccccc
Q 001143 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 983 (1141)
Q Consensus 948 gIvHrDLKP~NILld~~~~~~~~~~~vKL~DFGlA~ 983 (1141)
++||+|+.+.|||++.+ ..++||+-|.
T Consensus 193 ~liHgDlh~~NvL~~~~---------~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG---------PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS---------EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC---------ceEEechhcc
Confidence 68999999999999743 4579999874
|